PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sharma, V; Roy, S; Sekler, I; O'Halloran, DM				Sharma, Vishal; Roy, Soumitra; Sekler, Israel; O'Halloran, Damien M.			The NCLX-type Na+/Ca2+ Exchanger NCX-9 Is Required for Patterning of Neural Circuits in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON GUIDANCE; CALCIUM EXCHANGE; PIONEER AXONS; SODIUM; UNC-5; MIGRATIONS; NEURONS; CELLS; CONE	NCLX is a Na+/Ca2+ exchanger that uses energy stored in the transmembrane sodium gradient to facilitate the exchange of sodium ions for ionic calcium. Mammals have a single NCLX, which has been shown to function primarily at the mitochondrion and is an important regulator of neuronal physiology by contributing to neurotransmission and synaptic plasticity. The role of NCLX in developmental cell patterning (e.g. in neural circuits) is largely unknown. Here we describe a novel role for the Caenorhabditis elegans NCLX- type protein, NCX- 9, in neural circuit formation. NCX-9 functions in hypodermal seam cells that secrete the axon guidance cue UNC-129/ BMP, and our data revealed that ncx-9(-/-) mutant animals exhibit development defects in stereotyped left/right axon guidance choices within the GABAergic motor neuron circuit. Our data also implicate NCX-9 in a LON-2/heparan sulfate and UNC-6/netrin-mediated, RAC-dependent signaling pathway to guide left/ right patterning within this circuit. Finally, we also provide in vitro physiology data supporting the role for NCX-9 in handling calcium exchange at the mitochondrion. Taken together, our work reveals the specificity by which the handling by NCLX of calcium exchange can map to neural circuit patterning and axon guidance decisions during development.	[Sharma, Vishal; O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA; [Sharma, Vishal; O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA; [Roy, Soumitra; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-8499000 Beer Sheva, Israel	George Washington University; George Washington University; Ben Gurion University	O'Halloran, DM (corresponding author), George Washington Univ, Dept Biol Sci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA.; O'Halloran, DM (corresponding author), George Washington Univ, Inst Neurosci, 636 Ross Hall,2300 1 St NW, Washington, DC 20052 USA.	damienoh@gwu.edu		Sekler, Israel/0000-0002-7550-1550	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Anthony LaMantia and members of the O'Halloran laboratory for critical reading of the manuscript. We also thank David Sherwood, Piali Sengupta, Oliver Hobert, Sally Moody, Mary Ann Stepp, and John Hawdon for support and advice at various stages of the project. We thank Theresa Stiernagle and Aric Daul (Caenorhabditis Genetics Center (CGC), supported by National Institutes of Health Office of Research Infrastructure Programs Grant P40 OD010440) for the strains used. We also thank Eric Lundquist and Eric Struckhoff for kindly supplying mutant strains. We thank Anastas Popratiloff for imaging advice.	Ackley BD, 2014, DEV NEUROBIOL, V74, P781, DOI 10.1002/dneu.22146; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Blanchette CR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006525; Blanchette CR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002183; Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; BRENNER S, 1974, GENETICS, V77, P71; Broadbent ID, 2002, CURR BIOL, V12, P59, DOI 10.1016/S0960-9822(01)00624-8; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Canitano A, 2002, ANN NY ACAD SCI, V976, P394; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Firnhaber C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003921; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Gysi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074908; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Huang X, 2003, DEVELOPMENT, V130, P3147, DOI 10.1242/dev.00518; Hutter H, 2005, DEV BIOL, V284, P260, DOI 10.1016/j.ydbio.2005.05.025; LI ZP, 1994, J BIOL CHEM, V269, P17434; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; Mei D, 2004, EXP CELL RES, V301, P84, DOI 10.1016/j.yexcr.2004.08.017; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Norris AD, 2014, DEVELOPMENT, V141, P4395, DOI 10.1242/dev.110437; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Sharma V, 2013, GENETICS, V195, P611, DOI 10.1534/genetics.113.153106; Sheng JZ, 2000, BIOPHYS J, V79, P1945, DOI 10.1016/S0006-3495(00)76443-5; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	34	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5364	5377		10.1074/jbc.M116.758953	http://dx.doi.org/10.1074/jbc.M116.758953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196860	Green Published, hybrid			2022-12-26	WOS:000397875500018
J	Vaughan, JA; Turell, MJ				Vaughan, Jefferson A.; Turell, Michael J.			Brugia malayi microfilariae transport alphaviruses across the mosquito midgut	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; HEPARAN-SULFATE BINDING; AEDES-AEGYPTI; PAHANGI MICROFILARIAE; ENCEPHALOMYELITIS VIRUS; INCREASED DISSEMINATION; EXSHEATHMENT; VECTOR; TRANSMISSION; CULICIDAE	Concurrent ingestion of microfilariae (MF) and arboviruses by mosquitoes can enhance mosquito transmission of virus compared to when virus is ingested alone. Within hours of being ingested, MF penetrate the mosquito midgut and introduce virus into mosquito hemocoel, creating a disseminated viral infection much sooner than normal. How virus is actually introduced is not known. In this report, we present experimental evidence that suggests that certain alphaviruses may adhere or otherwise associate with sheathed Brugia malayi MF in the blood of a dually-infected host and that the virus is carried into the mosquito hemocoel by the MF during their penetration of the mosquito midgut. The mechanism of MF enhancement may be more complex than simple leakage of viremic blood into the hemocoel during MF penetration. The affinity of arboviruses to adhere to or otherwise associate with MF may depend on the specific combination of the virus and MF involved in a dual host infection. This in turn may determine the relative importance that MF enhancement has within an arbovirus transmission system.	[Vaughan, Jefferson A.; Turell, Michael J.] US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Vaughan, Jefferson A.] Univ North Dakota, Dept Biol, Grand Forks, ND 58201 USA; [Turell, Michael J.] 7217 Ridge Rd, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; University of North Dakota Grand Forks	Vaughan, JA (corresponding author), US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.; Vaughan, JA (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58201 USA.	Jefferson.vaughan@email.und.edu	Turell, Michael/ABE-1826-2020	Turell, Michael/0000-0003-1902-7740; Vaughan, Jefferson/0000-0002-7067-0654	National Research Council; NIAID grant [R21AI105662]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105662] Funding Source: NIH RePORTER	National Research Council; NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All experimental work was conducted while JAV was a research associated funded by the National Research Council. Additional data analysis was supported by NIAID grant R21AI105662 (JAV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUDELOSILVA F, 1985, J INVERTEBR PATHOL, V45, P117, DOI 10.1016/0022-2011(85)90058-8; ASH LR, 1964, J PARASITOL, V50, P119, DOI 10.2307/3276044; BAIN O, 1972, Annales de Parasitologie Humaine et Comparee, V47, P399; CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103; CHEN CC, 1988, ANN TROP MED PARASIT, V82, P201, DOI 10.1080/00034983.1988.11812229; CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478; CHRISTENSEN BM, 1987, J INVERTEBR PATHOL, V49, P14, DOI 10.1016/0022-2011(87)90120-0; DAVIS NL, 1989, VIROLOGY, V171, P189, DOI 10.1016/0042-6822(89)90526-6; de Thoisy B, 2001, AM J PRIMATOL, V54, P1, DOI 10.1002/ajp.1008; Gardner CL, 2013, J VIROL, V87, P8582, DOI 10.1128/JVI.00937-13; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; GARGAN TP, 1983, AM J TROP MED HYG, V32, P1154, DOI 10.4269/ajtmh.1983.32.1154; GRANATH WO, 1980, POULTRY SCI, V59, P996, DOI 10.3382/ps.0590996; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Highby Paul R., 1943, JOUR PARASITOL, V29, P253, DOI 10.2307/3272756; Highby PR, 1943, J PARASITOL, V29, P243; Intakhan N, 2014, PARASITOL RES, V113, P4141, DOI 10.1007/s00436-014-4086-3; Jariyapan N, 2013, PARASITOL RES, V112, P2431, DOI 10.1007/s00436-013-3404-5; KRAMER LD, 1981, AM J TROP MED HYG, V30, P190, DOI 10.4269/ajtmh.1981.30.190; Laaksonen S, 2009, PARASITOL RES, V104, P257, DOI 10.1007/s00436-008-1184-0; Laurence B. R., 1961, Journal of Helminthology, V35, P285, DOI 10.1017/S0022149X00004661; MELLOR PS, 1980, ANN TROP MED PARASIT, V74, P463, DOI 10.1080/00034983.1980.11687368; MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985; OWEN RR, 1977, T ROY SOC TROP MED H, V71, P110; OWEN RR, 1978, ANN TROP MED PARASIT, V72, P567, DOI 10.1080/00034983.1978.11719362; Paredes A, 2001, J VIROL, V75, P9532, DOI 10.1128/JVI.75.19.9532-9537.2001; PERRONE JB, 1986, J PARASITOL, V72, P723, DOI 10.2307/3281463; RAMACHANDRAN C. P., 1966, J MED ENTOMOL, V3, P239, DOI 10.1093/jmedent/3.3-4.239; ROBINSON EJ, 1955, J PARASITOL, V41, P209, DOI 10.2307/3273794; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; SOUSA OE, 1974, AM J TROP MED HYG, V23, P862, DOI 10.4269/ajtmh.1974.23.862; STABLER RM, 1961, J PARASITOL, V47, P413, DOI 10.2307/3275367; TURELL MJ, 1987, AM J TROP MED HYG, V37, P197, DOI 10.4269/ajtmh.1987.37.197; TURELL MJ, 1984, SCIENCE, V225, P1039, DOI 10.1126/science.6474165; Vaughan JA, 1996, AM J TROP MED HYG, V54, P105, DOI 10.4269/ajtmh.1996.54.105; Vaughan JA, 1999, J MED ENTOMOL, V36, P758, DOI 10.1093/jmedent/36.6.758; Vaughan JA, 2012, J MED ENTOMOL, V49, P1430, DOI 10.1603/ME12103; Vaughan JA, 2009, AM J TROP MED HYG, V80, P44, DOI 10.4269/ajtmh.2009.80.44; WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391; WEINMANN C J, 1973, Journal of Wildlife Diseases, V9, P213; ZYTOON EM, 1993, AM J TROP MED HYG, V49, P201, DOI 10.4269/ajtmh.1993.49.201	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172309	10.1371/journal.pone.0172309	http://dx.doi.org/10.1371/journal.pone.0172309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222120	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800049
J	Vluggen, C; Soetaert, K; Groenen, G; Wanlin, M; Spitaels, M; de Onate, WA; Fauville-Dufaux, M; Saegerman, C; Mathys, V				Vluggen, Christelle; Soetaert, Karine; Groenen, Guido; Wanlin, Maryse; Spitaels, Martine; de Onate, Wouter Arrazola; Fauville-Dufaux, Maryse; Saegerman, Claude; Mathys, Vanessa			Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010-2013	PLOS ONE			English	Article							MIRU-VNTRPLUS; IDENTIFICATION; SURVEILLANCE; NETHERLANDS	The tuberculosis (TB) incidence rate in Brussels-Capital Region is 3-fold higher than in Belgium as a whole. Eight years after the realization of initial prospective population-based molecular epidemiology investigations in this Region, a similar study over the period 2010-2013 was conducted. TB strains isolated from 945 patients were submitted to genotyping by standardized 24-locus-MIRU-VNTR typing and spoligotyping. The phylogenetic analysis showed that the LAM (16.7%) and Haarlem (15.7%) branches are the two most prevalent TB lineages circulating in Brussels. Analysis of the MDR subgroup showed an association with Beijing strains (39.9%) and patients native of Eastern Europe (40.7%). Genotyping detected 113 clusters involving 321 patients, giving a recent transmission index of 22.9%. Molecular-guided epidemiological investigations and routine surveillance activities revealed family transmission or social contact for patients distributed over 34 clusters. Most of the patients were foreign-born (75.7%). However, cluster analysis revealed only limited transnational transmission. Comparison with the previous study shows a stable epidemiological situation except for the mean age difference between Belgian-born and foreign-born patients which has disappeared. This study confirms that molecular epidemiology has become an important determinant for TB control programs. However, sufficient financial means need to be available to perform all required epidemiological investigations.	[Vluggen, Christelle; Soetaert, Karine; Fauville-Dufaux, Maryse; Mathys, Vanessa] Sci Inst Publ Hlth WIV ISP, Operat Direct Communicable & Infect Dis, Bacterial Dis Serv, Brussels, Belgium; [Groenen, Guido; Wanlin, Maryse; Spitaels, Martine; de Onate, Wouter Arrazola] Belgian Lung & TB Assoc, Brussels, Belgium; [Saegerman, Claude] Fundamental & Appl Res Anim & Hlth FARAH Ctr, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Liege, Belgium		Mathys, V (corresponding author), Sci Inst Publ Hlth WIV ISP, Operat Direct Communicable & Infect Dis, Bacterial Dis Serv, Brussels, Belgium.	vmathys@wiv-isp.be		Saegerman, Claude/0000-0001-9087-7436	European Community [FP7-223681]; Belgian Ministry of Social Affairs through Health Insurance System	European Community(European Commission); Belgian Ministry of Social Affairs through Health Insurance System	The study was supported by the European Community Seventh Framework Programme (FP7/2007-2013), Grant FP7-223681 Tuberculosis Pan European Network (TB PAN-NET). The National Reference Center is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. C.V. was a fellow of the RP/PJ WIV-ISP (TYPTUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C., 2007, MARQUEURS GE NE TIQU; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253; Cardoso OM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018256, DOI 10.1371/JOURNAL.PONE.0018256]; de Beer J, 2014, EURO SURVEILL, V19; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; de Colombani P, 2015, PUBLIC HEALTH ACTION, V5, P194, DOI 10.5588/pha.15.0026; Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413; FARES, 2016, REG TUB 2015; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Groenen G., 2015, EENDRACHTSTRAAT, V56; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Martiniello M, 2013, REV EUROPE ENNE MIGR, V29, P7; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Sandgren A, 2014, EUR RESPIR J, V43, P1159, DOI 10.1183/09031936.00117213; SMALL PM, 1993, J CLIN MICROBIOL, V31, P1677, DOI 10.1128/JCM.31.7.1677-1682.1993; Stoffels K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063128; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation, 2015, WHOHTMTB201613	29	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172554	10.1371/journal.pone.0172554	http://dx.doi.org/10.1371/journal.pone.0172554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222189	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800066
J	Wang, ZQ; Ma, YN; Liu, F; Chen, LJ; Gao, RT; Zhang, W				Wang, Zhiqiang; Ma, Younan; Liu, Fan; Chen, Linjie; Gao, Ruitong; Zhang, Wei			Autoantibodies against mono-and trimethylated lysine display similar but also distinctive characteristics	PLOS ONE			English	Article							ZONE B-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NEUTROPHIL EXTRACELLULAR TRAPS; MARGINAL ZONE; IGM ANTIBODIES; NATURAL IGM; ACTIVATION; NEPHRITIS; ANTIGEN; MICE	Autoantibodies can be either harmful or beneficial to the body. The beneficial autoantibodies play important roles in immunosurveillance, clearance of body waste and maintenance of immune homeostasis. Despite their importance, however, people's knowledge on the protective autoantibodies is still very limited. In the current study, we examined two autoantibodies that recognized epitopes with only one amino acid. One was against mono-methylated lysine (Kme) and the other was against tri-methylated lysine (Kme3). We found that the antibodies were highly specific and not polyreactive. They did not cross-react each other. Although antiKme antibodies were IgM only, a large proportion of the anti-Kme3 antibodies were switched to the IgG isotype. Mass spectrometric analysis showed that both of the antibodies were mainly derived from IGHV 3-7 and/or IGHV3-74 germ line genes with conserved CDR2. De novo sequencing showed that there was a mutation at either of the SS positions on the CDR1 region, which changed one of the serine residues to a basic amino acid, i. e., arginine or lysine. We also found that neither of the antibodies was expressed at birth, and their earliest appearance was approximately 5 months after birth. All healthy human beings expressed the antibodies when they reached age two and maintained the expression thereafter throughout their life. Patients with systemic lupus erythematosus had lower levels of the IgM isotype antibodies. Serum levels of the two IgM antibodies were closely correlated, implying that they were produced by cells from the same B cell subset. We also found that both anti-Kme and antiKme3 antibodies could bind and might take part in the clearance of neutrophil extracellular traps released from activated cells. In conclusion, although anti-Kme and anti-Kme3 antibodies share many similarities in their origins, they are different antibodies and have different characteristics.	[Wang, Zhiqiang; Ma, Younan; Zhang, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Immunol,Peking Union Med Coll, Beijing, Peoples R China; [Liu, Fan] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Utrecht, Netherlands; [Liu, Fan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Liu, Fan] Netherlands Prote Ctr, Utrecht, Netherlands; [Chen, Linjie] Bengbu Med Coll, Dept Rheumatol & Immunoloy, Affiliated Hosp 1, Bengbu, Peoples R China; [Gao, Ruitong] Chinese Acad Med Sci, Dept Nephrol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Utrecht University; Utrecht University; Bengbu Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Zhang, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Immunol,Peking Union Med Coll, Beijing, Peoples R China.	zw83423@hotmail.com			National Natural Science Foundation of China [30972717]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (no. 30972717) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) for WZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; Guo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068520; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mauerer K, 2005, BRIT J HAEMATOL, V129, P499, DOI 10.1111/j.1365-2141.2005.05480.x; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Peng YF, 2005, MOL IMMUNOL, V42, P781, DOI 10.1016/j.molimm.2004.07.045; SCHULTZ CL, 1991, CURR OPIN IMMUNOL, V3, P350, DOI 10.1016/0952-7915(91)90037-2; SENALDI G, 1988, ARTHRITIS RHEUM, V31, P1213, DOI 10.1002/art.1780310929; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; TEW JG, 1980, IMMUNOL REV, V53, P175; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Varettoni M, 2013, LEUKEMIA LYMPHOMA, V54, P2485, DOI 10.3109/10428194.2013.779689; Vas J, 2012, ARTHRITIS RHEUM-US, V64, P3388, DOI 10.1002/art.34537; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72166	10.1371/journal.pone.0172166	http://dx.doi.org/10.1371/journal.pone.0172166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222195	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800037
J	Hu, ZH; Wu, Q; Dalal, J; Vasani, N; Lopez, HO; Sederoff, HW; Qu, RD				Hu, Zhaohui; Wu, Qian; Dalal, Jyoti; Vasani, Naresh; Lopez, Harry O.; Sederoff, Heike W.; Qu, Rongda			Accumulation of medium-chain, saturated fatty acyl moieties in seed oils of transgenic Camelina sativa	PLOS ONE			English	Article							CARRIER-PROTEIN THIOESTERASES; MICROSOMAL PREPARATIONS; ARABIDOPSIS-THALIANA; ACID ACCUMULATION; BIOSYNTHESIS; PLANTS; PHOSPHATIDYLCHOLINE; TRANSFORMATION; EXPRESSION; ENDOSPERM	With its high seed oil content, the mustard family plant Camelina sativa has gained attention as a potential biofuel source. As a bioenergy crop, camelina has many advantages. It grows on marginal land with low demand for water and fertilizer, has a relatively short life cycle, and is stress tolerant. As most other crop seed oils, camelina seed triacylglycerols ( TAGs) consist of mostly long, unsaturated fatty acyl moieties, which is not desirable for biofuel processing. In our efforts to produce shorter, saturated chain fatty acyl moieties in camelina seed oil for conversion to jet fuel, a 12:0-acyl-carrier thioesterase gene, UcFATB1, from California bay ( Umbellularia californica Nutt.) was expressed in camelina seeds. Up to 40% of short chain laurate ( C12:0) and myristate ( C14:0) were present in TAGs of the seed oil of the transgenics. The total oil content and germination rate of the transgenic seeds were not affected. Analysis of positions of these two fatty acyl moieties in TAGs indicated that they were present at the sn-1 and sn-3 positions, but not sn-2, on the TAGs. Suppression of the camelina KASII genes by RNAi constructs led to higher accumulation of palmitate ( C16:0), from 7.5% up to 28.5%, and further reduction of longer, unsaturated fatty acids in seed TAGs. Co-transformation of camelina with both constructs resulted in enhanced accumulation of all three medium-chain, saturated fatty acids in camelina seed oils. Our results show that a California bay gene can be successfully used to modify the oil composition in camelina seed and present a new biological alternative for jet fuel production.	[Hu, Zhaohui; Wu, Qian; Dalal, Jyoti; Vasani, Naresh; Lopez, Harry O.; Qu, Rongda] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA; [Sederoff, Heike W.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Qu, RD (corresponding author), North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA.	rqu@ncsu.edu	Vasani, Naresh B/K-9082-2019; Sederoff, Heike/AAE-1505-2021	Sederoff, Heike/0000-0002-0960-9678; Vasani, Naresh/0000-0003-4814-3310				BAFOR M, 1990, BIOCHEM J, V272, P31, DOI 10.1042/bj2720031; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouchy C, 2009, OIL GAS SCI TECHNOL, V64, P91, DOI 10.2516/ogst/2008047; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Dalal J, 2015, PLASMID, V81, P55, DOI 10.1016/j.plasmid.2015.06.003; Dehesh K, 1998, PLANT J, V15, P383, DOI 10.1046/j.1365-313X.1998.00218.x; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Hu ZH, 2012, PLANT PHYSIOL, V158, P1944, DOI 10.1104/pp.111.192153; Nguyen HT, 2015, PLANT BIOTECHNOL J, V13, P38, DOI 10.1111/pbi.12233; Kang JL, 2011, PLANT PHYSIOL BIOCH, V49, P223, DOI 10.1016/j.plaphy.2010.12.004; Kim HJ, 2015, J EXP BOT, V66, P4251, DOI 10.1093/jxb/erv225; Knutzon DS, 1999, PLANT PHYSIOL, V120, P739, DOI 10.1104/pp.120.3.739; LAURENT P, 1992, PLANT PHYSIOL, V99, P1711, DOI 10.1104/pp.99.4.1711; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Mansour MP, 2014, NUTRIENTS, V6, P776, DOI 10.3390/nu6020776; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Pidkowich MS, 2007, P NATL ACAD SCI USA, V104, P4742, DOI 10.1073/pnas.0611141104; Pilgeram A.L., 2007, ISSUES NEW CROPS NEW; Poirier Y, 2000, THEOR APPL GENET, V100, P487, DOI 10.1007/s001220050063; Putnam D. H., 1993, New crops., P314; SHIMAKATA T, 1982, P NATL ACAD SCI-BIOL, V79, P5808, DOI 10.1073/pnas.79.19.5808; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Voelker TA, 1997, PLANT PHYSIOL, V114, P669, DOI 10.1104/pp.114.2.669; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Voelker TA, 1996, PLANT J, V9, P229, DOI 10.1046/j.1365-313X.1996.09020229.x; Xu YN, 1999, FETT-LIPID, V101, P104	30	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172296	10.1371/journal.pone.0172296	http://dx.doi.org/10.1371/journal.pone.0172296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212406	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700031
J	Zeriouh, W; Nani, A; Belarbi, M; Dumont, A; de Rosny, C; Aboura, I; Ghanemi, FZ; Murtaza, B; Patoli, D; Thomas, C; Apetoh, L; Rebe, C; Delmas, D; Khan, NA; Ghiringhelli, F; Rialland, M; Hichami, A				Zeriouh, Wafa; Nani, Abdelhafid; Belarbi, Meriem; Dumont, Adelie; de Rosny, Charlotte; Aboura, Ikram; Ghanemi, Fatima Zahra; Murtaza, Babar; Patoli, Danish; Thomas, Charles; Apetoh, Lionel; Rebe, Cedric; Delmas, Dominique; Khan, Naim Akhtar; Ghiringhelli, Francois; Rialland, Mickael; Hichami, Aziz			Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway	PLOS ONE			English	Article							OLIVE LEAF EXTRACT; COLORECTAL-CANCER; CARCINOMA CELLS; CYTOCHROME-C; CALCIUM; P53; POLYPHENOLS; ACTIVATION; DISEASE; PROTEIN	Dietary polyphenols, derived from natural products, have received a great interest for their chemopreventive properties against cancer. In this study, we investigated the effects of phenolic extract of the oleaster leaves ( PEOL) on tumor growth in mouse model and on cell death in colon cancer cell lines. We assessed the effect of oleaster leaf infusion on HCT116 ( human colon cancer cell line) xenograft growth in athymic nude mice. We observed that oleaster leaf polyphenol-rich infusion limited HCT116 tumor growth in vivo. Investigations of PEOL on two human CRC cell lines showed that PEOL induced apoptosis in HCT116 and HCT8 cells. We demonstrated an activation of caspase-3, -7 and -9 by PEOL and that pretreatment with the pan-caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone ( z-VAD-fmk), prevented PEOL-induced cell death. We observed an involvement of the mitochondrial pathway in PEOL-induced apoptosis evidenced by reactive oxygen species ( ROS) production, a decrease of mitochondrial membrane potential, and cytochrome c release. Increase in intracellular Ca2+ concentration induced by PEOL represents the early event involved in mitochondrial dysfunction, ROS-induced endoplasmic reticulum ( ER) stress and apoptosis induced by PEOL, as ruthenium red, an inhibitor of mitochondrial calcium uptake inhibited apoptotic effect of PEOL, BAPTA/AM inhibited PEOL-induced ROS generation and finally, N-acetyl-L-cysteine reversed ER stress and apoptotic effect of PEOL. These results demonstrate that polyphenols from oleaster leaves might have a strong potential as chemopreventive agent in colorectal cancer.	[Zeriouh, Wafa; Nani, Abdelhafid; Belarbi, Meriem; Aboura, Ikram; Ghanemi, Fatima Zahra] Aboubekr Belkaid Univ, Lab Nat Prod, Tilimsen, Algeria; [Nani, Abdelhafid] African Univ Ahmed Draia, Dept Nat & Life Sci, Adrar, Algeria; [Nani, Abdelhafid; Dumont, Adelie; de Rosny, Charlotte; Aboura, Ikram; Ghanemi, Fatima Zahra; Murtaza, Babar; Patoli, Danish; Thomas, Charles; Apetoh, Lionel; Rebe, Cedric; Delmas, Dominique; Khan, Naim Akhtar; Ghiringhelli, Francois; Rialland, Mickael; Hichami, Aziz] Univ Bourgogne Franche Comte, INSERM U1231, Dijon, France; [Rebe, Cedric; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France	Universite Abou Bekr Belkaid; Universite d'Adrar; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc	Hichami, A (corresponding author), Univ Bourgogne Franche Comte, INSERM U1231, Dijon, France.	aziz.hichami@u-bourgogne.fr	Delmas, Dominique/AAD-9749-2019; Apetoh, Lionel/G-3310-2014; REBE, Cédric/AAD-4316-2019; Thomas, charles/C-7130-2019; Apetoh, Lionel/AIC-2384-2022; Murtaza, Babar/AAR-8200-2021	Delmas, Dominique/0000-0003-3576-0248; Apetoh, Lionel/0000-0002-2774-438X; REBE, Cédric/0000-0001-8831-145X; Thomas, charles/0000-0001-9998-6698; Apetoh, Lionel/0000-0002-2774-438X; Khan, Naim Akhtar/0000-0002-8930-9332; Patoli, Danish/0000-0002-6837-336X; NANI, ABDELHAFID/0000-0002-8665-0447; ghiringhelli, francois/0000-0002-5465-8305; Delmas, Dominique/0000-0002-8911-8499; Rialland, Mickael/0000-0001-9693-9351	Inserm, Labex LipSTIC INSERM	Inserm, Labex LipSTIC INSERM	This study was supported by Inserm, Labex LipSTIC INSERM U866, bilateral Franco-Algerian collaborative project "Tassili."	Abaza L, 2007, BIOSCI BIOTECH BIOCH, V71, P1306, DOI 10.1271/bbb.60716; Aires V, 2004, MOL CELL BIOCHEM, V260, P103, DOI 10.1023/B:MCBI.0000026061.57326.28; Armutcu F, 2011, SPAT DD PER REV J CO, V1, P159; Banerjee A, 2016, ONCOTARGET IMPACT J, V5; Bennani-Kabchi N., 2000, Annales Pharmaceutiques Francaises, V58, P271; Boehning D, 2004, CELL CYCLE, V3, P252; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Corsi L, 2002, FITOTERAPIA, V73, P674, DOI 10.1016/S0367-326X(02)00227-7; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Fares R, 2011, PLANT FOOD HUM NUTR, V66, P58, DOI 10.1007/s11130-011-0213-9; Giovannini C, 2012, NUTR NEUROSCI, V15, P134, DOI 10.1179/1476830512Y.0000000006; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005; Han J, 2009, CYTOTECHNOLOGY, V59, P45, DOI 10.1007/s10616-009-9191-2; Hanene G, 2015, INT J PHARM PHARM SC, V7; Hannachi H, 2013, PAK J PHARM SCI, V26, P503; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Katiyar Santosh K., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P17; Kim ER, 2014, WORLD J GASTROENTERO, V20, P9872, DOI 10.3748/wjg.v20.i29.9872; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Lafka TI, 2013, FOODS, V2, P18, DOI 10.3390/foods2010018; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; McGuire S, 2014, ADV NUTR, V5, P456, DOI 10.3945/an.114.006171; Middleton E, 2000, PHARMACOL REV, V52, P673; Mijatovic SA, 2011, INT J CANCER, V128, P1955, DOI 10.1002/ijc.25526; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Nakazato T, 2005, HEMATOL J, V90; Nani A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0946-3; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Oak MH, 2005, J NUTR BIOCHEM, V16, P1, DOI 10.1016/j.jnutbio.2004.09.004; Obrenovich ME, 2010, REJUV RES, V13, P631, DOI 10.1089/rej.2010.1043; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Rodriguez M.L., 2013, J CARCINOG MUTAGEN, V6; Rodriguez ML, 2013, AFRIQUE SCI, V09, P159; Roy AM, 2005, MOL CANCER THER, V4, P81; Soni MG, 2006, FOOD CHEM TOXICOL, V44, P903, DOI 10.1016/j.fct.2006.01.008; Vasen HFA, 2015, NAT REV GASTRO HEPAT, V12, P88, DOI 10.1038/nrgastro.2014.229; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Zhong Y, 2010, EUR J CANCER, V46, P3365, DOI 10.1016/j.ejca.2010.07.007	48	22	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0170823	10.1371/journal.pone.0170823	http://dx.doi.org/10.1371/journal.pone.0170823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212423	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700003
J	Zhan, WB; Gedroyc, W; Xu, XY				Zhan, Wenbo; Gedroyc, Wladyslaw; Xu, Xiao Yun			The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images	PLOS ONE			English	Article							SOLID TUMORS; INTERSTITIAL PRESSURE; NEOPLASTIC TISSUES; BLOOD-FLOW; DELIVERY; MACROMOLECULES; DOXORUBICIN; VASCULATURE; FLUID; ADRIAMYCIN	Drug transport and its uptake by tumour cells are strongly dependent on tumour properties, which vary in different types of solid tumours. By simulating the key physical and biochemical processes, a numerical study has been carried out to investigate the transport of anticancer drugs in 3-D tumour models of different sizes. The therapeutic efficacy for each tumour is evaluated by using a pharmacodynamics model based on the predicted intracellular drug concentration. Simulation results demonstrate that interstitial fluid pressure and interstitial fluid loss vary non-linearly with tumour size. Transvascular drug exchange, driven by the concentration gradient of unbound drug between blood and interstitial fluid, is more efficient in small tumours, owing to the low spatial-mean interstitial fluid pressure and dense microvasculature. However, this has a detrimental effect on therapeutic efficacy over longer periods as a result of enhanced reverse diffusion of drug to the blood circulation after the cessation of drug infusion, causing more rapid loss of drug in small tumours.	[Zhan, Wenbo; Xu, Xiao Yun] Imperial Coll London, Dept Chem Engn, South Kensington Campus, London, England; [Gedroyc, Wladyslaw] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Radiol, London, England	Imperial College London; Imperial College London	Xu, XY (corresponding author), Imperial Coll London, Dept Chem Engn, South Kensington Campus, London, England.	yun.xu@imperial.ac.uk	Zhan, Wenbo/O-7709-2018	Zhan, Wenbo/0000-0003-0268-5042	Engineering and Physical Sciences Research Council [EP/I001700/1] Funding Source: researchfish; EPSRC [EP/I001700/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1991, MICROVASC RES, V41, P5, DOI 10.1016/0026-2862(91)90003-T; BAXTER LT, 1991, MICROVASC RES, V41, P252, DOI 10.1016/0026-2862(91)90026-8; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Eatock MM, 2000, CANCER TREAT REV, V26, P191, DOI 10.1053/ctrv.1999.0158; Eikenberry S, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-16; El-Kareh AW, 2000, NEOPLASIA, V2, P325, DOI 10.1038/sj.neo.7900096; Eliaz RE, 2004, CANCER RES, V64, P711, DOI 10.1158/0008-5472.CAN-03-0654; Goh YMF, 2001, PHARM RES-DORDR, V18, P761, DOI 10.1023/A:1011076110317; Goodman LS, 2005, GOODMAN GILMANS PHAR; GRANATH KA, 1967, J CHROMATOGR, V28, P69, DOI 10.1016/S0021-9673(01)85930-6; GREENE RF, 1983, CANCER RES, V43, P3417; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Jain HV, 2008, B MATH BIOL, V70, P89, DOI 10.1007/s11538-007-9242-9; JAIN RK, 1988, CANCER RES, V48, P7022; JAIN RK, 1988, CANCER RES, V48, P2641; JAIN RK, 1987, CANCER RES, V47, P3039; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; KERR DJ, 1986, BIOCHEM PHARMACOL, V35, P2817, DOI 10.1016/0006-2952(86)90195-4; LESS JR, 1991, CANCER RES, V51, P265; Lichtenbeld Hera C., 1996, Microcirculation (Philadelphia), V3, P349, DOI 10.3109/10739689609148307; Liu C, 2013, INTEGR BIOL-UK, V5, P555, DOI 10.1039/c2ib20238g; NUGENT LJ, 1984, CANCER RES, V44, P238; Pappenheimer J. R., 1951, AM J PHYSIOL, V167, P2578; ROBERT J, 1982, EUR J CANCER CLIN ON, V18, P739, DOI 10.1016/0277-5379(82)90072-4; Rubin P, 1966, Clin Radiol, V17, P220, DOI 10.1016/S0009-9260(66)80027-2; SALTZMAN WM, 1991, CHEM ENG SCI, V46, P2429, DOI 10.1016/0009-2509(91)80036-X; Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2; Sefidgar M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-12; Soltani M, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-4; SWABB EA, 1974, CANCER RES, V34, P2814; Taverna G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00015; VAUPEL P, 1989, CANCER RES, V49, P6449; WOLF MB, 1987, AM J PHYSIOL, V253, pH194, DOI 10.1152/ajpheart.1987.253.1.H194; WU NZ, 1993, MICROVASC RES, V46, P231, DOI 10.1006/mvre.1993.1049; YUAN F, 1995, CANCER RES, V55, P3752; Zhan WB, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/172529; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003	39	25	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172276	10.1371/journal.pone.0172276	http://dx.doi.org/10.1371/journal.pone.0172276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212385	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700026
J	Park, JY; Chung, TW; Jeong, YJ; Kwak, CH; Ha, SH; Kwon, KM; Abekura, F; Cho, SH; Lee, YC; Ha, KT; Magae, J; Chang, YC; Kim, CH				Park, Jun-Young; Chung, Tae-Wook; Jeong, Yun-Jeong; Kwak, Choong-Hwan; Ha, Sun-Hyung; Kwon, Kyung-Min; Abekura, Fukushi; Cho, Seung-Hak; Lee, Young-Choon; Ha, Ki-Tae; Magae, Junji; Chang, Young-Chae; Kim, Cheorl-Ho			Ascofuranone inhibits Iipopolysaccharide-induced inflammatory response via NF-kappaB and AP-1, p-ERK, TNF-alpha, IL-6 and IL-1 beta in RAW 264.7 macrophages	PLOS ONE			English	Article							SIGNALING PATHWAY; NITRIC-OXIDE; MAPK ACTIVATION; DOWN-REGULATION; CELLS; SUPPRESSES; CYCLOOXYGENASE-2; EXPRESSION; INDUCTION; DIFFERENTIATION	The natural fungal compound ascofuranone (5-chloro-3-[(2E,6E)-7-[(2S)-5,5-dimethyl-4-oxo-tetrahydrofuran-2-yl]-3-methyl-octa-2,6-dienyl]-2,4-dihydroxy-6-methyl-benzaldehyde, MW 420.93) (AF) isolated from Ascochyta viciae has been known to promote cell cycle arrest and inhibit invasion of tumor cells. We have previously studied a structurally similar compound ascochlorin (ASC; MW 404.93) with regard to its anti-inflammatory activity in LPS-stimulated RAW 264.7 macrophages. In order to examine the relationship between the anti-inflammatory activities and the molecular differences between AF and ASC, the activity of AF is herein studied, because ASC has a unique trimethyl oxocyclohexyl structure, while AF has a unique dimethyl-oxo-tetrahydrofuran structure. AF dose-dependently inhibited the production of NO and iNOS and the COX-2 mRNA and protein levels in RAW 264.7 cells. In addition, AF suppressed mRNA expression levels of inflammatory cytokines such as TNF-alpha, IL-6, and IL-1 beta, as assessed by RT-PCR. AF (30-50 mu g/ml) treatment clearly inhibited the nuclear translocation of NF-kappa B, AP-1 (p-c-Jun) from the cytosolic space. Phosphorylation of I kappa B, which functions to maintain the activity of NF-kappa B, was decreased by AF treatment. Moreover, AF suppressed the binding of NF-kappa B (p65). Inhibition of I kappa Ba phosphorylation and degradation inhibits nuclear translocation of p65. Immunofluorescence con focal microscopy analysis also revealed that translocation of NF-kappa B and AP-1 (p-c-Jun) was decreased upon AF treatment. AF specifically decreased the expression level of p-ERK, but not the expression level of p-p38 or p-JNK. Given these results, we suggest that AF suppresses the inflammatory response by targeting p-ERK. This indicates that AF is a negative regulator of LPS-stimulated nuclear translocation of NF-kappa B and AP-1 (p-c-Jun) in RAW 264.7 macrophages, and specifically it targets p-ERK. Therefore, AF and ASC exert their effects in different ways, most probably because their structural differences allow for specific recognition and inhibition of their target MAPKs. Our results further suggest that AF could be a natural bioactive compound useful for treating inflammation -mediated pathological diseases.	[Park, Jun-Young; Kwak, Choong-Hwan; Ha, Sun-Hyung; Kwon, Kyung-Min; Abekura, Fukushi; Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Seoburo 2066, Suwon, Gyunggi Do, South Korea; [Chung, Tae-Wook; Ha, Ki-Tae] Pusan Natl Univ, Korean Med Res Ctr, Sch Korean Med & Hlth Aging, Yangsan, Gyeongsangnam D, South Korea; [Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu, South Korea; [Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Daegu, South Korea; [Cho, Seung-Hak] Korea Natl Inst Hlth, Ctr Infect Dis Res, Div Enter Dis, Cheongju, South Korea; [Lee, Young-Choon] Dong A Univ, Fac Med Biotechnol, Busan, South Korea; [Magae, Junji] Magae Biosci Inst, 49-4 Fujimidai, Tsukuba, Ibaraki, Japan; [Kim, Cheorl-Ho] Sungkyunkwan Univ, SAIHST, Seoul, South Korea	Sungkyunkwan University (SKKU); Pusan National University; Catholic University of Daegu; Catholic University of Daegu; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Dong A University; Sungkyunkwan University (SKKU)	Kim, CH (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Seoburo 2066, Suwon, Gyunggi Do, South Korea.; Chang, YC (corresponding author), Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu, South Korea.; Chang, YC (corresponding author), Catholic Univ Daegu, Sch Med, Dept Med, Daegu, South Korea.; Kim, CH (corresponding author), Sungkyunkwan Univ, SAIHST, Seoul, South Korea.	ycchang@cu.ac.kr; chkimbio@skku.edu	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714; Park, Junyoung/0000-0003-3197-3908; Chung, Tae-Wook/0000-0001-5243-5020	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2014R1A2A1A 11050776]; Basic Science Research Program - Ministry of Education, Science and Technology (MEST) of Korea [NRF-2015R1D1A1A01057153]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2014R1A2A1A 11050776, NRF-2015R1D1A1A01057153]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP); Basic Science Research Program - Ministry of Education, Science and Technology (MEST) of Korea; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This study has in part been supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2014R1A2A1A 11050776 to Young-Chae Chang and the Basic Science Research Program funded by the Ministry of Education, Science and Technology (MEST) of Korea through NRF-2015R1D1A1A01057153 to Cheorl-Ho Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has in part supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2014R1A2A1A 11050776 to Young-Chae Chang and NRF-2015R1D1A1A01057153 to Cheorl-Ho Kim).	ab Yabu Y, PARASITOL INT, V52, P155; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Cho EJ, 2011, J CELL BIOCHEM, V112, P3648, DOI 10.1002/jcb.23294; Cho HJ, 2007, CARCINOGENESIS, V28, P1104, DOI 10.1093/carcin/bgl217; Cho HJ, 2009, J CELL BIOCHEM, V107, P335, DOI 10.1002/jcb.22130; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Gan K, 2016, INT IMMUNOPHARMACOL, V35, P294, DOI 10.1016/j.intimp.2016.03.038; Hsieh IN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-28; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035922; Jeong JH, 2010, MOL CANCER THER, V9, P2102, DOI 10.1158/1535-7163.MCT-09-1159; Jeong YJ, 2013, TOXICOL APPL PHARM, V273, P542, DOI 10.1016/j.taap.2013.09.027; Jin X, 2016, MOL MED REP; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim SJ, 2014, INT J BIOCHEM CELL B, V46, P32, DOI 10.1016/j.biocel.2013.09.015; Lee SH, 2016, J CELL BIOCHEM, V117, P978, DOI 10.1002/jcb.25383; Ma Y, 2016, INFLAMMATION; MAGAE J, 1986, CANCER RES, V46, P1073; MAGAE J, 1988, J ANTIBIOT, V41, P959, DOI 10.7164/antibiotics.41.959; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; MITCHELL JA, 1995, BIOCHEM PHARMACOL, V50, P1535, DOI 10.1016/0006-2952(95)00212-X; Morris KR, 2003, INFECT IMMUN, V71, P1442, DOI 10.1128/IAI.71.3.1442-1452.2003; Pourgholaminejad A, 2016, CYTOKINE, V85, P51, DOI 10.1016/j.cyto.2016.06.003; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Safdari Y, 2015, PHARMACOL RES, V93, P1, DOI 10.1016/j.phrs.2014.12.004; SASAKI H, 1973, J ANTIBIOT, V26, P676, DOI 10.7164/antibiotics.26.676; Suh SJ, 2007, ARCH BIOCHEM BIOPHYS, V467, P227, DOI 10.1016/j.abb.2007.08.025; Suh SJ, 2012, INFLAMMATION, V35, P736, DOI 10.1007/s10753-011-9369-6; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wang Z, 2016, ONCOL REP; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yu Q, 2016, INT IMMUNOPHARMACOL, V38, P104, DOI 10.1016/j.intimp.2016.05.010	32	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171322	10.1371/journal.pone.0171322	http://dx.doi.org/10.1371/journal.pone.0171322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207754	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424500023
J	Wang, R; Edrington, TC; Storrs, SB; Crowley, KS; Ward, JM; Lee, TC; Liu, ZL; Li, B; Glenn, KC				Wang, Rong; Edrington, Thomas C.; Storrs, S. Bradley; Crowley, Kathleen S.; Ward, Jason M.; Lee, Thomas C.; Liu, Zi L.; Li, Bin; Glenn, Kevin C.			Analyzing pepsin degradation assay conditions used for allergenicity assessments to ensure that pepsin susceptible and pepsin resistant dietary proteins are distinguishable	PLOS ONE			English	Article							LIPID-TRANSFER PROTEINS; HORSERADISH-PEROXIDASE; FOOD ALLERGENS; WHEY PROTEINS; ACTIVE-SITE; STABILITY; DIGESTION; DIGESTIBILITY; PH	The susceptibility of a dietary protein to proteolytic degradation by digestive enzymes, such as gastric pepsin, provides information on the likelihood of systemic exposure to a structurally intact and biologically active macromolecule, thus informing on the safety of proteins for human and animal consumption. Therefore, the purpose of standardized in vitro degradation studies that are performed during protein safety assessments is to distinguish whether proteins of interest are susceptible or resistant to pepsin degradation via a study design that enables study-to-study comparison. Attempting to assess pepsin degradation under a wide range of possible physiological conditions poses a problem because of the lack of robust and consistent data collected under a large-range of sub-optimal conditions, which undermines the needs to harmonize in vitro degradation conditions. This report systematically compares the effects of pH, incubation time, and pepsin-to-substrate protein ratio on the relative degradation of five dietary proteins: three pepsin susceptible proteins [ribulose 1,5-bisphosphate carboxylase-oxygenase (Rubisco), horseradish peroxidase (HRP), hemoglobin (Hb)], and two pepsin resistant proteins [lipid transfer protein (LTP) and soybean trypsin inhibitor (STI)]. The results indicate that proteins susceptible to pepsin degradation are readily distinguishable from pepsin-resistant proteins when the reaction conditions are within the well-characterized optima for pepsin. The current standardized in vitro pepsin resistant assay with low pH and high pepsin-to-substrate ratio fits this purpose. Using non-optimal pH and/or pepsin-to-substrate protein ratios resulted in susceptible proteins no longer being reliably degraded by this stomach enzyme, which compromises the ability of this in vitro assay to distinguish between resistant and susceptible proteins and, therefore, no longer providing useful data to an overall weight-of-evidence approach to assessing safety of proteins.	[Wang, Rong; Edrington, Thomas C.; Storrs, S. Bradley; Crowley, Kathleen S.; Ward, Jason M.; Lee, Thomas C.; Liu, Zi L.; Li, Bin; Glenn, Kevin C.] Monsanto Co, St Louis, MO 63141 USA; [Crowley, Kathleen S.] Tioma Therapeut, St Louis, MO USA; [Ward, Jason M.] Royal Canin, St Charles, MO USA	Monsanto	Wang, R (corresponding author), Monsanto Co, St Louis, MO 63141 USA.	rong.wang@monsanto.com		Wang, Rong/0000-0002-7198-7784	Monsanto Company	Monsanto Company	Monsanto Company funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, however Monsanto Company provided managerial guidance during the study and final approval to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; ANTONOV VK, 1974, FEBS LETT, V46, P29, DOI 10.1016/0014-5793(74)80327-3; Bannon G, 2003, ENVIRON HEALTH PERSP, V111, P1122; Bannon GA, 2004, CURR ALLERGY ASTHM R, V4, P43, DOI 10.1007/s11882-004-0042-0; Bogh KL, 2016, CRIT REV FOOD SCI, V56, P1545, DOI 10.1080/10408398.2013.779569; Campos LA, 2003, FEBS LETT, V538, P89, DOI 10.1016/S0014-5793(03)00152-2; CASPARY WF, 1992, AM J CLIN NUTR, V55, P299, DOI 10.1093/ajcn/55.1.299s; Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o; Chen EP, 2008, PHARM RES, V25, P123, DOI 10.1007/s11095-007-9358-5; Codex Alimentarius, 2009, FOODS DER MOD BIOT; Eriksen EK, 2010, BRIT J NUTR, V104, P374, DOI 10.1017/S0007114510000577; FAO/WHO, 2001, EV ALL GEN MOD FOODS; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Foster ES, 2013, TOXICOLOGY, V309, P30, DOI 10.1016/j.tox.2013.04.011; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; GARDNER MLG, 1988, ANNU REV NUTR, V8, P329, DOI 10.1146/annurev.nu.08.070188.001553; Gu X, 2017, J AGR FOOD IN PRESS; Hollebeeck S, 2013, FOOD CHEM, V138, P1936, DOI 10.1016/j.foodchem.2012.11.041; Hur SJ, 2011, FOOD CHEM, V125, P1, DOI 10.1016/j.foodchem.2010.08.036; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; KATZ DS, 1994, J MOL BIOL, V244, P541, DOI 10.1006/jmbi.1994.1751; Lang GH, 2015, FOOD CHEM, V168, P606, DOI 10.1016/j.foodchem.2014.07.089; LIN YZ, 1992, J BIOL CHEM, V267, P18413; Marcus Y, 2003, J BACTERIOL, V185, P1509, DOI 10.1128/JB.185.5.1509-1517.2003; McConnell EL, 2008, INT J PHARMACEUT, V364, P213, DOI 10.1016/j.ijpharm.2008.05.012; Mills ENC, 2013, EFSA J, P1; MINEKUS M, 1995, ATLA-ALTERN LAB ANIM, V23, P197; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Naegeli H, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4862; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Ofori-Anti AO, 2008, REGUL TOXICOL PHARM, V52, P94, DOI 10.1016/j.yrtph.2008.06.006; PIPER DW, 1965, GUT, V6, P506, DOI 10.1136/gut.6.5.506; Roychaudhuri R, 2004, BBA-PROTEINS PROTEOM, V1699, P207, DOI 10.1016/j.bbapap.2004.02.014; Salcedo G, 2007, BBA-MOL CELL BIOL L, V1771, P781, DOI 10.1016/j.bbalip.2007.01.001; SCHMIDT DG, 1995, CLIN EXP ALLERGY, V25, P1007, DOI 10.1111/j.1365-2222.1995.tb00404.x; Smeller L, 2003, BIOCHEMISTRY-US, V42, P553, DOI 10.1021/bi026192n; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Thomas K, 2004, REGUL TOXICOL PHARM, V39, P87, DOI 10.1016/j.yrtph.2003.11.003; TOMIMATSU Y, 1981, PLANT PHYSIOL, V68, P808, DOI 10.1104/pp.68.4.808; Untersmayr E, 2007, J ALLERGY CLIN IMMUN, V119, P711, DOI 10.1016/j.jaci.2006.10.039; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; Vieths S, 1999, EUR FOOD RES TECHNOL, V209, P379, DOI 10.1007/s002170050513; Yagami T, 2000, J ALLERGY CLIN IMMUN, V106, P752, DOI 10.1067/mai.2000.109171; ZUCKERKANDL E, 1960, P NATL ACAD SCI USA, V46, P1349, DOI 10.1073/pnas.46.10.1349	44	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171926	10.1371/journal.pone.0171926	http://dx.doi.org/10.1371/journal.pone.0171926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207780	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500060
J	Balandraud, N; Texier, G; Massy, E; Muis-Pistor, O; Martin, M; Auger, I; Guzian, MC; Guis, S; Pham, T; Roudier, J				Balandraud, Nathalie; Texier, Gaetan; Massy, Emmanuel; Muis-Pistor, Olivier; Martin, Marielle; Auger, Isabelle; Guzian, Marie-Caroline; Guis, Sandrine; Pham, Thao; Roudier, Jean			Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; T-CELL-ACTIVATION; PERIPHERAL-BLOOD; CLINICAL-TRIAL; DOUBLE-BLIND; METHOTREXATE; INHIBITION; LYMPHOMAS; BLOCKADE; RISK	Background Epstein-Barr Virus (EBV) is a widely disseminated lymphotropic herpes virus implicated in benign and malignant disorders. In transplant patients, immunosuppressive drugs (cyclosporine) diminish control of EBV replication, potentially leading to lymphoproliferative disorders (LPD). Rheumatoid arthritis (RA) patients have impaired control of EBV infection and have EBV load ten times higher than controls. As post transplant patients, patients with RA have increased risk of developing lymphomas. Immunosuppressive drugs used to treat RA (conventional disease modifying drugs cDMARDs or biologics bDMARDs) could enhance the risk of developing LPD in RA patients. We have previously shown that long term treatment with Methotrexate and/or TNF alpha antagonists does not increase EBV load in RA. Our objective was to monitor the Epstein-Barr Virus load in RA patients treated with Abatacept (CTLA4 Ig), a T cell coactivation inhibitor, and Tocilizumab, an anti IL6 receptor antibody. Methods EBV load in the peripheral blood mononuclear cells (PBMCs) of 55 patients under Abatacept (in 34% associated with Methotrexate) and 35 patients under Tocilizumab (in 37% associated with Methotrexate) was monitored for durations ranging from 6 months to 3 years by real time PCR. The influences of treatment duration and disease activity score 28 (DAS28) index on EBV load were analyzed. Results Abatacept did not significantly modify EBV load over time. Tocilizumab significantly diminished EBV load over time. No patient (of 90) developed EBV associated lymphoma. Conclusion Long term treatment with Abatacept or Tocilizumab does not increase EBV load in the PBMNCs of patients with RA.	[Balandraud, Nathalie; Massy, Emmanuel; Muis-Pistor, Olivier; Guzian, Marie-Caroline; Guis, Sandrine; Pham, Thao; Roudier, Jean] AP HM, IML, Rheumatol 1 2, 270 Blvd St Marguerite, Marseilles, France; [Balandraud, Nathalie; Martin, Marielle; Auger, Isabelle; Roudier, Jean] Aix Marseille Univ, INSERM UMRs 1097, 163 Ave Luminy, Aix En Provence, France; [Texier, Gaetan] Ctr Epidemiol & Sante Pbl Armees, CESPA, Marseilles, France; [Texier, Gaetan] Aix Marseille Univ, INSERM, SESSTIM, IRD, Marseilles, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Balandraud, N (corresponding author), AP HM, IML, Rheumatol 1 2, 270 Blvd St Marguerite, Marseilles, France.; Balandraud, N (corresponding author), Aix Marseille Univ, INSERM UMRs 1097, 163 Ave Luminy, Aix En Provence, France.	nathalie.balandraud@ap-hm.fr	roudier, jean/A-8654-2011; AUGER, ISABELLE/P-6294-2016; Balandraud, Nathalie/ABD-6012-2020; Pham, Thao/GYA-5092-2022	roudier, jean/0000-0001-5435-8567; AUGER, ISABELLE/0000-0002-1414-8095; Balandraud, Nathalie/0000-0002-3839-0185; 	Assistance Publique des Hopitaux de Marseille AP-HM (AORC); INSERM; ROCHE-CHUGAI	Assistance Publique des Hopitaux de Marseille AP-HM (AORC); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ROCHE-CHUGAI(Roche Holding)	This work has been supported by Assistance Publique des Hopitaux de Marseille AP-HM (AORC 2009), INSERM and ROCHE-CHUGAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1981, J CLIN INVEST, V67, P1134, DOI 10.1172/JCI110127; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baecklund E, 2004, CURR OPIN RHEUMATOL, V16, P254, DOI 10.1097/00002281-200405000-00014; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Baecklund E, 2006, ARTHRITIS RHEUM-US, V54, P3774, DOI 10.1002/art.22277; Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933; Balandraud N, 2007, ARTHRIT RHEUM-ARTHR, V57, P762, DOI 10.1002/art.22783; Baldanti F, 2000, J CLIN MICROBIOL, V38, P613, DOI 10.1128/JCM.38.2.613-619.2000; Bassil N, 2014, EXP CLIN TRANSPLANT, V12, P212, DOI 10.6002/ect.2013.0252; Emery P, 2003, EXPERT OPIN INV DRUG, V12, P673, DOI 10.1517/eoid.12.4.673.23757; Erre GL, 2015, VIRAL IMMUNOL, V28, P385, DOI 10.1089/vim.2015.0035; Fujieda M, 2016, MOD RHEUMATOL JPN RH, P1; Gartner B, 2010, J CLIN VIROL, V48, P82, DOI 10.1016/j.jcv.2010.03.016; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gridelli B, 2000, Transpl Int, V13 Suppl 1, pS399, DOI 10.1111/j.1432-2277.2000.tb02069.x; Harigai M, 2016, MOD RHEUMATOL, V26, P1; Hsu FJ, 2002, J IMMUNOTHER, V25, P455, DOI 10.1097/00002371-200211000-00002; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Lahaye C, 2016, RHEUMATOL OXF ENQL; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Mariette X, 2011, RHEUMATOLOGY, V50, P222, DOI 10.1093/rheumatology/keq368; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mourgues C, 2016, JOINT BONE SPINE, V83, P412, DOI 10.1016/j.jbspin.2015.07.009; Nishimoto N, 2006, CURR OPIN RHEUMATOL, V18, P277, DOI 10.1097/01.bor.0000218949.19860.d1; Ogawa J, 2006, ANN RHEUM DIS, V65, P1667, DOI 10.1136/ard.2006.054197; Paul-Pletzer K, 2006, DRUG TODAY, V42, P559, DOI 10.1358/dot.2006.42.9.1025692; Ruf S, 2012, J CLIN VIROL, V53, P186, DOI 10.1016/j.jcv.2011.11.010; San Juan R., 2015, CLIN MICROBIOL INFEC, V2015, pe1; San-Juan R, 2014, CLIN MICROBIOL INFEC, V20, P109, DOI 10.1111/1469-0691.12534; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; SMOLEN JS, 1995, ARTHRITIS RHEUM, V38, P38, DOI 10.1002/art.1780380106; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102; TOSATO G, 1984, J CLIN INVEST, V73, P1789, DOI 10.1172/JCI111388; Toussirot E, 2000, ANN RHEUM DIS, V59, P533, DOI 10.1136/ard.59.7.533; Weinblatt ME, 2013, J RHEUMATOL, V40, P787, DOI 10.3899/jrheum.120906; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J, 2004, STAT MED, V23, P879, DOI 10.1002/sim.1736	45	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171623	10.1371/journal.pone.0171623	http://dx.doi.org/10.1371/journal.pone.0171623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199343	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400036
J	Koo, ES; Kim, MS; Choi, YS; Park, KS; Jeong, YS				Koo, Eung Seo; Kim, Man Su; Choi, Yong Seon; Park, Kwon-Sam; Jeong, Yong Seok			Occurrence of novel GII. 17 and GII. 21 norovirus variants in the coastal environment of South Korea in 2015	PLOS ONE			English	Article							HERD-IMMUNITY; EVOLUTION; GASTROENTERITIS; RECOMBINATION; EMERGENCE; INFECTION; STRAINS; WATERS; DIVERSITY; ESCAPE	Human norovirus (HNoV), a positive-sense RNA virus, is the main causative agent of acute viral gastroenteritis. Multiple pandemic variants of the genogroup II genotype 4 (GII. 4) of NoV have attracted great attention from researchers worldwide. However, novel variants of GII. 17 have been overtaking those pandemic variants in some areas of East Asia. To investigate the environmental occurrence of GII in South Korea, we collected water samples from coastal streams and a neighboring waste water treatment plant in North Jeolla province (in March, July, and December of 2015). Based on capsid gene region C analysis, four different genotypes (GII. 4, GII. 13, GII. 17, and GII. 21) were detected, with much higher prevalence of GII. 17 than of GII. 4. Additional sequence analyses of the ORF1-ORF2 junction and ORF2 from the water samples revealed that the GII. 17 sequences in this study were closely related to the novel strains of GII. P17-GII. 17, the main causative variants of the 2014-2015 HNoV outbreak in China and Japan. In addition, the GII. P21-GII. 21 variants were identified in this study and they had new amino acid sequence variations in the blockade epitopes of the P2 domain. From these results, we present two important findings: 1) the novel GII. P17-GII. 17 variants appeared to be predominant in the study area, and 2) new GII. 21 variants have emerged in South Korea.	[Koo, Eung Seo; Kim, Man Su; Choi, Yong Seon; Jeong, Yong Seok] Kyung Hee Univ, Coll Sci, Dept Biol, Seoul, South Korea; [Park, Kwon-Sam] Kunsan Natl Univ, Dept Food Sci & Biotechnol, Gunsan, South Korea	Kyung Hee University; Kunsan National University	Jeong, YS (corresponding author), Kyung Hee Univ, Coll Sci, Dept Biol, Seoul, South Korea.	ysjeong@khu.ac.kr	Jeong, Yong Seok/AAK-4353-2020	Koo, Eung Seo/0000-0002-4413-3716; KIM, Man Su/0000-0002-3584-6589	Ministry of Korean Food and Drug Administration [14162-973]	Ministry of Korean Food and Drug Administration	The funds for water sampling of ESK were provided by the Ministry of Korean Food and Drug Administration, http://www.mfds.go.kr/index.do, Project Number 14162-973. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EURO SURVEILL; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Aw TG, 2009, APPL ENVIRON MICROB, V75, P4984, DOI 10.1128/AEM.00489-09; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Campos CJA, 2014, APPL ENVIRON MICROB, V80, P3552, DOI 10.1128/AEM.04188-13; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Fout G, 2010, 1615 US EPA NAT EXP; Fu J, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21157; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; Green K., 2013, FIELDS VIROLOGY, V1, P583; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Ham Hee-Jin, 2015, Journal of Bacteriology and Virology, V45, P376, DOI 10.4167/jbv.2015.45.4.376; Han JK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0370-9; Thanh HD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154284; Jones MK, 2015, NAT PROTOC, V10, P1939, DOI 10.1038/nprot.2015.121; Kim MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163800; Kim M, 2010, VIRUS RES, V147, P1, DOI 10.1016/j.virusres.2009.08.013; Koo ES, 2012, J MICROBIOL, V50, P726, DOI 10.1007/s12275-012-2279-y; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Lee SG, 2015, BMB REP, V48, P61, DOI 10.5483/BMBRep.2015.48.2.254; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Liu W, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005025; Lu J, 2015, EMERG INFECT DIS, V21, P1240, DOI 10.3201/eid2107.150226; Mans J, 2016, EPIDEMIOL INFECT, V144, P907, DOI 10.1017/S0950268815002150; Medici MC, 2014, VIRUS RES, V188, P142, DOI 10.1016/j.virusres.2014.04.005; Nataraju SM, 2011, INT J MOL EPIDEMIOL, V2, P130; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14; Said MA, 2008, CLIN INFECT DIS, V47, P1202, DOI 10.1086/592299; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Symes SJ, 2007, ARCH VIROL, V152, P1075, DOI 10.1007/s00705-007-0938-9; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Ueki Y, 2005, WATER RES, V39, P4271, DOI 10.1016/j.watres.2005.06.035; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Won YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085063	49	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172237	10.1371/journal.pone.0172237	http://dx.doi.org/10.1371/journal.pone.0172237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199388	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400083
J	Naidoo, P; Dunbar, R; Caldwell, J; Lombard, C; Beyers, N				Naidoo, Pren; Dunbar, Rory; Caldwell, Judy; Lombard, Carl; Beyers, Nulda			Has universal screening with Xpert (R) MTB/RIF increased the proportion of multidrugresistant tuberculosis cases diagnosed in a routine operational setting?	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; SPUTUM SMEAR MICROSCOPY; PULMONARY TUBERCULOSIS; SOUTH-AFRICA; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; RISK-FACTORS; GENDER; SENSITIVITY; ALGORITHMS	Setting Primary health services in Cape Town, South Africa where the introduction of Xpert MTB/RIF (Xpert) enabled simultaneous screening for tuberculosis (TB) and drug susceptibility in all presumptive cases. Study aim To compare the proportion of TB cases with drug susceptibility tests undertaken and multi drug-resistant tuberculosis (MDR-TB) diagnosed pre-treatment and during the course of 1st line treatment in the previous smear/culture and the newly introduced Xpert-based algorithms. Methods TB cases identified in a previous stepped-wedge study of TB yield in five sub-districts over seven one-month time-points prior to, during and after the introduction of the Xpert-based algorithm were analysed. We used a combination of patient identifiers to identify all drug susceptibility tests undertaken from electronic laboratory records. Differences in the proportions of DST undertaken and MDR-TB cases diagnosed between algorithms were estimated using a binomial regression model. Results Pre-treatment, the probability of having a DST undertaken (RR = 1.82)(p<0.001) and being diagnosed with MDR-TB (RR =1.42)(p<0.001) was higher in the Xpert-based algorithm than in the smear/culture-based algorithm. For cases evaluated during the course of 1st-line TB treatment, there was no significant difference in the proportion with DST undertaken (RR = 1.02)(p = 0.848) or MDR-TB diagnosed (RR = 1.12)(p = 0.678) between algorithms. Conclusion Universal screening for drug susceptibility in all presumptive TB cases in the Xpert-based algorithm resulted in a higher overall proportion of MDR-TB cases being diagnosed and is an important strategy in reducing transmission. The previous strategy of only screening new TB cases when 1st line treatment failed did not compensate for cases missed pretreatment.	[Naidoo, Pren; Dunbar, Rory; Beyers, Nulda] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Fac Med & Hlth Sci, Stellenbosch, South Africa; [Caldwell, Judy] City Hlth Directorate, Cape Town, South Africa; [Lombard, Carl] South African Med Res Council, Biostat Unit, Cape Town, South Africa	Stellenbosch University; South African Medical Research Council	Naidoo, P (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Fac Med & Hlth Sci, Stellenbosch, South Africa.	pnaidoo@icon.co.za		Lombard, Carl/0000-0002-2136-6533	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB) [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB)(United States Agency for International Development (USAID))	This research was partially supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Caulfield Adam J, 2016, J Clin Tuberc Other Mycobact Dis, V4, P33, DOI 10.1016/j.jctube.2016.05.005; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox HS, PLOS MED, V11; du Toit E, 2015, INT J TUBERC LUNG D, V19, P960, DOI 10.5588/ijtld.14.0703; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Furin JJ, 2000, EUR J CLIN MICROBIOL, V19, P132, DOI 10.1007/s100960050445; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hof Susan V, 2010, SYSTEMATIC REV ROLE; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Naidoo P, 2016, INT J TUBERC LUNG D, V20, P1377, DOI 10.5588/ijtld.16.0081; Naidoo P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150487; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Naidoo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103328; National Institute for Communicable Diseases, 2016, S AFR TUB DRUG RES S; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Rifat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105214; Schnippel K, 2015, INT J INFECT DIS, V39, P89, DOI 10.1016/j.ijid.2015.09.002; Seddon JA, 2012, EMERG INFECT DIS, V18, P1342, DOI 10.3201/eid1808.111650; Smith A, 2016, INT J TUBERC LUNG D, V20, P350, DOI 10.5588/ijtld.15.0312; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2013, MTB RIF ASSAY PULMON; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2015, GLOB TUB REP 2015	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172143	10.1371/journal.pone.0172143	http://dx.doi.org/10.1371/journal.pone.0172143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199375	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400076
J	Nkuipou-Kenfack, E; Schanstra, JP; Bajwa, S; Pejchinovski, M; Vinel, C; Dray, C; Valet, P; Bascands, JL; Vlahou, A; Koeck, T; Borries, M; Busch, H; Bechtel-Walz, W; Huber, TB; Rudolph, KL; Pich, A; Mischak, H; Zurbig, P				Nkuipou-Kenfack, Esther; Schanstra, Joost P.; Bajwa, Seerat; Pejchinovski, Martin; Vinel, Claire; Dray, Cedric; Valet, Philippe; Bascands, Jean-Loup; Vlahou, Antonia; Koeck, Thomas; Borries, Melanie; Busch, Hauke; Bechtel-Walz, Wibke; Huber, Tobias B.; Rudolph, Karl L.; Pich, Andreas; Mischak, Harald; Zuerbig, Petra			The use of urinary proteomics in the assessment of suitability of mouse models for ageing	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; COLLAGEN; KIDNEY; SKIN; BIOMARKERS; CANCER; AGE	Ageing is a complex process characterised by a systemic and progressive deterioration of biological functions. As ageing is associated with an increased prevalence of age related chronic disorders, understanding its underlying molecular mechanisms can pave the way for therapeutic interventions and managing complications. Animal models such as mice are commonly used in ageing research as they have a shorter lifespan in comparison to humans and are also genetically close to humans. To assess the translatability of mouse ageing to human ageing, the urinary proteome in 89 wild-type (C57BL/6) mice aged between 8-96 weeks was investigated using capillary electrophoresis coupled to mass spectrometry (CE-MS). Using age as a continuous variable, 295 peptides significantly correlated with age in mice were identified. To investigate the relevance of using mouse models in human ageing studies, a comparison was performed with a previous correlation analysis using 1227 healthy subjects. In mice and humans, a decrease in urinary excretion of fibrillar collagens and an increase of uromodulin fragments was observed with advanced age. Of the 295 peptides correlating with age, 49 had a strong homology to the respective human age-related peptides. These ortholog peptides including several collagen (N = 44) and uromodulin (N = 5) fragments were used to generate an ageing classifier that was able to discriminate the age among both wild-type mice and healthy subjects. Additionally, the ageing classifier depicted that telomerase knock-out mice were older than their chronological age. Hence, with a focus on ortholog urinary peptides mouse ageing can be translated to human ageing.	[Nkuipou-Kenfack, Esther; Borries, Melanie; Zuerbig, Petra] Mosa Diagnost GmbH, Hannover, Germany; [Bajwa, Seerat; Valet, Philippe; Koeck, Thomas] Hannover Med Sch, Core Facil Prote, Hannover, Germany; [Pejchinovski, Martin; Bascands, Jean-Loup; Borries, Melanie] INSERM, U1048, Inst Cardiovasc & Metab Dis, Toulouse, France; [Vinel, Claire; Koeck, Thomas; Huber, Tobias B.; Rudolph, Karl L.] Univ Toulouse III Paul Sabatier, Toulouse, France; [Schanstra, Joost P.; Vinel, Claire; Bascands, Jean-Loup; Koeck, Thomas] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Bajwa, Seerat; Bechtel-Walz, Wibke; Pich, Andreas] Plateforme CYROI, Diabet Atherothrombose Thrapies Re Union Oce Indi, Inserm UMR, St Clotilde, Reunion, France; [Pejchinovski, Martin; Valet, Philippe] Biomed Res Fdn Acad Athens, Div Biotechnol, Athens, Greece; [Bajwa, Seerat; Bascands, Jean-Loup; Bechtel-Walz, Wibke; Mischak, Harald] Albert Ludwigs Univ, Inst Mol Med & Cell Res, Cellular Microenvironment Grp, Syst Biol, Freiburg Im Breisgau, Germany; [Vinel, Claire; Vlahou, Antonia; Bechtel-Walz, Wibke; Rudolph, Karl L.] Freiburg & German Canc Res Ctr DKFZ, German Canc Consortium DKTK, Heidelberg, Germany; [Bajwa, Seerat; Bechtel-Walz, Wibke; Pich, Andreas] Univ Hosp Freiburg, Freiburg, Germany; [Bajwa, Seerat; Bascands, Jean-Loup; Borries, Melanie; Busch, Hauke] Univ Freiburg, Dept Med 4, Med Ctr, Fac Med, Freiburg, Germany; [Bajwa, Seerat; Borries, Melanie; Rudolph, Karl L.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Bajwa, Seerat; Valet, Philippe; Koeck, Thomas; Bechtel-Walz, Wibke] Albert Ludwigs Univ Freiburg, Ctr Syst Biol ZBSA, Freiburg, Germany; [Dray, Cedric; Koeck, Thomas; Bechtel-Walz, Wibke] Albert Ludwigs Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Freiburg, Germany; [Schanstra, Joost P.; Vinel, Claire; Borries, Melanie; Rudolph, Karl L.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	Modular Open Systems Approach (MOSA) Solutions; Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Institut National de la Sante et de la Recherche Medicale (Inserm); Academy of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Glasgow	Zurbig, P (corresponding author), Mosa Diagnost GmbH, Hannover, Germany.	zuerbig@mosaiques-diagnostics.com	Busch, Hauke/R-6452-2016; Schanstra, Joost P/X-7724-2018; Valet, Philippe/N-7472-2017; dray, cedric/N-7440-2017	Busch, Hauke/0000-0003-4763-4521; Schanstra, Joost P/0000-0002-7471-372X; Valet, Philippe/0000-0001-6520-7393; DRAY, Cedric/0000-0002-4712-791X; Bascands, Jean-loup/0000-0002-1667-5913; Bechtel-Walz, Wibke/0000-0001-6032-3627; Vinel, Claire/0000-0003-3329-321X; Zurbig, Petra/0000-0003-3465-2173; Mischak, Harald/0000-0003-0323-0306; Vlahou, Antonia/0000-0003-3284-5713; Huber, Tobias B./0000-0001-7175-5062	FP7-PEOPLE-ITN program [GA 31354]; BMBF Gerontosys II project (NephAge) [031 5896A]; Marie Curie EU grant [293568]; Margarete von Wrangell Habilitationsprogramm, (Ministerium fur Wissenschaft Baden-Wurttemberg); Mathilde-Wagner-Habilitationspreis; German Research Foundation (DFG) [CRC 992]; Heisenberg program; European Research Council-ERC grant [616891]; BMBF-STOP-FSGS [01GM1518C]; Excellence Initiative of the German Federal and State Governments [EXC294, BIOSS II]	FP7-PEOPLE-ITN program; BMBF Gerontosys II project (NephAge)(Federal Ministry of Education & Research (BMBF)); Marie Curie EU grant(European Commission); Margarete von Wrangell Habilitationsprogramm, (Ministerium fur Wissenschaft Baden-Wurttemberg); Mathilde-Wagner-Habilitationspreis; German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg program(German Research Foundation (DFG)); European Research Council-ERC grant(European Research Council (ERC)); BMBF-STOP-FSGS; Excellence Initiative of the German Federal and State Governments	The project was partly funded by grant GA 31354 (CodeAge) FP7-PEOPLE-2011-ITN program (to HM and ENK), BMBF Gerontosys II project (NephAge, 031 5896A) (to PZ, MB, WBW and TBH), by a Marie Curie EU grant (CIG 293568) (to WBW), by the Margarete von Wrangell Habilitationsprogramm, (Ministerium fur Wissenschaft Baden-Wurttemberg) (to WBW), by the Mathilde-Wagner-Habilitationspreis (to WBW), by the German Research Foundation (DFG): CRC 992 (to TBH) and Heisenberg program (to TBH), by the European Research Council-ERC grant 616891 (to TBH); by the BMBF-STOP-FSGS 01GM1518C (to TBH), and by the Excellence Initiative of the German Federal and State Governments (EXC294, BIOSS II to TBH). The funders provided support in the form of salaries for authors [ENK, SB, MP, TK, MB, WBW, TBH, KLR, HM and PZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arab S, 2006, J AM COLL CARDIOL, V48, P1733, DOI 10.1016/j.jacc.2006.06.063; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Burkhardt AM, 2013, CELL MOL IMMUNOL, V10, P373, DOI 10.1038/cmi.2013.19; Dissard R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076703; Ganceviciene R, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22804; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Gu YM, 2014, NEPHROL DIAL TRANSPL; HAMLIN CR, 1972, EXP GERONTOL, V7, P377, DOI 10.1016/0531-5565(72)90061-7; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Klein J, 2016, URINARY PEPTIDOMICS; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Nkuipou-Kenfack E, 2015, ONCOTARGET; Nkuipou-Kenfack E, 2014, AGEING RES REV, V18, P74, DOI 10.1016/j.arr.2014.09.002; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; R Core Team, 2018, R LANG ENV STAT COMP; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rodriguez-Feo JA, 2005, CURR PHARM DESIGN, V11, P2501, DOI 10.2174/1381612054367544; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schanstra JP, 2015, J AM SOC NEPHROL; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Stevenson K, 2006, MOL CELL BIOCHEM, V283, P107, DOI 10.1007/s11010-006-2388-1; Vafaie F, 2014, AGING CELL, V13, P121, DOI 10.1111/acel.12155; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; von zur Muhlen C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013847; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2009, PROTEOMICS, V9, P2108, DOI 10.1002/pmic.200800560	34	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0166875	10.1371/journal.pone.0166875	http://dx.doi.org/10.1371/journal.pone.0166875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199320	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000394424400002
J	Chewchuk, S; Guo, BQ; Parissenti, AM				Chewchuk, Simon; Guo, Baoqing; Parissenti, Amadeo Mark			Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells	PLOS ONE			English	Article							ALDO-KETO REDUCTASES; CANCER-CELLS; ENDOCRINE THERAPY; RECEPTOR-ALPHA; MCF-7 CELLS; NEOADJUVANT CHEMOTHERAPY; DOXORUBICIN RESISTANCE; DRUG-RESISTANCE; GROWTH-FACTORS; ER-ALPHA	Intrinsic or acquired drug resistance is a major impediment to the successful treatment of women with breast cancer using chemotherapy. We have observed that MCF-7 breast tumor cells selected for resistance to doxorubicin or epirubicin (MCF-7(DOX2) and MCF-(7EPI) cells, respectively) exhibited increased expression of several members of the aldo-keto reductase (AKR) gene family (in particular AKR1C3 and AKR1B10) relative to control MCF-7(CC) cells selected by propagation in the absence of drug. Normal cellular roles for the AKRs include the promotion of estrogen (E2) synthesis from estrone (E1) and the hydroxylation and detoxification of exogenous xenobiotics such as anthracycline chemotherapy drugs. While hydroxylation of anthracyclines strongly attenuates their cytotoxicity, it is unclear whether the enhanced AKR expression in the above anthracycline-resistant cells promotes E2 synthesis and/or alterations in E2 signalling pathways and whether such changes contribute to enhanced survival and anthracycline resistance. To determine the role of AKRs and E2 pathways in doxorubicin resistance, we examined changes in the expression of E2 related genes and proteins upon acquisition of doxorubicin resistance. We also assessed the effects of AKR overexpression or downregulation or the effects of activators or inhibitors of E2-dependent pathways on previously acquired resistance to doxorubicin. In this study we observed that the enhanced AKR expression upon acquisition of anthracycline resistance was, in fact, associated with enhanced E2 production. However, the expression of estrogen receptor alpha (ER alpha) was reduced by 2- to 5-fold at the gene transcript level and 2-to 20-fold at the protein level upon acquisition of anthracycline resistance. This was accompanied by an even stronger reduction in ERa phosphorylation and activity, including highly suppressed expression of two proteins under E2-dependent control (Bcl-2 and cyclin D1). The diminished Bcl-2 and cyclin D1 expression would be expected to reduce the growth rate of the cells, a hypothesis which was confirmed in subsequent cell proliferation experiments. AKR1C3 or AKR1B10overexpression alone had no effect on doxorubicin sensitivity in MCF-7(CC) cells, while siRNA-mediated knockdown of AKR1C3 and/or AKR1B10 expression had no significant effect on sensitivity to doxorubicin in MCF-7(DOX2) or MCF-7(EPI) cells. This suggested that enhanced or reduced AKR expression/activity is insufficient to conferanthracycline resistance or sensitivity to breast tumor cells, respectively. Rather, it would appear that AKR overexpression acts in concert with other proteins to confer anthracycline resistance, including reduced E2-dependent expression of both an important apoptosis inhibitor (Bcl-2) and a key protein associated with activation of cell cycle-dependent kinases (cyclin D1).	[Chewchuk, Simon; Parissenti, Amadeo Mark] Laurentian Univ, PhD Program Biomol Sci, Sudbury, ON, Canada; [Guo, Baoqing; Parissenti, Amadeo Mark] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Parissenti, Amadeo Mark] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [Parissenti, Amadeo Mark] Univ Ottawa, Div Oncol, Fac Med, Ottawa, ON, Canada	Laurentian University; Health Sciences North; Northern Ontario School of Medicine; Northern Ontario School of Medicine; University of Ottawa	Guo, BQ (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.	aparissenti@amric.ca			Canadian Institutes of Health Research [MOP-89993]; Northern Cancer Foundation of Sudbury	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern Cancer Foundation of Sudbury	This study was supported, in part, by a grant from the Canadian Institutes of Health Research (MOP-89993). Core funding to support this work is also acknowledged from the Northern Cancer Foundation of Sudbury.	Almeida M, 2006, ENDOCRINOLOGY, V147, P1986, DOI 10.1210/en.2005-1314; Arendt LM, 2015, J MAMMARY GLAND BIOL, V20, P9, DOI 10.1007/s10911-015-9337-0; Barnadas A, 2008, ANTI-CANCER DRUG, V19, P339, DOI 10.1097/CAD.0b013e3282f97f75; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Bartlett JMS, 2011, J CLIN ONCOL, V29, P1531, DOI 10.1200/JCO.2010.30.3677; BONNEY RC, 1983, CLIN ENDOCRINOL, V19, P727, DOI 10.1111/j.1365-2265.1983.tb00051.x; Burow ME, 2001, J STEROID BIOCHEM, V78, P409, DOI 10.1016/S0960-0760(01)00117-0; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Chantzi MI, 2013, J CANCER RES CLIN, V139, P1489, DOI 10.1007/s00432-013-1467-4; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; DARBRE P, 1983, CANCER RES, V43, P349; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Gaui MDD, 2007, AM J CLIN ONCOL-CANC, V30, P78, DOI 10.1097/01.coc.0000245475.41324.6d; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Guo LY, 2015, EXP THER MED, V9, P2147, DOI 10.3892/etm.2015.2380; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Heibein AD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-381; Hembruff SL, 2005, ANAL BIOCHEM, V345, P237, DOI 10.1016/j.ab.2005.07.014; Hembruff SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-318; Herold CI, 2008, CLIN BREAST CANCER, V8, P50, DOI 10.3816/CBC.2008.n.003; Hirata T, 2009, BRIT J CANCER, V101, P1529, DOI 10.1038/sj.bjc.6605360; Hofman J, 2014, TOXICOL APPL PHARM, V278, P238, DOI 10.1016/j.taap.2014.04.027; Ishizuna Kazuo, 2013, BMC Res Notes, V6, P254, DOI 10.1186/1756-0500-6-254; Jin Y, 2006, STEROIDS, V71, P380, DOI 10.1016/j.steroids.2005.12.002; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; KOMIYAMA T, 1983, BIOCHIM BIOPHYS ACTA, V740, P80, DOI 10.1016/0167-4781(83)90124-0; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Leung LK, 1999, BRIT J CANCER, V81, P387, DOI 10.1038/sj.bjc.6690706; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li YW, 2011, J CELL BIOCHEM, V112, P217, DOI 10.1002/jcb.22922; Matsunaga T, 2014, ANTI-CANCER DRUG, V25, P868, DOI 10.1097/CAD.0000000000000112; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; O'Driscoll L, 2006, CHEMOTHERAPY, V52, P125, DOI 10.1159/000092540; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pennery E, 2008, EUR J ONCOL NURS, V12, P233, DOI 10.1016/j.ejon.2008.01.007; Penning TM, 2001, MOL CELL ENDOCRINOL, V171, P137, DOI 10.1016/S0303-7207(00)00426-3; POMMERENKE E, 1994, J CANCER RES CLIN, V120, P422, DOI 10.1007/BF01240142; Ram PT, 1998, MOL CELL ENDOCRINOL, V141, P53, DOI 10.1016/S0303-7207(98)00095-1; Rastogi P, 2013, AM SOC CLIN ONCOL ED, V33, P73; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rizner TL, 2006, MOL CELL ENDOCRINOL, V248, P126, DOI 10.1016/j.mce.2005.10.009; Rochefort H, 1995, CIBA F SYMP, V191, P254; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Sasano H, 2008, J STEROID BIOCHEM, V108, P181, DOI 10.1016/j.jsbmb.2007.09.012; Savatier J, 2012, LEUKEMIA RES, V36, P791, DOI 10.1016/j.leukres.2012.02.017; Schiavon G, 2013, HEMATOL ONCOL CLIN N, V27, P715, DOI 10.1016/j.hoc.2013.05.004; Shields-Botella J, 2005, J STEROID BIOCHEM, V93, P1, DOI 10.1016/j.jsbmb.2004.11.004; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Sundar SN, 2008, CARCINOGENESIS, V29, P2252, DOI 10.1093/carcin/bgn214; Tanos T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3166; Toldo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058421; Turner N, 2015, LANCET ONCOL, V16, pE362, DOI 10.1016/S1470-2045(15)00079-0; Veitch ZW, 2009, PHARMACOGENET GENOM, V19, P477, DOI 10.1097/FPC.0b013e32832c484b; Vihko P, 2001, MOL CELL ENDOCRINOL, V171, P71, DOI 10.1016/S0303-7207(00)00389-0; WILSON RG, 1981, CHEM-BIOL INTERACT, V37, P351, DOI 10.1016/0009-2797(81)90120-4; Zhong T, 2015, BIOMED PHARMACOTHER, V69, P317, DOI 10.1016/j.biopha.2014.12.022	61	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172244	10.1371/journal.pone.0172244	http://dx.doi.org/10.1371/journal.pone.0172244			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196134	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900064
J	Moran-Ramos, S; He, X; Chin, EL; Tovar, AR; Torres, N; Slupsky, CM; Raybould, HE				Moran-Ramos, Sofia; He, Xuan; Chin, Elizabeth L.; Tovar, Armando R.; Torres, Nimbe; Slupsky, Carolyn M.; Raybould, Helen E.			Nopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OPUNTIA-FICUS-INDICA; GUT MICROBIOTA; OXIDATIVE STRESS; BETAINE; LIVER; MICE; MECHANISM; INSULIN; GLUCOSE	Nopal is a cactus plant widely consumed in Mexico that has been used in traditional medicine to aid in the treatment of type-2 diabetes. We previously showed that chronic consumption of dehydrated nopal ameliorated hepatic steatosis in obese (fa/fa) rats; however, description of the effects on other tissues is sparse. The aim of the present study was to investigate the effects of nopal cladode consumption on intestinal physiology, microbial community structure, adipose tissue, and serum biochemistry in diet-induced obese rats. Rats were fed either a normal fat (NF) diet or a HF diet containing 4% of dietary fiber from either nopal or cellulose for 6 weeks. Consumption of nopal counteracted HF-induced adiposity and adipocyte hypertrophy, and induced profound changes in intestinal physiology. Nopal consumption reduced biomarkers of intestinal inflammation (mRNA expression of IL-6) and oxidative stress (ROS), modfied gut microbiota composition, increasing microbial diversity and cecal fermentation (SCFA), and altered the serum metabolome. Interestingly, metabolomic analysis of dehydrated nopal revealed a high choline content, which appeared to generate high levels of serum betaine, that correlated negatively with hepatic triglyceride (TAG) levels. A parallel decrease in some of the taxa associated with the production of trimethylamine, suggest an increase in choline absorption and bioavailability with transformation to betaine. The latter may partially explain the previously observed effect of nopal on the development of hepatic steatosis. In conclusion, this study provides new evidence on the effects of nopal consumption on normal and HF-diet induced changes in the intestine, the liver and systemic metabolism.	[Moran-Ramos, Sofia; Tovar, Armando R.; Torres, Nimbe] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City, DF, Mexico; [Moran-Ramos, Sofia] Inst Nacl Med Genom, Unidad Genom Poblac, Conacyt, Mexico City, DF, Mexico; [He, Xuan; Chin, Elizabeth L.; Slupsky, Carolyn M.] Univ Calif Davis, Dept Food Sci & Technol, One Shields Ave, Davis, CA 95616 USA; [He, Xuan; Slupsky, Carolyn M.] Univ Calif Davis, Dept Nutr, One Shields Ave, Davis, CA 95616 USA; [Raybould, Helen E.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, One Shields Ave, Davis, CA 95616 USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Medicina Genomica; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Raybould, HE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, One Shields Ave, Davis, CA 95616 USA.	heraybould@ucdavis.edu	Torres, Nimbe/AAY-8821-2020; Moran, Sofia/AAK-8815-2021; Torres, Nimbe/AAI-4340-2020	Torres, Nimbe/0000-0002-1741-0984; Chin, Elizabeth/0000-0003-1395-1836	National Institute of Health [DK41004]; USDA National Institute of Food and Agriculture Hatch Project [1005945]; Conacyt Scholarship Mexico	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture Hatch Project; Conacyt Scholarship Mexico	This work was supported by the National Institute of Health DK41004 (HR); USDA National Institute of Food and Agriculture Hatch Project 1005945 (CS); Conacyt Scholarship Mexico (S M-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Aguilar FJ, 2003, P W PHARMACOL SOC, V46, P139; Bielohuby M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1059, DOI 10.1152/ajpendo.00208.2013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chen HC, 2002, J LIPID RES, V43, P986; Chen YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19076; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Erdelyi I, 2009, J NUTR, V139, P2072, DOI 10.3945/jn.108.104125; Feugang JM, 2006, FRONT BIOSCI-LANDMRK, V11, P2574, DOI 10.2741/1992; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRATIMUNARI AC, 1983, ARCH INVEST MED, V14, P117; FRATIMUNARI AC, 1983, ARCH INVEST MED, V14, P269; Guevara-Cruz M, 2012, J NUTR, V142, P64, DOI 10.3945/jn.111.147447; He X, 2014, J PROTEOME RES, V13, P5281, DOI 10.1021/pr500629t; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kim A, 2015, J CLIN GASTROENTEROL, V49, pS20, DOI 10.1097/MCG.0000000000000356; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kong LC, 2013, AM J CLIN NUTR, V98, P16, DOI 10.3945/ajcn.113.058743; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Luo CA, 2010, CHEM BIODIVERS, V7, P2869, DOI 10.1002/cbdv.201000077; Matsuzawa Toshiaki, 1997, Journal of Toxicological Sciences, V22, P25; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Neyrinck AM, 2009, INT IMMUNOPHARMACOL, V9, P767, DOI 10.1016/j.intimp.2009.02.015; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806; Orozco-Ibarra M, 2007, TOXICOLOGY, V229, P123, DOI 10.1016/j.tox.2006.10.008; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pedersen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056612; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao Y, 2013, APPL MICROBIOL BIOT, V97, P1689, DOI 10.1007/s00253-012-4323-6; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Torres N, 2015, ARCH MED RES, V46, P408, DOI 10.1016/j.arcmed.2015.05.010; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Wang LJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-34; Wang ZG, 2010, AM J PHYSIOL-GASTR L, V298, pG634, DOI 10.1152/ajpgi.00249.2009; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Ye JHQ, 2009, WORLD J GASTROENTERO, V15, P4491, DOI 10.3748/wjg.15.4491; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	60	18	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171672	10.1371/journal.pone.0171672	http://dx.doi.org/10.1371/journal.pone.0171672			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196086	Green Published, gold			2022-12-26	WOS:000394423900028
J	Tanaka, KR; Belknap, SL; Homola, JJ; Chen, Y				Tanaka, Kisei R.; Belknap, Samuel L.; Homola, Jared J.; Chen, Yong			A statistical model for monitoring shell disease in inshore lobster fisheries: A case study in Long Island Sound	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SQUID OMMASTREPHES-BARTRAMII; WINTER-SPRING COHORT; SOUTHERN NEW-ENGLAND; AMERICAN LOBSTER; HOMARUS-AMERICANUS; SPATIOTEMPORAL VARIABILITY; SPATIAL-DISTRIBUTION; SPECIES ABUNDANCE; COASTAL WATERS	The expansion of shell disease is an emerging threat to the inshore lobster fisheries in the northeastern United States. The development of models to improve the efficiency and precision of existing monitoring programs is advocated as an important step in mitigating its harmful effects. The objective of this study is to construct a statistical model that could enhance the existing monitoring effort through (1) identification of potential disease-associated abiotic and biotic factors, and (2) estimation of spatial variation in disease prevalence in the lobster fishery. A delta-generalized additive modeling (GAM) approach was applied using bottom trawl survey data collected from 2001 - 2013 in Long Island Sound, a tidal estuary between New York and Connecticut states. Spatial distribution of shell disease prevalence was found to be strongly influenced by the interactive effects of latitude and longitude, possibly indicative of a geographic origin of shell disease. Bottom temperature, bottom salinity, and depth were also important factors affecting the spatial variability in shell disease prevalence. The delta-GAM projected high disease prevalence in non-surveyed locations. Additionally, a potential spatial discrepancy was found between modeled disease hotspots and survey-based gravity centers of disease prevalence. This study provides a modeling framework to enhance research, monitoring and management of emerging and continuing marine disease threats.	[Tanaka, Kisei R.; Chen, Yong] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Tanaka, Kisei R.; Belknap, Samuel L.; Homola, Jared J.; Chen, Yong] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Belknap, Samuel L.] Univ Maine, Dept Anthropol, Orono, ME USA; [Homola, Jared J.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Tanaka, KR (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.; Tanaka, KR (corresponding author), Univ Maine, Climate Change Inst, Orono, ME 04469 USA.	kisei.tanaka@maine.edu		Tanaka, Kisei/0000-0002-1901-6972	National Science Foundation Adaptation to Abrupt Climate Change Integrative Graduate Education and Research Traineeship program [1144423]; National Science Foundation Coastal Science, Engineering and Education for Sustainability program [1325369]; Maine Sea Grant College Program	National Science Foundation Adaptation to Abrupt Climate Change Integrative Graduate Education and Research Traineeship program; National Science Foundation Coastal Science, Engineering and Education for Sustainability program; Maine Sea Grant College Program	Financial support for this study was provided by National Science Foundation Adaptation to Abrupt Climate Change Integrative Graduate Education and Research Traineeship program (grant number 1144423, URL http://www.igert.org/projects/297), National Science Foundation Coastal Science, Engineering and Education for Sustainability program (grant number 1325369, URL http://www.nsf.gov/awardsearch/showAward?AWD_ID=1325369, and Maine Sea Grant College Program.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2010, MAPPING SPECIES DIST; Atlantic States Marine Fisheries Commision (ASMFC), 2012, ADD 17 SO NEW ENGL M; Atlantic States Marine Fisheries Commission American Lobster Stock Assessment Review Panel, 2015, AM LOBST STOCK ASS R; Atlantic States Marine Fisheries Commission American Lobster Stock Assessment Subcommittee, 2009, 0901 ATL STAT MAR FI, V1; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Benson J, 2013, THE DAY; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Cao J, 2009, MAR ECOL PROG SER, V381, P119, DOI 10.3354/meps07969; Castro K., 2005, AQUATIC FORUM SERIES; Castro KM, 2006, J CRUSTACEAN BIOL, V26, P646, DOI 10.1651/S-2761a.1; Castro KM, 2012, J SHELLFISH RES, V31, P423, DOI 10.2983/035.031.0202; Chang J-H, 2010, SPATIAL TEMPORAL COH, P2010; Chang JH, 2010, MAR ECOL PROG SER, V420, P145, DOI 10.3354/meps08849; Chen C., 2006, OCEANOGRAPHY, V19, P78, DOI [DOI 10.5670/OCEANOG.2006.92, 10.5670/oceanog.2006.92]; Chen XJ, 2008, FISH RES, V92, P221, DOI 10.1016/j.fishres.2008.01.011; Cobb J. S., 2006, SHELL DIS LOBSTERS S; Connecticut Department of Energy and Environmental Protection, 2013, STUD MAR RECR FISH C; Crossin GT, 1998, J EXP BIOL, V201, P365; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Glenn RP, 2006, J CRUSTACEAN BIOL, V26, P639, DOI 10.1651/S-2754.1; Gottschall K, 2013, STUDY MARINE RECREAT; Gottschall K, 2013, LONG ISLAND SOUND TR; Groner ML, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0364; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Harding GC, 1992, AM LOBSTER HOMARUS A, P49; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hess E., 1937, Journal of the Biological Board of Canada, V3, P358; Horodysky AZ, 2015, REV FISH BIOL FISHER, V25, P425, DOI 10.1007/s11160-015-9393-y; Howell P, 2012, J SHELLFISH RES, V31, P573, DOI 10.2983/035.031.0217; Jacobs M, 2012, J SHELLFISH RES, V31, P563, DOI 10.2983/035.031.0216; Jensen OP, 2005, MAR ECOL PROG SER, V299, P239, DOI 10.3354/meps299239; JURY SH, 1994, J EXP MAR BIOL ECOL, V180, P23, DOI 10.1016/0022-0981(94)90076-0; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Lacurci J, 2014, NATURE WORLD NE 0908; Landers D.F, 2005, AQUATIC FORUM SERIES, P94; Laufer H, 2013, CAN J FISH AQUAT SCI, V70, P1588, DOI 10.1139/cjfas-2013-0148; Laufer H, 2012, J SHELLFISH RES, V31, P555, DOI 10.2983/035.031.0215; Lee YJ, 2008, ESTUAR COAST SHELF S, V76, P187, DOI 10.1016/j.ecss.2007.07.001; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Li B, 2015, N AM J FISH MANAGE, V35, P942, DOI 10.1080/02755947.2015.1074961; Loots C, 2010, ICES J MAR SCI, V67, P244, DOI 10.1093/icesjms/fsp238; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Maynard J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0208; McCreesh Nicky, 2015, Parasites & Vectors, V8, P4, DOI 10.1186/s13071-014-0617-0; Mercaldo- Allen R., 1994, NMFSNE105 NOAA; Meres NJ, 2012, J SHELLFISH RES, V31, P463, DOI 10.2983/035.031.0206; National Marine Fisheries Service (NMFS), ANN COMM LAND STAT; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pedersen Ulrik B., 2014, Geospatial Health, V8, P335; Poppe LJ, 2000, 00304 US GEOL SURV; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; RICHARDS LJ, 1986, CAN J FISH AQUAT SCI, V43, P1214, DOI 10.1139/f86-151; Robohm RA, 2005, J SHELLFISH RES, V24, P773; Rooper CN, 2016, MAR ECOL PROG SER, V551, P117, DOI 10.3354/meps11703; Rooper CN, 2014, MAR ECOL PROG SER, V503, P157, DOI 10.3354/meps10710; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P847, DOI 10.1139/cjfas-2013-0342; Shelton AO, 2014, CAN J FISH AQUAT SCI, V71, P1655, DOI 10.1139/cjfas-2013-0508; Shields JD, 2013, CAN J FISH AQUAT SCI, V70, P1576, DOI 10.1139/cjfas-2013-0050; Sissenwine M.P., 1978, INTERNATIONAL COMMISSION FOR THE NORTHWEST ATLANTIC FISHERIES RESEARCH BULLETIN, P81; SMOLOWITZ RM, 1992, BIOL BULL, V183, P99, DOI 10.2307/1542411; Stevens BG, 2009, DIS AQUAT ORGAN, V78, P249; Tanaka K, 2016, FISH RES, V177, P137, DOI 10.1016/j.fishres.2016.01.010; Tanaka K, 2015, J SHELLFISH RES, V34, P531, DOI 10.2983/035.034.0238; Tlusty MF, 2007, J AQUAT ANIM HEALTH, V19, P215, DOI 10.1577/H06-014.1; Tlusty MF, 2008, DIS AQUAT ORGAN, V78, P249, DOI 10.3354/dao01867; Tlusty MF, 2012, J SHELLFISH RES, V31, P533, DOI 10.2983/035.031.0213; Truesdell S., 2013, MODELING JUVENILE AT; Tseng CT, 2011, ICES J MAR SCI, V68, P1105, DOI 10.1093/icesjms/fsr070; Winton MV, 2014, CAN J FISH AQUAT SCI, V71, P1279, DOI 10.1139/cjfas-2013-0617; Wood S., 2011, GAMS R GEN ADDITIVE; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Yasuda T, 2014, MAR ECOL PROG SER, V501, P239, DOI 10.3354/meps10679; Zhang H, 2015, J APPL ICHTHYOL, V31, P646, DOI 10.1111/jai.12765; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1; [No title captured]	81	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172123	10.1371/journal.pone.0172123	http://dx.doi.org/10.1371/journal.pone.0172123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196150	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900052
J	Zielke, C; Kosik, O; Ainalem, ML; Lovegrove, A; Stradner, A; Nilsson, L				Zielke, Claudia; Kosik, Ondrej; Ainalem, Marie-Louise; Lovegrove, Alison; Stradner, Anna; Nilsson, Lars			Characterization of cereal beta-glucan extracts from oat and barley and quantification of proteinaceous matter	PLOS ONE			English	Article							FIELD-FLOW FRACTIONATION; MOLECULAR-WEIGHT; PHYSICOCHEMICAL PROPERTIES; PHYSICAL-PROPERTIES; SOLUTION BEHAVIOR; MOLAR-MASS; PART I.; WATER; MACROMOLECULES; SOLUBILITY	An extraction method for mixed-linkage beta-glucan from oat and barley was developed in order to minimize the effect of extraction on the beta-glucan structure. beta-Glucan were characterized in terms of molecular size and molar mass distributions using asymmetric flow field flow fractionation (AF4) coupled to multiangle light scattering (MALS), differential refractive index (dRI) and fluorescence (FL) detection. The carbohydrate composition of the extracts was analysed using polysaccharide analysis by carbohydrate gel electrophoresis (PACE) and high-performance anion-exchange chromatography (HPAEC). Whether there were any proteinaceous moieties linked to beta-glucan was also examined. Purified extracts contained 65% and 53% 6-glucan for oats and barley, respectively. The main impurities were degradation products of starch. The extracts contained high molecular weight beta-glucan (10(5)-10(8) g/ mol) and large sizes (root-mean-square radii from 20 to 140 nm). No proteins covalently bound to beta-glucan were detected; therefore, any suggested functionality of proteins regarding the health benefits of beta-glucan can be discounted.	[Zielke, Claudia; Nilsson, Lars] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Kosik, Ondrej; Lovegrove, Alison] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Ainalem, Marie-Louise] European Spallat Source ESS AB, Lund, Sweden; [Stradner, Anna] Lund Univ, Dept Phys Chem, Lund, Sweden	Lund University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; European Spallation Source (ESS); Lund University	Zielke, C (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden.	claudia.zielke@food.lth.se	Zielke, Claudia/I-5864-2019; Kosik, Ondrej/AAR-1206-2021; Stradner, Anna/B-5195-2015	Kosik, Ondrej/0000-0003-3117-0224; Stradner, Anna/0000-0003-3310-3412; Zielke, Claudia/0000-0003-4654-4903	Swedish research council (VR), Stockholm, Sweden; Biotechnology and Biological Sciences Research Council of the United Kingdom; European Spallation Source ESS AB; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005206] Funding Source: researchfish; BBSRC [BBS/E/C/000I0250, BB/J019380/1, BBS/E/C/00005206, BB/I00582X/1] Funding Source: UKRI	Swedish research council (VR), Stockholm, Sweden(Swedish Research Council); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Spallation Source ESS AB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support was provided by the Swedish research council (VR), Stockholm, Sweden and from the Biotechnology and Biological Sciences Research Council of the United Kingdom. The sponsors had no influence on study design, collection, analysis and interpretation of data, nor in writing the manuscript and neither in the decision to submit the article for publication. European Spallation Source ESS AB, provided support in the form of salaries for author MLA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER L., 1955, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung, V100, P180, DOI 10.1007/BF01713465; Ahmad A, 2012, CRIT REV FOOD SCI, V52, P201, DOI 10.1080/10408398.2010.499806; Ahmad A, 2010, INT J BIOL MACROMOL, V46, P304, DOI 10.1016/j.ijbiomac.2010.01.002; Ajayi AO, 2007, AFR J BIOTECHNOL, V6, P1181; Alftren J, 2012, FOOD HYDROCOLLOID, V26, P54, DOI 10.1016/j.foodhyd.2011.04.008; Alves LA, 2007, J CHEM ENG DATA, V52, P2166, DOI 10.1021/je700177n; Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+; Andersson M, 2001, ANAL CHEM, V73, P4852, DOI 10.1021/ac0104734; AUTIO K, 1992, FOOD HYDROCOLLOID, V5, P513, DOI 10.1016/S0268-005X(09)80121-5; Beer MU, 1997, CEREAL CHEM, V74, P476, DOI 10.1094/CCHEM.1997.74.4.476; BERRY GC, 1966, J CHEM PHYS, V44, P4550, DOI 10.1063/1.1726673; CALDWELL KD, 1979, SEPAR SCI TECHNOL, V14, P935, DOI 10.1080/01496397908058103; Cui SW, 2009, STRUCT CHEM, V20, P291, DOI 10.1007/s11224-009-9441-0; DAWKINS NL, 1993, J FOOD SCI, V58, P562, DOI 10.1111/j.1365-2621.1993.tb04324.x; Food and Drug Administration S, 2008, FED REGISTER, V73, P47828; FORREST IS, 1977, J I BREWING, V83, P279, DOI 10.1002/j.2050-0416.1977.tb03809.x; GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990; Gomez C, 1997, CARBOHYD POLYM, V34, P141, DOI 10.1016/S0144-8617(97)00134-3; Gong XC, 2012, J CHEM ENG DATA, V57, P3264, DOI 10.1021/je300885g; Goubet F, 2009, PLANT J, V60, P527, DOI 10.1111/j.1365-313X.2009.03977.x; Hakansson A, 2012, J CHROMATOGR A, V1253, P120, DOI 10.1016/j.chroma.2012.07.029; Hakansson A, 2012, CARBOHYD POLYM, V87, P518, DOI 10.1016/j.carbpol.2011.08.014; Immerstrand T, 2009, CEREAL CHEM, V86, P601, DOI 10.1094/CCHEM-86-6-0601; Izydorczyk MS, 2008, FOOD RES INT, V41, P850, DOI 10.1016/j.foodres.2008.04.001; JOHANSEN HN, 1993, J AGR FOOD CHEM, V41, P2347, DOI 10.1021/jf00036a025; Kim S, 2006, J FOOD COMPOS ANAL, V19, P466, DOI 10.1016/j.jfca.2005.11.006; Kosik O, 2012, METHOD ENZYMOL, V510, P51, DOI 10.1016/B978-0-12-415931-0.00004-5; Lazaridou A, 2007, J CEREAL SCI, V46, P101, DOI 10.1016/j.jcs.2007.05.003; Li W, 2011, FOOD HYDROCOLLOID, V25, P189, DOI 10.1016/j.foodhyd.2010.02.005; Nilsson L, 2013, FOOD HYDROCOLLOID, V30, P1, DOI 10.1016/j.foodhyd.2012.04.007; Papageorgiou M, 2005, J CEREAL SCI, V42, P213, DOI 10.1016/j.jcs.2005.03.002; Perez-Rea D, 2015, ANAL BIOANAL CHEM, V407, P4315, DOI 10.1007/s00216-015-8611-8; Robyt JF, 2009, FOOD SCI TECH-INT SE, P237, DOI 10.1016/B978-0-12-746275-2.00007-0; Tugel I, 2015, J I BREWING, V121, P44, DOI 10.1002/jib.195; U.S. Food and Drug Administration, 1992, FED REGISTER, V62, P15343; Ulmius M, 2012, FOOD CHEM, V130, P536, DOI 10.1016/j.foodchem.2011.07.066; Ulmius M, 2012, FOOD HYDROCOLLOID, V26, P175, DOI 10.1016/j.foodhyd.2011.05.004; VARUM KM, 1988, CARBOHYD POLYM, V9, P103, DOI 10.1016/0144-8617(88)90008-2; WAHLUND KG, 1987, ANAL CHEM, V59, P1332, DOI 10.1021/ac00136a016; Webster F. H., 2011, OATS CHEM TECHNOLOGY; Wolever TMS, 2010, AM J CLIN NUTR, V92, P723, DOI 10.3945/ajcn.2010.29174; Wood PJ, 2004, TRENDS FOOD SCI TECH, V15, P313, DOI 10.1016/j.tifs.2003.03.001; WOOD PJ, 1977, CEREAL CHEM, V54, P524; Zhou MX, 2000, J SCI FOOD AGR, V80, P1486, DOI 10.1002/1097-0010(200008)80:10<1486::AID-JSFA668>3.3.CO;2-R	44	23	25	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172034	10.1371/journal.pone.0172034	http://dx.doi.org/10.1371/journal.pone.0172034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196092	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900046
J	Sacco, NJ; Bonetto, MC; Corton, E				Sacco, Natalia J.; Celina Bonetto, M.; Corton, Eduardo			Isolation and Characterization of a Novel Electrogenic Bacterium, Dietzia sp RNV-4	PLOS ONE			English	Article							MICROBIAL FUEL-CELL; BIOFILMS; IDENTIFICATION; CANTHAXANTHIN; COMMUNITY; POWER; BIOELECTRICITY; VOLTAMMETRY; GENERATION; TRANSPORT	Electrogenic bacteria are organisms that can transfer electrons to extracellular electron acceptors and have the potential to be used in devices such as bioelectrochemical systems (BES). In this study, Dietzia sp. RNV-4 bacterium has been isolated and identified based on its biochemical, physiological and morphological characteristics, as well as by its 16S rRNA sequence analysis. Furthermore, the current density production and electron transfer mechanisms were investigated using bioelectrochemical methods. The chronoamperometric data showed that the biofilm of Dietzia sp. RNV-4 grew as the current increased with time, reaching a maximum of 176.6 +/- 66.1 mA/m(2) at the end of the experiment (7 d); this highly suggests that the current was generated by the biofilm. The main electron transfer mechanism, indicated by the cyclic voltammograms, was due to secreted redox mediators. By high performance liquid chromatography, canthaxanthin was identified as the main compound involved in charge transfer between the bacteria and the solid electrodes. Dietzia sp. RNV-4 was used as biological material in a microbial fuel cell (MFC) and the current density production was 299.4 +/- 40.2 mA/m(2). This is the first time that Dietzia sp. RNV-4 has been electrochemically characterized and identified as a new electrogenic strain.	[Sacco, Natalia J.] Univ Buenos Aires, Dept Quim Biol, Lab Biosensors & Bioanal LABB, Fac Ciencias Exactas & Nat, Ciudad Univ, Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Ciudad Univ, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Sacco, NJ (corresponding author), Univ Buenos Aires, Dept Quim Biol, Lab Biosensors & Bioanal LABB, Fac Ciencias Exactas & Nat, Ciudad Univ, Buenos Aires, DF, Argentina.	nsacco@qb.fcen.uba.ar	, EduardoCorton/AAE-6023-2019	Sacco, Natalia/0000-0003-3556-7018	Consejo Nacional de Investigaciones Cientfficas y Tecnicas [PIP 112-200801-00502]; Agencia Nacional de Prom ocion Cientifica y Tecnologica (Prestamo BID) [PICT 2013-0033, PICT 20140402]; EC; University of Buenos Aires; National Council for Scientific and Technological Research (CONICET) [PIP 112-200801-00502]; ANPCyT (Prestamo BID) [PICT 2013-0033, PICT 2014-0402]	Consejo Nacional de Investigaciones Cientfficas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Prom ocion Cientifica y Tecnologica (Prestamo BID); EC(European CommissionEuropean Commission Joint Research Centre); University of Buenos Aires(University of Buenos Aires); National Council for Scientific and Technological Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT (Prestamo BID)(ANPCyT)	This work was supported by the Consejo Nacional de Investigaciones Cientfficas y Tecnicas (PIP 112-200801-00502), and The Agencia Nacional de Prom ocion Cientifica y Tecnologica (Prestamo BID, PICT 2013-0033 and PICT 20140402). Funding was received by EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Buenos Aires, the National Council for Scientific and Technological Research (CONICET, PIP 112-200801-00502), and the ANPCyT (Prestamo BID, PICT 2013-0033 and PICT 2014-0402). We also want to thank to Lic. Fabian Tricarico for his help with SEM photography, to Dr. Laura J. Raiger Iustman for her contribution in this section of bioinformatics and phylogenetic analysis, and to Lic. Silvia Rodriguez, for editing our manuscript.	Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P591, DOI 10.1016/j.bios.2014.04.053; Abrevaya XC, 2015, BIOSENS BIOELECTRON, V63, P580, DOI 10.1016/j.bios.2014.04.034; Asker D, 1999, J BIOSCI BIOENG, V88, P617, DOI 10.1016/S1389-1723(00)87089-9; Bard A. J., 2001, ELECTROCHEMICAL METH; Baron D, 2009, J BIOL CHEM, V284, P28865, DOI 10.1074/jbc.M109.043455; Bhosale P, 2005, APPL MICROBIOL BIOT, V68, P445, DOI 10.1007/s00253-005-0032-8; Bodtker G, 2009, ANTON LEEUW INT J G, V96, P459, DOI 10.1007/s10482-009-9359-y; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Esfahani-Mashhour M, 2009, ASIAN AUSTRAL J ANIM, V22, P254, DOI 10.5713/ajas.2009.80202; GABY WL, 1957, J BACTERIOL, V74, P356, DOI 10.1128/JB.74.3.356-358.1957; Guo K, 2013, ENVIRON SCI TECHNOL, V47, P7563, DOI 10.1021/es400901u; Harnisch F, 2012, CHEM-ASIAN J, V7, P466, DOI 10.1002/asia.201100740; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Inoue K, 2011, ENV MICROBIOL REP, V3, P211, DOI 10.1111/j.1758-2229.2010.00210.x; Jain A, 2012, BIOELECTROCHEMISTRY, V87, P28, DOI 10.1016/j.bioelechem.2011.12.012; Jayashree C, 2016, J ENVIRON MANAGE, V180, P351, DOI 10.1016/j.jenvman.2016.05.050; Khodaiyan F, 2007, J MICROBIOL BIOTECHN, V17, P195; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Kumar R, 2016, RENEW SUST ENERG REV, V56, P1322, DOI 10.1016/j.rser.2015.12.029; Kumar R, 2015, INT J ENERG RES, V39, P1048, DOI 10.1002/er.3305; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Labelle E., 2009, INTEGRATED ENV TECHN; Lanthier M, 2008, FEMS MICROBIOL LETT, V278, P29, DOI 10.1111/j.1574-6968.2007.00964.x; Liu DZ, 2000, J ELECTROANAL CHEM, V488, P140, DOI 10.1016/S0022-0728(00)00205-9; Liu YM, 2014, ENV MICROBIOL REP, V6, P776, DOI 10.1111/1758-2229.12204; Logan B. E., 2008, MICROBIAL FUEL CELLS, P44; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Mahon CR, 2014, TXB DIAGNOSTIC MICRO; Malvankar NS, 2014, NAT NANOTECHNOL, V9, P1012, DOI [10.1038/nnano.2014.236, 10.1038/NNANO.2014.236]; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Merchant IA, 1969, VET BACTERIOLOGY VIR; NELIS HJ, 1991, J APPL BACTERIOL, V70, P181, DOI 10.1111/j.1365-2672.1991.tb02922.x; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Sacco NJ, 2012, BIORESOURCE TECHNOL, V126, P328, DOI 10.1016/j.biortech.2012.09.060; Samsudeen N, 2015, BIORESOURCE TECHNOL, V195, P242, DOI 10.1016/j.biortech.2015.07.023; Schaeffer A B, 1933, Science, V77, P194, DOI 10.1126/science.77.1990.194; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Velasquez-Orta SB, 2010, APPL MICROBIOL BIOT, V85, P1373, DOI 10.1007/s00253-009-2172-8; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; von der Weid I, 2007, SYST APPL MICROBIOL, V30, P331, DOI 10.1016/j.syapm.2006.11.001; Wang VB, 2014, ELECTROCHEM COMMUN, V41, P55, DOI 10.1016/j.elecom.2014.01.025; Watson VJ, 2010, BIOTECHNOL BIOENG, V105, P489, DOI 10.1002/bit.22556; Yumoto I, 2002, INT J SYST EVOL MICR, V52, P85, DOI 10.1099/00207713-52-1-85	51	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0169955	10.1371/journal.pone.0169955	http://dx.doi.org/10.1371/journal.pone.0169955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192491	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800007
J	Jin, L; Chun, J; Pan, C; Alesi, GN; Li, D; Magliocca, KR; Kang, Y; Chen, ZG; Shin, DM; Khuri, FR; Fan, J; Kang, S				Jin, L.; Chun, J.; Pan, C.; Alesi, G. N.; Li, D.; Magliocca, K. R.; Kang, Y.; Chen, Z. G.; Shin, D. M.; Khuri, F. R.; Fan, J.; Kang, S.			Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis	ONCOGENE			English	Article							LACTATE-DEHYDROGENASE; TYROSINE PHOSPHORYLATION; REDOX HOMEOSTASIS; DOWN-REGULATION; SRC ACTIVATION; NECK-CANCER; HEAD; PROGRESSION; CARCINOMA; METABOLISM	Metastases remain the major cause of death from cancer. Recent molecular advances have highlighted the importance of metabolic alterations in cancer cells, including the Warburg effect that describes an increased glycolysis in cancer cells. However, how this altered metabolism contributes to tumour metastasis remains elusive. Here, we report that phosphorylation-induced activation of lactate dehydrogenase A (LDHA), an enzyme that catalyses the interconversion of pyruvate and lactate, promotes cancer cell invasion, anoikis resistance and tumour metastasis. We demonstrate that LDHA is phosphorylated at tyrosine 10 by upstream kinases, HER2 and Src. Targeting HER2 or Src attenuated LDH activity as well as invasive potential in head and neck cancer and breast cancer cells. Inhibition of LDH activity by small hairpin ribonucleic acid or expression of phospho-deficient LDHA Y10F sensitized the cancer cells to anoikis induction and resulted in attenuated cell invasion and elevated reactive oxygen species, whereas such phenotypes were reversed by its product lactate or antioxidant N-acetylcysteine, suggesting that Y10 phosphorylation-mediated LDHA activity promotes cancer cell invasion and anoikis resistance through redox homeostasis. In addition, LDHA knockdown or LDHA Y10F rescue expression in human cancer cells resulted in decreased tumour metastasis in xenograft mice. Furthermore, LDHA phosphorylation at Y10 positively correlated with progression of metastatic breast cancer in clinical patient tumour samples. Our findings demonstrate that LDHA phosphorylation and activation provide pro-invasive, antianoikis and pro-metastatic advantages to cancer cells, suggesting that Y10 phosphorylation of LDHA may represent a promising therapeutic target and a prognostic marker for metastatic human cancers.	[Jin, L.; Chun, J.; Pan, C.; Alesi, G. N.; Li, D.; Chen, Z. G.; Shin, D. M.; Khuri, F. R.; Kang, S.] Emory Univ, Winship Canc Inst, Sch Med, Dept Hematol Med Oncol, Atlanta, GA 30322 USA; [Magliocca, K. R.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kang, Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Fan, J.] Emory Univ, Winship Canc Inst, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Princeton University; Emory University	Kang, S (corresponding author), Emory Univ, Winship Canc Inst, Sch Med, Hematol & Med Oncol, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	smkang@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Kang, Yibin/0000-0002-1626-6730	NIH [R01 CA175316, F31 CA183365]; ACS grant [RSG-11-08101]; NATIONAL CANCER INSTITUTE [R01CA175316] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01 CA175316 (Sumin Kang), F31 CA183365 (Gina N. Alesi), and ACS grant RSG-11-08101 (Sumin Kang).	Alesi GN, 2016, ONCOGENE, V35, P5412, DOI 10.1038/onc.2016.79; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x; Birkeland AC, 2016, JAMA OTOLARYNGOL, V142, P559, DOI 10.1001/jamaoto.2016.0335; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; De Souza JA, 2012, CLIN CANCER RES, V18, P2336, DOI 10.1158/1078-0432.CCR-11-2825; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fury MG, 2011, ANTICANCER RES, V31, P249; Gao S, 2016, BIOMED PHARMACOTHER, V81, P388, DOI 10.1016/j.biopha.2016.04.029; Granchi C, 2011, J MED CHEM, V54, P1599, DOI 10.1021/jm101007q; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Jin LT, 2013, MOL CELL BIOL, V33, P2574, DOI 10.1128/MCB.01677-12; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li D, 2013, J BIOL CHEM, V288, P32528, DOI 10.1074/jbc.M113.500561; Li J, 2016, NEUROREPORT, V27, P110, DOI 10.1097/WNR.0000000000000506; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Puls LN, 2011, ONCOLOGIST, V16, P566, DOI 10.1634/theoncologist.2010-0408; Rizwan A, 2013, CLIN CANCER RES, V19, P5158, DOI 10.1158/1078-0432.CCR-12-3300; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Stabile LP, 2013, CLIN CANCER RES, V19, P380, DOI 10.1158/1078-0432.CCR-12-1555; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Xian ZY, 2015, TUMOR BIOL, V36, P8093, DOI 10.1007/s13277-015-3540-x; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Zhang X, 2002, CANCER-AM CANCER SOC, V95, P1663, DOI 10.1002/cncr.10837; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690	51	130	138	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 6	2017	36	27					3797	3806		10.1038/onc.2017.6	http://dx.doi.org/10.1038/onc.2017.6			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EZ6SM	28218905	Green Accepted			2022-12-26	WOS:000404848200001
J	Mills, MG; Gallagher, EP				Mills, Margaret G.; Gallagher, Evan P.			A targeted gene expression platform allows for rapid analysis of chemical-induced antioxidant mRNA expression in zebrafish larvae	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; INDUCED OXIDATIVE STRESS; COHO SALMON; DEVELOPMENTAL TOXICOLOGY; INDUCIBLE EXPRESSION; RESPONSIVE ELEMENT; AQUATIC ORGANISMS; OLFACTORY SYSTEM; FREE-RADICALS; DANIO-RERIO	Chemical-induced oxidative stress and the biochemical pathways that protect against oxidative damage are of particular interest in the field of toxicology. To rapidly identify oxidative stress-responsive gene expression changes in zebrafish, we developed a targeted panel of antioxidant genes using the Affymetrix QuantiGene Plex ( QGP) platform. The genes contained in our panel include eight putative Nrf2 ( Nfe2l2a)-dependent antioxidant genes ( hmox1a, gstp1, gclc, nqo1, prdx1, gpx1a, sod1, sod2), a stress response gene ( hsp70), an inducible DNA damage repair gene ( gadd45bb), and three reference genes ( actb1, gapdh, hprt1). We tested this platform on larval zebrafish exposed to tert-butyl hydroperoxide ( tBHP) and cadmium ( Cd), two model oxidative stressors with different modes of action, and compared our results with those obtained using the more common quantitative PCR ( qPCR) method. Both methods showed that exposure to tBHP and Cd induced expression of prdx1, gstp1, and hmox1a ( 2-to 12-fold increase via QGP), indicative of an activated Nrf2 response in larval zebrafish. Both compounds also elicited a general stress response as reflected by elevation of hsp70 and gadd45bb, with Cd being the more potent inducer. Transient changes were observed in sod2 and gpx1a expression, whereas nqo1, an Nrf2-responsive gene in mammalian cells, was minimally affected by either tBHP or Cd chemical exposures. Developmental expression analysis of the target genes by QGP revealed marked upregulation of sod2 between 0-96hpf, and to a lesser extent, of sod1 and gstp1. Once optimized, QGP analysis of these experiments was accomplished more rapidly, using far less tissue, and at lower total costs than qPCR analysis. In summary, the QGP platform as applied to higher-throughput zebrafish studies provides a reasonable cost-effective alternative to qPCR or more comprehensive transcriptomics approaches to rapidly assess the potential for chemicals to elicit oxidative stress as a mechanism of chemical toxicity.	[Mills, Margaret G.; Gallagher, Evan P.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gallagher, EP (corresponding author), Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	evang3@uw.edu			U.S. National Science Foundation [CHE-1339637]; U.S. National Institutes of Health [P42-ES004696]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, P42ES004696] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this study was provided to EG by the U.S. National Science Foundation [https://www.nsf.gov/] (CHE-1339637, the Molecular Design Research Network) and by the U.S. National Institutes of Health [https://www.nih.gov/] Superfund Research Program (P42-ES004696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball JS, 2014, TOXICOL SCI, V139, P210, DOI 10.1093/toxsci/kfu017; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Blechinger SR, 2007, TOXICOL APPL PHARM, V224, P72, DOI 10.1016/j.taap.2007.06.025; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Canning P, 2015, FREE RADICAL BIO MED, V88, P101, DOI 10.1016/j.freeradbiomed.2015.05.034; Corrales J, 2016, CHEM RES TOXICOLOGY; Dell'Orco M, 2016, BBA-GENE REGUL MECH, V1859, P315, DOI 10.1016/j.bbagrm.2015.11.009; Espinoza HM, 2012, AQUAT TOXICOL, V110, P37, DOI 10.1016/j.aquatox.2011.12.012; Fischer BM, 2015, ARCH TOXICOL, P1; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hahn ME, 2015, FREE RADICAL BIO MED, V88, P275, DOI 10.1016/j.freeradbiomed.2015.06.022; Hahn ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113158; Hall JS, 2015, J MOL DIAGN, V17, P402, DOI 10.1016/j.jmoldx.2015.03.010; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hu JJ, 2015, J AM CHEM SOC, V137, P6837, DOI 10.1021/jacs.5b01881; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Kaur P, 2006, REPROD TOXICOL, V22, P479, DOI 10.1016/j.reprotox.2006.03.017; Khedoe PPSJ, 2016, AM J PHYSL LUNG CELL; Kim Hyun Soo, 2015, J Cancer Prev, V20, P232, DOI 10.15430/JCP.2015.20.4.232; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Lagana AS, 2016, INT J FERTIL STERIL, V9, P416; Lambert MJ, 2015, GENOME RES, V25, P624, DOI 10.1101/gr.184473.114; Lambert MJ, 2014, GENE, V546, P271, DOI 10.1016/j.gene.2014.05.068; Larsen MK, 2016, MEDICINA-LITHUANIA, V52, P19, DOI 10.1016/j.medici.2016.01.005; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Liu J, 2012, DNA REPAIR, V11, P167, DOI 10.1016/j.dnarep.2011.10.016; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Lu JG, 2010, MOL GENET GENOMICS, V283, P531, DOI 10.1007/s00438-010-0538-3; Luis A, 2014, FREE RADICAL BIO MED, V77, P217, DOI 10.1016/j.freeradbiomed.2014.09.008; Lunge VR, 2002, J MICROBIOL METH, V51, P361, DOI 10.1016/S0167-7012(02)00113-6; Lushchak VI, 2016, FISH PHYSIOL BIOCHEM, V42, P711, DOI 10.1007/s10695-015-0171-5; McMahon M, 2001, CANCER RES, V61, P3299; Metzger DC, 2013, GEN COMP ENDOCR, V189, P134, DOI 10.1016/j.ygcen.2013.04.022; Meyer JN, 2003, AQUAT TOXICOL, V65, P377, DOI 10.1016/j.aquatox.2003.06.001; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Mimura J, 2015, FREE RADICAL BIO MED, V88, P221, DOI 10.1016/j.freeradbiomed.2015.06.019; Montezano AC, 2015, CAN J CARDIOL, V31, P631, DOI 10.1016/j.cjca.2015.02.008; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mukaigasa K, 2012, MOL CELL BIOL, V32, P4455, DOI 10.1128/MCB.00481-12; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Pascual I, 2010, EXP EYE RES, V90, P420, DOI 10.1016/j.exer.2009.12.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Planchart A, 2016, ALTEX; Ramsden R, 2016, REDOX BIOL, V9, P114, DOI 10.1016/j.redox.2016.07.001; Rotman Janneke, 2011, BMC Res Notes, V4, P196, DOI 10.1186/1756-0500-4-196; Rousseau ME, 2015, AQUAT TOXICOL, V167, P157, DOI 10.1016/j.aquatox.2015.08.002; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sarkar S, 2014, ECOTOX ENVIRON SAFE, V107, P1, DOI 10.1016/j.ecoenv.2014.05.012; SCHWARZ MA, 1994, J BIOL CHEM, V269, P15238; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sun Hong, 2015, Curr Environ Health Rep, V2, P295, DOI 10.1007/s40572-015-0054-z; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Tinkov AA, 2015, BIOMETALS, V28, P231, DOI 10.1007/s10534-015-9823-2; Toyokuni S., 2016, PATHOLOGY INT; Truong L, 2016, REPROD TOXICOL, V65, P139, DOI 10.1016/j.reprotox.2016.05.015; Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wadle S, 2016, Biomol Detect Quantif, V7, P1, DOI 10.1016/j.bdq.2015.12.002; Wang L, 2013, TOXICOL APPL PHARM, V266, P177, DOI 10.1016/j.taap.2012.11.010; Wilmes A, 2011, TOXICOL IN VITRO, V25, P613, DOI 10.1016/j.tiv.2010.12.009; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008	80	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171025	10.1371/journal.pone.0171025	http://dx.doi.org/10.1371/journal.pone.0171025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212397	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700005
J	Dagher, D; Ungar, K; Robison, R; Dagher, F				Dagher, Dori; Ungar, Ken; Robison, Richard; Dagher, Fadi			The wide spectrum high biocidal potency of Bioxy formulation when dissolved in water at different concentrations	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; DISINFECTANTS; SUSCEPTIBILITY; MYCOBACTERIA; RESISTANCE; EFFICACY	Traditional surface disinfectants that have long been applied in medicine, animal husbandry, manufacturing and institutions are inconvenient at best and dangerous at worst. Moreover, some of these substances have adverse environmental impacts: for example, quaternary ammonium compounds ("quats") are reproductive toxicants in both fish and mammals. Halogens are corrosive both to metals and living tissues, are highly reactive, can be readily neutralized by metals, and react with organic matter to form toxic, persistent by-products such as dioxins and furans. Aldehydes may be carcinogenic to both human and animals upon repeated exposures, are corrosive, cross-link living tissues and many synthetic materials, and may lose efficacy when pathogens enzymatically adapt to them. Alcohols are flammable and volatile and can be enzymatically degraded by certain bacterial pathogens. Quats are highly irritating to mucous membranes and over time can induce pathogen resistance, especially if they are not alternated with functionally different disinfectants. In contrast, peracetic acid (PAA), a potent oxidizer, liberates hydrogen peroxide (itself a disinfectant), biodegrades to carbon dioxide, water and oxygen, and is at least as efficacious as contact biocides e.g., halogens and aldehydes. Nevertheless, the standard form of liquid PAA is highly corrosive, is neutralized by metals and organic matter, gives off noxious odours and must be stored in vented containers. For the reasons stated above, Bioxy formulations were developed, a series of powder forms of PAA, which are odourless, stable in storage and safe to transport and handle. They generate up to 10% PAA in situ when dissolved in water. A 0.2% aqueous solution of Bioxy (equivalent to 200 ppm PAA) effected a 6.76 log reduction in Methicillin-resistant Staphylococcus aureus (MRSA) within 2 minutes after application. A 5% aqueous solution of Bioxy achieved a 3.93 log reduction in the bovine tuberculosis bacillus Mycobacterium bovis, within 10 minutes after contact. A 1% solution of Bioxy reduced vancomycin-resistant enterococci (VRE) and Pseudomonas aeruginosa by 6.31 and 7.18 logs, respectively, within 3 minutes after application. A 0.5% solution of Bioxy inactivated porcine epidemic diarrhea virus (PEDV) within 15 minutes of contact, and a 5% solution of Bioxy realized a 5.36 log reduction in the spores of Clostridium difficile within 10 minutes of application. In summary, Bioxy is safe and easy to transport and store, poses negligible human, animal and environmental health risks, shows high levels of pathogen control efficacy and does not induce microbial resistance. Further investigations are recommended to explore its use as an industrial biocide.	[Dagher, Dori; Ungar, Ken; Dagher, Fadi] Bioxy AFD Inc, St Laurent, PQ, Canada; [Dagher, Dori; Ungar, Ken; Dagher, Fadi] Atomes FD Inc, St Laurent, PQ, Canada; [Robison, Richard] Brigham Young Univ, Provo, UT 84602 USA	Brigham Young University	Dagher, F (corresponding author), Bioxy AFD Inc, St Laurent, PQ, Canada.; Dagher, F (corresponding author), Atomes FD Inc, St Laurent, PQ, Canada.	fadi@atomesbio.com		Robison, Richard/0000-0002-4324-5169	Atomes FD Inc.; Bioxy AFD Inc.	Atomes FD Inc.; Bioxy AFD Inc.	This study was funded by Atomes FD Inc. and Bioxy AFD Inc. Dori Dagher, Ken Ungar and Fadi Dagher are affiliated with Atomes FD Inc. and Bioxy AFD Inc. Atomes FD Inc. and Bioxy AFD Inc. provided support in the form of salaries for authors DD, KU and FD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2000, REP PER AC; [Anonymous], 1998, GLUT SCREEN INF DAT; [Anonymous], 2008, GD DIS 101 BIOS; Carvajal A, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0007-9; De Groote MA, 2014, AM J INFECT CONTROL, V42, P932, DOI 10.1016/j.ajic.2014.05.014; Eleraky NZ, 2002, J AM ANIM HOSP ASSOC, V38, P231, DOI 10.5326/0380231; Estrela Carlos, 2002, Braz. Dent. J., V13, P113, DOI 10.1590/S0103-64402002000200007; Hirose Ryoji, 1994, Journal of Dermatology (Tokyo), V21, P248; Konkel, 2014, ENV HEAL NEWS; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P1025, DOI 10.1128/AEM.68.3.1025-1032.2002; Leggett MJ, 2015, J ANTIMICROB CHEMOTH, V70, P773, DOI 10.1093/jac/dku445; Liou JW, 2012, ARCH IMMUNOL THER EX, V60, P267, DOI 10.1007/s00005-012-0178-x; MARIS P, 1995, REV SCI TECH OIE, V14, P47, DOI 10.20506/rst.14.1.829; Martinez, 2005, BIOPROCESS INT, V8, P32; Meyers J, 2014, J ANTIMICROB CHEMOTH, V69, P1546, DOI 10.1093/jac/dku006; Nemoto M, 2014, J VET MED SCI, V76, P1061, DOI 10.1292/jvms.14-0018; Pandian SRK, 2010, BRAZ J MICROBIOL, V41, P805, DOI 10.1590/S1517-83822010000300033; Pleskova SN, 2016, MAT SCI ENG C-MATER, V59, P807, DOI 10.1016/j.msec.2015.10.021; Rabenau HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086128; Rahman S., 2007, HDB FOOD PRESERVATIO, DOI 10.1201/9781420017373; Rutala WA, WD GUIDELINE DISINFE; Ryndock E, 2016, J MED VIROL, V88, P1076, DOI 10.1002/jmv.24421; Tarquinio KM, 2010, INT J NANOMED, V5, P177; Tetraacetylethylenediamine (TAED), 2002, 10543574 TAED CAS; TURKHEIM H J, 1955, J Dent Res, V34, P295, DOI 10.1177/00220345550340021801; Wirtanen G, 2001, EUR FOOD RES TECHNOL, V213, P409, DOI 10.1007/s002170100375; Zhang TY, 2007, CHINESE J CHEM ENG, V15, P320, DOI 10.1016/S1004-9541(07)60087-1; [ZHAO Xuebing 赵雪冰], 2008, [过程工程学报, The Chinese Journal of Process Engineering], V8, P35	28	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172224	10.1371/journal.pone.0172224	http://dx.doi.org/10.1371/journal.pone.0172224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207828	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500103
J	Turner, D; Wand, ME; Briers, Y; Lavigne, R; Sutton, JM; Reynolds, DM				Turner, Dann; Wand, Matthew E.; Briers, Yves; Lavigne, Rob; Sutton, J. Mark; Reynolds, Darren M.			Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki	PLOS ONE			English	Article							PROGRAMMED TRANSLATIONAL FRAMESHIFT; COLISTIN RESISTANCE; CRYSTAL-STRUCTURE; PROTEIN; PHAGE; INFECTION; CALCIUM; IDENTIFICATION; MECHANISMS; SOFTWARE	Acinetobacter baumannii has emerged as an important nosocomial pathogen in healthcare and community settings. While over 100 of Acinetobacter phages have been described in the literature, relatively few have been sequenced. This work describes the characterisation and genome annotation of a new lytic Acinetobacter siphovirus, vB_AbaS_Loki, isolated from activated sewage sludge. Sequencing revealed that Loki encapsulates a 41,308 bp genome, encoding 51 predicted open reading frames. Loki is most closely related to Acinetobacter phage IME_AB3 and more distantly related to Burkholderia phage KL1, Paracoccus phage vB_PmaS_IMEP1 and Pseudomonas phages vB_Pae_Kakheti25, vB_PaeS_SCH_Ab26 and PA73. Loki is characterised by a narrow host range, among the 40 Acinetobacter isolates tested, productive infection was only observed for the propagating host, A. baumannii ATCC 17978. Plaque formation was found to be dependent upon the presence of Ca2+ ions and adsorption to host cells was abolished upon incubation with a mutant of ATCC 17978 encoding a premature stop codon in lpxA. The complete genome sequence of vB_AbaS_Loki was deposited in the European Nucleotide Archive (ENA) under the accession number LN890663.	[Turner, Dann; Reynolds, Darren M.] Univ West England, Fac Hlth & Appl Sci, Dept Appl Sci, Ctr Res Biosci, Coldharbour Lane, Bristol, Avon, England; [Wand, Matthew E.; Sutton, J. Mark] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England; [Briers, Yves] Univ Ghent, Dept Appl Biosci, Lab Appl Biotechnol, Ghent, Belgium; [Briers, Yves; Lavigne, Rob] Katholieke Univ Leuven, Biosyst Dept, Lab Gene Technol, Heverlee, Belgium	University of West England; Public Health England; Ghent University; KU Leuven	Reynolds, DM (corresponding author), Univ West England, Fac Hlth & Appl Sci, Dept Appl Sci, Ctr Res Biosci, Coldharbour Lane, Bristol, Avon, England.	darren.reynolds@uwe.ac.uk	Wand, Matthew/AAJ-1111-2020; Turner, Dann/P-5043-2019	Turner, Dann/0000-0002-0249-4513; Sutton, J. Mark/0000-0002-2288-0446; Wand, Matthew/0000-0002-9277-8869; Reynolds, Darren M/0000-0002-7002-1320	University of the West of England, Bristol; Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven	University of the West of England, Bristol; Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven	This work was supported by a QR2015 award from the University of the West of England, Bristol to D.T. R.L. is supported by a the Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven. R.L. & Y.B. are members of the FWO research community Phagebiotics". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a QR2015 award from the University of the West of England, Bristol. R.L. is supported by a the Geconcerteerde Onderzoeks Actie grant 'Phage Biosystems' from KU Leuven. R.L. & Y.B. are members of the FWO research community Thagebiotics". The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. We wish to thank Dr J. Turton (Public Health England) and Dr D. Centron (Universidad de Buenos Airies-Consejo Nacional de Investigaciones Cientificas y Tecnologicas) for the supply and permission to use bacterial strains, and Wessex Water PLC for the provision of sewage and activated sludge samples. We thank Professor H.-W. Ackermann (Universite Laval) for his advice and informative discussions on the bacteriophages of Acinetobacter sp.	Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Adams MJ, 2015, ARCH VIROL, V160, P1837, DOI 10.1007/s00705-015-2425-z; Adriaenssens EM, 2015, VIROLOGY, V477, P144, DOI 10.1016/j.virol.2014.10.016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS HJ, 1986, J HOSP INFECT, V7, P169, DOI 10.1016/0195-6701(86)90060-5; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bollivar DW, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00051-16; BONHIVERS M, 1995, FEBS LETT, V374, P169, DOI 10.1016/0014-5793(95)01101-J; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Michael JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002048; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Chagot B, 2012, PROTEINS, V80, P319, DOI 10.1002/prot.23191; Christie GE, 2002, J BACTERIOL, V184, P6522, DOI 10.1128/JB.184.23.6522-6531.2002; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Flayhan A, 2014, J VIROL, V88, P820, DOI 10.1128/JVI.02135-13; Fullner KJ, 1997, MOL MICROBIOL, V26, P755, DOI 10.1046/j.1365-2958.1997.6111984.x; Geisinger E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004691; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hatfull GF, 2015, J VIROL, V89, P8107, DOI 10.1128/JVI.01340-15; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jeon J, 2015, ARCH VIROL, V160, P3157, DOI 10.1007/s00705-015-2604-y; Jeon J, 2012, J VIROL, V86, P12437, DOI 10.1128/JVI.02132-12; Karumidze N, 2012, APPL MICROBIOL BIOT, V94, P1609, DOI 10.1007/s00253-012-4119-8; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEVIN ME, 1993, J MOL BIOL, V234, P124, DOI 10.1006/jmbi.1993.1568; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; Lynch KH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-223; Mahony J, 2015, INT J FOOD MICROBIOL, V201, P47, DOI 10.1016/j.ijfoodmicro.2015.02.017; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Maxwell KL, 2002, J MOL BIOL, V318, P1395, DOI 10.1016/S0022-2836(02)00276-0; Merrill BD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3018-2; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Pell LG, 2013, J MOL BIOL, V425, P2436, DOI 10.1016/j.jmb.2013.03.035; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Peters DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1848-y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; STEENSMA HY, 1979, J GEN VIROL, V42, P305, DOI 10.1099/0022-1317-42-2-305; Turner D, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01051-16; Van den Bossche A, 2016, ELIFE, V5, DOI 10.7554/eLife.16413; Van den Bossche A, 2014, J PROTEOME RES, V13, P4446, DOI 10.1021/pr500796n; Wagemans J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01242; Wagemans J, 2014, CELL MICROBIOL, V16, P1822, DOI 10.1111/cmi.12330; Wand ME, 2015, J ANTIMICROB CHEMOTH, V70, P2209, DOI 10.1093/jac/dkv097; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002	82	18	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172303	10.1371/journal.pone.0172303	http://dx.doi.org/10.1371/journal.pone.0172303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207864	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500117
J	Wilks, M; Phillips, CJC				Wilks, Matti; Phillips, Clive J. C.			Attitudes to in vitro meat: A survey of potential consumers in the United States	PLOS ONE			English	Article							PERCEPTIONS; FOOD	Positivity towards meat consumption remains strong, despite evidence of negative environmental and ethical outcomes. Although awareness of these repercussions is rising, there is still public resistance to removing meat from our diets. One potential method to alleviate these effects is to produce in vitro meat: meat grown in a laboratory that does not carry the same environmental or ethical concerns. However, there is limited research examining public attitudes towards in vitro meat, thus we know little about the capacity for it be accepted by consumers. This study aimed to examine perceptions of in vitro meat and identify potential barriers that might prevent engagement. Through conducting an online survey with US participants, we identified that although most respondents were willing to try in vitro meat, only one third were definitely or probably willing to eat in vitro meat regularly or as a replacement for farmed meat. Men were more receptive to it than women, as were politically liberal respondents compared with conservative ones. Vegetarians and vegans were more likely to perceive benefits compared to farmed meat, but they were less likely to want to try it than meat eaters. The main concerns were an anticipated high price, limited taste and appeal and a concern that the product was unnatural. It is concluded that people in the USA are likely to try in vitro meat, but few believed that it would replace farmed meat in their diet.	[Wilks, Matti] Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia; [Phillips, Clive J. C.] Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton, Australia	University of Queensland; University of Queensland	Wilks, M (corresponding author), Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia.	matti.wilks@uqconnect.edu.au						Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; [Anonymous], 2010, NATURE, V466, P531, DOI 10.1038/466531a; [Anonymous], 2005, BIOTECHNOLOGY PIOFA; [Anonymous], 2013, SCI ENV; Baron J, 2000, J EXP PSYCHOL-APPL, V6, P183, DOI 10.1037/1076-898X.6.3.183; Bartneck C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121595; Bastian B, 2012, PERS SOC PSYCHOL B, V38, P247, DOI 10.1177/0146167211424291; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bhat ZF, 2015, CRITICAL REV FOOD SC; Bratanova B, 2011, APPETITE, V57, P193, DOI 10.1016/j.appet.2011.04.020; Buckingham D., 2000, MAKING CITIZENS YOUN; Buhrmester M, 2016, AMAZONS MECH TURK NE, P133; Cooney N., 2014, VEGANOMICS SUPRISING; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Dilworth T, 2015, J AGR ENVIRON ETHIC, V28, P85, DOI 10.1007/s10806-014-9522-y; Frewer LJ, 2013, TRENDS FOOD SCI TECH, V30, P142, DOI 10.1016/j.tifs.2013.01.003; Gaskell G, 1999, SCIENCE, V285, P384, DOI 10.1126/science.285.5426.384; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hocquette A, 2015, J INTEGR AGR, V14, P273, DOI 10.1016/S2095-3119(14)60886-8; James C., 2013, GLOBAL STATUS COMMER; Laestadius LI, 2015, PUBLIC HEALTH NUTR, V18, P2457, DOI 10.1017/S1368980015000622; Mahar D, 2014, 2014 INT COMM ASS IC; Post MJ, 2014, ANN NY ACAD SCI, V1328, P29, DOI 10.1111/nyas.12569; Post MJ, 2014, J SCI FOOD AGR, V94, P1039, DOI 10.1002/jsfa.6474; Rollin BE, 2004, ANIMALS AGR FACTORY, P212; Rozin P, 2005, PSYCHOL SCI, V16, P652, DOI 10.1111/j.1467-9280.2005.01589.x; Ruby MB, 2011, APPETITE, V56, P447, DOI 10.1016/j.appet.2011.01.018; Schaefer GO, 2014, J APPL PHILOS, V31, P188, DOI 10.1111/japp.12056; Scott SE, 2016, PERSPECT PSYCHOL SCI, V11, P315, DOI 10.1177/1745691615621275; Thomas MA, 2016, APPETITE, V97, P79, DOI 10.1016/j.appet.2015.11.021; Tucker CA, 2014, APPETITE, V81, P168, DOI 10.1016/j.appet.2014.06.022; USDA, 2016, CHICK COWS PIGS OH M; Verbeke W, 2015, J INTEGR AGR, V14, P285, DOI 10.1016/S2095-3119(14)60884-4; Verbeke W, 2015, MEAT SCI, V102, P49, DOI 10.1016/j.meatsci.2014.11.013; Walker P, 2005, PUBLIC HEALTH NUTR, V8, P348, DOI 10.1079/PHN2005727	37	129	132	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171904	10.1371/journal.pone.0171904	http://dx.doi.org/10.1371/journal.pone.0171904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207878	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500059
J	Wu, CY; Lu, YY; Lu, CC; Su, YF; Tsai, TH; Wu, CH				Wu, Ching-Ying; Lu, Ying-Yi; Lu, Chun-Ching; Su, Yu-Feng; Tsai, Tai-Hsin; Wu, Chieh-Hsin			Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; VITAMIN-D; CARDIOVASCULAR-DISEASES; HIP FRACTURE; RISK; TAIWAN; WOMEN; ASSOCIATION	The aim of this study was to investigate osteoporosis risk in atopic dermatitis (AD) patients. This study included patients in the Taiwan National Health Insurance Research dataset. The population-based study included all patients aged 20-49 years who had been diagnosed with AD during 1996-2010. In total, 35,229 age and gender-matched patients without AD in a 1:1 ratio were randomly selected as the non-AD group. Cox proportional-hazards regression and Kaplan-Meier analyses were used to measure the hazard ratios and the cumulative incidences of osteoporosis, respectively. During the follow-up period, 360 (1.02%) AD patients and 127(0.36%) non-AD patients developed osteoporosis. The overall incidence of osteoporosis was4.72-fold greater in the AD patients compared to the non-AD patients (1.82 vs. 0.24 per 1,000 person-years, respectively) after adjusting for potential confounding factors. Osteoporosis risk factors included female gender, age, advanced Charlson Comorbidity Index, depression and use of corticosteroids. The dataset analysis showed that AD was significantly associated with subsequent risk of osteoporosis.	[Wu, Ching-Ying] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Wu, Ching-Ying; Lu, Ying-Yi; Wu, Chieh-Hsin] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lu, Ying-Yi] Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung, Taiwan; [Lu, Chun-Ching] Taipei Vet Gen Hosp, Dept Orthoped, Taipei, Taiwan; [Su, Yu-Feng; Tsai, Tai-Hsin; Wu, Chieh-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan; [Su, Yu-Feng; Tsai, Tai-Hsin; Wu, Chieh-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wu, CH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Wu, CH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Neurosurg, Kaohsiung, Taiwan.; Wu, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan.	wujoeys@gmail.com		Wu, Ching-Ying/0000-0002-3645-5117; Su, Yu-feng/0000-0003-0355-3981				AaltoKorte K, 1997, BRIT J DERMATOL, V136, P172; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Boyanov M, 2003, CLIN RHEUMATOL, V22, P318, DOI 10.1007/s10067-003-0743-0; Chen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002086; Cheng CM, 2015, J AFFECT DISORDERS, V178, P60, DOI 10.1016/j.jad.2015.02.025; Chow SN, 1997, J FORMOS MED ASSOC, V96, P806; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Finlay AY, 2001, J AM ACAD DERMATOL, V45, pS64, DOI 10.1067/mjd.2001.117010; Guttman-Yassky E, 2013, EXPERT OPIN BIOL TH, V13, P549, DOI 10.1517/14712598.2013.758708; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Haeck IM, 2009, BRIT J DERMATOL, V161, P1248, DOI 10.1111/j.1365-2133.2009.09327.x; Hashiro M, 1997, J DERMATOL SCI, V14, P63, DOI 10.1016/S0923-1811(96)00553-1; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P522, DOI 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y; Hwang CY, 2013, J PEDIATR-US, V163, P811, DOI 10.1016/j.jpeds.2013.03.068; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Keller JJ, 2013, OSTEOPOROSIS INT, V24, P1835, DOI 10.1007/s00198-012-2185-5; Lai SW, 2013, J EPIDEMIOL, V23, P109, DOI 10.2188/jea.JE20120071; Lin CH, 2016, BRIT J DERMATOL, V174, P88, DOI 10.1111/bjd.14166; Lin CH, 2015, BONE, V72, P9, DOI 10.1016/j.bone.2014.11.007; Lippuner K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13624; Lodder MC, 2004, ANN RHEUM DIS, V63, P1576, DOI 10.1136/ard.2003.016253; Mutgi K, 2013, PEDIATR DERMATOL, V30, P303, DOI 10.1111/j.1525-1470.2012.01850.x; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Oren E, 2008, J ALLERGY CLIN IMMUN, V121, P533, DOI 10.1016/j.jaci.2007.11.005; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Pedreira CC, 2007, PEDIATR DERMATOL, V24, P613, DOI 10.1111/j.1525-1470.2007.00549.x; Peterlik M, 2009, INT J ENV RES PUB HE, V6, P2585, DOI 10.3390/ijerph6102585; Ramsey-Goldman R, 1999, ARTHRITIS RHEUM, V42, P882, DOI 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C; Schmitt J, 2013, J ALLERGY CLIN IMMUN, V132, P1337, DOI 10.1016/j.jaci.2013.07.008; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Silverberg JI, 2015, ALLERGY; Silverberg JI, 2015, J ALLERGY CLIN IMMUN, V135, P721, DOI 10.1016/j.jaci.2014.11.023; Silverberg JI, 2015, PEDIAT ALLERG IMM-UK, V26, P54, DOI 10.1111/pai.12315; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Tsai MS, 2015, INT J CLIN PRACT, V69, P235, DOI 10.1111/ijcp.12526; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; van Velsen SGA, 2010, J AM ACAD DERMATOL, V63, P824, DOI 10.1016/j.jaad.2009.12.015; Wang TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132447; Weller MSD, 2013, CLIN EXP ALLERGY, V43, P279, DOI 10.1111/cea.12030; Wu Q, 2009, OSTEOPOROSIS INT, V20, P1309, DOI 10.1007/s00198-009-0918-x; Yang NP, 2006, HEALTH POLICY, V75, P329, DOI 10.1016/j.healthpol.2005.04.009; Zhang A, 2015, J AM ACAD DERMATOL, V72, P606, DOI 10.1016/j.jaad.2014.12.013	45	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171667	10.1371/journal.pone.0171667	http://dx.doi.org/10.1371/journal.pone.0171667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207767	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500044
J	Chabalko, MJ; Shahmohammadi, M; Sample, AP				Chabalko, Matthew J.; Shahmohammadi, Mohsen; Sample, Alanson P.			Quasistatic Cavity Resonance for Ubiquitous Wireless Power Transfer	PLOS ONE			English	Article							EFFICIENCY; FIELD	Wireless power delivery has the potential to seamlessly power our electrical devices as easily as data is transmitted through the air. However, existing solutions are limited to near contact distances and do not provide the geometric freedom to enable automatic and un-aided charging. We introduce quasistatic cavity resonance (QSCR), which can enable purposebuilt structures, such as cabinets, rooms, and warehouses, to generate quasistatic magnetic fields that safely deliver kilowatts of power to mobile receivers contained nearly anywhere within. A theoretical model of a quasistatic cavity resonator is derived, and field distributions along with power transfer efficiency are validated against measured results. An experimental demonstration shows that a 54 m(3) QSCR room can deliver power to small coil receivers in nearly any position with 40% to 95% efficiency. Finally, a detailed safety analysis shows that up to 1900 watts can be transmitted to a coil receiver enabling safe and ubiquitous wireless power.	[Chabalko, Matthew J.; Shahmohammadi, Mohsen; Sample, Alanson P.] Disney Res, 4720 Forbes Ave,Lower Level,Suite 110, Pittsburgh, PA 15213 USA		Sample, AP (corresponding author), Disney Res, 4720 Forbes Ave,Lower Level,Suite 110, Pittsburgh, PA 15213 USA.	alanson.sample@disneyresearch.com		Chabalko, Matthew/0000-0002-9618-0522; Sample, Alanson/0000-0002-8046-0538	Disney Research	Disney Research	Disney Research provided support in the form of salaries for authors MC, MS, and AS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdolkhani A, 2013, IEEE IND ELEC, P1416, DOI 10.1109/IECON.2013.6699340; Chabalko M, 2014, IEEE ANTENNAS PROP, P645, DOI 10.1109/APS.2014.6904653; Chabalko MJ, 2015, IEEE T POWER ELECTR, V30, P6163, DOI 10.1109/TPEL.2015.2440914; Chabalko MJ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904344; Cheng DK, 2014, FUNDAMENTALS ENG ELE; Choi J, 2012, EUR MICROW CONF, P916; Christ A, 2013, IEEE T ELECTROMAGN C, V55, P265, DOI 10.1109/TEMC.2012.2219870; Deyle T, 2008, IEEE INT CONF ROBOT, P1036, DOI 10.1109/ROBOT.2008.4543341; Finkenzeller K., 1999, RFID HDB RADIO FREQU; Ghotbi I, 2015, IRAN CONF ELECTR ENG, P1249, DOI 10.1109/IranianCEE.2015.7146407; Hans S, 1964, Patent No. [US3143697 A, 3143697]; Hoang H, 2012, IEEE T CONSUM ELECTR, V58, P327, DOI 10.1109/TCE.2012.6227430; Institute of Electrical and Electronics Engineers (IEEE), 1992, SCC28 IEEE; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Jang Y. J., 2012, P IEEE INT EL VEH C, P1, DOI DOI 10.1109/1EVC.2012.6183294; KAJFEZ D, 1984, IEEE T MICROW THEORY, V32, P666, DOI 10.1109/TMTT.1984.1132751; Kuo R. C., 2015, P 2015 IEEE WIR POW, P1; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Li PF, 2007, IEEE T CIRCUITS-II, V54, P912, DOI 10.1109/TCSII.2007.901613; Mitsuhashi N, 2009, NUCLEIC ACIDS RES, V37, pD782, DOI 10.1093/nar/gkn613; Ng WM, 2014, IEEE T POWER ELECTR, V29, P4470, DOI 10.1109/TPEL.2014.2300866; Parks AN, 2013, IEEE TOPIC CONF BIOM, P154, DOI 10.1109/BioWireleSS.2013.6613706; Ricketts DS, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788748; Sample AP, 2011, IEEE T IND ELECTRON, V58, P544, DOI 10.1109/TIE.2010.2046002; Schauer DA, 2009, RADIOLOGY, V253, P293, DOI 10.1148/radiol.2532090494; Scheible G, 2002, IEEE IND ELEC, P1358, DOI 10.1109/IECON.2002.1185473; Tesla N., 1914, U.S. Patent, Patent No. 1119732; Waters BH, 2014, IEEE INT SYMP CIRC S, P2045, DOI 10.1109/ISCAS.2014.6865567; Waters BH, 2012, P IEEE, V100, P138, DOI 10.1109/JPROC.2011.2165309; Zargham M, 2012, IEEE T BIOMED CIRC S, V6, P228, DOI 10.1109/TBCAS.2011.2174794	30	31	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169045	10.1371/journal.pone.0169045	http://dx.doi.org/10.1371/journal.pone.0169045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199321	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400004
J	Fu, CH; Tseng, HJ; Huang, CC; Chang, PH; Chen, YW; Lee, TJ				Fu, Chia-Hsiang; Tseng, Hsiao-Jung; Huang, Chi-Che; Chang, Po-Hung; Chen, Yi-Wei; Lee, Ta-Jen			Nasal nitric oxide in unilateral sinus disease	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; SINONASAL DISEASE	Unilateral sinus disease (USD) can sometimes be difficult to accurately diagnose before surgery. The application of nasal nitric oxide (nNO) for USD diagnosis and its surgical outcome in USD has not been reported in the literature. We prospectively enrolled sixty-six USD patients who underwent endoscopic sinus surgery for fungal rhinosinusitis (n = 19), chronic rhinosinusitis (CRS) without nasal polyps (n = 13), CRS with nasal polyps (n = 12) and sinonasal mass lesions (n = 22). nNO levels were measured preoperatively and at three and six months postoperatively. Correlations between nNO levels and potential clinical parameters, type of disease, disease severity, and disease-related quality of life (QOL) were assessed. Unlike bilateral CRS, in USD, nNO levels did not correlate with disease severity or postoperative QOL improvements. Except for fungus group, there were no differences in nNO levels between lesion and non-lesion sides in all the other groups. nNO levels on both sides were significantly elevated six months postoperatively in all groups. Fungal rhinosinusitis patients had the lowest preoperative nNO levels, and a cutoff of 239.3 ppb had the best sensitivity (79.0%) and specificity (87.2%) for preoperative diagnosis. While preoperative nNO levels cannot serve as an alternative marker for disease severity of USD, they were lower in fungal rhinosinusitis patients than in other USD patients and may be useful for more accurate diagnosis prior to surgery.	[Fu, Chia-Hsiang; Huang, Chi-Che; Chang, Po-Hung; Chen, Yi-Wei; Lee, Ta-Jen] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Huang, Chi-Che; Chang, Po-Hung; Chen, Yi-Wei; Lee, Ta-Jen] Chang Gung Univ, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Huang, Chi-Che; Chang, Po-Hung] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tseng, Hsiao-Jung] Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lee, TJ (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan.; Lee, TJ (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.	entlee@adm.cgmh.org.tw	Chen, Yi/HIR-2608-2022	Lee, Ta-Jen/0000-0003-0508-1359	Chang Gung Memorial Hospital [CMRPG3E1671, CMRPG3A1003]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Chang Gung Memorial Hospital (CMRPG3E1671 and CMRPG3A1003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Collette JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096203; Deroee AF, 2009, AM J RHINOL ALLERGY, V23, P159, DOI 10.2500/ajra.2009.23.3289; EICHEL BS, 1977, LARYNGOSCOPE, V87, P737, DOI 10.1002/lary.5540870509; Ferguson BJ, 2000, OTOLARYNG CLIN N AM, V33, P389, DOI 10.1016/S0030-6665(00)80013-4; Ferreiro JA, 1997, HEAD NECK-J SCI SPEC, V19, P481, DOI 10.1002/(SICI)1097-0347(199709)19:6&lt;481::AID-HED4&gt;3.0.CO;2-V; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fu CH, 2015, AM J RHINOL ALLERGY, V29, pE187, DOI 10.2500/ajra.2015.29.4249; Ikeda K, 1997, ARCH OTOLARYNGOL, V123, P198; JAIN B, 1993, BIOCHEM BIOPH RES CO, V191, P83, DOI 10.1006/bbrc.1993.1187; Jeong JH, 2014, AM J RHINOL ALLERGY, V28, pE11, DOI 10.2500/ajra.2014.28.3984; Li DD, 2016, INDIAN J MICROBIOL, V56, P214, DOI 10.1007/s12088-016-0580-x; Phillips PS, 2011, OTOLARYNG HEAD NECK, V144, P159, DOI 10.1177/0194599810392667; Ragab SM, 2006, ALLERGY, V61, P717, DOI 10.1111/j.1398-9995.2006.01044.x; Sidhu R, 2014, GCSMC J MED SCI, V3, P42; Silva MP, 2015, INT FORUM ALLERGY RH, V5, P590, DOI 10.1002/alr.21526; Soler ZM, 2010, OTOLARYNG HEAD NECK, V143, P621, DOI 10.1016/j.otohns.2010.07.014; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Wodehouse T, 2003, EUR RESPIR J, V21, P43, DOI 10.1183/09031936.03.00305503; Yoon JH, 1999, AM J NEURORADIOL, V20, P571	20	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171965	10.1371/journal.pone.0171965	http://dx.doi.org/10.1371/journal.pone.0171965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199369	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400061
J	Zhang, X; Zhou, ZL; Cheng, D				Zhang, Xi; Zhou, Zhili; Cheng, Dong			Efficient path routing strategy for flows with multiple priorities on scale-free networks	PLOS ONE			English	Article							TRAFFIC FLOW; COMPLEX; CONGESTION; TRANSITION; DYNAMICS	In real networks, traffic flows are different in amount as well as their priorities. However, the latter priority has rarely been examined in routing strategy studies. In this paper, a novel routing algorithm, which is based on the efficient path routing strategy (EP), is proposed to overcome network congestion problem caused by large amount of traffic flows with different priorities. In this scheme, traffic flows with different priorities are transmitted through different routing paths, which are based on EP with different parameters. Simulation results show that the traffic capacity for flows with different priorities can be enhanced by 12% with this method, compared with EP. In addition, the new method contributes to more balanced network traffic load distribution and reduces average transmission jump and delay of packets.	[Zhang, Xi; Zhou, Zhili; Cheng, Dong] Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China	Xi'an Jiaotong University	Zhang, X (corresponding author), Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China.	xjtu_zhangxi@163.com						Arenas A, 2001, PHYS REV LETT, V86, P3196, DOI 10.1103/PhysRevLett.86.3196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen SY, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/732698; Chen ZY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036107; Danila B, 2007, CHAOS, V17, DOI 10.1063/1.2731718; Danila B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046106; Danila B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066116; De Martino D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/08/P08023; De Martino D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.015101; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; Echenique P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056105; Echenique P, 2005, EUROPHYS LETT, V71, P325, DOI 10.1209/epl/i2005-10080-8; Ericsson M, 2002, J COMB OPTIM, V6, P299, DOI 10.1023/A:1014852026591; Fortz B, 2002, IEEE J SEL AREA COMM, V20, P756, DOI 10.1109/JSAC.2002.1003042; Guan ZH, 2011, PHYSICA A, V390, P1131, DOI 10.1016/j.physa.2010.10.002; Guimera R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026704; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Huang W, 2010, CHAOS, V20, DOI 10.1063/1.3490745; Huang W, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/01/P01016; Jiang Z, 2013, PLOS ONE; Jiang ZY, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500167; Kawamoto H, 2012, PHYSICA A, V391, P895, DOI 10.1016/j.physa.2011.08.064; Kim K, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/58002; Li K, 2011, INT J MOD PHYS B, V25, P1419, DOI 10.1142/S0217979211100655; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Ling X, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066110; Liu Z, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.037101; Low SH, 2002, IEEE CONTROL SYSTEMS, V22; Ohira T, 1998, PHYS REV E, V58, P193, DOI 10.1103/PhysRevE.58.193; Sreenivasan S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036105; Tan F, 2013, PHYSICA A, V392, P4146, DOI 10.1016/j.physa.2013.04.032; Wang K, 2011, PHYSICA A, V390, P2593, DOI 10.1016/j.physa.2011.01.026; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016101; Wang WX, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026111; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xia YX, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58004; Xia YX, 2006, IEEE INT SYMP CIRC S, P2625; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Yin CY, 2006, PHYS LETT A, V351, P220, DOI 10.1016/j.physleta.2005.10.104; Yu Y, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/48004; Zhang GQ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.017101; Zhang H, 2007, PHYS LETT A, V364, P177, DOI 10.1016/j.physleta.2006.12.009; Zhao L, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026125; Zhou SY, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/8/080501	45	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172035	10.1371/journal.pone.0172035	http://dx.doi.org/10.1371/journal.pone.0172035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199382	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400068
J	Dehbandi, B; Barachant, A; Smeragliuolo, AH; Long, JD; Bumanlag, SJ; He, V; Lampe, A; Putrino, D				Dehbandi, Behdad; Barachant, Alexandre; Smeragliuolo, Anna H.; Long, John Davis; Bumanlag, Silverio Joseph; He, Victor; Lampe, Anna; Putrino, David			Using data from the Microsoft Kinect 2 to determine postural stability in healthy subjects: A feasibility trail	PLOS ONE			English	Article							BERG BALANCE SCALE; XBOX ONE KINECT; CONCURRENT VALIDITY; CLINICAL-ASSESSMENT; RELIABILITY; REHABILITATION; CLASSIFICATION; UTILITY; PEOPLE; CAMERA	The objective of this study was to determine whether kinematic data collected by the Microsoft Kinect 2 (MK2) could be used to quantify postural stability in healthy subjects. Twelve subjects were recruited for the project, and were instructed to perform a sequence of simple postural stability tasks. The movement sequence was performed as subjects were seated on top of a force platform, and the MK2 was positioned in front of them. This sequence of tasks was performed by each subject under three different postural conditions: "both feet on the ground" (1), "One foot off the ground" (2), and "both feet off the ground" (3). We compared force platform and MK2 data to quantify the degree to which the MK2 was returning reliable data across subjects. We then applied a novel machine-learning paradigm to the MK2 data in order to determine the extent to which data from the MK2 could be used to reliably classify different postural conditions. Our initial comparison of force plate and MK2 data showed a strong agreement between the two devices, with strong Pearson correlations between the trunk centroids "Spine_Mid" (0.85 +/- 0.06), "Neck" (0.86 +/- 0.07) and "Head" (0.87 +/- 0.07), and the center of pressure centroid inferred by the force platform. Mean accuracy for the machine learning classifier from MK2 was 97.0%, with a specific classification accuracy breakdown of 90.9%, 100%, and 100% for conditions 1 through 3, respectively. Mean accuracy for the machine learning classifier derived from the force platform data was lower at 84.4%. We conclude that data from the MK2 has sufficient information content to allow us to classify sequences of tasks being performed under different levels of postural stability. Future studies will focus on validating this protocol on large populations of individuals with actual balance impairments in order to create a toolkit that is clinically validated and available to the medical community.	[Dehbandi, Behdad; Smeragliuolo, Anna H.; Lampe, Anna; Putrino, David] Burke Med Res Inst, Dept Telemed & Virtual Rehabil, White Plains, NY 10605 USA; [Dehbandi, Behdad; Smeragliuolo, Anna H.; Putrino, David] Weill Cornell Med Coll, Dept Rehabil Med, New York, NY 10065 USA; [Barachant, Alexandre] Burke Med Res Inst, Clin Lab Early Brain Injury Recovery, White Plains, NY USA; [Long, John Davis] NYU, Langone Sch Med, New York, NY USA; [Bumanlag, Silverio Joseph; He, Victor] Mercy Coll, Dept Phys Therapy, Dobbs Ferry, NY 10522 USA	Cornell University; New York University; NYU Langone Medical Center	Putrino, D (corresponding author), Burke Med Res Inst, Dept Telemed & Virtual Rehabil, White Plains, NY 10605 USA.; Putrino, D (corresponding author), Weill Cornell Med Coll, Dept Rehabil Med, New York, NY 10065 USA.	dap3002@med.cornell.edu		Putrino, David/0000-0002-2232-3324	Burke Medical Research Institute	Burke Medical Research Institute	This research was funded by the Burke Medical Research Institute.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Burke Medical Research Institute for their generous support of this research.	Adlerton Anna-Karin, 2003, Physiother Res Int, V8, P187, DOI 10.1002/pri.289; [Anonymous], 2003, J PHYS THERAPY SCI, DOI [10.1589/jpts.15.93, DOI 10.1589/JPTS.15.93]; Arnaudon M, 2013, IEEE J-STSP, V7, P595, DOI 10.1109/JSTSP.2013.2261798; Baldewijns G, 2014, IEEE ENG MED BIO, P5920, DOI 10.1109/EMBC.2014.6944976; Barachant A, 2013, NEUROCOMPUTING, V112, P172, DOI 10.1016/j.neucom.2012.12.039; Barachant A, 2012, IEEE T BIO-MED ENG, V59, P920, DOI 10.1109/TBME.2011.2172210; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Bonnechere B, 2014, GAIT POSTURE, V39, P593, DOI 10.1016/j.gaitpost.2013.09.018; Chan C. L., 2012, 2012 Second International Conference on Digital Information and Communication Technology and it's Applications (DICTAP), P159, DOI 10.1109/DICTAP.2012.6215343; Chang YJ, 2013, RES DEV DISABIL, V34, P3654, DOI 10.1016/j.ridd.2013.08.021; Clark RA, 2015, GAIT POSTURE, V42, P210, DOI 10.1016/j.gaitpost.2015.03.005; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Congedo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121423; Datta S, 2012, ARCH PHYS MED REHAB, V93, P1565, DOI 10.1016/j.apmr.2012.01.026; Eroglu S., 2012, SAUDI MED J, P3; Forstner W, 2003, AMETRIE COVARIANCE M; Frykberg GE, 2007, J REHABIL MED, V39, P448, DOI 10.2340/16501977-0071; Funaya H, 2013, INT SYM MED INFORM, P213, DOI 10.1109/ISMICT.2013.6521731; Harel NY, 2013, J SPINAL CORD MED, V36, P127, DOI 10.1179/2045772312Y.0000000053; Hebert-Losier K, 2014, J STRENGTH COND RES, V28, P1849, DOI 10.1519/JSC.0000000000000343; Herda L, 2001, HUM MOVEMENT SCI, V20, P313, DOI 10.1016/S0167-9457(01)00050-1; Howland Jonathan, 2015, Inj Epidemiol, V2, P25; Hussein Mohamed E, 2013, 23 INT JOINT C ART I; Jbabdi Myriam, 2008, BMC Geriatr, V8, P8, DOI 10.1186/1471-2318-8-8; Kumar M. S. N., 2012, P 8 IND C COMP VIS G, P1; Li WB, 2010, 2010 THE 3RD INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND INDUSTRIAL APPLICATION (PACIIA2010), VOL I, P9, DOI 10.1109/cvprw.2010.5543273; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Moakher M, 2005, SIAM J MATRIX ANAL A, V26, P735, DOI 10.1137/S0895479803436937; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Putrino D, 2014, CURR OPIN NEUROL, V27, P631, DOI 10.1097/WCO.0000000000000152; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stone E, 2011, J AMB INTEL SMART EN, V3, P349, DOI 10.3233/AIS-2011-0124; Suma EA, 2011, P IEEE VIRT REAL ANN, P247, DOI 10.1109/VR.2011.5759491; Tao D, 2013, IEEE T IND INFORM, V10, P1; Tao Dapeng, 2014, IEEE T NEURAL NETWOR, P1; Tuzel O, 2008, IEEE T PATTERN ANAL, V30, P1713, DOI 10.1109/TPAMI.2008.75; Vernadakis N, 2014, PHYS THER SPORT, V15, P148, DOI 10.1016/j.ptsp.2013.08.004; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Yang Y, 2016, LATENT MAX MARGIN MU, P1; Yang Y, 2014, IEEE SENS J, V14, P1633, DOI 10.1109/JSEN.2013.2296509; Yeung LF, 2014, GAIT POSTURE, V40, P532, DOI 10.1016/j.gaitpost.2014.06.012; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	44	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170890	10.1371/journal.pone.0170890	http://dx.doi.org/10.1371/journal.pone.0170890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196139	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900007
J	Rovira, S; Puertas, E; Igual, L				Rovira, Sergi; Puertas, Eloi; Igual, Laura			Data-driven system to predict academic grades and dropout	PLOS ONE			English	Article							MODEL	Nowadays, the role of a tutor is more important than ever to prevent students dropout and improve their academic performance. This work proposes a data-driven system to extract relevant information hidden in the student academic data and, thus, help tutors to offer their pupils a more proactive personal guidance. In particular, our system, based on machine learning techniques, makes predictions of dropout intention and courses grades of students, as well as personalized course recommendations. Moreover, we present different visualizations which help in the interpretation of the results. In the experimental validation, we show that the system obtains promising results with data from the degree studies in Law, Computer Science and Mathematics of the Universitat de Barcelona.	[Rovira, Sergi; Puertas, Eloi; Igual, Laura] Univ Barcelona, Dept Matemat & Informat, Gran Via Corts Catalanes 585, E-08007 Barcelona, Spain	University of Barcelona	Igual, L (corresponding author), Univ Barcelona, Dept Matemat & Informat, Gran Via Corts Catalanes 585, E-08007 Barcelona, Spain.	ligual@ub.edu	Igual, Laura/H-5606-2015; Puertas, Eloi/F-9425-2016	Igual, Laura/0000-0002-7225-7441; Puertas, Eloi/0000-0001-6292-6448; Rovira Cisterna, Sergi/0000-0001-8440-9345	Spanish Ministry of Science and Innovation [TIN2013-43478-P, TIN2015-66951-C2-1-R]; Catalan Government award [SGR-1219, SGR-561]; Universitat de Barcelona (INDOMAIN Innovation and Teaching Group) [2014PID-UB/068, REDICE-1602]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government award; Universitat de Barcelona (INDOMAIN Innovation and Teaching Group)	This work was supported by Spanish Ministry of Science and Innovation (Grant TIN2013-43478-P and Grant TIN2015-66951-C2-1-R), by Catalan Government award 2014 SGR-1219 and SGR-561 and by Universitat de Barcelona (Grant 2014PID-UB/068 and Grant REDICE-1602 of the INDOMAIN Innovation and Teaching Group).	[Anonymous], 2016, INDICATORS ED DEV AN; [Anonymous], 2013, ED GLANC OECD IND; Belloc F, 2010, J APPL STAT, P1; Bernardo-Gutierrez AB, 2016, REV FUENTES; Casaravilla A., 2014, REV PENSAMLENTO MATE, V4, P7; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Davila N, 2015, RIE-REV INVESTIG EDU, V33, P27, DOI 10.6018/rie.33.1.178481; de Wit H., 2007, EUROPEAN INTEGRATION, P461; Duque LC, 2014, TOTAL QUAL MANAG BUS, V25, P1, DOI 10.1080/14783363.2013.807677; Esteban G. M., 2016, AULA ABIERTA, V44, P1, DOI [10.1016/j.aula.2015.04.001, DOI 10.1016/J.AULA.2015.04.001]; Gairin J, 2014, QUAL HIGH EDUC, V20, P165, DOI 10.1080/13538322.2014.925230; Goldenhersh H., 2011, REV ARGENTINA ED SUP, V3, P96; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Huberth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137001; Iba W, 1992, P 10 C ART INT, P223; KNIGHT WR, 1966, J AM STAT ASSOC, V61, P436, DOI 10.2307/2282833; Learning J., 2013, ED STUDIES, V39, P261, DOI [10.1080/03055698.2012.724353, DOI 10.1080/03055698.2012.724353]; Lemaitre G., 2016, CORR; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Montmarquette C, 2001, ECON EDUC REV, V20, P475, DOI 10.1016/S0272-7757(00)00029-7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Rennie J., 2003, P 20 INT C MACH LEAR, ppp; Rodriguez-Gomez D, 2015, STUD HIGH EDUC, V40, P690, DOI 10.1080/03075079.2013.842966; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shani G, 2011, RECOMMENDER SYSTEMS HANDBOOK, P257, DOI 10.1007/978-0-387-85820-3_8; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Tekin A, 2014, EURASIAN J EDUC RES, P207, DOI 10.14689/ejer.2014.54.12; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Tinto V, 2006, J COLL STUD RETENT-R, V8, P1; Van Soom C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112489; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	34	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171207	10.1371/journal.pone.0171207	http://dx.doi.org/10.1371/journal.pone.0171207			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196078	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423900013
J	Lee, SA; Suh, Y; Lee, S; Jeong, J; Kim, SJ; Kim, SJ; Park, SK				Lee, Seol-Ae; Suh, Yeongjun; Lee, Saebom; Jeong, Jaehoon; Kim, Soo Jeong; Kim, So Jung; Park, Sang Ki			Functional expression of dopamine D2 receptor is regulated by tetraspanin 7-mediated postendocytic trafficking	FASEB JOURNAL			English	Article						endocytosis; cell surface trafficking; dopaminergic signaling	PROTEIN-PROTEIN INTERACTIONS; TRANSMEMBRANE 4 SUPERFAMILY; MEDIUM SPINY NEURONS; DEFICIENT MICE; INTERNALIZATION; LYSOSOMES; GENE; D-1; IDENTIFICATION; SCHIZOPHRENIA	The dopaminergic system plays an essential role in various functions of the brain, including locomotion, memory, and reward, and the deregulation of dopaminergic signaling as a result of altered functionality of dopamine D2 receptor (DRD2) is implicated in multiple neurologic and psychiatric disorders. Tetraspanin-7 (TSPAN7) is expressed to variable degrees in different tissues, with the highest level in the brain, and multiple mutations in TSPAN7 have been implicated in intellectual disability. Here, we tested the hypothesis that TSPAN7 may be a binding partner of DRD2 that is involved in the regulation of its functional activity. Our results showed that TSPAN7 was associated with DRD2 and reduced its surface expression by enhancing DRD2 internalization. Immunocytochemical analysis revealed that TSPAN7 that resides in the plasma membrane and early and late endosomes promoted internalization of DRD2 and its localization to endosomal compartments of the endocytic pathway. Furthermore, we observed that TSPAN7 deficiency increased surface localization of DRD2 concurrent with the decrease of its endocytosis, regardless of dopamine treatment. Finally, TSPAN7 negatively affects DRD2-mediated signaling. These results disclosed a previously uncharacterized role of TSPAN7 in the regulation of the expression and functional activity of DRD2 by postendocytic trafficking.	[Lee, Seol-Ae; Suh, Yeongjun; Lee, Saebom; Jeong, Jaehoon; Kim, Soo Jeong; Kim, So Jung; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, 77 Cheongam Ro, Pohang 790784, South Korea; [Jeong, Jaehoon] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, 77 Cheongam Ro, Pohang 790784, South Korea.	skpark@postech.ac.kr		Kim, Soo Jeong/0000-0002-6640-9445; Suh, Yeongjun/0000-0002-1841-4792	South Korea Ministry of Science, ICT and Future Planning (MSIP) [NRF-2012R1A4A1028200, NRF-2015M3C7A1030964]; Pohang, South Korea (POSCO) Green Science Fund	South Korea Ministry of Science, ICT and Future Planning (MSIP); Pohang, South Korea (POSCO) Green Science Fund	This work was supported by South Korea Ministry of Science, ICT and Future Planning (MSIP) Grants NRF-2012R1A4A1028200 and NRF-2015M3C7A1030964. This work was also supported, in part, by the Pohang, South Korea (POSCO) Green Science Fund.	Abidi FE, 2002, J MED GENET, V39, P430, DOI 10.1136/jmg.39.6.430; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Berlanga ML, 2011, BRAIN RES, V1390, P41, DOI 10.1016/j.brainres.2011.03.044; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borroto-Escuela DO, 2010, BIOCHEM BIOPH RES CO, V401, P605, DOI 10.1016/j.bbrc.2010.09.110; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Carlsson A, 2000, BRAIN RES REV, V31, P342, DOI 10.1016/S0165-0173(99)00050-8; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Fuxe K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00071; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Guo MX, 2008, BIOCHEM BIOPH RES CO, V365, P154, DOI 10.1016/j.bbrc.2007.10.160; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hosokawa Y, 1999, NEUROSCI RES, V35, P281, DOI 10.1016/S0168-0102(99)00093-0; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Jeong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084482; Jia JM, 2013, NAT NEUROSCI, V16, P1627, DOI 10.1038/nn.3542; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; Kamiya T, 2003, BIOCHEM BIOPH RES CO, V306, P544, DOI 10.1016/S0006-291X(03)00991-4; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kim JH, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0003.2001; Kim OJ, 2008, J NEUROCHEM, V106, P83, DOI 10.1111/j.1471-4159.2008.05348.x; Koschatzky S, 2011, ACS CHEM NEUROSCI, V2, P308, DOI 10.1021/cn200020y; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045618; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Li Y, 2012, J NEUROSCI, V32, P7178, DOI 10.1523/JNEUROSCI.0008-12.2012; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Neely MD, 2007, NEUROSCIENCE, V149, P457, DOI 10.1016/j.neuroscience.2007.06.044; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Paspalas CD, 2006, EUR J NEUROSCI, V24, P1395, DOI 10.1111/j.1460-9568.2006.05023.x; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; SEEMAN P, 1992, NEUROPSYCHOPHARMACOL, V7, P261; Spano P F, 1978, Adv Biochem Psychopharmacol, V19, P155; Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7; Thaminy S, 2003, GENOME RES, V13, P1744, DOI 10.1101/gr.1276503; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wrighton KH, 2014, NAT REV MOL CELL BIO, V15, DOI 10.1038/nrm3863; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	67	19	19	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2301	2313		10.1096/fj.201600755RR	http://dx.doi.org/10.1096/fj.201600755RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223337				2022-12-26	WOS:000401553400008
J	Jadalannagari, S; Converse, G; McFall, C; Buse, E; Filla, M; Villar, MT; Artigues, A; Mellot, AJ; Wang, JX; Detamore, MS; Hopkins, RA; Aljitawi, OS				Jadalannagari, Sushma; Converse, Gabriel; McFall, Christopher; Buse, Eric; Filla, Michael; Villar, Maria T.; Artigues, Antonio; Mellot, Adam J.; Wang, Jinxi; Detamore, Michael S.; Hopkins, Richard A.; Aljitawi, Omar S.			Decellularized Wharton's Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CLINICAL-APPLICATIONS; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; BONE; IMMUNOFLUORESCENCE	In tissue engineering, an ideal scaffold attracts and supports cells thus providing them with the necessary mechanical support and architecture as they reconstruct new tissue in vitro and in vivo. This manuscript details a novel matrix derived from decellularized Wharton's jelly (WJ) obtained from human umbilical cord for use as a scaffold for tissue engineering application. This decellularized Wharton's jelly matrix (DWJM) contained 0.66 +/- 0.12 mu g/mg sulfated glycosaminoglycans (GAGs), and was abundant in hyaluronic acid, and completely devoid of cells. Mass spectroscopy revealed the presence of collagen types II, VI and XII, fibronectin- I, and lumican I. When seeded onto DWJM, WJ mesenchymal stem cells (WJMSCs), successfully attached to, and penetrated the porous matrix resulting in a slower rate of cell proliferation. Gene expression analysis of WJ and bone marrow (BM) MSCs cultured on DWJM demonstrated decreased expression of proliferation genes with no clear pattern of differentiation. When this matrix was implanted into a murine calvarial defect model with, green fluorescent protein (GFP) labeled osteocytes, the osteocytes were observed to migrate into the matrix as early as 24 hours. They were also identified in the matrix up to 14 days after transplantation. Together with these findings, we conclude that DWJM can be used as a 3D porous, bioactive and biocompatible scaffold for tissue engineering and regenerative medicine applications.	[Jadalannagari, Sushma; Converse, Gabriel; Hopkins, Richard A.; Aljitawi, Omar S.] Univ Kansas, Dept Bioengn, Lawrence, KS 66045 USA; [Jadalannagari, Sushma; Aljitawi, Omar S.] Univ Kansas, Med Ctr, Dept Hematol Oncol, Kansas City, KS 66103 USA; [Converse, Gabriel; McFall, Christopher; Buse, Eric; Hopkins, Richard A.] Childrens Mercy Hosp & Clin, Cardiac Regenerat Surg Res Labs, Kansas City, MO USA; [Filla, Michael] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Villar, Maria T.; Artigues, Antonio] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Mellot, Adam J.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66103 USA; [Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66103 USA; [Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas	Aljitawi, OS (corresponding author), Univ Kansas, Dept Bioengn, Lawrence, KS 66045 USA.; Aljitawi, OS (corresponding author), Univ Kansas, Med Ctr, Dept Hematol Oncol, Kansas City, KS 66103 USA.	omar_aljitawi@urmc.rochester.edu	Aljitawi, Omar/R-6053-2019; Hopkins, Richard/AAI-5007-2020		G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. CD Little and BJ Rongish, Department of Anatomy and Cell Biology, KUMC, for advice and use of their time-lapse instrumentation, supported by the The G. Harold and Leila Y. Mathers Foundation. We would also like to thank Dr. David W Rowe, University of Connecticut Health Center and Dr. Lynda Bonewald, University of Missouri Kansas City, for their generous gift of GFP mice. We also thank Dr. Sonia Rawal, Peggy Keefe, Yinghua Xiao, Barbara Fegley, Dr. Yi Feng, Mingcai Zhang, and Dr. Dandan Li for their help with some of the experiments and Da Zhang for his help with microscopy imaging.	Aljitawi O, 2012, STEM CELLS DEV; Altmann B, 2011, BIOMATERIALS, V32, P8947, DOI 10.1016/j.biomaterials.2011.08.023; Bai J, 2012, J GERIATR CARDIOL, V9, P166, DOI 10.3724/SP.J.1263.2011.12091; Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chan RW, 2009, TISSUE ENG PT A, V15, P3537, DOI [10.1089/ten.tea.2009.0064, 10.1089/ten.TEA.2009.0064]; Clarke SA, 2011, BIOTECHNOL ADV, V29, P610, DOI 10.1016/j.biotechadv.2011.04.003; Conconi MT, 2006, INT J MOL MED, V18, P1089; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Feng JQ, 2008, GENESIS, V46, P87, DOI 10.1002/dvg.20370; Foschi F, 2011, J BIOMATER APPL; Foschi F, 2012, J BIOMATER APPL, V26, P1035, DOI 10.1177/0885328210393046; Franc S, 1998, PLACENTA, V19, P95, DOI 10.1016/S0143-4004(98)90104-7; Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hopkins RA, 2005, CARDIAC RECONSTRUCTI; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19; Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Loebel C, 2015, TISSUE ENG PT A, V21, P115, DOI [10.1089/ten.tea.2014.0096, 10.1089/ten.TEA.2014.0096]; Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Scaglione S, 2006, BIOTECHNOL BIOENG, V93, P181, DOI 10.1002/bit.20677; Schagemann JC, 2012, J BIOMED MAT RES A, DOI 10.1002/jbm.a.34457; Schieker M, 2004, J ANAT, V204, P133, DOI 10.1111/j.1469-7580.2004.00252.x; Schieker M, 2007, J ANAT, V210, P592, DOI 10.1111/j.1469-7580.2007.00716.x; Sobolewski K, 2005, PLACENTA, V26, P747, DOI 10.1016/j.placenta.2004.10.008; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831; van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3; Wang LM, 2009, J TISSUE ENG REGEN M, V3, P398, DOI 10.1002/term.176; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhao LM, 2011, VITAM HORM, V87, P127, DOI 10.1016/B978-0-12-386015-6.00042-1; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	43	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e172098	10.1371/journal.pone.0172098	http://dx.doi.org/10.1371/journal.pone.0172098			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222169	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800031
J	Muradian, ML; Branch, TA; Moffitt, SD; Hulson, PJF				Muradian, Melissa L.; Branch, Trevor A.; Moffitt, Steven D.; Hulson, Peter-John F.			Bayesian stock assessment of Pacific herring in Prince William Sound, Alaska	PLOS ONE			English	Article							VALDEZ OIL-SPILL; CLUPEA-PALLASI; FISHERY; HISTOPATHOLOGY; ABUNDANCE; RECOVERY; IMPACTS; DISEASE; CATCH	The Pacific herring (Clupea pallasii) population in Prince William Sound, Alaska crashed in 1993 and has yet to recover, affecting food web dynamics in the Sound and impacting Alaskan communities. To help researchers design and implement the most effective monitoring, management, and recovery programs, a Bayesian assessment of Prince William Sound herring was developed by reformulating the current model used by the Alaska Department of Fish and Game. The Bayesian model estimated pre-fishery spawning biomass of herring age-3 and older in 2013 to be a median of 19,410 mt (95% credibility interval 12,150-31,740 mt), with a 54% probability that biomass in 2013 was below the management limit used to regulate fisheries in Prince William Sound. The main advantages of the Bayesian model are that it can more objectively weight different datasets and provide estimates of uncertainty for model parameters and outputs, unlike the weighted sum-of-squares used in the original model. In addition, the revised model could be used to manage herring stocks with a decision rule that considers both stock status and the uncertainty in stock status.	[Muradian, Melissa L.] Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Moffitt, Steven D.] Alaska Dept Fish & Game, Cordova, AK USA; [Hulson, Peter-John F.] NOAA, Alaska Fisheries Sci Ctr, Juneau, AK USA; [Muradian, Melissa L.] Henrys Fork Fdn, Ashton, ID USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Alaska Department of Fish & Game; National Oceanic Atmospheric Admin (NOAA) - USA	Muradian, ML (corresponding author), Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA.; Muradian, ML (corresponding author), Henrys Fork Fdn, Ashton, ID USA.	melissa@henrysfork.org		Branch, Trevor/0000-0003-4308-8930	Exxon Valdez Oil Spill Trustee Council [13120111-Q]; Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA [NA10OAR4320148, 2448]; Richard C. and Lois M. Worthington Endowed Professor in Fisheries Management	Exxon Valdez Oil Spill Trustee Council(Exxon Mobil Corporation); Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA; Richard C. and Lois M. Worthington Endowed Professor in Fisheries Management	MLM and TAB were funded by the Exxon Valdez Oil Spill Trustee Council, grant 13120111-Q. Supplementary funding was also received from the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement No. NA100AR4320148, Contribution No. 2448. TAB was funded in part by the Richard C. and Lois M. Worthington Endowed Professor in Fisheries Management. The funders encourage publications but did not have any role in design, data, writing, or the decision to submit this particular article for publication. Author contributions: TAB and MLM designed the study, MLM and TAB conducted the analyses and wrote the paper, SDM contributed data and interpreted results, PJFH contributed computer code.	Botz J., 2010, 1055 AL DEP FISH GAM; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Francis RICC, 2011, CAN J FISH AQUAT SCI, V68, P1124, DOI 10.1139/F2011-025; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; Hose JE, 1996, CAN J FISH AQUAT SCI, V53, P2355, DOI 10.1139/cjfas-53-10-2355; Hulson PJF, 2008, ICES J MAR SCI, V65, P25, DOI 10.1093/icesjms/fsm162; Hurtado-Ferro F, 2015, ICES J MAR SCI, V72, P99, DOI 10.1093/icesjms/fsu198; Kocan RM, 1996, CAN J FISH AQUAT SCI, V53, P2388, DOI 10.1139/cjfas-53-10-2388; Kurota H, 2010, POPUL ECOL, V52, P359, DOI 10.1007/s10144-010-0201-1; Marty GD, 2010, DIS AQUAT ORGAN, V90, P1, DOI 10.3354/dao02210; Marty GD, 2003, CAN J FISH AQUAT SCI, V60, P1258, DOI [10.1139/f03-109, 10.1139/F03-109]; Marty GD, 1999, CAN J FISH AQUAT SCI, V56, P419, DOI 10.1139/cjfas-56-3-419; MCALLISTER MK, 1994, CAN J FISH AQUAT SCI, V51, P2673, DOI 10.1139/f94-267; McAllister MK, 1997, CAN J FISH AQUAT SCI, V54, P284, DOI 10.1139/cjfas-54-2-284; Mohn R, 1999, ICES J MAR SCI, V56, P473, DOI 10.1006/jmsc.1999.0481; Monson DH, 2000, P NATL ACAD SCI USA, V97, P6562, DOI 10.1073/pnas.120163397; Norcross BL, 1996, CAN J FISH AQUAT SCI, V53, P2376, DOI 10.1139/cjfas-53-10-2376; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Peterson CH, 2001, ADV MAR BIOL, V39, P1, DOI 10.1016/S0065-2881(01)39008-9; PIATT JF, 1990, AUK, V107, P387, DOI 10.2307/4087623; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; Quinn Terrance J. II, 2001, VAK-SG-01-04, P363; Reum JCP, 2013, FISH OCEANOGR, V22, P324, DOI 10.1111/fog.12025; Rooper CN, 1999, CAN J FISH AQUAT SCI, V56, P1133, DOI 10.1139/cjfas-56-6-1133; Shertzer KW, 2010, MAR COAST FISH, V2, P451, DOI 10.1577/C10-014.1; Smith ADM, 1999, ICES J MAR SCI, V56, P967, DOI 10.1006/jmsc.1999.0540; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Stewart IJ, 2014, CAN J FISH AQUAT SCI, V71, P581, DOI 10.1139/cjfas-2013-0289; Stokesbury KDE, 1999, ENVIRON BIOL FISH, V56, P409, DOI 10.1023/A:1007557509202; Thomas GL, 2003, AQUAT LIVING RESOUR, V16, P247, DOI 10.1016/S0990-7440(03)00044-5; Thomas GL, 2001, NATURE, V411, P1013, DOI 10.1038/35082745; Thorne RE, 2008, ICES J MAR SCI, V65, P44, DOI 10.1093/icesjms/fsm176; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72153	10.1371/journal.pone.0172153	http://dx.doi.org/10.1371/journal.pone.0172153			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222151	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800036
J	Duan, XL; Wang, K; Su, S; Tian, RZ; Li, YT; Chen, MH				Duan, Xinle; Wang, Kang; Su, Sha; Tian, Ruizheng; Li, Yuting; Chen, Maohua			De novo transcriptome analysis and microsatellite marker development for population genetic study of a serious insect pest, Rhopalosiphum padi (L.) (Hemiptera: Aphididae)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; PARTHENOGENETIC SITOBION APHIDS; BIRD-CHERRY APHID; EST-SSR MARKERS; ACETYLCHOLINESTERASE GENES; THROUGHPUT DISCOVERY; LIFE-CYCLE; TRANSFERABILITY; AVENAE; WHEAT	The bird cherry-oat aphid, Rhopalosiphum padi (L.), is one of the most abundant aphid pests of cereals and has a global distribution. Next-generation sequencing (NGS) is a rapid and efficient method for developing molecular markers. However, transcriptomic and genomic resources of R. padi have not been investigated. In this study, we used transcriptome information obtained by RNA-Seq to develop polymorphic microsatellites for investigating population genetics in this species. The transcriptome of R. padi was sequenced on an Illumina HiSeq 2000 platform. A total of 114.4 million raw reads with a GC content of 40.03% was generated. The raw reads were cleaned and assembled into 29,467 unigenes with an N50 length of 1,580 bp. Using several public databases, 82.47% of these unigenes were annotated. Of the annotated unigenes, 8,022 were assigned to COG pathways, 9,895 were assigned to GO pathways, and 14,586 were mapped to 257 KEGG pathways. A total of 7,936 potential microsatellites were identified in 5,564 unigenes, 60 of which were selected randomly and amplified using specific primer pairs. Fourteen loci were found to be polymorphic in the four R. padi populations. The transcriptomic data presented herein will facilitate gene discovery, gene analyses, and development of molecular markers for future studies of R. padi and other closely related aphid species.	[Duan, Xinle; Wang, Kang; Su, Sha; Tian, Ruizheng; Li, Yuting; Chen, Maohua] Northwest A&F Univ, Coll Plant Protect, Minist Agr, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Peoples R China; [Duan, Xinle] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Fujian Agriculture & Forestry University	Chen, MH (corresponding author), Northwest A&F Univ, Coll Plant Protect, Minist Agr, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Peoples R China.	maohua.chen@nwsuaf.edu.cn			National Natural Science Foundation of China [31272036, 31471766]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the National Natural Science Foundation of China (No. 31272036 and No. 31471766). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2002, FSTAT VERSION 2 9 3; Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Artigaud S, 2014, MAR GENOM, V15, P3, DOI 10.1016/j.margen.2014.03.006; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Chen EH, 2014, INSECT MOL BIOL, V23, P52, DOI 10.1111/imb.12060; Chen MH, 2007, GENOME, V50, P172, DOI 10.1139/G07-021; Chen MH, 2007, PESTIC BIOCHEM PHYS, V87, P189, DOI 10.1016/j.pestbp.2006.07.009; Chen XM, 2016, GENE, V576, P537, DOI 10.1016/j.gene.2015.11.001; Comeault AA, 2012, MOL ECOL RESOUR, V12, P549, DOI 10.1111/j.1755-0998.2012.03121.x; Cook N, 2011, CONSERV GENET RESOUR, V3, P789, DOI 10.1007/s12686-011-9459-7; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Deng YW, 2014, BIOSCI BIOTECH BIOCH, V78, P1685, DOI 10.1080/09168451.2014.936351; Duan XL, 2017, J PEST SCI, V90, P103, DOI 10.1007/s10340-016-0752-9; Duan XL, 2015, J PLANT PROTECT, V42, P297; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Karaiskou N, 2008, J HERED, V99, P688, DOI 10.1093/jhered/esn052; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Karsten M, 2016, MOL ECOL, V25, P3019, DOI 10.1111/mec.13646; Karsten M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054281; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kim TS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-31; LEATHER SR, 1981, ANN APPL BIOL, V99, P115, DOI 10.1111/j.1744-7348.1981.tb05136.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu GH, 2016, GENE, V576, P333, DOI 10.1016/j.gene.2015.10.045; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lu Y, 2009, B ENTOMOL RES, V99, P611, DOI 10.1017/S0007485309006725; Luo Mei, 2014, Acta Entomologica Sinica, V57, P395; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; MartinezTorres D, 1997, B ENTOMOL RES, V87, P161, DOI 10.1017/S0007485300027309; Meglecz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040861; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ollivier M, 2012, GENOME BIOL EVOL, V4, P155, DOI 10.1093/gbe/evr140; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Park SDE, 2001, THESIS; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; PIKE KS, 1985, J ECON ENTOMOL, V78, P676, DOI 10.1093/jee/78.3.676; Rispe C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2530-8; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Shiel BP, 2015, MAR BIOTECHNOL, V17, P23, DOI 10.1007/s10126-014-9591-y; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMON JC, 1991, B ENTOMOL RES, V81, P315, DOI 10.1017/S0007485300033599; Simon JC, 1996, HEREDITY, V76, P305, DOI 10.1038/hdy.1996.44; Simon JC, 2001, MOL ECOL NOTES, V1, P4, DOI 10.1046/j.1471-8278.2000.00002.x; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Sunnucks P, 1996, GENETICS, V144, P747; Tang Yuan-ju, 2007, Zhongguo Yufang Shouyi Xuebao, V29, P629; TATCHELL GM, 1988, ANN APPL BIOL, V112, P1, DOI 10.1111/j.1744-7348.1988.tb02035.x; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Uliano-Silva M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102973; Valenzuela I, 2010, ANN ENTOMOL SOC AM, V103, P886, DOI 10.1603/AN09113; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang BA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120054; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wei Dan-dan, 2014, Yingyong Shengtai Xuebao, V25, P1799; Wilson ACC, 1999, MOL ECOL, V8, P1655, DOI 10.1046/j.1365-294x.1999.00751.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Yeh F. C., 2000, POPGENE32 MICROSOFT; Yuan Yuan, 2014, Huanjing Kunchong Xuebao, V36, P166; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang LY, 2005, THEOR APPL GENET, V111, P677, DOI 10.1007/s00122-005-2041-5; Zhang XC, 1985, J PLANT PROTECT, V12, P9; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhou Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep20549; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411	87	22	26	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172513	10.1371/journal.pone.0172513	http://dx.doi.org/10.1371/journal.pone.0172513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212394	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700057
J	Foschi, C; Laghi, L; Parolin, C; Giordani, B; Compri, M; Cevenini, R; Marangoni, A; Vitali, B				Foschi, Claudio; Laghi, Luca; Parolin, Carola; Giordani, Barbara; Compri, Monica; Cevenini, Roberto; Marangoni, Antonella; Vitali, Beatrice			Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and H-1-NMR	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; SPECIES IDENTIFICATION; VAGINAL MICROBIOME; CASEI GROUP; HUMAN GUT; PCR; STRAINS; FOOD; PROBIOTICS	Lactobacilli represent a wide range of bacterial species with several implications for the human host. They play a crucial role in maintaining the ecological equilibrium of different biological niches and are essential for fermented food production and probiotic formulation. Despite the consensus about the 'health-promoting' significance of Lactobacillus genus, its genotypic and phenotypic characterization still poses several difficulties. The aim of this study was to assess the integration of different approaches, genotypic (16S rRNA gene sequencing), proteomic (MALDI-TOF MS) and metabolomic (H-1-NMR), for the taxonomic and metabolic characterization of Lactobacillus species. For this purpose we analyzed 40 strains of various origin (intestinal, vaginal, food, probiotics), belonging to different species. The high discriminatory power of MALDI-TOF for species identification was underlined by the excellent agreement with the genotypic analysis. Indeed, MALDI-TOF allowed to correctly identify 39 out of 40 Lactobacillus strains at the species level, with an overall concordance of 97.5%. In the perspective to simplify the MALDI TOF sample preparation, especially for routine practice, we demonstrated the perfect agreement of the colony-picking from agar plates with the protein extraction protocol. H-1-NMR analysis, applied to both culture supernatants and bacterial lysates, identified a panel of metabolites whose variations in concentration were associated with the taxonomy, but also revealed a high intra-species variability that did not allow a species-level identification. Therefore, despite not suitable for mere taxonomic purposes, metabolomics can be useful to correlate particular biological activities with taxonomy and to understand the mechanisms related to the antimicrobial effect shown by some Lactobacillus species.	[Foschi, Claudio; Compri, Monica; Cevenini, Roberto; Marangoni, Antonella] Univ Bologna, Microbiol, DIMES, Bologna, Italy; [Laghi, Luca] Univ Bologna, Dept Agrofood Sci & Technol, Ctr Food, Bologna, Italy; [Parolin, Carola; Giordani, Barbara; Vitali, Beatrice] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Marangoni, A (corresponding author), Univ Bologna, Microbiol, DIMES, Bologna, Italy.	antonella.marangoni@unibo.it	Giordani, Barbara/AAC-2941-2020; Mattei, Benedetta/F-1504-2015; parolin, carola/C-1144-2013; Foschi, Claudio/A-7299-2016; Laghi, Luca/R-5278-2016	Mattei, Benedetta/0000-0003-2927-6329; parolin, carola/0000-0003-1536-9276; Foschi, Claudio/0000-0001-7253-8799; Laghi, Luca/0000-0003-1593-7376; Marangoni, Antonella/0000-0002-7397-6560	Ministry of Instruction, University and Research (MIUR), Italy [RF02014]	Ministry of Instruction, University and Research (MIUR), Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministry of Instruction, University and Research (MIUR), Italy to BV and RC (RF02014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Angelakis E, 2011, J FOOD SCI, V76, pM568, DOI 10.1111/j.1750-3841.2011.02369.x; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Bauer E, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0121-6; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Bourdichon F, 2012, INT J FOOD MICROBIOL, V154, P87, DOI 10.1016/j.ijfoodmicro.2011.12.030; Callaway A, 2013, CLIN LAB, V59, P1373, DOI 10.7754/Clin.Lab.2013.121225; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chavagnat F, 2002, FEMS MICROBIOL LETT, V217, P177, DOI 10.1111/j.1574-6968.2002.tb11472.x; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Cruciani F, 2015, ANTIMICROB AGENTS CH, V59, P2825, DOI 10.1128/AAC.00225-15; Cruciani F, 2012, ANTIMICROB AGENTS CH, V56, P4062, DOI 10.1128/AAC.00061-12; Dec M, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0732-5; Dec M, 2014, RES MICROBIOL, V165, P190, DOI 10.1016/j.resmic.2014.02.003; Doan NTL, 2012, LETT APPL MICROBIOL, V55, P265, DOI 10.1111/j.1472-765X.2012.03287.x; Duskova M, 2012, INT J FOOD MICROBIOL, V159, P107, DOI 10.1016/j.ijfoodmicro.2012.07.029; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Food and Agriculture Organization of the United Nations/World Health Organization FAO/WHO, 2002, GUID EV PROB FOOD, DOI DOI 10.1111/J.1469-0691.2012.03873; Helland MH, 2004, INT J FOOD MICROBIOL, V91, P305, DOI 10.1016/j.ijfoodmicro.2003.07.007; Huang CH, 2014, MOL CELL PROBE, V28, P192, DOI 10.1016/j.mcp.2014.03.003; Kern CC, 2014, FOOD MICROBIOL, V40, P18, DOI 10.1016/j.fm.2013.11.015; Kern CC, 2013, J MICROBIOL METH, V93, P185, DOI 10.1016/j.mimet.2013.03.012; Laghi L, 2014, TRAC-TREND ANAL CHEM, V59, P93, DOI 10.1016/j.trac.2014.04.009; Laghi L, 2014, ANTIMICROB AGENTS CH, V58, P3411, DOI 10.1128/AAC.02469-14; Lee IJ, 2009, J PROTEOME RES, V8, P4104, DOI 10.1021/pr8010759; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Massi M, 2004, J APPL MICROBIOL, V96, P777, DOI 10.1111/j.1365-2672.2004.02228.x; Mastromarino P, 2014, INT J MED MICROBIOL, V304, P654, DOI 10.1016/j.ijmm.2014.04.006; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Mencacci A, 2013, J CLIN MICROBIOL, V51, P603, DOI 10.1128/JCM.01811-12; Meyer H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-69; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; O'Callaghan J, 2013, CURR TOP MICROBIOL, V358, P119, DOI 10.1007/82_2011_187; Parolin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131220; Patel JB, 2001, MOL DIAGN, V6, P313, DOI 10.1054/modi.2001.29158; Patel R, 2015, CLIN INFECT DIS, V60, pS108, DOI 10.1093/cid/civ177; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Pot B, 2014, LACTIC ACID BACTERIA: BIODIVERSITY AND TAXONOMY, P249; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Riegel SD, 2016, TRAC TRENDS ANAL CHE; Rossi M, 2016, ENV MICROBIOL REP, V8, P399, DOI 10.1111/1758-2229.12405; Martinez RCR, 2015, BRIT J NUTR, V114, P1993, DOI 10.1017/S0007114515003864; Salvetti E, 2013, SYST APPL MICROBIOL, V36, P291, DOI 10.1016/j.syapm.2013.03.009; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sato H, 2012, SYST APPL MICROBIOL, V35, P447, DOI 10.1016/j.syapm.2012.08.008; Sheu SJ, 2009, J FOOD PROTECT, V72, P93, DOI 10.4315/0362-028X-72.1.93; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; Vielfort K, 2008, MICROBES INFECT, V10, P1325, DOI 10.1016/j.micinf.2008.07.032; Vitali B, 2015, EUR J CLIN MICROBIOL, V34, P2367, DOI 10.1007/s10096-015-2490-y; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Yang JS, 2016, J DAIRY SCI, V99, P5325, DOI 10.3168/jds.2016-10952; Zhang B, 2012, FUTURE MED CHEM, V4, P1273, DOI [10.4155/FMC.12.59, 10.4155/fmc.12.59]; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106185; Zheng JS, 2015, APPL ENVIRON MICROB, V81, P7233, DOI 10.1128/AEM.02116-15	61	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172483	10.1371/journal.pone.0172483	http://dx.doi.org/10.1371/journal.pone.0172483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207855	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500141
J	Nkwouano, V; Witkowski, S; Rehberg, N; Kalscheuer, R; Nausch, N; Mayatepek, E; Jacobsen, M				Nkwouano, Vanesa; Witkowski, Sven; Rehberg, Nidja; Kalscheuer, Rainer; Nausch, Norman; Mayatepek, Ertan; Jacobsen, Marc			A novel mycobacterial In Vitro infection assay identifies differences of induced macrophage apoptosis between CD4(+) and CD8(+) T cells	PLOS ONE			English	Article							IFN-GAMMA; TUBERCULOSIS; IMMUNITY; GROWTH; REQUIREMENT; INHIBITION	Macrophages are natural host cells for pathogenic mycobacteria, like Mycobacterium tuberculosis (M.tb). Immune surveillance by T cells and interaction with M.tb infected macrophages is crucial for protection against M.tb reactivation and development of active tuberculosis. Several factors play a role in the control of M.tb infection but reliable biomarkers remain elusive. One major obstacle is the absence of functional in vitro assays which allow concomitant determination of i) mycobacterial eradication; ii) cytotoxic effects on host macrophages; and iii) effector T-cell functions. We established a novel functional in vitro assay based on flow cytometry analysis of monocyte-derived macrophages (MDM) infected with a Mycobacterium bovis BCG strain containing a tetracycline inducible live/dead reporter plasmid (LD-BCG). MDM of healthy human donors were generated in vitro and infected with defined LD-BCG numbers. After short-term MDM/LD-BCG co-incubation with autologous effector T cells or in the presence of antibiotics, proportions of MDM containing live or dead LD-BCG were determined by flow cytometry. Concomitant measure of defined numbers of added beads allowed comparison of absolute MDM numbers between samples. Differential effects of T-cell subpopulations on anti-mycobacterial cytotoxicity and on MDM apoptosis were determined. Flow cytometry measure of MDM/LD-BCG treated with rifampicin correlated well with mycobacterial colony forming units and fluorescence microscopy results. Co culture with pre-activated effector T cells reduced viability of both, LD-BCG and MDM, in a concentration-dependent manner. M.tb protein specific CD4(+) and CD8(+) T-cells contributed similarly to anti-mycobacterial cytotoxicity but CD4(+) T cells induced higher levels of apoptosis in infected MDMs. This novel assay enables rapid quantification of anti-mycobacterial cytotoxicity and characterization of effector functions. Our functional in vitro assay has the potential to contribute to the identification of biomarkers for protective T-cell responses against tuberculosis.	[Nkwouano, Vanesa; Witkowski, Sven; Nausch, Norman; Mayatepek, Ertan; Jacobsen, Marc] Heinrich Heine Univ, Dept Gen Pediat Neonatol & Pediat Cardiol, Univ Childrens Hosp, Dusseldorf, Germany; [Rehberg, Nidja; Kalscheuer, Rainer] Heinrich Heine Univ, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf	Jacobsen, M (corresponding author), Heinrich Heine Univ, Dept Gen Pediat Neonatol & Pediat Cardiol, Univ Childrens Hosp, Dusseldorf, Germany.	marc.jacobsen@med.uni-duesseldorf.de	Kalscheuer, Rainer/AAF-1381-2020; Kalscheuer, Rainer/A-2852-2015; Nausch, Norman/L-9276-2013; Nausch, Norman/M-4526-2019	Kalscheuer, Rainer/0000-0002-3378-2067; Nausch, Norman/0000-0002-9704-2148; Nausch, Norman/0000-0002-9704-2148; Jacobsen, Marc/0000-0002-4703-5652; Witkowski, Sven/0000-0001-5398-7572	Jurgen Manchot Foundation; Graduate School 'Molecules of Infection II'	Jurgen Manchot Foundation; Graduate School 'Molecules of Infection II'	This study was supported by the Jurgen Manchot Foundation and the Graduate School 'Molecules of Infection II' project 13 to V. Nkwouano and M. Jacobsen. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Attiyah R, 2006, CLIN EXP IMMUNOL, V145, P520, DOI 10.1111/j.1365-2249.2006.03133.x; Bonecini-Almeida MG, 1998, J IMMUNOL, V160, P4490; Boselli D, 2007, EUR J IMMUNOL, V37, P2196, DOI 10.1002/eji.200636541; Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003; Brookes RH, 2003, EUR J IMMUNOL, V33, P3293, DOI 10.1002/eji.200324109; Fletcher HA, 2013, CLIN VACCINE IMMUNOL, V20, P1683, DOI 10.1128/CVI.00427-13; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Newton S, 2011, JOVE-J VIS EXP, DOI 10.3791/3332; Oddo M, 1998, J IMMUNOL, V160, P5448; Santucci MB, 2000, J INFECT DIS, V181, P1506, DOI 10.1086/315371; Silver RF, 1998, J IMMUNOL, V160, P2408; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Wallis RS, 2003, J INFECT DIS, V187, P270, DOI 10.1086/346053; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Worku S, 2000, CLIN INFECT DIS, V30, pS257, DOI 10.1086/313887; World Health Organization, 2015, GLOB TUB REP 2015	23	4	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171817	10.1371/journal.pone.0171817	http://dx.doi.org/10.1371/journal.pone.0171817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199374	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400051
J	Poli, D; Fabbri, E; Goffredo, S; Airi, V; Franzellitti, S				Poli, Davide; Fabbri, Elena; Goffredo, Stefano; Airi, Valentina; Franzellitti, Silvia			Physiological plasticity related to zonation affects hsp70 expression in the reef-building coral Pocillopora verrucosa	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GENE-EXPRESSION; MOLECULAR CHAPERONES; RAPID ACCLIMATION; TRANSCRIPTOME; TEMPERATURE; RESILIENCE; MECHANISMS; RESISTANCE; ACIDIFICATION	This study investigates for the first time the transcriptional regulation of a stress-inducible 70-kDa heat shock protein (hsp70) in the scleractinian coral Pocillopora verrucosa sampled at three locations and two depths (3 m and 12 m) in Bangka Island waters (North Sulawesi, Indonesia). Percentage of coral cover indicated reduced habitat suitability with depth and at the Tanjung Husi (TA) site, which also displayed relatively higher seawater temperatures. Expression of the P. verrucosa hsp70 transcript evaluated under field conditions followed a depth-related profile, with relatively higher expression levels in 3-m collected nubbins compared to the 12-m ones. Expression levels of metabolism-related transcripts ATP synthase and NADH dehydrogenase indicated metabolic activation of nubbins to cope with habitat conditions of the TA site at 3 m. After a 14-day acclimatization to common and fixed temperature conditions in the laboratory, corals were subjected for 7 days to an altered thermal regime, where temperature was elevated at 31 degrees C during the light phase and returned to 28 C during the dark phase. Nubbins collected at 12 m were relatively more sensitive to thermal stress, as they significantly over-expressed the selected transcripts. Corals collected at 3 m appeared more resilient, as they showed unaffected mRNA expressions. The results indicated that local habitat conditions may influence transcription of stress-related genes in P. verrucosa. Corals exhibiting higher basal hsp70 levels may display enhanced tolerance towards environmental stressors.	[Poli, Davide; Fabbri, Elena; Franzellitti, Silvia] Univ Bologna, Dept Biol Geol & Environm Sci, Via S Alberto, Ravenna, Italy; [Poli, Davide; Fabbri, Elena; Franzellitti, Silvia] Univ Bologna, Interdept Ctr Environm Sci Res, Via S Alberto, Ravenna, Italy; [Goffredo, Stefano; Airi, Valentina] Univ Bologna, Marine Sci Grp, Dept Biol Geol & Environm Sci, Via F Selmi 3, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Franzellitti, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Via S Alberto, Ravenna, Italy.; Franzellitti, S (corresponding author), Univ Bologna, Interdept Ctr Environm Sci Res, Via S Alberto, Ravenna, Italy.	silvia.franzellitti@unibo.it		Airi, Valentina/0000-0002-6118-7441; Franzellitti, Silvia/0000-0001-6104-7812; FABBRI, Elena/0000-0002-9957-8202; goffredo, stefano/0000-0002-5022-9503	Italian Ministry of University and Research [MIUR RF02013]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	Support was provided by the Italian Ministry of University and Research (MIUR RF02013) to EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelman HE, 2016, ECOL EVOL; Al-Sofyani AA, 2013, OCEANOLOGIA, V55, P917, DOI 10.5697/oc.55-4.917; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anestis A, 2008, J EXP BIOL, V211, P2889, DOI 10.1242/jeb.016782; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bay Line K., 2013, PLoS ONE, V8, P1; Bay RA, 2015, GENOME BIOL EVOL, V7, P1602, DOI 10.1093/gbe/evv085; Bedulina DS, 2010, COMP BIOCHEM PHYS B, V155, P413, DOI 10.1016/j.cbpb.2010.01.004; Bellantuono AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050685; Bhattacharya D, 2016, ELIFE, V5, DOI 10.7554/eLife.13288; Bianchi C.N., 2004, BIOL MAR MEDITERR, V11, P185; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Brown T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067246; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; Dixon GB, 2015, SCIENCE, V348, P1460, DOI 10.1126/science.1261224; Dong YW, 2010, BIOL BULL-US, V218, P87, DOI 10.1086/BBLv218n1p87; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Fabbri E., 2008, ISJ, V5, P135; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fantazzini P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8785; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Franzellitti S, 2005, BIOCHEM BIOPH RES CO, V336, P1157, DOI 10.1016/j.bbrc.2005.08.244; Franzellitti S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16966; Franzellitti S, 2010, COMP BIOCHEM PHYS C, V152, P24, DOI 10.1016/j.cbpc.2010.02.010; Freeman LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128875; Gates RD, 1999, AM ZOOL, V39, P30; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Goffredo S, 2014, NAT CLIM CHANGE, V4, P593, DOI [10.1038/nclimate2241, 10.1038/NCLIMATE2241]; Granados-Cifuentes C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-228; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoeksema BW, 2014, IUCN RED LIST THREAT; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jovanovic B, 2014, ENVIRON TOXICOL CHEM, V33, P1346, DOI 10.1002/etc.2560; Kegler P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142744; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Levin RA, 2016, MOL BIOL EVOL, V33, P2201, DOI 10.1093/molbev/msw119; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Levy O, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3025; Maor-Landaw K, 2014, GLOBAL CHANGE BIOL, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; Morris JP, 2013, MOL ECOL, V22, P1494, DOI 10.1111/mec.12216; Moya A, 2015, MOL ECOL, V24, P438, DOI 10.1111/mec.13021; Moya A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2355-x; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Piano A, 2005, GENE, V361, P119, DOI 10.1016/j.gene.2005.06.034; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Pratlong M, 2015, MOL ECOL RESOUR, V15, P1205, DOI 10.1111/1755-0998.12383; Richier S, 2008, J EXP MAR BIOL ECOL, V357, P48, DOI 10.1016/j.jembe.2007.12.026; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Sawall Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08940; Sawall Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103179; Seneca FO, 2015, MOL ECOL, V24, P1467, DOI 10.1111/mec.13125; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Tambutte E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8368; Tomanek L, 2002, J EXP BIOL, V205, P677; Turak E, 2013, RAP B BIOL ASSESSMEN, P78; Venn AA, 2009, AQUAT TOXICOL, V93, P188, DOI 10.1016/j.aquatox.2009.05.003; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wilkinson CR, 2003, P 7 INT COR REEF S G, V1, P11; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004; Ziegler M, 2014, CORAL REEFS; Ziegler M, 2015, MAR ECOL PROG SER, V533, P149, DOI 10.3354/meps11365	83	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171456	10.1371/journal.pone.0171456	http://dx.doi.org/10.1371/journal.pone.0171456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199351	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400031
J	Riehl, BD; Lee, JS; Ha, L; Kwon, IK; Lim, JY				Riehl, Brandon D.; Lee, Jeong Soon; Ha, Ligyeom; Kwon, Il Keun; Lim, Jung Yul			Flowtaxis of osteoblast migration under fluid shear and the effect of RhoA kinase silencing	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BONE-CELLS; MC3T3-E1 OSTEOBLASTS; FLOW; PROLIFERATION; CYTOSKELETON; ROCK; DIFFERENTIATION; REGENERATION; RECRUITMENT	Despite the important role of mechanical signals in bone remodeling, relatively little is known about how fluid shear affects osteoblastic cell migration behavior. Here we demonstrated that MC3T3-E1 osteoblast migration could be activated by physiologically-relevant levels of fluid shear in a shear stress-dependent manner. Interestingly, shear-sensitive osteoblast migration behavior was prominent only during the initial period after the onset of the steady flow (for about 30 min), exhibiting shear stress-dependent migration speed, displacement, arrest coefficient, and motility coefficient. For example, cell speed at 1 min was 0.28, 0.47, 0.51, and 0.84 pm min(-1) for static, 2, 15, and 25 dyne cm(-2) shear stress, respectively. Arrest coefficient (measuring how often cells are paused during migration) assessed for the first 30 min was 0.40, 0.26, 0.24, and 0.12 respectively for static, 2, 15, and 25 dyne cm(-2). After this initial period, osteoblasts under steady flow showed decreased migration capacity and diminished shear stress dependency. Molecular interference of RhoA kinase (ROCK), a regulator of cytoskeletal tension signaling, was found to increase the shear-sensitive window beyond the initial period. Cells with ROCK-shRNA had increased migration in the flow direction and continued shear sensitivity, resulting in greater root mean square displacement at the end of 120 min of measurement. It is notable that the transient osteoblast migration behavior was in sharp contrast to mesenchymal stem cells that exhibited sustained shear sensitivity (as we recently reported, J. R. Soc. Interface. 2015; 12:20141351). The study of fluid shear as a driving force for cell migration, i.e., "flowtaxis", and investigation of molecular mechanosensors governing such behavior (e.g., ROCK as tested in this study) may provide new and improved insights into the fundamental understanding of cell migration-based homeostasis.	[Riehl, Brandon D.; Lee, Jeong Soon; Ha, Ligyeom; Kwon, Il Keun; Lim, Jung Yul] Univ Nebraska, Coll Engn, Dept Mech & Mat Engn, Lincoln, NE USA; [Kwon, Il Keun; Lim, Jung Yul] Kyung Hee Univ, Grad Sch Dent, Seoul, South Korea	University of Nebraska System; University of Nebraska Lincoln; Kyung Hee University	Lim, JY (corresponding author), Univ Nebraska, Coll Engn, Dept Mech & Mat Engn, Lincoln, NE USA.; Lim, JY (corresponding author), Kyung Hee Univ, Grad Sch Dent, Seoul, South Korea.	jlim4@unl.edu		Kwon, Il Keun/0000-0001-9649-3003	National Science Foundation CAREER Award [1351570]; Nebraska Tobacco Settlement Biomedical Research Seed Grant; Layman New Directions Award; Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115458] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); Nebraska Tobacco Settlement Biomedical Research Seed Grant; Layman New Directions Award; Nebraska Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation CAREER Award (1351570) to JYL (http://www.nsf.gov/); Nebraska Tobacco Settlement Biomedical Research Seed Grant to JYL; Layman New Directions Award to JYL; Nebraska Research Initiative to JYL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalib MN, 2013, ACTA BIOMATER, V9, P7737, DOI 10.1016/j.actbio.2013.04.013; Bacabac RG, 2005, ANN BIOMED ENG, V33, P104, DOI 10.1007/s10439-005-8968-5; Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080; Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047; Fritton K, 2012, TISSUE ENG PT A, V18, P2559, DOI [10.1089/ten.tea.2012.0086, 10.1089/ten.TEA.2012.0086]; Gardinier JD, 2009, CELL MOL BIOENG, V2, P133, DOI 10.1007/s12195-008-0038-2; Gildner CD, 2014, MATRIX BIOL, V34, P33, DOI 10.1016/j.matbio.2014.01.017; Huth J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-24; Jackson WM, 2008, AM J PHYSIOL-CELL PH, V295, pC1007, DOI 10.1152/ajpcell.00509.2007; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Karadag A, 2006, J BONE MINER RES, V21, P1627, DOI 10.1359/JBMR.060710; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kurosawa H, 2012, J BIOSCI BIOENG, V114, P577, DOI 10.1016/j.jbiosc.2012.07.013; Lai XH, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.9; Li P, 2012, MOL CELL BIOCHEM, V364, P321, DOI 10.1007/s11010-012-1233-y; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020; Lim JY, 2005, J R SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019; Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19; Liu LY, 2012, BIOMECH MODEL MECHAN, V11, P391, DOI 10.1007/s10237-011-0319-x; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Orr DE, 2008, ANN BIOMED ENG, V36, P1228, DOI 10.1007/s10439-008-9505-0; Pan J, 2010, CELL MOL BIOENG, V3, P376, DOI 10.1007/s12195-010-0132-0; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pignolo RJ, 2011, J BONE MINER RES, V26, P1685, DOI 10.1002/jbmr.370; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Price C, 2011, J BONE MINER RES, V26, P277, DOI 10.1002/jbmr.211; Proksch S, 2015, STEM CELLS, V33, P3114, DOI 10.1002/stem.2119; Prowse PDH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058898; Riehl BD, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1351; Riehl Brandon D, 2012, Cells, V1, P1225, DOI 10.3390/cells1041225; Salvi JD, 2010, J BIOMECH, V43, P3058, DOI 10.1016/j.jbiomech.2010.07.015; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Tian YS, 2009, BIOCHEM BIOPH RES CO, V386, P499, DOI 10.1016/j.bbrc.2009.06.087; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Worton LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074205; Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015; Zhang XJ, 2011, CELL MOL BIOL LETT, V16, P279, DOI 10.2478/s11658-011-0006-z	42	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171857	10.1371/journal.pone.0171857	http://dx.doi.org/10.1371/journal.pone.0171857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199362	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400053
J	Carrieri, MP; Marcellin, F; Fressard, L; Preau, M; Sagaon-Teyssier, L; Suzan-Monti, M; Guagliardo, V; Mora, M; Roux, P; Dray-Spira, R; Spire, B				Carrieri, Maria Patrizia; Marcellin, Fabienne; Fressard, Lisa; Preau, Marie; Sagaon-Teyssier, Luis; Suzan-Monti, Marie; Guagliardo, Valerie; Mora, Marion; Roux, Perrine; Dray-Spira, Rosemary; Spire, Bruno		ANRS VESPA2 Study Grp	Suicide risk in a representative sample of people receiving HIV care: Time to target most-at-risk populations (ANRS VESPA2 French national survey)	PLOS ONE			English	Article							HEPATITIS-C; COMPLETED SUICIDE; USE DISORDERS; ALCOHOL-USE; SMOKING; IDEATION; AIDS; ASSOCIATION; INFECTION; BEHAVIOR	Background Suicide risk is high among people living with HIV (PLHIV). This study aimed to identify major correlates of suicide risk in a representative sample of PLHIV in France, in order to help target individuals who would benefit from suicide risk screening and psychiatric care. Methods The ANRS VESPA2 cross-sectional survey (April 2011-January 2012) collected sociodemographic, medical and behavioral data from 3,022 PLHIV recruited in 73 French HIV hospital departments. The study sample comprised the 2,973 participants with available self-reported data on suicide risk (defined as having either thought about and planned to commit suicide during the previous 12 months or attempted suicide during the same period of time) and medical data on comorbidities. Weighted Poisson models adjusted for HCV co infection and significant clinical variables were used to estimate the relationship between suicide risk and HIV transmission groups, experience with HIV disease and other psychosocial factors. Results Suicide risk was reported by 6.3% of PLHIV in the study sample. After adjustment for HIV immunological status and HCV co-infection, women (IRR [95%Cl]:1.93 [1.17; 3.19]) and men who have sex with men (MSM) (1.97 [1.22; 3.19]) had a higher suicide risk than the rest of the sample. Moreover, the number of discrimination-related social contexts reported (1.39 [1.19; 1.61]), homelessness (4.87 [1.82; 13.02]), and reporting a feeling of loneliness (4.62 [3.06; 6.97]) were major predictors of suicide risk. Conclusions Reducing the burden of precarious social conditions and discrimination is an important lever for preventing suicide risk among PLHIV in France. Comprehensive care models involving peer/community social interventions targeted at women and MSM need to be implemented to lower the risk of suicide in these specific subgroups of PLHIV.	[Carrieri, Maria Patrizia; Marcellin, Fabienne; Fressard, Lisa; Preau, Marie; Sagaon-Teyssier, Luis; Suzan-Monti, Marie; Guagliardo, Valerie; Mora, Marion; Roux, Perrine; Spire, Bruno] Aix Marseille Univ, INSERM, Sci Econ & Sociales Sante & Traitement Informat M, IRD,SESSTIM, Marseille, France; [Carrieri, Maria Patrizia; Marcellin, Fabienne; Fressard, Lisa; Sagaon-Teyssier, Luis; Suzan-Monti, Marie; Guagliardo, Valerie; Mora, Marion; Roux, Perrine; Spire, Bruno; ANRS VESPA2 Study Grp] ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France; [Preau, Marie] Univ Lyon 2, Inst Psychol, GREPS, 5 Ave Pierre Mendes France, Bron, France; [Dray-Spira, Rosemary] INSERM, UMR S1136, Pierre Louis Inst Epidemiol & Publ Hlth, Team Res Social Epidemiol, Paris, France; [Dray-Spira, Rosemary] UPMC Univ Paris 06, Sorbonne Univ, Pierre Louis Inst Epidemiol & Publ Hlth, Team Res Social Epidemiol,UMR S1136, Paris, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite Lyon 2; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Marcellin, F; Fressard, L (corresponding author), Aix Marseille Univ, INSERM, Sci Econ & Sociales Sante & Traitement Informat M, IRD,SESSTIM, Marseille, France.; Marcellin, F; Fressard, L (corresponding author), ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France.	fabienne.marcellin@inserm.fr; lisa.fressard@inserm.fr	Marcellin, Fabienne/H-7911-2019; Spire, Bruno/F-5546-2013	Marcellin, Fabienne/0000-0001-8853-3829; Spire, Bruno/0000-0002-3546-8020; Alvarez, Mario Moises/0000-0002-9131-5344; DENES, Eric/0000-0001-5321-3171; Lelievre, Jean-Daniel/0000-0002-8182-3628; Carrieri, Patrizia/0000-0002-6794-4837; Sagaon-Teyssier, Luis/0000-0001-7318-6596; Dray-Spira, Rosemary/0000-0001-7646-3667	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The ANRS-VESPA2 survey was sponsored and funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The grants were paid to the research units of the co-authors. htfplivevevenrs.fre.	Aubin HJ, 2011, AM J PSYCHIAT, V168, P326, DOI 10.1176/appi.ajp.2010.10101501; Balbuena L, 2015, PSYCHIAT SERV, V66, P186, DOI 10.1176/appi.ps.201300509; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Carrieri MP, 2015, AIDS IMPACT; Cazein F., 2015, Bulletin Epidemiologique Hebdomadaire, P152; Cooperman NA, 2005, J BEHAV MED, V28, P149, DOI 10.1007/s10865-005-3664-3; Daskalopoulou M, 2014, LANCET HIV; Douab T, 2014, AIDS CARE, V26, pS29, DOI 10.1080/09540121.2014.906553; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P321; Grassi L, 2001, J AFFECT DISORDERS, V64, P195, DOI 10.1016/S0165-0327(00)00244-5; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Kalichman SC, 2000, PSYCHIATR SERV, V51, P903, DOI 10.1176/appi.ps.51.7.903; Keiser O, 2010, AM J PSYCHIAT, V167, P143, DOI 10.1176/appi.ajp.2009.09050651; Kelly B, 1998, PSYCHOSOMATICS, V39, P405, DOI 10.1016/S0033-3182(98)71299-X; Kennedy MC, 2015, DRUG ALCOHOL DEPEN, V151, P272, DOI 10.1016/j.drugalcdep.2015.03.006; Komiti A, 2001, AUST NZ J PSYCHIAT, V35, P747, DOI 10.1046/j.1440-1614.2001.00943.x; Krueger C, 2011, J VIRAL HEPATITIS, V18, pE284, DOI 10.1111/j.1365-2893.2010.01408.x; Kuramoto SJ, 2013, SUICIDE LIFE-THREAT, V43, P366, DOI 10.1111/sltb.12023; Lucas M, 2013, J AFFECT DISORDERS, V151, P1053, DOI 10.1016/j.jad.2013.08.033; Marcellin F, 2014, SEX TRANSM INFECT; Marcellin F., 2016, DRUG ALCOHOL REV; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Marsicano E, 2014, AIDS CARE, P1; MCKEGNEY FP, 1992, AM J PSYCHIAT, V149, P396; McManus H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089089; Michel L, 2015, COMPR PSYCHIAT, V62, P123, DOI 10.1016/j.comppsych.2015.07.004; Mino A, 1999, Crisis, V20, P28, DOI 10.1027//0227-5910.20.1.28; Modabbernia A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8340; Nostlinger C, 2014, AIDS PATIENT CARE ST, V28, P155, DOI 10.1089/apc.2013.0247; ODOWD MA, 1993, PSYCHOSOMATICS, V34, P33; Paul JP, 2002, AM J PUBLIC HEALTH, V92, P1338, DOI 10.2105/AJPH.92.8.1338; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Preau M, 2008, AIDS CARE, V20, P917, DOI 10.1080/09540120701777249; Roux P., 2013, Bulletin Epidemiologique Hebdomadaire, P314; Schwartz R. C., 2004, COUNSELING PSYCHOL Q, V17, P89, DOI DOI 10.1080/09515070410001665712; Sherr L, 1995, AIDS CARE, V7, pS109; Sockalingam S, 2011, J VIRAL HEPATITIS, V18, P153, DOI 10.1111/j.1365-2893.2010.01393.x; Stutterheim SE, 2009, AIDS, V23, P2353, DOI 10.1097/QAD.0b013e3283320dce; Suzan-Monti M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20095; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003	43	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171645	10.1371/journal.pone.0171645	http://dx.doi.org/10.1371/journal.pone.0171645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192455	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800034
J	Higashiyama, T; Nishida, Y; Ohji, M				Higashiyama, Tomoaki; Nishida, Yasuhiro; Ohji, Masahito			Optical coherence tomography angiography in eyes with good visual acuity recovery after treatment for optic neuritis	PLOS ONE			English	Article							NERVE-FIBER LAYER; CHOROIDAL NEOVASCULARIZATION; AXONAL LOSS	Objective To evaluate the retinal perfusion using optical coherence tomography (OCT) angiography in eyes with good visual acuity recovery after treatment for optic neuritis (ON). Methods Seven eyes of seven patients with good visual acuity recovery after treatment for monocular ON and seven eyes of each fellow eye used as controls were studied. Retinal perfusion around the disc and at the macula was evaluated using OCT angiography. The retinal nerve fiber layer thickness was measured around the disc. The ganglion cell layer complex thickness or the ganglion cell layer plus the inner plexiform layer thickness were measured at the macula. Results The retinal perfusions in all eyes with ON decreased around the disc and at the macula compared with those of the fellow eyes, as shown by OCT angiography (disc, P= 0.003; macula, P= 0.001). The retinal thicknesses in all eyes with ON also decreased around the disc and at the macula compared with those of the fellow eyes (disc, P< 0.001; macula, P= 0.003). Conclusions Optic neuritis may cause not only retinal structural damage but also decreased retinal perfusion, even after the visual acuity recovered well after treatment.	[Higashiyama, Tomoaki; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan; [Nishida, Yasuhiro] Shiga Univ Med Sci, Clin Med Educ Ctr, Otsu, Shiga, Japan	Shiga University of Medical Science	Higashiyama, T (corresponding author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan.	higashi@belle.shiga-med.ac.jp						BECK RW, 1994, OPHTHALMOLOGY, V101, P1771; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Costello F, 2015, J NEUROL NEUROSUR PS, V86, P1369, DOI 10.1136/jnnp-2014-309704; de Carlo TE, 2015, OSLI RETINA, V46, P611, DOI 10.3928/23258160-20150610-03; GUY J, 1992, OPHTHALMOLOGY, V99, P720; Higashiyama T, 2016, NEURO-OPHTHALMOLOGY, V40, P146, DOI 10.3109/01658107.2016.1162174; Higashiyama T, 2016, OSLI RETINA, V47, P724, DOI 10.3928/23258160-20160808-05; Huang-Link YM, 2015, NEUROL SCI, V36, P617, DOI 10.1007/s10072-014-1982-3; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Pro MJ, 2006, J NEUROL SCI, V250, P114, DOI 10.1016/j.jns.2006.08.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spaide RF, 2015, AM J OPHTHALMOL, V160, P6, DOI 10.1016/j.ajo.2015.04.012; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Wang XG, 2014, BRIT J OPHTHALMOL, V98, P1368, DOI 10.1136/bjophthalmol-2013-304547; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437	22	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172168	10.1371/journal.pone.0172168	http://dx.doi.org/10.1371/journal.pone.0172168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192497	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800081
J	Liu, YY; Han, X; Yuan, JT; Geng, TY; Chen, SH; Hu, XM; Cui, IH; Cui, HM				Liu, Yangyang; Han, Xiao; Yuan, Junting; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Isabelle H.; Cui, Hengmi			Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; gene knockout; gene silencing; long non-coding RNA (long ncRNA; lncRNA); polyadenylation	HUMAN GENOME; LOCUS; LNCRNA; CELLS; MICE; CAS9; DNA	The type II bacterial CRISPR/Cas9 system is a simple, convenient, and powerful tool for targeted gene editing. Here, we describe a CRISPR/Cas9-based approach for inserting a poly(A) transcriptional terminator into both alleles of a targeted gene to silence protein-coding and non-protein-coding genes, which often play key roles in gene regulation but are difficult to silence via insertion or deletion of short DNA fragments. The integration of 225 bp of bovine growth hormone poly(A) signals into either the first intron or the first exon or behind the promoter of target genes caused efficient termination of expression of PPP1R12C, NSUN2 (protein-coding genes), and MALAT1 (non-protein-coding gene). Both NeoR and PuroR were used as markers in the selection of clonal cell lines with biallelic integration of a poly(A) signal. Genotyping analysis indicated that the cell lines displayed the desired biallelic silencing after a brief selection period. These combined results indicate that this CRISPR/Cas9-based approach offers an easy, convenient, and efficient novel technique for gene silencing in cell lines, especially for those in which gene integration is difficult because of a low efficiency of homology-directed repair.	[Liu, Yangyang; Han, Xiao; Yuan, Junting; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Hengmi] Yangzhou Univ, Inst Epigenet & Epigen, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Yangyang; Han, Xiao; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Hengmi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Yuan, Junting] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Hengmi] Yangzhou Univ, Inst Comparat Med, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Hengmi] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Isabelle H.] New York Presbyterian Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Cui, HM (corresponding author), Yangzhou Univ, Inst Epigenet & Epigen, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China.	hmcui@yzu.edu.cn			National Key Research and Development Program in China [2016YFC1303604]; National Natural Science Foundation of China [81171965, 81372237, 91540117]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine)	National Key Research and Development Program in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine)	This work was supported by National Key Research and Development Program in China Grant 2016YFC1303604, National Natural Science Foundation of China Grants 81171965, 81372237, and 91540117, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine). The authors declare that they have no conflicts of interest with the contents of this article.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BATT DB, 1994, NUCLEIC ACIDS RES, V22, P2811, DOI 10.1093/nar/22.14.2811; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Jiang Q, 2014, RNA BIOL, V11, P1243, DOI 10.1080/15476286.2014.996067; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Ling H, 2015, ONCOGENE, V34, P5003, DOI 10.1038/onc.2014.456; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhuang CL, 2015, ONCOTARGET, V6, P41194, DOI 10.18632/oncotarget.5880	21	27	28	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5624	5633		10.1074/jbc.M116.769034	http://dx.doi.org/10.1074/jbc.M116.769034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196870	hybrid, Green Published			2022-12-26	WOS:000398813200001
J	Webb, S; Nagy, T; Moseley, H; Fried, M; Dutch, R				Webb, Stacy; Nagy, Tamas; Moseley, Hunter; Fried, Michael; Dutch, Rebecca			Hendra virus fusion protein transmembrane domain contributes to pre-fusion protein stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; fusion protein; membrane fusion; transmembrane domain; virus; paramyxovirus; pre-fusion conformation	MEMBRANE-SPANNING DOMAIN; PARAMYXOVIRUS-F PROTEIN; MOLECULAR-DYNAMICS; INFLUENZA-VIRUS; HELIX PACKING; CELL-FUSION; HIV-1; GP41; HEMAGGLUTININ; GLYCOPROTEIN	Enveloped viruses utilize fusion (F) proteins studding the surface of the virus to facilitate membrane fusion with a target cell membrane. Fusion of the viral envelope with a cellular membrane is required for release of viral genomic material, so the virus can ultimately reproduce and spread. To drive fusion, the F protein undergoes an irreversible conformational change, transitioning from a metastable pre-fusion conformation to a more thermodynamically stable post-fusion structure. Understanding the elements that control stability of the pre-fusion state and triggering to the post-fusion conformation is important for understanding F protein function. Mutations in F protein transmembrane (TM) domains implicated the TM domain in the fusion process, but the structural and molecular details in fusion remain unclear. Previously, analytical ultracentrifugation was utilized to demonstrate that isolated TM domains of Hendra virus F protein associate in a monomer-trimer equilibrium (Smith, E. C., Smith, S. E., Carter, J. R., Webb, S. R., Gibson, K. M., Hellman, L. M., Fried, M. G., and Dutch, R. E. (2013) J. Biol. Chem. 288, 35726-35735). To determine factors driving this association, 140 paramyxovirus F protein TM domain sequences were analyzed. A heptad repeat of -branched residues was found, and analysis of the Hendra virus F TM domain revealed a heptad repeat leucine-isoleucine zipper motif (LIZ). Replacement of the LIZ with alanine resulted in dramatically reduced TM-TM association. Mutation of the LIZ in the whole protein resulted in decreased protein stability, including pre-fusion conformation stability. Together, our data suggest that the heptad repeat LIZ contributed to TM-TM association and is important for F protein function and pre-fusion stability.	[Webb, Stacy; Nagy, Tamas; Moseley, Hunter; Fried, Michael; Dutch, Rebecca] Univ Kentucky, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA	University of Kentucky	Dutch, R (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	rdutc2@uky.edu		Moseley, Hunter/0000-0003-3995-5368; Fried, Michael/0000-0002-5393-2640	National Institutes of Health [R01 AI051517, F31AI120653, P30GM110787]; Direct For Biological Sciences [1419282] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI120653, R01AI051517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI051517, F31AI120653, and P30GM110787. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Aller P, 2006, J BIOMOL STRUCT DYN, V24, P209, DOI 10.1080/07391102.2006.10507114; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; Bublil EM, 2016, BIOCHEMISTRY-US, V55, P5520, DOI 10.1021/acs.biochem.6b00450; Carter JR, 2005, J VIROL, V79, P7922, DOI 10.1128/JVI.79.12.7922-7925.2005; Chan YP, 2012, J VIROL, V86, P11457, DOI 10.1128/JVI.01318-12; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Decock M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00107; Dev J, 2016, SCIENCE, V353, P172, DOI 10.1126/science.aaf7066; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farzan SF, 2011, J BIOL CHEM, V286, P37945, DOI 10.1074/jbc.M111.256248; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Gao GF, 2013, J BIOL CHEM, V288, P234, DOI 10.1074/jbc.M112.424432; Gravel KA, 2011, J VIROL, V85, P3486, DOI 10.1128/JVI.02308-10; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; Kajanajmudeen A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3138jc6; KEMBLE GW, 1993, J CELL BIOL, V122, P1253, DOI 10.1083/jcb.122.6.1253; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kim JH, 2009, BBA-BIOMEMBRANES, V1788, P1804, DOI 10.1016/j.bbamem.2009.06.011; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Miyauchi K, 2006, JPN J INFECT DIS, V59, P77; Miyauchi K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-95; Muhlebach MD, 2008, J VIROL, V82, P11437, DOI 10.1128/JVI.00779-08; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; PATERSON RG, 1984, P NATL ACAD SCI-BIOL, V81, P6706, DOI 10.1073/pnas.81.21.6706; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Popa A, 2012, J VIROL, V86, P3014, DOI 10.1128/JVI.05826-11; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Ruan WM, 2004, PROTEIN SCI, V13, P555, DOI 10.1110/ps.03357404; Sergel TA, 2000, J VIROL, V74, P5101, DOI 10.1128/JVI.74.11.5101-5107.2000; Smith EC, 2013, J BIOL CHEM, V288, P35726, DOI 10.1074/jbc.M113.514554; Smith EC, 2012, J VIROL, V86, P3003, DOI 10.1128/JVI.05762-11; Smith EC, 2010, J VIROL, V84, P10928, DOI 10.1128/JVI.01108-10; Victor BL, 2012, J CHEM INF MODEL, V52, P3001, DOI 10.1021/ci3003396; Vitu E, 2013, J MOL BIOL, V425, P2056, DOI 10.1016/j.jmb.2013.03.001; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Wong JJW, 2016, P NATL ACAD SCI USA, V113, P1056, DOI 10.1073/pnas.1523303113; Xu K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005322; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	53	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5685	5694		10.1074/jbc.M117.777235	http://dx.doi.org/10.1074/jbc.M117.777235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213515	Green Published, hybrid			2022-12-26	WOS:000398813200007
J	Wofford, JD; Chakrabarti, M; Lindahl, PA				Wofford, Joshua D.; Chakrabarti, Mrinmoy; Lindahl, Paul A.			Mossbauer Spectra of Mouse Hearts Reveal Age-dependent Changes in Mitochondrial and Ferritin Iron Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALASSEMIA HEMOGLOBIN-E; HUMAN JURKAT CELLS; FRIEDREICHS-ATAXIA; BETA-THALASSEMIA; ENERGY-METABOLISM; MODEL; MICE; CARDIOMYOPATHY; PROTEINS; OVERLOAD	Cardiac function requires continuous high levels of energy, and so iron, a critical player in mitochondrial respiration, is an important component of the heart. Hearts from Fe-57-enriched mice were evaluated by Mossbauer spectroscopy. Spectra consisted of a sextet and two quadrupole doublets. One doublet was due to residual blood, whereas the other was due to [Fe4S4](2+) clusters and low-spin FeII hemes, most of which were associated with mitochondrial respiration. The sextet was due to ferritin; there was no evidence of hemosiderin, a ferritin decomposition product. Iron from ferritin was nearly absent in young hearts, but increased steadily with age. EPR spectra exhibited signals similar to those of brain, liver, and human cells. No age-dependent EPR trends were apparent. Hearts from HFE-/- mice with hemochromatosis contained slightly more iron overall than controls, including more ferritin and less mitochondrial iron; these differences typify slightly older hearts, perhaps reflecting the burden due to this disease. HFE-/- livers were overloaded with ferritin but had low mitochondrial iron levels. IRP2(-/-) hearts contained less ferritin than controls but normal levels of mitochondrial iron. Hearts of young mice born to an iron-deficient mother contained normal levels of mitochondrial iron and no ferritin; the heart from the mother contained low ferritin and normal levels of mitochondrial iron. High-spin FeII ions were nearly undetectable in heart samples; these were evident in brains, livers, and human cells. Previous Mossbauer spectra of unenriched diseased human hearts lacked mitochondrial and blood doublets and included hemosiderin features. This suggests degradation of iron-containing species during sample preparation.	[Wofford, Joshua D.; Chakrabarti, Mrinmoy; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chakrabarti, Mrinmoy] 221st River St, Hoboken, NJ 07030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Lindahl, PA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu			National Institutes of Health [GM084266]; Robert A. Welch Foundation [A1170]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084266 (for the non-vertebrate animal portion) and Robert A. Welch Foundation Grant A1170. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad S, 2013, INT J CLIN EXP PATHO, V6, P622; BELL SH, 1984, BIOCHIM BIOPHYS ACTA, V787, P227, DOI 10.1016/0167-4838(84)90313-3; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; Chakrabarti M., 2014, IRON SULFUR CLUSTERS, P49; Chakrabarti M, 2015, J BIOL CHEM, V290, P520, DOI 10.1074/jbc.M114.606731; Chakrabarti M, 2015, METALLOMICS, V7, P88, DOI 10.1039/c4mt00215f; Chua-anusorn W, 2000, INORG CHIM ACTA, V300, P932, DOI 10.1016/S0020-1693(00)00006-2; CHUAANUSORN W, 1994, HYPERFINE INTERACT, V91, P905, DOI 10.1007/BF02064626; Elas M, 2008, FREE RADICAL BIO MED, V45, P321, DOI 10.1016/j.freeradbiomed.2008.04.016; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gutierrez L, 2009, BBA-MOL BASIS DIS, V1792, P541, DOI 10.1016/j.bbadis.2009.03.007; Holmes-Hampton GP, 2012, METALLOMICS, V4, P761, DOI 10.1039/c2mt20086d; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Jhurry ND, 2013, BIOCHEMISTRY-US, V52, P7926, DOI 10.1021/bi401015t; Jhurry ND, 2012, BIOCHEMISTRY-US, V51, P5276, DOI 10.1021/bi300382d; KAUFMAN KS, 1980, BIOCHIM BIOPHYS ACTA, V629, P522, DOI 10.1016/0304-4165(80)90157-9; Kistler M, 2014, EXP HEMATOL, V42, P59, DOI 10.1016/j.exphem.2013.08.007; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Neves JV, 2010, AM J PHYSIOL-GASTR L, V298, pG525, DOI 10.1152/ajpgi.00449.2009; Omiya S, 2009, J MOL CELL CARDIOL, V46, P59, DOI 10.1016/j.yjmcc.2008.09.714; Payne RM, 2011, PROG PEDIATR CARDIOL, V31, P103, DOI 10.1016/j.ppedcard.2011.02.007; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Sanchis-Gomar F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.33; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; STPIERRE TG, 1992, HYPERFINE INTERACT, V71, P1279, DOI 10.1007/BF02397317; STPIERRE TG, 1991, BIOL MET, V4, P162, DOI 10.1007/BF01141308; Subramaniam VN, 2012, AM J PATHOL, V181, P1173, DOI 10.1016/j.ajpath.2012.06.025; Sutak R, 2008, PROTEOMICS, V8, P1731, DOI 10.1002/pmic.200701049; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Webb J, 1999, COORDIN CHEM REV, V190, P1199, DOI 10.1016/S0010-8545(99)00176-9; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124; Zhao N, 2010, CELL PHYSIOL BIOCHEM, V25, P587, DOI 10.1159/000315077; Zumbrennen-Bullough KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098072	43	16	16	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5546	5554		10.1074/jbc.M117.777201	http://dx.doi.org/10.1074/jbc.M117.777201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202542	hybrid, Green Published			2022-12-26	WOS:000397875500033
J	Wang, F; Zhan, RX; Chen, L; Dai, X; Wang, WP; Guo, R; Li, XG; Li, Z; Wang, L; Huang, SP; Shen, J; Li, SR; Cao, C				Wang, Fan; Zhan, Rixing; Chen, Liang; Dai, Xia; Wang, Wenping; Guo, Rui; Li, Xiaoge; Li, Zhe; Wang, Liang; Huang, Shupeng; Shen, Jie; Li, Shirong; Cao, Chuan			RhoA promotes epidermal stem cell proliferation via PKN1-cyclin D1 signaling	PLOS ONE			English	Article							PROTEIN-KINASE; CANCER-CELLS; CARDIAC MYOCYTES; GENE-EXPRESSION; CYCLIN D1; ACTIVATION; MIGRATION; GTPASE; PKN; PHOSPHORYLATION	Objective Epidermal stem cells (ESCs) play a critical role in wound healing, but the mechanism underlying ESC proliferation is not well defined. Here, we explore the effects of RhoA on ESC proliferation and the possible underlying mechanism. Methods Human ESCs were enriched by rapid adhesion to collagen IV. RhoA((+/+))(G14V), RhoA((-/-))(T19N) and pGFP control plasmids were transfected into human ESCs. The effect of RhoA on cell proliferation was detected by cell proliferation and DNA synthesis assays. Induction of PKN1 activity by RhoA was determined by immunoblot analysis, and the effects of PKN1 on RhoA in terms of inducing cell proliferation and cyclin D1 expression were detected using specific siRNA targeting PKN1. The effects of U-46619 (a RhoA agonist) and C3 transferase (a RhoA antagonist) on ESC proliferation were observed in vivo. Results RhoA had a positive effect on ESC proliferation, and PKN1 activity was up-regulated by the active RhoA mutant (G14V) and suppressed by RhoA T19N. Moreover, the ability of RhoA to promote ESC proliferation and DNA synthesis was interrupted by PKN1 siRNA. Additionally, cyclin D1 protein and mRNA expression levels were up-regulated by RhoA G14V, and these effects were inhibited by siRNA-mediated knock-down of PKN1. RhoA also promoted ESC proliferation via PKN in vivo. Conclusion This study shows that the effect of RhoA on ESC proliferation is mediated by activation of the PKN1-cyclin D1 pathway in vitro, suggesting that RhoA may serve as a new therapeutic target for wound healing.	[Wang, Fan; Chen, Liang; Dai, Xia; Wang, Wenping; Guo, Rui; Li, Xiaoge; Li, Zhe; Wang, Liang; Huang, Shupeng; Shen, Jie; Li, Shirong; Cao, Chuan] Third Mil Med Univ, Southwestern Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China; [Zhan, Rixing] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, SR; Cao, C (corresponding author), Third Mil Med Univ, Southwestern Hosp, Dept Plast & Reconstruct Surg, Chongqing, Peoples R China.	lishirongzx@sina.com; Caochuancc@126.com			National Natural Science Foundation of China [81272121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 81272121). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Chai LL, 2010, INT J MOL MED, V25, P723, DOI 10.3892/ijmm_00000397; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Du DS, 2016, MOL MED REP, V13, P550, DOI 10.3892/mmr.2015.4523; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Balana ME, 2015, WORLD J STEM CELLS, V7, P711, DOI 10.4252/wjsc.v7.i4.711; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Hashimoto T, 2011, CARDIOVASC RES, V91, P711, DOI 10.1093/cvr/cvr108; Horii Y, 2016, FOOD FUNCT, V7, P3176, DOI [10.1039/C6FO00177G, 10.1039/c6fo00177g]; Hu JJ, 2016, ANN BIOMED ENG, V44, P1462, DOI 10.1007/s10439-015-1442-0; Kajimoto K, 2011, AM J PHYSIOL-HEART C, V300, pH191, DOI 10.1152/ajpheart.00232.2010; Kim DS, 2004, CELL MOL LIFE SCI, V61, P2774, DOI 10.1007/s00018-004-4288-4; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Kim JY, 2016, MOL ENDOCRINOL; Lachmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021732; LaRock DL, 2012, J BIOL CHEM, V287, P29654, DOI 10.1074/jbc.M112.363598; Liu XJ, 2014, BIOSCI BIOTECH BIOCH, V78, P1895, DOI 10.1080/09168451.2014.943650; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Morasso MI, 2005, BIOL CELL, V97, P173; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Mukai M, 2003, INT J ONCOL, V22, P1247; Patel M, 2014, CELL ADHES MIGR, V8, P11, DOI 10.4161/cam.28058; Renteria LS, 2013, CELL PROLIFERAT, V46, P563, DOI 10.1111/cpr.12052; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Singh NK, 2012, J BIOL CHEM, V287, P36291, DOI 10.1074/jbc.M112.361220; Takagi H, 2010, CIRC RES, V107, P642, DOI 10.1161/CIRCRESAHA.110.217554; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Hernandez-Hernandez OT, 2013, MINI-REV MED CHEM, V13, P635; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Thauerer B, 2014, CURR NEUROPHARMACOL, V12, P213, DOI 10.2174/1570159X11666131225000518; Tseliou M, 2016, CELL PHYSIOL BIOCHEM, V38, P94, DOI 10.1159/000438612; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Zhan R, 2016, SCI REP, P30687, DOI [10.1038/1016/j.jebslet.2008.04.039, DOI 10.1038/1016/J.FEBSLET.2008.04.039]; Zhan RX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121551; Zhang J, 2015, CELL SIGNAL, V27, P1703, DOI 10.1016/j.cellsig.2015.05.009; Zhang WW, 2015, CAN J PHYSIOL PHARM, V93, P129, DOI 10.1139/cjpp-2014-0388	39	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172613	10.1371/journal.pone.0172613	http://dx.doi.org/10.1371/journal.pone.0172613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222172	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800073
J	Mazinska, B; Struzycka, I; Hryniewicz, W				Mazinska, Beata; Struzycka, Izabela; Hryniewicz, Waleria			Surveys of public knowledge and attitudes with regard to antibiotics in Poland: Did the European Antibiotic Awareness Day campaigns change attitudes?	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; RESISTANCE; BELIEFS; BEHAVIOR; MEDIA	Background Antimicrobial resistance is a global public health problem. Monitoring the level of knowledge regarding antibiotics is a part of the European Union Community strategy against antimicrobial resistance. Objective To assess knowledge by the general public in Poland regarding antibiotics, AMR, and the impact of the European Antibiotic Awareness Day campaigns. Methods The repeated cross-sectional study was developed and carried out among the general public in Poland ( in 5 waves between 2009 and 2011, embracing a total of 5004 respondents). The survey was based on a self-designed questionnaire, and carried out by Millward Brown SMG/KRC, using Computer Assisted Telephone Interviews ( CATI). Results A high percentage of Polish adults had used antibiotics within the 12 months preceding their participation in the study ( 38%). Statistically relevant differences were observed regarding the respondents' gender, age, education and employment status. The majority of the antibiotics used were prescribed by physicians ( 90%). In all five waves, 3% of the respondents purchased an antibiotic without a prescription. Prescriptions were mostly obtained from a general practitioner. The prevailing reasons for taking antibiotics were the common cold, sore throat, cough and flu. Approximately 40% of the respondents expected a prescription for an antibiotic against the flu. The vast majority knew that antibiotics kill bacteria ( 80%) but at the same time 60% of respondents believed antibiotics kill viruses. Physicians, pharmacists, hospital staff and nurses were mentioned as the most trustworthy sources of information. A third of the respondents declared to have come across information on the prudent use of antibiotics in the preceding 12 months. In the fifth wave, nearly half of the participants ( 48%), who had come across information about antibiotics in the preceding 12 months declared that the information resulted in a change in their attitude towards antibiotic use. Conclusion The survey generated information about the knowledge, attitude, and behavior regarding antibiotics among the general population of Poland. Inappropriate antibiotic use is still highly prevalent in Poland, although a positive trend in behavioral change was observed after the educational campaigns. Additional didactic and systematic education campaigns regarding appropriate antibiotic use are needed and the use of the Internet as an education tool should be enhanced.	[Mazinska, Beata; Hryniewicz, Waleria] Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland; [Struzycka, Izabela] Med Univ Warsaw, Dept Dent Comprehens Care, Warsaw, Poland	National Medicines Institute Lekow (NIL); Medical University of Warsaw	Mazinska, B (corresponding author), Natl Med Inst, Dept Epidemiol & Clin Microbiol, Warsaw, Poland.	sekret@cls.edu.pl		Mazinska, Beata/0000-0002-3744-0128				Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; [Anonymous], 2010, TNS OPINION SOCIAL S; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Belongia EA, 2002, PREV MED, V34, P346, DOI 10.1006/pmed.2001.0992; Bosevska G, 2012, MED GLAS, V9, P393; Broniatowski DA, 2015, MED DECIS MAKING, V35, P60, DOI 10.1177/0272989X14553472; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Cebotarenco N, 2008, HEALTH EDUC RES, V23, P146, DOI 10.1093/her/cym008; Curry Misty, 2006, N Z Med J, V119, pU1957; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P2568, DOI 10.1093/jac/dku165; Earnshaw S, 2014, EUROSURVEILLANCE, V19; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Faber MS, 2010, EUROSURVEILLANCE, P15; Godycki-Cwirko M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109248; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goossens H, 2006, EUR J CLIN PHARMACOL, V62, P373, DOI 10.1007/s00228-005-0094-7; Grigoryan L, 2010, CURR DRUG SAF, V5, P329, DOI 10.2174/157488610792246046; Gualano MR, 2015, PHARMACOEPIDEM DR S, V24, P2, DOI 10.1002/pds.3716; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Ilhan MN, 2009, PHARMACOEPIDEM DR S, V18, P1150, DOI 10.1002/pds.1829; Lambert MF, 2007, J ANTIMICROB CHEMOTH, V59, P537, DOI 10.1093/jac/dkl511; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Madle G, 2009, J ANTIMICROB CHEMOTH, V63, P221, DOI 10.1093/jac/dkn438; Madle Gemma, 2004, Inform Prim Care, V12, P19; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; McNulty CAM, 2010, J ANTIMICROB CHEMOTH, V65, P1526, DOI 10.1093/jac/dkq126; Mira JJ, 2014, PSYCHOL HEALTH MED, V19, P201, DOI 10.1080/13548506.2013.793370; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Panagakou SG, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-60; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Rossignoli A, 2007, EUR J CLIN PHARMACOL, V63, P1099, DOI 10.1007/s00228-007-0376-3; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; TNS Opinion & Social, 2013, TNS OPINION SOCIAL S; TNS Opinion & Social, 2016, TNS OPINION SOCIAL S; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Wilson AA, 1999, J GEN INTERN MED, V14, P658, DOI 10.1046/j.1525-1497.1999.08118.x; Wutzke SE, 2007, HEALTH PROMOT INT, V22, P53, DOI 10.1093/heapro/dal034; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5	43	51	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172146	10.1371/journal.pone.0172146	http://dx.doi.org/10.1371/journal.pone.0172146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212400	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700020
J	Abdelkader, MM; Aboshanab, KM; El-Ashry, MA; Aboulwafa, MM				Abdelkader, Mona M.; Aboshanab, Khaled M.; El-Ashry, Marwa A.; Aboulwafa, Mohammad M.			Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; EPIDEMIOLOGY; MECHANISMS; CAIRO; SURVEILLANCE	The aim of this study was identifying bacterial pathogens involved in meningitis, studying their antibiotic resistance profiles, investigating the antibiotic resistance genes as well as evaluating the use of various antibiotic combinations. Antibiotic susceptibility tests were evaluated according to CLSI guidelines. Antibiotic combinations were evaluated by calculating the Fractional Inhibitory Concentration (FIC) index. A total of 71 bacterial isolates were recovered from 68 culture positive CSF specimens. Sixty five of these isolates (91.5%) were recovered from single infection specimens, while 6 isolates (8.4%) were recovered from mixed infection specimens. Out of the 71 recovered isolates, 48 (67.6%) were Gram-positive, and 23 (32.4%) were Gram-negative. Thirty one of the Gram positive isolates were S. pneumoniae (64.6%, n = 48). Out of the recovered 71 isolates; 26 (36.6%) were multidrugresistant (MDR) isolates of which, 18 (69.2%) were Gram-negative and 8 (30.8%) were Gram-positive. All MDR isolates (100%) showed resistance to penicillin and ampicillin, however, they showed lower resistance to meropenem (50%), levofloxacin (50%), amikacin (48%), pipercillin-tazobactam (45.8%). Most common antibiotic resistance genes were investigated including: tern (21.1%), shv (15.8%), ctx-m (15.8%) coding for TEM-, SHV, CTX-M extended-spectrum beta-lactamases (ESBLs), respectively; aac(6)-I b(26.3%) coding for aminoglycoside 6'-N-acetyltransferase type lb ciprofloxacin resistant variant; and qnrA (5.3%) gene coding for quinolone resistance. The DNA sequences of the respective resistance genes of some selected isolates were PCR amplified, analyzed and submitted to the GenBank database under the accession numbers, KX214665, KX214664, KX214663, KX214662, respectively. The FIC values for ampicillin/sulbactam plus cefepime showed either additive or synergistic effect against ten tested Gram-negative MDR isolates, while doxycycline plus levofloxacin combination revealed synergism against two MDR Gram-positive isolates. The results indicate high prevalence of antibiotic resistance among MDR isolates. Therefore, new guidelines should be implemented in Egypt to rationalize the use and avoid the misuse and abuse of antimicrobial agents.	[Abdelkader, Mona M.; Aboshanab, Khaled M.; Aboulwafa, Mohammad M.] Ain Shams Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt; [El-Ashry, Marwa A.] Ain Shams Univ, Fac Med, Dept Clin & Chem Pathol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	Aboshanab, KM (corresponding author), Ain Shams Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt.	aboshanab2012@pharma.asu.edu.eg	Aboshanab, Khaled/L-9848-2019; Aboulwafa, Mohammad/V-5498-2018	Aboulwafa, Mohammad/0000-0002-0828-1420; Aboshanab, Khaled/0000-0002-7608-850X				Abdel-Aziz S, 2015, ACTAMICROBIOL, V6; Afifi S, 2007, EUR J CLIN MICROBIOL, V26, P331, DOI 10.1007/s10096-007-0280-x; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; [Anonymous], 2013, CHEMOTHERAPY; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; BERGOGNEBEREZIN E, 1995, J HOSP INFECT, V30, P441, DOI 10.1016/0195-6701(95)90048-9; Boctor W M, 1969, J Egypt Public Health Assoc, V44, P253; Bonnet R, 2001, ANTIMICROB AGENTS CH, V45, P2269, DOI 10.1128/AAC.45.8.2269-2275.2001; Borg MA, 2009, CLIN MICROBIOL INFEC, V15, P232, DOI 10.1111/j.1469-0691.2008.02651.x; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Carbonnelle E, 2009, MED MALADIES INFECT, V39, P581, DOI 10.1016/j.medmal.2009.02.017; Chandramohan L, 2012, ANTIMICROB AGENTS CH, V56, P4765, DOI 10.1128/AAC.00666-12; CLSI, 2011, M100S20 CLSI, P172; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; El Kholy A, 2003, J ANTIMICROB CHEMOTH, V51, P625, DOI 10.1093/jac/dkg101; Fernandez-Cuenca F, 2003, J ANTIMICROB CHEMOTH, V51, P565, DOI 10.1093/jac/dkg097; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gale E.F., 1981, MOL BASIS ANTIBIOTIC, Vsecond; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; GIRGIS NI, 1972, J TROP MED HYG, V73, P154; GIRGIS NI, 1993, AM J TROP MED HYG, V48, P97, DOI 10.4269/ajtmh.1993.48.97; GO ES, 1994, LANCET, V344, P1329, DOI 10.1016/S0140-6736(94)90694-7; Hamed SM., 2013, BRIT MICROBIOL RES J, V3, P448; Hirsch EB, 2013, J INFECT DIS, V207, P786, DOI 10.1093/infdis/jis766; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Hou XH, 2015, BRAZ J MICROBIOL, V46, P759, DOI 10.1590/S1517-838246320140138; HSIEH MH, 1993, DIAGN MICR INFEC DIS, V16, P343, DOI 10.1016/0732-8893(93)90087-N; Jones Mark E, 2004, Ann Clin Microbiol Antimicrob, V3, P3, DOI 10.1186/1476-0711-3-3; Lewis JS, 2007, ANTIMICROB AGENTS CH, V51, P4015, DOI 10.1128/AAC.00576-07; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; McGettigan SE, 2009, J CLIN MICROBIOL, V47, P2970, DOI 10.1128/JCM.00319-09; MINER WF, 1978, AM J TROP MED HYG, V27, P986, DOI 10.4269/ajtmh.1978.27.986; Ministry of Health and Population Egypt, 2000, ENH SURV COMM DIS AN; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Ostroff SM, 1996, CLIN INFECT DIS, V23, P1069, DOI 10.1093/clinids/23.5.1069; Owusu M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-28; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Peirano G, 2010, INT J ANTIMICROB AG, V36, P19, DOI 10.1016/j.ijantimicag.2010.02.016; Pitout JDD, 2004, CLIN INFECT DIS, V38, P1736, DOI 10.1086/421094; Rafi W, 2010, J EMERG MED, V38, P225, DOI 10.1016/j.jemermed.2008.02.053; Rasheed JK, 1997, ANTIMICROB AGENTS CH, V41, P647, DOI 10.1128/AAC.41.3.647; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sader HS, 2005, INT J ANTIMICROB AG, V25, P380, DOI 10.1016/j.ijantimicag.2005.01.011; Sambrook J., 2001, MOL CLONING LAB MANU; Shaban L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-26; Sidjabat HE, 2009, ANTIMICROB AGENTS CH, V53, P4733, DOI 10.1128/AAC.00533-09; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Taha N, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-2; Thigpen MC, 2007, NEW ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X; Walsh C., 2003, ANTIBIOTICS ACTIONS; Won H, 2012, DIAGN MICR INFEC DIS, V74, P22, DOI 10.1016/j.diagmicrobio.2012.05.015; Youssef FG, 2004, ANN EPIDEMIOL, V14, P44, DOI 10.1016/S1047-2797(03)00075-9; Zhao Chaoli, 2014, Zhonghua Shao Shang Za Zhi, V30, P166	62	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171349	10.1371/journal.pone.0171349	http://dx.doi.org/10.1371/journal.pone.0171349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207768	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500025
J	Baker, WL				Baker, William L.			Restoring and managing low-severity fire in dry-forest landscapes of the western USA	PLOS ONE			English	Article							MIXED-CONIFER FORESTS; SAN-PEDRO-MARTIR; NATIONAL-PARK; SOUTHERN CASCADES; MONTANE FORESTS; PRESCRIBED FIRE; JEFFREY PINE; HISTORY; CALIFORNIA; INTERVAL	Low-severity fires that killed few canopy trees played a significant historical role in dry forests of the western USA and warrant restoration and management, but historical rates of burning remain uncertain. Past reconstructions focused on on dating fire years, not measuring historical rates of burning. Past statistics, including mean composite fire interval (mean CFI) and individual-tree fire interval (mean ITFI) have biases and inaccuracies if used as estimators of rates. In this study, I used regression, with a calibration dataset of 96 cases, to test whether these statistics could accurately predict two equivalent historical rates, population mean fire interval (PMFI) and fire rotation (FR). The best model, using Weibull mean ITFI, had low prediction error and R-2 (adj) = 0.972. I used this model to predict historical PMFI/FR at 252 sites spanning dry forests. Historical PMFI/FR for a pool of 342 calibration and predicted sites had a mean of 39 years and median of 30 years. Short (< 25 years) mean PMFI/FRs were in Arizona and New Mexico and scattered in other states. Long (> 55 years) mean PMFI/FRs were mainly from northern New Mexico to South Dakota. Mountain sites often had a large range in PMFI/FR. Nearly all 342 estimates are for old forests with a history of primarily low-severity fire, found across only about 34% of historical dry-forest area. Frequent fire (PMFI/FR < 25 years) was found across only about 14% of historical dry-forest area, with 86% having multidecadal rates of low-severity fire. Historical fuels (e.g., understory shrubs and small trees) could fully recover between multidecadal fires, allowing some denser forests and some ecosystem processes and wildlife habitat to be less limited by fire. Lower historical rates mean less restoration treatment is needed before beginning managed fire for resource benefits, where feasible. Mimicking patterns of variability in historical low-severity fire regimes would likely benefit biological diversity and ecosystem functioning.	[Baker, William L.] Univ Wyoming, Dept Geog, Program Ecol, Dept 3371,1000 E Univ Ave, Laramie, WY 82071 USA	University of Wyoming	Baker, WL (corresponding author), Univ Wyoming, Dept Geog, Program Ecol, Dept 3371,1000 E Univ Ave, Laramie, WY 82071 USA.	bakerwl@uwyo.edu	Baker, William/A-7008-2008					Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Agee J. K., 1994, FIRE WEATHER DISTURB; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Arno S. F., 1983, INT301 USDA FOR SERV; Baker W. L., 2008, Open Forest Science Journal, V1, P1, DOI 10.2174/1874398600801010001; Baker WL, 2015, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00088; Baker WL, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0136147, 10.1080/1554480X.2014.999777]; Baker WL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00046.1; Baker WL, 2013, CAN J FOREST RES, V43, P951, DOI 10.1139/cjfr-2013-0176; Baker WL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00320.1; Baker WL, 2001, CAN J FOREST RES, V31, P1205, DOI 10.1139/cjfr-31-7-1205; Baker WL., 2009, FIRE ECOLOGY ROCKY M; BARRETT SW, 1997, INTGTR370 USDA FOR S; Beaty RM, 2001, J BIOGEOGR, V28, P955, DOI 10.1046/j.1365-2699.2001.00591.x; Brewer PW., 2016, FIRE HIST ANAL EXPLO; BROWN JK, 1994, INT J WILDLAND FIRE, V4, P157, DOI 10.1071/WF9940157; Collins B.M., 2007, FIRE ECOL, V3, P53, DOI [10.4996/fireecology.0302053, DOI 10.4996/FIREEC0L0GY.0302053]; Cooper C. F., 1960, Ecological Monographs, V30, P129, DOI 10.2307/1948549; COVINGTON WW, 1994, J FOREST, V92, P39; Dugan AJ, 2015, J VEG SCI, V26, P697, DOI 10.1111/jvs.12266; Dugan AJ, 2014, INT J WILDLAND FIRE, V23, P58, DOI 10.1071/WF12162; Falk DA, 2002, US FOR SERV RMRS-P, P301; Falk DA, 2007, ECOSYSTEMS, V10, P809, DOI 10.1007/s10021-007-9070-7; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Farris CA, 2013, INT J WILDLAND FIRE, V22, P1021, DOI 10.1071/WF13026; Farris CA, 2010, ECOL APPL, V20, P1598, DOI 10.1890/09-1535.1; Fiegener RP, 2001, THESIS; GOLDBLUM D, 1992, PHYS GEOGR, V13, P133, DOI 10.1080/02723646.1992.10642449; Grissino-Mayer H. D., 1995, THESIS; Grissino-Mayer HD, 1999, INT J WILDLAND FIRE, V9, P37, DOI 10.1071/WF99004; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Hessl A, 2007, PROF GEOGR, V59, P87, DOI 10.1111/j.1467-9272.2007.00593.x; JOHNSON EA, 1994, ADV ECOL RES, V25, P239, DOI 10.1016/S0065-2504(08)60216-0; Jordan GJ, 2005, LANDSCAPE ECOL, V20, P719, DOI 10.1007/s10980-005-0071-7; Kaufmann MR, 1992, RMGTR213 USDA FOR SE; Keeley JE, 2007, INT J WILDLAND FIRE, V16, P96, DOI 10.1071/WF06052; Kolden CA, 2012, FOREST ECOL MANAG, V286, P38, DOI 10.1016/j.foreco.2012.08.020; Kou XJ, 2006, LANDSCAPE ECOL, V21, P735, DOI 10.1007/s10980-005-5325-x; Kou XJ, 2006, INT J WILDLAND FIRE, V15, P489, DOI 10.1071/WF05113; Laughlin DC, 2006, OIKOS, V114, P60, DOI 10.1111/j.0030-1299.2006.14424.x; Leiberg JB, 1902, US GEOLOGICAL SURVEY; Lombardo K. J., 2009, Fire Ecology, V5, P35; LORIMER CG, 1985, CAN J FOREST RES, V15, P200, DOI 10.1139/x85-038; Margolis EQ, 2009, FOREST ECOL MANAG, V258, P2416, DOI 10.1016/j.foreco.2009.08.019; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P27, DOI 10.1007/978-94-007-0301-8_2; Moritz MA, 2009, ENVIRON ECOL STAT, V16, P271, DOI 10.1007/s10651-007-0088-y; North MP, 2015, SCIENCE, V349, P1280, DOI 10.1126/science.aab2356; Odion DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087852; Parsons RA, 2007, CAN J FOREST RES, V37, P1605, DOI 10.1139/X07-013; R Development Core Team, 2007, R LANG ENV STAT COMP; Reynolds R.T., 2013, RMRSGTR310 US DEP AG; Scholl AE, 2010, ECOL APPL, V20, P362, DOI 10.1890/08-2324.1; Shapiro-Miller LB, 2007, CAN J FOREST RES, V37, P1933, DOI 10.1139/X07-054; Show S.B., 1924, ROLE FIRE CALIFORNIA; Stephens SL, 2007, FOREST ECOL MANAG, V251, P205, DOI 10.1016/j.foreco.2007.06.005; Stephens SL, 2012, FOREST ECOL MANAG, V285, P204, DOI 10.1016/j.foreco.2012.08.030; Stephens SL, 2010, CAN J FOREST RES, V40, P1497, DOI 10.1139/X10-083; Stephens SL, 2003, CAN J FOREST RES, V33, P1090, DOI [10.1139/x03-031, 10.1139/X03-031]; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Swetnam T, 2011, ECOL STUD-ANAL SYNTH, V213, P165, DOI 10.1007/978-94-007-0301-8_7; Taylor AH, 1998, FOREST ECOL MANAG, V111, P285, DOI 10.1016/S0378-1127(98)00342-9; Taylor AH, 2000, J BIOGEOGR, V27, P87, DOI 10.1046/j.1365-2699.2000.00353.x; Tiedemann AR, 2000, FOREST ECOL MANAG, V127, P1, DOI 10.1016/S0378-1127(99)00114-0; Van Horne ML, 2006, CAN J FOREST RES, V36, P855, DOI 10.1139/X05-289; van Mantgem PJ, 2016, FOREST ECOL MANAG, V379, P265, DOI 10.1016/j.foreco.2016.07.028; VANKAT JL, 1978, J BIOGEOGR, V5, P377, DOI 10.2307/3038030; Veblen TT, 2002, US FOR SERV RMRS-P, P259; WHITE AS, 1985, ECOLOGY, V66, P589, DOI 10.2307/1940407; Williams MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P831, DOI 10.1111/geb.12152; Williams MA, 2013, LANDSCAPE ECOL, V28, P297, DOI 10.1007/s10980-012-9835-z; Williams MA, 2012, GLOBAL ECOL BIOGEOGR, V21, P1042, DOI 10.1111/j.1466-8238.2011.00750.x; Williams MA, 2011, ECOL MONOGR, V81, P63, DOI 10.1890/10-0256.1	72	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172288	10.1371/journal.pone.0172288	http://dx.doi.org/10.1371/journal.pone.0172288			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199416	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400088
J	Ohara, WM; Mirande, JM; de Lima, FCT				Ohara, Willian Massaharu; Marcos Mirande, Juan; Thadeo de Lima, Flavio Cesar			Phycocharax rasbora, a new genus and species of Brazilian tetra (Characiformes: Characidae) from Serra do Cachimbo, rio Tapajos basin	PLOS ONE			English	Article							PHYLOGENY; TELEOSTEI; REPRODUCTION; HEMIGRAMMUS	A new genus and species of characid fish is described from rio Braco Norte, a tributary of rio Teles Pires, Tapajos basin, Mato Groso, Brazil. The new taxa can be diagnosed from the remaining characids by a unique combination of characters that includes the presence of a single row of relatively compressed premaxillary teeth, large teeth with four to nine cusps on premaxillary and dentary, absence of pseudotympanum, incomplete lateral line with 7-13 pored scales, sexually-dimorphic males with distal margin of anal fin approximately straight, and presence of a nearly triangular and horizontally elongated blotch from the posterior half of the body to caudal peduncle. The most parsimonious phylogenetic hypothesis, using morphological data, recovered the new genus and species in a clade including Paracheirodon axelrodi and Hyphessobrycon elachys.	[Ohara, Willian Massaharu] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Marcos Mirande, Juan] Fdn Miguel Lillo, CONICET, Miguel Lillo, San Miguel De T, Argentina; [Thadeo de Lima, Flavio Cesar] Univ Estadual Campinas Adao Jose Cardoso, Museu Zool, Campinas, SP, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; Universidade Estadual de Campinas	Ohara, WM (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil.	willianmohara@gmail.com	Lima, Flávio C.T./B-6218-2013	Lima, Flávio C.T./0000-0002-7636-5431; Mirande, Juan Marcos/0000-0003-4370-3526	South American Characiformes Inventory [FAPESP 2011/502827]; FAPESP [2013/22473-8, 2011/51532-7, 2013/20936-0]; CONICET [PIP-0301]; FONCyT [PICT 2011-0992]	South American Characiformes Inventory; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT)	Part of the type series was collected during an expedition funded by the South American Characiformes Inventory (FAPESP 2011/502827, http//www.projeto-saci.com). The authors are supported by FAPESP (WMO: grant # 2013/22473-8; FCTL: grants # 2011/51532-7 and 2013/20936-0), CONICET (JMM: PIP-0301), and FONCyT (JMM: PICT 2011-0992). A travel by the second author to ZUEC was funded by FAPESP [grant # 2011/51532-7, "Systematics of tetras (genera Hemigrammus, Hyphessobrycon, Thayeria, Parapristella and Bryconella), with emphasis on the species from northern cis-andean South America"]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT A, 1988, ENVIRON BIOL FISH, V22, P15, DOI 10.1007/BF00000541; Eigenmann C.H., 1917, MEM MUS COMP ZOOL, V43, P1; Eigenmann CH, 1915, MEM CARNEGIE MUS, V7, P1, DOI [10.5962/bhl.title.46579, DOI 10.5962/BHL.TITLE.46579]; Eschmeyer W.N., 2016, SPECIES FAMILY SUBFA; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Gery J., 1977, CHARACOIDS WORLD; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2014, CLADISTICS, V30, P260, DOI 10.1111/cla.12047; Gonçalves Cristina da Silva, 2013, Acta Limnol. Bras., V25, P398; Kottelat Maurice, 1999, Journal of South Asian Natural History, V4, P49; Lima Flavio C. T., 2016, Aqua, V22, P123; Lima Flavio C. T., 2009, Aqua, V15, P153; Malabarba Luiz R., 1998, P193; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2011, ZOOTAXA, P1; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Netto-Ferreira AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052098; O'Leary MA, 2011, CLADISTICS, V27, P529, DOI 10.1111/j.1096-0031.2011.00355.x; OLeary M. A., 2012, MORPHOBANK 3 0 WEB A; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pastana MNL, 2016, ZOOTAXA, V4161, P386, DOI 10.11646/zootaxa.4161.3.6; TAYLOR W R, 1985, Cybium, V9, P107; Teixeira TF, 2013, COPEIA, P612, DOI 10.1643/CI-13-026; WEITZMAN S H, 1983, Bulletin of the Museum of Comparative Zoology, V150, P339; Weitzman Stanley H., 1998, P161; Zanata Angela M., 2004, Neotrop. ichthyol., V2, P45, DOI 10.1590/S1679-62252004000200001	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170648	10.1371/journal.pone.0170648	http://dx.doi.org/10.1371/journal.pone.0170648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199336	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400018
J	Okino, CH; Mores, MAZ; Trevisol, IM; Coldebella, A; Montassier, HJ; Brentano, L				Okino, Cintia Hiromi; Zanella Mores, Marcos Antonio; Trevisol, Iara Maria; Coldebella, Arlei; Montassier, Helio Jose; Brentano, Liana			Early immune responses and development of pathogenesis of avian infectious bronchitis viruses with different virulence profiles	PLOS ONE			English	Article							TISSUE TROPISM; CHICKENS; GENOTYPE; STRAINS; OVIDUCT; VARIANT; TRANSCRIPTOME; EXPRESSION; EMERGENCE; NEPHRITIS	Avian infectious bronchitis virus (IBV) primarily replicates in epithelial cells of the upper respiratory tract of chickens, inducing both morphological and immune modulatory changes. However, the association between the local immune responses induced by IBV and the mechanisms of pathogenesis has not yet been completely elucidated. This study compared the expression profile of genes related to immune responses in tracheal samples after challenge with two Brazilian field isolates (A and B) of IBV from the same genotype, associating these responses with viral replication and with pathological changes in trachea and kidney. We detected a suppressive effect on the early activation of TLR7 pathway, followed by lower expression levels of inflammatory related genes induced by challenge with the IBV B isolate when compared to the challenge with to the IBV A isolate. Cell-mediated immune (CMI) related genes presented also lower levels of expression in tracheal samples from birds challenged with B isolate at 1dpi. Increased viral load and a higher percentage of birds with relevant lesions were observed in both tracheal and renal samples from chickens exposed to challenge with IBV B isolate. This differential pattern of early immune responses developed after challenge with IBV B isolate, related to the downregulation of TLR7, leading to insufficient pro-inflammatory response and lower CMI responses, seem to have an association with a most severe renal lesion and an enhanced capability of replication of this isolate in chicken.	[Okino, Cintia Hiromi; Zanella Mores, Marcos Antonio; Trevisol, Iara Maria; Coldebella, Arlei; Brentano, Liana] Embrapa Swine & Poultry, Concordia, SC, Brazil; [Montassier, Helio Jose] Univ Estadual Paulista, UNESP, Dept Vet Pathol, Lab Immunol & Virol Imunovir, Jaboticabal, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista	Okino, CH (corresponding author), Embrapa Swine & Poultry, Concordia, SC, Brazil.	cintia.okino@embrapa.br	Okino, Cintia/P-6563-2014; Okino, Cintia/N-9601-2019	Okino, Cintia/0000-0002-3692-3902; Okino, Cintia/0000-0002-3692-3902	Brazilian Agricultural Research Corporation (Embrapa), a governamental institution os research from Brazil	Brazilian Agricultural Research Corporation (Embrapa), a governamental institution os research from Brazil	The whole study was supported by Brazilian Agricultural Research Corporation (Embrapa), a governamental institution os research from Brazil. The funder had role in study design, data collection and analysis, decision to publish and also on the preparation of the manuscript, as most of authors (CHO, MAZM, IMT, AC and LB) work for the funder.	Abdel-Moneim AS, 2012, ARCH VIROL, V157, P2453, DOI 10.1007/s00705-012-1445-1; Asif M, 2007, VIRAL IMMUNOL, V20, P479, DOI 10.1089/vim.2006.0109; Burggraaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014561; Chhabra R, 2016, VIROLOGY, V488, P232, DOI 10.1016/j.virol.2015.11.011; Chhabra R, 2015, VIRAL IMMUNOL, V28, P478, DOI 10.1089/vim.2015.0027; Chhabra R, 2015, CLIN VACCINE IMMUNOL, V22, P1050, DOI 10.1128/CVI.00368-15; Chousalkar KK, 2009, J VIROL METHODS, V155, P67, DOI 10.1016/j.jviromet.2008.09.028; Cong F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-743; de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260; Fernando FS, 2015, PESQUI VET BRASIL, V35, P216, DOI 10.1590/S0100-736X2015000300002; Fraga AP, 2013, AVIAN DIS, V57, P225, DOI 10.1637/10346-090412-Reg.1; Franca M, 2011, AVIAN DIS, V55, P422, DOI 10.1637/9417-060510-Reg.1; Gelb J, 2013, AVIAN DIS, V57, P65, DOI 10.1637/10313-080212-Reg.1; Guo XH, 2008, VET IMMUNOL IMMUNOP, V121, P332, DOI 10.1016/j.vetimm.2007.09.016; Kameka AM, 2014, VIROLOGY, V450, P114, DOI 10.1016/j.virol.2013.12.001; Kim BY, 2013, AVIAN DIS, V57, P667, DOI 10.1637/10519-022213-ResNote.1; Kotani T, 2000, J VET MED SCI, V62, P397, DOI 10.1292/jvms.62.397; Li H, 2001, AVIAN PATHOL, V30, P535, DOI 10.1080/03079450120078734; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HB, 2012, VIRUS GENES, V44, P19, DOI 10.1007/s11262-011-0657-x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mork AK, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-67; Nii T, 2014, THERIOGENOLOGY, V81, P1129, DOI 10.1016/j.theriogenology.2014.02.002; Okino CH, 2014, VIRAL IMMUNOL, V27, P383, DOI 10.1089/vim.2014.0054; Okino CH, 2013, VIRAL IMMUNOL, V26, P259, DOI 10.1089/vim.2013.0015; OWEN RL, 1991, AVIAN PATHOL, V20, P663, DOI 10.1080/03079459108418805; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rue CA, 2011, J GEN VIROL, V92, P931, DOI 10.1099/vir.0.025486-0; Smith J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0575-6; Vervelde L, 2013, VET IMMUNOL IMMUNOP, V151, P337, DOI 10.1016/j.vetimm.2012.11.012; Wang XQ, 2006, VIRAL IMMUNOL, V19, P768, DOI 10.1089/vim.2006.19.768; Zhong YX, 2012, VIRUSES-BASEL, V4, P980, DOI 10.3390/v4060980	32	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172275	10.1371/journal.pone.0172275	http://dx.doi.org/10.1371/journal.pone.0172275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199419	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424400087
J	Puchner, SE; Funovics, PT; Bohler, C; Kaider, A; Stihsen, C; Hobusch, GM; Panotopoulos, J; Windhager, R				Puchner, Stephan E.; Funovics, Philipp T.; Boehler, Christoph; Kaider, Alexandra; Stihsen, Christoph; Hobusch, Gerhard M.; Panotopoulos, Joannis; Windhager, Reinhard			Oncological and surgical outcome after treatment of pelvic sarcomas	PLOS ONE			English	Article							MALIGNANT-TUMORS; RECONSTRUCTION; RESECTION; COMPLICATIONS; OSTEOSARCOMA; EXPERIENCE; PROSTHESES; SURVIVAL; BONE; LIMB	Background and objectives Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication rates. We sought to investigate the long-term oncological and surgical outcome of these patients. Methods Between 1980 and 2012, 147 patients underwent surgical treatment for pelvic sarcoma. Histological diagnosis was Chondrosarcoma in 54, Ewing's Sarcoma/PNET in 37, Osterosar-coma in 32 and others in 24 patients. Statistical analysis for the evaluation of oncological and surgical outcome was performed by applying Cox proportional hazards regression and Fine-Gray regression models for competing risk (CR) endpoints. Results The estimated overall survival (OS) to death was 80%, 45% and 37% at 1, 5 and 10 years, respectively. Univariate analyses revealed a statistically significant unadjusted influence of age age (p = 0.038; HR = 1.01), margin (p = 0.043; HR = 0.51) and grade (p = 0.001; HR = 2.27) on OS. Considering the multivariable model, grade (p = 0.005; HR = 3.04) and tumor volume (p = 0.014; HR = 1.18) presented themselves as independent prognostic factors on OS. CR analysis showed a cumulative incidence for major complication of 31% at 5 years. Endoprosthetic reconstruction had a higher risk for experiencing a major complication (p<0.0001) and infection (p = 0.001). Conclusions Pelvic resections are still associated with a high incidence of complications. Patients with pelvic reconstruction and high volume tumors are especially at risk. Consequently, a cautious decision-making process is necessary when indicating pelvic reconstruction, although a restrictive approach to pelvic reconstruction is not necessarily reasonable when the other option is major amputation.	[Puchner, Stephan E.; Funovics, Philipp T.; Boehler, Christoph; Stihsen, Christoph; Hobusch, Gerhard M.; Panotopoulos, Joannis; Windhager, Reinhard] Med Univ Vienna, Dept Orthoped, Waehringer Guertel 18-20, Vienna, Austria; [Kaider, Alexandra] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Waehringer Guertel 18-20, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Puchner, SE (corresponding author), Med Univ Vienna, Dept Orthoped, Waehringer Guertel 18-20, Vienna, Austria.	stephan.puchner@meduniwien.ac.at	Hobusch, Gerhard/AAA-6637-2021	Hobusch, Gerhard M/0000-0002-4123-6680; Windhager, Reinhard/0000-0002-6321-1804				Abudu A, 1997, J BONE JOINT SURG BR, V79B, P773, DOI 10.1302/0301-620X.79B5.6749; Angelini A, 2013, CLIN ORTHOPAEDICS RE; Beadel GP, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000180048.43208.2f; Bergh P, 2001, CANCER-AM CANCER SOC, V91, P1201, DOI 10.1002/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO;2-W; CAMPANACCI M, 1991, ORTHOP CLIN N AM, V22, P65; CAPANNA R, 1987, ARCH ORTHOP TRAUM SU, V106, P71, DOI 10.1007/BF00435417; CARTER SR, 1990, J BONE JOINT SURG BR, V72, P490; Cottias P, 2001, J SURG ONCOL, V78, P90, DOI 10.1002/jso.1127; Delloye C, 2007, J BONE JOINT SURG AM, V89A, P579, DOI 10.2106/JBJS.F.00943; EILBER FR, 1979, CANCER, V43, P806, DOI 10.1002/1097-0142(197903)43:3<806::AID-CNCR2820430305>3.0.CO;2-Y; ENNEKING WF, 1978, J BONE JOINT SURG AM, V60, P731, DOI 10.2106/00004623-197860060-00002; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Gebert C, 2011, J SURG ONCOL, V103, P269, DOI 10.1002/jso.21820; Guo W, 2007, CLIN ORTHOP RELAT R, P180, DOI 10.1097/BLO.0b013e31806165d5; Guo W, 2012, J SURG ONCOL, V106, P406, DOI 10.1002/jso.23076; Guo Z, 2010, SURG ONCOL, V19, P95, DOI 10.1016/j.suronc.2009.04.003; Han I, 2010, CLIN ORTHOP SURG, V2, P160, DOI 10.4055/cios.2010.2.3.160; HARRINGTON KD, 1992, J BONE JOINT SURG AM, V74A, P331, DOI 10.2106/00004623-199274030-00003; Hillmann A, 2003, ARCH ORTHOP TRAUM SU, V123, P340, DOI 10.1007/s00402-003-0543-7; Jawad MU, 2011, CANCER-AM CANCER SOC, V117, P1529, DOI 10.1002/cncr.25684; Kohl M, 2015, COMPUT METH PROG BIO, V118, P218, DOI 10.1016/j.cmpb.2014.11.009; Mankin HJ, 2004, CLIN ORTHOP RELAT R, P212, DOI 10.1097/01.blo.0000137241.24906.bf; Mavrogenis AF, 2013, J SURG ONCOL, V108, P19, DOI 10.1002/jso.23351; Mavrogenis AF, 2012, ORTHOPEDICS, V35, pE232, DOI 10.3928/01477447-20120123-40; OConnor MI, 1997, SEMIN SURG ONCOL, V13, P49, DOI 10.1002/(SICI)1098-2388(199701/02)13:1<49::AID-SSU8>3.0.CO;2-4; OCONNOR MI, 1989, J BONE JOINT SURG AM, V71A, P481, DOI 10.2106/00004623-198971040-00002; Ozaki T, 2003, J CLIN ONCOL, V21, P334, DOI 10.1200/JCO.2003.01.142; Ozaki T, 2002, CLIN ORTHOP RELAT R, P197; Ozaki T, 1996, ACTA ORTHOP SCAND, V67, P333, DOI 10.3109/17453679609002326; Pring ME, 2001, J BONE JOINT SURG AM, V83A, P1630, DOI 10.2106/00004623-200111000-00003; Puchner SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135736; Satcher RL, 2003, CLIN ORTHOP RELAT R, P209, DOI 10.1097/01.blo.0000057791.10364.7c; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schuh R, 2015, CLIN ORTHOP RELAT R, V473, P900, DOI 10.1007/s11999-014-3703-x; Schwameis E, 2002, CLIN ORTHOP RELAT R, P220; SHIN KH, 1994, CLIN ORTHOP RELAT R, P207; Sucato DJ, 2000, CLIN ORTHOP RELAT R, P193; Windhager R, 1996, CLIN ORTHOP RELAT R, P265; Wirbel RJ, 2001, CLIN ORTHOP RELAT R, P190; Wirbel RJ, 1999, ACTA ORTHOP SCAND, V70, P348, DOI 10.3109/17453679908997823	40	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172203	10.1371/journal.pone.0172203	http://dx.doi.org/10.1371/journal.pone.0172203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199377	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400081
J	Yun, J; Olkkola, S; Hanninen, ML; Oliviero, C; Heinonen, M				Yun, Jinhyeon; Olkkola, Satu; Hanninen, Marja-Liisa; Oliviero, Claudio; Heinonen, Mari			The effects of amoxicillin treatment of newborn piglets on the prevalence of hernias and abscesses, growth and ampicillin resistance of intestinal coliform bacteria in weaned pigs	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SWINE; ANTIBIOTICS; PERFORMANCE; MICROFLORA; DIVERSITY; IMPACT; FEED	This study investigated the effects of a single amoxicillin treatment of newborn piglets on the prevalence of hernias and abscesses until the age of nine weeks. We also studied whether the treatment was associated with growth and mortality, the need for treatment of other diseases, the proportions of ampicillin resistant coliforms and antimicrobial resistance patterns of intestinal Escherichia coli (E. coli). A total of 7156 piglets, from approximately 480 litters, were divided into two treatment groups: ANT (N = 3661) and CON (N = 3495), where piglets were treated with or without a single intramuscular injection of 75 mg amoxicillin one day after birth, respectively. The umbilical and inguinal areas of weaned pigs were palpated at four and nine weeks of age. At the same time, altogether 124 pigs with hernias or abscesses and 820 non -defective pigs from three pens per batch were weighed individually. Mortality and the need to treat piglets for other diseases were recorded. Piglet faecal samples were collected from three areas of the floors of each pen at four weeks of age. The prevalence of umbilical hernias or abscesses did not differ between the groups at four weeks of age, but it was higher in the CON group than in the ANT group at nine weeks of age (2.3% vs. 0.7%, P<0.05). Numbers of inguinal hernias and abscesses did not differ between the groups at four or nine weeks of age. The ANT group, when it compared with the CON group, increased the weight gain between four and nine weeks of age (LS means SE; 497.5 g/d 5.0 vs. 475.3 g/d 4.9, P< 0.01),and decreased piglet mortality (19.5% 1.0 vs. 6.9% 1.0, P < 0.05) and the need to treat the piglets for leg problems (3.4% 0.3 vs. 1.9% 0.3%, P < 0.01) but not for other diseases by the age of four weeks. The proportion of ampicillin resistant intestinal coliform bacteria and the resistance patterns of the E. coli isolates were not different between the ANT and CON groups. In conclusion, our results showed that the amoxicillin treatment of new-born piglets produced statistically significant effect in some of the parameters studied. However, as these effects were only minor, we did not find grounds to recommend preventive antibiotic treatment. Further, continuous antimicrobial treatment of newborn piglets could negatively influence the development of the normal microbiota of the piglet and promote selection of antimicrobial resistance genes in herds. Therefore we suggest rejection of the use of routine administration of antimicrobial agents at birth.	[Yun, Jinhyeon] Univ Helsinki, Dept Prod Anim Med, Res Ctr Anim Welf, Fac Vet Med, Helsinki, Finland; [Olkkola, Satu] Finnish Food Safety Author Evira, Antibiot Sect, Food & Feed Microbiol Res Unit, Res & Lab Dept, Mustialankatu 3, Helsinki, Finland; [Olkkola, Satu; Hanninen, Marja-Liisa] Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland; [Oliviero, Claudio; Heinonen, Mari] Univ Helsinki, Dept Prod Anim Med, Fac Vet Med, Paroninkuja 20, Saarentaus, Finland	University of Helsinki; Finnish Food Authority; University of Helsinki; University of Helsinki	Yun, J (corresponding author), Univ Helsinki, Dept Prod Anim Med, Res Ctr Anim Welf, Fac Vet Med, Helsinki, Finland.	jinhyeon.yun@helsinki.fi	Yun, Jinhyeon/S-3453-2019	Yun, Jinhyeon/0000-0002-0697-0679; Olkkola, Satu/0000-0001-6966-7151; Heinonen, Mari/0000-0002-5732-0692; Oliviero, Claudio/0000-0001-8910-9595	Ministry of Agriculture and Forestry in Finland; Vetcare Ltd	Ministry of Agriculture and Forestry in Finland; Vetcare Ltd	Support was provided by the Ministry of Agriculture and Forestry in Finland and Vetcare Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso H, 1989, J VET PHARMACOL THER, V21, P41; Anderson DE, 2012, ANESTHESIA SURG PROC, P119; ANGUS K, 1972, VET REC, V90, P245; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Bennet R, 2002, INFECTION, V30, P158, DOI 10.1007/s15010-002-2140-z; Bibbal D, 2007, APPL ENVIRON MICROB, V73, P4785, DOI 10.1128/AEM.00252-07; Bibbal D, 2009, APPL ENVIRON MICROB, V75, P2999, DOI 10.1128/AEM.02143-08; Callens B, 2015, MICROB DRUG RESIST, V21, P50, DOI 10.1089/mdr.2014.0037; Cavaco L, 2015, PCR PLASMID MEDIATED; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Ding NS, 2009, J ANIM SCI, V87, P2469, DOI 10.2527/jas.2008-1601; Du ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004837; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; GARDNER IA, 1989, J AM VET MED ASSOC, V194, P659; Gibbons JF, 2015, ANTIMICROBIAL RESIST; Grindflek E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-25; Harada K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/180682; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Kluge H, 2006, J ANIM PHYSIOL AN N, V90, P316, DOI 10.1111/j.1439-0396.2005.00604.x; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Literak I, 2009, MICROB DRUG RESIST, V15, P229, DOI 10.1089/mdr.2009.0913; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; MAGEE WT, 1951, J ANIM SCI, V10, P516, DOI 10.2527/jas1951.102516x; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Martinez-Larranaga MR, 2004, VET REC, V154, P627, DOI 10.1136/vr.154.20.627; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Reiman J., 2012, Integrating science, welfare, and economics in practice. American Association of Swine Veterinarians 43rd Annual Meeting Proceedings, Denver, Colorado, USA, 10-13 March 2012, P55; Reiman J, 2010, AM ASS SWIN VET ANN; Rutten-Ramos SC, 2006, J SWINE HEALTH PROD, V14, P317; Schmidt Bettina, 2011, PLoS One, V6, pe28284, DOI 10.1371/journal.pone.0028284; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; SEARCYBERNAL R, 1994, J AM VET MED ASSOC, V204, P1660; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Varga C, 2008, CAN J VET RES, V72, P175; Vestergaard K, 2002, 556 VID SVIN; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Wu SY, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-47; Zoric M., 2016, Porcine Health Management, V2; Zoric M, 2004, J VET MED B, V51, P278, DOI 10.1111/j.1439-0450.2004.00777.x	44	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172150	10.1371/journal.pone.0172150	http://dx.doi.org/10.1371/journal.pone.0172150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199379	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400077
J	Kuo, WC; Kao, MC; Tsou, MY; Ting, CK				Kuo, Wen-Chuan; Kao, Meng-Chun; Tsou, Mei-Yung; Ting, Chien-Kun			In vivo images of the epidural space with two- and three-dimensional optical coherence tomography in a porcine model	PLOS ONE			English	Article							SPONTANEOUS INTRACRANIAL HYPOTENSION; BLIND BLOOD PATCH; CATHETER PLACEMENT; ULTRASOUND; FEASIBILITY; SYSTEM	Background No reports exist concerning in vivo optical coherence tomography visualization of the epidural space and the blood patch process in the epidural space. In this study, we produced real-time two-dimensional and reconstructed three-dimensional images of the epidural space by using optical coherence tomography in a porcine model. We also aimed to produce three-dimensional optical coherence tomography images of the dura puncture and blood patch process. Methods Two-dimensional and three-dimensional optical coherence tomography images were obtained using a swept source optical coherence tomography (SSOCT) system. Four laboratory pigs were intubated and ventilated after the induction of general anesthesia. An 18-gauge Tuohy needle was used as a tunnel for the optical coherence tomography probe to the epidural space. Two-dimensional and three-dimensional reconstruction optical coherence tomography images of the epidural space were acquired in four stages. Results In stage 1, real-time two-dimensional and reconstructed three-dimensional optical coherence tomography of the lumbar and thoracic epidural space were successfully acquired. In stage 2, the epidural catheter in the epidural space was successfully traced in the 3D optical coherence tomography images. In stage 3, water injection and lumbar puncture were successfully monitored in all study animals. In stage 4, 10 mL of fresh blood was injected into the epidural space and two-dimensional and three-dimensional optical coherence tomography images were successfully acquired. Conclusions These animal experiments suggest the potential capability of using an optical coherence tomography-based imaging needle in the directed two-dimensional and three-dimensional visualization of the epidural space. More investigations involving humans are required before optical coherence tomography can be recommended for routine use. However, three-dimensional optical coherence tomography may provide a novel, minimally invasive, and safe way to observe the spinal epidural space, epidural catheter, lumbar puncture hole, and blood patch.	[Kuo, Wen-Chuan; Kao, Meng-Chun] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Kuo, Wen-Chuan] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei, Taiwan; [Tsou, Mei-Yung; Ting, Chien-Kun] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsou, Mei-Yung; Ting, Chien-Kun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Ting, CK (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	ckting@vghtpe.gov.tw	Ting, Chien-Kun/C-1389-2012	Ting, Chien-Kun/0000-0002-3156-8139	Taiwan Ministry of Science and Technology Grant, Taipei, Taiwan: MOST [MOST 103-2221-E-075 -004, MOST 104-2221-E-075-002]	Taiwan Ministry of Science and Technology Grant, Taipei, Taiwan: MOST	This work was supported by Taiwan Ministry of Science and Technology Grant, Taipei, Taiwan: MOST, MOST 103-2221-E-075 -004 and MOST 104-2221-E-075-002 (https://www.most.gov.tw/ch/academic).	Palomero-Rodriguez MA, 2015, SAUDI J ANAESTH, V9, P467, DOI 10.4103/1658-354X.159478; Beamer J, 2000, ANAESTHESIA, V55, P1233, DOI 10.1046/j.1365-2044.2000.01798-33.x; Cadotte DW, 2012, BIOMED OPT EXPRESS, V3, P911, DOI 10.1364/BOE.3.000911; Chang Pi-Ying, 2010, Acta Anaesthesiol Taiwan, V48, P45, DOI 10.1016/S1875-4597(10)60010-0; Chen YC, 2016, CEPHALALGIA, V36, P225, DOI 10.1177/0333102415585095; Chen Y, 2009, J NEUROSCI METH, V178, P162, DOI 10.1016/j.jneumeth.2008.11.026; Chiang HK, 2011, ANESTHESIOLOGY, V114, P1320, DOI 10.1097/ALN.0b013e31821b5746; Chiu SC, 2012, REGION ANESTH PAIN M, V37, P354, DOI 10.1097/AAP.0b013e31824c0310; Cho KI, 2011, NEUROLOGY, V76, P1139, DOI 10.1212/WNL.0b013e318212ab43; Correia I, 2016, CASE REP MED, V2016, DOI 10.1155/2016/9809017; Ferrante E, 2016, ACTA NEUROL BELG, V116, P503, DOI 10.1007/s13760-016-0617-2; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; HEAVNER J E, 1991, Regional Anesthesia, V16, P85; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Jones MR, 2012, AM J NEURORADIOL, V33, P1494, DOI 10.3174/ajnr.A3016; Karraz MA, 2002, ANESTH ANALG, V95, P257, DOI 10.1097/00000539-200207000-00065; Kumar Yogesh, 2015, Conn Med, V79, P547; Kuo WC, 2015, ANESTHESIOLOGY, V122, P585, DOI 10.1097/ALN.0000000000000531; Gutierrez-Chico JL, 2012, EUR HEART J-CARD IMG, V13, P370, DOI 10.1093/ehjci/jes025; Motamed C, 2006, ANESTH ANALG, V103, P1026, DOI 10.1213/01.ane.0000237291.30499.32; Nakai E, 2016, J NEUROSURG, V124, P580, DOI 10.3171/2015.2.JNS142746; Pagani-Estevez GL, 2016, REGION ANESTH PAIN M, V41, P164, DOI 10.1097/AAP.0000000000000352; Shah Manish, 2015, J Anaesthesiol Clin Pharmacol, V31, P560, DOI 10.4103/0970-9185.169091; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Smith KA, 2016, J CLIN NEUROSCI, V25, P10, DOI 10.1016/j.jocn.2015.07.009; Srinivasan KK, 2014, MED ULTRASON, V16, P356; Tsui BCH, 1999, CAN J ANAESTH, V46, P675, DOI 10.1007/BF03013957; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Yeager MP, 2016, ACTA ANAESTH SCAND, V60, P513, DOI 10.1111/aas.12649; Zahid Yaqoob, J BIOMEDICAL OPTICS, V11	30	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172149	10.1371/journal.pone.0172149	http://dx.doi.org/10.1371/journal.pone.0172149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196128	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900056
J	Sheng, WW; Dong, M; Chen, CP; Wang, ZX; Li, YW; Wang, KW; Li, YJ; Zhou, JP				Sheng, Weiwei; Dong, Ming; Chen, Chuanping; Wang, Zixin; Li, Yunwei; Wang, Kewei; Li, Yuji; Zhou, Jianping			Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer	FASEB JOURNAL			English	Article						chemosensitivity; cell invasion; tumor growth; clinical significance	RNA-BINDING PROTEIN; CELL LUNG-CANCER; COLORECTAL-CANCER; MYELOID-LEUKEMIA; STEM-CELLS; IN-VITRO; CARCINOMA; PATHWAY; PROGRESSION; EXPRESSION	Our earlier work showed thatMusashi (MSI)-2 promoted the development of pancreatic cancer (PC) by down-regulating Numb, which prevented murine double-minute (MDM)-2-mediated p53 ubiquitin degradation. Thus, we investigate the relationship amongMSI2, Numb, MDM2, and p53 in PCin vitro and in vivo, anassociation that has not been reported to our knowledge. MSI2 had no relationship with mutant p53 (mtp53) andwild-type p53 (wtp53) in normal PC cells. However, in response to gemcitabine or cisplatin treatment, MSI2 silencing simultaneously down-regulated MDM2 and up-regulated Numb and wtp53 protein levels. Moreover, these 4 endogenous proteins can be coimmuno precipitated as a quaternary complex. Numb small interferingRNA(siRNA) reversed the MSI2 silencing-induced p53 increase. During treatment with chemical agents, MSI2 silencing decreased drug resistance and cellmotility in vitro and inhibited tumor growth in vivo, all of which were significantly reversed by p53 siRNA. MSI2 was also negatively associated with Numb and positively associated with MDM2 expression in tissue. Overexpression of MSI2, MDM2, and mtp53 and weak expression of Numb were closely associated with aggressive clinicopathologic characteristics and poor prognosis for patients with PC. MSI2 negatively regulates wtp53 protein by up-regulating MDM2 and down-regulating Numb after treatment with chemical agents. MSI2 promotes drug resistance andmalignant biology ofPCina p53-dependent manner.	[Sheng, Weiwei; Dong, Ming; Wang, Zixin; Li, Yunwei; Wang, Kewei; Li, Yuji; Zhou, Jianping] China Med Univ, Hosp 1, Dept Gastrointestinal & Hernia & Abdominal Wall S, Shenyang 110001, Peoples R China; [Chen, Chuanping] Sixth Peoples Hosp Shenyang City, Clin Lab, Shenyang, Peoples R China	China Medical University	Dong, M (corresponding author), China Med Univ, Hosp 1, Dept Gastrointestinal & Hernia & Abdominal Wall S, Shenyang 110001, Peoples R China.	dongming@cmu.edu.cn	Wang, Kewei/J-8974-2019; Wang, Zhiquan/HHS-6768-2022	Wang, Kewei/0000-0002-3816-1024; 	Chinese National Science Foundation [81672835]; Shenyang Science and Technology Bureau (Social Development Program) [F15-139-9-19]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shenyang Science and Technology Bureau (Social Development Program)	This work was supported by the Chinese National Science Foundation (Grant 81672835 to M.D.) and the Shenyang Science and Technology Bureau (Social Development Program Grant F15-139-9-19). The authors declare no conflicts of interest.	BARTON CM, 1991, BRIT J CANCER, V64, P1076, DOI 10.1038/bjc.1991.467; Bergman AM, 1996, CLIN CANCER RES, V2, P521; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Branch P, 2000, ONCOGENE, V19, P3138, DOI 10.1038/sj.onc.1203668; Brighenti E, 2014, ONCOGENE, V33, P4396, DOI 10.1038/onc.2014.1; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Chen B, 2013, BIOCHEM BIOPH RES CO, V437, P526, DOI 10.1016/j.bbrc.2013.06.103; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; de Andres-Aguayo L, 2012, CURR OPIN HEMATOL, V19, P268, DOI 10.1097/MOH.0b013e328353c778; Emadi-Baygi M, 2013, PATHOL RES PRACT, V209, P689, DOI 10.1016/j.prp.2013.07.008; Glazer RI, 2008, CELL CYCLE, V7, P2635, DOI 10.4161/cc.7.17.6522; Han YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136484; He L, 2014, J CELL MOL MED, V18, P49, DOI 10.1111/jcmm.12158; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jiang WL, 2016, CANCER LETT, V371, P314, DOI 10.1016/j.canlet.2015.12.002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kudinov AE, 2016, P NATL ACAD SCI USA, V113, P6955, DOI 10.1073/pnas.1513616113; Lavarino C, 1997, LANCET, V349, P1556, DOI 10.1016/S0140-6736(05)62140-X; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Liu H, 2015, CANCER LETT, V361, P218, DOI 10.1016/j.canlet.2015.03.001; Momand J, 1996, ONCOGENE, V12, P2279; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Owonikoko TK, 2014, CANCER MED-US, V3, P1579, DOI 10.1002/cam4.317; Paajarvi G, 2004, FASEB J, V18, P476, DOI 10.1096/fj.04-2745fje; REDSTON MS, 1994, CANCER RES, V54, P3025; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sheng W., 2016, ONCOTARGET; Sheng WW, 2014, J CELL PHYSIOL, V229, P887, DOI 10.1002/jcp.24519; Sheng WW, 2013, CELL TISSUE RES, V354, P521, DOI 10.1007/s00441-013-1679-6; Sui XB, 2015, ONCOTARGET, V6, P22869, DOI 10.18632/oncotarget.5137; Wang MH, 2015, AM J CANCER RES, V5, P1089; Wang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7517; Waning DL, 2011, J BIOL CHEM, V286, P216, DOI 10.1074/jbc.M110.183012; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827; Yang CL, 2016, LAB INVEST, V96, P950, DOI 10.1038/labinvest.2016.71	41	34	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2429	2438		10.1096/fj.201601240R	http://dx.doi.org/10.1096/fj.201601240R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223335				2022-12-26	WOS:000401553400018
J	Aksnes, H; Goris, M; Stromland, O; Drazic, A; Waheed, Q; Reuter, N; Arnesen, T				Aksnes, Henriette; Goris, Marianne; Stromland, Oyvind; Drazic, Adrian; Waheed, Qaiser; Reuter, Nathalie; Arnesen, Thomas			Molecular determinants of the N-terminal acetyltransferase Naa60 anchoring to the Golgi membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; ALPHA-ACETYLTRANSFERASE; CELLULAR-PROTEINS; GTPASE ARL3P; FORCE-FIELD; ACETYLATION; DYNAMICS; YEAST; CHARMM; REVEALS	N alpha-Acetyltransferase 60 (Naa60 or NatF) was recently identified as an unconventional N-terminal acetyltransferase (NAT) because it localizes to organelles, in particular the Golgi apparatus, and has a preference for acetylating N termini of the transmembrane proteins. This knowledge challenged the prevailing view of N-terminal acetylation as a co-translational ribosomeassociated process and suggested a new mechanistic functioning for the enzymes responsible for this increasingly recognized protein modification. Crystallography studies on Naa60 were unable to resolve the C-terminal tail of Naa60, which is responsible for the organellar localization. Here, we combined modeling, in vitro assays, and cellular localization studies to investigate the secondary structure and membrane interacting capacity of Naa60. The results show that Naa60 is a peripheral membrane protein. Two amphipathic helices within the Naa60 C terminus bind the membrane directly in a parallel position relative to the lipid bilayer via hydrophobic and electrostatic interactions. A peptide corresponding to the C terminus was unstructured in solution and only folded into an alpha-helical conformation in the presence of liposomes. Computational modeling and cellular mutational analysis revealed the hydrophobic face of two alpha-helices to be critical for membranous localization. Furthermore, we found a strong and specific binding preference of Naa60 toward membranes containing the phosphatidylinositol PI(4) P, thus possibly explaining the primary residency of Naa60 at the PI(4) P-rich Golgi. In conclusion, we have defined the mode of cytosolic Naa60 anchoring to the Golgi apparatus, most likely occurring post-translationally and specifically facilitating post-translational N-terminal acetylation of many transmembrane proteins.	[Aksnes, Henriette; Goris, Marianne; Stromland, Oyvind; Drazic, Adrian; Waheed, Qaiser; Reuter, Nathalie; Arnesen, Thomas] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Waheed, Qaiser; Reuter, Nathalie] Univ Bergen, Dept Informat, Computat Biol Unit, N-5020 Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Arnesen, T (corresponding author), Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway.; Arnesen, T (corresponding author), Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway.	thomas.arnesen@uib.no	Reuter, Nathalie/G-2037-2012; Arnesen, Thomas/J-7139-2017; Arnesen, Thomas/Q-8117-2019; Aksnes, Henriette/AAD-6290-2020; Drazic, Adrian/AAC-6120-2019	Reuter, Nathalie/0000-0002-3649-7675; Arnesen, Thomas/0000-0002-3005-147X; Arnesen, Thomas/0000-0002-3005-147X; Aksnes, Henriette/0000-0003-4968-2324; Drazic, Adrian/0000-0001-9263-5502; Goris, Marianne/0000-0003-0175-3082; Waheed, Qaiser/0000-0002-7566-2506	Research Council of Norway [230865, 249843]; Norwegian Cancer Society; Bergen Research Foundation BFS; Deutsche Forschungsgemeinschaft [DR 998/2-1]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Bergen Research Foundation BFS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Research Council of Norway Grants 230865 and 249843 (to T. A.), grants from the Norwegian Cancer Society (to T. A.), the Bergen Research Foundation BFS (to T. A.), and fellowship Grant DR 998/2-1 from the Deutsche Forschungsgemeinschaft (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Aksnes H, 2015, TRENDS BIOCHEM SCI, V40, P422, DOI 10.1016/j.tibs.2015.05.003; Aksnes H, 2015, CELL REP, V10, P1362, DOI 10.1016/j.celrep.2015.01.053; Aksnes H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061012; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bienvenut WV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015131; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carney Joanne, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1912s45; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Chen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31425; Chon NL, 2015, BIOCHEMISTRY-US, V54, P5696, DOI 10.1021/acs.biochem.5b00422; Coulton AT, 2010, J CELL SCI, V123, P3235, DOI 10.1242/jcs.069971; Dinh TV, 2015, PROTEOMICS, V15, P2426, DOI 10.1002/pmic.201500025; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Fritzsching KJ, 2013, BBA-BIOMEMBRANES, V1828, P1889, DOI 10.1016/j.bbamem.2013.03.028; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Guixa-Gonzalez R, 2014, BIOINFORMATICS, V30, P1478, DOI 10.1093/bioinformatics/btu037; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Holmes WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5383; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Izaguirre JA, 1999, J CHEM PHYS, V110, P9853, DOI 10.1063/1.478995; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miller MB, 2015, J BIOL CHEM, V290, P13541, DOI 10.1074/jbc.M115.636746; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Myklebust LM, 2015, HUM MOL GENET, V24, P1956, DOI 10.1093/hmg/ddu611; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Rathore OS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21304; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Saunier C, 2016, HUM MUTAT, V37, P755, DOI 10.1002/humu.23001; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Sodt AJ, 2015, BIOPHYS J, V109, P948, DOI 10.1016/j.bpj.2015.07.036; Stove SI, 2016, STRUCTURE, V24, P1044, DOI 10.1016/j.str.2016.04.020; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233	58	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6821	6837		10.1074/jbc.M116.770362	http://dx.doi.org/10.1074/jbc.M116.770362			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28196861	Green Published, hybrid			2022-12-26	WOS:000399813400032
J	Li, W; Hofer, MJ; Songkhunawej, P; Jung, SR; Hancock, D; Denyer, G; Campbell, IL				Li, Wen; Hofer, Markus J.; Songkhunawej, Pattama; Jung, So Ri; Hancock, Dale; Denyer, Gareth; Campbell, Iain L.			Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; glial cell; interferon; interferon regulatory factor (IRF); signal transducers and activators of transcription 1 (STAT1)	CENTRAL-NERVOUS-SYSTEM; IFN-ALPHA; UNPHOSPHORYLATED STAT1; TARGETED DISRUPTION; MEDIATED DISEASE; IMMUNE-SYSTEM; MICE; PATHWAYS; GAMMA; INFECTION	Type I interferons (IFN-I) are critical in antimicrobial and antitumor defense. Although IFN-I signal via the interferon-stimulated gene factor 3 (ISGF3) complex consisting of STAT1, STAT2, and IRF9, IFN-I can mediate significant biological effects via ISGF3-independent pathways. For example, the absence of STAT1, STAT2, or IRF9 exacerbates neurological disease in transgenic mice with CNS production of IFN-I. Here we determined the role of IFN-I-driven, ISGF3-independent signaling in regulating global gene expression in STAT1-, STAT2-, or IRF9-deficient murine mixed glial cell cultures (MGCs). Compared with WT, the expression of IFN--stimulated genes (ISGs) was reduced in number and magnitude in MGCs that lacked STAT1, STAT2, or IRF9. There were significantly fewer ISGs in the absence of STAT1 or STAT2 versus in the absence of IRF9. The majority of ISGs regulated in the STAT1-, STAT2-, or IRF9-deficient MGCs individually were shared with WT. However, only a minor number of ISGs were common to WT and STAT1-, STAT2-, and IRF9-deficient MGCs. Whereas signal pathway activation in response to IFN- was rapid and transient in WT MGCs, this was delayed and prolonged and correlated with increased numbers of ISGs expressed at 12 h versus 4 h of IFN- exposure in all three IFN-I signaling-deficient MGCs. In conclusion, 1) IFN-I can mediate ISG expression in MGCs via ISGF3-independent signaling pathways but with reduced efficiency, with delayed and prolonged kinetics, and is more dependent on STAT1 and STAT2 than IRF9; and 2) signaling pathways not involving STAT1, STAT2, or IRF9 play a minor role only in mediating ISG expression in MGCs.	[Li, Wen; Hofer, Markus J.; Songkhunawej, Pattama; Jung, So Ri; Hancock, Dale; Denyer, Gareth; Campbell, Iain L.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Hofer, Markus J.; Campbell, Iain L.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Hofer, Markus J.; Campbell, Iain L.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Campbell, IL (corresponding author), Mol Biosci Bldg,G08, Sydney, NSW 2006, Australia.	iain.campbell@sydney.edu.au	Hofer, Markus J/C-3688-2013	Hofer, Markus J/0000-0001-5111-3978; Campbell, Iain/0000-0001-8681-1100; Jung, David/0000-0003-1611-7644	National Health and Medical Research Council of Australia [512407]; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 512407 (to I. L. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Australian Postgraduate Award.	Abdul-Sater AA, 2015, J IMMUNOL, V195, P210, DOI 10.4049/jimmunol.1401139; Akwa Y, 1998, J IMMUNOL, V161, P5016; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Blaszczyk K, 2015, BIOCHEM J, V466, P511, DOI 10.1042/BJ20140644; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Carter SL, 2007, GLIA, V55, P1728, DOI 10.1002/glia.20587; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ghislain JJ, 1996, J BIOL CHEM, V271, P12408, DOI 10.1074/jbc.271.21.12408; Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Gupta S, 1999, J IMMUNOL, V163, P3834; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; Hofer MJ, 2012, J VIROL, V86, P6932, DOI 10.1128/JVI.07147-11; Hofer MJ, 2010, J NEUROSCI, V30, P1149, DOI 10.1523/JNEUROSCI.3711-09.2010; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Li W, 2014, J VIROL, V88, P7578, DOI 10.1128/JVI.03117-13; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Maier J, 2002, AM J PATHOL, V160, P271, DOI 10.1016/S0002-9440(10)64371-4; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mulligan C, 2002, J BIOL CHEM, V277, P42480, DOI 10.1074/jbc.M206206200; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Ousman SS, 2005, METH MOLEC MED, V116, P115; Ousman SS, 2005, J VIROL, V79, P7514, DOI 10.1128/JVI.79.12.7514-7527.2005; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Plumlee CR, 2009, J BIOL CHEM, V284, P30058, DOI 10.1074/jbc.M109.018283; Rani MRS, 2005, J INTERF CYTOK RES, V25, P788, DOI 10.1089/jir.2005.25.788; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Santoni FA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001008; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Testoni B, 2011, J BIOL CHEM, V286, P20217, DOI 10.1074/jbc.M111.231068; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wang JP, 2002, P NATL ACAD SCI USA, V99, P16209, DOI 10.1073/pnas.252454799; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463; Zimmerman MA, 2012, CANCER RES, V72, P4724, DOI 10.1158/0008-5472.CAN-12-1347	63	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5845	5859		10.1074/jbc.M116.756510	http://dx.doi.org/10.1074/jbc.M116.756510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213522	Green Published, hybrid			2022-12-26	WOS:000398813200020
J	Harris, ML; Oldmeadow, C; Hure, A; Luu, J; Loxton, D; Attia, J				Harris, Melissa L.; Oldmeadow, Christopher; Hure, Alexis; Luu, Judy; Loxton, Deborah; Attia, John			Stress increases the risk of type 2 diabetes onset in women: A 12-year longitudinal study using causal modelling	PLOS ONE			English	Article							PERCEIVED STRESS; PSYCHOSOCIAL FACTORS; METABOLIC SYNDROME; MELLITUS; EXERCISE; JAPANESE; OBESITY; HEALTH; TRIALS	Background Type 2 diabetes is associated with significant morbidity and mortality. Modifiable risk factors have been found to contribute up to 60% of type 2 diabetes risk. However, type 2 diabetes continues to rise despite implementation of interventions based on traditional risk factors. There is a clear need to identify additional risk factors for chronic disease prevention. The aim of this study was to examine the relationship between perceived stress and type 2 diabetes onset, and partition the estimates into direct and indirect effects. Methods and findings Women born in 1946 -1951 (n = 12,844) completed surveys for the Australian Longitudinal Study on Women's Health in 1998, 2001, 2004, 2007 and 2010. The total causal effect was estimated using logistic regression and marginal structural modelling. Controlled direct effects were estimated through conditioning in the regression model. A graded association was found between perceived stress and all mediators in the multivariate time lag analyses. A significant association was found between hypertension, as well as physical activity and body mass index, and diabetes, but not smoking or diet quality. Moderate/high stress levels were associated with a 2.3-fold increase in the odds of diabetes three years later, for the total estimated effect. Results were only slightly attenuated when the direct and indirect effects of perceived stress on diabetes were partitioned, with the mediators only explaining 10-20% of the excess variation in diabetes. Conclusions Perceived stress is a strong risk factor for type 2 diabetes. The majority of the effect estimate of stress on diabetes risk is not mediated by the traditional risk factors of hypertension,physical activity, smoking, diet quality, and body mass index. This gives a new pathway for diabetes prevention trials and clinical practice.	[Harris, Melissa L.; Hure, Alexis; Loxton, Deborah] Univ Newcastle, Fac Hlth & Med, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Oldmeadow, Christopher; Attia, John] Hunter Med Res Inst, Clin Res Design IT & Stat Support Unit, Newcastle, NSW, Australia; [Oldmeadow, Christopher; Hure, Alexis; Luu, Judy; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth & Med, Newcastle, NSW, Australia; [Luu, Judy; Attia, John] Hunter New England Hlth, John Hunter Hosp, Div Med, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital	Hure, A (corresponding author), Univ Newcastle, Fac Hlth & Med, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia.; Hure, A (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth & Med, Newcastle, NSW, Australia.	Alexis.Hure@newcastle.edu.au	Attia, John R/F-5376-2013	Attia, John R/0000-0001-9800-1308; Harris, Melissa/0000-0002-5733-9684; Oldmeadow, Christopher/0000-0001-6104-1322; Hure, Alexis/0000-0003-2225-0986	Australian Government Department of Health; John Hunter Hospital Charitable Trust	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); John Hunter Hospital Charitable Trust	This work uses data from the Australian Longitudinal Study on Women's Health, which is funded by the Australian Government Department of Health. This analysis was funded by a John Hunter Hospital Charitable Trust Grant received by MLH, JL, DL, and JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Barr E, 2006, AUSTR DIABETES OBESI; Beatty LJ, 2012, COMPLEMENT THER MED, V20, P61, DOI 10.1016/j.ctim.2011.09.008; Bell S, 2003, PSYCHOL HEALTH MED, V8, P343, DOI DOI 10.1080/1354850031000135786; Bell S, 2002, PSYCHOL HEALTH MED, V7, P189; Bergmann N, 2014, ENDOCR CONNECT, V3, pR55, DOI 10.1530/EC-14-0031; BJORNTORP P, 1991, J INTERN MED, V230, P195; Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Brown WJ, 2000, AUST NZ J PUBL HEAL, V24, P520, DOI 10.1111/j.1467-842X.2000.tb00503.x; COHEN S, 1988, CLAR SYMP, P31; Collins CE, 2008, J AM COLL NUTR, V27, P146, DOI 10.1080/07315724.2008.10719686; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; Dobson AJ, 2015, INT J EPIDEMIOL, V44, DOI 10.1093/ije/dyv110; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Harris ML, 2013, ANN BEHAV MED, V46, P9, DOI 10.1007/s12160-013-9478-6; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hawkley LC, 2005, CAN PSYCHOL, V46, P115, DOI 10.1037/h0087015; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Jackson JM, 2013, J CLIN EPIDEMIOL, V66, P349, DOI 10.1016/j.jclinepi.2012.01.013; Kahle EB, 1996, INT J SPORTS MED, V17, P1, DOI 10.1055/s-2007-972799; Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003; Kelly SJ, 2015, ANN REV PUBLIC HLTH; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Magnavita N, 2014, RADIOL MED, V119, P142, DOI 10.1007/s11547-013-0329-0; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Roberts AL, 2015, JAMA PSYCHIAT, V72, P203, DOI 10.1001/jamapsychiatry.2014.2632; Strodl E, 2003, INT J BEHAV MED, V10, P205, DOI 10.1207/S15327558IJBM1003_02; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Twisk JWR, 2003, APPL LONGITUDINAL DA; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y	37	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e172126	10.1371/journal.pone.0172126	http://dx.doi.org/10.1371/journal.pone.0172126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222165	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800032
J	Ramirez-Ponce, A; Garfias-Lozano, G; Contreras-Ramos, A				Ramirez-Ponce, Andres; Garfias-Lozano, Gabriela; Contreras-Ramos, Atilano			The nature of allometry in an exaggerated trait: The postocular flange in Platyneuromus Weele (Insecta: Megaloptera)	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; STATIC ALLOMETRY; EVOLUTION; SELECTION; ORNAMENTS; SHAPE; CONSTRAINTS; COLEOPTERA; ORIGIN	The origin and function of exaggerated traits exhibited by a great number of species with sexual dimorphism remain largely unexplored. The usual model considered as the evolutionary mechanism for the development of these structures is sexual selection. The nature of growth of the postocular flange (POF) in three species of the dobsonfly genus Platyneuromus (Megaloptera, Corydalidae, Corydalinae) is analyzed to explore sexual size dimorphism and allometric scaling. Results involve positive allometry of POF in males of two species, and negative allometry in males of one species, in general with a female-biased sexual dimorphism. We suggest an ancestral condition of dual incipient ornamentation in Platyneuromus, with a subsequent departure of size and shape of POF in males, triggered by sexual selection. Different sexual selection intensities may explain the parallel or divergent growth of POF within the scheme of dual ornamentation. Empirical behavioral data as well as a phylogenetic framework are necessary to clarify possible causes of phenotypic development, time of origin, and evolution of the POF.	[Ramirez-Ponce, Andres] UNAM, Inst Biol, Lab Reg Biodiversidad & Cult Tejidos Vegetales, Catedrat CONACYT, Santa Cruz Tlaxcala, Tlaxcala, Mexico; [Garfias-Lozano, Gabriela] Univ Nacl Autonoma Mexico, Fac Ciencias, Biol, Mexico City, DF, Mexico; [Contreras-Ramos, Atilano] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Contreras-Ramos, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico.	acontreras@ib.unam.mx	Contreras-Ramos, Atilano/AAE-5966-2021; Ramírez-Ponce, Andrés/N-8965-2017	Contreras-Ramos, Atilano/0000-0001-8044-1348; Ramírez-Ponce, Andrés/0000-0003-4742-7397	Consejo Nacional de Ciencia y Tecnologia-Mexico, Apoyos Complementarios para el Establecimiento y Consolidacion de Laboratorios Nacionales [CONACYT 2015-2]; Nacional de Biodiversidad, Instituto de Biologia, UNAM [261145]; Programa Catedras CONACYT	Consejo Nacional de Ciencia y Tecnologia-Mexico, Apoyos Complementarios para el Establecimiento y Consolidacion de Laboratorios Nacionales; Nacional de Biodiversidad, Instituto de Biologia, UNAM; Programa Catedras CONACYT	This work received support from Consejo Nacional de Ciencia y Tecnologia-Mexico, Apoyos Complementarios para el Establecimiento y Consolidacion de Laboratorios Nacionales CONACYT 2015-2, Solicitud 261145 Laboratorio Nacional de Biodiversidad, Instituto de Biologia, UNAM, institutional project (conacyt.gob.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cristina Mayorga Martinez for help with access to the National Insect Collection (CNIN), Instituto de Biologia-UNAM, and Susana Guzman Gomez for technical support with stereomicroscope photos. Andres Ramirez thanks Programa Catedras CONACYT for funding for laboratory equipment and general support.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Baker RH, 2001, EVOLUTION, V55, P1373; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Berns C. M., 2013, SEXUAL DIMORPHISM, P1, DOI DOI 10.5772/55154; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Calabuig CP, 2013, ZOOLOGIA-CURITIBA, V30, P424, DOI 10.1590/S1984-46702013000400008; Contreras-Ramos A, 1999, ENTOMOL NEWS, V110, P125; Contreras-Ramos A, 1998, T SAY PUBLICATIONS E; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Gates TA, 2016, NAT COMMUN NATURE PU, V7, P1; Gidaszewski NA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-110; GLORIOSO MJ, 1981, SYST ENTOMOL, V6, P253, DOI 10.1111/j.1365-3113.1981.tb00440.x; GLORIOSO MJ, 1984, P BIOL SOC WASH, V97, P601; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanley RS, 2001, BIOL J LINN SOC, V72, P451, DOI 10.1111/j.1095-8312.2001.tb01330.x; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Huxley J., 1932, PROBLEMS RELATIVE GR; Kawano K, 2000, ANN ENTOMOL SOC AM, V93, P198, DOI 10.1603/0013-8746(2000)093[0198:GAAITS]2.0.CO;2; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kunte K, 2007, FUNCT ECOL, V21, P982, DOI 10.1111/j.1365-2435.2007.01299.x; Lavine L, 2016, ANNU REV ENTOMOL, V60, P1; Liu XY, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0247; Marlowe MH, 2015, PEERJ, V3, DOI 10.7717/peerj.1123; Mascaro J, 2014, BIOL J LINN SOC, V111, P230, DOI 10.1111/bij.12177; Matsuo Y, 2005, J INSECT BEHAV, V18, P465, DOI 10.1007/s10905-005-5605-y; McCullough EL, 2016, TRENDS ECOL EVOL, V31, P742, DOI 10.1016/j.tree.2016.07.004; Painting CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082467; Pelabon C, 2014, ANN NY ACAD SCI, V1320, P58, DOI 10.1111/nyas.12470; Raia P, 2016, AM NAT, V186, P1; Randau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072868; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Sanger TJ, 2013, EVOLUTION, V67, P2180, DOI 10.1111/evo.12100; Sheets H. D., 2014, COORDGEN8; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Stern DL, 1999, DEVELOPMENT, V126, P1091; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Tomkins JL, 2010, AM NAT, V176, P141, DOI 10.1086/653001; Vencl FV, 2004, INTEGR COMP BIOL, V44, P242, DOI 10.1093/icb/44.3.242; Voje KL, 2014, EVOLUTION, V68, P866, DOI 10.1111/evo.12312; Wilkinson Gerald S., 1997, P310, DOI 10.1017/CBO9780511721946.019; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]	54	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172388	10.1371/journal.pone.0172388	http://dx.doi.org/10.1371/journal.pone.0172388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212437	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700041
J	Springer, DJ; Mohan, R; Heitman, J				Springer, Deborah J.; Mohan, Rajinikanth; Heitman, Joseph			Plants promote mating and dispersal of the human pathogenic fungus Cryptococcus	PLOS ONE			English	Article							CANDIDA-ALBICANS; NEOFORMANS; OUTBREAK; DIVERSITY; COCCIDIOIDOMYCOSIS; FILOBASIDIELLA; BLASTOMYCOSIS; RHIZOSPHERE; POPULATION; INFECTIONS	Infections due to Cryptococcus are a leading cause of fungal infections worldwide and are acquired as a result of environmental exposure to desiccated yeast or spores. The ability of Cryptococcus to grow, mate, and produce infectious propagules in association with plants is important for the maintenance of the genetic diversity and virulence factors important for infection of animals and humans. In the Western United States and Canada, Cryptococcus has been associated with conifers and tree species other than Eucalyptus; however, to date Cryptococcus has only been studied on live Arabidopsis thaliana, Eucalyptus sp., and Terminalia catappa ( almond) seedlings. Previous research has demonstrated the ability of Cryptococcus to colonize live plants, leaves, and vasculature. We investigated the ability of Cryptococcus to grow on live seedlings of the angiosperms, A. thaliana, Eucalyptus camaldulensis, Colophospermum mopane, and the gymnosperms, Pseudotsuga menziesii ( Douglas fir), and Tsuga heterophylla ( Western hemlock). We observed a broad-range ability of Cryptococcus to colonize both traditional infection models as well as newly tested conifer species. Furthermore, C. neoformans, C. deneoformans, C. gattii ( VGI), C. deuterogattii ( VGII) and C. bacillisporus ( VGIII) were able to colonize live plant leaves and needles but also undergo filamentation and mating on agar seeded with plant materials or in saprobic association with dead plant materials. The ability of Cryptococcus to grow and undergo filamentation and reproduction in saprobic association with both angiosperms and gymnosperms highlights an important role of plant debris in the sexual cycle and exposure to infectious propagules. This study highlights the broad importance of plants ( and plant debris) as the ecological niche and reservoirs of infectious propagules of Cryptococcus in the environment.	[Springer, Deborah J.; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Mohan, Rajinikanth] Hamilton Coll, Dept Biol, Clinton, NY 13323 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Pharmacol Canc Biol, Durham, NC USA; [Springer, Deborah J.] Novozymes North Amer INC, Durham, NC 27713 USA	Duke University; Hamilton College; Duke University; Duke University	Springer, DJ; Heitman, J (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol Canc Biol, Durham, NC USA.; Springer, DJ (corresponding author), Novozymes North Amer INC, Durham, NC 27713 USA.	dbs@novozymes.com; heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021		NIAID NIH HHS [R01 AI050113, R37 AI039115] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050113, R37AI039115] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barker BM, 2007, ANN NY ACAD SCI, V1111, P147, DOI 10.1196/annals.1406.040; Bennett JW, 2009, MED MYCOL, V47, pS5, DOI 10.1080/13693780802712515; Botes A, 2009, MICROB ECOL, V57, P757, DOI 10.1007/s00248-008-9452-1; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Cairns L, 2000, CLIN INFECT DIS, V30, P61, DOI 10.1086/313602; Chamany S, 2004, PEDIATR INFECT DIS J, V23, P909, DOI 10.1097/01.inf.0000141738.60845.da; COLES FB, 1992, AM J EPIDEMIOL, V136, P475, DOI 10.1093/oxfordjournals.aje.a116521; Durden FM, 1997, SEMIN CUTAN MED SURG, V16, P200, DOI 10.1016/S1085-5629(97)80043-0; ERKE KH, 1976, J BACTERIOL, V128, P445, DOI 10.1128/JB.128.1.445-455.1976; Fanfair RN, 2012, NEW ENGL J MED, V367, P2214, DOI 10.1056/NEJMoa1204781; Ferreira-Paim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108633; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009; Hebecker B, 2014, EXPERT REV ANTI-INFE, V12, P867, DOI 10.1586/14787210.2014.916210; HOWARD DH, 1984, ZBL BAKT-INT J MED M, V257, P219, DOI 10.1016/S0174-3031(84)80075-X; Huerfano Sandra, 2001, Revista Iberoamericana de Micologia, V18, P131; Johnson LB, 1998, MYCOSES, V41, P277, DOI 10.1111/j.1439-0507.1998.tb00338.x; Khawcharoenporn T, 2007, INFECTION, V35, P51, DOI 10.1007/s15010-007-6142-8; Kidd SE, 2007, EMERG INFECT DIS, V13, P51, DOI 10.3201/eid1301.060823; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1978, INT J SYST BACTERIOL, V28, P616, DOI 10.1099/00207713-28-4-616; Li WJ, 2012, G3-GENES GENOM GENET, V2, P83, DOI 10.1534/g3.111.001255; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; O'Gorman Celine M., 2011, Fungal Biology Reviews, V25, P151, DOI 10.1016/j.fbr.2011.07.002; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Phadke SS, 2013, EUKARYOT CELL, V12, P1155, DOI 10.1128/EC.00147-13; Powel MS, 2012, J CLIN MICROBIOL, V50, P1125, DOI 10.1128/JCM.05678-11; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; Rhoden SA, 2013, GENET MOL RES, V12, P935, DOI 10.4238/2013.April.2.10; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Shahid M, 2008, GENOME, V51, P272, DOI 10.1139/G08-004; Shinde S M, 2004, Indian Pediatr, V41, P1162; Smith RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088875; Springer D. J., 2009, BIOMENDICAL SCI, P317; Springer DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004285; Springer DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010978; Vieira MLA, 2012, CAN J MICROBIOL, V58, P54, DOI [10.1139/w11-105, 10.1139/W11-105]; Warpeha KM, 2013, APPL ENVIRON MICROB, V79, P2979, DOI 10.1128/AEM.03697-12; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Zachow C, 2009, ISME J, V3, P79, DOI 10.1038/ismej.2008.87	48	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171695	10.1371/journal.pone.0171695	http://dx.doi.org/10.1371/journal.pone.0171695			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212396	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700010
J	Vasta, R; Nicoletti, A; Mostile, G; Dibilio, V; Sciacca, G; Contrafatto, D; Cicero, CE; Raciti, L; Luca, A; Zappia, M				Vasta, Rosario; Nicoletti, Alessandra; Mostile, Giovanni; Dibilio, Valeria; Sciacca, Giorgia; Contrafatto, Donatella; Cicero, Calogero Edoardo; Raciti, Loredana; Luca, Antonina; Zappia, Mario			Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; DIAGNOSTIC-CRITERIA; CONSENSUS STATEMENT	Introduction Acute levodopa challenge may be performed to predict levodopa chronic responsiveness. The aim of the study was to investigate frequency of side effects during the acute levodopa challenge in PD and atypical parkinsonisms. Methods We enrolled 34 de novo PD patients and 29 patients affected by atypical parkinsonisms ( Multiple System Atrophy, MSA, n = 10; Progressive Supranuclear Palsy, PSP, n = 12 and Corticobasal Degeneration, CBD, n = 7) who underwent an acute levodopa challenge. Side effects occurring during test were recorded. Results Side effects were more frequent among atypical parkinsonisms as unique group when compared to PD patients ( 64.3% versus 23.5%; p-value 0.002) with an adjusted OR of 4.36 ( 95% CI 1.40-13.5). Each atypical parkinsonisms showed almost double occurrence of side effects ( MSA 90%, PSP 41.7% and CBD 57%). Conclusions Side effects during acute levodopa challenge may be frequent in atypical parkinsonisms. This information could be useful in order to better prepare the patient for the test. Furthermore, it could represent a useful cue in differential diagnosis with PD.	[Vasta, Rosario; Nicoletti, Alessandra; Mostile, Giovanni; Dibilio, Valeria; Sciacca, Giorgia; Contrafatto, Donatella; Cicero, Calogero Edoardo; Raciti, Loredana; Luca, Antonina; Zappia, Mario] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy	University of Catania	Zappia, M (corresponding author), Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy.	m.zappia@unict.it	Vasta, Rosario/AAB-9040-2019; Luca, Antonina/AAA-6614-2022; Zappia, Mario/AAB-7800-2019; Nicoletti, Alessandra/K-4486-2018; Cicero, Calogero Edoardo CE/K-4055-2018; Luca, Antonina/AAA-6605-2022; Mostile, Giovanni/AAA-9014-2022; Sciacca, Giorgia/AAA-6704-2022	Vasta, Rosario/0000-0002-0393-4736; Luca, Antonina/0000-0002-8397-3478; Nicoletti, Alessandra/0000-0001-6757-340X; Cicero, Calogero Edoardo CE/0000-0002-8647-8851; Luca, Antonina/0000-0002-8397-3478; Mostile, Giovanni/0000-0002-3556-7432; Sciacca, Giorgia/0000-0002-1629-1282				Albanese A, 2001, MOVEMENT DISORD, V16, P197, DOI 10.1002/mds.1069; Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Estevez S, 2009, INT J NEUROSCI, V119, P2257, DOI 10.3109/00207450903139721; Fahn S., 1987, RECENT DEV PARKINSON, P153; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; HUGHES AJ, 1991, NEUROLOGY, V41, P1723, DOI 10.1212/WNL.41.11.1723; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; QUATTRONE A, 1995, ANN NEUROL, V38, P389, DOI 10.1002/ana.410380308; RAJPUT AH, 1991, CAN J NEUROL SCI, V18, P275, DOI 10.1017/S0317167100031814; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; Zappia M, 1997, MOVEMENT DISORD, V12, P103, DOI 10.1002/mds.870120118	13	19	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172145	10.1371/journal.pone.0172145	http://dx.doi.org/10.1371/journal.pone.0172145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207803	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500089
J	Joo, MW; Kang, YK; Yoo, CY; Cha, SH; Chung, YG				Joo, Min Wook; Kang, Yong Koo; Yoo, Chang-Young; Cha, Sung Ho; Chung, Yang-Guk			Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts	PLOS ONE			English	Article							MALIGNANT BONE-TUMORS; RESECTION; SURGERY; SARCOMA; RECONSTRUCTION; TEMPERATURE; REPLACEMENT; ALLOGRAFT; FEMUR	Background Among various reconstruction methods after wide excision for osteosarcoma, pasteurized autograft is often preferred. While the whole area of the tumor can be assessed for chemo-therapy-induced necrosis, one of the important prognostic factors, in other reconstructive techniques, only a portion removed from a wide-resection specimen is available when using pasteurized autograft method. The assessment, therefore, may be unreliable. We analyzed the prognostic significance of the chemotherapy-induced necrosis in osteosarcoma patients who underwent reconstruction with pasteurized autografts. Patients and methods We reviewed the records of osteosarcoma patients who underwent treatment in our institution from 1998 to 2013. Cases of reconstruction with pasteurized autografts were defined as the patient group, and the same number of patients who underwent other reconstruction methods served as controls. Chemotherapy-induced necrosis was evaluated for removed extra-osseous and curetted intramedullary tumor tissues. Results A total of 22 patients were identified; the median age was 15.5 years, and there were 12 males. The most common tumor location was the distal femur. The most common histological subtype was osteoblastic. Median size was 8.1 cm. Disease status was stage IIB in 13 patients and IIA in 9. Median follow-up was 76 months. No differences between the patient and control groups were observed in potential prognostic factors, overall survival, metastasis-free survival, or recurrence-free survival. Univariate analyses demonstrated that histological response was a significant prognostic factor for metastasis-free survival and also significant for recurrence-free survival. Conclusion Chemotherapy-induced necrosis grading, using only available tumor tissues, could be a prognostic factor for osteosarcoma patients receiving pasteurized autografts for reconstructive surgery.	[Joo, Min Wook; Kang, Yong Koo; Cha, Sung Ho] Catholic Univ Korea, St Vincents Hosp, Dept Orthopaed Surg, Coll Med, Seoul, South Korea; [Yoo, Chang-Young] Catholic Univ Korea, St Vincents Hosp, Dept Hosp Pathol, Coll Med, Seoul, South Korea; [Chung, Yang-Guk] Catholic Univ Korea, Seoul St Marys Hosp, Dept Orthopaed Surg, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Chung, YG (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Orthopaed Surg, Coll Med, Seoul, South Korea.	ygchung@catholic.ac.kr	Joo, Min Wook/AAM-6417-2020	Joo, Min Wook/0000-0003-1348-2187; Chung, Yang-Guk/0000-0001-8153-8205				Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Asada N, 1997, ACTA ORTHOP SCAND, V68, P392, DOI 10.3109/17453679708996184; Berner Kjetil, 2015, Sarcoma, V2015, P516843, DOI 10.1155/2015/516843; Bielack SS, 2004, EXPERT OPIN PHARMACO, V5, P1243, DOI 10.1517/14656566.5.6.1243; Bramer JAM, 2009, EJSO-EUR J SURG ONC, V35, P1030, DOI 10.1016/j.ejso.2009.01.011; Chen J, 2014, J CANCER RES CLIN, V140, P1205, DOI 10.1007/s00432-014-1644-0; Chen TH, 2005, J BONE JOINT SURG BR, V87B, P704, DOI 10.1302/0301-620X.87B5.15491; Chen WM, 2002, J BONE JOINT SURG BR, V84B, P1156, DOI 10.1302/0301-620X.84B8.13508; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; DAHLIN DC, 1977, AM J SURG PATHOL, V1, P61, DOI 10.1097/00000478-197701010-00007; Grimer RJ, 2005, LANCET ONCOL, V6, P85, DOI 10.1016/S1470-2045(05)01734-1; Hameed M, 2011, SEMIN DIAGN PATHOL, V28, P86, DOI 10.1053/j.semdp.2011.02.002; INOKUCHI T, 1991, J CRANIO MAXILL SURG, V19, P31, DOI 10.1016/S1010-5182(05)80269-0; ITO T, 1995, CLIN ORTHOP RELAT R, P267; Iwamoto Y, 1997, CLIN ORTHOP RELAT R, P292; Joo MW, 2015, ANN SURG ONCOL, V22, P3557, DOI 10.1245/s10434-015-4414-6; Kawai A, 1998, J BONE JOINT SURG AM, V80A, P636, DOI 10.2106/00004623-199805000-00004; Manabe J, 1993, Nihon Seikeigeka Gakkai Zasshi, V67, P255; Manabe J, 2004, CLIN ORTHOP RELAT R, P258, DOI 10.1097/01.blo.0000122665.47154.8f; Mankin HJ, 1996, CLIN ORTHOP RELAT R, P86; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Miwa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071362; Nakanishi K, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P949; Nishida J, 2008, MED SCI MONITOR, V14, pRA107; Ogura Koichi, 2015, Sarcoma, V2015, P861575, DOI 10.1155/2015/861575; PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; RONG Y, 1995, CLIN ORTHOP RELAT R, P227; ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E; Sugiura H, 2003, ARCH ORTHOP TRAUM SU, V123, P514, DOI 10.1007/s00402-003-0556-2; Sugiura H, 2012, ARCH ORTHOP TRAUM SU, V132, P1685, DOI 10.1007/s00402-012-1606-4; Tsuchiya H, 2004, J ORTHOP SCI, V9, P619, DOI 10.1007/s00776-004-0836-x; Umer M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/698461; Yi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094632; Zhu LM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00230	35	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172155	10.1371/journal.pone.0172155	http://dx.doi.org/10.1371/journal.pone.0172155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196121	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900057
J	Nauwelaerts, S; Hobbs, SJ; Back, W				Nauwelaerts, Sandra; Hobbs, Sarah Jane; Back, Willem			A horse's locomotor signature: COP path determined by the individual limb	PLOS ONE			English	Article							HOOF WALL; THOROUGHBRED RACEHORSE; WARMBLOOD HORSES; PRESSURE PLATE; UNEVEN FEET; ASYMMETRY; MORPHOLOGY; FORELIMB; LENGTH; GAIT	Introduction Ground reaction forces in sound horses with asymmetric hooves show systematic differences in the horizontal braking force and relative timing of break-over. The Center Of Pressure (COP) path quantifies the dynamic load distribution under the hoof in a moving horse. The objective was to test whether anatomical asymmetry, quantified by the difference in dorsal wall angle between the left and right forelimbs, correlates with asymmetry in the COP path between these limbs. In addition, repeatability of the COP path was investigated. Methods A larger group (n = 31) visually sound horses with various degree of dorsal hoof wall asymmetry trotted three times over a pressure mat. COP path was determined in a hoof-bound coordinate system. A relationship between correlations between left and right COP paths and degree of asymmetry was investigated. Results Using a hoof-bound coordinate system made the COP path highly repeatable and unique for each limb. The craniocaudal patterns are usually highly correlated between left and right, but the mediolateral patterns are not. Some patterns were found between COP path and dorsal wall angle but asymmetry in dorsal wall angle did not necessarily result in asymmetry in COP path and the same could be stated for symmetry. Conclusion This method is a highly sensitive method to quantify the net result of the interaction between all of the forces and torques that occur in the limb and its inertial properties. We argue that changes in motor control, muscle force, inertial properties, kinematics and kinetics can potentially be picked up at an early stage using this method and could therefore be used as an early detection method for changes in the musculoskeletal apparatus.	[Nauwelaerts, Sandra] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Nauwelaerts, Sandra] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Hobbs, Sarah Jane] Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston, Lancs, England; [Back, Willem] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Back, Willem] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesiol Domest Anim, Merelbeke, Belgium	University of Antwerp; University of Central Lancashire; Utrecht University; Ghent University	Nauwelaerts, S (corresponding author), Univ Antwerp, Dept Biol, Antwerp, Belgium.; Nauwelaerts, S (corresponding author), Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium.	sandra.nauwelaerts@uantwerpen.be		Hobbs, Sarah Jane/0000-0002-1552-8647	Qualisys grant; FWO-Flanders grant; IOF grant [IOF SBO ID 34424]	Qualisys grant; FWO-Flanders grant; IOF grant	This work was supported by a Qualisys grant to SJH, an FWO-Flanders grant to Sandra Nauwelaerts and an IOF grant (IOF SBO ID 34424).; We would like to thank the owners of the patients for their informed consent, Wouter Kuijsten (Kistler), Jempi Wilssens (RsScan) and Maarten Oosterlinck (U Gent) for their technical assistance, and also Qualisys (Sweden) for their kind financial support. This study was supported by an FWO-Flanders grant to Sandra Nauwelaerts and an IOF grant (IOF SBO ID 34424).	Bellenzani MCR, 2012, AM J VET RES, V73, P1735, DOI 10.2460/ajvr.73.11.1735; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Clayton HM, 2011, AUST VET J, V89, P305, DOI 10.1111/j.1751-0813.2011.00806.x; DALIN G, 1985, EQUINE VET J, V17, P292, DOI 10.1111/j.2042-3306.1985.tb02501.x; De Cock A, 2008, GAIT POSTURE, V27, P669, DOI 10.1016/j.gaitpost.2007.08.013; Dyson S, 2016, J EQUINE VET SCI, V38, P1, DOI 10.1016/j.jevs.2015.12.012; Faramarzi B, 2009, AM J VET RES, V70, P1354, DOI 10.2460/ajvr.70.11.1354; Han TR, 1999, GAIT POSTURE, V10, P248, DOI 10.1016/S0966-6362(99)00040-5; Hertsch B, 1996, HOOF PROTECT IT NAIL; Ishihara A, 2009, JAVMA-J AM VET MED A, V234, P644, DOI 10.2460/javma.234.5.644; Kaufman KR, 1996, J PEDIATR ORTHOPED, V16, P144, DOI 10.1097/01241398-199603000-00002; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kroekenstoel AM, 2006, EQUINE VET J, V38, P652, DOI 10.2746/042516406X159089; Kummer M, 2006, VET J, V172, P58, DOI 10.1016/j.tvjl.2005.03.008; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Maupas E, 1999, CLIN BIOMECH, V14, P403, DOI 10.1016/S0268-0033(99)00005-4; Moleman M, 2005, EQUINE VET EDUC, V17, P319, DOI 10.1111/j.2042-3292.2005.tb00401.x; Oosterlinck M, 2013, VET J, V198, pE9, DOI 10.1016/j.tvjl.2013.09.026; Oosterlinck M, 2011, VET J, V190, P71, DOI 10.1016/j.tvjl.2010.08.016; Oosterlinck M, 2010, VET J, V183, P305, DOI 10.1016/j.tvjl.2008.12.012; Parks A.H., 2003, DIAGNOSIS MANAGEMENT, P250; Pearce GP, 2005, AUST VET J, V83, P367, DOI 10.1111/j.1751-0813.2005.tb15636.x; Ross M.W., 2011, DIAGNOSIS MANAGEMENT, V2nd edition, P426, DOI DOI 10.1016/B978-1-4160-6069-7.00002-X; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Seminati E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074134; Stashak TS, 2002, ADAMS LAMENESS HORSE, V6th, P1081; THOMASON JJ, 1992, J EXP BIOL, V166, P145; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; Van Heel MCV, 2006, EQUINE VET J, V38, P258, DOI 10.2746/042516406776866471; Van Heel MCV, 2004, EQUINE VET J, V36, P778, DOI 10.2746/0425164044847993; van Heel MCV, 2005, EQUINE VET J EQUINE, V37, P536; Watson KM, 2003, EQUINE VET J, V35, P712, DOI 10.2746/042516403775696348; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; White JM, 2008, EQUINE VET J, V40, P623, DOI 10.2746/042516408X313625; White SC, 2004, CLIN ORTHOP RELAT R, P287, DOI 10.1097/01.blo.0000119460.33630.6d; Wiggers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114836; Wilson AM, 2001, EQUINE VET J, V33, P159, DOI 10.1111/j.2042-3306.2001.tb00594.x; Wilson GH, 2009, EQUINE VET J, V41, P238, DOI 10.2746/042516409X395561	38	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0167477	10.1371/journal.pone.0167477	http://dx.doi.org/10.1371/journal.pone.0167477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196073	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000394423900002
J	Zhu, CK; Pan, ZJ; Wang, H; Chang, GL; Wu, N; Ding, HY				Zhu, Chuankun; Pan, Zhengjun; Wang, Hui; Chang, Guoliang; Wu, Nan; Ding, Huaiyu			De novo assembly, characterization and annotation for the transcriptome of Sarcocheilichthys sinensis	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMPLETE MITOCHONDRIAL GENOME; IMMUNE-RELATED GENES; PROVIDES INSIGHTS; CYPRINIFORMES CYPRINIDAE; POSITIVE SELECTION; PROFILING ANALYSIS; ASIAN CYPRINIDAE; ANALYSIS REVEALS; DUPLICATION	The Chinese lake gudgeon Sarcocheilichthys sinensis is a small cyprinid fish with great aquaculture potential both for its edible and ornamental values. Nevertheless, available genomic and transcriptomic information for this fish is extremely deficient. In this study, a normalized cDNA library was constructed using 13 mixed tissues of an adult male S. sinensis, and was sequenced by the Illumina HiSeq2500 platform. De novo assembly was performed using 38,911,511 obtained clean reads, and a total of 147,282 unigenes with an average length of 900 bp were finally achieved. 96.2% of these unigenes were annotated in 9 public databases, and 16 segments of growth-related genes were identified for future studies. In addition, 28,493 unigenes were assigned to 61 subcategories of Gene Ontology ( GO), and 10,483 unigenes were assigned to 25 categories of Cluster of Orthologous Group ( COG). Moreover, 14,943 unigenes were classified into 225 pathways of the Kyoto Encyclopedia of Genes and Genomes ( KEGG) database. A total of 30,666 microsatellites were detected from 17,627 unigenes with an average distribution density of 1: 2405 bp. This transcriptome data set will be valuable for researches on discovery, expression and evolution on genes of interest. Meanwhile, the identified microsatellites would be useful tools for genetic and genomic studies in S. sinensis.	[Zhu, Chuankun; Pan, Zhengjun; Wang, Hui; Chang, Guoliang; Wu, Nan; Ding, Huaiyu] Huaiyin Normal Univ, Jiangsu Engn Lab Breeding Special Aquat Organisms, Huaian, Peoples R China; [Zhu, Chuankun; Pan, Zhengjun; Wang, Hui; Chang, Guoliang; Wu, Nan; Ding, Huaiyu] Huaiyin Normal Univ, Jiangsu Collaborat Innovat Ctr Reg Modern Agr & E, Huaian, Peoples R China	Huaiyin Normal University; Huaiyin Normal University	Zhu, CK (corresponding author), Huaiyin Normal Univ, Jiangsu Engn Lab Breeding Special Aquat Organisms, Huaian, Peoples R China.; Zhu, CK (corresponding author), Huaiyin Normal Univ, Jiangsu Collaborat Innovat Ctr Reg Modern Agr & E, Huaian, Peoples R China.	zhuchuankun@hytc.edu.cn	Zhu, Chuankun/AFE-0407-2022		University Natural Science Foundation of Jiangsu Province [15KJB240001]; Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection [HSXT307]; Huaiyin Normal University [31ZCK00]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	University Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection; Huaiyin Normal University; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	This study was supported by University Natural Science Foundation of Jiangsu Province (15KJB240001), funds from Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection (HSXT307), the Startup Funds of Scientific Research from Huaiyin Normal University (31ZCK00) and the Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP) .The funders harole in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Chen JJ, 2015, THERIOGENOLOGY, V83, P1416, DOI 10.1016/j.theriogenology.2015.01.001; Chen XM, 2016, GENE, V576, P537, DOI 10.1016/j.gene.2015.11.001; Cheng F, 2013, ICHTHYOL RES, V60, P165, DOI 10.1007/s10228-012-0329-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09836; He SP, 2004, SCI CHINA SER C, V47, P130, DOI 10.1360/03yc0034; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117642; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Li CJ, 2015, GENE, V557, P201, DOI 10.1016/j.gene.2014.12.034; Li C, 2016, MITOCHONDRIAL DNA A, V27, P1056, DOI 10.3109/19401736.2014.928865; Li GX, 2015, FISH SHELLFISH IMMUN, V44, P420, DOI 10.1016/j.fsi.2015.03.014; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Malachowicz M, 2015, MAR GENOM, V23, P37, DOI 10.1016/j.margen.2015.04.005; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Tran NT, 2015, FISH SHELLFISH IMMUN, V45, P72, DOI 10.1016/j.fsi.2015.01.034; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Ren L, 2014, GENE, V552, P265, DOI 10.1016/j.gene.2014.09.053; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Shi Z., 2015, JIANGZI FISHERY SCI, V2, P21; Song TX, 1994, ZOOLOGICAL RES, V15, P96; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wan QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12946; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang XZ, 2012, SCI CHINA LIFE SCI, V55, P761, DOI 10.1007/s11427-012-4366-z; Wang Y, 2015, GENE, V565, P211, DOI 10.1016/j.gene.2015.04.023; Wang ZJ, 2016, COMP BIOCHEM PHYS D, V19, P120, DOI 10.1016/j.cbd.2016.05.003; Werner GDA, 2013, MAR BIOTECHNOL, V15, P230, DOI 10.1007/s10126-012-9481-0; XiangHui K, 2007, SCI CHINA SER C, V50, P780, DOI 10.1007/s11427-007-0076-3; Xiao J, 2015, FISH SHELLFISH IMMUN, V44, P60, DOI 10.1016/j.fsi.2015.01.022; Xuan Y, 2010, J AQUACULTURE, V11, P35; Yang SB, 2014, MITOCHONDR DNA, V25, P286, DOI 10.3109/19401736.2013.796461; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhao Z., 2015, SCI AQUACULTURE, V10, P68; Zhou ZH, 2015, MITOCHONDR DNA, V26, P141, DOI 10.3109/19401736.2013.815176; Zhu JJ, 2011, CONSERV GENET RESOUR, V3, P239, DOI 10.1007/s12686-010-9331-1; Zhu R, 2016, FISH SHELLFISH IMMUN, V55, P699, DOI 10.1016/j.fsi.2016.06.051; Zou M, 2014, GENE, V547, P267, DOI 10.1016/j.gene.2014.06.056	46	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171966	10.1371/journal.pone.0171966	http://dx.doi.org/10.1371/journal.pone.0171966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196101	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423900038
J	Browne, SH; Diaz-Perez, JA; Preziosi, M; King, CC; Jones, GA; Jain, S; Sun, XY; Reid, EG; VandenBerg, S; Wang, HY				Browne, Sara H.; Diaz-Perez, Julio A.; Preziosi, Michael; King, Charles C.; Jones, George A.; Jain, Sonia; Sun, Xiaoying; Reid, Erin G.; VandenBerg, Scott; Wang, Huan-You			mTOR activity in AIDS-related diffuse large B-cell lymphoma	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; ANTIRETROVIRAL THERAPY; TISSUE MICROARRAY; MAMMALIAN TARGET; RAPAMYCIN; EXPRESSION; INHIBITORS; AUTOCRINE; MALIGNANCIES; ACTIVATION	Background Patients infected with HIV have a significantly increased risk of developing non-Hodgkin lymphomas despite the widespread use of HAART. To investigate mTOR pathway activity in acquired immunodeficiency syndrome (AIDS) related diffuse large B-cell lymphoma AR-DLBCL, we used immunohistochemistry to examine the presence of the phosphorylated 70 ribosomal S6 protein-kinase (p70S6K), an extensively studied effector of mTOR Complex 1 (mTORC1) and the phosphorylated phosphatase and tensin homolog (pPTEN), a negative regulator of mTORC1 pathway. Materials and methods We evaluated tissue samples from 126 patients with AR-DLBCL. Among them, 98 samples were from tissue microarrays (TMAs) supplied by the Aids and Cancer Specimen Resource (ACSR), the remaining 28 samples were from cases diagnosed and treated at the University of California, San Diego (UCSD). The presence of p70S6K was evaluated with two antibodies directed against the combined epitopes Ser235/236 and Ser240/244, respectively; and additional monoclonal anti-bodies were used to identify pPTEN and phosphorylated proline-rich Akt substrate of 40kDa (pPRAS40). The degree of intensity and percentage of cells positive for p70S6K and pPTEN were assessed in all the samples. In addition, a subgroup of 28 patients from UCSD was studied to assess the presence of pPRAS40, an insulin-regulated activator of the mTORC1. The expression of each of these markers was correlated with clinical and histopathologic features. Results The majority of the patients evaluated were males (88%); only two cases (1.6%) were older than 65 years of age. We found high levels of both p70S6K-paired epitopes studied, 48% positivity against Ser235/236 (44% in ACSR and 64% in UCSD group), and 86% positivity against Ser240/244 (82% in ACSR and 100% in UCSD group). We observed more positive cells and stronger intensity with epitope Ser 240/244 in comparison to Ser 235/236 (p < 0.0001). The degree of intensity and percentage of cells positive for pPTEN was positively correlated with p70S6K levels (p = 0.016 for 235/236 and p = 0.007 for 240/244). High levels of pPRAS40 were observed in the majority of the cases evaluated (64.3%), but no correlation was found with either pPTEN (p = 0.9) or p70S6K (p = 0.9) levels. Conclusion AR-DLBCL frequently contain p70S6K, a main downstream effector of the mTOR pathway. The presence of p70S6K is positively correlated with pPTEN, an inactive form of PTEN, which makes mTORC1 activated. The presence of p70S6K was independent of HIV viral load or CD4 (+) counts. These results suggest that the mTOR pathway is active in the majority of AR-DLBCL, and p70S6K, particularly the Ser240/244 epitope immunohistochemistry is an excellent surrogate biomarker, which could be used to identify cases expected to be responsive to mTOR inhibitors.	[Browne, Sara H.; Diaz-Perez, Julio A.; Preziosi, Michael] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [King, Charles C.; Jones, George A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Dept Family Med & Publ Hlth, Biostat Res Ctr, La Jolla, CA 92093 USA; [Reid, Erin G.] Univ Calif San Diego, Dept Med, Div Hematol, La Jolla, CA 92093 USA; [VandenBerg, Scott; Wang, Huan-You] Univ Calif San Diego, Dept Pathol, Div Clin Pathol, La Jolla, CA 92093 USA; [VandenBerg, Scott] Univ Calif San Diego, Human Tissue Technol Core, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Browne, SH (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.; Wang, HY (corresponding author), Univ Calif San Diego, Dept Pathol, Div Clin Pathol, La Jolla, CA 92093 USA.	shbrowne@ucsd.edu; hywang2@ucsd.edu	Diaz-Perez, Julio A/L-4057-2013; Diaz-Perez, Julio A./G-7377-2017	Diaz-Perez, Julio A/0000-0001-8166-7314; Diaz-Perez, Julio A./0000-0001-8166-7314; Browne, Sara/0000-0003-0360-3301	UC San Diego Center for AIDS Research; Moores Cancer Center [100893]; World Pathology Foundation	UC San Diego Center for AIDS Research; Moores Cancer Center; World Pathology Foundation	This work is supported by the UC San Diego Center for AIDS Research (http://cfar.ucsd.edu) and Moores Cancer Center Grant No. #100893, which received an NIH supplement to support collaborative studies in HIV-associated malignancies (SH Browne, HY Wang, EG Reid and S VandenBerg), and in part by the World Pathology Foundation.	Barta SK, 2013, BLOOD, V122, P3251, DOI 10.1182/blood-2013-04-498964; Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082; Cesarman E, 2012, HEMATOLOGY, V17, pS83, DOI 10.1179/102453312X13336169155899; Chadburn A, 2009, J CLIN ONCOL, V27, P5039, DOI 10.1200/JCO.2008.20.5450; Chao C, 2012, CLIN CANCER RES, V18, P4702, DOI 10.1158/1078-0432.CCR-11-3169; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; El-Salem M, 2009, AM J PATHOL, V175, P817, DOI 10.2353/ajpath.2009.080451; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hong JY, 2014, ANN ONCOL, V25, P182, DOI 10.1093/annonc/mdt530; Johnston PB, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-45; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Matthews GV, 2000, BLOOD, V96, P2730; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Roy D, 2013, CANCER RES, V73, P2235, DOI 10.1158/0008-5472.CAN-12-1851; Roy D, 2011, AM J PATHOL, V179, P2108, DOI 10.1016/j.ajpath.2011.06.017; Sebestyen A, 2012, MODERN PATHOL, V25, P1623, DOI 10.1038/modpathol.2012.141; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Smith SM, 2012, BEST PRACT RES CL HA, V25, P175, DOI 10.1016/j.beha.2012.04.008; Teachey DT, 2009, BRIT J HAEMATOL, V145, P569, DOI 10.1111/j.1365-2141.2009.07657.x; Vajpayee N, 2012, LEUKEMIA RES, V36, P1403, DOI 10.1016/j.leukres.2012.07.016; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008; Younes A, 2011, ONCOLOGIST, V16, P730, DOI 10.1634/theoncologist.2010-0318; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zhao MY, 2009, CLIN CANCER RES, V15, P1708, DOI 10.1158/1078-0432.CCR-08-1543	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170771	10.1371/journal.pone.0170771	http://dx.doi.org/10.1371/journal.pone.0170771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192480	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800011
J	Wu, SC; Bergey, EA				Wu, Shelly C.; Bergey, Elizabeth A.			Diatoms on the carapace of common snapping turtles: Luticola spp. dominate despite spatial variation in assemblages	PLOS ONE			English	Article							ALGAL GENUS BASICLADIA; FRESH-WATER TURTLES; CLADOPHORALES; CHLOROPHYTA; BASIN; RIVER	Filamentous algae are often visible on the carapaces of freshwater turtles and these algae are dominated by a few species with varying geographic distributions. Compared to filamentous algae, little is known about the much more speciose microalgae on turtles. Our objectives were to compare the diatom flora on a single turtle species (the common snapping turtle, Chelydra serpentina) across part of its range to examine spatial patterns and determine whether specific diatom taxa were consistently associated with turtles (as occurs in the filamentous alga Basicladia spp.). Using preserved turtle specimens from museums, we systematically sampled diatoms on the carapaces of 25 snapping turtles across five states. The diverse diatom assemblages formed two groups-the southern Oklahoma group and the northern Illinois/ Wisconsin/New York group, with Arkansas not differing from either group. Of the six diatom species found in all five states, four species are widespread, whereas Luticola cf. goeppertiana and L. cf. mutica are undescribed species, known only from turtles in our study. L. cf. goeppertiana comprised 83% of the diatom abundance on Oklahoma turtles and was relatively more abundant on southern turtles (Oklahoma and Arkansas) than on northern turtles (where mean abundance/state was > 10%). L. cf. mutica was the most abundant species (40%) on New York turtles. Some Luticola species are apparently turtle associates and results support a pattern of spatial variation in Luticola species, similar to that in Basicladia. Using museum specimens is an efficient and effective method to study the distribution of micro-epibionts.	[Wu, Shelly C.; Bergey, Elizabeth A.] Oklahoma Biol Survey, Norman, OK 73019 USA; [Wu, Shelly C.; Bergey, Elizabeth A.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Wu, Shelly C.] Texas Christian Univ, Andrews Inst, Ft Worth, TX 76129 USA	University of Oklahoma System; University of Oklahoma - Norman; Texas Christian University	Wu, SC (corresponding author), Oklahoma Biol Survey, Norman, OK 73019 USA.; Wu, SC (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.; Wu, SC (corresponding author), Texas Christian Univ, Andrews Inst, Ft Worth, TX 76129 USA.	shelly.wu@tcu.edu			National Science Collections Alliance	National Science Collections Alliance	The Collections-Web Award from the National Science Collections Alliance was granted to the corresponding author (SW). The University of Oklahoma Department of Biology and the Oklahoma Biological Survey provided travel support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DIATOMS APPL ENV EAR; BELUSZ LC, 1969, AM MIDL NAT, V81, P598, DOI 10.2307/2423999; Boedeker C, 2012, J PHYCOL, V48, P808, DOI 10.1111/j.1529-8817.2012.01145.x; BOYER DR, 1965, ECOLOGY, V46, P99, DOI 10.2307/1935262; Bury R. Bruce, 2015, Northwestern Naturalist, V96, P150; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colt LC, 1995, CAN FIELD NAT, V109, P454; EDGREN RA, 1953, ECOLOGY, V34, P733, DOI 10.2307/1931336; ERNST CH, 1978, ESTUARIES, V1, P54, DOI 10.2307/1351650; Ernst CH, 2009, TURTLES US CANADA; Ersanli ET, 2014, BANGL J BOT, V43, P157; Garbary DJ, 2007, J FRESHWATER ECOL, V22, P677, DOI 10.1080/02705060.2007.9664828; GOLLADAY SW, 1991, FRESHWATER BIOL, V25, P437, DOI 10.1111/j.1365-2427.1991.tb01387.x; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; HULSE A C, 1976, Journal of Herpetology, V10, P45, DOI 10.2307/1562927; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kramer K., 1986, SUSSWASSERFLORA MITT; LIPSEY LL, 1978, RHODORA, V80, P441; Lowe RL, 2007, SOUTHEAST NAT, V6, P135, DOI 10.1656/1528-7092(2007)6[135:DBADOW]2.0.CO;2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; NEILL WT, 1954, ECOLOGY, V35, P581, DOI 10.2307/1931051; NORMANDIN ROBERT F., 1959, OHIO JOUR SCI, V59, P58; OBBARD ME, 1981, COPEIA, P630; Pavlov A, 2016, DIATOM RES, V31, P85, DOI 10.1080/0269249X.2016.1157376; Peres CK, 2012, CRYPTOGAMIE ALGOL, V33, P329, DOI 10.7872/crya.v33.iss4.2012.329; PLOTKIN PT, 1995, MAR BIOL, V122, P137, DOI 10.1007/BF00349287; PROCTOR VW, 1958, ECOLOGY, V39, P634, DOI 10.2307/1931604; Robinson NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157011; Round F. E., 1990, DIATOMS BIOL MORPHOL; Skinner S, 2008, TELOPEA, V12, P279, DOI 10.7751/telopea20085817; Smith P. W., 1961, Bulletin of the Illinois Natural History Survey, V28, P1; Souffreau C, 2010, PHYCOLOGIA, V49, P309, DOI 10.2216/09-30.1; Soylu EN, 2006, J FRESHWATER ECOL, V21, P535, DOI 10.1080/02705060.2006.9665033; Spaulding S, 2008, LUTICOLA; Spaulding S. A., 2010, DIATOMS US; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Tumlison R., 1996, P ARKANSAS ACAD SCI, V50, P148; Van De Vijver B, 2008, PHYCOLOGIA, V47, P451, DOI 10.2216/07-67.1; Wetzel CE, 2010, VIE MILIEU, V60, P177; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Williner V, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0071-x; Yoneda Y., 1952, Publications of the Seto Marine Biological Laboratory, V2, P227; Zanelli H. R. R., 2009, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V12, P91; Ziglar CL, 2005, J FRESHWATER ECOL, V20, P389, DOI 10.1080/02705060.2005.9664979	44	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171910	10.1371/journal.pone.0171910	http://dx.doi.org/10.1371/journal.pone.0171910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192469	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800050
J	Qian, Q; Liu, QJ; Zhou, DM; Pan, HY; Liu, ZW; He, FP; Ji, SY; Wang, DP; Bao, WX; Liu, XY; Liu, ZL; Zhang, H; Zhang, XQ; Zhang, L; Wang, MK; Xu, Y; Huang, FD; Luo, BY; Sun, BG				Qian, Qi; Liu, Qiuji; Zhou, Dongming; Pan, Hongyu; Liu, Zhiwei; He, Fangping; Ji, Suying; Wang, Dongpi; Bao, Wangxiao; Liu, Xinyi; Liu, Zhaoling; Zhang, Heng; Zhang, Xiaoqin; Zhang, Ling; Wang, Mingkai; Xu, Ying; Huang, Fude; Luo, Benyan; Sun, Binggui			Brain-specific ablation of Efr3a promotes adult hippocampal neurogenesis via the brain-derived neurotrophic factor pathway	FASEB JOURNAL			English	Article						Efr3; BDNF; dentate gyrus; development; mouse	FORKHEAD TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; DROSOPHILA-MELANOGASTER; SIGNAL-TRANSDUCTION; ROLLING BLACKOUT; CELL-SURVIVAL; PROTEIN; KINASE; AKT; PHOSPHORYLATION	Efr3 is a newly identified plasma membrane protein and plays an important role in the phosphoinositide metabolism on the plasma membrane. However, although it is highly expressed in the brain, the functional significance of Efr3 in the brain is not clear. In the present study, we generated Efr3a(f/f) mice and then crossed them with Nestin-Cre mice to delete Efr3a, one of the Efr3 isoforms, specifically in the brain. We found that brain-specific ablation of Efr3a promoted adult hippocampal neurogenesis by increasing survival and maturation of newborn neurons without affecting their dendritic tree morphology. Moreover, the brain-derived neurotrophic factor (BDNF)-tropomyosin-related kinase B (TrkB) signaling pathway was significantly enhanced in the hippocampus of Efr3a-deficient mice, as reflected by increased expression of BDNF, TrkB, and the downstream molecules, including phospho-MAPK and phospho-Akt. Furthermore, the number of TUNEL+ cells was decreased in the subgranular zone of dentate gyrus in Efr3a-deficient mice compared with that of control mice. Our data suggest that brain-specific deletion of Efr3a could promote adult hippocampal neurogenesis, presumably by upregulating the expression of BDNF and its receptor, TrkB, and therefore provide new insight into the roles of Efr3 in the brain.Qian, Q., Liu, Q., Zhou, D., Pan, H., Liu, Z., He, F., Ji, S., Wang, D., Bao, W., Liu, X., Liu, Z., Zhang, H., Zhang, X., Zhang, L., Wang, M., Xu, Y., Huang, F., Luo, B., Sun B. Brain-specific ablation of Efr3a promotes adult hippocampal neurogenesis via the brain-derived neurotrophic factor pathway.	[Qian, Qi; He, Fangping; Luo, Benyan; Sun, Binggui] Minist Hlth China, Dept Neurobiol, Key Lab Med Neurobiol, Beijing, Peoples R China; [Ji, Suying; Bao, Wangxiao; Zhang, Xiaoqin; Xu, Ying] Key Lab Neurobiol Zhejiang Prov, Beijing, Peoples R China; [Liu, Qiuji; Zhou, Dongming; Pan, Hongyu; Bao, Wangxiao; Zhang, Xiaoqin; Xu, Ying; Luo, Benyan] Zhejiang Univ, First Affiliated Hosp, Dept Neurol, Collaborat Innovat Ctr Brain Sci,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Dongpi; Huang, Fude] Univ Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai, Peoples R China; [Wang, Dongpi; Zhang, Ling; Luo, Benyan] Nanjing Univ, Model Anim Res Ctr, Minist Educ MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University	Luo, BY; Sun, BG (corresponding author), Minist Hlth China, Dept Neurobiol, Key Lab Med Neurobiol, Beijing, Peoples R China.	luobenyan@zju.edu.cn; bsun@zju.edu.cn	liu, xinyi/GWZ-8739-2022; Xu, Ying/AAF-3081-2019; Xu, Ying/A-3009-2013; Sun, Binggui/J-9028-2016	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; Sun, Binggui/0000-0002-0386-6569	Major State Basic Research Program of China [2014CB964602]; National Natural Science Foundation of China [91132713, 81371400, 81471284]; Zhejiang Province Natural Science Foundation of China [LR13H090001]; Research Fund for the Doctoral Program of Higher Education of China [20110101120094]; Zhejiang Province Medical Science and Technology Project [2016152769]	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Zhejiang Province Medical Science and Technology Project	The authors thank Dr. Fred Gage (Salk Institute, La Jolla, CA, USA) for the MoMLV-based vector; Dr. Jianwei Jiao (Institute of Zoology, Chinese Academy of Sciences, Beijing, China) for the Nestin-cre mice; and Drs. Yudong Zhou and Xiaodong Wang (Zhejiang University School of Medicine) for some of the reagents. This work was supported by Grant 2014CB964602 from the Major State Basic Research Program of China, Grants 91132713, 81371400, and 81471284 from the National Natural Science Foundation of China, Grant LR13H090001 from the Zhejiang Province Natural Science Foundation of China, Grant 20110101120094 from the Research Fund for the Doctoral Program of Higher Education of China, and Grant 2016152769 from the Zhejiang Province Medical Science and Technology Project. The authors declare no conflicts of interest.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Aimone JB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018960; Apple DM, 2017, BRAIN RES, V1655, P270, DOI 10.1016/j.brainres.2016.01.023; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Baskin JM, 2016, NAT CELL BIOL, V18, P132, DOI 10.1038/ncb3271; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bojjireddy N, 2015, J CELL SCI, V128, P118, DOI 10.1242/jcs.157495; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; CHANDRASHEKARAN S, 1993, GENETICA, V90, P61, DOI 10.1007/BF01435179; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Faulkner DL, 1998, DEV GENET, V23, P264, DOI 10.1002/(SICI)1520-6408(1998)23:4<264::AID-DVG2>3.0.CO;2-6; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Gupta AR, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-31; Huang FD, 2006, J NEUROSCI, V26, P2369, DOI 10.1523/JNEUROSCI.3770-05.2006; Huang FD, 2004, NAT NEUROSCI, V7, P1070, DOI 10.1038/nn1313; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Middleton G, 2001, DEVELOPMENT, V128, P4715; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MIYASHITA T, 1995, CELL, V80, P293; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SHYNGLE J, 1985, INDIAN J EXP BIOL, V23, P235; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WH, 2002, J NEUROCHEM, V80, P1049, DOI 10.1046/j.0022-3042.2002.00783.x	43	5	5	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2104	2113		10.1096/fj.201601207R	http://dx.doi.org/10.1096/fj.201601207R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28193719				2022-12-26	WOS:000399195500029
J	Rujas, E; Caaveiro, JMM; Insausti, S; Garca-Porras, M; Tsumoto, K; Nieva, JL				Rujas, Edurne; Caaveiro, Jose M. M.; Insausti, Sara; Garca-Porras, Miguel; Tsumoto, Kouhei; Nieva, Jose L.			Peripheral Membrane Interactions Boost the Engagement by an Anti-HIV-1 Broadly Neutralizing Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL EXTERNAL REGION; HIV-1 GP41; MONOCLONAL-ANTIBODIES; TRANSMEMBRANE DOMAIN; EPITOPE RECOGNITION; AROMATIC RESIDUES; PERFRINGOLYSIN-O; ANTI-GP41 2F5; 4E10; BINDING	The 4E10 antibody displays an extreme breadth of HIV-1 neutralization and therefore constitutes a suitable model system for structure-guided vaccine design and immunotherapeutics against AIDS. In this regard, the relevance of autoreactivity with membrane lipids for the biological function of this antibody is still a subject of controversy. To address this dispute, herein we have compared the membrane partitioning ability of the 4E10 antibody and several of its variants, which were mutated at the region of the paratope surface in contact with the membrane interface. We first employed a physical separation approach (vesicle flotation) and subsequently carried out quantitative fluorescence measurements in an intact system (spectroscopic titration), using 4E10 Fab labeled with a polarity-sensitive fluorescent probe. Moreover, recognition of epitope peptide in membrane was demonstrated by photo-cross-linking assays using a Fab that incorporated the genetically encoded unnatural amino acid p-benzoylphenylalanine. The experimental data ruled out that the proposed stereospecific recognition of viral lipids was necessary for the function of the antibody. In contrast, our data suggest that nonspecific electrostatic interactions between basic residues of 4E10 and acidic phospholipids in the membranes contribute to the observed biological function. Moreover, the energetics of membrane partitioning indicated that 4E10 behaves as a peripheral membrane protein, tightening the binding to the ligand epitope inserted in the viral membrane. The implications of these findings for the natural production and biological function of this antibody are discussed.	[Rujas, Edurne; Insausti, Sara; Garca-Porras, Miguel; Nieva, Jose L.] Univ Basque Country, UPV EHU, Biofisika Inst, Consejo Super Invest Cientif, Bilbao 48080, Spain; [Rujas, Edurne; Insausti, Sara; Garca-Porras, Miguel; Nieva, Jose L.] Univ Basque Country, UPV EHU, Dept Biochem & Mol Biol, POB 644, Bilbao 48080, Spain; [Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Phar maceut Sci, Lab Global Healthcare, Fukuoka 8128582, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Tokyo; Kyushu University	Nieva, JL (corresponding author), Univ Basque Country, UPV EHU, Dept Biochem & Mol Biol, POB 644, Bilbao 48080, Spain.; Tsumoto, K (corresponding author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.	tsumoto@k.u-tokyo.ac.jp; gbpniesj@lg.ehu.es	Nieva, Jose L/Q-2063-2019; Rujas, Edurne/P-1969-2018; Caaveiro, Jose/J-2790-2013; Rujas, Edurne/AGV-1475-2022; Rujas, Edurne/GXG-7368-2022	Nieva, Jose L/0000-0001-6446-5649; Caaveiro, Jose/0000-0001-5568-2369; Insausti, Sara/0000-0003-0871-1344; Rujas, Edurne/0000-0002-4465-5071	National Institutes of Health; Basque Government [AI097051, IT838-13]; Japanese Society for the Promotion of Science (JSPS) KAKENHI-A [25249115, 16H02420]; Platform for Drug Discovery, Informatics and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI-C [15K06962]; Basque Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basque Government(Basque Government); Japanese Society for the Promotion of Science (JSPS) KAKENHI-A; Platform for Drug Discovery, Informatics and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI-C(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Basque Government(Basque Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health and Basque Government Grants AI097051 and IT838-13 (to J. L. N.). Work in the Tsumoto laboratory was supported by Japanese Society for the Promotion of Science (JSPS) KAKENHI-A Grants 25249115 and 16H02420 (to K. T.), by the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by JSPS KAKENHI-C Grant 15K06962 (to J. M. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a predoctoral fellowship from the Basque Government.	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alving CR, 2008, AIDS, V22, P649, DOI 10.1097/QAD.0b013e3282f51922; Apellaniz B, 2015, J BIOL CHEM, V290, P12999, DOI 10.1074/jbc.M115.644351; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Arbuzova A, 1997, J BIOL CHEM, V272, P27167, DOI 10.1074/jbc.272.43.27167; Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Finton KAK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003639; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Huarte N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34190; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; Jacob RA, 2015, J VIROL, V89, P5264, DOI 10.1128/JVI.00129-15; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Kim AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004271; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwon YD, 2016, J VIROL, V90, P5899, DOI 10.1128/JVI.03246-15; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P205; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Rujas E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38177; Rujas E, 2016, J VIROL, V90, P3276, DOI 10.1128/JVI.02970-15; Rujas E, 2015, J VIROL, V89, P11975, DOI 10.1128/JVI.01793-15; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sanchez-Martinez S, 2006, FEBS LETT, V580, P2395, DOI 10.1016/j.febslet.2006.03.067; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Serrano S, 2014, J BIOL CHEM, V289, P6565, DOI 10.1074/jbc.M113.527747; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Verkoczy L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004073; White SH, 1998, METHOD ENZYMOL, V295, P62; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	59	7	7	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5571	5583		10.1074/jbc.M117.775429	http://dx.doi.org/10.1074/jbc.M117.775429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213514	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000397875500035
J	Barasch, N; Gong, X; Kwei, KA; Varma, S; Biscocho, J; Qu, KB; Xiao, N; Lipsick, JS; Pelham, RJ; West, RB; Pollack, JR				Barasch, Nicholas; Gong, Xue; Kwei, Kevin A.; Varma, Sushama; Biscocho, Jewison; Qu, Kunbin; Xiao, Nan; Lipsick, Joseph S.; Pelham, Robert J.; West, Robert B.; Pollack, Jonathan R.			Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma	PLOS ONE			English	Article							HUMAN CANCER; FUSION TRANSCRIPTS; CRYSTAL-STRUCTURE; BREAST-CANCER; SANT DOMAIN; EXPRESSION; IDENTIFICATION; TRANSLOCATION; MUTATIONS; RECEPTOR	Pathogenic gene fusions have been identified in several histologic types of salivary gland neoplasia, but not previously in acinic cell carcinoma ( AcCC). To discover novel gene fusions, we performed whole-transcriptome sequencing surveys of three AcCC archival cases. In one specimen we identified a novel HTN3-MSANTD3 gene fusion, and in another a novel PRB3-ZNF217 gene fusion. The structure of both fusions was consistent with the promoter of the 5' partner ( HTN3 or PRB3), both highly expressed salivary gland genes, driving overexpression of full-length MSANTD3 or ZNF217. By fluorescence in situ hybridization of an expanded AcCC case series, we observed MSANTD3 rearrangements altogether in 3 of 20 evaluable cases ( 15%), but found no additional ZNF217 rearrangements. MSANTD3 encodes a previously uncharacterized Myb/SANT domain-containing protein. Immunohistochemical staining demonstrated diffuse nuclear MSANTD3 expression in 8 of 27 AcCC cases ( 30%), including the three cases with MSANTD3 rearrangement. MSANTD3 displayed heterogeneous expression in normal salivary ductal epithelium, as well as among other histologic types of salivary gland cancer though without evidence of translocation. In a broader survey, MSANTD3 showed variable expression across a wide range of normal and neoplastic human tissue specimens. In preliminary functional studies, engineered MSANTD3 overexpression in rodent salivary gland epithelial cells did not enhance cell proliferation, but led to significant upregulation of gene sets involved in protein synthesis. Our findings newly identify MSANTD3 rearrangement as a recurrent event in salivary gland AcCC, providing new insight into disease pathogenesis, and identifying a putative novel human oncogene.	[Barasch, Nicholas; Gong, Xue; Varma, Sushama; Biscocho, Jewison; Lipsick, Joseph S.; West, Robert B.; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Kwei, Kevin A.; Qu, Kunbin; Pelham, Robert J.] Genom Hlth, Redwood City, CA USA; [Xiao, Nan] Univ Pacific, Arthur A Dugoni Sch Dent, San Francisco, CA USA; [Kwei, Kevin A.] Pharmacyclics, Sunnyvale, CA USA; [Qu, Kunbin] OncoMed Pharmaceut, Redwood City, CA USA; [Pelham, Robert J.] Amgen Inc, San Francisco, CA USA	Stanford University; Genomic Health; University of the Pacific; Pharmacyclics; Amgen	West, RB; Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	rbwest@stanford.edu; pollack1@stanford.edu		Xiao, Nan/0000-0001-7264-3046; West, Robert/0000-0002-8330-8283	Stanford University Department of Pathology; NIH/NCI [R01 CA128836]; Genomic Health; NATIONAL CANCER INSTITUTE [R01CA128836] Funding Source: NIH RePORTER	Stanford University Department of Pathology; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genomic Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Stanford authors (NB, XG, SV, JB, JSL, RBW, JRP) were funded by the Stanford University Department of Pathology, and by the NIH/NCI (R01 CA128836 to JSL); those funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Genomic Health authors (KAK, KQ, RJP) were funded by Genomic Health, whose interest had been in developing robust methods for RNAseq analysis of FFPE specimens; Genomic Health (the funders) had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; AZEN E, 1993, INFECT IMMUN, V61, P4434, DOI 10.1128/IAI.61.10.4434-4439.1993; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bell D, 2012, CURR ONCOL REP, V14, P166, DOI 10.1007/s11912-012-0220-5; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Brayer KJ, 2015, CANC DISCOV; Brenner JC, 2009, BBA-REV CANCER, V1796, P201, DOI 10.1016/j.bbcan.2009.04.005; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Cohen PA, 2015, ONCOTARGET; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Ellis GLA., 2008, AFIP ATLAS TUMOR PAT, P301; GODWIN JT, 1954, AM J PATHOL, V30, P465; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hall DA, 2008, DIAGN CYTOPATHOL, V36, P380, DOI 10.1002/dc.20852; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hoffman HT, 1999, HEAD NECK-J SCI SPEC, V21, P297, DOI 10.1002/(SICI)1097-0347(199907)21:4<297::AID-HED2>3.0.CO;2-R; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marinelli RJ, 2008, NUCLEIC ACIDS RES, V36, pD871, DOI 10.1093/nar/gkm861; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mitani Y, 2015, CLIN CANC RES; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Quissell D O, 1997, In Vitro Cell Dev Biol Anim, V33, P164; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Stenman G, 2013, HEAD NECK PATHOL, V7, pS12, DOI 10.1007/s12105-013-0462-z; Stenner M, 2009, EUR ARCH OTO-RHINO-L, V266, P333, DOI 10.1007/s00405-008-0882-7; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; Vasquez MM, 2009, EXP BIOL MED, V234, P522, DOI 10.3181/0806-RM-209; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Weinreb I, 2013, ADV ANAT PATHOL, V20, P367, DOI 10.1097/PAP.0b013e3182a92cc3; West RB, 2011, AM J SURG PATHOL, V35, P92, DOI 10.1097/PAS.0b013e3182002777; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947	50	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171265	10.1371/journal.pone.0171265	http://dx.doi.org/10.1371/journal.pone.0171265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212443	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700006
J	Lu, XF; Wang, YF; Liu, CY; Wang, YG				Lu, Xiaofang; Wang, Yuefen; Liu, Chunyan; Wang, Yangang			Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; GUT-BRAIN AXIS; SEROTONIN SYNTHESIS; MAJOR DEPRESSION; KYNURENINE; TRYPTOPHAN; MODEL; BOWEL; VULNERABILITY; METAANALYSIS	In this study, we investigated the relationship between tryptophan-5-hydroxytryptamine metabolism, depressive disorder, and gastrointestinal dysfunction in rats after myocardial infarction. Our goal was to elucidate the physiopathologic bases of somatic/psychiatric depression symptoms after myocardial infarction. A myocardial infarction model was established by permanent occlusion of the left anterior descending coronary artery. Depression-like behavior was evaluated using the sucrose preference test, open field test, and forced swim test. Gastric retention and intestinal transit were detected using the carbon powder labeling method. Immunohistochemical staining was used to detect indoleamine 2,3-dioxygenase expression in the hippocampus and ileum. High-performance liquid chromatography with fluorescence and ultraviolet detection determined the levels of 5-hydroxytryptamine, its precursor tryptophan, and its metabolite 5-hydroxyindoleacetic acid in the hippocampus, distal ileum, and peripheral blood. All data were analyzed using one-way analyses of variance. Three weeks after arterial occlusion, rats in the model group began to exhibit depression-like symptoms. For example, the rate of sucrose consumption was reduced, the total and central distance traveled in the open field test were reduced, and immobility time was increased, while swimming, struggling and latency to immobility were decreased in the forced swim test. Moreover, the gastric retention rate and gastrointestinal transit rate were increased in the model group. Expression of indoleamine 2,3-dioxygenase was increased in the hippocampus and ileum, whereas 5-hydroxytryptamine metabolism was decreased, resulting in lower 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels in the hippocampus and higher levels in the ileum. Depressive disorder and gastrointestinal dysfunction after myocardial infarction involve abnormal tryptophan-5-hydroxytryptamine metabolism, which may explain the somatic, cognitive, and psychiatric symptoms of depression commonly observed after myocardial infarction. Peripheral 5-hydroxytryptamine is an important substance in the gut-brain axis, and its abnormal metabolism is a critical finding after myocardial infarct.	[Lu, Xiaofang] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Ctr Digest Dis, Beijing, Peoples R China; [Wang, Yuefen] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Dept Nephropathy, Beijing, Peoples R China; [Liu, Chunyan] Hebei Med Univ, Hosp 3, Dept Rheumatol, Shijiazhuang, Hebei, Peoples R China; [Wang, Yangang] Hebei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Shijiazhuang, Hebei, Peoples R China	Capital Medical University; Capital Medical University; Hebei Medical University	Lu, XF (corresponding author), Capital Med Univ, Beijing Hosp Tradit Chinese Med, Ctr Digest Dis, Beijing, Peoples R China.; Wang, YG (corresponding author), Hebei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Shijiazhuang, Hebei, Peoples R China.	hbydlu@163.com; piwei001@163.com						Al-Ebrahim F, 2012, CAN J GASTROENTEROL, V26, P151, DOI 10.1155/2012/841792; Arnold SA, 2012, NEUROPHARMACOLOGY, V63, P1238, DOI 10.1016/j.neuropharm.2012.07.047; Arseneault-Breard J, 2012, BRIT J NUTR, V107, P1793, DOI 10.1017/S0007114511005137; Badawy AAB, 2013, J PSYCHOPHARMACOL, V27, P878, DOI 10.1177/0269881113499209; Basova N A, 2003, Ross Fiziol Zh Im I M Sechenova, V89, P1010; CAMPBELL AW, 2015, ALTERN THER HEALT S3, V21, P8; Castilla-Ortega E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085348; Chen S, 2013, PLOS ONE, V27; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Dale E, 2015, CNS SPECTRUMS, V8, P1; Dennis RL, 2012, POULTRY SCI, V91, P817, DOI 10.3382/ps.2011-01779; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; GAL EM, 1980, NEUROCHEM RES, V5, P223, DOI 10.1007/BF00964611; Georgin-Lavialle S, 2016, ALLERGY, V71, P416, DOI 10.1111/all.12802; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Gold AB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-17; Grandjean J., 2016, NEUROIMAGE; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Keszthelyi D, 2013, J PSYCHOSOM RES, V74, P501, DOI 10.1016/j.jpsychores.2013.01.008; Knapton AD, 2010, METHOD FIND EXP CLIN, V32, P489, DOI 10.1358/mf.2010.32.7.1507854; Lapin IP, 2003, ADV EXP MED BIOL, V527, P121; LAPIN IP, 1969, LANCET, V1, P132; Larsson MBO, 2012, GASTROENTEROLOGY, V142, P463, DOI 10.1053/j.gastro.2011.11.022; Lesurtel M, 2008, CELL MOL LIFE SCI, V65, P940, DOI 10.1007/s00018-007-7377-3; Liu HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024928; Ma XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056053; Mazarei G, 2013, EXP NEUROL, V249, P144, DOI 10.1016/j.expneurol.2013.08.007; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Mohamed BM, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S41020; Muller N, 2008, EUR ARCH PSY CLIN N, V258, P97, DOI 10.1007/s00406-008-2012-3; Nakamura R, 2002, CARDIOVASC RES, V56, P373, DOI 10.1016/S0008-6363(02)00594-1; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; O'Malley D, 2010, STRESS, V13, P114, DOI 10.3109/10253890903067418; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Oxenkrug G, 2013, CURR DRUG TARGETS, V14, P514, DOI 10.2174/1389450111314050002; Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Rogoz Z, 2012, PHARMACOL REP, V64, P1391, DOI 10.1016/S1734-1140(12)70936-2; Shi Rong-xing, 2015, Zhen Ci Yan Jiu, V40, P444; Sui Zhi-Yan, 2012, Clin Psychopharmacol Neurosci, V10, P155, DOI 10.9758/cpn.2012.10.3.155; Tang Yamei, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P790, DOI 10.3969/j.issn.1672-7347.2012.08.006; Teramoto Y, 1998, JPN J PHYSIOL, V48, P333, DOI 10.2170/jjphysiol.48.333; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Wang Y-H, 2013, WCJD, V21, P1226, DOI DOI 10.11569/WCJD.V21.I13.1226; Wang YM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-32; Wann BP, 2007, J PSYCHIATR NEUROSCI, V32, P11; Won E., 2015, CURR NEUROPHARMACOL, P1; Wood JD, 2010, CURR OPIN GASTROEN, V26, P102, DOI 10.1097/MOG.0b013e328334df4f; Wu Q, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002815; [张仲林 ZHANG Zhong-lin], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P3151; Zhou LP, 2012, EUR J GASTROEN HEPAT, V24, P695, DOI 10.1097/MEG.0b013e328351c1c2	52	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172339	10.1371/journal.pone.0172339	http://dx.doi.org/10.1371/journal.pone.0172339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212441	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424700034
J	Fletcher, DE; Lindell, AH; Stillings, GK; Blas, SA; McArthur, JV				Fletcher, Dean E.; Lindell, Angela H.; Stillings, Garrett K.; Blas, Susan A.; McArthur, J. Vaun			Trace element accumulation in lotic dragonfly nymphs: Genus matters	PLOS ONE			English	Article							COAL COMBUSTION RESIDUES; METAL CONCENTRATIONS; STABLE-ISOTOPES; TROPHIC STRUCTURE; INTRAGUILD PREDATION; DISSOLVED CADMIUM; AQUATIC DISPOSAL; UNITED-STATES; HEAVY-METALS; RIVER-BASIN	Constituents of coal combustion waste (CCW) expose aquatic organisms to complex mixtures of potentially toxic metals and metalloids. Multi-element trace element analyses were used to distinguish patterns of accumulation among 8 genera of dragonfly nymphs collected from two sites on a CCW contaminated coastal plain stream. Dragonfly nymphs are exceptional for comparing trace element accumulation in syntopic macroinvertebrates that are all predators within the same order (Odonata) and suborder (Anisoptera), but differ vastly in habitat use and body form. Sixteen trace element (Be, V, Cr, Ni, Cu, Zn, As, Se, Sr, Cd, Sb, Cs, Ba, Hg, Tl, and Pb) were analyzed and trophic position and basal carbon sources assessed with stable isotope analyses (C and N). Trophic positions varied within relatively narrow ranges. Size did not appear to influence trophic position. Trophic position rarely influenced trace element accumulation within genera and did not consistently correlate with accumulation among genera. Patterns between delta C-13 and trace element accumulation were generally driven by differences between sites. An increase in trace element accumulation was associated with a divergence of carbon sources between sites in two genera. Higher trace element concentrations tended to accumulate in nymphs from the upstream site, closer to contaminant sources. Influences of factors such as body form and habitat use appeared more influential on trace element accumulation than phylogeny for several elements (Ni, Ba, Sr, V, Be, Cd, and Cr) as higher concentrations accumulated in sprawler and the climber-sprawler genera, irrespective of family. In contrast, As and Se accumulated variably higher in burrowers, but accumulation in sprawlers differed between sites. Greater variation between genera than within genera suggests genus as an acceptable unit of comparison in dragonfly nymphs. Overall, taxonomic differences in trace element accumulation can be substantial, often exceeding variation between sites. Our results underscore the element and taxa specific nature of trace element accumulation, but we provide evidence of accumulation of some trace elements differing among dragonflies that differ in body form and utilize different sub-habitats within a stream reach.	[Fletcher, Dean E.; Lindell, Angela H.; Stillings, Garrett K.; McArthur, J. Vaun] Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29808 USA; [Blas, Susan A.] Savannah River Nucl Solut, Area Complet Projects, Aiken, SC USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Fletcher, DE (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29808 USA.	fletcher@srel.uga.edu			Department of Energy; Area Completion Projects group-Savannah River Nuclear Solutions [DE-EM0004391]	Department of Energy(United States Department of Energy (DOE)); Area Completion Projects group-Savannah River Nuclear Solutions	This material is based upon work supported by the Department of Energy and the Area Completion Projects group-Savannah River Nuclear Solutions under Award Number DE-EM0004391 to the University of Georgia Research Foundation. SAB of Area Completion Projects assisted with establishing the project goals and general study design of providing a detailed assessment of contaminant accumulation in biota of Beaver Dam Creek. This work has led to several publications on contaminant accumulations in this system. SAB is a trained fish ecologist with experience on the Savannah River Site where the study was conducted. The funding agency provided support in the form of salaries for authors [DEF, JVM, AHL, GKS] and research materials. The funding agency did not have an additional role in the detailed study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. All final decisions on study design, data interpretation, and presentation in the submitted manuscript were made by DEF and JVM.; This material is based upon work supported by the Department of Energy and the Area Completion Projects group-Savannah River Nuclear Solutions under Award Number DE-EM0004391 to the University of Georgia Research Foundation. We thank David Kling, Cynthia Tant and Beryl Walker for field and lab assistance, Tracye Murphy and John Seaman for trace element analysis, and Tom Maddox for SIA.	Arribere MA, 2010, WATER AIR SOIL POLL, V212, P167, DOI 10.1007/s11270-010-0330-3; BENKE AC, 1978, J ANIM ECOL, V47, P335, DOI 10.2307/3787; Bennett PM, 2009, ENTOMOL SCI, V12, P17, DOI 10.1111/j.1479-8298.2009.00308.x; BLOIS C, 1985, FRESHWATER BIOL, V15, P505, DOI 10.1111/j.1365-2427.1985.tb00220.x; Bo T, 2011, ENTOMOL FENNICA, V22, P255; Buchwalter DB, 2008, P NATL ACAD SCI USA, V105, P8321, DOI 10.1073/pnas.0801686105; Buchwalter DB, 2005, ENVIRON SCI TECHNOL, V39, P498, DOI 10.1021/es0404421; Burcher CL, 2002, AM MIDL NAT, V148, P75, DOI 10.1674/0003-0031(2002)148[0075:HDDCAL]2.0.CO;2; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; CAIN DJ, 1992, CAN J FISH AQUAT SCI, V49, P2141, DOI 10.1139/f92-237; Casey RE, 2007, WATER AIR SOIL POLL, V178, P69, DOI 10.1007/s11270-006-9132-z; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cherry D.S., 2004, STATE REGULATION COA, P193; CHERRY DS, 1979, HYDROBIOLOGIA, V62, P257, DOI 10.1007/BF00043543; CHERRY DS, 1978, WATER AIR SOIL POLL, V9, P403; Chumchal MM, 2011, ENVIRON TOXICOL CHEM, V30, P1153, DOI 10.1002/etc.477; Clayden MG, 2013, ENVIRON SCI TECHNOL, V47, P12047, DOI 10.1021/es4022975; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbi JJ, 2008, WATER AIR SOIL POLL, V195, P325, DOI 10.1007/s11270-008-9749-1; Corbi JJ, 2011, BRAZ ARCH BIOL TECHN, V54, P613, DOI 10.1590/S1516-89132011000300023; Corbi JJ, 2011, ENVIRON MONIT ASSESS, V177, P545, DOI 10.1007/s10661-010-1655-5; Corbi JJ, 2010, QUIM NOVA, V33, P644, DOI 10.1590/S0100-40422010000300030; Cordoba-Aguilar A, 2008, DRAGONFLIES DAMSELFL; Cremona F, 2014, FRESHW SCI, V33, P885, DOI 10.1086/677540; Crumrine Patrick W., 2008, P21; Crumrine PW, 2003, ECOLOGY, V84, P1588, DOI 10.1890/0012-9658(2003)084[1588:PCORRI]2.0.CO;2; Demirak A, 2006, CHEMOSPHERE, V63, P1451, DOI 10.1016/j.chemosphere.2005.09.033; Donahue WF, 2006, J PALEOLIMNOL, V35, P111, DOI 10.1007/s10933-005-7878-8; Edwards PG, 2014, HUM ECOL RISK ASSESS, V20, P1565, DOI 10.1080/10807039.2013.862107; Evans D.W., 1978, ECOLOGY COAL RESOURC, V2, P782; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Fletcher DE, 2015, SOUTHEAST NAT, V14, P373, DOI 10.1656/058.014.0217; Fletcher DE, 2014, ARCH ENVIRON CON TOX, V66, P341, DOI 10.1007/s00244-013-9984-3; Fletcher DE, 2014, ECOTOX ENVIRON SAFE, V101, P196, DOI 10.1016/j.ecoenv.2013.12.024; Gu B, 1996, J FISH BIOL, V49, P1233, DOI 10.1111/j.1095-8649.1996.tb01792.x; GUTHRIE RK, 1979, WATER RESOUR BULL, V15, P244; Guthrie RK, 1976, WATER RESOUR B, V12, P889; Halverson N.V., 1997, WSRCTR970223, P67; Henderson BL, 2012, ENVIRON TOXICOL CHEM, V31, P870, DOI 10.1002/etc.1760; Herwig BR, 2004, CAN J FISH AQUAT SCI, V61, P12, DOI 10.1139/F03-139; Hicks BJ, 1997, NEW ZEAL J MAR FRESH, V31, P651, DOI 10.1080/00288330.1997.9516796; Hopkins WA, 2001, ENVIRON POLLUT, V115, P1, DOI 10.1016/S0269-7491(01)00098-7; Jardine TD, 2005, J N AM BENTHOL SOC, V24, P290, DOI 10.1899/04-092.1; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Karimi R, 2006, ECOL LETT, V9, P1273, DOI 10.1111/j.1461-0248.2006.00979.x; Karouna-Renier NK, 2001, ENVIRON POLLUT, V112, P183, DOI 10.1016/S0269-7491(00)00119-6; KENNEDY GH, 1950, ECOL MONOGR, V20, P105, DOI 10.2307/1943547; Kilham SS, 2009, INT VER THEOR ANGEW, V30, P749; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Kormondy E. J., 1965, Limnology and Oceanography, V10, P427; Kupfer A, 2006, J TROP ECOL, V22, P469, DOI 10.1017/S0266467406003336; Lavilla I, 2010, J ENVIRON MONITOR, V12, P724, DOI 10.1039/b920379f; Lemly AD, 2012, ENVIRON SCI TECHNOL, V46, P8595, DOI 10.1021/es301467q; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P279, DOI 10.2307/1467463; Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e; Luther L., 2010, 75700 CRS, P1; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Merritt R. W., 2008, INTRO AQUATIC INSECT; Metts BS, 2013, ENVIRON SCI TECHNOL, V47, P2846, DOI 10.1021/es303989u; Molina CI, 2011, HYDROBIOLOGIA, V663, P135, DOI 10.1007/s10750-010-0565-4; MORIN PJ, 1984, ECOLOGY, V65, P1866, DOI 10.2307/1937784; Needham J. G., 2014, DRAGONFLIES N AM, V3rd; Nummelin M, 2007, ENVIRON POLLUT, V145, P339, DOI 10.1016/j.envpol.2006.03.002; Overman NC, 2001, CAN J FISH AQUAT SCI, V58, P1253, DOI 10.1139/cjfas-58-6-1253; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Peltier GL, 2009, ECOTOX ENVIRON SAFE, V72, P1384, DOI 10.1016/j.ecoenv.2009.01.011; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Poteat MD, 2013, ENVIRON SCI TECHNOL, V47, P7989, DOI 10.1021/es401368u; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Rowe CL, 2014, SCI TOTAL ENVIRON, V485, P490, DOI 10.1016/j.scitotenv.2014.03.119; Rowe CL, 2002, ENVIRON MONIT ASSESS, V80, P207, DOI 10.1023/A:1021127120575; Rowe CL, 2001, ARCH ENVIRON CON TOX, V40, P399; Roy I, 1999, CAN J FISH AQUAT SCI, V56, P1143, DOI 10.1139/cjfas-56-7-1143; Ruhl L, 2012, ENVIRON SCI TECHNOL, V46, P12226, DOI 10.1021/es303263x; Schaller J, 2015, SCI TOTAL ENVIRON, V530, P430, DOI 10.1016/j.scitotenv.2015.06.015; Scheuhammer AM, 1997, ENVIRON POLLUT, V96, P235, DOI 10.1016/S0269-7491(97)00032-8; SHELTON LR, 1994, 94458 US GEOL SURV; SMOCK LA, 1983, FRESHWATER BIOL, V13, P301, DOI 10.1111/j.1365-2427.1983.tb00682.x; Snodgrass JW, 2003, ENVIRON TOXICOL CHEM, V22, P1597, DOI 10.1002/etc.5620220724; Taylor KG, 2009, J SOIL SEDIMENT, V9, P281, DOI 10.1007/s11368-009-0103-z; THORP JH, 1984, ECOLOGY, V65, P1546, DOI 10.2307/1939134; Tollett VD, 2009, ARCH ENVIRON CON TOX, V56, P77, DOI 10.1007/s00244-008-9170-1; Unrine JM, 2007, ENVIRON POLLUT, V149, P182, DOI 10.1016/j.envpol.2007.01.039; VANBUSKIRK J, 1992, OIKOS, V65, P455, DOI 10.2307/3545563; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI; WALLACE JB, 1987, CAN J ZOOL, V65, P35, DOI 10.1139/z87-006; Wiener J, 2008, GLKN2008VERSION10; Wilkinson L., 1996, DESKTOP DATA ANAL SY; Wilson AL, 2005, AQUAT ECOL, V39, P189, DOI 10.1007/s10452-004-7085-0; WISSINGER S, 1993, ECOLOGY, V74, P207, DOI 10.2307/1939515; Worthen Wade B., 2004, International Journal of Odonatology, V7, P97; Worthen WB, 2002, SOUTHEAST NAT, V1, P205, DOI 10.1656/1528-7092(2002)001[0205:TSOLOA]2.0.CO;2	94	14	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172016	10.1371/journal.pone.0172016	http://dx.doi.org/10.1371/journal.pone.0172016			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207806	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500072
J	Grune, F; Kazmaier, S; Hoeks, SE; Stolker, RJ; Coburn, M; Weyland, A				Grune, Frank; Kazmaier, Stephan; Hoeks, Sanne Elisabeth; Stolker, Robert Jan; Coburn, Marc; Weyland, Andreas			Argon does not affect cerebral circulation or metabolism in male humans	PLOS ONE			English	Article							BLOOD-FLOW VELOCITY; TRANSCRANIAL DOPPLER SONOGRAPHY; INERT-GAS NARCOSIS; XENON ANESTHESIA; STABLE XENON; ORGANOPROTECTIVE PROPERTIES; ORGAN PERFUSION; NOBLE-GAS; PRESSURE; RESISTANCE	Objective Accumulating data have recently underlined argon As neuroprotective potential. However, to the best of our knowledge, no data are available on the cerebrovascular effects of argon (Ar) in humans. We hypothesized that argon inhalation does not affect mean blood flow velocity of the middle cerebral artery (Vmca), cerebral flow index (FI), zero flow pressure (ZFP), effective cerebral perfusion pressure (CPPe), resistance area product (RAP) and the arterio-jugular venous content differences of oxygen (AJVDO(2)), glucose (AJVDG), and lactate (AJVDL) in anesthetized patients. Materials and methods In a secondary analysis of an earlier controlled cross-over trial we compared parameters of the cerebral circulation under 15 minutes exposure to 70%Ar/30%O-2 versus 70%N-2/30%O-2 in 29 male patients under fentanyl-midazolam anaesthesia before coronary surgery. Vmca was measured by transcranial Doppler sonography. ZFP and RAP were estimated by linear regression analysis of pressure-flow velocity relationships of the middle cerebral artery. CPPe was calculated as the difference between mean arterial pressure and ZFP. AJVDO2, AJVDG and AJVDL were calculated as the differences in contents between arterial and jugular-venous blood of oxygen, glucose, and lactate. Statistical analysis was done by t-tests and ANOVA. Results Mechanical ventilation with 70% Ar did not cause any significant changes in mean arterial pressure, Vmca, FI, ZFP, CPPe, RAP, AJVDO2, AJVDG, and AJVDL. Discussion Short-term inhalation of 70% Ar does not affect global cerebral circulation or metabolism in male humans under general anaesthesia.	[Grune, Frank; Hoeks, Sanne Elisabeth; Stolker, Robert Jan] Erasmus Univ, Dept Anaesthesiol, Med Ctr, Rotterdam, Netherlands; [Kazmaier, Stephan] Univ Hosp Gottingen, Ctr Anaesthesiol Crit Care Emergency Med & Pain T, Gottingen, Germany; [Coburn, Marc] Rhein Westfal TH Aachen, Dept Anaesthesiol, Univ Hosp, Aachen, Germany; [Weyland, Andreas] Carl von Ossietzky Univ Oldenburg, Klinikum Oldenburg, Dept Anaesthesiol Crit Care Emergency Med & Pain, Med Campus, Oldenburg, Germany	Erasmus University Rotterdam; Erasmus MC; University of Gottingen; RWTH Aachen University; RWTH Aachen University Hospital; Carl von Ossietzky Universitat Oldenburg; Klinikum Oldenburg	Grune, F (corresponding author), Erasmus Univ, Dept Anaesthesiol, Med Ctr, Rotterdam, Netherlands.	f.grune@erasmusmc.nl; weyland.andreas@klinikum-oldenburg.de	Grüne, Frank/G-4869-2018; Hoeks, Sanne/AAM-3313-2020	Grüne, Frank/0000-0001-5693-3721; 				AASLID R, 1987, STROKE, V18, P771, DOI 10.1161/01.STR.18.4.771; Alderliesten T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113575; Ashina M, 2012, CEPHALALGIA, V32, P428, DOI 10.1177/0333102412438978; Behnke AR, 1939, AM J PHYSIOL, V126, P409, DOI 10.1152/ajplegacy.1939.126.2.409; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Coburn M, 2012, EUR J ANAESTH, V29, P549, DOI 10.1097/EJA.0b013e328357bfdd; COESA, 1976, NOAAST761562 COESA, P1; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; EVANS DH, 1988, ULTRASOUND MED BIOL, V14, P103, DOI 10.1016/0301-5629(88)90176-7; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; FOWLER B, 1985, UNDERSEA BIOMED RES, V12, P369; Frietsch T, 2001, ANESTHESIOLOGY, V94, P290, DOI 10.1097/00000542-200102000-00019; Giller CA, 1998, NEUROSURGERY, V42, P1076, DOI 10.1097/00006123-199805000-00077; GILLER CA, 1990, AM J NEURORADIOL, V11, P177; Grune F, 2001, ANASTH INTENSIV NOTF, V36, P538, DOI 10.1055/s-2001-17259; Grune F, 2015, J CEREBR BLOOD F MET, V35, P1470, DOI 10.1038/jcbfm.2015.63; Grune F, 2014, ANESTHESIOLOGY, V120, P335, DOI 10.1097/ALN.0b013e3182a8eb09; GUR D, 1985, STROKE, V16, P871, DOI 10.1161/01.STR.16.5.871; HARTMANN A, 1991, STROKE, V22, P182, DOI 10.1161/01.STR.22.2.182; HARTMANN A, 1987, STROKE, V18, P643, DOI 10.1161/01.STR.18.3.643; Hatab MR, 1997, ULTRASOUND MED BIOL, V23, P1025, DOI 10.1016/S0301-5629(97)00030-6; Hoellig A, 2014, INT J MOL SCI, V15, P18175, DOI 10.3390/ijms151018175; ITOH T, 1993, STROKE, V24, P1192, DOI 10.1161/01.STR.24.8.1192; Laitio RM, 2007, ANESTHESIOLOGY, V106, P1128, DOI 10.1097/01.anes.0000267596.57497.92; Law LSC, 2016, ANESTH ANALG, V122, P678, DOI 10.1213/ANE.0000000000000914; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lunt MJ, 2004, PHYSIOL MEAS, V25, P467, DOI 10.1088/0967-3334/25/2/006; LUTTROPP HH, 1993, ANAESTHESIA, V48, P1045; Maller K, 2002, ACTA ANAESTH SCAND, V46, P567; McCulloch TJ, 2005, ANESTH ANALG, V100, P1463, DOI 10.1213/01.ANE.0000148623.06596.7E; Mielck F, 1999, ANESTH ANALG, V89, P364, DOI 10.1097/00000539-199908000-00022; Mielck F, 1998, BRIT J ANAESTH, V81, P155, DOI 10.1093/bja/81.2.155; Ogoh S, 2010, EXP PHYSIOL, V95, P678, DOI 10.1113/expphysiol.2010.052340; Pavlov BN, 1999, ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY, P561; Rau G, 1969, BASIC RES CARDIOL, V58, P322; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Rostain JC, 2006, UNDERSEA HYPERBAR M, V33, P197; Sawilowsky S., 2002, J MODERN APPL STAT M, V1, P461, DOI DOI 10.22237/JMASM/1036109940; Schmidt M, 2001, ANAESTHESIA, V56, P1154, DOI 10.1046/j.1365-2044.2001.02322.x; Shulagin IA, 2001, HUM PHYSL, V27, P84; STEPHAN H, 1989, ANAESTHESIA, V44, P310, DOI 10.1111/j.1365-2044.1989.tb11284.x; Stephan H, 1996, ANAESTHESIST, V45, P1030, DOI 10.1007/s001010050336; Tarek R, 2014, AIN SHAMS J ANAESTHE, V7, P444; TAUCHERT M, 1971, Z KREISLAUFFORSCH, V60, P871; Ulbrich F, 2015, NEURAL REGEN RES, V10, P1043, DOI 10.4103/1673-5374.160071; Valdueza JM, 1999, STROKE, V30, P81, DOI 10.1161/01.STR.30.1.81; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Victor A, 2010, DTSCH ARZTEBL INT, V107, P50, DOI [10.3238/arztebl.2009.0050, 10.3238/arztebl.2010.0050]; Weyland A, 1996, ANAESTHESIST, V45, P1037, DOI 10.1007/s001010050337; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; WEYLAND A, 1994, ANESTHESIOLOGY, V81, P1401, DOI 10.1097/00000542-199412000-00015; YAO LP, 1992, STROKE, V23, P69, DOI 10.1161/01.STR.23.1.69; YAO LP, 1992, J NEUROSURG ANESTH, V4, P268, DOI 10.1097/00008506-199210000-00007	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171962	10.1371/journal.pone.0171962	http://dx.doi.org/10.1371/journal.pone.0171962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207907	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500064
J	Shattock, AJ; Benedikt, C; Bokazhanova, A; Duric, P; Petrenko, I; Ganina, L; Kelly, SL; Stuart, RM; Kerr, CC; Vinichenko, T; Zhang, SF; Hamelmann, C; Manova, M; Masaki, E; Wilson, DP; Gray, RT				Shattock, Andrew J.; Benedikt, Clemens; Bokazhanova, Aliya; Duric, Predrag; Petrenko, Irina; Ganina, Lolita; Kelly, Sherrie L.; Stuart, Robyn M.; Kerr, Cliff C.; Vinichenko, Tatiana; Zhang, Shufang; Hamelmann, Christoph; Manova, Manoela; Masaki, Emiko; Wilson, David P.; Gray, Richard T.			Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies	PLOS ONE			English	Article							DRUG-USERS; PRIORITIZATION; INTERVENTIONS; EPIDEMIC; COVERAGE; PEOPLE; COSTS; RISK	Background Despite a non-decreasing HIV epidemic, international donors are soon expected to withdraw funding from Kazakhstan. Here we analyze how allocative, implementation, and technical efficiencies could strengthen the national HIV response under assumptions of future budget levels. Methodology We used the Optima model to project future scenarios of the HIV epidemic in Kazakhstan that varied in future antiretroviral treatment unit costs and management expenditure D two areas identified for potential cost- reductions. We determined optimal allocations across HIV programs to satisfy either national targets or ambitious targets. For each scenario, we considered two cases of future HIV financing: the 2014 national budget maintained into the future and the 2014 budget without current international investment. Findings Kazakhstan can achieve its national HIV targets with the current budget by (1) optimally reallocating resources across programs and (2) either securing a 35% [30% - 39%] reduction in antiretroviral treatment drug costs or reducing management costs by 44% [36% - 58%] of 2014 levels. Alternatively, a combination of antiretroviral treatment and management cost-reductions could be sufficient. Furthermore, Kazakhstan can achieve ambitious targets of halving new infections and AIDS-related deaths by 2020 compared to 2014 levels by attaining a 67% reduction in antiretroviral treatment costs, a 19% [14% - 27%] reduction in management costs, and allocating resources optimally. Significance With Kazakhstan facing impending donor withdrawal, it is important for the HIV response to achieve more with available resources. This analysis can help to guide HIV response planners in directing available funding to achieve the greatest yield from investments. The key changes recommended were considered realistic by Kazakhstan country representatives.	[Shattock, Andrew J.; Stuart, Robyn M.; Kerr, Cliff C.; Wilson, David P.; Gray, Richard T.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Benedikt, Clemens; Masaki, Emiko] World Bank Grp, Washington, DC USA; [Bokazhanova, Aliya; Manova, Manoela] Joint United Nations Programme HIV AIDS, Geneva, Switzerland; [Duric, Predrag; Hamelmann, Christoph] United Nations Dev Programme, Istanbul Reg Hub, Istanbul, Turkey; [Petrenko, Irina; Ganina, Lolita] Republican Ctr Prevent & Control AIDS, Alma Ata, Kazakhstan; [Kelly, Sherrie L.; Wilson, David P.] Burnet Inst, Melbourne, Australia; [Stuart, Robyn M.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW, Australia; [Vinichenko, Tatiana; Zhang, Shufang] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	University of New South Wales Sydney; Kirby Institute; The World Bank; Burnet Institute; University of Copenhagen; University of Sydney	Shattock, AJ (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.	ashattock@kirby.unsw.edu.au	Duric, Predrag/L-9002-2019	Duric, Predrag/0000-0001-5770-7224; Shattock, Andrew/0000-0002-2285-8425; Manova, Manoela/0000-0002-8749-7974; Gray, Richard/0000-0002-2885-0483	World Bank Group; Australian National Health and Medical Research Council [APP1064192, APP1086540]; Australian Government, Department of Health and Ageing	World Bank Group; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This study was funded by the World Bank Group and the Australian National Health and Medical Research Council (APP1064192 and APP1086540, both awarded to DPW). The World Bank Group also provided support in the form of salaries for CB and EM. The Kirby Institute at UNSW Australia is funded by the Australian Government, Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. As members of the study team, CB and EM (employed by the World Bank Group) supported the project by engaging with the Kazakhstan HIV sector and requesting data from the national Ministry of Health. They did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond what is specified in the Author Contributions Statement.	Aceijas CC, 2006, SEX TRANSM INFECT; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; Binford MC, 2012, CURR HIV-AIDS REP, V9, P287, DOI 10.1007/s11904-012-0134-8; Bobkov AF, 2004, AIDS RES HUM RETROV, V20, P1134, DOI 10.1089/aid.2004.20.1134; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bunupuradah T, 2015, J INT AIDS SOC; Carey D., 2014, J INT AIDS SOC S3, V17; Caucasus Research Resource Centers, 2013, LAB MIGR STI HIV RIS; Clayden P, 2016, DRUGS DIAGNOSTICS VA; DeHovitz J, 2014, CURR HIV-AIDS REP, V11, P168, DOI 10.1007/s11904-014-0202-3; Development Continuum Working Group, 2015, EV GLOB FOUND GREAT; Duric P, 2015, MODELLING OPTIMISED; Duric P, 2015, MODELLING OPTIMIZED; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; El-Bassel N, 2014, CURR OPIN HIV AIDS, V9, P150, DOI 10.1097/COH.0000000000000035; El-Bassel N, 2013, AIDS BEHAV, V17, P2490, DOI 10.1007/s10461-013-0484-2; Enserink M, 2014, SCIENCE, V345, P1258, DOI 10.1126/science.345.6202.1258; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, P1; Fraser N, 2015, JAIDS-J ACQ IMM DEF, V68, pS213, DOI 10.1097/QAI.0000000000000456; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Holmes CB, 2012, HEALTH AFFAIR, V31, P1553, DOI 10.1377/hlthaff.2012.0562; Kelly SL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20772; Kerr CC, PLOS ONE IN PRESS; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Medecins Sans Frontieres, 2014, UNT WEB ANT PRIC RED; Ministry of Health of the Republic of Kazakhstan, 2011, EP PROF HIV AIDS KAZ; Organization for Economic Cooperation and Development, 2014, CRED REP SYST; Palmer S, 1999, BRIT MED J, V318, P1136, DOI 10.1136/bmj.318.7191.1136; Panovska-Griffiths J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107066; Roux P, 2009, CLIN INFECT DIS, V49, P1433, DOI 10.1086/630209; Sagaon-Teyssier L, 2016, J INT AIDS SOC, V19; Sandgren E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-295; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The Global Fund to Fight AIDS, 2007, 15 BOARD M GEN; The World Bank, 2015, MATH ED; The World Bank, 2012, UKR HIV PROGR EFF ST; Thorne C, 2010, LANCET INFECT DIS, V10, P479, DOI 10.1016/S1473-3099(10)70118-3; UNAIDS, 2013, EFFICIENT SUSTAINABL; UNAIDS, 2013, AIDS BY THE NUMB; UNDP, 2015, DOM FIN NAT HIV RESP; UNGASS, 2013, COUNTR PROGR REP HIV; UNICEF, 2007, UNICEF PROC HIV AIDS; WHO, 2010, EL MOTH TO CHILD TRA; Wilson DP, 2012, GETTING ZERO HIV PRE; Wirtz AL, 2013, INT J STD AIDS, V24, P18, DOI 10.1177/0956462412472291; World Health Organization, 2015, CONS STRAT INF GUID	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169530	10.1371/journal.pone.0169530	http://dx.doi.org/10.1371/journal.pone.0169530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207809	Green Published, gold			2022-12-26	WOS:000394424500004
J	Ambler, GK; Stimpson, AL; Wardle, BG; Bosanquet, DC; Hanif, UK; Germain, S; Chick, C; Goyal, N; Twine, CP				Ambler, G. K.; Stimpson, A. L.; Wardle, B. G.; Bosanquet, D. C.; Hanif, U. K.; Germain, S.; Chick, C.; Goyal, N.; Twine, C. P.			Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy	PLOS ONE			English	Article							ENDOVASCULAR REVASCULARIZATION; DIABETIC FOOT; ISCHEMIA; DISEASE; METAANALYSIS; INFECTION; SURGERY; THERAPY; BYPASS; TRIAL	Introduction Infra-popliteal angioplasty continues to be widely performed with minimal evidence to guide practice. Endovascular device selection is contentious and there is even uncertainty over which artery to treat for optimum reperfusion. Direct reperfusion (DR) targets the artery supplying the ischaemic tissue. Indirect reperfusion (IR) targets an artery supplying collaterals to the ischaemic area. Our unit practice for the last eight years has been to attempt to open all tibial arteries at the time of angioplasty. When successful, this results in both direct and indirect; or combined reperfusion (CR). The aim was to review the outcomes of CR and compare them with DR or IR alone. Methods An eight year retrospective review from a single unit of all infra-popliteal angioplasties was undertaken. Wound healing, limb salvage, amputation-free and overall survival data as well as re-intervention rates were captured for all patients. Subgroup analysis for diabetics was undertaken. Kaplan Meier curves are presented for survival outcomes. All odds and hazard ratios (HR) and p values were corrected for bias from confounders using multivariate analysis. Results 250 procedures were performed: 22 (9%) were CR; 115 (46%) DR and 113 (45%) IR. Amputation- free survival (HR 0.504, p = 0.039) and re-intervention and amputation-free survival (HR 0.414, p = 0.005) were significantly improved in patients undergoing CR compared to IR. Wound healing was similarly affected by reperfusion strategy (OR = 0.35, p = 0.047). Effects of CR over IR were similar when only diabetic patients were considered. Conclusions Combined revascularisation can only be achieved in approximately 10% of patients. However, when successful, it results in significant improvements in wound healing and amputation- free survival over simple indirect reperfusion techniques.	[Ambler, G. K.; Twine, C. P.] Cardiff Univ, Div Populat Med, 3rd Floor Neuadd Meirionnydd,Heath Pk, Cardiff, S Glam, Wales; [Ambler, G. K.; Stimpson, A. L.; Wardle, B. G.; Bosanquet, D. C.; Hanif, U. K.; Germain, S.; Chick, C.; Goyal, N.; Twine, C. P.] Royal Gwent Hosp, South East Wales Vasc Network, Cardiff Rd, Newport, Gwent, Wales	Cardiff University; Royal Gwent Hospital	Twine, CP (corresponding author), Cardiff Univ, Div Populat Med, 3rd Floor Neuadd Meirionnydd,Heath Pk, Cardiff, S Glam, Wales.; Twine, CP (corresponding author), Royal Gwent Hosp, South East Wales Vasc Network, Cardiff Rd, Newport, Gwent, Wales.	christopher.twine@wales.nhs.uk	Twine, Chris/GLS-2275-2022; Bosanquet, David Charles/AAB-1557-2022	Twine, Chris/0000-0003-0385-5760; Bosanquet, David Charles/0000-0003-2304-0489; Ambler, Graeme/0000-0002-3024-6365				Acin F, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/270539; Aerden D, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/672897; Bosanquet DC, 2014, EUR J VASC ENDOVASC, V48, P88, DOI 10.1016/j.ejvs.2014.04.002; Bradbury AW, 2010, J VASC SURG, V51, p5S, DOI 10.1016/j.jvs.2010.01.073; Conrad MF, 2009, J VASC SURG, V50, P799, DOI 10.1016/j.jvs.2009.05.026; Farber A, 2014, TECH VASC INTERV RAD, V17, P221, DOI 10.1053/j.tvir.2014.08.012; Fossaceca R, 2013, CARDIOVASC INTER RAD, V36, P637, DOI 10.1007/s00270-012-0544-4; Iida O, 2013, EUR J VASC ENDOVASC, V46, P575, DOI 10.1016/j.ejvs.2013.08.002; Jens S, 2014, EUR J VASC ENDOVASC, V47, P536, DOI 10.1016/j.ejvs.2014.02.012; Lejay A, 2014, ANN VASC SURG, V28, P983, DOI 10.1016/j.avsg.2013.08.026; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Peregrin JH, 2010, CARDIOVASC INTER RAD, V33, P720, DOI 10.1007/s00270-010-9881-3; Popplewell MA, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1114-2; Soderstrom M, 2013, J VASC SURG, V57, P427, DOI 10.1016/j.jvs.2012.07.057; Spillerova K, 2015, EUR J VASC ENDOVASC, V49, P412, DOI 10.1016/j.ejvs.2014.12.023; Sumpio BE, 2013, J VASC SURG, V58, P814, DOI 10.1016/j.jvs.2013.06.056; Sun NF, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-32; Tan TW, 2011, INT J ANGIOL, V20, P19, DOI 10.1055/s-0031-1272545; TAYLOR GI, 1992, BRIT J PLAST SURG, V45, P327, DOI 10.1016/0007-1226(92)90063-4; VARTY K, 1995, EUR J VASC ENDOVASC, V9, P341, DOI 10.1016/S1078-5884(05)80141-8	20	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172023	10.1371/journal.pone.0172023	http://dx.doi.org/10.1371/journal.pone.0172023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199363	gold, Green Published, Green Accepted			2022-12-26	WOS:000394424400067
J	Taylor, RP; Martin, TP; Montgomery, RD; Smith, JH; Micolich, AP; Boydston, C; Scannell, BC; Fairbanks, MS; Spehar, B				Taylor, R. P.; Martin, T. P.; Montgomery, R. D.; Smith, J. H.; Micolich, A. P.; Boydston, C.; Scannell, B. C.; Fairbanks, M. S.; Spehar, B.			Seeing shapes in seemingly random spatial patterns: Fractal analysis of Rorschach inkblots	PLOS ONE			English	Article							RESPONSES; GEOMETRY	Rorschach inkblots have had a striking impact on the worlds of art and science because of the remarkable variety of associations with recognizable and namable objects they induce. Originally adopted as a projective psychological tool to probe mental health, psychologists and artists have more recently interpreted the variety of induced images simply as a signature of the observers' creativity. Here we analyze the relationship between the spatial scaling parameters of the inkblot patterns and the number of induced associations, and suggest that the perceived images are induced by the fractal characteristics of the blot edges. We discuss how this relationship explains the frequent observation of images in natural scenery.	[Taylor, R. P.; Montgomery, R. D.; Smith, J. H.; Boydston, C.; Scannell, B. C.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA; [Martin, T. P.] US Naval Res Lab, Code 7165, Washington, DC USA; [Micolich, A. P.] UNSW Australia, Sch Phys, Sydney, NSW, Australia; [Fairbanks, M. S.] Calif State Univ, Dept Sci & Math, Maritime Acad, Vallejo, CA USA; [Spehar, B.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia	University of Oregon; United States Department of Defense; United States Navy; Naval Research Laboratory; University of New South Wales Sydney; University of New South Wales Sydney	Taylor, RP (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	rpt@uoregon.edu	spehar, branka/D-8519-2012	spehar, branka/0000-0002-3344-7162; Taylor, Richard/0000-0002-5248-4524	Australian Research Council, the Research Corporation for Science Advancement; W. M. Keck Foundation	Australian Research Council, the Research Corporation for Science Advancement(Australian Research Council); W. M. Keck Foundation(W.M. Keck Foundation)	This study was supported by the Australian Research Council, the Research Corporation for Science Advancement, and the W. M. Keck Foundation.	Aks DJ, 1996, J EMPIRICAL STUDIES, V4, P1; Avnir D, 1998, SCIENCE, V279, P39, DOI 10.1126/science.279.5347.39; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Bies AJ, VIS SCI ANN M 2016; Bies AJ, 2015, J VISION, V15, P769; Bies AJ, 2016, NEUROSCIENCE, V10, P1; Bies AJ, 2016, SYMMETRY, V66, P1; Castrejon Pita JR, 2005, J MATH BIOL, V50, P584, DOI [10.1007/s00285-004-0302-6, DOI 10.1007/S00285-004-0302-6]; Cerf M, 2007, VISION RES, V47, P3052, DOI 10.1016/j.visres.2007.06.025; Conte E, 2008, CHAOS COMPLEXITY LET, V4, P1; CUTTING JE, 1987, PERCEPT PSYCHOPHYS, V42, P365, DOI 10.3758/BF03203093; Fairbanks MS, 2011, NONLINEAR DYNAMICAL; Frame M, 2002, FRACTALS GRAPHICS MA; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; GILDEN DL, 1993, PSYCHOL REV, V100, P460, DOI 10.1037/0033-295X.100.3.460; Gouyet J. F., 1996, PHYS FRACTAL STRUCTU; Gregory R, 2000, NATURE, V404, P19, DOI 10.1038/35003661; Hagerhall CM, 2015, NONLIN DYNAM PSYCHOL, V19, P1; Hagerhall CM, 2008, PERCEPTION, V37, P1488, DOI 10.1068/p5918; Hagerhall CM, 2004, J ENVIRON PSYCHOL, V24, P247, DOI 10.1016/j.jenvp.2003.12.004; Hertz MR, 1936, CHILD DEV, V7, P237; Hertz MR, FREQUENCY TABLES SCO, P5; Hunt G, 1949, TIME, P45; KNILL DC, 1990, J OPT SOC AM A, V7, P1113, DOI 10.1364/JOSAA.7.001113; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Montgomery R. T., 2014, THESIS; Mureika JR, 2013, SIGNAL PROCESS, V93, P573, DOI 10.1016/j.sigpro.2012.05.002; PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P661, DOI 10.1109/TPAMI.1984.4767591; Richards R, 2001, J HUMANIST PSYCHOL, V41, P59, DOI 10.1177/0022167801412006; ROGOWITZ BE, 1990, P SOC PHOTO-OPT INS, V1249, P387, DOI 10.1117/12.19691; Rorschach H., 1921, PSYCHODIAGNOSTIK MET; Spehar B, 2003, COMPUT GRAPH-UK, V27, P813, DOI 10.1016/S0097-8493(03)00154-7; Spehar B, FRONTIERS HUMAN NEUR, V9, P1; Spehar B, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00350; Spehar B, 2013, PROC SPIE, V8651, DOI 10.1117/12.2012076; Stangos N, 1994, CONCEPTS MODERN ART; Street N, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00213; Taylor RP, 2007, PATTERN RECOGN LETT, V28, P695, DOI 10.1016/j.patrec.2006.08.012; Taylor R P, 2008, Nonlinear Dynamics Psychol Life Sci, V12, P117; Taylor RP, 1999, NATURE, V442, P399; Taylor RP., 2011, FRONT HUM NEUROSCI, V5, P1, DOI [10.3389/fnhum.2011.00060, DOI 10.3389/FNHUM.2011.00060, DOI 10.1002/NME.3048.URL]; Taylor RP, 2006, NATURE COMMUNICATION, P44; Turner MJ., 1998, FRACTAL GEOMETRY DIG; Wirt RD, 1953, J PROJ TECH, V17, P493, DOI 10.1080/08853126.1953.10380520; Wood JM., 2003, WHATS WRONG RORSCHAC	46	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171289	10.1371/journal.pone.0171289	http://dx.doi.org/10.1371/journal.pone.0171289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196082	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900015
J	Oehlke, K; Behsnilian, D; Mayer-Miebach, E; Weidler, PG; Greiner, R				Oehlke, Kathleen; Behsnilian, Diana; Mayer-Miebach, Esther; Weidler, Peter G.; Greiner, Ralf			Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; BETA-CAROTENE; PHYSICOCHEMICAL CHARACTERIZATION; ALPHA-TOCOPHEROL; VITAMIN-E; STABILITY; ACID; TRISTEARIN; LOCATION; IMPACT	Ferulic acid (FA) and tocopherol (Toc) loaded solid lipid nanoparticles (SLN) were prepared by a hot homogenisation method. The particle size distribution, zeta potential and melting behaviour of the SLN as well as the stability, encapsulation efficiency and radical scavenging activity of FA and Toc in the SLN were analysed. The different formulations containing up to 2.8 mg g(-1) of FA or Toc were stable during at least 15 weeks of storage at room temperature. Despite partial degradation and / or release of FA and Toc during storage, significant radical scavenging activity was maintained. DSC measurements and radical scavenging tests after different time periods revealed that the re-structuring of the lipid matrix was connected to the enhanced antioxidant activity of Toc but did not affect the activity of FA.	[Oehlke, Kathleen; Behsnilian, Diana; Mayer-Miebach, Esther; Greiner, Ralf] Max Rubner Inst, Inst Food Technol & Bioproc Engn, Karlsruhe, Germany; [Weidler, Peter G.] KIT, Inst Funct Interfaces, Div Oxid & Organ Interfaces, Hermann von Helmoltz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Oehlke, K (corresponding author), Max Rubner Inst, Inst Food Technol & Bioproc Engn, Karlsruhe, Germany.	kathleen.oehlke@mri.bund.de			Federal Ministry of Food and Agriculture (BMEL)	Federal Ministry of Food and Agriculture (BMEL)	The project was supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditya NP, 2014, LWT-FOOD SCI TECHNOL, V59, P115, DOI 10.1016/j.lwt.2014.04.058; Ahlin P, 2000, INT J PHARM, V196, P241, DOI 10.1016/S0378-5173(99)00431-7; Berton-Carabin CC, 2013, COLLOID SURFACE A, V431, P9, DOI 10.1016/j.colsurfa.2013.04.016; Bondi ML, 2009, CURR NANOSCI, V5, P26, DOI 10.2174/157341309787314656; Bose S, 2013, INT J PHARMACEUT, V441, P56, DOI 10.1016/j.ijpharm.2012.12.013; Bunjes H, 2000, LANGMUIR, V16, P5234, DOI 10.1021/la990856l; Bunjes H, 2007, ADV DRUG DELIVER REV, V59, P379, DOI 10.1016/j.addr.2007.04.013; Bunjes H, 2011, CURR OPIN COLLOID IN, V16, P405, DOI 10.1016/j.cocis.2011.06.007; Campos DA, 2014, COLLOID SURFACE B, V115, P109, DOI 10.1016/j.colsurfb.2013.10.035; Carbone C, 2014, EUR J PHARM SCI, V52, P12, DOI 10.1016/j.ejps.2013.10.003; Carvalho S.M., 2013, IND CROP PROD, V49, P278; Dijkstra A. J., 2007, LIPID HDB, P471, DOI DOI 10.1201/9781420009675.CH7; Dingler A, 1999, J MICROENCAPSUL, V16, P751; Elisabettini P, 1996, J AM OIL CHEM SOC, V73, P187, DOI 10.1007/BF02523893; Freitas C, 1999, EUR J PHARM BIOPHARM, V47, P125, DOI 10.1016/S0939-6411(98)00074-5; Gokce EH, 2012, INT J NANOMED, V7, P1841, DOI 10.2147/IJN.S29710; Heins A, 2007, LIPIDS, V42, P573, DOI 10.1007/s11745-007-3052-6; Heins A, 2007, LIPIDS, V42, P561, DOI 10.1007/s11745-007-3053-5; Helgason T, 2008, J AM OIL CHEM SOC, V85, P501, DOI 10.1007/s11746-008-1219-9; Helgason T, 2009, J COLLOID INTERF SCI, V334, P75, DOI 10.1016/j.jcis.2009.03.012; Helgason T, 2009, J AGR FOOD CHEM, V57, P8033, DOI 10.1021/jf901682m; Hentschel A, 2008, J FOOD SCI, V73, pN1, DOI 10.1111/j.1750-3841.2007.00641.x; Jenning V, 2000, J CONTROL RELEASE, V66, P115, DOI 10.1016/S0168-3659(99)00223-0; Jores K, 2005, PHARM RES-DORDR, V22, P1887, DOI 10.1007/s11095-005-7148-5; Jores K, 2003, PHARM RES-DORDR, V20, P1274, DOI 10.1023/A:1025065418309; Korkmaz E, 2013, ACTA PHARMACEUT, V63, P517, DOI 10.2478/acph-2013-0039; Lacatusu I, 2013, SOFT MATER, V11, P75, DOI 10.1080/1539445X.2011.582914; LAVIGNE F, 1993, J PHYS IV, V3, P137, DOI 10.1051/jp4:1993825; Niculae G, 2014, COMPTES RENDUS CHIMI; Nik AM, 2012, J AGR FOOD CHEM, V60, P4126, DOI 10.1021/jf204810m; Noack A, 2012, INT J PHARMACEUT, V423, P440, DOI 10.1016/j.ijpharm.2011.12.011; Oehlke K, 2011, FOOD CHEM, V124, P781, DOI 10.1016/j.foodchem.2010.06.095; Oehlke K, 2010, FOOD CHEM, V118, P48, DOI 10.1016/j.foodchem.2009.04.078; Oh JH, 2005, J AM OIL CHEM SOC, V82, P13, DOI 10.1007/s11746-005-1036-y; Oh JH, 2002, J FOOD SCI, V67, P2911, DOI 10.1111/j.1365-2621.2002.tb08837.x; Rousseau D, 2005, J AM OIL CHEM SOC, V82, P7, DOI 10.1007/s11746-005-1035-z; Sanchez-Paz V, 2008, J COLLOID INTERF SCI, V320, P1, DOI 10.1016/j.jcis.2007.12.018; Seetapan N, 2010, MICRON, V41, P51, DOI 10.1016/j.micron.2009.08.003; Sonnen AFP, 2005, J AM CHEM SOC, V127, P15575, DOI 10.1021/ja054367l; Trombino S, 2013, COLLOID SURFACE B, V109, P273, DOI 10.1016/j.colsurfb.2013.04.005; Trombino S, 2009, COLLOID SURFACE B, V72, P181, DOI 10.1016/j.colsurfb.2009.03.032; Unruh T, 2001, COLLOID POLYM SCI, V279, P398, DOI 10.1007/s003960000436; Weiss J, 2008, FOOD BIOPHYS, V3, P146, DOI 10.1007/s11483-008-9065-8; Westesen K, 1997, J CONTROL RELEASE, V48, P223, DOI 10.1016/S0168-3659(97)00046-1; Yucel U, 2013, J COLLOID INTERF SCI, V394, P20, DOI 10.1016/j.jcis.2012.12.042; Zimmermann E, 2001, EUR J PHARM BIOPHARM, V52, P203, DOI 10.1016/S0939-6411(01)00167-9	46	48	48	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171662	10.1371/journal.pone.0171662	http://dx.doi.org/10.1371/journal.pone.0171662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192494	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800036
J	Ogbo, FA; Agho, K; Ogeleka, P; Woolfenden, S; Page, A; Eastwood, J				Ogbo, Felix A.; Agho, Kingsley; Ogeleka, Pascal; Woolfenden, Sue; Page, Andrew; Eastwood, John		Global Child Hlth Res Interest Grp	Infant feeding practices and diarrhoea in sub-Saharan African countries with high diarrhoea mortality	PLOS ONE			English	Article							BREAST-MILK SUBSTITUTES; INTERNATIONAL CODE; NIGERIA EVIDENCE; CHILD-MORTALITY; DETERMINANTS; PREVALENCE; PATTERNS; DISEASE; AGE	Background The impacts of optimal infant feeding practices on diarrhoea have been documented in some developing countries, but not in countries with high diarrhoea mortality as reported by the World Health Organisation/United Nations Children's Fund. We aimed to investigate the association between infant feeding practices and diarrhoea in sub-Saharan African countries with high diarrhoea mortality. Method The study used the most recent Demographic and Health Survey datasets collected in nine sub-Saharan African countries with high diarrhoea mortality, namely: Burkina Faso (2010, N = 9,733); Demographic Republic of Congo (2013; N = 10,458); Ethiopia (2013, N = 7,251); Kenya (2014, N = 14,034); Mali (2013, N = 6,365); Niger (2013, N = 7,235); Nigeria (2013, N = 18,539); Tanzania (2010, N = 5,013); and Uganda (2010, N = 4,472). Multilevel logistic regression models that adjusted for cluster and sampling weights were used to investigate the association between infant feeding practices and diarrhoea in these nine African countries. Results Diarrhoea prevalence was lower among children whose mothers practiced early initiation of breastfeeding, exclusive and predominant breastfeeding. Early initiation of breastfeeding and exclusive breastfeeding were significantly associated with lower risk of diarrhoea (OR = 0.81; 95% confidence interval (CI): 0.77-0.85, P<0.001 and OR = 0.50; 95% CI: 0.43-0.57, respectively). In contrast, introduction of complementary foods (OR = 1.31; 95% CI: 1.14-1.50) and continued breastfeeding at one year (OR = 1.27; 95% CI: 1.05-1.55) were significantly associated with a higher risk of diarrhoea. Conclusion Early initiation of breastfeeding and exclusive breastfeeding are protective of diarrhoea in sub-Saharan African countries with high diarrhoea mortality. To reduce diarrhoea mortality and also achieve the health-related sustainable development goals in sub-Saharan African, an integrated, multi-agency strategic partnership within each country is needed to improve optimal infant feeding practices.	[Ogbo, Felix A.; Page, Andrew] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Sydney, NSW, Australia; [Ogbo, Felix A.; Woolfenden, Sue; Page, Andrew; Eastwood, John] Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Agho, Kingsley] Univ Western Sydney, Sch Sci & Hlth, Campbelltown Campus, Sydney, NSW, Australia; [Ogeleka, Pascal] La Trobe Univ, Coll Sci, Sch Publ Hlth Hlth & Engn, Dept Publ Hlth, Bundoora, Vic, Australia; [Woolfenden, Sue] Sydney Childrens Hosp Network, Dept Commun Child Hlth Integrated Care, Randwick, NSW, Australia; [Eastwood, John] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Eastwood, John] Univ Sydney, Sch Publ Hlth, Charles Perkins Ctr, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Eastwood, John] Griffith Univ, Sch Publ Hlth, Gold Coast, Qld, Australia; [Eastwood, John] Croydon Community Hlth Ctr, Sydney Local Hlth Dist, Dept Commun Paediat, Croydon, NSW, Australia; [Global Child Hlth Res Interest Grp] Sydney Childrens Hosp Network, Randwick, NSW, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; Western Sydney University; La Trobe University; University of New South Wales Sydney; University of Sydney; Griffith University	Ogbo, FA (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Sydney, NSW, Australia.; Ogbo, FA (corresponding author), Ingham Inst Appl Med Res, Liverpool, NSW, Australia.	felgbo@yahoo.co.uk	Agho, Kingsley/AAE-9971-2020; Agho, Kingsley/AAW-5622-2021; Woolfenden, Susan/S-9234-2019; Zwi, Karen/S-4547-2016	Agho, Kingsley/0000-0003-4111-3207; Woolfenden, Susan/0000-0002-6954-5071; Oei, Ju Lee/0000-0002-7799-3771; Homaira, Nusrat/0000-0003-3341-7964; Zwi, Karen/0000-0002-5561-5200; Gunasekera, Hasantha/0000-0003-4900-1277; Jaffe, Adam/0000-0002-1963-5415				Abrahams SW, 2012, J HUM LACT, V28, P400, DOI 10.1177/0890334412447080; Abrahams SW, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-11; Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Aguayo VM, 2003, BRIT MED J, V326, P127, DOI 10.1136/bmj.326.7381.127; Agunbiade OM, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-5; Ahs J.W., 2010, OPEN INFECT DIS J, V4, P113, DOI 10.2174/1874279301004010113; Anigo KM, 2009, AFRICAN J BIOTECHNOL, V8; [Anonymous], 2010, CONS REP 6 COUNTR RE; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Baker P, 2016, PUBLIC HEALTH NUTR, V19, P2540, DOI 10.1017/S1368980016001117; Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Centers for Disease Control and Prevention, 2016, DIARRH COMM ILLN GLO; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Ehiri JE, 2001, B WORLD HEALTH ORGAN, V79, P423; Federal Ministry of Health-Nigeria, 2015, WORLD BREASTF TRENDS; Fuller JA, 2015, TROP MED INT HEALTH, V20, P284, DOI 10.1111/tmi.12441; Future Market Insights, 2016, INF FORM MARK RAP IN; Gibson RS, 1998, EUR J CLIN NUTR, V52, P764, DOI 10.1038/sj.ejcn.1600645; Godana W, 2013, RURAL REMOTE HEALTH, V13; Hajeebhoy N, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-12; Horta B., 2013, EVIDENCE LONG TERM E, P1; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Institute for Health Metrics and Evaluation, 2016, FIN GLOB HLTH 2015 D; Issaka AI, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12193; Kaferstein FK, 2003, B WORLD HEALTH ORGAN, V81, P842; Kent G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0020-7; Kerr RB, 2008, SOC SCI MED, V66, P1095, DOI 10.1016/j.socscimed.2007.11.019; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Liu AH, 2014, BREASTFEED MED, V9, P467, DOI 10.1089/bfm.2014.0053; MICKLESON KNP, 1982, J PEDIATR GASTR NUTR, V1, P381, DOI 10.1097/00005176-198201030-00018; Mihrshahi S, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-28; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Ogbo FA, 2016, PAEDIATR PERINAT EP, V30, P346, DOI 10.1111/ppe.12293; Ogbo FA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008467; Ogbo FA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1595-7; Ogbo FA, 2015, PUBLIC HEALTH NUTR, V18, P3287, DOI 10.1017/S136898001500052X; Oni GA, 1996, E AFR MED J, V73, P283; Onofiok N. O., 1998, Food and Nutrition Bulletin, V19, P27; Philipp BL, 2001, PEDIATRICS, V108, P677, DOI 10.1542/peds.108.3.677; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Save the Children, 2015, BREASTF POL MATT ID; Sheth Mini, 2006, Indian Journal of Pediatrics, V73, P61, DOI 10.1007/BF02758262; Tambe AB., 2015, CHALLENGES, V6, P229, DOI [DOI 10.3390/CHALLE6020229, 10.3390/challe6020229]; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; Unicef, 2010, DIARRH WHY CHILDR AR; UNICEF WHO, 2012, PNEUM DIARRH TRACKL; Unicef World Health Organization, 2015, PROGR SAN DRINK WAT; United Nations, 2022, SUSTAIN DEV, DOI DOI 10.1002/SD.2445; Verduci E, 2014, NUTRIENTS, V6, P1711, DOI 10.3390/nu6041711; Victor R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001529; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Victora CG, 2005, ACTA PAEDIATR, V94, P1656, DOI 10.1080/08035250500252658; WHO, 2008, IND ASS INF YOUNG CH, V1; WHO; UNICEF USAID AED UCDAVIS IFPRI, 2008, IND ASS INF YOUNG 2; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2014, POLICY BRIEF SERIES; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2011, AB DECL 10 YEARS; World Health Organization, 2013, COUNTR IMPL INT COD; World Health Organization, 2013, SHORT TERM EFF BREAS; World Health Organization, 1991, IND ACC BREASTF PRAC; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ziyane IS, 1999, J ADV NURS, V29, P721, DOI 10.1046/j.1365-2648.1999.00942.x	71	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171792	10.1371/journal.pone.0171792	http://dx.doi.org/10.1371/journal.pone.0171792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192518	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800041
J	Rogier, E; Plucinski, M; Lucchi, N; Mace, K; Chang, M; Lemoine, JF; Candrinho, B; Colborn, J; Dimbu, R; Fortes, F; Udhayakumar, V; Barnwell, J				Rogier, Eric; Plucinski, Mateusz; Lucchi, Naomi; Mace, Kimberly; Chang, Michelle; Lemoine, Jean Frantz; Candrinho, Baltazar; Colborn, James; Dimbu, Rafael; Fortes, Filomeno; Udhayakumar, Venkatachalam; Barnwell, John			Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests	PLOS ONE			English	Article							ANTIGEN-DETECTION; PREGNANT-WOMEN; PARASITE; PLASMA; HRP2; PERFORMANCE; PFHRP2; BLOOD; COMBINATION; MANAGEMENT	Detection of histidine-rich protein 2 (HRP2) from the malaria parasite Plasmodium falciparum provides evidence for active or recent infection, and is utilized for both diagnostic and surveillance purposes, but current laboratory immunoassays for HRP2 are hindered by low sensitivities and high costs. Here we present a new HRP2 immunoassay based on antigen capture through a bead-based system capable of detecting HRP2 at sub-picogram levels. The assay is highly specific and cost-effective, allowing fast processing and screening of large numbers of samples. We utilized the assay to assess results of HRP2-based rapid diagnostic tests (RDTs) in different P. falciparum transmission settings, generating estimates for true performance in the field. Through this method of external validation, HRP2 RDTs were found to perform well in the high-endemic areas of Mozambique and Angola with 86.4% and 73.9% of persons with HRP2 in their blood testing positive by RDTs, respectively, and false-positive rates of 4.3% and 0.5%. However, in the low-endemic setting of Haiti, only 14.5% of persons found to be HRP2 positive by the bead assay were RDT positive. Additionally, 62.5% of Haitians showing a positive RDT test had no detectable HRP2 by the bead assay, likely indicating that these were false positive tests. In addition to RDT validation, HRP2 biomass was assessed for the populations in these different settings, and may provide an additional metric by which to estimate P. falciparum transmission intensity and measure the impact of interventions.	[Rogier, Eric; Plucinski, Mateusz; Lucchi, Naomi; Mace, Kimberly; Chang, Michelle; Udhayakumar, Venkatachalam; Barnwell, John] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30329 USA; [Lemoine, Jean Frantz] Minist Sante Publ & Populat, Programme Natl Controle Malaria, Port Au Prince, Haiti; [Candrinho, Baltazar] Natl Malaria Control Program, Maputo, Mozambique; [Colborn, James] Clinton Hlth Access Initiat, Boston, MA USA; [Dimbu, Rafael; Fortes, Filomeno] Natl Malaria Control Program, Luanda, Angola	Centers for Disease Control & Prevention - USA	Rogier, E (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA 30329 USA.	erogier@cdc.gov		Fortes, Fabiane/0000-0001-6217-3474; Lucchi, Naomi/0000-0001-8789-8041; Plucinski, Mateusz/0000-0002-7322-4625	Global Fund; President's Malaria Initiative; World Health Organization	Global Fund; President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); World Health Organization(World Health Organization)	This work was supported by: The Global Fund, grant number not available, http://www.theglobalfund.org/en/; President's Malaria Initiative, grant number not available, https://www.pmi.gov/; and the World Health Organization, www.who.int, grant number not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1990, AM J TROP MED HYG, V43, P30, DOI 10.4269/ajtmh.1990.43.30; Atroosh WM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1008-x; Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bashir IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056828; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Biswas S, 2005, ANN TROP MED PARASIT, V99, P553, DOI 10.1179/136485905X51463; Boncy PJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0753-9; Bushman M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3038; Butterworth AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-95; Candrinho B. MJ, 2016, EVALUATING COVERAGE; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675; Ho MF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-480; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Imwong M, 2016, J INFECT DIS, V213, P1322, DOI 10.1093/infdis/jiv596; Imwong M, 2015, J INFECT DIS, V211, P1128, DOI 10.1093/infdis/jiu590; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Kifude CM, 2008, CLIN VACCINE IMMUNOL, V15, P1012, DOI 10.1128/CVI.00385-07; KILEJIAN A, 1974, J BIOL CHEM, V249, P4650; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Laban NM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0544-3; Martin SK, 2009, AM J TROP MED HYG, V80, P516, DOI 10.4269/ajtmh.2009.80.516; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Noedl H, 2007, ANTIMICROB AGENTS CH, V51, P651, DOI 10.1128/AAC.01023-06; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; PARRA ME, 1991, J CLIN MICROBIOL, V29, P1629, DOI 10.1128/JCM.29.8.1629-1634.1991; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Plucinski MM, 2015, TROP MED INT HEALTH, V20, P1685, DOI 10.1111/tmi.12596; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sinha I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0900-3; Sullivan RT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1190-0; Tjitra E, 1999, J CLIN MICROBIOL, V37, P2412, DOI 10.1128/JCM.37.8.2412-2417.1999; Tjitra E, 2001, J CLIN MICROBIOL, V39, P1025, DOI 10.1128/JCM.39.3.1025-1031.2001; Williams JE, 2016, CLIN INFECT DIS, V62, P837, DOI 10.1093/cid/civ1198; World Health Oganization, 2015, WORLD MALARIA REPORT, DOI [10.1186/s12936-015-0544-3PMID:25888818, DOI 10.1186/S12936-015-0544-3]; World Health Organization, 2015, MAL RAP DIAGN TEST P, DOI [10.1186/s12936-015-0753-9, DOI 10.1186/S12936-015-0753-9]	43	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172139	10.1371/journal.pone.0172139	http://dx.doi.org/10.1371/journal.pone.0172139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192523	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800075
J	Sabran, MI; Rahim, SKA; Leow, CY; Soh, PJ; Chew, BW; Vandenbosch, GAE				Sabran, Mursyidul Idzam; Rahim, Sharul Kamal Abdul; Leow, Chee Yen; Soh, Ping Jack; Chew, Beng Wah; Vandenbosch, Guy A. E.			Compact circularly polarized truncated square ring slot antenna with suppressed higher resonances	PLOS ONE			English	Article							DEFECTED GROUND STRUCTURE; WIRELESS POWER TRANSMISSION; MICROSTRIP ANTENNA; HARMONIC SUPPRESSION; DATA COMMUNICATION; RECTENNA; DESIGN; FILTENNA	This paper presents a compact circularly polarized (CP) antenna with an integrated higher order harmonic rejection filter. The proposed design operates within the ISM band of 2.32 GHz-2.63 GHz and is suitable for example for wireless power transfer applications. Asymmetrical truncated edges on a square ring create a defected ground structure to excite the CP property, simultaneously realizing compactness. It offers a 50.5% reduced patch area compared to a conventional design. Novel stubs and slot shapes are integrated in the transmission line to reduce higher (up to the third) order harmonics. The proposed prototype yields a -10 dB reflection coefficient (S-11) impedance bandwidth of 12.53%, a 3 dB axial ratio bandwidth of 3.27%, and a gain of 5.64 dBi. Measurements also show good agreement with simulations.	[Sabran, Mursyidul Idzam; Rahim, Sharul Kamal Abdul; Leow, Chee Yen] Univ Teknol Malaysia, Wireless Commun Ctr, Skudai, Johor, Malaysia; [Soh, Ping Jack] Univ Malaysia Perlis, Sch Comp & Commun Engn, Adv Commun Engn ACE CoE, Arau, Perlis, Malaysia; [Chew, Beng Wah] Intel Microelect, Halaman Kampung Jawa, Penang, Malaysia; [Vandenbosch, Guy A. E.] Katholieke Univ Leuven, Dept Elect Engn, Leuven, Belgium	Universiti Teknologi Malaysia; Universiti Malaysia Perlis; Intel Corporation; KU Leuven	Rahim, SKA (corresponding author), Univ Teknol Malaysia, Wireless Commun Ctr, Skudai, Johor, Malaysia.	sharulkamal@fke.utm.my	Soh, Ping Jack/C-7255-2008; rahim, sharul kamal abdul/K-6346-2012; LEOW, CHEE YEN/J-9206-2018; Vandenbosch, Guy A/J-3209-2012; Sabran, Mursyidul Idzam/AAM-2727-2021	Soh, Ping Jack/0000-0002-6394-5330; rahim, sharul kamal abdul/0000-0003-4511-1989; LEOW, CHEE YEN/0000-0001-6418-0184; 	Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia [4B151]; Universiti Teknologi Malaysia [05H39, 4F617]	Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia; Universiti Teknologi Malaysia	This work was supported in part by the Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia, under Grant Number 4B151; and Universiti Teknologi Malaysia under Grant Numbers 05H39 and 4F617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for author BWC, and was involved in the decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section	Abedian M, 2012, IEEE ANTENN WIREL PR, V11, P1533, DOI 10.1109/LAWP.2012.2232639; Ali M, 2005, IEEE ANTENN WIREL PR, V4, P205, DOI 10.1109/LAWP.2005.851004; Ali M, 2006, IEEE ANTENNAS WIRELE, V5; Biswas S, 2013, IEEE T ANTENN PROPAG, V61, P3349, DOI 10.1109/TAP.2013.2250240; Chen JX, 2011, PROG ELECTROMAGN RES, V111, P25, DOI 10.2528/PIER10100808; Chen L, 2014, ELECTRON LETT, V50, P1496, DOI 10.1049/el.2014.2703; Chen XW, 2013, IEEE ANTENN WIREL PR, V12, P857, DOI 10.1109/LAWP.2013.2271972; Dahlan A, 2010, J ELECTROMAGNET WAVE, V24, P27; Huang FJ, 2012, IEEE ANTENN WIREL PR, V11, P592, DOI 10.1109/LAWP.2012.2201437; Liu HW, 2003, MICROW OPT TECHN LET, V39, P453, DOI 10.1002/mop.11246; Liu Q, 2013, IEEE ANTENN WIREL PR, V12, P1280, DOI 10.1109/LAWP.2013.2283218; Ma ZK, 2014, IEEE T ANTENN PROPAG, V62, P371, DOI 10.1109/TAP.2013.2287009; Monti G, 2011, IEEE ANTENN WIREL PR, V10, P1116, DOI 10.1109/LAWP.2011.2171029; Park JY, 2004, IEEE ANTENN WIREL PR, V3, P52, DOI 10.1109/LAWP.2004.827889; Pei-Ling C, 2011, IEEE T ANTENN PROPAG, V57, P2854; POZAR DM, 1992, P IEEE, V80, P79, DOI 10.1109/5.119568; Prajapati PR, 2015, IET MICROW ANTENNA P, V9, P1179, DOI 10.1049/iet-map.2014.0596; Reddy BRS, 2015, IEEE ANTENN WIREL PR, V14, P678, DOI 10.1109/LAWP.2014.2376984; Reddy VV, 2014, IEEE ANTENN WIREL PR, V13, P118, DOI 10.1109/LAWP.2013.2296951; Ren YJ, 2006, IEEE T MICROW THEORY, V54, P2970, DOI 10.1109/TMTT.2006.877422; Sabran MI, 2014, ASIA PACIF MICROWAVE, P1007; Sabran M. I., 2014, 2014 IEEE Symposium on Wireless Technology and Applications (ISWTA), P81, DOI 10.1109/ISWTA.2014.6981201; Sim CYD, 2014, IEEE T ANTENN PROPAG, V62, P4828, DOI 10.1109/TAP.2014.2330595; Suh YH, 2000, ELECTRON LETT, V36, P600, DOI 10.1049/el:20000527; Takhedmit H, 2012, ELECTRON LETT, V48, P253, DOI 10.1049/el.2011.3890; Tu WH, 2007, IEEE ANTENN WIREL PR, V6, P282, DOI 10.1109/LAWP.2007.898555; Visser HJ, 2013, P IEEE, V101, P1410, DOI 10.1109/JPROC.2013.2250891; Yang XX, 2013, IEEE T ANTENN PROPAG, V61, P2532, DOI 10.1109/TAP.2013.2244550; Yo TC, 2008, IEEE T ANTENN PROPAG, V56, P882, DOI 10.1109/TAP.2008.916956; Yu C, 2012, IEEE ANTENN WIREL PR, V11, P310, DOI 10.1109/LAWP.2012.2191259	30	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172162	10.1371/journal.pone.0172162	http://dx.doi.org/10.1371/journal.pone.0172162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192504	Green Published, gold			2022-12-26	WOS:000394423800079
J	Yaesoubi, M; Miller, RL; Calhoun, VD				Yaesoubi, Maziar; Miller, Robyn L.; Calhoun, Vince D.			Time-varying spectral power of resting-state fMRI networks reveal cross-frequency dependence in dynamic connectivity	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NEURONAL OSCILLATIONS; BRAIN; PHASE; EEG; SYNCHRONY; COHERENCE; MEMORY	Brain oscillations and synchronicity among brain regions (brain connectivity) have been studied in resting-state (RS) and task-induced settings. RS-connectivity which captures brain functional integration during an unconstrained state is shown to vary with the frequency of oscillations. Indeed, high temporal resolution modalities have demonstrated both between and cross-frequency connectivity spanning across frequency bands such as theta and gamma. Despite high spatial resolution, functional magnetic resonance imaging (fMRI) suffers from low temporal resolution due to modulation with slow-varying hemodynamic response function (HRF) and also relatively low sampling rate. This limits the range of detectable frequency bands in fMRI and consequently there has been no evidence of cross frequency dependence in fMRI data. In the present work we uncover recurring patterns of spectral power in network timecourses which provides new insight on the actual nature of frequency variation in fMRI network activations. Moreover, we introduce a new measure of dependence between pairs of rs-fMRI networks which reveals significant cross-frequency dependence between functional brain networks specifically default-mode, cerebellar and visual networks. This is the first strong evidence of cross-frequency dependence between functional networks in fMRI and our subject group analysis based on age and gender supports usefulness of this observation for future clinical applications.	[Yaesoubi, Maziar; Miller, Robyn L.; Calhoun, Vince D.] Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Yaesoubi, Maziar; Calhoun, Vince D.] 1 Univ New Mexico, Deptartment ECE, MSC01 1100, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico	Yaesoubi, M (corresponding author), Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA.; Yaesoubi, M (corresponding author), 1 Univ New Mexico, Deptartment ECE, MSC01 1100, Albuquerque, NM 87131 USA.	myaesoubi@mrn.org	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747	National Institutes of Health (NIH) [1R01B3006841, R01EB020407, P20GM103472]; National Science Foundation (NSF) [1539067]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020407] Funding Source: NIH RePORTER; Office of Integrative Activities [1539067] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Support was provided by the National Institutes of Health (NIH) 1R01B3006841 (to VC), R01EB020407, P20GM103472; and the National Science Foundation (NSF) 1539067.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Berendse HW, 2000, CLIN NEUROPHYSIOL, V111, P604, DOI 10.1016/S1388-2457(99)00309-0; BESTHORN C, 1994, ELECTROEN CLIN NEURO, V90, P242, DOI 10.1016/0013-4694(94)90095-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Yaesoubi M, 2015, NEUROIMAGE, V120, P133, DOI 10.1016/j.neuroimage.2015.07.002; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171647	10.1371/journal.pone.0171647	http://dx.doi.org/10.1371/journal.pone.0171647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192457	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800035
J	Zhao, N; Wu, J; Xiong, SM; Zhang, LY; Lu, X; Chen, SL; Wu, QF; Wang, HL; Liu, Y; Chen, ZL; Zuo, DM				Zhao, Na; Wu, Jie; Xiong, Simin; Zhang, Liyun; Lu, Xiao; Chen, Shangliang; Wu, Qifeng; Wang, Hailan; Liu, Ying; Chen, Zhengliang; Zuo, Daming			Mannan-binding lectin, a serum collectin, suppresses T-cell proliferation via direct interaction with cell surface calreticulin and inhibition of proximal T-cell receptor signaling	FASEB JOURNAL			English	Article						T-cell activation; cell cycle; silicosis	COAL-WORKERS PNEUMOCONIOSIS; LYMPHOCYTE-PROLIFERATION; PROTEIN-A; ACTIVATION; KINASES; C1Q; INTERLEUKIN-2; INTEGRIN; SILICA; PHASE	Mannan binding lectin (MBL), initially reported to activate the complement pathway, is also known to be involved in the pathogenesis of autoimmune diseases. We report a thus far unknown function of MBL as a suppressor of T-cell activation. MBL markedly inhibited T-cell proliferation induced by anti-CD3 and anti-CD28 antibodies. Moreover, the presence ofMBL during T-cell priming interfered with proximal T-cell receptor signaling by decreasing phosphorylation of Lck, ZAP-70, and LAT. MBL bound to T cells through interaction between the collagen-like region ofMBLand calreticulin (CRT) expressed on theT-cell surface. The neutralizing antibody against CRT abrogated MBL mediated suppression of T-cell proliferation, suggesting thatMBL down-modulates T-cell proliferation via cell surface CRT. We further demonstrated that the feature of MBL-mediatedT-cell suppression is shared by other serum collectins (e.g., C1q and collectin 11). The concentrations of MBL correlated negatively with in vivo T-cell activation status in patients with early-stage silicosis. Furthermore, MBL efficiently inhibited activation and proliferation of autoreactive T cells derived from patients with silicosis, indicating that MBL serves as a negative feedback control of the T-cell responses.	[Zhao, Na; Xiong, Simin; Zhang, Liyun; Lu, Xiao; Chen, Shangliang; Liu, Ying; Chen, Zhengliang; Zuo, Daming] Southern Med Univ, Dept Immunol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Zhengliang; Zuo, Daming] Southern Med Univ, Guangdong Prov Key Lab Prote, Guangzhou, Guangdong, Peoples R China; [Zhao, Na; Wu, Jie; Wu, Qifeng; Wang, Hailan] Guangdong Prov Hosp Occupat Dis Prevent & Treatme, Dept Occupat Med, Guangzhou, Guangdong, Peoples R China; [Wu, Jie; Wang, Hailan] Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Peoples R China	Southern Medical University - China; Southern Medical University - China; Shanxi Medical University	Chen, ZL; Zuo, DM (corresponding author), Southern Med Univ, Dept Immunol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China.	zhlchen@smu.edu.cn; zdaming@smu.edu.cn	Zuo, Daming/AAO-8461-2021	chen, zhengliang/0000-0002-2657-7970	Natural Science Foundation of China [31070784, 81571608, 81671568]; Natural Science Foundation of Guangdong [2016A030313537]; Foundation for Distinguished Young Teacher in Higher Education of Guangdong [Yq2013034]; Science and Technology Planning Project of Guangdong Province [2016A020215106]; Science and Technology Planning Project of Guangzhou [201607010195]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Teacher in Higher Education of Guangdong; Science and Technology Planning Project of Guangdong Province; Science and Technology Planning Project of Guangzhou	This work was supported, in part, by grants from the Natural Science Foundation of China (31070784 to Y.L.; 81571608 to Z.C.; 81671568 to D.Z.), Natural Science Foundation of Guangdong (2016A030313537 to Z.C.), Foundation for Distinguished Young Teacher in Higher Education of Guangdong (Yq2013034 to D.Z.), Science and Technology Planning Project of Guangdong Province (2016A020215106 to D.Z.), and Science and Technology Planning Project of Guangzhou (201607010195 to D.Z.). The authors declare no conflicts of interest.	Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Borron P, 1996, AM J RESP CELL MOL, V15, P115, DOI 10.1165/ajrcmb.15.1.8679215; Borron PJ, 1998, J IMMUNOL, V161, P4599; Brennan P, 1999, MOL CELL BIOL, V19, P4729; CHEN A, 1994, J IMMUNOL, V153, P1430; Cope AP, 2007, CLIN EXP RHEUMATOL, V25, pS4; Cui K, 2015, INT J ENV RES PUB HE, V12, P7444, DOI 10.3390/ijerph120707444; Dean MM, 2011, IMMUNOLOGY, V132, P296, DOI 10.1111/j.1365-2567.2010.03365.x; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Graudal NA, 1998, J RHEUMATOL, V25, P629; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P4857, DOI 10.1210/jc.2003-030742; HAREGEWOIN A, 1984, IMMUNOL REV, V80, P77, DOI 10.1111/j.1600-065X.1984.tb00495.x; Jacobsen S, 2001, J RHEUMATOL, V28, P935; Konya C, 2014, CURR OPIN RHEUMATOL, V26, P493, DOI 10.1097/BOR.0000000000000082; Krishna S, 2012, J IMMUNOL, V189, P1209, DOI 10.4049/jimmunol.1102429; Lee S, 2014, ENVIRON HEALTH PREV, V19, P322, DOI 10.1007/s12199-014-0403-9; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; MODIANO JF, 1994, J BIOL CHEM, V269, P32972; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Otsuki T, 2007, CELL MOL IMMUNOL, V4, P261; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Pernis Benvenuto, 2005, Acta Biomed, V76 Suppl 2, P38; Porcellini S, 2006, J EXP MED, V203, P461, DOI 10.1084/jem.20051519; Seelen MA, 2005, RHEUMATOLOGY, V44, P111, DOI 10.1093/rheumatology/keh417; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Turner M W, 2000, Rev Immunogenet, V2, P305; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-1; Wang XT, 2008, AM J IND MED, V51, P548, DOI 10.1002/ajim.20587; Wang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050175, 10.1371/journal.pone.0064617]; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; YOKOTA Y, 1995, J BIOCHEM-TOKYO, V117, P414, DOI 10.1093/jb/117.2.414; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zuo DM, 2010, PROTEIN PEPTIDE LETT, V17, P131, DOI 10.2174/092986610789909566	46	21	22	4	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2405	2417		10.1096/fj.201601200RR	http://dx.doi.org/10.1096/fj.201601200RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28209773				2022-12-26	WOS:000401553400016
J	Bukiya, AN; Durdagi, S; Noskov, S; Rosenhouse-Dantsker, A				Bukiya, Anna N.; Durdagi, Serdar; Noskov, Sergei; Rosenhouse-Dantsker, Avia			Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; K-ACH CHANNEL; MEMBRANE CHOLESTEROL; LARGE-CONDUCTANCE; HYPERCHOLESTEROLEMIA; IDENTIFICATION; RECTIFIER; RECEPTORS; SENSITIVITY; MECHANISMS	Hypercholesterolemia is a well known risk factor for the development of neurodegenerative disease. However, the underlying mechanisms are mostly unknown. In recent years, it has become increasingly evident that cholesterol-driven effects on physiology and pathophysiology derive from its ability to alter the function of a variety of membrane proteins including ion channels. Yet, the effect of cholesterol on G protein-gated inwardly rectifying potassium (GIRK) channels expressed in the brain is unknown. GIRK channels mediate the actions of inhibitory brain neurotransmitters. As a result, loss of GIRK function can enhance neuron excitability, whereas gain of GIRK function can reduce neuronal activity. Here we show that in rats on a high-cholesterol diet, cholesterol levels in hippocampal neurons are increased. We also demonstrate that cholesterol plays a critical role in modulating neuronal GIRK currents. Specifically, cholesterol enrichment of rat hippocampal neurons resulted in enhanced channel activity. In accordance, elevated currents upon cholesterol enrichment were also observed in Xenopus oocytes expressing GIRK2 channels, the primary GIRK subunit expressed in the brain. Furthermore, using planar lipid bilayers, we show that although cholesterol did not affect the unitary conductance of GIRK2, it significantly enhanced the frequency of channel openings. Last, combining computational and functional approaches, we identified two putative cholesterol-binding sites in the transmembrane domain of GIRK2. These findings establish that cholesterol plays a critical role in modulating GIRK activity in the brain. Because up-regulation of GIRK function can reduce neuronal activity, our findings may lead to novel approaches for prevention and therapy of cholesterol-driven neurodegenerative disease.	[Rosenhouse-Dantsker, Avia] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Bukiya, Anna N.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38103 USA; [Durdagi, Serdar; Noskov, Sergei] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Durdagi, Serdar; Noskov, Sergei] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Durdagi, Serdar] Bahcesehir Univ, Dept Biophys, Sch Med, TR-34353 Istanbul, Turkey	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Calgary; University of Calgary; Bahcesehir University	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.	dantsker@uic.edu	Bukiya, Anna/N-5361-2019; Durdagi, Serdar/J-1904-2018	Durdagi, Serdar/0000-0002-0426-0905; Noskov, Sergei/0000-0001-7769-335X	Scientist Development Grant from the American Heart Association [11SDG5190025]; National Sciences and Engineering Research Council (NSERC) [RGPIN-315019]; Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation	Scientist Development Grant from the American Heart Association(American Heart Association); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation	This work was supported in part by Scientist Development Grant 11SDG5190025 from the American Heart Association (to A. R.-D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the National Sciences and Engineering Research Council (NSERC) Discovery Grants RGPIN-315019 (to S. N.) and the Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation.	Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254; Aleksandrov A, 1996, BIOPHYS J, V70, P2680, DOI 10.1016/S0006-3495(96)79837-5; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; Awayda MS, 2011, J BIOL CHEM, V286, P1683, DOI 10.1074/jbc.M110.159194; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Bajic D, 2002, P NATL ACAD SCI USA, V99, P14494, DOI 10.1073/pnas.222379999; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; BOND CT, 1995, FEBS LETT, V367, P61, DOI 10.1016/0014-5793(95)00497-W; Bukiya A. N., 2015, HYPERCHOLESTEROLEMIA, P95; Bukiya A, 2014, ALCOHOL CLIN EXP RES, V38, P1216, DOI 10.1111/acer.12373; Bukiya AN, 2015, BBA-BIOMEMBRANES, V1848, P2406, DOI 10.1016/j.bbamem.2015.07.007; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Christian AE, 1997, J LIPID RES, V38, P2264; Chubinskiy-Nadezhdin VI, 2011, BIOCHEM BIOPH RES CO, V412, P80, DOI 10.1016/j.bbrc.2011.07.046; Clayton PT, 1998, ARCH DIS CHILD, V78, P185, DOI 10.1136/adc.78.2.185; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; Deng W, 2012, J BIOL CHEM, V287, P4925, DOI 10.1074/jbc.M111.306134; Dias IHK, 2014, BIOCHEM SOC T, V42, P1001, DOI 10.1042/BST20140164; Dopico AM, 2012, PHARMACOL THERAPEUT, V135, P133, DOI 10.1016/j.pharmthera.2012.05.002; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Grigg JJ, 1996, J NEUROPHYSIOL, V75, P318, DOI 10.1152/jn.1996.75.1.318; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Ho YS, 2012, CURR PHARM DESIGN, V18, P15, DOI 10.2174/138161212798919039; Jones PJH, 1996, ARTERIOSCL THROM VAS, V16, P1222, DOI 10.1161/01.ATV.16.10.1222; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; Kawano T, 2004, NEUROSCI LETT, V358, P63, DOI 10.1016/j.neulet.2003.12.104; Kitamura H, 2000, J PHARMACOL EXP THER, V293, P196; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kruth Howard S., 2001, Current Molecular Medicine (Hilversum), V1, P633, DOI 10.2174/1566524013363212; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Michaeli A, 2010, NEUROSCIENCE, V165, P1159, DOI 10.1016/j.neuroscience.2009.11.045; MIYAKE M, 1989, P NATL ACAD SCI USA, V86, P3419, DOI 10.1073/pnas.86.9.3419; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nelson CS, 1997, MOL BRAIN RES, V46, P185, DOI 10.1016/S0169-328X(96)00301-4; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Rosenhouse-Dantsker A, 2013, J BIOL CHEM, V288, P31154, DOI 10.1074/jbc.M113.496117; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Singh A. K., 2012, J ENV SCI TOXICOL FO, V1, P1, DOI DOI 10.1016/J.BMC.2011.09.022; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Surmeier DJ, 1996, P NATL ACAD SCI USA, V93, P11191, DOI 10.1073/pnas.93.20.11191; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vaithianathan T, 2010, AM J PHYSIOL-CELL PH, V299, pC264, DOI 10.1152/ajpcell.00318.2009; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; VELIMIROVIC BM, 1995, P NATL ACAD SCI USA, V92, P1590, DOI 10.1073/pnas.92.5.1590; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Witkowski G, 2008, NEUROSCIENCE, V155, P53, DOI 10.1016/j.neuroscience.2008.05.021; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	91	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6135	6147		10.1074/jbc.M116.753350	http://dx.doi.org/10.1074/jbc.M116.753350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28213520	hybrid, Green Published			2022-12-26	WOS:000399538700011
J	Liu, F; Qin, YY; Yu, SS; Soares, DC; Yang, LF; Weng, J; Li, C; Gao, M; Lu, ZJ; Hu, XB; Liu, XL; Jiang, T; Liu, JY; Shu, XH; Tang, ZH; Liu, MG				Liu, Fei; Qin, Yayun; Yu, Shanshan; Soares, Dinesh C.; Yang, Lifang; Weng, Jun; Li, Chang; Gao, Meng; Lu, Zhaojing; Hu, Xuebin; Liu, Xiliang; Jiang, Tao; Liu, Jing Yu; Shu, Xinhua; Tang, Zhaohui; Liu, Mugen			Pathogenic mutations in retinitis pigmentosa 2 predominantly result in loss of RP2 protein stability in humans and zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORTH-AMERICAN COHORT; RETINITIS-PIGMENTOSA-2 PROTEIN; PHOTORECEPTOR DEGENERATION; GENE; FAMILIES; RPGR; IDENTIFICATION; PHENOTYPE; TRAFFICKING; INTERACTS	Mutations in retinitis pigmentosa 2 (RP2) account for 10-20% of X-linked retinitis pigmentosa (RP) cases. The encoded RP2 protein is implicated in ciliary trafficking of myristoylated and prenylated proteins in photoreceptor cells. To date > 70 mutations in RP2 have been identified. How these mutations disrupt the function of RP2 is not fully understood. Here we report a novel in-frame 12-bp deletion (c. 357_ 368del, p. Pro120_ Gly123del) in zebrafish rp2. The mutant zebrafish shows reduced rod phototransduction proteins and progressive retinal degeneration. Interestingly, the protein level of mutant Rp2 is almost undetectable, whereas itsmRNAlevel is near normal, indicating a possible post-translational effect of the mutation. Consistent with this hypothesis, the equivalent 12-bp deletion in human RP2 markedly impairs RP2 protein stability and reduces its protein level. Furthermore, we found that a majority of the RP2 pathogenic mutations (including missense, single-residue deletion, and C-terminal truncation mutations) severely destabilize the RP2 protein. The destabilized RP2 mutant proteins are degraded via the proteasome pathway, resulting in dramatically decreased protein levels. The remaining non-destabilizing mutations T87I, R118H/R118G/R118L/R118C, E138G, and R211H/R211L are suggested to impair the interaction between RP2 and its protein partners (such as ARL3) or with as yet unknown partners. By utilizing a combination of in silico, in vitro, and in vivo approaches, our work comprehensively indicates that loss of RP2 protein structural stability is the predominating pathogenic consequence for most RP2 mutations. Our study also reveals a role of the C-terminal domain of RP2 in maintaining the overall protein stability.	[Liu, Fei; Qin, Yayun; Yu, Shanshan; Yang, Lifang; Weng, Jun; Li, Chang; Gao, Meng; Lu, Zhaojing; Hu, Xuebin; Liu, Xiliang; Jiang, Tao; Liu, Jing Yu; Tang, Zhaohui; Liu, Mugen] Huazhong Univ Sci & Technol, Dept Genet & Dev Biol, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Soares, Dinesh C.] Univ Edinburgh, MRC Human Genet Unit, Ctr Genom & Expt Med, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Shu, Xinhua] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland	Huazhong University of Science & Technology; University of Edinburgh; Glasgow Caledonian University	Liu, MG (corresponding author), Huazhong Univ Sci & Technol, Dept Genet & Dev Biol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	lium@hust.edu.cn	Liu, Fei/AAR-6464-2021; Soares, Dinesh/A-4425-2012	Liu, Fei/0000-0002-0310-1072; Soares, Dinesh/0000-0001-7557-0495	National Natural Science Foundation of China [81670890, 31601026, 81500762, 31571303, 31471194, 81371064]; China Postdoctoral Science Foundation [2015M582216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81670890, 31601026, 81500762, 31571303, 31471194, and 81371064) and the China Postdoctoral Science Foundation (2015M582216). The authors declare that they have no conflicts of interest with the contents of this article.	Alibes A, 2010, NUCLEIC ACIDS RES, V38, P7422, DOI 10.1093/nar/gkq683; Bader I, 2003, INVEST OPHTH VIS SCI, V44, P1458, DOI 10.1167/iovs.02-0605; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Chapple JP, 2000, HUM MOL GENET, V9, P1919, DOI 10.1093/hmg/9.13.1919; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Dandekar SS, 2004, BRIT J OPHTHALMOL, V88, P528, DOI 10.1136/bjo.2003.027979; Evans RJ, 2006, EXP EYE RES, V82, P543, DOI 10.1016/j.exer.2005.10.023; Grayson C, 2002, J MED GENET, V39, P62, DOI 10.1136/jmg.39.1.62; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Li C, 2014, BBA-MOL BASIS DIS, V1842, P1121, DOI 10.1016/j.bbadis.2014.04.009; Li LJ, 2015, CYTOSKELETON, V72, P447, DOI 10.1002/cm.21255; Li LJ, 2013, INVEST OPHTH VIS SCI, V54, P4503, DOI 10.1167/iovs.13-12140; Liu F, 2015, HUM MOL GENET, V24, P4648, DOI 10.1093/hmg/ddv197; Mears AJ, 1999, AM J HUM GENET, V64, P897, DOI 10.1086/302298; Miano MG, 2001, HUM MUTAT, V18, P109, DOI 10.1002/humu.1160; Neidhardt J, 2008, MOL VIS, V14, P1081; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Patil SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021379; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Pomares E, 2009, INVEST OPHTH VIS SCI, V50, P5107, DOI 10.1167/iovs.08-3208; Prokisch H, 2007, INVEST OPHTH VIS SCI, V48, P4012, DOI 10.1167/iovs.07-0071; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Schwahn U, 2001, HUM MOL GENET, V10, P1177, DOI 10.1093/hmg/10.11.1177; Schwarz N, 2012, HUM MOL GENET, V21, P863, DOI 10.1093/hmg/ddr520; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Thiselton D L, 2000, Hum Mutat, V15, P580, DOI 10.1002/1098-1004(200006)15:6<580::AID-HUMU15>3.0.CO;2-3; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Villaverde-Montero Cristina, 2007, Hum Genet, V121, P289; Wada Y, 2000, INVEST OPHTH VIS SCI, V41, P290; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Wright ZC, 2016, HUM MOL GENET, V25, P2031, DOI 10.1093/hmg/ddw077; Yoon JH, 2006, EXP CELL RES, V312, P1323, DOI 10.1016/j.yexcr.2005.12.026; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915	50	14	14	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6225	6239		10.1074/jbc.M116.760314	http://dx.doi.org/10.1074/jbc.M116.760314			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28209709	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000399538700018
J	Kahende, J; Malarcher, A; England, L; Zhang, L; Mowery, P; Xu, X; Sevilimedu, V; Rolle, I				Kahende, Jennifer; Malarcher, Ann; England, Lucinda; Zhang, Lei; Mowery, Paul; Xu, Xin; Sevilimedu, Varadan; Rolle, Italia			Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; COVERAGE; SMOKERS; IMPACT; AIDS	Objective To assess state coverage and utilization of Medicaid smoking cessation medication benefits among fee-for-service enrollees who smoked cigarettes. Methods We used the linked National Health Interview Survey (survey years 1995, 1997 - 2005) and the Medicaid Analytic eXtract files (1999 - 2008) to assess utilization of smoking cessation medication benefits among 5,982 cigarette smokers aged 18 - 64 years enrolled in Medicaid fee-for-service whose state Medicaid insurance covered at least one cessation medication. We excluded visits during pregnancy, and those covered by managed care or under dual enrollment (Medicaid and Medicare). Multivariate logistic regression was used to determine correlates of cessation medication benefit utilization among Medicaid fee-for-service enrollees, including measures of drug coverage (comprehensive cessation medication coverage, number of medications in state benefit, varenicline coverage), individual-level demographics at NHIS interview, age at Medicaid enrollment, and state-level cigarette excise taxes, statewide smoke-free laws, and per-capita tobacco control funding. Results In 1999, the percent of smokers with >= 1 medication claims was 5.7% in the 30 states that covered at least one Food and Drug Administration (FDA)-approved cessation medication; this increased to 9.9% in 2008 in the 44 states that covered at least one FDA-approved medication (p < 0.01). Cessation medication utilization was greater among older individuals ( >= 25 years), females, non-Hispanic whites, and those with higher educational attainment. Comprehensive coverage, the number of smoking cessation medications covered and varenicline coverage were all positively associated with utilization; cigarette excise tax and percapita tobacco control funding were also positively associated with utilization. Conclusions Utilization of medication benefits among fee-for-service Medicaid enrollees increased from 1999 - 2008 and varied by individual and state-level characteristics. Given that the Affordable Care Act bars state Medicaid programs from excluding any FDA-approved cessation medications from coverage as of January 2014, monitoring Medicaid cessation medication claims may be beneficial for informing efforts to increase utilization and maximize smoking cessation.	[Kahende, Jennifer; Malarcher, Ann; England, Lucinda; Zhang, Lei; Xu, Xin; Rolle, Italia] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Mowery, Paul; Sevilimedu, Varadan] Biostatistics Inc, Sarasota, FL USA	Centers for Disease Control & Prevention - USA	Kahende, J (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	izk7@cdc.gov	Sevilimedu, Varadan/AHD-5676-2022	Xu, Xin/0000-0002-5219-499X	Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion [4157-026]; Biostatistics, Inc.	Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion; Biostatistics, Inc.	The Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion provided funding for this project (contract 4157-026). Through this funding, Biostatistics, Inc. served as a contractor to CDC for this project and did not provide any funding for the project. Biostatistics, Inc. provided support in the form of salaries for authors Paul Mowery and Varadan Sevilimedu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association, 2008, TOB POL TREND REP HE; Babb S, 2017, MMWR-MORBID MORTAL W, V65, P1457, DOI 10.15585/mmwr.mm6552a1; Blackwell DL, 2012, VITAL HLTH STAT, V10, P1; Bondy SJ, 2012, CHRON DIS INJ CAN, V33, P19; Bush T, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/314740; Carpenter MJ, 2011, J NATL MED ASSOC, V103, P885, DOI 10.1016/S0027-9684(15)30444-2; Center for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P1199; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1194; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, P117; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P54; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P496; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P979; Centers for Medicare and Medicaid Services, 2014, MED MAN CAR ENR REP; Chaloupka FJ, 2000, HANDB ECON, V17, P1539; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; Community Preventive Services Task Force, GUID COMM PREV SERV; Cook-Shimanek M, 2013, NICOTINE TOB RES, V15, P1926, DOI 10.1093/ntr/ntt085; Curry SJ, 2007, AM J PUBLIC HEALTH, V97, P1464, DOI 10.2105/AJPH.2006.103788; Fiore MC, 2008, TREATING TOBACCO USE; Frieden Thomas R, 2012, MMWR Suppl, V61, P1; Fu SS, 2005, AM J HEALTH PROMOT, V20, P108, DOI 10.4278/0890-1171-20.2.108; Fu SS, 2007, PREV MED, V44, P235, DOI 10.1016/j.ypmed.2006.11.002; Greene J, 2014, AM J PREV MED, V46, P331, DOI 10.1016/j.amepre.2013.11.019; Guide to Community Preventive Services, 2012, RED TOB US SEC SMOK; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Kotz D, 2009, ADDICTION, V104, P1403, DOI 10.1111/j.1360-0443.2009.02639.x; Ku L, 2016, HEALTH AFFAIR, V35, P62, DOI 10.1377/hlthaff.2015.0756; Land T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009770; Levinson AH, 2004, AM J PREV MED, V26, P105, DOI 10.1016/j.amepre.2003.10.012; Li CH, 2012, AM J PREV MED, V42, P588, DOI 10.1016/j.amepre.2012.02.018; Liu F, 2010, PUBLIC HEALTH, V124, P553, DOI 10.1016/j.puhe.2010.05.015; McMenamin SB, 2006, AM J PREV MED, V31, P369, DOI 10.1016/j.amepre.2006.07.015; Metzger KB, 2005, AM J PUBLIC HEALTH, V95, P1050, DOI 10.2105/AJPH.2004.048025; O'Hara B, 2012, CURR POPUL REP, V2012, P70; Orzechowski W, 2007, TAX BURDEN TOBACCO H; Shiffman S, 2008, DRUG ALCOHOL DEPEN, V93, P121, DOI 10.1016/j.drugalcdep.2007.09.005; Simon AE, 2014, DOCUMENTATION ANAL G; Singleterry J, 2015, MMWR-MORBID MORTAL W, V64, P1194, DOI 10.15585/mmwr.mm6442a3; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; US Department of Health and Human Services, 2011, HLTH PEOPL 2020; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724	43	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170381	10.1371/journal.pone.0170381	http://dx.doi.org/10.1371/journal.pone.0170381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207744	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500010
J	Kaushik, MK; Kaul, SC; Wadhwa, R; Yanagisawa, M; Urade, Y				Kaushik, Mahesh K.; Kaul, Sunil C.; Wadhwa, Renu; Yanagisawa, Masashi; Urade, Yoshihiro			Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction	PLOS ONE			English	Article							LEAF EXTRACT; OLDER-ADULTS; RATS; MICE	Insomnia is the most common sleep complaint which occurs due to difficulty in falling asleep or maintaining it. Most of currently available drugs for insomnia develop dependency and/or adverse effects. Hence natural therapies could be an alternative choice of treatment for insomnia. The root or whole plant extract of Ashwagandha (Withania somnifera) has been used to induce sleep in Indian system of traditional home medicine, Ayurveda. However, its active somnogenic components remain unidentified. We investigated the effect of various components of Ashwagandha leaf on sleep regulation by oral administration in mice. We found that the alcoholic extract that contained high amount of active withanolides was ineffective to induce sleep in mice. However, the water extract which contain triethylene glycol as a major component induced significant amount of non-rapid eye movement sleep with slight change in rapid eye movement sleep. Commercially available triethylene glycol also increased non-rapid eye movement sleep in mice in a dose-dependent (10-30 mg/mouse) manner. These results clearly demonstrated that triethylene glycol is an active sleep inducing component of Ashwagandha leaves and could potentially be useful for insomnia therapy.	[Kaushik, Mahesh K.; Urade, Yoshihiro] Univ Tsukuba, Dept Mol Sleep, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Kaushik, Mahesh K.; Yanagisawa, Masashi] Univ Tsukuba, Dept Mol Genet, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DBT AIST Int Lab Adv Biomed, Higashi 1-1-1, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Kaushik, MK; Urade, Y (corresponding author), Univ Tsukuba, Dept Mol Sleep, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.; Kaushik, MK (corresponding author), Univ Tsukuba, Dept Mol Genet, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	kaushik.m.k.kb@u.tsukuba.ac.jp; yoshihiro.ft@u.tsukuba.ac.jp	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; Kaushik, Mahesh K./AAD-5977-2019	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Kaushik, Mahesh K./0000-0003-4286-1573	"Japan Society for the Promotion of Science", KAKENHI [16H01881]	"Japan Society for the Promotion of Science", KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported financially by grant from "Japan Society for the Promotion of Science", KAKENHI grant number 16H01881 to Yoshihiro Urade.	Akhoon BA, 2016, EXP GERONTOL, V78, P47, DOI 10.1016/j.exger.2016.03.004; Ballantyne B, 2007, J APPL TOXICOL, V27, P291, DOI 10.1002/jat.1220; Borron SW, 1997, VET HUM TOXICOL, V39, P26; Calcaterra NE, 2014, ACS CHEM NEUROSCI, V5, P253, DOI 10.1021/cn5000056; Chandrasekhar K, 2012, Indian J Psychol Med, V34, P255, DOI 10.4103/0253-7176.106022; Cho S, 2014, PSYCHOPHARMACOLOGY, V231, P2825, DOI 10.1007/s00213-014-3445-1; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Gooneratne NS, 2008, CLIN GERIATR MED, V24, P121, DOI 10.1016/j.cger.2007.08.002; Gooneratne NS, 2014, CLIN GERIATR MED, V30, P591, DOI 10.1016/j.cger.2014.04.007; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jacobson LH, 2014, EXPERT REV CLIN PHAR, V7, P711, DOI 10.1586/17512433.2014.966813; Kaur K, 2004, FOOD CHEM TOXICOL, V42, P2015, DOI 10.1016/j.fct.2004.07.015; Kaushik MK, 2014, EXP NEUROL, V253, P82, DOI 10.1016/j.expneurol.2013.12.002; Kohtoh S, 2008, SLEEP BIOL RHYTHMS, V6, P163, DOI 10.1111/j.1479-8425.2008.00355.x; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kumar A, 2008, INDIAN J PHARM SCI, V70, P806, DOI 10.4103/0250-474X.49130; Kumar A, 2007, INDIAN J EXP BIOL, V45, P524; Manchanda S, 2016, MOL NEUROBIOL; MCKENNIS H, 1962, TOXICOL APPL PHARM, V4, P411, DOI 10.1016/0041-008X(62)90029-7; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; PATCHEV V, 1991, HOMEOSTASIS HLTH DIS, V33, P97; Rani G, 2005, FOOD CHEM TOXICOL, V43, P95, DOI 10.1016/j.fct.2004.07.021; Reddy M S, 2011, Indian J Psychol Med, V33, P1, DOI 10.4103/0253-7176.85388; Schwartz Thomas L, 2013, Drugs Context, V2013, P212257, DOI 10.7573/dic.212257; Vassiliadis J, 1999, J TOXICOL-CLIN TOXIC, V37, P773, DOI 10.1081/CLT-100102455; Verma SK., 2011, ASIAN J PHARM CLIN R, V4, P1; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; ZAKUSOV VV, 1977, ARCH INT PHARMACOD T, V229, P313; Zhang DY, 2010, J CLIN PSYCHOPHARM, V30, P694, DOI 10.1097/JCP.0b013e3181fa8526	31	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172508	10.1371/journal.pone.0172508	http://dx.doi.org/10.1371/journal.pone.0172508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207892	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500143
J	Kiwanuka, N; Ssetaala, A; Ssekandi, I; Nalutaaya, A; Kitandwe, PK; Ssempiira, J; Bagaya, BS; Balyegisawa, A; Kaleebu, P; Hahn, J; Lindan, C; Sewankambo, NK				Kiwanuka, Noah; Ssetaala, Ali; Ssekandi, Ismail; Nalutaaya, Annet; Kitandwe, Paul Kato; Ssempiira, Julius; Bagaya, Bernard Ssentalo; Balyegisawa, Apolo; Kaleebu, Pontiano; Hahn, Judith; Lindan, Christina; Sewankambo, Nelson Kaulukusi			Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda	PLOS ONE			English	Article							RISKY SEXUAL-BEHAVIOR; UNPROTECTED SEX; RURAL UGANDA; RAKAI; PREVALENCE; INTERVENTION; METAANALYSIS; DISTRICT; VIOLENCE; COST	Background Although the association between alcohol consumption and HIV risk is well documented, few studies have examined the magnitude of new HIV infections that could be prevented by controlling alcohol use. We report the population attributable fraction (PAF) of incident HIV infections due to alcohol consumption among the HIV high-risk population of fishing communities along Lake Victoria, Uganda. Methods In a community-based cohort study, 1607 HIV sero-negative participants aged 18-49 years were enrolled from eight fishing communities along Lake Victoria, Uganda. At follow up 12 months later, 1288 (80.1%) were seen and interviewed. At baseline and follow-up visits, participants completed interviewer-administered questionnaires on alcohol consumption, demographics, and sexual risk behavior, and were tested for HIV infection. HIV incidence and adjusted incident rate ratios (adjusted IRRs) were estimated using Poisson regression models; the crude and adjusted PAFs of incident HIV infections associated with alcohol consumption were calculated using the Greenland and Drescher method for cohort studies. Results Among the 1288 participants seen at follow up, 53.5% reported drinking alcohol of whom 24.4% drank occasionally (2 days a week or less) and 29.1% drank regularly (3-7 days a week). Forty eight incident HIV infections occurred giving an incidence rate of 3.39/100 person years at-risk (pyar) (95% CI, 2.55-4.49). Compared to non-drinkers, the adjusted IRR of HIV was 3.09 (1.13-8.46) among occasional drinkers and 5.34 (2.04-13.97) among regular drinkers. The overall adjusted PAF of incident HIV infections due alcohol was 64.1 (95% CI; 23.5-83.1); ranging from 52.3 (11.9-74.2) among Muslims to 71.2 (32.6-87.7) for participants who reported >= 2 sexual partners in the past 12 months. Conclusion In fishing communities along Lake Victoria, Uganda, 64% of new HIV infections can be attributed to drinking alcohol. Interventions to reduce alcohol consumption should be integrated in HIV/AIDS prevention activities for populations in whom both HIV and alcohol consumption are highly prevalent.	[Kiwanuka, Noah] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Kiwanuka, Noah; Ssetaala, Ali; Ssekandi, Ismail; Nalutaaya, Annet; Kitandwe, Paul Kato; Ssempiira, Julius; Bagaya, Bernard Ssentalo] Uganda Virus Res Inst, Int AIDS Vaccine Initiat, HIV Vaccine Program, Entebbe, Uganda; [Bagaya, Bernard Ssentalo] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Balyegisawa, Apolo] Int AIDS Vaccine Initiat, New York, NY USA; [Kaleebu, Pontiano] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Kaleebu, Pontiano] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Hahn, Judith; Lindan, Christina] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Sewankambo, Nelson Kaulukusi] Makerere Univ, Sch Med, Clin Epidemiol Unit, Coll Hlth Sci, Kampala, Uganda	Makerere University; International AIDS Vaccine Initiative; Uganda Virus Research Institute; Makerere University; International AIDS Vaccine Initiative; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; Makerere University	Kiwanuka, N (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.; Kiwanuka, N (corresponding author), Uganda Virus Res Inst, Int AIDS Vaccine Initiat, HIV Vaccine Program, Entebbe, Uganda.	nkiwanuka@gmail.com	Hahn, Judith/J-5813-2014; Ssetaala, Ali/AAB-3832-2020	Hahn, Judith/0000-0002-2697-8264; Ssetaala, Ali/0000-0003-2156-3024; Ssentalo Bagaya, Bernard/0000-0002-3847-2615	Training Health Researchers into Vocational Excellence in East Africa Project (THRIVE); Wellcome Trust [087540/Z/08/Z]; Canada-Africa Prevention Trials Network (CAPTN) [1063357-001]; International AIDS Vaccine Initiative (IAVI) through UVRI-IAVI HIV Vaccine Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA022586] Funding Source: NIH RePORTER	Training Health Researchers into Vocational Excellence in East Africa Project (THRIVE); Wellcome Trust(Wellcome TrustEuropean Commission); Canada-Africa Prevention Trials Network (CAPTN); International AIDS Vaccine Initiative (IAVI) through UVRI-IAVI HIV Vaccine Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Training Health Researchers into Vocational Excellence in East Africa Project (THRIVE), grant number 087540/Z/08/Z funded by the Wellcome Trust, and the Canada-Africa Prevention Trials Network (CAPTN) grant number 1063357-001. We greatly appreciated the support given by the International AIDS Vaccine Initiative (IAVI) through the UVRI-IAVI HIV Vaccine Program in form of clinical research sites where study coordination activities were carried out. We also thank the study participants and the UVRI-IAVI Community Advisory Board. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Brady AR, 1998, STATA TECHNICAL B, P8; Burnhams NH, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0014-5; Carrasco MA, 2016, AIDS BEHAV, V20, P484, DOI 10.1007/s10461-015-1233-5; Chersich MF, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-22; Chersich MF, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-16; Chiva-Blanch G, 2014, NUTR METAB CARDIOVAS; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Fritz K, 2010, LANCET, V376, P398, DOI 10.1016/S0140-6736(10)60884-7; Fromme K, 1999, J STUD ALCOHOL, V60, P54, DOI 10.15288/jsa.1999.60.54; Geis S, 2011, JAIDS-J ACQ IMM DEF, V56, P453, DOI 10.1097/QAI.0b013e3182118fa3; Glymour MM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4334; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Guizzetti M, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00123; Hahn JA, 2016, ADDICTION, V111, P272, DOI 10.1111/add.13173; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Ippolito JA, 2013, ALCOHOL, V47, P589, DOI 10.1016/j.alcohol.2013.09.003; Kessler J, 2015, ALCOHOL CLIN EXP RES, V39, P2179, DOI 10.1111/acer.12890; Kiene SA, 2009, J ADOLESCENT HEALTH, V44, P73, DOI 10.1016/j.jadohealth.2008.05.008; Kiene SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-583; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; Kiwanuka N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-986; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Loganantharaj N, 2014, AIDS RES HUM RETROV, V30, P783, DOI [10.1089/aid.2014.0065, 10.1089/AID.2014.0065]; Lubega M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2371-4; Lubega M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132740; MacDonald TK, 2000, HEALTH PSYCHOL, V19, P290, DOI 10.1037/0278-6133.19.3.290; Matzopoulos RG, 2014, SAMJ S AFR MED J, V104, P127, DOI 10.7196/SAMJ.7644; Medley A, 2014, AIDS CARE, P1; Messaoudi I, 2013, VACCINE, V32, P54, DOI 10.1016/j.vaccine.2013.10.076; Messaoudi I, 2014, EXPERT REV VACCINES, V13, P817, DOI 10.1586/14760584.2014.924405; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Nkosi S, 2014, AIDS BEHAV; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Parcesepe AM, 2016, DRUG ALCOHOL DEPEN, V161, P21, DOI 10.1016/j.drugalcdep.2015.12.037; PERRY MJ, 1994, AIDS, V8, P1321, DOI 10.1097/00002030-199409000-00016; Scott-Sheldon LA, 2014, DRUG ALCOHOL DEPEND; Scott-Sheldon LAJ, 2013, CURR HIV-AIDS REP, V10, P314, DOI 10.1007/s11904-013-0177-5; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Stockwell T, 2000, J SUBST ABUSE, V12, P139, DOI 10.1016/S0899-3289(00)00046-8; Teferra S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2911-6; Theall KP, 2008, J STUD ALCOHOL DRUGS, V69, P454, DOI 10.15288/jsad.2008.69.454; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; Vandepitte J, 2012, J ACQUIR IMMUNE DEFI; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; Williams PP, 2015, J MIDWIFERY WOM HEAL, V60, P401, DOI 10.1111/jmwh.12328; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	59	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171200	10.1371/journal.pone.0171200	http://dx.doi.org/10.1371/journal.pone.0171200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207844	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500018
J	Sham, A; Moustafa, K; Al-Shamisi, S; Alyan, S; Iratni, R; AbuQamar, S				Sham, Arjun; Moustafa, Khaled; Al-Shamisi, Shamma; Alyan, Sofyan; Iratni, Rabah; AbuQamar, Synan			Microarray analysis of Arabidopsis WRKY33 mutants in response to the necrotrophic fungus Botrytis cinerea	PLOS ONE			English	Article							TGA TRANSCRIPTION FACTORS; GENE-EXPRESSION; SALICYLIC-ACID; JASMONIC ACID; 12-OXO-PHYTODIENOIC ACID; PHYTOALEXIN BIOSYNTHESIS; PLANT-RESPONSES; ABIOTIC STRESS; DEFENSE; RESISTANCE	The WRKY33 transcription factor was reported for resistance to the necrotrophic fungus Botrytis cinerea. Using microarray-based analysis, we compared Arabidopsis WRKY33 overexpressing lines and wrky33 mutant that showed altered susceptibility to B. cinerea with their corresponding wild-type plants. In the wild-type, about 1660 genes (7% of the transcriptome) were induced and 1054 genes (5% of the transcriptome) were repressed at least twofold at early stages of inoculation with B. cinerea, confirming previous data of the contribution of these genes in B. cinerea resistance. In Arabidopsis wild-type plant infected with B. cinerea, the expressions of the differentially expressed genes encoding for proteins and metabolites involved in pathogen defense and non-defense responses, seem to be dependent on a functional WRKY33 gene. The expression profile of 12-oxo-phytodienoic acidand phytoprostane A1-treated Arabidopsis plants in response to B. cinerea revealed that cyclopentenones can also modulate WRKY33 regulation upon inoculation with B. cinerea. These results support the role of electrophilic oxylipins in mediating plant responses to B. cinerea infection through the TGA transcription factor. Future directions toward the identification of the molecular components in cyclopentenone signaling will elucidate the novel oxylipin signal transduction pathways in plant defense.	[Sham, Arjun; Al-Shamisi, Shamma; Alyan, Sofyan; Iratni, Rabah; AbuQamar, Synan] United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates; [Moustafa, Khaled] Conservatoire Natl Arts & Metiers, Paris, France	United Arab Emirates University; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	AbuQamar, S (corresponding author), United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates.	sabuqamar@uaeu.ac.ae	Sham, Arjun/K-3691-2019; AbuQamar, Synan/AAV-1229-2021; Sham, Arjun/AAF-2531-2019	AbuQamar, Synan/0000-0002-2129-7689; Sham, Arjun/0000-0003-1762-3709; Moustafa, Khaled/0000-0002-0819-9064	UAEU Program for Advanced Research [31S255]; Khalifa Center for Biotechnology and Genetic Engineering-UAEU [31R081]	UAEU Program for Advanced Research; Khalifa Center for Biotechnology and Genetic Engineering-UAEU	This project was funded by the UAEU Program for Advanced Research (Grant #: 31S255); and the Khalifa Center for Biotechnology and Genetic Engineering-UAEU (Grant #: 31R081) to SAQ.	AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; AbuQamar S, 2017, CRIT REV BIOTECHNOL, V37, P262, DOI 10.1080/07388551.2016.1271767; Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; AbuQamar SF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01658; Benito EP, 1998, EUR J PLANT PATHOL, V104, P207, DOI 10.1023/A:1008698116106; Berrocal-Lobo M, 2008, TRENDS PLANT SCI, V13, P145, DOI 10.1016/j.tplants.2007.12.004; Bhosale R, 2013, PLANT CELL, V25, P2865, DOI 10.1105/tpc.113.112268; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grun C, 2007, FUNCT PLANT BIOL, V34, P65, DOI 10.1071/FP06205; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; LAGRIMINI LM, 1987, P NATL ACAD SCI USA, V84, P7542, DOI 10.1073/pnas.84.21.7542; Laluk K, 2011, PLANT CELL, V23, P2831, DOI 10.1105/tpc.111.087122; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Liu SA, 2015, ELIFE, V4, DOI 10.7554/eLife.07295; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Luo HL, 2010, PLANT PHYSIOL, V154, P1766, DOI 10.1104/pp.110.163915; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mengiste T, 2010, PLANT PATH 21ST, P13, DOI 10.1007/978-1-4020-8930-5_2; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Montesano M, 2003, MOL PLANT PATHOL, V4, P73, DOI 10.1046/j.1364-3703.2003.00150.x; Muckenschnabel I, 2002, J EXP BOT, V53, P207, DOI 10.1093/jexbot/53.367.207; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Mulema JMK, 2012, MOL BIOL REP, V39, P4039, DOI 10.1007/s11033-011-1185-4; Mulema JMK, 2011, AFR J BIOTECHNOL, V10, P17551, DOI 10.5897/AJB10.2558; Pan X, 2013, PLOS ONE; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Prins TW, 2000, FUNGAL PATHOLOGY, P33; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; SAS Inst, 1999, SAS SYST WIND; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Schenk PM, 2003, PLANT PHYSIOL, V132, P999, DOI 10.1104/pp.103.021683; Segarra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056075; Sham A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125666; Sham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113718; Smith JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-334; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu T, 2000, PLANT PHYSIOL, V124, P1472, DOI 10.1104/pp.124.4.1472; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	72	27	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2								10.1371/journal.pone.0172343	http://dx.doi.org/10.1371/journal.pone.0172343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207847	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500123
J	Tomlekova, NB; White, PJ; Thompson, JA; Penchev, EA; Nielen, S				Tomlekova, Nasya B.; White, Philip J.; Thompson, Jacqueline A.; Penchev, Emil A.; Nielen, Stephan			Mutation increasing beta-carotene concentrations does not adversely affect concentrations of essential mineral elements in pepper fruit	PLOS ONE			English	Article							CAPSICUM-ANNUUM; GREEN-PEPPER; VARIETIES; ACCUMULATION; PROVITAMIN; CULTIVARS; COLORS; COPPER; CROPS; IRON	Vitamin and mineral deficiencies are prevalent in human populations throughout the world. Vitamin A deficiency affects hundreds of millions of pre-school age children in low income countries. Fruits of pepper (Capsicum annuum L.) can be a major dietary source of precursors to Vitamin A biosynthesis, such as beta-carotene. Recently, pepper breeding programs have introduced the orange-fruited (ot) trait of the mutant variety Oranzheva kapiya, which is associated with high fruit beta-carotene concentrations, to the mutant variety Albena. In this manuscript, concentrations of beta-carotene and mineral elements (magnesium, phosphorus, sulphur, potassium, zinc, calcium, manganese, iron and copper) were compared in fruit from P31, a red-fruited genotype derived from the variety Albena, and M38, a genotype developed by transferring the orange-fruited mutation (ot) into Albena. It was observed that fruit from M38 plants had greater beta-carotene concentration at both commercial and botanical maturity (4.9 and 52.7 mg /kg fresh weight, respectively) than fruit from P31 plants (2.3 and 30.1 mg /kg fresh weight, respectively). The mutation producing high beta-carotene concentrations in pepper fruits had no detrimental effect on the concentrations of mineral elements required for human nutrition.	[Tomlekova, Nasya B.] Maritsa Vegetable Crops Res Inst, Dept Breeding Variety Maintenance & Introduct, Plovdiv, Bulgaria; [White, Philip J.; Thompson, Jacqueline A.] James Hutton Inst, Dept Ecol Sci, Dundee, Scotland; [Penchev, Emil A.] Dobroudja Agr Inst, Dept Breeding, General Toshevo, Bulgaria; [Nielen, Stephan] IAEA, Vienna Int Ctr, Joint FAO IAEA Div, Vienna, Austria	Agricultural Academy - Bulgaria; James Hutton Institute; Agricultural Academy - Bulgaria; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Tomlekova, NB (corresponding author), Maritsa Vegetable Crops Res Inst, Dept Breeding Variety Maintenance & Introduct, Plovdiv, Bulgaria.	nasia.tomlekova@gmail.com	White, Philip John/C-5860-2008	White, Philip John/0000-0003-0827-288X; Tomlekova, Nasya/0000-0003-0965-170X	IAEA Coordinated Research Project [CRP15406, D23028]; Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government	IAEA Coordinated Research Project(International Atomic Energy Agency); Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government	This work was conducted in the IAEA Coordinated Research Project D23028 under the research contract CRP15406 (NBT, EAP, SN). This work was supported by the Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government (PJW, JAT).	Bates B., NATL DIET NUTR SURVE; Bernardo A, 2008, J FOOD QUALITY, V31, P701, DOI 10.1111/j.1745-4557.2008.00229.x; Biehler E, 2012, J FOOD COMPOS ANAL, V25, P56, DOI 10.1016/j.jfca.2011.07.005; Bohn T, 2008, CURR NUTR FOOD SCI, V4, P240, DOI 10.2174/157340108786263685; Chaiter Y, 2007, INT J VITAM NUTR RES, V77, P398, DOI 10.1024/0300-9831.77.6.398; Daskalov S., 1992, Mutation Breeding Newsletter, P9; Daskalov S., 1991, Capsicum Newsletter, P13; Daskalov S, 1995, P 9 EUC M GEN BREED, P24; Daskalov S, 1975, HORTICULTURE, V12, P22; Department of Health UK Dietary reference values for food energy and nutrients for the United Kingdom, 1991, UK DIET REF VAL FOOD; Esayas K, 2011, B CHEM SOC ETHIOPIA, V25, P451; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; Guzman I, 2010, PLANT SCI, V179, P49, DOI 10.1016/j.plantsci.2010.04.014; Ha SH, 2007, J EXP BOT, V58, P3135, DOI 10.1093/jxb/erm132; Holland B, 1991, VEGETABLES HERBS SPI; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Hulshof PJM, 1997, J AGR FOOD CHEM, V45, P1174, DOI 10.1021/jf9603137; Jadczak D, 2010, J ELEMENTOL, V15, P509, DOI 10.5601/jelem.2010.15.3.509-515; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; Vera-Guzman AM, 2011, CHIL J AGR RES, V71, P578, DOI 10.4067/S0718-58392011000400013; O'Neill ME, 2001, BRIT J NUTR, V85, P499, DOI 10.1079/BJN2000284; Park H, 2006, NUTR RES, V26, P546, DOI 10.1016/j.nutres.2006.09.001; Periago MJ, 2004, J AGR FOOD CHEM, V52, P5796, DOI 10.1021/jf049345h; Petrov V, 2013, CR ACAD BULG SCI, V66, P303; Rodriguez-Uribe L, 2012, J EXP BOT, V63, P517, DOI 10.1093/jxb/err302; Rubio C, 2002, EUR FOOD RES TECHNOL, V214, P501, DOI 10.1007/s00217-002-0534-x; Simonne A. H., 1997, Journal of Food Composition and Analysis, V10, P299, DOI 10.1006/jfca.1997.0544; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Subramanian NK, 2011, ANN BOT-LONDON, V107, P681, DOI 10.1093/aob/mcr009; Timina OO, 2011, VAVILOV J GENETICS B, V15, P585; Todorova V, 2009, ACTA HORTIC, V830, P297, DOI 10.17660/ActaHortic.2009.830.42; Tomlekova N., 2009, Induced plant mutations in the genomics era. Proceedings of an International Joint FAO/IAEA Symposium, 2008, P187; Tomlekova NB, 2009, ACTA HORTIC, V830, P205; Tomlekova N. B., 2010, Plant Mutation Reports, V2, P4; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; United States Department of Agriculture, 2007, AGR RES SERV USDA AR; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wall MM, 2001, HORTSCIENCE, V36, P746, DOI 10.21273/HORTSCI.36.4.746; West K. P. Jr., 2003, Food and Nutrition Bulletin, V24, pS78; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; White PJ, 2005, J HORTIC SCI BIOTECH, V80, P660, DOI 10.1080/14620316.2005.11511995; World Health Organization (WHO), 2009, GLOB PREV VIT DEF PO	43	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172180	10.1371/journal.pone.0172180	http://dx.doi.org/10.1371/journal.pone.0172180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207797	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500093
J	Zhang, HH; Wang, YP; Ai, ST; Chen, XJ; Wang, L; Dai, KR				Zhang, Henghui; Wang, Yiping; Ai, Songtao; Chen, Xiaojun; Wang, Liao; Dai, Kerong			Three-dimensional acetabular orientation measurement in a reliable coordinate system among one hundred Chinese	PLOS ONE			English	Article							TOTAL HIP-REPLACEMENT; CUP NAVIGATION; INCLINATION; ANGLE; TILT	Determining three-dimensional (3D) acetabular orientation is important for several orthopaedic scenarios, but the complex geometries of both pelvis and acetabulum make measurements of orientation unreliable. Acetabular orientation may also differ between the sexes or racial groups. We aimed to (1) establish and evaluate a novel method for measuring 3D acetabular orientation, (2) apply this new method to a large population of Chinese subjects, and (3) report relevant characteristics of native acetabular orientation in this population. We obtained computed tomography scans taken for non-orthopaedic indications in 100 Chinese subjects (50 male, 50 female). A novel algorithm tailored to segmentation of the hip joint was used to construct 3D pelvic models from these scans. We developed a surface-based method to establish a reliable 3D pelvic coordinate system and software to semi-automatically measure 3D acetabular orientation. Differences in various acetabular orientations were compared within and between subjects, between male and female subjects, and between our subjects and subjects previously reported by another group. The reported method was reliable (intraclass correlation coefficient >0.999). Acetabular orientations were symmetrical within subjects, but ranged widely between subjects. The sexes differed significantly in acetabular anteversion (average difference, 3.0 E; p < 0.001) and inclination (1.5 E; p < 0.03). Acetabular anteversion and inclination were substantially smaller among our Chinese subjects than previously reported for American subjects. Thus, our method was reliable and sensitive, and we detected sex differences in 3D acetabular orientation. Awareness of differences between the sexes and races is the first step towards better reconstruction of the hip joint for all individuals and could also be applied to other orthopaedic scenarios.	[Zhang, Henghui; Wang, Liao; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants,Dept Orthopae, Shanghai, Peoples R China; [Wang, Yiping; Chen, Xiaojun] Shanghai Jiao Tong Univ, Inst Biomed Mfg & Life Qual Engn, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai, Peoples R China; [Ai, Songtao] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Shanghai Peoples Hosp 9, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, L; Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants,Dept Orthopae, Shanghai, Peoples R China.	wang821127@163.com; krdai@163.com	Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022	Chen, Xiaojun/0000-0002-0298-4491	National Natural Science Foundation of China [81201412]; Science and Technology Commission of Shanghai Municipality [16441908700, 15PJD025]; Office of Research Management [YG2016MS11]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant [20152221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Office of Research Management; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant	This study was funded by National Natural Science Foundation of China (no. 81201412, to LW), http://www.nsfc.gov.cn/publish/portal1/; Science and Technology Commission of Shanghai Municipality (16441908700, to LW; 15PJD025, to SA), http://www.stcsm.gov.cn/english/; Office of Research Management affiliated to Shanghai Jiao Tong University (YG2016MS11, to LW), http://kejichu.sjtu.edu.cn/; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (20152221, to SA), http://en.study-shanghai.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDA S, 1990, ACTA RADIOL, V31, P389; Babisch JW, 2008, J BONE JOINT SURG AM, V90A, P357, DOI 10.2106/JBJS.F.00628; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; Higgins SW, 2014, J BONE JOINT SURG AM, V96A, P1776, DOI 10.2106/JBJS.L.01141; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Lembeck B, 2005, ACTA ORTHOP, V76, P517, DOI 10.1080/17453670510041501; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146452; Lubovsky O, 2010, INT J COMPUT ASS RAD, V5, P449, DOI 10.1007/s11548-010-0521-9; Maruyama M, 2001, CLIN ORTHOP RELAT R, P52; MURPHY SB, 1990, CLIN ORTHOP RELAT R, P214; MURRAY DW, 1993, J BONE JOINT SURG BR, V75, P228, DOI 10.1302/0301-620X.75B2.8444942; Murtha PE, 2008, J BONE JOINT SURG BR, V90B, P308, DOI 10.1302/0301-620X.90B3.19548; Nagao Y, 2008, J ORTHOP SCI, V13, P62, DOI 10.1007/s00776-007-1188-0; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Puls M, 2011, COMPUT BIOL MED, V41, P285, DOI 10.1016/j.compbiomed.2011.03.004; Tan S, 2008, MED IMAGING; Tannast M, 2005, CLIN ORTHOP RELAT R, P144, DOI 10.1097/01.blo.00001576957.22894.29; Tannast M, 2008, J ORTHOP RES, V26, P1199, DOI 10.1002/jor.20653; Tarwala R, 2011, CURR REV MUSCULOSKE, V4, P151, DOI 10.1007/s12178-011-9086-7; TONNIS D, 1976, CLIN ORTHOP RELAT R, P39; Vandenbussche E, 2008, CLIN ORTHOP RELAT R, V466, P417, DOI 10.1007/s11999-007-0062-x; Vandenbussche E, 2007, ACTA ORTHOP, V78, P327, DOI 10.1080/174536707100013870; YANG Z, 2014, PLOS ONE, V0009	25	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172297	10.1371/journal.pone.0172297	http://dx.doi.org/10.1371/journal.pone.0172297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207829	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500114
J	Hagemann, N; Kammann, CI; Schmidt, HP; Kappler, A; Behrens, S				Hagemann, Nikolas; Kammann, Claudia I.; Schmidt, Hans-Peter; Kappler, Andreas; Behrens, Sebastian			Nitrate capture and slow release in biochar amended compost and soil	PLOS ONE			English	Article							SUSTAINABLE AGRICULTURE; ABIOTIC IMMOBILIZATION; ORGANIC NITROGEN; TRANSFORMATION; MECHANISMS; ADSORPTION; AMENDMENTS; SORPTION; YIELD; MODEL	Slow release of nitrate by charred organic matter used as a soil amendment (i. e. biochar) was recently suggested as potential mechanism of nutrient delivery to plants which may explain some agronomic benefits of biochar. So far, isolated soil-aged and composted biochar particles were shown to release considerable amounts of nitrate only in extended (>1 h) extractions ("slow release"). In this study, we quantified nitrate and ammonium release by biochar-amended soil and compost during up to 167 h of repeated extractions in up to six consecutive steps to determine the effect of biochar on the overall mineral nitrogen retention. We used composts produced from mixed manures amended with three contrasting biochars prior to aerobic composting and a loamy soil that was amended with biochar three years prior to analysis and compared both to non-biochar amended controls. Composts were extracted with 2 M KCl at 22 degrees C and 65 degrees C, after sterilization, after treatment with H2O2, after removing biochar particles or without any modification. Soils were extracted with 2 M KCl at 22 degrees C. Ammonium was continuously released during the extractions, independent of biochar amendment and is probably the result of abiotic ammonification. For the pure compost, nitrate extraction was complete after 1 h, while from biochar-amended composts, up to 30% of total nitrate extracted was only released during subsequent extraction steps. The loamy soil released 70% of its total nitrate amount in subsequent extractions, the biochar-amended soil 58%. However, biochar amendment doubled the amount of total extractable nitrate. Thus, biochar nitrate capture can be a relevant contribution to the overall nitrate retention in agroecosystems. Our results also indicate that the total nitrate amount in biochar amended soils and composts may frequently be underestimated. Furthermore, biochars could prevent nitrate loss from agroecosystems and may be developed into slow-release fertilizers to reduce global N fertilizer demands.	[Hagemann, Nikolas; Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, Sigwartstr 10, Tubingen, Germany; [Kammann, Claudia I.] Hsch Geisenheim Univ, Dept Soil Sci & Plant Nutr, Working Grp Climate Change Res Special Crops, Geisenheim, Germany; [Schmidt, Hans-Peter] Ithaka Inst Carbon Strategies, Ancienne Eglise 9, Arbaz, Switzerland; [Behrens, Sebastian] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA; [Behrens, Sebastian] Inst Biotechnol, 140 Gortner Labs,1479 Gortner Ave, St Paul, MN 55108 USA	Eberhard Karls University of Tubingen; University of Minnesota System; University of Minnesota Twin Cities	Hagemann, N (corresponding author), Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, Sigwartstr 10, Tubingen, Germany.; Behrens, S (corresponding author), Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA.; Behrens, S (corresponding author), Inst Biotechnol, 140 Gortner Labs,1479 Gortner Ave, St Paul, MN 55108 USA.	nikolas@hagemann.at; sbehrens@umn.edu	Hagemann, Nikolas/AAI-1379-2019; Schmidt, Hans Peter/AAJ-1031-2020; Kammann, Claudia/GSD-6286-2022	Hagemann, Nikolas/0000-0001-8005-9392; Schmidt, Hans Peter/0000-0001-8275-7506; Kappler, Andreas/0000-0002-3558-9500	BMBF PhD scholarship - Rosa Luxemburg Foundation, Berlin, Germany; EU COST Action [TD1107]; DFG [KA-3442/1-1]	BMBF PhD scholarship - Rosa Luxemburg Foundation, Berlin, Germany(Federal Ministry of Education & Research (BMBF)); EU COST Action(European Cooperation in Science and Technology (COST)European Commission); DFG(German Research Foundation (DFG))	NH was financially supported by a BMBF PhD scholarship provided by the Rosa Luxemburg Foundation, Berlin, Germany. The composts used in this experiments were produced during a Short Term Scientific Mission (STSM) granted to NH by EU COST Action TD1107 Biochar as option for sustainable resource management. CK gratefully acknowledges DFG grant KA-3442/1-1 and the FACCE-JPI project "DesignerChar4Food" that enabled her to work on nitrate capture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen, 1847, BRIEF COMPEND AM AGR, DOI 10.5962/bhl.title.20151; Alling V, 2014, J PLANT NUTR SOIL SC, V177, P671, DOI 10.1002/jpln.201400109; Angst TE, 2013, J ENVIRON QUAL, V42, P672, DOI 10.2134/jeq2012.0341; Bhardwaj D, 2012, J HAZARD MATER, V227, P292, DOI 10.1016/j.jhazmat.2012.05.058; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chintala R, 2013, MICROPOR MESOPOR MAT, V179, P250, DOI 10.1016/j.micromeso.2013.05.023; Conte P, 2014, J AGR FOOD CHEM, V62, P4917, DOI 10.1021/jf5010034; Conte P, 2013, GCB BIOENERGY, V5, P116, DOI 10.1111/gcbb.12009; Cordovil CMDS, 2007, COMMUN SOIL SCI PLAN, V38, P989, DOI 10.1080/00103620701278088; Cornelissen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154617; Cornelissen G, 2013, AGRONOMY-BASEL, V3, P256, DOI 10.3390/agronomy3020256; Curtin D, 2008, SOIL SAMPLING METHOD, P599; Dail DB, 2001, BIOGEOCHEMISTRY, V54, P131, DOI 10.1023/A:1010627431722; Davidson EA, 2003, GLOBAL CHANGE BIOL, V9, P228, DOI 10.1046/j.1365-2486.2003.00592.x; Davidson EA, 2008, BIOGEOCHEMISTRY, V90, P65, DOI 10.1007/s10533-008-9231-6; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; de Vries W, 2013, CURR OPIN ENV SUST, V5, P392, DOI 10.1016/j.cosust.2013.07.004; Dempster DN, 2012, SOIL RES, V50, P216, DOI 10.1071/SR11316; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eklind Y, 2000, BIORESOURCE TECHNOL, V74, P125, DOI 10.1016/S0960-8524(00)00005-5; European Biochar Foundation, 2012, GUID SUST PROD BIOCH; Fischer D, 2012, MANAGEMENT ORGANIC W, P1; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2007, PHILOS T R SOC B, V362, P187, DOI 10.1098/rstb.2006.1978; Haber F, 1934, P ROYAL SOC LOND MAT; Hagemann N, 2016, BIOCHAR APPLICATION: ESSENTIAL SOIL MICROBIAL ECOLOGY, P163, DOI 10.1016/B978-0-12-803433-0.00007-2; Hagemann N, EXTENT KINETICS NITR; Haider G, J ENV QUALI IN PRESS, V45; Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P10641, DOI 10.1021/es302971d; Hilber I, 2012, J AGR FOOD CHEM, V60, P3042, DOI 10.1021/jf205278v; Jeffery S., 2015, BIOCHAR ENV MANAGEME, V2nd, DOI [10.4324/9780203762264, DOI 10.1016/J.ECOLENG.2012.01.016]; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Kammann C., 2016, BIOCHAR EUROPEAN SOI, P136, DOI DOI 10.4324/9781315884462; Kammann CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11080; Klucakova M, 2010, ENVIRON CHEM LETT, V8, P145, DOI 10.1007/s10311-009-0201-6; Komarneni S, 2003, J POROUS MAT, V10, P243, DOI 10.1023/B:JOPO.0000011385.19108.49; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Laird D., 2015, BIOCHAR ENV MANAGEME, V2, P521; Lehmann J, 2015, BIOCHAR ENV MANAGEME, P235, DOI DOI 10.4324/9780203762264; Maynard DG, 1993, SOIL SAMPLING METHOD, P97; McLean W, 1931, J AGR SCI, V21, P251, DOI 10.1017/S0021859600008662; Pignatello J. J., 2015, BIOCHAR ENV MANAGEME, P195, DOI DOI 10.4324/9780203762264; Prost K, 2013, J ENVIRON QUAL, V42, P164, DOI 10.2134/jeq2012.0064; Schmidt H.-P., 2014, BIOCHAR J, V1, P14; Schmidt HP, 2015, AGRICULTURE-BASEL, V5, P723, DOI 10.3390/agriculture5030723; Sehn W, 2010, BWK-ENERGIE-FACHMAG, V62, P55; Spokas KA, 2014, ENVIRON SCI TECH LET, V1, P326, DOI 10.1021/ez500199t; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tani M, 2004, SOIL SCI PLANT NUTR, V50, P439, DOI 10.1080/00380768.2004.10408498; TRYON EH, 1948, ECOL MONOGR, V18, P81, DOI 10.2307/1948629; Wiedner K, 2015, BIOCHAR ENV MANAGEME, P15; Wiedner K, 2015, CATENA, V132, P114, DOI 10.1016/j.catena.2014.10.024; WONG MTF, 1990, J SOIL SCI, V41, P655, DOI 10.1111/j.1365-2389.1990.tb00234.x; Xi YF, 2010, APPL CLAY SCI, V48, P92, DOI 10.1016/j.clay.2009.11.047; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002	58	96	97	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171214	10.1371/journal.pone.0171214	http://dx.doi.org/10.1371/journal.pone.0171214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199354	Green Published, gold			2022-12-26	WOS:000394424400025
J	Tan, JR; Tan, KS; Yong, FL; Armugam, A; Wang, CW; Jeyaseelan, K; Wong, PTH				Tan, Jun Rong; Tan, Kay Sin; Yong, Fung Lin; Armugam, Arunmozhiarasi; Wang, Chee Woon; Jeyaseelan, Kandiah; Wong, Peter Tsun-Hon			MicroRNAs regulating cluster of differentiation 46 (CD46) in cardioembolic and non-cardioembolic stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BINDING LECTIN LEVELS; ENRICHMENT ANALYSIS; TARGET PREDICTION; GENE-EXPRESSION; CLIP-SEQ; RNA; DATABASE; INFLAMMATION; HOMEOSTASIS	Ischemic stroke is a major cause of mortality and morbidity globally. Among the ischemic stroke subtypes, cardioembolic stroke is with poor functional outcome (Modified Rankin score > 2). Early diagnosis of cardioembolic stroke will prove beneficial. This study examined the microRNAs targeting cluster of differentiation 46 (CD46), a potential biomarker for cardioembolic stroke. CD46 mRNA level was shown to be differentially expressed (p < 0.001) between cardioembolic stroke (median = 1.32) and non-cardioembolic stroke subtypes (large artery stroke median = 5.05; small vessel stroke median = 6.45). Bioinformatic search showed that miR-19a,-20a,-185 and-374b were found to target CD46 mRNA and further verified by luciferase reporter assay. The levels of miRNAs targeting CD46 were significantly reduced (p < 0.05) in non-cardioembolic stroke patients (large artery stroke median: miR-19a = 0.63, miR-20a = 0.42, miR-185 = 0.32, miR-374b = 0.27; small artery stroke median: miR-19a = 0.07, miR-20a = 0.06, miR-185 = 0.07, miR-374b = 0.05) as compared to cardioembolic stroke patients (median: miR-19a = 2.69, miR-20a = 1.36, miR-185 = 1.05, miR-374b = 1.23). ROC curve showed that the miRNAs could distinguish cardioembolic stroke from non-cardioembolic stroke with better AUC value as compared to CD46. Endogenous expression of CD46 in Human Umbilical Vein Endothelial Cells (HUVECs) were found to be regulated by miR-19a and miR-20a. Thus implicating that miR-19a and-20a may play a role in pathogenesis of cardioembolic stroke, possibly via the endothelial cells.	[Tan, Jun Rong; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Tan, Kay Sin; Yong, Fung Lin] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Wang, Chee Woon] MAHSA Univ, Dept Biochem, Fac Med, Kuala Lumpur, Malaysia; [Jeyaseelan, Kandiah] Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Wong, Peter Tsun-Hon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, MD3, Singapore, Singapore	National University of Singapore; Universiti Malaya; Mahsa University; Monash University; National University of Singapore	Wong, PTH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, MD3, Singapore, Singapore.	phcwth@nus.edu.sg	TAN, KAY SIN/B-9911-2010; Wang, Chee/GQZ-3436-2022; WANG, CHEE WOON/GQZ-3715-2022; WOON, WANG CHEE/H-7458-2019	Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Research Foundation (NRF) [R-184-002-165-281]; National Medical Research Council (NMRC/EDG) [R-183-000-230-275]; National Medical Research Council (NMRC/IRG), Singapore [R-183-000-290-213]; University of Malaya (UM/HIR) [E0067, E0036]	National Research Foundation (NRF); National Medical Research Council (NMRC/EDG)(National Medical Research Council, Singapore); National Medical Research Council (NMRC/IRG), Singapore(National Medical Research Council, Singapore); University of Malaya (UM/HIR)	This work was supported by the research grants from National Research Foundation (NRF): R-184-002-165-281, National Medical Research Council (NMRC/EDG): R-183-000-230-275, and the National Medical Research Council (NMRC/IRG): R-183-000-290-213, Singapore; and the University of Malaya (UM/HIR): E0067 & E0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bohmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081427; Burke TA, 2006, INT J STROKE, V1, P208, DOI 10.1111/j.1747-4949.2006.00060.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; De Martino I, 2009, ONCOGENE, V28, P1432, DOI 10.1038/onc.2008.495; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elefant N, 2011, NUCLEIC ACIDS RES, V39, pD188, DOI 10.1093/nar/gkq1233; Enright AJ, 2004, GENOME BIOL, V5; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hallevi H, 2008, ARCH NEUROL-CHICAGO, V65, P1169, DOI 10.1001/archneur.65.9.noc70105; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Jiang WL, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0034-8; Jickling GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099283; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kaur P, 2016, BBA-MOL CELL RES, V1863, P533, DOI 10.1016/j.bbamcr.2015.12.012; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li SH, 2004, CIRCULATION, V109, P833, DOI 10.1161/01.CIR.0000117087.27524.0E; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu Chang-zheng, 2012, Chinese Medical Sciences Journal, V27, P65; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEIFERT PS, 1989, ARTERIOSCLEROSIS, V9, P802, DOI 10.1161/01.ATV.9.6.802; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Song FY, 2015, MOL NEUROBIOL, V52, P1330, DOI 10.1007/s12035-014-8941-0; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Truelsen T., 2006, GLOBAL BURDEN CEREBR; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wang ZY, 2014, NEUROCHEM RES, V39, P248, DOI 10.1007/s11064-013-1214-x; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056	59	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172131	10.1371/journal.pone.0172131	http://dx.doi.org/10.1371/journal.pone.0172131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199366	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400075
J	Wang, RJ; Cui, Y; Xu, Y; Irudayaraj, J				Wang, Renjie; Cui, Yi; Xu, Yi; Irudayaraj, Joseph			Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in vitro	PLOS ONE			English	Article							DNA-REPAIR GENES; PROMOTER HYPERMETHYLATION; CELL-PROLIFERATION; BETA-CARBOLINES; HUMAN CANCER; TRANSCRIPTION; METHYLATION; MECHANISMS; NEUROTOXIN; HYPOMETHYLATION	1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) has been widely studied as a neurotoxic substance, however, only few reports have explored its effect on carcinogenicity. Since the aberrant modification of DNA methylation occurs very early in almost all human cancers, the focus of this study is to assess the carcinogenicity of TaClo by characterizing alterations of the epigenetic state, specifically, DNA methylation, upon exposure to TaClo in a HEK 293 model cell line. Our results suggest that TaClo could induce global DNA hypomethylation and transcriptional repression of critical tumor suppressor genes by increasing their promoter methylation. Enhanced cell proliferation, migration and anchorage independent growth were observed in cells exposed to TaClo. Our study highlights the epigenetic toxicity of TaClo, which contributes to its carcinogenicity by altering the DNA methylation status.	[Wang, Renjie; Xu, Yi] Chongqing Univ, Coll Chem & Chem Engn, Chongqing, Peoples R China; [Wang, Renjie; Cui, Yi; Irudayaraj, Joseph] Purdue Univ, Bindley Biosci Ctr, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Wang, Renjie; Xu, Yi] Chongqing Univ, Int R&D Ctr Micronano Syst & New Mat Technolog, Chongqing, Peoples R China; [Wang, Renjie; Xu, Yi] Chongqing Univ, Key Disciplines Lab Novel Micronano Devices & Sys, Chongqing, Peoples R China; [Xu, Yi] Chongqing Univ, Sch Optoelect Engn, Microsyst Res Ctr, Chongqing, Peoples R China; [Cui, Yi] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA USA	Chongqing University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chongqing University; Chongqing University; Chongqing University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Irudayaraj, J (corresponding author), Purdue Univ, Bindley Biosci Ctr, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA.	josephi@purdue.edu	Cui, Yi/O-4109-2019	Irudayaraj, Joseph/0000-0002-0630-1520; Wang, Renjie/0000-0002-2969-0987	Executive Vice President for Research and Partnerships office for the Toxicology Pillar; W.M. Keck foundation; China scholarship council [201506050054]	Executive Vice President for Research and Partnerships office for the Toxicology Pillar; W.M. Keck foundation(W.M. Keck Foundation); China scholarship council(China Scholarship Council)	JI received funding from the Executive Vice President for Research and Partnerships office for the Toxicology Pillar (grant number:0000, URL: http://www.purdue.edu/research/), and the W.M. Keck foundation (grant number:0000, URLs: http://www.wmkeck.org/). RW was funded through the China scholarship council (grant number: 201506050054, URL: http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akundi RS, 2004, J NEUROCHEM, V91, P263, DOI 10.1111/j.1471-4159.2004.02710.x; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Benbrahim TL, 2007, ENV HLTH PERSPECT, V115, P1454; Bernd J, 1999, DRUG DEVELOP RES, V46, P51; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bringmann G, 2000, BIOORGAN MED CHEM, V8, P1467, DOI 10.1016/S0968-0896(00)00073-0; Bringmann G, 2004, TETRAHEDRON, V60, P8143, DOI 10.1016/j.tet.2004.06.093; Bringmann G, 2002, BIOORGAN MED CHEM, V10, P2207, DOI 10.1016/S0968-0896(02)00060-3; Bringmann G, 2001, NEUROSCI LETT, V304, P41, DOI 10.1016/S0304-3940(01)01731-1; BRINGMANN G, 1990, ARCH PHARM, V323, P567, DOI 10.1002/ardp.19903230903; Bringmann G, 2000, NEUROCHEM RES, V25, P837, DOI 10.1023/A:1007521625088; Bringmann G, 2006, Z NATURFORSCH C, V61, P601; Brocato J, 2013, CRIT REV TOXICOL, V43, P493, DOI 10.3109/10408444.2013.794769; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Cui Y, 2016, TOXICOL RES-UK, V5, P641, DOI [10.1039/c5tx00454c, 10.1039/C5TX00454C]; Cui Y, 2015, MOL PHARMACEUT, V12, P1279, DOI 10.1021/mp500815b; Cui Y, 2015, NUCLEIC ACIDS RES, V43, P3046, DOI 10.1093/nar/gkv098; Cui Y, 2013, EPIGENETICS-US, V8, P1089, DOI 10.4161/epi.25958; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Drosten M, 2014, P NATL ACAD SCI USA, V111, P15155, DOI 10.1073/pnas.1417549111; Esteller M, 2000, EUR J CANCER, V36, P2294, DOI 10.1016/S0959-8049(00)00303-8; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Foley P, 2000, J NEUROL, V247, P82; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gerlach M, 1998, NEUROSCI LETT, V257, P17, DOI 10.1016/S0304-3940(98)00791-5; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Jiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116179; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Komashko VM, 2014, EPIGENETICS, V5, P229; Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lawrence LH, 2000, ENVIRON HEALTH PER S, V108, P177; Mazumder DNG, 2005, TOXICOL APPL PHARM, V206, P169, DOI 10.1016/j.taap.2004.08.025; Ordway JM, 2004, ONCOGENE, V23, P3737, DOI 10.1038/sj.onc.1207483; Pogribny IP, 2013, CANCER LETT, V334, P39, DOI 10.1016/j.canlet.2012.09.010; Przedborski S, 2001, CLIN NEUROSCI RES, V1, P407, DOI 10.1016/S1566-2772(01)00019-6; Riederer P, 2002, EUR J PHARMACOL, V442, P1, DOI 10.1016/S0014-2999(02)01308-0; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Statement S, 2013, SUMMARY STATEMENT, V14, P1; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Storch A, 2006, J NEURAL TRANSM, V113, P1895, DOI 10.1007/s00702-006-0495-5; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Torano EG, 2012, CLIN CHEM LAB MED, V50, P1733, DOI 10.1515/cclm-2011-0902; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; White RF, 1997, ENVIRON RES, V73, P113, DOI 10.1006/enrs.1997.3699; Wild CP, 2009, MUTAGENESIS, V24, P117, DOI 10.1093/mutage/gen061; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088	53	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172243	10.1371/journal.pone.0172243	http://dx.doi.org/10.1371/journal.pone.0172243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199384	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400085
J	Bor, D; Schwartzman, DJ; Barrett, AB; Seth, AK				Bor, Daniel; Schwartzman, David J.; Barrett, Adam B.; Seth, Anil K.			Theta-burst transcranial magnetic stimulation to the prefrontal or parietal cortex does not impair metacognitive visual awareness	PLOS ONE			English	Article							ACTIVITY FLUCTUATIONS; ACCURACY; DECISION; MEMORY; CONSCIOUSNESS; MECHANISMS; STRATEGIES; THRESHOLD; RIVALRY	Neuroimaging studies commonly associate dorsolateral prefrontal cortex (DLPFC) and posterior parietal cortex with conscious perception. However, such studies only investigate correlation, rather than causation. In addition, many studies conflate objective performance with subjective awareness. In an influential recent paper, Rounis and colleagues addressed these issues by showing that continuous theta burst transcranial magnetic stimulation (cTBS) applied to the DLPFC impaired metacognitive (subjective) awareness for a perceptual task, while objective performance was kept constant. We attempted to replicate this finding, with minor modifications, including an active cTBS control site. Using a between-subjects design for both DLPFC and posterior parietal cortices, we found no evidence of a cTBS-induced metacognitive impairment. In a second experiment, we devised a highly rigorous within-subjects cTBS design for DLPFC, but again failed to find any evidence of metacognitive impairment. One crucial difference between our results and the Rounis study is our strict exclusion of data deemed unsuitable for a signal detection theory analysis. Indeed, when we included this unstable data, a significant, though invalid, metacognitive impairment was found. These results cast doubt on previous findings relating metacognitive awareness to DLPFC, and inform the current debate concerning whether or not prefrontal regions are preferentially implicated in conscious perception.	[Bor, Daniel; Schwartzman, David J.; Barrett, Adam B.; Seth, Anil K.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Bor, Daniel; Barrett, Adam B.; Seth, Anil K.] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Sussex; University of Sussex	Bor, D (corresponding author), Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England.; Bor, D (corresponding author), Univ Sussex, Dept Informat, Brighton, E Sussex, England.	danielxbor@gmail.com		Schwartzman, David/0000-0002-3779-396X; Bor, Daniel/0000-0002-0741-8157	Dr Mortimer and Theresa Sackler Foundation; EPSRC [EP/L005131/1]; EPSRC [EP/G007543/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L005131/1] Funding Source: researchfish	Dr Mortimer and Theresa Sackler Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by The Dr Mortimer and Theresa Sackler Foundation. ABB is funded by EPSRC grant EP/L005131/1.; We thank the Alex Henderson and Arin Baboumian for all their work collecting the data, Ryan Scott and Zoltan Dienes for helpful theoretical discussions, and Justyna Hobot on many constructive comments on an earlier draft. This work was supported by The Dr Mortimer and Theresa Sackler Foundation. ABB is funded by EPSRC grant EP/L005131/1.	Barrett AB, 2013, PSYCHOL METHODS, V18, P535, DOI 10.1037/a0033268; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2004, EUR J NEUROSCI, V19, P3365, DOI 10.1111/j.1460-9568.2004.03438.x; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; Bor D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00063; Brascamp J, 2015, NAT NEUROSCI, V18, P1672, DOI 10.1038/nn.4130; Civardi C, 2000, CLIN NEUROPHYSIOL, V111, P624, DOI 10.1016/S1388-2457(99)00301-6; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Del Cul A, 2009, BRAIN, V132, P2531, DOI 10.1093/brain/awp111; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fleming SM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00443; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Herwig U, 2001, BIOL PSYCHIAT, V50, P58, DOI 10.1016/S0006-3223(01)01153-2; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kaller CP, 2013, HUM BRAIN MAPP, V34, P36, DOI 10.1002/hbm.21423; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macmillan NA, 2005, DETECTION THEORY USE; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; Rahnev D, 2016, P NATL ACAD SCI USA, V113, P6059, DOI 10.1073/pnas.1522551113; Rees G, 2007, PHILOS T R SOC B, V362, P877, DOI 10.1098/rstb.2007.2094; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schicktanz N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120640; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Tsuchiya N, 2015, TRENDS COGN SCI, V19, P757, DOI 10.1016/j.tics.2015.10.002; Turatto M, 2004, NEUROREPORT, V15, P2549, DOI 10.1097/00001756-200411150-00024; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Westin GG, 2014, CLIN NEUROPHYSIOL, V125, P142, DOI 10.1016/j.clinph.2013.06.187	45	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171793	10.1371/journal.pone.0171793	http://dx.doi.org/10.1371/journal.pone.0171793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192502	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800042
J	Paillamanque, J; Sanchez-Tusie, A; Carmona, EM; Trevino, CL; Sandoval, C; Nualart, F; Osses, N; Reyes, JG				Paillamanque, Joaquin; Sanchez-Tusie, Ana; Carmona, Emerson M.; Trevino, Claudia L.; Sandoval, Carolina; Nualart, Francisco; Osses, Nelson; Reyes, Juan G.			Arachidonic acid triggers [Ca2+](i) increases in rat round spermatids by a likely GPR activation, ERK signalling and ER/acidic compartments Ca2+ release	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ALLOSTERIC MODULATOR SCH-202676; SPERMATOGENIC CELLS; SELECTIVE INHIBITOR; RYANODINE RECEPTOR; IN-VITRO; INTRACELLULAR CA2+; ARISTOLOCHIC ACID; SMALL MOLECULES; SERTOLI-CELLS	Arachidonic acid (AA), a compound secreted by Sertoli cells (SC) in a FSH-dependent manner, is able to induce the release of Ca2+ from internal stores in round spermatids and pachytene spermatocytes. In this study, the possible site(s) of action of AA in round spermatids, the signalling pathways associated and the intracellular Ca2+ stores targeted by AA-induced signalling were pharmacologically characterized by measuring intracellular Ca2+ using fluorescent Ca-2+ probes. Our results suggest that AA acts by interacting with a fatty acid G protein coupled receptor, initiating a G protein signalling cascade that may involve PLA2 and ERK activation, which in turn opens intracellular ryanodine-sensitive channels as well as NAADP-sensitive channels in acidic intracellular Ca2+ stores. The results presented here also suggest that AMPK and PKA modulate this AA-induced Ca2+ release from intracellular Ca2+ stores in round spermatids. We propose that unsaturated free fatty acid lipid signalling in the seminiferous tubule is a novel regulatory component of rat spermatogenesis.	[Paillamanque, Joaquin; Carmona, Emerson M.; Sandoval, Carolina; Osses, Nelson; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Sanchez-Tusie, Ana; Trevino, Claudia L.] Univ Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Nualart, Francisco] Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Concepcion, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad Nacional Autonoma de Mexico; Universidad de Concepcion	Reyes, JG (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	juan.reyes@pucv.cl	Nualart, Francisco/AAB-9342-2021; Osses, Nelson/V-9065-2019	Osses, Nelson/0000-0003-0974-1051; Trevino, Claudia L/0000-0002-7281-0534; Carmona, Emerson/0000-0003-1332-0372; Sanchez Tusie, Ana Alicia/0000-0003-2671-2789	Fondecyt [1110267, 1140758]; PUCV [125.754/2011 125792/2014]; Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) [128566]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) [IN202212-3]; Alexander von Humboldt Foundation	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PUCV; Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM)(Universidad Nacional Autonoma de Mexico); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by Fondecyt grant numbers 1110267 and 1140758; and PUCV grant number 125.754/2011 125792/2014 to JGR; and Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) (128566 to CT), Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) (IN202212-3 to CT) and The Alexander von Humboldt Foundation (to CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adasme T, 2015, BIOCHEM BIOPH RES CO, V458, P57, DOI 10.1016/j.bbrc.2015.01.065; AWAD JA, 1983, J BIOL CHEM, V258, P2960; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BECKMAN JK, 1979, LIPIDS, V14, P262, DOI 10.1007/BF02533912; Berrios J, 1998, BIOL CELL, V90, P391, DOI 10.1016/S0248-4900(98)80088-9; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; CHEN J, 1994, J BIOL CHEM, V269, P23018; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Christiansen E, 2011, J MED CHEM, V54, P6691, DOI 10.1021/jm2005699; Gao ZG, 2004, LIFE SCI, V74, P3173, DOI 10.1016/j.lfs.2003.11.014; GROGAN WM, 1981, LIPIDS, V16, P401, DOI 10.1007/BF02535006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Herrera E, 2000, BIOL CELL, V92, P429, DOI 10.1016/S0248-4900(00)01082-0; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Huleihel M, 2007, GROWTH FACTORS, V25, P236, DOI 10.1080/08977190701783400; JANNINI EA, 1994, BIOL REPROD, V51, P140, DOI 10.1095/biolreprod51.1.140; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAMERS JMJ, 1983, CELL CALCIUM, V4, P281, DOI 10.1016/0143-4160(83)90005-2; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; LEVIN RM, 1980, NEUROPHARMACOLOGY, V19, P169, DOI 10.1016/0028-3908(80)90134-3; Lewandowicz AM, 2006, BRIT J PHARMACOL, V147, P422, DOI 10.1038/sj.bjp.0706624; Lizama C, 2007, APOPTOSIS, V12, P499, DOI 10.1007/s10495-006-0012-1; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; MACDONALD ML, 1984, J NUTR, V114, P719, DOI 10.1093/jn/114.4.719; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Mauger JP, 2012, BIOL CELL, V104, P70, DOI 10.1111/boc.201100103; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Meroni SB, 2003, INT J ANDROL, V26, P310, DOI 10.1046/j.1365-2605.2003.00432.x; Mobraten K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-101; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; MUKAI H, 1992, J BIOL CHEM, V267, P16237; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Paillamanque J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158518; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; POWIS G, 1994, CANCER RES, V54, P2419; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Pozzan T, 2000, EUR J BIOCHEM, V267, P5269, DOI 10.1046/j.1432-1327.2000.01567.x; Qin J, 2009, PFLUG ARCH EUR J PHY, V458, P643, DOI 10.1007/s00424-009-0658-y; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; REGOLI D, 1984, PHARMACOLOGY, V28, P301, DOI 10.1159/000137979; Reyes JG, 1997, BIOL CELL, V89, P53, DOI 10.1016/S0248-4900(99)80081-1; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; ROSENTHAL MD, 1989, BIOCHIM BIOPHYS ACTA, V1001, P1, DOI 10.1016/0005-2760(89)90299-3; Sanchez-Tusie AA, 2014, BIOCHEM BIOPH RES CO, V443, P531, DOI 10.1016/j.bbrc.2013.12.011; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Smith RJ, 1996, J PHARMACOL EXP THER, V278, P320; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Sun RQ, 2006, PAIN, V120, P86, DOI 10.1016/j.pain.2005.10.017; Sutko JL, 1997, PHARMACOL REV, V49, P53; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; TOHDA M, 1991, NEUROSCI LETT, V129, P47, DOI 10.1016/0304-3940(91)90717-8; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trevino CL, 1998, ZYGOTE, V6, P159, DOI 10.1017/S0967199498000094; Ulisse S, 2000, CELL DEATH DIFFER, V7, P916, DOI 10.1038/sj.cdd.4400716; VISHWANATH BS, 1988, INFLAMMATION, V12, P549, DOI 10.1007/BF00914317; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	76	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172128	10.1371/journal.pone.0172128	http://dx.doi.org/10.1371/journal.pone.0172128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192519	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800074
J	Tal, N; Morag, Y; Shatz, L; Levron, Y				Tal, Nikolay; Morag, Yahav; Shatz, Lisa; Levron, Yoash			Design optimization of transmitting antennas for weakly coupled magnetic induction communication systems	PLOS ONE			English	Article							SEARCH COIL MAGNETOMETER; NETWORKS	This work focuses on the design of transmitting coils in weakly coupled magnetic induction communication systems. We propose several optimization methods that reduce the active, reactive and apparent power consumption of the coil. These problems are formulated as minimization problems, in which the power consumed by the transmitting coil is minimized, under the constraint of providing a required magnetic field at the receiver location. We develop efficient numeric and analytic methods to solve the resulting problems, which are of high dimension, and in certain cases non-convex. For the objective of minimal reactive power an analytic solution for the optimal current distribution in flat disc transmitting coils is provided. This problem is extended to general three-dimensional coils, for which we develop an expression for the optimal current distribution. Considering the objective of minimal apparent power, a method is developed to reduce the computational complexity of the problem by transforming it to an equivalent problem of lower dimension, allowing a quick and accurate numeric solution. These results are verified experimentally by testing a number of coil geometries. The results obtained allow reduced power consumption and increased performances in magnetic induction communication systems. Specifically, for wideband systems, an optimal design of the transmitter coil reduces the peak instantaneous power provided by the transmitter circuitry, and thus reduces its size, complexity and cost.	[Tal, Nikolay; Morag, Yahav; Levron, Yoash] Technion Israel Inst Technol, Dept Elect Engn, Haifa, Israel; [Shatz, Lisa] Suffolk Univ, Dept Engn, Boston, MA 02114 USA	Technion Israel Institute of Technology; Suffolk University	Tal, N (corresponding author), Technion Israel Inst Technol, Dept Elect Engn, Haifa, Israel.	nikolayt@campus.technion.ac.il	Morag, Yahav/N-2579-2019	Morag, Yahav/0000-0002-1941-4284				Agbinya Johnson I., 2013, Progress In Electromagnetics Research B, V49, P129; Agbinya J. I., 2010, J BATTLEFIELD TECHNO, V13, P21; Agbinya JI, 2012, WIRELESS PERS COMMUN, V64, P831, DOI 10.1007/s11277-011-0222-x; Ahmed N., 2014, P UND COMM NETW C SE, P1; Akyildiz I.F., 2009, PHYS COMMUN-AMST, V2, P167, DOI [10.1016/j.phycom.2009.03.004, DOI 10.1016/J.PHYCOM.2009.03.004, DOI 10.1016/j.phycom.2009.03.004]; Al-Asadi MM, 1998, MICROW OPT TECHN LET, V19, P84, DOI 10.1002/(SICI)1098-2760(19981005)19:2<84::AID-MOP2>3.0.CO;2-B; Balanis C., 2005, ANTENNA THEORY ANAL, P236; Bansal R., 2004, IEEE Antennas and Propagation Magazine, V46, P114, DOI 10.1109/MAP.2004.1305555; Domingo MC, 2012, IEEE T ANTENN PROPAG, V60, P2929, DOI 10.1109/TAP.2012.2194670; Cavoit C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2214693; Coillot C, 2010, IEEE SENS J, V10, P255, DOI 10.1109/JSEN.2009.2030977; Drude S., 2007, MOB WIR COMM SUMM 20, P1, DOI DOI 10.1109/ISTMWC.2007.4299336; Evans-Pughe C, 2005, IEE REVIEW, V51, P38, DOI 10.1049/ir:20050505; Grosz A, 2012, IEEE SENS J, V12, P2719, DOI 10.1109/JSEN.2012.2202179; Grosz A, 2011, IEEE SENS J, V11, P1088, DOI 10.1109/JSEN.2010.2079929; Gulbahar B, 2012, IEEE T WIREL COMMUN, V11, P3326, DOI 10.1109/TWC.2012.070912.111943; Kisseleff S, 2014, IEEE T COMMUN, V62, P4426, DOI 10.1109/TCOMM.2014.2367030; Latre B, 2011, WIREL NETW, V17, P1, DOI 10.1007/s11276-010-0252-4; Li H. B., 2008, SPRINGER J ADV MOBIL, P223, DOI DOI 10.1007/978-3-540-79041-9_12; LUKOSCHUS DG, 1979, IEEE T GEOSCI REMOTE, V17, P56, DOI 10.1109/TGE.1979.294613; Masihpour M, 2013, J NETWORKS, V8; Shatz LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111643; Sun Z, 2013, IEEE T WIREL COMMUN, V12, P996, DOI 10.1109/TWC.2013.011713.111896; Sun Z, 2010, IEEE T ANTENN PROPAG, V58, P2426, DOI 10.1109/TAP.2010.2048858; Tal Nikolay, 2015, 2015 IEEE International Conference on Microwaves, Communications, Antennas and Electronic Systems (COMCAS), P1, DOI 10.1109/COMCAS.2015.7360398; Tal N, 2015, INT S POW EL EE2015; Tal N, 2016, IEEE SENS J, V16, P4671, DOI 10.1109/JSEN.2016.2550604; Volk T, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2300042; Yenchek MR, 2012, IEEE T IND APPL, V48, P1700, DOI 10.1109/TIA.2012.2209853	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171982	10.1371/journal.pone.0171982	http://dx.doi.org/10.1371/journal.pone.0171982			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192463	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800057
J	McKee, SE; Grissom, NM; Herdt, CT; Reyes, TM				McKee, Sarah E.; Grissom, Nicola M.; Herdt, Christopher T.; Reyes, Teresa M.			Methyl donor supplementation alters cognitive performance and motivation in female offspring from high-fat diet-fed dams	FASEB JOURNAL			English	Article						folate; one carbon metabolism; vitamin B-12; choline; operant	ONE-CARBON METABOLISM; PREFRONTAL CORTEX; MATERNAL OBESITY; DNA METHYLATION; BRAIN SYNAPSES; MEMORY; FOLATE; DISORDERS; MICE; AGE	During gestation, fetal nutrition is entirely dependent on maternal diet. Maternal consumption of excess fat during pregnancy has been linked to an increased risk of neurologic disorders in offspring, including attention deficit/hyperactivity disorder, autism, and schizophrenia. In a mouse model, high-fat diet (HFD)-fed offspring have cognitive and executive function deficits as well as whole-genome DNA and promoter-specific hypomethylation in multiple brain regions. Dietary methyl donor supplementation during pregnancy or adulthood has been used to alter DNA methylation and behavior. Given that extensive brain development occurs during early postnatal life-particularly within the prefrontal cortex (PFC), a brain region critical for executive function-we examined whether early life methyl donor supplementation (e.g., during adolescence) could ameliorate executive function deficits observed in offspring that were exposed to maternal HFD. By using operant testing, progressive ratio, and the PFC-dependent 5-choice serial reaction timed task (5-CSRTT), we determined that F1 female offspring (B6D2F1/J) from HFD-fed dams have decreased motivation (decreased progressive ratio breakpoint) and require a longer stimulus length to complete the 5-CSRTT task successfully, whereas early life methyl donor supplementation increased motivation and shortened the minimum stimulus length required for a correct response in the 5-CSRTT. Of interest, we found that expression of 2 chemokines, CCL2 andCXCL10, correlated with the median stimulus length in the 5-CSRTT. Furthermore, we found that acute adult supplementation of methyl donors increased motivation in HFD-fed offspring and those who previously received supplementation with methyl donors. These data point to early life as a sensitive time during which dietary methyl donor supplementation can alter PFC-dependent cognitive behaviors.	[McKee, Sarah E.; Herdt, Christopher T.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grissom, Nicola M.] Univ Minnesota, Coll Liberal Arts, Dept Psychol, Minneapolis, MN 55455 USA; [Reyes, Teresa M.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, 2120 East Galbraith Rd,A-129, Cincinnati, OH 45237 USA	University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati	Reyes, TM (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, 2120 East Galbraith Rd,A-129, Cincinnati, OH 45237 USA.	reyesta@ucmail.uc.edu	Grissom, Nicola/AAW-4022-2021; Grissom, Nicola/GQO-7655-2022; Reyes, Teresa/GYI-8942-2022	Reyes, Teresa/0000-0003-3009-3749	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [ES019851]; NIH National Institute of Mental Health [MH087978]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES019851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087978] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge the technical support of Landis Walsh, Matt Marini (both from the University of Pennsylvania), and Amanda Fritsch (University of Cincinnati). This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant ES019851 to S.E.M.) and NIH National Institute of Mental Health (Grant MH087978 to T.M.R.). The authors declare no conflicts of interest.	Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Anderson RI, 2013, BEHAV BRAIN RES, V257, P83, DOI 10.1016/j.bbr.2013.09.021; [Anonymous], 2009, NCHS DATA BRIEF; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; BEATTY WW, 1979, HORM BEHAV, V12, P112, DOI 10.1016/0018-506X(79)90017-5; Berrocal-Zaragoza MI, 2014, BRIT J NUTR, V112, P1323, DOI 10.1017/S0007114514002116; Camprubi Robles M., 2015, PLOS ONE, V10; Cansev M, 2008, ALZHEIMERS DEMENT, V4, pS153, DOI 10.1016/j.jalz.2007.10.005; Carlin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063549; COHEN EL, 1976, SCIENCE, V191, P561, DOI 10.1126/science.1251187; Cooney CA, 2002, J NUTR, V132, p2393S; Cordero P, 2013, MOL GENET METAB, V110, P388, DOI 10.1016/j.ymgme.2013.08.022; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; da Silva VR, 2013, INT J OBESITY, V37, P1608, DOI 10.1038/ijo.2013.41; Desai A, 2017, MOL PSYCHIATR, V22, P1291, DOI 10.1038/mp.2016.153; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Floresco SB, 2011, NEUROPSYCHOPHARMACOL, V36, P227, DOI 10.1038/npp.2010.158; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Frye RE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00080; Fujii A, 1996, GEN PHARMACOL, V27, P995, DOI 10.1016/0306-3623(95)02072-1; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goodspeed D, 2015, FASEB J, V29, P807, DOI 10.1096/fj.14-259614; Gosselin RD, 2005, J NEUROCHEM, V95, P1023, DOI 10.1111/j.1471-4159.2005.03431.x; Grissom N, 2014, MAMM GENOME, V25, P41, DOI 10.1007/s00335-013-9487-6; Grissom NM, 2015, NEUROPSYCHOPHARMACOL, V40, P1353, DOI 10.1038/npp.2014.313; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; Guyon A, 2009, PEPTIDES, V30, P2031, DOI 10.1016/j.peptides.2009.05.028; Hatanaka Y, 2016, NEUROCHEM INT, V97, P99, DOI 10.1016/j.neuint.2016.03.008; Jiang XN, 2016, NEUROBIOL DIS, V92, P3, DOI 10.1016/j.nbd.2015.07.007; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kavaliers M, 2001, HORM BEHAV, V40, P497, DOI 10.1006/hbeh.2001.1714; Kavaliers M, 2013, ARCH SEX BEHAV, V42, P331, DOI 10.1007/s10508-013-0069-1; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Loke YJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00107; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Martin SAL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099226; Martin TJ, 2015, J NEUROSCI METH, V241, P37, DOI 10.1016/j.jneumeth.2014.12.007; Masho SW, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1002-0; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Mayford M., 2012, COLD SPRING HARB PER, V4; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Morris MS, 2012, ADV NUTR, V3, P801, DOI 10.3945/an.112.002535; O'Neill RJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00289; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Poon K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077668; Ramaekers VT, 2014, MOL GENET METAB, V113, P307, DOI 10.1016/j.ymgme.2014.10.002; Rivera HM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00194; Rocha NP, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/903796; Sakurai Y, 2004, EUR J NEUROSCI, V20, P1069, DOI 10.1111/j.1460-9568.2004.03525.x; Savelkoul PJM, 2012, J NEUROCHEM, V120, P631, DOI 10.1111/j.1471-4159.2011.07616.x; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Schuch V, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00126; Seferovic MD, 2015, FASEB J, V29, P2640, DOI 10.1096/fj.14-266387; Selhub J, 2011, BIOFACTORS, V37, P269, DOI 10.1002/biof.173; Sen S, 2014, J PERINATOL, V34, P105, DOI 10.1038/jp.2013.153; Sequeira JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152249; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Valenta JP, 2016, ALCOHOL CLIN EXP RES, V40, P187, DOI 10.1111/acer.12928; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; van Wijk N, 2014, J ALZHEIMERS DIS, V38, P459, DOI 10.3233/JAD-130998; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Warden CH, 2008, CELL METAB, V7, P277, DOI 10.1016/j.cmet.2008.03.014; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weng YL, 2013, NEUROTHERAPEUTICS, V10, P556, DOI 10.1007/s13311-013-0223-4; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227; Yu LX, 2016, J ALZHEIMERS DIS, V54, P297, DOI 10.3233/JAD-160329	74	21	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2352	2363		10.1096/fj.201601172R	http://dx.doi.org/10.1096/fj.201601172R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28209774	Green Published			2022-12-26	WOS:000401553400012
J	Anderson, NC; Donk, M				Anderson, Nicola C.; Donk, Mieke			Salient object changes influence overt attentional prioritization and object-based targeting in natural scenes	PLOS ONE			English	Article							REAL-WORLD SCENES; EYE-MOVEMENTS; COMPETITIVE INTEGRATION; SELECTION; FIXATION; GUIDANCE; LOCATIONS; CAPTURE; PREDICT; PERCEPTION	A change to an object in natural scenes attracts attention when it occurs during a fixation. However, when a change occurs during a saccade, and is masked by saccadic suppression, it typically does not capture the gaze in a bottom- up manner. In the present work, we investigated how the type and direction of salient changes to objects affect the prioritization and targeting of objects in natural scenes. We asked observers to look around a scene in preparation for a later memory test. After a period of time, an object in the scene was increased or decreased in salience either during a fixation (with a transient signal) or during a saccade (without transient signal), or it was not changed at all. Changes that were made during a fixation attracted the eyes both when the change involved an increase and a decrease in salience. However, changes that were made during a saccade only captured the eyes when the change was an increase in salience, relative to the baseline no-change condition. These results suggest that the prioritization of object changes can be influenced by the underlying salience of the changed object. In addition, object changes that occurred with a transient signal (which is itself a salient signal) resulted in more central object targeting. Taken together, our results suggest that salient signals in a natural scene are an important component in both object prioritization and targeting in natural scene viewing, insofar as they align with object locations.	[Anderson, Nicola C.; Donk, Mieke] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Anderson, NC (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	n.c.c.anderson@vu.nl		Donk, Mieke/0000-0001-9310-8210				Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Anderson NC, 2016, PSYCHON B REV; Anderson NC, 2015, J VISION, V15, DOI 10.1167/15.5.9; Brockmole JR, 2008, VIS COGN, V16, P375, DOI 10.1080/13506280701453623; Brockmole JR, 2005, PSYCHON B REV, V12, P1061, DOI 10.3758/BF03206444; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Donk M, 2011, PERCEPTION, V40, P63, DOI 10.1068/p6718; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Einhauser W, 2003, EUR J NEUROSCI, V17, P1089, DOI 10.1046/j.1460-9568.2003.02508.x; Enns JT, 2001, J EXP PSYCHOL HUMAN, V27, P1287, DOI 10.1037/0096-1523.27.6.1287; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Foulsham T, 2013, Q J EXP PSYCHOL, V66, P1707, DOI 10.1080/17470218.2012.762798; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Henderson JM, 2009, PSYCHON B REV, V16, P850, DOI 10.3758/PBR.16.5.850; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Jonikaitis D, 2014, J NEUROSCI, V34, P6687, DOI 10.1523/JNEUROSCI.4453-13.2014; Jonikaitis D, 2013, J NEUROPHYSIOL, V109, P1425, DOI 10.1152/jn.00656.2012; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Mannan SK, 1996, SPATIAL VISION, V10, P165, DOI 10.1163/156856896X00123; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Matsukura M, 2011, VISION RES, V51, P546, DOI 10.1016/j.visres.2011.01.014; Matsukura M, 2009, VIS COGN, V17, P835, DOI 10.1080/13506280902868660; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Nuthmann A, 2010, J VISION, V10, DOI 10.1167/10.8.20; OREGAN JK, 1992, J EXP PSYCHOL HUMAN, V18, P185, DOI 10.1037/0096-1523.18.1.185; Pajak M, 2013, J VISION, V13, DOI 10.1167/13.5.2; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Siebold A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023552; Silvis JD, 2014, ATTEN PERCEPT PSYCHO, V76, P1803, DOI 10.3758/s13414-014-0688-1; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; 't Hart BM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00455; Tatler BW, 2006, VISION RES, V46, P1857, DOI 10.1016/j.visres.2005.12.005; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Underwood G, 2006, EUR J COGN PSYCHOL, V18, P321, DOI 10.1080/09541440500236661; Underwood G, 2009, VIS COGN, V17, P812, DOI 10.1080/13506280902771278; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu CC, 2014, VISION RES, V105, P10, DOI 10.1016/j.visres.2014.08.019; Yang Shun-Nan, 2007, P293, DOI 10.1016/B978-008044980-7/50015-X; Yarbus A. L., 1967, EYE MOVEMENTS PERCEP, DOI [10.1007/978-1-4899-5379-7_8, DOI 10.1007/978-1-4899-5379-7_8]; Zehetleitner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052595; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72132	10.1371/journal.pone.0172132	http://dx.doi.org/10.1371/journal.pone.0172132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222190	gold, Green Published, Green Submitted			2022-12-26	WOS:000394676800033
J	Fereshtehnejad, SM; Rahmani, A; Shafieesabet, M; Soori, M; Delbari, A; Motamed, MR; Lokk, J				Fereshtehnejad, Seyed-Mohammad; Rahmani, Arash; Shafieesabet, Mahdiyeh; Soori, Mahshid; Delbari, Ahmad; Motamed, Mohammad Reza; Lokk, Johan			Prevalence and associated comorbidities of restless legs syndrome (RLS): Data from a large population-based door-to-door survey on 19176 adults in Tehran, Iran	PLOS ONE			English	Article							PARKINSONS-DISEASE; SCREENING QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; HEART-DISEASE; RISK-FACTORS; HEALTH; EPIDEMIOLOGY; VALIDATION; SLEEP	Background Discrepancies have been reported in the prevalence rate of restless legs syndrome (RLS) among different ethnic groups and geographic populations. Furthermore, there are disagreements on determinant factors and associated comorbidities of RLS. We aimed to estimate prevalence of RLS and investigate its associated comorbid conditions and risk factors in a large population-based door-to-door survey. Methods Following a multistage random sampling from the households lived in 22 urban districts of Tehran, Iran, 19176 participants with >= 30 years of age were recruited. Trained surveyors filled study checklist consisting of baseline characteristics, risk factors and comorbidity profile and the International RLS Study Group (IRLSSG) diagnostic criteria through face-toface interviews. Results In total, 1580 individuals were positively screened for RLS resulting in a standardized prevalence rate of 60.0/1000. There was a gradual increase in RLS prevalence by advancing age, however, sex difference disappeared after adjustment. Parkinsonism [adjusted odds' ratio (adj-OR) = 7.4 (95% CI: 5.3-10.4)], peripheral neuropathy [adj-OR = 3.7 (95% CI: 3.3-4.1)], subjective cognitive impairment (SCI) [adj-OR = 3.1 (95% CI: 2.7-3.4)], acting out dreams [adj-OR = 2.8 (95% CI: 2.5-3.2)], hyposmia [adj-OR = 2.5 (95% CI: 2.2-2.9)], active smoking [adj-OR = 1.5 (95% CI: 1.3-1.9)] and additional number of cardiometabolic diseases associated with higher risk of RLS [adj-OR = 1.6 (95% CI: 1.2-2.3)]. Conclusion Our findings showed that neuro-cognitive co-morbidities such as parkinsonism, peripheral neuropathy, SCI, acting out dreams and hyposmia as well as cardio-metabolic risk factors and diseases were independent determinants of RLS. It is recommended to screen individuals with either these comorbid conditions for RLS or the ones with RLS for the accompanying diseases.	[Fereshtehnejad, Seyed-Mohammad; Delbari, Ahmad; Lokk, Johan] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] McGill Univ, Montreal Gen Hosp, Dept Neurol & Neurosurg, Fac Med, Montreal, PQ, Canada; [Fereshtehnejad, Seyed-Mohammad; Motamed, Mohammad Reza] Iran Univ Med Sci, Firoozgar Hosp, Firoozgar Clin Res Dev Ctr, Tehran, Iran; [Rahmani, Arash] Iran Univ Med Sci, Med Student Res Comm, Mental Hlth Res Ctr, Tehran Psychiat Inst, Tehran, Iran; [Shafieesabet, Mahdiyeh; Soori, Mahshid] Iran Univ Med Sci, Med Student Res Comm, Fac Med, Tehran, Iran; [Delbari, Ahmad] Iranian Res Ctr Aging, Univ Social Welf & Rehabil, Tehran, Iran; [Motamed, Mohammad Reza] Iran Univ Med Sci, Dept Neurol, Fac Med, Tehran, Iran; [Lokk, Johan] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; McGill University; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Fereshtehnejad, SM (corresponding author), Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.; Fereshtehnejad, SM (corresponding author), McGill Univ, Montreal Gen Hosp, Dept Neurol & Neurosurg, Fac Med, Montreal, PQ, Canada.; Fereshtehnejad, SM (corresponding author), Iran Univ Med Sci, Firoozgar Hosp, Firoozgar Clin Res Dev Ctr, Tehran, Iran.	sm.fereshtehnejad@ki.se	rahmani, arash/AAL-5457-2020; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Delbari, Ahmad/D-8560-2017	rahmani, arash/0000-0002-2948-3478; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; 				Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Batool-Anwar S, 2016, J CLIN SLEEP MED, V12, P187, DOI 10.5664/jcsm.5482; Bower JH, 2009, NEUROEPIDEMIOLOGY, V32, P313, DOI 10.1159/000209265; Carlos K, 2015, SLEEP MED, V16, P1156, DOI 10.1016/j.sleep.2015.05.022; Chan DKY, 2000, J NEUROL NEUROSUR PS, V69, P117, DOI 10.1136/jnnp.69.1.117; De Vito K, 2014, MOVEMENT DISORD, V29, P1044, DOI 10.1002/mds.25860; DUARTE J, 1995, MOVEMENT DISORD, V10, P643, DOI 10.1002/mds.870100518; Edwards RR, 2011, SLEEP MED, V12, P603, DOI 10.1016/j.sleep.2010.09.018; Fereshtehnejad SM, 2015, NEUROPSYCH DIS TREAT, V11, P321, DOI 10.2147/NDT.S77391; Fereshtehnejad SM, 2014, NEUROEPIDEMIOLOGY, V43, P178, DOI 10.1159/000368167; Fereshtehnejad SM, 2014, ACTA NEUROL SCAND, P1; Fulda S, 2010, MOVEMENT DISORD, V25, P2641, DOI 10.1002/mds.23353; Gao X, 2009, NEUROLOGY, V72, P1255, DOI 10.1212/01.wnl.0000345673.35676.1c; Gupta R, 2016, ACTA NEUROL SCAND, V133, P320, DOI 10.1111/ane.12520; Hening W, 2004, SLEEP MED, V5, P237, DOI 10.1016/j.sleep.2004.03.006; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Hunter CB, 2008, MOVEMENT DISORD, V23, pS361; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Koo BB, 2015, SLEEP MED CLIN, V10, P189, DOI 10.1016/j.jsmc.2015.05.004; Li YP, 2013, NEUROLOGY, V81, P52, DOI 10.1212/WNL.0b013e318297eee0; Li YP, 2012, CIRCULATION, V126, P1689, DOI 10.1161/CIRCULATIONAHA.112.112698; McCrink L, 2007, SLEEP MED, V8, P73, DOI 10.1016/j.sleep.2006.03.014; Mckinnon J, 2010, INT J NEUROSCI, V120, P36, DOI 10.3109/00207450903428954; MENEGHINI F, 1992, J CLIN EPIDEMIOL, V45, P319, DOI 10.1016/0895-4356(92)90033-J; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Rijsman Roselyne M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS5, DOI 10.1016/S1353-8020(13)70004-X; Rocca WA, 1998, J CLIN EPIDEMIOL, V51, P517, DOI 10.1016/S0895-4356(98)00017-1; Setthawatcharawanich S, 2011, CLIN NEUROL NEUROSUR, V113, P885, DOI 10.1016/j.clineuro.2011.07.001; Sevillano MD, 2002, MOVEMENT DISORD, V17, P258, DOI 10.1002/mds.10088; Sevim S, 2004, J NEUROL NEUROSUR PS, V75, P226; Sevim S, 2003, NEUROLOGY, V61, P1562, DOI 10.1212/01.WNL.0000096173.91554.B7; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Szentkiralyi A, 2013, J SLEEP RES, V22, P434, DOI 10.1111/jsr.12040; TANNER CM, 1990, ANN NEUROL, V28, P267; Teodoro T, 2015, PARKINSONISM RELAT D, P21; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Wali SO, 2015, ANN THORAC MED, V10, P193, DOI 10.4103/1817-1737.160839; Walters AS, 2009, SLEEP, V32, P589, DOI 10.1093/sleep/32.5.589; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Wong JC, 2014, SLEEP, V37, P369, DOI 10.5665/sleep.3416	42	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172593	10.1371/journal.pone.0172593	http://dx.doi.org/10.1371/journal.pone.0172593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212408	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700062
J	Southern, WM; Nichenko, AS; Shill, DD; Spencer, CC; Jenkins, NT; McCully, KK; Call, JA				Southern, William M.; Nichenko, Anna S.; Shill, Daniel D.; Spencer, Corey C.; Jenkins, Nathan T.; McCully, Kevin K.; Call, Jarrod A.			Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment	PLOS ONE			English	Article							STATIN THERAPY; ATORVASTATIN TREATMENT; OXIDATIVE STRESS; AUTOPHAGY; INCREASES; PROTECTS; HEART; IMPROVEMENT; RESPIRATION; EXPRESSION	We tested the hypothesis that a 6-week regimen of simvastatin would attenuate skeletal muscle adaptation to low-intensity exercise. Male C57BLI6J wildtype mice were subjected to 6-weeks of voluntary wheel running or normal cage activities with or without simvastatin treatment (20 mg/kg/d, n = 7-8 per group). Adaptations in in vivo fatigue resistance were determined by a treadmill running test, and by ankle plantarflexor contractile assessment. The tibialis anterior, gastrocnemius, and plantaris muscles were evaluated for exercised induced mitochondrial adaptations (i.e., biogenesis, function, autophagy). There was no difference in weekly wheel running distance between control and simvastatin-treated mice (P = 0.51). Trained mice had greater treadmill running distance (296%, P<0.001), and ankle plantarflexor contractile fatigue resistance (9%, P<0.05) compared to sedentary mice, independent of simvastatin treatment. At the cellular level, trained mice had greater mitochondrial biogenesis (e.g., similar to 2-fold greater PGC1 alpha expression, P<0.05) and mitochondrial content (e.g., 25% greater citrate synthase activity, P<0.05), independent of simvastatin treatment. Mitochondrial autophagy-related protein contents were greater in trained mice (e.g., 40% greater Bnip3, P<0.05), independent of simvastatin treatment. However, Drp1, a marker of mitochondrial fission, was less in simvastatin treated mice, independent of exercise training, and there was a significant interaction between training and statin treatment (P<0.022) for LC3-II protein content, a marker of autophagy flux. These data indicate that whole body and skeletal muscle adaptations to endurance exercise training are attainable with simvastatin treatment, but simvastatin may have side effects on muscle mitochondrial maintenance via autophagy, which could have long-term implications on muscle health.	[Southern, William M.; Nichenko, Anna S.; Shill, Daniel D.; Spencer, Corey C.; Jenkins, Nathan T.; McCully, Kevin K.; Call, Jarrod A.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Call, Jarrod A.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Call, JA (corresponding author), Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA.; Call, JA (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.	call@uga.edu	McCully, Kevin K./P-5141-2015	McCully, Kevin K./0000-0001-9850-487X; Call, Jarrod/0000-0002-1094-4940				Ashfield TA, 2010, AGE AGEING, V39, P185, DOI 10.1093/ageing/afp203; Ballard KD, 2013, ATHEROSCLEROSIS, V230, P121, DOI 10.1016/j.atherosclerosis.2013.07.001; Baltgalvis KA, 2012, MED SCI SPORT EXER, V44, P1671, DOI 10.1249/MSS.0b013e31825703f0; Baltgalvis KA, 2009, MUSCLE NERVE, V40, P443, DOI 10.1002/mus.21327; Bea F, 2003, ATHEROSCLEROSIS, V167, P187, DOI 10.1016/S0021-9150(02)00387-8; Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Bonifacio A, 2015, BBA-MOL CELL RES, V1853, P1841, DOI 10.1016/j.bbamcr.2015.04.010; Bouitbir J, 2012, MUSCLE NERVE, V46, P367, DOI 10.1002/mus.23309; Bouitbir J, 2011, J APPL PHYSIOL, V111, P1477, DOI 10.1152/japplphysiol.00107.2011; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Call JA, 2011, J APPL PHYSIOL, V111, P200, DOI 10.1152/japplphysiol.00248.2011; Call JA, 2010, MUSCLE NERVE, V42, P871, DOI 10.1002/mus.21764; Choudhury RP, 2004, J VASC RES, V41, P75, DOI 10.1159/000076436; Davis ME, 2015, J SHOULDER ELB SURG, V24, P280, DOI 10.1016/j.jse.2014.06.048; Fox J. G., 2007, MOUSE BIOMEDICAL RES, V3; Ganga HV, 2014, AM HEART J, V168, P6, DOI 10.1016/j.ahj.2014.03.019; Garcia-Cazarin ML, 2011, JOVE-J VIS EXP, DOI 10.3791/2452; Goodman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128398; Gorassini M, 2000, J NEUROPHYSIOL, V83, P2002, DOI 10.1152/jn.2000.83.4.2002; Gu Q, 2014, NCHS DATA BRIEF, P1; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Jenkins NT, 2011, J PHYSIOL-LONDON, V589, P5539, DOI 10.1113/jphysiol.2011.215277; Krishnan GM, 2010, CURR OPIN LIPIDOL, V21, P324, DOI 10.1097/MOL.0b013e32833c1edf; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muraki A, 2012, J APPL PHYSIOL, V113, P479, DOI 10.1152/japplphysiol.01362.2011; Nichenko AS, 2016, AM J PHYSIOL-CELL PH, V311, pC190, DOI 10.1152/ajpcell.00066.2016; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Palmer G, 2004, ARTHRITIS RHEUM-US, V50, P4051, DOI 10.1002/art.20673; Panza GA, 2015, J CLIN LIPIDOL, V9, P351, DOI 10.1016/j.jacl.2015.01.004; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rengo JL, 2016, MUSCLE NERVE, V53, P242, DOI 10.1002/mus.24722; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008; Skoglund RN, 2004, SIMVASTATIN IMPROVES, V17, P2004; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Traustadottir T, 2008, AGE, V30, P283, DOI 10.1007/s11357-008-9070-3; Wang YX, 2002, ATHEROSCLEROSIS, V162, P23, DOI 10.1016/S0021-9150(01)00678-5; Whitehead NP, 2016, AUTOPHAGY, V12, P705, DOI 10.1080/15548627.2016.1144005; Whitehead NP, 2015, P NATL ACAD SCI USA, V112, P12864, DOI 10.1073/pnas.1509536112; Wu JS, 2011, MUSCLE NERVE, V43, P76, DOI 10.1002/mus.21847; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	60	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172551	10.1371/journal.pone.0172551	http://dx.doi.org/10.1371/journal.pone.0172551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207880	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500145
J	Kosaka, PM; Pini, V; Calleja, M; Tamayo, J				Kosaka, Priscila M.; Pini, Valerio; Calleja, Montserrat; Tamayo, Javier			Ultrasensitive detection of HIV-1 p24 antigen by a hybrid nanomechanical-optoplasmonic platform with potential for detecting HIV-1 at first week after infection	PLOS ONE			English	Article							SENSITIVITY; BIOMARKERS; BIOSENSORS; DIAGNOSIS; PROTEIN	Early detection of HIV infection is the best way to prevent spread of the disease and to improve the efficiency of the antiretroviral therapy. Nucleic acid amplification tests (NAAT) have become the gold-standard for detecting low-concentrations of the virus in blood. However, these methods are technically demanding and cost-prohibitive in developing countries. Immunoassays are more affordable and can be more easily adapted for point-of-care diagnosis. However, the sensitivity so far of these methods has been too low. We here report the development of a sandwich immunoassay that combines nanomechanical and optoplasmonic transduction methods for detecting the HIV-1 capsid antigen p24 in human serum. The immunoreactions take place on the surface of a compliant microcantilever where gold nano particles are used as both mechanical and plasmonic labels. The microcantilever acts as both a mechanical resonator and an optical cavity for the transduction of the mechanical and plasmonic signals. The limit of detection of the immunoassay is 10(-17) g/mL that is equivalent to one virion in 10 mL of plasma. This is 5 orders of magnitude better than last generation of approved immunoassays and 2 orders of magnitude better than NAAT. This technology meets the demands to be produced en masse at low cost and the capability for miniaturization to be used at the point-of-care.	[Kosaka, Priscila M.; Pini, Valerio; Calleja, Montserrat; Tamayo, Javier] CSIC, IMM, CNM, PTM, Isaac Newton 8, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Kosaka, PM; Tamayo, J (corresponding author), CSIC, IMM, CNM, PTM, Isaac Newton 8, Madrid, Spain.	priscila@imm.cnm.csic.es; jtamayo@imm.cnm.csic.es	calleja, montserrat/B-7857-2014; Tamayo, Javier/M-2781-2014; Kosaka, Priscila M/A-4641-2012; Pini, Valerio/A-1682-2014	calleja, montserrat/0000-0003-2414-5725; Tamayo, Javier/0000-0002-5280-7215; Kosaka, Priscila M/0000-0003-4242-7064; Pini, Valerio/0000-0001-5615-1471	Spanish Ministry of Economy and Competitiveness [MAT2015-66904-R]; Spanish Association against Cancer (AECC) Scientific Foundation [PS15153089TAMA]; Fundacion General CSIC (Program ComFuturo)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Association against Cancer (AECC) Scientific Foundation; Fundacion General CSIC (Program ComFuturo)	This study has been supported by the Spanish Ministry of Economy and Competitiveness (grant MAT2015-66904-R) and Spanish Association against Cancer (AECC) Scientific Foundation (grant PS15153089TAMA). PMK acknowledges financial support by Fundacion General CSIC (Program ComFuturo).	Alvarez M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2164537; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN; Cabrera C, 2015, CLIN CHEM, V61, P1372, DOI 10.1373/clinchem.2015.243287; Cohen MS, 2001, NEW ENGL J MED, V364, P1943; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]; Fan PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125701; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Kosaka PM, 2014, NAT NANOTECHNOL, V9, P1047, DOI [10.1038/nnano.2014.250, 10.1038/NNANO.2014.250]; Kosaka PM, 2013, ANALYST, V138, P863, DOI 10.1039/c2an36192b; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Malvar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13452; Martinez NF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3525090; Nakatsuma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131319; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002; Schmidt MA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2109; Tamayo J, 2013, CHEM SOC REV, V42, P1287, DOI 10.1039/c2cs35293a; Tamayo J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/31/315501; Uddin R, 2016, BIOSENS BIOELECTRON, V85, P351, DOI 10.1016/j.bios.2016.05.023	23	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171899	10.1371/journal.pone.0171899	http://dx.doi.org/10.1371/journal.pone.0171899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199410	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400058
J	Kleinstern, G; Abu Seir, R; Perlman, R; Khatib, A; Abdeen, Z; Elyan, H; Nirel, R; Amir, G; Ramlawi, A; Sabatin, F; Boffetta, P; Dann, EJ; Kedmi, M; Ellis, M; Nagler, A; Ben Yehuda, D; Paltiel, O				Kleinstern, Geffen; Abu Seir, Rania; Perlman, Riki; Khatib, Areej; Abdeen, Ziad; Elyan, Husein; Nirel, Ronit; Amir, Gail; Ramlawi, Asad; Sabatin, Fouad; Boffetta, Paolo; Dann, Eldad J.; Kedmi, Meirav; Ellis, Martin; Nagler, Arnon; Ben Yehuda, Dina; Paltiel, Ora			Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians	PLOS ONE			English	Article							POOLED ANALYSIS; HEMATOLOGICAL MALIGNANCIES; ALCOHOL-CONSUMPTION; EPIDEMIOLOGY; COHORT; CLASSIFICATION; CONSORTIUM; INTERLYMPH; PATTERNS; EXPOSURE	Background Risk factors for B-cell non-Hodgkin lymphoma (B-NHL) have not been assessed among Palestinian Arabs (PA) and Israeli Jews (IJ). Methods In a case-control study we investigated self-reported medical and lifestyle exposures, reporting odds ratios (ORs) and 95% confidence intervals [CIs], by ethnicity, for overall B-NHL and subtypes. Results We recruited 823 cases and 808 healthy controls. Among 307 PA/516 IJ B-NHL cases (mean age at diagnosis = 51 [+/- 17] versus 60 [+/- 15] years, respectively) subtype distributions differed, with diffuse large B-cell lymphoma (DLBCL) being prominent among PA (71%) compared to IJ (41%); follicular lymphoma (FL), was observed in 14% versus 28%, and marginal zone lymphoma, in 2% versus 14%, respectively. Overall B-NHL in both populations was associated with recreational sun exposure OR = 1.43 [CI: 1.07-1.91], black hair-dye use OR = 1.70 [CI: 1.00-2.87], hospitalization for infection OR = 1.68 [CI: 1.34-2.11], and first-degree relative with hematopoietic cancer, OR = 1.69 [CI: 1.16-2.48]. An inverse association was noted with alcohol use, OR = 0.46 [CI: 0.34-0.62]. Subtype-specific exposures included smoking (FL, OR = 1.46 [CI: 1.01-2.11]) and > monthly indoor pesticide use (DLBCL, OR = 2.01 [CI: 1.35-3.00]). Associations observed for overall B-NHL in PA only included: gardening OR = 1.93 [CI: 1.39-2.70]; history of herpes, mononucleosis, rubella, blood transfusion (OR> 2.5, P< 0.01 for all); while for IJ risk factors included growing fruits and vegetables, OR = 1.87 [CI: 1.11-3.15]; and self-reported autoimmune diseases, OR = 1.99 [CI: 1.34-2.95]. Conclusions In these geographically proximate populations we found some unique risk factors for B-NHL. Heterogeneity in the observed associations by ethnicity could reflect differences in lifestyle, medical systems, and reporting patterns, while variations by histology infer specific etiologic factors for lymphoma subtypes.	[Kleinstern, Geffen; Paltiel, Ora] Hadassah Hebrew Univ Med Org, Sch Publ Hlth, Jerusalem, Israel; [Abu Seir, Rania; Perlman, Riki; Ben Yehuda, Dina; Paltiel, Ora] Hadassah Hebrew Univ Med Ctr, Dept Hematol, Jerusalem, Israel; [Abu Seir, Rania] Al Quds Univ, Dept Med Lab Sci, Fac Hlth Profess, Abu Deis, West Bank, Palestine; [Khatib, Areej; Sabatin, Fouad] Augusta Victoria Hosp, Canc Care Ctr, East Jerusalem, Palestine; [Abdeen, Ziad] Al Quds Univ, Dept Community Med, Sch Fac Med, Abu Deis, West Bank, Palestine; [Elyan, Husein] Beit Jalla Hosp, West Bank, PA, Palestine; [Nirel, Ronit] Hebrew Univ Jerusalem, Dept Stat, Jerusalem, Israel; [Amir, Gail] Hadassah Med Ctr, Dept Pathol, Jerusalem, Israel; [Ramlawi, Asad] Minist Hlth, Dept Primary Hlth Care, Ramallah, Palestine; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Dann, Eldad J.] Technion, Rambam Med Ctr, Haifa, Israel; [Dann, Eldad J.] Technion, Rappaport Fac Med, Haifa, Israel; [Kedmi, Meirav; Nagler, Arnon] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Kedmi, Meirav; Nagler, Arnon] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Ellis, Martin] Meir Med Ctr, Kefar Sava, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Paltiel, O (corresponding author), Hadassah Hebrew Univ Med Org, Sch Publ Hlth, Jerusalem, Israel.; Paltiel, O (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Hematol, Jerusalem, Israel.	Orap@hadassah.org.il	Boffetta, Paolo/AAI-7767-2021; Abdeen, Ziad/AAC-7889-2019; Abu Seir, Rania/AAB-2992-2019	Boffetta, Paolo/0000-0002-3811-2791; Abu Seir, Rania/0000-0002-4625-9742; Kleinstern, Geffen/0000-0001-6148-0421	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government; Israel Science Foundation; and the Hadassah University Hospital compensatory fund. We gratefully acknowledge Dr. Paul Brennan from IARC for support of the original 2003 Epilymph study and for reviewing the manuscript. The funding sources played no role in the design, execution or analysis of the study.	Akhtar SS, 2009, SAUDI MED J, V30, P677; Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Ali A, 2013, ASIAN PAC J CANCER P, V14, P841, DOI 10.7314/APJCP.2013.14.2.841; Almasri NM, 2004, SAUDI MED J, V25, P609; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Besson H, 2006, INT J CANCER, V119, P901, DOI 10.1002/ijc.21913; Cahoon EK, 2015, INT J CANCER, V136, pE432, DOI 10.1002/ijc.29237; Cerhan JR, 2015, BLOOD, V126, P2265, DOI 10.1182/blood-2015-04-537498; Chiu Brian C-H, 2015, Cancer Treat Res, V165, P1, DOI 10.1007/978-3-319-13150-4_1; Diver WR, 2012, CANCER CAUSE CONTROL, V23, P1231, DOI 10.1007/s10552-012-0001-3; Engels EA, 2007, CANCER EPIDEM BIOMAR, V16, P401, DOI 10.1158/1055-9965.EPI-06-1056; Fallah M, 2014, ANN ONCOL, V25, P2025, DOI 10.1093/annonc/mdu365; GLOBOCAN, 2012, GLOBOCAN 2012 EST CA; Goldman L, 2009, CANCER CAUSE CONTROL, V20, P981, DOI 10.1007/s10552-009-9316-0; Hagner PR, 2009, BLOOD, V113, P5526, DOI 10.1182/blood-2008-11-191783; Howlader N, SEER CANC STAT REV; Israel Ministry of Health, NAT CANC REG NONH LY; Israeli Central Bureau of Statistics, HLTH SURV 2009 PEOPL; Kleinstern G, 2016, HAEMATOLOGICA; Kricker A, 2008, INT J CANCER, V122, P144, DOI 10.1002/ijc.23003; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Morton LM, 2005, LANCET ONCOL, V6, P469, DOI 10.1016/S1470-2045(05)70214-X; Nelson RA, 1997, BRIT J CANCER, V76, P1532, DOI 10.1038/bjc.1997.590; Novack L, 2008, T ROY SOC TROP MED H, V102, P787, DOI 10.1016/j.trstmh.2008.04.005; Palestinian Ministry of Health, HLTH ANN REP 2014; Paltiel O, 2000, CANCER, V88, P2357, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2357::AID-CNCR21>3.3.CO;2-V; Paltiel O, 2006, CANCER EPIDEM BIOMAR, V15, P1964, DOI 10.1158/1055-9965.EPI-06-0313; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Roman E, 2011, HISTOPATHOLOGY, V58, P4, DOI 10.1111/j.1365-2559.2010.03696.x; Sader-Ghorra C, 2014, ASIAN PAC J CANCER P, V15, P5825, DOI 10.7314/APJCP.2014.15.14.5825; Thomson WM, 2010, J DENT RES, V89, P307, DOI 10.1177/0022034509356779; Tramacere I, 2012, ANN ONCOL, V23, P2791, DOI 10.1093/annonc/mds013; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Wang SS, 2015, AM J EPIDEMIOL, V181, P406, DOI 10.1093/aje/kwu290; Yassin K, 2002, J INFECTION, V44, P252, DOI 10.1053/jinf.2001.0998	35	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171709	10.1371/journal.pone.0171709	http://dx.doi.org/10.1371/journal.pone.0171709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196110	gold, Green Published			2022-12-26	WOS:000394423900030
J	Lee, HH; Bellat, V; Law, B				Lee, Hyun Hee; Bellat, Vanessa; Law, Benedict			Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; FACTOR-I; CXCR4; CHEMOKINE; CXCL12; GROWTH; AXIS; IDENTIFICATION; ACTIVATION	Ovarian cancer (OVC) patients who receive chemotherapy often acquire drug resistance within one year. This can lead to tumor reoccurrence and metastasis, the major causes of mortality. We report a transient increase of a small distinctive CXCR4(High)/CD24(Low) cancer stem cell population (CXCR4(High)) in A2780 and SKOV-3 OVC cell lines in response to cisplatin, doxorubicin, and paclitaxel, treatments. The withdrawal of the drug challenges reversed this cell-state transition. CXCR4(High) exhibits dormancy in drug resistance and mesenchymal-like invasion, migration, colonization, and tumor formation properties. The removal of this cell population from a doxorubicin-resistant A2780 lineage (A2780/ADR) recovered the sensitivity to drug treatments. A cytotoxic peptide (CXCR4-KLA) that can selectively target cell-surface CXCR4 receptor was further synthesized to investigate the therapeutic merits of targeting CXCR4(High). This peptide was more potent than the conventional CXCR4 antagonists(AMD3100 and CTCE-9908) in eradicating the cancer stem cells. When used together with cytotoxic agents such as doxorubicin and cisplatin, the combined drug-peptide regimens exhibited a synergistic cell-killing effect on A2780, A2780/ADR,and SKOV-3. Our data suggested that chemotherapy could establish drug-resistant and tumor-initiating properties of OVC via reversible CXCR4 cell state transition. Therapeutic strategies designed to eradicate rather than antagonize CXCR4(High) might offer a far-reaching potential as supportive chemotherapy.	[Lee, Hyun Hee; Bellat, Vanessa; Law, Benedict] Weill Cornell Med, Dept Radiol, Mol Imaging Innovat Inst, New York, NY 10065 USA	Cornell University	Law, B (corresponding author), Weill Cornell Med, Dept Radiol, Mol Imaging Innovat Inst, New York, NY 10065 USA.	sbl2004@med.cornell.edu			National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000457]; Radiology Department, WCM; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Radiology Department, WCM; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000457 and Radiology Department, WCM.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; Cain JW, 2011, MOL CANCER RES, V9, P637, DOI 10.1158/1541-7786.MCR-09-0237; Casagrande F, 2011, CANCER-AM CANCER SOC, V117, P5519, DOI 10.1002/cncr.26215; Chen YF, 2016, ACTA BIOCH BIOPH SIN, V48, P282, DOI 10.1093/abbs/gmv132; Chiaramonte R, 2015, INT J BIOCHEM CELL B, V66, P134, DOI 10.1016/j.biocel.2015.07.015; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cioffi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10357; Elisseeva EL, 2000, J BIOL CHEM, V275, P26799; Ferrandina G, 2008, INT J GYNECOL CANCER, V18, P506, DOI 10.1111/j.1525-1438.2007.01056.x; Forster R, 1998, J IMMUNOL, V160, P1522; Gao Y, 2015, ONCOTARGET, V6, P9313, DOI 10.18632/oncotarget.3220; Goldman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7139; Gravina GL, 2015, PROSTATE, V75, P1227, DOI 10.1002/pros.23007; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hsu EL, 2008, CANCER LETT, V265, P113, DOI 10.1016/j.canlet.2008.02.033; Huang AF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-115; Huang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115249; Jankowski K, 2003, CANCER RES, V63, P7926; Jung HK, 2016, J CONTROL RELEASE, V235, P259, DOI 10.1016/j.jconrel.2016.06.008; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kang KS, 2013, BIOCHEM BIOPH RES CO, V432, P333, DOI 10.1016/j.bbrc.2013.01.102; Kryczek I, 2005, CANCER RES, V65, P465; Kwong J, 2009, MOL CANCER THER, V8, P1893, DOI 10.1158/1535-7163.MCT-08-0966; Law B, 2006, MOL CANCER THER, V5, P1944, DOI 10.1158/1535-7163.MCT-05-0509; Li J, 2014, BMB REP, V47, P33, DOI 10.5483/BMBRep.2014.47.1.069; Li XQ, 2014, MOL CELL BIOCHEM, V392, P77, DOI 10.1007/s11010-014-2020-8; Li XQ, 2012, CANCER LETT, V322, P169, DOI 10.1016/j.canlet.2012.02.035; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Liu W, 2014, CELL BIOCHEM BIOPHYS, V70, P1893, DOI 10.1007/s12013-014-0148-5; Long HX, 2015, ONCOTARGET, V6, P5846, DOI 10.18632/oncotarget.3462; Ma WZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18789; Margolin DA, 2011, NEOPLASIA, V13, P874, DOI 10.1593/neo.11324; Meng EH, 2012, CLIN EXP METASTAS, V29, P939, DOI 10.1007/s10585-012-9482-4; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Porcile C, 2004, ANN NY ACAD SCI, V1030, P162, DOI 10.1196/annals.1329.021; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Salomonnson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051500; Scotton CJ, 2002, CANCER RES, V62, P5930; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Takenaga M, 2004, BIOCHEM BIOPH RES CO, V320, P226, DOI 10.1016/j.bbrc.2004.05.155; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Xue BY, 2013, MOL CELL BIOCHEM, V380, P177, DOI 10.1007/s11010-013-1671-1; Yu ZH, 2014, TUMOR BIOL, V35, P4637, DOI 10.1007/s13277-014-1607-8; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	51	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171044	10.1371/journal.pone.0171044	http://dx.doi.org/10.1371/journal.pone.0171044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196146	Green Submitted, gold, Green Published			2022-12-26	WOS:000394423900010
J	Ouyang, W; Yan, QC; Zhang, Y; Fan, ZH				Ouyang, Wei; Yan, Qichao; Zhang, Yu; Fan, Zhiheng			Moderate injury in motor-sensory cortex causes behavioral deficits accompanied by electrophysiological changes in mice adulthood	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATERAL FLUID PERCUSSION; SPATIAL MEMORY; RECOGNITION MEMORY; THETA-FREQUENCY; WORKING-MEMORY; HIPPOCAMPAL; STIMULATION; MODEL; ANTAGONISTS	Moderate traumatic brain injury (TBI) in children often happen when there's a sudden blow to the frontal bone, end with long unconscious which can last for hours and progressive cognitive deficits. However, with regard to the influences of moderate TBI during children adulthood, injury-induced alterations of locomotive ability, long-term memory performance, and hippocampal electrophysiological firing changes have not yet been fully identified. In this study, lateral fluid percussion (LFP) method was used to fabricate moderate TBI in motor and somatosensory cortex of the 6-weeks-old mice. The motor function, learning and memory function, extracellular CA1 neural spikes were assessed during acute and subacute phase. Moreover, histopathology was performed on day post injury (DPI) 16 to evaluate the effect of TBI on tissue and cell morphological changes in cortical and hippocampal CA1 subregions. After moderate LFP injury, the 6-weeks-old mice showed severe motor deficits at the early stage in acute phase but gradually recovered later during adulthood. At the time points in acute and subacute phase after TBI, novel object recognition (NOR) ability and spatial memory functions were consistently impaired in TBI mice; hippocampal firing frequency and burst probability were hampered. Analysis of the altered burst firing shows a clear hippocampal theta rhythm drop. These electrophysiological impacts were associated with substantially lowered NOR preference as compared to the sham group during adulthood. These results suggest that moderate TBI introduced at motorsenory cortex in 6-weeks- old mice causes obvious motor and cognitive deficits during their adulthood. While the locomotive ability progressively recovers, the cognitive deficits persisted while the mice mature as adult mice. The cognitive deficits may be attributed to the general suppressing of whole neural network, which could be labeled by marked reduction of excitability in hippocampal CA1 subregion.	[Ouyang, Wei; Yan, Qichao; Fan, Zhiheng] Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China; [Zhang, Yu] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China	Zhejiang Normal University; Shanxi Medical University	Ouyang, W (corresponding author), Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China.	wouyang@zjnu.cn		Ouyang, Wei/0000-0003-2866-491X	Zhejiang Province Natural Science Foundation [LY15H090012]; General Administration of Sport of China [2014B101]	Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); General Administration of Sport of China	This work was supported by Zhejiang Province Natural Science Foundation (no. LY15H090012) and the General Administration of Sport of China (no. 2014B101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Constantinou M, 2015, BIOSYSTEMS, V136, P73, DOI 10.1016/j.biosystems.2015.08.004; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dewan MC, 2016, EPIDEMIOLOGY GLOBAL; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Guderian S, 2015, J NEUROSCI, V35, P14123, DOI 10.1523/JNEUROSCI.0801-15.2015; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Ho JW, 2015, J NEUROSCI, V35, P13323, DOI 10.1523/JNEUROSCI.2278-15.2015; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hoy K. E., 2015, CEREBRAL CORTEX; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kirkcaldie MTK, 2011, MOUSE NERVOUS SYSTEM; KUBIE JL, 1990, J NEUROSCI, V10, P1110; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miller JP, 2015, BRAIN, V138, P1833, DOI 10.1093/brain/awv095; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parker A, 1997, EUR J NEUROSCI, V9, P2423, DOI 10.1111/j.1460-9568.1997.tb01659.x; PARKIN AJ, 1994, NEUROPSYCHOLOGIA, V32, P39, DOI 10.1016/0028-3932(94)90067-1; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Verleye M, 2003, NEUROSCI LETT, V353, P127, DOI 10.1016/j.neulet.2003.09.010; Warburton EC, 2015, BEHAV BRAIN RES, V285, P131, DOI 10.1016/j.bbr.2014.09.050; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9	61	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171976	10.1371/journal.pone.0171976	http://dx.doi.org/10.1371/journal.pone.0171976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196142	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900040
J	Shibulal, B; Al-Bahry, SN; Al-Wahaibi, YM; Elshafie, AE; Al-Bemani, AS; Joshi, SJ				Shibulal, Biji; Al-Bahry, Saif N.; Al-Wahaibi, Yahya M.; Elshafie, Abdulkadir E.; Al-Bemani, Ali S.; Joshi, Sanket J.			The potential of indigenous Paenibacillus ehimensis BS1 for recovering heavy crude oil by biotransformation to light fractions	PLOS ONE			English	Article							HYDROCARBON-DEGRADING BACTERIA; CHAIN N-ALKANES; GENUS PAENIBACILLUS; CONTAMINATED SOIL; BACILLUS-SUBTILIS; BIODEGRADATION; WATER; DEGRADATION; REDUCTION; RESERVOIR	Microbial Enhanced Oil Recovery (MEOR) is a potential technology for residual heavy oil recovery. Many heavy oil fields in Oman and elsewhere have difficulty in crude oil recovery because it is expensive due to its high viscosity. Indigenous microbes are capable of improving the fluidity of heavy oil, by changing its high viscosity and producing lighter oil fractions. Many spore forming bacteria were isolated from soil samples collected from oil fields in Oman. Among the isolates, an autochthonous spore-forming bacterium was found to enhance heavy oil recovery, which was identified by 16S rDNA sequencing as Paenibacillus ehimensis BS1. The isolate showed maximum growth at high heavy oil concentrations within four days of incubation. Biotransformation of heavy crude oil to light aliphatic and aromatic compounds and its potential in FOR was analyzed under aerobic and anaerobic reservoir conditions. The isolates were grown aerobically in Bushnell-Haas medium with 1% (w/v) heavy crude oil. The crude oil analyzed by GC-MS showed a significant biotransformation from the ninth day of incubation under aerobic conditions. The total biotransformation of heavy crude oil was 67.1% with 45.9% in aliphatic and 85.3% in aromatic fractions. Core flooding experiments were carried out by injecting the isolates in brine supplemented with Bushnell-Haas medium into Berea sandstone cores and were incubated for twelve days under oil reservoir conditions (50 degrees C). The extra recovered oil was analyzed by GC-MS. The residual oil recovered from core flood experiments ranged between 10-13% compared to the control experiment. The GC-MS analyses of the extra recovered oil showed 38.99% biotransformation of heavy to light oil. The results also indicated the presence of 22.9% extra aliphatic compounds in the residual crude oil recovered compared to that of a control. The most abundant compound in the extra recovered crude oil was identified as 1-bromoeicosane. The investigations showed the potential of P. ehimensis BS1 in MEOR technology by the biotransformation of heavy to lighter crude oil under aerobic and reservoir conditions. Heavy oil recovery and biotransformation to lighter components are of great economic value and a few studies have been done.	[Shibulal, Biji; Al-Bahry, Saif N.; Elshafie, Abdulkadir E.; Joshi, Sanket J.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Al-Wahaibi, Yahya M.; Al-Bemani, Ali S.] Sultan Qaboos Univ, Dept Petr & Chem Engn, Coll Engn, Muscat, Oman; [Joshi, Sanket J.] Sultan Qaboos Univ, Coll Sci, Cent Analyt & Appl Res Unit, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University	Al-Bahry, SN (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	snbahry@squ.edu.om	SHIBULAL, BIJI/ABD-6344-2021; Joshi, Sanket J./ABF-4999-2020	Joshi, Sanket J./0000-0001-7746-9905; Al-Bemani, Ali/0000-0003-3535-2586; Al-Wahaibi, Yahya/0000-0001-9580-6274; Shibulal, Biji/0000-0001-5339-2333				Al-Hattali R, 2013, J PETROL SCI ENG, V112, P178, DOI 10.1016/j.petrol.2013.11.003; Al-Sayegh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0330-5; Alinnor I.J., 2013, J ENV CHEM ECOTOXICO, V5, P292, DOI [10.5897/JECE2013.0298, DOI 10.5897/JECE2013.0298]; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Bagga J, 2015, ENG TECHNOLOGY, V4, P9993, DOI DOI 10.15680/IHRSET.2015.0410098; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Beckman J., 1926, IND ENG CHEM NEWS, V4, P3; Binazadeh M, 2009, ENZYME MICROB TECH, V45, P195, DOI 10.1016/j.enzmictec.2009.06.001; Brooijmans RJW, 2009, MICROB BIOTECHNOL, V2, P587, DOI 10.1111/j.1751-7915.2009.00151.x; Brown F. G., 1992, PERM BAS OIL GAS REC; Bruins MR, 2000, ECOTOX ENVIRON SAFE, V45, P198, DOI 10.1006/eesa.1999.1860; Calvo C, 2004, J BIOTECHNOL, V109, P255, DOI 10.1016/j.jbiotec.2004.01.009; COOPER DG, 1981, APPL ENVIRON MICROB, V42, P408, DOI 10.1128/AEM.42.3.408-412.1981; da Cunha CD, 2006, APPL MICROBIOL BIOT, V73, P949, DOI 10.1007/s00253-006-0531-2; Davey ME, 1998, GEOMICROBIOL J, V15, P335, DOI 10.1080/01490459809378087; Deng D, 1999, SPE AS PAC OIL GAS C; DIBBLE JT, 1979, APPL ENVIRON MICROB, V37, P729, DOI 10.1128/AEM.37.4.729-739.1979; Etoumi A, 2008, J IND MICROBIOL BIOT, V35, P1241, DOI 10.1007/s10295-008-0420-z; FELIX JA, 1971, J APPL BACTERIOL, V34, P411, DOI 10.1111/j.1365-2672.1971.tb02300.x; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fingas M., 2014, BASICS OIL SPILL CLE; Grishchenkov VG, 2000, PROCESS BIOCHEM, V35, P889, DOI 10.1016/S0032-9592(99)00145-4; Gudina EJ, 2012, INT BIODETER BIODEGR, V68, P56, DOI 10.1016/j.ibiod.2012.01.001; Haferburg G, 2007, J BASIC MICROB, V47, P453, DOI 10.1002/jobm.200700275; HAMBRICK GA, 1980, APPL ENVIRON MICROB, V40, P365, DOI 10.1128/AEM.40.2.365-369.1980; Hilyard EJ, 2008, APPL ENVIRON MICROB, V74, P1176, DOI 10.1128/AEM.01518-07; Hunt J.M., 1979, PETROLEUM GEOCHEMIST; IJAH U J J, 1992, Waste Management, V12, P55, DOI 10.1016/0956-053X(92)90009-8; Kalish PJ, 1964, EFFECT BACTERIA SAND; Kato T, 2001, APPL MICROBIOL BIOT, V55, P794, DOI 10.1007/s002530000556; Kleinheinz GT, 1997, J MICROBIOL METH, V29, P139, DOI 10.1016/S0167-7012(97)00033-X; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Koubek J, 2012, INT BIODETER BIODEGR, V69, P82, DOI 10.1016/j.ibiod.2011.12.007; Lee JS, 2004, INT J SYST EVOL MICR, V54, P929, DOI 10.1099/ijs.0.02765-0; LEON V, 2000, J CODICID, V2, P34; Li QX, 2002, BIOCHEM ENG J, V11, P197, DOI 10.1016/S1369-703X(02)00025-6; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Liu JF, 2005, J PETROL SCI ENG, V48, P265, DOI 10.1016/j.petrol.2005.06.008; Madigan M.T., 2003, BROCK BIOL MICROORGA, P137; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Marshall S.L., 2008, FUNDAMENTAL ASPECTS; Martinez AR, 1984, FUTURE HEAVY CRUDE T; Minai-Tehrani Dariush, 2007, Bioremediation Journal, V11, P71, DOI 10.1080/10889860701351589; Mittal A, 2009, INDIAN J EXP BIOL, V47, P760; Ojo OA, 2006, AFR J BIOTECHNOL, V5, P333; Ouoba LII, 2003, J APPL MICROBIOL, V95, P868, DOI 10.1046/j.1365-2672.2003.02063.x; Palanisamy N, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/s40201-014-0142-2; Petersen N, 1987, CALIFORNIA PLIO MIOC; Rahman KSM, 2002, BIORESOURCE TECHNOL, V85, P257, DOI 10.1016/S0960-8524(02)00119-0; RAIDERS RA, 1989, J IND MICROBIOL, V4, P215, DOI 10.1007/BF01574079; Roadifer RE, 1987, SIZE DISTRIBUTION WO; Sabirova JS, 2006, J BACTERIOL, V188, P3763, DOI 10.1128/JB.00072-06; Scherzer J., 1996, HYDROCRACKING SCI TE, V1st ed.; Sepahi AA, 2008, IRAN J ENVIRON HEALT, V5, P149; She YH, 2011, APPL BIOCHEM BIOTECH, V163, P223, DOI 10.1007/s12010-010-9032-y; Shibulal B, 2014, SCI WORLD J, DOI 10.1155/2014/309159; Sobolev Dmitri, 2008, Int J Environ Res Public Health, V5, P450; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; US Environmental Protection Agency (USEPA), 2014, 8270D USEPA; Wang J, 2008, PETROL SCI, V5, P367, DOI 10.1007/s12182-008-0061-x; Wang L, 2006, EXTREMOPHILES, V10, P347, DOI 10.1007/s00792-006-0505-4; Wentzel A, 2007, APPL MICROBIOL BIOT, V76, P1209, DOI 10.1007/s00253-007-1119-1; Wu L, 2014, INT J CURR MICROBIOL, V3, P586; Wu WH, 1999, J PETROL SCI ENG, V22, P25, DOI 10.1016/S0920-4105(98)00053-9; Xu J, 2012, BIOREMEDIATION CRUDE; Yaghi BM, 2002, ENERG SOURCE, V24, P93, DOI 10.1080/00908310252774417; Yan SP, 2013, BIOTECHNOL BIOTEC EQ, V27, P3932, DOI 10.5504/BBEQ.2013.0050; Zhang Y, 1999, MICROBIAL EOR LAB ST; Zhuang WQ, 2003, LETT APPL MICROBIOL, V36, P251, DOI 10.1046/j.1472-765X.2003.01297.x	69	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171432	10.1371/journal.pone.0171432	http://dx.doi.org/10.1371/journal.pone.0171432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196087	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900020
J	Desselas, E; Pansieri, C; Leroux, S; Bonati, M; Jacqz-Aigrain, E				Desselas, Emilie; Pansieri, Claudia; Leroux, Stephanie; Bonati, Maurizio; Jacqz-Aigrain, Evelyne			Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry	PLOS ONE			English	Review							INHALED NITRIC-OXIDE; PREVENT BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; CLINICAL-TRIALS; PREMATURE-INFANTS; POSTNATAL CORTICOSTEROIDS; RESPIRATORY-FAILURE; MULTICENTER TRIAL; UNETHICAL USE; DOUBLE-BLIND	Background Despite specific initiatives and identified needs, most neonatal drugs are still used off-label, with variable dosage administrations and schedules. In high risk preterm and term neonates, drug evaluation is challenging and randomized controlled trials (RCT) are difficult to conduct and even more is the use of a placebo, required in the absence of a reference validated drug to be used as comparator. Methods We analyzed the complete ClinicalTrials.gov registry 1) to describe neonatal RCT involving a placebo, 2) to report on the medical context and ethical aspects of placebo use. Results Placebo versus drug RCT (n = 146), either prevention trials (n = 57, 39%) or therapeutic interventions (n = 89, 61%), represent more than a third of neonatal trials registered in the National Institute of Health clinical trial database (USA) since 1999. They mainly concerned preterm infants, evaluating complications of prematurity. Most trials were conducted in the USA, were single centered, and funded by non-profit organizations. For the three top drug trials evaluating steroids (n = 13, 9.6%), erythropoietin (EPO, n = 10, 6.8%) and nitric oxide (NO, n = 9, 6.2%), the objectives of the trial and follow-up were analyzed in more details. Conclusion Although a matter of debate, the use of placebo should be promoted in neonates to evaluate a potential new treatment, in the absence of reference drug. Analysis of the trials evaluating steroids showed that long-term follow-up of exposed patients, although required by international guidelines, is frequently missing and should be planned to collect additional information and optimize drug evaluation in these high-risk patients.	[Desselas, Emilie; Leroux, Stephanie; Jacqz-Aigrain, Evelyne] Hop Robert Debre, Dept Pediat Pharmacol & Pharmacogenet, Paris, France; [Desselas, Emilie; Leroux, Stephanie; Jacqz-Aigrain, Evelyne] Hop Robert Debre, INSERM, CIC1426, Clin Invest Ctr, Paris, France; [Pansieri, Claudia; Bonati, Maurizio] IRCCS, Ist Ric Farmacol Mario Negri, Dept Publ Hlth, Lab Mother & Child Hlth, Milan, Italy; [Jacqz-Aigrain, Evelyne] Univ Paris 7 Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; UDICE-French Research Universities; Universite Paris Cite	Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, Dept Pediat Pharmacol & Pharmacogenet, Paris, France.; Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, INSERM, CIC1426, Clin Invest Ctr, Paris, France.; Jacqz-Aigrain, E (corresponding author), Univ Paris 7 Diderot, Paris, France.	evelyne.jacqzaigrain@gmail.com	Bonati, Maurizio/K-8980-2016; Jacqz-Aigrain, Evelyne/AAW-7089-2021; Pansieri, Claudia/ABI-2205-2020	Bonati, Maurizio/0000-0003-3997-3726; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; Pansieri, Claudia/0000-0002-0976-7756				Ackerman Terrence F., 2002, American Journal of Bioethics, V2, P21, DOI 10.1162/152651602317533587; Allen Marilee C, 2010, Evid Rep Technol Assess (Full Rep), P1; Allmark P, 2001, J MED ETHICS, V27, P110, DOI 10.1136/jme.27.2.110; Ambalavanan N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004312; Askie LM, 2011, PEDIATRICS, V128, P729, DOI 10.1542/peds.2010-2725; Bachiocco V, 2010, PAIN, V150, P582, DOI 10.1016/j.pain.2010.05.023; Baer GR, 2006, CLIN THER, V28, P1399, DOI 10.1016/j.clinthera.2006.09.008; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; BARBIER P, 1994, THERAPIE, V49, P113; Barrington KJ, 2010, EVID BASED CHILD HLT, V5, P301; Bassler D, 2015, NEW ENGL J MED, V373, P1497, DOI 10.1056/NEJMoa1501917; Baud O, 2016, LANCET, V387, P1827, DOI 10.1016/S0140-6736(16)00202-6; Rivas AB, 2016, ARCH DIS CHILD, V101, P371, DOI 10.1136/archdischild-2015-309396; Bellieni CV, 2010, ACTA PAEDIATR, V99, P30, DOI 10.1111/j.1651-2227.2009.01570.x; Benedetti F, 2011, CLIN PHARMACOL THER, V90, P651, DOI 10.1038/clpt.2011.206; Benedetti F, 2014, EMBO REP, V15, P329, DOI 10.1002/embr.201338399; Benedetti F, 2012, WORLD PSYCHIATRY, V11, P70, DOI 10.1016/j.wpsyc.2012.05.003; Bevilacqua G, 2011, J MATERN-FETAL NEO M, V24, P171, DOI 10.3109/14767051003792779; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Boots I, 2007, EUR J PEDIATR, V166, P849, DOI 10.1007/s00431-006-0381-z; Braga LHP, 2010, J PEDIATR UROL, V6, P435, DOI 10.1016/j.jpurol.2010.02.208; Carlino E, 2012, CURR OPIN SUPPORT PA, V6, P220, DOI 10.1097/SPC.0b013e32835269c1; Chalumeau M, 2000, ARCH DIS CHILD, V83, P502, DOI 10.1136/adc.83.6.502; Choonara I, 2007, BRIT MED J, V335, P1221, DOI 10.1136/bmj.39400.376424.BE; Cohen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002632; Cole CH, 1999, NEW ENGL J MED, V340, P1005, DOI 10.1056/NEJM199904013401304; Cole FS, 2011, PEDIATRICS, V127, P363, DOI 10.1542/peds.2010-3507; Conroy S, 1999, ARCH DIS CHILD-FETAL, V80, pF142, DOI 10.1136/fn.80.2.F142; Cyna AM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000029; Davis JM, 2012, JAMA-J AM MED ASSOC, V308, P1435, DOI 10.1001/jama.2012.12883; de Wildt SN, 2014, ARCH DIS CHILD, V99, P1137, DOI 10.1136/archdischild-2013-305212; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Garattini S, 2013, EUR J CLIN PHARMACOL, V69, P711, DOI 10.1007/s00228-012-1383-6; Giacoia GP, 2012, CLIN PERINATOL, V39, P11, DOI 10.1016/j.clp.2011.12.016; Guimaraes H, 2011, J MATERN-FETAL NEO M, V24, P855, DOI 10.3109/14767058.2010.531314; Hochwald O, 2014, INDIAN J PEDIATR, V81, P808, DOI 10.1007/s12098-013-1151-3; Jacqz-Aigrain E, 2012, CLIN INFECT DIS, V55, P1503, DOI 10.1093/cid/cis767; Jacqz-Aigrain E, 2011, EARLY HUM DEV, V87, pS27, DOI 10.1016/j.earlhumdev.2011.01.007; Jaillon P, 2007, B ACAD NAT MED PARIS, V191, P739, DOI 10.1016/S0001-4079(19)33007-9; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P573, DOI 10.1093/pch/17.10.573; Kaguelidou F, 2012, EUR J PEDIATR, V171, P439, DOI 10.1007/s00431-011-1565-8; Kairalla JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-145; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kinsella JP, 2014, J PEDIATR-US, V165, P1104, DOI 10.1016/j.jpeds.2014.06.018; Korppi M, 2013, ACTA PAEDIATR, V102, P1035, DOI 10.1111/apa.12372; Kumar P, 2014, PEDIATRICS, V133, P164, DOI 10.1542/peds.2013-3444; Li JS, 2007, JAMA-J AM MED ASSOC, V297, P480, DOI 10.1001/jama.297.5.480; Ligi I, 2011, EUR J CLIN PHARMACOL, V67, pS29, DOI 10.1007/s00228-010-0921-3; Meldrum ML, 2000, HEMATOL ONCOL CLIN N, V14, P745, DOI 10.1016/S0889-8588(05)70309-9; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Michels KB, 2003, BIOETHICS, V17, P188, DOI 10.1111/1467-8519.00332; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Neubert A, 2010, EUR J CLIN PHARMACOL, V66, P87, DOI 10.1007/s00228-009-0722-8; Pandolfini C, 2008, EUR J CLIN PHARMACOL, V64, P611, DOI 10.1007/s00228-007-0458-2; Pandolfini C, 2013, EUR J CLIN PHARMACOL, V69, P1031, DOI 10.1007/s00228-012-1415-2; Pandolfini C, 2009, ARCH DIS CHILD, V94, P717, DOI 10.1136/adc.2008.148155; Pansieri C, 2014, ARCH DIS CHILD-FETAL, V99, pE438, DOI 10.1136/archdischild-2013-305900; Papile LA, 1998, NEW ENGL J MED, V338, P1112, DOI 10.1056/NEJM199804163381604; Parikh NA, 2013, J PEDIATR-US, V162, P685, DOI 10.1016/j.jpeds.2012.09.054; Pasquali SK, 2012, PEDIATRICS, V130, pE1269, DOI 10.1542/peds.2011-3565; Peliowski A, 2012, PAED CHILD HEALT-CAN, V17, P95, DOI 10.1093/pch/17.2.95; Peltoniemi OM, 2016, ACTA PAEDIATR, V105, P159, DOI 10.1111/apa.13074; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Soll RF, 2012, NEONATOLOGY, V102, P251, DOI 10.1159/000338552; Stork E, 1997, NEW ENGL J MED, V336, P597; Turner MA, 2014, ADV DRUG DELIVER REV, V73, P2, DOI 10.1016/j.addr.2014.02.003; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Wang J, 2015, CLIN PHARMACOL THER, V98, P328, DOI 10.1002/cpt.149; Ward RM, 2015, PEDIATR DRUGS, V17, P37, DOI 10.1007/s40272-014-0099-8; Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159; Watterberg KL, 2010, PEDIATRICS, V126, P800, DOI 10.1542/peds.2010-1534; Winner P, 2000, PEDIATRICS, V106, P989, DOI 10.1542/peds.106.5.989; Yeh TF, 2016, AM J RESP CRIT CARE, V193, P86, DOI 10.1164/rccm.201505-0861OC	76	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171760	10.1371/journal.pone.0171760	http://dx.doi.org/10.1371/journal.pone.0171760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192509	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800040
J	Novakovic, B; Evain-Brion, D; Murthi, P; Fournier, T; Saffery, R				Novakovic, Boris; Evain-Brion, Daniele; Murthi, Padma; Fournier, Thiery; Saffery, Richard			Variable DAXX gene methylation is a common feature of placental trophoblast differentiation, preeclampsia, and response to hypoxia	FASEB JOURNAL			English	Article						DNA methylation; placenta; Infinium HM450	EMBRYONIC STEM-CELLS; DNA METHYLATION; UP-REGULATION; PROTEIN DAXX; INVASION; ATRX; H3.3; SYNCYTIOTROPHOBLAST; HYPOMETHYLATION; MICROARRAY	Placental functioning relies on the appropriate differentiation of progenitor villous cytotrophoblasts (CTBs) into extravillous cytotrophoblasts (EVCTs), including invasive EVCTs, and the multinucleated syncytiotrophoblast (ST) layer. This is accompanied by a general move away from a proliferative, immature phenotype. Genome-scale expression studies have provided valuable insight into genes that are associated with the shift to both an invasive EVCT and ST phenotype, whereas genome-scale DNA methylation analysis has shown that differentiation to ST involves wide spread methylation shifts, which are counteracted by low oxygen. In the current study, we sought to identify DNA methylation variation that is associated with transition from CTB to ST in vitro and from a noninvasive to invasive EVCT phenotype after culture on Matrigel. Of the several hundred differentially methylated regions that were identified in each comparison, the majority showed a loss of methylation with differentiation. This included a large differentially methylated region (DMR) in the gene body of death domain-associated protein 6 (DAXX), which lost methylation during both CTB syncytialization to ST and EVCT differentiation to invasive EVCT. Comparison to publicly available methylation array data identified the same DMR as among the most consistently differentially methylated genes in placental samples from preeclampsia pregnancies. Of interest, in vitro culture of CTB or ST in low oxygen increases methylation in the same region, which correlates with delayed differentiation. Analysis of combined epigenomics signatures confirmed DAXX DMR as a likely regulatory element, and direct gene expression analysis identified a positive association between methylation at this site and DAXX expression levels. The widespread dynamic nature of DAXX methylation in association with trophoblast differentiation and placenta-associated pathologies is consistent with an important role for this gene in proper placental development and function.	[Novakovic, Boris; Saffery, Richard] Murdoch Childrens Res Inst, Canc & Dis Epigenet, Parkville, Vic, Australia; [Novakovic, Boris; Saffery, Richard] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Evain-Brion, Daniele; Fournier, Thiery] Univ Paris 05, Sorbonne Paris Cite, INSERM, Unite Mixte Rech S1139, Paris, France; [Evain-Brion, Daniele; Fournier, Thiery] PremUp Fdn, Paris, France; [Murthi, Padma] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Monash University	Saffery, R (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	richard.saffery@mcri.edu.au	Fournier, Thierry C/E-5836-2016; Saffery, Richard/GLS-1976-2022; Novakovic, Boris/D-8018-2013; Murthi, Padma/AAY-5395-2021	Saffery, Richard/0000-0002-9510-4181; Novakovic, Boris/0000-0002-5623-9008; Fournier, Thierry/0000-0002-7515-339X	Australian National Health and Medical Research Council (NHMRC) C. J. Martin Early Career Fellowship; NHMRC Senior Research Fellowship; Victorian Government's Operational Infrastructure Support Program; NHMRC Project [509140]	Australian National Health and Medical Research Council (NHMRC) C. J. Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Dr. Alexandra Sexton-Oates (Murdoch Childrens Research Institute) for critical reading of this manuscript. B.N. is supported by an Australian National Health and Medical Research Council (NHMRC) C. J. Martin Early Career Fellowship. R.S. is supported by an NHMRC Senior Research Fellowship. The Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. P.M. was supported by NHMRC Project Grant 509140. The authors declare no conflicts of interest.	APLIN JD, 1991, J CELL SCI, V99, P681; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fogarty NME, 2015, PLACENTA, V36, P796, DOI 10.1016/j.placenta.2015.05.006; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; Handschuh K, 2007, ENDOCRINOLOGY, V148, P5011, DOI 10.1210/en.2007-0286; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32280; Hu YX, 2015, MOL HUM REPROD, V21, P452, DOI 10.1093/molehr/gav007; Huppertz B, 2009, J ANAT, V215, P14, DOI 10.1111/j.1469-7580.2008.01036.x; Januar V, 2015, AM J OBSTET GYNECOL, V213, pS182, DOI 10.1016/j.ajog.2015.07.011; Kliman HJ, 2000, AM J PATHOL, V157, P1759, DOI 10.1016/S0002-9440(10)64813-4; Lan X., 2016, REPROD FERTIL DEV; Lecarpentier E, 2016, HYPERTENSION, V68, P1438, DOI 10.1161/HYPERTENSIONAHA.116.07890; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lin CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13867; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620; Martino D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r42; Novakovic B, 2016, MOL HUM REPROD, V22, P791, DOI 10.1093/molehr/gaw053; Novakovic Boris, 2013, Frontiers in Genetics, V4, P285, DOI 10.3389/fgene.2013.00285; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Sadic D, 2015, EMBO REP, V16, P836, DOI 10.15252/embr.201439937; Segond N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079413; Shalginskikh N, 2013, J VIROL, V87, P2137, DOI 10.1128/JVI.02026-12; Shankar K, 2015, PLACENTA, V36, P1342, DOI 10.1016/j.placenta.2015.10.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; van Dijk Marie, 2012, Frontiers in Genetics, V3, P22, DOI 10.3389/fgene.2012.00022; Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong NC, 2008, CANCER LETT, V268, P56, DOI 10.1016/j.canlet.2008.03.033; Yuen RKC, 2013, EPIGENETICS-US, V8, P192, DOI 10.4161/epi.23400; Zhou Y, 2013, J CLIN INVEST, V123, P2862, DOI 10.1172/JCI66966	52	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2380	2392		10.1096/fj.201601189RR	http://dx.doi.org/10.1096/fj.201601189RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223336				2022-12-26	WOS:000401553400014
J	Bas-Orth, C; Tan, YW; Lau, D; Bading, H				Bas-Orth, Carlos; Tan, Yan-Wei; Lau, David; Bading, Hilmar			Synaptic Activity Drives a Genomic Program That Promotes a Neuronal Warburg Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; AEROBIC GLYCOLYSIS; GENE-EXPRESSION; BRAIN-FUNCTION; CANCER-CELLS; METABOLISM; CALCIUM; DEATH; GLUCOSE; PHOSPHORYLATION	Synaptic activity drives changes in gene expression to promote long lasting adaptations of neuronal structure and function. One example of such an adaptive response is the buildup of acquired neuroprotection, a synaptic activity-and gene transcription-mediated increase in the resistance of neurons against harmful conditions. A hallmark of acquired neuroprotection is the stabilization of mitochondrial structure and function. We therefore re-examined previously identified sets of synaptic activity-regulated genes to identify genes that are directly linked to mitochondrial function. In mouse and rat primary hippocampal cultures, synaptic activity caused an up-regulation of glycolytic genes and a concomitant down-regulation of genes required for oxidative phosphorylation, mitochondrial biogenesis, and maintenance. Changes in metabolic gene expression were induced by action potential bursting, but not by glutamate bath application activating extrasynaptic NMDA receptors. The specific and coordinate pattern of gene expression changes suggested that synaptic activity promotes a shift of neuronal energy metabolism from oxidative phosphorylation toward aerobic glycolysis, also known as the Warburg effect. The ability of neurons to up-regulate glycolysis has, however, been debated. We therefore used FACS sorting to show that, in mixed neuron glia co-cultures, activity-dependent regulation of metabolic gene expression occurred in neurons. Changes in gene expression were accompanied by changes in the phosphorylation-dependent regulation of the key metabolic enzyme, pyruvate dehydrogenase. Finally, increased synaptic activity caused an increase in the ratio of L-lactate production to oxygen consumption in primary hippocampal cultures. Based on these data we suggest the existence of a synaptic activity-mediated neuronal Warburg effect that may promote mitochondrial homeostasis and neuroprotection.	[Bas-Orth, Carlos; Tan, Yan-Wei; Lau, David; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany; [Tan, Yan-Wei] Univ Basel, Dept Biomed, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	Ruprecht Karls University Heidelberg; University of Basel	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Bading@nbio.uni-heidelberg.de		Bas Orth, Carlos/0000-0002-6037-8350	ERC Advanced Grant; German Ministry of Education and Research [1134, 01GQ1003A]; German-Israeli Project Cooperation Grant [SE 2372/1-1]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology of Heidelberg University	ERC Advanced Grant; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German-Israeli Project Cooperation Grant; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology of Heidelberg University	This work was supported by an ERC Advanced Grant (to H.B.), Sonderforschungsbereich Grant 1134, German Ministry of Education and Research Grant 01GQ1003A, German-Israeli Project Cooperation Grant SE 2372/1-1, and funds from the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology of Heidelberg University. The authors declare that they have no conflicts of interest with the contents of this article.	BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Banker G., 1998, CULTURING NERVE CELL, P357; Bas-Orth C, 2013, MECH DEVELOP, V130, P396, DOI 10.1016/j.mod.2012.09.008; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Dienel GA, 2016, J NEUROCHEM, V138, P14, DOI 10.1111/jnc.13630; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Galow Lukas V, 2014, Front Neurosci, V8, P398, DOI 10.3389/fnins.2014.00398; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hai T, 1999, GENE EXPRESSION, V7, P321; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; Magistretti PJ, 2016, P NATL ACAD SCI USA, V113, P7015, DOI 10.1073/pnas.1607423113; Mangia S, 2011, J CEREBR BLOOD F MET, V31, P1346, DOI 10.1038/jcbfm.2011.29; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195; Newington JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019191; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Sun JH, 2016, J ETHNOPHARMACOL, V187, P249, DOI 10.1016/j.jep.2016.04.034; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tadi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141568; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	47	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5183	5194		10.1074/jbc.M116.761106	http://dx.doi.org/10.1074/jbc.M116.761106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196867	hybrid, Green Published			2022-12-26	WOS:000397875500003
J	Lu, JH; Guo, SY; Xue, XL; Chen, Q; Ge, J; Zhuo, YJ; Zhong, HQ; Chen, BX; Zhao, MM; Han, W; Suzuki, T; Zhu, MJ; Xia, L; Schneider, C; Blackwell, TS; Porter, NA; Zheng, LM; Tsimikas, S; Yin, HY				Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Ge, Jing; Zhuo, Yujuan; Zhong, Huiqin; Chen, Buxing; Zhao, Mingming; Han, Wei; Suzuki, Takashi; Zhu, Mingjiang; Xia, Lin; Schneider, Claus; Blackwell, Timothy S.; Porter, Ned A.; Zheng, Lemin; Tsimikas, Sotirios; Yin, Huiyong			Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; OXIDIZED PHOSPHOLIPIDS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); STRUCTURAL IDENTIFICATION; MASS-SPECTROMETRY; MACROPHAGES; PATHWAY; INFLAMMATION; GENERATION	Oxidative stress and inflammation are two major contributing factors to atherosclerosis, a leading cause of cardiovascular disease. Oxidation of phospholipids on the surface of low density lipoprotein (LDL) particles generated under oxidative stress has been associated with the progression of atherosclerosis, but the underlying molecular mechanisms remain poorly defined. We identified a novel series of oxidation products containing the cyclopentenone moiety, termed deoxy-A(2)/J(2)-isoprostanesphosphocholine, from 1-palmitoyl-2-arachidonoyl-sn-glycero3- phosphocholine in vivo using mass spectrometry and by comparison to a chemically synthesized standard. Transcriptomic analysis (RNA-seq) demonstrated that these compounds affected > 200 genes in bone marrow-derived macrophages, and genes associated with inflammatory and anti-oxidative responses are among the top 5 differentially expressed. To further investigate the biological relevance of these novel oxidized phospholipids in atherosclerosis, we chemically synthesized a representative compound 1-palmitoyl-2-15-deoxy-delta-12,14prostaglandin J(2)-sn-glycero-3-phosphocholine (15d-PGJ(2)-PC) and found that it induced anti-inflammatory and anti-oxidant responses in macrophages through modulation of NF-kappa B, peroxisome proliferator-activated receptor gamma (PPAR gamma), and Nrf2 pathways; this compound also showed potent anti-inflammatory properties in a mice model of LPS-induced systematic inflammatory response syndrome. Additionally, 15d-PGJ(2)-PC inhibited macrophage foam cell formation, suggesting a beneficial role against atherosclerosis. These properties were consistent with decreased levels of these compounds in the plasma of patients with coronary heart disease compared with control subjects. Our findings uncovered a novel molecular mechanism for the negative regulation of inflammation and positive enhancement of anti-oxidative responses in macrophages by these oxidized phospholipids in LDL in the context of atherosclerosis.	[Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Zhuo, Yujuan; Zhong, Huiqin; Zhu, Mingjiang; Xia, Lin; Yin, Huiyong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China; [Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Zhuo, Yujuan; Zhong, Huiqin; Yin, Huiyong] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lu, Jianhong; Guo, Shuyuan; Xue, Xinli; Chen, Qun; Zhuo, Yujuan; Zhong, Huiqin; Zhu, Mingjiang; Xia, Lin; Yin, Huiyong] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100000, Peoples R China; [Guo, Shuyuan; Zhuo, Yujuan; Yin, Huiyong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Ge, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Chen, Buxing] Capital Med Univ, Beijing Tiantan Hosp, Dept Cardiol, Beijing 100050, Peoples R China; [Zhao, Mingming; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Beijing 100191, Peoples R China; [Zhao, Mingming; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Sch Basic Med Sci,Key Lab Mol Cardiovasc Sci,Mini, Beijing 100191, Peoples R China; [Han, Wei; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Suzuki, Takashi; Schneider, Claus] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Dept Vet Affairs, Nashville, TN 37232 USA; [Porter, Ned A.] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Tsimikas, Sotirios] Univ Calif San Diego, Sulpizio Cardiovasc Ctr, Dept Med, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Capital Medical University; Peking University; Peking University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Yin, HY (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Rm 1826,New Life Sci Bldg,320 Yueyang Rd, Shanghai 200031, Peoples R China.	hyyin@sibs.ac.cn		yin, hui yong/0000-0001-7049-1560	National Natural Science Foundation of China [31470831, 91439103, 91539127, 21402221, 31170809, 31671231]; Ministry of Science and Technology of China [2016YFC0903403, 2016YFD0400205, 2012CB524905]; Hundred Talents Program from the Chinese Academy of Sciences [2012OHTP07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hundred Talents Program from the Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Natural Science Foundation of China (31470831, 91439103, 91539127, 21402221, 31170809, and 31671231), Ministry of Science and Technology of China (2016YFC0903403, 2016YFD0400205, and 2012CB524905), and Hundred Talents Program from the Chinese Academy of Sciences (2012OHTP07). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Bochkov VN, 2007, THROMB HAEMOSTASIS, V97, P348, DOI 10.1160/TH06-08-0474; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bretscher P, 2015, EMBO MOL MED, V7, P593, DOI 10.15252/emmm.201404702; Brown HA, 2011, CHEM REV, V111, P5817, DOI 10.1021/cr200363s; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen B, 2016, VASC PHARMACOL, V85, P1, DOI 10.1016/j.vph.2015.08.012; Davies SS, 2004, CHEM PHYS LIPIDS, V128, P85, DOI 10.1016/j.chemphyslip.2003.10.007; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hardy KD, 2011, J LIPID RES, V52, P113, DOI 10.1194/jlr.M010264; Harmon GS, 2011, CHEM REV, V111, P6321, DOI 10.1021/cr2001355; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Lin CS, 2012, CARDIOVASC RES, V95, P346, DOI 10.1093/cvr/cvs189; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Mendis S, 2015, STROKE, V46, pE121, DOI 10.1161/STROKEAHA.115.008097; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Ravandi A, 2004, LIPIDS, V39, P97, DOI 10.1007/s11745-004-1207-5; Ravandi A, 2014, J AM COLL CARDIOL, V63, P1961, DOI 10.1016/j.jacc.2014.01.055; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Salomon RG, 2012, CIRC RES, V111, P930, DOI 10.1161/CIRCRESAHA.112.275388; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Seno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025541; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yin HY, 2013, MITOCHONDRION, V13, P209, DOI 10.1016/j.mito.2012.10.003; Yin HY, 2009, J MASS SPECTROM, V44, P672, DOI 10.1002/jms.1542; Yin HY, 2005, ANTIOXID REDOX SIGN, V7, P170, DOI 10.1089/ars.2005.7.170; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006; Yu ZY, 2007, LIPIDS, V42, P491, DOI 10.1007/s11745-007-3054-4	47	25	28	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5378	5391		10.1074/jbc.M116.751909	http://dx.doi.org/10.1074/jbc.M116.751909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202546	Green Published, hybrid			2022-12-26	WOS:000397875500019
J	Ma, J; Shui, SF; Han, XW; Guo, D; Li, TF; Yan, L				Ma, Ji; Shui, Shaofeng; Han, Xinwei; Guo, Dong; Li, Tengfei; Yan, Lei			microRNA-200a silencing protects neural stem cells against cerebral ischemia/reperfusion injury	PLOS ONE			English	Article							CANCER PROGRESSION; MIR-200 FAMILY; C-MYC; DIFFERENTIATION; ACTIVATION; PATHWAY; PROLIFERATION; INFARCTION; RENEWAL; NOTCH	Neural stem cells (NSCs) play major roles in neurological recovery after cerebral infarction (CI). This study was trying to investigate whether miR-200a, a vital regulator in cell proliferation, migration and apoptosis, also has a role in oxygen-glucose deprivation/reperfusion (OGD/R) injured NSCs. In this study, primary NSCs were subjected to OGD/R conditions to mimic an in vitro CI model. Before OGD/R induction, NSCs were transfected with vector or shRNA against miR-200a to overexpress or suppress miR-200a expression. The changes in cell viability, apoptosis, migration, the expression of c-Myc, and the phosphorylation of STAT1, STAT3 and MAPK were respectively assessed. Inhibitors of STAT1/3 and MAPK, i. e., Nifuroxazide and BIRB 796, were used to administrate miR-200a-silenced NSCs, and the expressions of above mentioned proteins were detected. After OGD/R exposure, miR200a was up-regulated in NSCs (P < 0.001)- miR-200a silencing alleviated OGD/R-induced the decrease of cell viability and migration (P < 0.01); meanwhile, alleviated OGD/R-induced apoptosis via reducing Bax/Bcl-2 ratio and down-regulating p53 and cytochrome c (P < 0.01 or P < 0.001). c-Myc, p-STAT1, p-STAT3, p-MAPK were all negatively regulated by miR200a (P < 0.01 or P < 0.001); more important, the increase of c-Myc induced by miR-200a silencing was abolished by Nifuroxazide or BIRB 796 (P < 0.01 or P < 0.001). These data indicate miR-200a silencing protects NSCs from OGD/R-induced injury, possibly via regulating the STATs/c-Myc and MAPK/c-Myc signalings.	[Ma, Ji; Shui, Shaofeng; Han, Xinwei; Guo, Dong; Li, Tengfei; Yan, Lei] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China	Zhengzhou University	Han, XW (corresponding author), Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China.	hanxinwei666@126.com	han, wei/ABG-2691-2021					Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Aparicio-Siegmund S, 2014, ONCOTARGET, V5, P2131, DOI 10.18632/oncotarget.1852; Becker LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048474; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Han JY, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1611-y; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Koh SH, 2015, J CLIN NEUROL, V11, P297, DOI 10.3988/jcn.2015.11.4.297; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lee WD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165460; Lin HW, 2011, ANTIOXID REDOX SIGN, V14, P1853, DOI 10.1089/ars.2010.3467; Muralidhar GG, 2015, INT J MOL SCI, V16, P16833, DOI 10.3390/ijms160816833; Narayanan G, 2016, JOVE-J VIS EXP, V65, P875; Onteddu SR, 2015, J NEUROL SCI, V359, P418, DOI 10.1016/j.jns.2015.10.005; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Perera D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29741; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Praskova M, 2002, ARCH DERMATOL RES, V294, P198, DOI 10.1007/s00403-002-0312-4; Roese-Koerner B, 2016, STEM CELL REP, V7, P207, DOI 10.1016/j.stemcr.2016.06.008; Subramaniam KS, 2016, AM J CANCER RES, V6, P200; Suliman MA, 2016, INT J MOL MED, V38, P776, DOI 10.3892/ijmm.2016.2689; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	29	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72178	10.1371/journal.pone.0172178	http://dx.doi.org/10.1371/journal.pone.0172178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222148	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800039
J	Sumioka, R; Nakata, M; Okahashi, N; Li, YX; Wada, S; Yamaguchi, M; Sumitomo, T; Hayashi, M; Kawabata, S				Sumioka, Ryuichi; Nakata, Masanobu; Okahashi, Nobuo; Li, Yixuan; Wada, Satoshi; Yamaguchi, Masaya; Sumitomo, Tomoko; Hayashi, Mikako; Kawabata, Shigetada			Streptococcus sanguinis induces neutrophil cell death by production of hydrogen peroxide	PLOS ONE			English	Article							VIRIDANS STREPTOCOCCI; PYRUVATE OXIDASE; EXTRACELLULAR TRAPS; VIRULENCE; ENDOCARDITIS; PNEUMONIAE; PLATELETS; GORDONII; GENE; SPXB	Streptococcus is the dominant bacterial genus in the human oral cavity and a leading cause of infective endocarditis. Streptococcus sanguinis belongs to the mitis group of streptococci and produces hydrogen peroxide (H2O2) by the action of SpxB, a pyruvate oxidase. In this study, we investigated the involvement of SpxB in survival of S. sanguinis in human blood and whether bacterial H2O2 exhibits cytotoxicity against human neutrophils. Results of a bactericidal test with human whole blood revealed that the spxB mutation in S. sanguinis is detrimental to its survival in blood. When S. sanguinis strains were exposed to isolated neutrophils, the bacterial survival rate was significantly decreased by spxB deletion. Furthermore, human neutrophils exposed to the S. sanguinis wild-type strain, in contrast to those exposed to an spxB mutant strain, underwent cell death with chromatin de-condensation and release of web-like extracellular DNA, reflecting induction of neutrophil extracellular traps (NETs). Since reactive oxygen species-mediated NET induction requires citrullination of arginine residues in histone proteins and subsequent chromatin de-condensation, we examined citrullination levels of histone in infected neutrophils. It is important to note that the citrullinated histone H3 was readily detected in neutrophils infected with the wild-type strain, as compared to infection with the spxB mutant strain. Moreover, decomposition of streptococcal H2O2 with catalase reduced NET induction. These results suggest that H2O2 produced by S. sanguinis provokes cell death of neutrophils and NET formation, thus potentially affecting bacterial survival in the bloodstream.	[Sumioka, Ryuichi; Nakata, Masanobu; Li, Yixuan; Wada, Satoshi; Yamaguchi, Masaya; Sumitomo, Tomoko; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Sumioka, Ryuichi; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka, Japan; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Ctr Frontier Oral Sci, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Nakata, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan.	nakata@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Yamaguchi, Masaya/I-8156-2019	okahashi, nobuo/0000-0002-8045-7021; Yamaguchi, Masaya/0000-0001-6218-7112; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [JP15H05012, JP26463112, JP26462779]; Grants-in-Aid for Scientific Research [16K15787, 26462780, 15H05012, 26463112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grants-in-Aid for Scientific Research (B) (#JP15H05012), (C) (#JP26463112), and (C) (#JP26462779) awarded to SK, NO, and MN, respectively, from the Japan Society for the Promotion of Science (https://www.jsps.go.ip/english/).	Al-Salih G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045695; Augustin P, 2013, INFECT IMMUN, V81, P1721, DOI 10.1128/IAI.00775-12; Battig P, 2008, J BACTERIOL, V190, P1184, DOI 10.1128/JB.01517-07; Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Barton CD, 2015, J INFECTION, V71, pS27, DOI 10.1016/j.jinf.2015.04.026; Bejarano I, 2007, MOL CELL BIOCHEM, V296, P77, DOI 10.1007/s11010-006-9301-9; Belanger AE, 2004, J BACTERIOL, V186, P8164, DOI 10.1128/JB.186.24.8164-8171.2004; Benisty R, 2010, BBA-MOL CELL BIOL L, V1801, P1098, DOI 10.1016/j.bbalip.2010.06.004; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Bhatt V, 2004, ANN CLIN LAB SCI, V34, P131; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; BOCHUD PY, 1994, AM J MED, V97, P256, DOI 10.1016/0002-9343(94)90009-4; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068277; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; FARMER ED, 1954, J GEN MICROBIOL, V11, P131, DOI 10.1099/00221287-11-2-131; Feldman C, 2002, RESP MED, V96, P580, DOI 10.1053/rmed.2002.1316; Ford I, 1997, PLATELETS, V8, P285; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240; HERZBERG MC, 1983, INFECT IMMUN, V39, P1457, DOI 10.1128/IAI.39.3.1457-1469.1983; Hoffmann O, 2006, INFECT IMMUN, V74, P5058, DOI 10.1128/IAI.01932-05; Jung CJ, 2015, CIRCULATION, V131, P571, DOI 10.1161/CIRCULATIONAHA.114.011432; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lee SY, 2006, INFECT IMMUN, V74, P3148, DOI 10.1128/IAI.00087-06; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Liu XH, 2011, P NATL ACAD SCI USA, V108, P2668, DOI 10.1073/pnas.1018391108; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; Okahashi N, 2016, INFECT IMMUN, V84, P2042, DOI 10.1128/IAI.00134-16; Okahashi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088136; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Okahashi N, 2011, MICROB PATHOGENESIS, V50, P148, DOI 10.1016/j.micpath.2011.01.005; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Roberts GJ, 2006, HEART, V92, P1274, DOI 10.1136/hrt.2004.046581; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Saito M, 2007, MICROBIOL IMMUNOL, V51, P889, DOI 10.1111/j.1348-0421.2007.tb03971.x; Sass LA, 2016, J PEDIAT INF DIS SOC, V5, P85, DOI 10.1093/jpids/piu087; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Stacy A, 2014, P NATL ACAD SCI USA, V111, P7819, DOI 10.1073/pnas.1400586111; SUNDQVIST G, 1988, ORAL MICROBIOL IMMUN, V3, P103, DOI 10.1111/j.1399-302X.1988.tb00093.x; Syk A, 2014, J INFECT DIS, V210, P4, DOI 10.1093/infdis/jiu038; Thornhill MH, 2016, BRIT DENT J, V220, P51, DOI 10.1038/sj.bdj.2016.49; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; WHITE JC, 1946, J BACTERIOL, V51, P717, DOI 10.1128/JB.51.6.717-722.1946; Wray D, 2008, BRIT DENT J, V204, P555, DOI 10.1038/sj.bdj.2008.404; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Xu YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086685, 10.1371/journal.pone.0087863]	68	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172223	10.1371/journal.pone.0172223	http://dx.doi.org/10.1371/journal.pone.0172223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222125	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800043
J	Rothe, H; Brandenburg, V; Haun, M; Kollerits, B; Kronenberg, F; Ketteler, M; Wanner, C				Rothe, Hansjoerg; Brandenburg, Vincent; Haun, Margot; Kollerits, Barbara; Kronenberg, Florian; Ketteler, Markus; Wanner, Christoph			Ecto-5 ' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry	PLOS ONE			English	Article							VASCULAR CALCIFICATION; MALIGNANT-MELANOMA; PREDICTORS; DEFICIENCY; MORTALITY; DISEASE; MODEL	Introduction Calciphylaxis/calcific uremic arteriolopathy affects mainly end-stage kidney disease patients but is also associated with malignant disorders such as myeloma, melanoma and breast cancer. Genetic risk factors of calciphylaxis have never been studied before. Methods We investigated 10 target genes using a tagging SNP approach: the genes encoding CD73/ecto-5'-nucleotidase (purinergic pathway), Matrix Gla protein, Fetuin A, Bone Gla protein, VKORC1 (all related to intrinsic calcification inhibition), calcium-sensing receptor, FGF23, Klotho, vitamin D receptor, stanniocalcin 1 (all related to CKD-MBD). 144 dialysis patients from the German calciphylaxis registry were compared with 370 dialysis patients without history of CUA. Genotyping was performed using iPLEX Gold MassARRAY(Sequenom, San Diego, USA), KASP genotyping chemistry (LGC, Teddington, Middlesex, UK) or sequencing. Statistical analysis comprised logistic regression analysis with adjustment for age and sex. Results 165 SNPs were finally analyzed and 6 SNPs were associated with higher probability for calciphylaxis (OR> 1) in our cohort. Nine SNPs of three genes (CD73, FGF23 and Vitamin D receptor) reached nominal significance (p<0.05), but did not reach statistical significance after correction for multiple testing. Of the CD73 gene, rs4431401 (OR = 1.71, 95% CI 1.08-2.17, p = 0.023) and rs9444348 (OR = 1.48, 95% CI 1.11-1.97, p = 0.008) were associated with a higher probability for CUA. Of the FGF23 and VDR genes, rs7310492, rs11063118, rs13312747 and rs17882106 were associated with a higher probability for CUA. Conclusion Polymorphisms in the genes encoding CD73, vitamin D receptor and FGF23 may play a role in calciphylaxis development. Although our study is the largest genetic study on calciphylaxis, it is limited by the low sample sizes. It therefore requires replication in other cohorts if available.	[Rothe, Hansjoerg; Ketteler, Markus] Klinikum Coburg, Coburg, Germany; [Rothe, Hansjoerg; Wanner, Christoph] Julius Maximilians Univ Wurzburg, Div Nephrol, Dept Med, Wurzburg, Germany; [Brandenburg, Vincent] Rhein Westfal TH Aachen, Dept Cardiol, Aachen, Germany; [Haun, Margot; Kollerits, Barbara; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Innsbruck, Austria	Klinikum Coburg; University of Wurzburg; RWTH Aachen University; Medical University of Innsbruck	Rothe, H (corresponding author), Klinikum Coburg, Coburg, Germany.; Rothe, H (corresponding author), Julius Maximilians Univ Wurzburg, Div Nephrol, Dept Med, Wurzburg, Germany.	hansjoerg.rothe@hs-coburg.de	Kronenberg, Florian/B-1736-2008	Kronenberg, Florian/0000-0003-2229-1120; Rothe, Hansjorg/0000-0003-1163-6576	AMGEN	AMGEN(Amgen)	This work was supported by AMGEN, grant name: CASPAC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank AMGEN for supporting the German calciphylaxis registry and this study in particular.	Akhtar E, 2015, ACG CASE REP J, V9, P209; Albright RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10006; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bae GH, 2015, AM J MED, V128, pE19, DOI 10.1016/j.amjmed.2015.05.049; Barnes MR, 2006, BRIEF BIOINFORM, V7, P211, DOI 10.1093/bib/bbl021; Barth Syndrome, 1993, GENEREVIEWS; Bosler DS, 2007, AM J DERMATOPATH, V29, P400, DOI 10.1097/DAD.0b013e3180ddb535; Brandenburg VM, 2011, HAUTARZT, V62, P452, DOI 10.1007/s00105-011-2169-y; Brandenburg VM, 2014, PEDIATR NEPHROL, V29, P2289, DOI 10.1007/s00467-013-2746-7; Brandenburg VM, 2012, NEPHROL DIAL TRANSPL, V27, P1314, DOI 10.1093/ndt/gfs015; Brandonlnirp C CI, 2016, NEPHROL DIAL TRANSPL; Csakany B, 2009, ACTA OPHTHALMOL, V87, P575, DOI 10.1111/j.1755-3768.2008.01231.x; ESCOVITZ W, 1950, Ann West Med Surg, V4, P339; Evenepoel P, 2014, SEMIN NEPHROL, V34, P151, DOI 10.1016/j.semnephrol.2014.02.007; Falaleeva M, 2016, P NATL ACAD SCI USA, V113, pE1625, DOI 10.1073/pnas.1519292113; Gao ZW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/460654; Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680; Ichigozaki Y, 2016, EXP DERMATOL, V25, P67, DOI 10.1111/exd.12868; Idelevich A, 2011, ARTERIOSCL THROM VAS, V31, pE55, DOI 10.1161/ATVBAHA.111.230904; Kerk N, 2012, J DTSCH DERMATOL GES, V10, P518, DOI 10.1111/j.1610-0387.2012.07947.x; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Ketteler M, 2011, NAT REV NEPHROL, V7, P509, DOI 10.1038/nrneph.2011.91; Kim HJ, 2014, BJU INT, V114, P303, DOI 10.1111/bju.12396; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Koopmann TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097380; Kress M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00033; KUDEJKO J, 1968, GERONTOLOGY, V14, P35, DOI 10.1159/000211640; Kutlu NO, 2003, PEDIATR HEMAT ONCOL, V20, P141, DOI 10.1080/0880010390158621; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Li QL, 2014, CELL CYCLE, V13, P2609, DOI 10.4161/15384101.2014.943567; Lloyd WR, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.080501; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moe SM, 2003, PEDIATR NEPHROL, V18, P969, DOI 10.1007/s00467-003-1276-0; Nigwekar SU, 2008, CLIN J AM SOC NEPHRO, V3, P1139, DOI 10.2215/CJN.00530108; Petit-Jentreau L, 2015, INFECT IMMUN, V83, P3666, DOI 10.1128/IAI.00418-15; Raymond CB, 2008, AM J HEALTH-SYST PH, V65, P1419, DOI 10.2146/ajhp070546; SELYE H, 1970, CLIN ORTHOP RELAT R, P28; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Sullivan Emily, 2011, Br J Haematol, V155, P136, DOI 10.1111/j.1365-2141.2011.08751.x; TWERSKY J, 1975, RADIOLOGY, V116, P627, DOI 10.1148/116.3.627; Vossen LM, 2015, NUTRIENTS, V7, P8905, DOI 10.3390/nu7115443; Wheat D, 1998, CLIN NUCL MED, V23, P824, DOI 10.1097/00003072-199812000-00007	44	14	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172407	10.1371/journal.pone.0172407	http://dx.doi.org/10.1371/journal.pone.0172407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212442	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700044
J	Gonzalez-Juarbe, N; Shen, HQ; Bergman, MA; Orihuela, CJ; Dube, PH				Gonzalez-Juarbe, Norberto; Shen, Haiqian; Bergman, Molly A.; Orihuela, Carlos J.; Dube, Peter H.			YopE specific CD8(+) T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection	PLOS ONE			English	Article							III SECRETION SYSTEM; LISTERIA-MONOCYTOGENES; PNEUMONIC PLAGUE; EFFECTOR YOPE; PESTIS; EPITOPE; ANTIGEN; PROTEIN; ENTEROCOLITICA; DETERMINANTS	Prior studies indicated that CD8(+) T cells responding to a surrogate single antigen expressed by Y. pseudotuberculosis, ovalbumin, were insufficient to protect against yersiniosis. Herein we tested the hypothesis that CD8(+) T cells reactive to the natural Yersinia antigen YopE would be more effective at providing mucosal protection. We first confirmed that immunization with the attenuated ksgA-strain of Y. pseudotuberculosis generated YopE-specific CD8(+) T cells. These T cells were protective against challenge with virulent Listeria monocytogenes expressing secreted YopE. Mice immunized with an attenuated L. monocytogenes YopE(+) strain generated large numbers of functional YopE(-) specific CD8(+) T cells, and initially controlled a systemic challenge with virulent Y. pseudotuberculosis, yet eventually succumbed to yersiniosis. Mice vaccinated with a YopE peptide and cholera toxin vaccine generated robust T cell responses, providing protection to 60% of the mice challenged mucosally but failed to show complete protection against systemic infection with virulent Y. pseudotuberculosis. These studies demonstrate that vaccination with recombinant YopE vaccines can generate YopE-specific CD8(+) T cells, that can provide significant mucosal protection but these cells are insufficient to provide sterilizing immunity against systemic Y. pseudotuberculosis infection. Our studies have implications for Yersinia vaccine development studies.	[Gonzalez-Juarbe, Norberto; Orihuela, Carlos J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Shen, Haiqian; Bergman, Molly A.; Dube, Peter H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio	Dube, PH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	dube@uthscsa.edu			National Institute of Allergy and Infectious Disease, National Institutes of Health [AI085116, AI114800, AI067716, AI070412]; Cancer Prevention and Research Institute of Texas [RP160152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114800, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Allergy and Infectious Disease, National Institutes of Health, grant numbers AI085116 awarded to Molly Bergman, AI114800 awarded to Carlos Orihuela, AI067716 and AI070412 awarded to Peter Dube (https://www.niaid.nih.gov/); and Cancer Prevention and Research Institute of Texas, grant number RP160152 awarded to Peter Dube (www.cprit.texas.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Angelakopoulos H, 2002, INFECT IMMUN, V70, P3592, DOI 10.1128/IAI.70.7.3592-3601.2002; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Arlen PA, 2008, INFECT IMMUN, V76, P3640, DOI 10.1128/IAI.00050-08; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; BOLIN I, 1982, INFECT IMMUN, V37, P506; Boyer JL, 2010, HUM GENE THER, V21, P891, DOI 10.1089/hum.2009.148; Bubeck SS, 2007, CLIN VACCINE IMMUNOL, V14, P1235, DOI 10.1128/CVI.00137-07; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Embry A, 2011, VACCINE, V29, P5331, DOI 10.1016/j.vaccine.2011.05.088; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; HOLMSTROM A, 1995, INFECT IMMUN, V63, P2269; Janeway CA., 2001, MAJOR HISTOCOMPATIBI; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; Long C, 2010, EMERG INFECT DIS, V16, P566, DOI 10.3201/eid1603.091106; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Medina JL, 2012, AM J RESP CELL MOL, V46, P815, DOI 10.1165/rcmb.2011-0135OC; Quenee LE, 2011, VACCINE, V29, P6572, DOI 10.1016/j.vaccine.2011.06.119; Shen H, 2016, INFECT GENET EVOL, V43, P289, DOI 10.1016/j.meegid.2016.06.008; Smiley ST, 2008, EXPERT REV VACCINES, V7, P209, DOI 10.1586/14760584.7.2.209; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Tscharke DC, 2015, NAT REV IMMUNOL, V15, P705, DOI 10.1038/nri3905; VISELTEAR AJ, 1974, YALE J BIOL MED, V47, P40; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wang SX, 2011, VACCINE, V29, P6802, DOI 10.1016/j.vaccine.2010.12.062; Williamson ED, 2013, CLIN EXP IMMUNOL, V172, P1, DOI 10.1111/cei.12044; Zhang Y, 2014, INFECT IMMUN, V82, P3033, DOI 10.1128/IAI.01687-14; Zhang Y, 2012, INFECT IMMUN, V80, P206, DOI 10.1128/IAI.05971-11; Zhong YM, 2010, INFECT IMMUN, V78, P3716, DOI 10.1128/IAI.00203-10	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172314	10.1371/journal.pone.0172314	http://dx.doi.org/10.1371/journal.pone.0172314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207901	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500120
J	de Opakua, AI; Merino, N; Villate, M; Cordeiro, TN; Ormaza, G; Sanchez-Carbayo, M; Diercks, T; Bernado, P; Blanco, FJ				Ibanez de Opakua, Alain; Merino, Nekane; Villate, Maider; Cordeiro, Tiago N.; Ormaza, Georgina; Sanchez-Carbayo, Marta; Diercks, Tammo; Bernado, Pau; Blanco, Francisco J.			The metastasis suppressor KISS1 is an intrinsically disordered protein slightly more extended than a random coil	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEINS; SMALL-ANGLE SCATTERING; NMR CHEMICAL-SHIFTS; COUPLED RECEPTOR; BLADDER-CANCER; CONFORMATIONAL SELECTION; DIPOLAR COUPLINGS; CELLS; GENE; EXPRESSION	The metastasis suppressor KISS1 is reported to be involved in the progression of several solid neoplasias, making it a promising molecular target for controlling their metastasis. The KISS1 sequence contains an N-terminal secretion signal and several dibasic sequences that are proposed to be the proteolytic cleavage sites. We present the first structural characterization of KISS1 by circular dichroism, multi-angle light scattering, small angle X-Ray scattering and NMR spectroscopy. An analysis of the KISS1 backbone NMR chemical shifts does not reveal any preferential conformation and deviation from a random coil ensemble. The backbone N-15 transverse relaxation times indicate a mildly reduced mobility for two regions that are rich in bulky residues. The small angle X-ray scattering curve of KISS1 is likewise consistent with a predominantly random coil ensemble, although an ensemble optimization analysis indicates some preference for more extended conformations possibly due to positive charge repulsion between the abundant basic residues. Our results support the hypothesis that KISS1 mostly samples a random coil conformational space, which is consistent with its high susceptibility to proteolysis and the generation of Kisspeptin fragments.	[Ibanez de Opakua, Alain; Merino, Nekane; Villate, Maider; Ormaza, Georgina; Diercks, Tammo; Blanco, Francisco J.] CIC bioGUNE, Derio, Spain; [Cordeiro, Tiago N.; Bernado, Pau] Univ Montpellier I, CNRS UMR 5048, INSERM U1054, Ctr Biochim Struct, Montpellier, France; [Cordeiro, Tiago N.; Bernado, Pau] Univ Montpellier 2, CNRS UMR 5048, INSERM U1054, Ctr Biochim Struct, Montpellier, France; [Sanchez-Carbayo, Marta] Univ Basque Country, Lucio Lascaray Res Ctr, Vitoria, Spain; [Sanchez-Carbayo, Marta; Blanco, Francisco J.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Cordeiro, Tiago N.] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark	CIC bioGUNE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Basque Country; Basque Foundation for Science; University of Copenhagen; Niels Bohr Institute	Blanco, FJ (corresponding author), CIC bioGUNE, Derio, Spain.; Blanco, FJ (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	fblanco@cicbiogune.es	Blanco, Francisco J/D-4401-2009; Cordeiro, Tiago N/E-9842-2012; Diercks, Tammo/G-1167-2011; Merino, Nekane/L-8203-2014; Diercks, Tammo/AAT-3731-2021; Ibáñez de Opakua, Alain/H-5081-2018	Blanco, Francisco J/0000-0003-2545-4319; Cordeiro, Tiago N/0000-0003-2663-3220; Diercks, Tammo/0000-0002-5200-0905; Merino, Nekane/0000-0003-0721-4813; Diercks, Tammo/0000-0002-5200-0905; Ibáñez de Opakua, Alain/0000-0003-1700-9354; Bernado, Pau/0000-0001-7395-5922	Ministerio de Economia y Competitividad [CTQ2014-56966-R]; Agence National de Recherche SR1N-HD ANR Chaires d'Excellence; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; ATIP-Avenir	Ministerio de Economia y Competitividad(Spanish Government); Agence National de Recherche SR1N-HD ANR Chaires d'Excellence(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); ATIP-Avenir	Support was provided by: Ministerio de Economia y Competitividad [http://www.mineco.gob.es/portal/site/mineco/] CTQ2014-56966-R to FJB; Agence National de Recherche [http://www.agence-nationale-recherche.fr/] SR1N-HD ANR Chaires d'Excellence to PB; ATIP-Avenir [http://www.aviesan.fr/en/aviesan/home/atip-averur-prograrp] to PB; The French Infrastructure for Integrated Structural Biology (FRISBI - ANR-10-INSB-05-01) to PB.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bernado A P, 2012, ROYAL SOC CHEM, V8, P151, DOI [10.1039/c1mb05275f, DOI 10.1039/C1MB05275F]; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2009, BIOPHYS J, V97, P2839, DOI 10.1016/j.bpj.2009.08.044; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cebrian V, 2011, AM J PATHOL, V179, P540, DOI 10.1016/j.ajpath.2011.05.009; Cho MK, 2007, J AM CHEM SOC, V129, P3032, DOI 10.1021/ja067482k; Click TH, 2010, INT J MOL SCI, V11, P5293, DOI 10.3390/ijms11125292; De Biasio A, 2014, BIOPHYS J, V106, P865, DOI 10.1016/j.bpj.2013.12.046; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ganguly D, 2012, MOL BIOSYST, V8, P198, DOI 10.1039/c1mb05156c; Goddar T. D., 2008, SPARKY NMR ASSIGNMEN; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Harihar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084958; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jung YS, 2004, ANGEW CHEM INT EDIT, V43, P3479, DOI 10.1002/anie.200353588; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Knott M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002605; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marsh JA, 2012, PROTEINS, V80, P556, DOI 10.1002/prot.23220; Milton NGN, 2012, ACS CHEM NEUROSCI, V3, P706, DOI 10.1021/cn300045d; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Navarro VM, 2012, NAT REV ENDOCRINOL, V8, P40, DOI 10.1038/nrendo.2011.147; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Orsini MJ, 2007, J MED CHEM, V50, P462, DOI 10.1021/jm0609824; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ruppen I, 2010, MOL CELL PROTEOMICS, V9, P2276, DOI 10.1074/mcp.M900255-MCP200; Sanchez-Carbayo M, 2003, AM J PATHOL, V162, P609, DOI 10.1016/S0002-9440(10)63854-0; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shin R, 2009, CLIN EXP METASTAS, V26, P527, DOI 10.1007/s10585-009-9252-0; Sibille N, 2012, BIOCHEM SOC T, V40, P955, DOI 10.1042/BST20120149; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WELCH DR, 1994, ONCOGENE, V9, P255; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	63	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172507	10.1371/journal.pone.0172507	http://dx.doi.org/10.1371/journal.pone.0172507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207895	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500142
J	Li, JC; Wang, XB; Song, WW; Huang, XY; Zhou, J; Zeng, HY; Sun, S; Jia, HC; Li, WB; Zhou, XN; Li, SZ; Chen, PY; Wu, CX; Guo, Y; Han, TF; Qiu, LJ				Li, Jicun; Wang, Xiaobo; Song, Wenwen; Huang, Xinyang; Zhou, Jing; Zeng, Haiyan; Sun, Shi; Jia, Hongchang; Li, Wenbin; Zhou, Xinan; Li, Suzhen; Chen, Pengyin; Wu, Cunxiang; Guo, Yong; Han, Tianfu; Qiu, Lijuan			Genetic variation of maturity groups and four E genes in the Chinese soybean mini core collection	PLOS ONE			English	Article							MAP-BASED CLONING; AGRONOMIC TRAITS; RESISTANCE; CLASSIFICATION; DIVERSITY; SELECTION; TIME	The mini core collection (MCC) has been established by streamlining core collection (CC) chosen from China National Genebank including 23,587 soybean (Glycine max) accessions by morphological traits and simple sequence repeat (SSR) markers. Few studies have been focused on the maturity that has been considered as one of the most critical traits for the determination of the adaptation-growing region of the soybean. In the current study, two hundred and ninty-nine accessions of MCC planted for two years at four locations namely in Heihe, Harbin, Jining and Wuhan cities in China were used to assess the variation of maturity in MCC and identify the integrated effect of 4 E loci on flowering and maturity time in soybean. Forty-two North American varieties served as references of maturity groups (MG). Each accession in MCC was classified by comparing with the MG references in the days from VE (emergence) and physiological maturity (R7). The results showed that MCC covered a large range of MGs from MG000 to MGIX/X. Original locations and sowing types were revealed as the major affecting factors for maturity groups of the MCC accessions. The ratio of the reproductive period to the vegetative period (R/V) varied among MCC accessions. Genotyping of 4 maturity genes (i.e. E1, E2, E3 and E4) in 228 accessions indicated that recessive alleles e1, e2, e3 and e4 promoted earlier flowering and shortened the maturity time with different effects, while the dominate alleles were always detected in accessions with longer maturity. The allelic combinations determined the diversification of soybean maturity groups and adaptation to different regions. Our results indicated that the maturity of Chinese soybean MCC showed genetic diversities in phenotype and genotype, which provided information for further MG classification, geographic adaptation analysis of Chinese soybean cultivars, as well as developing new soybean varieties with adaptation to specific regions.	[Li, Jicun; Wang, Xiaobo; Song, Wenwen; Zeng, Haiyan; Sun, Shi; Wu, Cunxiang; Guo, Yong; Han, Tianfu; Qiu, Lijuan] Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing, Peoples R China; [Li, Jicun; Huang, Xinyang; Zhou, Jing; Li, Suzhen] Jining Acad Agr Sci, Jining, Shandong, Peoples R China; [Wang, Xiaobo] Anhui Agr Univ, Sch Agron, Hefei, Peoples R China; [Jia, Hongchang] Heilongjiang Acad Agr Sci, Heihe Branch, Heihe, Peoples R China; [Li, Wenbin] Northeast Agr Univ, Coll Agron, Harbin, Peoples R China; [Zhou, Xinan] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Chen, Pengyin] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Anhui Agricultural University; Heilongjiang Academy of Agricultural Sciences; Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; University of Arkansas System; University of Arkansas Fayetteville	Wu, CX; Guo, Y; Han, TF; Qiu, LJ (corresponding author), Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing, Peoples R China.	wucunxiang@caas.cn; guoyong@caas.cn; hantianfu@caas.cn; qiulijuan@caas.cn	wang, xiaobo/T-7023-2019		Chinese Academy of Agricultural Sciences (CAAS); China Agriculture Research System (CARS) [CARS-04]	Chinese Academy of Agricultural Sciences (CAAS); China Agriculture Research System (CARS)	This study was supported by the Chinese Academy of Agricultural Sciences (CAAS) Innovation Project to LQ and TH, and China Agriculture Research System (CARS) to TH (CARS-04).; This study was supported by the Chinese Academy of Agricultural Sciences (CAAS) Innovation Project to LQ and TH, and China Agriculture Research System (CARS) to TH (CARS-04). We thank Professor Randall L. Nelson (Pathology and Genetics Research Unit and Department of Crop Sciences, Soybean/Maize Germplasm, Agricultural Research Service, United States Department of Agriculture, University of Illinois, Urbana, Illinois, United States of America) for providing the US soybean germplasm.	Alliprandini LF, 2009, CROP SCI, V49, P801, DOI 10.2135/cropsci2008.07.0390; [Anonymous], ACTA AGRONOMICA SINI; Baigorri HE, 2002, AN 2 C BRAS SOJ MERC, P84; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Brown A. H. D., 1995, P3; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chang RZ, 1989, CHINA SEED IND, P4; Chang RZ, 1992, SOYBEAN SCI, V11, P127; [陈珊宇 CHEN Shan-yu], 2009, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V31, P513; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cui YH, 2003, J PLANT GENET RESOUR, V27, P286; Curtis DF, 2000, CROP SCI, V40, P1624, DOI 10.2135/cropsci2000.4061624x; Dong YS, 2004, THEOR APPL GENET, V108, P931, DOI 10.1007/s00122-003-1503-x; Doyle J. J., 1987, PHYTOCHEM B, P11; Ellis PR, 1998, EUPHYTICA, V103, P149, DOI 10.1023/A:1018342101069; FEHR W. R., 1977, STAGES SOYBEAN DEV; FRANKEL OH, 1984, CURRENT PLANT GENETI; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gai J., 2001, ACTA AGRONOMICA SINI, V27, P286; Gai JY, 1999, REV CHINA AGR SCI TE, V1, P26; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; Han TianFu, 1998, Acta Agronomica Sinica, V24, P550; Hao G., 1992, Acta Agronomica Sinica, V18, P275; Hartwig EE, 1970, CROP SCI, V12, P47; Hill JL, 2005, USDA TECHNICAL B, V1914; Holbrook CC, 2000, CROP SCI, V40, P1172, DOI 10.2135/cropsci2000.4041172x; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Jiang HongWei, 2009, Acta Agronomica Sinica, V35, P1268, DOI 10.3724/SP.J.1006.2009.01268; Khan NA, 2008, THEOR APPL GENET, V117, P479, DOI 10.1007/s00122-008-0792-5; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; [刘亚男 LIU Ya-nan], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P211; Malvar RA, 2004, J ECON ENTOMOL, V97, P628, DOI 10.1603/0022-0493-97.2.628; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Poehlman J.M., 1987, BREEDING FIELD CROPS, P421, DOI [10.1007/978-94-015-7271-2_17, DOI 10.1007/978-94-015-7271-2_17]; Qiu LJ, 2013, PLANT MOL BIOL, V83, P41, DOI 10.1007/s11103-013-0076-6; Qiu LiJuan, 2009, Acta Agronomica Sinica, V35, P571, DOI 10.3724/SP.J.1006.2009.00571; Qiu PengCheng, 2011, Acta Agronomica Sinica, V37, P477, DOI 10.3724/SP.J.1006.2011.00477; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Ren Q. X., 1987, Scientia Agricultura Sinica, V20, P23; Scott W.O., 1970, MODERN SOYBEAN PRODU; Song XiE, 2010, Scientia Agricultura Sinica, V43, P2209; Takahashi R, 1999, CROP SCI, V39, P1657, DOI 10.2135/cropsci1999.3961657x; Tardivel A, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0034; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Wang GX, 1981, SCI AGR SIN, V14, P21; Wang JL, 1956, J AGR SCI, V7, P169; [王林林 WANG Linlin], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P68; Wang LX, 2006, EUPHYTICA, V151, P215, DOI 10.1007/s10681-006-9142-3; Wang Ying, 2008, Acta Agronomica Sinica, V34, P1160, DOI 10.3724/SP.J.1006.2008.01160; Wang Y, 2015, EUPHYTICA, V201, P275, DOI 10.1007/s10681-014-1209-y; Wang YS, 2006, GENET RESOUR CROP EV, V53, P803, DOI 10.1007/s10722-004-5731-y; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu CX, 2013, ACTA AGRON SIN, V38, P1977; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zhang L, 2007, CROP MANAGE	61	17	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172106	10.1371/journal.pone.0172106	http://dx.doi.org/10.1371/journal.pone.0172106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207889	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500084
J	Chi, L; Li, X; Liu, QH; Liu, Y				Chi, Liang; Li, Xian; Liu, Qinghua; Liu, Ying			Photoperiod regulate gonad development via kisspeptin/kissr in hypothalamus and saccus vasculosus of Atlantic salmon (Salmo solar)	PLOS ONE			English	Article							TYPE-2 DEIODINASE GENE; ENVIRONMENTAL-CONTROL; CIRCADIAN REGULATION; RECEPTOR GPR54; EXPRESSION; REPRODUCTION; NEURONS; INSIGHTS; SYSTEM; IDENTIFICATION	Atlantic salmon exhibit seasonal reproduction. However, the mechanisms governing this are still unclear. Generally speaking, kisspeptin has been recognized as a regulator of reproduction. Here, we report a relationship between kisspeptin, GnRH and photoperiod in Atlantic salmon. The results demonstrated that the expression of the Atlantic salmon kisspeptinreceptor (skissr) was not always consistent with the expression pattern of Atlantic salmon GnRH3 (sGnRH3) during all developmental processes. Kisspeptin may exert its influence primarily in the early and later stages of gonad development by promoting the secretion of sGnRH3. Meanwhile, the expression levels of kissrwere higher in fish with gonads at stage II and stage V under the long-day photoperiod regime than under the short-day regime. In addition, both skissrand sGnRH3 were also expressed in the saccus vasculosus (SV), an organ only found in fish. The SV might be a seasonal sensor regulating reproduction in addition to the hypothalamus (Hyp).	[Chi, Liang; Li, Xian; Liu, Qinghua; Liu, Ying] Chinese Acad Sci, Inst Oceanol, Ctr Biotechnol R&D, Qingdao, Peoples R China; [Chi, Liang] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Li, Xian; Liu, Ying] Natl & Local Joint Engn Lab Ecol Mari Culture, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao Agricultural University	Liu, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Ctr Biotechnol R&D, Qingdao, Peoples R China.; Liu, Y (corresponding author), Natl & Local Joint Engn Lab Ecol Mari Culture, Qingdao, Peoples R China.	Yinliuaquaculture@gmail.com			National Natural Science Fund of China [31402283, 31472312, 41306152]; fund of Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China [0F2015N001]; Qingdao Innovation Talents Program [13-CX-16]; National Key Technologies RD Program [2014BAD08B09]; earmarked fund for Modern Agro-industry Technology Research System [CARS-48]; Shandong Oriental Ocean Sci-Tech Co., Ltd	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); fund of Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China; Qingdao Innovation Talents Program; National Key Technologies RD Program(National Key Technology R&D Program); earmarked fund for Modern Agro-industry Technology Research System; Shandong Oriental Ocean Sci-Tech Co., Ltd	This research was supported by the National Natural Science Fund of China (No 31402283, 31472312, 41306152),the fund of Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China (No. 0F2015N001), the Qingdao Innovation Talents Program (13-CX-16), the National Key Technologies R&D Program (2014BAD08B09), and the earmarked fund for Modern Agro-industry Technology Research System (CARS-48).; The authors would like to give thanks to the Shandong Oriental Ocean Sci-Tech Co., Ltd for their supports during the experiment.	Beck BH, 2012, COMP BIOCHEM PHYS A, V162, P265, DOI 10.1016/j.cbpa.2012.03.019; BITTMAN EL, 1983, ENDOCRINOLOGY, V113, P2276, DOI 10.1210/endo-113-6-2276; Bromage N, 2001, AQUACULTURE, V197, P63, DOI 10.1016/S0044-8486(01)00583-X; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Elizur A, 2009, PEPTIDES, V30, P164, DOI 10.1016/j.peptides.2008.08.018; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Greives TJ, 2007, ENDOCRINOLOGY, V148, P1158, DOI 10.1210/en.2006-1249; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Iigo M, 2007, GEN COMP ENDOCR, V154, P91, DOI 10.1016/j.ygcen.2007.06.013; Iigo M, 2007, ZOOL SCI, V24, P67, DOI 10.2108/zsj.24.67; JANSEN WF, 1982, CELL TISSUE RES, V224, P169, DOI 10.1007/BF00217276; Kanda S, 2012, J NEUROENDOCRINOL, V24, P897, DOI 10.1111/j.1365-2826.2012.02296.x; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Lincoln G A, 1980, Recent Prog Horm Res, V36, P1; Martinez-Chavez CC, 2008, GEN COMP ENDOCR, V156, P224, DOI 10.1016/j.ygcen.2008.01.019; Mechaly AS, 2009, BIOL REPROD, V80, P60, DOI 10.1095/biolreprod.108.072173; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Nakane Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00115; Nakane Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3108; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Oka Y, 2009, J NEUROENDOCRINOL, V21, P334, DOI 10.1111/j.1365-2826.2009.01850.x; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Pankhurst NW, 2003, FISH PHYSIOL BIOCHEM, V28, P385, DOI 10.1023/B:FISH.0000030602.51939.50; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Revel FG, 2007, REV ENDOCR METAB DIS, V8, P57, DOI 10.1007/s11154-007-9031-7; Revel FG, 2006, CURR BIOL, V16, P1730, DOI 10.1016/j.cub.2006.07.025; Selvaraj S, 2010, GEN COMP ENDOCR, V169, P28, DOI 10.1016/j.ygcen.2010.07.011; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Simonneaux V, 2009, PEPTIDES, V30, P146, DOI 10.1016/j.peptides.2008.06.006; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Sueiro C, 2007, BRAIN BEHAV EVOLUT, V70, P187, DOI 10.1159/000104309; Taranger GL, 1998, AQUACULTURE, V162, P85, DOI 10.1016/S0044-8486(98)00168-9; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Wagner GC, 2008, ENDOCRINOLOGY, V149, P32, DOI 10.1210/en.2007-0658; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Wood S, 2014, J ENDOCRINOL, V222, pR39, DOI 10.1530/JOE-14-0141; Yang B, 2010, GEN COMP ENDOCR, V165, P60, DOI 10.1016/j.ygcen.2009.06.001; Yasuo S, 2006, ENDOCRINOLOGY, V147, P432, DOI 10.1210/en.2005-0507; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Zmora N, 2012, BIOLOGY OF REPRODUCT; Zmora N, 2014, ENDOCRINOLOGY, V155, P1874, DOI 10.1210/en.2013-1894	46	25	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169569	10.1371/journal.pone.0169569	http://dx.doi.org/10.1371/journal.pone.0169569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199332	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400008
J	Kusama, K; Bai, R; Nakamura, K; Okada, S; Yasuda, J; Imakawa, K				Kusama, Kazuya; Bai, Rulan; Nakamura, Keigo; Okada, Sayaka; Yasuda, Jiro; Imakawa, Kazuhiko			Endometrial factors similarly induced by IFNT2 and IFNTc1 through transcription factor FOXS1	PLOS ONE			English	Article							OVINE TROPHOBLAST PROTEIN-1; INTERFERON-TAU; BOVINE CONCEPTUSES; NERVOUS-SYSTEM; GENES; EXPRESSION; PROSTAGLANDIN; PREGNANCY; PERIOD	In ruminants, Interferon tau (IFNT) is the pregnancy recognition protein produced by the mononuclear trophectoderm of the conceptus, and is secreted into the uterine lumen during the peri-attachment period. In our previous study, the high-throughput RNA sequencing (RNA-seq) data obtained from bovine conceptuses during the peri-attachment period identified two /FNTmRNAs, IFNT2and IFNTc1. However, how each of these IFNT variants regulates endometrial gene expression has not been characterized. Using RNA-seq analysis, we evaluated how IFNT2 and IFNTc1 affected transcript expression in primary bovine endometrial epithelial cells (EECs). IFNT treatment induced 348 differentially expressed genes (DEGs); however, there are few DEGs in IFNT2 or IFNTc1 treated EECs, indicating that IFNT2-induced DEGs were similar to those induced by IFNTc1 treatment. In in silico analysis, we identified four IFNT2- and IFNTc1-induced pathways: 1) type II interferon signaling, 2) proteasome degradation, 3) type III interferon signaling, and 4) DNA damage response. We further demonstrated that IFNT2 and IFNTc1 up-regulated several transcription factors, among which forkhead box S1 (FOXS1) was identified as the most highly expressed gene. Furthermore, the knockdown of FOXS1 in IFNT2- or IFNTc1-treated EECs similarly down regulated 9 genes including IRF3 and IRF9, and up-regulated 9 genes including STAT1, STAT2, and IRF8. These represent the first demonstration that effects of each IFNT on EECs were studied, and suggest that endometrial response as well as signaling mechanisms were similar between two IFNT variants existed in utero.	[Kusama, Kazuya; Bai, Rulan; Nakamura, Keigo; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan; [Okada, Sayaka; Yasuda, Jiro] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Emerging Infect Dis, Nagasaki, Japan	University of Tokyo; Nagasaki University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; Yasuda, Jiro/0000-0001-9928-5621	Ministry of Agriculture, Forestry and Fisheries [25030AB]; Japan Society for the Promotion of Science [15K18767]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Agriculture, Forestry and Fisheries (25030AB), http://www.maff.go.jp/e/index.html (to KI); and Japan Society for the Promotion of Science (15K18767), https://www.jsps.go.jp (to KK). These funders had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi AQ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105684; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Ealy AD, 2001, ENDOCRINOLOGY, V142, P2906, DOI 10.1210/en.142.7.2906; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2014, REPRODUCTION, V147, P575, DOI 10.1530/REP-13-0010; GODKIN JD, 1984, ENDOCRINOLOGY, V114, P120, DOI 10.1210/endo-114-1-120; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Heglind M, 2005, MOL CELL BIOL, V25, P5616, DOI 10.1128/MCB.25.13.5616-5625.2005; Ideta A, 2010, MOL REPROD DEV, V77, P954, DOI 10.1002/mrd.21243; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Kim MS, 2013, ASIAN AUSTRAL J ANIM, V26, P795, DOI 10.5713/ajas.2012.12529; Kusama K, 2016, DOMEST ANIM ENDOCRIN, V57, P21, DOI 10.1016/j.domaniend.2016.05.002; Kusama K, 2016, MOL CELL ENDOCRINOL, V434, P81, DOI 10.1016/j.mce.2016.06.017; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Nakagawa S, 2013, GENOME BIOL EVOL, V5, P296, DOI 10.1093/gbe/evt007; NEPHEW KP, 1993, BIOL REPROD, V48, P768, DOI 10.1095/biolreprod48.4.768; Noizet M, 2016, WOUND REPAIR REGEN, V24, P247, DOI 10.1111/wrr.12392; Pihlajoki M, 2013, ENDOCRINOLOGY, V154, P1754, DOI 10.1210/en.2012-1892; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; Romero JJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132860; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080427; Sakurai T, 2013, MOL REPROD DEV, V80, P371, DOI 10.1002/mrd.22171; SALAMONSEN LA, 1988, J ENDOCRINOL, V117, pR1, DOI 10.1677/joe.0.117R001; Sato Y, 2008, MOL REPROD DEV, V75, P1361, DOI 10.1002/mrd.20888; Schillebeeckx M, 2015, MOL CELL ENDOCRINOL, V399, P122, DOI 10.1016/j.mce.2014.09.029; Spencer TE, 1996, ENDOCRINOLOGY, V137, P1144, DOI 10.1210/en.137.3.1144; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Tanikawa M, 2008, J ENDOCRINOL, V199, P425, DOI 10.1677/JOE-08-0237; Walker AM, 2009, THERIOGENOLOGY, V72, P44, DOI 10.1016/j.theriogenology.2009.01.017	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171858	10.1371/journal.pone.0171858	http://dx.doi.org/10.1371/journal.pone.0171858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199372	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400054
J	Singh, H; Nugent, Z; Yu, BN; Lix, LM; Targownik, L; Bernstein, C				Singh, Harminder; Nugent, Zoann; Yu, B. Nancy; Lix, Lisa M.; Targownik, Laura; Bernstein, Charles			Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; ULCERATIVE-COLITIS; EPIDEMIOLOGY; DIAGNOSIS; RISK; SURVEILLANCE; MANITOBA; OUTCOMES; BURDEN; IMPACT	Background Hospital discharge databases are used to study the epidemiology of Clostridium difficile infections (CDI) among hospitalized patients with inflammatory bowel disease (IBD). CDI in IBD is increasingly important and accurately estimating its occurrence is critical in understanding its comorbidity. There are limited data on the reliability of the International Classification of Diseases 10th revision (ICD-10) (now widely used in North America) CDI code in determining occurrence of CDI among hospitalized patients. We compared the performance of ICD-10 CDI coding to laboratory confirmed CDI diagnoses. Methods The University of Manitoba IBD Epidemiology Database was used to identify individuals with and without IBD discharged with CDI diagnoses between 07/01/2005 and 3/31/2014. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of ICD-10 CDI code was compared to laboratory CDI diagnoses recorded in a province wide CDI dataset. Multivariable logistic regression models were performed to test the predictors of diagnostic inaccuracy of ICD-10 CDI code. Results There were 273 episodes of laboratory confirmed CDI ( hospitalized and non-hospitalized) among 7396 individuals with IBD and 536 among 66,297 matched controls. The sensitivity, specificity, PPV and NPV of ICD-10 CDI code in discharge abstracts was 72.8%, 99.6%, 64.1% and 99.7% among those with IBD and 70.8%, 99.9%, 79.0% and 99.9% among those without IBD. Predictors of diagnostic inaccuracy included IBD, older age, increased co-morbidity and earlier years of hospitalization. Conclusions Identification of CDI using ICD-10 CDI code in hospital discharge abstracts may not identify up to 30% of CDI cases, with worse performance among those with IBD.	[Singh, Harminder; Nugent, Zoann; Targownik, Laura; Bernstein, Charles] Univ Manitoba, Internal Med, Winnipeg, MB, Canada; [Singh, Harminder; Nugent, Zoann; Targownik, Laura; Bernstein, Charles] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada; [Singh, Harminder; Yu, B. Nancy; Lix, Lisa M.] Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada; [Nugent, Zoann] CancerCare Manitoba, Dept Epidemiol & Canc Registry, Winnipeg, MB, Canada; [Yu, B. Nancy] Manitoba Hlth Seniors & Act Living, Publ Hlth Branch, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation	Singh, H (corresponding author), Univ Manitoba, Internal Med, Winnipeg, MB, Canada.; Singh, H (corresponding author), Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada.; Singh, H (corresponding author), Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada.	Harminder.singh@umanitoba.ca	Singh, Harminder/E-1848-2012; Targownik, Laura/ABD-2427-2021	Singh, Harminder/0000-0002-0024-5855; Targownik, Laura/0000-0002-4366-9076	American College of Gastroenterology	American College of Gastroenterology(General Electric)	This study was funded by an operating research grant from American College of Gastroenterology. The funding agency had no role in the conduct of the study or the reporting of the findings.	Berg AM, 2013, INFLAMM BOWEL DIS, V19, P194, DOI 10.1002/ibd.22964; Bernstein CN, 2008, CLIN GASTROENTEROL H, V6, P41, DOI 10.1016/j.cgh.2007.09.016; Bernstein CN, 2009, AM J GASTROENTEROL, V104, P2774, DOI 10.1038/ajg.2009.417; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Chan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015603; Chateau D, 2012, CAN J PUBLIC HEALTH, V103, pS23, DOI 10.1007/BF03403825; Collins CE, 2014, J AM COLL SURGEONS, V218, P1141, DOI 10.1016/j.jamcollsurg.2014.01.053; Dubberke ER, 2011, CLIN INFECT DIS, V53, P20, DOI 10.1093/cid/cir246; Goto M, 2014, CLIN INFECT DIS, V58, P688, DOI 10.1093/cid/cit737; Green C, 2006, AM J EPIDEMIOL, V164, P615, DOI 10.1093/aje/kwj260; Jones G, 2012, EMERG INFECT DIS, V18, P979, DOI 10.3201/eid1806.111188; Longobardi T, 2007, AM J GASTROENTEROL, V102, P1683, DOI 10.1111/j.1572-0241.2007.01232.x; Murphy CR, 2012, INFECT CONT HOSP EP, V33, P20, DOI 10.1086/663209; Negron ME, 2016, AM J GASTROENTEROL, V111, P691, DOI 10.1038/ajg.2016.106; Pencina MJ, 2015, JAMA-J AM MED ASSOC, V314, P1063, DOI 10.1001/jama.2015.11082; REDELMEIER DA, 1991, J CLIN EPIDEMIOL, V44, P1141, DOI 10.1016/0895-4356(91)90146-Z; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Singh H, 2009, GASTROENTEROLOGY, V136, P451, DOI 10.1053/j.gastro.2008.10.021; To KB, 2014, SURG INFECT, V15, P490, DOI 10.1089/sur.2013.186; Walkty A, 2013, J CLIN MICROBIOL, V51, P1152, DOI 10.1128/JCM.03203-12; Welker JA, 2012, J HOSP MED, V7, P170, DOI 10.1002/jhm.990; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171266	10.1371/journal.pone.0171266	http://dx.doi.org/10.1371/journal.pone.0171266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199401	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400026
J	Zhang, T; Zhang, XQ; Han, KP; Zhang, GX; Wang, JY; Xie, KZ; Xue, Q; Fan, XM				Zhang, Tao; Zhang, Xiangqian; Han, Kunpeng; Zhang, Genxi; Wang, Jinyu; Xie, Kaizhou; Xue, Qian; Fan, Xiaomei			Analysis of long noncoding RNA and mRNA using RNA sequencing during the differentiation of intramuscular preadipocytes in chicken	PLOS ONE			English	Article							COEXPRESSION NETWORK ANALYSIS; SIGNALING PATHWAY; ADIPOSE-TISSUE; ADIPOGENIC DIFFERENTIATION; FAT DEPOSITION; CELL-DIFFERENTIATION; GENE-EXPRESSION; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INHIBITS ADIPOGENESIS	Long noncoding RNAs (lncRNAs) regulate metabolic tissue development and function, including adipogenesis. However, little is known about the function and profile of lncRNAs in intramuscular preadipocyte differentiation in chicken. Here, we identified lncRNAs in chicken intramuscular preadipocytes at different differentiation stages using RNA sequencing. A total of 1,311,382,604 clean reads and 25,435 lncRNAs were obtained from 12 samples. In total, 7,433 differentially expressed genes (4,698 lncRNAs and 2,735 mRNAs) were identified by pairwise comparison. These 7,433 differentially expressed genes were grouped into 11 clusters based on their expression patterns by K-means clustering. Using Weighted Gene Coexpression Network Analysis, we identified four stage-specific modules positively related to I0, I2, I4, and I6 stages and two stage-specific modules negatively related to I0 and I2 stages, respectively. Many well-known and novel pathways associated with intramuscular preadipocyte differentiation were identified. We also identified hub genes in each stage-specific module and visualized them in Cytoscape. Our analysis revealed many highly-connected genes, including XLOC_058593, BMP3, MYOD1, and LAMP3. This study provides a valuable resource for chicken lncRNA study and improves our understanding of the biology of preadipocyte differentiation in chicken.	[Zhang, Tao; Zhang, Xiangqian; Han, Kunpeng; Zhang, Genxi; Wang, Jinyu; Xie, Kaizhou; Xue, Qian] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Zhang, Tao; Zhang, Xiangqian; Han, Kunpeng; Zhang, Genxi; Wang, Jinyu; Xie, Kaizhou; Xue, Qian] Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China; [Fan, Xiaomei] Vazyme Biotech Co Ltd, Econ & Technol Dev Zone, Nanjing, Jiangsu, Peoples R China	Yangzhou University	Wang, JY (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.; Wang, JY (corresponding author), Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.	jywang@yzu.edu.cn			National Broiler Industrial and Technology Sestem [nycytx-42-G1-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Broiler Industrial and Technology Sestem; Priority Academic Program Development of Jiangsu Higher Education Institutions	Support was provided by the National Broiler Industrial and Technology Sestem: nycytx-42-G1-05 and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dominguez JR, 2015, CELL METAB, V21, P764, DOI 10.1016/j.cmet.2015.04.003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bonny SPF, 2016, ANIMAL, V10, P987, DOI 10.1017/S175173111500292X; Borensztein M, 2012, FASEB J, V26, P4584, DOI 10.1096/fj.12-208496; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen JT, 2015, MOL GENET GENOMICS, V290, P699, DOI 10.1007/s00438-014-0954-x; Chen QM, 2013, J APPL GENET, V54, P119, DOI 10.1007/s13353-012-0122-0; Chen XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151056; Chen X, 2016, INT J GRID DISTRIB, V9, P1, DOI 10.14257/ijgdc.2016.9.6.01; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Divoux A, 2014, OBESITY, V22, P1781, DOI 10.1002/oby.20793; Dong JQ, 2015, J ANIM SCI, V93, P3278, DOI 10.2527/jas.2015-8871; Dong XW, 2015, CHIN CONT DECIS CONF, P36, DOI 10.1109/CCDC.2015.7161663; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu YY, 2016, MOL CELL BIOCHEM, V418, P39, DOI 10.1007/s11010-016-2731-0; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gu HJ, 2014, CELL IMMUNOL, V290, P138, DOI 10.1016/j.cellimm.2014.05.004; Guiu-Jurado E., 2016, OBESITY SILVER SPRIN; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2014, CELL BIOL INT, V38, P1384, DOI 10.1002/cbin.10334; Ji XH, 2000, J BONE MINER METAB, V18, P132, DOI 10.1007/s007740050103; Jiang SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077094; Jiang ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-756; Kim M, 2015, ARCH BIOCHEM BIOPHYS, V583, P79, DOI 10.1016/j.abb.2015.07.007; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Li HL, 2011, MOL BIOL REP, V38, P4045, DOI 10.1007/s11033-010-0523-2; Li L, 2012, FEBS LETT, V586, P4100, DOI 10.1016/j.febslet.2012.10.030; Li MX, 2016, BBA-GENE REGUL MECH, V1859, P871, DOI 10.1016/j.bbagrm.2016.05.003; Li PL, 2013, CHIN RES PERSP SOC, V1, P1; Li QY, 2015, PHARM BIOL, V53, P1567, DOI 10.3109/13880209.2014.993038; Liu Z. H., 2015, HIGHWAY, V2015, P1, DOI DOI 10.1016/J.FUPR0C.2015.01.025; Luan A, 2015, PLAST RECONSTR SURG, V136, P752, DOI 10.1097/PRS.0000000000001582; Nie F, 2015, FOOD FUNCT, V6, DOI [10.1007/s13353-012-0122-0, DOI 10.1007/S13353-012-0122-0]; Nikolopoulou E, 2014, J LIPID RES, V55, P2479, DOI 10.1194/jlr.M049551; Pang WJ, 2014, J ANIM SCI, V92, P1968, DOI 10.2527/jas.2013-7098; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren HX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2365-3; Schwab CR, 2006, J ANIM SCI, V84, P1577, DOI 10.2527/2006.8461577x; Shu G, 2011, POULTRY SCI, V90, P2557, DOI 10.3382/ps.2010-01238; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Sun WX, 2016, DOMEST ANIM ENDOCRIN, V55, P25, DOI 10.1016/j.domaniend.2015.10.005; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tang HN, 2015, ENDOCR J, V62, P835, DOI 10.1507/endocrj.EJ15-0133; Tang Y, 2016, J MOL CELL BIOL, V8, P302, DOI 10.1093/jmcb/mjw019; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang GQ, 2015, J AGR FOOD CHEM, V63, P6212, DOI 10.1021/acs.jafc.5b01680; Wang H, 2013, ANIM GENET, V44, P458, DOI 10.1111/age.12025; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang SB, 2013, CELL PHYSIOL BIOCHEM, V31, P981, DOI 10.1159/000350116; Wang Y, 2015, ASIAN AUSTRAL J ANIM, V28, P1380, DOI 10.5713/ajas.14.0886; Wang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20238; Wu GF, 2014, ACTA BIOCH BIOPH SIN, V46, P1087, DOI 10.1093/abbs/gmu087; Xi G, 2013, ENDOCRINOLOGY, V154, P4146, DOI 10.1210/en.2013-1236; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan J, 2013, MOL BIOL REP, V40, P7017, DOI 10.1007/s11033-013-2821-y; Yau SW, 2014, INT J OBES LOND, V39, P770; Ye MH, 2010, ANIM BIOTECHNOL, V21, P14, DOI 10.1080/10495390903328116; Yonekura S, 2016, ANIM BIOTECHNOL, V27, P96, DOI 10.1080/10495398.2015.1102148; You LH, 2015, MOL GENET GENOMICS, V290, P1659, DOI 10.1007/s00438-015-1026-6; Yuan ZQ., 2013, SCREENING OF FAT DEP; Zappaterra M, 2016, MEAT SCI, V121, P27, DOI 10.1016/j.meatsci.2016.05.007; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang ZW, 2014, BIOSCI BIOTECH BIOCH, V78, P614, DOI 10.1080/09168451.2014.896735; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002	80	31	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172389	10.1371/journal.pone.0172389	http://dx.doi.org/10.1371/journal.pone.0172389			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199418	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400090
J	Catalani, S; Palma, F; Battistelli, S; Benedetti, S				Catalani, Simona; Palma, Francesco; Battistelli, Serafina; Benedetti, Serena			Oxidative stress and apoptosis induction in human thyroid carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts	PLOS ONE			English	Article							BETA-CARYOPHYLLENE; ALPHA-PINENE; ANTICANCER; ANTIOXIDANT; CONSTITUENTS; PATHWAYS	Background Essential oils from the aerial parts (leaves, twigs and berries) of Pistacia lentiscus (PLEO) have been well characterized for their antibacterial and anti-inflammatory properties; however, poor information exists on their potential anticancer activity. Methods Increasing concentrations of PLEO (0.01 - 0.1% v/v, 80 - 800 mu g/ml) were administered to a wide variety of cultured cancer cells from breast, cervix, colon, liver, lung, prostate, and thyroid carcinomas. Fibroblasts were also included as healthy control cells. Cell viability was monitored by WST-8 assay up to 72 hours after PLEO administration. The intracellular formation of reactive oxygen species (ROS), the induction of apoptosis, and the enhancement of chemotherapeutic drug cytotoxicity by PLEO were further investigated in the most responsive cancer cell line. Results A dose-dependent reduction of tumor cell viability was observed upon PLEO exposure; while no cytotoxic effect was revealed in healthy fibroblasts. FTC-133 thyroid cancer cells were found to be the most sensitive cells to PLEO treatment; accordingly, an intracellular accumulation of ROS and an activation of both the extrinsic and intrinsic apoptotic pathways were evidenced in FTC-133 cells after PLEO administration. Furthermore, the cytotoxic effect of the antineoplastic drugs cisplatin, 5-fluorouracil and etoposide was enhanced in PLEO-exposed FTC-133 cells. Conclusion Taking into account its mode of action, PLEO might be considered as a promising source of natural antitumor agents which might have therapeutic potential in integrated oncology.	[Catalani, Simona; Battistelli, Serafina; Benedetti, Serena] Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy; [Palma, Francesco] Univ Urbino Carlo Bo, Sect Biochem & Mol Biol, Dept Biomol Sci, Urbino, Italy	University of Urbino; University of Urbino	Benedetti, S (corresponding author), Univ Urbino Carlo Bo, Sect Clin Biochem & Mol Genet, Dept Biomol Sci, Urbino, Italy.	serena.benedetti@uniurb.it		PALMA, Francesco/0000-0001-9836-1821; Benedetti, Serena/0000-0002-9719-2381	onlus RUOTA (Rapallo, GE, Italy)	onlus RUOTA (Rapallo, GE, Italy)	SC had received a research grant from the onlus RUOTA (Rapallo, GE, Italy). RUOTA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorjan B, 2010, FLAVOUR FRAG J, V25, P407, DOI 10.1002/ffj.2024; Amorim JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153643; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Barra A, 2007, J AGR FOOD CHEM, V55, P7093, DOI 10.1021/jf071129w; Bayala B, 2014, AM J CANCER RES, V4, P591; Benedetti S, 2011, FOOD CHEM TOXICOL, V49, P2292, DOI 10.1016/j.fct.2011.06.029; Bhalla Y, 2013, J SCI FOOD AGR, V93, P3643, DOI 10.1002/jsfa.6267; Bozorgi M, 2013, SCI WORLD J, DOI 10.1155/2013/219815; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrows N, 2010, ENDOCR-RELAT CANCER, V17, P61, DOI 10.1677/ERC-08-0251; Burrows N, 2011, J THROID RES, V2011, DOI 10.4061/2011/762905; Catalani S, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-63; Chen WQ, 2015, J PHARMACOL SCI, V127, P332, DOI 10.1016/j.jphs.2015.01.008; Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808; Dimas KS, 2012, IN VIVO, V26, P777; Giaginis C, 2011, NUTR CANCER, V63, P1174, DOI 10.1080/01635581.2011.607546; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Jin KS, 2010, FOOD SCI BIOTECHNOL, V19, P1325, DOI 10.1007/s10068-010-0189-5; Lesgards JF, 2014, PHYTOTHER RES, V28, P1423, DOI 10.1002/ptr.5165; Li GQ, 2012, CANCER BIOTHER RADIO, V27, P56, DOI 10.1089/cbr.2011.1003; Maxia A, 2011, NAT PROD COMMUN, V6, P1543; Mharti FZ, 2011, NAT PROD COMMUN, V6, P1505; Paraschos S, 2012, CURR MED CHEM, V19, P2292; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Russo R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/397821; Saviuc CM, 2015, CURR PHARM BIOTECHNO, V16, P137, DOI 10.2174/138920101602150112151549; Sheweita SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165667; Sobral Marianna Vieira, 2014, ScientificWorldJournal, V2014, P953451, DOI 10.1155/2014/953451	28	36	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172138	10.1371/journal.pone.0172138	http://dx.doi.org/10.1371/journal.pone.0172138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196126	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900054
J	Luo, QY; Zhao, L; Hu, JX; Jin, HW; Liu, ZM; Zhang, LR				Luo, Qiyao; Zhao, Liang; Hu, Jianxing; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren			The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing	PLOS ONE			English	Article							PROTEIN INVERSE DOCKING; DRUG DISCOVERY; SMALL-MOLECULE; PHARMACOLOGY; PREDICTION; CHALLENGES; POLYPHARMACOLOGY; ACCURACY; SEARCH; GLIDE	Target fishing often relies on the use of reverse docking to identify potential target proteins of ligands from protein database. The limitation of reverse docking is the accuracy of current scoring funtions used to distinguish true target from non-target proteins. Many contemporary scoring functions are designed for the virtual screening of small molecules without special optimization for reverse docking, which would be easily influenced by the properties of protein pockets, resulting in scoring bias to the proteins with certain properties. This bias would cause lots of false positives in reverse docking, interferring the identification of true targets. In this paper, we have conducted a large-scale reverse docking (5000 molecules to 100 proteins) to study the scoring bias in reverse docking by DOCK, Glide, and AutoDock Vina. And we found that there were actually some frequency hits, namely interference proteins in all three docking procedures. After analyzing the differences of pocket properties between these interference proteins and the others, we speculated that the interference proteins have larger contact area (related to the size and shape of protein pockets) with ligands (for all three docking programs) or higher hydrophobicity (for Glide), which could be the causes of scoring bias. Then we applied the score normalization method to eliminate this scoring bias, which was effective to make docking score more balanced between different proteins in the reverse docking of benchmark dataset. Later, the Astex Diver Set was utilized to validate the effect of score normalization on actual cases of reverse docking, showing that the accuracy of target prediction significantly increased by 21.5% in the reverse docking by Glide after score normalization, though there was no obvious change in the reverse docking by DOCK and AutoDock Vina. Our results demonstrate the effectiveness of score normalization to eliminate the scoring bias and improve the accuracy of target prediction in reverse docking. Moreover, the properties of protein pockets causing scoring bias to certain proteins we found here can provide the theory basis to further optimize the scoring functions of docking programs for future research.	[Luo, Qiyao; Zhao, Liang; Hu, Jianxing; Jin, Hongwei; Liu, Zhenming; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing, Peoples R China	Peking University	Liu, ZM; Zhang, LR (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing, Peoples R China.	zmliu@bjmu.edu.cn; liangren@bjmu.edu.cn	liu, zhenming/D-8766-2012; Zhang, Liang/GWM-6088-2022; Hu, Jianxing/AAP-5351-2020	Hu, Jianxing/0000-0002-0635-3814	National Natural Science Foundation of China [21272017, 21572010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 21272017, 21572010). Author: Zhenming Liu [http://www.nsfc.gov.cn]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulHameed MDM, 2012, J CHEM INF MODEL, V52, P492, DOI 10.1021/ci2003544; [Anonymous], PIP PIL 7 5; [Anonymous], 2013, LIGPREP VERS 2 6; [Anonymous], AV CHEM DIR; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Bottegoni G, 2012, DRUG DISCOV TODAY, V17, P23, DOI 10.1016/j.drudis.2011.08.002; Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y; Burbaum J, 2002, CURR OPIN CHEM BIOL, V6, P427, DOI 10.1016/S1367-5931(02)00337-X; Cereto-Massague A, 2015, METHODS, V71, P98, DOI 10.1016/j.ymeth.2014.09.006; Chen X, 2003, NAT PROD REP, V20, P432, DOI 10.1039/b303745b; Chen YZ, 2001, J MOL GRAPH MODEL, V20, P199, DOI 10.1016/S1093-3263(01)00109-7; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Ekins S, 2007, BRIT J PHARMACOL, V152, P21, DOI 10.1038/sj.bjp.0707306; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Eric S, 2012, BIOORGAN MED CHEM, V20, P5220, DOI 10.1016/j.bmc.2012.06.051; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gowthaman R, 2013, J CHEM INF MODEL, V53, P2073, DOI 10.1021/ci4002316; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Huggins DJ, 2012, J MED CHEM, V55, P1424, DOI 10.1021/jm2010332; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Jenwitheesuk E, 2008, TRENDS PHARMACOL SCI, V29, P62, DOI 10.1016/j.tips.2007.11.007; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kellenberger E, 2008, J CHEM INF MODEL, V48, P1014, DOI 10.1021/ci800023x; Khanna I, 2012, DRUG DISCOV TODAY, V17, P1088, DOI 10.1016/j.drudis.2012.05.007; Kinnings SL, 2011, J CHEM INF MODEL, V51, P624, DOI 10.1021/ci1003174; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Liu X, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-33; Liu ZC, 2013, DRUG DISCOV TODAY, V18, P110, DOI 10.1016/j.drudis.2012.08.005; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; McCulley TJ, 2000, J NEURO-OPHTHALMOL, V20, P227, DOI 10.1097/00041327-200020040-00001; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Merino A, 2010, DRUG DISCOV TODAY, V15, P749, DOI 10.1016/j.drudis.2010.06.006; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524; Schomburg KT, 2014, J CHEM INF MODEL, V54, P1676, DOI 10.1021/ci500130e; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang W, 2012, PROTEINS, V80, P169, DOI 10.1002/prot.23173	45	19	21	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171433	10.1371/journal.pone.0171433	http://dx.doi.org/10.1371/journal.pone.0171433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196116	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423900021
J	Saintas, E; Abrahams, L; Ahmad, GT; Ajakaiye, AOM; AlHumaidi, ASHAM; Ashmore-Harris, C; Clark, I; Dura, UK; Fixmer, CN; Ike-Morris, C; Prado, MM; Mccullough, D; Mishra, S; Scholer, KMU; Timur, H; Williamson, MDC; Alatsatianos, M; Bahsoun, B; Blackburn, E; Hogwood, CE; Lithgow, PE; Rowe, M; Yiangou, L; Rothweiler, F; Cinatl, J; Zehner, R; Baines, AJ; Garrett, MD; Gourlay, CW; Griffin, DK; Gullick, WJ; Hargreaves, E; Howard, MJ; Lloyd, DR; Rossman, JS; Smales, CM; Tsaousis, AD; von der Haar, T; Wass, MN; Michaelis, M				Saintas, Emily; Abrahams, Liam; Ahmad, Gulshan T.; Ajakaiye, Anu-Oluwa M.; AlHumaidi, Abdulaziz S. H. A. M.; Ashmore-Harris, Candice; Clark, Iain; Dura, Usha K.; Fixmer, Carine N.; Ike-Morris, Chinedu; Prado, Mireia Mato; Mccullough, Danielle; Mishra, Shishir; Schoeler, Katia M. U.; Timur, Husne; Williamson, Maxwell D. C.; Alatsatianos, Markella; Bahsoun, Basma; Blackburn, Edith; Hogwood, Catherine E.; Lithgow, Pamela E.; Rowe, Michelle; Yiangou, Lyto; Rothweiler, Florian; Cinatl, Jindrich, Jr.; Zehner, Richard; Baines, Anthony J.; Garrett, Michelle D.; Gourlay, Campbell W.; Griffin, Darren K.; Gullick, William J.; Hargreaves, Emma; Howard, Mark J.; Lloyd, Daniel R.; Rossman, Jeremy S.; Smales, C. Mark; Tsaousis, Anastasios D.; von der Haar, Tobias; Wass, Mark N.; Michaelis, Martin			Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-AS(r) OXALI(4000), a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS	PLOS ONE			English	Article							PHASE-I; MOLECULAR-MECHANISMS; INFLUENZA-VIRUS; LUNG-CANCER; ANTICANCER; GEMCITABINE; CISPLATIN; THERAPY; COMBINATIONS; DOXORUBICIN	The formation of acquired drug resistance is a major reason for the failure of anti-cancer therapies after initial response. Here, we introduce a novel model of acquired oxaliplatin resistance, a sub-line of the non-MYCN-amplified neuroblastoma cell line SK-N-AS that was adapted to growth in the presence of 4000 ng/mL oxaliplatin (SK-N-AS(r) OXALI(4000)). SK-N-AS(r) OXALI(4000) cells displayed enhanced chromosomal aberrations compared to SK-N-AS, as indicated by 24-chromosome fluorescence in situ hybridisation. Moreover, SK-N-AS(r) OXALI(4000) cells were resistant not only to oxaliplatin but also to the two other commonly used anti-cancer platinum agents cisplatin and carboplatin. SK-N-AS(r) OXALI(4000) cells exhibited a stable resistance phenotype that was not affected by culturing the cells for 10 weeks in the absence of oxaliplatin. Interestingly, SK-N-AS(r) OXALI(4000) cells showed no cross resistance to gemcitabine and increased sensitivity to doxorubicin and UVC radiation, alternative treatments that like platinum drugs target DNA integrity. Notably, UVC-induced DNA damage is thought to be predominantly repaired by nucleotide excision repair and nucleotide excision repair has been described as the main oxaliplatin-induced DNA damage repair system. SK-N- AS(r) OXAL(4000) cells were also more sensitive to lysis by influenza A virus, a candidate for oncolytic therapy, than SK-N-AS cells. In conclusion, we introduce a novel oxaliplatin resistance model. The oxaliplatin resistance mechanisms in SK-N-AS(r) OXALI(4000) cells appear to be complex and not to directly depend on enhanced DNA repair capacity. Models of oxaliplatin resistance are of particular relevance since research on platinum drugs has so far predominantly focused on cisplatin and carboplatin.	[Saintas, Emily; Abrahams, Liam; Ahmad, Gulshan T.; Ajakaiye, Anu-Oluwa M.; AlHumaidi, Abdulaziz S. H. A. M.; Ashmore-Harris, Candice; Clark, Iain; Dura, Usha K.; Fixmer, Carine N.; Ike-Morris, Chinedu; Prado, Mireia Mato; Mccullough, Danielle; Mishra, Shishir; Schoeler, Katia M. U.; Timur, Husne; Williamson, Maxwell D. C.; Alatsatianos, Markella; Bahsoun, Basma; Blackburn, Edith; Hogwood, Catherine E.; Lithgow, Pamela E.; Rowe, Michelle; Yiangou, Lyto; Baines, Anthony J.; Garrett, Michelle D.; Gourlay, Campbell W.; Griffin, Darren K.; Gullick, William J.; Hargreaves, Emma; Howard, Mark J.; Lloyd, Daniel R.; Rossman, Jeremy S.; Smales, C. Mark; Tsaousis, Anastasios D.; von der Haar, Tobias; Wass, Mark N.; Michaelis, Martin] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Saintas, Emily; Hogwood, Catherine E.; Yiangou, Lyto; Hargreaves, Emma; Smales, C. Mark; Wass, Mark N.; Michaelis, Martin] Univ Kent, Ind Biotechnol Ctr, Canterbury, Kent, England; [Rothweiler, Florian; Cinatl, Jindrich, Jr.] Klinikum Goethe Univ, Inst Med Virol, Frankfurt, Germany; [Zehner, Richard] Klinikum Goethe Univ, Inst Rechtsmed, Frankfurt, Germany; [Howard, Mark J.] Univ Western Australia, Sch Chem & Biochem, Perth, WA, Australia	University of Kent; University of Kent; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Western Australia	Michaelis, M (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.; Michaelis, M (corresponding author), Univ Kent, Ind Biotechnol Ctr, Canterbury, Kent, England.	M.Michaelis@kent.ac.uk	Wass, Mark/H-3398-2019; z, r/ABA-2962-2021; Prado, Mireia Mato/W-4964-2019	Wass, Mark/0000-0001-5428-6479; Prado, Mireia Mato/0000-0002-0574-4098; Howard, Mark/0000-0002-0762-2887; Michaelis, Martin/0000-0002-5710-5888; Gourlay, Campbell/0000-0002-2373-6788; von der Haar, Tobias/0000-0002-6031-9254; Rossman, Jeremy/0000-0001-6124-4103; Lloyd, Daniel/0000-0002-4888-6790; Tsaousis, Anastasios/0000-0002-5424-1905; Schoeler, Katia/0000-0001-5136-5147; Abrahams, Liam/0000-0002-6466-5832; Smales, Christopher Mark/0000-0002-2762-4724	Kent Cancer Trust; Hilfe fuer krebskranke Kinder Frankfurt; Frankfurter Stiftung fuer krebskranke Kinder; BBSRC [BB/K017640/1] Funding Source: UKRI; MRC [MR/L00870X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G19438/2, BB/K017640/1] Funding Source: researchfish	Kent Cancer Trust; Hilfe fuer krebskranke Kinder Frankfurt; Frankfurter Stiftung fuer krebskranke Kinder; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Kent Cancer Trust, http://www.kentcancertrust.org.uk; Hilfe fuer krebskranke Kinder Frankfurt e.V., https://www.kinderkrebs-frankfurt.de; Frankfurter Stiftung fuer krebskranke Kinder, http://www.kinderkrebsstiftung-frankfurt.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2009, J CLIN ONCOL, V27, P365, DOI 10.1200/JCO.2008.17.9184; Bergmann M, 2001, CANCER RES, V61, P8188; Bhattacharya B, 2016, BRIT J PHARMACOL, V173, P970, DOI 10.1111/bph.13422; Bianchi G, 2015, ONCOTARGET, V6, P11806, DOI 10.18632/oncotarget.3688; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Bucheit AD, 2014, BIOCHEM PHARMACOL, V87, P381, DOI 10.1016/j.bcp.2013.11.013; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; COHEN PS, 1995, CANCER RES, V55, P2380; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Faivre S, 2002, ANN ONCOL, V13, P1479, DOI 10.1093/annonc/mdf219; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Geoerger B, 2008, J CLIN ONCOL, V26, P4394, DOI 10.1200/JCO.2008.16.7585; Geoerger B, 2011, EUR J CANCER, V47, P230, DOI 10.1016/j.ejca.2010.09.015; GRIFFIN DK, 1994, J ASSIST REPROD GEN, V11, P132, DOI 10.1007/BF02332090; Guo ZS, 2008, BBA-REV CANCER, V1785, P217, DOI 10.1016/j.bbcan.2008.02.001; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hartmann C, 2011, J PEDIAT HEMATOL ONC, V33, P344, DOI 10.1097/MPH.0b013e31820994ec; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Ioannou D, 2012, CHROMOSOME RES, V20, P447, DOI 10.1007/s10577-012-9294-z; Ioannou D, 2011, MOL CELL PROBE, V25, P199, DOI 10.1016/j.mcp.2011.08.002; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Kasloff SB, 2014, J VIROL, V88, P9321, DOI 10.1128/JVI.00929-14; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kotchetkov R, 2005, INT J ONCOL, V27, P1029; Kushner BH, 2014, CANCER-AM CANCER SOC, V120, P2050, DOI 10.1002/cncr.28687; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Martinez-Balibrea E, 2015, MOL CANCER THER, V14, P1767, DOI 10.1158/1535-7163.MCT-14-0636; Mascarenhas L, 2013, PEDIATR BLOOD CANCER, V60, P1103, DOI 10.1002/pbc.24471; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Michaelis M, 2010, BIOCHEM PHARMACOL, V79, P130, DOI 10.1016/j.bcp.2009.08.013; Mir O, 2012, LUNG CANCER, V77, P104, DOI 10.1016/j.lungcan.2012.01.014; Morgenstern DA, 2013, J PEDIAT HEMATOL ONC, V35, P337, DOI 10.1097/MPH.0b013e318299d637; Nagano K, 2014, J CONTROL RELEASE, V189, P72, DOI 10.1016/j.jconrel.2014.06.010; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Perego P, 2016, CANCER CHEMOTH PHARM, V77, P5, DOI 10.1007/s00280-015-2901-x; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Raez LE, 2010, CLIN LUNG CANCER, V11, P18, DOI 10.3816/CLC.2010.n.003; Rammal H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00055; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Riccardi A, 1999, EUR J CANCER, V35, P86, DOI 10.1016/S0959-8049(98)00342-6; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Schneiderman J, 2008, J CLIN ONCOL, V26, P913, DOI 10.1200/JCO.2007.13.9493; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Seymour LW, 2016, BRIT J CANCER, V114, P357, DOI 10.1038/bjc.2015.481; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Taguchi K, 1997, JPN J CANCER RES, V88, P394, DOI 10.1111/j.1349-7006.1997.tb00395.x; Vallo S, 2015, TRANSL ONCOL, V8, P210, DOI 10.1016/j.tranon.2015.04.002; van Rikxoort M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036506; Wetterskog D, 2009, MOL CANCER RES, V7, P2031, DOI 10.1158/1541-7786.MCR-08-0501	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172140	10.1371/journal.pone.0172140	http://dx.doi.org/10.1371/journal.pone.0172140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192521	Green Published, gold, Green Accepted			2022-12-26	WOS:000394423800076
J	Stevens, RL; McNeil, HP; Wensing, LA; Shin, K; Wong, GW; Hansbro, PM; Krilis, SA				Stevens, Richard L.; McNeil, H. Patrick; Wensing, Lislaine A.; Shin, Kichul; Wong, G. William; Hansbro, Philip M.; Krilis, Steven A.			Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY ARTHRITIS; TRICHINELLA-SPIRALIS; NEUTRAL PROTEASES; HUMAN CHYMASE; RHEUMATOID-ARTHRITIS; CARBOXYPEPTIDASE-A; GRANULE PROTEASES; MOLECULAR-CLONING; TRYPTASE MMCP-6; SYNOVIAL-FLUID	The constitutive heparin(+) (HP) mast cells (MCs) in mice express mouseMCprotease (mMCP)-5 and carboxypeptidaseA (mMC-CPA). The amino acid sequence ofmMCP-5is most similar to that of human chymase-1, as are the nucleotide sequences of their genes and transcripts. Using a homologous recombination approach, a C57BL/6 mouse line was created that possessed a disrupted mMCP-5 gene. The resulting mice were fertile and had no obvious developmental abnormality. Lack of mMCP-5 protein did not alter the granulation of the IL-3/IL-9-dependent mMCP-2(+) MCs in the jejunal mucosa of Trichinella spiralisinfected mice. In contrast, the constitutive HP+ MCs in the tongues of mMCP-5-null mice were poorly granulated and lacked mMC-CPA protein. Bone marrow-derived MCs were readily developed from the transgenic mice using IL-3. Although these MCs contained high levels of mMC-CPA mRNA, they also lacked the latter exopeptidase. mMCP-5 protein is therefore needed to target translated mMC-CPA to the secretory granule along with HP-containing serglycin proteoglycans. Alternately, mMCP-5 is needed to protect mMC-CPA from autolysis in the cell's granules. Fibronectin was identified as a target of mMCP-5, and the exocytosis ofmMCP-5from theMCs in the mouse's peritoneal cavity resulted in the expression of metalloproteinase protease-9, which has been implicated in arthritis. In support of the latter finding, experimental arthritis was markedly reduced in mMCP-5-null mice relative to wildtype mice in two disease models.	[Stevens, Richard L.; Wensing, Lislaine A.; Krilis, Steven A.] Univ New South Wales, Dept Infect Dis Immunol & Sexual Hlth, St George Hosp, Sydney, NSW 2217, Australia; [Stevens, Richard L.; Wensing, Lislaine A.; Krilis, Steven A.] Univ New South Wales, Fac Med, St George & Sutherland Clin Sch, Sydney, NSW 2217, Australia; [Stevens, Richard L.; Krilis, Steven A.] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Newcastle, NSW 2308, Australia; [McNeil, H. Patrick] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia; [Wensing, Lislaine A.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Shin, Kichul] SNU, SMG, Div Rheumatol, Boramae Med Ctr, Seoul 07061, South Korea; [Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Hansbro, Philip M.] Hunter Med Res Inst, Newcastle, NSW 2308, Australia	St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; University of Newcastle; Macquarie University; Universidade de Sao Paulo; Seoul National University (SNU); Seoul National University Hospital; Johns Hopkins University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Stevens, RL (corresponding author), St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Res & Educ Ctr, Level 3,4-10 South St, Sydney, NSW 2217, Australia.	rstevens@richardstevensphd.org	Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Wong, G. William/0000-0002-5286-6506; McNeil, Hugh Patrick/0000-0003-4336-2960	St. George and Sutherland Medical Research Foundation; Harvard Club of Australia Foundation; Australian Research Council; University of Newcastle; National Institutes of Health [DK084171, AI059746]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	St. George and Sutherland Medical Research Foundation; Harvard Club of Australia Foundation; Australian Research Council(Australian Research Council); University of Newcastle; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by funds from the St. George and Sutherland Medical Research Foundation (to R. L. S. and S. K.), the Harvard Club of Australia Foundation (to R. L. S., S. K., and P. M. H.), the Australian Research Council (to P. M. H. and R. L. S.), and the University of Newcastle (to R. L. S.); National Institutes of Health Grants DK084171 (to G. W. W.) and AI059746 (to R. L. S.); a fellowship from the National Health and Medical Research Council of Australia (to P. M. H.); the Brawn Fellowship from the University of Newcastle (to P. M. H.); and a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (to L. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abonia JP, 2005, J IMMUNOL, V174, P7285, DOI 10.4049/jimmunol.174.11.7285; Buckley MG, 1997, CLIN SCI, V93, P363, DOI 10.1042/cs0930363; CAUGHEY GH, 1991, J BIOL CHEM, V266, P12956; DAYTON ET, 1989, J IMMUNOL, V142, P4307; DUBUSKE L, 1984, J IMMUNOL, V133, P1535; EKLUND KK, 1993, J IMMUNOL, V151, P4266; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 1998, J IMMUNOL, V160, P5537; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; GODFREY HP, 1984, ARTHRITIS RHEUM, V27, P852, DOI 10.1002/art.1780270803; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Gotis-Graham I, 1998, ANN RHEUM DIS, V57, P664, DOI 10.1136/ard.57.11.664; HALPERN BN, 1963, BRIT J PHARM CHEMOTH, V20, P389, DOI 10.1111/j.1476-5381.1963.tb01477.x; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; IRANI AMA, 1991, J IMMUNOL, V147, P247; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; KATZ HR, 1986, J IMMUNOL, V136, P3819; KOOLWIJK P, 1995, J RHEUMATOL, V22, P385; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Lazaar AL, 2002, J IMMUNOL, V169, P1014, DOI 10.4049/jimmunol.169.2.1014; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEES M, 1994, EUR J BIOCHEM, V223, P171, DOI 10.1111/j.1432-1033.1994.tb18980.x; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; McGrath ME, 1997, BIOCHEMISTRY-US, V36, P14318, DOI 10.1021/bi971403n; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Okumura K, 2004, CLIN CHIM ACTA, V347, P223, DOI 10.1016/j.cccn.2004.04.019; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Peschke K, 2015, METHODS MOL BIOL, V1220, P403, DOI 10.1007/978-1-4939-1568-2_25; Prieto-Garcia A, 2012, J BIOL CHEM, V287, P7834, DOI 10.1074/jbc.M111.325712; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; SALI A, 1993, J BIOL CHEM, V268, P9023; Semaan W, 2015, BIOCHEM PHARMACOL, V94, P91, DOI 10.1016/j.bcp.2015.02.001; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Stevens R. L., 2000, PROTEOGLYCANS STRUCT, P177; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; STEVENS RL, 1982, J BIOL CHEM, V257, P253; Tchougounova E, 2001, J BIOL CHEM, V276, P3772, DOI 10.1074/jbc.M008434200; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; URATA H, 1991, J BIOL CHEM, V266, P17173; URATA H, 1990, J BIOL CHEM, V265, P22348; Wang YF, 2001, ARTERIOSCL THROM VAS, V21, P1928, DOI 10.1161/hq1201.100227; Xia ZN, 1996, J BIOL CHEM, V271, P8747, DOI 10.1074/jbc.271.15.8747; XIE DL, 1992, J RHEUMATOL, V19, P1448; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803	64	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5392	5404		10.1074/jbc.M116.773416	http://dx.doi.org/10.1074/jbc.M116.773416			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193842	Green Published, hybrid			2022-12-26	WOS:000397875500020
J	Huang, JY; Zhou, QL; Huang, CH; Song, Y; Sharma, AG; Liao, ZP; Zhu, K; Massidda, MW; Jamieson, RR; Zhang, JY; Tenen, DG; Jiang, ZY				Huang, Jun-Yuan; Zhou, Qiong Lin; Huang, Chun-Hong; Song, Ye; Sharma, Andria G.; Liao, Zhangping; Zhu, Kavin; Massidda, Miles W.; Jamieson, Ryan R.; Zhang, Jun-Yuan; Tenen, Daniel G.; Jiang, Zhen Y.			Neutrophil Elastase Regulates Emergency Myelopoiesis Preceding Systemic Inflammation in Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; C/EBP-ALPHA; SELF-RENEWAL; EXPRESSION; GFI-1; DIFFERENTIATION; PROLIFERATION	Inflammation plays a significant role in the development of obesity-related complications, but the molecular events that initiate and propagate such inflammation remain unclear. Here, we report that mice fed a high fat diet (HFD) for as little as 1-3 days show increased differentiation of myeloid progenitors into neutrophils and monocytes but reduced B lymphocyte production in the bone marrow. Levels of neutrophil elastase (NE) and the nuclear factors CCAAT/ enhancer-binding protein alpha (C/ EBP alpha) and growth factor-independent 1 (GFI-1) are elevated in hematopoietic stem and progenitor cells from HFD-fed mice, but mice lacking either NE or C/EBP alpha are resistant to HFDinduced myelopoiesis. NE deletion increases expression of the inhibitory isoform of p30 C/EBP alpha, impairs the transcriptional activity of p42 C/EBP alpha, and reduces expression of the C/EBP alpha target gene GFI-1 in hematopoietic stem and progenitor cells, suggesting a mechanism by which NE regulates myelopoiesis. Furthermore, NE deletion prevents HFD-induced vascular leakage. Thus, HFD feeding rapidly activates bone marrow myelo-poiesis through the NE-dependent C/EBP alpha-GFI-1 pathway preceding vascular damage and systemic inflammation.	[Huang, Jun-Yuan; Zhou, Qiong Lin; Huang, Chun-Hong; Song, Ye; Sharma, Andria G.; Liao, Zhangping; Zhu, Kavin; Massidda, Miles W.; Jamieson, Ryan R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Huang, Jun-Yuan; Zhou, Qiong Lin; Huang, Chun-Hong; Song, Ye; Sharma, Andria G.; Liao, Zhangping; Zhu, Kavin; Massidda, Miles W.; Jamieson, Ryan R.; Jiang, Zhen Y.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 700 Albany St, Boston, MA 02118 USA; [Zhang, Jun-Yuan; Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Huang, Chun-Hong; Liao, Zhangping] Nanchang Univ, Med Ctr, Nanchang 330006, Jiangxi, Peoples R China; [Song, Ye] Southern Med Univ, Nanfang Hosp, Guangzhou 510000, Guangdong, Peoples R China	Boston University; Boston University; Harvard University; National University of Singapore; Nanchang University; Southern Medical University - China	Jiang, ZY (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 700 Albany St, Boston, MA 02118 USA.	zyjiang@bu.edu		Massidda, Miles/0000-0001-7704-9273	American Diabetes Association [1-16-IBS146]; National Institutes of Health [R01DK094025]; Boston University Clinical & Translational Science Institute (CTSI) [1UL1TR001430]; National Research Foundation Singapore; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR); China Scholarship Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094025] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Clinical & Translational Science Institute (CTSI); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR)(Ministry of Health-SingaporeNational Medical Research Council, Singapore); China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association Grant 1-16-IBS146 and National Institutes of Health Grant R01DK094025 (to Z.Y.J.), a Boston University Clinical & Translational Science Institute (CTSI) Pilot Grant 1UL1TR001430 (to Q.L.Z.), a grant from the National Research Foundation Singapore and the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (to D.G.T.), and visiting scholarships from the China Scholarship Council ( to C.H.,Y.S., and Z.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Flach RJR, 2013, J BIOL CHEM, V288, P2882, DOI 10.1074/jbc.M112.412346; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Lidonnici MR, 2010, CANCER RES, V70, P7949, DOI 10.1158/0008-5472.CAN-10-1667; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu X, 2015, INT J OBESITY, V39, P26, DOI 10.1038/ijo.2014.194; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	23	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4770	4776		10.1074/jbc.C116.758748	http://dx.doi.org/10.1074/jbc.C116.758748			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28202548	hybrid, Green Published			2022-12-26	WOS:000397590400002
J	Hengl, T; de Jesus, JM; Heuvelink, GBM; Gonzalez, MR; Kilibarda, M; Blagotic, A; Shangguan, W; Wright, MN; Geng, XY; Bauer-Marschallinger, B; Guevara, MA; Vargas, R; MacMillan, RA; Batjes, NH; Leenaars, JGB; Ribeiro, E; Wheeler, I; Mantel, S; Kempen, B				Hengl, Tomislav; de Jesus, Jorge Mendes; Heuvelink, Gerard B. M.; Gonzalez, Maria Ruiperez; Kilibarda, Milan; Blagotic, Aleksandar; Shangguan, Wei; Wright, Marvin N.; Geng, Xiaoyuan; Bauer-Marschallinger, Bernhard; Guevara, Mario Antonio; Vargas, Rodrigo; MacMillan, Robert A.; Batjes, Niels H.; Leenaars, Johan G. B.; Ribeiro, Eloi; Wheeler, Ichsani; Mantel, Stephan; Kempen, Bas			SoilGrids250m: Global gridded soil information based on machine learning	PLOS ONE			English	Article							SPATIOTEMPORAL INTERPOLATION; ORGANIC-CARBON; DATABASE; PREDICTIONS; DATASETS; FORESTS; MODELS; WATER; MAPS; TOOL	This paper describes the technical development and accuracy assessment of the most recent and improved version of the SoilGrids system at 250m resolution (June 2016 update). SoilGrids provides global predictions for standard numeric soil properties (organic carbon, bulk density, Cation Exchange Capacity (CEC), pH, soil texture fractions and coarse fragments) at seven standard depths (0, 5, 15, 30, 60, 100 and 200 cm), in addition to predictions of depth to bedrock and distribution of soil classes based on the World Reference Base (WRB) and USDA classification systems (ca. 280 raster layers in total). Predictions were based on ca. 150,000 soil profiles used for training and a stack of 158 remote sensing-based soil covariates (primarily derived from MODIS land products, SRTM DEM derivatives, climatic images and global landform and lithology maps), which were used to fit an ensemble of machine learning methods D random forest and gradient boosting and/or multinomial logistic regression D as implemented in the R packages ranger, xgboost, nnet and caret. The results of 10 -fold cross-validation show that the ensemble models explain between 56% (coarse fragments) and 83% (pH) of variation with an overall average of 61%. Improvements in the relative accuracy considering the amount of variation explained, in comparison to the previous version of SoilGrids at 1 km spatial resolution, range from 60 to 230%. Improvements can be attributed to: (1) the use of machine learning instead of linear regression, (2) to considerable investments in preparing finer resolution covariate layers and (3) to insertion of additional soil profiles. Further development of SoilGrids could include refinement of methods to incorporate input uncertainties and derivation of posterior probability distributions (per pixel), and further automation of spatial modeling so that soil maps can be generated for potentially hundreds of soil variables. Another area of future research is the development of methods for multiscale merging of SoilGrids predictions with local and/or national gridded soil products (e.g. up to 50 m spatial resolution) so that increasingly more accurate, complete and consistent global soil information can be produced. SoilGrids are available under the Open Data Base License.	[Hengl, Tomislav; de Jesus, Jorge Mendes; Heuvelink, Gerard B. M.; Gonzalez, Maria Ruiperez; Batjes, Niels H.; Leenaars, Johan G. B.; Ribeiro, Eloi; Mantel, Stephan; Kempen, Bas] ISRIC World Soil Informat, Wageningen, Netherlands; [Kilibarda, Milan] Univ Belgrade, Fac Civil Engn, Belgrade, Serbia; [Blagotic, Aleksandar] GILab Ltd, Belgrade, Serbia; [Shangguan, Wei] Sun Yat Sen Univ, Sch Atmospher Sci, Guangzhou, Guangdong, Peoples R China; [Wright, Marvin N.] Inst Med Biometrie & Stat, Lubeck, Germany; [Geng, Xiaoyuan] Agr & Agri Food Canada, Ottawa, ON, Canada; [Bauer-Marschallinger, Bernhard] Vienna Univ Technol, Dept Geodesy & Geoinformat, Vienna, Austria; [Guevara, Mario Antonio; Vargas, Rodrigo] Univ Delaware, Newark, DE USA; [MacMillan, Robert A.] LandMapper Environm Solut Inc, Edmonton, AB, Canada; [Wheeler, Ichsani] Envirometrix Inc, Wageningen, Netherlands	University of Belgrade; Sun Yat Sen University; Agriculture & Agri Food Canada; Technische Universitat Wien; University of Delaware	Hengl, T (corresponding author), ISRIC World Soil Informat, Wageningen, Netherlands.	tom.hengl@isric.org	Hengl, Tomislav/AAE-9320-2019; Heuvelink, Gerard/AAD-5916-2022; Shangguan, Wei/C-5157-2008; Vargas, Rodrigo/C-4720-2008; Guevara, Mario/AAH-9539-2019; Marschallinger, Berhard/AAP-8088-2020; Snow, Val O/O-8693-2016; Batjes, Niels H./F-7195-2010	Hengl, Tomislav/0000-0002-9921-5129; Heuvelink, Gerard/0000-0003-0959-9358; Shangguan, Wei/0000-0001-7622-8210; Vargas, Rodrigo/0000-0001-6829-5333; Guevara, Mario/0000-0002-9788-9947; Marschallinger, Berhard/0000-0001-7356-7516; Snow, Val O/0000-0002-6911-8184; Batjes, Niels H./0000-0003-2367-3067; Leenaars, Johan G.B./0000-0003-1091-7114; Ribeiro, Eloi/0000-0002-2324-3000; Mendes de Jesus, Jorge Samuel/0000-0001-9890-067X; Wright, Marvin/0000-0002-8542-6291; Kilibarda, Milan/0000-0002-2930-3596	Dutch government; GILAB DOO	Dutch government; GILAB DOO	ISRIC is a non-profit organization primarily funded by the Dutch government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GILAB DOO provided support in the form of salaries for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions' section.	Aksoy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152098; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Baade Jussi, 2014, 2014 IEEE Geoscience and Remote Sensing Symposium. (IGARSS). Proceedings, P4327, DOI 10.1109/IGARSS.2014.6947447; Batjes NH, 2009, SOIL USE MANAGE, V25, P124, DOI 10.1111/j.1475-2743.2009.00202.x; Bauer-Marschallinger B, 2014, COMPUT GEOSCI-UK, V72, P84, DOI 10.1016/j.cageo.2014.07.005; BORDA M, 2011, FUND INF THEOR COD, P1; Brevik EC, 2016, GEODERMA, V264, P256, DOI 10.1016/j.geoderma.2015.05.017; Brus DJ, 2011, EUR J SOIL SCI, V62, P394, DOI 10.1111/j.1365-2389.2011.01364.x; Carroll ML, 2009, INT J DIGIT EARTH, V2, P291, DOI 10.1080/17538940902951401; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Chen T, 2016, XG BOOST A SCALABLE; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cooper M, 2005, SOIL SCI SOC AM J, V69, P649, DOI 10.2136/sssaj2004.0140; Danielson JJ, 2011, OPEN FILE REPORT 201; Domisch S, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.73; Eberhardt E., 2011, NCSS NATIONAL CONFER, P1; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; FAO, 2006, GUIDELINES FOR SOIL; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2012, HARMONIZED WORLD SOI; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Folberth C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11872; Gasch CK, 2015, SPAT STAT-NETH, V14, P70, DOI 10.1016/j.spasta.2015.04.001; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Griffiths RI, 2016, APPL SOIL ECOL, V97, P61, DOI 10.1016/j.apsoil.2015.06.018; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; Hall DK, 2007, HYDROL PROCESS, V21, P1534, DOI 10.1002/hyp.6715; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hijmans R., 2012, RASTER GEOGRAPHIC DA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hollis JM, 2006, SPADE 2 THE SOIL PRO; Huffman GJ, 2009, GPCP VERSION 2 COMBI, V1; Hugelius G, 2013, EARTH SYST SCI DATA, V5, P3, DOI 10.5194/essd-5-3-2013; IUSS Working Group WRB, 2006, WORLD SOIL RESOURCES; Jenny H, 1994, DOVER BOOKS ON EARTH; Karssies L, 2011, CSIRO NATIONAL SOIL; Kempen B, 2011, THESIS; Kidd D, 2015, SOIL RES, V53, P932, DOI 10.1071/SR14268; Kilibarda M, 2014, J GEOPHYS RES-ATMOS, V119, P2294, DOI 10.1002/2013JD020803; Knaus J, 2009, R J, V1, P54; Krasilnikov P, 2009, A HANDBOOK OF SOIL T; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lang V, 2013, GEODERMA, V192, P269, DOI 10.1016/j.geoderma.2012.07.023; Leenaars JGB, 2014, AFRICA SOIL PROFILES; Lei SA, 1998, SOUTHWEST NAT, V43, P47; Liaw A, 2002, APPLIED PREDICTIVE M, V2, P18; Lopes ME, 2015, MEASURING THE ALGORI; MacDonald KB, 1992, CANSIS NSDB A GENERA; Malone BP, 2014, GEODERMA, V232, P34, DOI 10.1016/j.geoderma.2014.04.033; Mantel S, 2007, ISRIC REPORT 2007 01; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Minasny B, 2006, COMPUT GEOSCI-UK, V32, P1378, DOI 10.1016/j.cageo.2005.12.009; Mira M, 2015, REMOTE SENS ENVIRON, V170, P216, DOI 10.1016/j.rse.2015.09.021; Mitchell T., 2014, GEOSPATIAL POWER TOO; Montanarella L., 2013, JRC TECHNICAL REPORT; Montanarella L, 2012, CURR OPIN ENV SUST, V4, P559, DOI 10.1016/j.cosust.2012.06.007; Mulder VL, 2016, GEODERMA, V263, P16, DOI 10.1016/j.geoderma.2015.08.035; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pebesma E.J., 2005, R NEWS, V5; Pelletier JD, 2016, J ADV MODEL EARTH SY, V8, P41, DOI 10.1002/2015MS000526; Pogson M, 2012, ENVIRON MODELL SOFTW, V29, P37, DOI 10.1016/j.envsoft.2011.10.008; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Raup B, 2007, GLOBAL PLANET CHANGE, V56, P101, DOI 10.1016/j.gloplacha.2006.07.018; Ribeiro E, 2015, ISRIC REPORT 2015 03; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Sayre R, 2014, A NEW MAP OF GLOBAL; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Searle R, 2014, GLOBALSOILMAP: BASIS OF THE GLOBAL SPATIAL SOIL INFORMATION SYSTEM, P127; Shangguan W, 2016, JOURNAL OF ADVANCES; Shangguan W, 2013, J ADV MODEL EARTH SY, V5, P212, DOI 10.1002/jame.20026; Shani U, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005313; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shaw C, 2005, INFORMATION REPORT; Shepherd KD, 2015, AGR SYST, V132, P93, DOI 10.1016/j.agsy.2014.09.002; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sing T, 2016, ROCR VISUALIZING THE; Sollich P, 1996, ADV NEUR IN, V8, P190; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Stockmann U, 2015, GLOB FOOD SECUR-AGR, V6, P9, DOI 10.1016/j.gfs.2015.07.001; U S Department of Agriculture, 2014, KEYS TO SOIL TAXONOM; Van Engelen VWP, 2012, GLOBAL AND NATIONAL; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Wan Z., 2013, MODIS LAND SURFACE T; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Wright MN, 2015, RANGER A FAST IMPLEM	89	1538	1584	132	672	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169748	10.1371/journal.pone.0169748	http://dx.doi.org/10.1371/journal.pone.0169748			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207752	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500005
J	Leske, H; Hornemann, S; Herrmann, US; Zhu, CH; Pelczar, P; Li, B; Laferriere, F; Polymenidou, M; Pelczar, P; Reimann, RR; Schwarz, P; Rushing, EJ; Wuthrich, K; Aguzzi, A				Leske, Henning; Hornemann, Simone; Herrmann, Uli Simon; Zhu, Caihong; Dametto, Paolo; Li, Bei; Laferriere, Florent; Polymenidou, Magdalini; Pelczar, Pawel; Reimann, Regina Rose; Schwarz, Petra; Rushing, Elisabeth Jane; Wuthrich, Kurt; Aguzzi, Adriano			Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein	PLOS ONE			English	Article							FATAL FAMILIAL INSOMNIA; TRANSGENIC MICE; NMR STRUCTURE; BETA-2-ALPHA-2 LOOP; SPONGIFORM ENCEPHALOPATHY; SCRAPIE; DISEASE; PRP; SHEEP; TRANSMISSION	Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues of organisms suffering from transmissible spongiform encephalopathies. Detection of proteinase K-resistant prion protein (PrPSc) still represents the diagnostic gold standard for prion diseases in humans, sheep and cattle. However, it has become increasingly apparent that the accumulation of PrPSc does not always accompany prion infections: high titers of prion infectivity can be reached also in the absence of protease resistant PrPSc. Here, we describe a structural basis for the phenomenon of protease-sensitive prion infectivity. We studied the effect on proteinase K (PK) resistance of the amino acid substitution Y169F, which removes a single oxygen atom from the beta 2-alpha 2 loop of the cellular prion protein (PrPC). When infected with RML or the 263K strain of prions, transgenic mice lacking wildtype (wt) PrPC but expressing MoPrP169F generated prion infectivity at levels comparable to wt mice. The newly generated MoPrP169F prions were biologically indistinguishable from those recovered from prion-infected wt mice, and elicited similar pathologies in vivo. Surprisingly, MoPrP169F prions showed greatly reduced PK resistance and density gradient analyses showed a significant reduction in high-density aggregates. Passage of MoPrP169F prions into mice expressing wt MoPrP led to full recovery of protease resistance, indicating that no strain shift had taken place. We conclude that a subtle structural variation in the beta 2-alpha 2 loop of PrPC affects the sensitivity of PrPSc to protease but does not impact prion replication and infectivity. With these findings a specific structural feature of PrPC can be linked to a physicochemical property of the corresponding PrPSc.	[Leske, Henning; Hornemann, Simone; Herrmann, Uli Simon; Zhu, Caihong; Dametto, Paolo; Li, Bei; Reimann, Regina Rose; Schwarz, Petra; Rushing, Elisabeth Jane; Aguzzi, Adriano] Univ Zurich, Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, Zurich, Switzerland; [Laferriere, Florent; Polymenidou, Magdalini] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, Zurich, Switzerland; [Pelczar, Pawel] ETH, Inst Mol Biol & Biophys, Otto Stern Weg 5, Zurich, Switzerland; [Wuthrich, Kurt] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wuthrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Leske, Henning] Oslo Univ Hosp, Dept Neuro Pathol, Sognsvannsveien 20, Oslo, Norway; [Herrmann, Uli Simon] Univ Zurich, Dept Pediat, Kinderspital Zurich, Steinwiesstr 75, Zurich, Switzerland; [Dametto, Paolo] CSL Behring AG, Wankdorfstr 10, Bern, Switzerland; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, Mattenstr 22, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute; Scripps Research Institute; University of Oslo; University Children's Hospital Zurich; University of Zurich; CSL; University of Basel	Aguzzi, A (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, Zurich, Switzerland.; Wuthrich, K (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wuthrich, K (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wuthrich@mol.biol.ethz.ch; adriano.aguzzi@usz.ch	Polymenidou, Magdalini/D-2254-2014; Reimann, Regina Rose/A-1195-2016	Reimann, Regina Rose/0000-0002-6396-4195; Aguzzi, Adriano/0000-0002-0344-6708; Wuthrich, Kurt/0000-0001-8739-6965; Laferriere, Florent/0000-0002-0753-5505; Leske, Henning/0000-0002-3057-8730	European Research Council [ERC: 670958]; Swiss National Foundation [SNF: 160329, 147660]; Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases", SystemsX.ch [2014/260, 2015/320]; Novartis Research Foundation; JPND Neurodegenerative Disease Research "Reframe" and" Cure ALS"; SystemsX.ch [2015/320]; commission innovations of the University Hospital of Zurich	European Research Council(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases", SystemsX.ch; Novartis Research Foundation; JPND Neurodegenerative Disease Research "Reframe" and" Cure ALS"; SystemsX.ch; commission innovations of the University Hospital of Zurich	AA is a recipient of an Advanced Grant of the European Research Council (ERC: 670958 http://erc.europa.eu/advanced-grants) and the Swiss National Foundation (SNF: 160329 and 147660), the Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases", SystemsX.ch (2014/260 and 2015/320), the Novartis Research Foundation, and the JPND Neurodegenerative Disease Research "Reframe" and" Cure ALS". KW is the Cecil H. and Ida M. Green Professor of Structural Biology at The Scripps Research Institute. SH is the recipient of SystemsX.ch (2015/320) and the commission innovations of the University Hospital of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante E, 2015, NATURE, P1; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Breyer J, 2012, VET MICROBIOL, V157, P23, DOI 10.1016/j.vetmic.2011.12.008; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2013, P NATL ACAD SCI USA, V110, P8549, DOI 10.1073/pnas.1306178110; Christen B, 2012, J MOL BIOL, V423, P496, DOI 10.1016/j.jmb.2012.08.011; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Colucci M, 2006, J NEUROPATH EXP NEUR, V65, P642, DOI 10.1097/01.jnen.0000228198.81797.4d; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Gorfe AA, 2007, FASEB J, V21, P3279, DOI 10.1096/fj.07-8292com; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Laferriere F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003702; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Miyazawa K, 2011, J CELL BIOCHEM, V112, P3630, DOI 10.1002/jcb.23286; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Reimann RR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005401; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rossetti G, 2011, J MOL BIOL, V411, P700, DOI 10.1016/j.jmb.2011.06.008; Rossetti G, 2010, PROTEINS, V78, P3270, DOI 10.1002/prot.22834; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Saverioni D, 2013, J BIOL CHEM, V288, P27972, DOI 10.1074/jbc.M113.477547; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Sigurdson CJ, 2011, J NEUROSCI, V31, P13840, DOI 10.1523/JNEUROSCI.3504-11.2011; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170503	10.1371/journal.pone.0170503	http://dx.doi.org/10.1371/journal.pone.0170503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207746	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500011
J	Luo, ZP; Dauter, Z				Luo, Zhipu; Dauter, Zbigniew			Embarras de richesses - It is not good to be too anomalous: Accurate structure of selenourea, a chiral crystal of planar molecules	PLOS ONE			English	Article							DIFFRACTION	Selenourea, SeC(NH2)(2), recently found an application as a derivatization reagent providing a significant anomalous diffraction signal used for phasing macromolecular crystal structures. The crystal structure of selenourea itself was solved about 50 years ago, from data recorded on films and evaluated by eye and refined to R= 0.15 with errors of bond lengths and angles about 0.1 angstrom and 6 degrees. In the current work this structure is re-evaluated on the basis of synchrotron data and refined to R1 = 0.021 with bond and angle errors about 0.007 angstrom and 0.5. The nine planar molecules of selenourea pack either in the P3(1) or in the P3(2) unit cell. All unique molecules are connected by a complex network of Se center dot center dot center dot H-N hydrogen bonds and Se center dot center dot center dot Se contacts. The packing of selenourea molecules is highly pseudosymmetric, approximating either of the P3(1(2))12, R3, and R32 space groups. Because the overwhelming majority of diffracted X-ray intensity originates form the anomalously scattering selenium atoms, the measurable anomalous Bijvoet differences are diminished and it was not possible to solve this crystal structure based on the anomalous signal alone.	[Luo, Zhipu; Dauter, Zbigniew] NCI, Synchrotron Radiat Res Sect, Argonne Natl Lab, Argonne, IL 60439 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Argonne National Laboratory	Dauter, Z (corresponding author), NCI, Synchrotron Radiat Res Sect, Argonne Natl Lab, Argonne, IL 60439 USA.	dauter@anl.gov			Intramural Research Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010378] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibelayi D, 2016, ACTA CRYSTALLOGR B, V72, P317, DOI 10.1107/S2052520616003644; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; Hendrickson WA, 2014, Q REV BIOPHYS, V47, P49, DOI 10.1017/S0033583514000018; James RW, 1954, OPTICAL PRINCIPLES D, P32; Kondrashev YD, 1964, J STRUCT CHEM, V4, P413; Luo ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37123; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; McCrea WH, 1940, P ROY SOC EDINB, V60, P281, DOI [10.1017/S0370164600020265, DOI 10.1017/S0370164600020265]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARTHASARATHY S, 1967, ACTA CRYSTALLOGR, V22, P98, DOI 10.1107/S0365110X67000179; RODRIGUEZ MP, 1964, NATURE, V201, P180, DOI 10.1038/201180a0; RUTHERFORD JS, 1969, Z KRISTALLOGR KRIST, V128, P229, DOI 10.1524/zkri.1969.128.3-6.229; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; WILSON AJC, 1949, ACTA CRYSTALLOGR, V2, P318, DOI 10.1107/S0365110X49000813; Wohler F., 1828, ANN PHYS CHEM, V88, P253, DOI DOI 10.1002/ANDP.18280880206	18	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171740	10.1371/journal.pone.0171740	http://dx.doi.org/10.1371/journal.pone.0171740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207770	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500049
J	Merali, Z; Huang, K; Mikulis, D; Silver, F; Kassner, A				Merali, Zamir; Huang, Kun; Mikulis, David; Silver, Frank; Kassner, Andrea			Evolution of blood-brain-barrier permeability after acute ischemic stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; ARTERY OCCLUSION; TRANSFER CONSTANTS; REPERFUSION; RATS; MRI; THERAPY; INJURY; DISRUPTION	The dynamics of BBB permeability after AIS in humans are not well understood. In the present study we measured the evolution of BBB permeability after AIS in humans using MRI. Patients presenting to our institution with a diagnosis of AIS underwent a single dynamic contrast-enhanced MRI (DCE-MRI) sequence to measure BBB permeability during their initial workup. Forty-two patients were included in the final analysis. The patient sample underwent DCE-MRI at a mean time of 23.8hrs after the onset of AIS symptoms (range: 1.3 - 90.7hrs). At all time-points the BBB permeability within the infarct region of the brain as defined on DWI/ADC was higher compared to the homologous region of the contralateral hemisphere (p<0.005). BBB permeability, expressed as a ratio of infarct permeability to contralateral permeability, was greatest at 6- 48hrs after the onset of AIS. Although the data was not acquired longitudinally, these findings suggest that the permeability of the BBB is continually elevated following AIS, which contradicts previous assertions that BBB permeability after AIS follows a biphasic course. Knowledge of BBB dynamics following AIS may provide insight into future treatments for AIS, especially BBB stabilizing agents.	[Merali, Zamir; Kassner, Andrea] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Merali, Zamir; Kassner, Andrea] Hosp Sick Children, Div Physiol & Expt Med, Toronto, ON, Canada; [Huang, Kun] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Mikulis, David] Toronto Western Hosp, Joint Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [Silver, Frank] Toronto Western Hosp, Div Neurol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kassner, A (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON, Canada.; Kassner, A (corresponding author), Hosp Sick Children, Div Physiol & Expt Med, Toronto, ON, Canada.	andrea.kassner@utoronto.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892	Heart and Stroke Foundation of Canada [NA 7035]; Canada Research Chairs Program [950-220786]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chairs Program(Canada Research Chairs)	This study was funded by The Heart and Stroke Foundation of Canada (NA 7035) and the Canada Research Chairs Program (950-220786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Durukan A, 2009, BRAIN RES, V1280, P158, DOI 10.1016/j.brainres.2009.05.025; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Heye AK, 2016, NEUROIMAGE, V125, P446, DOI 10.1016/j.neuroimage.2015.10.018; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Karonen JO, 2001, AM J NEURORADIOL, V22, P103; Kassner A, 2005, AM J NEURORADIOL, V26, P2213; Kassner A, 2009, AM J NEURORADIOL, V30, P1864, DOI 10.3174/ajnr.A1774; Kassner A, 2011, METHODS MOL BIOL, V686, P229, DOI 10.1007/978-1-60761-938-3_10; Kastrup A, 1999, J NEUROL SCI, V166, P91, DOI 10.1016/S0022-510X(99)00121-5; Kastrup A, 2008, STROKE, V39, P2385, DOI 10.1161/STROKEAHA.107.505420; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; Liu HS, 2013, STROKE, V44, P1872, DOI 10.1161/STROKEAHA.113.001558; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2; Nagel S, 2004, BRAIN RES PROTOC, V12, P172, DOI 10.1016/j.brainresprot.2003.11.004; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Singh V, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/510481; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wang XY, 2003, MOL NEUROBIOL, V28, P229, DOI 10.1385/MN:28:3:229; Wu XD, 2001, ACUPUNCTURE ELECTRO, V26, P1	34	94	95	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171558	10.1371/journal.pone.0171558	http://dx.doi.org/10.1371/journal.pone.0171558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207745	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424500036
J	Qu, PF; Mi, BB; Wang, DL; Zhang, R; Yang, JM; Liu, DM; Dang, SN; Yan, H				Qu, Pengfei; Mi, Baibing; Wang, Duolao; Zhang, Ruo; Yang, Jiaomei; Liu, Danmeng; Dang, Shaonong; Yan, Hong			Association between the Infant and Child Feeding Index (ICFI) and nutritional status of 6-to 35-month-old children in rural western China	PLOS ONE			English	Article							QUANTILE REGRESSION; GROWTH	Background The objective of this study was to determine the relationship between the quality of feeding practices and children's nutritional status in rural western China. Methods A sample of 12,146 pairs of 6- to 35-month-old children and their mothers were recruited using stratified multistage cluster random sampling in rural western China. Quantile regression was used to analyze the relationship between the Infant and Child Feeding Index (ICFI) and children's nutritional status. Results In rural western China, 24.37% of all infants and young children suffer from malnutrition. Of this total, 19.57%, 8.74% and 4.63% of infants and children are classified as stunting, underweight and wasting, respectively. After adjusting for covariates, the quantile regression results suggested that qualified ICFI (ICFI > 13.8) was associated with all length and HAZ quantiles (P<0.05) and had a greater effect on the following: poor length and HAZ, the beta-estimates (length) from 0.76 cm (95% CI: 0.53 to 0.99 cm) to 0.34 cm (95% CI: 0.09 to 0.59 cm) and the beta-estimates (HAZ) from 0.17 (95% CI: 0.10 to 0.24) to 0.11 (95% CI: 0.04 to 0.19). Qualified ICFI was also associated with most weight quantiles (P<0.05 except the 80th and 90th quantiles) and poor and intermediate WAZ quantiles (P<0.05 including the 10th, 20th 30th and 40th quantiles). Additionally, qualified ICFI had a greater effect on poor weight and WAZ quantiles in which the beta-estimates (weight) were from 0.20 kg (95% CI: 0.14 to 0.26 kg) to 0.06 kg (95% CI: 0.00 to 0.12 kg) and the beta-estimates (WAZ) were from 0.14 (95% CI: 0.08 to 0.21) to 0.05 (95% CI: 0.01 to 0.10). Conclusions Feeding practices were associated with the physical development of infants and young children, and proper feeding practices had a greater effect on poor physical development in infants and young children. For mothers in rural western China, proper guidelines and messaging on complementary feeding practices are necessary.	[Qu, Pengfei; Mi, Baibing; Zhang, Ruo; Yang, Jiaomei; Liu, Danmeng; Dang, Shaonong; Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi Provinc, Peoples R China; [Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Pembroke Pl, Liverpool, Merseyside, England; [Yan, Hong] Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Liverpool School of Tropical Medicine; University of Liverpool	Dang, SN; Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi Provinc, Peoples R China.; Yan, H (corresponding author), Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi Provinc, Peoples R China.	tjdshn@mail.xjtu.edu.cn; xjtu_yh.paper@aliyun.com	Shaonong, Dang/J-7421-2019; mi, baibing/ABO-1246-2022	Shaonong, Dang/0000-0002-6980-8169; mi, baibing/0000-0002-5208-7633; Wang, Duolao/0000-0003-2788-2464	National Natural Science Foundation of China [81230016]; Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF) [YH001]; Project of birth defect control and prevention in Shaanxi [Sxwsjswzfcght2016-013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF); Project of birth defect control and prevention in Shaanxi	This work was supported by the National Natural Science Foundation of China 81230016. Financial support was provided by the Chinese Ministry of Health (MOH), the United Nations Childrens Fund (UNICEF) - YH001; Project of birth defect control and prevention in Shaanxi - Sxwsjswzfcght2016-013.	Austin PC, 2005, STAT MED, V24, P791, DOI 10.1002/sim.1851; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Dang S, 2005, EUR J CLIN NUTR, V59, P1022, DOI 10.1038/sj.ejcn.1602207; Garg A, 2009, J HEALTH POPUL NUTR, V27, P763; Jian-qiang L, 2005, J HYGIENE RES, V34, P617; Langendorf C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001714; Lohia N, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0290-7; Ma JQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-568; Qu PF, 2015, PUBLIC HEALTH NUTR, V18, P3386, DOI 10.1017/S1368980015000208; Ruel MT, 2002, J NUTR, V132, P1180, DOI 10.1093/jn/132.6.1180; Rutstein SO, 2004, DHS COMP REPORTS, V6; Sawadogo PS, 2006, J NUTR, V136, P656, DOI 10.1093/jn/136.3.656; Watkins K, 2016, STATES WORLDS CHILDR, P1; Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271; World Health Organization, 2006, WORLD HLTH REP 2006; World Health Organization, 2009, INF YOUNG CHILD FEED, P1, DOI 10.1659/0276-4741(2004)024[0019:MDFR]2.0.CO;2; Yu K, 2012, J AM STAT ASSOC, V93, P228; Zheng Q., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1214/15-A0S1340	18	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171984	10.1371/journal.pone.0171984	http://dx.doi.org/10.1371/journal.pone.0171984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207774	gold, Green Accepted, Green Published			2022-12-26	WOS:000394424500066
J	Salas, IH; Callaerts-Vegh, Z; Arranz, AM; Guix, FX; D'Hooge, R; Esteban, JA; De Strooper, B; Dotti, CG				Salas, Isabel H.; Callaerts-Vegh, Zsuzsanna; Arranz, Amaia M.; Guix, Francesc X.; D'Hooge, Rudi; Esteban, Jose A.; De Strooper, Bart; Dotti, Carlos G.			Tetraspanin 6: A novel regulator of hippocampal synaptic transmission and long term plasticity	PLOS ONE			English	Article							AMPA RECEPTORS; TRAFFICKING; EPILEPSY; POTENTIATION; DENSITY; MICE; ORGANIZATION; MICRODOMAINS; DISORDER; FEMALES	Tetraspanins (Tspan) are transmembrane proteins with important scaffold and signalling functions. Deletions of Tetraspanin 6 (Tspan6) gene, a member of the tetraspanin family, have been reported in patients with Epilepsy Female-restricted with Mental Retardation (EFMR). Interestingly, mutations in Tspan7, highly homologous to Tspan6, are associated with X-linked intellectual disability, suggesting that these two proteins are important for cognition. Considering recent evidences showing that Tspan7 plays a key role in synapse development and AMPAR trafficking, we initiated the study of Tspan6 in synaptic function using a Tspan6 knock out mouse model. Here we report that hippocampal field recordings from Tspan6 knock out mice show an enhanced basal synaptic transmission and impaired long term potentiation (LTP). A normal paired-pulse facilitation response suggests that Tspan6 affects the properties of the postsynaptic rather than the presynaptic terminal. However, no changes in spine morphology or postsynaptic markers could be detected in Tspan6 KO mice compared with wild types. In addition, Tspan6 KO mice show normal locomotor behaviour and no defects in hippocampus-dependent memory tests.	[Salas, Isabel H.; Arranz, Amaia M.; Guix, Francesc X.; De Strooper, Bart] VIB, VIB Ctr Biol Dis, Leuven, Belgium; [Salas, Isabel H.; Arranz, Amaia M.; Guix, Francesc X.; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Gasthuisberg O&N4, Leuven, Belgium; [Salas, Isabel H.; Arranz, Amaia M.; Guix, Francesc X.; De Strooper, Bart] Katholieke Univ Leuven, LIND, Gasthuisberg O&N4, Leuven, Belgium; [Callaerts-Vegh, Zsuzsanna; D'Hooge, Rudi] Katholieke Univ Leuven, Lab Biol Psychol, Leuven, Belgium; [Esteban, Jose A.; Dotti, Carlos G.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	De Strooper, B (corresponding author), VIB, VIB Ctr Biol Dis, Leuven, Belgium.; De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Gasthuisberg O&N4, Leuven, Belgium.; De Strooper, B (corresponding author), Katholieke Univ Leuven, LIND, Gasthuisberg O&N4, Leuven, Belgium.; Dotti, CG (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	bart.DeStrooper@cme.vib-kuleuven.be; cdotti@cbm.csic.es	Arranz, Amaia M/C-3776-2017; Arranz, Amaia/ACV-3437-2022; de+Strooper, Bart/Z-1638-2019; Guix, Francesc/AAA-7462-2020	Arranz, Amaia M/0000-0002-8314-7870; 	Fund for Scientific Research Flanders (FWO) grant; KU Leuven; Flemish Institute for Biotechnology (VIB); IUAP [P7/16]; Spanish Ministry of Science [SAF2010-14906]; Innovation Ingenio-Consolider [CSD2010-00045]; Spanish Ministry of Economy and Competitiveness [SAF2013-45392]; MRC [MC_PC_17116] Funding Source: UKRI; Medical Research Council [MC_PC_17116] Funding Source: researchfish	Fund for Scientific Research Flanders (FWO) grant(FWO); KU Leuven(KU Leuven); Flemish Institute for Biotechnology (VIB); IUAP; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Innovation Ingenio-Consolider; Spanish Ministry of Economy and Competitiveness(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was financially supported by Fund for Scientific Research Flanders (FWO) grant, KU Leuven, Flemish Institute for Biotechnology (VIB), IUAP (P7/16). Bart De Strooper is the Arthur Bax and Anna Vanluffelen chair for Alzheimer disease. This paper was also supported by Spanish Ministry of Science (SAF2010-14906), Innovation Ingenio-Consolider (CSD2010-00045) and Spanish Ministry of Economy and Competitiveness (SAF2013-45392) grants to Carlos G. Dotti.	Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018; Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Callaerts-Vegh Z, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00179; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Depienne C, 2011, HUM MUTAT, V32, pE1959, DOI 10.1002/humu.21373; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang SF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-306; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Marini C, 2010, NEUROLOGY, V75, P646, DOI 10.1212/WNL.0b013e3181ed9e67; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Ribeiro LF, 2014, P NATL ACAD SCI USA, V111, pE149, DOI 10.1073/pnas.1313798111; Ryan SG, 1997, NAT GENET, V17, P92, DOI 10.1038/ng0997-92; Savas JN, 2015, NEURON, V87, P764, DOI 10.1016/j.neuron.2015.08.007; Scheffer IE, 2008, BRAIN, V131, P918, DOI 10.1093/brain/awm338; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Stein V, 2003, J NEUROSCI, V23, P5503; Straub C, 2012, CURR OPIN NEUROBIOL, V22, P488, DOI 10.1016/j.conb.2011.09.005; Tang AH, 2016, NATURE, V536, P210, DOI 10.1038/nature19058; Vincent AK, 2012, CLIN GENET, V82, P540, DOI 10.1111/j.1399-0004.2011.01812.x; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wu K, 2003, NEUROSCIENCE, V116, P599, DOI 10.1016/S0306-4522(02)00567-5; Xu X, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00097; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171968	10.1371/journal.pone.0171968	http://dx.doi.org/10.1371/journal.pone.0171968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207852	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500065
J	Etxeberria, J; Goicoa, T; Lopez-Abente, G; Riebler, A; Ugarte, MD				Etxeberria, Jaione; Goicoa, Tomas; Lopez-Abente, Gonzalo; Riebler, Andrea; Dolores Ugarte, Maria			Spatial gender-age-period-cohort analysis of pancreatic cancer mortality in Spain (1990-2013)	PLOS ONE			English	Article							RATES; SUSCEPTIBILITY; TRENDS	Recently, the interest in studying pancreatic cancer mortality has increased due to its high lethality. In this work a detailed analysis of pancreatic cancer mortality in Spanish provinces was performed using recent data. A set of multivariate spatial gender-age-period-cohort models was considered to look for potential candidates to analyze pancreatic cancer mortality rates. The selected model combines features of APC (age-period-cohort) models with disease mapping approaches. To ensure model identifiability sum-to-zero constraints were applied. A fully Bayesian approach based on integrated nested Laplace approximations (INLA) was considered for model fitting and inference. Sensitivity analyses were also conducted. In general, estimated average rates by age, cohort, and period are higher in males than in females. The higher differences according to age between males and females correspond to the age groups [65, 70), [70, 75), and [75, 80). Regarding the cohort, the greatest difference between men and women is observed for those born between the forties and the sixties. From there on, the younger the birth cohort is, the smaller the difference becomes. Some cohort differences are also identified by regions and age-groups. The spatial pattern indicates a North-South gradient of pancreatic cancer mortality in Spain, the provinces in the North being the ones with the highest effects on mortality during the studied period. Finally, the space-time evolution shows that the space pattern has changed little over time.	[Etxeberria, Jaione; Goicoa, Tomas; Dolores Ugarte, Maria] Univ Publ Navarra, Dept Stat & Operat Res, Pamplona, Spain; [Etxeberria, Jaione; Goicoa, Tomas; Dolores Ugarte, Maria] Univ Publ Navarra, Inst Adv Mat, InaMat, Pamplona, Spain; [Etxeberria, Jaione] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Goicoa, Tomas] Res Network Hlth Serv Chron Dis REDISSEC, Madrid, Spain; [Lopez-Abente, Gonzalo] Inst Hlth Carlos III, Madrid, Spain; [Riebler, Andrea] Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway	Universidad Publica de Navarra; Universidad Publica de Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Norwegian University of Science & Technology (NTNU)	Ugarte, MD (corresponding author), Univ Publ Navarra, Dept Stat & Operat Res, Pamplona, Spain.; Ugarte, MD (corresponding author), Univ Publ Navarra, Inst Adv Mat, InaMat, Pamplona, Spain.	lola@unavarra.es	Etxeberria, Jaione/J-7199-2017; Ugarte, Maria Dolores/J-8834-2014; Goicoa, Tomás/J-8848-2014; Lopez-Abente, Gonzalo/E-5221-2010	Ugarte, Maria Dolores/0000-0002-3505-8400; Goicoa, Tomás/0000-0002-0588-0137; Lopez-Abente, Gonzalo/0000-0003-2423-8075; Etxeberria, Jaione/0000-0003-2415-4322	Spanish Ministry of Economy and Competitiveness [MTM 2014-51992-R]; Health Department of the Navarre Government (Project 113) [2186/2014]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Health Department of the Navarre Government (Project 113)	This work was supported by Spanish Ministry of Economy and Competitiveness (Project MTM 2014-51992-R) (Ugarte, Etxeberria, Goicoa) and Health Department of the Navarre Government (Project 113, Res.2186/2014) (Ugarte, Elm be rria, Goicoa).	BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Cabanes A, 2010, ANN ONCOL, V3, P14, DOI DOI 10.1093/ANN0NC/MDQ089; Eurostat, 2012, REV EUR STAND POP 20; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Heuer C, 1997, BIOMETRICS, V53, P161, DOI 10.2307/2533105; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Klein AP, 2012, MOL CARCINOGEN, V51, P14, DOI 10.1002/mc.20855; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Leon-Gomez B, 2016, EUR J PUBLIC HLTH; Lopez-Abente G, 2010, ANN ONCOL, V21, piii76, DOI 10.1093/annonc/mdq091; Lopez-Abente G, 2006, ATLAS MUNICIPAL MORT; Lopez-Abente G, 2015, SITUACION CANC INFOR; Lopez-Abente G, 1984, ATLAS CANC; Maisonneuve P, 2015, INT J EPIDEMIOL, V44, P186, DOI 10.1093/ije/dyu240; Papoila AL, 2014, BIOMETRICAL J, V56, P403, DOI 10.1002/bimj.201200264; Rosso T, 2016, EUROPEAN J CANC PREV; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Seoane-Mato D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-254; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	24	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169751	10.1371/journal.pone.0169751	http://dx.doi.org/10.1371/journal.pone.0169751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199327	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400009
J	Medina, JL; Brooks, EG; Chaparro, A; Dube, PH				Medina, Jorge L.; Brooks, Edward G.; Chaparro, Adriana; Dube, Peter H.			Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice	PLOS ONE			English	Article							MAST-CELLS PROTECT; IMMUNOGLOBULIN-E; VACUOLATING CYTOTOXIN; ASTHMA; INFECTION; PERTUSSIS; ALLERGY; RISK; INFLAMMATION; EPITHELIUM	Mycoplasma pneumoniae is strongly associated with new onset asthma and asthma exacerbations. Until recently, the molecular mechanisms utilized by M. pneumoniae to influence asthma symptoms were unknown. However, we recently reported that an ADP-ribosylating and vacuolating toxin called the Community Acquired Respiratory Distress Syndrome toxin, CARDS toxin, produced by M. pneumoniae was sufficient to promote allergic inflammation and asthma-like disease in mice. A mouse model of CARDS toxin exposure was used to evaluate total and CARDS-toxin specific serum IgE responses. Mast cell sensitization, challenge, and degranulation studies determined functionality of the CARDS toxin-specific IgE. In the current study, we report that a single mucosal exposure to CARDS toxin was sufficient to increase total serum IgE and CARDS toxin-specific IgE in mice. Mice given a second mucosal challenge of CARDS toxin responded with significant increases in total and CARDS toxin-specific IgE. CARDS toxin-specific IgE bound to an N-terminal peptide of CARDS toxin but not the C-terminal peptide. Likewise, full-length CARDS toxin and the N-terminal peptide induced mast cell degranulation. Altogether, these data demonstrate that exposure to CARDS toxin is sufficient to generate functional IgE in mice. M. pneumoniae and CARDS toxin are strongly associated with asthma exacerbations raising the possibility that the CARDS toxin-specific IgE-mast cell axis contributes to disease pathogenesis.	[Medina, Jorge L.; Brooks, Edward G.; Dube, Peter H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Brooks, Edward G.; Chaparro, Adriana] Univ Texas Hlth Sci Ctr San Antonio, Div Immunol & Infect Dis, Dept Pediat, San Antonio, TX 78229 USA; [Medina, Jorge L.] US Army Inst Surg Res, JBSA Ft Sam Houston, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; United States Department of Defense; United States Army	Dube, PH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Dube@uthscsa.edu			National Institutes of Health [AI070412]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health, AI070412, WWW.NIH.GOV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akinbami Lara J, 2012, NCHS Data Brief, P1; Anto JM, 2012, J ALLERGY CLIN IMMUN, V129, P943, DOI 10.1016/j.jaci.2012.01.047; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arroyave WD, 2013, J ALLER CL IMM-PRACT, V1, P501, DOI 10.1016/j.jaip.2013.06.013; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; BASEMAN JB, 1982, J BACTERIOL, V151, P1514, DOI 10.1128/JB.151.3.1514-1522.1982; Becker A, 2015, P NATL ACAD SCI USA, V112, P5165, DOI 10.1073/pnas.1420308112; Boulay ME, 2003, CURR OPIN ALLERGY CL, V3, P51, DOI 10.1097/01.all.0000053268.39029.19; Burks ML, 2013, ANN ALLERG ASTHMA IM, V111, P14, DOI 10.1016/j.anai.2013.05.008; Capili CR, 2012, J ALLERGY CLIN IMMUN, V129, P957, DOI 10.1016/j.jaci.2011.11.020; Darveaux JI, 2014, J ALLER CL IMM-PRACT, V2, P658, DOI 10.1016/j.jaip.2014.09.011; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Dema B, 2014, DISCOV MED, V17, P247; Dema B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090424; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Feldman AS, 2015, AM J RESP CRIT CARE, V191, P34, DOI 10.1164/rccm.201405-0901PP; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Graham AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00238; Graham AC, 2013, J IMMUNOL, V190, P4676, DOI 10.4049/jimmunol.1202096; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hardy RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007562; Holgate ST, 2006, J ALLERGY CLIN IMMUN, V118, P587, DOI 10.1016/j.jaci.2006.06.023; Holgate ST, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-17; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Jain S, 2015, NEW ENGL J MED, V373, P2382; Jensen Bettina M, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0323s74; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022877; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kannan TR, 2010, MOL MICROBIOL, V76, P1127, DOI 10.1111/j.1365-2958.2010.07092.x; Kannan TR, 2014, MOL MICROBIOL, V93, P568, DOI 10.1111/mmi.12680; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kennedy JL, 2012, CLIN EXP ALLERGY, V42, P659, DOI 10.1111/j.1365-2222.2011.03944.x; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Medina JL, 2012, AM J RESP CELL MOL B; Medina JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102613; Michels NM, 2010, CLIN EXP ALLERGY, V40, P1406, DOI 10.1111/j.1365-2222.2010.03488.x; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; MU HH, 1993, INFECT IMMUN, V61, P2834, DOI 10.1128/IAI.61.7.2834-2840.1993; MUNOZ JJ, 1990, CELL IMMUNOL, V127, P327, DOI 10.1016/0008-8749(90)90136-F; Munoz S, 2003, J IMMUNOL, V170, P5590, DOI 10.4049/jimmunol.170.11.5590; NAGAYAMA Y, 1987, J ASTHMA, V24, P159, DOI 10.3109/02770908709070932; Peters J, 2011, CHEST; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Sauteur PMM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00329; SEKIYA K, 1983, MICROBIOL IMMUNOL, V27, P905, DOI 10.1111/j.1348-0421.1983.tb00656.x; Sohn MH, 2012, ALLERGY ASTHMA IMMUN, V4, P264, DOI 10.4168/aair.2012.4.5.264; Starkl P, 2015, J ALLERGY CLIN IMMUN, DOI [10.1186/1939-4551-7-17, DOI 10.1186/1939-4551-7-17]; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wood PR, 2013, ANN ALLERG ASTHMA IM, V110, P328, DOI 10.1016/j.anai.2013.01.022; Wu LC, 2011, J BIOL CHEM, V286, P32891, DOI 10.1074/jbc.R110.205104; Xu X, 2006, AM J RESP CRIT CARE, V173, P219, DOI 10.1164/rccm.200507-1034OC; Yeh JJ, 2015, J ALLERGY CLIN IMMUN	64	12	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172447	10.1371/journal.pone.0172447	http://dx.doi.org/10.1371/journal.pone.0172447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199385	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400092
J	Neulen, A; Pantel, T; Kosterhon, M; Kirschner, S; Brockmann, MA; Kantelhardt, SR; Giese, A; Thal, SC				Neulen, Axel; Pantel, Tobias; Kosterhon, Michael; Kirschner, Stefanie; Brockmann, Marc A.; Kantelhardt, Sven R.; Giese, Alf; Thal, Serge C.			A segmentation-based volumetric approach to localize and quantify cerebral vasospasm based on tomographic imaging data	PLOS ONE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; GLA PROTEIN-DEFICIENCY; ARTERIOVENOUS-MALFORMATIONS; CT ANGIOGRAPHY; MICE; MANAGEMENT; DIAGNOSIS; ISCHEMIA; VESSELS; MODEL	Introduction Quantification of cerebral vasospasm after subarachnoid hemorrhage (SAH) is crucial in animal studies as well as clinical routine. We have developed a method for computer-based volumetric assessment of intracranial blood vessels from cross-sectional imaging data. Here we demonstrate the quantification of vasospasm from micro computed tomography (micro-CT) data in a rodent SAH model and the transferability of the volumetric approach to clinical data. Methods We obtained rodent data by performing an ex vivo micro-CT of murine brains after sham surgery or SAH by endovascular filament perforation on day 3 post hemorrhage. Clinical CT angiography (CTA) was performed for diagnostic reasons unrelated to this study. We digitally reconstructed and segmented intracranial vascular trees, followed by calculating volumes of defined vessel segments by standardized protocols using Amira r software. Results SAH animals demonstrated significantly smaller vessel diameters compared with sham (MCA: 134.4 +/- 26.9 mu m vs. 165.0 +/- 18.7 mu m, p< 0.05). We could highlight this difference by analyzing vessel volumes of a defined MCA-ICA segment (SAH: 0.044 +/- 0.017 mu l vs. sham: 0.07 +/- 0.006 mu l, p<0.001). Analysis of clinical CTA data allowed us to detect and volumetrically quantify vasospasm in a series of 5 SAH patients. Vessel diameters from digital reconstructions correlated well with those measured microscopically (rodent data, correlation coefficient 0.8, p<0.001), or angiographically (clinical data, 0.9, p<0.001). Conclusions Our methodological approach provides accurate anatomical reconstructions of intracranial vessels from cross-sectional imaging data. It allows volumetric assessment of entire vessel segments, hereby highlighting vasospasm-induced changes objectively in a murine SAH model. This method could also be a helpful tool for analysis of clinical CTA.	[Neulen, Axel; Pantel, Tobias; Kosterhon, Michael; Kantelhardt, Sven R.; Giese, Alf] Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany; [Kirschner, Stefanie; Brockmann, Marc A.] Univ Med Ctr Mainz, Dept Neuroradiol, Mainz, Germany; [Thal, Serge C.] Univ Med Ctr Mainz, Dept Anesthesiol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Neulen, A (corresponding author), Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany.; Thal, SC (corresponding author), Univ Med Ctr Mainz, Dept Anesthesiol, Mainz, Germany.	axel.neulen@unimedizin-mainz.de; thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Neulen, Axel/0000-0003-3547-1630	Friedhelm Frees Stiftung; Stiftung Neurochirurgische Forschung	Friedhelm Frees Stiftung; Stiftung Neurochirurgische Forschung	The study was supported by the Friedhelm Frees Stiftung (http://www.unimedizin-mainz.de/friedhelmfreesstiftung/) and by the Stiftung Neurochirurgische Forschung (http://www.dgnc.de/mitgliederbereich/stipendien-stiftungen/stiftungen/neurochirurgische-forschung/stiftung.html) (grants to A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay T, 2009, J NEUROSCI METH, V183, P136, DOI 10.1016/j.jneumeth.2009.06.027; Beseoglu Kerim, 2015, Acta Neurochir Suppl, V120, P35, DOI 10.1007/978-3-319-04981-6_6; Chaudhary SR, 2008, CEREBROVASC DIS, V25, P144, DOI 10.1159/000112325; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Felix MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126246; Figueiredo G, 2012, CLIN NEURORADIOL, V22, P21, DOI 10.1007/s00062-011-0113-2; Froehler MT, 2010, J CLIN NEUROSCI, V17, P1169, DOI 10.1016/j.jocn.2010.04.014; Ghanavati S, 2014, NEUROIMAGE, V95, P117, DOI 10.1016/j.neuroimage.2014.03.044; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; Kamp MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114946; Kerl HU, 2011, J COMPUT ASSIST TOMO, V35, P517, DOI 10.1097/RCT.0b013e31821c662b; Laslo AM, 2006, AM J NEURORADIOL, V27, P624; Lin CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151772; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Momin EN, 2009, NEUROSURGERY, V65, P937, DOI 10.1227/01.NEU.0000356974.14230.B8; Murphy PA, 2014, P NATL ACAD SCI USA, V111, P18007, DOI 10.1073/pnas.1415316111; Otawara Y, 2002, NEUROSURGERY, V51, P939, DOI 10.1097/00006123-200210000-00015; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wilson CD, 2014, CAN J NEUROL SCI, V41, P314, DOI 10.1017/S031716710001725X; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Xie BH, 2012, TRANSL STROKE RES, V3, pS174, DOI 10.1007/s12975-012-0164-y; Yao YC, 2013, P NATL ACAD SCI USA, V110, P19071, DOI 10.1073/pnas.1310905110; Yao YC, 2011, J CLIN INVEST, V121, P2993, DOI 10.1172/JCI57567	31	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172010	10.1371/journal.pone.0172010	http://dx.doi.org/10.1371/journal.pone.0172010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199398	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400066
J	Sama, CB; Feteh, VF; Tindong, M; Tanyi, JT; Bihle, NM; Angwafo, FF				Sama, Carlson-Babila; Feteh, Vitalis F.; Tindong, Maxime; Tanyi, John T.; Bihle, Nestor Mbinkar; Angwafo, Fru F., III			Prevalence of maternal HIV infection and knowledge on mother-to-child transmission of HIV and its prevention among antenatal care attendees in a rural area in northwest Cameroon	PLOS ONE			English	Article							INFANTS	Background In 2010, an estimated 141 new HIV infections occurred per day in Cameroon and reports suggest an upsurge of these rates by 2020 if current trends continue. Mother to child transmission (MTCT) of HIV is a major public health challenge, and maternal knowledge on HIV transmission during pregnancy and its prevention is important in curtailing paediatric HIV acquisition. Objectives We aimed at establishing the prevalence of maternal HIV infection as well as assessing knowledge on HIV, MTCT and prevention of MTCT (PMTCT) of HIV among pregnant women in a rural area of Cameroon. Methods This study was conducted in two phases: a 29 month retrospective analysis of 1866 deliveries within three rural health facilities in the Babessi sub division, Northwest Cameroon and a 1 month prospective phase wherein 150 consenting pregnant women attending antenatal care (ANC) at the study centres were consecutively recruited. Results Overall, the prevalence of maternal HIV infection was 5.0% (100/2016). All (100%) of the interviewed pregnant women were aware of HIV infection and most (76.7%) had adequate knowledge on its routes of transmission. Meanwhile, only 79.3% (119/150) of them were aware of MTCT with slightly above a third (37.0%) having adequate knowledge on the periods of transmission. The proportions of women correctly stating: during pregnancy, during labour/delivery and during breastfeeding as possible periods of MTCT of HIV were 63.0%, 60.5% and 89.1% respectively. A majority (76.3%) of these women had inadequate knowledge on PMTCT of HIV. Conclusion The overall prevalence of maternal HIV warrants strengthening of current intervention strategies including scaling up of PMTCT measures. Among others, intensification of HIV related ANC services to improve the pregnant women's awareness and knowledge on MTCT and its prevention are vital steps in curbing the growing burden of paediatric HIV.	[Sama, Carlson-Babila] Islamic Medicalized Hlth Ctr, Babessi, Northwest Regio, Cameroon; [Sama, Carlson-Babila; Tindong, Maxime; Bihle, Nestor Mbinkar] GCRG, Buea, Southwest Regio, Cameroon; [Feteh, Vitalis F.] Mboppi Baptist Hosp Douala, Douala, Cameroon; [Feteh, Vitalis F.; Tindong, Maxime] Hlth & Human Dev 2HD Res Grp, Douala, Cameroon; [Tindong, Maxime] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Tanyi, John T.] Konye Subdiv Hosp, Konye, Southwest Regio, Cameroon; [Bihle, Nestor Mbinkar] Babessi Subdiv Hosp, Babessi, Northwest Regio, Cameroon; [Angwafo, Fru F., III] Gynaecoobstet & Paediat Hosp, Yaounde, Cameroon; [Angwafo, Fru F., III] Univ Teaching Hosp, Dept Surg, Yaounde, Cameroon	Universite Libre de Bruxelles	Sama, CB (corresponding author), Islamic Medicalized Hlth Ctr, Babessi, Northwest Regio, Cameroon.; Sama, CB (corresponding author), GCRG, Buea, Southwest Regio, Cameroon.	sama.carlson@yahoo.com		Feteh, Vitalis Fambombi/0000-0001-7072-7422; Tanyi, John/0000-0001-5438-1599				[Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], 2010, PMTCT STRAT VIS 2010; [Anonymous], 2010, ARCADIS GEOTECNIA RE, P1; Asefa A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-66; Awungafac G, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.20.5137; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Birhane T, 2015, J PREGNANCY, V2015, DOI 10.1155/2015/960830; Byamugisha R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-52; Egbe TO, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/7397695; Ezechi O. C., 2004, Tropical Journal of Obstetrics and Gynaecology, V21, P164; Hussein M, 2011, ETHIOP J HEALTH SCI, V21, P1; Igwegbe A O, 2005, Niger J Clin Pract, V8, P97; Koye DN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-398; Lamina MA, 2012, OPEN J OBSTET GYNECO, V2, P98, DOI DOI 10.4236/ojog.2012.22019; Malaju MT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-73; Manyahi J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1848-5; MINSANTE-CNLS Cameroun, 2012, RAPP NAT SUIV DECL P; National AIDS Control Committee (NACC), RAPP ANN 2014 ACT LU; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nguefack HLN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1336-2; UNAIDS, CAM DEM HLTH SURV DH; Wudineh F, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/3262746; Zoung-Kanyi Bissek Anne-Cirenecile, 2011, Open AIDS J, V5, P25, DOI 10.2174/1874613601105010025	23	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172102	10.1371/journal.pone.0172102	http://dx.doi.org/10.1371/journal.pone.0172102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199373	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400071
J	Kijak, E; Pyza, E				Kijak, Ewelina; Pyza, Elzbieta			TOR signaling pathway and autophagy are involved in the regulation of circadian rhythms in behavior and plasticity of L2 interneurons in the brain of Drosophila melanogaster	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE-AKT-MAMMALIAN TARGET; LONG-TERM POTENTIATION; 1ST OPTIC NEUROPIL; VISUAL-SYSTEM; EXPRESSION; ACTIVATION; INDUCTION; LAMINA; GROWTH; CLOCK	Drosophila melanogaster is a common model used to study circadian rhythms in behavior and circadian clocks. However, numerous circadian rhythms have also been detected in non-clock neurons, especially in the first optic neuropil (lamina) of the fly's visual system. Such rhythms have been observed in the number of synapses and in the structure of interneurons, which exhibit changes in size and shape in a circadian manner. Although the patterns of these changes are known, the mechanism remains unclear. In the present study, we investigated the role of the TOR signaling pathway and autophagy in regulating circadian rhythms based on the behavior and structural plasticity of the lamina L2 monopolar cell dendritic trees. In addition, we examined the cyclic expression of the TOR signaling pathway (Tor, Pi3K class 1, Akt1) and autophagy (Atg5 and Atg7) genes in the fly's brain. We observed that Tor, Atg5 and Atg7 exhibit rhythmic expressions in the brain of wild-type flies in day/night conditions (LD 12: 12) that are abolished in per 01 clock mutants. The silencing of Tor in per expressing cells shortens a period of the locomotor activity rhythm of flies. In addition, silencing of the Tor and Atg5 genes in L2 cells disrupts the circadian plasticity of the L2 cell dendritic trees measured in the distal lamina. In turn, silencing of the Atg7 gene in L2 cells changes the pattern of this rhythm. Our results indicate that the TOR signaling pathway and autophagy are involved in the regulation of circadian rhythms in the behavior and plasticity of neurons in the brain of adult flies.	[Kijak, Ewelina; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Krakow, Poland	Jagiellonian University	Pyza, E (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Krakow, Poland.	elzbieta.pyza@uj.edu.pl			Polish National Science Centre [DEC-2 011/03/N/NZ/01250]; The Polish Ministry of Science and High Education [3118/7.PR/2014/2]	Polish National Science Centre; The Polish Ministry of Science and High Education	This study was supported by the Polish National Science Centre based on award No DEC-2 011/03/N/NZ/01250 to EK and by The Polish Ministry of Science and High Education grant no 3118/7.PR/2014/2 to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban BK, 2013, MOL CELL BIOL, V33, P3907, DOI 10.1128/MCB.00627-13; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Damulewicz M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00353, 10.3389/fncel.2075.00353]; Damulewicz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073690; Damulewicz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021258; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Gorska-Andrzejak J, 2015, CURR OPIN INSECT SCI, V7, P76, DOI 10.1016/j.cois.2015.01.005; Gorska-Andrzejak J, 2013, DEV NEUROBIOL, V73, P14, DOI 10.1002/dneu.22032; Gorska-Andrzejak J, 2009, J INSECT PHYSIOL, V55, P459, DOI 10.1016/j.jinsphys.2009.02.003; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kula E, 2007, DEV NEUROBIOL, V67, P1433, DOI 10.1002/dneu.20518; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Ma D, 2012, TRENDS ENDOCRIN MET, V23, P319, DOI 10.1016/j.tem.2012.03.004; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Parisi F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-65; Pyza E, 2002, MICROSC RES TECHNIQ, V58, P335, DOI 10.1002/jemt.10141; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 2008, ACTA NEUROBIOL EXP, V68, P322; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rowland AM, 2006, J NEUROSCI, V26, P1711, DOI 10.1523/JNEUROSCI.2279-05.2006; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Tataroglu O, 2015, CURR OPIN INSECT SCI, V7, P51, DOI 10.1016/j.cois.2015.01.002; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Weber P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004290; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zheng XZ, 2010, CURR BIOL, V20, P1203, DOI 10.1016/j.cub.2010.05.027	43	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171848	10.1371/journal.pone.0171848	http://dx.doi.org/10.1371/journal.pone.0171848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196106	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900036
J	Long, Y; Liu, L				Long, Ying; Liu, Liu			How green are the streets? An analysis for central areas of Chinese cities using Tencent Street View	PLOS ONE			English	Article							URBAN STREET; NEIGHBORHOODS	Extensive evidence has revealed that street greenery, as a quality-of-life component, is important for oxygen production, pollutant absorption, and urban heat island effect mitigation. Determining how green our streets are has always been difficult given the time and money consumed using conventional methods. This study proposes an automatic method using an emerging online street-view service to address this issue. This method was used to analyze street greenery in the central areas (28.3 km(2) each) of 245 major Chinese cities; this differs from previous studies, which have investigated small areas in a given city. Such a city-system-level study enabled us to detect potential universal laws governing street greenery as well as the impact factors. We collected over one million Tencent Street View pictures and calculated the green view index for each picture. We found the following rules: (1) longer streets in more economically developed and highly administrated cities tended to be greener; (2) cities in western China tend to have greener streets; and (3) the aggregated green view indices at the municipal level match with the approved National Garden Cities of China. These findings can prove useful for drafting more appropriate policies regarding planning and engineering practices for street greenery.	[Long, Ying] Tsinghua Univ, Sch Architecture, Beijing, Peoples R China; [Long, Ying] Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing, Peoples R China; [Liu, Liu] China Acad Urban Planning & Design, Shanghai, Peoples R China	Tsinghua University; Tsinghua University	Long, Y (corresponding author), Tsinghua Univ, Sch Architecture, Beijing, Peoples R China.; Long, Y (corresponding author), Tsinghua Univ, Hang Lung Ctr Real Estate, Beijing, Peoples R China.	ylong@tsinghua.edu.cn	LONG, YING/AAG-4329-2021; Liu, Liu/GXA-0581-2022	Liu, Liu/0000-0003-0100-9763; Long, Ying/0000-0002-8657-6988	National Natural Science Foundation of China [51408039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The first author would like to acknowledge the funding of the National Natural Science Foundation of China (No. 51408039).	Aoki Y., 1987, J JPN I LANDSC ARCHI, V51, P1, DOI [DOI 10.5632/JILA1934.51.1, 10.5632/jila1934.51.1]; Badrinarayanan V., 2015, ARXIV; Batty M, 2012, CITIES, V29, pS9, DOI 10.1016/j.cities.2011.11.008; BLODGETT G, 1976, J AM HIST, V62, P869, DOI 10.2307/1903842; Carrasco-Hernandez R, 2015, ENERG BUILDINGS, V86, P340, DOI 10.1016/j.enbuild.2014.10.001; FABOS JG, 1995, LANDSCAPE URBAN PLAN, V33, P1, DOI 10.1016/0169-2046(95)02035-R; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Frome A, 2009, IEEE I CONF COMP VIS, P2373, DOI 10.1109/ICCV.2009.5459413; Gatta C, 2014, IEEE COMPUT SOC CONF, P504, DOI 10.1109/CVPRW.2014.80; Gupta S, 2013, PROC CVPR IEEE, P564, DOI 10.1109/CVPR.2013.79; Hara K., 2013, P SIGCHI C HUMAN FAC, P631, DOI [10.1145/2470654.2470744, DOI 10.1145/2470654.2470744]; Howard E., 2010, MORROW PEACEFUL PATH; Hwang J, 2014, AM SOCIOL REV, V79, P726, DOI 10.1177/0003122414535774; Kelly CM, 2013, ANN BEHAV MED, V45, pS108, DOI 10.1007/s12160-012-9419-9; Li X., 2016, ENVIRONMENTAL INEQUI; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P751, DOI 10.1016/j.ufug.2015.07.006; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P675, DOI 10.1016/j.ufug.2015.06.006; Liu L., 2014, C IMAGE CITY COGNITI; Liu M. Y., 2015, ARXIV PREPRINT ARXIV; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; Liu XJ, 2015, CITIES, V47, P53, DOI 10.1016/j.cities.2015.03.006; Long Y., 2015, GEOSPATIAL ANAL SUPP, DOI [10.1007/978-3-319-19342-7_10, DOI 10.1007/978-3-319-19342-7_10]; Lynch K, 1960, IMAGE CITY, V11; NASAR JL, 1984, J CROSS CULT PSYCHOL, V15, P79, DOI 10.1177/0022002184015001005; Neumann L, 2012, PROC CVPR IEEE, P3538, DOI 10.1109/CVPR.2012.6248097; Odgers CL, 2012, J CHILD PSYCHOL PSYC, V53, P1009, DOI 10.1111/j.1469-7610.2012.02565.x; Ohno R., 1991, HLTH ENV, P237; Ohno R., 2000, THEORETICAL PERSPECT, P149; Pugh TAM, 2012, ENVIRON SCI TECHNOL, V46, P7692, DOI 10.1021/es300826w; Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034; Saw LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133781; Shashua-Bar L, 2000, ENERG BUILDINGS, V31, P221, DOI 10.1016/S0378-7788(99)00018-3; Torii Akihiko, 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P2188, DOI 10.1109/ICCVW.2009.5457551; Yang J, 2009, LANDSCAPE URBAN PLAN, V91, P97, DOI 10.1016/j.landurbplan.2008.12.004; Zamir A. R., 2011, Proceedings of the 2011 Tenth International Conference on Machine Learning and Applications (ICMLA 2011), P380, DOI 10.1109/ICMLA.2011.181	35	94	101	18	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171110	10.1371/journal.pone.0171110	http://dx.doi.org/10.1371/journal.pone.0171110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196071	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900012
J	Wu, CL; Kor, CT; Chiu, PF; Tsai, CC; Lian, IB; Yang, TH; Tarng, DC; Chang, CC				Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Tsai, Chun-Chieh; Lian, Ie-Bin; Yang, Tao-Hsiang; Tarng, Der-Cherng; Chang, Chia-Chu			Long-term renal outcomes in patients with traumatic brain injury: A nationwide population-based cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; HEAD-INJURY; DEATH; TAIWAN; SYSTEM	Background Traumatic brain injury (TBI) is an important cause of death and disability worldwide. The relationship between TBI and kidney diseases is largely unknown. Methods We aimed to determine whether TBI is associated with long-term adverse renal outcomes. We performed a nationwide, population-based, propensity score-matched cohort study of 32,152 TBI patients and 128,608 propensity score-matched controls. Data were collected by the National Health Insurance Research Database of Taiwan from 2000 to 2012. Our clinical outcomes were chronic kidney disease (CKD), end-stage renal disease (ESRD) and the composite endpoint of ESRD or all-cause mortality. Results The incidence rate of CKD was higher in the TBI than in the control cohort (8.99 vs. 7.4 per 1000 person-years). The TBI patients also showed higher risks of CKD (adjusted hazard ratio [aHR] 1.14, 95% confidence interval [CI] 1.08-1.20; P < 0.001) and composite endpoints (aHR 1.08, 95% CI 1.01-1.15; P = 0.022) than the control groups, but the ESRD was not significantly different between the groups. In subgroup analyses, the risks of incident CKD and composite endpoints were significantly raised in TBI patients aged < 65 years and/ or without comorbidities. However, the risks of both CKD and composite outcome were little affected by the severity of TBI. Conclusions TBI has a modest but significant effect on incident CKD and composite endpoint, but not on ESRD alone. TBI patients under 65 are at greater risk of CKD and composite outcome than their older counterparts.	[Wu, Chia-Lin; Chiu, Ping-Fang; Tsai, Chun-Chieh; Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Wu, Chia-Lin; Chiu, Ping-Fang; Tsai, Chun-Chieh; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Wu, Chia-Lin; Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan; [Lian, Ie-Bin] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Physiol, Taipei, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; National Changhua University of Education; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, CC (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan.; Tarng, DC (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei, Taiwan.	dctarng@vghtpe.gov.tw; 27509@cch.org.tw	Lian, Ie-Bin/AAE-3368-2021; Wu, Chia-Lin/V-8888-2017	Wu, Chia-Lin/0000-0001-6045-6956; Lian, Ie-bin/0000-0003-3992-6049	Changhua Christian Hospital Research Foundation [104-CCH-IRP-010]	Changhua Christian Hospital Research Foundation	This study was funded by grants 104-CCH-IRP-010 from the Changhua Christian Hospital Research Foundation.	[Anonymous], 2015, 2015 USRDS ANN DAT R; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Herijgers P, 1996, TRANSPLANTATION, V62, P330, DOI 10.1097/00007890-199608150-00005; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Levin A, 2001, NEPHROL DIAL TRANSPL, V16, P57, DOI 10.1093/ndt/16.suppl_7.57; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lin JW, 2008, ACT NEUR S, V101, P113; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Morariu AM, 2008, AM J TRANSPLANT, V8, P933, DOI 10.1111/j.1600-6143.2008.02166.x; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Sanchez-Fructuoso AI, 2004, TRANSPLANTATION, V78, P142, DOI 10.1097/01.TP.0000134769.65550.70; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SIPKINS JH, 1981, NEPHRON, V28, P36, DOI 10.1159/000182092; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131; Wu CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158533; Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	30	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171999	10.1371/journal.pone.0171999	http://dx.doi.org/10.1371/journal.pone.0171999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196132	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900041
J	Cortez, V; Verdu, JR; Ortiz, AJ; Halffter, G				Cortez, Vieyle; Verdu, Jose R.; Ortiz, Antonio J.; Halffter, Gonzalo			Identification and evaluation of semiochemicals for the biological control of the beetle Omorgus suberosus (F.) (Coleoptera: Trogidae), a facultative predator of eggs of the sea turtle Lepidochelys olivacea (Eschscholtz)	PLOS ONE			English	Article							MALE DUNG BEETLE; EAD-ACTIVE CONSTITUENTS; OLIVE RIDLEY TURTLE; ANAL-SAC SECRETION; ATTRACTING SECRETION; AGGREGATION PHEROMONE; INFECTED CHICKENS; HATCHING SUCCESS; SCARABAEINAE; VIRUS	The beetle Omorgus suberosus (F.) is a facultative predator of eggs of the olive ridley turtle Lepidochelys olivacea (Eschscholtz). Laboratory and field investigations were conducted in order to characterize volatile attractants of 0. suberosus and to explore the potential for application of these volatiles in a selective mass trapping method. Headspace sorptive extraction (HSSE) coupled to thermo-desorption gas chromatography mass spectrometry (TD-GC-MS) analysis of the volatile constituents from beetles or turtle nests revealed 24 potential compounds. However, electroantennographic (EAG) measurements revealed antennal sensitivity only to indole, linoleic acid, trimethylamine, dimethyl sulphide, dimethyl disulphide and ammonia. Behavioural tests showed that these compounds are highly attractive to O. suberosus. Field trapping experiments revealed that indole and ammonia were more attractive than the other volatile compounds and showed similar attractiveness to that produced by conventional baits (chicken feathers). The use of a combined bait of indole and NH3 would therefore be the most effective trap design. The data presented are the first to demonstrate effective massive capture of O. suberosus using an attractant-based trapping method. These findings have potential for the development of an efficient mass trapping method for control of this beetle as part of efforts towards conservation of L. olivacea at La Escobilla in Oaxaca, Mexico.	[Cortez, Vieyle; Verdu, Jose R.] Univ Alicante, IUI CIBIO, Alicante, Spain; [Ortiz, Antonio J.] Univ Jaen, EPS Linares, Dept Quim Inorgan & Quim Organ, Linares, Spain; [Halffter, Gonzalo] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico	Universitat d'Alacant; Universidad de Jaen; Instituto de Ecologia - Mexico	Verdu, JR (corresponding author), Univ Alicante, IUI CIBIO, Alicante, Spain.	jr.verdu@ua.es	Halffter, Gonzalo/R-3652-2018; Verdú, José/F-8269-2010; Gallardo, Vieyle Cortez/L-4692-2014	Verdú, José/0000-0002-0805-8341; Gallardo, Vieyle Cortez/0000-0003-0217-3899	Programa de Conservacion de Especies en Riesgo (PROCER); Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP); National Commission for Protected Natural Areas (CONANP Mexico); INECOL A.G.	Programa de Conservacion de Especies en Riesgo (PROCER); Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP); National Commission for Protected Natural Areas (CONANP Mexico); INECOL A.G.	The study was funded by the Programa de Conservacion de Especies en Riesgo (PROCER) and the Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP) to GH. We are also grateful to INECOL A.G. for financial support awarded to GH. This research was fully funded by the National Commission for Protected Natural Areas (CONANP Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois A., LEPIDOCHELYS OLIVACE; Allgower K, 1979, INF ESTAC CI CH DARW, P152; [Anonymous], 1992, THREATENED BIRDS AM; Baena ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139538; BANKS GR, 1992, Z NATURFORSCH C, V47, P618; Bartelt RJ, 2009, J CHEM ECOL, V35, P422, DOI 10.1007/s10886-009-9611-y; Bernardo Joseph, 2007, P58; BirdLife International, 2012, BUT ALB IUCN RED LIS, V2012; BirdLife International, 2012, ACC STRAIT, V2012; BirdLife International, 2014, AUL PRAS IUCN RED LI, V2014; Burger BV, 2008, J CHROMATOGR A, V1186, P245, DOI 10.1016/j.chroma.2007.09.041; BURGER BV, 1983, Z NATURFORSCH C, V38, P848; Burger BV, 2002, J CHEM ECOL, V28, P2527, DOI 10.1023/A:1021440220329; Burger BV, 2002, J CHEM ECOL, V28, P501, DOI 10.1023/A:1014583826875; Clarke KR, 2008, PRIMER 6 USER MANUAL; Cortez V, 2015, CHEMOECOLOGY, V25, P201, DOI 10.1007/s00049-015-0189-2; Cortez Vieyle, 2013, Cuadernos de Biodiversidad, V41, P16; Davidson I, 2009, BRAZ J POULTRY SCI, V11, P139, DOI 10.1590/S1516-635X2009000300001; DAVIS CJ, 1967, P HAWAII ENTOMOL SOC, V19, P375; Donlan EM, 2004, CARIBB J SCI, V40, P415; Emden F. I. van., 1948, Proceedings of the Royal Entomological Society of London (B), V17, P145; FOWLER LE, 1979, ECOLOGY, V60, P946, DOI 10.2307/1936863; Gitau CW, 2013, FOREST ECOL MANAG, V297, P1, DOI 10.1016/j.foreco.2013.02.019; Gorley C.K., 2006, GETTING STARTED PRIM; Harfush M, 2008, P 25 ANN S SEA TURTL, P89; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; HONDA K, 1982, APPL ENTOMOL ZOOL, V17, P325, DOI 10.1303/aez.17.325; HOOP RK, 1992, AVIAN PATHOL, V21, P493, DOI 10.1080/03079459208418867; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; Lopez-Castro MC, 2004, MAR BIOL, V145, P811, DOI 10.1007/s00227-004-1359-x; Lopez-Reyes E, 2000, P 20 ANN S SEA TURTL, P477; Marquez R, 1996, MARINE TURTLE NEWSLE, V75, P5; MASON RT, 1990, J CHEM ECOL, V16, P27, DOI 10.1007/BF01021265; Morgan ED, 2003, J CHEM ECOL, V29, P95, DOI 10.1023/A:1021928630441; Nuradji H, 2015, J VET DIAGN INVEST, V27, P704, DOI 10.1177/1040638715611443; Ocana M., 2012, Endangered Species Research, V16, P45, DOI 10.3354/esr00388; Ortius-Lechner D, 2000, J CHEM ECOL, V26, P1667, DOI 10.1023/A:1005543030518; PALESTRINI C, 1992, B ZOOL, V59, P69, DOI 10.1080/11250009209386650; Plotkin PT, 1997, J HERPETOL, V31, P17, DOI 10.2307/1565323; Podskalska H, 2009, ENTOMOL EXP APPL, V132, P59, DOI 10.1111/j.1570-7458.2009.00871.x; RAYMER J, 1985, J CHEM ECOL, V11, P593, DOI 10.1007/BF00988570; Rosano-Hernández María C., 2002, Acta Zool. Mex, P29; Sarles L, 2015, CROP PROT, V78, P114, DOI 10.1016/j.cropro.2015.09.001; Schat KA, 2008, DIS POULTRY, P449; Shanker K, 2004, BIOL CONSERV, V115, P149, DOI 10.1016/S0006-3207(03)00104-6; Singh N, 2012, J ECON ENTOMOL, V105, P2196, DOI 10.1603/EC11422; Soini HA, 2005, J CHEM ECOL, V31, P1125, DOI 10.1007/s10886-005-4252-2; Soini HA, 2012, J CHEM ECOL, V38, P145, DOI 10.1007/s10886-012-0075-0; SPENCER JL, 1983, AVIAN PATHOL, V12, P85, DOI 10.1080/03079458308436151; Stavert JR, 2014, ECOL ENTOMOL, V39, P556, DOI 10.1111/een.12133; Swayne D.E., 2008, DIS POULTRY, P153; Tribe G.D., 2011, P87; Valverde RA, 2012, CHELONIAN CONSERV BI, V11, P1; Verdu JR, 2007, ANIM BEHAV, V74, P1697, DOI 10.1016/j.anbehav.2007.03.016; von Hoermann C, 2011, FORENSIC SCI INT, V212, P173, DOI 10.1016/j.forsciint.2011.06.009; Yamamoto Y, 2007, AVIAN DIS, V51, P52, DOI 10.1637/0005-2086(2007)051[0052:SNEWMA]2.0.CO;2; Zarate P, 2013, AQUAT BIOL, V19, P217, DOI 10.3354/ab00534; Zito P, 2014, CHEMOECOLOGY, V24, P261, DOI 10.1007/s00049-014-0169-y	58	6	6	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172015	10.1371/journal.pone.0172015	http://dx.doi.org/10.1371/journal.pone.0172015			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192472	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800059
J	Li, YR; Geary, DC				Li, Yaoran; Geary, David C.			Children's visuospatial memory predicts mathematics achievement through early adolescence	PLOS ONE			English	Article							LEARNING-DISABILITY; PRECOCIOUS YOUTH; WORKING-MEMORY; SPATIAL SKILLS; PRIMARY-SCHOOL; INTELLIGENCE; ABILITY	A previous study showed that gains in visuospatial memory from first to fifth grade predicted end-of-fifth grade mathematics but not reading achievement, controlling other factors. In this follow up study, these relations were assessed from sixth to ninth grade, inclusive (n = 145). The results showed that growth in visuospatial memory across the elementary school years was related to growth in mathematics achievement after fifth grade, controlling intelligence, the central executive and phonological memory components of working memory, in-class attentive behavior, parental education, and fifth grade mathematics achievement. As found for fifth grade, this relation was not found for reading achievement after fifth grade. In total, the results suggest that visuospatial memory has a unique influence on ease of learning some types of mathematics and that this influence becomes more important across successive grades.	[Li, Yaoran] Univ San Diego, Inst Entrepreneurship Educ, San Diego, CA 92110 USA; [Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Geary, David C.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO 65211 USA	University of San Diego; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Geary, DC (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.; Geary, DC (corresponding author), Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO 65211 USA.	GearyD@Missouri.edu		Geary, David/0000-0003-3029-6343	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD38283, R37 HD045914]; National Science Foundation [DRL-1250359]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants R01 HD38283 and R37 HD045914 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and DRL-1250359 from the National Science Foundation.	Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bull R, 2014, CHILD DEV PERSPECT, V8, P36, DOI 10.1111/cdep.12059; Casey MB, 1997, DEV PSYCHOL, V33, P669, DOI 10.1037/0012-1649.33.4.669; Chu FW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00775; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Fuchs LS, 2006, J EDUC PSYCHOL, V98, P29, DOI 10.1037/0022-0663.98.1.29; Fuchs LS, 2016, CHILD DEV; Fuchs LS, 2016, CHILD DEV, V87, P558, DOI 10.1111/cdev.12474; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; GEARY DC, 1987, J EXP PSYCHOL GEN, V116, P154, DOI 10.1037/0096-3445.116.2.154; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, J ED PSYCHO IN PRESS; JOHNSON ES, 1984, J EDUC PSYCHOL, V76, P1359, DOI 10.1037/0022-0663.76.6.1359; Kell HJ, 2013, PSYCHOL SCI, V24, P1831, DOI 10.1177/0956797613478615; Kyttala M, 2008, EUR J PSYCHOL EDUC, V23, P77, DOI 10.1007/BF03173141; Lee K, 2016, J ED PSYCHOL; Li YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070160; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Mazzocco MMM, 2003, ANN DYSLEXIA, V53, P218, DOI 10.1007/s11881-003-0011-7; Mix KS, 2012, ADV CHILD DEV BEHAV, V42, P197; Pickering S., 2001, WORKING MEMORY TEST; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Swanson J. M., 2008, CATEGORICAL DIMENSIO; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; Van de Weijer-Bergsma E, 2015, MEM COGNITION, V43, P367, DOI 10.3758/s13421-014-0480-4; Webb RM, 2007, J EDUC PSYCHOL, V99, P397, DOI 10.1037/0022-0663.99.2.397; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond	30	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e172046	10.1371/journal.pone.0172046	http://dx.doi.org/10.1371/journal.pone.0172046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192484	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800064
J	Pattamayutanon, P; Angeli, S; Thakeow, P; Abraham, J; Disayathanoowat, T; Chantawannakul, P				Pattamayutanon, Praetinee; Angeli, Sergio; Thakeow, Prodpran; Abraham, John; Disayathanoowat, Terd; Chantawannakul, Panuwan			Volatile organic compounds of Thai honeys produced from several floral sources by different honey bee species	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; GC-MS ANALYSIS; CHEMICAL-COMPOSITION; AROMA COMPOUNDS; ESSENTIAL OILS; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; MASS-SPECTROMETRY; UNIFLORAL HONEYS; ALPHA-TERPINEOL	The volatile organic compounds (VOCs) of four monofloral and one multifloral of Thai honeys produced by Apis cerana, Apis dorsata and Apis mellifera were analyzed by headspace solid-phase microextraction (HS-SPME) followed by gas chromatography and mass spectrometry (GC-MS). The floral sources were longan, sunflower, coffee, wild flowers (wild) and lychee. Honey originating from longan had more VOCs than all other floral sources. Sunflower honey had the least numbers of VOCs. cis-Linalool oxide, trans-linalool oxide, ho-trienol, and furan-2,5-dicarbaldehyde were present in all the honeys studied, independent of their floral origin. Interestingly, 2-phenylacetaldehyde was detected in all honey sample except longan honey produced by A. cerana. Thirty-two VOCs were identified as possible floral markers. After validating differences in honey volatiles from different floral sources and honeybee species, the results suggest that differences in quality and quantity of honey volatiles are influenced by both floral source and honeybee species. The group of honey volatiles detected from A. cerana was completely different from those of A. mellifera and A. dorsata. VOCs could therefore be applied as chemical markers of honeys and may reflect preferences of shared floral sources amongst different honeybee species.	[Pattamayutanon, Praetinee; Disayathanoowat, Terd; Chantawannakul, Panuwan] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Angeli, Sergio; Abraham, John] Free Univ Bozen Bolzano, Fac Sci & Technol, Piazza Univ, Bolzano, Italy; [Thakeow, Prodpran] Chiang Mai Univ, Fac Agroind, Div Prod Dev Technol, Chiang Mai, Thailand; [Abraham, John] Univ Cape Coast, Sch Biol Sci, Dept Conservat Biol & Entomol, Cape Coast, Ghana	Chiang Mai University; Free University of Bozen-Bolzano; Chiang Mai University; University of Cape Coast	Chantawannakul, P (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.	panuwan@gmail.com	Angeli, Sergio/A-7720-2008; Abraham, John/L-5517-2018	Angeli, Sergio/0000-0002-8463-7476; Abraham, John/0000-0001-6049-6042; Disayathanoowat, Terd/0000-0002-6416-2266; Thakeow, Prodpran/0000-0001-5824-1171	Royal Golden Jubilee (RGJ) Ph.D. Programme	Royal Golden Jubilee (RGJ) Ph.D. Programme	This work was supported by The Royal Golden Jubilee (RGJ) Ph.D. Programme Tel: 02-278-8200 ext. 1 (http://rgj.trf.or.th/main/en/) to PP and PC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol D. P, 2013, J INDIAN I SCI, V68, P43; Al-Qassemi R., 2003, Nutrition & Food Science, V33, P254, DOI 10.1108/00346650310507073; Alissandrakis E, 2005, J SCI FOOD AGR, V85, P91, DOI 10.1002/jsfa.1934; Alissandrakis E, 2007, J AGR FOOD CHEM, V55, P8152, DOI 10.1021/jf071442y; Alissandrakis E, 2011, LWT-FOOD SCI TECHNOL, V44, P1042, DOI 10.1016/j.lwt.2010.10.002; Alviano WS, 2005, ORAL MICROBIOL IMMUN, V20, P101, DOI 10.1111/j.1399-302X.2004.00201.x; Aronne G., 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/428141; Baroni MV, 2006, J AGR FOOD CHEM, V54, P7235, DOI 10.1021/jf061080e; Bentivenga G, 2004, INT J FOOD SCI TECH, V39, P1079, DOI 10.1111/j.1365-2621.2004.00889.x; Bianchi F, 2005, FOOD CHEM, V89, P527, DOI 10.1016/j.foodchem.2004.03.009; Bonvehi JS, 2003, J SCI FOOD AGR, V83, P275, DOI 10.1002/jsfa.1308; Bougatsos C, 2004, Z NATURFORSCH C, V59, P368; Brickell C, 2008, ENCY GARDEN PLANTS, P1136; Cajka T, 2007, J SEP SCI, V30, P534, DOI 10.1002/jssc.200600413; Vazquez LC, 2006, EUR FOOD RES TECHNOL, V224, P27, DOI 10.1007/s00217-006-0284-2; Castro-Vazquez L, 2003, CHROMATOGRAPHIA, V57, P227, DOI 10.1007/BF02491721; Castro-Vazquez L, 2006, J AGR FOOD CHEM, V54, P4809, DOI 10.1021/jf0604384; Cha JD, 2007, J MICROBIOL BIOTECHN, V17, P2061; Soria AC, 2009, EUR FOOD RES TECHNOL, V228, P579, DOI 10.1007/s00217-008-0966-z; de la Fuente E, 2007, FOOD CHEM, V105, P84, DOI 10.1016/j.foodchem.2007.03.039; de la Fuente E, 2005, J SEP SCI, V28, P1093, DOI 10.1002/jssc.200500018; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; El-Moaty H. I. A., 2010, Journal of Natural Products (India), V3, P103; Elsheikh ATA, 2015, PHYSICOCHEMICAL PROP; Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0; Ferreira ACS, 2004, ANAL CHIM ACTA, V513, P169, DOI 10.1016/j.aca.2003.12.027; Gomez-Caravaca AM, 2006, J PHARMACEUT BIOMED, V41, P1220, DOI 10.1016/j.jpba.2006.03.002; Gopanraj G, 2005, Acta Pharm, V55, P315; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Jerkovic I, 2009, FOOD CHEM, V112, P239, DOI 10.1016/j.foodchem.2008.05.080; Jerkovic I, 2007, 55 INT C ANN M SOC M; Jerkovic I, 2013, CHEM BIODIVERS, V10, P1549, DOI 10.1002/cbdv.201300074; Jerkovic I, 2010, MOLECULES, V15, P4572, DOI 10.3390/molecules15074572; Jerkovic I, 2010, MOLECULES, V15, P2911, DOI 10.3390/molecules15042911; Jerkovic I, 2009, CHEM BIODIVERS, V6, P421, DOI 10.1002/cbdv.200800074; KOENIGER N, 1979, J APICULT RES, V18, P95, DOI 10.1080/00218839.1979.11099952; Kotan R, 2007, Z NATURFORSCH C, V62, P507; Lee SJ, 2005, FOOD CHEM, V91, P131, DOI 10.1016/j.foodchem.2004.05.056; Molan P, 1988, J APICULT RES; Montenegro G, 2009, PHYTON-INT J EXP BOT, V78, P61; Ningrum A, 2015, INT J FOOD PROP, V18, P1905, DOI 10.1080/10942912.2014.971186; Odeh I, 2007, FOOD CHEM, V101, P1393, DOI 10.1016/j.foodchem.2006.03.046; Park MJ, 2009, FITOTERAPIA, V80, P290, DOI 10.1016/j.fitote.2009.03.007; Park SN, 2012, ANAEROBE, V18, P369, DOI 10.1016/j.anaerobe.2012.04.001; Pattamayutanon P, 2015, J FOOD SCI, V80, pM2228, DOI 10.1111/1750-3841.12993; Pena RM, 2004, J SEP SCI, V27, P1540, DOI 10.1002/jssc.200301705; Piasenzotto L, 2003, J SCI FOOD AGR, V83, P1037, DOI 10.1002/jsfa.1502; Pripdeevech P, 2010, J SERB CHEM SOC, V75, P1503, DOI 10.2298/JSC100203125P; Radovic BS, 2001, FOOD CHEM, V72, P511, DOI 10.1016/S0308-8146(00)00263-6; Samarghandian S, 2013, J PHARM PHARM SCI, V16, P352, DOI 10.18433/J3ZS3Q; Shimoda M, 1996, J AGR FOOD CHEM, V44, P3913, DOI 10.1021/jf9601168; Sokovic M, 2010, MOLECULES, V15, P7532, DOI 10.3390/molecules15117532; Soria AC, 2003, J SEP SCI, V26, P793, DOI 10.1002/jssc.200301368; Stanimirova I, 2010, FOOD CHEM, V118, P171, DOI 10.1016/j.foodchem.2009.04.079; TAN ST, 1988, J AGR FOOD CHEM, V36, P453, DOI 10.1021/jf00081a012; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Viuda-Martos M, 2010, INT J FOOD SCI TECH, V45, P1111, DOI 10.1111/j.1365-2621.2010.02243.x; Wall MM, 2006, J FOOD COMPOS ANAL, V19, P655, DOI 10.1016/j.jfca.2005.12.001; Wang SL, 2012, INT J FOOD PROP, V15, P1381, DOI 10.1080/10942912.2010.526275; White J W Jr, 1978, Adv Food Res, V24, P287; WOLSKI T, 2006, J APIC SCI, V50, P115; Yue XD, 2012, J ASIAN NAT PROD RES, V14, P486, DOI 10.1080/10286020.2012.678331	62	15	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172099	10.1371/journal.pone.0172099	http://dx.doi.org/10.1371/journal.pone.0172099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192487	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800067
J	Raza, QS; Vanderploeg, JL; Jacobs, JR				Raza, Qanber S.; Vanderploeg, Jessica L.; Jacobs, J. Roger			Matrix Metalloproteinases are required for membrane motility and lumenogenesis during Drosophila heart development	PLOS ONE			English	Article							CELL-MIGRATION; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; LUMEN FORMATION; CARDIAC MORPHOGENESIS; DORSAL CLOSURE; TUBE FORMATION; EXPRESSION; DISEASE; LAMININ	Matrix Metalloproteinases (Mmps) degrade glycoproteins and proteoglycans of the extracellular matrix (ECM) or cell surface and are crucial for morphogenesis. Mmps and their inhibitors are expressed during early stages of cardiac development in vertebrates and expression is altered in multiple congenital cardiomyopathies such as cardia bifida. Drosophila genome encodes two copies of Mmps, Mmp1 and Mmp2 whereas in humans up to 25 Mmps have been identified with overlapping functions. We investigated the role of Mmps during embryonic heart development in Drosophila, a process which is morphogenetically similar to early heart tube formation in vertebrates. We demonstrate that the two Mmps in Drosophila have distinct and overlapping roles in cell motility, cell adhesion and cardiac lumenogenesis. We determined that Mmp1 and Mmp2 promote Leading Edge membrane dynamics of cardioblasts during collective migration. Mmp2 is essential for cardiac lumen formation, and mutants generate a cardia bifida phenotype. Mmp1 is required for luminal expansion. Mmp1 and Mmp2 both localise to the basal domains of cardiac cells, however, occupy non-overlapping domains apically. Mmp1 and Mmp2 regulate the proteoglycan composition and size of the apical and basal ECM, yet only Mmp2 is required to restrict ECM assembly to the lumen. Mmp1 negatively regulates the size of the adhesive Cadherin cell surface domain, whereas in a complementary fashion, Mmp2 negatively regulates the size of the Integrin-ECM domain and thereby prescribes the domain to establish and restrict Slit morphogen signalling. Inhibition of Mmp activity through ectopic expression of Tissue Inhibitor of Metalloproteinase in the ectoderm blocks lumen formation. Therefore, Mmp expression and function identifies ECM differentiation and remodelling as a key element for cell polarisation and organogenesis.	[Raza, Qanber S.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Vanderploeg, Jessica L.] Taylor Univ, Dept Biol, Upland, IN USA; [Jacobs, J. Roger] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McMaster University	Raza, QS (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	syr10@pitt.edu		jacobs, j roger/0000-0002-5878-5416	Natural Sciences and Engineering Research Council Discovery [46651]	Natural Sciences and Engineering Research Council Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council Discovery 46651 - JRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brauer PR, 2002, MECH DEVELOP, V113, P175, DOI 10.1016/S0925-4773(02)00016-3; Cai DH, 2000, ANAT RECORD, V259, P168, DOI 10.1002/(SICI)1097-0185(20000601)259:2<168::AID-AR7>3.0.CO;2-U; Cantemir V, 2004, DEV DYNAM, V231, P709, DOI 10.1002/dvdy.20171; Chartier A, 2002, DEVELOPMENT, V129, P3241; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Deady LD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004989; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Glasheen BM, 2010, DEV BIOL, V344, P772, DOI 10.1016/j.ydbio.2010.05.504; Godenschwege TA, 2000, EUR J CELL BIOL, V79, P495, DOI 10.1078/0171-9335-00072; Haack T, 2014, DEV BIOL, V396, P169, DOI 10.1016/j.ydbio.2014.08.033; Haag TA, 1999, DEV BIOL, V208, P56, DOI 10.1006/dbio.1998.9188; Hollfelder D, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-26; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Jia QQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07535; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Knox J, 2011, DEV BIOL, V356, P279, DOI 10.1016/j.ydbio.2011.04.006; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Linask KK, 2005, DEV DYNAM, V233, P739, DOI 10.1002/dvdy.20377; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Manon-Jensen T, 2013, FEBS J, V280, P2320, DOI 10.1111/febs.12174; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Miller CM, 2011, J NEUROSCI, V31, P5335, DOI 10.1523/JNEUROSCI.4811-10.2011; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Raza Q, 2016, DEV BIOL, DOI [10.1186/1471-213X-14-26, DOI 10.1186/1471-213X-14-26]; Reed BH, 2009, JOVE; Roper JA, 2012, CURR OPIN STRUC BIOL, V22, P583, DOI 10.1016/j.sbi.2012.07.003; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Urbano JM, 2009, DEVELOPMENT, V136, P4165, DOI 10.1242/dev.044263; Vanderploeg J, 2015, DEV BIOL, DOI [10.1016/j.sbi.2012.07.003, DOI 10.1016/J.SBI.2012.07.003]; Vanderploeg J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-8; Vogler G, 2014, J CELL BIOL, V206, P909, DOI 10.1083/jcb.201405075; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Watanabe A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003086; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; YARNITZKY T, 1995, DEV BIOL, V169, P609, DOI 10.1006/dbio.1995.1173; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243	60	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171905	10.1371/journal.pone.0171905	http://dx.doi.org/10.1371/journal.pone.0171905			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192468	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800049
J	Yaya, S; Bishwajit, G; Ekholuenetale, M				Yaya, Sanni; Bishwajit, Ghose; Ekholuenetale, Michael			Factors associated with the utilization of institutional delivery services in Bangladesh	PLOS ONE			English	Article							REDUCING MATERNAL MORTALITY; CARE SERVICES; HEALTH; WOMEN	Introduction Bangladesh has made remarkable progress towards reducing its maternal mortality rate (MMR) over the last two decades and is one of the few countries on track to achieving the MMR-related Millennium Development Goals (MDG-5A). However, the provision of universal access to reproductive healthcare (MDG-5B) and the utilization of maternal healthcare services (MHS) such as institutional delivery, which are crucial to the reduction of maternal mortality, are far behind the internationally agreed-upon target. Effective policymaking to promote the utilization of MHS can be greatly facilitated by the identification of the factors that hinder service uptake. In this study, we therefore aim to measure the prevalence of institutional delivery services and explore the factors associated with their utilization in Bangladesh. Methods Data for this study were extracted from the 2011 Bangladesh Demographic and Health Survey (BDHS, 2011); participants were 7,313 women between the ages of 15 and 49 years, selected from both urban and rural households. Data were analyzed using Chi-square analysis, and conditional logistic regression. Results According to the findings, fewer than one in three women reported delivering at a health facility. The multivariable regression analysis showed that participants from rural areas were 46.9% less likely to have institutional deliveries compared to urban dwellers (OR = 0.531; p<0.001; 95% CI: 0.467-0.604), and participants aged between 30 and 49 years had a 23.6% higher prevalence of institutional delivery service utilization compared to those aged 15 to 29 years (OR = 1.236; p = 0.006; 95% CI: 1.062-1.437). Moreover, participants with higher educational attainment were about twice as likely to deliver at a standard health facility when compared to those without formal education (OR = 2.081; p<0.001; 95% CI: 1.650-2.624), and similarly, husbands with higher educational attainment exhibited an approximately 71% higher service utilization of institutional delivery facilities compared to those without formal education (OR = 1.709; p<0.001; 95% CI: 1.412-2.069). Wealth status was also a significant predictor of institutional delivery service use, with participants belonging to the highest economic stratum being more likely to receive skilled care compared to the lowest economic stratum (OR = 2.507; p<0.001; 95% CI: 2.118-2.968). In addition, results indicated that households of average economic class had a 27% higher level of institutional delivery service utilization compared to those of lower economic status (OR = 1.272; p = 0.011; 95% CI: 1.057-1.531). Furthermore, institutional health service use was 18% higher among participants who were aware of community clinical services compared to those who were hardly aware of these services (OR = 0.816; p = 0.012; 95% CI: 0.696-0.957). Lastly, the odds of utilizing delivery services was 1.553 times more likely for participants who use family planning compared to those who do not (p<0.001; 95% CI: 1.374-1.754), and 3.639 times more likely for those who receive antenatal care compared to those who do not (p<0.001; 95% CI: 3.074-4.308). These were found to be significant predictors of the choice of delivery services. Discussion Our results suggest that efforts towards reducing national maternal mortality in Bangladesh could be aided by investments into education, poverty reduction and the strengthening of reproductive healthcare services through community clinics, with particular focus on rural areas.	[Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada; [Bishwajit, Ghose] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Ekholuenetale, Michael] Womens Hlth & Act Res Ctr, Benin, Nigeria	University of Ottawa; Huazhong University of Science & Technology	Yaya, S (corresponding author), Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Yaya, Sanni/C-1079-2019; Ekholuenetale, Michael/AAL-3655-2021	Yaya, Sanni/0000-0002-4876-6043; Ekholuenetale, Michael/0000-0002-2372-3020				Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; ALAUDDIN M, 1986, STUD FAMILY PLANN, V17, P13, DOI 10.2307/1966951; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Bishwajit G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3915-y; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130077; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Dutamo Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1047-1; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; El Mhamdi S, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0198-x; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Igberase GO, 2009, ANN AFR MED, V8, P261, DOI 10.4103/1596-3519.59582; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1372, DOI 10.1177/1010539513486178; Karkee R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004372; Khan N, 2013, J HEALTH POPUL NUTR, V31, P262; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; NIPORT, 2013, NAT I POP RES TRAIN; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Prakash R, 2013, J BIOSOC SCI, V45, P433, DOI 10.1017/S0021932012000831; Prata N, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-78; Ruiz JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140796; Sen A, 2013, LANCET, V382, P1966, DOI 10.1016/S0140-6736(13)62162-5; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; United Nations, 2000, UN MILL DECL; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; Yaya S, 2016, BMJ GLOBAL HLTH; Zahodne LB, 2015, J INT NEUROPSYCH SOC, V21, P297, DOI 10.1017/S1355617715000193; Zanconato G, 2006, SEMIN FETAL NEONAT M, V11, P15, DOI 10.1016/j.siny.2005.10.002	34	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171573	10.1371/journal.pone.0171573	http://dx.doi.org/10.1371/journal.pone.0171573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192478	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800030
J	Yurie, H; Ikeguchi, R; Aoyama, T; Kaizawa, Y; Tajino, J; Ito, A; Ohta, S; Oda, H; Takeuchi, H; Akieda, S; Tsuji, M; Nakayama, K; Matsuda, S				Yurie, Hirofumi; Ikeguchi, Ryosuke; Aoyama, Tomoki; Kaizawa, Yukitoshi; Tajino, Junichi; Ito, Akira; Ohta, Souichi; Oda, Hiroki; Takeuchi, Hisataka; Akieda, Shizuka; Tsuji, Manami; Nakayama, Koichi; Matsuda, Shuichi			The efficacy of a scaffold-free Bio 3D conduit developed from human fibroblasts on peripheral nerve regeneration in a rat sciatic nerve model	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; ELECTRICAL-STIMULATION; EXTRACELLULAR-MATRIX; REPAIR; TRANSPLANTATION; GUIDE; EXPERIENCE; LOCOMOTION; EXPRESS	Background Although autologous nerve grafting is the gold standard treatment of peripheral nerve injuries, several alternative methods have been developed, including nerve conduits that use supportive cells. However, the seeding efficacy and viability of supportive cells injected in nerve grafts remain unclear. Here, we focused on a novel completely biological, tissue-engineered, scaffold-free conduit. Methods We developed six scaffold-free conduits from human normal dermal fibroblasts using a Bio 3D Printer. Twelve adult male rats with immune deficiency underwent mid-thigh-level transection of the right sciatic nerve. The resulting 5-mm nerve gap was bridged using 8-mm Bio 3D conduits (Bio 3D group, n = 6) and silicone tube (silicone group, n = 6). Several assessments were conducted to examine nerve regeneration eight weeks post-surgery. Results Kinematic analysis revealed that the toe angle to the metatarsal bone at the final segment of the swing phase was significantly higher in the Bio 3D group than the silicone group (-35.78 +/- 10.68 versus -62.48 +/- 6.15, respectively; p < 0.01). Electrophysiological studies revealed significantly higher compound muscle action potential in the Bio 3D group than the silicone group (53.60 +/- 26.36% versus 2.93 +/- 1.84%; p < 0.01). Histological and morphological studies revealed neural cell expression in all regions of the regenerated nerves and the presence of many well-myelinated axons in the Bio 3D group. The wet muscle weight of the tibialis anterior muscle was significantly higher in the Bio 3D group than the silicone group (0.544 +/- 0.063 versus 0.396 +/- 0.031, respectively; p < 0.01). Conclusions We confirmed that scaffold-free Bio 3D conduits composed entirely of fibroblast cells promote nerve regeneration in a rat sciatic nerve model.	[Yurie, Hirofumi; Ikeguchi, Ryosuke; Ito, Akira; Ohta, Souichi; Oda, Hiroki; Takeuchi, Hisataka; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Aoyama, Tomoki; Tajino, Junichi] Kyoto Univ, Dept Phys Therapy, Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Kaizawa, Yukitoshi] Iseikai Yawata Chuo Hosp, Dept Orthopaed Surg, Kyoto, Japan; [Akieda, Shizuka; Tsuji, Manami] Cyfuse Biomed KK, Tokyo, Japan; [Nakayama, Koichi] Saga Univ, Dept Regenerat Med & Biomed Engn, Fac Med, Saga, Japan	Kyoto University; Kyoto University; Saga University	Ikeguchi, R (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.	ikeguchir@me.com	Ito, Akira/AAA-4872-2021	Ito, Akira/0000-0002-9645-9777; Nakayama, Koichi/0000-0002-7324-8862	JSPS KAKENHI [15K10441]; Collaborative Research Agreement with Kyoto University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Collaborative Research Agreement with Kyoto University	This study was supported by JSPS KAKENHI Grant Number 15K10441. Cyfuse provided access to the Bio 3D printer that was used in this study, and contributed financially to this study via a Collaborative Research Agreement with Kyoto University. Cyfuse also provided support in the form of salaries for authors SA, KN, and MT and provided research grants to RI, TA, KN and SM. Cyfuse did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127; Bojados M, 2013, BEHAV BRAIN RES, V244, P48, DOI 10.1016/j.bbr.2013.01.017; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184; Chiriac S, 2012, J HAND SURG-EUR VOL, V37E, P342, DOI 10.1177/1753193411422685; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Cuevas P, 2004, NEUROL RES, V26, P230, DOI 10.1179/016164104225013897; Cuevas P, 2002, NEUROL RES, V24, P634, DOI 10.1179/016164102101200564; de Luca AC, 2014, NEURAL REGEN RES, V9, P1943, DOI 10.4103/1673-5374.145366; Dikina AD, 2015, BIOMATERIALS, V52, P452, DOI 10.1016/j.biomaterials.2015.01.073; Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]; Francoise M, 2012, BIOFABRICATION, P4; Grayson WL, 2008, TRENDS BIOTECHNOL, V26, P181, DOI 10.1016/j.tibtech.2007.12.009; Ishihara K, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0098-z; Itoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136681; Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004; Jesuraj NJ, 2011, J NEUROSCI METH, V197, P209, DOI 10.1016/j.jneumeth.2011.02.015; Jia H, 2012, SYNAPSE, V66, P256, DOI 10.1002/syn.21508; Kaizawa Y, 2015, MICROSURGER IN PRESS; KAKINOKI R, 1995, NEUROSCI RES, V23, P35, DOI 10.1016/0168-0102(95)00923-H; Kim DH, 2003, J NEUROSURG, V98, P993, DOI 10.3171/jns.2003.98.5.0993; Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316; Luk HW, 2003, J NEUROSCI RES, V73, P644, DOI 10.1002/jnr.10701; LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; MACKINNON SE, 1985, PLAST RECONSTR SURG, V75, P833, DOI 10.1097/00006534-198506000-00013; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Millesi H, 2000, HAND CLIN, V16, P73; Nakayama K, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-17; Nijhuis THJ, 2010, MICROSURG, V30, P639, DOI 10.1002/micr.20818; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Lopes FRP, 2010, MICRON, V41, P783, DOI 10.1016/j.micron.2010.05.010; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Siemionow M, 2011, ANN PLAS SURG, V67, P73, DOI 10.1097/SAP.0b013e318223c2db; Tajino J, 2015, J MOTOR BEHAV, V47, P397, DOI 10.1080/00222895.2014.1003779; Tajino J, 2015, BEHAV BRAIN RES, V287, P276, DOI 10.1016/j.bbr.2015.03.030; Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037; Walsh SK, 2012, STEM CELL RES, V8, P226, DOI 10.1016/j.scr.2011.11.004; Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098; Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056; Wang Y, 2015, NEURAL REGEN RES, V10, P965, DOI 10.4103/1673-5374.158362; Widgerow AD, 2014, MICROSURG, V34, P324, DOI 10.1002/micr.22219; Yamakawa T, 2007, CELL TRANSPLANT, V16, P811, DOI 10.3727/000000007783465226	47	70	76	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171448	10.1371/journal.pone.0171448	http://dx.doi.org/10.1371/journal.pone.0171448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192527	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800026
J	Jolly, AL; Agarwal, P; Metruccio, MME; Spiciarich, DR; Evans, DJ; Bertozzi, CR; Fleiszig, SMJ				Jolly, Amber L.; Agarwal, Paresh; Metruccio, Matteo M. E.; Spiciarich, David R.; Evans, David J.; Bertozzi, Carolyn R.; Fleiszig, Suzanne M. J.			Corneal surface glycosylation is modulated by IL-1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding	FASEB JOURNAL			English	Article						GalNAz metabolic label; imaging; mass spectrometry; Muc4; MyD88	MEMBRANE-ASSOCIATED MUCINS; OCULAR SURFACE; EPITHELIAL-CELLS; O-GLYCANS; CONJUNCTIVAL EPITHELIA; INTERLEUKIN-1 RECEPTOR; TEAR FLUID; PROTEIN-D; KAPPA-B; ADHERENCE	Cell surface glycosylation is thought to be involved in barrier function against microbes at mucosal surfaces. Previously we showed that the epithelium of healthy mouse corneas becomes vulnerable to Pseudomonas aeruginosa adhesion if it lacks the innate defense proteinMyD88 (myeloid differentiation primary response gene 88), or after superficial injury by blotting with tissue paper. Here we explored their effect on corneal surface glycosylation using ametabolic label, tetra-acetylated N-azidoacetyl galactosamine (Ac(4)GalNAz).Ac(4)GalNAz treatment labeled the surface of healthy mouse corneas, leaving most cells viable, and bacteria preferentially associated with GalNAz-labeled regions. Surprisingly, corneas from My D88(-/-) mice displayed similar GalNAz labeling to wild-type corneas, but labeling was reduced and patchy on IL-1 receptor (IL-1R)-knockout mouse corneas (P < 0.05, ANOVA). Tissue paper blotting removed GalNAz-labeled surface cells, causingDAPI labeling (permeabilization) of underlying cells. MS of material collected on the tissue paper blots revealed 67 GalNAz-labeled proteins, including intracellular proteins. These data show that the normal distribution of surface glycosylation requires IL-1R, but not MyD88, and is not sufficient to prevent bacterial binding. They also suggest increased P. aeruginosa adhesion to MyD88(-/-) and blotted corneas is not due to reduction in total surface glycosylation, and for tissue paper blotting is likely due to cell permeabilization.	[Jolly, Amber L.; Metruccio, Matteo M. E.; Evans, David J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Agarwal, Paresh; Spiciarich, David R.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Div Vis Sci, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Div Microbiol, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Div Infect Dis & Immun, Berkeley, CA 94720 USA; [Evans, David J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Touro University California; Stanford University	Fleiszig, SMJ (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu	Metruccio, Matteo/I-1467-2019; Jolly, Amber/T-2644-2019	Metruccio, Matteo/0000-0002-2456-2652; Fleiszig, Suzanne/0000-0001-6324-3462; Evans, David/0000-0002-6885-2053	National Institutes of Health (National Eye Institute) [EY011221, EY024060]; National Institutes of Health (National Cancer Institute) [CA200423]; National Institutes of Health (National Institute of General Medical Sciences) [GM058867]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA200423] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011221, R01EY024060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM058867, R37GM058867] Funding Source: NIH RePORTER	National Institutes of Health (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the National Institutes of Health (National Eye Institute Grants EY011221 and EY024060 to S.M.J.F.; National Cancer Institute Grant CA200423 to C.R.B.; and National Institute of General Medical Sciences Grant GM058867 to C.R.B.). D.R.S. was supported by a predoctoral fellowship from the National Science Foundation. The authors thank J. Singer (University of Maine, Orono, ME, USA) for providing the plasmid construct p67T1 (dTomato), G. Barton (University of California, Berkeley) for providing gene-knockout mice, and M. Gadjeva (Harvard Medical School, Boston, MA, USA) for helpful discussions.	Ablamowicz AF, 2016, OCUL SURF, V14, P331, DOI 10.1016/j.jtos.2016.03.003; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Bielory BP, 2016, CURR OPIN ALLERGY CL, V16, P477, DOI 10.1097/ACI.0000000000000309; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Bucior I, 2010, INFECT IMMUN, V78, P939, DOI 10.1128/IAI.01215-09; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Desseyn JL, 2002, EUR J BIOCHEM, V269, P3150, DOI 10.1046/j.1432-1033.2002.02988.x; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P1799, DOI 10.1128/IAI.62.5.1799-1804.1994; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; GIPSON IK, 1992, INVEST OPHTH VIS SCI, V33, P218; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Govindarajan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032418; Gupta SK, 1997, INFECT IMMUN, V65, P2747, DOI 10.1128/IAI.65.7.2747-2753.1997; Guzman-Aranguez A, 2010, OCUL SURF, V8, P8, DOI 10.1016/S1542-0124(12)70213-6; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hori Y, 2004, INVEST OPHTH VIS SCI, V45, P114, DOI 10.1167/iovs.03-0903; Hou JZ, 2013, P NATL ACAD SCI USA, V110, P3913, DOI 10.1073/pnas.1217996110; INATOMI T, 1995, INVEST OPHTH VIS SCI, V36, P1818; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lomako J, 2010, J CELL PHYSIOL, V223, P209, DOI 10.1002/jcp.22028; Masinick SA, 1997, INVEST OPHTH VIS SCI, V38, P910; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Navabi N, 2013, INFECT IMMUN, V81, P829, DOI 10.1128/IAI.01000-12; Ng ALK, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/769436; Ni M, 2005, INFECT IMMUN, V73, P2147, DOI 10.1128/IAI.73.4.2147-2156.2005; Peter-Katalinic J, 2005, METHOD ENZYMOL, V405, P139, DOI 10.1016/S0076-6879(05)05007-X; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Plotkowski MC, 1996, INFECT IMMUN, V64, P600, DOI 10.1128/IAI.64.2.600-605.1996; Reddy SAG, 2004, BIOCHEM BIOPH RES CO, V316, P1022, DOI 10.1016/j.bbrc.2004.02.155; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Ricciuto J, 2008, INFECT IMMUN, V76, P5215, DOI 10.1128/IAI.00708-08; Roger P, 1999, EUR RESPIR J, V13, P1301, DOI 10.1183/09031936.99.13613109; Singer JT, 2010, APPL ENVIRON MICROB, V76, P3467, DOI 10.1128/AEM.01679-09; Sullivan AB, 2015, INFECT IMMUN, V83, P1629, DOI 10.1128/IAI.02329-14; Sumiyoshi M, 2008, INVEST OPHTH VIS SCI, V49, P197, DOI 10.1167/iovs.07-1038; Swan JS, 2002, CURR EYE RES, V24, P397, DOI 10.1076/ceyr.24.5.397.8521; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Tam C, 2012, J CLIN INVEST, V122, P3665, DOI 10.1172/JCI64416; Tam C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024008; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; TSANG KWT, 1994, EUR RESPIR J, V7, P1746, DOI 10.1183/09031936.94.07101746; Vijmasi T, 2013, MOL VIS, V19, P1957; Williamson YM, 2008, MICROB PATHOGENESIS, V44, P175, DOI 10.1016/j.micpath.2007.08.016; Woodward AM, 2014, INVEST OPHTH VIS SCI, V55, P6132, DOI 10.1167/iovs.14-15269	54	7	7	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2393	2404		10.1096/fj.201601198R	http://dx.doi.org/10.1096/fj.201601198R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223334	Green Published			2022-12-26	WOS:000401553400015
J	Karam, JA; Parikh, RY; Nayak, D; Rosenkranz, D; Gangaraju, VK				Karam, Joseph A.; Parikh, Rasesh Y.; Nayak, Dhananjaya; Rosenkranz, David; Gangaraju, Vamsi K.			Co-chaperone Hsp70/Hsp90-organizing protein (Hop) is required for transposon silencing and Piwi-interacting RNA (piRNA) biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; PHENOTYPIC VARIATION; MAMMALIAN OOCYTES; EARLY EMBRYOS; STEM-CELLS; GERM-LINE; ZUCCHINI; PATHWAY; HSP90	Piwi-interacting RNAs (piRNAs) are 26-30-nucleotide germ line-specific small non-coding RNAs that have evolutionarily conserved function in mobile genetic element (transposons) silencing and maintenance of genome integrity. Drosophila Hsp70/90-organizing protein homolog (Hop), a co-chaperone, interacts with piRNA-binding protein Piwi and mediates silencing of phenotypic variations. However, it is not known whether Hop has a direct role in piRNA biogenesis and transposon silencing. Here, we show that knockdown of Hop in the germ line nurse cells (GLKD) of Drosophila ovaries leads to activation of transposons. Hop GLKD females can lay eggs at the same rate as wild-type counterparts, but the eggs do not hatch into larvae. Hop GLKD leads to the accumulation of gamma-H2Av foci in the germ line, indicating increased DNA damage in the ovary. We also show that Hop GLKD-induced transposon up-regulation is due to inefficient piRNA biogenesis. Based on these results, we conclude that Hop is a critical component of the piRNA pathway and that it maintains genome integrity by silencing transposons.	[Karam, Joseph A.; Parikh, Rasesh Y.; Nayak, Dhananjaya; Gangaraju, Vamsi K.] Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Karam, Joseph A.; Parikh, Rasesh Y.; Nayak, Dhananjaya; Gangaraju, Vamsi K.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Rosenkranz, David] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolutionary Biol, D-55122 Mainz, Germany	Medical University of South Carolina; Medical University of South Carolina; Johannes Gutenberg University of Mainz	Gangaraju, VK (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	gangaraj@musc.edu		Karam, Joseph/0000-0002-4536-7362	Genomics/shRNA Shared Resource; National Institutes of Health Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021736] Funding Source: NIH RePORTER	Genomics/shRNA Shared Resource; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Mikiko Siomi and Haifan Lin for antibodies, members of the Gangaraju lab for critical reading of the manuscript, Robert Wilson and Jennifer Schulte for preparing mRNA and small RNA sequencing libraries, and Philip Zamore and Bo Han for answering our queries during installation and execution of piPipes. We acknowledge support of the Genomics/shRNA Shared Resource and National Institutes of Health Grant P30 CA138313 to Cell & Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina.	Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; Feltzin VL, 2015, AGING CELL, V14, P443, DOI 10.1111/acel.12323; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Hayashi R, 2016, NATURE, V539, P588, DOI 10.1038/nature20162; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hu YH, 2013, GENETICS, V195, P37, DOI 10.1534/genetics.113.151340; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Iwasaki S, 2015, NATURE, V521, P533, DOI 10.1038/nature14254; Izumi N, 2013, RNA, V19, P896, DOI 10.1261/rna.037200.112; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Olivieri D, 2012, MOL CELL, V47, P954, DOI 10.1016/j.molcel.2012.07.021; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Preall JB, 2012, RNA, V18, P1446, DOI 10.1261/rna.034405.112; Qi H, 2011, J BIOL CHEM, V286, P3789, DOI 10.1074/jbc.M110.193888; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Rosenkranz D, 2015, GENOM DATA, V5, P309, DOI 10.1016/j.gdata.2015.06.026; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schisa JA, 2014, WIRES RNA, V5, P231, DOI 10.1002/wrna.1204; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Wickersheim ML, 2013, BIOTECHNIQUES, V55, P271, DOI 10.2144/000114102; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Yamamoto S, 2014, J BIOL CHEM, V289, P9880, DOI 10.1074/jbc.M114.553255; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	62	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6039	6046		10.1074/jbc.C117.777730	http://dx.doi.org/10.1074/jbc.C117.777730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28193840	Green Published, hybrid			2022-12-26	WOS:000399538700002
J	Menon, D; Salloum, D; Bernfeld, E; Gorodetsky, E; Akselrod, A; Frias, MA; Sudderth, J; Chen, PH; DeBerardinis, R; Foster, DA				Menon, Deepak; Salloum, Darin; Bernfeld, Elyssa; Gorodetsky, Elizabeth; Akselrod, Alla; Frias, Maria A.; Sudderth, Jessica; Chen, Pei-Hsuan; DeBerardinis, Ralph; Foster, David A.			Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; RAS-TRANSFORMED CELLS; ENDOPLASMIC-RETICULUM; LYSOPHOSPHATIDIC ACID; CANCER-CELLS; ACYLTRANSFERASE-BETA; MAMMALIAN-CELLS; TGF-BETA; RAPAMYCIN; TARGET	mTOR, the mammalian target of rapamycin, integrates growth factor and nutrient signals to promote a transformation from catabolic to anabolic metabolism, cell growth, and cell cycle progression. Phosphatidic acid (PA) interacts with the FK506-binding protein-12-rapamycin-binding (FRB) domain of mTOR, which stabilizes both mTOR complexes: mTORC1 and mTORC2. We report here that mTORC1 and mTORC2 are activated in response to exogenously supplied fatty acids via the de novo synthesis of PA, a central metabolite for membrane phospholipid biosynthesis. We examined the impact of exogenously supplied fatty acids on mTOR in KRas-driven cancer cells, which are programmed to utilize exogenous lipids. The induction of mTOR by oleic acid was dependent upon the enzymes responsible for de novo synthesis of PA. Suppression of the de novo synthesis of PA resulted in G(1) cell cycle arrest. Although it has long been appreciated that mTOR is a sensor of amino acids and glucose, this study reveals that mTOR also senses the presence of lipids via production of PA.	[Menon, Deepak; Salloum, Darin; Bernfeld, Elyssa; Gorodetsky, Elizabeth; Akselrod, Alla; Frias, Maria A.; Foster, David A.] CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Menon, Deepak; Bernfeld, Elyssa; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Salloum, Darin; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Sudderth, Jessica; Chen, Pei-Hsuan; DeBerardinis, Ralph] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Foster, DA (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Frias, Maria A/0000-0001-7753-6290; Lehman, Elyssa/0000-0002-9869-1588	National Institutes of Health [R01-CA046677, R01-CA179542, R01-CA157996]; Research Centers in Minority Institutions of the National Center for Research Resources of the National Institutes of Health [RP-03037]; Robert A. Welch Foundation [I-1733]; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions of the National Center for Research Resources of the National Institutes of Health; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01-CA046677 and R01-CA179542 (to D. A. F.) and Pilot Project Award RP-03037 from the Research Centers in Minority Institutions of the National Center for Research Resources of the National Institutes of Health. Ralph DeBerardinis is on the Scientific Advisory Board of Agios Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant R01-CA157996 and Robert A. Welch Foundation Award I-1733.	Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Chatterjee A, 2015, CANCER LETT, V360, P134, DOI 10.1016/j.canlet.2015.01.043; Chun SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-293; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	43	71	71	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6303	6311		10.1074/jbc.M116.772988	http://dx.doi.org/10.1074/jbc.M116.772988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223357	Green Published, hybrid			2022-12-26	WOS:000399538700024
J	Yi, Y; Chen, DS; Ao, J; Sun, SN; Wu, M; Li, XR; Bergholz, J; Zhang, YJ; Xiao, ZX				Yi, Yong; Chen, Deshi; Ao, Juan; Sun, Shengnan; Wu, Min; Li, Xiaorong; Bergholz, Johann; Zhang, Yujun; Xiao, Zhi-Xiong			Metformin Promotes AMP-activated Protein Kinase-independent Suppression of Delta Np63 alpha Protein Expression and Inhibits Cancer Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P63; METASTASIS; APOPTOSIS; SURVIVAL; GROWTH; 2-DEOXYGLUCOSE; METABOLISM; STABILITY; CARCINOMA; MECHANISM	The blood glucose modifier metformin is used to treat type II diabetes and has also been shown to possess anticancer activities. Recent studies indicate that glucose deprivation can greatly enhance metformin-mediated inhibition of cell viability, but the molecular mechanism involved in this inhibition is unclear. In this study, we report that, under glucose deprivation, metformin inhibited expression of Delta Np63 alpha, a p53 family member involved in cell adhesion pathways, resulting in disruption of cell matrix adhesion and subsequent apoptosis in human squamous carcinoma cells. We further show that metformin promoted Delta Np63 alpha protein instability independent of AMP-activated protein kinase and that WWP1, an E3 ligase of Delta Np63 alpha, was involved in metformin-mediated down-regulation of Delta Np63 alpha levels. In addition, we demonstrate that a combination of metformin and the glycolysis inhibitor 2-deoxy-D-glucose significantly inhibited Delta Np63 alpha expression and also suppressed xenographic tumor growth in vivo. In summary, this study reveals a new mechanism for metformin-mediated anticancer activity and suggests a new strategy for treating human squamous cell carcinoma.	[Yi, Yong; Chen, Deshi; Ao, Juan; Sun, Shengnan; Wu, Min; Li, Xiaorong; Bergholz, Johann; Zhang, Yujun; Xiao, Zhi-Xiong] Sichuan Univ, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm, Minist Educ,Coll Life Sci, Chengdu 610064, Peoples R China; [Bergholz, Johann] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA	Sichuan University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Xiao, ZX (corresponding author), Sichuan Univ, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm, Minist Educ,Coll Life Sci, Chengdu 610064, Peoples R China.	jimzx@scu.edu.cn		Yi, Yong/0000-0003-4664-9692	National Natural Science Foundation of China [81330054, 81520108020]; Ministry of Science and Technology of China [2012CB910700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 81330054 and 81520108020 and Ministry of Science and Technology of China Grant 2012CB910700 (to Z.X.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Bergholz J, 2012, CANCER MICROENVIRON, V5, P311, DOI 10.1007/s12307-012-0116-9; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Menendez JA, 2011, AGING-US, V3, P1063, DOI 10.18632/aging.100407; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ogawa T, 2016, P NATL ACAD SCI USA, V113, P11913, DOI 10.1073/pnas.1604047113; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Verma S, 2000, J HYPERTENS, V18, P1445, DOI 10.1097/00004872-200018100-00012; WICK AN, 1957, J BIOL CHEM, V224, P963; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	41	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5253	5261		10.1074/jbc.M116.769141	http://dx.doi.org/10.1074/jbc.M116.769141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193839	Green Published, hybrid			2022-12-26	WOS:000397875500009
J	Kavka, M; Polle, A				Kavka, Mareike; Polle, Andrea			Dissecting nutrient-related co-expression networks in phosphate starved poplars	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PHR1; STARVATION RESPONSE 1; ARABIDOPSIS-THALIANA; PHOSPHORUS ACQUISITION; IRON DEFICIENCIES; ROOT-SYSTEM; CROSS-TALK; GENE; EXPRESSION; AVAILABILITY	Phosphorus (P) is an essential plant nutrient, but its availability is often limited in soil. Here, we studied changes in the transcriptome and in nutrient element concentrations in leaves and roots of poplars (Populus x canescens) in response to P deficiency. P starvation resulted in decreased concentrations of S and major cations (K, Mg, Ca), in increased concentrations of N, Zn and Al, while C, Fe and Mn were only little affected. In roots and leaves >4,000 and >9,000 genes were differently expressed upon P starvation. These genes clustered in eleven co-expression modules of which seven were correlated with distinct elements in the plant tissues. One module (4.7% of all differentially expressed genes) was strongly correlated with changes in the P concentration in the plant. In this module the GO term "response to P starvation was enriched with phosphoenolpyruvate carboxylase kinases, phosphatases and pyrophosphatases as well as regulatory domains such as SPX, but no phosphate transporters. The P-related module was also enriched in genes of the functional category "galactolipid synthesis". Galactolipids substitute phospholipids in membranes under P limitation. Two modules, one correlated with C and N and the other with bio-mass, S and Mg, were connected with the P-related module by co-expression. In these modules GO terms indicating "DNA modification" and "cell division" as well as "defense" and "RNA modification" and "signaling" were enriched; they contained phosphate transporters. Bark storage proteins were among the most strongly upregulated genes in the growth-related module suggesting that N, which could not be used for growth, accumulated in typical storage compounds. In conclusion, weighted gene coexpression network analysis revealed a hierarchical structure of gene clusters, which separated phosphate starvation responses correlated with P tissue concentrations from other gene modules, which most likely represented transcriptional adjustments related to down-stream nutritional changes and stress.	[Kavka, Mareike; Polle, Andrea] Georg August Univ Gottingen, Forstbot & Baumphysiol, Gottingen, Germany; [Kavka, Mareike; Polle, Andrea] Georg August Univ Gottingen, Lab Radio Isotope, Gottingen, Germany	University of Gottingen; University of Gottingen	Polle, A (corresponding author), Georg August Univ Gottingen, Forstbot & Baumphysiol, Gottingen, Germany.; Polle, A (corresponding author), Georg August Univ Gottingen, Lab Radio Isotope, Gottingen, Germany.	apolle@gwdg.de		Polle, Andrea/0000-0001-8697-6394; Kavka, Mareike/0000-0003-0124-1167	Georg-August University of Gottingen; Deutsche Forschungsgemeinschaft (DFG) [SPP 1685, Po362/22-2]; University of Gottingen	Georg-August University of Gottingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Gottingen	The Georg-August University of Gottingen (http://www.uni-goettingen.de/de/1.html) funded the PhD position of MJK. The Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/foerderung/programme/listen/projektdetails/index.jsp?id=220238996), Priority Program SPP 1685 "Ecosystem Nutrition" provided financial support for this research Project under grant number Po362/22-2. The publication fund of the University of Gottingen and the Deutsche Forschungsgemeinschaft supported open access publication of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Baker A, 2015, J EXP BOT, V66, P3523, DOI 10.1093/jxb/erv210; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BIELESKI RL, 1973, ANNU REV PLANT PHYS, V24, P225, DOI 10.1146/annurev.pp.24.060173.001301; Bournier M, 2013, J BIOL CHEM, V288, P22670, DOI 10.1074/jbc.M113.482281; Burg J van den, 1985, RAPP RIJKSINST VOOR; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; COLEMAN GD, 1991, PLANT PHYSIOL, V96, P686, DOI 10.1104/pp.96.3.686; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; Desai S, 2014, MYCORRHIZA, V24, P369, DOI 10.1007/s00572-013-0548-1; Ducic T, 2007, FUNCT PLANT BIOL, V34, P31, DOI 10.1071/FP06157; Gan HH, 2016, TREE PHYSIOL, V36, P22, DOI 10.1093/treephys/tpv093; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hartel H, 2000, BIOCHEM SOC T, V28, P729, DOI 10.1042/BST0280729; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; HEINRICHS H, 1986, Z PFLANZ BODENKUNDE, V149, P350, DOI 10.1002/jpln.19861490313; Hewitt EJ, 1974, PLANT MINERAL NUTR L; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kavka M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0892-3; Kellermeier F, 2014, PLANT CELL, V26, P1480, DOI 10.1105/tpc.113.122101; Khan GA, 2014, J EXP BOT, V65, P871, DOI 10.1093/jxb/ert444; Kobayashi K, 2006, PLANT J, V47, P238, DOI 10.1111/j.1365-313X.2006.02778.x; Lan P, 2015, ANNU PLANT REV, V48, P65, DOI 10.1002/9781118958841.ch3; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Puga MI, 2014, P NATL ACAD SCI USA, V111, P14947, DOI 10.1073/pnas.1404654111; R Development Core Team, 2012, R LANG ENV STAT COMP; Rai V, 2015, PLANT CELL PHYSIOL, V56, P1107, DOI 10.1093/pcp/pcv035; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Saenchai C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00396; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Scheible WR, 2015, ANNU PLANT REV, V48, P25, DOI 10.1002/9781118958841.ch2; Schwender H., 2011, SIGGENES MULTIPLE TE; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tsai C. J., 2011, Genetics, genomics and breeding of poplar, P112; Valentinuzzi F, 2015, J EXP BOT, V66, P6483, DOI 10.1093/jxb/erv364; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wang XF, 2014, PLANT CELL ENVIRON, V37, P1159, DOI 10.1111/pce.12224; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Wang ZY, 2014, P NATL ACAD SCI USA, V111, P14953, DOI 10.1073/pnas.1404680111; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; Wildhagen H, 2010, TREE PHYSIOL, V30, P1096, DOI 10.1093/treephys/tpq018; Woo J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-62; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Zhang CX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01398; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051; Zhu BL, 2001, PLANT PHYSIOL, V126, P342, DOI 10.1104/pp.126.1.342	67	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171958	10.1371/journal.pone.0171958	http://dx.doi.org/10.1371/journal.pone.0171958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222153	Green Published, gold			2022-12-26	WOS:000394676800023
J	Seemann, R; Jirku, A; Wagner, F; Wutzl, A				Seemann, Rudolf; Jirku, Alexander; Wagner, Florian; Wutzl, Arno			What do sales data tell us about implant survival?	PLOS ONE			English	Article							DENTAL IMPLANTS; FAILURE RATES; BONE; IMPACT; METAANALYSIS; MM	Objective The aim of this study was to evaluate the influence of implant diameter, length and shape on a surrogate parameter of implant survival; i.e. the implant return rate in a big data analysis. Materials and methods A retrospective study was conducted and the factors influencing the success rates of 69,377 sold implants over a seven-year period were evaluated. The osseointegration program of a reseller provides reliable data of a single country. Implant loss rates were investigated using logistic regression models and regressed by implant type, diameter, and length. Results The return rate of 69,377 sold implants was 2.78% and comparable to implant loss rates in previous published prospective studies as its surrogate parameter. A total of 80% of implant returns had occurred within 157 days, and an additional 15% within 750.25 days. Diameters of 3.8 to 5.0mm showed the lowest return rates with its bottom in the 4.3mm implant whilst 6.0mm implants had significantly higher return rates. In comparison to the most sold implant length ( 13mm) shorter implants showed significantly higher early return rates. Conclusions The study provides evidence that in cases of standard indications and sufficient bone, the use of screw typed dental implants with 3.8 or 4.3 diameter and 11 or 13 mm length shows the lowest implant return rates. Other implants may be selected only in specific indications.	[Seemann, Rudolf; Wagner, Florian; Wutzl, Arno] Med Univ Vienna, Univ Clin Cranio Maxillofacial & Oral Surg, Vienna, Austria; [Jirku, Alexander] Alexas AG, Mauren, Liechtenstein	Medical University of Vienna	Seemann, R (corresponding author), Med Univ Vienna, Univ Clin Cranio Maxillofacial & Oral Surg, Vienna, Austria.	rudolf.seemann@meduniwien.ac.at		Seemann, Rudolf/0000-0003-4234-4090				Albrektsson T, 2012, CLIN ORAL IMPLAN RES, V23, P63, DOI 10.1111/j.1600-0501.2012.02557.x; Alsaadi G, 2008, J CLIN PERIODONTOL, V35, P51, DOI 10.1111/j.1600-051X.2007.01165.x; Atieh MA, 2010, J PERIODONTOL, V81, P1350, DOI 10.1902/jop.2010.100232; French D, 2015, CLIN ORAL IMPLAN RES, V26, P1345, DOI 10.1111/clr.12463; Haas R, 1996, Int J Oral Maxillofac Implants, V11, P581; Herrmann I, 2005, INT J ORAL MAX IMPL, V20, P220; Jemt T, 2016, CLIN IMPLANT DENT R, V18, P861, DOI 10.1111/cid.12379; Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x; Kinsel RP, 2007, INT J ORAL MAX IMPL, V22, P823; Koodaryan R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4987526; Lee CT, 2016, CLIN ORAL IMPLAN RES, V27, P1251, DOI 10.1111/clr.12730; Lee SA, 2014, INT J ORAL MAX IMPL, V29, P1085, DOI 10.11607/jomi.3504; Moraschini V, 2016, INT J ORAL MAX SURG, V45, P205, DOI 10.1016/j.ijom.2015.08.996; Nickenig HJ, 2009, CLIN ORAL IMPLAN RES, V20, P550, DOI 10.1111/j.1600-0501.2008.01684.x; Pjetursson BE, 2014, INT J ORAL MAX IMPL, V29, P308, DOI 10.11607/jomi.2014suppl.g5.2; Pommer B, 2011, J CLIN PERIODONTOL, V38, P856, DOI 10.1111/j.1600-051X.2011.01750.x; Romeo E, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2012.02551.x; Sakka S, 2012, J INVESTIG CLIN DENT, V3, DOI 10.1111/j.2041-1626.2012.00162.x; Sesma N, 2012, INT J ORAL MAX IMPL, V27, P1243; Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603; Sohrabi K, 2012, CLIN ORAL IMPLAN RES, V23, P515, DOI 10.1111/j.1600-0501.2011.02410.x; Strietzel FP, 2015, CLIN ORAL IMPLAN RES, V26, P342, DOI 10.1111/clr.12339; Sun HL, 2011, INT J ORAL MAX IMPL, V26, P816; World Health Organization, 2016, TOB FACT SHEET	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171128	10.1371/journal.pone.0171128	http://dx.doi.org/10.1371/journal.pone.0171128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222128	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800008
J	Turcsan, B; Miklosi, A; Kubinyi, E				Turcsan, Borbala; Miklosi, Adam; Kubinyi, Eniko			Owner perceived differences between mixed-breed and purebred dogs	PLOS ONE			English	Article							SHELTER DOGS; RISK-FACTORS; PET DOGS; BEHAVIOR; TEMPERAMENT; PREVALENCE; FAMILIARIS; MORTALITY; RESPONSES; TRAITS	Studies about the behaviours of mixed-breed dogs are rare, although mixed-breeds represent the majority of the world's dog population. We have conducted two surveys to investigate the behavioural, demographic, and dog keeping differences between purebred and mixed-breed companion dogs. Questionnaire data were collected on a large sample of dogs living in Germany (N = 7,700 purebred dogs representing more than 200 breeds, and N = 7,691 mixedbreeds). We found that according to their owners, mixed-breeds were (1) less calm, (2) less sociable toward other dogs, and (3) showed more problematic behaviour than purebreds (p < 0.001 for all). Mixed-breeds and purebreds were similar in trainability and boldness scores. However, twelve out of 20 demographic and dog keeping factors differed between purebred and mixed-breed dogs, and two factors showed considerable (>10%) differences: neutering was more frequent among mixed-breeds, and they were acquired at older ages than purebreds (p < 0.001 for both), which could result in the observed behaviour differences. After controlling for the distribution of the demographic and dog keeping factors, we found that mixedbreeds were (1) more trainable than purebreds, (2) less calm, and (3) showed more problematic behaviour than purebreds (p < 0.001 for all). We discuss that these differences at least partly might be due to selective forces. Our results suggest that instead of being the "average" dogs, mixed-breeds represent a special group with characteristic behavioural traits.	[Turcsan, Borbala; Miklosi, Adam; Kubinyi, Eniko] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Turcsan, Borbala] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group	Turcsan, B (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.; Turcsan, B (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.	borbala.turcsan@gmail.com	Kubinyi, Eniko/B-5824-2013; Turcsán, Borbála/I-7983-2018	Kubinyi, Eniko/0000-0002-4468-9845; Turcsán, Borbála/0000-0002-0197-5243	European Research Council (ERC) under the European Union [680040]; Hungarian Scientific Research Fund [K84036, K112138]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; MTA-ELTE Comparative Ethological Research Group [MTA 01 031]	European Research Council (ERC) under the European Union(European Research Council (ERC)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); MTA-ELTE Comparative Ethological Research Group	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant Agreement No. 680040), the Hungarian Scientific Research Fund (K84036, K112138), the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, and the MTA-ELTE Comparative Ethological Research Group (MTA 01 031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; American Pet Products Association (APPA), 2009, 2010 NAT PET OWN SUR; [Anonymous], PET OWN AUSTR 2013; [Anonymous], 2012, GESCH ZUM JAHR 2012; AVMA, 2012, US PET OWN DEM SOURC; Barrera G, 2010, J VET BEHAV, V5, P339, DOI 10.1016/j.jveb.2010.08.012; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Birkenheuer AJ, 2004, THESIS; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Coppinger Roger, 2002, DOGS NEW UNDERSTANDI; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; Diverio S, 2014, J VET BEHAV, V9, P151, DOI 10.1016/j.jveb.2014.02.007; Egenvall A, 2000, VET REC, V146, P519, DOI 10.1136/vr.146.18.519; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Harvey ND, 2016, J VET BEHAV IN PRESS; Hennessy MB, 1997, PHYSIOL BEHAV, V62, P485, DOI 10.1016/S0031-9384(97)80328-9; Howell TJ, 2015, VET MED-RES REP, V6, P143, DOI 10.2147/VMRR.S62081; Hsu YY, 2010, APPL ANIM BEHAV SCI, V123, P108, DOI 10.1016/j.applanim.2010.01.013; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; McGreevy PD, 2008, APPL ANIM BEHAV SCI, V109, P320, DOI 10.1016/j.applanim.2007.04.001; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Mellanby RJ, 2013, VET J, V196, P92, DOI 10.1016/j.tvjl.2012.08.009; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Ottenheimer-Carrier L, 2016, J VET BEHAV IN PRESS; Patronek GJ, 1995, ANTHROZOOS, V8, P199, DOI 10.2752/089279395787156590; Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171; People's Dispensary for Sick Animals (PDSA), 2013, AN WELLB REP 2013 ST; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Proschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2; Salvin HE, 2012, J VET BEHAV, V7, P61, DOI 10.1016/j.jveb.2011.06.002; Schneider LA, 2013, J VET BEHAV, V8, P124, DOI 10.1016/j.jveb.2012.06.004; Temesi A, 2014, APPL ANIM BEHAV SCI, V161, P121, DOI 10.1016/j.applanim.2014.09.009; Tuber DS, 1999, PSYCHOL SCI, V10, P379, DOI 10.1111/1467-9280.00173; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Wells DL, 2000, APPL ANIM BEHAV SCI, V69, P55, DOI 10.1016/S0168-1591(00)00118-0	40	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172720	10.1371/journal.pone.0172720	http://dx.doi.org/10.1371/journal.pone.0172720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222103	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800079
J	Dawson, MRW; Gupta, M				Dawson, Michael R. W.; Gupta, Maya			Probability matching in perceptrons: Effects of conditional dependence and linear nonseparability	PLOS ONE			English	Article							BINARY VARIABLES; JUDGMENT; CONTINGENCY; INFORMATION; NETWORKS; MODEL	Probability matching occurs when the behavior of an agent matches the likelihood of occurrence of events in the agent's environment. For instance, when artificial neural networks match probability, the activity in their output unit equals the past probability of reward in the presence of a stimulus. Our previous research demonstrated that simple artificial neural networks (perceptrons, which consist of a set of input units directly connected to a single output unit) learn to match probability when presented different cues in isolation. The current paper extends this research by showing that perceptrons can match probabilities when presented simultaneous cues, with each cue signaling different reward likelihoods. In our first simulation, we presented up to four different cues simultaneously; the likelihood of reward signaled by the presence of one cue was independent of the likelihood of reward signaled by other cues. Perceptrons learned to match reward probabilities by treating each cue as an independent source of information about the likelihood of reward. In a second simulation, we violated the independence between cues by making some reward probabilities depend upon cue interactions. We did so by basing reward probabilities on a logical combination (AND or XOR) of two of the four possible cues. We also varied the size of the reward associated with the logical combination. We discovered that this latter manipulation was a much better predictor of perceptron performance than was the logical structure of the interaction between cues. This indicates that when perceptrons learn to match probabilities, they do so by assuming that each signal of a reward is independent of any other; the best predictor of perceptron performance is a quantitative measure of the independence of these input signals, and not the logical structure of the problem being learned.	[Dawson, Michael R. W.; Gupta, Maya] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	University of Alberta	Dawson, MRW (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	mdawson@ualberta.ca	Dawson, Michael RW/R-2573-2018	Dawson, Michael RW/0000-0002-9152-199X				Agresti A, 2002, CATEGORICAL DATA ANA, Vxv; ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; ALLAN LG, 1980, CAN J PSYCHOL, V34, P1, DOI 10.1037/h0081013; ALLAN LG, 1980, B PSYCHONOMIC SOC, V15, P147; Arbib M., 1969, IEEE T INFORM THEORY, V15, P738; Bishop C. M., 2006, PATTERN RECOGNITION, Vxx; Bishop CM, 1995, NEURAL NETWORKS PATT, Vxvii; CHENG PW, 1990, J PERS SOC PSYCHOL, V58, P545, DOI 10.1037/0022-3514.58.4.545; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; Cheng PW, 1995, COMP APPROACHES COGN, P271; Costa RP, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00075; Costa RP, 2015, ELIFE, V4, DOI 10.7554/eLife.09457; Dawson M., 2013, MIND BODY WORLD FDN; Dawson M. R. W., 1998, UNDERSTANDING COGNIT; Dawson M. R. W., 2008, COMP COGNITION BEHAV, V3, P1, DOI DOI 10.3819/CCBR.2008.30008; Dawson MRW, 2008, J EXP PSYCHOL-ANIM L, V34, P415, DOI 10.1037/0097-7403.34.3.415; Dawson MRW, 2005, CONNECTIONISM: A HANDS-ON APPROACH, P1; Dawson MRW, 2010, COGNITION, V114, P207, DOI 10.1016/j.cognition.2009.09.006; Dawson MRW, 2009, IEEE T NEURAL NETWOR, V20, P1368, DOI 10.1109/TNN.2009.2025588; Dawson MRW, 2012, IEEE T NEUR IN PRESS; Dawson MRW., 2004, MINDS AND MACHINES C; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; Dupuis B, 2013, J EXPT PSYCHOL ANIMA; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; RESCORLA RA, 1968, J COMP PHYSIOL PSYCH, V66, P1, DOI 10.1037/h0025984; RESCORLA RA, 1967, PSYCHOL REV, V74, P71, DOI 10.1037/h0024109; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rozanov YA, 1977, PROBABILITY THEORY C, Vix; Rudas T, 1998, ODDS RATIOS ANAL CON, Vvi; Schumacher M, 1996, COMPUT STAT DATA AN, V21, P661, DOI 10.1016/0167-9473(95)00032-1; Shanks DR., 1995, PSYCHOL  ASS LEARNIN; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; WARD WC, 1965, CAN J PSYCHOLOGY, V19, P231, DOI 10.1037/h0082908	38	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172431	10.1371/journal.pone.0172431	http://dx.doi.org/10.1371/journal.pone.0172431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212422	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700050
J	Limbrick, DD; Baksh, B; Morgan, CD; Habiyaremye, G; McAllister, JP; Inder, TE; Mercer, D; Holtzman, DM; Strahle, J; Wallendorf, MJ; Morales, DM				Limbrick, David D., Jr.; Baksh, Brandon; Morgan, Clinton D.; Habiyaremye, Gakwaya; McAllister, James P., II; Inder, Terrie E.; Mercer, Deanna; Holtzman, David M.; Strahle, Jennifer; Wallendorf, Michael J.; Morales, Diego M.			Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; AMYLOID PRECURSOR PROTEIN; KAOLIN-INDUCED HYDROCEPHALUS; WHITE-MATTER DAMAGE; CELL JUNCTION PATHOLOGY; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; POSTHEMORRHAGIC HYDROCEPHALUS; NEUROLOGICAL DISEASES	Introduction Hydrocephalus is a complex neurological disorder with a pervasive impact on the central nervous system. Previous work has demonstrated derangements in the biochemical profile of cerebrospinal fluid ( CSF) in hydrocephalus, particularly in infants and children, in whom neurodevelopment is progressing in parallel with concomitant neurological injury. The objective of this study was to examine the CSF of children with congenital hydrocephalus ( CHC) to gain insight into the pathophysiology of hydrocephalus and identify candidate biomarkers of CHC with potential diagnostic and therapeutic value. Methods CSF levels of amyloid precursor protein ( APP) and derivative isoforms ( sAPP alpha, sAPP beta, A beta(42)), tau, phosphorylated tau ( pTau), L1CAM, NCAM-1, aquaporin 4 ( AQP4), and total protein ( TP) were measured by ELISA in 20 children with CHC. Two comparative groups were included: age-matched controls and children with other neurological diseases. Demographic parameters, ventricular frontal-occipital horn ratio, associated brain malformations, genetic alterations, and surgical treatments were recorded. Logistic regression analysis and receiver operating characteristic curves were used to examine the association of each CSF protein with CHC. Results CSF levels of APP, sAPP alpha, sAPP beta, A beta(42), tau, pTau, L1CAM, and NCAM-1 but not AQP4 or TP were increased in untreated CHC. CSF TP and normalized L1CAM levels were associated with FOR in CHC subjects, while normalized CSF tau levels were associated with FOR in control subjects. Predictive ability for CHC was strongest for sAPPa, especially in subjects <= 12 months of age ( p<0.0001 and AUC = 0.99), followed by normalized sAPP beta ( p = 0.0001, AUC = 0.95), tau, APP, and L1CAM. Among subjects <= 12 months, a normalized CSF sAPP alpha cut-point of 0.41 provided the best prediction of CHC ( odds ratio = 528, sensitivity = 0.94, specificity = 0.97); these infants were 32 times more likely to have CHC. Conclusions CSF proteins such as sAPPa and related proteins hold promise as biomarkers of CHC in infants and young children, and provide insight into the pathophysiology of CHC during this critical period in neurodevelopment.	[Limbrick, David D., Jr.; Baksh, Brandon; Habiyaremye, Gakwaya; McAllister, James P., II; Mercer, Deanna; Strahle, Jennifer; Morales, Diego M.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Limbrick, David D., Jr.; Strahle, Jennifer] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Morgan, Clinton D.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Inder, Terrie E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pediat, Boston, MA USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Barrow Neurological Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL)	Morales, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA.	moralesd@wudosis.wustl.edu	McAllister, James P./N-9657-2019	Morgan, Clinton/0000-0002-7511-0488; Morales, Diego/0000-0001-6672-9046	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075151] Funding Source: NIH RePORTER; NIGMS NIH HHS [T34 GM083914] Funding Source: Medline; NINDS NIH HHS [K23 NS075151] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agren-Wilsson A, 2007, ACTA NEUROL SCAND, V116, P333, DOI 10.1111/j.1600-0404.2007.00890.x; Aojula A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0033-2; Blennow K, 2016, MOVEMENT DISORD, V31, P836, DOI 10.1002/mds.26656; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Del Bigio MR, 2012, J NEUROPATH EXP NEUR, V71, P274, DOI 10.1097/NEN.0b013e31824c1b44; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; Di Curzio DL, 2013, EXP NEUROL, V248, P112, DOI 10.1016/j.expneurol.2013.06.004; Douglas MR, 2009, J NEUROL NEUROSUR PS, V80, P545, DOI 10.1136/jnnp.2008.155671; Eskandari R, 2004, J NEUROSURG, V101, P196, DOI 10.3171/ped.2004.101.2.0196; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; GONZALEZDARDER J, 1984, J NEUROSURG, V61, P918, DOI 10.3171/jns.1984.61.5.0918; Gopal SC, 2008, CHILD NERV SYST, V24, P713, DOI 10.1007/s00381-007-0546-8; Gopal SC, 2007, PEDIATR SURG INT, V23, P571, DOI 10.1007/s00383-006-1689-5; Heep A, 2006, CHILD NERV SYST, V22, P1249, DOI 10.1007/s00381-006-0102-y; Herukka SK, 2015, J ALZHEIMERS DIS, V46, P261, DOI 10.3233/JAD-142862; Huang H, 2016, NEUROCHEM RES, V41, P1713, DOI 10.1007/s11064-016-1887-z; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Jimenez AJ, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28426; Jingami N, 2015, J ALZHEIMERS DIS, V45, P109, DOI 10.3233/JAD-142622; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang K, 2014, J CLIN NEUROSCI, V21, P1398, DOI 10.1016/j.jocn.2013.11.039; Klarica M, 2013, NEUROSCIENCE, V248, P278, DOI 10.1016/j.neuroscience.2013.06.022; Kondziella D, 2002, BRAIN RES, V927, P35, DOI 10.1016/S0006-8993(01)03320-0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Krishnamurthy S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-13; Krishnamurthy S, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-16; Kudo T, 2000, PSYCHIAT CLIN NEUROS, V54, P199, DOI 10.1046/j.1440-1819.2000.00658.x; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Leinonen Ville, 2011, Int J Alzheimers Dis, V2011, P312526, DOI 10.4061/2011/312526; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Lim TS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-66; McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Merhar S, 2012, NEONATOLOGY, V101, P1, DOI 10.1159/000323498; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Morales DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115045; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Morales DM SS, NEUROSURGER IN PRESS; Murlidharan G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88034; Nakajima M, 2015, J NEUROL SCI, V357, P88, DOI 10.1016/j.jns.2015.07.001; Nakajima Madoka, 2010, Rinsho Shinkeigaku, V50, P973; Narita K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00039; Naureen I, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-34; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Ohata S, 2016, TRENDS NEUROSCI; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Pyykko OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091974; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005; Savman K, 2002, ACTA PAEDIATR, V91, P1357; Schirinzi T, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00086; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Schmitz T, 2011, J PERINAT MED, V39, P83, DOI [10.1515/JPM.2010.125, 10.1515/jpm.2010.125]; Schob S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160680; Sendrowski K, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P236; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Tarnaris A, 2009, BIOMARK MED, V3, P787, DOI 10.2217/BMM.09.37; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, CEREBROSPINAL FLUID, V5, P9, DOI DOI 10.1186/1743-8454-5-9; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Waybright T, 2010, J PROTEOMICS, V73, P1156, DOI 10.1016/j.jprot.2010.02.004; Zhang SL, 2013, INT J NEUROSCI, V123, P392, DOI 10.3109/00207454.2012.762363	81	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172353	10.1371/journal.pone.0172353	http://dx.doi.org/10.1371/journal.pone.0172353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212403	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700037
J	Mitchell, NJ; Hsu, HH; Chandyo, RK; Shrestha, B; Bodhidatta, L; Tu, YK; Gong, YY; Egner, PA; Ulak, M; Groopman, JD; Wu, F				Mitchell, Nicole J.; Hsu, Hui-Husan; Chandyo, Ram Krishna; Shrestha, Binob; Bodhidatta, Ladaporn; Tu, Yu-Kang; Gong, Yun-Yun; Egner, Patricia A.; Ulak, Manjeswori; Groopman, John D.; Wu, Felicia			Aflatoxin exposure during the first 36 months of life was not associated with impaired growth in Nepalese children: An extension of the MAL-ED study	PLOS ONE			English	Article							YOUNG-CHILDREN; ALBUMIN ADDUCTS; BIRTH COHORT; BENIN; UNDERNUTRITION; TOGO; DIARRHEA; DEATHS	Exposure to aflatoxin, a mycotoxin common in many foods, has been associated with child growth impairment in sub-Saharan Africa. To improve our understanding of growth impairment in relation to aflatoxin and other risk factors, we assessed biospecimens collected in Nepalese children at 15, 24, and 36 months of age for aflatoxin exposure. Children ( N = 85) enrolled in the Bhaktapur, Nepal MAL-ED study encompassed the cohort analysed in this study. Exposure was assessed through a plasma biomarker of aflatoxin exposure: the AFB1-lysine adduct. The aflatoxin exposures in the study participants were compared to anthropometrics at each time period ( length-for-age [ LAZ], weight-for-age [ WAZ], and weight-for-length [ WLZ] z-scores), growth trajectories over time, age, and breastfeeding status. Results demonstrated chronic aflatoxin exposure in this cohort of children, with a geometric mean of 3.62 pg AFB1-lysine/mg albumin. However, the chronic aflatoxin exposure in this cohort was not significantly associated with anthropometric z-scores, growth trajectories, age, or feeding status, based on the available time points to assess aflatoxin exposure. Low mean levels of aflatoxin exposure and infrequent occurrence of stunting, wasting, or underweight z-score values in this cohort are possible contributing factors to a lack of evidence for an association. Further research is needed to examine whether a threshold dose of aflatoxin exists that could induce child growth impairment.	[Mitchell, Nicole J.; Wu, Felicia] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Hsu, Hui-Husan; Tu, Yu-Kang] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chandyo, Ram Krishna] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Chandyo, Ram Krishna; Ulak, Manjeswori] Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Shrestha, Binob] Walter Reed Armed Forces Res Inst Med Sci, Res Unit, Kathmandu, Nepal; [Bodhidatta, Ladaporn] Armed Forces Res Inst Med Sci, Dept Enter Dis, Bangkok, Thailand; [Gong, Yun-Yun] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Egner, Patricia A.; Groopman, John D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Michigan State University; National Taiwan University; University of Bergen; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Queens University Belfast; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wu, F (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	fwu@msu.edu	Gong, Yun Yun/C-8412-2018; Gong, Yun Yun/L-7094-2016; /X-4205-2019	Gong, Yun Yun/0000-0003-4927-5526; Gong, Yun Yun/0000-0003-4927-5526; /0000-0003-4690-2133; Tu, Yu-Kang/0000-0002-2461-474X				Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Applegate TJ, 2009, POULTRY SCI, V88, P1235, DOI 10.3382/ps.2008-00494; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bodine AB, 1983, SO COOPERATIVE SERIE, V279; CAST, 2003, MYCOTOXINS RISKS PLA; Caulfield LE, 2014, CLIN INFECT DIS, V59, pS248, DOI 10.1093/cid/ciu421; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Central Bureau of Statistics & UNICEF Nepal, 2015, MULT IND CLUST SURV; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Egal S, 2005, INT J FOOD MICROBIOL, V104, P215, DOI 10.1016/j.ijfoodmicro.2005.03.004; Ghosh A, 2009, ANN HUM BIOL, V36, P38, DOI 10.1080/03014460802555650; Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954; Gong YY, 2003, INT J EPIDEMIOL, V32, P556, DOI 10.1093/ije/dyg109; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Grantham-McGregor Sally M., 1999, Food and Nutrition Bulletin, V20, P53; Groopman JD, 2014, FOOD CHEM TOXICOL, V74, P184, DOI 10.1016/j.fct.2014.09.016; Houpt E, 2014, CLIN INFECT DIS, V59, pS225, DOI 10.1093/cid/ciu413; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Koirala P, 2005, Indian J Med Sci, V59, P331; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Mccoy LF, 2008, CANCER EPIDEM BIOMAR, V17, P1653, DOI 10.1158/1055-9965.EPI-07-2780; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Mitchell N.J., 2016, J EXPO SCI ENV EPIDE; Mitchell NJ, 2016, FOOD ADDIT CONTAM A, V33, P540, DOI 10.1080/19440049.2016.1138545; OKUMURA H, 1993, CARCINOGENESIS, V14, P1233, DOI 10.1093/carcin/14.6.1233; Partanen HA, 2010, TOXICOL SCI, V113, P216, DOI 10.1093/toxsci/kfp257; Patil CL, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0004-2; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Psaki S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-24; Psaki SR, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-8; Richard SA, 2014, CLIN INFECT DIS, V59, pS255, DOI 10.1093/cid/ciu436; Scholl PF, 2006, CANCER EPIDEM BIOMAR, V15, P823, DOI 10.1158/1055-9965.EPI-05-0890; Shirima CP, 2015, ENVIRON HEALTH PERSP, V123, P173, DOI 10.1289/ehp.1408097; Shrestha PS, 2014, CLIN INFECT DIS, V59, pS300, DOI 10.1093/cid/ciu459; Smith LE, 2011, ADV NUTR, V3, P1; Turner PC, 2007, INT J EPIDEMIOL, V36, P1119, DOI 10.1093/ije/dym122; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; World Health Organization, 1997, WHO GLOB DAT CHILD G; Wu F, 2011, WORLD MYCOTOXIN J, V4, P79, DOI 10.3920/WMJ2010.1246; Yunus AW, 2011, POULTRY SCI, V90, P1683, DOI 10.3382/ps.2011-01448	42	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172124	10.1371/journal.pone.0172124	http://dx.doi.org/10.1371/journal.pone.0172124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212415	Green Published, gold			2022-12-26	WOS:000394424700018
J	Nakano, M; Arai, Y; Kotera, I; Okabe, K; Kamei, Y; Nagai, T				Nakano, Masahiro; Arai, Yoshiyuki; Kotera, Ippei; Okabe, Kohki; Kamei, Yasuhiro; Nagai, Takeharu			Genetically encoded ratiometric fluorescent thermometer with wide range and rapid response	PLOS ONE			English	Article							SINGLE-CELL THERMOMETRY; 10(5) GAP ISSUE; INTRACELLULAR TEMPERATURE; POLYMERIC THERMOMETER; LIVING CELLS; IN-VIVO; PROTEIN; THERMOSENSORS; MITOCHONDRIA; VARIANTS	Temperature is a fundamental physical parameter that plays an important role in biological reactions and events. Although thermometers developed previously have been used to investigate several important phenomena, such as heterogeneous temperature distribution in a single living cell and heat generation in mitochondria, the development of a thermometer with a sensitivity over a wide temperature range and rapid response is still desired to quantify temperature change in not only homeotherms but also poikilotherms from the cellular level to in vivo. To overcome the weaknesses of the conventional thermometers, such as a limitation of applicable species and a low temporal resolution, owing to the narrow temperature range of sensitivity and the thermometry method, respectively, we developed a genetically encoded ratiometric fluorescent temperature indicator, gTEMP, by using two fluorescent proteins with different temperature sensitivities. Our thermometric method enabled a fast tracking of the temperature change with a time resolution of 50 ms. We used this method to observe the spatiotemporal temperature change between the cytoplasm and nucleus in cells, and quantified thermogenesis from the mitochondria matrix in a single living cell after stimulation with carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, which was an uncoupler of oxidative phosphorylation. Moreover, exploiting the wide temperature range of sensitivity from 5 degrees C to 50 degrees C of gTEMP, we monitored the temperature in a living medaka embryo for 15 hours and showed the feasibility of in vivo thermometry in various living species.	[Nakano, Masahiro; Arai, Yoshiyuki; Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan; [Kotera, Ippei] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Okabe, Kohki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Okabe, Kohki] JST, PRESTO, Kawaguchi, Saitama, Japan; [Kamei, Yasuhiro] Natl Inst Basic Biol, Okazaki, Aichi, Japan	Osaka University; Hokkaido University; University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nagai, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan.	ng1@sanken.osaka-u.ac.jp	Kamei, Yasuhiro/AAD-9281-2019	Kamei, Yasuhiro/0000-0001-6382-1365; Nagai, Takeharu/0000-0003-2650-9895				Arai S, 2015, CHEM COMMUN, V51, P8044, DOI 10.1039/c5cc01088h; Baffou G, 2015, NAT METHODS, V12, P803, DOI 10.1038/nmeth.3552; Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/nmeth.3891, 10.1038/NMETH.3891]; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Gota C, 2009, J AM CHEM SOC, V131, P2766, DOI 10.1021/ja807714j; Hayashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117677; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kitano T, 2012, MOL REPROD DEV, V79, P719, DOI 10.1002/mrd.22080; Kiyonaka S, 2015, NAT METHODS, V12, P801, DOI 10.1038/nmeth.3548; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/NMETH.2690, 10.1038/nmeth.2690]; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Kummer AD, 2002, CHEMBIOCHEM, V3, P659, DOI 10.1002/1439-7633(20020703)3:7<659::AID-CBIC659>3.0.CO;2-U; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; NAKAMURA T, 1978, J BIOCHEM-TOKYO, V84, P39, DOI 10.1093/oxfordjournals.jbchem.a132117; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Suzuki M, 2015, NAT METHODS, V12, P802, DOI 10.1038/nmeth.3551; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tanimoto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22071; Tiwari DK, 2015, NAT METHODS, V12, P515, DOI 10.1038/nmeth.3362; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Uchiyama S, 2015, ANALYST, V140, P4498, DOI 10.1039/c5an00420a; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Yatsu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18581; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	26	61	62	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172344	10.1371/journal.pone.0172344	http://dx.doi.org/10.1371/journal.pone.0172344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212432	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700035
J	Kala, A; Kamra, DN; Kumar, A; Agarwal, N; Chaudhary, LC; Joshi, CG				Kala, Anju; Kamra, D. N.; Kumar, Avinash; Agarwal, Neeta; Chaudhary, L. C.; Joshi, C. G.			Impact of levels of total digestible nutrients on microbiome, enzyme profile and degradation of feeds in buffalo rumen	PLOS ONE			English	Article							REAL-TIME PCR; CELLULOLYTIC BACTERIA; COLORIMETRIC DETERMINATION; CATTLE; DIVERSITY; ACID; DIET; FERMENTATION; POPULATIONS; ADAPTATION	The present study was aimed at understanding a shift in rumen microbiome of buffaloes fed various levels of total digestible nutrients. To understand the process, the metagenomics of rumen microbes, in vivo and in vitro rumen fermentation studies were carried out. Three rumen fistulated adult male Murrah buffaloes were fed three isonitrogenous diets varying in total digestible nutrients (70, 85 and 100% of TDN requirement) in 3X3 switch over design. On dry matter basis, wheat straw/roughage content were 81, 63 and 51% and that of maize grain was 8, 16 and 21% in three diets respectively. After 20 d of feeding, rumen liquor and rumen contents were sampled just before (0h) and 4h post feeding. Ruminococcus flavefaciens and R. albus (estimated with real time PCR) were higher in high roughage diets. The predominant phyla in all the three groups were Bacteroidetes, Firmicutes followed by Proteobacteria, Actinobacteria and Fibrobacteres. A core group of more than fifty rumen bacteria was present in all the animals with very little variations due to level of TDN. The most predominant bacterial genera reported in order of decreasing abundance were: Prevotella, Bacteroides, Clostridium, Ruminococcus, Eubacterium, Parabacteroides, Fibrobacter, Butyrivibrio etc. The higher diversity of the enyzmes families GH 23, GH 28, GH 39, GH 97, GH 106, and GH 127 (the enzymes active in fibre and starch degradation) were significantly higher on 100% TDN diet while CE 14 (required for the hydrolysis of bond between carbohydrate and lignin) was higher on low TDN (70%) diet, indicating ester bond cleavage was better in animals fed high roughage (wheat straw) diet.	[Kala, Anju; Kamra, D. N.; Kumar, Avinash; Agarwal, Neeta; Chaudhary, L. C.] Indian Vet Res Inst, Ctr Adv Fac Training Anim Nutr, ICAR Natl Professorial Chair, Izatnagar, Uttar Pradesh, India; [Joshi, C. G.] Anand Agr Univ, Coll Vet Sci, Dept Biotechnol, Anand, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Anand Agricultural University	Kala, A (corresponding author), Indian Vet Res Inst, Ctr Adv Fac Training Anim Nutr, ICAR Natl Professorial Chair, Izatnagar, Uttar Pradesh, India.	anjukalavet2002@gmail.com	Joshi, Chaitanya G/AAK-1842-2020	Joshi, Chaitanya G/0000-0003-4680-2861	Indian Council of Agricultural Research, Ministry of agriculture, India [27(17)/2011-HRD]	Indian Council of Agricultural Research, Ministry of agriculture, India	This work was funded by a grant recieved from Indian Council of Agricultural Research, Ministry of agriculture, India via F.No. 27(17)/2011-HRD dated 24/12/2012 to DNK.	Agarwal N, 2000, J APPL ANIM RES, V18, P73, DOI 10.1080/09712119.2000.9706325; Agarwal N, 2008, ASIAN AUSTRAL J ANIM, V21, P818, DOI 10.5713/ajas.2008.70336; Atis I, 2012, INT J AGRIC BIOL, V14, P879; Barker SB, 1941, J BIOL CHEM, V138, P535; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; Dai X, 2015, APPL ENVIRON MICROB, V81, P1375, DOI 10.1128/AEM.03682-14; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Jesus Raphael Barbetta de, 2015, Acta Sci., Anim. Sci., V37, P251, DOI 10.4025/actascianimsci.v37i3.26535; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Harper D, 2001, PAST PALAEONTOLOGICA; Hristov AN, 1999, CAN J ANIM SCI, V79, P73, DOI 10.4141/A98-056; HUGGINS C, 1947, J BIOL CHEM, V170, P467; ICAR, 2013, NUTRIENT REQUIREMENT; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kamra DN, 2005, CURR SCI INDIA, V89, P124; Kamra DN, 2013, INT TRAINING COURSE, P48; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Li YD, 2014, ANN MICROBIOL, V64, P1385, DOI 10.1007/s13213-013-0783-x; Lim S, 2013, ASIAN AUSTRAL J ANIM, V26, P1144, DOI 10.5713/ajas.2013.13219; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; SHEWALE JG, 1978, CAN J MICROBIOL, V24, P1204, DOI 10.1139/m78-195; Singh KM, 2011, MOL BIOL REP; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sun YZ, 2010, ANIMAL, V4, P210, DOI 10.1017/S175173110999111X; Tapio I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151220; Van Soest P. J., 1988, LAB MANUAL ANIMAL SC, V612; Wallace RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2032-0; Wanapat M, 2009, CURR MICROBIOL, V58, P294, DOI 10.1007/s00284-008-9322-6; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Zhao LP, 2015, ASIAN AUSTRAL J ANIM, V28, P1433, DOI 10.5713/ajas.15.0091	44	29	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172051	10.1371/journal.pone.0172051	http://dx.doi.org/10.1371/journal.pone.0172051			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207851	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500078
J	Shelake, RM; Ito, Y; Masumoto, J; Morita, EH; Hayashi, H				Shelake, Rahul Mahadev; Ito, Yuki; Masumoto, Junya; Morita, Eugene Hayato; Hayashi, Hidenori			A novel mechanism of "metal gel -shift" by histidine-rich Ni2+-binding Hpn protein from Helicobacter pylori strain SS1	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; SODIUM DODECYL-SULFATE; SDS-PAGE MIGRATION; MASS-SPECTROMETRY; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; BINDING PROTEINS; ZINC-BINDING; ICP-MS; ELECTROPHORESIS	Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is a universally used method for determining approximate molecular weight (MW) in protein research. Migration of protein that does not correlate with formula MW, termed "gel shifting" appears to be common for histidine-rich proteins but not yet studied in detail. We investigated "gel shifting" in Ni2+-binding histidine-rich Hpn protein cloned from Helicobacter pylori strain SS1. Our data demonstrate two important factors determining "gel shifting" of Hpn, polyacrylamide-gel concentration and metal binding. Higher polyacrylamide-gel concentrations resulted in faster Hpn migration. Irrespective of polyacrylamide-gel concentration, preserved Hpn-Ni2+ complex migrated faster (3-4 kDa) than apo-Hpn, phenomenon termed "metal gel-shift" demonstrating an intimate link between Ni2+ binding and "gel shifting". To examine this discrepancy, eluted samples from corresponding spots on SDS-gel were analyzed by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOFMS). The MW of all samples was the same (6945.66 +/- 0.34 Da) and identical to formula MW with or without added mass of Ni2+. MALDI-TOF-MS of Ni2+-treated Hpn revealed that monomer bound up to six Ni2+ ions non-cooperatively, and equilibrium between protein metal species was reliant on Ni2+ availability. This corroborates with gradually increased heterogeneity of apo-Hpn band followed by compact "metal-gel shift" band on SDS-PAGE. In view of presented data metal-binding and "metal-gel shift" models are discussed.	[Shelake, Rahul Mahadev; Ito, Yuki; Masumoto, Junya; Hayashi, Hidenori] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan; [Morita, Eugene Hayato] Ehime Univ, Lab Mol Cell Physiol, Fac Agr, Matsuyama, Ehime, Japan; [Morita, Eugene Hayato] Josai Univ, Dept Chem, Fac Sci, Saitama, Japan	Ehime University; Ehime University; Josai University	Hayashi, H (corresponding author), Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan.	hayashi.hidenori.mj@ehime-u.ac.jp	Shelake, Rahul Mahadev/H-8349-2019	Shelake, Rahul Mahadev/0000-0003-0691-560X				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akiyama H, 1998, DNA Res, V5, P327, DOI 10.1093/dnares/5.6.327; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Binet MRB, 2003, ANAL BIOCHEM, V318, P30, DOI 10.1016/S0003-2697(03)00190-8; Brayman TG, 1996, J BACTERIOL, V178, P5410, DOI 10.1128/jb.178.18.5410-5416.1996; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Chen F, 2007, MASS SPECTROM REV, V26, P223; Chen SH, 2014, J AM CHEM SOC, V136, P9499, DOI 10.1021/ja5047878; Chiera NM, 2013, METALLOMICS, V5, P214, DOI 10.1039/c3mt20166j; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; DAMIANI E, 1991, BIOCHEM J, V277, P825, DOI 10.1042/bj2770825; de Reuse H, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00094; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Finney L, 2010, ACS CHEM BIOL, V5, P577, DOI 10.1021/cb1000263; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gao YX, 2003, ANAL CHIM ACTA, V485, P131, DOI 10.1016/S0003-2670(03)00347-7; Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160; Ge RG, 2006, J AM CHEM SOC, V128, P11330, DOI 10.1021/ja062589t; GILBERT JV, 1995, INFECT IMMUN, V63, P2682, DOI 10.1128/IAI.63.7.2682-2688.1995; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jin Y, 2005, ELECTROPHORESIS, V26, P1019, DOI 10.1002/elps.200410187; Kaluarachchi H, 2009, J AM CHEM SOC, V131, P18489, DOI 10.1021/ja9081765; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Kohler C, 2000, FEBS LETT, V471, P133, DOI 10.1016/S0014-5793(00)01383-1; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Laemmli UK, 1970, NATURE, P680; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Mena ML, 2011, J CHROMATOGR A, V1218, P1281, DOI 10.1016/j.chroma.2010.12.115; Mahadev SR, 2013, PROTEIN J, V32, P626, DOI 10.1007/s10930-013-9525-y; Mobley HLT, 1999, HELICOBACTER, V4, P162, DOI 10.1046/j.1523-5378.1999.99286.x; Nowakowski AB, 2014, METALLOMICS, V6, P1068, DOI 10.1039/c4mt00033a; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; PANAYOTATOS N, 1993, J BIOL CHEM, V268, P19000; Pinato O, 2013, J INORG BIOCHEM, V122, P27, DOI 10.1016/j.jinorgbio.2013.01.007; PITTRIVE.R, 1968, BIOCHEM J, V109, P825, DOI 10.1042/bj1090825; Raab A, 2009, ELECTROPHORESIS, V30, P303, DOI 10.1002/elps.200800264; Rath A, 2013, P NATL ACAD SCI USA, V110, P15668, DOI 10.1073/pnas.1311305110; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Romeis T, 2011, CALCIUM DEPENDENT PR, V4, DOI [10.1093/mp/ssq064, DOI 10.1093/MP/SSQ064]; Rowinska-Zyrek M, 2011, DALTON T, V40, P5604, DOI 10.1039/c1dt10187k; Saha S, 2009, J BIOL CHEM, V284, P27135, DOI 10.1074/jbc.M109.020032; Schlosser G, 2003, RAPID COMMUN MASS SP, V17, P2741, DOI 10.1002/rcm.1239; Seshadri S, 2007, J BACTERIOL, V189, P4120, DOI 10.1128/JB.01245-06; Shi R, 2010, BIOCHEMISTRY-US, V49, P7080, DOI 10.1021/bi100372h; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Solis C, 1998, NUCL INSTRUM METH B, V136, P928, DOI 10.1016/S0168-583X(97)00896-3; Strupat K, 2005, METHOD ENZYMOL, V405, P1, DOI 10.1016/S0076-6879(05)05001-9; Sussulini A, 2011, METALLOMICS, V3, P1271, DOI 10.1039/c1mt00116g; Sutherland DEK, 2008, BIOCHEM BIOPH RES CO, V372, P840, DOI 10.1016/j.bbrc.2008.05.142; Szajli E, 2008, MOL CELL PROTEOMICS, V7, P2410, DOI 10.1074/mcp.M800108-MCP200; Tham SJ, 2010, BIOSCI BIOTECH BIOCH, V74, P727, DOI 10.1271/bbb.90773; Tulumello DV, 2011, BIOCHEMISTRY-US, V50, P3928, DOI 10.1021/bi200238g; Verbi FM, 2005, J BIOCHEM BIOPH METH, V62, P97, DOI 10.1016/j.jbbm.2004.09.008; Vinella D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005312; Watanabe Y, 2005, J IMMUNOL METHODS, V300, P115, DOI 10.1016/j.jim.2005.02.014; Wegner SV, 2011, CHEM SCI, V2, P451, DOI 10.1039/c0sc00411a; Weseloh G, 2004, J RADIOANAL NUCL CH, V259, P473, DOI 10.1023/B:JRNC.0000020921.66046.1c; Witkowska D, 2012, CHEM-EUR J, V18, P11088, DOI 10.1002/chem.201200780; Yamauchi S, 2012, EXTREMOPHILES, V16, P871, DOI 10.1007/s00792-012-0483-7; Yoon GM, 1999, PLANT MOL BIOL, V39, P991, DOI 10.1023/A:1006170512542	68	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172182	10.1371/journal.pone.0172182	http://dx.doi.org/10.1371/journal.pone.0172182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207866	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500095
J	Abadi, SH; Tolstoy, M; Wilcock, WSD				Abadi, Shima H.; Tolstoy, Maya; Wilcock, William S. D.			Estimating the location of baleen whale calls using dual streamers to support mitigation procedures in seismic reflection surveys	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; NORTHEAST PACIFIC; DIVE PROFILES; FIN WHALES; ARRAY; TRACKING; SEA; OCEAN; BLUE	In order to mitigate against possible impacts of seismic surveys on baleen whales it is important to know as much as possible about the presence of whales within the vicinity of seismic operations. This study expands on previous work that analyzes single seismic streamer data to locate nearby calling baleen whales with a grid search method that utilizes the propagation angles and relative arrival times of received signals along the streamer. Three dimensional seismic reflection surveys use multiple towed hydrophone arrays for imaging the structure beneath the seafloor, providing an opportunity to significantly improve the uncertainty associated with streamer-generated call locations. All seismic surveys utilizing airguns conduct visual marine mammal monitoring surveys concurrent with the experiment, with powering-down of seismic source if a marine mammal is observed within the exposure zone. This study utilizes data from power-down periods of a seismic experiment conducted with two 8-km long seismic hydrophone arrays by the R/V Marcus G. Langseth near Alaska in summer 2011. Simulated and experiment data demonstrate that a single streamer can be utilized to resolve left-right ambiguity because the streamer is rarely perfectly straight in a field setting, but dual streamers provides significantly improved locations. Both methods represent a dramatic improvement over the existing Passive Acoustic Monitoring (PAM) system for detecting low frequency baleen whale calls, with similar to 60 calls detected utilizing the seismic streamers, zero of which were detected using the current R/V Langseth PAM system. Furthermore, this method has the potential to be utilized not only for improving mitigation processes, but also for studying baleen whale behavior within the vicinity of seismic operations.	[Abadi, Shima H.] Univ Washington, Sch STEM, Bothell, WA 98011 USA; [Tolstoy, Maya] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Wilcock, William S. D.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Bothell; Columbia University; University of Washington; University of Washington Seattle	Abadi, SH (corresponding author), Univ Washington, Sch STEM, Bothell, WA 98011 USA.	abadi@uw.edu		Wilcock, William/0000-0001-7224-7246	National Science Foundation [OCE12-14328]	National Science Foundation(National Science Foundation (NSF))	OCE12-14328, National Science Foundation (https://www.nsf.gov), MT.	Abadi SH, 2015, J ACOUST SOC AM, V138, P3951, DOI 10.1121/1.4937768; Abadi SH, 2014, J ACOUST SOC AM, V136, P130, DOI 10.1121/1.4881924; Baker K., 2013, NATL STANDARDS PROTE; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Blackwell SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125720; Crone T. J., 2014, GEOCHEM GEOPHYS GEOS; Diebold JB, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003216; Gambell R, 1985, HDB MARINE MAMMALS, P3171; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104733; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Guerra M, 2011, J ACOUST SOC AM, V130, P3046, DOI 10.1121/1.3628326; Lee S, 2006, J ACOUST SOC AM, V119, P336, DOI 10.1121/1.2139074; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; McCauley R. D., 1998, APPEA J, P692; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; PORTER M, 1984, J ACOUST SOC AM, V76, P244, DOI 10.1121/1.391101; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Shillington DJ, 2015, NAT GEOSCI, V8, P961, DOI [10.1038/ngeo2586, 10.1038/NGEO2586]; Sirovic A, 2013, MAR BIOL, V160, P47, DOI 10.1007/s00227-012-2061-z; Thode A, 2005, J ACOUST SOC AM, V118, P3575, DOI 10.1121/1.2049068; Thode A, 2004, J ACOUST SOC AM, V116, P245, DOI 10.1121/1.1758972; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; Tolstoy M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020234; Tolstoy M., 2009, GEOCHEM GEOPHY GEOSY, P10; Tran DD, 2014, J ACOUST SOC AM, V135, P3352, DOI 10.1121/1.4874601; WATKINS WA, 1981, SCI REP WHALES RES, V33, P83; Wilcock WSD, 2012, J ACOUST SOC AM, V132, P2408, DOI 10.1121/1.4747017	28	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171115	10.1371/journal.pone.0171115	http://dx.doi.org/10.1371/journal.pone.0171115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199400	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400024
J	Aziz, S; Wik, E; Knutsvik, G; Klingen, TA; Chen, Y; Davidsen, B; Aas, H; Aas, T; Akslen, LA				Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Klingen, Tor Audun; Chen, Ying; Davidsen, Benedicte; Aas, Hans; Aas, Turid; Akslen, Lars A.			Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer	PLOS ONE			English	Article							EXTRACAPSULAR EXTENSION; POSTOPERATIVE IRRADIATION; TUMOR BURDEN; RECURRENCE; METASTASIS; DISSECTION; EXPRESSION; SPREAD; SIZE	Presence of lymph node (LN) metastasis is a strong prognostic factor in breast cancer, whereas the importance of extra-nodal extension and other nodal tumor features have not yet been fully recognized. Here, we examined microscopic features of lymph node metastases and their prognostic value in a population-based cohort of node positive breast cancer (n = 218), as part of the prospective Norwegian Breast Cancer Screening Program NBCSP (1996-2009). Sections were reviewed for the largest metastatic tumor diameter (TD-MET), nodal afferent and efferent vascular invasion (AVI and EVI), extra-nodal extension (ENE), number of ENE foci, as well as circumferential (CD-ENE) and perpendicular (PD-ENE) diameter of extra-nodal growth. Number of positive lymph nodes, EVI, and PD-ENE were significantly increased with larger primary tumor (PT) diameter. Univariate survival analysis showed that several features of nodal metastases were associated with disease-free (DFS) or breast cancer specific survival (BCSS). Multivariate analysis demonstrated an independent prognostic value of PD-ENE (with 3 mm as cut-off value) in predicting DFS and BCSS, along with number of positive nodes and histologic grade of the primary tumor (for DFS: P= 0.01, P= 0.02, P= 0.01, respectively; for BCSS: P = 0.02, P = 0.008, P= 0.02, respectively). To conclude, the extent of ENE by its perpendicular diameter was independently prognostic and should be considered in line with nodal tumor burden in treatment decisions of node positive breast cancer.	[Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Klingen, Tor Audun; Chen, Ying; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Klingen, Tor Audun] Vestfold Hosp Trust, Dept Pathol, Tonsberg, Norway; [Chen, Ying] Akershus Univ Hosp, Dept Pathol, Lorenskog, Norway; [Davidsen, Benedicte; Aas, Turid] Haukeland Hosp, Dept Surg, Bergen, Norway; [Aas, Hans] Vestfold Hosp Trust, Dept Surg, Tonsberg, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway.; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	lars.akslen@uib.no	Akslen, Lars A/C-1202-2017; Wik, E./AAA-9105-2020; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Akslen, Lars A./0000-0003-2710-9543	Research Council of Norway through its Centre of Excellence [223250]; Norwegian Cancer Society, Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen; Vestfold Hospital Research Fund	Research Council of Norway through its Centre of Excellence(Research Council of Norway); Norwegian Cancer Society, Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen; Vestfold Hospital Research Fund	This work was partly supported by the Research Council of Norway through its Centre of Excellence funding scheme, project number 223250 (received by LA). The study was also supported by the Norwegian Cancer Society, Helse Vest RHF, and the Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen and Vestfold Hospital Research Fund.	Aziz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150979; Bucci JA, 2001, BREAST, V10, P213, DOI 10.1054/brst.2000.0233; Chen Y, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0230-8; Choi AH, 2014, AM SURGEON, V80, P932; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Colleoni M, 2005, J CLIN ONCOL, V23, P1379, DOI 10.1200/JCO.2005.07.094; Cserni G, 2008, J CLIN PATHOL, V61, P115, DOI 10.1136/jcp.2007.047357; Cserni G, 1990, EUR J CANCER, V44, P2185; Dobi E, 2013, INT J CLIN ONCOL, V18, P607, DOI 10.1007/s10147-012-0439-z; Drinka E, 2015, METASTATIC TUMOR VOL; Fan YG, 2005, ANN SURG ONCOL, V12, P705, DOI 10.1245/ASO.2005.08.020; Gooch J, 2014, ANN SURG ONCOL, V21, P2897, DOI 10.1245/s10434-014-3752-0; Hartveit FM, 2000, ACTA ONCOL, V39, P309, DOI 10.1080/028418600750013069; Katz A, 2000, J CLIN ONCOL, V18, P2817, DOI 10.1200/JCO.2000.18.15.2817; Klingen TA, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-80; Knutsvik G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112121; Neri A, 2005, ANN SURG ONCOL, V12, P246, DOI 10.1245/ASO.2005.02.029; Nottegar A, 2016, EUROPEAN J SURG ONCO; ROSEN PP, 1981, ANN SURG, V194, P585, DOI 10.1097/00000658-198111000-00006; Stitzenberg KB, 2003, ANN SURG, V237, P607, DOI 10.1097/00000658-200305000-00002; Stranzl H, 2006, STRAHLENTHER ONKOL, V182, P583, DOI 10.1007/s00066-006-1562-4	21	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171853	10.1371/journal.pone.0171853	http://dx.doi.org/10.1371/journal.pone.0171853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199370	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400052
J	Kim, B; Kim, SZ; Lee, J; Jung, AH; Jung, SH; Hahn, HJ; Kang, HR; Suh, DI				Kim, Bomi; Kim, Sunwha Zara; Lee, Jin; Jung, Ae Hee; Jung, Sun-Hoi; Hahn, Hyeon-Joo; Kang, Hye Ryun; Suh, Dong In			Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions	PLOS ONE			English	Article							OFF-LABEL; CARE; PHARMACOVIGILANCE; SAFETY; COHORT; WARDS; ADR	Children with complex chronic conditions (CCC) are presumed to be vulnerable to adverse drug reactions (ADRs). The clinical profiles of ADRs in CCC are not well known. Herein, we aim to describe the ADR profiles in CCC with regard to typical presentations and vulnerable groups. We accessed the ADR yearly reports at a tertiary children's hospital whose practice is mainly dedicated to CCC and descriptively analyzed their clinical profiles according to the presence of a complex chronic condition, ADR severity, and age groups. A total of 1841 cases were analyzed, among which 1258 (68.3%) were mild, 493 (26.8%) moderate, and 90 (4.9%) cases were severe. A total of 1581 (85.9%) cases of complex chronic condition were reported. The proportion of CCC in each severity group increased as the ADR becomes more severe. In CCC, ADRs were most frequently reported by nurses in the adolescent group and in cases where the symptoms involved the gastrointestinal system. The class of antineoplastic and immunomodulating drugs was the most commonly suspected of causing an ADR, followed by one of the antibiotics. When we focus on the trend across the age groups, the ratio of severe-to-total ADRs decreased with older age. Among severe cases, the ratio of off-label prescription-related cases was the highest in the infant/toddler group and decreased as the groups aged. In conclusion, ADRs of CCCs admitted to a tertiary children's hospital have a unique profile. These groups are vulnerable to ADRs and thus they should be monitored closely, especially when they are infants or toddlers, so that severe ADRs can be identified and treated immediately.	[Kim, Bomi; Lee, Jin; Jung, Ae Hee; Jung, Sun-Hoi; Hahn, Hyeon-Joo] Seoul Natl Univ Hosp, Dept Pharm, Seoul, South Korea; [Kim, Sunwha Zara] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China; [Lee, Jin; Kang, Hye Ryun; Suh, Dong In] Seoul Natl Univ Hosp, Reg Drug Safety Monitoring Ctr, Seoul, South Korea; [Kang, Hye Ryun] Seoul Natl Univ Hosp, Dept Internal Med, Div Allergy, Seoul, South Korea; [Suh, Dong In] Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Fudan University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Suh, DI (corresponding author), Seoul Natl Univ Hosp, Reg Drug Safety Monitoring Ctr, Seoul, South Korea.; Suh, DI (corresponding author), Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea.	dongins0@snu.ac.kr		Suh, Dong In/0000-0002-7817-8728				Aagaard L, 2010, DRUG SAFETY, V33, P327, DOI 10.2165/11319100-000000000-00000; Lobo MGAD, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-5; Baek HJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3151-z; Bellis JR, 2014, BRIT J CLIN PHARMACO, V77, P545, DOI 10.1111/bcp.12222; Bergqvist M, 2008, EUR J CLIN PHARMACOL, V64, P451, DOI 10.1007/s00228-007-0449-3; chungjihyeon, 2013, [Journal of Korean Society of Health-System Pharmacists, 병원약사회지], V30, P108; Dang A, 2012, J CLIN DIAGN RES, V6, P1504, DOI 10.7860/JCDR/2012/4340.2544; Digra KK, 2015, CLIN MED INSIGHTS-PE, V9, P73, DOI 10.4137/CMPed.S29493; European Commission, 2014, CHMP43704 REV 1, P1; Feudtner C., 2000, PEDIATRICS 2, V106, P205; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Gholami K, 2015, J RES PHARM PRACT, V4, P212, DOI 10.4103/2279-042X.167045; Gor AP, 2008, INDIAN J PHARMACOL, V40, P37, DOI 10.4103/0253-7613.40488; Haile DB, 2013, ETHIOP J HEALTH SCI, V23, P39; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; ICH, 2022, E11A PED EXTR ICH AP; Ilhan MN, 2009, PHARMACOEPIDEM DR S, V18, P1150, DOI 10.1002/pds.1829; Kairuz TE, 2007, CURR DRUG SAF, V2, P89; Kim HM, 2012, KOREAN SOC PHARMACOE, V5, P40; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089829; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Patidar Dindayal, 2013, Interdiscip Toxicol, V6, P41, DOI 10.2478/intox-2013-0008; Rehan HS, 2012, CURR DRUG SAF, V7, P384, DOI 10.2174/1574886311207050011; Rosli R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155385; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Smith PB, 2008, PEDIATRICS, V122, pE628, DOI 10.1542/peds.2008-0585; Srivastava R, 2005, PEDIATR CLIN N AM, V52, P1165, DOI 10.1016/j.pcl.2005.03.007; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; Thiesen S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-237; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; U.S. Food and Drug Administration, 2020, FDA ONL LAB REP; Ufer M, 2004, PHARMACOEPIDEM DR S, V13, P147, DOI 10.1002/pds.858; Valente S, 2007, J NURS CARE QUAL, V22, P322, DOI 10.1097/01.NCQ.0000290413.04522.0b; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Wallerstedt SM, 2011, DRUG SAFETY, V34, P669, DOI 10.2165/11591730-000000000-00000; WHO-UMC, US WHO UMC SYST STAN; World Health Organization the UMC, WHO ART WHO ADV REAC; 김정미, 2015, [Journal of Korean Society of Health-System Pharmacists, 병원약사회지], V32, P318	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172425	10.1371/journal.pone.0172425	http://dx.doi.org/10.1371/journal.pone.0172425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199420	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400091
J	Wang, XF; Hui, Y; Zhao, L; Hao, YL; Guo, HY; Ren, FZ				Wang, Xifan; Hui, Yan; Zhao, Liang; Hao, Yanling; Guo, Huiyuan; Ren, Fazheng			Oral administration of Lactobacillus paracasei L9 attenuates PM2.5-induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma	PLOS ONE			English	Article							IL-17 FAMILY CYTOKINES; REGULATORY T-CELLS; MOUSE MODEL; TH17 CELLS; POLLUTION; MICE; INFLAMMATION; PROBIOTICS; PARTICLES; METAL	This study investigated allergy immunotherapy potential of Lactobacillus paracasei L9 to prevent or mitigate the particulate matter 2.5 (PM2.5) enhanced pre-existing asthma in mice. Firstly, we used a mouse model of asthma (a 21-day ovalbumin (OVA) sensitization and challenge model) followed by PM2.5 exposure twice on the same day of the last challenge. PM2.5 was collected from the urban area of Beijing and underwent analysis for metals and polycyclic aromatic hydrocarbon contents. The results showed that PM2.5 exposure enhanced airway hyper-responsiveness (AHR) and lead to a mixed Th2/IL-17 response in asthmatic mice. Secondly, the PM2.5 exposed asthmatic mice were orally administered with L9 (4x10(7), 4x10(9) CFU/mouse, day) from the day of first sensitization to the endpoint, for 20 days, to investigate the potential mitigative effect of L9 on asthma. The results showed that L9 ameliorated PM2.5 exposure enhanced AHR with an approximate 50% decrease in total airway resistance response to methacholine (48 mg/ml). L9 also prevented the exacerbated eosinophil and neutrophil infiltration in bronchoalveolar lavage fluid (BALF), and decreased the serum level of total IgE and OVA-specific IgG1 by 0.44-fold and 0.3-fold, respectively. Additionally, cytokine production showed that L9 significantly decreased T-helper cell type 2 (Th2)- related cytokines (IL-4, -5, -13) and elevated levels of Th1 related IFN-gamma in BALF. L9 also reduced the level of IL-17A and increased the level of TGF-beta. Taken together, these results indicate that L9 may exert the anti-allergic benefit, possibly through rebalancing Th1/Th2 immune response and modulating IL-17 pro-inflammatory immune response. Thus, L9 is a promising candidate for preventing PM exposure enhanced pre-existing asthma.	[Wang, Xifan; Hui, Yan; Zhao, Liang; Hao, Yanling; Guo, Huiyuan; Ren, Fazheng] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Wang, Xifan; Hui, Yan; Guo, Huiyuan; Ren, Fazheng] China Agr Univ, Key Lab Funct Dairy, Minist Educ & Beijing Govt, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Zhao, Liang; Ren, Fazheng] China Agr Univ, Beijing Higher Inst Engn Res Ctr Anim Prod, Coll Food Sci & Nutr Engn, Beijing, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University	Ren, FZ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.; Ren, FZ (corresponding author), China Agr Univ, Key Lab Funct Dairy, Minist Educ & Beijing Govt, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Ren, FZ (corresponding author), China Agr Univ, Beijing Higher Inst Engn Res Ctr Anim Prod, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.	renfazheng@cau.edu.cn	Hui, Yan/J-8811-2017; Hui, Yan/X-4011-2019	Hui, Yan/0000-0002-2388-131X; Hui, Yan/0000-0002-2388-131X; Zhao, Liang/0000-0001-9244-3121	National Natural Science Foundation of China [31401668]; Beijing Municipal Commission of Education Co-constructed program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education Co-constructed program	This study was supported by National Natural Science Foundation of China (31401668), and the Beijing Municipal Commission of Education Co-constructed program.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Aldinucci C, 2002, EUR J CLIN NUTR, V56, P1155, DOI 10.1038/sj.ejcn.1601465; Belkaid Y, 2003, EXPERT OPIN BIOL TH, V3, P875, DOI 10.1517/14712598.3.6.875; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Chen RJ, 2013, AM J RESP CRIT CARE, V188, P1170, DOI 10.1164/rccm.201304-0678LE; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P1471, DOI 10.1289/ehp.6300; Gavett SH, 1997, ENVIRON RES, V72, P162, DOI 10.1006/enrs.1997.3732; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Heinrich J, 1999, ENVIRON HEALTH PERSP, V107, P53, DOI 10.2307/3434289; Hong HJ, 2010, J CLIN IMMUNOL, V30, P449, DOI 10.1007/s10875-010-9375-8; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Jan RL, 2012, BRIT J NUTR, V108, P130, DOI 10.1017/S0007114511005265; Jang SO, 2012, ALLERGY ASTHMA IMMUN, V4, P150, DOI 10.4168/aair.2012.4.3.150; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kim H, 2005, FEMS IMMUNOL MED MIC, V45, P259, DOI 10.1016/j.femsim.2005.05.005; Kim HJ, 2014, CLIN IMMUNOL, V153, P178, DOI 10.1016/j.clim.2014.04.008; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Laake KO, 2005, SCAND J GASTROENTERO, V40, P43, DOI 10.1080/00365520410009339; Laan M, 1999, J IMMUNOL, V162, P2347; Lambert AL, 1999, AM J RESP CRIT CARE, V159, pA26; Li N, 2010, AM J PHYSIOL-LUNG C, V299, pL374, DOI 10.1152/ajplung.00115.2010; Lim LH, 2009, INT ARCH ALLERGY IMM, V148, P297, DOI 10.1159/000170383; Liu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085323; Luo X, 2015, J MICROBIOL BIOTECHN, V25, P1687, DOI [10.4014/imb.1503.03022, DOI 10.4014/JMB.1503.03022]; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Nikasinovic L, 2006, J ALLERGY CLIN IMMUN, V117, P1382, DOI 10.1016/j.jaci.2006.03.023; Ogino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092710; Olin JT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5517; Ouyang YD, 2013, LANCET RESP MED, V1, P12, DOI 10.1016/S2213-2600(12)70065-6; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Penton PC, 2013, J ALLERGY CLIN IMMUN, V131, P512, DOI 10.1016/j.jaci.2012.07.039; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Shibamori M, 2006, LIFE SCI, V78, P987, DOI 10.1016/j.lfs.2005.06.020; Triggianese P, 2016, CLIN EXP RHEUMATOL, V34, P1085; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wagner JG, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-45; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yao XJ, 2014, CLIN EXP ALLERGY, V44, P765, DOI 10.1111/cea.12298; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	60	42	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171721	10.1371/journal.pone.0171721	http://dx.doi.org/10.1371/journal.pone.0171721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199353	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400046
J	Necchi, F; Saul, A; Rondini, S				Necchi, Francesca; Saul, Allan; Rondini, Simona			Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout	PLOS ONE			English	Article							INFLUENZAE TYPE-B; NEISSERIA-MENINGITIDIS; HAEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSES; ANTIBODY; ASSAY; SALMONELLA; COMPLEMENT; SEROGROUP; STANDARDIZATION	Serum Bactericidal Activity (SBA) assay is the method of choice to evaluate the complement- mediated functional activity of both infection-and vaccine-induced antibodies. To perform a typical SBA assay, serial dilutions of sera are incubated with target bacterial strains and complement. The conventional SBA assay is based on plating on agar the SBA reaction mix and counting the surviving bacterial colony forming units (CFU) at each serum dilution. Even with automated colony counting, it is labor-intensive, time-consuming and not amenable for large-scale studies. Here, we have developed a luminescence-based SBA (L-SBA) method able to detect surviving bacteria by measuring their ATP. At the end of the SBA reaction, a single commercially available reagent is added to each well of the SBA plate, and the resulting luminescence signal is measured in a microplate reader. The signal obtained is proportional to the ATP present, which is directly proportional to the number of viable bacteria. Bactericidal activity is subsequently calculated. We demonstrated the applicability of L-SBA with multiple bacterial serovars, from 5 species: Citrobacter freundii, Salmonella enterica serovars Typhimurium and Enteritidis, Shigella flexneri serovars 2a and 3a, Shigella sonnei and Neisseria meningitidis. Serum bactericidal titers obtained by the luminescence readout method strongly correlate with the data obtained by the conventional agar plate-based assay, and the new assay is highly reproducible. L-SBA considerably shortens assay time, facilitates data acquisition and analysis and reduces the operator dependency, avoiding the plating and counting of CFUs. Our results demonstrate that LSBA is a useful high-throughput bactericidal assay.	[Necchi, Francesca; Saul, Allan; Rondini, Simona] GSK Vaccines Inst Global Hlth GVGH Srl, Siena, Italy	GlaxoSmithKline	Necchi, F (corresponding author), GSK Vaccines Inst Global Hlth GVGH Srl, Siena, Italy.	francesca.x.necchi@gsk.com	Saul, Allan J/I-6968-2013; Saul, Allan/ABH-2091-2020; Rondini, Simona/GLN-4357-2022	Saul, Allan J/0000-0003-0665-4091; Saul, Allan/0000-0003-0665-4091; Necchi, Francesca/0000-0003-1239-8696	Novartis Vaccines Institute	Novartis Vaccines Institute	This study was sponsored by Novartis Vaccines Institute for Global Health, now acquired by the GSK group of companies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrow R, 2006, VACCINE, V24, P5093, DOI 10.1016/j.vaccine.2006.03.091; Boyd MA, 2014, CLIN VACCINE IMMUNOL, V21, P712, DOI 10.1128/CVI.00115-14; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; ELKINS C, 1992, MOL MICROBIOL, V6, P2617, DOI 10.1111/j.1365-2958.1992.tb01439.x; Gerke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134478; Gill CJ, 2010, HUM VACCINES, V6, P881, DOI 10.4161/hv.6.11.12849; Goh YS, 2013, J IMMUNOL METHODS, V387, P121, DOI 10.1016/j.jim.2012.10.005; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GREEN BA, 1987, INFECT IMMUN, V55, P2878, DOI 10.1128/IAI.55.12.2878-2883.1987; Jacobs JFM, 2015, AUTOIMMUN REV, V14, P160, DOI 10.1016/j.autrev.2014.10.018; Jang MS, 2016, MICROB PATHOGENESIS, V97, P19, DOI 10.1016/j.micpath.2016.05.013; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Mak PA, 2011, CLIN VACCINE IMMUNOL, V18, P1252, DOI 10.1128/CVI.05028-11; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; McIntosh EDG, 2015, VACCINE, V33, P4414, DOI 10.1016/j.vaccine.2015.07.019; MOUNTZOUROS KT, 1992, INFECT IMMUN, V60, P5316, DOI 10.1128/IAI.60.12.5316-5318.1992; Mountzouros KT, 2000, J CLIN MICROBIOL, V38, P2878, DOI 10.1128/JCM.38.8.2878-2884.2000; Onsare RS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003573; Rodriguez T, 2003, BIOLOGICALS, V31, P209, DOI 10.1016/S1045-1056(03)00060-5; Romero-Steiner S, 2004, CLIN DIAGN LAB IMMUN, V11, P89, DOI 10.1128/CDLI.11.1.89-93.2004; Rondini S, 2013, MICROB PATHOGENESIS, V63, P19, DOI 10.1016/j.micpath.2013.05.014; Rondini S, 2012, J INFECT DEV COUNTR, V6, P763, DOI 10.3855/jidc.2495; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; Son MS., 2011, CURR PROTOC MICROBIO, VChapter 6, pUnit6A.3; Yang JS, 2007, J MICROBIOL METH, V71, P141, DOI 10.1016/j.mimet.2007.08.009	27	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172163	10.1371/journal.pone.0172163	http://dx.doi.org/10.1371/journal.pone.0172163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192483	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800080
J	Yamashita, T; Miyamoto, Y; Bando, Y; Ono, T; Kobayashi, S; Doi, A; Araki, T; Kato, Y; Shirakawa, T; Suzuki, Y; Yamauchi, J; Yoshida, S; Sato, N				Yamashita, Tomoko; Miyamoto, Yuki; Bando, Yoshio; Ono, Takashi; Kobayashi, Sakurako; Doi, Ayano; Araki, Toshihiro; Kato, Yosuke; Shirakawa, Takayuki; Suzuki, Yutaka; Yamauchi, Junji; Yoshida, Shigetaka; Sato, Naoya			Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder free cultured pluripotent stem cells	PLOS ONE			English	Article							EFFICIENT GENERATION; MULTIPLE-SCLEROSIS; PRIMATE MODELS; NERVOUS-SYSTEM; MYELINATION; MOUSE; INVOLVEMENT	Oligodendrocytes myelinate axons and form myelin sheaths in the central nervous system. The development of therapies for demyelinating diseases, including multiple sclerosis and leukodystrophies, is a challenge because the pathogenic mechanisms of disease remain poorly understood. Primate pluripotent stem cell-derived oligodendrocytes are expected to help elucidate the molecular pathogenesis of these diseases. Oligodendrocytes have been successfully differentiated from human pluripotent stem cells. However, it is challenging to prepare large amounts of oligodendrocytes over a short amount of time because of manipulation difficulties under conventional primate pluripotent stem cell culture methods. We developed a proprietary dissociated monolayer and feeder-free culture system to handle pluripotent stem cell cultures. Because the dissociated monolayer and feeder-free culture system improves the quality and growth of primate pluripotent stem cells, these cells could potentially be differentiated into any desired functional cells and consistently cultured in large-scale conditions. In the current study, oligodendrocyte progenitor cells and mature oligodendrocytes were generated within three months from monkey embryonic stem cells. The embryonic stem cell-derived oligodendrocytes exhibited in vitro myelinogenic potency with rat dorsal root ganglion neurons. Additionally, the transplanted oligodendrocyte progenitor cells differentiated into myelin basic protein-positive mature oligodendrocytes in the mouse corpus callosum. This preparative method was used for human induced pluripotent stem cells, which were also successfully differentiated into oligodendrocyte progenitor cells and mature oligodendrocytes that were capable of myelinating rat dorsal root ganglion neurons. Moreover, it was possible to freeze, thaw, and successfully re-culture the differentiating cells. These results showed that embryonic stem cells and human induced pluripotent stem cells maintained in a dissociated monolayer and feeder-free culture system have the potential to generate oligodendrocyte progenitor cells and mature oligodendrocytes in vitro and in vivo. This culture method could be applied to prepare large amounts of oligodendrocyte progenitor cells and mature oligodendrocytes in a relatively short amount of time.	[Yamashita, Tomoko; Ono, Takashi; Kobayashi, Sakurako; Doi, Ayano; Araki, Toshihiro; Kato, Yosuke; Shirakawa, Takayuki; Suzuki, Yutaka; Sato, Naoya] Mitsubishi Tanabe Pharma Corp, Div Res, Discovery Res Labs, Yokohama, Kanagawa, Japan; [Miyamoto, Yuki; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo, Japan; [Bando, Yoshio; Yoshida, Shigetaka] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Asahikawa, Hokkaido, Japan; [Sato, Naoya] MP Healthcare Venture Management, Boston, MA USA	Mitsubishi Tanabe Pharma Corporation; National Center for Child Health & Development - Japan; Asahikawa Medical College	Yamashita, T (corresponding author), Mitsubishi Tanabe Pharma Corp, Div Res, Discovery Res Labs, Yokohama, Kanagawa, Japan.	yamashita.tomoko@md.mt-pharma.co.jp	Ono, Takashi/ABC-4644-2020	Ono, Takashi/0000-0002-8043-660X; Yamashita, Tomoko/0000-0001-5167-1128	Mitsubishi Tanabe Pharma Corporation	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This study was funded by Mitsubishi Tanabe Pharma Corporation. The funder also provided support in the form of salaries for TY, TO, SK, AD, TA, YK, TS, YS and NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bando Y, 2015, NEUROCHEM INT, V81, P16, DOI 10.1016/j.neuint.2015.01.002; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Chan Anthony W S, 2004, Reprod Biol Endocrinol, V2, P39, DOI 10.1186/1477-7827-2-39; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chew LJ, 2015, NEUROPHARMA IN PRESS; Cui QL, 2012, STEM CELLS DEV, V21, P1831, DOI 10.1089/scd.2011.0494; Davidson KC, 2015, DEVELOPMENT, V142, P3090, DOI 10.1242/dev.116061; Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gorris R, 2015, GLIA, V63, P2152, DOI 10.1002/glia.22882; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Miyamoto Y, 2015, MOL BIOL CELL, V26, P3489, DOI 10.1091/mbc.E14-05-1020; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Neely MD, 2012, ACS CHEM NEUROSCI, V3, P482, DOI 10.1021/cn300029t; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Ono T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088346; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Simena AA, 2009, PROG BRAIN RES, V179, P117, DOI 10.1016/S0079-6123(09)17913-X; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Fonseca SAS, 2015, WORLD J STEM CELLS, V7, P649, DOI 10.4252/wjsc.v7.i3.649; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Verdier JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00064; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Watson KK, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-21	30	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171947	10.1371/journal.pone.0171947	http://dx.doi.org/10.1371/journal.pone.0171947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192470	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800054
J	Zhang, K; Zheng, H; Chen, FL; Li, RD; Yang, M; Ouyang, ZY; Lan, J; Xiang, XW				Zhang, Kai; Zheng, Hua; Chen, Falin; Li, Ruida; Yang, Miao; Ouyang, Zhiyun; Lan, Jun; Xiang, Xuewu			Impact of nitrogen fertilization on soil-Atmosphere greenhouse gas exchanges in eucalypt plantations with different soil characteristics in southern China	PLOS ONE			English	Article							METHANE OXIDATION; UNDERSTORY REMOVAL; FOREST; EMISSIONS; CARBON; RESPIRATION; N2O; FLUXES; OXIDE; ECOSYSTEMS	Nitrogen (N) fertilization is necessary to sustain productivity in eucalypt plantations, but it can increase the risk of greenhouse gas emissions. However, the response of soil greenhouse gas emissions to N fertilization might be influenced by soil characteristics, which is of great significance for accurately assessing greenhouse gas budgets and scientific fertilization in plantations. We conducted a two-year N fertilization experiment (control [CK], low N [LN], middle N [MN] and high N [HN] fertilization) in two eucalypt plantations with different soil characteristics (higher and lower soil organic carbon sites [HSOC and LSOC]) in Guangxi, China, and assessed soil-atmosphere greenhouse gas exchanges. The annual mean fluxes of soil CO2, CH4, and N2O were separately 153-266 mg m(-2) h(-1), -55 -40 mu g m(-2) h(-1), and 11-95 mu g m(-2) h(-1), with CO2 and N2O emis sions showing significant seasonal variations. N fertilization significantly increased soil CO2 and N2O emissions and decreased CH4 uptake at both sites. There were significant interactions of N fertilization and SOC level on soil CO2 and N2O emissions. At the LSOC site, the annual mean flux of soil CO2 emission was only significantly higher than the CK treatment in the HN treatment, but, at the HSOC site, the annual mean flux of soil CO2 emission was significantly higher for both the LN (or MN) and HN treatments in comparison to the CK treatment. Under the CK and LN treatments, the annual mean flux of N2O emission was not significantly different between HSOC and LSOC sites, but under the HN treatment, it was significantly higher in the HSOC site than in the LSOC site. Correlation analysis showed that changes in soil CO2 and N2O emissions were significantly related to soil dissolved organic carbon, ammonia, nitrate and pH. Our results suggested significant interactions of N fertilization and soil characteristics existed in soil - atmosphere greenhouse gas exchanges, which should be considered in assessing greenhouse gas budgets and scientific fertilization strategies in eucalypt plantations.	[Zhang, Kai; Zheng, Hua; Li, Ruida; Yang, Miao; Ouyang, Zhiyun] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Kai] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Chen, Falin] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Lan, Jun; Xiang, Xuewu] Guangxi Dongmen Forest Farm, Inst Forestry Sci, Fusui, Guangxi, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Xinjiang Agricultural University; Hunan Agricultural University	Zheng, H (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	zhenghua@rcees.ac.cn		Zheng, Hua/0000-0002-2301-1744	Chinese Academy of Science [KZCX2-EW-QN406]; National Natural Science Foundation of China [31170425, 40871130]	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Science (grant number KZCX2-EW-QN406) and the National Natural Science Foundation of China (grant numbers 31170425, 40871130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M, 2010, NUTR CYCL AGROECOSYS, V86, P53, DOI 10.1007/s10705-009-9273-8; ADAMSEN APS, 1993, APPL ENVIRON MICROB, V59, P485, DOI 10.1128/AEM.59.2.485-490.1993; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Bradford MA, 2001, SOIL BIOL BIOCHEM, V33, P1695, DOI 10.1016/S0038-0717(01)00091-8; Carle J, 2002, FOREST PROD J, V52, P12; Chen FL, 2013, FOREST ECOL MANAG, V291, P65, DOI 10.1016/j.foreco.2012.11.016; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Du Rui, 2004, Huanjing Kexue, V25, P12; Fang HJ, 2014, GEODERMA, V213, P444, DOI 10.1016/j.geoderma.2013.08.006; Fest BJ, 2009, AGR FOREST METEOROL, V149, P393, DOI 10.1016/j.agrformet.2008.09.007; Franzluebbers A. J., 2012, AGROCIENCIA, V16, P162; [龚伟 GONG Wei], 2008, [生态学报, Acta Ecologica Sinica], V28, P2536; Gulledge J, 2004, FEMS MICROBIOL ECOL, V49, P389, DOI 10.1016/j.femsec.2004.04.013; Hall SJ, 1999, NATURE, V400, P152, DOI 10.1038/22094; Jassal RS, 2011, GEODERMA, V162, P182, DOI 10.1016/j.geoderma.2011.02.002; KING GM, 1994, APPL ENVIRON MICROB, V60, P3508, DOI 10.1128/AEM.60.10.3508-3513.1994; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Li Hai-Fang, 2009, Chinese Journal of Plant Ecology, V33, P1015, DOI 10.3773/j.issn.1005-264x.2009.06.001; Li HF, 2010, SOIL SCI PLANT NUTR, V56, P541, DOI 10.1111/j.1747-0765.2010.00498.x; Li Rui-da, 2014, Huanjing Kexue, V35, P3903; [李睿达 Li Ruida], 2015, [生态学报, Acta Ecologica Sinica], V35, P5931; Malhi SS, 2006, SOIL TILL RES, V90, P171, DOI 10.1016/j.still.2005.09.001; MATSON PA, 1992, BIOGEOCHEMISTRY, V18, P101, DOI 10.1007/BF00002705; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Reth S, 2005, PLANT SOIL, V268, P21, DOI 10.1007/s11104-005-0175-5; Russow R, 2008, SOIL BIOL BIOCHEM, V40, P380, DOI 10.1016/j.soilbio.2007.08.020; [李长生 Li Changsheng], 2003, [第四纪研究, Quaternary Sciences], V23, P493; Senbayram M, 2012, AGR ECOSYST ENVIRON, V147, P4, DOI 10.1016/j.agee.2011.06.022; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; [苏丹 Su Dan], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P423; Suwanwaree P, 2005, SOIL SCI SOC AM J, V69, P1722, DOI 10.2136/sssaj2004.0223; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Turnbull JW, 1999, NEW FOREST, V17, P37, DOI 10.1023/A:1006524911242; Uchida Y, 2012, AGR ECOSYST ENVIRON, V156, P116, DOI 10.1016/j.agee.2012.05.012; Wang YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093571; [项文化 XIANG WenHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P2365; Xu MJ, 2014, FOREST SCI, V60, P973, DOI 10.5849/forsci.13-075; Yu GuiRui, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1; Yu X.B., 2000, STUDIES LONG TERM PR, P1; Zhang Kai, 2015, Shengtaixue Zazhi, V34, P1779; Zhang W, 2008, PLANT SOIL, V306, P221, DOI 10.1007/s11104-008-9575-7; Zhang W, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009195; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010	44	14	14	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172142	10.1371/journal.pone.0172142	http://dx.doi.org/10.1371/journal.pone.0172142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192496	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800078
J	Li, XG; Eberhardt, A; Hansen, JN; Bohmann, D; Li, HT; Schor, NF				Li, Xingguo; Eberhardt, Allison; Hansen, Jeanne N.; Bohmann, Dirk; Li, Haitao; Schor, Nina F.			Methylation of the phosphatase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, and structural studies	FASEB JOURNAL			English	Article						protein phosphatase; post-translational modification; protein arginine methylation; gamma-H2A.X; Drosophila eye development	EYES ABSENT GENE; CELL-SURVIVAL; DEPHOSPHORYLATION; PROLIFERATION; MUTATIONS; COMPLEX; FORM	The eyes absent (EYA) family proteins are conserved transcriptional coactivators with intrinsic protein phosphatase activity. They play an essential role in the development of various organs in metazoans. These functions are associated with a unique combination of phosphatase and transactivation activities. However, it remains poorly understood how these activities and the consequent biologic functions of EYA are regulated. Here, we demonstrate that 2 conserved arginine residues, R304 and R306, of EYA1 are essential for its in vitro phosphatase activity and in vivo function during Drosophila eye development. EYA1 physically interacts with protein arginine methyltransferase 1, which methylates EYA1 at these residues both in vitro and in cultured mammalian and insect cells. Moreover, we show that wild-type, but not methylation-defective, EYA1 associates with gamma-H2A.X in response to ionizing radiation. Taken together, our results identify the conserved arginine residues of EYA1 that play an important role for its activity, thus implicating arginine methylation as a novel regulatory mechanism of EYA function.	[Li, Xingguo; Eberhardt, Allison; Hansen, Jeanne N.; Schor, Nina F.] Univ Rochester, Med Ctr, Dept Pediat, 601 Elmwood Ave,POB 777, Rochester, NY 14642 USA; [Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Li, Haitao] Tsinghua Univ, Key Lab Prot Sci, Minist Educ MOE, Ctr Struct Biol,Sch Life Sci, Beijing, Peoples R China; [Li, Haitao] Tsinghua Univ, Sch Med, Beijing, Peoples R China	University of Rochester; University of Rochester; Tsinghua University; Tsinghua University	Li, XG; Schor, NF (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, 601 Elmwood Ave,POB 777, Rochester, NY 14642 USA.	xingguo_li@urmc.rochester.edu; nina_schor@urmc.rochester.edu	Li, Haitao/B-2668-2012; Li, Xingguo/T-9582-2019	Li, Haitao/0000-0001-6741-293X; Li, Xingguo/0000-0002-2801-7555; Li, Xing-Guo/0000-0003-1952-3445; Schor, Nina/0000-0002-3817-7376	Crosby's Fund for Neuroblastoma Pediatric Cancer Research; Strong Children's Research Center Small Grants Program; William H. Eilinger Endowment	Crosby's Fund for Neuroblastoma Pediatric Cancer Research; Strong Children's Research Center Small Grants Program; William H. Eilinger Endowment	This work was funded by Crosby's Fund for Neuroblastoma Pediatric Cancer Research and the William H. Eilinger Endowment (to N.F.S.), and by a grant from the Strong Children's Research Center Small Grants Program (to X.L.). The authors thank Drs. Stephane Richard (McGill University, Montreal, QC, Canada) and Ailan Guo (Cell Signaling Technology, Danvers, MA, USA) for providing Prmt1<SUP>fl/-</SUP>ER-Cre MEF cells and asymmetric dimethyl-arginine antibody D6A8, respectively; Fanju Meng, Drs. Benoit Biteau, and Nirmalya Chatterjee (University of Rochester) for helpful discussion; and Simeng Wang and Louis Lotta (both from the University of Rochester) for technical assistance. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The authors declare no conflicts of interest.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Bicker KL, 2011, MOL BIOSYST, V7, P48, DOI 10.1039/c0mb00015a; Blanc RS, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00457-16; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Bui QT, 2000, GENETICS, V155, P709; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Davies CC, 2013, EMBO J, V32, P1556, DOI 10.1038/emboj.2013.98; Eberhardt A, 2016, ONCOTARGET, V7, P63629, DOI 10.18632/oncotarget.11556; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058818; Jung SK, 2010, FASEB J, V24, P560, DOI 10.1096/fj.09-143891; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Krueger AB, 2013, J BIOMOL SCREEN, V18, P85, DOI 10.1177/1087057112453936; Li J, 2016, MOL CELL BIOL, V37; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Sun Y, 2015, ONCOGENE, V34, P2527, DOI 10.1038/onc.2014.179; Sun Y, 2014, MOL CELL BIOL, V34, P2409, DOI 10.1128/MCB.00104-14; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09	39	0	1	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2327	2339		10.1096/fj.201601050RR	http://dx.doi.org/10.1096/fj.201601050RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28213359				2022-12-26	WOS:000401553400010
J	Qiu, YJ; Gilmour, DS				Qiu, Yijun; Gilmour, David S.			Identification of Regions in the Spt5 Subunit of DRB Sensitivity-inducing Factor (DSIF) That Are Involved in Promoter-proximal Pausing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NEGATIVE ELONGATION-FACTOR; TERMINAL DOMAIN CTD; HEAT-SHOCK GENES; TRANSCRIPTION ELONGATION; IN-VIVO; P-TEFB; FISSION YEAST; DROSOPHILA; COMPLEX	DRB sensitivity-inducing factor (DSIF or Spt4/5) is a conserved transcription elongation factor that both inhibits and stimulates transcription elongation in metazoans. In Drosophila and vertebrates, DSIF together with negative elongation factor (NELF) associates with RNA polymerase II during early elongation and causes RNA polymerase II to pause in the promoterproximal region of genes. The mechanism of how DSIF establishes pausing is not known. We constructed Spt5 mutant forms of DSIF and tested their capacity to restore promoter-proximal pausing to DSIF-depleted Drosophila nuclear extracts. The C-terminal repeat region of Spt5, which has been implicated in both inhibition and stimulation of elongation, is dispensable for promoter-proximal pausing. A region encompassing KOW4 and KOW5 of Spt5 is essential for pausing, and mutations in KOW5 specifically shift the location of the pause. RNA crosslinking analysis reveals that KOW5 directly contacts the nascent transcript, and deletion of KOW5 disrupts this interaction. Our results suggest that KOW5 is involved in promoter-proximal pausing through contact with the nascent RNA.	[Qiu, Yijun; Gilmour, David S.] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gilmour, DS (corresponding author), Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dsg11@psu.edu			TRiP at Harvard Medical School (National Institutes of Health (NIH)/NIGMS) [R01-GM084947]; Bloomington Drosophila Stock Center (NIH) [P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM047477] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	TRiP at Harvard Medical School (National Institutes of Health (NIH)/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloomington Drosophila Stock Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Song Tan for providing the polycistronic expression vector, Mitzi Kuroda for providing the MSL-2 antibody, and the TRiP at Harvard Medical School (National Institutes of Health (NIH)/NIGMS Grant R01-GM084947) for providing the transgenic RNAi stock. Stocks obtained from the Bloomington Drosophila Stock Center (NIH Grant P40OD018537) were used in this study. We thank Joseph Reese for critiquing the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Booth GT, 2016, GENOME RES, V26, P799, DOI 10.1101/gr.204578.116; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHAMPLIN DT, 1991, GENE DEV, V5, P1611, DOI 10.1101/gad.5.9.1611; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crickard JB, 2016, J BIOL CHEM, V291, P9853, DOI 10.1074/jbc.M116.716001; Cubillos-Rojas M, 2010, ELECTROPHORESIS, V31, P1318, DOI 10.1002/elps.200900657; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Ghosh SKB, 2011, MOL CELL BIOL, V31, P4232, DOI 10.1128/MCB.05930-11; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hartzog GA, 2013, BBA-GENE REGUL MECH, V1829, P105, DOI 10.1016/j.bbagrm.2012.08.007; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jennings BH, 2004, CURR BIOL, V14, P1680, DOI 10.1016/j.cub.2004.08.066; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Li WT, 2014, NUCLEIC ACIDS RES, V42, P7069, DOI 10.1093/nar/gku333; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mayer A, 2012, MOL CELL BIOL, V32, P1321, DOI 10.1128/MCB.06310-11; Meyer PA, 2015, MOL CELL BIOL, V35, P3354, DOI 10.1128/MCB.00520-15; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Schulz S, 2016, P NATL ACAD SCI USA, V113, pE1816, DOI 10.1073/pnas.1515817113; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang ZQ, 2004, J BIOL CHEM, V279, P23223, DOI 10.1074/jbc.M402956200	60	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5555	5570		10.1074/jbc.M116.760751	http://dx.doi.org/10.1074/jbc.M116.760751			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213523	Green Published, hybrid			2022-12-26	WOS:000397875500034
J	Singh, AK; Rastogi, S; Shukla, H; Asalam, M; Rath, SK; Akhtar, MS				Singh, Amit Kumar; Rastogi, Shivangi; Shukla, Harish; Asalam, Mohd.; Rath, Srikanta Kumar; Akhtar, Md. Sohail			Cdc15 Phosphorylates the C-terminal Domain of RNA Polymerase II for Transcription during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; MITOTIC REPRESSION; GENE; TFIIH; CTD; CHROMATIN; PHOSPHATASE; INHIBITION; ACTIVATION	In eukaryotes, the basal transcription in interphase is orchestrated through the regulation by kinases (Kin28, Bur1, and Ctk1) and phosphatases (Ssu72, Rtr1, and Fcp1), which act through the post-translational modification of the C-terminal domain (CTD) of the largest subunit of RNA polymerase II. The CTD comprises the repeated Tyr-Ser-Pro-Thr-Ser-Pro-Ser motif with potential epigenetic modification sites. Despite the observation of transcription and periodic expression of genes during mitosis with entailing CTD phosphorylation and dephosphorylation, the associated CTD specific kinase(s) and its role in transcription remains unknown. Here we have identified Cdc15 as a potential kinase phosphorylating Ser-2 and Ser-5 of CTD for transcription during mitosis in the budding yeast. The phosphorylation of CTD by Cdc15 is independent of any prior Ser phosphorylation(s). The inactivation of Cdc15 causes reduction of global CTD phosphorylation during mitosis and affects the expression of genes whose transcript levels peak during mitosis. Cdc15 also influences the complete transcription of clb2 gene and phosphorylates Ser-5 at the promoter and Ser-2 toward the 3' end of the gene. The observation that Cdc15 could phosphorylate Ser-5, as well as Ser-2, during transcription in mitosis is in contrast to the phosphorylation marks put by the kinases in interphase (G(1), S, and G(2)), where Cdck7/Kin28 phosphorylates Ser-5 at promoter and Bur1/Ctk1 phosphorylates Ser-2 at the 3' end of the genes.	[Singh, Amit Kumar; Shukla, Harish; Asalam, Mohd.; Akhtar, Md. Sohail] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Rastogi, Shivangi] Cent Drug Res Inst, CSIR, Div Microbiol, Lucknow 226031, Uttar Pradesh, India; [Rath, Srikanta Kumar] Cent Drug Res Inst, CSIR, Div Toxicol, Lucknow 226031, Uttar Pradesh, India; [Rath, Srikanta Kumar; Akhtar, Md. Sohail] Acad Sci & Innovat Res, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Akhtar, MS (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India.; Akhtar, MS (corresponding author), Acad Sci & Innovat Res, New Delhi 110025, India.	sohail@cdri.res.in	Singh, Amit/AAB-8820-2022; Rastogi, Shivangi/AAV-5521-2021; Shukla, Harish/O-6453-2018	Singh, Amit/0000-0002-5564-3236; Rastogi, Shivangi/0000-0002-0046-0045; Shukla, Harish/0000-0002-5919-6808	Science and Engineering Research Board (SERB) [EMR/2016/002167, BSC-0118, BSC-0103]; CSIR; University Grants Commission (UGC); Department of Biotechnology (DBT), India	Science and Engineering Research Board (SERB); CSIR(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported in part by Science and Engineering Research Board (SERB) Grants EMR/2016/002167 and BSC-0118 (EpiHed) (to M. S. A.) and BSC-0103 (UNDO) (to S. K. R.) and by funds from CSIR (to A. K. S. and H. S.), University Grants Commission (UGC) (to S. R.), and Department of Biotechnology (DBT), India (to M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Bharati AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31294; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chymkowitch P, 2012, P NATL ACAD SCI USA, V109, P10450, DOI 10.1073/pnas.1200067109; Clemente-Blanco A, 2011, NAT CELL BIOL, V13, P1450, DOI 10.1038/ncb2365; Corden JL, 2013, CHEM REV, V113, P8423, DOI 10.1021/cr400158h; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kao L, 2014, MOL CELL PROTEOMICS, V13, P594, DOI 10.1074/mcp.M113.032680; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Liang KW, 2015, MOL CELL, V60, P435, DOI 10.1016/j.molcel.2015.09.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Rock JM, 2011, GENE DEV, V25, P1943, DOI 10.1101/gad.17257711; Rodriguez-Molina JB, 2016, MOL CELL, V63, P433, DOI 10.1016/j.molcel.2016.06.036; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; SCHWEITZER B, 1991, YEAST, V7, P265, DOI 10.1002/yea.320070308; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Veis J, 2007, MOL CELL BIOL, V27, P8364, DOI 10.1128/MCB.01253-07; Yellman CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128604; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214	37	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5507	5518		10.1074/jbc.M116.761056	http://dx.doi.org/10.1074/jbc.M116.761056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202544	Green Published, hybrid			2022-12-26	WOS:000397875500030
J	Mourer, T; Normant, V; Labbe, S				Mourer, Thierry; Normant, Vincent; Labbe, Simon			Heme Assimilation in Schizosaccharomyces pombe Requires Cell-surface-anchored Protein Shu1 and Vacuolar Transporter Abc3.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON ACQUISITION; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; REGULATORY MOTIF; CRYPTOCOCCUS-NEOFORMANS; COPPER TRANSPORTER; MEMBRANE-PROTEINS; ZINC STORAGE; HEMOGLOBIN; YEAST	The Schizosaccharomyces pombe shu1(+) gene encodes a cell-surface protein required for assimilation of exogenous heme. In this study, shaving experiments showed that Shu1 is released from membrane preparations when spheroplast lysates are incubated with phosphoinositide-specific phospholipase C (PI-PLC). Shu1 cleavability by PI-PLC and its predicted hydropathy profile strongly suggested that Shu1 is a glycosylphosphatidyli-nositol-anchored protein. When heme biosynthesis is selec-tively blocked in hem1 Delta mutant cells, the heme analog zinc mesoporphyrin IX (ZnMP) first accumulates into vacuoles and then subsequently, within the cytoplasm in a rapid and Shu1-de-pendent manner. An HA(4)-tagged shu1(+) allele that retained wild-type function localizes to the cell surface in response to low hemin concentrations, but under high hemin concentrations, Shu1-HA(4) re-localizes to the vacuolar membrane. Inactivation of abc3(+), encoding a vacuolar membrane transporter, results in hem1 Delta abc3 Delta mutant cells being unable to grow in the presence of hemin as the sole iron source. In hem1 Delta abc3 Delta cells, ZnMP accumulates primarily in vacuoles and does not sequentially accumulate in the cytosol. Consistent with a role for Abc3 as vacuolar hemin exporter, results with hemin-agarose pulldown assays showed that Abc3 binds to hemin. In contrast, an Abc3 mutant in which an inverted Cys-Pro motif had been replaced with Ala residues fails to bind hemin with high affinity. Taken together, these results show that Shu1 undergoes rapid hemininduced internalization from the cell surface to the vacuolar membrane and that the transporter Abc3 participates in the mobilization of stored heme from the vacuole to the cytosol.	[Mourer, Thierry; Normant, Vincent; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci La Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci La Sante, 3201,Pavillon Z-8,Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Mourer, Thierry/0000-0003-1651-6768	Natural Sciences and Engineering Research of Canada (NSERC) [RGPIN-2015/2020-04878]	Natural Sciences and Engineering Research of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research "helical basket"-fold that consists of six-helices(15). Based on Council of Canada (NSERC) Grant RGPIN-2015/2020-04878 (to S.L.). The authors declare that they have no conflict of interest with the content of this article.	Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Cadieux B, 2013, J INFECT DIS, V207, P1339, DOI 10.1093/infdis/jit029; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Christ L, 2017, TRENDS BIOCHEM SCI, V42, P42, DOI 10.1016/j.tibs.2016.08.016; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Duffy SP, 2010, MOL CELL BIOL, V30, P5318, DOI 10.1128/MCB.00690-10; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu GG, 2015, MOL MICROBIOL, V96, P973, DOI 10.1111/mmi.12985; Hu GG, 2013, INFECT IMMUN, V81, P292, DOI 10.1128/IAI.01037-12; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Liu XM, 2015, MOL CELL, V59, P1035, DOI 10.1016/j.molcel.2015.07.034; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Mizushima N, 2015, MOL CELL, V59, P887, DOI 10.1016/j.molcel.2015.09.004; Mourer T, 2015, J BIOL CHEM, V290, P10176, DOI 10.1074/jbc.M115.642058; Nasser L, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.156, 10.1038/NMICROBIOL.2016.156]; Nichols B, 2009, J CELL BIOL, V186, P457, DOI 10.1083/jcb.200907119; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pendrak ML, 2004, J BIOL CHEM, V279, P3426, DOI 10.1074/jbc.M311550200; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Santos R, 2003, MICROBIOL-SGM, V149, P579, DOI 10.1099/mic.0.26108-0; Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x; Schubert E, 2015, J INORG BIOCHEM, V148, P49, DOI 10.1016/j.jinorgbio.2015.05.008; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang ZW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008066	60	19	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					4898	4912		10.1074/jbc.M117.776807	http://dx.doi.org/10.1074/jbc.M117.776807			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28193844	hybrid, Green Published			2022-12-26	WOS:000397590400013
J	Tejada, MA; Hashem, N; Calloe, K; Klaerke, DA				Tejada, Maria A.; Hashem, Nadia; Calloe, Kirstine; Klaerke, Dan A.			Heteromeric Slick/Slack K+ channels show graded sensitivity to cell volume changes	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; SLACK; SLICK; MODULATION; PHYSIOLOGY; ISCHEMIA; ATP; NA+	Slick and Slack high-conductance K+ channels are found in the CNS, kidneys, pancreas, among other organs, where they play an important role in cell excitability as well as in ion transport processes. They are both activated by Na+ and Cl- but show a differential regulation by cell volume changes. Slick has been shown to be regulated by cell volume changes, whereas Slack is insensitive. alpha-subunits of these channels form homomeric as well as heteromeric channels. It is the aim of this work to explore whether the subunit composition of the Slick/Slack heteromeric channel affects the response to osmotic challenges. In order to provide with the adequate water permeability to the cell membrane of Xenopus laevis oocytes, mRNA of aquaporin 1 was co-expressed with homomeric or heteromeric Slick and Slack alpha-subunits. Oocytes were superfused with hypotonic or hypertonic buffers and changes in currents were measured by two-electrode voltage clamp. This work presents the first heteromeric K+ channel with a characteristic graded sensitivity to small and fast changes in cell volume. Our results show that the cell volume sensitivity of Slick/Slack heteromeric channels is dependent on the number of volume sensitive Slick alpha-subunits in the tetrameric channels, giving rise to graded cell volume sensitivity. Regulation of the subunit composition of a channel may constitute a novel mechanism to determine volume sensitivity of cells.	[Tejada, Maria A.; Hashem, Nadia; Calloe, Kirstine; Klaerke, Dan A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol, IKVH, Frederiksberg C, Denmark	University of Copenhagen	Klaerke, DA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Physiol, IKVH, Frederiksberg C, Denmark.	dk@sund.ku.dk	Calloe, Kirstine/H-8643-2016	Calloe, Kirstine/0000-0002-1777-7938	Lund beck Foundation [R9-A1131]; Innovation Fund Denmark [5184000488]	Lund beck Foundation(Lundbeckfonden); Innovation Fund Denmark	This work was supported by grants from the Lund beck Foundation (grant ref. R9-A1131) and the Innovation Fund Denmark (grant ref. 5184000488). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; COETZEE WA, 1992, CARDIOVASC DRUG THER, V6, P201, DOI 10.1007/BF00051140; Grunnet M, 2003, J PHYSIOL-LONDON, V549, P419, DOI 10.1113/jphysiol.2003.038455; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Hayashi M, 2012, AM J PHYSIOL-CELL PH, V303, pC151, DOI 10.1152/ajpcell.00089.2012; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hougaard C, 2004, BBA-BIOMEMBRANES, V1660, P1, DOI 10.1016/j.bbamem.2003.11.015; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Rizzi S, 2016, J COMP NEUROL, V524, P2093, DOI 10.1002/cne.23934; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Soe R, 2009, NEUROSCI LETT, V457, P80, DOI 10.1016/j.neulet.2009.04.010; Tano JY, 2014, AM J PHYSIOL-HEART C, V307, pH811, DOI 10.1152/ajpheart.00319.2014; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Tejada MD, 2012, BIOCHEM BIOPH RES CO, V424, P208, DOI 10.1016/j.bbrc.2012.06.038; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	24	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0169914	10.1371/journal.pone.0169914	http://dx.doi.org/10.1371/journal.pone.0169914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222129	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800003
J	Hayes, HL; Peterson, BS; Haldeman, JM; Newgard, CB; Hohmeier, HE; Stephens, SB				Hayes, Heather L.; Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Hohmeier, Hans E.; Stephens, Samuel B.			Delayed apoptosis allows islet beta-cells to implement an autophagic mechanism to promote cell survival	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STIMULATED INSULIN-SECRETION; CYTOCHROME-C; ENDOGENOUS XIAP; PROLIFERATION; MITOPHAGY; DEATH; MASS; CARDIOMYOCYTES; RESISTANCE	Increased beta-cell death coupled with the inability to replicate existing beta-cells drives the decline in beta-cell mass observed in the progression of both major forms of diabetes. Understanding endogenous mechanisms of islet cell survival could have considerable value for the development of novel strategies to limit beta-cell loss and thereby promote beta-cell recovery. Insulinoma cells have provided useful insight into beta-cell death pathways but observations made in cell lines sometimes fail to translate to primary islets. Here, we report dramatic differences in the temporal regulation and engagement of the apoptotic program in primary rodent islets relative to the INS-1 derived 832/13 cell line. As expected, 832/13 cells rapidly induced cell stress markers in response to ER stress or DNA damage and were fully committed to apoptosis, resulting in >80% cell death within 24 h. In contrast, primary rat islets were largely refractory to cell death in response to ER stress and DNA damage, despite rapid induction of stress markers, such as XBP-1(s), CHOP, and PUMA. Gene expression profiling revealed a general suppression of pro-apoptotic machinery, such as Apaf-1 and caspase 3, and sustained levels of pro-survival factors, such as cIAP-1, cIAP-2, and XIAP, in rat islets. Furthermore, we observed sustained induction of autophagy following chronic ER stress and found that inhibition of autophagy rendered islet beta-cells highly vulnerable to ER stress-induced cell death. We propose that islet beta-cells dampen the apoptotic response to delay the onset of cell death, providing a temporal window in which autophagy can be activated to limit cellular damage and promote survival.	[Hayes, Heather L.; Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Hohmeier, Hans E.; Stephens, Samuel B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27708 USA; [Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Hohmeier, Hans E.; Stephens, Samuel B.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Peterson, Brett S.; Haldeman, Jonathan M.; Newgard, Christopher B.; Stephens, Samuel B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Newgard, Christopher B.; Hohmeier, Hans E.] Duke Univ, Med Ctr, Dept Med, Div Endocrinol, Durham, NC USA; [Hayes, Heather L.] ZenBio Inc, Res Triangle Pk, NC USA; [Stephens, Samuel B.] Univ Iowa, Dept Internal Med, Fraternal Order Eagles Diabet Ctr, Iowa City, IA 52242 USA	Duke University; Duke University; Duke University; Duke University; University of Iowa	Stephens, SB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27708 USA.; Stephens, SB (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA.; Stephens, SB (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Stephens, SB (corresponding author), Univ Iowa, Dept Internal Med, Fraternal Order Eagles Diabet Ctr, Iowa City, IA 52242 USA.	samuel-b-stephens@uiowa.edu		Stephens, Samuel/0000-0003-1152-2691; Haldeman, Jonathan/0000-0002-8270-7039	National Institutes of Health [DK099294]; American Heart Association [09POST2250151]; Juvenile Diabetes Research Foundation [17-2011-214, 17-2011-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health K01 award (DK099294) and American Heart Association (09POST2250151) post-doctoral fellowship to SBS and a Juvenile Diabetes Research Foundation awards (17-2011-214) to HEH and (17-2011-15) to CBN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jensen MV, 2013, J BIOL CHEM, V288, P23128, DOI 10.1074/jbc.M113.491654; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lavine JA, 2010, MOL ENDOCRINOL, V24, P464, DOI 10.1210/me.2009-0384; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NABER SP, 1980, DIABETOLOGIA, V19, P439, DOI 10.1007/BF00281823; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Quan W, 2012, EXP MOL MED, V44, P81, DOI 10.3858/emm.2012.44.2.030; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Soleimanpour SA, 2015, DIABETES, V64, P3475, DOI 10.2337/db15-0376; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Walpita D, 2012, J BIOMOL SCREEN, V17, P509, DOI 10.1177/1087057111430253; Wright KM, 2007, J CELL BIOL, V179, P825, DOI 10.1083/jcb.200708086; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073; Yang YHC, 2013, J CELL SCI, V126, P4286, DOI 10.1242/jcs.133017	44	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172567	10.1371/journal.pone.0172567	http://dx.doi.org/10.1371/journal.pone.0172567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212395	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700060
J	Ostermeir, K; Zacharias, M				Ostermeir, Katja; Zacharias, Martin			Accelerated flexible protein-ligand docking using Hamiltonian replica exchange with a repulsive biasing potential	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DRUG DISCOVERY; COMPUTATIONAL DOCKING; BINDING; FLEXIBILITY; DESIGN; TARGET; MACROMOLECULES; CHALLENGES; ACCURACY	A molecular dynamics replica exchange based method has been developed that allows rapid identification of putative ligand binding sites on the surface of biomolecules. The approach employs a set of ambiguity restraints in replica simulations between receptor and ligand that allow close contacts in the reference replica but promotes transient dissociation in higher replicas. This avoids long-lived trapping of the ligand or partner proteins at nonspecific, sticky, sites on the receptor molecule and results in accelerated exploration of the possible binding regions. In contrast to common docking methods that require knowledge of the binding site, exclude solvent and often keep parts of receptor and ligand rigid the approach allows for full flexibility of binding partners. Application to peptide-protein, protein-protein and a drug-receptor system indicate rapid sampling of near-native binding regions even in case of starting far away from the native binding site outperforming continuous MD simulations. An application on a DNA minor groove binding ligand in complex with DNA demonstrates that it can also be used in explicit solvent simulations.	[Ostermeir, Katja; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, Garching, Germany	Technical University of Munich	Zacharias, M (corresponding author), Tech Univ Munich, Phys Dept T38, Garching, Germany.	martin.zacharias@ph.tum.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft.	Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; Beier C, 2010, EXPERT OPIN DRUG DIS, V5, P347, DOI 10.1517/17460441003713462; Bracher A, 2011, ACTA CRYSTALLOGR D, V67, P549, DOI 10.1107/S0907444911013862; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Carlson HA, 2002, CURR OPIN CHEM BIOL, V6, P447, DOI 10.1016/S1367-5931(02)00341-1; Case DA, 2014, AMBER 14; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Harvey MJ, 2012, DRUG DISCOV TODAY, V17, P1059, DOI 10.1016/j.drudis.2012.03.017; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Luitz M, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/32/323101; Luitz MP, 2014, J CHEM INF MODEL, V54, P1669, DOI 10.1021/ci500296f; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; May A, 2008, CURR COMPUT-AID DRUG, V4, P143, DOI 10.2174/157340908784533265; Miller DW, 1997, PROTEIN SCI, V6, P2166; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Ostermeir K, 2013, BBA-PROTEINS PROTEOM, V1834, P847, DOI 10.1016/j.bbapap.2012.12.016; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Schindler CEM, 2015, PROTEINS, V83, P248, DOI 10.1002/prot.24728; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Soderhjelm P, 2012, P NATL ACAD SCI USA, V109, P5170, DOI 10.1073/pnas.1201940109; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Swift RV, 2015, MOL MODELING PROTEIN, V11, P445; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; WANG HJ, 1991, J COMPUT CHEM, V12, P868, DOI 10.1002/jcc.540120712; Wang K, 2013, J COMPUT AID MOL DES, V27, P989, DOI 10.1007/s10822-013-9689-8; Wong CF, 2015, EXPERT OPIN DRUG DIS, V10, P1189, DOI 10.1517/17460441.2015.1078308; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077; Zacharias M, 2004, PROTEINS, V54, P759, DOI 10.1002/prot.10637	34	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172072	10.1371/journal.pone.0172072	http://dx.doi.org/10.1371/journal.pone.0172072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207811	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500079
J	Tsuchiya, N; Doai, M; Usuda, K; Uramoto, H; Tonami, H				Tsuchiya, Naoko; Doai, Mariko; Usuda, Katsuo; Uramoto, Hidetaka; Tonami, Hisao			Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion	PLOS ONE			English	Article							AGGRESSIVENESS; LIVER	Purpose Investigating the diagnostic accuracy of histogram analyses of apparent diffusion coefficient (ADC) values for determining non-small cell lung cancer (NSCLC) tumor grades, lymphovascular invasion, and pleural invasion. Materials and methods We studied 60 surgically diagnosed NSCLC patients. Diffusion-weighted imaging (DWI) was performed in the axial plane using a navigator-triggered single-shot, echo-planar imaging sequence with prospective acquisition correction. The ADC maps were generated, and we placed a volume-of-interest on the tumor to construct the whole-lesion histogram. Using the histogram, we calculated the mean, 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles of ADC, skewness, and kurtosis. Histogram parameters were correlated with tumor grade, lymphovascular invasion, and pleural invasion. We performed a receiver operating characteristics (ROC) analysis to assess the diagnostic performance of histogram parameters for distinguishing different pathologic features. Results The ADC mean, 10th, 25th, 50th, 75th, 90th, and 95th percentiles showed significant differences among the tumor grades. The ADC mean, 25th, 50th, 75th, 90th, and 95th percentiles were significant histogram parameters between high-and low-grade tumors. The ROC analysis between high-and low-grade tumors showed that the 95th percentile ADC achieved the highest area under curve (AUC) at 0.74. Lymphovascular invasion was associated with the ADC mean, 50th, 75th, 90th, and 95th percentiles, skewness, and kurtosis. Kurtosis achieved the highest AUC at 0.809. Pleural invasion was only associated with skewness, with the AUC of 0.648. Conclusions ADC histogram analyses on the basis of the entire tumor volume are able to stratify NSCLCs' tumor grade, lymphovascular invasion and pleural invasion.	[Tsuchiya, Naoko; Doai, Mariko; Tonami, Hisao] Kanazawa Med Univ, Dept Radiol, Uchinada, Ishikawa, Japan; [Usuda, Katsuo; Uramoto, Hidetaka] Kanazawa Med Univ, Dept Thorac Surg, Uchinada, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University	Tonami, H (corresponding author), Kanazawa Med Univ, Dept Radiol, Uchinada, Ishikawa, Japan.	tonami@kanazawa-med.ac.jp						Asbach P, 2008, J COMPUT ASSIST TOMO, V32, P372, DOI 10.1097/RCT.0b013e3180dc930c; Bernardin L, 2014, EUR RADIOL, V24, P502, DOI 10.1007/s00330-013-3048-y; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Coolen J, 2014, EUR RADIOL, V24, P531, DOI 10.1007/s00330-013-3053-1; Donati OF, 2014, RADIOLOGY, V271, P143, DOI 10.1148/radiol.13130973; Guan Y, 2016, J COMPUT ASSIST TOMO, V40, P212, DOI 10.1097/RCT.0000000000000349; Guo JF, 2011, ANN NUCL MED, V25, P29, DOI 10.1007/s12149-010-0427-1; Higashi K, 2005, J NUCL MED, V46, P267; Just N, 2014, BRIT J CANCER, V111, P2215; Kartalis N, 2012, EUR RADIOL, V22, P2186, DOI 10.1007/s00330-012-2469-3; Koyama H, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130307; Koyama H, 2015, EUR J RADIOL, V84, P509, DOI 10.1016/j.ejrad.2014.11.024; Lee J, 2014, NMR BIOMED, V27, P1046, DOI 10.1002/nbm.3153; Lin YN, 2015, AM J ROENTGENOL, V204, P1125, DOI 10.2214/AJR.14.13350; Liu HD, 2015, J MAGN RESON IMAGING, V42, P595, DOI 10.1002/jmri.24823; Liu L, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/907310; Nomori H, 2015, J THORAC CARDIOV SUR, V149, P991, DOI 10.1016/j.jtcvs.2015.01.019; Nougaret S, 2015, RADIOLOGY, V276, P797, DOI 10.1148/radiol.15141212; Razek AAKA, 2012, CANCER IMAGING, V12, P452, DOI 10.1102/1470-7330.2012.0041; Rosenkrantz AB, 2015, ABDOM IMAGING, V40, P327, DOI 10.1007/s00261-014-0213-y; Tanaka R, 2013, CLIN IMAG, V37, P876, DOI 10.1016/j.clinimag.2013.06.001; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Xue HD, 2014, ARCH GYNECOL OBSTET, V290, P341, DOI 10.1007/s00404-014-3221-9; Yu JX, 2014, ADV COND MATTER PHYS, V2014, DOI 10.1155/2014/364627	25	28	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172433	10.1371/journal.pone.0172433	http://dx.doi.org/10.1371/journal.pone.0172433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207858	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500135
J	Afonso, E; Goydadin, AC; Giraudoux, P; Farny, G				Afonso, Eve; Goydadin, Anne-Claude; Giraudoux, Patrick; Farny, Gilles			Investigating Hybridization between the Two Sibling Bat Species Myotis myotis and M-blythii from Guano in a Natural Mixed Maternity Colony	PLOS ONE			English	Article							MOUSE-EARED BATS; SEX IDENTIFICATION; HYBRID INDIVIDUALS; POPULATION-SIZE; DOMESTIC CATS; VESPERTILIONIDAE; CHIROPTERA; HABITS; AMPLIFICATION; STRATEGY	Because they can form seasonal mixed-species groups during mating and maternal care, bats are exciting models for studying interspecific hybridization. Myotis myotis and M. blythii are genetically close and morphologically almost identical, but they differ in some aspects of their ecology and life-history traits. When they occur in sympatry, they often form large mixed maternity colonies, in which their relative abundance can vary across time due to a shift in the timing of parturition. For the first time, we used non-invasive genetic methods to assess the hybridization rate and colony composition in a maternity colony of M. myotis and M. blythii located in the French Alps. Bat guano was collected on five sampling dates spread across the roost occupancy period and was analysed for individual genotype. We investigated whether the presence of hybrids followed the pattern of one of the parental species or if it was intermediate. We identified 140 M. myotis, 12 M. blythii and 13 hybrids among 250 samples. Parental species appeared as genetically well-differentiated clusters, with an asymmetrical introgression towards M. blythii. By studying colony parameters (effective size, sex ratio and proportion of the three bat types) across the sampling dates, we found that the abundances of hybrid and M. blythii individuals were positively correlated. Our study provides a promising non-invasive method to study hybridization in bats and raises questions about the taxonomic status of the two Myotis species. We discuss the contribution of this study to the knowledge of hybrid ecology, and we make recommendations for possible future research to better understand the ecology and behaviour of hybrid individuals.	[Afonso, Eve; Goydadin, Anne-Claude; Giraudoux, Patrick] Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France; [Giraudoux, Patrick] Inst Univ France, Paris, France; [Farny, Gilles] Parc Natl Ecrins, Gap, France	Universite de Franche-Comte; Institut Universitaire de France	Afonso, E (corresponding author), Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France.	eve.afonso@univ-fcomte.fr	Afonso, Eve/L-1286-2013; Giraudoux, Patrick/B-9274-2011	Afonso, Eve/0000-0001-5836-9909; Giraudoux, Patrick/0000-0003-2376-0136	Conseil Regional de Rhone Alpes	Conseil Regional de Rhone Alpes(Region Auvergne-Rhone-Alpes)	The authors was supported by the Conseil Regional de Rhone Alpes (http://www.rhonealpes.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Adams JR, 2007, MOL ECOL, V16, P1823, DOI 10.1111/j.1365-294X.2007.03270.x; Afonso E, 2016, GLOB ECOL CONSERV, V8, P123, DOI 10.1016/j.gecco.2016.09.002; Aguiar LM, 2008, PRIMATES, V49, P149, DOI 10.1007/s10329-007-0065-y; Anderson EC, 2002, GENETICS, V160, P1217; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Arlettaz R, 2001, OIKOS, V95, P105, DOI 10.1034/j.1600-0706.2001.950112.x; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; ARLETTAZ R, 1991, MYOTIS, V29, P7; Arlettaz R, 1994, THESIS; Arnold ML, 2004, EVOL GENET, P399; Artyushin IV, 2009, ZOOTAXA, P40; Bachanek J, 2010, ACTA CHIROPTEROL, V12, P439, DOI 10.3161/150811010X538007; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Bilgin R, 2012, ACTA CHIROPTEROL, V14, P279, DOI 10.3161/150811012X661611; Biro Z, 2005, J ZOOL, V266, P187, DOI 10.1017/S0952836905006771; Bogdanowicz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053334; Bogdanowicz W, 2009, ACTA CHIROPTEROL, V11, P289, DOI 10.3161/150811009X485530; Bradley RD, 2003, SOUTHWEST NAT, V48, P654, DOI 10.1894/0038-4909(2003)048&lt;0654:IOHBWD&gt;2.0.CO;2; Bryja J, 2003, FOLIA ZOOL, V52, P269; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Burland TM, 2001, BIOL REV, V76, P389, DOI 10.1017/S1464793101005747; Castella V, 2000, MOL ECOL, V9, P1000, DOI 10.1046/j.1365-294x.2000.00939-6.x; Dietz C, 2009, ENCY CHAUVES SOURIS; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Galpern P, 2012, MOL ECOL RESOUR, V12, P771, DOI 10.1111/j.1755-0998.2012.03137.x; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Germain E, 2009, MAMM BIOL, V74, P412, DOI 10.1016/j.mambio.2009.05.008; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hoffmann FG, 2003, MOL ECOL, V12, P2981, DOI 10.1046/j.1365-294X.2003.01959.x; Jan C, 2012, MOL ECOL RESOUR, V12, P532, DOI 10.1111/j.1755-0998.2012.03114.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RUEDI M, 1990, MAMMALIA, V54, P415, DOI 10.1515/mamm.1990.54.3.415; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Sanchez A, 1996, MAMM GENOME, V7, P536, DOI 10.1007/s003359900158; Schwartz MK, 2004, CONSERV GENET, V5, P349, DOI 10.1023/B:COGE.0000031141.47148.8b; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Sztencel-Jablonka A, 2012, CAN J ZOOL, V90, P1251, DOI 10.1139/Z2012-092; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vallo P, 2013, ZOOL SCR, V42, P1, DOI 10.1111/j.1463-6409.2012.00563.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; Zahn A, 1997, J ZOOL, V243, P659, DOI 10.1111/j.1469-7998.1997.tb01968.x	51	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170534	10.1371/journal.pone.0170534	http://dx.doi.org/10.1371/journal.pone.0170534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199337	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400016
J	Chen, Y; Min, LF; Ren, CL; Xu, XX; Yang, JQ; Sun, XC; Wang, T; Wang, F; Sun, CJ; Zhang, XZ				Chen, Yong; Min, Lingfeng; Ren, Chuanli; Xu, Xingxiang; Yang, Jianqi; Sun, Xinchen; Wang, Tao; Wang, Fang; Sun, Changjiang; Zhang, Xizhi			miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; BREAST-CANCER; STEM-CELLS; HEPATOCELLULAR-CARCINOMA; SURGICAL RESECTION; EARLY MORTALITY; POOR-PROGNOSIS; GASTRIC-CANCER; FRESH-FROZEN	Lung cancer is the leading cause of cancer death in the world, and aberrant expression of miRNA is a common feature during the cancer initiation and development. Our previous study showed that levels of miRNA-148a assessed by quantitative real-time polymerase chain reaction (qRT-PCR) were a good prognosis factor for non-small cell lung cancer (NSCLC) patients. In this study, we used high-throughput formalin-fixed and paraffinembedded (FFPE) lung cancer tissue arrays and in situ hybridization (ISH) to determine the clinical significances of miRNA-148a and aimed to find novel target of miRNA-148a in lung cancer. Our results showed that there were 86 of 159 patients with low miRNA-148a expression and miRNA-148a was significantly down-regulated in primary cancer tissues when compared with their adjacent normal lung tissues. Low expression of miRNA-148a was strongly associated with high tumor grade, lymph node (LN) metastasis and a higher risk of tumor-related death in NSCLC. Lentivirus mediated overexpression of miRNA-148a inhibited migration and invasion of A549 and H1299 lung cancer cells. Furthermore, we validated Wnt1 as a direct target of miRNA-148a. Our data showed that the Wnt1 expression was negatively correlated with the expression of miRNA-148a in both primary cancer tissues and their corresponding adjacent normal lung tissues. In addition, overexpression of miRNA148a inhibited Wnt1 protein expression in cancer cells. And knocking down of Wnt-1 by siRNA had the similar effect of miRNA-148a overexpression on cell migration and invasion in lung cancer cells. In conclusion, our results suggest that miRNA-148a inhibited cell migration and invasion through targeting Wnt1 and this might provide a new insight into the molecular mechanisms of lung cancer metastasis.	[Chen, Yong; Yang, Jianqi; Wang, Tao; Sun, Changjiang; Zhang, Xizhi] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Med Oncol, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Min, Lingfeng; Xu, Xingxiang; Wang, Fang] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Resp Med, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Ren, Chuanli] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Clin Med Testing Lab, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Sun, Xinchen] Nanjing Med Univ, Dept Radiotherapy, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Nanjing Medical University	Sun, CJ; Zhang, XZ (corresponding author), Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Med Oncol, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China.	835052071@qq.com; zhangxizhi@medmail.com.cn	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [81302015, 81302016]; National Natural Science Foundation of Jiangsu Province [BK20130455]; Natural Science Foundation of Yangzhou City [YZ2014044]; Jiangsu Government Scholarship for Overseas Study	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Yangzhou City; Jiangsu Government Scholarship for Overseas Study	This work is supported by the National Natural Science Foundation of China (No. 81302015, 81302016), the National Natural Science Foundation of Jiangsu Province (BK20130455), the Natural Science Foundation of Yangzhou City (YZ2014044) and Jiangsu Government Scholarship for Overseas Study.	Aoi T, 2016, GEN THORAC CARDIOVAS, V64, P517, DOI 10.1007/s11748-016-0682-8; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Y, 2013, ONCOL REP, V30, P1832, DOI 10.3892/or.2013.2611; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Dong N, 2016, SEMIN CELL DEV BIOL; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Ganti S, 2012, BRIT J SURG, V99, P1602, DOI 10.1002/bjs.8948; Grivaux M, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0205-5; Heo MJ, 2014, ONCOTARGET, V5, P2792, DOI 10.18632/oncotarget.1920; Huang MX, 2016, J CANCER RES THER, V12, P671, DOI 10.4103/0973-1482.150420; Hug KA, 2015, ANTICANCER RES, V35, P3175; Jang K, 2014, TRANSL RES, V163, P242, DOI 10.1016/j.trsl.2013.11.005; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Jiang Q, 2016, ONCOL REP, V35, P1425, DOI 10.3892/or.2015.4502; Jin JJ, 2016, TRANSL LUNG CANCER R, V5, P436, DOI 10.21037/tlcr.2016.08.08; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Li J, 2015, CELL PHYSIOL BIOCHEM, V37, P1847, DOI 10.1159/000438546; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li JP, 2013, MOL CELL BIOCHEM, V380, P277, DOI 10.1007/s11010-013-1682-y; Li L, 2015, MED SCI MONITOR, V21, P1155, DOI 10.12659/MSM.892940; Li Y, 2016, J CANCER, V7, P1233, DOI 10.7150/jca.14616; Liu L, 2015, INT J CLIN EXP MED, V8; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Powell HA, 2013, THORAX, V68, P826, DOI 10.1136/thoraxjnl-2012-203123; REMMELE W, 1987, PATHOLOGE, V8, P138; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Sakamoto N, 2014, CANCER SCI, V105, P236, DOI 10.1111/cas.12330; Sheffield KM, 2012, ANN SURG ONCOL, V19, P1670, DOI 10.1245/s10434-011-2152-y; Shi CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09930; Si WT, 2016, AM J MED SCI, V352, P191, DOI 10.1016/j.amjms.2016.05.002; Sun YJ, 2015, COMPUT AIDED GEOM D, V35-36, P2, DOI 10.1016/j.cagd.2015.03.011; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046684; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wang SH, 2013, TUMOR BIOL, V34, P3705, DOI 10.1007/s13277-013-0954-1; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu X, 2016, ONCOTARGET, V7, P20381, DOI 10.18632/oncotarget.7953; Yan H, 2014, MOL CARCINOGEN, V53, P960, DOI 10.1002/mc.22064; Yang JS, 2015, TUMOR BIOL, V36, P3035, DOI 10.1007/s13277-014-2938-1; Yu B, 2016, PLOS ONE, V11; Zhang JP, 2014, ONCOGENE, V33, P4069, DOI 10.1038/onc.2013.369; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zhao SG, 2013, NEURO-ONCOLOGY, V15, P707, DOI 10.1093/neuonc/not001; Zhu M, 2014, PATHOL RES PRACT, V210, P909, DOI 10.1016/j.prp.2014.07.008	49	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171751	10.1371/journal.pone.0171751	http://dx.doi.org/10.1371/journal.pone.0171751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199399	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400047
J	Lee, TJ; Fu, CH; Wang, CH; Huang, CC; Huang, CC; Chang, PH; Chen, YW; Wu, CC; Wu, CL; Kuo, HP				Lee, Ta-Jen; Fu, Chia-Hsiang; Wang, Chun-Hua; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung; Chen, Yi-Wei; Wu, Chia-Chen; Wu, Ching-Lung; Kuo, Han-Pin			Impact of chronic rhinosinusitis on severe asthma patients	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; ENDOSCOPIC SINUS SURGERY; NATURAL HELPER-CELLS; ALLERGIC RHINITIS; INFLAMMATION; EXPRESSION; CYTOKINES; INTERLEUKIN-13; ASSOCIATION; EPITHELIUM	Coexistence of chronic rhinosinusitis (CRS) with asthma appears to impair asthma control. Type-2 innate lymphoid cells (ILC2s) respond to the cytokines of thymic stromal lymphopoietin (TSLP), interleukin (IL)-25 and IL-33, thus contributing to airway diseases such as CRS and asthma. We investigate whether the augmented Th-2-cytokines in CRS might be related to sinonasal tract ILC2s corresponding to enhanced IL-25, IL-33 and TSLP release in severe asthmatics, and be involved in asthma control. Twenty-eight asthmatics (12 non-severe and 16 severe) with CRS receiving nasal surgery were enrolled. The predicted FEV1 inversely associated with CRS severity of CT or endoscopy scores. Higher expression of Th-2-driven cytokines (IL-4, IL-5, IL-9, and IL-13), TSLP, IL-25 and IL-33 in nasal tissues was observed in severe asthma. Severe asthmatics had higher ILC2 cell counts in their nasal tissues. ILC2 counts were positively correlated with Th-2-cytokines. Nasal surgery significantly improved asthma control and lung function decline in severe asthma and CRS. The higher expression of IL-33/ILC2 axis-directed type 2 immune responses in nasal tissue of CRS brought the greater decline of lung function in severe asthma. ILC2-induced the upregulated activity of Th-2-related cytokines in asthmatics with CRS may contribute to a recalcitrant status of asthma control.	[Lee, Ta-Jen; Fu, Chia-Hsiang; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung; Chen, Yi-Wei; Wu, Chia-Chen; Wu, Ching-Lung] Chang Gung Mem Hosp, Dept Otolaryngol, Div Rhinol, Taoyuan, Taiwan; [Lee, Ta-Jen; Fu, Chia-Hsiang; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung; Chen, Yi-Wei; Wu, Chia-Chen; Wu, Ching-Lung] Chang Gung Univ, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Huang, Chi-Che; Huang, Chien-Chia; Chang, Po-Hung] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Kuo, Han-Pin] Chang Gung Mem Hosp, Dept Thorac Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Kuo, HP (corresponding author), Chang Gung Mem Hosp, Dept Thorac Med, Taipei, Taiwan.	q8828@ms11.hinet.net	Chen, Yi/HIR-2608-2022; Huang, Chien-Chia/ABF-3606-2020; Wang, Chun-Hua/C-1488-2016; Huang, Chien-Chia/GLR-6528-2022	Huang, Chien-Chia/0000-0003-4188-3498; Lee, Ta-Jen/0000-0003-0508-1359	Chang Gung Memorial Hospital [CMRPG3D0831]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The research grant of this work was supported by Chang Gung Memorial Hospital (CMRPG3D0831).	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; [Anonymous], 2014, GLOB STRAT ASTHM MAN; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Chen FH, 2014, LARYNGOSCOPE, V124, P24, DOI 10.1002/lary.24196; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Dejima K, 2005, INT ARCH ALLERGY IMM, V138, P97, DOI 10.1159/000088430; Dixon AE, 2006, CHEST, V130, P429, DOI 10.1378/chest.130.2.429; Doherty TA, 2015, J INVEST ALLERG CLIN, V25, P1; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P187, DOI 10.2500/ajra.2012.26.3762; Firszt R, 2014, EUR RESPIR J, V43, P464, DOI 10.1183/09031936.00068712; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Garetier M, 2013, RHINOLOGY, V51, P162, DOI [10.4193/Rhin12.131, 10.4193/Rhino12.131]; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Miljkovic D, 2014, ALLERGY, V69, P1154, DOI 10.1111/all.12440; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mortuaire G, 2015, ANN ALLERG ASTHMA IM, V114, P299, DOI 10.1016/j.anai.2015.01.012; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Riccio AN, 2002, CLIN EXP ALLERGY, V32, P422, DOI 10.1046/j.1365-2222.2002.01315.x; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Suzaki H, 2013, CURR OPIN ALLERGY CL, V13, P45, DOI 10.1097/ACI.0b013e32835b34f6; Tay TR, 2016, RESPIROLOGY, V21, P1384, DOI 10.1111/resp.12838; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; ten Brinke A, 2002, J ALLERGY CLIN IMMUN, V109, P621, DOI 10.1067/mai.2002.122458; Truyen E, 2006, THORAX, V61, P202, DOI 10.1136/thx.2005.052399; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wabnitz DAM, 2005, AM J RHINOL, V19, P91, DOI 10.1177/194589240501900116; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831	40	28	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171047	10.1371/journal.pone.0171047	http://dx.doi.org/10.1371/journal.pone.0171047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199345	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400021
J	Rudd, KE; Tutaryebwa, LK; West, TE				Rudd, Kristina E.; Tutaryebwa, Leonard K.; West, T. Eoin			Presentation, management, and outcomes of sepsis in adults and children admitted to a rural Ugandan hospital: A prospective observational cohort study	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SURVIVING SEPSIS; CLINICAL CARE; SEPTIC SHOCK; MORTALITY; GUIDELINES; INFECTIONS; BACTERIAL; AVAILABILITY; DEFINITIONS	Objectives Limited data are available on sepsis in low-resource settings, particularly outside of urban referral centers. We conducted a prospective observational single-center cohort study in May 2013 to assess the presentation, management and outcomes of adult and pediatric patients admitted with sepsis to a community hospital in rural Uganda. Methods We consecutively screened all patients admitted to medical wards who met sepsis criteria. We evaluated eligible patients within 24 hours of presentation and 24-48 hours after admission, and followed them until hospital discharge. In addition to chart review, mental status evaluation, peripheral capillary oxygen saturation, and point-of-care venous whole blood lactate and glucose testing were performed. Results Of 56 eligible patients, we analyzed data on 51 (20 adults and 31 children). Median age was 8 years (IQR 2-23 years). Sepsis accounted for a quarter of all adult and pediatric medical ward admissions during the study period. HIV prevalence among adults was 30%. On enrollment, over half of patients had elevated point-of-care whole blood lactate, few were hypoglycemic or had altered mental status, and one third were hypoxic. Over 80% of patients received at least one antibiotic, all severely hypoxic patients received supplemental oxygen, and half of patients with elevated lactate received fluid resuscitation. The most common causes of sepsis were malaria and pneumonia. In-hospital mortality was 3.9%. Conclusions This study highlights the importance of sepsis among adult and pediatric patients admitted to a rural Ugandan hospital and underscores the need for continued research on sepsis in low resource settings.	[Rudd, Kristina E.; West, T. Eoin] Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA; [Rudd, Kristina E.; West, T. Eoin] Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA 98195 USA; [Tutaryebwa, Leonard K.] Bwindi Community Hosp, Dept Paediat & Child Hlth, Kanungu, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudd, KE (corresponding author), Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA.; Rudd, KE (corresponding author), Univ Washington, Div Pulm & Crit Care Med, Dept Med, Seattle, WA 98195 USA.	krudd@uw.edu	Rudd, Kristina/AFM-0440-2022; Rudd, Kristina/AAH-2770-2022	Rudd, Kristina/0000-0002-6695-8401; Rudd, Kristina/0000-0002-6695-8401; West, T Eoin/0000-0001-5503-7204	INTERSECT-Ellison Fellowship; National Heart, Lung, and Blood Institute (NIH-NHLBI) [T32 HL007287]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER	INTERSECT-Ellison Fellowship; National Heart, Lung, and Blood Institute (NIH-NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Rudd was supported by a grant from the INTERSECT-Ellison Fellowship (http://depts.washington.edu/intrsect/fellowship/) and by the National Heart, Lung, and Blood Institute (NIH-NHLBI T32 HL007287; http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Tutaryebwa received no specific funding for this work. Dr. West received no specific funding for this work.	Abou Dagher G, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0068-1; Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Asiimwe SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089879; Auma MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-146; Bachou Hanifa, 2006, BMC Pediatr, V6, P7, DOI 10.1186/1471-2431-6-7; Baelani Inipavudu, 2012, Middle East Journal of Anesthesiology, V21, P559; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Banajeh SM, 1998, J TROP PEDIATRICS, V44, P343, DOI 10.1093/tropej/44.6.343; Bass CM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0995-5; Bataar O, 2010, B WORLD HEALTH ORGAN, V88, P839, DOI 10.2471/BLT.10.077073; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Bell M, 2001, Int J Infect Dis, V5, P63, DOI 10.1016/S1201-9712(01)90027-X; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bwindi Community Hospital, 2014, BWINDI COMM HOSP ANN; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Chimese Sophie Mwinsa, 2012, Med J Zambia, V39, P19; Chisti MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139966; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Doka NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048356; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Jacob ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070305; Jacob ST, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-107; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2011, CRIT CARE, V15, DOI 10.1186/cc9981; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahavanakul W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029858; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; Moore CC, 2008, CLIN INFECT DIS, V46, P215, DOI 10.1086/524665; Moore CC, 2009, AM J TROP MED HYG, V80, P723, DOI 10.4269/ajtmh.2009.80.723; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Norrgren H, 1997, SCAND J INFECT DIS, V29, P453, DOI 10.3109/00365549709011853; Ortiz JR, 2013, INFLUENZA OTHER RESP, V7, P87, DOI 10.1111/irv.12086; Papali A, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.04.003; Pollach G, 2013, PEDIATR CRIT CARE ME, V14, P561, DOI 10.1097/PCC.0b013e318291774b; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Ssekitoleko R, 2011, AM J TROP MED HYG, V85, P697, DOI 10.4269/ajtmh.2011.10-0692; Ssekitoleko R, 2011, CRIT CARE MED, V39, P2271, DOI 10.1097/CCM.0b013e3182227bd2; Uganda AIDS Commission, 2015, HIV AIDS UG COUNTR P; Waitt PI, 2015, J INFECTION, V70, P11, DOI 10.1016/j.jinf.2014.07.004	46	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171422	10.1371/journal.pone.0171422	http://dx.doi.org/10.1371/journal.pone.0171422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199348	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400029
J	Bailey, RC; Nyaboke, I; Otieno, FO				Bailey, Robert C.; Nyaboke, Irene; Otieno, Fredrick O.			What device would be best for early infant male circumcision in east and southern Africa? Provider experiences and opinions with three different devices in Kenya	PLOS ONE			English	Article							HIV PREVENTION; ACCUCIRC DEVICE; MOGEN CLAMP; RANDOMIZED-TRIAL; AMPUTATION; ZIMBABWE; BOTSWANA; MEN	Voluntary medical male circumcision (VMMC) reduces risk of HIV acquisition in heterosexual men by approximately 60%. As some countries approach targets for proportions of adolescents and adults circumcised, some are considering early infant male circumcision (EIMC) as a means to achieve sustainability of VMMC for long term reduction of HIV incidence. Evaluations of specialized devices for EIMC are important to provide programs with information required to make informed decisions about how to design safe, effective EIMC programs. We provide assessments by 11 providers with experience in Kenya employing all three of the devices most likely to be considered by various EIMC programs in east and Southern Africa. There was no one device that was seen to be clearly superior to the others. Each had its own advantages and disadvantages. Provider preferences were situation-specific. Most preferred the Mogen Clamp if they themselves were performing the procedure. However, most were concerned that not everyone will have the skills necessary for optimal safety. If someone else were circumcising their son, most would opt for the AccuCirc because of the risk of severing the glans when using the Mogen. A minority preferred the PrePex, but only if the baby received local anesthesia, not EMLA cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%), as presently prescribed by the manufacturer. In the context of a national EIMC program, all participants agreed that AccuCirc would be the device they would recommend due to protection of the glans from laceration and to the provision of a pre-assembled sterile kit that overcomes the need for additional supplies or autoclaving. All agreed that scaling up EIMC, integrating it with existing maternal child health services, will face significant challenges, not least of which is persuading already over-burdened providers to take on additional workload. These results will be useful to programmers considering introduction of EIMC services in sub-Saharan African settings.	[Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Nyaboke, Irene; Otieno, Fredrick O.] Nyanza Reprod Hlth Soc, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bailey, RC (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA.	rcbailey@uic.edu		Otieno, Fredrick Odhiambo/0000-0003-0823-412X	Division of AIDS, National Institute of Allergy and Infectious Disease [R01A1108371]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108371, U01AI099953] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grant R01A1108371 to RCB from the Division of AIDS, National Institute of Allergy and Infectious Disease. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adera F, 2016, AIDS 2016 21 INT AID; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2016, FACTORS ASS UPTAKE E; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Fitzgerald L, 2016, GLOB HEALTH-SCI PRAC, V4, pS76, DOI 10.9745/GHSP-D-15-00186; Government of Kenya, 2009, KEN NAT STRAT VOL ME; Government of Kenya Ministry of Health National AIDS and STD Control Programme, 2014, CLIN MAN EARL INF MA; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kankaka EN, 2016, BJU INT; Kikaya V, 2016, GLOB HEALTH-SCI PRAC, V4, pS87, DOI 10.9745/GHSP-D-15-00231; Mangenah C, 2015, JAIDS-J ACQ IMM DEF, V69, P560, DOI 10.1097/QAI.0000000000000699; Mavhu W, 2016, GLOB HEALTH-SCI PRAC, V4, pS42, DOI 10.9745/GHSP-D-15-00199; Mehta SD, 2013, J INFECT DIS, V30, P30; Nyaboke I, 2016, AIDS 2016 21 INT AID; Otieno FO, 2016, HIV PREVENTION FEASI; Patel HI, 2001, J PEDIATR SURG, V36, P235, DOI 10.1053/jpsu.2001.20062; Plank RM, 2014, JAIDS-J ACQ IMM DEF, V66, P1, DOI 10.1097/QAI.0000000000000136; Plank RM, 2013, JAIDS-J ACQ IMM DEF, V62, pE131, DOI 10.1097/QAI.0b013e318285d449; Sherman J, 1996, J UROLOGY, V156, P842, DOI 10.1016/S0022-5347(01)65836-1; Strimling BS, 1996, PEDIATRICS, V97, P906; World Health Organization, 2009, MAN MAL CIRC LOC AN; World Health Organization; Johns Hopkins Program for International Education in Gynecology and Obstetrics, 2010, MAN EARL INF MAL CIR; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047395; Young MR, 2012, PEDIATRICS, V130, pE175, DOI 10.1542/peds.2011-2290	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171445	10.1371/journal.pone.0171445	http://dx.doi.org/10.1371/journal.pone.0171445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196085	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900022
J	Hora, M; Soumar, L; Pontzer, H; Sladek, V				Hora, Martin; Soumar, Libor; Pontzer, Herman; Sladek, Vladimir			Body size and lower limb posture during walking in humans	PLOS ONE			English	Article							3-DIMENSIONAL GAIT ANALYSIS; GENERATING MUSCULAR FORCE; JOINT COORDINATE SYSTEM; HIGH-HEELED SHOES; ENERGY-COST; METABOLIC COST; KINETIC-PARAMETERS; GENDER-DIFFERENCES; INVERSE DYNAMICS; HUMAN LOCOMOTION	We test whether locomotor posture is associated with body mass and lower limb length in humans and explore how body size and posture affect net joint moments during walking. We acquired gait data for 24 females and 25 males using a three-dimensional motion capture system and pressure-measuring insoles. We employed the general linear model and commonality analysis to assess the independent effect of body mass and lower limb length on flexion angles at the hip, knee, and ankle while controlling for sex and velocity. In addition, we used inverse dynamics to model the effect of size and posture on net joint moments. At early stance, body mass has a negative effect on knee flexion (p < 0.01), whereas lower limb length has a negative effect on hip flexion (p < 0.05). Body mass uniquely explains 15.8% of the variance in knee flexion, whereas lower limb length uniquely explains 5.4% of the variance in hip flexion. Both of the detected relationships between body size and posture are consistent with the moment moderating postural adjustments predicted by our model. At late stance, no significant relationship between body size and posture was detected. Humans of greater body size reduce the flexion of the hip and knee at early stance, which results in the moderation of net moments at these joints.	[Hora, Martin; Sladek, Vladimir] Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic; [Soumar, Libor] CASRI Sports Res Inst Czech Armed Forces, Prague, Czech Republic; [Pontzer, Herman] Hunter Coll, Dept Anthropol, New York, NY USA	Charles University Prague; City University of New York (CUNY) System; Hunter College (CUNY)	Hora, M (corresponding author), Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic.	mrtnh@seznam.cz	Hora, Martin/L-7253-2017	Hora, Martin/0000-0002-9742-6985; Pontzer, Herman/0000-0003-2397-6543	Czech Science Foundation [14-22823S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was funded by the Czech Science Foundation, grant number 14-22823S to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. M., 1992, BIOL SCI, V338, P189, DOI [10.1098/rstb.1992.0138, DOI 10.1098/RSTB.1992.0138]; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Begon M, 2007, GAIT POSTURE, V25, P353, DOI 10.1016/j.gaitpost.2006.04.010; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Blaszczyk JW, 2011, ACTA NEUROBIOL EXP, V71, P528; Boyer KA, 2008, J BIOMECH, V41, P3360, DOI 10.1016/j.jbiomech.2008.09.030; Brauer G., 1988, HDB VERGLEICHENDEN B, V1, P160; BRESLER B, 1950, T AM SOC MECH ENG, V72, P27; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chang YH, 1999, J APPL PHYSIOL, V86, P1657, DOI 10.1152/jappl.1999.86.5.1657; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Chung MJ, 2010, GAIT POSTURE, V31, P131, DOI 10.1016/j.gaitpost.2009.09.013; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; de David AC, 2015, J SPORT SCI, V33, P391, DOI 10.1080/02640414.2014.946074; Derrick TR, 2016, J BIOMECH, V49, P429, DOI 10.1016/j.jbiomech.2016.01.003; DeVita P, 2003, J BIOMECH, V36, P1355, DOI 10.1016/S0021-9290(03)00119-2; Duffell LD, 2014, P I MECH ENG H, V228, P206, DOI 10.1177/0954411913518747; EBBELING CJ, 1994, J ORTHOP SPORT PHYS, V19, P190, DOI 10.2519/jospt.1994.19.4.190; Edwards WB, 2016, J BIOMECH, V49, P1206, DOI 10.1016/j.jbiomech.2016.03.007; Edwards WB, 2008, CLIN BIOMECH, V23, P1269, DOI 10.1016/j.clinbiomech.2008.06.011; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; Foster AD, 2013, J HUM EVOL, V65, P294, DOI 10.1016/j.jhevol.2013.06.012; Gregory WK., 1912, ANN NY ACAD SCI, V22, P267, DOI DOI 10.1111/J.1749-6632.1912.TB55164.X; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Gruben KG, 2012, HUM MOVEMENT SCI, V31, P649, DOI 10.1016/j.humov.2011.07.006; Gruss LT, 2007, AM J PHYS ANTHROPOL, V134, P106, DOI 10.1002/ajpa.20642; Gushue DL, 2005, J PEDIATR ORTHOPED, V25, P763, DOI 10.1097/01.bpo.0000176163.17098.f4; Hanlon M, 2006, GAIT POSTURE, V24, P280, DOI 10.1016/j.gaitpost.2005.10.007; Harding GT, 2012, OSTEOARTHR CARTILAGE, V20, P1234, DOI 10.1016/j.joca.2012.08.004; HEGLUND NC, 1988, J EXP BIOL, V138, P301; HENNIG EM, 1995, J APPL BIOMECH, V11, P299, DOI 10.1123/jab.11.3.299; Holliday TW, 1999, J HUM EVOL, V36, P549, DOI 10.1006/jhev.1998.0289; Hora M, 2014, J HUM EVOL, V67, P19, DOI 10.1016/j.jhevol.2013.09.011; Hora M, 2012, FOLIA ZOOL, V61, P330, DOI 10.25225/fozo.v61.i3.a15.2012; Hortobagyi T, 2011, J APPL PHYSIOL, V111, P1391, DOI 10.1152/japplphysiol.00291.2011; Hoyt DF, 2000, J EXP BIOL, V203, P221; Hurd WJ, 2004, CLIN BIOMECH, V19, P465, DOI 10.1016/j.clinbiomech.2004.01.013; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kerrigan DC, 1998, AM J PHYS MED REHAB, V77, P2, DOI 10.1097/00002060-199801000-00002; KETTELKAMP DB, 1970, J BONE JOINT SURG AM, VA 52, P775, DOI 10.2106/00004623-197052040-00008; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Maus HM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1073; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; MOOD AM, 1969, OPER RES, V17, P770, DOI 10.1287/opre.17.5.770; NEWTON RG, 1967, ROY STAT SOC C-APP, V16, P51; OBERG T, 1994, J REHABIL RES DEV, V31, P199; PANDOLF KB, 1976, ERGONOMICS, V19, P683, DOI 10.1080/00140137608931583; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Pandy MG, 2001, ANNU REV BIOMED ENG, V3, P245, DOI 10.1146/annurev.bioeng.3.1.245; PANDY MG, 1991, J BIOMECH, V24, P1, DOI 10.1016/0021-9290(91)90321-D; Patel BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071020; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; PETERS M, 1988, PSYCHOL BULL, V103, P179, DOI 10.1037/0033-2909.103.2.179; Polk JD, 2002, J EXP BIOL, V205, P3399; Pontzer H, 2005, J EXP BIOL, V208, P1513, DOI 10.1242/jeb.01549; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Pontzer H, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0935; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Redl C, 2007, HUM MOVEMENT SCI, V26, P306, DOI 10.1016/j.humov.2007.01.008; Ren L, 2008, J EXP BIOL, V211, P2735, DOI 10.1242/jeb.018820; Roberts TJ, 1998, J EXP BIOL, V201, P2753; Roislien J, 2009, GAIT POSTURE, V30, P441, DOI 10.1016/j.gaitpost.2009.07.002; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; SCOTT SH, 1990, MED SCI SPORT EXER, V22, P357; Sellers WI, 2010, INT J PRIMATOL, V31, P321, DOI 10.1007/s10764-010-9396-4; Sladek V, 2010, AM J PHYS ANTHROPOL, V141, P325, DOI 10.1002/ajpa.21153; SPYROPOULOS P, 1991, ARCH PHYS MED REHAB, V72, P1065; Stansfield BW, 2001, J PEDIATR ORTHOPED, V21, P403, DOI 10.1097/00004694-200105000-00027; Stefanyshyn DJ, 2000, J APPL BIOMECH, V16, P309, DOI 10.1123/jab.16.3.309; Steudel-Numbers KL, 2007, J HUM EVOL, V53, P191, DOI 10.1016/j.jhevol.2007.04.001; Steudel-Numbers KL, 2004, J HUM EVOL, V47, P95, DOI 10.1016/j.jhevol.2004.06.002; Stoquart G, 2008, NEUROPHYSIOL CLIN, V38, P105, DOI 10.1016/j.neucli.2008.02.002; TAYLOR CR, 1980, J EXP BIOL, V86, P9; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; van der Linden ML, 2002, J PEDIATR ORTHOPED, V22, P800, DOI 10.1097/00004694-200211000-00021; van Hedel HJA, 2006, GAIT POSTURE, V24, P35, DOI 10.1016/j.gaitpost.2005.06.015; Warrener AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118903; Whittlesey S, 2013, 2 DIMENSIONAL INVERS; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WITTE H, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P407; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Yoshioka S, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-27; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1; ZAMPARO P, 1992, EUR J APPL PHYSIOL O, V65, P183, DOI 10.1007/BF00705078; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	101	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172112	10.1371/journal.pone.0172112	http://dx.doi.org/10.1371/journal.pone.0172112			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192522	Green Published, gold			2022-12-26	WOS:000394423800071
J	Vaitaitis, GM; Yussman, MG; Waid, DM; Wagner, DH				Vaitaitis, Gisela M.; Yussman, Martin G.; Waid, Dan M.; Wagner, David H., Jr.			Th40 cells (CD4(+)CD40(+) Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; EXPRESSION; MODEL; MICE; RECEPTOR; DISEASE; ACTIVATION; POPULATION; PROTEINS; PREVENTS	CD40-CD154 interaction is critically involved in autoimmune diseases, and CD4 T cells play a dominant role in the Experimental Autoimmune Encephalomyelitis (EAE) model of Multiple Sclerosis (MS). CD4 T cells expressing CD40 (Th40) are pathogenic in type I diabetes but have not been evaluated in EAE. We demonstrate here that Th40 cells drive a rapid, more severe EAE disease course than conventional CD4 T cells. Adoptively transferred Th40 cells are present in lesions in the CNS and are associated with wide spread demyelination. Primary Th40 cells from EAE-induced donors adoptively transfer EAE without further in-vitro expansion and without requiring the administration of the EAE induction regimen to the recipient animals. This has not been accomplished with primary, non-TCR-transgenic donor cells previously. If co-injection of Th40 donor cells with Freund's adjuvant (CFA) in the recipient animals is done, the disease course is more severe. The CFA component of the EAE induction regimen causes generalized inflammation, promoting expansion of Th40 cells and infiltration of the CNS, while MOG-antigen shapes the antigen-specific TCR repertoire. Those events are both necessary to precipitate disease. In MS, viral infections or trauma may induce generalized inflammation in susceptible individuals with subsequent disease onset. It will be important to further understand the events leading up to disease onset and to elucidate the contributions of the Th40 T cell subset. Also, evaluating Th40 levels as predictors of disease onset would be highly useful because if either the generalized inflammation event or the TCR-honing can be interrupted, disease onset may be prevented.	[Vaitaitis, Gisela M.; Yussman, Martin G.; Waid, Dan M.; Wagner, David H., Jr.] Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Vaitaitis, Gisela M.; Yussman, Martin G.; Waid, Dan M.; Wagner, David H., Jr.] Univ Colorado Denver, Webb Waring Ctr, Anschutz Med Campus, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wagner, DH (corresponding author), Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Wagner, DH (corresponding author), Univ Colorado Denver, Webb Waring Ctr, Anschutz Med Campus, Aurora, CO 80045 USA.	david.wagner@ucdenver.edu		Vaitaitis, Gisela/0000-0001-6413-8322	National Institute of Diabetes and Digestive and Kidney Diseases [5R01 DK075013]; National Institute of Allergy and Infectious Diseases [R41 AI113977]; National Multiple Sclerosis Society [RG 5070-A-1]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was funded by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov; grant number 5R01 DK075013), the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov; grant number R41 AI113977) and the National Multiple Sclerosis Society (http://www.nationalmssociety.org/; grant number RG 5070-A-1) awarded to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten K, 2008, J NEUROIMMUNOL, V195, P1, DOI 10.1016/j.jneuroim.2007.11.008; Baker RL, 2008, J AUTOIMMUN, V31, P385, DOI 10.1016/j.jaut.2008.09.001; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Carter J, 2012, EUR J IMMUNOL, V42, P424, DOI 10.1002/eji.201141880; Casiraghi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13995; Casiraghi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002715; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Deng GY, 2014, J NEUROIMMUNOL, V274, P132, DOI 10.1016/j.jneuroim.2014.07.009; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Elyaman W, 2008, AM J PATHOL, V173, P411, DOI 10.2353/ajpath.2008.080142; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Ghalamfarsa G, 2016, J IMMUNOTOXICOL, V13, P274, DOI 10.3109/1547691X.2015.1089343; Girvin AM, 2002, J AUTOIMMUN, V18, P83, DOI 10.1006/jaut.2001.0573; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hong GU, 2013, J NEUROIMMUNOL, V260, P60, DOI 10.1016/j.jneuroim.2013.04.002; Howard LM, 1999, J CLIN INVEST, V103, P281, DOI 10.1172/JCI5388; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ichikawa M, 2000, J NEUROIMMUNOL, V102, P56, DOI 10.1016/S0165-5728(99)00153-8; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Rabchevsky AG, 1999, BRAIN RES, V832, P84, DOI 10.1016/S0006-8993(99)01479-1; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; Suh HS, 2009, CURR TOP MICROBIOL, V336, P63, DOI 10.1007/978-3-642-00549-7_4; Vaitaitis Gisela, 2010, Current Immunology Reviews, V6, P130; Vaitaitis GM, 2013, CELL MOL IMMUNOL, V10, P483, DOI 10.1038/cmi.2013.24; Vaitaitis GM, 2010, MOL IMMUNOL, V47, P2303, DOI 10.1016/j.molimm.2010.05.288; Vaitaitis GM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002076; Vaitaitis GM, 2003, J IMMUNOL, V170, P3455, DOI 10.4049/jimmunol.170.7.3455; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Waid DM, 2008, J LEUKOCYTE BIOL, V84, P431, DOI 10.1189/jlb.1207857; Waid DM, 2007, CLIN IMMUNOL, V124, P138, DOI 10.1016/j.clim.2007.05.003; Waid DM, 2014, J NEUROIMMUNOL, V270, P75, DOI 10.1016/j.jneuroim.2014.03.009; Waid DM, 2004, EUR J IMMUNOL, V34, P1488, DOI 10.1002/eji.200324703; Williams JL, 2011, J NEUROIMMUNOL, V234, P84, DOI 10.1016/j.jneuroim.2011.02.008	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172037	10.1371/journal.pone.0172037	http://dx.doi.org/10.1371/journal.pone.0172037			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192476	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800063
J	Li, Y; Zhou, T; Wang, Y; Ning, C; Lv, Z; Han, G; Morris, JC; Taylor, EN; Wang, R; Xiao, H; Hou, C; Ma, Y; Shen, B; Feng, J; Guo, R; Li, Y; Chen, G				Li, Y.; Zhou, T.; Wang, Y.; Ning, C.; Lv, Z.; Han, G.; Morris, J. C.; Taylor, E. N.; Wang, R.; Xiao, H.; Hou, C.; Ma, Y.; Shen, B.; Feng, J.; Guo, R.; Li, Y.; Chen, G.			The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation	ONCOGENE			English	Article							TUMOR-BEARING MICE; SUPPRESSOR-CELLS; MULTIPLE-SCLEROSIS; HEPATOCELLULAR-CARCINOMA; LYMPHOCYTE EGRESS; GM-CSF; FINGOLIMOD; RECEPTOR; CANCER; ACTIVATION	FTY720 (also called fingolimod) is recognized as an immunosuppressant and has been approved by the Food and Drug Administration to treat refractory multiple sclerosis. However, long-term administration of FTY720 potentially increases the risk for cancer in recipients. The underlying mechanisms remain poorly understood. Herein, we provided evidence that FTY720 administration potentiated tumor growth. Mechanistically, FTY720 enhanced extramedullary hematopoiesis and massive accumulation of myeloid-derived suppressor cells (MDSCs), which actively suppressed antitumor immune responses. Granulocyte-macrophage colony-stimulating factor (GM-CSF), mainly produced by MDSCs, was identified as a key factor to mediate these effects of FTY720 in tumor microenvironment. Furthermore, we showed that FTY720 triggers MDSCs to release GM-CSF via S1P receptor 3 (S1pr3) through Rho kinase and extracellular signal-regulated kinase-dependent pathway. Thus, our findings provide mechanistic explanation for the protumorigenic potentials of FTY720 and suggest that targeting S1pr3 simultaneously may be beneficial for the patients receiving FTY720 treatment.	[Li, Y.; Zhou, T.; Wang, Y.; Ning, C.; Lv, Z.; Han, G.; Wang, R.; Xiao, H.; Hou, C.; Shen, B.; Feng, J.; Li, Y.; Chen, G.] Inst Basic Med Sci, Dept Immunol, Taiping Rd 27, Beijing 100850, Peoples R China; [Li, Y.; Ma, Y.] Henan Univ, Med Sch, Lab Cellular & Mol Immunol, Kaifeng, Peoples R China; [Li, Y.] Peoples Hosp Luanchuan Cty, Dept Internal Med, Luoyang, Peoples R China; [Li, Y.; Zhou, T.; Han, G.; Wang, R.; Xiao, H.; Hou, C.; Shen, B.; Feng, J.; Li, Y.; Chen, G.] State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China; [Wang, Y.] Acad Mil Med Sci, Affiliated Hosp, Dept Hematol & Transplantat, Beijing, Peoples R China; [Ning, C.] 161st Hosp PLA, Dept Oncol, Wuhan, Peoples R China; [Morris, J. C.; Taylor, E. N.] Univ New South Wales, Sch Chem, Sydney, NSW, Australia; [Guo, R.] Univ Michigan, Dept Pathol, Ann Arbor, MI USA	Henan University; Academy of Military Medical Sciences - China; University of New South Wales Sydney; University of Michigan System; University of Michigan	Han, G; Chen, G (corresponding author), Inst Basic Med Sci, Dept Immunol, Taiping Rd 27, Beijing 100850, Peoples R China.	genchenghan@163.com; guogangch@yahoo.com	Wang, Renxi/AAM-1326-2020; Morris, Jonathan C/A-9923-2008	Morris, Jonathan C/0000-0002-5109-9069; Wang, Renxi/0000-0003-4130-3334	National Key Basic Research Program of China [2015CB553704, 2013CB530506]; National Natural Science Foundation of China [81672803, 81472647, 81272320]; Beijing Natural Science Foundation [7132151]; Service Industry Scientific Research of National Health and Family Planning Commission of China [2015SQ00192]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Service Industry Scientific Research of National Health and Family Planning Commission of China	This work was supported by grants from the National Key Basic Research Program of China (2015CB553704, 2013CB530506), the National Natural Science Foundation of China (81672803, 81472647, 81272320), Beijing Natural Science Foundation (7132151), Service Industry Scientific Research of National Health and Family Planning Commission of China (2015SQ00192).	Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Conzett KB, 2011, ARCH DERMATOL, V147, P991, DOI 10.1001/archdermatol.2011.212; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Hung JH, 2008, CANCER RES, V68, P1204, DOI 10.1158/0008-5472.CAN-07-2621; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kim EK, 2014, CANCER RES, V74, P6705, DOI 10.1158/0008-5472.CAN-14-1482; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Liu GW, 2014, J IMMUNOL, V192, P3068, DOI 10.4049/jimmunol.1301193; Liu Q, 2010, CLIN CANCER RES, V16, P3182, DOI 10.1158/1078-0432.CCR-09-2484; Lorvik KB, 2012, BLOOD, V119, P2176, DOI 10.1182/blood-2011-10-388892; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pitman MR, 2012, CURR MOL MED, V12, P1207, DOI 10.2174/156652412803833599; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Quatromoni JG, 2015, J LEUKOCYTE BIOL, V97, P201, DOI 10.1189/jlb.5TA0814-373; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sevko A, 2013, J CANCER, V4, P3, DOI 10.7150/jca.5047; Sio A, 2013, CANCER RES, V73, P5892, DOI 10.1158/0008-5472.CAN-13-0842; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Ueha S, 2011, INT IMMUNOPHARMACOL, V11, P783, DOI 10.1016/j.intimp.2011.03.003; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	50	14	14	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3760	3771		10.1038/onc.2017.2	http://dx.doi.org/10.1038/onc.2017.2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28218904				2022-12-26	WOS:000404349700011
J	Gkekas, S; Singh, RK; Shkumatov, AV; Messens, J; Fauvart, M; Verstraeten, N; Michiels, J; Versees, W				Gkekas, Sotirios; Singh, Ranjan Kumar; Shkumatov, Alexander V.; Messens, Joris; Fauvart, Maarten; Verstraeten, Natalie; Michiels, Jan; Versees, Wim			Structural and biochemical analysis of Escherichia coli ObgE, a central regulator of bacterial persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; crystal structure; enzyme kinetics; enzyme structure; GTPase; X-ray crystallography; X-ray scattering	50S RIBOSOMAL-SUBUNIT; G-PROTEINS; STRINGENT RESPONSE; BACILLUS-SUBTILIS; GTPASE REACTION; G-DOMAIN; BINDING; DIMERIZATION; MODEL; MACROMOLECULES	The Obg protein family belongs to the TRAFAC (translation factor) class of P-loop GTPases and is conserved from bacteria to eukaryotes. Essential roles in many different cellular processes have been suggested for the Obg protein from Escherichia coli (ObgE), and we recently showed that it is a central regulator of bacterial persistence. Here, we report the first crystal structure of ObgE at 1.85- resolution in the GDP-bound state, showing the characteristic N-terminal domain and a central G domain that are common to all Obg proteins. ObgE also contains an intrinsically disordered C-terminal domain, and we show here that this domain specifically contributed to GTP binding, whereas it did not influence GDP binding or GTP hydrolysis. Biophysical analysis, using small angle X-ray scattering and multi-angle light scattering experiments, revealed that ObgE is a monomer in solution, regardless of the bound nucleotide. In contrast to recent suggestions, our biochemical analyses further indicate that ObgE is neither activated by K+ ions nor by homodimerization. However, the ObgE GTPase activity was stimulated upon binding to the ribosome, confirming the ribosome-dependent GTPase activity of the Obg family. Combined, our data represent an important step toward further unraveling the detailed molecular mechanism of ObgE, which might pave the way to further studies into how this GTPase regulates bacterial physiology, including persistence.	[Gkekas, Sotirios; Singh, Ranjan Kumar; Shkumatov, Alexander V.; Messens, Joris; Versees, Wim] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Gkekas, Sotirios; Singh, Ranjan Kumar; Shkumatov, Alexander V.; Messens, Joris; Versees, Wim] VIB VUB Ctr Struct Biol, B-1050 Brussels, Belgium; [Fauvart, Maarten; Verstraeten, Natalie; Michiels, Jan] Univ Leuven, KU Leuven, Ctr Microbial & Plant Genet, B-3001 Leuven, Belgium; [Fauvart, Maarten] IMEC, Dept Life Sci Technol, Smart Syst & Emerging Technol Unit, B-3001 Leuven, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; IMEC	Versees, W (corresponding author), Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium.	wim.versees@vib-vub.be	Verstraeten, Natalie/AAH-3963-2019; Messens, Joris/AAH-3008-2020; Fauvart, Maarten/B-1612-2010; Michiels, Jan/F-1601-2010; Verstraeten, Natalie/AAJ-1464-2021; SINGH, RANJAN/Q-2752-2017	Verstraeten, Natalie/0000-0002-9548-4647; Messens, Joris/0000-0002-2128-8264; Fauvart, Maarten/0000-0002-6256-9193; Michiels, Jan/0000-0001-5829-0897; Verstraeten, Natalie/0000-0002-9548-4647; SINGH, RANJAN/0000-0002-6929-0670; Versees, Wim/0000-0002-4695-696X	Fonds voor Wetenschappelijk Onderzoek [G0471.12N, G0B2515N]; Hercules Foundation; BioStruct-X by the European Community's Seventh Framework Programme; VUB [SRP34]; Interuniversity Attraction Poles Program; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT); Belgian Science Policy Office	Fonds voor Wetenschappelijk Onderzoek(FWO); Hercules Foundation; BioStruct-X by the European Community's Seventh Framework Programme; VUB; Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy Office(Belgian Federal Science Policy Office)	This work was supported in part by Fonds voor Wetenschappelijk Onderzoek Grants G0471.12N and G0B2515N, the Hercules Foundation, BioStruct-X by the European Community's Seventh Framework Programme, a Strategic Research Program (SRP34) from the VUB, and the Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT).	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2012, FEBS LETT, V586, P2218, DOI 10.1016/j.febslet.2012.06.030; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; Bang WY, 2009, PLANT MOL BIOL, V71, P379, DOI 10.1007/s11103-009-9529-3; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Chatterjee A, 2015, BIOCHEM BIOPH RES CO, V461, P636, DOI 10.1016/j.bbrc.2015.04.079; Cheung MY, 2016, P NATL ACAD SCI USA, V113, P2648, DOI 10.1073/pnas.1522966113; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Fislage M, 2016, BIOPOLYMERS, V105, P568, DOI 10.1002/bip.22813; Fislage M, 2014, NUCLEIC ACIDS RES, V42, P5978, DOI 10.1093/nar/gku213; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Foucher AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046795; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hirano Y, 2006, GENES CELLS, V11, P1295, DOI 10.1111/j.1365-2443.2006.01017.x; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kint C, 2014, CRIT REV MICROBIOL, V40, P207, DOI 10.3109/1040841X.2013.776510; Kint CI, 2012, FEBS J, V279, P3692, DOI 10.1111/j.1742-4658.2012.08731.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Maracci C, 2016, BIOPOLYMERS, V105, P463, DOI 10.1002/bip.22832; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Mishra AK, 2016, BIOPOLYMERS, V105, P431, DOI 10.1002/bip.22833; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rafay A, 2012, FEBS OPEN BIO, V2, P173, DOI 10.1016/j.fob.2012.07.008; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004	68	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5871	5883		10.1074/jbc.M116.761809	http://dx.doi.org/10.1074/jbc.M116.761809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223358	Green Published, hybrid			2022-12-26	WOS:000398813200022
J	Wills, MKB; Chahi, AK; Lau, HR; Tilak, M; Guild, BD; New, LA; Lu, PH; Jacquet, K; Meakin, SO; Bisson, N; Jones, N				Wills, Melanie K. B.; Chahi, Ava Keyvani; Lau, Hayley R.; Tilak, Manali; Guild, Brianna D.; New, Laura A.; Lu, Peihua; Jacquet, Kevin; Meakin, Susan O.; Bisson, Nicolas; Jones, Nina			Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular signal-regulated kinase (ERK); growth factor receptor-bound protein 2 (GRB2); neurotrophin; signal transduction; TRK1-transforming tyrosine kinase protein (Trk-A); RaLP; ShcD; Shp2; TrkB; phosphotyrosine adaptor	NEGATIVE REGULATOR; DOCKING PROTEIN; ACTIVATION; GROWTH; EXPRESSION; FAMILY; BINDING; NEUROBLASTOMA; MECHANISM; PATHWAY	Proteins of the Src homology and collagen (Shc) family are typically involved in signal transduction events involving Ras/MAPK and PI3K/Akt pathways. In the nervous system, they function proximal to the neurotrophic factors that regulate cell survival, differentiation, and neuron-specific characteristics. The least characterized homolog, ShcD, is robustly expressed in the developing and mature nervous system, but its contributions to neural cell circuitry are largely uncharted. We now report that ShcD binds to active Ret, TrkA, and TrkB neurotrophic factor receptors predominantly via its phosphotyrosine-binding (PTB) domain. However, in contrast to the conventional Shc adaptors, ShcD suppresses distal phosphorylation of the Erk MAPK. Accordingly, genetic knock-out of mouse ShcD enhances Erk phosphorylation in the brain. In cultured cells, this capacity is tightly aligned to phosphorylation of ShcD CH1 region tyrosine motifs, which serve as docking platforms for signal transducers, such as Grb2. Erk suppression is relieved through independent mutagenesis of the PTB domain and the CH1 tyrosine residues, and successive substitution of these tyrosines breaks the interaction between ShcD and Grb2, thereby promoting TrkB-Grb2 association. Erk phosphorylation can also be restored in the presence of wild type ShcD through Grb2 overexpression. Conversely, mutation of the ShcD SH2 domain results in enhanced repression of Erk. Although the SH2 domain is a less common binding interface in Shc proteins, we demonstrate that it associates with the Ptpn11 (Shp2) phosphatase, which in turn regulates ShcD tyrosine phosphorylation. We therefore propose a model whereby ShcD competes with neurotrophic receptors for Grb2 binding and opposes activation of the MAPK cascade.	[Wills, Melanie K. B.; Chahi, Ava Keyvani; Lau, Hayley R.; Tilak, Manali; Guild, Brianna D.; New, Laura A.; Lu, Peihua; Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Jacquet, Kevin; Bisson, Nicolas] Univ Laval, Canc Res Ctr, Quebec Network Res Prot Funct Engn & Applicat PRO, Quebec City, PQ G1R 2J6, Canada; [Jacquet, Kevin; Bisson, Nicolas] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ G1R 2J6, Canada; [Meakin, Susan O.] Western Univ, Dept Biochem, London, ON N6A 5B7, Canada	University of Guelph; Laval University; Laval University; Western University (University of Western Ontario)	Jones, N (corresponding author), Univ Guelph, Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	jonesmcb@uoguelph.ca		Wills, Melanie/0000-0002-7448-8657; Bisson, Nicolas/0000-0001-7752-9517	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; Canada Research Chair awards; Canadian Institutes of Health Research Vanier Scholarship; University of Guelph Brock Doctoral Scholarship; NSERC Alexander Graham Bell Canada graduate scholarship; Canadian Imperial Bank of Commerce Health and Science studentship; University of Guelph College of Biological Sciences studentship; NSERC; PROTEO scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair awards(Canada Research Chairs); Canadian Institutes of Health Research Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); University of Guelph Brock Doctoral Scholarship; NSERC Alexander Graham Bell Canada graduate scholarship; Canadian Imperial Bank of Commerce Health and Science studentship; University of Guelph College of Biological Sciences studentship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); PROTEO scholarship	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (to N. J.) and Tier 2 Canada Research Chair awards (to N. J. and N. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canadian Institutes of Health Research Vanier Scholarship, the University of Guelph Brock Doctoral Scholarship, and an NSERC Alexander Graham Bell Canada graduate scholarship (M.Sc.).; Held a Canadian Imperial Bank of Commerce Health and Science studentship.; Received a University of Guelph College of Biological Sciences studentship.; Recipient of an NSERC undergraduate student research award.; Supported by a PROTEO scholarship.	Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Aoudjit Lamine, 2011, J Signal Transduct, V2011, P376543, DOI 10.1155/2011/376543; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Beigbeder A, 2016, METHODS MOL BIOL, V1458, P339, DOI 10.1007/978-1-4939-3801-8_23; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Conti L, 2001, NAT NEUROSCI, V4, P579, DOI 10.1038/88395; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Ferro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029899; George R, 2008, J MOL BIOL, V377, P740, DOI 10.1016/j.jmb.2007.12.040; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hawley SP, 2011, DEV DYNAM, V240, P221, DOI 10.1002/dvdy.22506; Jones N, 2007, MOL CELL BIOL, V27, P4759, DOI 10.1128/MCB.00184-07; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Kumamaru E, 2011, FEBS LETT, V585, P3224, DOI 10.1016/j.febslet.2011.09.010; Lai KMV, 2000, GENE DEV, V14, P1132; Ledda F, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00199; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; MacDonald JIS, 2000, J BIOL CHEM, V275, P18225, DOI 10.1074/jbc.M001862200; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Miyake I, 2009, ONCOGENE, V28, P662, DOI 10.1038/onc.2008.413; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelicci G, 2002, MOL CELL BIOL, V22, P7351, DOI 10.1128/MCB.22.20.7351-7363.2002; Ponti G, 2005, NEUROSCIENCE, V133, P105, DOI 10.1016/j.neuroscience.2005.02.014; Ponti G, 2010, NEUROSCIENCE, V168, P314, DOI 10.1016/j.neuroscience.2010.03.008; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Savino MT, 2009, J IMMUNOL, V182, P301, DOI 10.4049/jimmunol.182.1.301; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Suen KM, 2013, NAT STRUCT MOL BIOL, V20, P620, DOI 10.1038/nsmb.2557; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Terui E, 2005, CLIN CANCER RES, V11, P3280, DOI 10.1158/1078-0432.CCR-04-1681; Villanacci V, 2008, NEUROGASTROENT MOTIL, V20, P206, DOI 10.1111/j.1365-2982.2007.01017.x; Wills MKB, 2014, MOL BIOL CELL, V25, P739, DOI 10.1091/mbc.E13-08-0434; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; You YG, 2010, BMB REP, V43, P485, DOI 10.5483/BMBRep.2010.43.7.485	43	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5748	5759		10.1074/jbc.M116.770511	http://dx.doi.org/10.1074/jbc.M116.770511			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213521	Green Published, hybrid			2022-12-26	WOS:000398813200013
J	Cheng, Q; Arner, ESJ				Cheng, Qing; Arner, Elias S. J.			Selenocysteine Insertion at a Predefined UAG Codon in a Release Factor 1 (RF1)-depleted Escherichia coli Host Strain Bypasses Species Barriers in Recombinant Selenoprotein Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; SECIS ELEMENTS; GENETIC-CODE; IN-VIVO; EXPRESSION; SELENIUM; RNA; PROTEINS; PURIFICATION; EFFICIENCY	Selenoproteins contain the amino acid selenocysteine (Sec), co-translationally inserted at a predefined UGA opal codon by means of Sec-specific translation machineries. In Escherichia coli, this process is dependent upon binding of the Sec-dedicated elongation factor SelB to a Sec insertion sequence (SECIS) element in the selenoprotein-encoding mRNA and competes with UGA-directed translational termination. Here, we found that Sec can also be efficiently incorporated at a predefined UAG amber codon, thereby competing with RF1 rather than RF2. Subsequently, utilizing the RF1-depleted E. coli strain C321. Delta A, we could produce mammalian selenoprotein thioredoxin reductases with unsurpassed purity and yield. We also found that a SECIS element was no longer absolutely required in such a system. Human glutathione peroxidase 1 could thereby also be produced, and we could confirm a previously proposed catalytic tetrad in this selenoprotein. We believe that the versatility of this new UAG-directed production methodology should enable many further studies of diverse selenoproteins.	[Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	elias.arner@ki.se	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114	Swedish Research Council; Swedish Cancer Society; Knut Foundation; Alice Wallenberg Foundation; Karolinska Institutet; NATIONAL INSTITUTE ON AGING [R21AG055022] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut Foundation; Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Swedish Research Council, the Swedish Cancer Society, The Knut and Alice Wallenberg Foundations, and Karolinska Institutet. The authors declare that they have no conflicts of interest with the contents of this article.	Aldag C, 2013, ANGEW CHEM INT EDIT, V52, P1441, DOI 10.1002/anie.201207567; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; ARNER ESJ, 2000, CURRENT PROTOCOLS TO; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brocker MJ, 2014, ANGEW CHEM INT EDIT, V53, P319, DOI 10.1002/anie.201308584; Casi G, 2008, CHEMBIOCHEM, V9, P1623, DOI 10.1002/cbic.200700745; Castellano S, 2008, NUCLEIC ACIDS RES, V36, pD332, DOI 10.1093/nar/gkm731; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; Esworthy RS, 2001, CURR PROTOC TOXICOL; Fletcher JE, 2001, RNA, V7, P1442; George S, 2016, FEBS LETT, V590, P1530, DOI 10.1002/1873-3468.12182; Hondal RJ, 2009, BBA-GEN SUBJECTS, V1790, P1501, DOI 10.1016/j.bbagen.2009.04.015; Jiang ZH, 2004, BIOCHEM BIOPH RES CO, V321, P94, DOI 10.1016/j.bbrc.2004.06.110; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2004, EMBO REP, V5, P538, DOI 10.1038/sj.embor.7400126; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Metanis N, 2014, CURR OPIN CHEM BIOL, V22, P27, DOI 10.1016/j.cbpa.2014.09.010; Miller C, 2015, FEBS LETT, V589, P2194, DOI 10.1016/j.febslet.2015.06.039; Mukai T, 2016, ANGEW CHEM INT EDIT, V55, P5337, DOI 10.1002/anie.201511657; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nilsson M, 2003, BBA-GENE STRUCT EXPR, V1627, P1, DOI 10.1016/S0167-4781(03)00050-2; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Reich HJ, 2016, ACS CHEM BIOL, V11, P821, DOI 10.1021/acschembio.6b00031; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rengby O, 2007, APPL ENVIRON MICROB, V73, P432, DOI 10.1128/AEM.02019-06; Rengby O, 2009, FREE RADICAL BIO MED, V46, P893, DOI 10.1016/j.freeradbiomed.2008.12.017; Rother M, 2001, MOL MICROBIOL, V40, P900, DOI 10.1046/j.1365-2958.2001.02433.x; SAWERS G, 1991, J BACTERIOL, V173, P4983, DOI 10.1128/jb.173.16.4983-4993.1991; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Thanbichler M, 2002, EMBO J, V21, P6925, DOI 10.1093/emboj/cdf673; Thyer R, 2015, J AM CHEM SOC, V137, P46, DOI 10.1021/ja510695g; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Xu JQ, 2013, NUCLEIC ACIDS RES, V41, P9800, DOI 10.1093/nar/gkt764; Zhang Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r37; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000095; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660	53	35	35	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5476	5487		10.1074/jbc.M117.776310	http://dx.doi.org/10.1074/jbc.M117.776310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193838	Green Published, hybrid			2022-12-26	WOS:000397875500027
J	Vitvitsky, V; Yadav, PK; An, S; Seravalli, J; Cho, US; Banerjee, R				Vitvitsky, Victor; Yadav, Pramod K.; An, Sojin; Seravalli, Javier; Cho, Uhn-Soo; Banerjee, Ruma			Structural and Mechanistic Insights into Hemoglobin-catalyzed Hydrogen Sulfide Oxidation and the Fate of Polysulfide Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PECTINATA BACTERIA SYMBIOSIS; CYSTEINE PERSULFIDES; MIGRATION; KINETICS; THIOSULFATE; UNDERSTAND; SYNTHASE; MODEL; O-2	Hydrogen sulfide is a cardioprotective signaling molecule but is toxic at elevated concentrations. Red blood cells can synthesize H2S but, lacking organelles, cannot dispose of H2S via the mitochondrial sulfide oxidation pathway. We have recently shown that at high sulfide concentrations, ferric hemoglobin oxidizes H2S to a mixture of thiosulfate and iron-bound polysulfides in which the latter species predominates. Here, we report the crystal structure of human hemoglobin containing low spin ferric sulfide, the first intermediate in heme-catalyzed sulfide oxidation. The structure provides molecular insights into why sulfide is susceptible to oxidation in human hemoglobin but is stabilized against it in HbI, a specialized sulfide-carrying hemoglobin from a mollusk adapted to life in a sulfide-rich environment. We have also captured a second sulfide bound at a postulated ligand entry/exit site in the alpha-subunit of hemoglobin, which, to the best of our knowledge, represents the first direct evidence for this site being used to access the heme iron. Hydrodisulfide, a postulated intermediate at the junction between thiosulfate and polysulfide formation, coordinates ferric hemoglobin and, in the presence of air, generated thiosulfate. At low sulfide/heme iron ratios, the product distribution between thiosulfate and iron-bound polysulfides was approximately equal. The iron-bound polysulfides were unstable at physiological glutathione concentrations and were reduced with concomitant formation of glutathione persulfide, glutathione disulfide, and H2S. Hence, although polysulfides are unlikely to be stable in the reducing intracellular milieu, glutathione persulfide could serve as a persulfide donor for protein persulfidation, a posttranslational modification by which H2S is postulated to signal.	[Vitvitsky, Victor; Yadav, Pramod K.; An, Sojin; Cho, Uhn-Soo; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [GM112455, DK111465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM112455 (to R. B.) and DK111465 (to U.-S. C). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAGARINAO T, 1992, J COMP PHYSIOL B, V162, P614, DOI 10.1007/BF00296642; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; Cumnock K, 2013, BIOCONJUGATE CHEM, V24, P1154, DOI 10.1021/bc4000299; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Lucas MF, 2012, BIOPHYS J, V102, P887, DOI 10.1016/j.bpj.2012.01.011; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; HYLIN JW, 1959, J BIOL CHEM, V234, P2141; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P347, DOI 10.1089/ars.2014.6082; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagy P, 2010, CHEM RES TOXICOL, V23, P1541, DOI 10.1021/tx100266a; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Savino C, 2009, BIOPOLYMERS, V91, P1097, DOI 10.1002/bip.21201; Shadrina MS, 2015, BIOCHEMISTRY-US, V54, P5279, DOI 10.1021/acs.biochem.5b00369; Shadrina MS, 2015, BIOCHEMISTRY-US, V54, P5268, DOI 10.1021/acs.biochem.5b00368; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2015, METHOD ENZYMOL, V554, P111, DOI 10.1016/bs.mie.2014.11.013; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Yi J, 2008, BIOCHEMISTRY-US, V47, P8247, DOI 10.1021/bi801015c	36	39	39	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5584	5592		10.1074/jbc.M117.774943	http://dx.doi.org/10.1074/jbc.M117.774943			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213526	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000397875500036
J	Dalgic, OO; Ozaltin, OY; Ciccotelli, WA; Erenay, FS				Dalgic, Ozden O.; Ozaltin, Osman Y.; Ciccotelli, William A.; Erenay, Fatih S.			Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model	PLOS ONE			English	Article							SEASONAL INFLUENZA; DYNAMIC MITIGATION; PRIORITIZATION; INFECTION; HETEROGENEITY; EFFICACY; DISEASE; IMPACT; VIRUS	Individuals are prioritized based on their risk profiles when allocating limited vaccine stocks during an influenza pandemic. Computationally expensive but realistic agent-based simulations and fast but stylized compartmental models are typically used to derive effective vaccine allocation strategies. A detailed comparison of these two approaches, however, is often omitted. We derive age-specific vaccine allocation strategies to mitigate a pandemic influenza outbreak in Seattle by applying derivative-free optimization to an agent-based simulation and also to a compartmental model. We compare the strategies derived by these two approaches under various infection aggressiveness and vaccine coverage scenarios. We observe that both approaches primarily vaccinate school children, however they may allocate the remaining vaccines in different ways. The vaccine allocation strategies derived by using the agent-based simulation are associated with up to 70% decrease in total cost and 34% reduction in the number of infections compared to the strategies derived by using the compartmental model. Nevertheless, the latter approach may still be competitive for very low and/or very high infection aggressiveness. Our results provide insights about potential differences between the vaccine allocation strategies derived by using agent-based simulations and those derived by using compartmental models.	[Dalgic, Ozden O.; Erenay, Fatih S.] Univ Waterloo, Dept Management Sci, Waterloo, ON, Canada; [Ozaltin, Osman Y.] North Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA; [Ciccotelli, William A.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ciccotelli, William A.] Grand River Hosp, Kitchener, ON, Canada	University of Waterloo; University of North Carolina; North Carolina State University; McMaster University	Ozaltin, OY (corresponding author), North Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA.	oyozalti@ncsu.edu	Dalgic, Ozden Onur/M-6881-2019	Ozaltin, Osman/0000-0002-0093-5645; Erenay, Fatih Safa/0000-0002-3408-0366	Natural Sciences and Engineering Research Council of Canada [DG 113788, DG 113790]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (DG 113788 and DG 113790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M.A., 2009, THE NOMAD PROJECT; ANDERSON R., 1991, INFECT DIS; [Anonymous], [No title captured], DOI DOI 10.1080/19488300.2014.880093; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Arias E, 2014, NAT VITAL STAT REP, V63, P1; Atkinson K. A., 1989, AN INTRODUCTION TO N; Audet C, 2009, NOMAD USER GUIDE; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Basta Nicole E, 2009, Am J Epidemiol, V170, P679, DOI 10.1093/aje/kwp237; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CDC, 2016, VACCINE EFFECTIVENES; CDC, 2014, LEADING CAUSES OF DE; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Chhatwal J, 2015, PHARMACOECONOMICS, V33, P423, DOI 10.1007/s40273-015-0254-2; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Das TK, 2008, IIE TRANS, V40, P893, DOI 10.1080/07408170802165856; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; Dhamodharan A, 2012, HEALTH CARE MANAG SC, V15, P188, DOI 10.1007/s10729-012-9200-4; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Feng WH, 2013, J SIMUL, V7, P109, DOI 10.1057/jos.2012.21; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hladish T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-76; Huang GP, 2009, ANN OPER RES, V168, P41, DOI 10.1007/s10479-008-0373-7; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Le Digabel S, 2011, ACM T MATH SOFTWARE, V37, DOI 10.1145/1916461.1916468; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Medlock Jan, 2009, PLoS Curr, V1, pRRN1134; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Merler S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-117; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MOLLISON D, 1994, J R STAT SOC A STAT, V157, P115, DOI 10.2307/2983509; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Struchiner CJ, 2010, DESIGN AND ANALYSIS; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; United States Census Bureau, 2014, POPULATION ESTIMATES; Uribe-Sanchez A, 2011, OR SPECTRUM, V33, P751, DOI 10.1007/s00291-011-0249-0; World Health Organization, 2009, PANDEMIC INFLUENZA V; Zaric GS, 2001, MATH BIOSCI, V171, P33, DOI 10.1016/S0025-5564(01)00050-5	52	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172261	10.1371/journal.pone.0172261	http://dx.doi.org/10.1371/journal.pone.0172261			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222123	Green Submitted, gold, Green Published			2022-12-26	WOS:000394676800045
J	Munoz-Prieto, A; Tvarijonaviciute, A; Escribano, D; Martinez-Subiela, S; Ceron, JJ				Munoz-Prieto, Alberto; Tvarijonaviciute, Asta; Escribano, Damian; Martinez-Subiela, Silvia; Ceron, Jose J.			Use of heterologous immunoassays for quantification of serum proteins: The case of canine C-reactive protein	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; LINKED-IMMUNOSORBENT-ASSAY; DOGS; VALIDATION; CRP	The use of heterologous immunoassays containing antibodies raised against a different biological species for quantification of serum proteins is studied and discussed, taking as example the case of the use of a commercially available heterologous assay containing antibodies against human C-reactive protein (hCRP) for quantification of CRP in serum of dogs. This assay was adapted and validated for measurements of canine CRP (cCRP) and compared with three different homologous assays containing species-specific canine antibodies, which are currently commercially available for cCRP determination. Serum samples from healthy and diseased dogs (n = 44) were used. Analytical evaluation included precision, accuracy, limit of detection and lower limit of quantification for all assays. In the case of the heterologous assay also cross-reactivity of the antibody of the heterologous assay with cCRP was evaluated by a Western-Blot analysis giving a positive result. The heterologous assay showed similar results than the homologous assays in all the tests of the analytical evaluation that indicated that the assay was precise and accurate. Method comparison showed a high correlation between all assays (r >= 0.9). The Bland-Altman test revealed that the heterologous assay showed a proportional error when compared with the homologous automated assays and a random error when compared with the point-of-care assay. All four CRP assays were able to detect higher CRP values in dogs with inflammatory conditions compared with healthy dogs. It is concluded that heterologous immunoassays could be used for quantification of serum proteins in different species, provided that the antibody has cross-reactivity with the protein to be measured and the assay give satisfactory results in the analytical validation tests. In addition, use of species-specific calibrators and an appropriate batch validation are recommended in these cases.	[Munoz-Prieto, Alberto; Tvarijonaviciute, Asta; Escribano, Damian; Martinez-Subiela, Silvia; Ceron, Jose J.] Univ Murcia, Interdisciplinary Lab Clin Anal, Interlab UMU, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain	University of Murcia	Martinez-Subiela, S (corresponding author), Univ Murcia, Interdisciplinary Lab Clin Anal, Interlab UMU, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	silviams@um.es	Tvarijonaviciute, Asta/U-4303-2017; Martinez-Subiela, Silvia/H-5719-2015; Tortosa, Damian Escribano/L-6138-2017; Tortosa, Damian Escribano/AAG-1780-2019; Ceron, Jose J/H-9043-2015; Muñoz, Alberto/GSE-1110-2022	Tvarijonaviciute, Asta/0000-0002-5323-5001; Martinez-Subiela, Silvia/0000-0002-1524-1558; Tortosa, Damian Escribano/0000-0001-9439-6779; Tortosa, Damian Escribano/0000-0001-9439-6779; Ceron, Jose J/0000-0002-8654-1793; Muñoz, Alberto/0000-0001-6865-8712	Ministerio de Economia y Competitividad of Spain; University of Murcia	Ministerio de Economia y Competitividad of Spain(Spanish Government); University of Murcia	This work was supported by The Ministerio de Economia y Competitividad of Spain funded AT through a postdoctoral grant (Juan de la Cierva) and The University of Murcia funded AMP through a predoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; Bathen-Noethen A, 2008, J VET INTERN MED, V22, P1149, DOI 10.1111/j.1939-1676.2008.0164.x; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASPI D, 1984, IMMUNOLOGY, V53, P307; Ceron JJ, 2008, VET J, V177, P6, DOI 10.1016/j.tvjl.2007.12.001; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; ECKERSALL PD, 1989, VET REC, V124, P490, DOI 10.1136/vr.124.18.490; Escribano D, 2012, RES VET SCI, V93, P682, DOI 10.1016/j.rvsc.2011.09.018; Fransson BA, 2007, AM J VET RES, V68, P1281, DOI 10.2460/ajvr.68.12.1281; Gentilini F, 2005, 15 ECVIM CA C GLASG; Hillstrom A, 2014, VET CLIN PATH, V43, P235, DOI 10.1111/vcp.12150; Jasensky AK, 2015, VET CLIN PATH, V44, P205, DOI 10.1111/vcp.12264; Jensen AL, 2006, VET CLIN PATH, V35, P276, DOI 10.1111/j.1939-165X.2006.tb00131.x; Kjelgaard-Hansen M, 2003, VET CLIN PATH, V32, P81, DOI 10.1111/j.1939-165X.2003.tb00319.x; Kjelgaard-Hansen M, 2003, J VET MED A, V50, P164, DOI 10.1046/j.1439-0442.2003.00509.x; Kjelgaard-Hansen M, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-9; Kjelgaard-Hansen M, 2010, VET CLIN PATH, V39, P402, DOI 10.1111/j.1939-165X.2010.00276.x; Klenner S, 2010, J VET DIAGN INVEST, V22, P544, DOI 10.1177/104063871002200408; Martinez-Subiela S, 2002, VET REC, V150, P241, DOI 10.1136/vr.150.8.241; Matijatko V, 2007, VET PARASITOL, V144, P242, DOI 10.1016/j.vetpar.2006.10.004; Mischke R, 2007, VET J, V174, P188, DOI 10.1016/j.tvjl.2006.05.018; Mylonakis ME, 2011, J VET INTERN MED, V25, P811, DOI 10.1111/j.1939-1676.2011.0728.x; Nielsen L, 2008, J VET INTERN MED, P214, DOI 10.1111/vcp.12264; Otabe K, 1998, VET RES COMMUN, V22, P77, DOI 10.1023/A:1006071211779; Parra MD, 2006, VET RES COMMUN, V30, P113, DOI 10.1007/s11259-006-3201-z; Tagata K, 1996, VET RES COMMUN, V20, P21, DOI 10.1007/BF00346573; YAMAMOTO S, 1992, VET IMMUNOL IMMUNOP, V30, P329, DOI 10.1016/0165-2427(92)90103-W	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72188	10.1371/journal.pone.0172188	http://dx.doi.org/10.1371/journal.pone.0172188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222144	Green Submitted, gold, Green Published			2022-12-26	WOS:000394676800040
J	Noll, M; Silveira, EA; de Avelar, IS				Noll, Matias; Silveira, Erika Aparecida; de Avelar, Ivan Silveira			Evaluation of factors associated with severe and frequent back pain in high school athletes	PLOS ONE			English	Article							ADOLESCENT ATHLETE; RISK-FACTORS; PREVALENCE; POSTURE; ALIGNMENT; STRENGTH; SPINE; REPRODUCIBILITY; VALIDATION; BACKPACKS	Several studies have shown that half of all young athletes experience back pain (BP). However, high intensity and frequency of BP may be harmful, and the factors associated with BP severity have not been investigated in detail. Here, we investigated the factors associated with a high intensity and high frequency of BP in high school athletes. We included 251 athletes (173 boys and 78 girls [14-20 years old]) in this cross-sectional study. The dependent variables were a high frequency and high intensity of BP, and the independent variables were demographic, socioeconomic, psychosocial, hereditary, anthropometric, behavioural, and postural factors and the level of exercise. The effect measure is presented as prevalence ratio (PR) with 95% confidence interval (CI). Of 251 athletes, 104 reported BP; thus, only these athletes were included in the present analysis. Results of multivariable analysis showed an association between high BP intensity and time spent using a computer (PR: 1.15, CI: 1.01-1.33), posture while writing (PR: 1.41, CI: 1.27-1.58), and posture while using a computer (PR: 1.39, CI: 1.26-1.54). Multivariable analysis also revealed an association of high BP frequency with studying in bed (PR: 1.19, CI: 1.01-1.40) and the method of carrying a backpack (PR: 1.19, CI: 1.01-1.40). In conclusion, we found that behavioural and postural factors are associated with a high intensity and frequency of BP. To the best of our knowledge, this study is the first to compare different intensities and frequencies of BP, and our results may help physicians and coaches to better understand BP in high school athletes.	[Noll, Matias; Silveira, Erika Aparecida; de Avelar, Ivan Silveira] Univ Fed Goias, Postgrad Program Hlth Sci, Fac Med, Jatai, Go, Brazil; [Noll, Matias] Inst Fed Goiano, Rio Verde, Go, Brazil	Universidade Federal de Goias; Instituto Federal Goiano	Noll, M; Silveira, EA (corresponding author), Univ Fed Goias, Postgrad Program Hlth Sci, Fac Med, Jatai, Go, Brazil.; Noll, M (corresponding author), Inst Fed Goiano, Rio Verde, Go, Brazil.	matiasnoll@yahoo.com.br; erikasil@terra.com.br	noll, matias/E-6993-2013; noll, matias/AAT-6582-2020; Silveira, Erika Aparecida/O-7585-2018	noll, matias/0000-0002-1482-0718; noll, matias/0000-0002-1482-0718; Silveira, Erika Aparecida/0000-0002-8839-4520	FAPEG; Instituto Federal Goiano	FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Instituto Federal Goiano	Support was provided by Scholarship - FAPEG [www.fapeg.go.gov.br]; Instituto Federal Goiano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael A, 2004, Acupunct Med, V22, P178; Altmann D.B., 1999, PRACTICAL STAT MED R; Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Azeredo CM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011571; Bailey CA, 2015, J STRENGTH COND RES, V29, P3188, DOI 10.1519/JSC.0000000000000983; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boonstra AM, 2014, PAIN, V155, P2545, DOI 10.1016/j.pain.2014.09.014; Brazil. IBGE, 2014, NAT HLTH SURV 2013 H; Choi BKL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006555.pub2; Dankaerts W, 2006, SPINE, V31, P698, DOI 10.1097/01.brs.0000202532.76925.d2; De Luigi AJ, 2014, PHYS MED REH CLIN N, V25, P763, DOI 10.1016/j.pmr.2014.06.004; Dizdarevic I, 2015, PHYSICIAN SPORTSMED, V43, P421, DOI 10.1080/00913847.2015.1093668; Fess E. E., 1992, GRIP STRENGTH; Garcia-Pinillos F, 2015, J STRENGTH COND RES, V29, P11, DOI 10.1519/JSC.0000000000000591; Gupta N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121159; Hakala PT, 2006, EUR J PUBLIC HEALTH, V16, P536, DOI 10.1093/eurpub/ckl025; Haus BM, 2012, CLIN SPORT MED, V31, P423, DOI 10.1016/j.csm.2012.03.011; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Kanosue K., 2015, SPORTS INJURIES PREV; Korovessis P, 2005, SPINE, V30, P247, DOI 10.1097/01.brs.0000150505.59690.1b; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Leilnahari K, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-103; Lis AM, 2007, EUR SPINE J, V16, P283, DOI 10.1007/s00586-006-0143-7; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; Meziat N, 2015, EUR SPINE J, V24, P425, DOI 10.1007/s00586-014-3571-9; Mortazavi J, 2015, ASIAN J SPORTS MED, V6, DOI [10.5812/asjsm.6(2)2015.24718, DOI 10.5812/ASJSM.6(2)2015.24718]; Mueller S, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0064-7; Muller J, 2016, SCAND J MED SCI SPOR; Muslim K, 2015, ERGONOMICS, V0139, P1; Negrini S, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-8; Neuschwander TB, 2010, SPINE, V35, P83, DOI 10.1097/BRS.0b013e3181b21a5d; Noll M, 2013, J HUM GROWTH DEV, V23, P129; Noll M, 2016, PEDIATR PHYS THER, V28, P435, DOI 10.1097/PEP.0000000000000292; Noll M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150542; Noll M, 2013, INT J PUBLIC HEALTH, V58, P565, DOI 10.1007/s00038-012-0434-1; Noormohammadpour P, 2016, EUR SPINE J, V25, P1196, DOI 10.1007/s00586-015-4034-7; O'Sullivan K, 2012, MANUAL THER, V17, P432, DOI 10.1016/j.math.2012.04.007; O'Sullivan PB, 2011, PHYS THER, V91, P470, DOI 10.2522/ptj.20100160; Puentedura EJ, 2012, PHYS THER SPORT, V13, P123, DOI 10.1016/j.ptsp.2011.12.001; Rivinoja AE, 2011, AM J EPIDEMIOL, V173, P890, DOI 10.1093/aje/kwq459; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Roffey DM, 2010, SPINE J, V10, P89, DOI 10.1016/j.spinee.2009.09.003; Rossi M, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1114-8; Schmidt CP, 2014, INT J SPORTS MED, V35, P684, DOI 10.1055/s-0033-1358731; Schulz SS, 2016, EUR SPINE J, V25, P1204, DOI 10.1007/s00586-015-4210-9; Sedrez Juliana Adami, 2015, Rev. paul. pediatr., V33, P72, DOI 10.1016/j.rpped.2014.11.012; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Standaert CJ, 2008, PHYS MED REH CLIN N, V19, P287, DOI 10.1016/j.pmr.2008.01.002; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P2679, DOI 10.1590/0102-311X00016814; Trigueiro MJ, 2013, EUR J PUBLIC HEALTH, V23, P499, DOI 10.1093/eurpub/cks105; Triki M, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.26802; Um K, 2003, SPORT MED, V33, P869; van Hilst J, 2015, J BACK MUSCULOSKELET, V28, P67, DOI 10.3233/BMR-140491; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wirth B, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0344-5; Womersley L, 2006, J MANIP PHYSIOL THER, V29, P213, DOI 10.1016/j.jmpt.2006.01.002; World Health Organization, 2007, WHO 2007 GROWTH REF	57	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171978	10.1371/journal.pone.0171978	http://dx.doi.org/10.1371/journal.pone.0171978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222141	gold, Green Published, Green Submitted			2022-12-26	WOS:000394676800025
J	Arsic, N; Ho-Pun-Cheung, A; Evelyne, C; Assenat, E; Jarlier, M; Anguille, C; Colard, M; Pezet, M; Roux, P; Gadea, G				Arsic, Nikola; Ho-Pun-Cheung, Alexandre; Evelyne, Crapez; Assenat, Eric; Jarlier, Marta; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre; Gadea, Gilles			The p53 isoform delta133p53 beta regulates cancer cell apoptosis in a RhoB-dependent manner	PLOS ONE			English	Article							P53-DEPENDENT APOPTOSIS; GERANYLGERANYLATED RHOB; TUMOR-GROWTH; ACTIVATION; TRANSCRIPTION; SUPPRESSION; EXPRESSION; PROGNOSIS; GAIN; EGFR	The TP53 gene plays essential roles in cancer. Conventionally, wild type ( WT) p53 is thought to prevent cancer development and metastasis formation, while mutant p53 has transforming abilities. However, clinical studies failed to establish p53 mutation status as an unequivocal predictive or prognostic factor of cancer progression. The recent discovery of p53 isoforms that can differentially regulate cell cycle arrest and apoptosis suggests that their expression, rather than p53 mutations, could be a more clinically relevant biomarker in patients with cancer. In this study, we show that the p53 isoform delta133p53 beta is involved in regulating the apoptotic response in colorectal cancer cell lines. We first demonstrate delta133p53 beta association with the small GTPase RhoB, a well-described anti-apoptotic protein. We then show that, by inhibiting RhoB activity, delta133p53 beta protects cells from camptothecin-induced apoptosis. Moreover, we found that high delta133p53 mRNA expression levels are correlated with higher risk of recurrence in a series of patients with locally advanced rectal cancer ( n = 36). Our findings describe how a WT TP53 isoform can act as an oncogene and add a new layer to the already complex p53 signaling network.	[Arsic, Nikola; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre] CNRS, Ctr Rech Biol Cellulaire Montpellier, Montpellier, France; [Arsic, Nikola; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre] Univ Montpellier, Montpellier, France; [Ho-Pun-Cheung, Alexandre; Evelyne, Crapez] Inst Canc Montpellier, Translat Res Unit, Montpellier, France; [Assenat, Eric] Inst Canc Montpellier, Dept Gastroenterol, Montpellier, France; [Jarlier, Marta] Inst Canc Montpellier, Dept Biostat, Montpellier, France; [Roux, Pierre] INSERM, Montpellier, France; [Gadea, Gilles] Univ Reunion, CNRS Unite Mixte Rech 9192, INSERM Unite 1187,IRD Unite Mixte Rech 249,Platef, Unite Mixte Proc Infect Milieu Insulaire Trop 134, St Clotilde, Reunion, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of La Reunion	Gadea, G (corresponding author), Univ Reunion, CNRS Unite Mixte Rech 9192, INSERM Unite 1187,IRD Unite Mixte Rech 249,Platef, Unite Mixte Proc Infect Milieu Insulaire Trop 134, St Clotilde, Reunion, France.	gilles.gadea@inserm.fr	Gilles, Gadea/M-9966-2015	Gilles, Gadea/0000-0001-6325-4866; Crapez, evelyne/0000-0002-8261-3470				Arsic N, 2015, STEM CELL REP, V4, P531, DOI 10.1016/j.stemcr.2015.02.001; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; De Roock W, 2009, MOL DIAGN THER, V13, P103, DOI 10.2165/01250444-200913020-00004; Delarue FL, 2001, ONCOGENE, V20, P6531, DOI 10.1038/sj.onc.1204801; Du W, 1999, CANCER RES, V59, P5492; Du W, 1999, MOL CELL BIOL, V19, P1831; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; Gadea G, 2004, J CELL SCI, V117, P6355, DOI 10.1242/jcs.01566; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gadea G, 2016, ELIFE, V5, DOI [10.7554/elife.14734, 10.7554/eLife.14734]; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gong L, 2015, CELL RES, V25, P351, DOI 10.1038/cr.2015.22; Gottlieb TM, 1998, SEMIN CANCER BIOL, V8, P359, DOI 10.1006/scbi.1998.0098; Ho-Pun-Cheung A, 2011, INT J CANCER, V128, P2938, DOI 10.1002/ijc.25639; Ho-Pun-Cheung A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-31; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, FEBS LETT, V481, P205, DOI 10.1016/S0014-5793(00)02003-2; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Mamouni K, 2014, MOL CELLULAR BIOL; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Ory S, 2000, J CELL SCI, V113, P1177; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	38	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172125	10.1371/journal.pone.0172125	http://dx.doi.org/10.1371/journal.pone.0172125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212429	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700019
J	Bogusz, AM; Kovach, AE; Le, LP; Feng, D; Baxter, RHG; Sohani, AR				Bogusz, Agata M.; Kovach, Alexandra E.; Le, Long P.; Feng, Derek; Baxter, Richard H. G.; Sohani, Aliyah R.			Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence	PLOS ONE			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; PARAFFIN-EMBEDDED TISSUE; GENE-EXPRESSION; MIR-17-SIMILAR-TO-92 FAMILY; POOR-PROGNOSIS; C-MYC; INHIBITION; SUBTYPES; SURVIVAL; FEATURES	B-cell receptor ( BCR)-mediated signaling plays an important role in the pathogenesis of a subset of diffuse large B-cell lymphoma ( DLBCL), and novel agents targeting this pathway are now in clinical use. We have previously identified a signature of active BCR signaling on formalin-fixed paraffin-embedded specimens using quantitative immunofluorescence, allowing for identification of patients who might benefit from anti-BCR therapies. We sought to characterize the clinicopathologic significance of active BCR signaling in DLBCL by correlating measures of signaling intensity with clinical features and various tumor cell characteristics. High MYC and concurrent high MYC and BCL2 double-expression was positively correlated with individual markers of active BCR signaling and cases with MYC/BCL2 double-expression showed overall greater BCR activation compared to cases lacking double-expression. Our findings suggest that the BCR signaling pathway may be more active in MYC/BCL2 double-expressor DLBCL and may represent a rational therapeutic target in this aggressive DLBCL subgroup.	[Bogusz, Agata M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kovach, Alexandra E.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Le, Long P.; Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Feng, Derek] Yale Univ, Dept Stat, New Haven, CT USA; [Baxter, Richard H. G.] Yale Univ, Dept Chem, New Haven, CT USA; [Baxter, Richard H. G.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	University of Pennsylvania; Vanderbilt University; Harvard University; Massachusetts General Hospital; Yale University; Yale University; Yale University	Bogusz, AM (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	Agata.Bogusz@uphs.upenn.edu	Baxter, Richard/F-3027-2013; Kovach, Alexandra/AAP-7332-2020; Kovach, Alexandra Elizabeth/ABC-4382-2021	Baxter, Richard/0000-0001-5140-1726; Kovach, Alexandra Elizabeth/0000-0002-6742-6749	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001863] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Bogusz AM, 2012, CLIN CANCER RES, V18, P6122, DOI 10.1158/1078-0432.CCR-12-0397; Bomben R, 2012, LEUKEMIA, V26, P1584, DOI 10.1038/leu.2012.44; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Flinn IW, 2016, EUR J CANCER, V54, P11, DOI 10.1016/j.ejca.2015.10.005; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Jardin F, 2014, DISCOV MED, V18, P51; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kohrer S, 2016, LEUKEMIA, V30, P1246, DOI 10.1038/leu.2016.9; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2015, CANCERS, V7, P811, DOI 10.3390/cancers7020812; Li SY, 2015, MODERN PATHOL, V28, P208, DOI 10.1038/modpathol.2014.95; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pasqualucci L, 2015, SEMIN HEMATOL, V52, P67, DOI 10.1053/j.seminhematol.2015.01.005; Pasqualucci L, 2013, CURR OPIN HEMATOL, V20, P336, DOI 10.1097/MOH.0b013e3283623d7f; Pedersen MO, 2012, EUR J HAEMATOL, V89, P63, DOI 10.1111/j.1600-0609.2012.01787.x; Perry AM, 2014, BRIT J HAEMATOL, V165, P382, DOI 10.1111/bjh.12763; Psathas JN, 2013, BLOOD, V122, P4220, DOI 10.1182/blood-2012-12-473090; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Scott DW, 2015, J CLIN ONCOL, V33, P2848, DOI 10.1200/JCO.2014.60.2383; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Stasik CJ, 2010, HAEMATOL-HEMATOL J, V95, P597, DOI 10.3324/haematol.2009.012864; Stein H, 2008, WHO CLASSIFICATION T, V4th, P233; Testoni M, 2011, BRIT J HAEMATOL, V155, P274, DOI 10.1111/j.1365-2141.2011.08675.x; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang WG, 2015, AM J SURG PATHOL, V39, P902, DOI 10.1097/PAS.0000000000000396; Wang WG, 2015, MODERN PATHOL, V28, p385A; Weremowicz S, 2007, CURR PROTOC HUM GENE; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Young RM, 2015, SEMIN HEMATOL, V52, P77, DOI 10.1053/j.seminhematol.2015.01.008	48	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172364	10.1371/journal.pone.0172364	http://dx.doi.org/10.1371/journal.pone.0172364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212447	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424700038
J	Kashiwadani, H; Kanmura, Y; Kuwaki, T				Kashiwadani, Hideki; Kanmura, Yuichi; Kuwaki, Tomoyuki			Application of calibrated forceps for assessing mechanical nociception with high time resolution in mice	PLOS ONE			English	Article							REMIFENTANIL GI87084B; INDUCED HYPERALGESIA; OPIOID REMIFENTANIL; ANALGESIC ACTIVITY; RESTRAINT STRESS; FORMALIN TEST; PAIN; PHARMACOKINETICS; STIMULATION; SENSITIVITY	In order to investigate the basic physiological mechanisms of pain and the anti-nociceptive effects of analgesics, development of pain assays in mice is critical due to the advances of genetic manipulation techniques. The von Frey hairs/Semmes-Weinstein monofilaments test (von Frey test) has long been applied to examine mechanical nociception in mice. Though the von Frey test is a well-established and standardized method, it is inappropriate to assess a rapid change in the nociceptive threshold because voluntary resting/sleeping states are necessary to examine the response. In this study, we assessed the effectiveness of calibrated forceps to determine the mechanical nociceptive threshold in mice. Repeated daily measurements of the threshold over 5 days indicated that the device obtained stable and reliable values. Furthermore, repeated measurements with 5 minute intervals revealed that the device detected the rapid change of the threshold induced by remifentanil, a short-acting mu-receptor agonist. These results indicate that the calibrated forceps are well-suited for measuring the mechanical nociceptive threshold in mice, and are useful in assessing the effects of short-acting analgesics on mechanical nociception.	[Kashiwadani, Hideki; Kuwaki, Tomoyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Physiol, Kagoshima, Japan; [Kanmura, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Kagoshima, Japan	Kagoshima University; Kagoshima University	Kashiwadani, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Physiol, Kagoshima, Japan.	danny@m3.kufm.kagoshima-u.ac.jp	Kashiwadani, Hideki/R-3404-2019; Kuwaki, Tomoyuki/B-3247-2019	Kuwaki, Tomoyuki/0000-0003-4226-3610	Cosmetology Research Foundation [J-13-12]; JSPS KAKENHI [16H05130]	Cosmetology Research Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Cosmetology Research Foundation (#J-13-12, http://www.cosmetology.or.jp/index.html)(HK) and JSPS KAKENHI 16H05130 (http://www.jsps.go.jp/english/index.html) (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseloni VCZ, 2003, J NEUROSCI METH, V131, P93, DOI 10.1016/S0165-0270(03)00241-3; Back SK, 2002, NEUROSCI LETT, V322, P153, DOI 10.1016/S0304-3940(02)00067-8; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bevans T, 2016, ANESTH ANALG; Bradman MJG, 2015, J NEUROSCI METH, V255, P92, DOI 10.1016/j.jneumeth.2015.08.010; Buerkle H, 1996, ANESTHESIOLOGY, V84, P94, DOI 10.1097/00000542-199601000-00012; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; CALCAGNETTI DJ, 1992, BRAIN RES, V592, P305, DOI 10.1016/0006-8993(92)91689-C; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; Costa A, 2005, NEUROSCI LETT, V383, P7, DOI 10.1016/j.neulet.2005.03.026; Cui JG, 1999, EUR J PAIN, V3, P365, DOI 10.1016/S1090-3801(99)90018-6; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; EGAN TD, 1993, ANESTHESIOLOGY, V79, P881, DOI 10.1097/00000542-199311000-00004; GLASS PSA, 1993, ANESTH ANALG, V77, P1031; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Luis-Delgado OE, 2006, J PAIN, V7, P32, DOI 10.1016/j.jpain.2005.07.011; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; OCALLAGHAN JP, 1975, J PHARMACOL EXP THER, V192, P497; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Skyba DA, 2005, J PAIN, V6, P41, DOI 10.1016/j.jpain.2004.10.002; Sluka KA, 2013, J APPL PHYSIOL, V114, P725, DOI 10.1152/japplphysiol.01317.2012; Sluka KA, 2010, PAIN, V148, P188, DOI 10.1016/j.pain.2009.07.001; Sung B, 2000, NEUROSCI LETT, V291, P163, DOI 10.1016/S0304-3940(00)01394-X; TAIWO YO, 1989, BRAIN RES, V487, P148, DOI 10.1016/0006-8993(89)90950-5; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Woolfe G, 1944, J PHARMACOL EXP THER, V80, P300	31	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172461	10.1371/journal.pone.0172461	http://dx.doi.org/10.1371/journal.pone.0172461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212389	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700053
J	Byun, TM; Tiede, M				Byun, Tara McAllister; Tiede, Mark			Perception-production relations in later development of American English rhotics	PLOS ONE			English	Article							R-VERTICAL-BAR; AUDITORY-FEEDBACK CONTROL; SPEECH SOUND DISORDERS; SENSORIMOTOR ADAPTATION; CHILDREN; VOWEL; DISCRIMINATION; ARTICULATION; DYSLEXIA; PERTURBATION	It is known that some adult listeners have more sharply defined perceptual categories than others, and listeners with more precise auditory targets are also more precise in their production of contrasts. There is additionally evidence that children who have not yet mastered production of a contrast show diminished performance on perceptual measures of the same contrast. To date, however, few studies have investigated developmental perception-production relations using the fine-grained measures typical of adult studies. Existing evidence suggests that perception and production can be closely connected in development, but this relationship may break down as perception and articulation mature at different rates. This study evaluated perception and production of the English /r-w/ contrast in 40 typically-developing children aged 9-14. Perceptual sensitivity was measured with a logistic function fitted over responses in a forced-choice identification task using two synthetic 10-step continua from rake to wake. Participants also produced rhotic and non-rhotic words. Across participants, there was a significant correlation between perceptual acuity and rhoticity in production, although this effect was only observed for one of two continua tested. These results provide preliminary evidence compatible with the hypothesis that children with a more refined auditory target for a sound also produce that sound more accurately.	[Byun, Tara McAllister] NYU, Dept Commun Sci & Disorders, New York, NY 10003 USA; [Tiede, Mark] Haskins Labs Inc, New Haven, CT USA	New York University; Yale University; Haskins Laboratories	Byun, TM (corresponding author), NYU, Dept Commun Sci & Disorders, New York, NY 10003 USA.	tara.byun@nyu.edu			NIH NIDCD grant [R03DC012883, R01DC013668]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013668, R03DC012883] Funding Source: NIH RePORTER	NIH NIDCD grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by NIH NIDCD grant R03DC012883 to TMB and R01DC013668 to TMB and MT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Bock M, 2007, AM J SPEECH-LANG PAT, V16, P128, DOI 10.1044/1058-0360(2007/017); Becker M, 2013, EXPERIGEN D ONLINE E; Blomert L, 2004, J SPEECH LANG HEAR R, V47, P1030, DOI 10.1044/1092-4388(2004/077); Boersma P., 2015, PRAAT; Boyce S, 1997, J ACOUST SOC AM, V101, P3741, DOI 10.1121/1.418333; Boyce SE, 2015, SEMIN SPEECH LANG, V36, P257, DOI 10.1055/s-0035-1562909; Burris C, 2014, J SPEECH LANG HEAR R, V57, P26, DOI 10.1044/1092-4388(2013/12-0103); Byun T McAllister, 2016, INT J LANG IN PRESS; Byun TM, 2015, J COMMUN DISORD, V53, P70, DOI 10.1016/j.jcomdis.2014.11.003; Byun TM, 2012, CLIN LINGUIST PHONET, V26, P397, DOI 10.3109/02699206.2011.641060; Cai SQ, 2010, J ACOUST SOC AM, V128, P2033, DOI 10.1121/1.3479539; Callan DE, 2000, J SPEECH LANG HEAR R, V43, P721, DOI 10.1044/jslhr.4303.721; DELATTRE P, 1968, LINGUISTICS, P29; Ghosh SS, 2010, J ACOUST SOC AM, V128, P3079, DOI 10.1121/1.3493430; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Guenther FH, 1999, J ACOUST SOC AM, V105, P2854, DOI 10.1121/1.426900; Hagiwara R., 1995, THESIS; Hazan V, 2000, J PHONETICS, V28, P377, DOI 10.1006/jpho.2000.0121; HOFFMAN PR, 1985, J SPEECH HEAR DISORD, V50, P46, DOI 10.1044/jshd.5001.46; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Idemaru K, 2013, J ACOUST SOC AM, V133, P4232, DOI 10.1121/1.4802905; Klein HB, 2013, AM J SPEECH-LANG PAT, V22, P540, DOI 10.1044/1058-0360(2013/12-0137); KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Lane H, 2005, J ACOUST SOC AM, V118, P1636, DOI 10.1121/1.2001527; Lane H, 2007, J SPEECH LANG HEAR R, V50, P913, DOI 10.1044/1092-4388(2007/065); Lennes M., 2003, COLLECT FORMANT DATA; Lewis BA, 1994, P MIN ANN CONV AM SP; Lin S, 2015, J SPEECH LANG HEAR R, V58, P13, DOI 10.1044/2014_JSLHR-S-14-0041; LOCKE JL, 1980, J SPEECH HEAR DISORD, V45, P431, DOI 10.1044/jshd.4504.431; Manis FR, 1997, J EXP CHILD PSYCHOL, V66, P211, DOI 10.1006/jecp.1997.2383; Matthies ML, 2008, J ACOUST SOC AM, V124, P3191, DOI 10.1121/1.2987427; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; McBrideChang C, 1996, CHILD DEV, V67, P1836, DOI 10.1111/j.1467-8624.1996.tb01831.x; McGowan RS, 2004, J ACOUST SOC AM, V115, P871, DOI 10.1121/1.1642624; Menard L, 2008, J ACOUST SOC AM, V124, P1192, DOI 10.1121/1.2945704; Messaoud-Galusi S, 2011, J SPEECH LANG HEAR R, V54, P1682, DOI 10.1044/1092-4388(2011/09-0261); Mielke J, 2016, LANGUAGE, V92, P101, DOI 10.1353/lan.2016.0019; Munson B., 2012, PERSPECT LANG LEARN, V19, P19, DOI 10.1044/lle19.1.19; Newman RS, 2003, J ACOUST SOC AM, V113, P2850, DOI 10.1121/1.1567280; Perkell JS, 2004, J SPEECH LANG HEAR R, V47, P1259, DOI 10.1044/1092-4388(2004/095); Perkell JS, 2004, J ACOUST SOC AM, V116, P2338, DOI 10.1121/1.1787524; Preston JL, 2015, SEMIN SPEECH LANG, V36, P224, DOI 10.1055/s-0035-1562906; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; RUSCELLO DM, 1995, J COMMUN DISORD, V28, P279, DOI 10.1016/0021-9924(95)00058-X; RVACHEW S, 1989, J SPEECH HEAR DISORD, V54, P193, DOI 10.1044/jshd.5402.193; Scobbie JM, 2015, P 18 ICPHS GLASG; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Shiller DM, 2014, J EXP PSYCHOL HUMAN, V40, P1308, DOI 10.1037/a0036660; Shiller DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012975; Shuster LI, 1998, J SPEECH LANG HEAR R, V41, P941, DOI 10.1044/jslhr.4104.941; SMIT AB, 1990, J SPEECH HEAR DISORD, V55, P779, DOI 10.1044/jshd.5504.779; Terband H, 2014, J COMMUN DISORD, V51, P64, DOI 10.1016/j.jcomdis.2014.06.009; Terband H, 2009, J SPEECH LANG HEAR R, V52, P1595, DOI 10.1044/1092-4388(2009/07-0283); Tiede M.K., 2004, J ACOUST SOC AM, V115, P2633, DOI [10.1121/1.4784878, DOI 10.1121/1.4784878]; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Whitehill TL, 2003, J SPEECH LANG HEAR R, V46, P451, DOI 10.1044/1092-4388(2003/037)	59	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172022	10.1371/journal.pone.0172022	http://dx.doi.org/10.1371/journal.pone.0172022			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207800	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500074
J	Gleitz, HFE; O'Leary, C; Holley, RJ; Bigger, BW				Gleitz, Helene F. E.; O'Leary, Claire; Holley, Rebecca J.; Bigger, Brian W.			Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; BONE-MARROW-TRANSPLANTATION; HUNTER-SYNDROME; HURLER-SYNDROME; MPS-II; MICE; DISEASE; CHILDREN; DEFICITS; DEFECTS	Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by mutations in the IDS gene, leading to a deficiency in the iduronate-2-sulfatase enzyme that is involved in heparan sulphate and dermatan sulphate catabolism. In constitutive form, MPS II is a multi-system disease characterised by progressive neurocognitive decline, severe skeletal abnormalities and hepatosplenomegaly. Although enzyme replacement therapy has been approved for treatment of peripheral organs, no therapy effectively treats the cognitive symptoms of the disease and novel therapies are in development to remediate this. Therapeutic efficacy and subsequent validation can be assessed using a variety of outcome measures that are translatable to clinical practice, such as behavioural measures. We sought to consolidate current knowledge of the cognitive, skeletal and motor abnormalities present in the MPS II mouse model by performing time course behavioural examinations of working memory, anxiety, activity levels, sociability and coordination and balance, up to 8 months of age. Cognitive decline associated with alterations in spatial working memory is detectable at 8 months of age in MPS II mice using spontaneous alternation, together with an altered response to novel environments and anxiolytic behaviour in the open-field. Coordination and balance on the accelerating rotarod were also significantly worse at 8 months, and may be associated with skeletal changes seen in MPS II mice. We demonstrate that the progressive nature of MPS II disease is also seen in the mouse model, and that cognitive and motor differences are detectable at 8 months of age using spontaneous alternation, the accelerating rotarod and the open-field tests. This study establishes neurological, motor and skeletal measures for use in pre-clinical studies to develop therapeutic approaches in MPS II.	[Gleitz, Helene F. E.; O'Leary, Claire; Holley, Rebecca J.; Bigger, Brian W.] Univ Manchester, Stem Cell & Neurotherapies, Div Cell Matrix Biol & Regenerat Med, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Manchester	Bigger, BW (corresponding author), Univ Manchester, Stem Cell & Neurotherapies, Div Cell Matrix Biol & Regenerat Med, Fac Biol Med & Hlth, Manchester, Lancs, England.	brian.bigger@manchester.ac.uk	Gleitz, Helene/AAX-5620-2020; Bigger, Brian/I-3553-2012	Gleitz, Helene/0000-0001-6138-8916; Bigger, Brian/0000-0002-9708-1112; O'Leary, Claire/0000-0001-8616-7466	Isaac Foundation; Newlife Foundation for Disabled Children; National Mucopolysaccharidosis Society	Isaac Foundation; Newlife Foundation for Disabled Children; National Mucopolysaccharidosis Society	This study was funded by grants awarded by the Isaac Foundation (https://www.theisaacfoundation.com/, awarded to BWB), the Newlife Foundation for Disabled Children (http://www.newlifecharity.co.uk/, awarded to BWB) and the National Mucopolysaccharidosis Society (http://mpssociety.org/, awarded to BWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven M, 2015, BLOOD, V125, P2164, DOI 10.1182/blood-2014-11-608075; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Boelens JJ, 2013, BLOOD, V121, P3981, DOI 10.1182/blood-2012-09-455238; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Cardone M, 2006, HUM MOL GENET, V15, P1225, DOI 10.1093/hmg/ddl038; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cross EM, 2013, J INHERIT METAB DIS, V36, P189, DOI 10.1007/s10545-012-9572-0; Eng C, 2007, MOL GENET METAB, V92, pS18, DOI 10.1016/j.ymgme.2007.08.034; FERRER I, 1988, NEUROPATH APPL NEURO, V14, P315, DOI 10.1111/j.1365-2990.1988.tb00891.x; Garcia AR, 2007, J INHERIT METAB DIS, V30, P924, DOI 10.1007/s10545-007-0641-8; Guffon N, 2009, J PEDIATR-US, V154, P733, DOI 10.1016/j.jpeds.2008.11.041; Guo ZR, 2016, NEUROSCI LETT, V616, P152, DOI 10.1016/j.neulet.2016.01.048; Higuchi T, 2012, MOL GENET METAB, V107, P122, DOI 10.1016/j.ymgme.2012.05.005; Hinderer C, 2016, HUM GENE THER; Holt JB, 2011, PEDIATRICS, V127, pE1258, DOI 10.1542/peds.2010-1274; Jiang LN, 2015, NEUROBIOL DIS, V76, P137, DOI 10.1016/j.nbd.2015.02.006; Kakkis ED, 2001, MOL GENET METAB, V72, P199, DOI 10.1006/mgme.2000.3140; Langford-Smith A, 2011, GENES BRAIN BEHAV, V10, P673, DOI 10.1111/j.1601-183X.2011.00706.x; Langford-Smith A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025717; Martins C, 2015, BRAIN, V138, P336, DOI 10.1093/brain/awu355; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Motas S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86696; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Mumford RA, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9126-5; Neufeld EF, LYSOSOMAL DISORDERS2, P3421; O'Leary C, 2014, NEUROSCIENCE, V277, P294, DOI 10.1016/j.neuroscience.2014.06.028; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Polito VA, 2010, HUM MOL GENET, V19, P4871, DOI 10.1093/hmg/ddq420; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Reolon GK, 2009, CELL MOL NEUROBIOL, V29, P443, DOI 10.1007/s10571-008-9335-5; Shapiro EG, 2015, MOL GENET METAB, V114, P594, DOI 10.1016/j.ymgme.2015.02.008; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Vellodi A, 1999, J INHERIT METAB DIS, V22, P638, DOI 10.1023/A:1005525931994; Wakabayashi T, 2015, HUM GENE THER; Wall PM, 2002, PSYCHOPHARMACOLOGY, V160, P233, DOI 10.1007/s00213-001-0979-9; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005; YOUNG ID, 1981, CHILD CARE HLTH DEV, V7, P201, DOI 10.1111/j.1365-2214.1981.tb00838.x	45	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172435	10.1371/journal.pone.0172435	http://dx.doi.org/10.1371/journal.pone.0172435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207863	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424500136
J	Yang, SJ; Liu, DP; Liu, HB; Zhang, JY; Duan, ZQ				Yang, Shujuan; Liu, Danping; Liu, Hongbo; Zhang, Juying; Duan, Zhanqi			Relationship of work-family conflict, self-reported social support and job satisfaction to burnout syndrome among medical workers in southwest China: A cross-sectional study	PLOS ONE			English	Article							TURNOVER INTENTION; CARE WORKERS; STRESS; PHYSICIANS; NURSES; RISK	Background Burnout is a psychosomatic syndrome widely observed in Chinese medical workers due to the increasing cost of medical treatment, excessive workload, and excessive prescribing behavior. No studies have evaluated the interrelationship among occupational burnout, work-family conflict, social support, and job satisfaction in medical workers. The aim of this study was to evaluate these relationships among medical workers in southwest China. Methods This cross-sectional study was conducted between March 2013 and December 2013, and was based on the fifth National Health Service Survey (NHSS). A total of 1382 medical workers were enrolled in the study. Pearson correlation analysis and general linear model univariate analysis were used to evaluate the relationship of work-family conflict, self reported social support, and job satisfaction with burnout syndrome in medical workers. Results We observed that five dimensions of job satisfaction and self-reported social support were negatively associated with burnout syndrome, whereas three dimensions of work-family conflict showed a positive correlation. In a four-stage general linear model analysis, we found that demographic factors accounted for 5.4% of individual variance in burnout syndrome (F = 4.720, P<0.001, R-2 = 0.054), and that work-family conflict, self-reported social support, and job satisfaction accounted for 2.6% (F = 5.93, P<0.001, R-2 = 0.080), 5.7% (F = 9.532, P<0.001, R-2 = 0.137) and 17.8% (F = 21.608, P<0.001, R-2 = 0.315) of the variance, respectively. In the fourth stage of analysis, female gender and a lower technical title correlated to a higher level of burnout syndrome, and medical workers without administrative duties had more serious burnout syndrome than those with administrative duties. Conclusions In conclusion, the present study suggests that work-family conflict and self-reported social support slightly affect the level of burnout syndrome, and that job satisfaction is a much stronger influence on burnout syndrome in medical workers of southwest China.	[Yang, Shujuan; Liu, Danping] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China; [Liu, Hongbo] Chinese Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Liaoning, Peoples R China; [Zhang, Juying] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu, Sichuan, Peoples R China; [Duan, Zhanqi] Ctr Hlth Informat Sichuan Prov, Chengdu, Sichuan, Peoples R China	Sichuan University; China Medical University; Sichuan University	Liu, DP (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China.	liudanping03@163.com			fifth National Health Service Survey from Health and Family Planning Commission of Sichuan province [14QTZX005]	fifth National Health Service Survey from Health and Family Planning Commission of Sichuan province	This research was supported by grant funding from the special funding of the fifth National Health Service Survey from Health and Family Planning Commission of Sichuan province (14QTZX005) Prof. Juying Zhang, Ph.D Danping Liu.	Beschoner P, 2016, BUNDESGESUNDHEITSBLA, V59, P1343, DOI 10.1007/s00103-016-2431-7; BLUEDORN AC, 1982, HUM RELAT, V35, P135, DOI 10.1177/001872678203500204; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Boujut E, 2016, J AUTISM DEV DISORD, V46, P2874, DOI 10.1007/s10803-016-2833-2; Chen Yu-Meng, 2016, Hu Li Za Zhi, V63, P87, DOI 10.6224/JN.63.1.87; China NHaFPCotPsRo, 2014, CHIN HLTH STAT YB 20; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Conway N, 2009, INT REV IND ORGAN PS, V24, P71; Dall'Ora C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008331; Silva DDD, 2015, REV ESC ENFERM USP, V49, P1023, DOI 10.1590/S0080-623420150000600020; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; Fogarty L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-11; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Galletta M, 2016, RES NURS HEALTH, V39, P375, DOI 10.1002/nur.21733; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; He AJ, 2016, HEALTH ECON POLICY L, V11, P359, DOI 10.1017/S1744133116000128; Johnstone B, 2016, J GENET COUNS, V25, P731, DOI 10.1007/s10897-016-9968-3; [康勇军 Kang Yongjun], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P234; Kramer T, 2016, INT J QUAL HLTH CARE; KRAUT AI, 1975, ORGAN BEHAV HUM PERF, V13, P233, DOI 10.1016/0030-5073(75)90047-1; Lu Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011388; Martini Mara, 2012, G Ital Med Lav Ergon, V34, pA41; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Masum AKM, 2016, PEERJ, V4, DOI 10.7717/peerj.1896; Michael R Frone, 2003, HDB OCCUPATIONAL HLT, P143; Park Sun-A, 2015, Asian Pac J Cancer Prev, V16, P5463; PORTER LW, 1973, PSYCHOL BULL, V80, P151, DOI 10.1037/h0034829; Price JL, 2000, DEV CAUSAL MODEL VOL; Pu J, 2016, PSYCHOL HEALTH MED, P1; Qiao ZX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2890-7; Richa N, 2016, ENCEPHALE, V42, P144, DOI 10.1016/j.encep.2015.12.016; Rouxel G, 2016, INT J NURS STUD, V62, P81, DOI 10.1016/j.ijnurstu.2016.07.010; Rzeszutek M, 2014, PSYCHOTHERAPY, V51, P574, DOI 10.1037/a0036020; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, P19; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Valente Mdo S, 2016, ANN OCCUP HYG, V60, P567, DOI [10.1093/annhyg/mew013, DOI 10.1093/ANNHYG/MEW013]; Xiao YB, 2014, EMERG MED AUSTRALAS, V26, P538, DOI 10.1111/1742-6723.12315; Ying GY, 2011, W CHINA MED J, V26, P735; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhang YM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-235; Zhou JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157013; Zhou WJ, 2015, NURS HEALTH SCI, V17, P444, DOI 10.1111/nhs.12213	43	20	23	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171679	10.1371/journal.pone.0171679	http://dx.doi.org/10.1371/journal.pone.0171679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207821	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500046
J	Matsumoto, Y; Mori, S; Ueda, K; Kurimoto, T; Kanamori, A; Yamada, Y; Nakashima, I; Nakamura, M				Matsumoto, Yoshiko; Mori, Sotaro; Ueda, Kaori; Kurimoto, Takuji; Kanamori, Akiyasu; Yamada, Yuko; Nakashima, Ichiro; Nakamura, Makoto			Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis	PLOS ONE			English	Article							NERVE-FIBER LAYER; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS-OPTICA; COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; SPECTRUM DISORDER; AQUAPORIN 4; THICKNESS; NMO; ABNORMALITIES	Purpose An autoantibody against aquaporin-4 (AQP4 Ab) is highly specific for neuromyelitis optica spectrum disorder and plays a pathogenic role in this disease. The purpose of this study was to investigate the impact of AQP4 Ab on inner retinal structure, function, and the structure -function relationships in eyes with optic neuritis. Methods Thirty five eyes from 25 cases who had received visual function tests and RTVue optical coherence tomography (OCT) measurement at least six months after the latest episode of optic neuritis were enrolled. Patients with multiple sclerosis were excluded. AQP4 Ab was measured using a cell -based assay. Visual acuity, mean deviation (MD) of the Humphrey visual field SITA standard 30-2 tests, retinal nerve fiber layer (RNFL), ganglion cell complex (GCC) thicknesses, and other clinical variables were compared between the AQP4 Ab-positive and-negative groups. Parameters associated with visual functions were evaluated by generalized estimating equation (GEE) models. Results The AQP4 Ab-positive group (20 eyes from 12 cases) had a higher proportion of bilateral involvement and longer duration of follow-up than the AQP4 Ab-negative group (15 eyes from 13 cases). Linear mixed effect models revealed worse MD and visual acuity in AQP4 Ab-positive eyes than those in AQP4 Ab-negative eyes after adjusting for within -patient inter-eye dependence, whereas there were no differences in RNFL and GCC thickness between the two groups. In seropositive eyes, GEE regression analyses revealed that depending on age and the number of recurrences of ON episodes, OCT parameters correlated strongly with MD and more weakly with visual acuity. Conclusions Reductions in RNFL and GCC thickness were proportional to the visual field defect in eyes with AQP4 Ab but not in eyes without AQP4 Ab. The presence of AQP4 Ab probably plays a critical role in retinal ganglion cell loss in optic neuritis.	[Matsumoto, Yoshiko; Mori, Sotaro; Ueda, Kaori; Kurimoto, Takuji; Kanamori, Akiyasu; Yamada, Yuko; Nakamura, Makoto] Kobe Univ, Div Ophthalmol, Dept Surg, Grad Sch Med, Kobe, Hyogo, Japan; [Nakashima, Ichiro] Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi, Japan	Kobe University; Tohoku University	Matsumoto, Y (corresponding author), Kobe Univ, Div Ophthalmol, Dept Surg, Grad Sch Med, Kobe, Hyogo, Japan.	manakamu@med.kobe-u.ac.jp	Mori, Sotaro/AAD-2574-2022; Nakashima, Ichiro/AAC-3073-2019	Mori, Sotaro/0000-0003-1991-3232; Nakashima, Ichiro/0000-0002-2612-8948; Nakamura, Makoto/0000-0002-6464-4302	Japan Society of the Promotion Science [26462661]	Japan Society of the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-Aid 26462661 (MN, AK, YY) from Japan Society of the Promotion Science (URL https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi T, 2016, J NEUROIMMUNOL, V293, P28, DOI 10.1016/j.jneuroim.2016.02.004; Akaishi T, 2016, J NEUROL NEUROSUR PS, V87, P446, DOI 10.1136/jnnp-2014-310206; Akashi A, 2015, INVEST OPHTH VIS SCI, V56, P6573, DOI 10.1167/iovs.15-17635; Bennett JL, 2015, MULT SCLER J, V21, P678, DOI 10.1177/1352458514567216; Bichuetti DB, 2013, J NEURO-OPHTHALMOL, V33, P220, DOI 10.1097/WNO.0b013e31829f39f1; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Harwerth RS, 2008, GRAEF ARCH CLIN EXP, V246, P305, DOI 10.1007/s00417-007-0691-5; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Kanamori A, 2003, OPHTHALMOLOGICA, V217, P273, DOI 10.1159/000070634; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Lange AP, 2013, J NEURO-OPHTHALMOL, V33, P213, DOI 10.1097/WNO.0b013e31829c510e; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Martinez-Hernandez E, 2015, JAMA NEUROL, V72, P187, DOI 10.1001/jamaneurol.2014.3602; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Matsumoto Y, 2014, EXP EYE RES, V119, P61, DOI 10.1016/j.exer.2013.12.010; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Merle H, 2007, OPHTHALMOLOGY, V114, P810, DOI 10.1016/j.ophtha.2006.06.060; Merle H, 2012, ARCH OPHTHALMOL-CHIC, V130, P858, DOI 10.1001/archophthalmol.2012.1126; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Naismith RT, 2009, NEUROLOGY, V73, P46, DOI 10.1212/WNL.0b013e3181aaea32; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Nakamura M, 2012, GRAEF ARCH CLIN EXP, V250, P1499, DOI 10.1007/s00417-012-2095-4; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; Noval S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/472790; Outteryck O, 2015, MULT SCLER J, V21, P1781, DOI 10.1177/1352458515578888; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Ueda K, 2016, J GLAUCOMA, V25, P383, DOI 10.1097/IJG.0000000000000216; von Glehn F, 2014, MULT SCLER J, V20, P1189, DOI 10.1177/1352458513519838; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	42	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171880	10.1371/journal.pone.0171880	http://dx.doi.org/10.1371/journal.pone.0171880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199381	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400057
J	McKenzie, LM; Allshouse, WB; Byers, TE; Bedrick, EJ; Serdar, B; Adgate, JL				McKenzie, Lisa M.; Allshouse, William B.; Byers, Tim E.; Bedrick, Edward J.; Serdar, Berrin; Adgate, John L.			Childhood hematologic cancer and residential proximity to oil and gas development	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PARENTAL OCCUPATIONAL-EXPOSURE; VOLATILE ORGANIC-COMPOUNDS; AMBIENT AIR-POLLUTION; BRITISH-COLUMBIA; BENZENE EXPOSURE; BIRTH OUTCOMES; RISK; HYDROCARBONS; PREGNANCY	Background Oil and gas development emits known hematological carcinogens, such as benzene, and increasingly occurs in residential areas. We explored whether residential proximity to oil and gas development was associated with risk for hematologic cancers using a registry-based case-control study design. Methods Participants were 0-24 years old, living in rural Colorado, and diagnosed with cancer between 2001-2013. For each child in our study, we calculated inverse distance weighted (IDW) oil and gas well counts within a 16.1-kilometer radius of residence at cancer diagnosis for each year in a 10 year latency period to estimate density of oil and gas development. Logistic regression, adjusted for age, race, gender, income, and elevation was used to estimate associations across IDW well count tertiles for 87 acute lymphocytic leukemia (ALL) cases and 50 non-Hodgkin lymphoma (NHL) cases, compared to 528 controls with non-hematologic cancers. Findings Overall, ALL cases 0-24 years old were more likely to live in the highest IDW well count tertiles compared to controls, but findings differed substantially by age. For ages 5-24, ALL cases were 4.3 times as likely to live in the highest tertile, compared to controls (95% CI: 1.1 to 16), with a monotonic increase in risk across tertiles (trend p-value = 0.035). Further adjustment for year of diagnosis increased the association. No association was found between ALL for children aged 0-4 years or NHL and IDW well counts. While our study benefited from the ability to select cases and controls from the same population, use of cancer- controls, the limited number of ALL and NHL cases, and aggregation of ages into five year ranges, may have biased our associations toward the null. In addition, absence of information on O&G well activities, meteorology, and topography likely reduced temporal and spatial specificity in IDW well counts. Conclusion Because oil and gas development has potential to expose a large population to known hematologic carcinogens, further study is clearly needed to substantiate both our positive and negative findings. Future studies should incorporate information on oil and gas development activities and production levels, as well as levels of specific pollutants of interest (e.g. benzene) near homes, schools, and day care centers; provide age-specific residential histories; compare cases to controls without cancer; and address other potential confounders, and environmental stressors.	[McKenzie, Lisa M.; Allshouse, William B.; Serdar, Berrin; Adgate, John L.] Univ Colorado Anschutz Campus, Colorado Sch Publ Hlth, Dept Environm & Occupat Hlth, Aurora, CO USA; [Byers, Tim E.] Univ Colorado Anschutz Campus, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Bedrick, Edward J.] Univ Arizona, Epidemiol & Biostat Dept, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arizona	McKenzie, LM (corresponding author), Univ Colorado Anschutz Campus, Colorado Sch Publ Hlth, Dept Environm & Occupat Hlth, Aurora, CO USA.	Lisa.McKenzie@ucdenver.edu	McKenzie, Lisa/AAX-2390-2021; McKenzie, Lisa M/D-4501-2014	Adgate, John/0000-0003-1271-3465	University of Colorado Cancer Center; Div Of Chem, Bioeng, Env, & Transp Sys [1240584] Funding Source: National Science Foundation	University of Colorado Cancer Center; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the University of Colorado Cancer Center: http://www. ucdenver.edu/academics/colleges/medicalschool/centters/cancercenter/Pages/CancerCeriter.aspx.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Antonopoulos CN, 2011, INT J CANCER, V129, P2694, DOI 10.1002/ijc.25929; ATSDR, 2007, TOX PROF BENZ; Bates MN, 2007, AM J IND MED, V50, P339, DOI 10.1002/ajim.20446; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Carlton EJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003444; CDPHE, 2012, AIR EM CAS STUD REL; Centers for Disease Control and Prevention Wonder, US CANC STAT PUBL IN; Colorado Department of Public Health and Environment (CDPHE), 2015, COL CENTR CANC REG A; Colorado Oil and Gas Conservation Commission (COGCC), STAFF REP SEPT 14 20; Colorado Oil and Gas Information System (COGIS), 2015, WELL PROD DAT; Coste A, 2015, CANCER CAUSE CONTROL, V26, P1339, DOI 10.1007/s10552-015-0629-x; Deziel NC, 2014, ENVIRON RES, V133, P388, DOI 10.1016/j.envres.2014.04.033; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Fang R, 2011, INT J ENV RES PUB HE, V8, P3821, DOI 10.3390/ijerph8103821; Fryzek J, 2013, J OCCUP ENVIRON MED, V55, P796, DOI 10.1097/JOM.0b013e318289ee02; Ghosh JKC, 2013, AM J EPIDEMIOL, V178, P1233, DOI 10.1093/aje/kwt129; Ghosh JKC, 2012, AM J EPIDEMIOL, V175, P1262, DOI 10.1093/aje/kwr469; Gilman JB, 2013, ENVIRON SCI TECHNOL, V47, P1297, DOI 10.1021/es304119a; Gittleman HR, 2015, CANCER-AM CANCER SOC, V121, P102, DOI 10.1002/cncr.29015; Gold R., 2013, WALL STR J; Goldstein BD, 2013, J OCCUP ENVIRON MED, V55, P1376, DOI 10.1097/JOM.0000000000000014; Greaves M, 2015, CANCER CELL, V27, P433, DOI 10.1016/j.ccell.2015.03.016; Gross SA, 2013, J AIR WASTE MANAGE, V63, P424, DOI 10.1080/10962247.2012.759166; Heck JE, 2014, INT J HYG ENVIR HEAL, V217, P662, DOI 10.1016/j.ijheh.2013.12.003; Helmig D, 2014, ENVIRON SCI TECHNOL, V48, P4707, DOI 10.1021/es405046r; Helmig D., 2015, FINAL REPORT BOULDER; Houot J, 2015, AM J EPIDEMIOL, V182, P685, DOI 10.1093/aje/kwv111; Howard J., 2013, MINIMUM LATENCY TYP; Kassotis CD, 2016, ENVIRON HEALTH PERSP, V124, P256, DOI 10.1289/ehp.1409535; MacArthur AC, 2009, AM J IND MED, V52, P221, DOI 10.1002/ajim.20663; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; McNally RJQ, 2006, LEUKEMIA LYMPHOMA, V47, P583, DOI 10.1080/10428190500420973; Miligi L, 2013, OCCUP ENVIRON MED, V70, P648, DOI 10.1136/oemed-2012-100951; Mokry BJ, 2010, SUMMARY INVESTIGATIO; Natelson EA, 2007, AM J HEMATOL, V82, P826, DOI 10.1002/ajh.20934; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Ritz B, 2008, BASIC CLIN PHARMACOL, V102, P182, DOI 10.1111/j.1742-7843.2007.00161.x; Ritz B, 2007, AM J EPIDEMIOL, V166, P1045, DOI 10.1093/aje/kwm181; Shu XO, 1999, CANCER EPIDEM BIOMAR, V8, P783; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Stacy SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126425; Steffen C, 2004, OCCUP ENVIRON MED, V61, P773, DOI 10.1136/oem.2003.010868; Szklo M., 2007, EPIDEMIOLOGY BASICS; Tamai H, 2010, J CLIN EXP HEMATOP, V50, P91, DOI 10.3960/jslrt.50.91; Thompson Chelsea R., 2014, Elementa-Science of the Anthropocene, V2, P000035, DOI 10.12952/journal.elementa.000035; Triebig G, 2010, CHEM-BIOL INTERACT, V184, P26, DOI 10.1016/j.cbi.2009.12.014; United State Environmental Protection Agency (EPA), 2015, RISK BAS SCR TABL; Urayama KY, 2009, ANN EPIDEMIOL, V19, P834, DOI 10.1016/j.annepidem.2009.03.001; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Whitworth KW, 2008, ENVIRON HEALTH PERSP, V116, P1576, DOI 10.1289/ehp.11593; Wiemels JL, 1999, BLOOD, V94, P1057, DOI 10.1182/blood.V94.3.1057.415k10_1057_1062; Wiemels J, 2015, EUR J EPIDEMIOL, V30, P1225, DOI 10.1007/s10654-015-0115-5; Yan KK, 2015, PEDIATR BLOOD CANCER, V62, P1162, DOI 10.1002/pbc.25443; Yousif L, 2013, GMS GERMAN MED SCI, V11	60	79	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170423	10.1371/journal.pone.0170423	http://dx.doi.org/10.1371/journal.pone.0170423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199334	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400014
J	Poole, CB; Li, ZR; Alhassan, A; Guelig, D; Diesburg, S; Tanner, NA; Zhang, YH; Evans, TC; LaBarre, P; Wanji, S; Burton, RA; Carlow, CKS				Poole, Catherine B.; Li, Zhiru; Alhassan, Andy; Guelig, Dylan; Diesburg, Steven; Tanner, Nathan A.; Zhang, Yinhua; Evans, Thomas C., Jr.; LaBarre, Paul; Wanji, Samuel; Burton, Robert A.; Carlow, Clotilde K. S.			Colorimetric tests for diagnosis of filarial infection and vector surveillance using non-instrumented nucleic acid loop-mediated isothermal amplification (NINA-LAMP)	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; WUCHERERIA-BANCROFTI DNA; ONCHOCERCA-VOLVULUS; VISUAL DETECTION; BLOOD; ELIMINATION; BRUGIA; ASSAY; COMMUNITIES; PROGRAMS	Accurate detection of filarial parasites in humans is essential for the implementation and evaluation of mass drug administration programs to control onchocerciasis and lymphatic filariasis. Determining the infection levels in vector populations is also important for assessing transmission, deciding when drug treatments may be terminated and for monitoring recrudescence. Immunological methods to detect infection in humans are available, however, cross-reactivity issues have been reported. Nucleic acid-based molecular assays offer high levels of specificity and sensitivity, and can be used to detect infection in both humans and vectors. In this study we developed loop-mediated isothermal amplification (LAMP) tests to detect three different filarial DNAs in human and insect samples using pH sensitive dyes for enhanced visual detection of amplification. Furthermore, reactions were performed in a portable, non-instrumented nucleic acid amplification (NINA) device that provides a stable heat source for LAMP. The efficacy of several strand displacing DNA polymerases were evaluated in combination with neutral red or phenol red dyes. Colorimetric NINA-LAMP assays targeting Brugia Hha I repeat, Onchocerca volvulus GST1a and Wuchereria bancrofti LDR each exhibit species-specificity and are also highly sensitive, detecting DNA equivalent to 1/10-1/5000th of one microfilaria. Reaction times varied depending on whether a single copy gene (70 minutes, O. volvulus) or repetitive DNA (40 min, B. malayiand W. bancrofti) was employed as a biomarker. The NINA heater can be used to detect multiple infections simultaneously. The accuracy, simplicity and versatility of the technology suggests that colorimetric NINA-LAMP assays are ideally suited for monitoring the success of filariasis control programs.	[Poole, Catherine B.; Li, Zhiru; Alhassan, Andy; Tanner, Nathan A.; Zhang, Yinhua; Evans, Thomas C., Jr.; Carlow, Clotilde K. S.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Guelig, Dylan; Diesburg, Steven; LaBarre, Paul; Burton, Robert A.] PATH, Seattle, WA USA; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	carlow@neb.com			New England Biolabs	New England Biolabs	CKSC, CBP, ZL, AA, NAT, YZ and TCE received funding from New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan A, 2015, EXPANDING MDX TOOLBO; Alhassan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108927; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P345; [Anonymous], 2011, WHOHTMNTDPCT20114; Bakajika DK, 2014, AM J TROP MED HYG, V91, P1142, DOI 10.4269/ajtmh.14-0358; Luz SLB, 2014, MEM I OSWALDO CRUZ, V109, P506, DOI 10.1590/0074-0276140079; Buser JR, 2015, LAB CHIP, V15, P4423, DOI 10.1039/c5lc01053e; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Crump A, 2012, TRENDS PARASITOL, V28, P280, DOI 10.1016/j.pt.2012.04.005; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Drame PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Fischer P, 2005, ANN TROP MED PARASIT, V99, P53, DOI 10.1179/136485905X13339; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Gounoue-Kamkumo R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1317-x; Joseph H, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/492023; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kouassi BL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1077-x; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; LOBOS E, 1991, SCIENCE, V251, P1603, DOI 10.1126/science.2011741; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; MEREDITH SEO, 1991, EXP PARASITOL, V73, P335, DOI 10.1016/0014-4894(91)90105-6; MEREDITH SEO, 1989, MOL BIOCHEM PARASIT, V36, P1, DOI 10.1016/0166-6851(89)90194-1; Merriweather A, 1996, EXP PARASITOL, V83, P164, DOI 10.1006/expr.1996.0062; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Noordin Rahmah, 2004, Filaria J, V3, P10, DOI 10.1186/1475-2883-3-10; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Oguttu D, 2014, AM J TROP MED HYG, V90, P339, DOI 10.4269/ajtmh.13-0546; Okorie PN, 2016, T ROY SOC TROP MED H, V110, P90, DOI 10.1093/trstmh/trv104; Osei-Atweneboana MY, 2012, INT J PARASITOL-DRUG, V2, P20, DOI 10.1016/j.ijpddr.2012.01.005; Poole CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139286; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; POOLE CB, 1990, MOL BIOCHEM PARASIT, V40, P129, DOI 10.1016/0166-6851(90)90086-2; Poon LLM, 2006, CLIN CHEM, V52, P303; Rao RU, 2006, AM J TROP MED HYG, V74, P826, DOI 10.4269/ajtmh.2006.74.826; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Sergev SS, 1981, Patent No. [US 4264362 A, 4264362]; Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693; Steel C, 2013, CLIN VACCINE IMMUNOL, V20, P1155, DOI 10.1128/CVI.00252-13; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Ton TGN, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0068-7; Wahl G, 1998, PARASITOLOGY, V116, P327, DOI 10.1017/S0031182097002333; Wanji S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1556-8; Wanji S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004184; Wanji S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0817-2; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	54	57	58	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169011	10.1371/journal.pone.0169011	http://dx.doi.org/10.1371/journal.pone.0169011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199317	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400003
J	Zheng, S; Xu, H; Zhou, H; Ren, XX; Han, TT; Chen, YW; Qiu, HY; Wu, PH; Zheng, J; Wang, LH; Liu, W; Hu, YM				Zheng, Shuang; Xu, Hua; Zhou, Huan; Ren, Xingxing; Han, Tingting; Chen, Yawen; Qiu, Huiying; Wu, Peihong; Zheng, Jun; Wang, Lihua; Liu, Wei; Hu, Yaomin			Associations of lipid profiles with insulin resistance and beta cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR RISK; FASTING GLUCOSE; NITRIC-OXIDE; SECRETION; CHOLESTEROL; SENSITIVITY; INDIVIDUALS; DYSFUNCTION; PREVALENCE	Aims To investigate the associations of dyslipidemia with insulin resistance and beta cell function in individuals with normal glucose tolerance (NGT) and different categories of impaired glucose regulation (IGR). Methods 544 subjects (365 with dyslipidemia and/or IGR and 179 with normal lipid and glucose tolerance) were enrolled in the study. All subjects underwent oral glucose tolerance test (OGTT). HOMA-IR was used to evaluate insulin sensitivity. Disposition index (DI) was used to evaluate beta cell function. Multiple linear regression analysis was performed to assess correlations among lipid profiles, insulin resistance and beta cell function. Results Among subjects with NGT, those with dyslipidemia had higher level of HOMA-IR but lower level of DI. While among subjects with different categories of IGR, those with dyslipidemia and CGI had significantly decreased DI. No obvious differences of insulin resistance or beta cell function were found in IFG or IGT subjects with or without dyslipidemia. TG and HDL-C were correlated with HOMA-IR (beta = 0.79, p < 0.001; beta = -0.38, p = 0.027, respectively, compared with subjects in the low level groups). Moreover, TG and TC were negatively correlated with DI (beta = -2.17, p = 0.013; beta = -2.01, p = 0.034 respectively, compared with subjects in the low level groups) after adjusting for confounding parameters. Conclusions Dyslipidemia induces insulin resistance and impaired beta cell response to insulin resistance in individuals with NGT. Furthermore, dyslipidemia diminishes beta cell function in subjects with CGI. TG and HDL-C were correlated with insulin resistance, and TG, TC were negatively correlated with beta cell response to insulin resistance in non-diabetic individuals.	[Zheng, Shuang; Xu, Hua; Zhou, Huan; Ren, Xingxing; Han, Tingting; Chen, Yawen; Qiu, Huiying; Wu, Peihong; Zheng, Jun; Wang, Lihua; Liu, Wei; Hu, Yaomin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Liu, W; Hu, YM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai, Peoples R China.	sue_liuwei@163.com; amin1031@hotmail.com	HAN, TINGTING/GQZ-8692-2022		National Natural Science Foundation of China [81270946, 81170758, 30670988]; Renji Hospital, school of medicine, Shanghai Jiaotong University [RJZZ14-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Renji Hospital, school of medicine, Shanghai Jiaotong University	This study was supported by the National Natural Science Foundation of China (No. 81270946, 81170758, 30670988) and the Foundation from Renji Hospital, school of medicine, Shanghai Jiaotong University (RJZZ14-003).	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aoyama-Sasabe S, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1298601; Baralla A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128029; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Brunisholz KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157729; Chen G, 2010, METABOLISM, V59, P1823, DOI 10.1016/j.metabol.2010.06.009; Chen GY, 2015, MED SCI MONITOR, V21, P2476, DOI 10.12659/MSM.894246; Colman PG, 1999, NEW ZEAL MED J, V112, P139; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Downing LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140267; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hong J, 2008, DIABETIC MED, V25, P73, DOI 10.1111/j.1464-5491.2007.02329.x; Kong XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143607; Li XY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0629-3; Man ZW, 1997, DIABETES, V46, P1718, DOI 10.2337/diabetes.46.11.1718; Novoa FJ, 2005, DIABETES CARE, V28, P2388, DOI 10.2337/diacare.28.10.2388; Ohashi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143880; Okwechime IO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145781; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pedersen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138654; Ren LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144182; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Rhee SY, 2010, DIABETES RES CLIN PR, V89, P250, DOI 10.1016/j.diabres.2010.05.002; De Ita JR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0684-9; SOSENKO JM, 1993, DIABETIC MED, V10, P814, DOI 10.1111/j.1464-5491.1993.tb00172.x; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Xu F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0407-2; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang L, 2008, DIABETES RES CLIN PR, V82, P364, DOI 10.1016/j.diabres.2008.08.022; Zheng S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1020-8; Zheng S, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0018-1; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580	40	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172221	10.1371/journal.pone.0172221	http://dx.doi.org/10.1371/journal.pone.0172221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199386	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400082
J	Perrotta, AR; Kumaraswamy, R; Bastidas-Oyanedel, JR; Alm, EJ; Rodriguez, J				Perrotta, Allison R.; Kumaraswamy, Rajkumari; Bastidas-Oyanedel, Juan R.; Alm, Eric J.; Rodriguez, Jorge			Inoculum composition determines microbial community and function in an anaerobic sequential batch reactor	PLOS ONE			English	Article							DARK FERMENTATION; WASTE-WATER; DIVERSITY; DIGESTION; DYNAMICS; PATTERNS; BIOTECHNOLOGY; INSTABILITY; BIOREACTOR; STABILITY	The sustainable recovery of resources from wastewater streams can provide many social and environmental benefits. A common strategy to recover valuable resources from wastewater is to harness the products of fermentation by complex microbial communities. In these fermentation bioreactors high microbial community diversity within the inoculum source is commonly assumed as sufficient for the selection of a functional microbial community. However, variability of the product profile obtained from these bioreactors is a persistent challenge in this field. In an attempt to address this variability, the impact of inoculum on the microbial community structure and function within the bioreactor was evaluated using controlled laboratory experiments. In the course of this work, sequential batch reactors were inoculated with three complex microbial inocula and the chemical and microbial compositions were monitored by HPLC and 16S rRNA amplicon analysis, respectively. Microbial community dynamics and chemical profiles were found to be distinct to initial inoculate and highly reproducible. Additionally we found that the generation of a complex volatile fatty acid profile was not specific to the diversity of the initial microbial inoculum. Our results suggest that the composition of the original inoculum predictably contributes to bioreactor community structure and function.	[Perrotta, Allison R.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kumaraswamy, Rajkumari; Bastidas-Oyanedel, Juan R.; Rodriguez, Jorge] Masdar Inst Sci & Technol, Dept Chem & Environm Engn, Abu Dhabi, U Arab Emirates; [Alm, Eric J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst MIT, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Khalifa University of Science & Technology; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rodriguez, J (corresponding author), Masdar Inst Sci & Technol, Dept Chem & Environm Engn, Abu Dhabi, U Arab Emirates.	jrodriguez@masdar.ac.ae	Bastidas-Oyanedel, Juan-Rodrigo/I-3372-2016; R., Jorge Rodríguez/A-9879-2008; R., Jorge Rodríguez/N-5916-2019	Bastidas-Oyanedel, Juan-Rodrigo/0000-0002-2418-441X; R., Jorge Rodríguez/0000-0002-5936-9676; R., Jorge Rodríguez/0000-0002-5936-9676	Masdar Institute/MIT joint research program [11WAMA1]; National Institute of Environmental Health Sciences of the NIH [P30-ES002109]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Masdar Institute/MIT joint research program; National Institute of Environmental Health Sciences of the NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Masdar Institute/MIT joint research program (grant 11WAMA1) to ARP, JRBO, and RK, and the National Institute of Environmental Health Sciences of the NIH (P30-ES002109) for sequencing efforts through the MIT BioMicro Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001; Baas-Becking LGM, 1934, GEOBIOLOGIE INLEIDIN, DOI [10.1038/ismej.2011.107, DOI 10.1038/ISMEJ.2011.107]; Bastidas-Oyanedel JR, 2015, REV ENVIRON SCI BIO, V14, P473, DOI 10.1007/s11157-015-9369-3; Bastidas-Oyanedel JR, 2010, TALANTA, V83, P482, DOI 10.1016/j.talanta.2010.09.034; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; De Vrieze J, 2015, APPL MICROBIOL BIOT, V99, P189, DOI 10.1007/s00253-014-6046-3; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Gentile ME, 2007, ISME J, V1, P714, DOI 10.1038/ismej.2007.87; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Hanski I., 2009, PRINCETON GUIDE ECOL, P177; Hawkes FR, 2002, INT J HYDROGEN ENERG, V27, P1339, DOI 10.1016/S0360-3199(02)00090-3; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Kleerebezem R, 2015, REV ENVIRON SCI BIO, V14, P787, DOI 10.1007/s11157-015-9374-6; Koskinen PEP, 2007, BIOTECHNOL BIOENG, V97, P742, DOI 10.1002/bit.21299; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mendez-Acosta HO, 2013, BIOTECHNOL BIOENG, V110, P2131, DOI 10.1002/bit.24838; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quemeneur M, 2011, INT J HYDROGEN ENERG, V36, P11654, DOI 10.1016/j.ijhydene.2011.06.010; Rodriguez J, 2008, TRENDS BIOTECHNOL, V26, P366, DOI 10.1016/j.tibtech.2008.04.003; Stegen JC, 2013, ISME J, V7, P2069, DOI 10.1038/ismej.2013.93; Temudo MF, 2007, BIOTECHNOL BIOENG, V98, P69, DOI 10.1002/bit.21412; Vanwonterghem I, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Walker M, 2009, BIORESOURCE TECHNOL, V100, P6339, DOI 10.1016/j.biortech.2009.07.018; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Zhou J, 2013, MBIO, V4, P1	42	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171369	10.1371/journal.pone.0171369	http://dx.doi.org/10.1371/journal.pone.0171369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196102	gold, Green Published			2022-12-26	WOS:000394423900018
J	Sun, LM; Liao, K; Hang, CC; Wang, DY				Sun, Lingmei; Liao, Kai; Hang, Chengcheng; Wang, Dayong			Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction	PLOS ONE			English	Article							SUPEROXIDE DISMUTASES; LIPID-PEROXIDATION; ANTIFUNGAL AGENTS; FLUORESCENT-PROBE; OXIDATIVE STRESS; DRUG-RESISTANCE; RESPONSES; MECHANISM; MAGNOLOL; CELLS	Objective To investigate the effects of honokiol on induction of reactive oxygen species (ROS), antioxidant defense systems, mitochondrial dysfunction, and apoptosis in Candida albicans. Methods To measure ROS accumulation, 2',7'-dichlorofluorescein diacetate fluorescence was used. Lipid peroxidation was assessed using both fluorescence staining and a thiobarbituric acid reactive substances (TBARS) assay. Protein oxidation was determined using dinitrophenylhydrazine derivatization. Antioxidant enzymatic activities were measured using commercially available detection kits. Superoxide dismutase (SOD) genes expression was measured using real time RT-PCR. To assess its antifungal abilities and effectiveness on ROS accumulation, honokiol and the SOD inhibitor N,N'-diethyldithiocarbamate (DDC) were used simultaneously. Mitochondrial dysfunction was assessed by measuring the mitochondrial membrane potential (mt Delta psi). Honokiol-induced apoptosis was assessed using an Annexin V-FITC apoptosis detection kit. Results ROS, lipid peroxidation, and protein oxidation occurred in a dose-dependent manner in C. albicans after honokiol treatment. Honokiol caused an increase in antioxidant enzymatic activity. In addition, honokiol treatment induced SOD genes expression in C. albicans cells. Moreover, addition of DDC resulted in increased endogenous ROS levels and potentiated the antifungal activity of honokiol. Mitochondrial dysfunction was confirmed by measured changes to mt Delta psi. The level of apoptosis increased in a dose-dependent manner after honokiol treatment. Conclusions Collectively, these results indicate that honokiol acts as a pro-oxidant in C. albicans. Furthermore, the SOD inhibitor DDC can be used to potentiate the activity of honokiol against C. albicans.	[Sun, Lingmei; Hang, Chengcheng] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Liao, Kai] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn			National Natural Science Foundation of China [81302814]; Jiangsu Province Natural Science Foundation [BK20130640, BK20140624]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (NO 81302814) and Jiangsu Province Natural Science Foundation (NO BK20130640; BK20140624).	Arora S, 2012, CURR MOL MED, V12, P1244, DOI 10.2174/156652412803833508; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bang KH, 2000, ARCH PHARM RES, V23, P46, DOI 10.1007/BF02976465; Bink A, 2011, ANTIMICROB AGENTS CH, V55, P4033, DOI 10.1128/AAC.00280-11; Chang WQ, 2011, BBA-GEN SUBJECTS, V1810, P569, DOI 10.1016/j.bbagen.2011.02.001; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; De Brucker K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/704654; Delattin N, 2014, FUTURE MED CHEM, V6, P77, DOI [10.4155/FMC.13.189, 10.4155/fmc.13.189]; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; GEORGOPAPADAKOU NH, 1987, ANTIMICROB AGENTS CH, V31, P46, DOI 10.1128/AAC.31.1.46; Haque F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23575; Jangra A, 2016, EUR J PHARMACOL, V770, P25, DOI 10.1016/j.ejphar.2015.11.047; Jiang QQ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-242; Jin J, 2010, LETT APPL MICROBIOL, V51, P351, DOI 10.1111/j.1472-765X.2010.02900.x; Khan A, 2015, MICROB PATHOGENESIS, V80, P50, DOI 10.1016/j.micpath.2015.02.004; Li Y, 2015, PLOS ONE, V10; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Marcos-Arias C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-119; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pan J, 2016, MOL NUTR FOOD RES, V60, P1383, DOI 10.1002/mnfr.201501007; Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391; Rawal MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27132; Richardson JP, 2015, VIRULENCE, V6, P327, DOI 10.1080/21505594.2015.1004977; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sharma M, 2010, BIOSCIENCE REP, V30, P391, DOI 10.1042/BSR20090151; Sun J, 2015, DRUG DES DEV THER, V9, P6327, DOI 10.2147/DDDT.S92777; Sun LM, 2015, J APPL MICROBIOL, V118, P826, DOI 10.1111/jam.12737; Sun LM, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0117695, 10.1371/journal.pone.0143820]; Teodoro GR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01420; Wang XD, 2015, INT J CLIN EXP PATHO, V8, P7929; Yu CH, 2013, BASIC CLIN PHARMACOL, V113, P377, DOI 10.1111/bcpt.12110	41	48	51	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172228	10.1371/journal.pone.0172228	http://dx.doi.org/10.1371/journal.pone.0172228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192489	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800085
J	Baytshtok, V; Chen, JJ; Glynn, SE; Nager, AR; Grant, RA; Baker, TA; Sauer, RT				Baytshtok, Vladimir; Chen, Jiejin; Glynn, Steven E.; Nager, Andrew R.; Grant, Robert A.; Baker, Tania A.; Sauer, Robert T.			Covalently linked HslU hexamers support a probabilistic mechanism that links ATP hydrolysis to protein unfolding and translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; ATPases associated with diverse cellular activities (AAA); crystal structure; protein engineering; protein turnover; AAA plus protease; mixed hexameric rings; protein unfolding; protein degradation; HslUV	ESCHERICHIA-COLI; DEPENDENT PROTEOLYSIS; I-DOMAIN; AAA; CLPXP; CRYSTAL; REVEAL; SUPERFAMILY; DEGRADATION; ACTIVATION	The HslUV proteolytic machine consists of HslV, a double-ring self-compartmentalized peptidase, and one or two AAA+ HslU ring hexamers that hydrolyze ATP to power the unfolding of protein substrates and their translocation into the proteolytic chamber of HslV. Here, we use genetic tethering and disulfide bonding strategies to construct HslU pseudohexamers containing mixtures of ATPase active and inactive subunits at defined positions in the hexameric ring. Genetic tethering impairs HslV binding and degradation, even for pseudohexamers with six active subunits, but disulfide-linked pseudohexamers do not have these defects, indicating that the peptide tether interferes with HslV interactions. Importantly, pseudohexamers containing different patterns of hydrolytically active and inactive subunits retain the ability to unfold protein substrates and/or collaborate with HslV in their degradation, supporting a model in which ATP hydrolysis and linked mechanical function in the HslU ring operate by a probabilistic mechanism.	[Baytshtok, Vladimir; Chen, Jiejin; Glynn, Steven E.; Nager, Andrew R.; Grant, Robert A.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chen, Jiejin] Takeda Pharmaceut, Cambridge, MA 02139 USA; [Glynn, Steven E.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Nager, Andrew R.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Glynn, Steven/0000-0001-6247-8913	National Institutes of Health [AI-16892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI-16892. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Baytshtok V, 2016, STRUCTURE, V24, P1766, DOI 10.1016/j.str.2016.08.012; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Stinson BM, 2015, NAT STRUCT MOL BIOL, V22, P411, DOI 10.1038/nsmb.3012; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Sundar S, 2012, PROTEIN SCI, V21, P188, DOI 10.1002/pro.2001; Sundar S, 2010, J MOL BIOL, V403, P420, DOI 10.1016/j.jmb.2010.09.008; Trame CB, 2001, ACTA CRYSTALLOGR D, V57, P1079, DOI 10.1107/S0907444901007673; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich J. A., 2008, THESIS; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696; Yoo SJ, 1998, J BIOL CHEM, V273, P22929, DOI 10.1074/jbc.273.36.22929	45	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5695	5704		10.1074/jbc.M116.768978	http://dx.doi.org/10.1074/jbc.M116.768978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223361	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000398813200008
J	Gouaref, I; Detaille, D; Wiernsperger, N; Khan, NA; Leverve, X; Koceir, EA				Gouaref, Ines; Detaille, Dominique; Wiernsperger, Nicolas; Khan, Naim Akhtar; Leverve, Xavier; Koceir, Elhadj-Ahmed			The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state	PLOS ONE			English	Article							BETA-CELL FUNCTION; FATTY-ACID; GLUCOSE-6-PHOSPHATE HYDROLYSIS; GLUCOSE-PRODUCTION; GUT MICROBIOTA; BODY-WEIGHT; FOOD-INTAKE; RATS; GLUCONEOGENESIS; INSULIN	Introduction While metformin (MET) is the most widely prescribed antidiabetic drug worldwide, its beneficial effects in Psammomys obesus (P. obesus), a rodent model that mimics most of the metabolic features of human diabetes, have not been explored thoroughly. Here, we sought to investigate whether MET might improve insulin sensitivity, glucose homeostasis, lipid profile as well as cellular redox and energy balance in P. obesus maintained on a high energy diet (HED). Materials and methods P. obesus gerbils were randomly assigned to receive either a natural diet (ND) consisting of halophytic plants (control group) or a HED (diabetic group) for a period of 24 weeks. MET (50 mg/kg per os) was administered in both animal groups after 12 weeks of feeding, i.e., the time required for the manifestation of insulin resistance in P. obesus fed a HED. Parallel in vitro experiments were conducted on isolated hepatocytes that were shortly incubated (30 min) with MET and energetic substrates (lactate + pyruvate or alanine, in the presence of octanoate). Results In vivo, MET lowered glycemia, glycosylated haemoglobin, circulating insulin and fatty acid levels in diabetic P. obesus. It also largely reversed HED-induced hepatic lipid alterations. In vitro, MET increased glycolysis but decreased both gluconeogenesis and ketogenesis in the presence of glucogenic precursors and medium-chain fatty acid. Importantly, these changes were associated with an increase in cytosolic and mitochondrial redox states along with a decline in respiration capacity. Conclusions MET prevents the progression of insulin resistance in diabetes-prone P. obesus, possibly through a tight control of gluconeogenesis and fatty acid beta-oxidation depending upon mitochondrial function. While the latter is increasingly becoming a therapeutic issue in diabetes, the gut microbiota is another promising target that would need to be considered as well.	[Gouaref, Ines; Koceir, Elhadj-Ahmed] Univ Sci & Technol Houari Boumediene, Bioenerget & Intermediary Metab Team, Lab Biol & Organism Physiol, Inst Biol Sci, BP 32, Algiers, Algeria; [Detaille, Dominique] Univ Bordeaux, Rhythmol & Heart Modeling Inst, Bordeaux, France; [Wiernsperger, Nicolas] INSERM, U1060, CarMeN Lab, Villeurbanne, France; [Khan, Naim Akhtar] UBFC, Physiol Nutr & Toxicol, INSERM, U1236, Dijon, France; [Leverve, Xavier] Univ Grenoble Alpes, LBFA, INSERM, U1055, Grenoble, France	University Science & Technology Houari Boumediene; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Koceir, EA (corresponding author), Univ Sci & Technol Houari Boumediene, Bioenerget & Intermediary Metab Team, Lab Biol & Organism Physiol, Inst Biol Sci, BP 32, Algiers, Algeria.	e.koceir@gmail.com		Khan, Naim Akhtar/0000-0002-8930-9332; KOCEIR, Elhadj-Ahmed/0000-0003-1345-2535	German Federal Ministry of Education and Research (BMBF) [01EZ0816, 01EZ0818, 13EZ0817]; Deutsche Herzstiftung e.V. [S/05/12]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Herzstiftung e.V.	This work was financially supported by a grant from the German Federal Ministry of Education and Research (BMBF; grant-ID 01EZ0816, 01EZ0818 and 13EZ0817), and in part by the Deutsche Herzstiftung e.V. (S/05/12, Y-X, Ye). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Arora T, 2016, J INTERN MED, V280, P339, DOI 10.1111/joim.12508; Atek-Mebarki F, 2015, BIOCHIMIE, V109, P60, DOI 10.1016/j.biochi.2014.12.004; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Boucaud-Maitre D, 2016, DIABETIC MED, V33, P1536, DOI 10.1111/dme.13098; Bouderba S, 2014, J DIABETES, V6, P184, DOI 10.1111/1753-0407.12083; Bouderba S, 2012, EXP DIABETES RES, DOI 10.1155/2012/430176; BRANDES R, 1986, COMP BIOCHEM PHYS B, V83, P837, DOI 10.1016/0305-0491(86)90156-2; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; CANO N, 1995, KIDNEY INT, V47, P1522, DOI 10.1038/ki.1995.215; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Collier GR, 1997, OBES RES, V5, P455, DOI 10.1002/j.1550-8528.1997.tb00670.x; DALY M, 1975, J MAMMAL, V56, P509, DOI 10.2307/1379378; DELPRATO S, 1995, DIABETES METAB REV, V11, pS33; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; Ferrannini E, 2014, METABOLISM, V63, P1217, DOI 10.1016/j.metabol.2014.05.012; Finlayson A, 2015, WORLD J GASTRO ENDOS, V7, P1103, DOI [10.4253/wjge.v7.i13.1103, 10.4291/wjgp.v6.i4.110]; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; FRENKEL G, 1972, LIFE SCI, V11, P209, DOI 10.1016/0024-3205(72)90006-9; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Hamilton MK, 2015, AM J PHYSIOL-GASTR L, V308, pG840, DOI 10.1152/ajpgi.00029.2015; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Harmel E, 2014, ENDOCRINOLOGY, V155, P873, DOI 10.1210/en.2013-1750; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Ichai C, 2001, J BIOL CHEM, V276, P28126, DOI 10.1074/jbc.M010186200; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; Khalkhal A, 2010, CR BIOL, V335, P271; KHAN NA, 1994, J ENDOCRINOL, V142, P245, DOI 10.1677/joe.0.1420245; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Koceir EA, 2003, DIABETES METAB, V29, P363, DOI 10.1016/S1262-3636(07)70047-2; Kuznetsova TA, 2013, MICROB ECOL, V66, P940, DOI 10.1007/s00248-013-0263-7; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lv WS, 2012, BRAIN RES, V1444, P11, DOI 10.1016/j.brainres.2012.01.028; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; MARQUIE G, 1984, DIABETES, V33, P438, DOI 10.2337/diabetes.33.5.438; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Nocito L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122818; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quadri I, 2016, MICROBIOL RES, V186, P119, DOI 10.1016/j.micres.2016.04.003; Radziuk J, 1997, DIABETES, V46, P1406, DOI 10.2337/diabetes.46.9.1406; Rapin JR, 2008, METFORMIN MECH INSIG, P131; Sahraoui A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148117; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; SCHAFER H, 1990, COMP BIOCHEM PHYS A, V95, P209, DOI 10.1016/0300-9629(90)90200-C; Shafrir E, 2001, Int J Exp Diabetes Res, V2, P299, DOI 10.1155/EDR.2001.299; Shafrir Eleazar, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P347; SHIBKO S, 1967, ANAL BIOCHEM, V19, P514, DOI 10.1016/0003-2697(67)90242-4; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271; Spolding B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092656; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Yasuda N, 2004, J PHARMACOL EXP THER, V310, P614, DOI 10.1124/jpet.103.064964; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	69	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172053	10.1371/journal.pone.0172053	http://dx.doi.org/10.1371/journal.pone.0172053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222147	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800029
J	Gupta, RS; Nanda, A; Khadka, B				Gupta, Radhey S.; Nanda, Anish; Khadka, Bijendra			Novel molecular, structural and evolutionary characteristics of the phosphoketolases from bifidobacteria and Coriobacteriales	PLOS ONE			English	Article							GUT MICROBIOTA; PROTEIN; GENE; METABOLISM; PATHWAY; EXPRESSION; PREDICTION; SIGNATURES; SEQUENCES; BACTERIAL	Members from the order Bifidobacteriales, which include many species exhibiting health promoting effects, differ from all other organisms in using a unique pathway for carbohydrate metabolism, known as the "bifid shunt", which utilizes the enzyme phosphoketolase ( PK) to carry out the phosphorolysis of both fructose-6-phosphate ( F6P) and xylulose-5-phosphate ( X5P). In contrast to bifidobacteria, the PKs found in other organisms ( referred to XPK) are able to metabolize primarily X5P and show very little activity towards F6P. Presently, very little is known about the molecular or biochemical basis of the differences in the two forms of PKs. Comparative analyses of PK sequences from different organisms reported here have identified multiple high-specific sequence features in the forms of conserved signature inserts and deletions ( CSIs) in the PK sequences that clearly distinguish the X5P/F6P phosphoketolases ( XFPK) of bifidobacteria from the XPK homologs found in most other organisms. Interestingly, most of the molecular signatures that are specific for the XFPK from bifidobacteria are also shared by the PK homologs from the Coriobacteriales order of Actinobacteria. Similarly to the Bifidobacteriales, the order Coriobacteriales is also made up of commensal organisms, that are saccharolytic and able to metabolize wide variety of carbohydrates, producing lactate and other metabolites. Phylogenetic studies provide evidence that the XFPK from bifidobacteria are specifically related to those found in the Coriobacteriales and suggest that the gene for PK ( XFPK) was horizontally transferred between these two groups. A number of the identified CSIs in the XFPK sequence, which serve to distinguish the XFPK homologs from XPK homologs, are located at the subunit interface in the structure of the XFPK dimer protein. The results of protein modelling and subunit docking studies indicate that these CSIs are involved in the formation/ stabilization of the protein dimer. The significance of these observations regarding the differences in the activities of the XFPK and XPK homologs are discussed. Additionally, this work also discusses the significance of the XFPK-like homologs, similar to those found in bifidobacteria, in the order Coriobacteriales.	[Gupta, Radhey S.; Nanda, Anish; Khadka, Bijendra] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Gupta, RS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	gupta@mcmaster.ca		Khadka, Bijendra/0000-0001-5137-860X				Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Biavati B, 2000, ANN MICROBIOL, V50, P117; Biavati B., 2012, BERGEYS MANUAL SYSTE, V5, P171, DOI DOI 10.1007/978-0-387-68233-4; Biavati B, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P322, DOI 10.1007/0-387-30743-5_17; Bottacini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044229; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burge G, 2015, J MICROBIOL, V53, P702, DOI 10.1007/s12275-015-5056-x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cherkasov A, 2006, PROTEINS, V62, P371, DOI 10.1002/prot.20631; Clavel T., 2014, PROKARYOTES ACTINOBA, P201, DOI DOI 10.1007/978-3-642-30138-4_343; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cronin M, 2011, INT J FOOD MICROBIOL, V149, P4, DOI 10.1016/j.ijfoodmicro.2011.01.019; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DEVRIES W, 1967, BIOCHIM BIOPHYS ACTA, V136, P415, DOI 10.1016/0304-4165(67)90001-3; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Eswar N, 2007, CURR PROTOC BIOINFOR; Fleige C, 2011, APPL MICROBIOL BIOT, V91, P769, DOI 10.1007/s00253-011-3284-5; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Glenn K, 2015, J BACTERIOL, V197, P1157, DOI 10.1128/JB.02380-14; Glenn K, 2014, EUKARYOT CELL, V13, P657, DOI 10.1128/EC.00055-14; Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164; GRILL JP, 1995, CURR MICROBIOL, V31, P49, DOI 10.1007/BF00294634; Gupta RS, 2016, FEMS MICROBIOL REV, V40, P520, DOI 10.1093/femsre/fuw011; Gupta RS, 2014, METHOD MICROBIOL, V41, P153, DOI 10.1016/bs.mim.2014.05.003; Gupta RS, 2013, INT J SYST EVOL MICR, V63, P3379, DOI 10.1099/ijs.0.048371-0; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; Milani C, 2016, APPL ENVIRON MICROB, V82, P980, DOI 10.1128/AEM.03500-15; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Orban JI, 2000, J MICROBIOL METH, V40, P221, DOI 10.1016/S0167-7012(00)00133-0; Palframan Richard J, 2003, Curr Issues Intest Microbiol, V4, P71; Petrareanu G, 2014, APPL MICROBIOL BIOT, V98, P7855, DOI 10.1007/s00253-014-5723-6; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Posthuma CC, 2002, APPL ENVIRON MICROB, V68, P831, DOI 10.1128/AEM.68.2.831-837.2002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ruiz L, 2016, J PROTEOMICS, V147, P28, DOI 10.1016/j.jprot.2016.03.023; Sanchez B, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600240; Sanchez B, 2010, J MOL MICROB BIOTECH, V18, P37, DOI 10.1159/000274310; Scardovi V., 1965, ANN MICROBIOL ENZ, V15, P19; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Singh B, 2009, MOL GENET GENOMICS, V281, P361, DOI 10.1007/s00438-008-0417-3; Suzuki R, 2010, J BIOL CHEM, V285, P34279, DOI 10.1074/jbc.M110.156281; Takahashi K, 2010, FEBS LETT, V584, P3855, DOI 10.1016/j.febslet.2010.07.043; Thorasin T, 2015, MICROBIOL-SGM, V161, P565, DOI 10.1099/mic.0.000016; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356; Vlkova E, 2005, J MICROBIOL METH, V60, P365, DOI 10.1016/j.mimet.2004.10.012; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xiong W, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.187, 10.1038/nplants.2015.187]; Yevenes A, 2008, BIOORG CHEM, V36, P121, DOI 10.1016/j.bioorg.2008.03.002; Yin XH, 2005, FEMS MICROBIOL LETT, V246, P251, DOI 10.1016/j.femsle.2005.04.013; Zhang G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00978; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0	68	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172176	10.1371/journal.pone.0172176	http://dx.doi.org/10.1371/journal.pone.0172176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212383	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700021
J	Hao, WR; Gong, SH; Wu, SN; Xu, JC; Go, MR; Friedman, A; Zhu, D				Hao, Wenrui; Gong, Shihua; Wu, Shuonan; Xu, Jinchao; Go, Michael R.; Friedman, Avner; Zhu, Dai			A mathematical model of aortic aneurysm formation	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MATRIX METALLOPROTEINASES; INTERLEUKIN-6 IL-6; IFN-GAMMA; T-CELLS; TRANSCRIPTION; ADVENTITIA; EXPRESSION; MACROPHAGES; RUPTURE	Abdominal aortic aneurysm ( AAA) is a localized enlargement of the abdominal aorta, such that the diameter exceeds 3 cm. The natural history of AAA is progressive growth leading to rupture, an event that carries up to 90% risk of mortality. Hence there is a need to predict the growth of the diameter of the aorta based on the diameter of a patient's aneurysm at initial screening and aided by non-invasive biomarkers. IL-6 is overexpressed in AAA and was suggested as a prognostic marker for the risk in AAA. The present paper develops a mathematical model which relates the growth of the abdominal aorta to the serum concentration of IL-6. Given the initial diameter of the aorta and the serum concentration of IL-6, the model predicts the growth of the diameter at subsequent times. Such a prediction can provide guidance to how closely the patient's abdominal aorta should be monitored. The mathematical model is represented by a system of partial differential equations taking place in the aortic wall, where the media is assumed to have the constituency of an hyperelastic material.	[Hao, Wenrui; Wu, Shuonan; Xu, Jinchao] Penn State Univ, Dept Math, State Coll, PA 16801 USA; [Gong, Shihua] Peking Univ, Beijing Int Ctr Math Res, Beijing, Peoples R China; [Go, Michael R.] Ohio State Univ, Div Vasc Dis & Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Zhu, Dai] Yunnan Cocreat Sci Comp & Datamining Ctr, Kunming, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Peking University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Penn State Univ, Dept Math, State Coll, PA 16801 USA.	wxh64@psu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	WH was a postdoctoral researcher at Mathematical Biosciences Institute at the time of the study and received financial support from the institution. WH and AF received funding from the National Science Foundation under Grant 0931642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2010, J VASC SURG, V51, P1479, DOI 10.1016/j.jvs.2010.01.057; Annabi B, 2002, J VASC SURG, V35, P539, DOI 10.1067/mva.2002.121124; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Bush RL, 2006, J AM COLL SURGEONS, V202, P577, DOI 10.1016/j.jamcollsurg.2006.01.005; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Filardo G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001835.pub3, 10.1002/14651858.CD001835.pub4]; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Galle C, 2005, CLIN EXP IMMUNOL, V142, P519, DOI 10.1111/j.1365-2249.2005.02938.x; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Grytsan A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029279; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Jones KG, 2001, CIRCULATION, V103, P2260; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; KOCH AE, 1993, AM J PATHOL, V142, P1423; Loppnow H, 1998, BLOOD, V91, P134, DOI 10.1182/blood.V91.1.134.134_134_141; LU ZY, 1995, BLOOD, V86, P3123; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; MCGREGOR JC, 1976, ANN ROY COLL SURG, V58, P388; Middleton RK, 2009, EUR J VASC ENDOVASC, V37, P46, DOI 10.1016/j.ejvs.2008.09.013; Moris D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925840; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Patel MI, 1996, J VASC SURG, V24, P82, DOI 10.1016/S0741-5214(96)70148-9; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; Schmid H, 2013, COMPUT METHOD BIOMEC, V16, P33, DOI 10.1080/10255842.2011.603309; Sule AA, 2010, INT J ANGIOL, V19, pE138, DOI 10.1055/s-0031-1278384; Takagi H, 2014, ANN VASC SURG, V28, P1913, DOI 10.1016/j.avsg.2014.06.058; Teixeira LK, 2005, J IMMUNOL, V175, P5931, DOI 10.4049/jimmunol.175.9.5931; Tian XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108105; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Veith Frank J, 2003, Semin Vasc Surg, V16, P171, DOI 10.1016/S0895-7967(03)00003-6; Volk T, 2000, MOL CELL BIOCHEM, V206, P105, DOI 10.1023/A:1007059616914; Volokh KY, 2011, J MECH BEHAV BIOMED, V4, P1582, DOI 10.1016/j.jmbbm.2011.01.002; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087; Wang Q, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-907; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; Watton PN, 2004, BIOMECH MODEL MECHAN, V3, P98, DOI 10.1007/s10237-004-0052-9; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724; Zelaya JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101353; 1998, LANCET, V352, P1649, DOI DOI 10.1016/S0140-6736(98)10137-X	48	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0170807	10.1371/journal.pone.0170807	http://dx.doi.org/10.1371/journal.pone.0170807			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212412	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424700002
J	Gerland, TA; Sun, B; Smialowski, P; Lukacs, A; Thomae, AW; Imhof, A				Gerland, Thomas Andreas; Sun, Bo; Smialowski, Pawel; Lukacs, Andrea; Thomae, Andreas Walter; Imhof, Axel			The Drosophila speciation factor HMR localizes to genomic insulator sites	PLOS ONE			English	Article							CHROMATIN INSULATOR; BINDING-SITES; DOSAGE COMPENSATION; CHIP DATA; MELANOGASTER; PROTEIN; GENE; HETEROCHROMATIN; SUPPRESSOR; CENTROMERE	Hybrid incompatibility between Drosophila melanogaster and D. simulans is caused by a lethal interaction of the proteins encoded by the Hmr and Lhr genes. In D. melanogaster the loss of HMR results in mitotic defects, an increase in transcription of transposable elements and a deregulation of heterochromatic genes. To better understand the molecular mechanisms that mediate HMR's function, we measured genome-wide localization of HMR in D. melanogaster tissue culture cells by chromatin immunoprecipitation. Interestingly, we find HMR localizing to genomic insulator sites that can be classified into two groups. One group belongs to gypsy insulators and another one borders HP1a bound regions at active genes. The transcription of the latter group genes is strongly affected in larvae and ovaries of Hmr mutant flies. Our data suggest a novel link between HMR and insulator proteins, a finding that implicates a potential role for genome organization in the formation of species.	[Gerland, Thomas Andreas; Sun, Bo; Smialowski, Pawel; Lukacs, Andrea; Thomae, Andreas Walter; Imhof, Axel] Ludwig Maximilians Univ Munchen, Biomed Ctr, Histone Modificat Grp, Dept Mol Biol, Planegg Martinsried, Germany; [Gerland, Thomas Andreas; Imhof, Axel] Ludwig Maximilians Univ Munchen, CIPSM, Munich, Germany; [Smialowski, Pawel] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Computat Biol, Planegg Martinsried, Germany; [Thomae, Andreas Walter] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Bioimaging, Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Imhof, A (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Histone Modificat Grp, Dept Mol Biol, Planegg Martinsried, Germany.; Imhof, A (corresponding author), Ludwig Maximilians Univ Munchen, CIPSM, Munich, Germany.	imhof@lmu.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Thomae, Andreas/0000-0003-3156-9075	Deutsche Forschungsgemeinschaft (DFG) [IM/9-1]; Chinese Scholarship Council	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Chinese Scholarship Council(China Scholarship Council)	The work was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG) to Andrea Lukacs (QBM) and Axel Imhof (IM/9-1). B. S. was funded by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD JP, 1992, P NATL ACAD SCI USA, V89, P4663, DOI 10.1073/pnas.89.10.4663; Andrews S, 2010, FATSQC QUALITY CONTR; Aruna S, 2009, GENETICS, V181, P1437, DOI 10.1534/genetics.108.100057; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Barth TK, 2014, PROTEOMICS, V14, P2167, DOI 10.1002/pmic.201400052; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Baxley RM, 2011, DEV BIOL, V356, P398, DOI 10.1016/j.ydbio.2011.05.666; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Bohla D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107765; Bolkan BJ, 2007, GENETICS, V177, P2233, DOI 10.1534/genetics.107.079939; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Brideau NJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-57; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Chen TW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-539; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dai HZ, 2008, P NATL ACAD SCI USA, V105, P7478, DOI 10.1073/pnas.0800693105; Emberly E, 2008, PLOS BIOL, V6, P2896, DOI 10.1371/journal.pbio.0060327; FRASCH M, 1986, J CELL SCI, V82, P155; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Golovnin A, 2003, DEVELOPMENT, V130, P3249, DOI 10.1242/dev.00543; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Hannon GJ, FASTX TOOLKITS FASTA; Heger P, 2013, EVOLUTION, V67, P2945, DOI 10.1111/evo.12155; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; KAMINKER JS, 2002, GENOME BIOL, V0003; Kelleher ES, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001428; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerat E, 2011, GENE, V473, P100, DOI 10.1016/j.gene.2010.11.009; Maheshwari S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002597; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ni XC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001420; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Olszak AM, 2011, NAT CELL BIOL, V13, P799, DOI 10.1038/ncb2272; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Padeken J, 2013, MOL CELL, P1; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parnell TJ, 2003, P NATL ACAD SCI USA, V100, P13436, DOI 10.1073/pnas.2333111100; Phadnis N, 2015, SCIENCE, V350, P1552, DOI 10.1126/science.aac7504; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Rodriguez MA, 2007, P NATL ACAD SCI USA, V104, P15412, DOI 10.1073/pnas.0707445104; Ross BD, 2013, SCIENCE, V340, P1211, DOI 10.1126/science.1234393; Roy S, 2007, GENETICS, V176, P801, DOI 10.1534/genetics.106.068056; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Satyaki PRV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004240; Sawamura Kyoichi, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/301894; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SPANA C, 1988, GENE DEV, V2, P1414, DOI 10.1101/gad.2.11.1414; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thomae AW, 2013, DEV CELL, V27, P412, DOI 10.1016/j.devcel.2013.10.001; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vieira C, 2004, GENETICA, V120, P115, DOI 10.1023/B:GENE.0000017635.34955.b5; Wei KHC, 2014, MOL BIOL EVOL, V31, P1767, DOI 10.1093/molbev/msu127; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang JP, 2012, GENOME RES, V22, P2199, DOI 10.1101/gr.142125.112; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	73	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171798	10.1371/journal.pone.0171798	http://dx.doi.org/10.1371/journal.pone.0171798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207793	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500054
J	Quinnies, KM; Harris, EP; Snyder, RW; Sumner, SS; Rissman, EF				Quinnies, Kayla M.; Harris, Erin P.; Snyder, Rodney W.; Sumner, Susan S.; Rissman, Emilie F.			Direct and transgenerational effects of low doses of perinatal di-(2-ethylhexyl) phthalate (DEHP) on social behaviors in mice	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; 1ST TRIMESTER PHTHALATE; BISPHENOL-A; DNA METHYLATION; IN-UTERO; ENVIRONMENTAL CHEMICALS; ENDOCRINE DISRUPTORS; LACTATIONAL EXPOSURE; ANOGENITAL DISTANCE; PUBERTAL EXPOSURE	Di-(2-ethylhexyl) phthalate (DEHP) is an endocrine disrupting chemical commonly used as a plasticizer in medical equipment, food packaging, flooring, and children's toys. DEHP exposure during early development has been associated with adverse neurobehavioral outcomes in children. In animal models, early exposure to DEHP results in abnormal development of the reproductive system as well as altered behavior and neurodevelopment. Based on these data, we hypothesized that developmental exposure to DEHP would decrease social interactions and increase anxiety-like behaviors in mice in a dose-dependent manner, and that the effects would persist over generations. C57BL/6J mice consumed one of three DEHP doses (0, 5, 40, and 400 mu g/kg body weight) throughout pregnancy and during the first ten days of lactation. The two higher doses yielded detectable levels of DEHP metabolites in serum. Pairs of mice from control, low, and high DEHP doses were bred to create three dose lineages in the third generation (F3). Average anogenital index (AGI: anogenital distance/body weight) was decreased in F1 males exposed to the low dose of DEHP and in F1 females exposed to the highest dose. In F1 mice, juvenile pairs from the two highest DEHP dose groups displayed fewer socially investigative behaviors and more exploratory behaviors as compared with control mice. The effect of DEHP on these behaviors was reversed in F3 mice as compared with F1 mice. F1 mice exposed to low and medium DEHP doses spent more time in the closed arms of the elevated plus maze than controls, indicating increased anxiety-like behavior. The generation-dependent effects on behavior and AGI suggest complex mechanisms by which DEHP directly impacts reproductive and neurobehavioral development and influences germline-inherited traits.	[Quinnies, Kayla M.; Harris, Erin P.; Rissman, Emilie F.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Quinnies, Kayla M.; Harris, Erin P.; Rissman, Emilie F.] Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA; [Snyder, Rodney W.; Sumner, Susan S.] RTI Int, Discovery Sci Technol, Res Triangle Pk, NC USA; [Sumner, Susan S.; Rissman, Emilie F.] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA	University of Virginia; University of Virginia; Research Triangle Institute; University of North Carolina; North Carolina State University	Rissman, EF (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.; Rissman, EF (corresponding author), Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA.; Rissman, EF (corresponding author), North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA.	e_rissman@ncsu.edu	Harris, Erin/T-7690-2019	Snyder, Rodney/0000-0001-5546-3158; Sumner, Susan/0000-0003-3381-6084; Harris, Erin/0000-0002-7710-732X	NIEHS [R01ES022759]; NIH Common Fund [U24DK097193];  [T32GM008328]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022759, P30ES025128] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS R01ES022759 (EFR), NIH Common Fund Grant U24DK097193 (SSS). EPH was supported in part by T32GM008328.	Adibi JJ, 2015, J CLIN ENDOCR METAB, V100, pE1216, DOI 10.1210/jc.2015-2370; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Araki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109039; Barrett ES, 2016, PAEDIATR PERINAT EP, V30, P105, DOI 10.1111/ppe.12264; Barrett ES, 2015, ENDOCRINOLOGY, V156, P3435, DOI 10.1210/en.2015-1335; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Bornehag CG, 2015, ENVIRON HEALTH PERSP, V123, P101, DOI 10.1289/ehp.1408163; Brummelte S, 2012, NEUROPHARMACOLOGY, V62, P406, DOI 10.1016/j.neuropharm.2011.08.017; Carbone S, 2013, HORM BEHAV, V63, P692, DOI 10.1016/j.yhbeh.2013.01.006; Chang YJ, 2013, CLIN CHIM ACTA, V420, P155, DOI 10.1016/j.cca.2012.10.009; Chen JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126403; Chourbaji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019218; Cottrell EC, 2014, ACTA PHYSIOL, V210, P288, DOI 10.1111/apha.12187; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Dobrzynska Malgorzata M, 2016, Rocz Panstw Zakl Hig, V67, P97; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Ejaredar M, 2015, ENVIRON RES, V142, P51, DOI 10.1016/j.envres.2015.06.014; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Hong D, 2009, BIOCHEM BIOPH RES CO, V389, P305, DOI 10.1016/j.bbrc.2009.08.134; Hopf NB, 2014, TOXICOL LETT, V224, P47, DOI 10.1016/j.toxlet.2013.10.004; Huen K, 2016, ENVIRON RES, V148, P55, DOI 10.1016/j.envres.2016.03.025; Jeddi MZ, 2016, ENVIRON RES, V151, P493, DOI 10.1016/j.envres.2016.08.021; Kardas F, 2016, J CHILD NEUROL, V31, P629, DOI 10.1177/0883073815609150; Katsikantami I, 2016, ENVIRON INT, V97, P212, DOI 10.1016/j.envint.2016.09.013; Kim S, 2015, SCI TOTAL ENVIRON, V508, P13, DOI 10.1016/j.scitotenv.2014.11.019; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; LaRocca J, 2014, ENVIRON RES, V133, P396, DOI 10.1016/j.envres.2014.04.032; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017; Li L, 2014, MOL BIOL REP, V41, P1227, DOI 10.1007/s11033-013-2967-7; Lien YJ, 2015, ENVIRON HEALTH PERSP, V123, P95, DOI 10.1289/ehp.1307154; Liu PY, 2010, AM J PHYSIOL-ENDOC M, V299, pE446, DOI 10.1152/ajpendo.00085.2010; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Martinez-Arguelles DB, 2013, J STEROID BIOCHEM, V137, P5, DOI 10.1016/j.jsbmb.2013.01.007; Martinez-Arguelles DB, 2016, ANDROLOGY, DOI 10.1016/j.reprotox.2012.09.006; McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002; Miodovnik A, 2014, NEUROTOXICOLOGY, V41, P112, DOI 10.1016/j.neuro.2014.01.007; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Park S, 2015, PSYCHOL MED, V45, P1601, DOI 10.1017/S0033291714002694; Park S, 2015, J CHILD NEUROL, V30, P48, DOI 10.1177/0883073814532544; Prados J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132136; Quinnies KM, 2015, ENDOCRINOLOGY, V156, P3077, DOI 10.1210/EN.2015-1326; Do RP, 2012, REPROD TOXICOL, V34, P614, DOI 10.1016/j.reprotox.2012.09.006; SINGH AR, 1975, J PHARM SCI-US, V64, P1347, DOI 10.1002/jps.2600640819; Singh S, 2012, INT J MOL SCI, V13, P10143, DOI 10.3390/ijms130810143; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Stein TP, 2013, J AUTISM DEV DISORD, V43, P2677, DOI 10.1007/s10803-013-1822-y; Stokes WS, 2004, ILAR J, V45, P387, DOI 10.1093/ilar.45.4.387; Swan SH, 2015, HUM REPROD, V30, P963, DOI 10.1093/humrep/deu363; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Wang DC, 2014, HORM BEHAV, V66, P674, DOI 10.1016/j.yhbeh.2014.09.010; Wang R, 2016, HORM BEHAV, V80, P117, DOI 10.1016/j.yhbeh.2016.01.012; Wang R, 2016, CHEMOSPHERE, V144, P1771, DOI 10.1016/j.chemosphere.2015.10.062; Wolstenholme JT, 2013, HORM BEHAV, V64, P833, DOI 10.1016/j.yhbeh.2013.09.007; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Wu SD, 2010, BASIC CLIN PHARMACOL, V106, P118, DOI 10.1111/j.1742-7843.2009.00483.x; Wu Y, 2014, J ENVIRON SCI-CHINA, V26, P1145, DOI 10.1016/S1001-0742(13)60504-5; Xu XH, 2015, CHEMOSPHERE, V124, P22, DOI 10.1016/j.chemosphere.2014.10.056; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Zhao BH, 2010, CHEM-BIOL INTERACT, V183, P79, DOI 10.1016/j.cbi.2009.09.014; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33449; Zhao Y, 2015, ENVIRON MOL MUTAGEN, V56, P286, DOI 10.1002/em.21916; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	73	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171977	10.1371/journal.pone.0171977	http://dx.doi.org/10.1371/journal.pone.0171977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199414	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400064
J	Hosoya, R; Uesawa, Y; Ishii-Nozawa, R; Kagaya, H				Hosoya, Ryuichiro; Uesawa, Yoshihiro; Ishii-Nozawa, Reiko; Kagaya, Hajime			Analysis of factors associated with hiccups based on the Japanese Adverse Drug Event Report database	PLOS ONE			English	Article							RECEPTOR; CATS; DEXAMETHASONE; STIMULATION; GENERATION; BIAS	Hiccups are occasionally experienced by most individuals. Although hiccups are not life threatening, they may lead to a decline in quality of life. Previous studies showed that hiccups may occur as an adverse effect of certain medicines during chemotherapy. Furthermore, a male dominance in hiccups has been reported. However, due to the limited number of studies conducted on this phenomenon, debate still surrounds the few factors influencing hiccups. The present study aimed to investigate the influence of medicines and patient characteristics on hiccups using a large-sized adverse drug event report database and, specifically, the Japanese Adverse Drug Event Report (JADER) database. Cases of adverse effects associated with medications were extracted from JADER, and Fisher's exact test was performed to assess the presence or absence of hiccups for each medication. In a multivariate analysis, we conducted a multiple logistic regression analysis using medication and patient characteristic variables exhibiting significance. We also examined the role of dexamethasone in inducing hiccups during chemotherapy. Medicines associated with hiccups included dexamethasone, levofolinate, fluorouracil, oxaliplatin, carboplatin, and irinotecan. Patient characteristics associated with hiccups included a male gender and greater height. The combination of anti-cancer agent and dexamethasone use was noted in more than 95% of patients in the dexamethasone-use group. Hiccups also occurred in patients in the anticancer agent-use group who did not use dexamethasone. Most of the medications that induce hiccups are used in chemotherapy. The results of the present study suggest that it is possible to predict a high risk of hiccups using patient characteristics. We confirmed that dexamethasone was the drug that has the strongest influence on the induction of hiccups. However, the influence of anti-cancer agents on the induction of hiccups cannot be denied. We consider the results of the present study to be helpful for the prevention and treatment of hiccups.	[Hosoya, Ryuichiro; Uesawa, Yoshihiro; Ishii-Nozawa, Reiko; Kagaya, Hajime] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose, Tokyo, Japan; [Hosoya, Ryuichiro] Japanese Red Cross Musashino Hosp, Dept Pharm, Musashino, Tokyo, Japan	Meiji Pharmaceutical University; Musashino RedCross Hospital	Uesawa, Y (corresponding author), Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose, Tokyo, Japan.	uesawa@my-pharm.ac.jp	, uesawa/AAA-1691-2020; Hosoya, Ryuichiro/AAU-8994-2020	Uesawa, Yoshihiro/0000-0002-5773-991X	KAKENHI from the Japan Society for the Promotion of Science [15K08111]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from the Japan Society for the Promotion of Science (Grant Number 15K08111). https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-15K08111/.	[Anonymous], 2014, PMDRS, V45, P98; ARITA H, 1994, NEUROSCI LETT, V175, P67, DOI 10.1016/0304-3940(94)91079-0; Avillach P, 2014, PHARMACOEPIDEM DR S, V23, P186, DOI 10.1002/pds.3454; Chen JJ, 2007, PHARMACOGENOMICS J, V7, P212, DOI 10.1038/sj.tpj.6500412; de Boissieu P, 2014, PHARMACOEPIDEM DR S, V23, P989, DOI 10.1002/pds.3622; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; GRUNBERG SM, 1993, NEW ENGL J MED, V329, P1790; Hayashi M., 2009, J PHARM HEALTH CARE, V35, P89, DOI [10.5649/jjphcs.35.89, DOI 10.5649/JJPHCS.35.89]; Hirooka T, 2012, DATABASE SAS USER GR, P263; JONES MV, 1995, J PHARMACOL EXP THER, V274, P962; Kitraki E, 2004, NEUROSCIENCE, V125, P47, DOI 10.1016/j.neuroscience.2003.12.024; KOLODZIK PW, 1991, ANN EMERG MED, V20, P565, DOI 10.1016/S0196-0644(05)81620-8; Kondo T, 2003, NEUROSCI RES, V47, P317, DOI 10.1016/S0168-0102(03)00225-6; Kondo T., 2005, J CLIN ANESTH, V29, P225; Lee GW, 2016, J PAIN SYMPTOM MANAG, V51, P278, DOI 10.1016/j.jpainsymman.2015.09.013; Lee GW, 2013, ONCOLOGIST, V18, P1229, DOI 10.1634/theoncologist.2013-0224; Liaw CC, 2005, J PAIN SYMPTOM MANAG, V30, P359, DOI 10.1016/j.jpainsymman.2005.08.008; MACDONALD RL, 1989, J PHYSIOL-LONDON, V417, P483, DOI 10.1113/jphysiol.1989.sp017814; Maeda R., 2014, JPN J PHARMACOEPIDEM, V19, P51, DOI [DOI 10.3820/JJPE.19.51, 10.3820/jjpe.19.51]; Nausheen F, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3034-3; OSHIMA T, 1994, J APPL PHYSIOL, V76, P1888, DOI 10.1152/jappl.1994.76.5.1888; Pariente A, 2012, DRUG SAFETY, V35, P855, DOI 10.2165/11631780-000000000-00000; Pharmaceuticals and Medical Devices Agency, 2014, GUID PHARM STUD SAF; Ray P, 2009, GEN HOSP PSYCHIAT, V31, P382, DOI 10.1016/j.genhosppsych.2008.09.014; Steger M, 2015, ALIMENT PHARM THER, V42, P1037, DOI 10.1111/apt.13374; Tamaoka A., 2005, BRAIN MED, V17, P133	26	31	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172057	10.1371/journal.pone.0172057	http://dx.doi.org/10.1371/journal.pone.0172057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196104	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900048
J	Klupp, E; Weidlich, D; Schlaeger, S; Baum, T; Cervantes, B; Deschauer, M; Kooijman, H; Rummeny, EJ; Zimmer, C; Kirschke, JS; Karampinos, DC				Klupp, Elisabeth; Weidlich, Dominik; Schlaeger, Sarah; Baum, Thomas; Cervantes, Barbara; Deschauer, Marcus; Kooijman, Hendrik; Rummeny, Ernst J.; Zimmer, Claus; Kirschke, Jan S.; Karampinos, Dimitrios C.			B1-insensitive T2 mapping of healthy thigh muscles using a T2-prepared 3D TSE sequence	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; STIMULATED ECHO COMPENSATION; SKELETAL-MUSCLE; TRANSVERSE RELAXOMETRY; RELAXATION-TIMES; T-2 PREPARATION; FAT-FRACTION; MRI; QUANTIFICATION; INVOLVEMENT	Purpose To propose a T2-prepared 3D turbo spin echo (T2prep 3D TSE) sequence for B1-insensitive skeletal muscle T2 mapping and compare its performance with 2D and 3D multi-echo spin echo (MESE) for T2 mapping in thigh muscles of healthy subjects. Methods The performance of 2D MESE, 3D MESE and the proposed T2prep 3D TSE in the presence of transmit B1 and B0 inhomogeneities was first simulated. The thigh muscles of ten young and healthy subjects were then scanned on a 3 T system and T2 mapping was performed using the three sequences. Transmit B1-maps and proton density fat fraction (PDFF) maps were also acquired. The subjects were scanned three times to assess reproducibility. T2 values were compared among sequences and their sensitivity to B1 inhomogeneities was compared to simulation results. Correlations were also determined between T2 values, PDFF and B1. Results The left rectus femoris muscle showed the largest B1 deviations from the nominal value (from 54.2% to 92.9%). Significant negative correlations between T2 values and B1 values were found in the left rectus femoris muscle for 3D MESE (r = -0.72, p<0.001) and 2D MESE (r = -0.71, p<0.001), but not for T2prep 3D TSE (r = -0.32, p = 0.09). Reproducibility of T2 expressed by root mean square coefficients of variation (RMSCVs) were equal to 3.5% in T2prep 3D TSE, 2.6% in 3D MESE and 2.4% in 2D MESE. Significant differences between T2 values of 3D sequences (T2prep 3D TSE and 3D MESE) and 2D MESE were found in all muscles with the highest values for 2D MESE (p<0.05). No significant correlations were found between PDFF and T2 values. Conclusion A strong influence of an inhomogeneous B1 field on the T2 values of 3D MESE and 2D MESE was shown, whereas the proposed T2prep 3D TSE gives B1-insensitive and reproducible thigh muscle T2 mapping.	[Klupp, Elisabeth; Schlaeger, Sarah; Zimmer, Claus; Kirschke, Jan S.] Tech Univ Munich, Inst Diagnost & Intervent Neuroradiol, Munich, Germany; [Weidlich, Dominik; Baum, Thomas; Cervantes, Barbara; Rummeny, Ernst J.; Karampinos, Dimitrios C.] Tech Univ Munich, Inst Diagnost & Intervent Radiol, Munich, Germany; [Deschauer, Marcus] Tech Univ Munich, Neurol Klin & Poliklin, Munich, Germany; [Kooijman, Hendrik] Philips Healthcare, Hamburg, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philips; Philips Healthcare	Klupp, E (corresponding author), Tech Univ Munich, Inst Diagnost & Intervent Neuroradiol, Munich, Germany.	Elisabeth.Klupp@tum.de	Baum, Thomas/M-6522-2014; Karampinos, Dimitrios C/A-5994-2011; Kirschke, Jan/E-2550-2012	Baum, Thomas/0000-0002-4574-5212; Karampinos, Dimitrios C/0000-0003-4922-3662; Kirschke, Jan/0000-0002-7557-0003	Philips Healthcare; European Research Council (ERC) under the European Unions Horizon research and innovation programme [637164, 677661]; German Research Foundation (DFG); Technical University of Munich (TUM)	Philips Healthcare; European Research Council (ERC) under the European Unions Horizon research and innovation programme(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This project has received funding from Philips Healthcare and the European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programme (GA No 637164 - iBack to J.S.K. and GA No 677661 - ProFatMRI to D.C.K.) and was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Azzabou N, 2015, EXP GERONTOL, V70, P54, DOI 10.1016/j.exger.2015.06.015; Azzabou N, 2015, J MAGN RESON IMAGING, V41, P645, DOI 10.1002/jmri.24613; Bydder M, 2011, MAGN RESON IMAGING, V29, P216, DOI 10.1016/j.mri.2010.08.011; Carlier PG, 2015, J INHERIT METAB DIS, V38, P565, DOI 10.1007/s10545-015-9825-9; Chen W, 2011, P 19 ANN M ISMRM MON; Coolen BF, 2014, MAGN RESON MED, V72, P409, DOI 10.1002/mrm.24952; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; Hogrel Jean-Yves, 2015, Age (Dordr), V37, P9798, DOI 10.1007/s11357-015-9798-5; HUANG YM, 1994, JMRI-J MAGN RESON IM, V4, P59, DOI 10.1002/jmri.1880040113; Karampinos DC, 2011, MAGN RESON MED, V66, P1312, DOI 10.1002/mrm.22925; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Lebel RM, 2010, MAGN RESON MED, V64, P1005, DOI 10.1002/mrm.22487; Li XJ, 2008, MAGN RESON MED, V59, P298, DOI 10.1002/mrm.21414; Maillard SM, 2004, RHEUMATOLOGY, V43, P603, DOI 10.1093/rheumatology/keh130; Marty B, 2016, NMR BIOMED, V29, P431, DOI 10.1002/nbm.3459; Mercuri E, 2002, NEUROPEDIATRICS, V33, P10, DOI 10.1055/s-2002-23593; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mugler JP, 2014, J MAGN RESON IMAGING, V39, P745, DOI 10.1002/jmri.24542; Nezafat R, 2006, MAGN RESON MED, V55, P858, DOI 10.1002/mrm.20835; Nguyen TD, 2015, MAGNETIC RESONANCE M; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Phoenix J, 1996, MUSCLE NERVE, V19, P302, DOI 10.1002/(SICI)1097-4598(199603)19:3<302::AID-MUS4>3.0.CO;2-H; Poliachik SL, 2012, PHYS MED REH CLIN N, V23, P107, DOI 10.1016/j.pmr.2011.11.016; POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Rooney WD PJ, 2011, P 19 ANN M ISMRM MON; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Wokke BH, 2015, T2 RELAXATION TIMES; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Yu W, 1995, OSTEOPOROSIS INT, V5, P433, DOI 10.1007/BF01626604	33	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171337	10.1371/journal.pone.0171337	http://dx.doi.org/10.1371/journal.pone.0171337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196133	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900016
J	Amjad, MS; Qaeem, MF; Ahmad, I; Khan, SU; Chaudhari, SK; Malik, NZ; Shaheen, H; Khan, AM				Amjad, Muhammad Shoaib; Qaeem, Mirza Faisal; Ahmad, Israr; Khan, Sami Ullah; Chaudhari, Sunbal Khalil; Malik, Nafeesa Zahid; Shaheen, Humaira; Khan, Arshad Mehmood			Descriptive study of plant resources in the context of the ethnomedicinal relevance of indigenous flora: A case study from Toli Peer National Park, Azad Jammu and Kashmir, Pakistan	PLOS ONE			English	Article							MEDICINAL-PLANTS; ETHNOBOTANICAL SURVEY; TRADITIONAL MEDICINE; HEALERS CONSENSUS; KNOWLEDGE; DISTRICT; PEOPLE; VALLEY; HILLS; COMMUNITIES	Background This paper presents the first quantitative ethnobotanical study of the flora in Toli Peer National Park of Azad Jammu and Kashmir, Pakistan. Being a remote area, there is a strong dependence by local people on ethnobotanical practices. Thus, we attempted to record the folk uses of the native plants of the area with a view to acknowledging and documenting the ethnobotanical knowledge. The aims of the study were to compile an inventory of the medicinal plants in the study area and to record the methods by which herbal drugs were prepared and administered. Materials and methods Information on the therapeutic properties of medicinal plants was collected from 64 local inhabitants and herbalists using open ended and semi-structured questionnaires over the period Aug 2013-Jul 2014. The data were recorded into a synoptic table comprising an ethnobotanical inventory of plants, the parts used, therapeutic indications and modes of application or administration. Different ethnobotanical indices i.e. relative frequencies of citation (RFC), relative importance (RI), use value (UV) and informant consensus factor (Fic), were calculated for each of the recorded medicinal plants. In addition, a correlation analysis was performed using SPSS ver. 16 to check the level of association between use value and relative frequency of citation. Results A total of 121 species of medicinal plants belonging to 57 families and 98 genera were recorded. The study area was dominated by herbaceous species (48%) with leaves (41%) as the most exploited plant part. The Lamiaceae and Rosaceae (9% each) were the dominant families in the study area. Among different methods of preparation, the most frequently used method was decoction (26 species) of different plant parts followed by use as juice and powder (24 species each), paste (22 species), chewing (16 species), extract (11 species), infusion (10 species) and poultice (8 species). The maximum Informant consensus factor (Fic) value was for gastro-intestinal, parasitic and hepatobiliary complaints (0.90). Berberis lycium Ajuga bracteosa, Prunella vulgaris, Adiantum capillus-veneris, Desmodium polycarpum, Pinus roxburgii, Albizia lebbeck, Cedrella serrata, Rosa brunonii, Punica granatum, Jasminum mesnyi and Zanthoxylum armatum were the most valuable plants with the highest UV, RFC and relative importance values. The Pearson correlation coefficient between UV and RFC (0.881) reflects a significant positive correlation between the use value and relative frequency of citation. The coefficient of determination indicated that 77% of the variability in UV could be explained in terms of RFC. Conclusion Systematic documentation of the medicinal plants in the Toli Peer National Park shows that the area is rich in plants with ethnomedicinal value and that the inhabitants of the area have significant knowledge about the use of such plants with herbal drugs commonly used to cure infirmities. The results of this study indicate that carrying out subsequent pharmacological and phytochemical investigations in this part of Pakistan could lead to new drug discoveries.	[Amjad, Muhammad Shoaib; Ahmad, Israr; Khan, Sami Ullah] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan; [Amjad, Muhammad Shoaib; Qaeem, Mirza Faisal; Chaudhari, Sunbal Khalil; Khan, Arshad Mehmood] Univ Arid Agr, PMAS, Dept Bot, Rawalpindi, Pakistan; [Malik, Nafeesa Zahid] Mirpur Univ Sci & Technol, Dept Bot, Mirpur, Pakistan; [Shaheen, Humaira] Comsat Gen Corp, Inst Informat Technol, Dept Biosci, Islamabad, Pakistan	Arid Agriculture University; COMSATS University Islamabad (CUI)	Amjad, MS (corresponding author), Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan.; Amjad, MS (corresponding author), Univ Arid Agr, PMAS, Dept Bot, Rawalpindi, Pakistan.	malikshoaib1165@yahoo.com	Khan, Arshad Mahmood/V-7426-2019; Amjad, Muhammad Shoaib/GQQ-1505-2022	Khan, Arshad Mahmood/0000-0003-0683-1553; Chaudhari, Sunbal Khalil/0000-0002-9590-3514	IDEA WILD USA; IDEA WILD of the U.S. Department of Agriculture; Women University of Azad Jammu Kashmir; PMAS-University of Arid Agriculture Rawalpindi, Pakistan	IDEA WILD USA; IDEA WILD of the U.S. Department of Agriculture; Women University of Azad Jammu Kashmir; PMAS-University of Arid Agriculture Rawalpindi, Pakistan	This work was supported by the The IDEA WILD USA (http://www.ideawild.org/). The IDEA WILD of the U.S. Department of Agriculture (http://www.sare.org/) provided research instrument and funding to carry out field survey. None of the current authors were Pls on the initial grants and the authors do not have a record of the grant numbers. Funding to support student research collaborators was received from Women University of Azad Jammu & Kashmir and PMAS-University of Arid Agriculture Rawalpindi, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-84; Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-66; Adzu B, 2003, ACTA TROP, V87, P245, DOI 10.1016/S0001-706X(03)00114-1; Ahmad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-36; Ahmed E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-13; Alam N, 2011, PAK J BOT, V43, P773; Albuquerque U. P., 2006, Ethnobotany Research and Applications, V4, P51; Ali H, 2009, PAK J BOT, V41, P2009; Ali S. I., 1993, FLORA PAKISTAN NOS 1; Amjad Muhammad Shoaib, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P292; Amjad Muhammad Shoaib, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P234, DOI 10.1016/S2221-1691(15)30011-3; Amjad Muhammad Shoaib, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P952; Ankli A, 1999, ECON BOT, V53, P144, DOI 10.1007/BF02866493; Arshad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-13; Bahar G., 2013, J ETHNOPHARMACOL, V146, P113, DOI DOI 10.1016/J.JEP.2012.12.012; Balick MJ, 1996, ANN MO BOT GARD, V83, P58, DOI 10.2307/2399968; Bano A, 2014, J ETHNOPHARMACOL, V155, P1046, DOI 10.1016/j.jep.2014.05.045; Bano A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-43; BASUALDO I, 1995, ECON BOT, V49, P387, DOI 10.1007/BF02863089; Baydoun S, 2015, J ETHNOPHARMACOL, V173, P139, DOI 10.1016/j.jep.2015.06.052; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Bibi T, 2014, J ETHNOPHARMACOL, V157, P79, DOI 10.1016/j.jep.2014.08.042; Bruni A, 1997, J ETHNOPHARMACOL, V57, P97, DOI 10.1016/S0378-8741(97)00055-X; Camou-Guerrero A, 2008, HUM ECOL, V36, P259, DOI 10.1007/s10745-007-9152-3; Chen GT, 2008, BIOMED CHROMATOGR, V22, P779, DOI 10.1002/bmc.1001; Edwards S, 2005, J ETHNOPHARMACOL, V100, P30, DOI 10.1016/j.jep.2005.05.026; El Amri J., 2015, J RES BIOL, V4, P1568; FAIZ AUH, 2014, BIOLOGIA-LAHORE, V60, P43; Farooq S., 2012, PAKISTAN J WEED SCI, V18, P277; Ghorbani A, 2005, J ETHNOPHARMACOL, V102, P58, DOI 10.1016/j.jep.2005.05.035; Ghorbani A, 2011, J ETHNOPHARMACOL, V134, P651, DOI 10.1016/j.jep.2011.01.011; Gonza T. M. R., 2008, J ETHNOPHARMACOL, V116, P341, DOI DOI 10.1016/J.JEP.2007.11.045; Hamayun M., 2005, ETHNOBOTANICAL PROFI; Han J, 2007, J PHARMACEUT BIOMED, V44, P430, DOI 10.1016/j.jpba.2007.02.023; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Heinrich M, 2009, J ETHNOPHARMACOL, V124, P1, DOI 10.1016/j.jep.2009.03.043; Husain SZ, 2008, PAK J BOT, V40, P1897; Ijaz F, 2016, J ETHNOPHARMACOL, V179, P208, DOI 10.1016/j.jep.2015.12.050; Islam MK, 2014, J ETHNOPHARMACOL, V151, P921, DOI 10.1016/j.jep.2013.11.056; JAIN S K, 1977, P157; Jamila F, 2014, J ETHNOPHARMACOL, V154, P76, DOI 10.1016/j.jep.2014.03.016; Jeruto P, 2008, J ETHNOPHARMACOL, V116, P370, DOI 10.1016/j.jep.2007.11.041; Kargioglu M, 2008, HUM ECOL, V36, P763, DOI 10.1007/s10745-008-9198-x; Kayani S, 2015, J ETHNOPHARMACOL, V164, P186, DOI 10.1016/j.jep.2015.02.004; Kayani S, 2014, J ETHNOPHARMACOL, V156, P47, DOI 10.1016/j.jep.2014.08.005; Khan M. A., 2012, Pakistan Journal of Weed Science Research, V18, P495; Khan M. A., 2010, Ethnobotany Research and Applications, V8, P107; Khan M. B., 2008, THESIS; Khan MPZ, 2015, J ETHNOPHARMACOL, V173, P191, DOI 10.1016/j.jep.2015.07.029; Khan SM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-4; Khatoon S., 2004, INT J BIOTECHNOLOGY, V1, P584; Kichu M, 2015, J ETHNOPHARMACOL, V166, P5, DOI 10.1016/j.jep.2015.02.053; Ladio A, 2007, J ARID ENVIRON, V69, P695, DOI 10.1016/j.jaridenv.2006.11.008; Leonti M, 2003, J ETHNOPHARMACOL, V88, P119, DOI 10.1016/S0378-8741(03)00188-0; Leonti M, 2011, J ETHNOPHARMACOL, V134, P542, DOI 10.1016/j.jep.2011.01.017; Lin J, 2002, J ETHNOPHARMACOL, V79, P53, DOI 10.1016/S0378-8741(01)00353-1; Madikizela B, 2012, J ETHNOPHARMACOL, V141, P61, DOI 10.1016/j.jep.2012.01.053; Mahmood A, 2011, J MED PLANTS RES, V5, P4493; Mahmood A, 2011, PAK J BOT, V43, P105; Mahmood AS, 2011, J APPL PHARM, V3, P212, DOI DOI 10.21065/19204159.3.212; Malla B, 2015, J ETHNOPHARMACOL, V165, P103, DOI 10.1016/j.jep.2014.12.057; Miraldi E, 2001, J ETHNOPHARMACOL, V75, P77, DOI 10.1016/S0378-8741(00)00381-0; Moerman Daniel, 1998, NATIVE AM ETHNOBOTAN; MOORE PD, 1994, NATURE, V372, P410, DOI 10.1038/372410a0; Mosaddegh M, 2012, J ETHNOPHARMACOL, V141, P80, DOI 10.1016/j.jep.2012.02.004; Muhammad Ishtiaq, 2012, African Journal of Biotechnology, V11, P3087; Mukheriee PK, 2006, J ETHNOPHARMACOL, V103, P25, DOI 10.1016/j.jep.2005.09.024; Mukherjee PK, 2012, J ETHNOPHARMACOL, V143, P424, DOI 10.1016/j.jep.2012.07.036; Murad W, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-77; Nasab FK, 2014, J ETHNOPHARMACOL, V154, P190, DOI 10.1016/j.jep.2014.04.003; Nasir E., 1970, FLORA PAKISTAN ISLAM; Nondo R. S. O., 2015, Journal of Medicinal Plants Research, V9, P179; Qureshi R, 2001, PAKISTAN J BOT, V33, P109; Qureshi R., 2002, HAMDARD MED, V45, P86; Qureshi R, 2008, FITOTERAPIA, V79, P468, DOI 10.1016/j.fitote.2008.03.010; ROBINSON T, 1974, SCIENCE, V184, P430, DOI 10.1126/science.184.4135.430; Sadeghi Z, 2014, J ETHNOPHARMACOL, V153, P111, DOI 10.1016/j.jep.2014.01.007; Safa O, 2012, AVICENNA J PHYTOMEDI, V3, P64; Savikin K, 2013, J ETHNOPHARMACOL, V146, P803, DOI 10.1016/j.jep.2013.02.006; Schlage C, 2000, PLANT BIOLOGY, V2, P83, DOI 10.1055/s-2000-296; Schoene RB, 1999, LUNG DIS HIGH ALTITU, P47; Shaheen H, 2012, PAK J BOT, V44, P739; Shinwari ZK, 2010, J MED PLANTS RES, V4, P161; Siew YY, 2014, J ETHNOPHARMACOL, V155, P1450, DOI 10.1016/j.jep.2014.07.024; Singh H, 2014, J ETHNOPHARMACOL, V154, P98, DOI 10.1016/j.jep.2014.03.026; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Tangjitman K, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0011-9; Thirumalai T., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS910; Trotter I. I. R. T., 1986, PLANTS INDIGENOUS ME; Ullah R, 2010, J MED PLANTS RES, V4, P1815; Vijayakumar S, 2015, J ETHNOPHARMACOL, V161, P238, DOI 10.1016/j.jep.2014.12.006; Vitalini S, 2013, J ETHNOPHARMACOL, V145, P517, DOI 10.1016/j.jep.2012.11.024; Zhang JL, 2005, J PHARMACEUT BIOMED, V36, P1029, DOI 10.1016/j.jpba.2004.09.009	93	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171896	10.1371/journal.pone.0171896	http://dx.doi.org/10.1371/journal.pone.0171896			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192466	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800048
J	Behbehani, R; Abu Al-Hassan, A; Al-Salahat, A; Sriraman, D; Oakley, JD; Alroughani, R				Behbehani, Raed; Abu Al-Hassan, Abdullah; Al-Salahat, Ali; Sriraman, Devarajan; Oakley, J. D.; Alroughani, Raed			Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis	PLOS ONE			English	Article							FIBER LAYER THICKNESS; PATHOLOGY; NEURITIS; MS	Introduction Optical coherence tomography (OCT) with retinal segmentation analysis is a valuable tool in assessing axonal loss and neuro-degeneration in multiple sclerosis ( MS) by in-vivo imaging, delineation and quantification of retinal layers. There is evidence of deep retinal involvement in MS beyond the inner retinal layers. The ultra-structural retinal changes in MS in different MS phenotypes can reflect differences in the pathophysiologic mechanisms. There is limited data on the pattern of deeper retinal layer involvement in progressive MS (PMS) versus relapsing remitting MS (RRMS). We have compared the OCT segmentation analysis in patients with relapsing-remitting MS and progressive MS. Methods Cross-sectional study of 113 MS patients (226 eyes) (29 PMS, 84 RRMS) and 38 healthy controls (72 eyes). Spectral domain OCT (SDOCT) using the macular cube acquisition protocol (Cirrus HDOCT 5000; Carl Zeiss Meditec) and segmentation of the retinal layers for quantifying the thicknesses of the retinal layers. Segmentation of the retinal layers was carried out utilizing Orion software (Voxeleron, USA) for quantifying the thicknesses of individual retinal layers. Results The retinal nerve finer layer (RNFL) (p = 0.023), the ganglion-cell/inner plexiform layer (GCIPL) (p = 0.006) and the outer plexiform layer (OPL) (p = 0.033) were significantly thinner in PMS compared to RRMS. There was significant negative correlation between the outer nuclear layer (ONL) and EDSS (r = -0.554, p = 0.02) in PMS patients. In RRMS patients with prior optic neuritis, the GCIPL correlated negatively (r = -0.317; p = 0.046), while the photoreceptor layer (PR) correlated positively with EDSS (r = 0.478; p = 0.003). Conclusions Patients with PMS exhibit more atrophy of both the inner and outer retinal layers than RRMS. The ONL in PMS and the GCIPL and PR in RRMS can serve as potential surrogate of disease burden and progression (EDSS). The specific retinal layer predilection and its correlation with disability may reflect different pathophysiologic mechanisms and various stages of progression in MS.	[Behbehani, Raed; Abu Al-Hassan, Abdullah; Al-Salahat, Ali] Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait; [Behbehani, Raed; Alroughani, Raed] Dasman Inst, Neurol Clin, Dasman, Kuwait; [Sriraman, Devarajan] Dasman Inst, Natl Dasman Diabet Biobank, Dasman, Kuwait; [Oakley, J. D.] Voxeleron LLC, Pleasanton, CA USA; [Alroughani, Raed] Amiri Hosp, Div Neurol, Sharq, Kuwait		Behbehani, R (corresponding author), Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Kuwait, Kuwait.; Behbehani, R (corresponding author), Dasman Inst, Neurol Clin, Dasman, Kuwait.	raed.behbehani@dasmaninstitute.org	Behbehani, Raed/CAF-0180-2022	BEHBEHANI, RAED/0000-0002-6633-3567; AL-SALAHAT, ALI/0000-0003-4047-0835				Al-Louzi OA, 2016, MULT SCLER J, V22, P362, DOI 10.1177/1352458515590646; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Balk LJ, 2014, MULT SCLER J, V20, P1198, DOI 10.1177/1352458513518626; Balk L. J., 2016, J NEUROL; Behbehani R, 2015, J NEUROL SCI, V359, P305, DOI 10.1016/j.jns.2015.11.017; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Gelfand JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036847; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Isobe N, 2013, GENES IMMUN, V14, P434, DOI 10.1038/gene.2013.37; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; PAPAKOSTOPOULOS D, 1989, ELECTROEN CLIN NEURO, V74, P1, DOI 10.1016/0168-5597(89)90045-2; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Ratchford JN, 2013, NEUROLOGY, V80, P47, DOI 10.1212/WNL.0b013e31827b1a1c; Rovaris M, 2001, BRAIN, V124, P2540, DOI 10.1093/brain/124.12.2540; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tremlett H, 2010, NEUROLOGY, V74, P2004, DOI 10.1212/WNL.0b013e3181e3973f; Weinshenker BG, 1996, NEUROLOGY, V46, P1613, DOI 10.1212/WNL.46.6.1613	24	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172120	10.1371/journal.pone.0172120	http://dx.doi.org/10.1371/journal.pone.0172120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192539	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800072
J	Neelofar, K; Arif, Z; Ahmad, J; Alam, K				Neelofar, Km; Arif, Zarina; Ahmad, Jamal; Alam, Khursheed			Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study	PLOS ONE			English	Article							DIABETES-MELLITUS; PROTEIN GLYCATION; MODIFIED DNA; PEROXYNITRITE; ANTIBODIES; IMMUNOGENICITY	Hyperglycaemia induced non enzymatic glycation is accelerated in diabetic patients and aggressively involved in diabetes progression. Human serum albumin (HSA) is the most abundant protein in blood circulation. In hyperglycaemia, it undergoes fast glycation and results in the impairment of structure. Our previous study has demonstrated structural alterations in Amadori-albumin modified with different glucose concentrations from physiological to pathophysiological range. Here, we focused on immunological characterization of Amadori- albumin. Immunogenicity of Amadori-albumin was analysed by direct binding and competitive ELISA. Amadori-albumin was found to be highly immunogenic (expect albumin modified with 5mM) and induced high titre antibodies depending upon the extent of modification. Very high titre antibodies were obtained with albumin modified with 75mM glucose as compared to native albumin. Anti-Amadori-albumin-IgG from rabbit sera exhibited increased recognition of Amadori-albumin than native albumin in competitive immunoassay. Alteration induced in albumin after glucosylation has made it highly immunogenic. Induced antibodies were quite specific for respective immunogens but showed cross-reaction with other Amadori/native proteins. It suggests that glucosylation has generated highly immunogenic epitopes on albumin. Formation of high molecular weight immune complex with retarded mobility further supports specificity of anti-Amadori-albumin-IgG towards Amadori-albumin. It may be concluded that due to early glycation, an array of modification occurred in HSA structure. Such gross structural changes might favour polymerization of most of the native epitopes into potent immunogenic neo-epitopes, but some original epitopes were still active and has contributed in the immunogenicity. It could be concluded that induction of anti-Amadori-albumin antibodies may be due to protection of glucose modified albumin from protiolytic breakdown. We assumed that this type of protein modifications might occur in diabetic patients in hyperglycaemic conditions that may be recognised as foreign molecules and can induce autoantibodies. Increased level of anti-Amadori-albumin autoantibodies may be used as a biomarker in disease diagnosis and its progression.	[Neelofar, Km; Ahmad, Jamal] Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India; [Arif, Zarina; Alam, Khursheed] Aligarh Muslim Univ, Dept Biochem, JN Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Neelofar, K (corresponding author), Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India.	neloferbiotech@gmail.com	Arif, Zarina/AAI-4441-2020	Arif, Zarina/0000-0002-8895-353X; Alam, Khursheed/0000-0001-9729-9966	Indian Council of Medical Research, New Delhi	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This study was supported by senior research fellowship (SRF) from the Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2013, INT J BIOL MACROMOL, V59, P349, DOI 10.1016/j.ijbiomac.2013.04.068; Alam K, 2007, CELL IMMUNOL, V247, P12, DOI 10.1016/j.cellimm.2007.06.007; Ali Rashid, 2002, Methods Mol Biol, V186, P171; Ansari NA, 2013, AGING DIS, V4, P50; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Arif B, 2012, ARCH BIOCHEM BIOPHYS, V522, P17, DOI 10.1016/j.abb.2012.04.005; Bustin M, 1972, J BIOL CHEM, V57, P16; Chesne S, 2006, BIOCHIMIE, V88, P1467, DOI 10.1016/j.biochi.2006.05.011; COHEN MP, 1994, KIDNEY INT, V45, P475, DOI 10.1038/ki.1994.62; Coussons PJ, 1997, FREE RADICAL BIO MED, V22, P1217, DOI 10.1016/S0891-5849(96)00557-6; DAY JF, 1979, J BIOL CHEM, V254, P595; Dixit K, 2004, LUPUS, V13, P95, DOI 10.1191/0961203304lu492oa; DOYEN N, 1985, MOL IMMUNOL, V22, P1, DOI 10.1016/0161-5890(85)90028-8; Elaheh R, 2015, J BIOMOL STRU DYN, V33, P513; Fatemeh PZ, 2014, J BIOMOL STRU DYN, V32, P613; GUTHROW CE, 1979, P NATL ACAD SCI USA, V76, P4258, DOI 10.1073/pnas.76.9.4258; Habib S, 2005, INT J BIOL MACROMOL, V35, P221, DOI 10.1016/j.ijbiomac.2005.02.005; Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645; Joseph L, 1983, MED SCI, V80, P2757; Khan MA, 2009, SCAND J IMMUNOL, V69, P99, DOI 10.1111/j.1365-3083.2008.02200.x; Khan MWA, 2010, INT ARCH ALLERGY IMM, V153, P207, DOI 10.1159/000312639; Maryam MM, 2014, LUMINESCENCE, V29, P314, DOI [10.1002/bio.2546, DOI 10.1002/BIO.2546]; Monnier VM, 2008, ANN NY ACAD SCI, V1126, P81, DOI 10.1196/annals.1433.052; Neelofar, 2015, RSC ADV, V5, P63605, DOI 10.1039/c5ra07232h; Neelofar K, 2016, MOL BIOSYST, V12, P2481, DOI 10.1039/c6mb00324a; Rondeau P, 2008, FREE RADIC BIOL MED, V132, P171; Schalkwijk CG, 1999, DIABETES, V48, P2446, DOI 10.2337/diabetes.48.12.2446; Smith EB, 1982, ATHEROSCLERO, V37, P579; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172074	10.1371/journal.pone.0172074	http://dx.doi.org/10.1371/journal.pone.0172074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192530	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800066
J	Nwosu, BU; Maranda, L; Candela, N				Nwosu, Benjamin Udoka; Maranda, Louise; Candela, Ninfa			Vitamin D status in pediatric irritable bowel syndrome	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D DEFICIENCY; DEPRESSIVE SYMPTOMS; 25-HYDROXYVITAMIN D; ASSOCIATION; CHILDREN; DISEASE; HEALTH; SERUM; ADOLESCENTS	Importance Irritable bowel syndrome (IBS) is associated with significant morbidity in children and adolescents, and the therapeutic efficacy of available treatment options is limited. The role of vitamin D supplementation in pediatric IBS is unclear as the vitamin D status of pediatric patients with IBS is unknown. Equally, the relationship of vitamin D status with psychosomatic symptoms in children and adolescents is unclear. Aim To characterize the vitamin D status of pediatric patients with IBS using a case-control study design. Hypothesis Serum 25-hydroxyvitamin D [25(OH)D] concentration will be similar between patients with IBS and controls. Subjects and methods A retrospective case-controlled study of 116 controls (age 14.6 +/- 4.3 y), female (n = 67; 58%) and 55 subjects with IBS (age 16.5 +/- 3.1y), female (n = 44; 80%). Overweight was defined as BMI of >= 85th but <= 95th percentile, and obesity as BMI >95th percentile. Vitamin D deficiency was defined as 25(OH)D of <50 nmol/L, while seasons of vitamin D draw were categorized as summer, winter, spring, and fall. Major psychosomatic manifestations included in the analysis were depression, anxiety, and migraine. Results More than 50% of IBS subjects had vitamin D deficiency at a cut-off point of <50 nmol/L (53% vs. 27%, p = 0.001); and >90% of IBS subjects had vitamin D deficiency at a cut-off point of <75 nmol/L (93% vs. 75%, p = 0.006). IBS subjects had significantly lower mean 25(OH)D: 53.2 +/- 15.8 nmol/L vs. 65.2 +/- 28.0 nmol/L, p = 0.003; and albumin: 6.2 +/- 0.6 vs. 6.5 +/- 0.6 pmol/L, p = 0.0.01. IBS subjects with migraine had significantly lower mean 25 (OH)D concentration compared to controls (p = 0.01). BMI z -score was similar between the controls and IBS subjects (0.5 +/- 1.4 vs. 1.2 +/- 2.9, p = 0.11). Conclusions Pediatric patients with IBS had significantly lower 25(OH)D concentration compared to controls despite having similar mean BMI values as controls. Only 7% of the children and adolescents with IBS were vitamin D sufficient, and >50% of the subjects with IBS had vitamin D deficiency. This is a much higher prevalence of vitamin D deficiency compared to IBD and other malabsorption syndromes. Monitoring for vitamin D deficiency should be part of the routine care for patients with IBS. Randomized control trials are warranted to determine the role of adjunctive vitamin D therapy in pediatric IBS.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Candela, Ninfa] Univ Massachusetts, Sch Med, Dept Pediat, Div Gastroenterol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org		Nwosu, Benjamin/0000-0003-2212-0276				Abbasnezhad A, 2016, NEUROGASTROENT MOTIL, V28, P1533, DOI 10.1111/nmo.12851; Abbasnezhad A, 2016, NEUROGASTROENTEROL M; Acosta A, 2015, EXPERT OPIN DRUG MET, V11, P1187, DOI 10.1517/17425255.2015.1048223; Ataie-Jafari A, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0191-9; Bohn L, 2013, NEUROGASTROENT MOTIL, V25, P23, DOI 10.1111/nmo.12001; Bours PHA, 2011, OSTEOPOROSIS INT, V22, P2857, DOI 10.1007/s00198-010-1484-y; Buettner C, 2015, CEPHALALGIA, V35, P757, DOI 10.1177/0333102414559733; Cheng H, 2016, J PSYCHOSOM RES, V88, P54, DOI 10.1016/j.jpsychores.2016.07.012; Chirila I, 2012, J GASTROINTEST LIVER, V21, P357; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; El-Matary W, 2011, DIGEST DIS SCI, V56, P825, DOI 10.1007/s10620-010-1380-5; Fletcher PC, 2006, CLIN NURSE SPEC, V20, P241, DOI 10.1097/00002800-200609000-00011; Gibson PR, 2011, J GASTROEN HEPATOL, V26, P128, DOI 10.1111/j.1440-1746.2011.06650.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Goodhand JR, 2012, ALIMENT PHARM THER, V35, P929, DOI 10.1111/j.1365-2036.2012.05043.x; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Guo YB, 2015, GUT LIVER, V9, P649, DOI 10.5009/gnl13437; Hayes P, 2014, J HUM NUTR DIET, V27, P36, DOI 10.1111/jhn.12114; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; Hogberg G, 2012, ACTA PAEDIATR, V101, P779, DOI 10.1111/j.1651-2227.2012.02655.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Jones KS, 2014, J CLIN ENDOCR METAB, V99, P3373, DOI 10.1210/jc.2014-1714; Khayyat Yasir, 2015, Oman Med J, V30, P115, DOI 10.5001/omj.2015.25; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Levin AD, 2011, DIGEST DIS SCI, V56, P830, DOI 10.1007/s10620-010-1544-3; Margulies SL, 2015, J DIGEST DIS, V16, P617, DOI 10.1111/1751-2980.12283; Middleton JP, 2013, J PEDIATR GASTR NUTR, V57, P587, DOI 10.1097/MPG.0b013e31829e0b89; Pappa HM, 2006, INFLAMM BOWEL DIS, V12, P1162, DOI 10.1097/01.mib.0000236929.74040.b0; Pappa HM, 2006, PEDIATRICS, V118, P1950, DOI 10.1542/peds.2006-0841; Pappa HM, 2011, J PEDIATR GASTR NUTR, V53, P361, DOI 10.1097/MPG.0b013e3182250b3e; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; Saps M, 2016, NEUROGASTROENT MOTIL, V28, P1619, DOI 10.1111/nmo.12896; Setty-Shah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078653; Sikoglu EM, 2015, J CHILD ADOL PSYCHOP, V25, P415, DOI 10.1089/cap.2014.0110; Skaaby T, 2013, ENDOCRINE; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Smith BA, 2014, PSYCHOSOMATICS, V55, P76, DOI 10.1016/j.psym.2013.01.012; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Sprake EF, 2012, BMJ CASE REPORTS, V2012; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Tazzyman S, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000052; Tolppanen AM, 2012, J CHILD PSYCHOL PSYC, V53, P757, DOI 10.1111/j.1469-7610.2011.02518.x; Veit LE, 2015, NUTRITION, V31, P994, DOI 10.1016/j.nut.2015.03.010; Veit LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101583; Veit LE, 2015, NUTRITION IN PRESS; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Zender R, 2009, NURS CLIN N AM, V44, P355, DOI 10.1016/j.cnur.2009.06.002	53	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172183	10.1371/journal.pone.0172183	http://dx.doi.org/10.1371/journal.pone.0172183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192499	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800082
J	Suarez-Garcia, S; del Bas, JM; Caimari, A; Escorihuela, RM; Arola, L; Suarez, M				Suarez-Garcia, Susana; del Bas, Josep M.; Caimari, Antoni; Escorihuela, Rosa M.; Arola, Lluis; Suarez, Manuel			Impact of a cafeteria diet and daily physical training on the rat serum metabolome	PLOS ONE			English	Article							INSULIN-RESISTANCE; ALPHA-TOCOPHEROL; AEROBIC EXERCISE; ACTIVATED RECEPTOR; GAMMA-TOCOPHEROL; ADIPOSE-TISSUE; OBESE CHILDREN; POTENTIAL ROLE; OLDER-ADULTS; FEMALE RATS	Regular physical activity and healthy dietary patterns are commonly recommended for the prevention and treatment of metabolic syndrome (MetS), which is diagnosed at an alarmingly increasing rate, especially among adolescents. Nevertheless, little is known regarding the relevance of physical exercise on the modulation of the metabolome in healthy people and those with MetS. We have previously shown that treadmill exercise ameliorated different symptoms of MetS. The aim of this study was to investigate the impact of a MetS-inducing diet and different intensities of aerobic training on the overall serum metabolome of adolescent rats. For 8 weeks, young rats were fed either standard chow (ST) or cafeteria diet (CAF) and were subjected to a daily program of training on a treadmill at different speeds. Non-targeted metabolomics was used to identify changes in circulating metabolites, and a combination of multivariate analysis techniques was implemented to achieve a holistic understanding of the metabolome. Among all the identified circulating metabolites influenced by CAF, lysophosphatidylcholines were the most represented family. Serum sphingolipids, bile acids, acylcarnitines, unsaturated fatty acids and vitamin E and A derivatives also changed significantly in CAF-fed rats. These findings suggest that an enduring systemic inflammatory state is induced by CAF. The impact of physical training on the metabolome was less striking than the impact of diet and mainly altered circulating bile acids and glycerophospholipids. Furthermore, the serum levels of monocyte chemoattractant protein-1 were increased in CAF-fed rats, and C-reactive protein was decreased in trained groups. The leptin/adiponectin ratio, a useful marker of MetS, was increased in CAF groups, but decreased in proportion to training intensity. Multivariate analysis revealed that ST-fed animals were more susceptible to exercise-induced changes in metabolites than animals with MetS, in which moderate-intensity seems more effective than high-intensity training. Our results indicate that CAF has a strong negative impact on the metabolome of animals that is difficult to reverse by daily exercise.	[Suarez-Garcia, Susana; Arola, Lluis; Suarez, Manuel] Univ Rovira & Virgili, Nutrigenom Res Grp, Dept Bioquim & Biotecnol, Tarragona, Spain; [del Bas, Josep M.; Caimari, Antoni; Arola, Lluis] EURECAT Technol Ctr Catalonia, Technol Unit Nutr & Hlth, Reus, Spain; [Escorihuela, Rosa M.] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Inst Neurociencies, Barcelona, Spain	Universitat Rovira i Virgili; Autonomous University of Barcelona	Arola, L (corresponding author), Univ Rovira & Virgili, Nutrigenom Res Grp, Dept Bioquim & Biotecnol, Tarragona, Spain.; Arola, L (corresponding author), EURECAT Technol Ctr Catalonia, Technol Unit Nutr & Hlth, Reus, Spain.	lluis.arola@urv.cat	Arola, Lluís/C-6074-2011; Escorihuela, Rosa M/L-4524-2014; del Bas, Josep M/K-2327-2014; Suárez-García, Susana/AAI-5703-2021; del Bas, Josep Maria/K-9310-2019; Recio, Manuel Suarez/F-5039-2016	Arola, Lluís/0000-0003-2767-1974; Escorihuela, Rosa M/0000-0001-9368-5173; del Bas, Josep M/0000-0002-0700-2004; Suárez-García, Susana/0000-0001-9482-5078; del Bas, Josep Maria/0000-0002-0700-2004; Recio, Manuel Suarez/0000-0003-0122-8253; Caimari, Antoni/0000-0001-6144-0294	Spanish Ministry of Economy and Competitiveness [AGL2013-40707-R, PSI 2011-29807-C02/PSIC]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	Support was provided by the Spanish Ministry of Economy and Competitiveness PSI 2011-29807-C02/PSIC to Rosa Maria Escorihuela, and by the Spanish Ministry of Economy and Competitiveness AGL2013-40707-R to Lluis Arola.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Auge N, 2000, PROG LIPID RES, V39, P207, DOI 10.1016/S0163-7827(00)00007-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bispo K., 2014, J FOOD NUTR DISORD, V3, P4; Bollard ME, 2001, ANAL BIOCHEM, V295, P194, DOI 10.1006/abio.2001.5211; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brozinick JT, 2013, INT J OBESITY, V37, P1064, DOI 10.1038/ijo.2012.191; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Campbell PT, 2009, MED SCI SPORT EXER, V41, P1533, DOI 10.1249/MSS.0b013e31819c7feb; CATHCART MK, 1985, J LEUKOCYTE BIOL, V38, P341, DOI 10.1002/jlb.38.2.341; Cigarroa I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153687; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Bas JM, 2016, IMPAIRMENT LYSOPHOSP, P1; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848; Donges CE, 2010, MED SCI SPORT EXER, V42, P304, DOI 10.1249/MSS.0b013e3181b117ca; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garvey SM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12319; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Gilardini L, 2006, ATHEROSCLEROSIS, V189, P401, DOI 10.1016/j.atherosclerosis.2005.12.021; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; HALEVY O, 1987, BIOCHIM BIOPHYS ACTA, V918, P304, DOI 10.1016/0005-2760(87)90235-9; Hardwick JP, 2013, ADV PHARMACOL, V66, P157, DOI 10.1016/B978-0-12-404717-4.00005-6; Heemskerk MM, 2015, NUTRIENTS, V7, P7676, DOI 10.3390/nu7095362; Heimerl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111348; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOPE WC, 1975, PROSTAGLANDINS, V10, P557, DOI 10.1016/S0090-6980(75)80002-5; Hrabovsky V, 2009, WIEN KLIN WOCHENSCHR, V121, P270, DOI 10.1007/s00508-009-1150-6; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Jedrychowski MP, 2015, CELL METAB, P1; Jialal I, 2001, J NUTR, V131, p389S, DOI 10.1093/jn/131.2.389S; Jiang Q, 2003, FASEB J, V17, P816, DOI 10.1096/fj.02-0877com; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kohut ML, 2006, BRAIN BEHAV IMMUN, V20, P201, DOI 10.1016/j.bbi.2005.12.002; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lalanza JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16166; Lalanza JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085049; Lavoie JM, 2016, WORLD J HEPATOL, V8, P961, DOI 10.4254/wjh.v8.i23.961; LIPID MAPS, 2010, LIP NAT LIP GAT 2010; Liu J, 2015, EUR REV MED PHARMACO, V19, P2168; MARTIN JE, 1990, CIRCULATION, V81, P1560, DOI 10.1161/01.CIR.81.5.1560; Martinez-Micaelo N, 2015, J FUNCT FOODS, V15, P61, DOI 10.1016/j.jff.2015.02.017; Memon RA, 2001, J BIOL CHEM, V276, P30118, DOI 10.1074/jbc.M102516200; Memon RA, 1998, ARTERIOSCL THROM VAS, V18, P1257, DOI 10.1161/01.ATV.18.8.1257; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Penno G, 2006, PHARMACOL RES, V53, P457, DOI 10.1016/j.phrs.2006.03.010; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Pruzanski W, 2015, INFLAMM RES, V64, P497, DOI 10.1007/s00011-015-0830-0; Ravipati S, 2015, METABOLOMICS, V11, P1600, DOI 10.1007/s11306-015-0811-x; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sakurai T, 2009, BIOCHEM BIOPH RES CO, V379, P605, DOI 10.1016/j.bbrc.2008.12.127; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Suizdak G, 2010, ABAGYAN LAB; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Troseid M, 2004, EUR HEART J, V25, P349, DOI 10.1016/j.ehj.2003.12.006; Valle M, 2005, DIABETES METAB, V31, P55, DOI 10.1016/S1262-3636(07)70167-2; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Wang Y, 2016, BIOMED CHROMATOGR, V30, P48, DOI 10.1002/bmc.3491; Weber LW, 2004, WORLD J GASTROENTERO, V10, P3081, DOI 10.3748/wjg.v10.i21.3081; Wishart D, 2009, HMDB HUMAN METABOLOM; Yao K, 2016, TRENDS PHARMACOL SCI, V37, P714, DOI 10.1016/j.tips.2016.05.004; Yoon JH, 2011, CLIN CHIM ACTA, V412, P2199, DOI 10.1016/j.cca.2011.08.003; Zeeni N, 2015, INFLAMM RES, V64, P501, DOI 10.1007/s00011-015-0831-z; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126952; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	80	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171970	10.1371/journal.pone.0171970	http://dx.doi.org/10.1371/journal.pone.0171970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192465	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800055
J	Unachukwu, U; Trischler, J; Goldklang, M; Xiao, R; D'Armiento, J				Unachukwu, Uchenna; Trischler, Jordis; Goldklang, Monica; Xiao, Rui; D'Armiento, Jeanine			Maternal smoke exposure decreases mesenchymal proliferation and modulates Rho-GTPase-dependent actin cytoskeletal signaling in fetal lungs	FASEB JOURNAL			English	Article						apoptosis; cigarette smoke; in utero; proliferation; Wnt/beta-catenin	ENDOTHELIAL BARRIER FUNCTION; FRIZZLED-RELATED PROTEIN-1; PARENTAL SMOKING; IN-VITRO; RNA-SEQ; GROWTH; PREGNANCY; MORPHOGENESIS; EMPHYSEMA; TOBACCO	The present study tested the hypothesis that maternal smoke exposure results in fetal lung growth retardation due to dysregulation in various signaling pathways, including the Wnt (wingless-related integration site)/beta-catenin pathway. Pregnant female C57BL/6J mice were exposed to cigarette smoke (100-150mg/m(3)) or room air, and offspring were humanely killed on 12.5, 14.5, 16.5, and 18.5 d post coitum (dpc). We assessed lung stereology with Cavalieri estimation; apoptosis with proliferating cell nuclear antigen, TUNEL, and caspase assays; and gene expression with quantitative PCR (qPCR) and RNA sequencing on lung epithelium and mesenchyme retrieved by laser capture microdissection. Results demonstrated a significant decrease in body weight and lung volume of smoke-exposed embryos. At 16.5 dpc, the reduction in lung volume was due to loss of lung mesenchymal tissue correlating with a decrease in cell proliferation (n = 10; air: 61.65% vs. smoke: 44.21%, P < 0.05). RNA sequence analysis demonstrated an alteration in the Wnt pathway, and qPCR confirmed an increased expression of secreted frizzled-related protein 1 (sFRP-1) [n = 12; relative quantification (RQ) 1 vs. 2.33, P < 0.05] and down-regulation ofCyclinD1 (n= 7; RQ1vs. 0.61, P < 0.05) inmesenchymal tissue. Furthermore, genome expression studies revealed a smoke-induced up-regulation of Rho-GTPase-dependent actin cytoskeletal signaling that can lead to loss of tissue integrity.	[Unachukwu, Uchenna; Trischler, Jordis; Goldklang, Monica; Xiao, Rui; D'Armiento, Jeanine] Columbia Univ, Dept Anesthesiol, Ctr Pulm Dis, Coll Phys & Surg, 630 West 168th St, New York, NY 10032 USA	Columbia University	D'Armiento, J (corresponding author), Columbia Univ, Dept Anesthesiol, Ctr Pulm Dis, Coll Phys & Surg, 630 West 168th St, New York, NY 10032 USA.	jmd12@cumc.columbia.edu		Goldklang, Monica/0000-0002-7019-3130; unachukwu, uchenna/0000-0001-8248-5723	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008464] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL086936] Funding Source: Medline; NIGMS NIH HHS [T32 GM008464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anblagan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067223; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blacquiere MJ, 2010, THORAX, V65, P553, DOI 10.1136/thx.2009.120154; Blacquiere MJ, 2009, EUR RESPIR J, V33, P1133, DOI 10.1183/09031936.00129608; Bogatcheva NV, 2009, MICROVASC RES, V77, P64, DOI 10.1016/S0026-2862(09)00021-1; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Caleyachetty R, 2014, LANCET GLOB HEALTH, V2, pE513, DOI 10.1016/S2214-109X(14)70283-9; Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021; COLLINS MH, 1985, PEDIATR RES, V19, P408, DOI 10.1203/00006450-198519040-00018; De Langhe Stijn P, 2008, Organogenesis, V4, P100; Elliot J, 1998, AM J RESP CRIT CARE, V158, P802, DOI 10.1164/ajrccm.158.3.9709055; Elliot J, 2001, AM J RESP CRIT CARE, V163, P140, DOI 10.1164/ajrccm.163.1.9805099; Esposito ER, 2008, TOXICOLOGY, V246, P193, DOI 10.1016/j.tox.2008.01.014; Foronjy R, 2010, AM J PATHOL, V177, P598, DOI 10.2353/ajpath.2010.090803; Garcia JGN, 2009, MICROVASC RES, V77, P1, DOI 10.1016/j.mvr.2009.01.001; Gilliland FD, 2000, THORAX, V55, P271, DOI 10.1136/thorax.55.4.271; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Iniguez C, 2013, AM J EPIDEMIOL, V178, P1067, DOI 10.1093/aje/kwt085; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kim HY, 2012, ORGANOGENESIS, V8, P56, DOI 10.4161/org.19813; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Larcombe AN, 2011, EUR RESPIR J, V38, P932, DOI 10.1183/09031936.00156910; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li CG, 2015, STEM CELLS, V33, P999, DOI 10.1002/stem.1911; Li XY, 1996, THORAX, V51, P465, DOI 10.1136/thx.51.5.465; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manoli SE, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-42; Minoo P, 1995, DEV BIOL, V172, P694, DOI 10.1006/dbio.1995.8080; Morrison D, 1999, AM J RESP CRIT CARE, V159, P473, DOI 10.1164/ajrccm.159.2.9804080; Moshammer H, 2006, AM J RESP CRIT CARE, V173, P1255, DOI 10.1164/rccm.200510-1552OC; Mukhametshina RT, 2013, J PROTEOME RES, V12, P5598, DOI 10.1021/pr400573k; Olivera DS, 2007, INHAL TOXICOL, V19, P13, DOI 10.1080/08958370600985768; Ornitz DM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008318; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Petre MA, 2011, INT J TOXICOL, V30, P244, DOI 10.1177/1091581810395332; Pollack D, 2015, TOXICOL LETT, V234, P120, DOI 10.1016/j.toxlet.2015.02.006; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Rehan VK, 2009, LUNG, V187, P281, DOI 10.1007/s00408-009-9158-2; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Salaets T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136569; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Schamberger AC, 2014, AM J RESP CELL MOL, V50, P1040, DOI 10.1165/rcmb.2013-0090OC; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang A, 2015, J CLIN INVEST, V125, P4021, DOI 10.1172/JCI80457; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014793; Wang T, 2010, AM J RESP CELL MOL, V42, P442, DOI 10.1165/rcmb.2008-0402OC; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Xiao R, 2012, AM J RESP CELL MOL, V47, P843, DOI 10.1165/rcmb.2012-0241OC; Yanagi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/573210	58	7	8	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2340	2351		10.1096/fj.201601063R	http://dx.doi.org/10.1096/fj.201601063R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28209772	Green Published			2022-12-26	WOS:000401553400011
J	McElroy, PB; Hari, AS; Day, BJ; Patel, M				McElroy, Pallavi B.; Hari, Ashwini Sri; Day, Brian J.; Patel, Manisha			Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol A NOVEL MECHANISM OF INHIBITING NEUROINFLAMMATION IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TEMPORAL-LOBE EPILEPSY; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; PROTEIN-KINASE; GLUTATHIONE SYNTHESIS; MULTIPLE-SCLEROSIS; CELL-DEATH; NEURODEGENERATIVE DISORDERS	Neuroinflammation and oxidative stress are hallmarks of various neurological diseases. However, whether and how the redox processes control neuroinflammation is incompletely understood. We hypothesized that increasing cellular glutathione (GSH) levels would inhibit neuroinflammation. A series of thiol compounds were identified to elevate cellular GSH levels by a novel approach (i.e. post-translational activation of glutamate cysteine ligase (GCL), the rate-limiting enzyme in GSH biosynthesis). These small thiol-containing compounds were examined for their ability to increase intracellular GSH levels in a murine microglial cell line (BV2), of which dimercaprol (2,3-dimercapto- 1-propanol (DMP)) was found to be the most effective compound. DMP increased GCL activity and decreased LPS-induced production of pro-inflammatory cytokines and inducible nitric-oxide synthase induction in BV2 cells in a concentration-dependent manner. The ability of DMP to elevate GSH levels and attenuate LPS-induced pro-inflammatory cytokine production was inhibited by buthionine sulfoximine, an inhibitor of GCL. DMP increased the expression of GCL holoenzyme without altering the expression of its subunits or Nrf2 target proteins (NQO1 and HO-1), suggesting a post-translational mechanism. DMP attenuated LPS-induced MAPK activation in BV2 cells, suggesting the MAPK pathway as the signaling mechanism underlying the effect of DMP. Finally, the ability of DMP to increase GSH via GCL activation was observed in mixed cerebrocortical cultures and N27 dopaminergic cells. Together, the data demonstrate a novel mechanism of GSH elevation by posttranslational activation of GCL. Post-translational activation of GCL offers a novel targeted approach to control inflammation in chronic neuronal disorders associated with impaired adaptive responses.	[McElroy, Pallavi B.; Hari, Ashwini Sri; Patel, Manisha] Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA; [Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Patel, M (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA.	Manisha.Patel@ucdenver.edu	HARI, ASHWINI SRI/AAH-8467-2019		National Institutes of Health [RO1NS039587, R01NS086423, RO1 NS45748]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039587, R01NS086423, R01NS045748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants RO1NS039587 (to M. P.), R01NS086423 (to M. P.), and RO1 NS45748 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6; Anderson MF, 2004, NEUROSCI LETT, V354, P163, DOI 10.1016/j.neulet.2003.09.067; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Backos DS, 2011, FREE RADICAL BIO MED, V50, P14, DOI 10.1016/j.freeradbiomed.2010.10.694; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Blum S, 1999, J NEUROSCI, V19, P3535; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Cantu D, 2011, J NEUROCHEM, V118, P79, DOI 10.1111/j.1471-4159.2011.07290.x; Carvalho AN, 2014, MULT SCLER J, V20, P1425, DOI 10.1177/1352458514533400; Cecchi C, 1999, NEUROSCI LETT, V275, P152, DOI 10.1016/S0304-3940(99)00751-X; Chen P, 2008, ACTA BIOCH BIOPH SIN, V40, P125, DOI 10.1111/j.1745-7270.2008.00386.x; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Chinta SJ, 2006, NEUROSCI LETT, V402, P137, DOI 10.1016/j.neulet.2006.03.056; Choi IY, 2011, MULT SCLER J, V17, P289, DOI 10.1177/1352458510384010; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Clarkson ED, 1998, P NATL ACAD SCI USA, V95, P1265, DOI 10.1073/pnas.95.3.1265; Diaz-Hernandez JI, 2005, J BIOL CHEM, V280, P38992, DOI 10.1074/jbc.M507065200; Drechsel DA, 2007, TOXICOL APPL PHARM, V220, P341, DOI 10.1016/j.taap.2007.02.002; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Gegg ME, 2002, ANAL BIOCHEM, V304, P26, DOI 10.1006/abio.2001.5607; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Haddad JJ, 2002, BIOCHEM PHARMACOL, V63, P305, DOI 10.1016/S0006-2952(01)00870-X; Haddad JJE, 2001, J PHARMACOL EXP THER, V296, P996; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kachadourian R, 2012, J MED CHEM, V55, P1382, DOI 10.1021/jm2016073; Kachadourian R, 2011, FREE RADICAL BIO MED, V51, P1146, DOI 10.1016/j.freeradbiomed.2011.05.041; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Koh K, 2011, J NEUROIMMUNOL, V233, P160, DOI 10.1016/j.jneuroim.2011.01.004; Krejsa CM, 2010, J BIOL CHEM, V285, P16116, DOI 10.1074/jbc.M110.116210; Lee IS, 2011, NEUROCHEM INT, V58, P153, DOI 10.1016/j.neuint.2010.11.008; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026; Limon-Pacheco JH, 2007, FREE RADICAL BIO MED, V43, P1335, DOI 10.1016/j.freeradbiomed.2007.06.028; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Mueller SG, 2001, NEUROLOGY, V57, P1422, DOI 10.1212/WNL.57.8.1422; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niso-Santano M, 2006, TOXICOL SCI, V92, P507, DOI 10.1093/toxsci/kfl013; Oh YT, 2010, NEUROSCI LETT, V474, P148, DOI 10.1016/j.neulet.2010.03.026; Palmeira CM, 1995, TOXICOL LETT, V81, P115, DOI 10.1016/0378-4274(95)03414-5; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; Ramachandiran S, 2007, TOXICOL SCI, V95, P163, DOI 10.1093/toxsci/kfl125; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Ryan K, 2014, NEUROBIOL DIS, V64, P8, DOI 10.1016/j.nbd.2013.12.006; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Svensson C, 2010, BRAIN RES, V1322, P1, DOI 10.1016/j.brainres.2010.01.082; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vilensky JA, 2003, ANN EMERG MED, V41, P378, DOI 10.1067/mem.2003.72; Waldbaum S, 2010, J NEUROCHEM, V115, P1172, DOI 10.1111/j.1471-4159.2010.07013.x; YAN CYI, 1995, J BIOL CHEM, V270, P26827, DOI 10.1074/jbc.270.45.26827; Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4	85	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5532	5545		10.1074/jbc.M116.723700	http://dx.doi.org/10.1074/jbc.M116.723700			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202547	Green Published, hybrid			2022-12-26	WOS:000397875500032
J	Li, YZ; Qin, L; Zhao, JJ; Muhammad, T; Cao, HH; Li, HL; Zhang, Y; Liang, Y				Li, Yunzhou; Qin, Lei; Zhao, Jingjing; Muhammad, Tayeb; Cao, Hehe; Li, Hailiang; Zhang, Yan; Liang, Yan			SlMAPK3 enhances tolerance to tomato yellow leaf curl virus (TYLCV) by regulating salicylic acid and jasmonic acid signaling in tomato (Solanum lycopersicum)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RESISTANCE GENE TY-2; ABSCISIC-ACID; MAP KINASE; PLANT-RESISTANCE; OXIDATIVE STRESS; MPK4 ACTIVATION; CELL-DEATH; DEFENSE; INFECTION	Several recent studies have reported on the role of mitogen-activated protein kinase (MAPK3) in plant immune responses. However, little is known about how MAPK3 functions in tomato (Solanum lycopersicum L.) infected with tomato yellow leaf curl virus (TYLCV). There is also uncertainty about the connection between plant MAPK3 and the salicylic acid (SA) and jasmonic acid (JA) defense-signaling pathways. The results of this study indicated that SlMAPK3 participates in the antiviral response against TYLCV. Tomato seedlings were inoculated with TYLCV to investigate the possible roles of SlMAPK1, SlMAPK2, and SlMAPK3 against this virus. Inoculation with TYLCV strongly induced the expression and the activity of all three genes. Silencing of SlMAPK1, SlMAPK2, and SlMAPK3 reduced tolerance to TYLCV, increased leaf H2O2 concentrations, and attenuated expression of defense-related genes after TYLCV infection, especially in SlMAPK3-silenced plants. Exogenous SA and methyl jasmonic acid (MeJA) both significantly induced SlMAPK3 expression in tomato leaves. Over-expression of SlMAPK3 increased the transcript levels of SA/JA-mediated defense-related genes (PR1, PR1b/SlLapA, SlPI-I, and SlPI-II) and enhanced tolerance to TYLCV. After TYLCV inoculation, the leaves of SlMAPK3 over-expressed plants compared with wild type plants showed less H2O2 accumulation and greater superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and ascorbate peroxidase (APX) activity. Overall, the results suggested that SlMAPK3 participates in the antiviral response of tomato to TYLCV, and that this process may be through either the SA or JA defense-signaling pathways.	[Li, Yunzhou; Qin, Lei; Zhao, Jingjing; Muhammad, Tayeb; Zhang, Yan; Liang, Yan] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Cao, Hehe] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Li, Hailiang] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y; Liang, Y (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	zhangyan2014@nwsuaf.edu.cn; liangyan@nwsuaf.edu.cn			Science and Technology Innovation Project of Shaanxi Province [2015KTTSNY03-01]; National Science AMP; Technology Projects of China [2013BAD01B00]	Science and Technology Innovation Project of Shaanxi Province; National Science AMP; Technology Projects of China	This work was supported by the Science and Technology Innovation Project of Shaanxi Province (2015KTTSNY03-01) and National Science & Technology Projects of China (2013BAD01B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, PLANT PHYSIOL BIOCH, V41, P355, DOI 10.1016/S0981-9428(03)00030-5; Alamillo JM, 2006, PLANT J, V48, P217, DOI 10.1111/j.1365-313X.2006.02861.x; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Anfoka G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25284; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baebler S, 2014, J EXP BOT, V65, P1095, DOI 10.1093/jxb/ert447; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Borges AA, 2015, FRONT PLANT SCI, P1; Butterbach P, 2014, P NATL ACAD SCI USA, V111, P12942, DOI 10.1073/pnas.1400894111; Campos L, 2014, PLANT PHYSIOL BIOCH, V77, P35, DOI 10.1016/j.plaphy.2014.01.016; Caro M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0329-y; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chan ED, 2001, AM J RESP CELL MOL, V24, P627, DOI 10.1165/ajrcmb.24.5.4280; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Maxwell Douglas P., 2007, P409, DOI 10.1007/978-1-4020-4769-5_24; Das SK, 2016, INT REV HYDROBIOL, V101, P3, DOI 10.1002/iroh.201401744; Devadas SK, 2002, PLANT PHYSIOL, V128, P1234, DOI 10.1104/pp.010941; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eybishtz A, 2010, PLANTA, V231, P537, DOI 10.1007/s00425-009-1072-6; Faoro F, 2015, PLANT SCI, V234, P1, DOI 10.1016/j.plantsci.2015.01.011; Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64; Frei dit Frey N, 2014, GENOME BIOL; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Gorovits R, 2007, MOL PLANT MICROBE IN, V20, P1376, DOI 10.1094/MPMI-20-11-1376; Gorovits R, 2014, PEST MANAG SCI, V70, P1632, DOI 10.1002/ps.3737; Gorovits R, 2013, VIRUS RES, V171, P33, DOI 10.1016/j.virusres.2012.09.017; Griffiths PD, 2001, J AM SOC HORTIC SCI, V126, P462, DOI 10.21273/JASHS.126.4.462; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hettenhausen C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0326-z; Huang L, 2012, PLANT BIOLOGY, V14, P905, DOI 10.1111/j.1438-8677.2012.00582.x; Hunter LJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066530; Hutton SF, 2012, HORTSCIENCE, V47, P324, DOI 10.21273/HORTSCI.47.3.324; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Ji Y, 2007, MOL BREEDING, V20, P271, DOI 10.1007/s11032-007-9089-7; Ji YF, 2009, J AM SOC HORTIC SCI, V134, P281, DOI 10.21273/JASHS.134.2.281; Ji YF, 2009, HORTSCIENCE, V44, P614, DOI 10.21273/HORTSCI.44.3.614; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kadotani N, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0748-x; Kandoth PK, 2007, P NATL ACAD SCI USA, V104, P12205, DOI 10.1073/pnas.0700344104; Kil EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19013; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kumar KRR, 2009, MOL GENET GENOMICS, V282, P65, DOI 10.1007/s00438-009-0446-6; Lee HY, 2016, J PINEAL RES, V60, P327, DOI 10.1111/jpi.12314; Lee WS, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0705-8; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Li C, 2014, BIOCHEM BIOPH RES CO, V443, P357, DOI 10.1016/j.bbrc.2013.11.061; Li C, 2013, INT J MOL SCI, V14, P21983, DOI 10.3390/ijms141121983; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu H, 2016, FRONT PLANT SCI, P1; Mayrose M, 2004, J BIOL CHEM, V279, P14819, DOI 10.1074/jbc.M313388200; Meldau S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-213; Melvin P, 2015, PLANT MOL BIOL, V87, P287, DOI 10.1007/s11103-014-0276-8; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Niu DD, 2016, BIOCHEM BIOPH RES CO, V469, P120, DOI 10.1016/j.bbrc.2015.11.081; Oliveira MDM, 2016, PHYTOCHEM LETT, V15, P152, DOI 10.1016/j.phytol.2015.12.011; Palukaitis P, 2008, J PLANT PATHOL, V90, P153; Parrella G, 2016, PLANT DIS, V100, P539, DOI 10.1094/PDIS-07-15-0742-PDN; Perez-Salamo I, 2014, PLANT PHYSIOL, V165, P319, DOI 10.1104/pp.114.237891; Pitzschke A, 2014, MOL PLANT, V7, P722, DOI 10.1093/mp/sst157; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Reuveni M, 2015, PHYSIOL MOL PLANT P, V92, P51, DOI 10.1016/j.pmpp.2015.08.001; Sade D, 2014, PLANT PHYSIOL, V165, P1684, DOI 10.1104/pp.114.243402; Seo S, 1999, PLANT CELL, V11, P289, DOI 10.1105/tpc.11.2.289; Seo S, 2007, PLANT J, V49, P899, DOI 10.1111/j.1365-313X.2006.03003.x; Shang J, 2011, PLANTA, V233, P299, DOI 10.1007/s00425-010-1308-5; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Sohrab Sayed Sartaj, 2016, VirusDisease, V27, P19, DOI 10.1007/s13337-015-0292-6; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Van Wezel R, 2002, MOL PLANT PATHOL, V3, P461, DOI 10.1046/j.1364-3703.2002.00141.x; Verlaan MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003399; Verlaan MG, 2011, PLANT J, V68, P1093, DOI 10.1111/j.1365-313X.2011.04762.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang AG, 1990, PLANT PHYSL COMMUNIC, V6; Wang Q, 2013, PLANT CELL REP, V32, P1075, DOI 10.1007/s00299-013-1389-2; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Xu J, 2014, PLANT J, V77, P222, DOI 10.1111/tpj.12382; Yang XH, 2014, MOL BREEDING, V34, P749, DOI 10.1007/s11032-014-0072-9; Ye LX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00953; Yi SY, 2015, PLANT PATHOLOGY J, V31, P192, DOI 10.5423/PPJ.NT.10.2014.0112; Yu L, 2015, PLANT CELL TISS ORG, V121, P21, DOI 10.1007/s11240-014-0675-1; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; Zhang H, 2009, VIRUS GENES, V39, P249, DOI 10.1007/s11262-009-0384-8; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809; Zhao JingJing, 2016, Journal of Agricultural Biotechnology, V24, P1017; Zhao PP, 2013, RUSS J PLANT PHYSL+, V60, P672, DOI 10.1134/S1021443713050166; Zong XJ, 2009, PLANTA, V229, P485, DOI 10.1007/s00425-008-0848-4	101	42	51	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172466	10.1371/journal.pone.0172466	http://dx.doi.org/10.1371/journal.pone.0172466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222174	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800058
J	Ramis, R; Tamayo-Uria, I; Gomez-Barroso, D; Lopez-Abente, G; Morales-Piga, A; Romaguera, E; Aragones, N; Garcia-Perez, J				Ramis, Rebeca; Tamayo-Uria, Ibon; Gomez-Barroso, Diana; Lopez-Abente, Gonzalo; Morales-Piga, Antonio; Pardo Romaguera, Elena; Aragones, Nuria; Garcia-Perez, Javier			Risk factors for central nervous system tumors in children: New findings from a case-control study	PLOS ONE			English	Article							CHILDHOOD BRAIN-TUMORS; RESIDENTIAL PROXIMITY; GREAT-BRITAIN; AIR-POLLUTION; EPIDEMIOLOGY-CONSORTIUM; CANCER INCIDENCE; WATER SOURCE; URBAN SITES; LEUKEMIA; EXPOSURE	Background Central nervous system tumors ( CNS) are the most frequent solid tumor in children. Causes of CNS tumors are mainly unknown and only 5% of the cases can be explained by genetic predisposition. We studied the effects of environmental exposure on the incidence of CNS tumors in children by subtype, according to exposure to industrial and/or urban environment, exposure to crops and according to socio-economic status of the child. Methods We carried out a population-based case-control study of CNS tumors in Spain, covering 714 incident cases collected from the Spanish Registry of Childhood Tumors ( period 1996-2011) and 4284 controls, individually matched by year of birth, sex, and autonomous region of residence. We built a covariate to approximate the exposure to industrial and/or urban environment and a covariate for the exposure to crops ( GCI) using the coordinates of the home addresses of the children. We used the 2001 Census to obtain information about socio-economic status ( SES). We fitted logistic regression models to estimate odds ratios ( ORs) and 95% confidence intervals ( 95% CIs). Results The results for all CNS tumors showed an excess risk ( OR = 1.37; 95%CI = 1.09-1.73) for SES, i.e., children living in the least deprived areas had 37% more risk of CNS tumor than children living in the most deprived areas. For GCI, an increase of 10% in crop surface in the 1-km buffer around the residence implied an increase of 22% in the OR ( OR = 1.22; 95%CI = 1.15-1.29). Children living in the intersection of industrial and urban areas could have a greater risk of CNS tumors than children who live outside these areas ( OR = 1.20; 95%CI = 0.82-1.77). Living in urban areas ( OR = 0.90; 95%CI = 0.65-1.24) or industrial areas ( OR = 0.96; 95%CI = 0.81-1.77) did not seem to increase the risk for all CNS tumors together. By subtype, Astrocytomas, Intracranial and intraspinal embryonal tumors, and other gliomas showed similar results. Conclusion Our results suggest that higher socioeconomic status and exposure to crops could increase the risk of CNS tumors in children.	[Ramis, Rebeca; Lopez-Abente, Gonzalo; Aragones, Nuria; Garcia-Perez, Javier] Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Ramis, Rebeca; Gomez-Barroso, Diana; Lopez-Abente, Gonzalo; Aragones, Nuria; Garcia-Perez, Javier] Consortium Biomed Res Epidemiol & Publ Hlth, CIBERESP, Madrid, Spain; [Tamayo-Uria, Ibon] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Tamayo-Uria, Ibon] UPF, Barcelona, Spain; [Gomez-Barroso, Diana] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain; [Morales-Piga, Antonio] Carlos III Inst Hlth, Rare Dis Res Inst IIER, Madrid, Spain; [Morales-Piga, Antonio] Consortium Biomed Res Rare Dis CIBERER, Madrid, Spain; [Pardo Romaguera, Elena] Univ Valencia, Spanish Registry Childhood Tumors RETI SEHOP, Valencia, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Pompeu Fabra University; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia	Ramis, R (corresponding author), Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain.; Ramis, R (corresponding author), Consortium Biomed Res Epidemiol & Publ Hlth, CIBERESP, Madrid, Spain.	rramis@isciii.es	Tamayo-Uria, Ibon/H-5283-2019; Lopez-Abente, Gonzalo/E-5221-2010; Ramis, Rebeca/E-1743-2015; Aragones, Nuria/O-5962-2015; García-Pérez, Javier/F-4566-2016; Gomez-Barroso, Diana/Q-5417-2018	Tamayo-Uria, Ibon/0000-0002-8183-7106; Lopez-Abente, Gonzalo/0000-0003-2423-8075; Ramis, Rebeca/0000-0001-6154-9142; Aragones, Nuria/0000-0003-0983-2156; García-Pérez, Javier/0000-0003-0300-1810; Gomez-Barroso, Diana/0000-0001-7388-1767				Badaloni C, 2013, OCCUP ENVIRON MED, V70, P876, DOI 10.1136/oemed-2013-101604; Bauchet L, 2009, J NEURO-ONCOL, V92, P87, DOI 10.1007/s11060-008-9740-0; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Brender JD, 2011, AM J PUBLIC HEALTH, V101, pS37, DOI 10.2105/AJPH.2011.300183; Chen M, 2015, PEDIATRICS; Choi HS, 2006, ENVIRON HEALTH PERSP, V114, P1113, DOI 10.1289/ehp.9145; Danysh HE, 2015, PEDIATR BLOOD CANCER, V62, P1572, DOI 10.1002/pbc.25549; de Vocht F, 2013, OCCUP ENVIRON MED, V70, P349, DOI 10.1136/oemed-2012-100954; Garcia-Perez J, 2016, ENVIRON INT, V92-93, P269, DOI 10.1016/j.envint.2016.04.023; Garcia-Perez J, 2016, ENVIRON RES, V147, P405, DOI 10.1016/j.envres.2016.02.036; Garcia-Perez J, 2015, ENVIRON RES, V140, P542, DOI 10.1016/j.envres.2015.05.014; Gomez-Barroso D, INTJHEALTH IN PRESS; Grill J, 2013, HAND CLINIC, V112, P931, DOI 10.1016/B978-0-444-52910-7.00015-5; Hajat Anjum, 2015, Curr Environ Health Rep, V2, P440, DOI 10.1007/s40572-015-0069-5; Infante-Rivard C, 2007, J TOXICOL ENV HEAL B, V10, P81, DOI 10.1080/10937400601034589; Jarup L, 2002, BRIT J CANCER, V86, P1732, DOI 10.1038/sj.bjc.6600311; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Keegan TJ, 2013, BRIT J CANCER, V108, P1907, DOI 10.1038/bjc.2013.171; Knox EG, 1997, J EPIDEMIOL COMMUN H, V51, P151, DOI 10.1136/jech.51.2.151; Kollerud RD, 2015, SCAND J PUBLIC HEALT, V43, P736, DOI 10.1177/1403494815590499; Liu CC, 2008, J TOXICOL ENV HEAL A, V71, P310, DOI 10.1080/15287390701738491; Lopez-Abente G, 2003, OCCUP ENVIRON MED, V60, P504, DOI 10.1136/oem.60.7.504; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McKinney PA, 2005, BIOELECTROMAGNETICS, pS60, DOI 10.1002/bem.20149; McNally RJQ, 2004, EUR J CANCER, V40, P2766, DOI 10.1016/j.ejca.2004.08.020; Mueller BA, 2004, INT J EPIDEMIOL, V33, P1209, DOI 10.1093/ije/dyh215; Mueller BA, 2001, ENVIRON HEALTH PERSP, V109, P551, DOI 10.2307/3455026; Ortega-Garcia JA, 2016, AN PEDIATR, V84, P154, DOI 10.1016/j.anpedi.2015.04.021; Pedersen C, 2014, CANCER CAUSE CONTROL, V25, P171, DOI 10.1007/s10552-013-0319-5; Peris-Bonet R, 2010, ANN ONCOL, V21, piii103, DOI 10.1093/annonc/mdq092; Peris-Bonet R, CANC INFANTIL ESPANA; Pollan M, 1999, J NEUROL SCI, V163, P127, DOI 10.1016/S0022-510X(99)00010-6; Ramis R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127273; Reynolds P, 2004, EPIDEMIOLOGY, V15, P6, DOI 10.1097/01.ede.0000101749.28283.de; Reynolds P, 2005, EPIDEMIOLOGY, V16, P93, DOI 10.1097/01.ede.0000147119.32704.5c; Reynolds P, 2002, CANCER CAUSE CONTROL, V13, P665, DOI 10.1023/A:1019579430978; Sadetzki S, 2014, FRONT PUBLIC HLTH, P2; Schuz J, 2011, CANCER EPIDEMIOL, V35, P37, DOI 10.1016/j.canep.2010.08.001; Selvin S, 2004, INT J HYG ENVIR HEAL, V207, P555, DOI 10.1078/1438-4639-00327; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Vinson F, 2011, OCCUP ENVIRON MED, V68, P694, DOI 10.1136/oemed-2011-100082; Zahm SH, 1998, ENVIRON HEALTH PERSP, V106, P893, DOI 10.2307/3434207	42	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171881	10.1371/journal.pone.0171881	http://dx.doi.org/10.1371/journal.pone.0171881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212424	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700013
J	Bartolino, V; Tian, HD; Bergstrom, U; Jounela, P; Aro, E; Dieterich, C; Meier, HEM; Cardinale, M; Bland, B; Casini, M				Bartolino, Valerio; Tian, Huidong; Bergstrom, Ulf; Jounela, Pekka; Aro, Eero; Dieterich, Christian; Meier, H. E. Markus; Cardinale, Massimiliano; Bland, Barbara; Casini, Michele			Spatio-temporal dynamics of a fish predator: Density-dependent and hydrographic effects on Baltic Sea cod population	PLOS ONE			English	Article							GADUS-MORHUA; SPATIAL-DISTRIBUTION; HABITAT SELECTION; TROPHIC CASCADES; CLIMATE IMPACT; RECRUITMENT; ATLANTIC; SURVIVAL; MODEL; SCALE	Understanding the mechanisms of spatial population dynamics is crucial for the successful management of exploited species and ecosystems. However, the underlying mechanisms of spatial distribution are generally complex due to the concurrent forcing of both density-dependent species interactions and density-independent environmental factors. Despite the high economic value and central ecological importance of cod in the Baltic Sea, the drivers of its spatio-temporal population dynamics have not been analytically investigated so far. In this paper, we used an extensive trawl survey dataset in combination with environmental data to investigate the spatial dynamics of the distribution of the Eastern Baltic cod during the past three decades using Generalized Additive Models. The results showed that adult cod distribution was mainly affected by cod population size, and to a minor degree by small-scale hydrological factors and the extent of suitable reproductive areas. As population size decreases, the cod population concentrates to the southern part of the Baltic Sea, where the preferred more marine environment conditions are encountered. Using the fitted models, we predicted the Baltic cod distribution back to the 1970s and a temporal index of cod spatial occupation was developed. Our study will contribute to the management and conservation of this important resource and of the ecosystem where it occurs, by showing the forces shaping its spatial distribution and therefore the potential response of the population to future exploitation and environmental changes.	[Bartolino, Valerio; Tian, Huidong; Cardinale, Massimiliano; Bland, Barbara; Casini, Michele] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Lysekil, Sweden; [Bergstrom, Ulf] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Oregrund, Sweden; [Jounela, Pekka] Nat Resources Inst Finland Luke, Turku, Finland; [Aro, Eero] Puolipaivankatu 4 A 6, Helsinki, Finland; [Dieterich, Christian; Meier, H. E. Markus] Swedish Meteorol & Hydrol Inst, Res Dept, Norrkoping, Sweden; [Meier, H. E. Markus] Leibniz Inst Baltic Sea Res Warnemunde, Dept Phys Oceanog & Instrumentat, Rostock, Germany	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Natural Resources Institute Finland (Luke); Swedish Meteorological & Hydrological Institute; Leibniz Institut fur Ostseeforschung Warnemunde	Casini, M (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Lysekil, Sweden.	michele.casini@slu.se	Dieterich, Christian/AAJ-8913-2020	Dieterich, Christian/0000-0001-7086-4881; Bartolino, Valerio/0000-0002-4506-4329; Meier, H. E. Markus/0000-0001-5855-4645; Bergstrom, Ulf/0000-0002-5478-0634; Casini, Michele/0000-0003-4910-5236	BONUS INSPIRE project - joint Baltic Sea research and development programme BONUS [185]; EU; Swedish Research Council Formas; PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; European Community [217246]; BONUS; Baltic Sea research and development program; Swedish Environmental Protection Agency [08/381]; Swedish Research Council	BONUS INSPIRE project - joint Baltic Sea research and development programme BONUS; EU(European Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); PLAN FISH project; Swedish Environmental Protection Agency; Swedish Agency for Marine and Water Management; European Community(European Commission); BONUS; Baltic Sea research and development program; Swedish Environmental Protection Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was financed by the BONUS INSPIRE project supported by the joint Baltic Sea research and development programme BONUS (Art 185), funded jointly by the EU and the Swedish Research Council Formas. This study was also funded by the PLAN FISH project funded by the Swedish Environmental Protection Agency and the Swedish Agency for Marine and Water Management (formerly the Swedish Board of Fisheries). The high-resolution, three-dimensional model simulation was performed within the project ECOSUPPORT (Advanced modeling tool for scenarios of the Baltic Sea ECOsystem to SUPPORT decision making) funded by the European Community's Seventh Framework Program (FP/2007-2013) under grant agreement no. 217246 made with BONUS, the joint Baltic Sea research and development program, and by the Swedish Environmental Protection Agency (08/381). Additional support came from the Swedish Research Council Formas within the project Impact of accelerated future global mean sea level rise on the phosphorus cycle in the Baltic Sea.; This work was financed by the BONUS INSPIRE project supported by the joint Baltic Sea research and development programme BONUS (Art 185), funded jointly by the EU and the Swedish Research Council Formas. This study was also funded by the PLAN FISH project funded by the Swedish Environmental Protection Agency and the Swedish Agency for Marine and Water Management (formerly the Swedish Board of Fisheries). The high-resolution, three-dimensional model simulation was performed within the project ECOSUPPORT (Advanced modeling tool for scenarios of the Baltic Sea ECOsystem to SUPPORT decision making) funded by the European Community's Seventh Framework Program (FP/2007-2013) under grant agreement no. 217246 made with BONUS, the joint Baltic Sea research and development program, and by the Swedish Environmental Protection Agency (08/381). Additional support came from the Swedish Research Council Formas within the project "Impact of accelerated future global mean sea level rise on the phosphorus cycle in the Baltic Sea".	Anderson JT, 2000, ICES J MAR SCI, V57, P349, DOI 10.1006/jmsc.1999.0530; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Bacheler NM, 2009, MAR ECOL PROG SER, V391, P1, DOI 10.3354/meps08259; Balbontin J, 2008, OIKOS, V117, P1111, DOI 10.1111/j.0030-1299.2008.16232.x; Barange M, 2009, PROG OCEANOGR, V83, P251, DOI 10.1016/j.pocean.2009.07.027; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bartolino V, 2012, MAR ECOL PROG SER, V444, P251, DOI 10.3354/meps09434; Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; Bergstrom U, 2015, ESTUAR COAST SHELF S, V163, P134, DOI 10.1016/j.ecss.2015.06.017; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cardinale M, 2000, CAN J FISH AQUAT SCI, V57, P2402, DOI 10.1139/cjfas-57-12-2402; Casas F, 2009, ANIM CONSERV, V12, P346, DOI 10.1111/j.1469-1795.2009.00259.x; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Dingsor GE, 2007, ECOLOGY, V88, P625, DOI 10.1890/05-1782; Eero M, 2015, ICES J MAR SCI, V72, P2180, DOI 10.1093/icesjms/fsv109; Eero M, 2011, ECOL APPL, V21, P214, DOI 10.1890/09-1879.1; Eilola K, 2009, J MARINE SYST, V75, P163, DOI 10.1016/j.jmarsys.2008.08.009; Eriksson BK, 2011, AMBIO, V40, P786, DOI 10.1007/s13280-011-0158-0; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Folmer EO, 2010, J ANIM ECOL, V79, P747, DOI 10.1111/j.1365-2656.2010.01680.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fromentin JM, 2001, ECOLOGY, V82, P567, DOI 10.1890/0012-9658(2001)082[0567:EODDAS]2.0.CO;2; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hansson M., 2013, 49 SWED MET HYDR I; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Haugen TO, 2007, ECOL MONOGR, V77, P483, DOI 10.1890/06-0163.1; Hines AH, 2009, MAR ECOL PROG SER, V385, P127, DOI 10.3354/meps08055; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Humphries AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028339; ICES, 2013, BALT FISH ASS WORK G; ICES, 2014, BALT INT FISH SURV W; ICES, 2013, STUD GROUP SPAT AN B, P2013; ICES. Report of the Baltic Fisheries Assessment Working Group (WGBFAS), 2015, BALT FISH ASS WORK G; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kendall MS, 2008, T AM FISH SOC, V137, P1134, DOI 10.1577/T07-210.1; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Lewin WC, 2010, ECOL INDIC, V10, P572, DOI 10.1016/j.ecolind.2009.09.006; Lindegren M, 2011, ECOLOGY, V92, P1407, DOI 10.1890/10-2229.1; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; MacKenzie BR, 2000, MAR ECOL PROG SER, V193, P143, DOI 10.3354/meps193143; Margonski P, 2010, PROG OCEANOGR, V87, P277, DOI 10.1016/j.pocean.2010.08.003; Marshall CT, 1999, CAN J FISH AQUAT SCI, V56, P347, DOI 10.1139/cjfas-56-3-347; Meier HEM, 2012, CLIM DYNAM, V39, P2421, DOI 10.1007/s00382-012-1339-7; Meier HEM, 2007, ESTUAR COAST SHELF S, V74, P610, DOI 10.1016/j.ecss.2007.05.019; Meier HEM, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000521; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; MORRIS DW, 1994, EVOL ECOL, V8, P387, DOI 10.1007/BF01238190; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x; Schaber M, 2012, FISH OCEANOGR, V21, P33, DOI 10.1111/j.1365-2419.2011.00607.x; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Slotte A, 1999, SARSIA, V84, P111, DOI 10.1080/00364827.1999.10420439; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Spencer PD, 2008, FISH OCEANOGR, V17, P396, DOI 10.1111/j.1365-2419.2008.00486.x; Stelzenmuller V, 2008, ICES J MAR SCI, V65, P1081, DOI 10.1093/icesjms/fsn073; Stige LC, 2006, MAR ECOL PROG SER, V325, P227, DOI 10.3354/meps325227; Swain DP, 1999, FISH OCEANOGR, V8, P1, DOI 10.1046/j.1365-2419.1999.00090.x; Tamdrari H, 2010, ICES J MAR SCI, V67, P1676, DOI 10.1093/icesjms/fsq108; Tomkiewicz J, 1998, FISH OCEANOGR, V7, P48, DOI 10.1046/j.1365-2419.1998.00051.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	71	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172004	10.1371/journal.pone.0172004	http://dx.doi.org/10.1371/journal.pone.0172004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207804	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500071
J	Amodeo, MR; Vazquez, MB; Zalba, SM				Raul Amodeo, Martin; Belen Vazquez, Maria; Martin Zalba, Sergio			Generalist dispersers promote germination of an alien fleshy-fruited tree invading natural grasslands	PLOS ONE			English	Article							CUTTING ANT NESTS; SEED DISPERSAL; PRUNUS-MAHALEB; PLANT INVASIONS; AVIAN FRUGIVORES; BIRDS; POPULATION; PATTERNS; PASSAGE; MANAGEMENT	Plants with animal-dispersed fruits seem to overcome the barriers that limit their spread into new habitats more easily than other invasive plants and, at the same time, they pose special difficulties for containment, control or eradication. The effects of animals on plant propagules can be very diverse, with positive, neutral or negative consequences for germination and recruitment. Moreover, the environmental conditions where the seeds are deposited and where the post-dispersal processes take place can be crucial for their fate. Prunus mahaleb is a fleshy-fruited tree invading natural grasslands in the Argentine Pampas. In this study, we analyzed the importance of pulp removal, endocarp scarification and the effects of vectors on its germination response, by means of germination experiments both in the laboratory and under semi-natural conditions. Our laboratory results demonstrated that endocarp scarification enhances germination and suggests that vestiges of pulp on the stones have inhibitory effects. Frugivores exert a variety of effects on germination responses and this variation can be explained by their differing influence on pulp removal and endocarp scarification. Most frugivores produced a positive effect on germination under laboratory conditions, in comparison to intact fruits and hand-peeled stones. We observed different degrees of pulp removal from the surface of the stones by the dispersers which was directly correlated to the germination response. On the other hand, all the treatments showed high germination responses under semi-natural conditions suggesting that post-dispersal processes, like seed burial, and the exposure to natural conditions might exert a positive effect on germination response, attenuating the plant's dependence on the dispersers' gut treatment. Our results highlight the need to consider the whole seed dispersal process and the value of combining laboratory and field tests.	[Raul Amodeo, Martin; Martin Zalba, Sergio] Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, GEKKO Grp Estudios Conservac & Manejo, Bahia Blanca, Buenos Aires, Argentina; [Belen Vazquez, Maria] Consejo Nacl Invest Cient & Tecn, Ctr Cient Tecnol Bahia Blanca, CERZOS Ctr Recursos Renovables Zona Semiarida, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Amodeo, MR (corresponding author), Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, GEKKO Grp Estudios Conservac & Manejo, Bahia Blanca, Buenos Aires, Argentina.	martin.amodeo@uns.edu.ar		Vazquez, Maria Belen/0000-0001-8748-3348; Amodeo, Martin/0000-0002-6773-5701; Zalba, Sergio/0000-0003-4940-6872	National Scientific and Technical Research Council from Argentina [11220120100413C0]; Universidad Nacional del Sur, Argentina	National Scientific and Technical Research Council from Argentina; Universidad Nacional del Sur, Argentina	This work was supported by the National Scientific and Technical Research Council from Argentina (grant number: 11220120100413C0, CONICET, http://www.conicet.gov.ar/) and Universidad Nacional del Sur, Argentina (http II www.uns.edu.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Absi KM, 2010, SEED SCI TECHNOL, V38, P332, DOI 10.15258/sst.2010.38.2.06; Amodeo M. r., 2014, THESIS U NAC BAH BLA; Amodeo MR, 2015, BIOL INVASIONS PATTE, P121; [Anonymous], 2014, R LANG ENV STAT COMP; Auguie B, 2012, GRIDEXTRA FUNCTIONS; BARNEA A, 1991, FUNCT ECOL, V5, P394, DOI 10.2307/2389811; Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Bass DA, 2006, EUPHYTICA, V148, P97, DOI 10.1007/s10681-006-5944-6; Bertonatti C, 2000, SITUACIO AMBIENTAL A; Bilenca D. N., 2004, AREAS VALIOSAS PASTI; Brouillet L, 2010, VASCAN DATABASE VASC; Buckley YM, 2006, J APPL ECOL, V43, P848, DOI 10.1111/j.1365-2664.2006.01210.x; CENET, 2008, PMEP PEST MAN ED; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; de Villalobos AE, 2010, ACTA OECOL, V36, P514, DOI 10.1016/j.actao.2010.07.004; Farji-Brener AG, 2000, STUD NEOTROP FAUNA E, V35, P131, DOI 10.1076/0165-0521(200008)35:2;1-9;FT131; Farji-Brener AG, 2000, J VEG SCI, V11, P453, DOI 10.2307/3236638; Farji-Brener AG, 2008, P ROY SOC B-BIOL SCI, V275, P1431, DOI 10.1098/rspb.2008.0154; Finch-Savage WE, 2012, SEED SCI RES, V22, P243, DOI 10.1017/S0960258512000165; Garcia C, 2007, MOL ECOL, V16, P1947, DOI 10.1111/j.1365-294X.2006.03126.x; Gercekcioglu R, 2012, TURK J AGRIC FOR, V23, P145; Ghayyad M., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P163; Gosper CR, 2005, DIVERS DISTRIB, V11, P549, DOI 10.1111/j.1366-9516.2005.00195.x; Grell MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-928; Grisez T. J., 2008, WOODY PLANT SEED MAN, V727, P875; Heidari M., 2008, American-Eurasian Journal of Agricultural and Environmental Science, V3, P114; Heleno RH, 2013, BIOL INVASIONS, V15, P1143, DOI 10.1007/s10530-012-0357-z; HERRERA CM, 1984, ECOL MONOGR, V54, P1, DOI 10.2307/1942454; HERRERA CM, 1981, ECOL MONOGR, V51, P203, DOI 10.2307/2937263; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Iliev N., 2012, FORESTRY IDEAS, V18, P28; Jeschke JM, 2013, AMBIO, V42, P541, DOI 10.1007/s13280-013-0387-5; Jordaan LA, 2012, S AFR J BOT, V80, P13, DOI 10.1016/j.sajb.2012.01.007; Jordaan LA, 2012, BIOTROPICA, V44, P738, DOI 10.1111/j.1744-7429.2012.00875.x; Jordaan LA, 2011, BIOL INVASIONS, V13, P1917, DOI 10.1007/s10530-011-0013-z; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; KREFTING LW, 1949, ECOL MONOGR, V19, P271, DOI 10.2307/1943538; Long M, 1997, ACTUALIZACIO CONOCIM; Meyer GA, 1998, AM MIDL NAT, V140, P129, DOI 10.1674/0003-0031(1998)140[0129:IOSPBF]2.0.CO;2; Munoz MC, 2013, INVASIVE PLANT ECOLOGY, P121; MURRAY KG, 1994, ECOLOGY, V75, P989, DOI 10.2307/1939422; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Pipinis E, 2012, NOT BOT HORTI AGROBO, V40, P183; Prada MA, 2008, MANUAL PROPAGACIO AR; Amodeo MR, 2013, PLANT ECOL, V214, P1299, DOI 10.1007/s11258-013-0252-4; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2014, BIOL INVASIONS, V16, P473, DOI 10.1007/s10530-013-0606-9; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Robertson AW, 2006, FUNCT ECOL, V20, P58, DOI 10.1111/j.1365-2435.2005.01057.x; Rodriguez-Perez J, 2005, FUNCT ECOL, V19, P699, DOI 10.1111/j.0269-8463.2005.00971.x; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sebert-Cuvillier E, 2010, BIOL INVASIONS, V12, P1183, DOI 10.1007/s10530-009-9539-8; SWEARINGEN J, 2008, WEEDUS DATABASE PLAN; Thabethe V, 2015, BIOL INVASIONS, V17, P3029, DOI 10.1007/s10530-015-0932-1; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; Traveset A, 1998, ECOL EVOL SYST, V1, P151, DOI DOI 10.1078/1433-8319-00057; Traveset A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P143; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; Vivian-Smith GE, 2010, INVAS PLANT SCI MANA, V3, P93, DOI 10.1614/IPSM-D-09-00011.1; Webb CJ, 1988, FLORA NZ, V4; Yagihashi T, 1999, ECOL RES, V14, P71, DOI 10.1046/j.1440-1703.1999.141278.x; Yagihashi T., 2000, J FOREST RES-JPN, V5, P213, DOI [10.1007/BF02762405, DOI 10.1007/BF02762405]; Zalba SM, 2015, WEED RES, V55, P546, DOI 10.1111/wre.12171; Zalba SM, 2002, BIOL INVASIONS, V4, P55, DOI DOI 10.1023/A:1020532609792	69	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172423	10.1371/journal.pone.0172423	http://dx.doi.org/10.1371/journal.pone.0172423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207815	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500133
J	Xu, LY; Munir, K; Kanabkaew, C; Le Coeur, S				Xu, Luyi; Munir, Kerim; Kanabkaew, Cheeraya; Le Coeur, Sophie			Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand	PLOS ONE			English	Article							DIAGNOSIS DISCLOSURE; MEDICATION ADHERENCE; POSITIVE CHILDREN; THERAPY; OUTCOMES; YOUTH; PREDICTORS; CHALLENGES; BARRIERS; HIV/AIDS	Background Existing studies have suggested decreased adherence and rebound in mortality in perinatally HIV-infected adolescents receiving antiretroviral therapy (ART) as compared to adults and young children. Methods We used both quantitative and qualitative approaches to identify factors influencing adherence among perinatally infected adolescents in Thailand. We analyzed data from 568 pairs of perinatally infected adolescents (aged 12-19) and their primary caregivers in the Teens Living With Antiretrovirals (TEEWA) study, a cross-sectional survey conducted in 2010-2012. We also conducted 12 in-depth interviews in 2014 with infected adolescents or their primary caregivers to elicit experiences of living with long-term ART. Results From the quantitative analysis, a total of 275 (48.4%) adolescents had evidence of suboptimal adherence based on this composite outcome: adolescents self-reported missing doses in the past 7 days, caregiver rating of overall adherence as suboptimal, or latest HIV-RNA viral load >= 1000 copies/ml. In multivariate logistic regression analysis, younger age, having grandparents or extended family members as the primary caregiver, caregiver-assessed poor intellectual ability, having a boy/girlfriend, frequent online chatting, self-reported unhappiness and easiness in asking doctors questions were significantly associated with suboptimal adherence. From the in-depth interviews, tensed relationships with caregivers, forgetfulness due to busy schedules, and fear of disclosing HIV status to others, especially boy/girlfriends, were important contributors to suboptimal adherence. Social and emotional support and counseling from peer group was consistently reported as a strong adherence-promoting factor. Conclusion Our findings highlight unique barriers of ART adherence among the perinatally infected adolescents. Future interventions should be targeted at helping adolescents to improve interpersonal relationships and build adaptive skills in recognizing and addressing challenging situations related to ART taking.	[Xu, Luyi; Munir, Kerim] Harvard Med Sch, Boston, MA 02115 USA; [Munir, Kerim] Boston Childrens Hosp, Div Dev Med, Dev Med Ctr, Boston, MA USA; [Kanabkaew, Cheeraya; Le Coeur, Sophie] Inst Rech Dev IRD 174 PHPT, Chiang Mai, Thailand; [Kanabkaew, Cheeraya; Le Coeur, Sophie] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai, Thailand; [Le Coeur, Sophie] INED, Paris, France; [Le Coeur, Sophie] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health	Xu, LY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	luyi_xu@hms.harvard.edu	Munir, Kerim/D-6910-2015	Munir, Kerim/0000-0002-2404-1806	Sidaction [AI22-1/01855]; Oxfam Great Britain, Thailand [THAA51]; Scholars in Medicine, Harvard Medical School, Boston, USA; Thai Studies Fund, Harvard University Asia Center, Boston, USA; NIMH / Fogarty International Center, National Institutes of Health NCD-LIFESPAN Global Mental Health/Developmental Disorders Research Program [D43TW009680]; FOGARTY INTERNATIONAL CENTER [D43TW009680] Funding Source: NIH RePORTER	Sidaction; Oxfam Great Britain, Thailand; Scholars in Medicine, Harvard Medical School, Boston, USA; Thai Studies Fund, Harvard University Asia Center, Boston, USA; NIMH / Fogarty International Center, National Institutes of Health NCD-LIFESPAN Global Mental Health/Developmental Disorders Research Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Sidaction, grant AI22-1/01855, (https://www.sidaction.org/) - receiver: SL; Oxfam Great Britain, Thailand, grant THAA51, (http://www.oxfam.org.uk/) -receiver: Marc Lallemant; Scholars in Medicine, Harvard Medical School, Boston, USA, (http://hms.harvard.edu/departments/medical-education/student-services/scholars-medicine-sim) -receiver: LX; Thai Studies Fund, Harvard University Asia Center, Boston, USA, (http://asiacenter.harvard.edu/grants/students/southeastasia) -receiver: LX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NIMH / Fogarty International Center, National Institutes of Health NCD-LIFESPAN Global Mental Health/Developmental Disorders Research Program, grant D43TW009680, (www.fic.nih.gov) -receiver: KM The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Bernays S, 2014, LANCET, V383, P1355, DOI 10.1016/S0140-6736(13)62328-4; Boon-yasidhi V, 2016, INT J STD AIDS, V27, P288, DOI 10.1177/0956462415579590; Boon-Yasidhi V, 2013, AIDS CARE, V25, P756, DOI 10.1080/09540121.2012.749331; Boussari O, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/1471-2288-15-10; Chandler CN AE, 2013, LOST TRANSITIONS CUR, DOI [10.1007/s10461-012-0364-1, DOI 10.1007/S10461-012-0364-1]; Chandwani S, 2012, J ADOLESCENT HEALTH, V51, P242, DOI 10.1016/j.jadohealth.2011.12.013; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; Evans SD, 2015, AIDS PATIENT CARE ST, V29, P43, DOI 10.1089/apc.2014.0058; Falagas ME, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-13; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; Kanabkaew C, 2012, C AM PUBL HLTH ASS S; Kang E, 2015, INT J STD AIDS, V26, P534, DOI 10.1177/0956462414545524; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kawuma R, 2014, AJAR-AFR J AIDS RES, V13, P189, DOI 10.2989/16085906.2014.927778; Konstantopoulos C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu119; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Louthrenoo O, 2013, J INT ASS PROVIDERS; Lowenthal ED, 2014, LANCET INFECT DIS; Lowenthal ED, 2015, JAMA PEDIATR, V169, P498, DOI 10.1001/jamapediatrics.2014.3785; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; Mofenson LM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18650; Mupambireyi Z, 2014, CHILD YOUTH SERV REV, V45, P106, DOI 10.1016/j.childyouth.2014.03.026; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Naar-King S, 2013, J PEDIATR PSYCHOL, V38, P664, DOI 10.1093/jpepsy/jst017; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nyogea D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0753-y; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Reisner Sari L, 2009, Top HIV Med, V17, P14; Rongkavilit Chokechai, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.004; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Sirikum C, 2014, AIDS CARE, V26, P1144, DOI 10.1080/09540121.2014.894614; Sohn AH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18555; Tulloch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099061; UNAIDS, 2015, 2014 HIV AIDS EST; UNICEF, 2015, AD RAD AS PAC AIDS R; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; White YRG, 2008, W INDIAN MED J, V57, P231; Williams PL, 2006, PEDIATRICS, V118, pE1745, DOI 10.1542/peds.2006-0493	47	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172392	10.1371/journal.pone.0172392	http://dx.doi.org/10.1371/journal.pone.0172392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207891	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500130
J	Alessandretti, L; Sapiezynski, P; Lehmann, S; Baronchelli, A				Alessandretti, Laura; Sapiezynski, Piotr; Lehmann, Sune; Baronchelli, Andrea			Multi-scale spatio-temporal analysis of human mobility	PLOS ONE			English	Article							BEHAVIOR; PATTERNS; MODEL	The recent availability of digital traces generated by phone calls and online logins has significantly increased the scientific understanding of human mobility. Until now, however, limited data resolution and coverage have hindered a coherent description of human displacements across different spatial and temporal scales. Here, we characterise mobility behaviour across several orders of magnitude by analysing similar to 850 individuals' digital traces sampled every similar to 16 seconds for 25 months with similar to 10 meters spatial resolution. We show that the distributions of distances and waiting times between consecutive locations are best described by log-normal and gamma distributions, respectively, and that natural time-scales emerge from the regularity of human mobility. We point out that log-normal distributions also characterise the patterns of discovery of new places, implying that they are not a simple consequence of the routine of modern life.	[Alessandretti, Laura; Baronchelli, Andrea] City Univ London, London EC1V 0HB, England; [Sapiezynski, Piotr; Lehmann, Sune] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Lehmann, Sune] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen O, Denmark	City University London; Technical University of Denmark; University of Copenhagen; Niels Bohr Institute	Baronchelli, A (corresponding author), City Univ London, London EC1V 0HB, England.	Andrea.Baronchelli.1@city.ac.uk	Baronchelli, Andrea/F-9550-2016	Baronchelli, Andrea/0000-0002-0255-0829; Lehmann, Sune/0000-0001-6099-2345; Alessandretti, Laura/0000-0001-6003-1165	Villum Foundation; University of Copenhagen; Villum Fonden [00007192] Funding Source: researchfish	Villum Foundation(Villum Fonden); University of Copenhagen; Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation, http://villumfoundation.dk/C12576AB0041F11B/0/4F7615B6F43A8EA5C1257AEF003D9930?OpenDocument, Young Investigator programme 2012, High Resolution Networks (SL) and University of Copenhagen, http://dsin.ku.dk/news/ucph_funds/, through the UCPH2016 Social Fabric grant (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2013, CHAOS SOLITON FRACT, V56, P101, DOI 10.1016/j.chaos.2013.07.013; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cheng Zhiyuan, 2011, ICWSM, P81; Deville P, 2016, PROCEEDINGS OF THE N; Gallotti R, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0055-z; Gong L, 2016, CARTOGR GEOGR INF SC, V43, P103, DOI 10.1080/15230406.2015.1014424; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Hasan S, 2013, J STAT PHYS, V151, P304, DOI 10.1007/s10955-012-0645-0; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kivela M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052813; Krings G, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds4; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Liu H, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60232-1; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Liu Y, 2012, J GEOGR SYST, V14, P463, DOI 10.1007/s10109-012-0166-z; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Mouri H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042124; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Paul T, 2016, LECT NOTES COMPUT SC, V9927, P145, DOI 10.1007/978-3-319-45738-3_10; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Poletto C, 2013, J THEOR BIOL, V338, P41, DOI 10.1016/j.jtbi.2013.08.032; Ranjan G, 2012, MOB COMPUT COMMUN RE, V16, P33, DOI 10.1145/2412096.2412101; Raposo EP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434003; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Riccardo G, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500611; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Santos MC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061114; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Tang JJ, 2015, PHYSICA A, V438, P140, DOI 10.1016/j.physa.2015.06.032; Van Mieghem P, 2011, EUR PHYS J B, V83, P251, DOI 10.1140/epjb/e2011-20124-0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang WJ, 2015, PHYSICA A, V420, P134, DOI 10.1016/j.physa.2014.10.085; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Yan X-Y., 2013, SCI REP-UK, P3; Yao CZ, 2016, TRANSPORT RES A-POL, V87, P51, DOI 10.1016/j.tra.2016.03.005; Zhao K, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P1136, DOI 10.1109/ICDMW.2015.176	57	42	42	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171686	10.1371/journal.pone.0171686	http://dx.doi.org/10.1371/journal.pone.0171686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199347	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000394424400043
J	Quyen, LTN; Nguyen, LH; Tran, BX; Huong, TTP; Le, HT; Nguyen, HD; Tran, TD; Do, CD; Nguyen, CM; Vu, TMT; Latkin, C; Zhang, MWB; Ho, RCM				Quyen Le Thi Nguyen; Long Hoang Nguyen; Bach Xuan Tran; Huong Thi Thu Phan; Huong Thi Le; Hinh Duc Nguyen; Tho Dinh Tran; Cuong Duy Do; Cuong Manh Nguyen; Vu Thi Minh Thuc; Latkin, Carl; Zhang, Melvyn W. B.; Ho, Roger C. M.			Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ATTITUDES; HIV; COHORT; RISK	Background Viral load testing is considered the gold standard for monitoring HIV treatment; however, given its high cost, some patients cannot afford viral load testing if this testing is not subsidized. Since foreign aid for HIV/AIDS in Vietnam is rapidly decreasing, we sought to assess willingness to pay (WTP) for viral load and CD4 cell count tests among HIV-positive patients, and identified factors that might inform future co-payment schemes. Methods A multi-site cross-sectional survey was conducted with 1133 HIV-positive patients on antiretroviral therapy (ART) in Hanoi and Nam Dinh. Patients' health insurance coverage, quality of life, and history of illicit drug use were assessed. A contingent valuation approach was employed to measure patients' WTP for CD4 cell count and viral load testing. Results HIV-positive patients receiving ART at provincial sites reported more difficulty obtaining health insurance (HI) and had the overall the poorest quality of life. Most patients (90.9%) were willing to pay for CD4 cell count testing; here, the mean WTP was valued at US$8.2 (95% CI = 7.6-8.8 US$) per test. Most patients (87.3%) were also willing to pay for viral load testing; here, mean WTP was valued at US$18.6 (95% CI = 16.3-20.9 US$) per test. High income, high education level, and hospitalization were positively associated with WTP, while co-morbidity with psychiatric symptoms and trouble paying for health insurance were both negatively related to WTP. Conclusions These findings raise concerns that HIV-positive patients in Vietnam might have low WTP for CD4 cell count and viral load testing. This means that without foreign financial subsidies, many of these patients would likely go without these important tests. Treating psychiatric co-morbidities, promoting healthcare services utilization, and removing barriers to accessing health insurance may increase WTP for monitoring of HIV/AIDS treatment among HIV+-positive Vietnamese patients.	[Quyen Le Thi Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Bach Xuan Tran; Huong Thi Le; Hinh Duc Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Vu Thi Minh Thuc] Natl Otolaryngol Hosp, Dept Immunol & Allergy, Hanoi, Vietnam; [Huong Thi Thu Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam; [Tho Dinh Tran] Viet Duc Hosp, Dept Hepatobiliary Surg, Hanoi, Vietnam; [Cuong Duy Do] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Cuong Manh Nguyen] Minist Hlth, Dept Int Affairs, Hanoi, Vietnam; [Latkin, Carl] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zhang, Melvyn W. B.] Natl Univ Singapore, Biomed Global Inst Healthcare Res Technol BIGHEAR, Singapore, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore	Duy Tan University; Vietnam National University Hanoi; Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National University of Singapore; National University of Singapore	Quyen, LTN (corresponding author), Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam.	quyen.ighi@gmail.com	Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; 				Arrow K.J., 1993, REPORT NOAA PANEL CO, V58; Bach TX, 2011, BUDGET IMPACT SCALIN; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Bank TW, 2014, GDP PER CAP CURR US; Cawley J, 2008, ECON HUM BIOL, V6, P281, DOI 10.1016/j.ehb.2008.05.003; CCRD, 2013, SUST FIN HIV AIDS SE; Control VAoHA, 2015, ANN REV HIV AIDS CON; Corso PS, 2013, INT J ENV RES PUB HE, V10, P1342, DOI 10.3390/ijerph10041342; Cross MJ, 2000, RHEUMATOLOGY, V39, P1242, DOI 10.1093/rheumatology/39.11.1242; Development FEAS, 2000, APPL CONT VAL METH D; EuroQol Research, 2015, EQ 5D 5L USER GUIDE; FAUCI AS, 1984, ANN INTERN MED, V100, P92, DOI 10.7326/0003-4819-100-1-92; [FHI360 PEPFAR USAID Committee HCMCPA], 2014, OPP EXP HIV TREATM P; [Finance Mo Health Mo], 2015, 372015TTLTBYTBTC HLT; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Frontieres MB, 2012, UNDETECTABLE VIRAL L; Frontieres MS, 2013, HIV STAT UND 4 ESS I; Gale HB, 2013, CLIN INFECT DIS, V5, P1340, DOI [10.1093/CID/CI004, DOI 10.1093/CID/CI004]; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; HANEMANN M, 1991, AM J AGR ECON, V73, P1255, DOI 10.2307/1242453; Health  V. M. o, 2014, OPT VIET NAMS HIV RE; Health VMo, 2015, 152015TTBYT HLTH VMO; Herriges JA, 1996, J ENVIRON ECON MANAG, V30, P112, DOI 10.1006/jeem.1996.0008; HIV/AIDS JUNPo, 2016, NEED ROUT VIR LOAD T; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jorgensen BS, 1999, ENVIRON RESOUR ECON, V14, P131, DOI 10.1023/A:1008372522243; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Lang HC, 2010, VALUE HEALTH, V13, P743, DOI 10.1111/j.1524-4733.2010.00743.x; Nguyen LH, 2016, AIDS BEHAV, V20, P848, DOI 10.1007/s10461-015-1188-6; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Organization WH, 2010, ANT THER HIV INF AD; Organization WH, 2015, GUID START ANT THER; Organization WH, 2014, GLOB UPD HLTH SECT R; Organization WH, 2013, CONS GUID US ANT DRU, P272; Organization WH, 2014, MARCH 2014 S 2013 CO; PHILLIPS AN, 1991, LANCET, V337, P389; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Rosenberger RS, 2012, J FOREST ECON, V18, P271, DOI 10.1016/j.jfe.2012.06.003; SAAH AJ, 1994, J ACQ IMMUN DEF SYND, V7, P287; Ternent L, 2010, EXPLORING BIASES DOU; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Tran BX, 2016, PLOS ONE, V11; Tran BX, 2016, INT J DRUG POLICY	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172050	10.1371/journal.pone.0172050	http://dx.doi.org/10.1371/journal.pone.0172050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199405	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424400069
J	De Groot, AS; Tounkara, K; Rochas, M; Beseme, S; Yekta, S; Diallo, FS; Tracy, JK; Teguete, I; Koita, OA				De Groot, Anne S.; Tounkara, Karamoko; Rochas, Mali; Beseme, Sarah; Yekta, Shahla; Diallo, Fanta Siby; Tracy, J. Kathleen; Teguete, Ibrahima; Koita, Ousmane A.			Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; RISK-FACTORS; PREVALENCE; DELIVERY; BARRIERS; AFRICA; WOMEN	Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.	[De Groot, Anne S.; Rochas, Mali; Beseme, Sarah; Yekta, Shahla] GAIA Vaccine Fdn, Providence, RI 02903 USA; [De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat iCubed, 825 Chalkstone Ave, Providence, RI 02908 USA; [Tounkara, Karamoko] Fdn GAIA, Bamako, Mali; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Publ Hlth, Baltimore, MD 21201 USA; [Teguete, Ibrahima] Hop Gabriel Toure, Bamako, Mali; [Koita, Ousmane A.] USTTB, Sci & Technol Fac FST, Lab Appl Mol Biol LBMA, Bamako, Mali	University of Rhode Island; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Science & Technology of Bamako	De Groot, AS (corresponding author), GAIA Vaccine Fdn, Providence, RI 02903 USA.; De Groot, AS (corresponding author), Univ Rhode Isl, Inst Immunol & Informat iCubed, 825 Chalkstone Ave, Providence, RI 02908 USA.	dr.annie.degroot@gmail.com	De Groot, Annie/B-6221-2013	De Groot, Annie/0000-0001-5911-1459	Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MSD); GAIA Vaccine Foundation; EpiVax, Inc.	Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MSD); GAIA Vaccine Foundation; EpiVax, Inc.	This study was supported in part by a research grant from the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (MS&D). The opinions expressed in this paper are those of the authors and do not necessarily represent those of MS&D. MS&D had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Donors to GAIA Vaccine Foundation provided additional financial support for field site identification and logistics. EpiVax, Inc. provided funding in the form of salaries for author Anne S De Groot, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bruni L, 2014, 20140131 ICO INF CTR; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Curry DW, 2014, J HEALTH POPUL NUTR, V32, P356; De Groot A, 2008, VACCINE, V26, P3783, DOI 10.1016/j.vaccine.2008.04.088; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Herrmann C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1660-8; Katz IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072094; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Markovic M, 2005, SOC SCI MED, V61, P2528, DOI 10.1016/j.socscimed.2005.05.001; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munthali AC, 2015, PATIENT PREFER ADHER, V9, P501, DOI 10.2147/PPA.S69286; Poole DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056402; Tagbo BN, 2014, VACCINE, V32, P6157, DOI 10.1016/j.vaccine.2014.08.053; Tracy JK, 2014, VACCINE, V32, P3316, DOI 10.1016/j.vaccine.2014.03.067; Tracy JK, 2011, TROP MED INT HEALTH, V16, P1432, DOI 10.1111/j.1365-3156.2011.02843.x; Tracy L, 2011, CLIN INFECT DIS, V52, P641, DOI 10.1093/cid/ciq190; Upadhyay UD, 2012, INT PERSPECT SEX R H, V38, P78, DOI 10.1363/3807812; Wong CA, 2011, VACCINE, V29, P878, DOI 10.1016/j.vaccine.2010.10.018; World Health Organization, 2013, COMPR CERV CANC PREV; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	25	20	20	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171631	10.1371/journal.pone.0171631	http://dx.doi.org/10.1371/journal.pone.0171631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192460	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800033
J	Johnson, AN; Weil, PA				Johnson, Amanda N.; Weil, P. Anthony			Identification of a transcriptional activation domain in yeast repressor activator protein 1 (Rap1) using an altered DNA-binding specificity variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; protein engineering; Saccharomyces cerevisiae; transcription regulation; yeast; altered DNA binding specificity; transcription activation; transcription activator	RNA-POLYMERASE-II; HYDROPHOBIC AMINO-ACIDS; C-TERMINAL DOMAINS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ESCHERICHIA-COLI; BUDDING YEAST; IN-VIVO; REGULATORY MECHANISMS; HISTONE ACETYLATION	Repressor activator protein 1 (Rap1) performs multiple vital cellular functions in the budding yeast Saccharomyces cerevisiae. These include regulation of telomere length, transcriptional repression of both telomere-proximal genes and the silent mating type loci, and transcriptional activation of hundreds of mRNA-encoding genes, including the highly transcribed ribosomal protein- and glycolytic enzyme-encoding genes. Studies of the contributions of Rap1 to telomere length regulation and transcriptional repression have yielded significant mechanistic insights. However, the mechanism of Rap1 transcriptional activation remains poorly understood because Rap1 is encoded by a single copy essential gene and is involved in many disparate and essential cellular functions, preventing easy interpretation of attempts to directly dissect Rap1 structure-function relationships. Moreover, conflicting reports on the ability of Rap1-heterologous DNA-binding domain fusion proteins to serve as chimeric transcriptional activators challenge use of this approach to study Rap1. Described here is the development of an altered DNA-binding specificity variant of Rap1 (Rap1(AS)). We used Rap1(AS) to map and characterize a 41-amino acid activation domain (AD) within the Rap1 C terminus. We found that this AD is required for transcription of both chimeric reporter genes and authentic chromosomal Rap1 enhancer-containing target genes. Finally, as predicted for a bona fide AD, mutation of this newly identified AD reduced the efficiency of Rap1 binding to a known transcriptional coactivator TFIID-binding target, Taf5. In summary, we show here that Rap1 contains an AD required for Rap1-dependent gene transcription. The Rap1(AS) variant will likely also be useful for studies of the functions of Rap1 in other biological pathways.	[Johnson, Amanda N.; Weil, P. Anthony] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu		Meyer Johnson, Amanda/0000-0001-7594-6747	National Institutes of Health [R01GM115892, T32DK007563]; National Institutes of Health Cancer Center Core Grant [5P30CA06848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM115892 (to P. A. W.) and National Institutes of Health Cancer Center Core Grant 5P30CA06848. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of National Institutes of Health Grant Training Grant T32DK007563 during the course of these studies.	An YF, 2005, APPL MICROBIOL BIOT, V68, P774, DOI 10.1007/s00253-005-1948-8; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Brachmann CB, 1998, YEAST, V14, P115; BRENNAN MB, 1980, J MOL BIOL, V136, P333, DOI 10.1016/0022-2836(80)90377-0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CHAMBERS A, 1989, MOL CELL BIOL, V9, P5516, DOI 10.1128/MCB.9.12.5516; Chambers A, 1995, CURR GENET, V29, P1, DOI 10.1007/BF00313187; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; CHOW J, 1994, MOL MICROBIOL, V11, P919, DOI 10.1111/j.1365-2958.1994.tb00371.x; Chu SW, 2012, GENOME RES, V22, P1889, DOI 10.1101/gr.139014.112; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Duffy EE, 2015, MOL CELL, V59, P858, DOI 10.1016/j.molcel.2015.07.023; Feeser EA, 2008, J MOL BIOL, V380, P520, DOI 10.1016/j.jmb.2008.04.078; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Graham IR, 1999, MOL CELL BIOL, V19, P7481; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Gregory BD, 2005, MOL MICROBIOL, V56, P1208, DOI 10.1111/j.1365-2958.2005.04624.x; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HENRY YAL, 1990, NUCLEIC ACIDS RES, V18, P2617, DOI 10.1093/nar/18.9.2617; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HUET J, 1985, EMBO J, V4, P3539, DOI 10.1002/j.1460-2075.1985.tb04114.x; Idrissi FZ, 1998, J MOL BIOL, V284, P925, DOI 10.1006/jmbi.1998.2215; Idrissi FZ, 2001, J BIOL CHEM, V276, P26090, DOI 10.1074/jbc.M101746200; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Irvin JD, 2006, J BIOL CHEM, V281, P6404, DOI 10.1074/jbc.M513776200; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kasahara K, 2008, NUCLEIC ACIDS RES, V36, P1343, DOI 10.1093/nar/gkm1068; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; KIM J, 1993, P NATL ACAD SCI USA, V90, P4513, DOI 10.1073/pnas.90.10.4513; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Knight B, 2014, GENE DEV, V28, P1695, DOI 10.1101/gad.244434.114; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Layer JH, 2013, J BIOL CHEM, V288, P23273, DOI 10.1074/jbc.M113.486829; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Ma DM, 1996, P NATL ACAD SCI USA, V93, P6583, DOI 10.1073/pnas.93.13.6583; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Matot B, 2012, NUCLEIC ACIDS RES, V40, P3197, DOI 10.1093/nar/gkr1166; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Miyake T, 2000, J BIOL CHEM, V275, P40169, DOI 10.1074/jbc.M007138200; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; MURTHY MSS, 1975, MUTAT RES, V27, P219, DOI 10.1016/0027-5107(75)90080-9; NIEUWINT RTM, 1989, CURR GENET, V15, P247, DOI 10.1007/BF00447039; Nilsson MTI, 2004, BIOCHEMISTRY-US, V43, P12038, DOI 10.1021/bi049122k; Ohtsuki K, 2010, NUCLEIC ACIDS RES, V38, P1805, DOI 10.1093/nar/gkp1172; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; PFAU J, 1994, BIOCHEMISTRY-US, V33, P11391, DOI 10.1021/bi00203a038; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ranish JA, 1996, CURR OPIN GENET DEV, V6, P151, DOI 10.1016/S0959-437X(96)80044-X; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Reja R, 2015, GENE DEV, V29, P1942, DOI 10.1101/gad.268896.115; Ren XD, 2011, MOL CELL, V42, P342, DOI 10.1016/j.molcel.2011.04.011; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; SCOTT EW, 1993, MOL CELL BIOL, V13, P543, DOI 10.1128/MCB.13.1.543; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Singh MV, 2004, MOL CELL BIOL, V24, P4929, DOI 10.1128/MCB.24.11.4929-4942.2004; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; Tomar RS, 2008, EMBO J, V27, P1575, DOI 10.1038/emboj.2008.93; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Uprety B, 2015, MOL CELL BIOL, V35, P2947, DOI 10.1128/MCB.01524-14; VIGNAIS ML, 1987, EMBO J, V6, P1451, DOI 10.1002/j.1460-2075.1987.tb02386.x; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Warfield L, 2014, P NATL ACAD SCI USA, V111, pE3506, DOI 10.1073/pnas.1412088111; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Yu LN, 2001, J BIOL CHEM, V276, P33257, DOI 10.1074/jbc.M104354200; Zhang W, 2011, BIOCHEM BIOPH RES CO, V404, P1055, DOI 10.1016/j.bbrc.2010.12.109; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05	130	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5705	5723		10.1074/jbc.M117.779181	http://dx.doi.org/10.1074/jbc.M117.779181			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196871	hybrid, Green Published			2022-12-26	WOS:000398813200009
J	Moody, LR; Barrett-Wilt, GA; Sussman, MR; Messing, A				Moody, Laura R.; Barrett-Wilt, Gregory A.; Sussman, Michael R.; Messing, Albee			Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of alexander disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glial cell; intermediate filament; mouse; protein turnover; Alexander disease; SILAC; SILAM; gfap; glial fibrillary acidic protein	ALPHA-B-CRYSTALLIN; CYTOSKELETAL PROTEINS; GFAP ACCUMULATION; ROSENTHAL FIBERS; STRESS-RESPONSE; CELL-CULTURE; ASTROCYTES; MUTATIONS; MICE; DEGRADATION	Mutations in the astrocyte-specific intermediate filament glial fibrillary acidic protein (GFAP) lead to the rare and fatal disorder, Alexander disease (AxD). A prominent feature of the disease is aberrant accumulation of GFAP. It has been proposed that this accumulation occurs because of an increase in gene transcription coupled with impaired proteasomal degradation, yet this hypothesis remains untested. We therefore sought to directly investigate GFAP turnover in a mouse model of AxD that is heterozygous for a disease-causing point mutation (Gfap(R236H/+)) (and thus expresses both wild-type and mutant protein). Stable isotope labeling by amino acids in cell culture, using primary cortical astrocytes, indicated that the in vitro half-lives of total GFAP in astrocytes from wild-type and mutant mice were similar at approximate to 3-4 days. Surprisingly, results obtained with stable isotope labeling of mammals revealed that, in vivo, the half-life of GFAP in mutant mice (15.4 +/- 0.5 days) was much shorter than that in wild-type mice (27.5 +/- 1.6 days). These unexpected in vivo data are most consistent with a model in which synthesis and degradation are both increased. Our work reveals that an AxD-causing mutation alters GFAP turnover kinetics in vivo and provides an essential foundation for future studies aimed at preventing or reducing the accumulation of GFAP. In particular, these data suggest that elimination of GFAP might be possible and occurs more quickly than previously surmised.	[Moody, Laura R.; Messing, Albee] Univ Wisconsin Madison, Waisman Ctr, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA; [Barrett-Wilt, Gregory A.; Sussman, Michael R.] Univ Wisconsin Madison, Ctr Biotechnol, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA; [Sussman, Michael R.] Univ Wisconsin Madison, Dept Biochem, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin Madison, Dept Comparat Biosci, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Messing, A (corresponding author), Univ Wisconsin Madison, Waisman Ctr, 1500 Highland Ave,Rm 713B, Madison, WI 53705 USA.	amessing@wisc.edu		Messing, Albee/0000-0001-6049-0521	Jelte Rijkaart Fund; National Institutes of Health [NS42803, HD076892, HD03352, HD090256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090256, P30HD003352, P01HD076892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER	Jelte Rijkaart Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Jelte Rijkaart Fund and by National Institutes of Health Grants NS42803, HD076892, HD03352, and HD090256. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Chen YS, 2011, EXP CELL RES, V317, P2252, DOI 10.1016/j.yexcr.2011.06.017; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Cho WS, 2010, HUM MOL GENET, V19, P3169, DOI 10.1093/hmg/ddq227; Cho WS, 2009, EXP CELL RES, V315, P1260, DOI 10.1016/j.yexcr.2008.12.012; Daniels CML, 2012, J NEUROSCI, V32, P10507, DOI 10.1523/JNEUROSCI.1494-12.2012; DEARMOND SJ, 1986, J NEUROCHEM, V47, P1749, DOI 10.1111/j.1471-4159.1986.tb13084.x; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Heaven MR, 2016, J PROTEOME RES, V15, P2265, DOI 10.1021/acs.jproteome.6b00316; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; INAGAKI M, 1994, BRAIN PATHOL, V4, P239, DOI 10.1111/j.1750-3639.1994.tb00839.x; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Perng MD, 1999, J CELL SCI, V112, P2099; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; RAJU TR, 1980, BRAIN RES, V200, P225, DOI 10.1016/0006-8993(80)91114-2; ROLLAND B, 1990, DEV BRAIN RES, V56, P144, DOI 10.1016/0165-3806(90)90175-X; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SMITH ME, 1984, NEUROCHEM RES, V9, P1493, DOI 10.1007/BF00964675; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tang GM, 2010, J BIOL CHEM, V285, P10527, DOI 10.1074/jbc.M109.067975; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Walker AK, 2014, J NEUROSCI, V34, P6448, DOI 10.1523/JNEUROSCI.0248-14.2014; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	51	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5814	5824		10.1074/jbc.M116.772020	http://dx.doi.org/10.1074/jbc.M116.772020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223355	Green Published, hybrid			2022-12-26	WOS:000398813200018
J	Schlame, M; Xu, Y; Ren, MD				Schlame, Michael; Xu, Yang; Ren, Mindong			The Basis for Acyl Specificity in the Tafazzin Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARTH-SYNDROME; LYSOPHOSPHOLIPID ACYLTRANSFERASES; BIOCHEMICAL THERMODYNAMICS; CARDIOLIPIN; TRANSACYLATION; METABOLISM; MECHANISM; MEMBRANE; KINETICS; P-31-NMR	Tafazzin is a mitochondrial enzyme that transfers fatty acids from phospholipids to lysophospholipids. Mutations in tafazzin cause abnormal molecular species of cardiolipin and the clinical phenotype of Barth syndrome. However, the mechanism by which tafazzin creates acyl specificity has been controversial. We have shown that the lipid phase state can produce acyl specificity in the tafazzin reaction, but others have reported that tafazzin itself carries enzymatic specificity. To resolve this issue, we replicated and expanded the controversial experiments, i.e. the transfer of different acyl groups from phosphatidylcholine to monolysocardiolipin by yeast tafazzin. Our data show that this reaction requires the presence of detergent and does not take place in liposomes but in mixed micelles. To separate thermodynamic (lipid-dependent) from kinetic (enzyme-dependent) parameters, we followed the accumulation of cardiolipin during the reaction from the initial state to the equilibrium state. The transacylation rates of different acyl groups varied over 2 orders of magnitude and correlated tightly with the concentration of cardiolipin in the equilibrium state (lipid-dependent parameter). In contrast, the rates by which different transacylations approached the equilibrium state were very similar (enzyme-dependent parameter). Furthermore, we found that tafazzin catalyzes the remodeling of cardiolipin by combinations of forward and reverse transacylations, essentially creating an equilibrium distribution of acyl groups. These data strongly support the idea that the acyl specificity of the tafazzin reaction results from the physical properties of lipids.	[Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Schlame, M (corresponding author), NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA.	michael.schlame@med.nyu.edu			National Institutes of Health [GM115593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM115593 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe M, 2016, J BIOL CHEM, V291, P15491, DOI 10.1074/jbc.M116.718510; Alberty RA, 2006, BIOPHYS CHEM, V124, P11, DOI 10.1016/j.bpc.2006.05.024; Alberty RA, 2011, BIOPHYS CHEM, V155, P89, DOI 10.1016/j.bpc.2011.03.007; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; CULLIS PR, 1980, BIOCHIM BIOPHYS ACTA, V600, P625, DOI 10.1016/0005-2736(80)90466-6; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V684, P47, DOI 10.1016/0005-2736(82)90047-5; DENNIS EA, 1974, ARCH BIOCHEM BIOPHYS, V165, P764, DOI 10.1016/0003-9861(74)90305-1; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Haldane JBS, 1930, ENZYMES, P74; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Neuwald AF, 1997, CURR BIOL, V7, pR465; Noor E, 2013, FEBS LETT, V587, P2772, DOI 10.1016/j.febslet.2013.07.028; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Tyurina YY, 2017, ACS CHEM BIOL, V12, P265, DOI 10.1021/acschembio.6b00995; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001	26	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5499	5506		10.1074/jbc.M116.769182	http://dx.doi.org/10.1074/jbc.M116.769182			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202545	hybrid, Green Published			2022-12-26	WOS:000397875500029
J	Costa, MC; Bessegatto, JA; Alfieri, AA; Weese, JS; Filho, JAB; Oba, A				Costa, Marcio C.; Bessegatto, Jose A.; Alfieri, Amauri A.; Weese, J. Scott; Filho, Joao A. B.; Oba, Alexandre			Different antibiotic growth promoters induce specific changes in the cecal microbiota membership of broiler chicken	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; FECAL MICROBIOTA; POULTRY; PERFORMANCE; DIETS	Antimicrobials are sometimes given to food animals at low doses in order to promote faster growth. However, the mechanisms by which those drugs improve performance are not fully understood. This study aimed to investigate the impact of zinc bacitracin (55g/ton), enramycin (10g/ton); halquinol((R)) (30g/ton); virginiamycin (16,5g/ton) and avilamycin (10g/ton) on the cecal microbiota of broiler chicken, compared to a control group. Six hundred and twenty four chicks (Cobb 500) arriving to an experimental unit were randomly assigned into each treatment with four repetitions per treatment. The cecal content of 16 animals per treatment (n = 96) was used for DNA extraction and sequencing of the V4 region of the 16S rRNA gene using Illumina technology. The use of antimicrobials induced significant changes in membership but not in structure of the cecal microbiota compared to the control group, suggesting a greater impact on the less abundant species of bacteria present in that environment. Halquinol was the only drug that did not affect microbial membership. Firmicutes comprised the major bacterial phylum present in the cecum of all groups. There was no statistical difference in relative abundances of the main phyla between treated animals and the control group (all P> 0.05). Treatment with enramycin was associated with decreased richness and with lower relative abundance of unclassified Firmicutes, Clostridium XI, unclassified Peptostreptococcaceae (all P< 0.001) and greater abundance of Clostridium XIVb (P = 0.004) and Anaerosporobacter spp. (P = 0.015), and treatment with bacitracin with greater relative abundance of Bilophila spp. (P = 0.004). Several bacterial genera were identified as representative of usage of each drug. This study used high throughput sequencing to characterize the impact of several antimicrobials in broiler chicken under controlled conditions and add new insights to the current knowledge on how AGPs affect the cecal microbiota of chicken.	[Costa, Marcio C.; Bessegatto, Jose A.; Alfieri, Amauri A.] Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil; [Weese, J. Scott] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada; [Filho, Joao A. B.; Oba, Alexandre] Univ Estadual Londrina, Dept Anim Sci, Londrina, Parana, Brazil; [Costa, Marcio C.] Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada	Universidade Estadual de Londrina; University of Guelph; Universidade Estadual de Londrina; Universite de Montreal	Costa, MC (corresponding author), Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil.; Costa, MC (corresponding author), Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada.	costamc@gmail.com		Costa, Marcio/0000-0001-5067-7501	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Fasina YO, 2015, POULT SCI; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Han GG, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2604-8; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Latorre JD, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00095; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lu J, 2008, ANIMAL, V2, P669, DOI 10.1017/S1751731108001894; Mancabelli L, 2016, ENVIRON MICROBIOL, P683, DOI [10.3382/ps.2012-02822, DOI 10.3382/PS.2012-02822]; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Miller Mark, 2015, MLO Med Lab Obs, V47, P28; Neumann AP, 2015, J APPL MICROBIOLOGY; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Pedroso AA, 2006, POULTRY SCI, V85, P747, DOI 10.1093/ps/85.4.747; Polansky O, 2016, APPL ENVIRON MICROB, V82, P1569, DOI 10.1128/AEM.03473-15; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Reed S, 2015, NUTRIENTS, V7, P9768, DOI 10.3390/nu7125497; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; STUTZ MW, 1984, POULTRY SCI, V63, P2036, DOI 10.3382/ps.0632036; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091	38	77	82	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171642	10.1371/journal.pone.0171642	http://dx.doi.org/10.1371/journal.pone.0171642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222110	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800016
J	Hajiluian, G; Farhangi, MA; Jahangiry, L				Hajiluian, Ghazaleh; Farhangi, Mahdieh Abbasalizad; Jahangiry, Leila			Mediterranean dietary pattern and VEGF+405 G/C gene polymorphisms in patients with metabolic syndrome: An aspect of gene-nutrient interaction	PLOS ONE			English	Article							SERUM TRIGLYCERIDE RESPONSES; CORONARY-ARTERY-DISEASE; LIFE-STYLE MODIFICATION; RISK-FACTORS; IRANIAN ADULTS; FAT; CHOLESTEROL; PLASMA; FRUIT; MEN	Aims To evaluate the relationship between Mediterranean dietary pattern, anthropometric and metabolic biomarkers and vascular endothelial growth factor ( VEGF) +405 G/C gene polymorphism in patient with metabolic syndrome ( Mets). Materials and methods In this study 150 patients with Mets and 50 healthy subjects were enrolled. Dietary intakes were evaluated with a semi-quantitative food-frequency questionnaire ( FFQ) and Mediterranean dietary quality index ( Med-DQI) was assessed. Anthropometric assessments and blood pressure measurement were performed. Biochemical assays including fasting serum glucose ( FSG), matrix metalloproteinase-3 ( MMP-3), liver enzymes and lipid profiles were also assessed. Polymorphism of +405 G/C VEGF gene was determined utilizing polymerase chain reaction-restriction fragments length polymorphism ( PCR-RFLP) method. Results Serum high density lipoprotein-cholesterol ( HDL-C) was significantly lower and low density lipoprotein cholesterol ( LDL-C), triglyceride ( TG), total cholesterol ( TC) concentrations and FSG were significantly higher in metabolic syndrome patients compared with control group ( P < 0.05). Metabolic syndrome group with high consumption of "cholesterol" had significantly upper serum TG; also high consumption of "fish" and "vegetables-fruits" was associated with a significantly lower serum LDL concentrations. In metabolic syndrome patients with CC genotype, mean score of "saturated fatty acid" subgroup was significantly higher compared with other genotypes; whereas, in healthy individuals, mean score of "fruit-vegetable" subgroup in individuals of CC and GG genotype was significantly higher ( P<0.05). Conclusion Our findings indicated a significant relationship between Mediterranean dietary quality index and both anthropometric and metabolic risk factors. We also indicated a higher "saturated fatty acid" intake in CC genotype among metabolic syndrome patients.	[Hajiluian, Ghazaleh] Tabriz Univ Med Sci, Student Res Comm, Nutr Res Ctr, Fac Nutr, Tabriz, Iran; [Farhangi, Mahdieh Abbasalizad] Tabriz Univ Med Sci, Nutr Res Ctr, Drug Appl Res Ctr, Dept Community Nutr, Tabriz, Iran; [Jahangiry, Leila] Tabriz Univ Med Sci, Hlth Educ & Hlth Promot Dept, Sch Publ Hlth, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Farhangi, MA (corresponding author), Tabriz Univ Med Sci, Nutr Res Ctr, Drug Appl Res Ctr, Dept Community Nutr, Tabriz, Iran.	abbasalizad_m@yahoo.com	, ../J-9427-2017; Jahangiry, Leila/F-9880-2017; Farhangi, Mahdieh Abbasalizad/AAC-6758-2019	, ../0000-0002-0491-5764; Jahangiry, Leila/0000-0002-0491-5764; 				Aggarwal A, 2014, J CARDIOVASC THORAC, V6, P169, DOI 10.15171/jcvtr.2014.006; Aggarwal A, 2014, J CARDIOVASC THORAC, V6, P15, DOI 10.5681/jcvtr.2014.003; Azizi F, 2003, DIABETES RES CLIN PR, V61, P29, DOI 10.1016/S0168-8227(03)00066-4; Azizi F, 2010, ARCH IRAN MED, V13, P243; Barylski M, 2009, ANGIOLOGY, V60, P87, DOI 10.1177/0003319708327165; Brown L, 1999, AM J CLIN NUTR, V69, P30; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COHEN JC, 1988, AM J CLIN NUTR, V47, P825, DOI 10.1093/ajcn/47.5.825; Delavar MA, 2009, ASIA PAC J CLIN NUTR, V18, P285; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Esposito K, 2007, MOL NUTR FOOD RES, V51, P1268, DOI 10.1002/mnfr.200600297; Esteghamati A, 2009, DIABETIC MED, V26, P745, DOI 10.1111/j.1464-5491.2009.02756.x; Farhangi MA, ORCP 2015; Farhangi MA, 2015, INT J DIABETES DEV C, P1; Farzi A, 2014, ASS VASCULAR ENDOTHE, V8, P122; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Georgoulis M, 2015, J HUM NUTR DIET, V28, P409, DOI 10.1111/jhn.12323; Gerber M, 2001, J NUTR, V131, p3051S, DOI 10.1093/jn/131.11.3051S; Gerber MJ, 2000, J AM DIET ASSOC, V100, P1164, DOI 10.1016/S0002-8223(00)00340-0; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Jacobs B, 2004, J NUTR, V134, P1400, DOI 10.1093/jn/134.6.1400; Jahangiry L, 2014, BMC PUBLIC HEALTH, V14, P1; Loktionov A, 2003, J NUTR BIOCHEM, V14, P426, DOI 10.1016/S0955-2863(03)00032-9; Mirmiran P, 2009, METABOLISM, V58, P460, DOI 10.1016/j.metabol.2008.11.002; Mohseni T, 2016, CURR TOP NUTRACEUT R, V14, P49; Moradzadegan A, 2015, J RENIN-ANGIO-ALDO S, V16, P672, DOI 10.1177/1470320313497819; Nunez-Cordoba JM, 2009, AM J EPIDEMIOL, V169, P339, DOI 10.1093/aje/kwn335; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; Reaven G, 2002, CIRCULATION, V106, P286, DOI 10.1161/01.CIR.0000019884.36724.D9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Romaguera D, 2009, J NUTR, V139, P1728, DOI 10.3945/jn.109.108902; Takahashi MM, 2010, ARCH LATINOAM NUTR, V60, P148; Tur JA, 2005, BRIT J NUTR, V93, P369, DOI 10.1079/BJN20041363; Tzima N, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-22; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138; Yolanda BL, 2006, J NUTR BIOCH, V17, P1, DOI DOI 10.1016/J.JNUTBI0.2005.08.002; Zabetian A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-138	41	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171637	10.1371/journal.pone.0171637	http://dx.doi.org/10.1371/journal.pone.0171637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212431	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700009
J	Bao, YH; Fan, GR; Zou, DD; Wang, T; Xue, D				Bao, Yuhua; Fan, Guanrong; Zou, Dongdong; Wang, Tong; Xue, Di			Patient experience with outpatient encounters at public hospitals in Shanghai: Examining different aspects of physician services and implications of overcrowding	PLOS ONE			English	Article							CARE; PERFORMANCE; OUTCOMES; QUALITY; TIME	Background Over 90% of outpatient care in China was delivered at public hospitals, making outpatient experience in this setting an important aspect of quality of care. Objective To assess outpatient experience with different aspects of physician services at China's public hospitals and its association with overcrowding of the hospital outpatient departments. Research design Retrospective analysis of a large survey of outpatient experience in Shanghai, China. We tested the hypotheses that patient experience was poorer with physician-patient communication, education, and shared decision-making and where and when there was greater overcrowding of the hospital outpatient departments. Ordered logistic models were estimated separately for general and specialty hospitals. Subjects 7,147 outpatients at 40 public hospitals in Shanghai, China, in 2014. Measures Patient experience with physician services were self-reported based on 12 questions as part of a validated instrument. Indicators of overcrowding included time of visit (morning vs. afternoon, Monday vs. rest of the week) and hospital outpatient volume in the first half of 2014. Results Overall, patients reported very favorable experience with physician services. Two out of the 12 questions pertaining to both communication and shared decision-making consistently received lower ratings. Hospitals whose outpatient volumes were in the top two quartiles received lower patient ratings, but the relationship achieved statistical significance among specialty hospitals only. Conclusions Inadequate physician-patient communication and shared decision-making and hospital overcrowding compromise outpatient experience with physician services at Chinese public hospitals. Effective diversion of patients with chronic and less complex conditions to community health centers will be critical to alleviate the extreme workloads at hospitals with high patient volumes and, in turn, improve patient experience.	[Bao, Yuhua] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Bao, Yuhua] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Fan, Guanrong; Zou, Dongdong] Shanghai Med Ethos Assoc, Shanghai, Peoples R China; [Wang, Tong] Shanghai Hlth & Family Planning Commiss, Shanghai, Peoples R China; [Xue, Di] Fudan Univ, Sch Publ Hlth, Dept Hosp Management, Shanghai, Peoples R China; [Xue, Di] Fudan Univ, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China	Cornell University; Cornell University; Fudan University; Fudan University	Xue, D (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Hosp Management, Shanghai, Peoples R China.; Xue, D (corresponding author), Fudan Univ, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China.	xuedi@shmu.edu.cn			Weill Cornell Medical College; Shanghai Health and Family Planning Commission	Weill Cornell Medical College; Shanghai Health and Family Planning Commission	The Shanghai Health and Family Planning Commission (www.wsjsw.gov.cn) funded the patient experience survey in 2014, which provided data for this study. The sponsor of the study facilitated the study team's access to the public hospitals included in the survey and provided input in interpretation of data. YB was supported by Weill Cornell Medical College (weill.cornell.edu) sabbatical fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2015, CLIN GROUP SURV CG C; [Anonymous], 2015, CHINESE HLTH RESOURC, V18, P115; CAREY RG, 1993, MED CARE, V31, P834, DOI 10.1097/00005650-199309000-00008; Centers for Medicare and Medicaid Services, 2014, CONS ASS HEALTHC PRO; Chen T, 2015, CHINA HOSP CEO, P38; Coulter A, 2011, ENGAGING PATIENTS HE; de Silva A, MEASURING RESPONSIVE; Department of Health, 2008, US COMM QUAL INN CQU; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Guangyu H, 2016, CHIN J HOSP ADM, V32, P423; Hays RD, 2003, AM J MED QUAL, V18, P190, DOI 10.1177/106286060301800503; He JA, 2016, HEALTH ECON POLICY L, V28, P1; Henderson JW, 2002, EDUC PSYCHOL MEAS, V62, P995, DOI 10.1177/0013164402238086; Hsiao WC, 2008, HEALTH AFFAIR, V27, P949, DOI 10.1377/hlthaff.27.4.949; IOM Quality of Health Care Committee, 2001, CROSSING QUALITY CHA; Isaac T, 2010, HEALTH SERV RES, V45, P1024, DOI 10.1111/j.1475-6773.2010.01122.x; Janssen PPM, 1999, J ADV NURS, V29, P1360, DOI 10.1046/j.1365-2648.1999.01022.x; Kahn KL, 2007, HEALTH SERV RES, V42, P63, DOI 10.1111/j.1475-6773.2006.00604.x; Li H., 2014, OXID MED CELL LONGEV, V2014, P1, DOI DOI 10.1016/J.BI0MATERIALS.2014.01.039; Liebman BL, 2013, COLUMBIA LAW REV, V113, P181; Liu YH, 2013, BREAST CANCER RES TR, V137, P829, DOI 10.1007/s10549-012-2387-8; National Health and Family Planning Commision of the People's Republic of China, 2014, 2014 CHIN HLTH FAM P; Nichols A, 2007, RES PAPERS EC; Price RA, 2014, MED CARE RES REV, V71, P522, DOI 10.1177/1077558714541480; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Safran DG, 1998, J FAM PRACTICE, V47, P213; Saman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061097; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; Tai-Seale M, 2012, HEALTH ECON, V21, P457, DOI 10.1002/hec.1726; Wang XQ, 2012, LANCET, V380, P647, DOI 10.1016/S0140-6736(12)61367-1; Wei W, 2017, CHINA MED ARCH, V14, P18; Wu Q., 2014, J TRADITIONAL CHINES, V22, P653; Xue D, 2013, HEALTH CARE MANAGE R, V38, P258, DOI 10.1097/HMR.0b013e3182678f9a; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; 张丹, 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P671	36	28	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171684	10.1371/journal.pone.0171684	http://dx.doi.org/10.1371/journal.pone.0171684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207783	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500047
J	Boeck, JM; Spencer, JV				Boeck, Jordan M.; Spencer, Juliet V.			Effect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; THROUGHPUT FLOW-CYTOMETRY; ENVELOPED VIRUS-PARTICLES; CELL-SURFACE PROTEINS; CHEMOKINE RECEPTOR; COUPLED RECEPTOR; CONGENITAL CYTOMEGALOVIRUS; VACCINE DEVELOPMENT; INFECTED-CELLS; WHIM-SYNDROME	Human cytomegalovirus (HCMV) is a widespread pathogen and a member of the Herpesviridae family. HCMV has a large genome that encodes many genes that are non-essential for virus replication but instead play roles in manipulation of the host immune environment. One of these is the US27 gene, which encodes a protein with homology to the chemokine receptor family of G protein-coupled receptors (GPCRs). The US27 protein has no known chemokine ligands but can modulate the signaling activity of host receptor CXCR4. We investigated the mechanism for enhanced CXCR4 signaling in the presence of US27 using a novel biosensor system comprised of fluorogen activating proteins (FAPs). FAP-tagged CXCR4 and US27 were used to explore receptor internalization and recovery dynamics, and the results demonstrate that significantly more CXCR4 internalization was observed in the presence of US27 compared to CXCR4 alone upon stimulation with CXCL12. While ligand-induced endocytosis rates were higher, steady state internalization of CXCR4 was not affected by US27. Additionally, US27 underwent rapid endocytosis at a rate that was independent of either CXCR4 expression or CXCL12 stimulation. These results demonstrate that one mechanism by which US27 can enhance CXCR4 signaling is to alter receptor internalization dynamics, which could ultimately have the effect of promoting virus dissemination by increasing trafficking of HCMV-infected cells to tissues where CXCL12 is highly expressed.	[Boeck, Jordan M.; Spencer, Juliet V.] Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA	University of San Francisco	Spencer, JV (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jspencer@usfca.edu			NIH [AI111232]; USF Faculty Development funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI111232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USF Faculty Development funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grant AI111232 and USF Faculty Development funds (to JVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; Arnolds KL, 2013, VIROLOGY, V439, P122, DOI 10.1016/j.virol.2013.02.006; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Beisser PS, 1999, J VIROL, V73, P7218, DOI 10.1128/JVI.73.9.7218-7230.1999; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Bradley AJ, 2008, J MED VIROL, V80, P1615, DOI 10.1002/jmv.21241; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cardin RD, 2009, J VIROL, V83, P7590, DOI 10.1128/JVI.00386-09; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Chow KYC, 2010, CELL HOST MICROBE, V8, P523, DOI 10.1016/j.chom.2010.11.006; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Deere JD, 2014, VIRUSES-BASEL, V6, P1483, DOI 10.3390/v6041483; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Farrell HE, 2011, J VIROL, V85, P6091, DOI 10.1128/JVI.02113-10; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fisher GW, 2014, J BIOMOL SCREEN, V19, P1220, DOI 10.1177/1087057114534299; Fisher GW, 2010, J BIOMOL SCREEN, V15, P703, DOI 10.1177/1087057110370892; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Frascaroli G, 2006, J VIROL, V80, P7578, DOI 10.1128/JVI.02421-05; Frascaroli G, 2009, J IMMUNOL, V182, P477, DOI 10.4049/jimmunol.182.1.477; GAO JL, 1994, J BIOL CHEM, V269, P28539; Goodrum F, 2012, CELL MICROBIOL, V14, P644, DOI 10.1111/j.1462-5822.2012.01774.x; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Gruijthuijsen YK, 2002, J VIROL, V76, P1328, DOI 10.1128/JVI.76.3.1328-1338.2002; Gulino AV, 2003, CURR OPIN ALLERGY CL, V3, P443, DOI 10.1097/01.all.0000104449.09202.d8; HANSHAW JB, 1971, J INFECT DIS, V123, P555, DOI 10.1093/infdis/123.5.555; Heo JH, 2008, VIROLOGY, V378, P86, DOI 10.1016/j.virol.2008.05.002; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Holleran J, 2010, CYTOM PART A, V77A, P776, DOI 10.1002/cyto.a.20925; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; KUHN DE, 1995, BIOCHEM BIOPH RES CO, V211, P325, DOI 10.1006/bbrc.1995.1814; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Margulies BJ, 2007, VIRUS RES, V123, P57, DOI 10.1016/j.virusres.2006.08.003; Margulies BJ, 1996, VIROLOGY, V225, P111, DOI 10.1006/viro.1996.0579; McSharry BP, 2012, VIRUSES-BASEL, V4, P2448, DOI 10.3390/v4112448; Millis BA, 2012, METHODS MOL BIOL, V823, P295, DOI 10.1007/978-1-60327-216-2_19; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Oliveira SA, 2001, P NATL ACAD SCI USA, V98, P3237, DOI 10.1073/pnas.051629898; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Reinhardt B, 2014, CARDIOVASC RES, V104, P315, DOI 10.1093/cvr/cvu204; Saunders MJ, 2012, METHODS, V57, P308, DOI 10.1016/j.ymeth.2012.02.003; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; Stapleton LK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-42; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tadagaki K, 2012, BLOOD, V119, P4908, DOI 10.1182/blood-2011-08-372516; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tschische P, 2011, BIOCHEM PHARMACOL, V82, P610, DOI 10.1016/j.bcp.2011.06.009; Varani S, 2005, J LEUKOCYTE BIOL, V77, P219, DOI 10.1189/jlb.0504301; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002; Warner JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-255; Wu Y, 2013, CYTOM PART A, V83A, P220, DOI 10.1002/cyto.a.22242; Wu Y, 2012, MOL PHARMACOL, V82, P645, DOI 10.1124/mol.112.079897	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172042	10.1371/journal.pone.0172042	http://dx.doi.org/10.1371/journal.pone.0172042			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207860	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500077
J	Hulo, C; Masson, P; de Castro, E; Auchincloss, AH; Foulger, R; Poux, S; Lomax, J; Bougueleret, L; Xenarios, I; Le Mercier, P				Hulo, Chantal; Masson, Patrick; de Castro, Edouard; Auchincloss, Andrea H.; Foulger, Rebecca; Poux, Sylvain; Lomax, Jane; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe			The ins and outs of eukaryotic viruses: Knowledge base and ontology of a viral infection	PLOS ONE			English	Article							STRANDED-RNA VIRUSES; DNA-REPLICATION; TRANSLATIONAL TERMINATION; GENE ONTOLOGY; ENTRY; INFLUENZA; CELLS; TRANSCRIPTION; MICROTUBULES; TRAFFICKING	Viruses are genetically diverse, infect a wide range of tissues and host cells and follow unique processes for replicating themselves. All these processes were investigated and indexed in ViralZone knowledge base. To facilitate standardizing data, a simple ontology of viral life cycle terms was developed to provide a common vocabulary for annotating data sets. New terminology was developed to address unique viral replication cycle processes, and existing terminology was modified and adapted. The virus life-cycle is classically described by schematic pictures. Using this ontology, it can be represented by a combination of successive terms: "entry", "latency", "transcription", "replication" and "exit". Each of these parts is broken down into discrete steps. For example Zika virus "entry" is broken down in successive steps: "Attachment", "Apoptotic mimicry", "Viral endocytosis/macropinocytosis", "Fusion with host endosomal membrane", "Viral factory". To demonstrate the utility of a standard ontology for virus biology, this work was completed by annotating virus data in the ViralZone, UniProtKB and Gene Ontology databases.	[Hulo, Chantal; Masson, Patrick; de Castro, Edouard; Auchincloss, Andrea H.; Poux, Sylvain; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe] Univ Geneva, Sch Med, CMU, SIB Swiss Inst Bioinformat, Geneva, Switzerland; [Foulger, Rebecca; Lomax, Jane] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England	Swiss Institute of Bioinformatics; University of Geneva; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Le Mercier, P (corresponding author), Univ Geneva, Sch Med, CMU, SIB Swiss Inst Bioinformat, Geneva, Switzerland.	philippe.lemercier@isb-sib.ch	Lomax, Jane/H-2788-2019; Xenarios, Ioannis/ABD-5045-2021	Lomax, Jane/0000-0001-8865-4321; Xenarios, Ioannis/0000-0002-3413-6841; de Castro, Edouard/0000-0001-5436-7383; Le Mercier, Philippe/0000-0001-8528-090X; Foulger, Rebecca/0000-0001-8682-8754; Poux, Sylvain/0000-0001-7299-6685; Masson, Patrick/0000-0001-7646-0052	Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; National Institute of General Medical Sciences (NIGMS) [U41HG007822]; Swiss National Science Foundation (SNSF) [IZLSZ3_148802]; National Institutes of Health (NIH); National Human Genome Research Institute (NHGRI)	Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Swiss-Prot group is part of the SIB Swiss Institute of Bioinformatics and of the UniProt Consortium. Swiss-Prot group activities are supported by the Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI, the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) and National Institute of General Medical Sciences (NIGMS) grant U41HG007822 and the Swiss National Science Foundation (SNSF) grant IZLSZ3_148802.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Brandes N, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0128-3; CALLAHAN L, 1994, AIDS RES HUM RETROV, V10, P231, DOI 10.1089/aid.1994.10.231; Cheung AK, 2012, VIRUS RES, V164, P46, DOI 10.1016/j.virusres.2011.10.012; Coenen A, 1997, GENET RES, V69, P1, DOI 10.1017/S001667239600256X; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Foulger RE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0481-x; Ghazal P, 2000, IMMUNOL RES, V21, P219, DOI 10.1385/IR:21:2-3:219; Goff SP, 2004, CELL CYCLE, V3, P123; Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Helenius A, 2013, CURR OPIN VIROL, V3, P1, DOI 10.1016/j.coviro.2013.01.003; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Howard AR, 2012, J VIROL, V86, P5905, DOI 10.1128/JVI.06997-11; Hu Wei-Shau, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006882; Huang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164787; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Masson P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108075; Mattei S, 2016, CURR OPIN VIROL, V18, P27, DOI 10.1016/j.coviro.2016.02.008; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Mhamdi M, 2007, HEPATOLOGY, V46, P95, DOI 10.1002/hep.21666; Moss B., 2013, COLD SPRING HARB PER, V5; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Niehl A, 2011, PROTOPLASMA, V248, P75, DOI 10.1007/s00709-010-0246-1; Onfelt Bjorn, 2005, Sci STKE, V2005, ppe55, DOI 10.1126/stke.3132005pe55; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Powell ML, 2008, BIOCHEM SOC T, V36, P717, DOI 10.1042/BST0360717; Raghava S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002116; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Schudt G., 2015, J INFECT DIS; Schudt G, 2013, P NATL ACAD SCI USA, V110, P14402, DOI 10.1073/pnas.1307681110; Shulla A, 2016, CURR OPIN MICROBIOL, V32, P82, DOI 10.1016/j.mib.2016.05.003; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; The Gene Ontology: enhancements for, 2011, NUCLEIC ACIDS RES, V40, pD559, DOI [10.1093/nar/gkr1028, DOI 10.1093/NAR/GKR1028]; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; Ward BM, 2011, VIROLOGY, V411, P244, DOI 10.1016/j.virol.2010.12.024; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171746	10.1371/journal.pone.0171746	http://dx.doi.org/10.1371/journal.pone.0171746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207819	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500050
J	Lin, SF; Lin, JD; Hsueh, C; Chou, TC; Wong, RJ				Lin, Shu-Fu; Lin, Jen-Der; Hsueh, Chuen; Chou, Ting-Chao; Wong, Richard J.			A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer	PLOS ONE			English	Article							AURORA-A KINASE; CELL-LINES; SCH 727965; DRUG DISCOVERY; CARCINOMA; SURVIVIN; TRIAL; CDK5	Background We explored the therapeutic effects of dinaciclib, a cyclin-dependent kinase (CDK) inhibitor, in the treatment of thyroid cancer. Materials and methods Seven cell lines originating from three pathologic types of thyroid cancer (papillary, follicular and anaplastic) were studied. The cytotoxicity of dinaciclib was measured using a lactate dehydrogenase assay. The expression of proteins associated with cell cycle and apoptosis was assessed using Western blot analysis and immunofluorescence microscopy. Cell cycle distribution was measured by flow cytometry and immunofluorescence microscopy. Apoptosis and caspase-3 activity were measured by flow cytometry and fluorometric assay. Mice bearing flank anaplastic thyroid cancer (ATC) were treated with intraperitoneal injections of dinaciclib. Results Dinaciclib inhibited thyroid cancer cell proliferation in a dose-dependent manner. Dinaciclib had a low median-effect dose (<= 16.0 nM) to inhibit cell proliferation in seven thyroid cancer cell lines. Dinaciclib decreased CDK1, cyclin B1, and Aurora A expression, induced cell cycle arrest in the G2/M phase, and induced accumulation of prophase mitotic cells. Dinaciclib decreased Mcl-1, Bcl-x(L) and survivin expression, activated caspase-3 and induced apoptosis. In vivo, the growth of ATC xenograft tumors was retarded in a dose-dependent fashion with daily dinaciclib treatment. Higher-dose dinaciclib (50 mg/kg) caused slight, but significant weight loss, which was absent with lower-dose dinaciclib (40 mg/kg) treatment. Conclusions Dinaciclib inhibited thyroid cancer proliferation both in vitro and in vivo. These findings support dinaciclib as a potential drug for further studies in clinical trials for the treatment of patients with refractory thyroid cancer.	[Lin, Shu-Fu; Lin, Jen-Der] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan; [Hsueh, Chuen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Chou, Ting-Chao] Mem Sloan Kettering Canc Ctr, Lab Preclin Pharmacol Core, 1275 York Ave, New York, NY 10021 USA; [Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Chou, Ting-Chao] PD Sci Inc, Paramus, NY USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lin, SF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan.	mmg@cgmh.org.tw	Chou, Ting-Chao/B-4111-2009; Chou, Ting-Chao/AAA-7881-2020	Chou, Ting-Chao/0000-0002-3340-1594; Chou, Ting-Chao/0000-0002-3340-1594; Lin, Shu-Fu/0000-0001-8877-9685; Hsueh, Chuen/0000-0001-7860-5964	Chang Gung Memorial Hospital and Chang Gung University [CMRPG3E0351, CMRPG3E0352, CMRPG3E0353]; Ministry of Science and Technology of Taiwan [NSC 102-2314-B-182A-011-MY3]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Chang Gung Memorial Hospital and Chang Gung University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Chang Gung Memorial Hospital and Chang Gung University (CMRPG3E0351, CMRPG3E0352 and CMRPG3E0353) and partly by the Ministry of Science and Technology of Taiwan (NSC 102-2314-B-182A-011-MY3) [https://www.cgmh.org.tw/]; [https://www.most.gov.tw/].	Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Booher RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108371; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Chen XX, 2015, ONCOTARGET, V6, P14926, DOI 10.18632/oncotarget.3717; Chou T.-W., 2005, MICROSTRUCTURAL DESI; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Fu W, 2011, MOL CANCER THER, V10, P1018, DOI 10.1158/1535-7163.MCT-11-0167; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gojo I, 2013, CANCER CHEMOTH PHARM, V72, P897, DOI 10.1007/s00280-013-2249-z; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; ITO T, 1994, INT J ONCOL, V4, P583; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Merrick KA, 2012, CELL CYCLE, V11, P2600, DOI 10.4161/cc.20758; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Pozo K, 2013, CANCER CELL, V24, P499, DOI 10.1016/j.ccr.2013.08.027; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431	37	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172315	10.1371/journal.pone.0172315	http://dx.doi.org/10.1371/journal.pone.0172315			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207834	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500121
J	Regenthal, P; Hansen, JS; Andre, I; Lindkvist-Petersson, K				Regenthal, Paulina; Hansen, Jesper S.; Andre, Ingemar; Lindkvist-Petersson, Karin			Thermal stability and structural changes in bacterial toxins responsible for food poisoning	PLOS ONE			English	Article							MHC CLASS-II; STAPHYLOCOCCAL-ENTEROTOXIN H; CRYSTAL-STRUCTURE; OUTBREAK	The staphylococcal enterotoxins (SEs) are secreted by the bacteria Staphylococcus aureus and are the most common causative agent in staphylococcal food poisoning. The staphylococcal enterotoxin A (SEA) has been associated with large staphylococcal food poisoning outbreaks, but newer identified SEs, like staphylococcal enterotoxin H (SEH) has recently been shown to be present at similar levels as SEA in food poisoning outbreaks. Thus, we set out to investigate the thermo-stability of the three-dimensional structures of SEA, SEH and staphylococcal enterotoxin E (SEE), since heat inactivation is a common method to inactivate toxins during food processing. Interestingly, the investigated toxins behaved distinctly different upon heating. SEA and SEE were more stable at slightly acidic pH values, while SEH adopted an extremely stable structure at neutral pH, with almost no effects on secondary structural elements upon heating to 95 degrees C, and with reversible formation of tertiary structure upon subsequent cooling to room temperature. Taken together, the data suggests that the family of staphylococcal enterotoxins have different ability to withstand heat, and thus the exact profile of heat inactivation for all SEs causing food poisoning needs to be considered to improve food safety.	[Regenthal, Paulina; Hansen, Jesper S.; Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, BMC, Lund, Sweden; [Andre, Ingemar] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Lund University; Lund University	Lindkvist-Petersson, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC, Lund, Sweden.	Karin.Lindkvist@med.lu.se		Lindkvist, Karin/0000-0002-5209-3160; Hansen, Jesper Soendergaard/0000-0003-1638-1285	Swedish Research Council [2011-2891, 2015-04203]; Cancerfoundation [2010/1171, 2014/575]; Novo Nordisk Foundation [9807]; AFA Forsakring; Olle Engkvist Byggmastare foundation; VINNOVA; Crafoord foundation [20160579]; Diabetesfonden [DIA2015-035]; Karin Lindkvist-Petersson; Novo Nordisk Fonden [NNF14OC0009807, NNF15OC0015906] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfoundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); AFA Forsakring; Olle Engkvist Byggmastare foundation; VINNOVA(Vinnova); Crafoord foundation; Diabetesfonden; Karin Lindkvist-Petersson; Novo Nordisk Fonden(Novo Nordisk Foundation)	This project was funded by the Swedish Research Council (2011-2891), the Cancerfoundation (2010/1171 and 2014/575), the Novo Nordisk Foundation (9807), AFA Forsakring, the Olle Engkvist Byggmastare foundation, VINNOVA, the Crafoord foundation (20160579) and Diabetesfonden (DIA2015-035), all received by Karin Lindkvist-Petersson, and the Swedish Research Council (2015-04203) received by Ingmar Andre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Cavallin A, 2000, J BIOL CHEM, V275, P1665, DOI 10.1074/jbc.275.3.1665; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; HUMBER JY, 1975, APPL MICROBIOL, V30, P755, DOI 10.1128/AEM.30.5.755-758.1975; Ikeda T, 2005, APPL ENVIRON MICROB, V71, P2793, DOI 10.1128/AEM.71.5.2793-2795.2005; Jorgensen HJ, 2005, FEMS MICROBIOL LETT, V252, P267, DOI 10.1016/j.femsle.2005.09.005; Krakauer T, 2013, VIRULENCE, V4, P759, DOI 10.4161/viru.23905; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Nilsson H, 1999, J IMMUNOL, V163, P6686; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; Plasencia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014674; Rene-Trouillefou M, 2010, BBA-PROTEINS PROTEOM, V1804, P1322, DOI 10.1016/j.bbapap.2010.01.014; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Rodstrom KEJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131988; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sospedra I, 2013, FOOD RES INT, V54, P1052, DOI 10.1016/j.foodres.2013.03.002; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	22	9	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172445	10.1371/journal.pone.0172445	http://dx.doi.org/10.1371/journal.pone.0172445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207867	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500138
J	Templer, PH; Reinmann, AB; Sanders-DeMott, R; Sorensen, PO; Juice, SM; Bowles, F; Sofen, LE; Harrison, JL; Halm, I; Rustad, L; Martin, ME; Grant, N				Templer, Pamela H.; Reinmann, Andrew B.; Sanders-DeMott, Rebecca; Sorensen, Patrick O.; Juice, Stephanie M.; Bowles, Francis; Sofen, Laura E.; Harrison, Jamie L.; Halm, Ian; Rustad, Lindsey; Martin, Mary E.; Grant, Nicholas			Climate Change Across Seasons Experiment (CCASE): A new method for simulating future climate in seasonally snow-covered ecosystems	PLOS ONE			English	Article							LONG-TERM; NITROGEN DYNAMICS; SOIL RESPIRATION; NEW-HAMPSHIRE; CARBON-CYCLE; FOREST; TUNDRA; MANIPULATION; METAANALYSIS; RESPONSES	Climate models project an increase in mean annual air temperatures and a reduction in the depth and duration of winter snowpack for many mid and high latitude and high elevation seasonally snow-covered ecosystems over the next century. The combined effects of these changes in climate will lead to warmer soils in the growing season and increased frequency of soil freeze-thaw cycles (FTCs) in winter due to the loss of a continuous, insulating snowpack. Previous experiments have warmed soils or removed snow via shoveling or with shelters to mimic projected declines in the winter snowpack. To our knowledge, no experiment has examined the interactive effects of declining snowpack and increased frequency of soil FTCs, combined with soil warming in the snow-free season on terrestrial ecosystems. In addition, none have mimicked directly the projected increase in soil FTC frequency in tall statured forests that is expected as a result of a loss of insulating snow in winter. We established the Climate Change Across Seasons Experiment (CCASE) at Hubbard Brook Experimental Forest in the White Mountains of New Hampshire in 2012 to assess the combined effects of these changes in climate on a variety of pedoclimate conditions, biogeochemical processes, and ecology of northern hardwood forests. This paper demonstrates the feasibility of creating soil FTC events in a tall statured ecosystem in winter to simulate the projected increase in soil FTC frequency over the next century and combines this projected change in winter climate with ecosystem warming throughout the snow-free season. Together, this experiment provides a new and more comprehensive approach for climate change experiments that can be adopted in other seasonally snow-covered ecosystems to simulate expected changes resulting from global air temperature rise.	[Templer, Pamela H.; Reinmann, Andrew B.; Sanders-DeMott, Rebecca; Sorensen, Patrick O.; Juice, Stephanie M.; Sofen, Laura E.; Harrison, Jamie L.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Bowles, Francis] Res Designs, Lyme, NH USA; [Halm, Ian; Rustad, Lindsey; Grant, Nicholas] US Forest Serv, Hubbard Brook Expt Forest, Woodstock, NH USA; [Martin, Mary E.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	Boston University; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire	Templer, PH (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	ptempler@bu.edu	Juice, Stephanie M/D-4316-2019; Sorensen, Patrick O./K-1401-2017; Brook, Hubbard/AAD-1112-2022	Juice, Stephanie M/0000-0002-0891-2202; Sorensen, Patrick O./0000-0002-0558-2789; Sanders-DeMott, Rebecca/0000-0002-0709-8042; Martin, Mary/0000-0003-1791-5584; Harrison, Jamie/0000-0001-7937-0503	National Science Foundation [1114804, NSF DEB 1149929]; Direct For Biological Sciences [1633026] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by an award from the National Science Foundation with the number 1114804 and by a National Science Foundation CAREER grant to PH Templer (NSF DEB 1149929). These awards were used as salary for authors PT, RSD, SMJ, FB, LEF, JLH, and the NSF did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Bailey A. S., 2003, HYDROMETEOROLOGICAL; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Bokhorst S, 2008, GLOBAL CHANGE BIOL, V14, P2603, DOI 10.1111/j.1365-2486.2008.01689.x; Borchers H. W., 2015, PRACMA PRACTICAL NUM; BOUTIN R, 1995, CAN J FOREST RES, V25, P588, DOI 10.1139/x95-066; Brown PJ, 2011, AGR FOREST METEOROL, V151, P947, DOI 10.1016/j.agrformet.2011.02.014; Burakowski EA, 2008, J GEOPHYS RES-ATMOS, P113; Campbell JL, 2014, GLOBAL CHANGE BIOL, V20, P2663, DOI 10.1111/gcb.12532; Campbell JL, 2010, HYDROL PROCESS, V24, P2465, DOI 10.1002/hyp.7666; Duran J, 2014, GLOBAL CHANGE BIOL, V20, P3568, DOI 10.1111/gcb.12624; Edenhofer O., 2014, CONTRIBUTION WORKING; Flanagan LB, 2013, AGR FOREST METEOROL, V173, P40, DOI 10.1016/j.agrformet.2013.01.002; Groffman PM, 2012, BIOSCIENCE, V62, P1056, DOI 10.1525/bio.2012.62.12.7; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P191, DOI 10.1023/A:1013024603959; Grogan P, 2004, SOIL BIOL BIOCHEM, V36, P641, DOI 10.1016/j.soilbio.2003.12.007; Hamburg SP, 2013, CLIMATIC CHANGE, V116, P457, DOI 10.1007/s10584-012-0517-2; Hardy JP, 2001, BIOGEOCHEMISTRY, V56, P151, DOI 10.1023/A:1013036803050; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Henry HAL, 2008, CLIMATIC CHANGE, V87, P421, DOI 10.1007/s10584-007-9322-8; Hothorn T., 2008, MULTCOMP SIMULTANEOU; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; Johnstone JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082903; Kreyling J, 2011, PLANT ECOL DIVERS, V4, P13, DOI 10.1080/17550874.2011.558125; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; LeCain D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116834; Li WB, 2016, SOIL BIOL BIOCHEM, V100, P51, DOI 10.1016/j.soilbio.2016.05.018; Lu M, 2013, ECOLOGY, V94, P726, DOI 10.1890/12-0279.1; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Melillo JM, 2011, PROCEEDINGS OF THE N; Pelini SL, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00097.1; Pinheiro J, 2016, R CORE TEAM LINEAR N; RICARD J, 1976, FIELD ASSEMBLED FROS; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schimel JP, 1996, SOIL BIOL BIOCHEM, V28, P1061, DOI 10.1016/0038-0717(96)00083-1; Shibata H, 2015, AMBIO, V44, P178, DOI 10.1007/s13280-014-0545-4; Sistla SA, 2013, NATURE, V497, P615, DOI 10.1038/nature12129; Templer PH, 2012, BIOL FERT SOILS, V48, P413, DOI 10.1007/s00374-011-0636-3; Templer PH, 2011, NEW PHYTOL, V192, P797, DOI 10.1111/j.1469-8137.2011.03959.x; Viglietti D, 2014, HYDROL PROCESS, V28, P5309, DOI 10.1002/hyp.10008; Winter TC, 2008, HYDROL PROCESS, V22, P21, DOI 10.1002/hyp.6593; Xu WF, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044027; Zhang T, 2003, PERMAFROST, VOLS 1 AND 2, P1289	44	26	26	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171928	10.1371/journal.pone.0171928	http://dx.doi.org/10.1371/journal.pone.0171928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207766	Green Published, gold			2022-12-26	WOS:000394424500061
J	Brozio, S; Manson, C; Gourevitch, E; Burns, TJ; Greener, MS; Downie, JR; Hoskisson, PA				Brozio, Sarah; Manson, Chloe; Gourevitch, Eleanor; Burns, Thomas J.; Greener, Mark S.; Downie, J. Roger; Hoskisson, Paul A.			Development and Application of an eDNA Method to Detect the Critically Endangered Trinidad Golden Tree Frog (Phytotriades auratus) in Bromeliad Phytotelmata	PLOS ONE			English	Article							ENVIRONMENTAL DNA; CONSERVATION	The use of environmental DNA (eDNA) to monitor rare and elusive species has great potential for conservation biology. Traditional surveying methods can be time-consuming, labourintensive, subject to error or can be invasive and potentially damaging to habitat. The Trinidad golden treefrog (Phytotriades auratus) is one such species that would benefit from such an approach. This species inhabits the giant bromeliad (Glomeropitcairnia erectiflora) on two peaks on the Caribbean island of Trinidad. Traditional survey methods for this species have required the destruction of the giant bromeliad, which is the only known habitat of this frog. Here we described the development of an eDNA PCR-based assay that uses water drawn from the water-filled phytotelmata of the giant bromeliad along with the use of a synthetic DNA positive control that can be easily amplified in the bacterium Escherichia coli. The assay can detect to a DNA concentration of 1.4ng. Sampling of 142 bromeliads using this method revealed 9% were positive for P. auratus DNA. These data suggest that eDNA methods also have great potential for revealing the presence of elusive species in arboreal habitats.	[Brozio, Sarah; Manson, Chloe; Hoskisson, Paul A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Gourevitch, Eleanor; Burns, Thomas J.; Greener, Mark S.; Downie, J. Roger] Univ Glasgow, Sch Life Sci, Graham Kerr Bldg, Glasgow, Lanark, Scotland	University of Strathclyde; University of Glasgow	Hoskisson, PA (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	Paul.hoskisson@strath.ac.uk	Gourevitch, Eleanor/ADY-9795-2022	Hoskisson, Paul/0000-0003-4332-1640; Greener, Mark/0000-0002-0600-0912; Burns, Thomas J/0000-0003-0408-8014; Gourevitch, Eleanor/0000-0003-1929-0135	Amphibian Survival Alliance's Seed Grant	Amphibian Survival Alliance's Seed Grant	This work was supported by Amphibian Survival Alliance's Seed Grant (http://www.amphibians.org/seedgrants/).	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bornschein MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142791; Brown RP, 2006, MOL ECOL, V15, P3631, DOI 10.1111/j.1365-294X.2006.03048.x; Clark FM, B BRIT HERPETOLOGICA, V54, P3; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hall EM, 2016, MOL ECOL RESOUR, V16, P423, DOI 10.1111/1755-0998.12461; Jowers MJ, 2008, STUD NEOTROP FAUNA E, V43, P181, DOI 10.1080/01650520801965490; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2016, METHODS MOL BIOL, V1452, P131, DOI 10.1007/978-1-4939-3774-5_8; Murphy J., 1997, REPTILES AMPHIBIANS; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Palumbi S. R., 1996, NUCL ACIDS; Rivas GA, 2015, HERPETOLOGICAL REV, V46, P1; Rowley JJL, 2014, ZOOTAXA, V3785, P25, DOI 10.11646/zootaxa.3785.1.2; Ryan MJ, 2011, J HERPETOL, V45, P438; Sambrook J., 2001, MOL CLONING LAB MANU; Stockley V, 2015, INNOVATION NEW TECHN, V9, P39; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Torresdal JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168787	20	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170619	10.1371/journal.pone.0170619	http://dx.doi.org/10.1371/journal.pone.0170619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199338	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000394424400017
J	Radell, ML; Beck, KD; Gilbertson, MW; Myers, CE				Radell, Milen L.; Beck, Kevin D.; Gilbertson, Mark W.; Myers, Catherine E.			Post-traumatic stress disorder symptom burden and gender each affect generalization in a reward- and punishment-learning task	PLOS ONE			English	Article							PTSD CHECKLIST; PSYCHOMETRIC PROPERTIES; HEALTH-PROBLEMS; PRIMARY-CARE; VETERANS; PREVALENCE; VIETNAM; DEPRESSION; BARRIERS; DUTY	traumatic stress disorder (PTSD) can develop following exposure to a traumatic event. Re-experiencing, which includes intrusive memories or flashbacks of the trauma, is a core symptom cluster of PTSD. From an associative learning perspective, this cluster may be attributed to cues associated with the trauma, which have come to elicit symptoms in a variety of situations encountered in daily life due to a tendency to overgeneralize. Consistent with this, prior studies have indicated that both individuals with clinically diagnosed with PTSD, and those with self-reported symptoms who may not meet full diagnostic criteria, show changes in generalization. Building on prior research, the current study examined whether PTSD symptom burden, but also gender, veteran status, and combat experience-all associated with PTSD vulnerability-modulate learning and generalization in a computer-based task. Participants were presented with stimulus compounds consisting of a foreground and background that could be predictive of reward, punishment or no outcome. Learning was followed by a generalization test where these components were recombined to form novel configurations. An interaction between PTSD symptom burden and gender was found where females with more severe PTSD symptoms showed no evidence of sensitivity to the background. This result is consistent with increased generalization, and may indicate a decrease in the ability to process cue configurations leading to re-experiencing in a variety of situations. Further work is indicated to help elucidate the cognitive processes driving gender differences that may confer vulnerability to PTSD.	[Radell, Milen L.] Niagara Univ, Dept Psychol, Lewiston, NY 14109 USA; [Radell, Milen L.; Beck, Kevin D.; Myers, Catherine E.] New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ 07018 USA; [Beck, Kevin D.; Myers, Catherine E.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Gilbertson, Mark W.] Dept Vet Affairs, Manchester, NH USA	New Jersey Department of Health & Senior Services; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Radell, ML (corresponding author), Niagara Univ, Dept Psychol, Lewiston, NY 14109 USA.; Radell, ML (corresponding author), New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ 07018 USA.	milenre@gmail.com	Myers, Catherine E./AAU-5804-2020	Myers, Catherine E./0000-0002-2776-4823	U. S. Department of Veterans Affairs Clinical Science Research and Development Service [I01 CX000771]; Veterans Affairs [I01CX000771] Funding Source: NIH RePORTER	U. S. Department of Veterans Affairs Clinical Science Research and Development Service; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Award I01 CX000771 to CEM from the U. S. Department of Veterans Affairs Clinical Science Research and Development Service (http://www.research.va.gov/services/csrd/default.cfm). The funder played no role in the study design, collection, analysis, or interpretation of the data, in the writing of the report, or decision to submit the article for publication. Opinions stated herein do not necessarily represent the official views of the Department of Veterans Affairs or the U. S. Government.	Alim TN, 2006, J CLIN PSYCHOL, V62, P801, DOI 10.1002/jclp.20280; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2004, DIAGN STAT MAN MENT, P136; Anastasides N, 2015, STRESS, V18, P484, DOI 10.3109/10253890.2015.1053450; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Davis RG, 2008, J TRAUMA STRESS, V21, P218, DOI 10.1002/jts.20313; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; Fetzner MG, 2013, COGNITIVE THER RES, V37, P725, DOI 10.1007/s10608-013-9531-6; Ginsberg JP, 2008, J ANXIETY DISORD, V22, P809, DOI 10.1016/j.janxdis.2007.08.009; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Ishihara S, 2012, ISHIHARAS TESTS COLO; JONES JC, 1990, CLIN PSYCHOL REV, V10, P299, DOI 10.1016/0272-7358(90)90064-H; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kostek JA, 2014, J TRAUMA STRESS, V27, P717, DOI 10.1002/jts.21974; Levy-Gigi E, 2015, NEUROPSYCHOLOGY, V29, P151, DOI 10.1037/neu0000131; Levy-Gigi E, 2012, NEUROPSYCHOLOGY, V26, P758, DOI 10.1037/a0029361; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Magruder KM, 2016, J TRAUMA STRESS, V29, P5, DOI 10.1002/jts.22075; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072508; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myers CE, 2012, STRESS, V15, P31, DOI 10.3109/10253890.2011.578184; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tryon WW, 1998, J ANXIETY DISORD, V12, P373, DOI 10.1016/S0887-6185(98)00021-8; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172144	10.1371/journal.pone.0172144	http://dx.doi.org/10.1371/journal.pone.0172144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196108	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423900055
J	Arora, N; Alsaied, O; Dauer, P; Majumder, K; Modi, S; Giri, B; Dudeja, V; Banerjee, S; Von Hoff, D; Saluja, A				Arora, Nivedita; Alsaied, Osama; Dauer, Patricia; Majumder, Kaustav; Modi, Shrey; Giri, Bhuwan; Dudeja, Vikas; Banerjee, Sulagna; Von Hoff, Daniel; Saluja, Ashok			Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; GROWTH-FACTOR EXPRESSION; HUMAN PANCREATIC-CANCER; NF-KAPPA-B; POOR SURVIVAL; CELL-DEATH; TRIPTOLIDE; ADENOCARCINOMA; PROLIFERATION; METASTASIS	Background Gastric cancer is the third leading cause of cancer related mortality worldwide with poor survival rates. Even though a number of chemotherapeutic compounds have been used against this disease, stomach cancer has not been particularly sensitive to these drugs. In this study we have evaluated the effect of triptolide, a naturally derived diterpene triepoxide and its water soluble pro-drug Minnelide on several gastric adenocarcinoma cell lines both as monotherapy and in combination with CPT-11. Methods Gastric cancer cell lines MKN28 and MKN45 were treated with varying doses of triptolide in vitro. Cell viability was measured using MTT based assay kit. Apoptotic cell death was assayed by measuring caspase activity. Effect of the triptolide pro-drug, Minnelide, was evaluated by implanting the gastric cancer cells subcutaneously in athymic nude mice. Results Gastric cancer cell lines MKN28 and MKN45 cells exhibited decreased cell viability and increased apoptosis when treated with varying doses of triptolide in vitro. When implanted in athymic nude mice, treatment with Minnelide reduced tumor burden in both MKN28 derived tumors as well as MKN45 derived tumors. Additionally, we also evaluated Minnelide as a single agent and in combination with CPT-11 in the NCI-N87 human gastric tumor xenograft model. Conclusion Our results indicated that the combination of Minnelide with CPT-11 resulted in significantly smaller tumors compared to control. These studies are extremely encouraging as Minnelide is currently undergoing phase 1 clinical trials for gastrointestinal cancers.	[Arora, Nivedita; Alsaied, Osama; Dauer, Patricia; Majumder, Kaustav; Modi, Shrey; Giri, Bhuwan; Dudeja, Vikas; Banerjee, Sulagna; Saluja, Ashok] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Dauer, Patricia; Modi, Shrey; Giri, Bhuwan; Dudeja, Vikas; Banerjee, Sulagna; Saluja, Ashok] Univ Miami, Div Surg Oncol, Dept Surg, Miami, FL 33146 USA; [Von Hoff, Daniel] TGen Virginia G Piper Canc Ctr, Suite 600, Phoenix, AZ USA	University of Minnesota System; University of Minnesota Twin Cities; University of Miami; Translational Genomics Research Institute	Saluja, A (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA.; Saluja, A (corresponding author), Univ Miami, Div Surg Oncol, Dept Surg, Miami, FL 33146 USA.	asaluja@miami.edu			NIH [R01-CA170946, CA124723, R01-CA184274]; Katherine and Robert Goodale foundation support; Minneamrita Therapeutics LLC	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katherine and Robert Goodale foundation support; Minneamrita Therapeutics LLC	This study was funded by NIH grants R01-CA170946 and CA124723 (to AS); NIH grant R01-CA184274 (to SB); Katherine and Robert Goodale foundation support (to AS) and Minneamrita Therapeutics LLC (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Banerjee S, 2013, J BIOL CHEM, V288, P33927, DOI 10.1074/jbc.M113.500983; Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bleiberg H, 1999, EUR J CANCER, V35, P371, DOI 10.1016/S0959-8049(98)00423-7; Carcas Lauren Peirce, 2014, J Carcinog, V13, P14, DOI 10.4103/1477-3163.146506; Chang HJ, 2007, ANTICANCER RES, V27, P3411; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dikken JL, 2012, THER ADV GASTROENTER, V5, P49, DOI 10.1177/1756283X11410771; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Guimbaud R, 2014, J CLIN ONCOL, V32, P3520, DOI 10.1200/JCO.2013.54.1011; Guo MM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0542-7; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; Lee HW, 2013, VIRCHOWS ARCH, V463, P489, DOI 10.1007/s00428-013-1461-x; Lim JW, 2002, J BIOL CHEM, V277, P46093, DOI 10.1074/jbc.M206603200; Mahipal A, 2015, J NATL COMPR CANC NE, V13, P1281, DOI 10.6004/jnccn.2015.0154; Mahipal A, 2015, INVEST NEW DRUG, V33, P1093, DOI 10.1007/s10637-015-0277-8; Meng CC, 2014, CHINESE J CANCER RES, V26, P622, DOI 10.3978/j.issn.1000-9604.2014.09.01; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Oliveira AR, 2015, LAB INVEST, V95, P648, DOI 10.1038/labinvest.2015.46; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Piazuelo MB, 2013, COLOMB MEDICA, V44, P192; Qiu TZ, 2014, FEBS LETT, V588, P1168, DOI 10.1016/j.febslet.2014.02.054; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Sherman MY, 2014, ONCOGENE; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vizcaino C, 2015, PHARM THER; Wang JH, 2002, J CANCER RES CLIN, V128, P547, DOI 10.1007/s00432-002-0379-5; Wang LW, 2008, INT J ONCOL, V33, P161; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wei DY, 2004, CANCER RES, V64, P2030, DOI 10.1158/0008-5472.CAN-03-1945; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zhang J, 2005, WORLD J GASTROENTERO, V11, P2213, DOI 10.3748/wjg.v11.i15.2213; Zhao SJ, 2003, CANCER RES, V63, P2624; Zhao ZG, 2005, WORLD J GASTROENTERO, V11, P73, DOI 10.3748/wjg.v11.i1.73	40	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171827	10.1371/journal.pone.0171827	http://dx.doi.org/10.1371/journal.pone.0171827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192510	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800043
J	Szantho, F; Mikloski, A; Kubinyi, E				Szantho, Flora; Mikloski, Adam; Kubinyi, Eniko			Is your dog empathic? Developing a Dog Emotional Reactivity Survey	PLOS ONE			English	Article							CANIS-FAMILIARIS; GENDER-DIFFERENCES; PERSONALITY; HUMANS; CONTAGION; ANTHROPOMORPHISM; QUESTIONNAIRE; ATTRIBUTION; PERFORMANCE; CHIMPANZEES	Dogs' seemingly empathic behaviour attracts general and scientific attention alike. Behaviour tests are usually not sufficiently realistic to evoke empathic-like behaviour; therefore we decided to ask owners about their experiences with their dogs in emotionally loaded situations. Owners from Hungary (N = 591) and from Germany (N = 2283) were asked to rate their level of agreement on a 1-5 Likert scale with statements about the reactivity of their dogs to their emotions and to other dogs' behaviour. We created two scales with satisfactory internal reliability: reactivity to the owner's emotion and reactivity to other dogs' behaviour. Based on an owner-dog personality matching theory, we hypothesised that the owner's empathy, as measured by the subscale on the cooperativeness character factor of the human personality, will correlate with their dog's emotional reactivity in emotionally loaded situations. In addition we also examined how anthropomorphism, contagious yawning, attitude toward the dog are related to emotional reactivity in dogs as perceived by the owner. In addition we examined how owners rate dog pictures. We found that the scale scores were largely independent from demographic and environmental variables like breed, sex, age, age at acquiring, keeping practices, training experiences and owner's age. However, anthropomorphic and emotional attitude of the owners probably biased the responses. In the German sample more empathic owners reported to have more emotionally reactive dog, as expected by the personality matching theory. More empathic owners reported to have fewer problems with their dogs and they rated a puppy picture as more cute in both countries. 62% of owners from Hungary and 36% of owner from Germany agreed with the statement "My dog is more important for me than any human being". In Germany, more empathic owners agreed less with this statement and indicated that their dogs have a tendency for contagious yawning. Owners whose attitudes toward their dogs were anthropomorphic (agreed more with the statement that ''My dog thinks like a child"), perceived their dogs as more reactive to their emotions. This findings highlights the importance of testing the attitudes of the respondents when they assess the personality and the emotions of animals. The criterion validity of the Dog Emotional Reactivity Survey should be confirmed by objective behavioural tests.	[Szantho, Flora; Mikloski, Adam; Kubinyi, Eniko] Eotvos Lorand Univ, Dept Ethol, Pazmany Ps 1-C, Budapest, Hungary; [Mikloski, Adam] MTA ELTE Comparat Ethol Res Grp, Pazmany Ps 1-C, Budapest, Hungary	Eotvos Lorand University; MTA-ELTE Comparative Ethology Research Group	Szantho, F (corresponding author), Eotvos Lorand Univ, Dept Ethol, Pazmany Ps 1-C, Budapest, Hungary.	floraceae@gmail.com	Kubinyi, Eniko/B-5824-2013	Kubinyi, Eniko/0000-0002-4468-9845	NKFIH [K84036, K112138]; Bolyai Foundation of the Hungarian Academy of Sciences; MTA-ELTE Comparative Ethological Research Group [01 031]; ERC Starting Grant [680040]; European Research Council (ERC) under the European Union's Horizon research and innovation programme [680040]	NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); MTA-ELTE Comparative Ethological Research Group; ERC Starting Grant(European Research Council (ERC)); European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC))	This work is supported by NKFIH (K84036, K112138) (http:/nkfih.gov.hu/english), Bolyai Foundation of the Hungarian Academy of Sciences (http:/mta.hu/english), MTA-ELTE Comparative Ethological Research Group (01 031) (http://mta-etologia.elte.hu/?p=0&s=0&lang=eng), and ERC Starting Grant to KE (680040) (https://erc.europa.eu/funding-and-grarts/funding-schemes/starting-grants).; This work was supported by the NKFIH (K84036, K112138), the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the MTA-ELTE Comparative Ethological Research Group (01 031). The research has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No [680040]). We are grateful for the owners for their participation and especially to Jesko Wilke journalist, Dr. Barbara Schoning, veterinary, who helped collect the German data, and Dr. Lisa J. Wallis for language editing and for useful comments.	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; BAENNINGER R, 1987, J COMP PSYCHOL, V101, P349, DOI 10.1037/0735-7036.101.4.349; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; BYRNE D, 1971, HUM RELAT, V24, P201, DOI 10.1177/001872677102400302; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Champagne F, 2009, CROSS CULTURAL COMP; COPPINGER R, 1987, ETHOLOGY, V75, P89; Custance D, 2012, EMPATHIC LIKE RESPON, P851; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; EDDY TJ, 1993, J SOC ISSUES, V49, P87, DOI 10.1111/j.1540-4560.1993.tb00910.x; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; Harrison M. A., 2010, J SOC EVOL CULT PSYC, V4, P34, DOI DOI 10.1037/H0099303; Hills AM, 1995, ANTHROZOOS, V8, P132, DOI 10.2752/089279395787156347; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kwan VSY, 2008, SOC COGNITION, V26, P129, DOI 10.1521/soco.2008.26.2.129; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lehmann V, 2013, BEHAV PROCESS, V94, P99, DOI 10.1016/j.beproc.2013.01.001; Lorenz K, 1943, Z TIERPSYCHOL, V5, P245; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Miklosi A., 2015, DOG BEHAV EVOLUTION; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Paul ES, 2000, ANTHROZOOS, V13, P194, DOI 10.2752/089279300786999699; Perez-Albeniz A, 2004, CHILD ABUSE NEGLECT, V28, P289, DOI 10.1016/j.chiabu.2003.11.017; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rieffe C, 2010, PERS INDIV DIFFER, V49, P362, DOI 10.1016/j.paid.2010.03.046; Robert Cloninger C., 1993, ARCH GEN PSYCHIAT, V50; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Rozsa S, 2008, J AFFECT DISORDERS, V106, P45, DOI 10.1016/j.jad.2007.03.016; Rueckert L, 2008, BRAIN COGNITION, V67, P162, DOI 10.1016/j.bandc.2008.01.002; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Silva K, 2011, BIOL LETTERS, V7, P489, DOI 10.1098/rsbl.2011.0083; Sumegi Z, 2014, APPL ANIM BEHAV SCI, V160, P106, DOI 10.1016/j.applanim.2014.09.001; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; TEMPLER DI, 1981, PSYCHOL REC, V31, P343, DOI 10.1007/BF03394747; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turcsan B, 2012, APPL ANIM BEHAV SCI, V140, P154, DOI 10.1016/j.applanim.2012.06.004; Yong MH, 2014, BEHAV PROCESS, V108, P155, DOI 10.1016/j.beproc.2014.10.006	50	9	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170397	10.1371/journal.pone.0170397	http://dx.doi.org/10.1371/journal.pone.0170397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192495	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800009
J	Castro, BA; Flanigan, P; Jahangiri, A; Hoffman, D; Chen, W; Kuang, R; De Lay, M; Yagnik, G; Wagner, JR; Mascharak, S; Sidorov, M; Shrivastav, S; Kohanbash, G; Okada, H; Aghi, MK				Castro, B. A.; Flanigan, P.; Jahangiri, A.; Hoffman, D.; Chen, W.; Kuang, R.; De Lay, M.; Yagnik, G.; Wagner, J. R.; Mascharak, S.; Sidorov, M.; Shrivastav, S.; Kohanbash, G.; Okada, H.; Aghi, M. K.			Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy	ONCOGENE			English	Article							ANTIANGIOGENIC THERAPY; VEGF THERAPY; MESENCHYMAL TRANSITION; RECURRENT GLIOBLASTOMA; MEDIATES RESISTANCE; RECEPTOR CD74; CELL INVASION; POLARIZATION; SURVIVAL; CANCER	Anti-angiogenic therapies for cancer such as VEGF neutralizing antibody bevacizumab have limited durability. While mechanisms of resistance remain undefined, it is likely that acquired resistance to anti-angiogenic therapy will involve alterations of the tumor microenvironment. We confirmed increased tumor-associated macrophages in bevacizumab-resistant glioblastoma patient specimens and two novel glioblastoma xenograft models of bevacizumab resistance. Microarray analysis suggested downregulated macrophage migration inhibitory factor (MIF) to be the most pertinent mediator of increased macrophages. Bevacizumab-resistant patient glioblastomas and both novel xenograft models of resistance had less MIF than bevacizumab-naive tumors, and harbored more M2/protumoral macrophages that specifically localized to the tumor edge. Xenografts expressing MIF-shRNA grew more rapidly with greater angiogenesis and had macrophages localizing to the tumor edge which were more prevalent and proliferative, and displayed M2 polarization, whereas bevacizumab-resistant xenografts transduced to upregulate MIF exhibited the opposite changes. Bone marrow-derived macrophage were polarized to an M2 phenotype in the presence of condition-media derived from bevacizumab-resistant xenograft-derived cells, while recombinant MIF drove M1 polarization. Media from macrophages exposed to bevacizumab-resistant tumor cell conditioned media increased glioma cell proliferation compared with media from macrophages exposed to bevacizumab-responsive tumor cell media, suggesting that macrophage polarization in bevacizumab-resistant xenografts is the source of their aggressive biology and results from a secreted factor. Two mechanisms of bevacizumab-induced MIF reduction were identified: (1) bevacizumab bound MIF and blocked MIF-induced M1 polarization of macrophages; and (2) VEGF increased glioma MIF production in a VEGFR2-dependent manner, suggesting that bevacizumab-induced VEGF depletion would downregulate MIF. Site-directed biopsies revealed enriched MIF and VEGF at the enhancing edge in bevacizumab-naive patients. This MIF enrichment was lost in bevacizumab-resistant glioblastomas, driving a tumor edge M1-to-M2 transition. Thus, bevacizumab resistance is driven by reduced MIF at the tumor edge causing proliferative expansion of M2 macrophages, which in turn promotes tumor growth.	[Castro, B. A.; Flanigan, P.; Jahangiri, A.; Hoffman, D.; Chen, W.; Kuang, R.; De Lay, M.; Yagnik, G.; Wagner, J. R.; Mascharak, S.; Sidorov, M.; Shrivastav, S.; Kohanbash, G.; Okada, H.; Aghi, M. K.] Univ Calif San Francisco, Dept Neurol Surg, Diller Canc Res Bldg,1450 Third St Room HD-465, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Aghi, MK (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Diller Canc Res Bldg,1450 Third St Room HD-465, San Francisco, CA 94158 USA.	aghim@neurosurg.ucsf.edu		Flanigan, Patrick/0000-0002-3611-8575; Chen, William/0000-0001-8924-5853; Hoffman, Daniel/0000-0002-2302-6786	American Brain Tumor Association (ABTA); James S. McDonnell Foundation; American Cancer Society (ACS); University of California Cancer Research Coordinating Committee; NIH [5K02NS64167, 1R01NS079697]; Howard Hughes Medical Institute (HHMI) fellowship; American Association of Neurological Surgeons (AANS); ABTA; UCSF School of Medicine (SOM) Pathways Explore Summer Grant; NATIONAL CANCER INSTITUTE [T32CA151022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS064167, R01NS079697] Funding Source: NIH RePORTER	American Brain Tumor Association (ABTA); James S. McDonnell Foundation; American Cancer Society (ACS)(American Cancer Society); University of California Cancer Research Coordinating Committee(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) fellowship; American Association of Neurological Surgeons (AANS); ABTA; UCSF School of Medicine (SOM) Pathways Explore Summer Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MKA was supported by the American Brain Tumor Association (ABTA), the James S. McDonnell Foundation, American Cancer Society (ACS), University of California Cancer Research Coordinating Committee and the NIH (5K02NS64167 and 1R01NS079697). BC was supported by the Howard Hughes Medical Institute (HHMI) fellowship, the American Association of Neurological Surgeons (AANS) and ABTA. DH was supported by the Howard Hughes Medical Institute (HHMI) fellowship. WC was supported by the UCSF School of Medicine (SOM) Pathways Explore Summer Grant.	Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carbonell WS, 2013, CANCER RES, V73, P3145, DOI 10.1158/0008-5472.CAN-13-0011; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Cho HR, 2016, ONCOTARGET, V7, P69606, DOI 10.18632/oncotarget.11901; Choudhary S, 2013, CARCINOGENESIS, V34, P2891, DOI 10.1093/carcin/bgt239; Clark AJ, 2012, NEUROSURGERY, V70, P361, DOI 10.1227/NEU.0b013e3182314f9d; de Groot JF, 2011, CLIN CANCER RES, V17, P6109, DOI 10.1158/1078-0432.CCR-11-1853; Delay M, 2012, CLIN CANCER RES, V18, P2930, DOI 10.1158/1078-0432.CCR-11-2390; Frentzas S, 2016, NAT MED, V22, P1294, DOI 10.1038/nm.4197; Gabrusiewicz K, 2014, ONCOTARGET, V5, P2208, DOI 10.18632/oncotarget.1893; Ghoochani A, 2016, ONCOGENE, V35, P6246, DOI 10.1038/onc.2016.160; Girard E, 2012, BRIT J CANCER, V107, P1498, DOI 10.1038/bjc.2012.392; Gupta Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146482; Hodi FS, 2014, CANCER IMMUNOL RES, V2, P632, DOI 10.1158/2326-6066.CIR-14-0053; Hoppstadter J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00055; Hu YL, 2012, AUTOPHAGY, V8, P979, DOI 10.4161/auto.20232; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jahangiri A, 2013, CLIN CANCER RES, V19, P1773, DOI 10.1158/1078-0432.CCR-12-1281; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kessler T, 2015, ONCOTARGET, V6, P31050, DOI 10.18632/oncotarget.2910; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Li Z, 2004, CHINESE MED J-PEKING, V117, P107; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Lu-Emerson C, 2013, NEURO-ONCOLOGY, V15, P1079, DOI 10.1093/neuonc/not082; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mao XG, 2016, ONCOTARGET, V7, P47808, DOI 10.18632/oncotarget.10029; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mittelbronn M, 2011, ACTA NEUROPATHOL, V122, P353, DOI 10.1007/s00401-011-0858-3; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Moughon DL, 2015, CANCER RES, V75, P4742, DOI 10.1158/0008-5472.CAN-14-3373; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Piao Y, 2016, NEURO-ONCOLOGY, V18, P1230, DOI 10.1093/neuonc/now030; Piao Y, 2013, CLIN CANCER RES, V19, P4392, DOI 10.1158/1078-0432.CCR-12-1557; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Piette C, 2009, J BIOL CHEM, V284, P32483, DOI 10.1074/jbc.M109.014589; Rahbari NN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5219; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Scholz A, 2016, EMBO MOL MED, V8, P39, DOI 10.15252/emmm.201505505; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Sun B, 2005, CLIN CANCER RES, V11, P1050; Thiele M, 2015, J IMMUNOL, V195, P2343, DOI 10.4049/jimmunol.1500572; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Wang X, 2012, CANCER RES, V72, P2867, DOI 10.1158/0008-5472.CAN-11-3247; Wei J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/285246; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Zeiner PS, 2015, BRAIN PATHOL, V25, P491, DOI 10.1111/bpa.12194	53	66	69	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 29	2017	36	26					3749	3759		10.1038/onc.2017.1	http://dx.doi.org/10.1038/onc.2017.1			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY9WM	28218903	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000404349700010
J	Adkins, NL; Swygert, SG; Kaur, P; Niu, HY; Grigoryev, SA; Sung, P; Wang, H; Peterson, CL				Adkins, Nicholas L.; Swygert, Sarah G.; Kaur, Parminder; Niu, Hengyao; Grigoryev, Sergei A.; Sung, Patrick; Wang, Hong; Peterson, Craig L.			Nucleosome-like, Single-stranded DNA (ssDNA)-Histone Octamer Complexes and the Implication for DNA Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; END-RESECTION; SEDIMENTATION-VELOCITY; RECOMBINANT HISTONES; DAMAGE RESPONSE; DISTINCT ROLES; CHROMATIN; RECRUITMENT; FUN30; PHOSPHORYLATION	Repair of DNA double strand breaks (DSBs) is key for maintenance of genome integrity. When DSBs are repaired by homologous recombination, DNA ends can undergo extensive processing, producing long stretches of single-stranded DNA (ssDNA). In vivo, DSB processing occurs in the context of chromatin, and studies indicate that histones may remain associated with processed DSBs. Here we demonstrate that histones are not evicted from ssDNA after in vitro chromatin resection. In addition, we reconstitute histone-ssDNA complexes (termed ssNucs) with ssDNA and recombinant histones and analyze these particles by a combination of native gel electrophoresis, sedimentation velocity, electron microscopy, and a recently developed electrostatic force microscopy technique, DREEM (dual-resonance frequency-enhanced electrostatic force microscopy). The reconstituted ssNucs are homogenous and relatively stable, and DREEM reveals ssDNA wrapping around histones. We also find that histone octamers are easily transferred in trans from ssNucs to either double-stranded DNA or ssDNA. Furthermore, the Fun30 remodeling enzyme, which has been implicated in DNA repair, binds ssNucs preferentially over nucleosomes, and ssNucs are effective at activating Fun30 ATPase activity. Our results indicate that ssNucs may be a hallmark of processes that generate ssDNA, and that posttranslational modification of ssNucs may generate novel signaling platforms involved in genome stability.	[Adkins, Nicholas L.; Swygert, Sarah G.; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kaur, Parminder; Wang, Hong] North Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Kaur, Parminder; Wang, Hong] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Peterson, CL (corresponding author), 373 Plantat St,Biotech 2,Ste 210, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu	Wang, Hong/F-3164-2014; Niu, Hengyao/AAE-9269-2020	Wang, Hong/0000-0003-0165-3559; kaur, Parminder/0000-0001-9183-4315	National Institutes of Health from the NIGMS from NIEHS [RO1 GM054096, RO1 GM107559, F32 GM096701, RO1 ES007061, P30 ES025128]; National Science Foundation [1516999]; Direct For Biological Sciences [1516999] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, P30ES025128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096701, R35GM122519, R01GM107559, R01GM054096] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS from NIEHS; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM054096 (to C. L. P.), RO1 GM107559 (to H. W.), and F32 GM096701 (to N. L. A.) from the NIGMS, RO1 ES007061 (to H. N. and P. S.) from NIEHS, Grant P30 ES025128 to the Center for Human Health and the Environment (CHHE), and National Science Foundation Grant 1516999 (to S. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Benarroch-Popivker D, 2016, MOL CELL, V61, P274, DOI 10.1016/j.molcel.2015.12.009; Bennett G, 2015, DNA REPAIR, V30, P38, DOI 10.1016/j.dnarep.2015.03.006; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; CAFFARELLI E, 1985, FEBS LETT, V181, P69, DOI 10.1016/0014-5793(85)81115-7; CAFFARELLI E, 1983, BIOCHIM BIOPHYS ACTA, V739, P235, DOI 10.1016/0167-4781(83)90034-9; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; Kaur P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20513; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; PALTER KB, 1979, CELL, V18, P451, DOI 10.1016/0092-8674(79)90064-3; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Swygert SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5751; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wang HD, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-10; Wu D, 2016, MOL CELL, V61, P315, DOI 10.1016/j.molcel.2015.12.012; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	37	25	25	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5271	5281		10.1074/jbc.M117.776369	http://dx.doi.org/10.1074/jbc.M117.776369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202543	Green Published, hybrid			2022-12-26	WOS:000397875500011
J	Rodriguez-Rodriguez, P; Pablo, ALL; Garcia-Prieto, CF; Somoza, B; Quintana-Villamandos, B; de Diego, JJG; Gutierrez-Arzapalo, PY; Ramiro-Cortijo, D; Gonzalez, MC; Arribas, SM				Rodriguez-Rodriguez, Pilar; Lopez de Pablo, Angel L.; Garcia-Prieto, Concha F.; Somoza, Beatriz; Quintana-Villamandos, Begona; Gomez de Diego, Jose J.; Gutierrez-Arzapalo, Perla Y.; Ramiro-Cortijo, David; Carmen Gonzalez, M.; Arribas, Silvia M.			Long term effects of fetal undernutrition on rat heart. Role of hypertension and oxidative stress	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; LEFT-VENTRICULAR HYPERTROPHY; RENIN-ANGIOTENSIN SYSTEM; LOW-PROTEIN DIET; CATCH-UP GROWTH; CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; GENDER-DIFFERENCES; BLOOD-PRESSURE; PREGNANCY	Background and aims Fetal undernutrition is a risk factor for heart disease in both genders, despite the protection of women against hypertension development. Using a rat model of maternal undernutrition ( MUN) we aimed to assess possible sex differences in the development of cardiac alterations and the implication of hypertension and cardiac oxidative stress. Methods Male and female offspring from rats fed ad libitum ( control) or with 50% of the normal daily intake during the second half of gestation ( MUN) were used. Heart weight/body weight ratio ( HW/BW), hemodynamic parameters ( anaesthetized rats) and plasma brain natriuretic peptide ( BNP, ELISA) were assessed in 21-day, 6-month and 22-month old rats. Plasma testosterone ( ELISA) and cardiac protein expression of enzymes related to reactive oxygen species synthesis ( p22 phox, xanthine-oxidase) and degradation ( catalase, Cu/Zn-SOD, Mn-SOD, Ec-SOD) were evaluated in 21-day and 6-month old rats ( Western Blot). Heart structure and function was studied at the age of 22 months ( echocardiography). Results At the age of 21 days MUN males exhibited significantly larger HW/BW and cardiac p22 phox expression while females had reduced p22 phox expression, compared to their respective sex-matched controls. At the age of 6-months, MUN males showed significantly larger blood pressure and cardiac xanthine-oxidase expression; MUN females were normotensive and had a lower cardiac expression of antioxidant enzymes, compared to their respective sex-matched controls. At the age of 22 months, both MUN males and females showed larger HW/BW and left ventricular mass and lower ejection fraction compared to sex-matched controls; only MUN males exhibited hypertension and a larger plasma BNP compared to aged male controls. Conclusions 1) During perinatal life females exposed to fetal undernutrition are protected from cardiac alterations, but in ageing they exhibit ventricular hypertrophy and functional loss, like MUN males; 2) cardiac oxidative stress might be implicated in the observed heart alterations in both sexes and 3) the severity of cardiac damage might be greater in males due to hypertension.	[Rodriguez-Rodriguez, Pilar; Lopez de Pablo, Angel L.; Gutierrez-Arzapalo, Perla Y.; Ramiro-Cortijo, David; Carmen Gonzalez, M.; Arribas, Silvia M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Garcia-Prieto, Concha F.; Somoza, Beatriz] Univ CEU San Pablo, Dept Ciencias Expt & Salud, Fac Farm, Madrid, Spain; [Quintana-Villamandos, Begona] Hosp Gen Univ Gregorio Maranon, Dept Anestesiol & Reanimac, Madrid, Spain; [Gomez de Diego, Jose J.] Hosp Clin San Carlos, Dept Cardiol, Madrid, Spain	Autonomous University of Madrid; San Pablo CEU University; General University Gregorio Maranon Hospital; Hospital Clinico San Carlos	Arribas, SM (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	silvia.arribas@uam.es	Ramiro Cortijo, David/V-1217-2019; Somoza, Beatriz/M-1260-2017; Rodríguez-Rodríguez, Pilar/Q-7664-2016; Gonzalez-Garcia, M Carmen/AAE-9533-2019	Ramiro Cortijo, David/0000-0001-7442-1586; Rodríguez-Rodríguez, Pilar/0000-0002-6483-8289; Gonzalez-Garcia, M Carmen/0000-0002-5522-0786; Gutierrez Arzapalo, Perla Yareli/0000-0002-3713-3056; Arribas, Silvia M/0000-0001-7103-6105; Somoza, Beatriz/0000-0003-1232-7791				Alexander BT, 2015, COMPR PHYSIOL, V5, P997, DOI 10.1002/cphy.c140036; [Anonymous], 2014, PHYSIOLOGY, V29, P4, DOI 10.1152/physiol.00064.2013; Balakumar P, 2014, CELL SIGNAL, V26, P2147, DOI 10.1016/j.cellsig.2014.06.011; Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105; BARKER DJP, 1986, LANCET, V1, P1077; Battista MC, 2005, J PHYSIOL-LONDON, V565, P197, DOI 10.1113/jphysiol.2004.078139; Byrne JA, 2003, ARCH MAL COEUR VAISS, V96, P214; Condezo-Hoyos L, 2012, J HYPERTENS, V30, P1185, DOI 10.1097/HJH.0b013e328353824b; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Dasinger JH, 2016, CLIN SCI, V130, P337, DOI 10.1042/CS20150611; DEVEREUX RB, 1987, HYPERTENSION, V9, P19; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Fabiansen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140472; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Franco MCP, 2007, LIFE SCI, V80, P709, DOI 10.1016/j.lfs.2006.10.028; Gezmish O, 2010, REPROD SCI, V17, P168, DOI 10.1177/1933719109349536; Gopalakrishnan K, 2016, HYPERTENSION, V67, P630, DOI 10.1161/HYPERTENSIONAHA.115.06946; Gray C, 2014, ENDOCRINOLOGY, V155, P4808, DOI 10.1210/en.2014-1567; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hu XW, 2000, CARDIOVASC RES, V48, P233, DOI 10.1016/S0008-6363(00)00167-X; Huxley VH, 2007, ADV PHYSIOL EDUC, V31, P17, DOI 10.1152/advan.00099.2006; Intapad S, 2013, HYPERTENSION, V61, P828, DOI 10.1161/HYPERTENSIONAHA.111.00645; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Lawlor DA, 2004, J EPIDEMIOL COMMUN H, V58, P120, DOI 10.1136/jech.58.2.120; Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Quintana-Villamandos B, 2013, HYPERTENS RES, V36, P408, DOI 10.1038/hr.2012.191; Reyes-Hernandez CG, 2016, J PHYSL BIOCH, V72, p[1, S64]; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rodriguez-Rodriguez P, 2015, J NUTR BIOCHEM, V26, P1650, DOI 10.1016/j.jnutbio.2015.08.004; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; SAVOLA JM, 1989, ACTA VET SCAND, P39; Sinclair MD, 2003, CAN VET J, V44, P885; Sirker A, 2007, AM J NEPHROL, V27, P649, DOI 10.1159/000109148; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stacy V, 2009, ANAT REC, V292, P29, DOI 10.1002/ar.20789; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Tappia PS, 2013, NUTR METAB CARDIOVAS, V23, P130, DOI 10.1016/j.numecd.2011.03.010; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Veskoukis AS, 2009, FREE RADICAL BIO MED, V47, P1371, DOI 10.1016/j.freeradbiomed.2009.07.014; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje	48	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171544	10.1371/journal.pone.0171544	http://dx.doi.org/10.1371/journal.pone.0171544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212445	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700008
J	Aoki, N; Mochizuki, K; Matsui, Y				Aoki, Nana; Mochizuki, Kentaro; Matsui, Yasuhisa			DNA methylation of the Fth1175 '-upstream region regulates differential Fth117 expression in lung cancer cells and germline stem cells	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASES G9A; PROLIFERATION; CHROMATIN; PLZF; SPERMATOGENESIS; UBIQUITINATION; DEMETHYLATION; SPERMATOGONIA; CHROMOSOME; LYSINE-9	The Ferritin heavy polypeptide-like 17 (Fth117) gene is a member of the cancer/testis antigen gene family, and is preferentially expressed in cancer cells and in testis. Although DNA methylation has been linked to the regulation of human FTHL17gene expression, detailed epigenetic regulation of its expression has not been investigated. To address this, we assessed the epigenetic regulation of murine Fth117gene expression in cancer cells and germ cells. Fthll7was more highly expressed in testis, a murine lung cancer cell line, KLN205, and in germline stem cells (GSCs) than in normal lung tissues. Furthermore, the Fth117expression level in GSCs was significantly higher than in KLN205 cells. We performed bisulfite-sequencing and luciferase (luc) reporter assays to examine the role of DNA methylation of the Fth/l7promoter in the regulation of Fth117expression. In KLN205 cells, testis, and GSCs, the Fth//75'-upstream region was hypo -methylated compared with normal lung tissues. Luc reporter assays indicated that hypo-methylation of the -0.6 kb to 0 kb region upstream from the transcription start site (TSS) was involved in the up -regulation of Fth/17 expression in KLN205 cells and GSCs. Because the -0.6 kb to -0.3 kb or the -0.3 kb to 0 kb region were relatively more hypo -methylated in KLN205 cells and in GSCs, respectively, compared with other regions between -0.6 kb to 0 kb, those regions may contribute to Fth117 up -regulation in each cell type. Following treatment with 5-Azacytidine, the -0.3 kb to 0 kb region became hypo -methylated, and Fth/17 expression was up -regulated in KLN205 cells to a level comparable to that in GSCs. Together, the results suggest that hypo-methylation of different but adjacent regions immediately upstream of the Fth117gene contribute to differential expression levels in lung cancer cells and GSCs, and hypo-methylation of the TSS-proximal region may be critical for high level expression.	[Aoki, Nana; Mochizuki, Kentaro; Matsui, Yasuhisa] Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan; [Aoki, Nana; Mochizuki, Kentaro; Matsui, Yasuhisa] Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Mochizuki, Kentaro; Matsui, Yasuhisa] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, AMED CREST, Tokyo, Japan; [Matsui, Yasuhisa] Tohoku Univ, Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Matsui, Y (corresponding author), Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, AMED CREST, Tokyo, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan.	yasuhisa.matsui.d3@tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Division for Interdisciplinary Advanced Research and Education in Tohoku University; Ministry of Education, Culture, Sports, Science and Technology of Japan [25114003]; AMED-CREST from the Japan Agency for Medical Research and Development [16gm0510017h0004]; Grants-in-Aid for Scientific Research [25114003] Funding Source: KAKEN	Division for Interdisciplinary Advanced Research and Education in Tohoku University; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by Division for Interdisciplinary Advanced Research and Education in Tohoku University (http://mv.iiare.tohoku.ac. jp/ed ucation/indextitrni), by Grants-in-Aid for Scientific Research on Innovative Areas (grant #25114003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/index.html) and by AMED-CREST (16gm0510017h0004) from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Choi WI, 2014, J BIOL CHEM, V289, P18625, DOI 10.1074/jbc.M113.538751; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Honda T, 2004, BRIT J CANCER, V90, P838, DOI 10.1038/sj.bjc.6601600; Hsu SH, 2005, CANCER RES, V65, P4041, DOI 10.1158/0008-5472.CAN-04-3658; Ikeda R, 2013, DNA RES, V20, P549, DOI 10.1093/dnares/dst030; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kobayashi S, 2010, NUCLEIC ACIDS RES, V38, P3672, DOI 10.1093/nar/gkq113; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Link PA, 2009, MOL CANCER RES, V7, P851, DOI 10.1158/1541-7786.MCR-08-0497; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Lovelace DL, 2016, DEVELOPMENT, V143, P1893, DOI 10.1242/dev.132761; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ruzzenenti P, 2015, BBA-GEN SUBJECTS, V1850, P1267, DOI 10.1016/j.bbagen.2015.02.016; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sin HS, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0159-8; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; WEBER J, 1994, CANCER RES, V54, P1766	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172219	10.1371/journal.pone.0172219	http://dx.doi.org/10.1371/journal.pone.0172219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207785	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500101
J	Gonzalez, SN; Valsecchi, WM; Maugeri, D; Delfino, JM; Cazzulo, JJ				Natalia Gonzalez, Soledad; Mariela Valsecchi, Wanda; Maugeri, Dante; Maria Delfino, Jose; Jose Cazzulo, Juan			Structure, kinetic characterization and subcellular localization of the two ribulose 5-phosphate epimerase isoenzymes from Trypanosoma cruzi	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; CYTOSOLIC D-RIBULOSE-5-PHOSPHATE 3-EPIMERASE; ISOMERASE B; ESCHERICHIA-COLI; PURIFICATION; LEISHMANIA; ENZYME; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; BRUCEI; TRANSKETOLASE	The enzyme of the pentose phosphate pathway (PPP) ribulose-5-phosphate-epimerase (RPE) is encoded by two genes present in the genome of Trypanosoma cruzi CL Brener clone: TcRPE1 and TcRPE2. Despite high sequence similarity at the amino acid residue level, the recombinant isoenzymes show a strikingly different kinetics. Whereas TcRPE2 follows a typical michaelian behavior, TcRPE1 shows a complex kinetic pattern, displaying a biphasic curve, suggesting the coexistence of -at least-two kinetically different molecular forms. Regarding the subcellular localization in epimastigotes, whereas TcRPE1 is a cytosolic enzyme, TcRPE2 is localized in glycosomes. To our knowledge, TcRPE2 is the first PPP isoenzyme that is exclusively localized in glycosomes. Over-expression of TcRPE1, but not of TcRPE2, significantly reduces the parasite doubling time in vitro, as compared with wild type epimastigotes. Both TcRPEs represent single domain proteins exhibiting the classical alpha/beta TIM-barrel fold, as expected for enzymes with this activity. With regard to the architecture of the active site, all the important amino acid residues for catalysis -with the exception of M58-are also present in both TcRPEs models. The superimposition of the binding pocket of both isoenzyme models shows that they adopt essentially identical positions in the active site with a residue specific RMSD < 2 angstrom, with the sole exception of S12, which displays a large deviation (residue specific RMSD: 11.07 angstrom). Studies on the quaternary arrangement of these isoenzymes reveal that both are present in a mixture of various oligomeric species made up of an even number of molecules, probably pointing to the dimer as their minimal functional unit. This multiplicity of oligomeric species has not been reported for any of the other RPEs studied so far and it might bear implications for the regulation of TcRPEs activity, although further investigation will be necessary to unravel the physiological significance of these structural findings.	[Natalia Gonzalez, Soledad; Maugeri, Dante; Jose Cazzulo, Juan] Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Dr Rodolfo A Ugalde, Inst Tecnol Chascomus Dr Raul Alfonsin IIB INTECH, Campus Miguelete, Buenos Aires, DF, Argentina; [Mariela Valsecchi, Wanda; Maria Delfino, Jose] Univ Buenos Aires, Inst Quim & Fisicoquim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Gonzalez, SN (corresponding author), Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Dr Rodolfo A Ugalde, Inst Tecnol Chascomus Dr Raul Alfonsin IIB INTECH, Campus Miguelete, Buenos Aires, DF, Argentina.	sgonzalez@iibintech.com.ar		Valsecchi, Wanda Mariela/0000-0002-8066-5445	National Agency for Promotion of Scientific and Technological Research; Argentinian Ministry of Science and Technology (ANPCyT, MinCyT) [PICT 2013-0969, PICT 2011-0861]	National Agency for Promotion of Scientific and Technological Research; Argentinian Ministry of Science and Technology (ANPCyT, MinCyT)	This work was supported by the National Agency for Promotion of Scientific and Technological Research, from the Argentinian Ministry of Science and Technology (ANPCyT, MinCyT), grant PICT 2013-0969 (JJC), grant PICT 2011-0861(JMD) (URL:www.agencia.mincyt.gob.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Bar J, 1996, BIOSEPARATION, V6, P233; Barrett MP, 1997, PARASITOL TODAY, V13, P11, DOI 10.1016/S0169-4758(96)10075-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNATA JJB, 1979, BIOCHEM J, V184, P409, DOI 10.1042/bj1840409; Capriles PVSZ, 2015, J MOL GRAPH MODEL, V55, P134, DOI 10.1016/j.jmgm.2014.11.002; Caruthers J, 2006, PROTEINS, V62, P338, DOI 10.1002/prot.20764; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Chen YR, 1998, PLANT PHYSIOL, V118, P199, DOI 10.1104/pp.118.1.199; Clarke JL, 2003, MOL BIOCHEM PARASIT, V127, P1, DOI 10.1016/S0166-6851(02)00298-0; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comini MA, 2013, DRUG DISCOV INFEC DI, P297; Cutler P., 2008, MOL BIOMETHODS HDB, P719; CYMERYNG C, 1995, MOL BIOCHEM PARASIT, V73, P91, DOI 10.1016/0166-6851(95)00099-M; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Duffieux F, 2000, J BIOL CHEM, V275, P27559; Esteve MI, 2004, MOL BIOCHEM PARASIT, V133, P197, DOI 10.1016/j.molbiopara.2003.10.007; Faria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26937; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Franzen O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-531; FUNAYAMA S, 1977, EXP PARASITOL, V43, P376, DOI 10.1016/0014-4894(77)90043-1; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gu MZ, 2013, MOL MICROBIOL, V89, P123, DOI 10.1111/mmi.12263; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Hanau S, 2013, BBA-PROTEINS PROTEOM, V1834, P2647, DOI 10.1016/j.bbapap.2013.09.018; Heise N, 1999, MOL BIOCHEM PARASIT, V99, P21, DOI 10.1016/S0166-6851(98)00176-5; Henderson EJ, 1970, BIOL CHEM, V245, P1416; Igoillo-Esteve M, 2007, AN ACAD BRAS CIENC, V79, P649, DOI 10.1590/S0001-37652007000400007; Igoillo-Esteve M, 2006, MOL BIOCHEM PARASIT, V149, P170, DOI 10.1016/j.molbiopara.2006.05.009; Jelakovic S, 2003, J MOL BIOL, V326, P127, DOI 10.1016/S0022-2836(02)01374-8; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KARMALI A, 1983, BIOCHEM J, V211, P617, DOI 10.1042/bj2110617; Kaur PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150764; Kaur PK, 2014, APPL BIOCHEM BIOTECH, V173, P1870, DOI 10.1007/s12010-014-0973-4; Kaur PK, 2012, BIOCHEM BIOPH RES CO, V421, P51, DOI 10.1016/j.bbrc.2012.03.107; Kopp J, 1999, J MOL BIOL, V287, P761, DOI 10.1006/jmbi.1999.2643; Kopriva S, 2000, J BIOL CHEM, V275, P1294, DOI 10.1074/jbc.275.2.1294; Liang WG, 2011, FASEB J, V25, P497, DOI 10.1096/fj.10-171207; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Loureiro I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003430; LUPIANEZ JA, 1987, INT J BIOCHEM, V19, P1085, DOI 10.1016/0020-711X(87)90310-7; Lyngstadaas A, 1998, BBA-GEN SUBJECTS, V1381, P319, DOI 10.1016/S0304-4165(98)00046-4; Maugeri DA, 2004, FEMS MICROBIOL LETT, V234, P117, DOI 10.1016/j.femsle.2004.03.018; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Nowitzki U, 1995, PLANT MOL BIOL, V29, P1279, DOI 10.1007/BF00020468; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Sodre CL, 2009, ARCH MICROBIOL, V191, P177, DOI 10.1007/s00203-008-0439-6; Stern AL, 2007, BIOCHEM J, V401, P279, DOI 10.1042/BJ20061049; Stern AL, 2011, FEBS J, V278, P793, DOI 10.1111/j.1742-4658.2010.07999.x; Stoffel SA, 2011, MOL BIOCHEM PARASIT, V179, P1, DOI 10.1016/j.molbiopara.2011.04.006; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Veitch NJ, 2004, BIOCHEM J, V382, P759, DOI 10.1042/BJ20040459; Voynov V, 2012, TERAPEUTIC PROTEINS; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; WALTER RD, 1979, TROPENMED PARASITOL, V30, P3; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wise EL, 2004, ACTA CRYSTALLOGR D, V60, P1687, DOI 10.1107/S0907444904015896; WOOD T, 1979, BIOCHIM BIOPHYS ACTA, V570, P352, DOI 10.1016/0005-2744(79)90155-4; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	69	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e172405	10.1371/journal.pone.0172405	http://dx.doi.org/10.1371/journal.pone.0172405			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207833	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500131
J	Ortiz, AJ; Cortez, V; Azzouz, A; Verdu, JR				Ortiz, Antonio J.; Cortez, Vieyle; Azzouz, Abdelmonaim; Verdu, Jose R.			Isolation and determination of ivermectin in post-mortem and in vivo tissues of dung beetles using a continuous solid phase extraction method followed by LC-ESI+-MS/MS	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; ANTI-PARASITIC AGENT; FLUORESCENCE DETECTION; MACROCYCLIC LACTONES; RESIDUE ANALYSIS; BOVINE LIVER; AVERMECTINS; ABAMECTIN; PLASMA	A new analytical method based on solvent extraction, followed by continuous solid-phase extraction (SPE) clean-up using a polymeric sorbent, was demonstrated to be applicable for the detection of ivermectin in complex biological matrices of dung beetles (hemolymph, excreta or dry tissues) using liquid chromatography combined with positive electrospray ionization tandem mass spectrometry (LC/ESI+-MS/MS). Using a signal-to-noise ratio of 3:1, the limit of detection (LOD) in the insect matrices at trace levels was 0.01 ng g-1 and the limit of quantification (LOO) was 0.1 ng g(-1). The proposed method was successfully used to quantitatively determine the levels of ivermectin in the analysis of small samples in in vivo and post mortem samples, demonstrating the usefulness for quantitative analyses that are focused on future pharmacokinetic and bioavailability studies in insects and the establishment of a new protocol to study the impact of ivermectin on non-target arthropods such as dung beetles and other insects that are related with the "dung community". Because satisfactory precision and accuracy values were obtained in both in vivo matrices, we suggest that the method can be consistently used for quantitative determinations that are focused on future pharmacokinetic and bioavailability studies in insects. Furthermore, this new analytical method was successfully applied to biological samples of dead dung beetles from the field suggesting that the method can be used to establish a new routine analysis of ivermectin residues in insect carcasses that is applied to complement typical mortality tests.	[Ortiz, Antonio J.; Azzouz, Abdelmonaim] Univ Jaen, Dept Quim Inorgan & Quim Organ, EPS Linares, Linares, Spain; [Cortez, Vieyle; Verdu, Jose R.] Univ Alicante, IUI CIBIO, Alicante, Spain	Universidad de Jaen; Universitat d'Alacant	Verdu, JR (corresponding author), Univ Alicante, IUI CIBIO, Alicante, Spain.	jr.verdu@ua.es	Azzouz, Abdelmonaim/O-2543-2019; Verdú, José/F-8269-2010; Gallardo, Vieyle Cortez/L-4692-2014	Azzouz, Abdelmonaim/0000-0001-5223-3146; Verdú, José/0000-0002-0805-8341; Gallardo, Vieyle Cortez/0000-0003-0217-3899	Secretaria de Estado de Investigacion Ministerio de Economia y Competitividad [CGL2015-68207-R]; Organism Autonomo de Parques Nacionales-Ministerio de Agricultura, Alimentacion y Medio Ambiente [OAPN 762/2012]	Secretaria de Estado de Investigacion Ministerio de Economia y Competitividad; Organism Autonomo de Parques Nacionales-Ministerio de Agricultura, Alimentacion y Medio Ambiente	Financial support was provided by Project CGL2015-68207-R of the Secretaria de Estado de Investigacion Ministerio de Economia y Competitividad, and by the Project OAPN 762/2012 of the Organism Autonomo de Parques Nacionales-Ministerio de Agricultura, Alimentacion y Medio Ambiente.	Abuin S, 2006, J CHROMATOGR A, V1114, P73, DOI 10.1016/j.chroma.2006.02.032; Aguilera-Luiz MM, 2012, FOOD CHEM, V132, P2171, DOI 10.1016/j.foodchem.2011.12.042; Asbakk K, 1999, J AGR FOOD CHEM, V47, P999, DOI 10.1021/jf980919q; Azzouz A, 2011, J AGR FOOD CHEM, V59, P5125, DOI 10.1021/jf200364w; Ballesteros E, 2004, J CHROMATOGR A, V1029, P267, DOI 10.1016/j.chroma.2003.12.009; Bassissi MF, 2004, COMP BIOCHEM PHYS C, V138, P437, DOI 10.1016/j.cca.2004.07.011; Berendsen Bjorn J.A., 2013, TRENDS ANAL CHEM, V43; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Campbell WW, 1989, IVERMECTIN ABAMECTIN; CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014; Cheng C, 2014, ANAL METHODS-UK, V6, P1581, DOI 10.1039/c3ay41943f; Croubels S, 2002, J MASS SPECTROM, V37, P840, DOI 10.1002/jms.343; Dahiya M, 2013, INDIAN J CHEM B, V52, P1313; Danaher M, 2001, ANALYST, V126, P576, DOI 10.1039/b101164m; Danaher M, 2006, J CHROMATOGR B, V844, P175, DOI 10.1016/j.jchromb.2006.07.035; Fink DW, 1989, IVERMECTIN ABAMECTIN, P173; FISHER MH, 1992, ANNU REV PHARMACOL, V32, P537, DOI 10.1146/annurev.pa.32.040192.002541; Giannetti L, 2011, ANAL CHIM ACTA, V700, P11, DOI 10.1016/j.aca.2010.12.035; Canga AG, 2009, VET J, V179, P25, DOI 10.1016/j.tvjl.2007.07.011; Howells L, 2001, ANALYST, V126, P155, DOI 10.1039/b008305o; Hu YQ, 2014, ANAL METHODS-UK, V6, P4734, DOI 10.1039/c4ay00107a; Huang JX, 2014, CHINESE CHEM LETT, V25, P635, DOI 10.1016/j.cclet.2014.01.036; Kitzman D, 2006, J PHARMACEUT BIOMED, V40, P1013, DOI 10.1016/j.jpba.2005.08.026; Krogh KA, 2008, J CHROMATOGR A, V1211, P60, DOI 10.1016/j.chroma.2008.09.081; Lehner AF, 2009, J MASS SPECTROM, V44, P111, DOI 10.1002/jms.1477; Lumaret JP, 2012, CURR PHARM BIOTECHNO, V13, P1004, DOI 10.2174/138920112800399257; Macedo F, 2015, FOOD CHEM, V179, P239, DOI 10.1016/j.foodchem.2015.01.046; Msagati TAM, 2006, TALANTA, V69, P243, DOI 10.1016/j.talanta.2005.10.002; Nilssen Arne C., 1999, Rangifer, V19, P61; PAYNE LD, 1995, J AGR FOOD CHEM, V43, P1233, DOI 10.1021/jf00053a021; Raich-Montiu J, 2008, J CHROMATOGR A, V1187, P275, DOI 10.1016/j.chroma.2008.02.063; Roncalli R. A., 1989, Ivermectin and abamectin., P173; Rubensam G, 2013, FOOD CONTROL, V29, P55, DOI 10.1016/j.foodcont.2012.05.075; Sanbonsuge A, 2011, ANAL METHODS-UK, V3, P2160, DOI 10.1039/c1ay05236e; Slootweg T, 2010, J SOIL SEDIMENT, V10, P1611, DOI 10.1007/s11368-010-0294-3; SOMMER C, 1992, B ENTOMOL RES, V82, P257, DOI 10.1017/S0007485300051804; Sutherland IH, 1989, ACT LEIDENS, V29, P161; Verdu JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13912; WALL R, 1987, NATURE, V327, P418, DOI 10.1038/327418a0; Wang H, 2009, B ENVIRON CONTAM TOX, V82, P395, DOI 10.1007/s00128-009-9638-3	40	9	9	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172202	10.1371/journal.pone.0172202	http://dx.doi.org/10.1371/journal.pone.0172202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207908	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500097
J	Ouyang, XH; Panetta, NJ; Talbott, MD; Payumo, AY; Halluin, C; Longaker, MT; Chen, JK				Ouyang, Xiaohu; Panetta, Nicholas J.; Talbott, Maya D.; Payumo, Alexander Y.; Halluin, Caroline; Longaker, Michael T.; Chen, James K.			Hyaluronic acid synthesis is required for zebrafish tail fin regeneration	PLOS ONE			English	Article							MOLECULAR-MASS HYALURONAN; TISSUE REGENERATION; CAUDAL FIN; VERTEBRATE REGENERATION; HEART REGENERATION; LIMB REGENERATION; WOUND EPIDERMIS; PROLIFERATION; MIGRATION; BLASTEMA	Using genome-wide transcriptional profiling and whole-mount expression analyses of zebrafish larvae, we have identified hyaluronan synthase 3 (has3) as an upregulated gene during caudal fin regeneration. has3 expression is induced in the wound epithelium within hours after tail amputation, and its onset and maintenance requires fibroblast growth factor, phosphoinositide 3-kinase, and transforming growth factor-beta signaling. Inhibition of hyaluronic acid (HA) synthesis by the small molecule 4-methylumbelliferone (4-MU) impairs tail regeneration in zebrafish larvae by preventing injury-induced cell proliferation. In addition, 4-MU reduces the expression of genes associated with wound epithelium and blastema function. Treatment with glycogen synthase kinase 3 inhibitors rescues 4-MU induced defects in cell proliferation and tail regeneration, while restoring a subset of wound epithelium and blastema markers. Our findings demonstrate a role for HA biosynthesis in zebrafish tail regeneration and delineate its epistatic relationships with other regenerative processes.	[Ouyang, Xiaohu; Talbott, Maya D.; Payumo, Alexander Y.; Halluin, Caroline; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Panetta, Nicholas J.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Chen, James K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Panetta, Nicholas J.] Univ Pittsburgh, Med Ctr, Dept Plast Surg, Pittsburgh, PA USA	Stanford University; Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011; Ouyang, Xiaohu/V-4452-2017	Chen, James/0000-0002-9220-8436; Ouyang, Xiaohu/0000-0003-1600-0251; Talbott, Maya/0000-0003-1197-2705	Stanford Interdisciplinary Graduate Fellowship; Hagey Fellowship in Pediatric Regenerative Medicine; Stanford Bio-X Undergraduate Summer Research Program Award; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Gunn/Olivier Fund; California Institute for Regenerative Medicine [TR1-01249]; National Institutes of Health, NHLBI [U01 HL099776]; National Institutes of Health, NICHD, NIH Pioneer Award [DP1 HD075622]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	Stanford Interdisciplinary Graduate Fellowship; Hagey Fellowship in Pediatric Regenerative Medicine; Stanford Bio-X Undergraduate Summer Research Program Award; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Gunn/Olivier Fund; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, NICHD, NIH Pioneer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: Stanford Interdisciplinary Graduate Fellowship, https//vpge.stanford.edu/fellmaships-funding/sisf, XO; Hagey Fellowship in Pediatric Regenerative Medicine, NJP; Stanford Bio-X Undergraduate Summer Research Program Award, http://biox.stanford.edu/research/undergraduate-research, MDT; Hagey Laboratory for Pediatric Regenerative Medicine, MTL; Oak Foundation, http://oakfrid.org, MTL; Gunn/Olivier Fund, MTL; California Institute for Regenerative Medicine, TR1-01249, https://www.cirm.ca.gov, MTL; National Institutes of Health, NHLBI. U01 HL099776, https://www.nhib. nh.gov, MTL; National Institutes of Health, NICHD, NIH Pioneer Award, DP1 HD075622, naps:// commonfund.nh.govipioneer/index, JKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Campbell LJ, 2008, CELL MOL LIFE SCI, V65, P73, DOI 10.1007/s00018-007-7433-z; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; Cowman MK, 2011, ANAL BIOCHEM, V417, P50, DOI 10.1016/j.ab.2011.05.023; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Govindan J, 2015, GENE EXPR PATTERNS; Grotek B, 2013, DEVELOPMENT, V140, P1412, DOI 10.1242/dev.087452; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Ishida T, 2010, DEV BIOL, V340, P468, DOI 10.1016/j.ydbio.2010.01.036; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koprunner M, 2000, MECH DEVELOP, V90, P275, DOI 10.1016/S0925-4773(99)00238-5; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Letamendia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036690; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Missinato MA, 2015, CARDIOVASC RES, V107, P487, DOI 10.1093/cvr/cvv190; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Nakatani Y, 2008, DEV GROWTH DIFFER, V50, P71, DOI 10.1111/j.1440-169x.2007.00977.x; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	60	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171898	10.1371/journal.pone.0171898	http://dx.doi.org/10.1371/journal.pone.0171898			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207787	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500058
J	Shahzad, K; Nizami, AS; Sagir, M; Rehan, M; Maier, S; Khan, MZ; Ouda, OKM; Ismail, IMI; BaFail, AO				Shahzad, K.; Nizami, A. S.; Sagir, M.; Rehan, M.; Maier, S.; Khan, M. Z.; Ouda, O. K. M.; Ismail, I. M. I.; BaFail, A. O.			Biodiesel production potential from fat fraction of municipal waste in Makkah	PLOS ONE			English	Article							BIOBASED PHA PRODUCTION; ECOLOGICAL FOOTPRINT; RESIDUES	In the Kingdom of Saudi Arabia (KSA), millions of Muslims come to perform Pilgrimage every year. Around one million ton of municipal solid waste (MSW) is generated in Makkah city annually. The collected MSW is disposed of in the landfills without any treatment or energy recovery. As a result, greenhouse gas (GHG) emissions and contamination of the soil and water bodies along with leachate and odors are occurring in waste disposal vicinities. The composition of MSW shows that food waste is the largest waste stream (up to 51%) of the total generated MSW. About 13% of the food waste consists of fat content that is equivalent to about 64 thousand tons per year. This study aims to estimate the production potential of biodiesel first time in Makkah city from fat/oil fractions of MSW and highlight its economic and environmental benefits. It has been estimated that 62.53, 117.15 and 6.38 thousand tons of biodiesel, meat and bone meal (MBM) and glycerol respectively could be produced in 2014. A total electricity potential of 852 Gigawatt hour (GWh) from all three sources based on their energy contents, Higher Heating Value (HHV) of 40.17, 18.33 and 19 MJ/kg, was estimated for 2014 that will increase up to 1777 GWh in 2050. The cumulative net savings from landfill waste diversion (256 to 533 million Saudi Riyal (SAR)), carbon credits (46 to 96 million SAR), fuel savings (146 to 303 million SAR) and electricity generation (273 to 569 million SAR) have a potential to add a total net revenue of 611 to 1274 million SAR every year to the Saudi economy, from 2014 to 2050 respectively. However, further studies including real-time data about annual slaughtering activities and the amount of waste generation and its management are critical to decide optimum waste management practices based on life cycle assessment (LCA) and life cycle costing (LCC) methodologies.	[Shahzad, K.; Nizami, A. S.; Rehan, M.; Ismail, I. M. I.] King Abdulaziz Univ, CEES, Jeddah, Saudi Arabia; [Sagir, M.] Univ Gujrat, Dept Chem Engn, Gujrat, Pakistan; [Maier, S.] Graz Univ Technol, Inst Proc & Particle Engn, Graz, Austria; [Khan, M. Z.] Aligarh Muslim Univ, Dept Chem, Environm Res Lab, Aligarh, Uttar Pradesh, India; [Ouda, O. K. M.] Prince Mohamed Bin Fahd Univ, Dept Civil Engn, Al Khobar, Saudi Arabia; [BaFail, A. O.] King Abdulaziz Univ, Dept Ind Engn, Jeddah, Saudi Arabia	King Abdulaziz University; University of Gujrat; Graz University of Technology; Aligarh Muslim University; Prince Mohammad Bin Fahd University; King Abdulaziz University	Shahzad, K (corresponding author), King Abdulaziz Univ, CEES, Jeddah, Saudi Arabia.	shahzadkhu@gmail.com	Shahzad, Khurram/H-6258-2017; Ouda, Omar K M/M-9107-2019; Khan, Mohammad/AAQ-2099-2020; Rehan, Mohammad/I-5609-2012; Shahzad, Khurram/GRX-8200-2022; Ismail, Iqbal/J-2319-2016; Sagir, Muhammad/F-2600-2017; Shahzad, Khurram/X-4852-2019; Nizami, Abdul-Sattar/G-5226-2014	Shahzad, Khurram/0000-0002-6434-3198; Khan, Mohammad/0000-0003-2009-0990; Rehan, Mohammad/0000-0002-1019-8677; Nizami, Abdul-Sattar/0000-0003-3294-9256	Deanship of Scientific Research (DSR) at KAU	Deanship of Scientific Research (DSR) at KAU	Authors acknowledge the Center of Excellence in Environmental Studies (CEES), King Abdulaziz University (KAU), Jeddah, KSA and Ministry of Education, KSA for technical support. Authors are also thankful to Deanship of Scientific Research (DSR) at KAU for their support to CEES.	Abdul Aziz H., 2007, NAT SEM HAJJ BEST PR; Abu-Qudais M, 2000, ENERG CONVERS MANAGE, V41, P983, DOI 10.1016/S0196-8904(99)00155-7; Amtul S, 2014, KINGDOM 2 5M ANIMALS; da Cunha ME, 2009, FUEL PROCESS TECHNOL, V90, P570, DOI 10.1016/j.fuproc.2009.01.001; Department for Transport (DfT), 2013, BIOUK10553 DFT; EIA.U.S. Energy Information Administration, 2013, INT EN OUTL; El Hanandeh A, 2013, J CLEAN PROD, V52, P53, DOI 10.1016/j.jclepro.2013.03.009; Energy Information Administration (EIA), 2012, TOT PRIM EN PROD 201; Fan MM, 2013, APPL ENERG, V108, P333, DOI 10.1016/j.apenergy.2013.03.063; Gardy J., 2014, INT SCI J ENV SCI, V3, P233; GREET, 2010, TRANSP MOD GREET 1 8; Hoover SL, 2005, ENERGY BALANCE GRASS; Ismail I. M. I, 2016, CAN SOC CIV ENG 14 I; Kettl KH, 2012, CHEM ENGINEER TRANS, V29, P439, DOI 10.3303/CET1229074; Kettl KH, 2011, CHEM ENGINEER TRANS, V25, P983, DOI 10.3303/CET1125164; Khan Muhammad Sadiq Munfath, 2013, International Journal of Innovation and Applied Studies, V4, P101; Khan MZ, 2017, APPL ENERG, V185, P410, DOI 10.1016/j.apenergy.2016.11.005; Mekonnen T, 2014, ENV RES ENG MANAGEME; Misra RD, 2011, RENEW SUST ENERG REV, V15, P2413, DOI 10.1016/j.rser.2011.02.023; Moser BR, 2009, IN VITRO CELL DEV-PL, V45, P229, DOI 10.1007/s11627-009-9204-z; Munir S, 2016, AEROSOL AIR QUALITY; Nizami AS, 2017, APPL ENERG, V186, P189, DOI 10.1016/j.apenergy.2016.04.116; Nizami A. S., 2016, TRENDS SUSTAINABILIT, P59, DOI [10.1201/9781315370743-1, DOI 10.1201/9781315370743-1]; Nizami A-S, 2015, C 15 SCI S HAJJ UMR; Nizami AS, 2013, GREEN ENERGY TECHNOL, P79, DOI 10.1007/978-1-4471-5364-1_4; Noor ZZ, 2013, RENEW SUST ENERG REV, V20, P378, DOI 10.1016/j.rser.2012.11.050; Ouda O.K.M., 2015, J KING SAUD U ENG SC; Rathore D, 2016, BIOFUEL RES J, V3, P380, DOI 10.18331/BRJ2016.3.2.3; Rehan M, 2016, ENERG SOURCE PART A, V38, P2598, DOI 10.1080/15567036.2016.1153753; Saudi Electric Company (SEC), 2016, CURR TAR; Shahzad K, 2015, THESIS; Shahzad K, 2013, CLEAN TECHNOL ENVIR, V15, P525, DOI 10.1007/s10098-013-0608-4; Sharma YC, 2008, FUEL, V87, P2355, DOI 10.1016/j.fuel.2008.01.014; Singh A, 2013, BIOENERGY PRODUCTION, P139; Tahir MS, 2015, CHEM ENGINEER TRANS, V45, P1309, DOI 10.3303/CET1545219; Thamsiriroj T, 2010, FUEL, V89, P3579, DOI 10.1016/j.fuel.2010.06.009; Titz M, 2012, CLEAN TECHNOL ENVIR, V14, P495, DOI 10.1007/s10098-012-0464-7; United Nation Environment Programme (UNEP), 2006, IPCC GUIDELINES NATL; Uzun BB, 2012, ENERGY; Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005; World Bank, 2009, GLOB STUD LIV MARK S	41	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171297	10.1371/journal.pone.0171297	http://dx.doi.org/10.1371/journal.pone.0171297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207856	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500022
J	Balan, A; Szaingurten-Solodkin, I; Swissa, SS; Feinshtein, V; Huleihel, M; Holcberg, G; Dukler, D; Beharier, O				Balan, Adelina; Szaingurten-Solodkin, Irit; Swissa, Shani S.; Feinshtein, Valeria; Huleihel, Mahmoud; Holcberg, Gershon; Dukler, Doron; Beharier, Ofer			The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models	PLOS ONE			English	Article							ENDOTHELIAL NITRIC-OXIDE; ANGIOTENSIN-II; ACUTE-HYPOXIA; MOUSE MODEL; FETAL; PREECLAMPSIA; PERFUSION; HYPERTENSION; HYPOXEMIA; IMBALANCE	Introduction Research in animal models and preliminary clinical studies in humans support the use of pravastatin for the prevention of preeclampsia. However, its use during pregnancy is still controversial due to limited data about its effect on the human placenta and fetus. Methods In the present study, human placental cotyledons were perfused in the absence or presence of pravastatin in the maternal reservoir (PraM). In addition, placental explants were treated with pravastatin for 5, 24 and 72 h under normoxia and hypoxia. We monitored the secretion of placental growth factor (PIGF), soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), endothelial nitric oxide synthase (eNOS) expression and activation and the fetal vasoconstriction response to angiotensin-II. Results The concentrations of PIGF, sFlt-1 and sEng were not significantly altered by pravastatin in PraM cotyledons and in placental explants compared to control. Under hypoxic conditions, pravastatin decreased sFlt-1 concentrations. eNOS expression was significantly increased in PraM cotyledons but not in pravastatin-treated placental explants cultured under normoxia or hypoxia. eNOS phosphorylation was not significantly affected by pravastatin. The feto-placental vascular tone and the fetal vasoconstriction response to angiotensin-II, did not change following exposure of the maternal circulation to pravastatin. Conclusion We found that pravastatin does not alter the essential physiological functions of the placenta investigated in the study. The relevance of the study lays in the fact that it expands the current knowledge obtained thus far regarding the effect of the drug on the normal human placenta. This data is reassuring and important for clinicians that consider the treatment of high-risk patients with pravastatin, a treatment that exposes some normal pregnancies to the drug.	[Balan, Adelina; Swissa, Shani S.; Huleihel, Mahmoud] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, Fac Hlth Sci, Beer Sheva, Israel; [Szaingurten-Solodkin, Irit] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Feinshtein, Valeria] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Holcberg, Gershon; Dukler, Doron; Beharier, Ofer] Soroka Univ, Med Ctr, Dept Obstet & Gynecol, Beer Sheva, Israel; [Holcberg, Gershon; Dukler, Doron; Beharier, Ofer] Ben Gurion Univ Negev, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Beharier, O (corresponding author), Soroka Univ, Med Ctr, Dept Obstet & Gynecol, Beer Sheva, Israel.; Beharier, O (corresponding author), Ben Gurion Univ Negev, Beer Sheva, Israel.	oferbeharier@gmail.com	Beharier, Ofer/AAC-8016-2021	Huleihel, Mahmoud/0000-0003-4246-9299	Faculty of Health Sciences, Ben-Gurion University of the Negev; Soroka University Medical Center	Faculty of Health Sciences, Ben-Gurion University of the Negev; Soroka University Medical Center	This study was sponsored by the "Medical Research during residency program fund granted by the Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Ala-Kokko TI, 2000, INT J OBSTET ANESTH, V9, P26, DOI 10.1054/ijoa.1999.0312; Basraon SK, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.020; Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Burke SD, 2016, J CLIN INVEST, V126, P2561, DOI 10.1172/JCI83918; Calabro P, 2005, CURR OPIN CARDIOL, V20, P541, DOI 10.1097/01.hco.0000181482.99067.bf; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; COHN HE, 1974, AM J OBSTET GYNECOL, V120, P817, DOI 10.1016/0002-9378(74)90587-0; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Eshkoli T, 2013, J MATERN-FETAL NEO M, V26, P116, DOI 10.3109/14767058.2012.722725; Forbes K, 2008, HORM RES, V69, P129, DOI 10.1159/000112585; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Gillis EE, 2016, HYPERTENSION, V67, P647, DOI 10.1161/HYPERTENSIONAHA.115.06071; Girardi G, 2014, J REPROD IMMUNOL, V101, P161, DOI 10.1016/j.jri.2013.07.005; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Gostamme MM, 2015, AM J OBSTET GYNECOL, V214; JONES CT, 1975, J PHYSIOL-LONDON, V248, P15, DOI 10.1113/jphysiol.1975.sp010960; Kaesemeyer WH, 1999, J AM COLL CARDIOL, V33, P234, DOI 10.1016/S0735-1097(98)00514-2; Kane AD, 2012, J PHYSIOL-LONDON, V590, P323, DOI 10.1113/jphysiol.2011.217968; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Lefkou E, 2016, J CLIN INVEST, V126, P2933, DOI 10.1172/JCI86957; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Low JA, 2004, BEST PRACT RES CL OB, V18, P375, DOI 10.1016/j.bpobgyn.2004.02.002; Ma FX, 2005, CARDIOVASC DRUG REV, V23, P281; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mathiesen L, 2010, REPROD TOXICOL, V30, P138, DOI 10.1016/j.reprotox.2010.01.006; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Morrison S, 2003, J PHYSIOL-LONDON, V547, P283, DOI 10.1113/jphysiol.2002.032615; MYATT L, 1992, AM J OBSTET GYNECOL, V166, P224, DOI 10.1016/0002-9378(92)91863-6; Nanovskaya TN, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.038; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Odiari EA, 2012, HUM REPROD, V27, P2933, DOI 10.1093/humrep/des288; Pauli JM, 2015, OBSTET GYN CLIN N AM, V42, P299, DOI 10.1016/j.ogc.2015.01.007; Ramma W, 2014, J REPROD IMMUNOL, V101, P153, DOI 10.1016/j.jri.2013.12.120; Saad AF, 2014, REPROD SCI, V21, P138, DOI 10.1177/1933719113492207; Schneider H, 1985, Contrib Gynecol Obstet, V13, P98; Toda N, 2007, PHARMACOL REV, V59, P54, DOI 10.1124/pr.59.1.2; Vahakangas K, 2006, MUTAT RES-GEN TOX EN, V608, P129, DOI 10.1016/j.mrgentox.2006.02.014; von Dadelszen P, 2011, BJOG-INT J OBSTET GY, V118, P624, DOI 10.1111/j.1471-0528.2010.02879.x; Yan C, 2003, ARTERIOSCL THROM VAS, V23, P26, DOI 10.1161/01.ATV.0000046231.17365.9D; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zarek J, 2013, PLACENTA, V34, P719, DOI 10.1016/j.placenta.2013.05.002; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	45	24	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172174	10.1371/journal.pone.0172174	http://dx.doi.org/10.1371/journal.pone.0172174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199380	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400080
J	Choi, BY; Bair, E; Lee, JW				Choi, Byeong Yeob; Bair, Eric; Lee, Jae Won			Nearest shrunken centroids via alternative genewise shrinkages	PLOS ONE			English	Article							LINEAR DISCRIMINANT-ANALYSIS; VARIABLE SELECTION; ORACLE PROPERTIES; CLASS PREDICTION; EXPRESSION; CLASSIFICATION; CANCER; MICROARRAYS; DISCOVERY; DIAGNOSIS	Nearest shrunken centroids (NSC) is a popular classification method for microarray data. NSC calculates centroids for each class and "shrinks" the centroids toward 0 using soft thresholding. Future observations are then assigned to the class with the minimum distance between the observation and the (shrunken) centroid. Under certain conditions the soft shrinkage used by NSC is equivalent to a LASSO penalty. However, this penalty can produce biased estimates when the true coefficients are large. In addition, NSC ignores the fact that multiple measures of the same gene are likely to be related to one another. We consider several alternative genewise shrinkage methods to address the aforementioned shortcomings of NSC. Three alternative penalties were considered: the smoothly clipped absolute deviation (SCAD), the adaptive LASSO (ADA), and the minimax concave penalty (MCP). We also showed that NSC can be performed in a genewise manner. Classification methods were derived for each alternative shrinkage method or alternative genewise penalty, and the performance of each new classification method was compared with that of conventional NSC on several simulated and real microarray data sets. Moreover, we applied the geometric mean approach for the alternative penalty functions. In general the alternative (genewise) penalties required fewer genes than NSC. The geometric mean of the class-specific prediction accuracies was improved, as well as the overall predictive accuracy in some cases. These results indicate that these alternative penalties should be considered when using NSC.	[Choi, Byeong Yeob] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Choi, Byeong Yeob; Bair, Eric] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Bair, Eric] Univ N Carolina, Dept Endodont, Chapel Hill, NC USA; [Lee, Jae Won] Korea Univ, Dept Stat, Seoul, South Korea	University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Lee, JW (corresponding author), Korea Univ, Dept Stat, Seoul, South Korea.	jael@korea.ac.kr		Choi, Byeong Yeob/0000-0002-4205-1442	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2016943438]; NIH/NIDCR [R03DE02359]; NIH/NCATS [UL1RR02574]; NIH/NIEHS [P03ES01012]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2016943438). Eric Bair was partially supported by NIH/NIDCR grant R03DE02359, NIH/NCATS grant UL1RR02574, and NIH/NIEHS grant P03ES01012.	Antoniadis A, 2001, J AM STAT ASSOC, V96, P939, DOI 10.1198/016214501753208942; BREIMAN L, 1995, TECHNOMETRICS, V37, P373, DOI 10.2307/1269730; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gravier E, 2010, GENE CHROMOSOME CANC, V49, P1125, DOI 10.1002/gcc.20820; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; Lusa, 2013, BMC BIOINFORMATICS, V14, P1; Mai Q, 2012, BIOMETRIKA, V99, P29, DOI 10.1093/biomet/asr066; Pang H, 2009, BIOMETRICS, V65, P1021, DOI 10.1111/j.1541-0420.2009.01200.x; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Shao J, 2011, ANN STAT, V39, P1241, DOI 10.1214/10-AOS870; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2003, STAT SCI, V18, P104, DOI 10.1214/ss/1056397488; Wang SJ, 2007, BIOINFORMATICS, V23, P972, DOI 10.1093/bioinformatics/btm046; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171068	10.1371/journal.pone.0171068	http://dx.doi.org/10.1371/journal.pone.0171068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199352	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400022
J	Vasconcellos, RCC; Oraguzie, OB; Soler, A; Arkwazee, H; Myers, JR; Ferreira, JJ; Song, QJ; McClean, P; Miklas, PN				Vasconcellos, Renato C. C.; Oraguzie, O. Blessing; Soler, Alvaro; Arkwazee, Haidar; Myers, James R.; Ferreira, Juan J.; Song, Qijian; McClean, Phil; Miklas, Phillip N.			Meta-QTL for resistance to white mold in common bean	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BUNSI-DERIVED RESISTANCE; PHYSIOLOGICAL RESISTANCE; SCLEROTINIA-SCLEROTIORUM; GERMPLASM LINE; DISEASE RESISTANCE; GENE-EXPRESSION; REGISTRATION; DEFENSE; ARABIDOPSIS	White mold, caused by the fungus Sclerotinia sclerotiorum (Lib.) de Bary, is a major disease that limits common bean production and quality worldwide. The host-pathogen interaction is complex, with partial resistance in the host inherited as a quantitative trait with low to moderate heritability. Our objective was to identify meta-QTL conditioning partial resistance to white mold from individual QTL identified across multiple populations and environments. The physical positions for 37 individual QTL were identified across 14 recombinant inbred bi-parental populations (six new, three re-genotyped, and five from the literature). A metaQTL analysis of the 37 QTL was conducted using the genetic linkage map of Stampede x Red Hawk population as the reference. The 37 QTL condensed into 17 named loci (12 previously named and five new) of which nine were defined as meta-QTL WM1.1, WM2.2, WM3.1, WM5.4, WM6.2, WM7.1, WM7.4, WM7.5, and WM8.3. The nine meta-QTL had confidence intervals ranging from 0.65 to 9.41 Mb. Candidate genes shown to express under S. sclerotiorum infection in other studies, including cell wall receptor kinase, CO/1, ethylene responsive transcription factor, peroxidase, and MYB transcription factor, were found within the confidence interval for five of the meta-QTL. The nine meta-QTL are recommended as potential targets for MAS for partial resistance to white mold in common bean.	[Vasconcellos, Renato C. C.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Oraguzie, O. Blessing] Washington State Univ, Irrigated Agr Res & Extens Ctr, Prosser, WA 99350 USA; [Soler, Alvaro; Miklas, Phillip N.] USDA ARS, Grain Legume Genet & Physiol Res Unit, Prosser, WA 99350 USA; [Arkwazee, Haidar; Myers, James R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Ferreira, Juan J.] Serv Reg Invest & Desarrollo Agroalimentario SERI, Area Cultivos Hort & Forestales, Villaviciosa, Asturias, Spain; [Song, Qijian] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [McClean, Phil] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA	Universidade Federal de Lavras; Washington State University; United States Department of Agriculture (USDA); Oregon State University; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; United States Department of Agriculture (USDA); North Dakota State University Fargo	Miklas, PN (corresponding author), USDA ARS, Grain Legume Genet & Physiol Res Unit, Prosser, WA 99350 USA.	phil.miklas@ars.usda.gov	Ferreira, Juan Jose/J-9470-2016	Ferreira, Juan Jose/0000-0002-8782-8868; Coelho de Castro Vasconcellos, Renato/0000-0002-2610-601X; Bouca-Machado, Raquel/0000-0003-3756-2763; Soler-Garzon, Alvaro/0000-0002-7671-3109	CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education) [BEX 10615/14-8]; USDA-ARS National Sclerotinia Initiative; USDA; National Institute of Food and Agricultural (NIFA); Agriculture and Food Research Initiative (AFRI) [2009-0192]	CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); USDA-ARS National Sclerotinia Initiative(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA(United States Department of Agriculture (USDA)); National Institute of Food and Agricultural (NIFA); Agriculture and Food Research Initiative (AFRI)	RV received support from CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate Education (BEX 10615/14-8) [www.iie.org/programs/capes]. PNM JM PM appreciate funding from the USDA-ARS National Sclerotinia Initiative [https://www.ars.usda.gov/plains-area/docs/white-mold-research/research/]. PM QS appreciate funding from the USDA, National Institute of Food and Agricultural (NIFA), Agriculture and Food Research Initiative (AFRI), Project #2009-0192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; [Anonymous], 2016, SCI REP; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bouchez O, 2007, PLANT PHYSIOL, V145, P465, DOI 10.1104/pp.107.106302; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Calla B, 2014, MOL PLANT PATHOL, V15, P576, DOI 10.1111/mpp.12113; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ender M, 2005, CROP SCI, V45, P2482, DOI 10.2135/cropsci2005.0064; Goffinet B, 2000, GENETICS, V155, P463; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; Haggard JE, 2007, THESIS; Hamon C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-45; Higgins R, 2016, ANN REP BEAN IMPROV, V59, P133; Hoyos-Villegas V, 2015, CROP SCI, V55, P2116, DOI 10.2135/cropsci2015.02.0106; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P244, DOI 10.1034/j.1399-3054.2002.1150210.x; Kean D., 2002, ANN REP BEAN IMPROV, V45, P64; KELLY JD, 1994, CROP SCI, V34, P1406, DOI 10.2135/cropsci1994.0011183X003400050052x; Khowaja FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-276; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Kolkman JM, 2003, CROP SCI, V43, P539, DOI 10.2135/cropsci2003.0539; Kwak M, 2008, J HERED, V99, P283, DOI 10.1093/jhered/esn005; Lara LADC, 2014, ISRN MOL BIOL, V2014; Leite ME, 2014, EUR J PLANT PATHOL, V138, P391, DOI 10.1007/s10658-013-0341-1; Levinson DF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S6; Malencic D, 2010, PLANT PHYSIOL BIOCH, V48, P903, DOI 10.1016/j.plaphy.2010.08.003; Maxwell JJ, 2007, CROP SCI, V47, P2285, DOI 10.2135/cropsci2007.01.0022; Miklas PN, 2006, CROP SCI, V46, P2339, DOI 10.2135/cropsci2006.04.0248; Miklas PN, 2007, CROP SCI, V47, P935, DOI 10.2135/cropsci2006.08.0525; Miklas PN, 2007, CROP SCI, V47, P174, DOI 10.2135/cropsci2006.06.0410; Miklas PN, 2014, J PLANT REGIST, V8, P183, DOI 10.3198/jpr2013.06.0034crg; Miklas PN, 2013, EUR J PLANT PATHOL, V135, P525, DOI 10.1007/s10658-012-0153-8; Miklas PN, 2004, CROP SCI, V44, P1584, DOI 10.2135/cropsci2004.1584; Miklas PN, 2003, J AM SOC HORTIC SCI, V128, P564, DOI 10.21273/JASHS.128.4.0564; Miklas PN, 2001, CROP SCI, V41, P309, DOI 10.2135/cropsci2001.412309x; Miklas PN, 1998, CROP SCI, V38, P1728, DOI 10.2135/cropsci1998.0011183X003800060073x; Mkwaila W, 2011, PLANT BREEDING, V130, P665, DOI 10.1111/j.1439-0523.2011.01876.x; Moghaddam SM, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.02.0012; Park SO, 2001, CROP SCI, V41, P1253, DOI 10.2135/cropsci2001.4141253x; Perez-Vega E, 2016, ANN REP BEAN IMPROV, V59, P189; Perez-Vega E, 2012, MOL BREEDING, V29, P31, DOI 10.1007/s11032-010-9522-1; Perez-Vega E, 2010, THEOR APPL GENET, V120, P1367, DOI 10.1007/s00122-010-1261-5; Petzoldt R., 1996, ANN REP BEAN IMPROV, V39, P142; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; SCHWARTZ HF, 1978, PHYTOPATHOLOGY, V68, P465, DOI 10.1094/Phyto-68-465; Schwartz HF, 2013, CROP SCI, V53, P1832, DOI 10.2135/cropsci2013.02.0081; Semagn K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-313; Singh S.P., 1982, ANN REP BEAN IMPROV, V25, P92; Singh SP, 2016, J PLANT REGIST, V10, P291, DOI 10.3198/jpr2015.04.0023crg; Singh SP, 2014, CAN J PLANT SCI, V94, P947, DOI [10.4141/CJPS2013-321, 10.4141/cjps2013-321]; Singh SP, 2009, CROP SCI, V49, P1629, DOI 10.2135/cropsci2008.08.0508; Singh SR, 2007, J PLANT REGIST, V1, P62, DOI 10.3198/jpr2006.10.0643crg; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; Soule M, 2011, CROP SCI, V51, P123, DOI 10.2135/cropsci2010.06.0356; Teran H, 2010, PLANT BREEDING, V129, P327, DOI 10.1111/j.1439-0523.2009.01679.x; Teran H, 2009, EUPHYTICA, V167, P271, DOI 10.1007/s10681-009-9885-8; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; TOUBART P, 1992, PLANT J, V2, P367; Trapp JJ, 2015, CROP SCI, V55, P1596, DOI 10.2135/cropsci2014.11.0792; TU JC, 1982, CAN J PLANT SCI, V62, P65, DOI 10.4141/cjps82-010; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Viteri DM, 2015, EUPHYTICA, V204, P457, DOI 10.1007/s10681-015-1366-7; Viteri DM, 2015, CROP SCI, V55, P44, DOI 10.2135/cropsci2014.02.0145; Viteri DM, 2014, CROP SCI, V54, P1598, DOI 10.2135/cropsci2014.01.0008; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; [No title captured]	81	33	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171685	10.1371/journal.pone.0171685	http://dx.doi.org/10.1371/journal.pone.0171685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199342	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400042
J	Kim, IY; Kim, JH; Lee, DW; Lee, SB; Rhee, H; Seong, EY; Kwak, IS; Song, SH				Kim, Il Young; Kim, Joo Hui; Lee, Dong Won; Lee, Soo Bong; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon			Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; SEPTIC SHOCK; RIFLE CRITERIA; FAILURE; BALANCE; MULTICENTER; MORTALITY; RECOVERY; MANAGEMENT; DIALYSIS	Background Fluid overload is known to be associated with increased mortality in patients with acute kidney injury (AKI) who are critically ill. In this study, we intended to uncover whether the adverse effect of fluid overload on survival could be applied to all of the patients with AKI who received continuous renal replacement therapy (CRRT). Methods We analyzed 341 patients with AKI who received CRRT in our intensive care units. The presence of fluid overload was defined as a minimum 10% increase in body weight from the baseline. Demographics, comorbid diseases, clinical data, severity of illness [the sequential organ failure assessment (SOFA) score, number of vasopressors, diagnosis of sepsis, use of ventilator] upon ICU admission, fluid overload status, and time elapsed from AKI diagnosis until CRRT initiation were reviewed from the medical charts. Results Patients with total fluid overload from 3 days before CRRT initiation to ICU discharge had a significantly lower survival rate after ICU admission, as compared to patients with no fluid overload (P < 0.001). Among patients with sepsis (P < 0.001) or with high SOFA scores (P < 0.001), there was a significant difference in survival of the patients with and without fluid overload. In patients without sepsis or with low SOFA score, there was no significant difference in survival of patients irrespective of fluid overload. Conclusion Our study demonstrates that the adverse effect of fluid overload on survival is more evident in patients with sepsis or with more severe illness, and that it might not apply to patients without sepsis or with less severe illness.	[Kim, Il Young; Kim, Joo Hui; Lee, Dong Won; Lee, Soo Bong; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan, South Korea; [Kim, Il Young; Kim, Joo Hui; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea; [Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Song, SH (corresponding author), Pusan Natl Univ, Dept Internal Med, Sch Med, Yangsan, South Korea.; Song, SH (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea.	shsong0209@gmail.com	Kim, Il Young/ABG-2153-2021; Kim, Il Young/ABG-2156-2021	Kim, Il Young/0000-0002-1731-6357; song, sangheon/0000-0002-8218-6974				Alsous F, 2000, CHEST, V117, P1749, DOI 10.1378/chest.117.6.1749; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Cantarovich F, 2004, AM J KIDNEY DIS, V44, P402, DOI 10.1053/j.ajkd.2004.05.021; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Gillespie RS, 2004, PEDIATR NEPHROL, V19, P1394, DOI 10.1007/s00467-004-1655-1; Goldstein SL, 2001, PEDIATRICS, V107, P1309, DOI 10.1542/peds.107.6.1309; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Jacobs R, 2011, BLOOD PURIFICAT, V32, P262, DOI 10.1159/000330244; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kielstein JT, 2004, AM J KIDNEY DIS, V43, P342, DOI 10.1053/j.ajkd.2003.10.021; Langenberg C, 2007, INTENS CARE MED, V33, P1614, DOI 10.1007/s00134-007-0734-8; Licari E, 2007, CONTRIB NEPHROL, V156, P167; Liu KD, 2006, CLIN J AM SOC NEPHRO, V1, P915, DOI 10.2215/CJN.01430406; Mehta RL, 2009, NAT CLIN PRACT NEPHR, V5, P10, DOI 10.1038/ncpneph0988; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Piccinni P, 2006, INTENS CARE MED, V32, P80, DOI 10.1007/s00134-005-2815-x; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Ricci Z, 2006, NEPHROL DIAL TRANSPL, V21, P690, DOI 10.1093/ndt/gfi296; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P733, DOI 10.2215/CJN.00060110; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	31	39	44	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172137	10.1371/journal.pone.0172137	http://dx.doi.org/10.1371/journal.pone.0172137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196107	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900053
J	Huang, NS; Quan, CL; Mo, M; Chen, JJ; Yang, BL; Huang, XY; Wu, J				Huang, Nai-si; Quan, Chen-lian; Mo, Miao; Chen, Jia-jian; Yang, Ben-long; Huang, Xiao-yan; Wu, Jiong			A prospective study of breast anthropomorphic measurements, volume and ptosis in 605 Asian patients with breast cancer or benign breast disease	PLOS ONE			English	Article							UNITED-STATES; FORMULA; WOMEN; RECONSTRUCTION	Objectives The current study aims to summarize breast anthropomorphic measurement features in Chinese patients with breast diseases and to investigate their potential correlations with demographic factors. Materials and methods Fifteen breast anthropomorphic parameters of 605 Chinese female patients were collected prospectively. Breast ptosis status was scaled by two methods and breast volume was calculated according to a modified formula of BREAST-V. Results Among 1210 breasts, the average breast volume was 340.0 +/- 109.1 ml (91.8 +/- 919.2 ml). The distance from the nipple to the inframammary fold was 7.5 +/- 1.6 cm in the standing position. The width of the breast base was 14.3 +/- 1.4 cm (8.5 +/- 23.5 cm). The incidence of breast ptosis was 22.8% (274/1204), of which 37 (23.5%) and 79 (31.7%) women had severe ptosis assessed by different criteria. Increased height (OR[ odds ratio] = 1.500, P<0.001), postmenopausal status (OR = 1.463, P = 0.02), increased BMI, breastfeeding for 7 - 12 months (OR = 1.882, P = 0.008) and more than one year (OR = 2.367, P = 0.001) were risk factors for an increased breast volume. Post-menopausal status (OR = 2.390, P< 0.001 and OR = 2.621, P< 0.001 for different scales), BMI >= 24.7 kg/m(2) (OR = 3.149, P< 0.001 and OR = 2.495, P = 0.002), breastfeeding for 7 - 12 months (OR = 4.136, P = 0.004 and OR = 4.010, P = 0.002), and breastfeeding for more than one year (OR = 6.934, P< 0.001 and OR = 6.707, P< 0.001) were independent risk factors for breast ptosis. Conclusions The current study provides anthropomorphic measurements data of Chinese women with breast diseases, which are useful for cosmetic and reconstructive breast surgery decisions. Post-menopausal status, increased BMI, and breastfeeding for more than six months were independent risk factors for both increased breast volume and breast ptosis.	[Huang, Nai-si; Quan, Chen-lian; Chen, Jia-jian; Yang, Ben-long; Huang, Xiao-yan; Wu, Jiong] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai, Peoples R China; [Huang, Nai-si; Quan, Chen-lian; Mo, Miao; Chen, Jia-jian; Yang, Ben-long; Huang, Xiao-yan; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Mo, Miao] Fudan Univ, Dept Clin Stat, Shanghai Canc Ctr, Shanghai, Peoples R China; [Wu, Jiong] Collaborat Innovat Ctr Canc Med, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai, Peoples R China.; Wu, J (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Wu, J (corresponding author), Collaborat Innovat Ctr Canc Med, Shanghai, Peoples R China.	wujiong1122@vip.sina.com						Avsar DK, 2010, AESTHET SURG J, V30, P44, DOI 10.1177/1090820X09358078; Brown RW, 2000, PLAST RECONSTR SURG, V106, P1342, DOI 10.1097/00006534-200011000-00018; DEWEY KG, 1995, J PEDIATR-US, V126, P696, DOI 10.1016/S0022-3476(95)70395-0; Jagsi R, 2014, J CLIN ONCOL, V32, P919, DOI 10.1200/JCO.2013.52.2284; Kayar R, 2011, BREAST CANCER-BASIC, V5, P43, DOI 10.4137/BCBCR.S6128; Kim SJ, 2014, BREASTFEED MED, V9, P73, DOI 10.1089/bfm.2013.0068; LaTrenta GS, 1994, BREAST REDUCTION AES, P971; Liu YJ, 2011, ANN PLAS SURG, V67, P7, DOI 10.1097/SAP.0b013e3181f77ab5; Longo B, 2013, PLAST RECONSTR SURG, V132, p1E, DOI 10.1097/PRS.0b013e318290f6bd; Qiao Q, 1997, AESTHET PLAST SURG, V21, P362, DOI 10.1007/s002669900139; Regnault P, 1976, Clin Plast Surg, V3, P193; Rinker B, 2010, ANN PLAS SURG, V64, P579, DOI 10.1097/SAP.0b013e3181c39377; Ryan AS, 2006, WOMEN HEALTH ISS, V16, P243, DOI 10.1016/j.whi.2006.08.001; Sanuki J, 2009, AESTHET PLAST SURG, V33, P295, DOI 10.1007/s00266-008-9194-y; Sigurdson LJ, 2006, PLAST RECONSTR SURG, V118, P313, DOI 10.1097/01.prs.0000227627.75771.5c; STROMBECK JO, 1986, ANN PLAS SURG, V17, P498; Tepper OM, 2008, BREAST J, V14, P543, DOI 10.1111/j.1524-4741.2008.00645.x; Westreich M, 1997, PLAST RECONSTR SURG, V100, P468, DOI 10.1097/00006534-199708000-00032; Xi WJ, 2014, AESTHET PLAST SURG, V38, P1116, DOI 10.1007/s00266-014-0412-5; Zhang BN, 2013, BREAST, V22, P676, DOI 10.1016/j.breast.2013.01.004	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172122	10.1371/journal.pone.0172122	http://dx.doi.org/10.1371/journal.pone.0172122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192525	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800073
J	Scholz, S; Schneider, SL; Rose, M				Scholz, Sebastian; Schneider, Signe Luisa; Rose, Michael			Differential effects of ongoing EEG beta and theta power on memory formation	PLOS ONE			English	Article							BRAIN OSCILLATIONS; PRESTIMULUS THETA; ALPHA-BAND; PREDICT; SYNCHRONIZATION; DISCRIMINATION; PERSPECTIVE; INHIBITION	Recently, elevated ongoing pre-stimulus beta power (13-17 Hz) at encoding has been associated with subsequent memory formation for visual stimulus material. It is unclear whether this activity is merely specific to visual processing or whether it reflects a state facilitating general memory formation, independent of stimulus modality. To answer that question, the present study investigated the relationship between neural pre-stimulus oscillations and verbal memory formation in different sensory modalities. For that purpose, a within-subject design was employed to explore differences between successful and failed memory formation in the visual and auditory modality. Furthermore, associative memory was addressed by presenting the stimuli in combination with background images. Results revealed that similar EEG activity in the low beta frequency range (13-17 Hz) is associated with subsequent memory success, independent of stimulus modality. Elevated power prior to stimulus onset differentiated successful from failed memory formation. In contrast, differential effects between modalities were found in the theta band (3-7 Hz), with an increased oscillatory activity before the onset of later remembered visually presented words. In addition, pre stimulus theta power dissociated between successful and failed encoding of associated context, independent of the stimulus modality of the item itself. We therefore suggest that increased ongoing low beta activity reflects a memory promoting state, which is likely to be moderated by modality-independent attentional or inhibitory processes, whereas high ongoing theta power is suggested as an indicator of the enhanced binding of incoming interlinked information.	[Scholz, Sebastian; Schneider, Signe Luisa; Rose, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Scholz, Sebastian] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Carl von Ossietzky Universitat Oldenburg	Rose, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	rose@uke.uni-hamburg.de		Scholz, Sebastian/0000-0003-1074-3281	DFG [2653/6-1]	DFG(German Research Foundation (DFG))	This work was funded by the DFG, www.dfg.de, Grant 2653/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Addante RJ, 2015, NEUROIMAGE, V105, P21, DOI 10.1016/j.neuroimage.2014.10.046; Bengson JJ, 2014, J COGNITIVE NEUROSCI, V26, P2578, DOI 10.1162/jocn_a_00650; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brysbaert M, 2011, EXP PSYCHOL, V58, P412, DOI 10.1027/1618-3169/a000123; Burke JF, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01055; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fell J, 2011, J NEUROSCI, V31, P5392, DOI 10.1523/JNEUROSCI.3668-10.2011; Fellner MC, 2013, NEUROIMAGE, V79, P361, DOI 10.1016/j.neuroimage.2013.04.121; Gruber MJ, 2013, NEUROIMAGE, V64, P68, DOI 10.1016/j.neuroimage.2012.07.064; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Hanslmayr S, 2014, CURR BIOL, V24, P904, DOI 10.1016/j.cub.2014.03.007; Hanslmayr S, 2014, NEUROIMAGE, V85, P648, DOI 10.1016/j.neuroimage.2013.05.121; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Herrmann C. S., 2013, FRONTIERS HUMAN NEUR, V7; Huster RJ, 2014, INT J PSYCHOPHYSIOL, V91, P36, DOI 10.1016/j.ijpsycho.2013.08.011; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kawasaki M, 2010, EUR J NEUROSCI, V31, P1683, DOI 10.1111/j.1460-9568.2010.07217.x; Kleberg FI, 2014, NEUROSCI RES, V83, P69, DOI 10.1016/j.neures.2014.02.010; Kleiner M, 2007, PERCEPTION, V36, P14; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kopell N, 2011, P NATL ACAD SCI USA, V108, P3779, DOI 10.1073/pnas.1019676108; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Long NM, 2014, NEUROIMAGE, V84, P488, DOI 10.1016/j.neuroimage.2013.08.052; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Merkow MB, 2014, HIPPOCAMPUS, V24, P1562, DOI 10.1002/hipo.22335; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Noh E, 2014, NEUROIMAGE, V84, P712, DOI 10.1016/j.neuroimage.2013.09.028; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Otten LJ, 2010, J COGNITIVE NEUROSCI, V22, P1212, DOI 10.1162/jocn.2009.21298; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Park H, 2010, HIPPOCAMPUS, V20, P24, DOI 10.1002/hipo.20663; Park H, 2014, HUM BRAIN MAPP, V35, P3972, DOI 10.1002/hbm.22452; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roberts DM, 2014, J COGNITIVE NEUROSCI, V26, P1615, DOI 10.1162/jocn_a_00569; Salari N, 2016, NEUROIMAGE, V125, P1013, DOI 10.1016/j.neuroimage.2015.10.037; Salari N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038090; Schneider SL, 2016, NEUROIMAGE, V125, P978, DOI 10.1016/j.neuroimage.2015.11.024; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Waldhauser GT, 2012, J NEUROSCI, V32, P1953, DOI 10.1523/JNEUROSCI.4201-11.2012; Weiss S, 2005, INT J PSYCHOPHYSIOL, V57, P129, DOI 10.1016/j.ijpsycho.2005.03.013; Weiss S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00201	48	30	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171913	10.1371/journal.pone.0171913	http://dx.doi.org/10.1371/journal.pone.0171913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192459	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800051
J	Hayashi, M; Suzuki, R; Colleoni, C; Ball, SG; Fujita, N; Suzuki, E				Hayashi, Mari; Suzuki, Ryuichiro; Colleoni, Christophe; Ball, Steven G.; Fujita, Naoko; Suzuki, Eiji			Bound Substrate in the Structure of Cyanobacterial Branching Enzyme Supports a New Mechanistic Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; CRYSTAL-STRUCTURE; AMYLOPECTIN BIOSYNTHESIS; MOLECULAR-REPLACEMENT; GLYCOGEN-METABOLISM; STARCH STRUCTURE; I BEI; COMPLEX; BINDING; CYANOTHECE	Branching enzyme (BE) catalyzes the formation of alpha-1,6-glucosidic linkages in amylopectin and glycogen. The reaction products are variable, depending on the organism sources, and the mechanistic basis for these different outcomes is unclear. Although most cyanobacteria have only one BE isoform belonging to glycoside hydrolase family 13, Cyanothece sp. ATCC 51142 has three isoforms (BE1, BE2, and BE3) with distinct enzymatic properties, suggesting that investigations of these enzymes might provide unique insights into this system. Here, we report the crystal structure of ligand-free wild-type BE1 (residues 5-759 of 1-773) at 1.85 angstrom resolution. The enzyme consists of four domains, including domain N, carbohydrate- binding module family 48 (CBM48), domain A containing the catalytic site, and domain C. The central domain A displays a (beta/alpha)(8)-barrel fold, whereas the other domains adopt beta-sandwich folds. Domain N was found in a new location at the back of the protein, forming hydrogen bonds and hydrophobic interactions with CBM48 and domain A. Site-directed mutational analysis identified a mutant (W610N) that bound maltoheptaose with sufficient affinity to enable structure determination at 2.30 angstrom resolution. In this structure, maltoheptaose was bound in the active site cleft, allowing us to assign subsites -7 to -1. Moreover, seven oligosaccharide-binding sites were identified on the protein surface, and we postulated that two of these in domain A served as the entrance and exit of the donor/acceptor glucan chains, respectively. Based on these structures, we propose a substrate binding model explaining the mechanism of glycosylation/deglycosylation reactions catalyzed by BE.	[Hayashi, Mari; Suzuki, Ryuichiro; Fujita, Naoko; Suzuki, Eiji] Akita Prefectural Univ, Fac Bioresource Sci, Dept Biol Prod, Akita 0100195, Japan; [Colleoni, Christophe; Ball, Steven G.] Univ Sci & Technol Lille, CNRS, Unite Mixte Rech 8576, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Akita Prefectural University; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Suzuki, R; Suzuki, E (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Dept Biol Prod, Akita 0100195, Japan.	ryuichi@akita-pu.ac.jp; esuzuki@akita-pu.ac.jp	Colleoni, Christophe/AAP-2411-2021	Ball, Steven/0000-0003-1629-1650	Shimadzu Science Foundation [120003]; JSPS KAKENHI [15K18685, 16K07467]; Grants-in-Aid for Scientific Research [16K07467] Funding Source: KAKEN	Shimadzu Science Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Shimadzu Science Foundation Grant 120003 (to R. S.) and JSPS KAKENHI Grants 15K18685 (to R. S.) and 16K07467 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaen K, 2012, BIOCHEM BIOPH RES CO, V424, P508, DOI 10.1016/j.bbrc.2012.06.145; Cockburn D, 2015, INT J BIOL MACROMOL, V75, P338, DOI 10.1016/j.ijbiomac.2015.01.054; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280; Devillers CH, 2003, ARCH BIOCHEM BIOPHYS, V418, P34, DOI 10.1016/S0003-9861(03)00341-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng L, 2016, ACTA CRYSTALLOGR D, V72, P641, DOI 10.1107/S2059798316003272; Feng L, 2015, BIOCHEMISTRY-US, V54, P6207, DOI 10.1021/acs.biochem.5b00228; Froese DS, 2015, HUM MOL GENET, V24, P5667, DOI 10.1093/hmg/ddv280; Fujita N., 2014, AGRIBIOSCI MONOGR, V4, P1, DOI [10.5047/agbm.2014.00401.0001, DOI 10.5047/AGBM.2014.00401.0001]; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; Hayashi M, 2015, ACTA CRYSTALLOGR F, V71, P1109, DOI 10.1107/S2053230X1501198X; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Janecek S, 2002, BIOLOGIA, V57, P29; Jo HJ, 2015, FEBS LETT, V589, P1089, DOI 10.1016/j.febslet.2015.03.011; Li C, 2016, PLANTA, V243, P13, DOI 10.1007/s00425-015-2421-2; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2005, PLANT CELL PHYSIOL, V46, P539, DOI 10.1093/pcp/pci045; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Pfister B, 2016, CELL MOL LIFE SCI, V73, P2781, DOI 10.1007/s00018-016-2250-x; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Robert X, 2005, J BIOL CHEM, V280, P32968, DOI 10.1074/jbc.M505515200; Sawada T, 2014, ARCH BIOCHEM BIOPHYS, V562, P9, DOI 10.1016/j.abb.2014.07.032; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Suzuki E., 2013, J APPL GLYOSCI, V60, P21, DOI 10.5458/jag.jag.JAG-2012_016; Suzuki E, 2016, CELL MOL LIFE SCI, V73, P2643, DOI 10.1007/s00018-016-2243-9; Suzuki E, 2013, PLANT CELL PHYSIOL, V54, P465, DOI 10.1093/pcp/pcs190; Suzuki R, 2015, BBA-PROTEINS PROTEOM, V1854, P476, DOI 10.1016/j.bbapap.2015.02.012; Svensson B., 2015, J APPL GLYCOSCI, V62, P87, DOI DOI 10.5458/JAG.JAG.JAG-2015_006; Tetlow IJ, 2014, IUBMB LIFE, V66, P546, DOI 10.1002/iub.1297; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Welkie DG, 2016, J BACTERIOL, V198, P701, DOI 10.1128/JB.00830-15; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x	45	24	25	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5465	5475		10.1074/jbc.M116.755629	http://dx.doi.org/10.1074/jbc.M116.755629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28193843	Green Published, hybrid			2022-12-26	WOS:000397875500026
J	Alekseeva, LA; Mironova, NL; Brenner, EV; Kurilshikov, AM; Patutina, OA; Zenkova, MA				Alekseeva, Ludmila A.; Mironova, Nadezhda L.; Brenner, Evgenyi V.; Kurilshikov, Alexander M.; Patutina, Olga A.; Zenkova, Marina A.			Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELL-FREE DNA; CIRCULATING NUCLEIC-ACIDS; EXTRACELLULAR DNA; CANCER-PATIENTS; PROGNOSTIC MARKER; BINDING PROTEIN; PLASMA DNA; RECEPTOR; DEOXYRIBONUCLEASE	Taking into account recently obtained data indicating the participation of circulating extracellular DNA (exDNA) in tumorigenesis, enzymes with deoxyribonucleic activity have again been considered as potential antitumour and antimetastatic drugs. Previously, using murine Lewis lung carcinoma and hepatocellular carcinoma A1 tumour models, we have shown the antimetastatic activity of bovine DNase I, which correlates with an increase of DNase activity and a decrease of exDNA concentration in the blood serum of tumour-bearing mice. In this work, using next-generation sequencing on the ABS SOLiD (TM) 5.500 platform, we performed a search for molecular targets of DNase I by comparing the exDNA profiles of healthy animals, untreated animals with Lewis lung carcinoma (LLC) and those with LLC treated with DNase I. We found that upon DNase I treatment of LLC-bearing mice, together with inhibition of metastasis, a number of strong alterations in the patterns of exDNA were observed. The major differences in exDNA profiles between groups were: i) the level of GC-poor sequences increased during tumour development was reduced to that of healthy mice; ii) levels of sequences corresponding to tumour-associated genes Hmga2, Myc and Jun were reduced in the DNase I-treated group in comparison with non-treated mice; iii) 224 types of tandem repeat over-presented in untreated LLC-bearing mice were significantly reduced after DNase I treatment. The most important result obtained in the work is that DNase I decreased the level of B-subfamily repeats having homology to human ALU repeats, known as markers of carcinogenesis, to the level of healthy animals. Thus, the obtained data lead us to suppose that circulating exDNA plays a role in tumour dissemination, and alteration of multiple molecular targets in the bloodstream by DNase I reduces the invasive potential of tumours.	[Alekseeva, Ludmila A.; Mironova, Nadezhda L.; Brenner, Evgenyi V.; Kurilshikov, Alexander M.; Patutina, Olga A.; Zenkova, Marina A.] RAS, SB, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Zenkova, MA (corresponding author), RAS, SB, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	marzen@niboch.nsc.ru	Zenkova, Marina A/G-5088-2013; Kurilshikov, Alexander/GWC-1519-2022; Alekseeva, Ludmila/AAF-2362-2021; Patutina, Olga/F-9159-2013	Kurilshikov, Alexander/0000-0003-2541-5627; Alekseeva, Ludmila/0000-0002-5826-5365; Zenkova, Marina/0000-0003-4044-1049; Mironova, Nadezhda/0000-0003-4375-0269	Russian Academy of Science [II.2P/VII.58-1]; Russian Foundation for Basic Research [14-04-01007];  [SS - 7623.2016.4]	Russian Academy of Science(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); 	This research was supported by the Russian Academy of Science under the programs 1.7 'Molecular and Cellular Biology' (grant # II.2P/VII.58-1), Russian Foundation for Basic Research (grant # 14-04-01007) and scientific schools SS - 7623.2016.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2014, GYNECOL ONCOL, V132, P462, DOI 10.1016/j.ygyno.2013.12.024; Alcazar-Leyva S, 2009, MED SCI MONITOR, V15, pCR51; Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; BENNET RM, 1988, J IMMUNOL, V140, P2937; BENNETT RM, 1987, J EXP MED, V166, P850, DOI 10.1084/jem.166.4.850; BENNETT RM, 1985, J CLIN INVEST, V76, P2182, DOI 10.1172/JCI112226; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carreira PE, 2014, FEBS J, V281, P63, DOI 10.1111/febs.12601; Casadio V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/270457; Chen Z, 2005, MED HYPOTHESES, V65, P956, DOI 10.1016/j.mehy.2005.04.042; Combaret V, 2002, CANCER RES, V62, P3646; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Demers M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134073; El-Gayar Dina, 2016, Asian Pac J Cancer Prev, V17, P939; Feng DX, 2002, PANCREAS, V25, P336, DOI 10.1097/00006676-200211000-00003; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fujihara J, 2012, COMP BIOCHEM PHYS B, V163, P263, DOI 10.1016/j.cbpb.2012.07.002; Gaiffe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036766; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Gotoh T, 2005, J CLIN ONCOL, V23, P5205, DOI 10.1200/JCO.2005.02.014; Hao TB, 2014, BRIT J CANCER, V111, P1482, DOI 10.1038/bjc.2014.470; Hawes MC, 2015, CANCER RES, V75, P4260, DOI 10.1158/0008-5472.CAN-15-1546; Healy LD, 2016, J IMMUNOL METHODS, V435, P77, DOI 10.1016/j.jim.2016.06.002; HEFENEIDER SH, 1990, J INVEST DERMATOL, V94, pS79, DOI 10.1111/1523-1747.ep12875170; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Hsieh SC, 2001, RHEUMATOLOGY, V40, P851, DOI 10.1093/rheumatology/40.8.851; Iqbal S, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1071-y; Jackson PE, 2003, CARCINOGENESIS, V24, P1657, DOI 10.1093/carcin/bgg101; Jahr S, 2001, CANCER RES, V61, P1659; Johnson PJ, 2002, CLIN CHEM, V48, P1186; Kemp JR, 2015, FRONT CHEM, V3, DOI [10.3389/fchem.2075.00068, 10.3389/fchem.2015.00068]; Kitada K, 2013, CYTOGENET GENOME RES, V139, P1, DOI 10.1159/000342885; Kostyuk S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/782123; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; LI JZ, 1989, ARTHRITIS RHEUM-US, V32, P726, DOI 10.1002/anr.1780320610; Lin X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1552-y; Lindforss U, 2005, ANTICANCER RES, V25, P657; LUNDQVIST EHA, 1991, EUR J CANCER, V27, P1313, DOI 10.1016/0277-5379(91)90103-K; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Marchenko MM, 1999, UKR BIOKHIM ZH, V76, P131; MATIENKO NA, 1967, DOKL AKAD NAUK SSSR+, V172, P1457; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; Otsuka J, 2004, INT J GYNECOL CANCER, V14, P459, DOI 10.1111/j.1048-891x.2004.014305.x; Park SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100429; Gallegos-Arreola MP, 2015, ARCH MED SCI, V11, P551, DOI 10.5114/aoms.2015.52357; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; Qin JB, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-23; Rawson JB, 2011, CARCINOGENESIS, V32, P741, DOI 10.1093/carcin/bgr020; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rodriguez-Martin C, 2016, J HUM GENET, V7, P9; Roman Angel C, 2011, Mob Genet Elements, V1, P66; Rosner K, 2011, EXPERT REV ANTICANC, V11, P981, DOI [10.1586/ERA.11.90, 10.1586/era.11.90]; Ryan BM, 2003, GUT, V52, P101, DOI 10.1136/gut.52.1.101; SALGANIK RI, 1967, NATURE, V214, P100, DOI 10.1038/214100a0; Salvi S, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/574120; SANO H, 1982, J IMMUNOL, V128, P1341; Schwarzenbach H, 2007, INT J CANCER, V120, P1465, DOI 10.1002/ijc.22470; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Stacey SN, 2016, HUM MOL GENET, V25, P1008, DOI 10.1093/hmg/ddv622; STROUN M, 1989, ONCOLOGY, V46, P318; SUGIHARA S, 1990, BRIT J CANCER, V62, P607, DOI 10.1038/bjc.1990.339; SUGIHARA S, 1993, BRIT J CANCER, V67, P66, DOI 10.1038/bjc.1993.10; Sunami E, 2008, ANN NY ACAD SCI, V1137, P171, DOI 10.1196/annals.1448.011; Taback B, 2004, ANN NY ACAD SCI, V1022, P17, DOI 10.1196/annals.1318.004; Taback B, 2004, ANN NY ACAD SCI, V1022, P1, DOI 10.1196/annals.1318.002; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Wen FS, 2013, CANCER RES, V73, P4256, DOI 10.1158/0008-5472.CAN-12-3287; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Winter N, 2008, PRENATAL DIAG, V28, P1126, DOI 10.1002/pd.2140; Xue XY, 2006, ANN NY ACAD SCI, V1075, P154, DOI 10.1196/annals.1368.021; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663	77	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171988	10.1371/journal.pone.0171988	http://dx.doi.org/10.1371/journal.pone.0171988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222152	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800027
J	Hall, JE; Schaller, MD				Hall, Jessica E.; Schaller, Michael D.			Phospholipid binding to the FAK catalytic domain impacts function	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE KINASE; STRUCTURAL BASIS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOTYROSINE-BINDING; PEPTIDE SUBSTRATE; CRYSTAL-STRUCTURE; PHOSPHORYLATION; ACTIVATION; CELLS	Focal adhesion kinase is an essential nonreceptor tyrosine kinase that plays an important role in development, in homeostasis and in the progression of human disease. Multiple stimuli activate FAK, which requires a change in structure from an autoinhibited to activated conformation. In the autoinhibited conformation the FERM domain associates with the catalytic domain of FAK and PI(4,5) P-2 binding to the FERM domain plays a role in the release of autoinhibition, activating the enzyme. An in silico model of FAK/PI(4,5) P2 interaction suggests that residues on the catalytic domain interact with PI(4,5) P2, in addition to the known FERM domain PI(4,5) P2 binding site. This study was undertaken to test the significance of this in silico observation. Mutations designed to disrupt the putative PI(4,5) P2 binding site were engineered into FAK. These mutants exhibited defects in phosphorylation and failed to completely rescue the phenotype associated with fak (-/-) phenotype fibroblasts demonstrating the importance of these residues in FAK function. The catalytic domain of FAK exhibited PI(4,5) P2 binding in vitro and binding activity was lost upon mutation of putative PI(4,5) P2 binding site basic residues. However, binding was not selective for PI(4,5) P2, and the catalytic domain bound to several phosphatidylinositol phosphorylation variants. The mutant exhibiting the most severe biological defect was defective for phosphatidylinositol phosphate binding, supporting the model that catalytic domain phospholipid binding is important for biochemical and biological function.	[Hall, Jessica E.; Schaller, Michael D.] West Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA; [Schaller, Michael D.] West Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA; [Hall, Jessica E.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA	West Virginia University; West Virginia University; Bucknell University	Schaller, MD (corresponding author), West Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA.; Schaller, MD (corresponding author), West Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Morgantown, WV 26506 USA.	mschaller@hsc.wvu.edu			WVU School of Medicine; WVU Cancer Institute; NIH [P20 RR016440, P30 GM103488, P20 GM103434]	WVU School of Medicine; WVU Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by funds from the WVU School of Medicine. Imaging experiments and image analysis were performed in the West Virginia University Microscope Imaging Facility, which has been supported by the WVU Cancer Institute and NIH grants P20 RR016440, P30 GM103488 and P20 GM103434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Chinthalapudi K, 2014, J CELL BIOL, V207, P643, DOI 10.1083/jcb.201404128; Choi CH, 2013, J CELL BIOL, V202, P849, DOI 10.1083/jcb.201302131; Clemente CFMZ, 2012, J MOL CELL CARDIOL, V52, P493, DOI 10.1016/j.yjmcc.2011.10.015; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Essayem S, 2006, ONCOGENE, V25, P1081, DOI 10.1038/sj.onc.1209130; Feng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132833; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; FURUTA Y, 1995, ONCOGENE, V11, P1989; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Heerkens EHJ, 2014, J VASC RES, V51, P305, DOI 10.1159/000365479; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; ILLC D, 1995, NATURE, V377, P539; Inazawa J, 1996, HUM GENET, V98, P508, DOI 10.1007/s004390050249; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim STS, 2013, MOL CELLS, V36, P1, DOI 10.1007/s10059-013-0139-1; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Lu Q, 2012, MICROVASC RES, V83, P56, DOI 10.1016/j.mvr.2011.05.003; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Peter BJ, 2003, SCIENCE; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Ren XD, 2000, J CELL SCI, V113, P3673; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, CANCER BIOL THER, V9, P791, DOI 10.4161/cbt.11729; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sugimura K, 2010, TOHOKU J EXP MED, V222, P201, DOI 10.1620/tjem.222.201; Tai YL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690690; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Walkiewicz KW, 2015, PROG BIOPHYS MOL BIO, V119, P60, DOI 10.1016/j.pbiomolbio.2015.06.001; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zhou J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004593; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454	60	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72136	10.1371/journal.pone.0172136	http://dx.doi.org/10.1371/journal.pone.0172136			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222177	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800034
J	Hayat, T; Zahir, H; Tanveer, A; Alsaedi, A				Hayat, Tasawar; Zahir, Hina; Tanveer, Anum; Alsaedi, Ahmad			Soret and Dufour effects on MHD peristaltic transport of Jeffrey fluid in a curved channel with convective boundary conditions	PLOS ONE			English	Article							MAGNETIC-FIELD; MASS-TRANSFER; HEAT-TRANSFER; FLOW; ANNULUS; STRESS; MOTION; SLIP	The purpose of present article is to examine the peristaltic flow of Jeffrey fluid in a curved channel. An electrically conducting fluid in the presence of radial applied magnetic field is considered. Analysis of heat and mass transfer is carried out. More generalized realistic constraints namely the convective conditions are utilized. Soret and Dufour effects are retained. Problems formulation is given for long wavelength and low Reynolds number assumptions. The expressions of velocity, temperature, heat transfer coefficient, concentration and stream function are computed. Effects of emerging parameters arising in solutions are analyzed in detail. It is found that velocity is not symmetric about centreline for curvature parameter. Also maximum velocity decreases with an increase in the strength of magnetic field. Further it is noticed that Soret and Dufour numbers have opposite behavior for temperature and concentration.	[Hayat, Tasawar] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Zahir, Hina; Tanveer, Anum; Alsaedi, Ahmad] King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tanveer, A (corresponding author), King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah 21589, Saudi Arabia.	anum@math.qau.edu.pk	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abd Elmaboud Y, 2012, COMMUN NONLINEAR SCI, V17, P685, DOI 10.1016/j.cnsns.2011.05.039; Abd-Alla AM, 2015, J MAGN MAGN MATER, V374, P680, DOI 10.1016/j.jmmm.2014.08.091; Abd-Alla AM, 2014, J MAGN MAGN MATER, V363, P166, DOI 10.1016/j.jmmm.2014.03.023; Akbar NS, 2015, RESULTS PHYS, V5, P115, DOI 10.1016/j.rinp.2015.04.003; Akbar NS, 2015, J MAGN MAGN MATER, V381, P405, DOI 10.1016/j.jmmm.2014.12.087; Akram S, 2014, J MAGN MAGN MATER, V362, P184, DOI 10.1016/j.jmmm.2014.02.063; Ali N, 2010, EUR J MECH B-FLUID, V29, P387, DOI 10.1016/j.euromechflu.2010.04.002; Ali N, 2010, INT J HEAT MASS TRAN, V53, P3319, DOI 10.1016/j.ijheatmasstransfer.2010.02.036; Ellahi R, 2016, COMMUN THEOR PHYS, V65, P66, DOI 10.1088/0253-6102/65/1/66; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Ellahi R, 2014, J POROUS MEDIA, V17, P143, DOI 10.1615/JPorMedia.v17.i2.50; Ellahi R, 2014, INT J HEAT MASS TRAN, V71, P706, DOI 10.1016/j.ijheatmasstransfer.2013.12.038; Gad NS, 2011, APPL MATH COMPUT, V217, P4313, DOI 10.1016/j.amc.2010.08.016; Hameed M, 2015, ENG SCI TECHNOL, V18, P496, DOI 10.1016/j.jestch.2015.03.004; Hayat T, 2016, INT J HEAT MASS TRAN, V103, P1133, DOI 10.1016/j.ijheatmasstransfer.2016.07.101; Hayat T, 2014, COMPUT FLUIDS, V89, P242, DOI 10.1016/j.compfluid.2013.10.038; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P5126, DOI 10.1016/j.ijheatmasstransfer.2011.07.036; Hayat T, 2011, COMMUN NONLINEAR SCI, V16, P3559, DOI 10.1016/j.cnsns.2010.12.038; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P1615, DOI 10.1016/j.ijheatmasstransfer.2010.11.022; Hina S, 2015, APPL MATH COMPUT, V263, P378, DOI 10.1016/j.amc.2015.04.068; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3511, DOI 10.1016/j.ijheatmasstransfer.2012.03.014; Hina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114168; Kalantari A, 2013, ANN T NORDIC RHEOLOG; Kothandapani M, 2015, INT J HEAT MASS TRAN, V81, P234, DOI 10.1016/j.ijheatmasstransfer.2014.09.062; Mekheimer KS, 2008, PHYS LETT A, V372, P1657, DOI 10.1016/j.physleta.2007.10.028; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Nadeem S, 2010, MATH COMPUT MODEL, V52, P107, DOI 10.1016/j.mcm.2010.02.001; Pandey SK, 2011, COMMUN NONLINEAR SCI, V16, P3591, DOI 10.1016/j.cnsns.2011.01.003; Ramesh K, 2015, J MAGN MAGN MATER, V394, P335, DOI 10.1016/j.jmmm.2015.06.052; Reddy MG, 2016, ALEX ENG J, V55, P1225, DOI 10.1016/j.aej.2016.04.009; Shehzad SA, 2015, INT J HEAT MASS TRAN, V91, P562, DOI 10.1016/j.ijheatmasstransfer.2015.07.076; Sinha A, 2015, ALEX ENG J, V54, P691, DOI 10.1016/j.aej.2015.03.030; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Vafai K, 2015, Z NATURFORSCH A, V70, P281, DOI 10.1515/zna-2014-0330; Wang YQ, 2011, APPL MATH MODEL, V35, P3737, DOI 10.1016/j.apm.2011.02.030	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0164854	10.1371/journal.pone.0164854	http://dx.doi.org/10.1371/journal.pone.0164854			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222160	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800002
J	Song, CJ; Mitter, SK; Qi, XP; Beli, E; Rao, HV; Ding, JD; Ip, CS; Gu, HM; Akin, D; Dunn, WA; Rickman, CB; Lewin, AS; Grant, MB; Boulton, ME				Song, Chunjuan; Mitter, Sayak K.; Qi, Xiaoping; Beli, Eleni; Rao, Haripriya V.; Ding, Jindong; Ip, Colin S.; Gu, Hongmei; Akin, Debra; Dunn, William A., Jr.; Rickman, Catherine Bowes; Lewin, Alfred S.; Grant, Maria B.; Boulton, Michael E.			Oxidative stress-mediated NF kappa B phosphorylation upregulates p62/SQSTM1 and promotes retinal pigmented epithelial cell survival through increased autophagy	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; GENE-EXPRESSION; ACTIVATION; PROTEASOME; PATHOGENESIS; DEGRADATION; CANCER; GROWTH; MODEL; RPE	p62 is a scaffolding adaptor implicated in the clearance of protein aggregates by autophagy. Reactive oxygen species (ROS) can either stimulate or inhibit NF kappa B-mediated gene expression influencing cellular fate. We studied the effect of hydrogen peroxide (H2O2)-mediated oxidative stress and NF kappa B signaling on p62 expression in the retinal pigment epithelium (RPE) and investigated its role in regulation of autophagy and RPE survival against oxidative damage. Cultured human RPE cell line ARPE-19 and primary human adult and fetal RPE cells were exposed to H2O2-induced oxidative stress. The human apolipoprotein E4 targeted-replacement (APOE4) mouse model of AMD was used to study expression of p62 and other autophagy proteins in the retina. p62, NF kappa B p65 (total, phosphorylated, nuclear and cytoplasmic) and ATG10 expression was assessed by mRNA and protein analyses. Cellular ROS and mitochondrial superoxide were measured by CM-H2DCFDA and Mito-SOX staining respectively. Mitochondrial viability was determined using MTT activity. qPCR-array system was used to investigate autophagic genes affected by p62. Nuclear and cytoplasmic levels of NF kappa B p65 were evaluated after cellular fractionation by Western blotting. We report that p62 is up-regulated in RPE cells under H2O2-induced oxidative stress and promotes autophagic activity. Depletion of endogenous p62 reduces autophagy by downregulation of ATG10 rendering RPE more susceptible to oxidative damage. NF kappa B p65 phosphorylation at Ser-536 was found to be critical for p62 upregulation in response to oxidative stress. Proteasome inhibition by H2O2 causes p62-NF kappa B signaling as antioxidant pre-treatment reversed p62 expression and p65 phosphorylation when RPE was challenged by H2O2 but not when by Lactacystin. p62 protein but not RNA levels are elevated in APOE4-HFC AMD mouse model, suggesting reduction of autophagic flux in disease conditions. Our findings suggest that p62 is necessary for RPE cytoprotection under oxidative stress and functions, in part, by modulating ATG10 expression. NF kappa B p65 activity may be a critical upstream initiator of p62 expression in RPE cells under oxidative stress.	[Song, Chunjuan; Rao, Haripriya V.; Akin, Debra; Dunn, William A., Jr.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Mitter, Sayak K.; Qi, Xiaoping; Beli, Eleni; Ip, Colin S.; Gu, Hongmei; Grant, Maria B.; Boulton, Michael E.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Ding, Jindong; Rickman, Catherine Bowes] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Ding, Jindong; Rickman, Catherine Bowes] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Song, Chunjuan] Appl Genet Technol Corp, Alachua, FL USA	State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington; Duke University; Duke University; State University System of Florida; University of Florida	Boulton, ME (corresponding author), Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA.	mboulton@iupui.edu	Beli, Eleni/AAL-7433-2020; Beli, Eleni/AGR-8255-2022	Beli, Eleni/0000-0003-1889-640X; Bowes Rickman, Catherine/0000-0002-8555-9596; Ip, Colin/0000-0003-3180-3108; Lewin, Alfred/0000-0002-4192-9727	NIH [EY019688, EY021626, EY020825]; Research to Prevent Blindness, Inc.; UF Vision Core [EY021721]; Edward N. & Della L. Thome Memorial Foundation Award [EY019038, P30 EY005722]; NATIONAL EYE INSTITUTE [R01EY026161, R01EY007739, P30EY005722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); UF Vision Core; Edward N. & Della L. Thome Memorial Foundation Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from NIH - EY019688 and EY021626 to MEB, EY020825 to ASL; EY021721 UF Vision Core; EY019038, P30 EY005722 (CBR): Edward N. & Della L. Thome Memorial Foundation Award and Research to Prevent Blindness, Inc. to CBR: Unrestricted Research to Prevent Blindness, Inc. award to MEB.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Algvere PV, 2002, ACTA OPHTHALMOL SCAN, V80, P136, DOI 10.1034/j.1600-0420.2002.800204.x; Martin MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Chen DF, 2013, NEUROSCI LETT, V538, P49, DOI 10.1016/j.neulet.2013.01.044; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deruy E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012712; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Geetha T, 2012, NEUROCHEM INT, V61, P1289, DOI 10.1016/j.neuint.2012.09.005; Heo SR, 2009, NEUROSCI LETT, V450, P45, DOI 10.1016/j.neulet.2008.11.011; Hochfeld WE, 2013, ACTA PHARMACOL SIN, V34, P600, DOI 10.1038/aps.2012.189; Hu YJ, 2014, DISCOV MED, V18, P7; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kaarniranta K, 2010, ACTA OPHTHALMOL, V88, P387, DOI 10.1111/j.1755-3768.2009.01840.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li Y, 2008, EXP GERONTOL, V43, P1114, DOI 10.1016/j.exger.2008.08.052; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; Mao HY, 2014, INVEST OPHTH VIS SCI, V55, P4613, DOI 10.1167/iovs.14-14633; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mitter SK, 2012, ADV EXP MED BIOL, V723, P83, DOI 10.1007/978-1-4614-0631-0_12; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Puissant A, 2012, AM J CANCER RES, V2, P397; Schimel AM, 2011, AM J PATHOL, V178, P2032, DOI 10.1016/j.ajpath.2011.01.036; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Stasiolek M, 2000, J BIOL CHEM, V275, P24847, DOI 10.1074/jbc.M910284199; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Unno T, 2012, P NATL ACAD SCI USA, V109, P17693, DOI 10.1073/pnas.1212786109; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Viiri J, 2010, MOL VIS, V16, P1399; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Wang XC, 1999, INVEST OPHTH VIS SCI, V40, P477; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Zou X, 2012, J NUTR BIOCHEM, V23, P994, DOI 10.1016/j.jnutbio.2011.05.006	51	62	67	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171940	10.1371/journal.pone.0171940	http://dx.doi.org/10.1371/journal.pone.0171940			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222108	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800021
J	Abram, ME; Ram, RR; Margot, NA; Barnes, TL; White, KL; Callebaut, C; Miller, MD				Abram, Michael E.; Ram, Renee R.; Margot, Nicolas A.; Barnes, Tiffany L.; White, Kirsten L.; Callebaut, Christian; Miller, Michael D.			Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; TENOFOVIR DISOPROXIL FUMARATE; REGIMEN ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DF; PLUS EMTRICITABINE/TENOFOVIR DF; TREATMENT-EXPERIENCED PATIENTS; TWICE-DAILY RALTEGRAVIR; ANTIRETROVIRAL-NAIVE; DRUG-RESISTANCE; DOUBLE-BLIND; HIV-1-INFECTED PATIENTS	T97A is an HIV-1 integrase polymorphism associated with integrase strand transfer inhibitor (INSTI) resistance. Using pooled data from 16 clinical studies, we investigated the prevalence of T97A (pre-existing and emergent) and its impact on INSTI susceptibility and treatment response in INSTI-naive patients who enrolled on elvitegravir (EVG)- or raltegravir (RAL)-based regimens. Prior to INSTI-based therapy, primary INSTI resistance-associated mutations (RAMs) were absent and T97A pre-existed infrequently (1.4%; 47 of 3367 integrase sequences); most often among non-B (5.3%) than B (0.9%) HIV-1 subtypes. During INSTI-based therapy, few patients experienced virologic failure with emergent INSTI RAMs (3%; 122 of 3881 patients), among whom T97A emerged infrequently in the presence (n = 6) or absence (n = 8) of primary INSTI RAMs. A comparison between pre-existing and emergent T97A patient populations (i.e., in the absence of primary INSTI RAMs) showed no significant differences in EVG or RAL susceptibility in vitro. Furthermore, among all T97A-containing viruses tested, only 38-44% exhibited reduced susceptibility to EVG and/or RAL (all of low magnitude; <11-fold), while all maintained susceptibility to dolutegravir. Of the patients with pre-existing T97A, 17 had available clinical follow-up: 16 achieved virologic suppression and 1 maintained T97A and INSTI sensitivity without further resistance development. Overall, T97A is an infrequent integrase polymorphism that is enriched among nonB HIV-1 subtypes and can confer low-level reduced susceptibility to EVG and/or RAL. However, detection of T97A does not affect response to INSTI-based therapy with EVG or RAL. These results suggest a very low risk of initiating INSTI-based therapy in patients with preexisting T97A.	[Abram, Michael E.; Ram, Renee R.; Margot, Nicolas A.; Barnes, Tiffany L.; White, Kirsten L.; Callebaut, Christian; Miller, Michael D.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	Abram, ME (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Michael.Abram@gilead.com	Abram, Michael E/AEY-5248-2022	Abram, Michael E/0000-0002-6505-7281; Barnes, Tiffany/0000-0002-5995-0495				Abram M, 2016, 23 ANN C RETR OPP IN; Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; [Anonymous], 2015, C RETR OPP INF FEBR; Armenia D, 2015, J ANTIMICROB CHEMOTH, V70, P1865, DOI 10.1093/jac/dkv029; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Baelen K Van, 2008, AIDS, V22, P1875, DOI [10.1097/QAD.0b013e328309efe3PMID, DOI 10.1097/QAD.0B013E328309EFE3]; Bar-Magen T, 2010, AIDS, V24, P2171, DOI 10.1097/QAD.0b013e32833cf265; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Boyd SD, 2011, ANTIVIR THER, V16, P257, DOI 10.3851/IMP1749; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Brun-Vezinet F, 2004, ANTIVIR THER, V9, P465; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Canducci F, 2009, AIDS, V23, P455, DOI 10.1097/QAD.0b013e328323da60; Cavalcanti JS, 2012, ANTIVIR RES, V95, P9, DOI 10.1016/j.antiviral.2012.04.007; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Ceccherini-Silberstein F, 2010, ANTIMICROB AGENTS CH, V54, P3938, DOI 10.1128/AAC.01720-09; Clumeck N, 2014, JAIDS-J ACQ IMM DEF, V65, pE121, DOI 10.1097/QAI.0000000000000089; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; DHHS, 2016, GUIDELINES USE ANTIR; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Doyle T, 2015, J ANTIMICROB CHEMOTH; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Fransen S, 2008, 48 INT C ANT AG CHEM; Fransen S, 2010, C RETR OPP INF CROI; Fransen S, 2012, J VIROL, V86, P7249, DOI 10.1128/JVI.06618-11; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Frentz D, 2012, AIDS REV, V14, P17; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garrido C, 2011, ANTIVIR RES, V90, P164, DOI 10.1016/j.antiviral.2011.03.178; Garrido C, 2010, J ANTIMICROB CHEMOTH, V65, P320, DOI 10.1093/jac/dkp423; Gaur A, 2010, 17 C RETR OPP INF CR; Gilead Sciences Inc, 2016, SIRIBILD ELV COB EMT; Gilead Sciences Inc, 2014, VITEKTA ELV TABL OR; GlaxoSmithKline, 2015, TIVICAY DOL TABL OR; Gotte M, 2012, CURR OPIN VIROL, V2, P644, DOI 10.1016/j.coviro.2012.08.004; Goodman D, 2008, 17 INT HIV DRUG RES; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Gutierrez C, 2013, HIV CLIN TRIALS, V14, P10, DOI [10.1310/hct1401-10, 10.1410/hct1401-10]; Hachiya A, 2015, ANTIVIR RES, V119, P84, DOI 10.1016/j.antiviral.2015.04.014; Haddad M, 2012, INT C ANT AG CHEM IC; Han YS, 2016, INFECT GENET EVOL, V46, P286, DOI 10.1016/j.meegid.2016.06.047; Hardy I, 2015, J ANTIMICROB CHEMOTH, V70, P405, DOI 10.1093/jac/dku387; Hazuda D, 2009, ANNU REV PHARMACOL, V49, P377, DOI 10.1146/annurev.pharmtox.011008.145553; Huang W, 2013, ANTIMICROB AGENTS CH, V57, P4105, DOI 10.1128/AAC.00204-13; Hurt CB, 2014, CLIN INFECT DIS, V58, P423, DOI 10.1093/cid/cit697; Hurt CB, 2011, ANTIVIR THER, V16, P137, DOI 10.3851/IMP1750; Johnson JA, 2010, J ANTIMICROB CHEMOTH, V65, P1322, DOI 10.1093/jac/dkq139; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kityo C, 2015, EFFICACY SAFETY ELVI; Kulkarni R, 2014, HIV CLIN TRIALS, V15, P218, DOI [10.1310/hct1505-218, 10.1310/hct1504-218]; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lataillade M, 2007, ANTIVIR THER, V12, P563; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Delicado TL, 2016, J ANTIMICROB CHEMOTH, V71, P362, DOI 10.1093/jac/dkv333; Low A, 2009, ANTIMICROB AGENTS CH, V53, P4275, DOI 10.1128/AAC.00397-09; Maiga AI, 2009, ANTIVIR THER, V14, P123; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Malet I, 2011, J ANTIMICROB CHEMOTH, V66, P1481, DOI 10.1093/jac/dkr152; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Marcelin AG, 2013, INT J ANTIMICROB AG, V42, P42, DOI 10.1016/j.ijantimicag.2013.02.016; Margot NA, 2016, HIV CLIN TRIALS, V17, P78, DOI 10.1080/15284336.2016.1142731; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Marsden MD, 2011, ANTIMICROB AGENTS CH, V55, P3696, DOI 10.1128/AAC.00566-11; MCCOLL DJ, 2007, 16 INT HIV DRUG RES; Merck Sharp & Dohme Corp, 2015, ISENTRESS RALT FILM; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Monleau M, 2012, AIDS RES HUM RETROV, V28, P957, DOI 10.1089/aid.2011.0326; Myers RE, 2008, J VIROL, V82, P9228, DOI 10.1128/JVI.01535-07; Nakahara K, 2009, ANTIVIR RES, V81, P141, DOI 10.1016/j.antiviral.2008.10.007; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Park TE, 2015, EXPERT REV ANTI-INFE, V13, P1195, DOI 10.1586/14787210.2015.1075393; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Piralla A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-149; Post FA, 2015, JAIDS-J ACQ IMM DEF, V68, P310, DOI 10.1097/QAI.0000000000000476; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Ramanathan S, 2011, CLIN PHARMACOKINET, V50, P229, DOI 10.2165/11584570-000000000-00000; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Reigadas S, 2013, J ANTIMICROB CHEMOTH, V68, P969, DOI 10.1093/jac/dks474; Reigadas S, 2011, ANTIMICROB AGENTS CH, V55, P3187, DOI 10.1128/AAC.00071-11; Reigadas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010311; Rhee SY, 2016, J VIROL, V90, P6058, DOI 10.1128/JVI.00495-16; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Rockstroh JK, 2011, AIDS, V25, P1365, DOI 10.1097/QAD.0b013e328348065a; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Seki T, 2015, ANTIMICROB AGENTS CH, V59, P2596, DOI 10.1128/AAC.04844-14; Sichtig N, 2009, J ANTIMICROB CHEMOTH, V64, P25, DOI 10.1093/jac/dkp153; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Squires K, 2003, ANN INTERN MED, V139, P313, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00006; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Stekler JD, 2015, ANTIVIR THER, V20, P77, DOI 10.3851/IMP2780; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Theys K, 2013, FUTURE MICROBIOL, V8, P303, DOI [10.2217/FMB.13.10, 10.2217/fmb.13.10]; van Hal SJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-12; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Varghese V, 2010, AIDS RES HUM RETROV, V26, P1323, DOI 10.1089/aid.2010.0123; Vavro C, 2013, ANTIMICROB AGENTS CH, V57, P1379, DOI 10.1128/AAC.01791-12; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; ViiV Healthcare. TRIUMEQ, 2014, TRIUMEQ AB DOL LAM T; Volpe Joseph M, 2015, J Int Assoc Provid AIDS Care, V14, P398, DOI 10.1177/2325957415596229; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Walmsley S, 2015, JAIDS-J ACQ IMM DEF, V70, P515, DOI 10.1097/QAI.0000000000000790; Waters JM, 2009, 18 INT HIV DRUG RES; White KL, 2015, ANTIVIR THER, V20, P317, DOI 10.3851/IMP2885; Winters MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040514; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Wohl D, 2016, JAIDS-J ACQ IMM DEF, V72, P58, DOI 10.1097/QAI.0000000000000940; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057; Young B, 2011, ANTIVIR THER, V16, P253, DOI 10.3851/IMP1748; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	121	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172206	10.1371/journal.pone.0172206	http://dx.doi.org/10.1371/journal.pone.0172206			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212411	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700023
J	McCullagh, BN; Comellas, AP; Ballas, ZK; Newell, JD; Zimmerman, B; Azar, AE				McCullagh, Brian N.; Comellas, Alejandro P.; Ballas, Zuhair K.; Newell, John D., Jr.; Zimmerman, Bridget; Azar, Antoine E.			Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							PRIMARY IMMUNODEFICIENCY; COMPUTED-TOMOGRAPHY; CLINICAL-PICTURE; BRONCHIECTASIS; IMPACT	Chronic Obstructive Pulmonary Disease is the third leading cause of death in the US, and is associated with periodic exacerbations, which account for the largest proportion of health care utilization, and lead to significant morbidity, mortality, and worsening lung function. A subset of patients with COPD have frequent exacerbations, occurring 2 or more times per year. Despite many interventions to reduce COPD exacerbations, there is a significant lack of knowledge in regards to their mechanisms and predisposing factors. We describe here an important observation that defines antibody deficiency as a potential risk factor for frequent COPD exacerbations. We report a case series of patients who have frequent COPD exacerbations, and who were found to have an underlying primary antibody deficiency syndrome. We also report on the outcome of COPD exacerbations following treatment in a subset with of these patients with antibody deficiency. We identified patients with COPD who had 2 or more moderate to severe exacerbations per year; immune evaluation including serum immunoglobulin levels and pneumococcal IgG titers was performed. Patients diagnosed with an antibody deficiency syndrome were treated with either immunoglobulin replacement therapy or prophylactic antibiotics, and their COPD exacerbations were monitored over time. A total of 42 patients were identified who had 2 or more moderate to severe COPD exacerbations per year. Twenty-nine patients had an underlying antibody deficiency syndrome: common variable immunodeficiency (8), specific antibody deficiency (20), and selective IgA deficiency (1). Twenty-two patients had a follow-up for at least 1 year after treatment of their antibody deficiency, which resulted in a significant reduction of COPD exacerbations, courses of oral corticosteroid use and cumulative annual dose of oral corticosteroid use, rescue antibiotic use, and hospitalizations for COPD exacerbations. This case series identifies antibody deficiency as a potentially treatable risk factor for frequent COPD exacerbations; testing for antibody deficiency should be considered in difficult to manage frequently exacerbating COPD patients. Further prospective studies are warranted to further test this hypothesis.	[McCullagh, Brian N.; Comellas, Alejandro P.] Univ Iowa Hosp & Clin, Dept Internal Med, Div Pulm & Crit Care, Iowa City, IA 52242 USA; [Ballas, Zuhair K.] Univ Iowa Hosp & Clin, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Newell, John D., Jr.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Newell, John D., Jr.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Zimmerman, Bridget] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Azar, Antoine E.] Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Johns Hopkins University	Azar, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	antoine.azar@jhmi.edu	Comellas, Alejandro/AAE-5661-2019	Ballas, Zuhair/0000-0001-5569-1230; Comellas, Alejandro/0000-0003-1521-7520; Knaack, Aaron/0000-0001-7712-1415	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK054759] Funding Source: Medline; NIEHS NIH HHS [P30 ES005605] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aghamohammadi A, 2008, AM J OTOLARYNG, V29, P385, DOI 10.1016/j.amjoto.2007.11.007; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Allinson James P, 2014, Evid Based Med, V19, P99, DOI 10.1136/eb-2013-101711; Azar AE, 2007, AM J MED, V120, P764, DOI 10.1016/j.amjmed.2006.12.013; Bondioni MP, 2010, J COMPUT ASSIST TOMO, V34, P395, DOI 10.1097/RCT.0b013e3181cad9da; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Boyle RJ, 2006, CLIN EXP IMMUNOL, V146, P486, DOI 10.1111/j.1365-2249.2006.03242.x; Carr TF, 2011, AM J RHINOL ALLERGY, V25, P241, DOI 10.2500/ajra.2011.25.3653; Costa-Carvalho BT, 2011, ALLERGOL IMMUNOPATH, V39, P128, DOI 10.1016/j.aller.2010.12.003; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Gharagozlou M, 2006, Monaldi Arch Chest Dis, V65, P69; Gregersen S, 2009, RESP MED, V103, P873, DOI 10.1016/j.rmed.2008.12.015; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Herath SC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009764.pub2; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Javier FC, 2000, ANN ALLERG ASTHMA IM, V84, P25, DOI 10.1016/S1081-1206(10)62736-6; Kainulainen L, 1999, J ALLERGY CLIN IMMUN, V104, P1031, DOI 10.1016/S0091-6749(99)70085-0; King PT, 2006, CLIN EXP IMMUNOL, V144, P440, DOI 10.1111/j.1365-2249.2006.03091.x; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Pasquale MK, 2012, INT J CHRONIC OBSTR, V7, P757, DOI 10.2147/COPD.S36997; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Tabatabaie P, 2008, IRAN J ALLERGY ASTHM, V7, P69, DOI 07.02/ijaai.6977; Truong T, 2013, IMMUNOL ALLERGY CLIN, V33, P61, DOI 10.1016/j.iac.2012.10.007; van Kessel DA, 2005, EUR RESPIR J, V25, P482, DOI 10.1183/09031936.05.00073204; Vendrell M, 2005, CHEST, V127, P197, DOI 10.1378/chest.127.1.197; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181	32	36	37	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172437	10.1371/journal.pone.0172437	http://dx.doi.org/10.1371/journal.pone.0172437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212436	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424700051
J	Zhang, Y; Li, Y; Liang, X; Cao, XJ; Huang, LF; Yan, J; Wei, YX; Gao, J				Zhang, Yin; Li, Yang; Liang, Xiao; Cao, Xiaojuan; Huang, Longfei; Yan, Jie; Wei, Yanxing; Gao, Jian			Hepatic transcriptome analysis and identification of differentially expressed genes response to dietary oxidized fish oil in loach Misgurnus anguillicaudatus	PLOS ONE			English	Article							ARACHIDONIC-ACID; ATLANTIC SALMON; VITAMIN-E; LIVER TRANSCRIPTOME; GROWTH-PERFORMANCE; ALPHA-TOCOPHEROL; LIPID OXIDATION; SUPPLEMENTATION; DEFENSE; PRODUCTS	RNA sequencing and short-read assembly were utilized to produce a transcriptome of livers from loaches ( Misgurnus anguillicaudatus) fed with three different diets respectively containing fresh fish oil ( FO group), medium oxidized fish oil ( MO group) and high oxidized fish oil ( HO group). A total of 60,663 unigenes were obtained in this study, with mean length 848.74 bp. 50,814, 49,584 and 49,814 unigenes were respectively obtained from FO, MO and HO groups. There were 2,343 differentially expressed genes between FO and MO, with 855 down-and 1,488 up-regulated genes in the MO group. 2,813 genes were differentially expressed between FO and HO, including 1,256 down-and 1,552 up-regulated genes in the HO group. 2,075 differentially expressed genes were found in the comparison of MO and HO, including 1,074 up-and 1,001 down-regulated genes in the MO group. Some differentially expressed genes, such as fatty acid transport protein ( fatp), fatty acid binding protein ( fabp), apolipoprotein ( apo), peroxisome proliferator activated receptor-gamma ( ppar-gamma), acetyl-CoA synthetase ( acs) and arachidonate 5-lipoxygenase ( alox5), were involved in lipid metabolism, suggesting these genes in the loach were responsive to dietary oxidized fish oil. Results of transcriptome profilings here were validated using quantitative real time PCR in fourteen randomly selected unigenes. The present study provides insights into hepatic transcriptome profile of the loach, which is a valuable resource for studies of loach genomics. More importantly, this study identifies some important genes responsible for dietary oxidized fish oil, which will benefit researches of lipid metabolism in fish.	[Zhang, Yin; Li, Yang; Liang, Xiao; Cao, Xiaojuan; Huang, Longfei; Yan, Jie; Wei, Yanxing; Gao, Jian] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Educ,Minist Agr, Wuhan, Peoples R China; [Cao, Xiaojuan] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Gao, J (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Educ,Minist Agr, Wuhan, Peoples R China.	gaojian@mail.hzau.edu.cn						[Anonymous], 1987, STANDARD METHODS ANA; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Baker RTM, 1997, AQUACULT NUTR, V3, P91, DOI 10.1046/j.1365-2095.1997.00078.x; Calder PC, 2007, BRIT J NUTR, V98, P451, DOI 10.1017/S0007114507761779; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Chen QL, 2016, FISH PHYSIOL BIOCHEM, V42, P979, DOI 10.1007/s10695-015-0190-2; Chen YJ, 2012, AQUACULT NUTR, V18, P321, DOI 10.1111/j.1365-2095.2011.00900.x; Cunha I, 2015, MAR BIOL, V162, P1673, DOI 10.1007/s00227-015-2706-9; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Dong GF, 2014, AQUAC RES, V45, P1867, DOI 10.1111/are.12138; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Frankel E.N., 2014, LIPID OXIDATION; Gao J, 2013, AQUACULT NUTR, V19, P35, DOI 10.1111/j.1365-2095.2011.00921.x; Gao J, 2012, AQUACULTURE, V324, P97, DOI 10.1016/j.aquaculture.2011.10.031; Gregory KE, 2014, J PEDIATR-US, V164, P1486, DOI 10.1016/j.jpeds.2014.01.057; Grigorakis K, 2010, ANIM FEED SCI TECH, V158, P73, DOI 10.1016/j.anifeedsci.2010.03.012; Hamre K, 2001, FISH PHYSIOL BIOCHEM, V25, P209, DOI 10.1023/A:1022257928437; Howell B.R., 1998, BIOL FARMED FISH, P27; Innis SM, 2007, P NUTR SOC, V66, P397, DOI 10.1017/S0029665107005666; Janssens BJ, 2000, J EXP BIOL, V203, P3717; Kaneko G, 2013, GEN COMP ENDOCR, V184, P51, DOI 10.1016/j.ygcen.2013.01.003; Keller U, 2004, EUR J NUTR, V43, P353, DOI 10.1007/s00394-004-0481-3; Kitagawa T, 2011, FOLIA ZOOL, V60, P343; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; KOSHIO S, 1994, J AGR FOOD CHEM, V42, P1164, DOI 10.1021/jf00041a022; KOSUTARAK P, 1995, FISHERIES SCI, V61, P696, DOI 10.2331/fishsci.61.696; Lewis-McCrea LM, 2007, AQUACULTURE, V262, P142, DOI 10.1016/j.aquaculture.2006.09.024; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luquet S, 2004, BIOCHIMIE, V86, P833, DOI 10.1016/j.biochi.2004.09.024; McKeown CR, 2014, DEV DYNAM, V243, P800, DOI 10.1002/dvdy.24115; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Mourente G, 2002, AQUACULTURE, V214, P343, DOI 10.1016/S0044-8486(02)00064-9; Mourente G, 2000, FISH PHYSIOL BIOCHEM, V23, P337, DOI 10.1023/A:1011128510062; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nuchi C, 2009, J AGR FOOD CHEM, V57, P1952, DOI 10.1021/jf803369h; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Panday A, 2016, ARCH IMMUNOL THER EX, V64, P463, DOI 10.1007/s00005-016-0405-y; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Rimoldi S, 2016, REV FISH BIOL FISHER, V26, P93, DOI 10.1007/s11160-015-9408-8; Rosen ED, 2000, GENE DEV, V14, P1293; SAKAI T, 1992, NIPPON SUISAN GAKK, V58, P1483, DOI 10.2331/suisan.58.1483; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schiavone A, 2010, CAN J ANIM SCI, V90, P197, DOI 10.4141/CJAS09095; Song JY, 2016, METAB ENG, V35, P38, DOI 10.1016/j.ymben.2015.09.006; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Tacchi L, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-363; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai ML, 2008, GENE, V425, P69, DOI 10.1016/j.gene.2008.08.004; Wang LG, 2015, AQUACULT NUTR, V21, P414, DOI 10.1111/anu.12171; Xiong YY, 2014, AQUACULTURE, V433, P299, DOI 10.1016/j.aquaculture.2014.06.009; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zeng LG, 2012, MITOCHONDR DNA, V23, P187, DOI 10.3109/19401736.2012.668893	57	78	83	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172386	10.1371/journal.pone.0172386	http://dx.doi.org/10.1371/journal.pone.0172386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212448	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700040
J	Lin, SC; Kappes, MA; Chen, MC; Lin, CC; Wang, TT				Lin, Shih-Chao; Kappes, Matthew A.; Chen, Mei-Chun; Lin, Chi-Chen; Wang, Tony T.			Distinct susceptibility and applicability of MDCK derivatives for influenza virus research	PLOS ONE			English	Article							CELL-LINES; IN-VITRO; ASSAYS; HEMAGGLUTININ; NEURAMINIDASE; SPECIFICITY; SENSITIVITY; VIABILITY; PROVIDE; MTS	Madin-Darby Canine Kidney (MDCK) cells are widely utilized as a substrate for influenza virus isolation and propagation due to the high yields of virus. Here we compared the conventional MDCK cell line, MDCK-SIAT1 and MDCK-London for viral production, cell survival, and suitability in testing antivirals using six influenza strains including two H1N1 (pandemic and epidemic strains), three H3N2 and one influenza B strain. Overall our results suggest that MDCK-London cell line is superior for virus culturing and quantification, and hence an ideal platform to evaluate antiviral drug efficacy against multiple strains of influenza. Our data also suggests that while virus titers determined by the hemagglutination assay (HA) and neuraminidase activity (NA) are widely used to indicate viral load, there is a poor correlation between these measurements and the infectious titer obtained by plaque assay.	[Lin, Shih-Chao] Natl Chung Hsing Univ, Program Med Biotechnol, Taichung, Taiwan; [Lin, Shih-Chao; Kappes, Matthew A.; Chen, Mei-Chun; Wang, Tony T.] SRI Int, Ctr Infect Dis, Harrisonburg, VA USA; [Lin, Chi-Chen] Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan; [Lin, Chi-Chen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Chi-Chen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Chung Hsing University; SRI International; National Chung Hsing University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, TT (corresponding author), SRI Int, Ctr Infect Dis, Harrisonburg, VA USA.; Lin, CC (corresponding author), Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan.; Lin, CC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	lincc@dragon.mail.nchu.edu.tw; tony.wang@sri.com	Lin, Shih-Chao/AAG-9173-2020	Lin, Shih-Chao/0000-0003-2942-5937; Lin, Chi-Chien/0000-0002-1464-0231	National Institutes of Health [R01DK088787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grant R01DK088787.	BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Fazekas De St., 1954, BRIT J EXP PATHOL, V35, P60; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; Govorkova EA, 1996, J VIROL, V70, P5519, DOI 10.1128/JVI.70.8.5519-5524.1996; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Hossain MJ, 2010, J CLIN MICROBIOL, V48, P2515, DOI 10.1128/JCM.02286-09; Hussain AI, 2010, VACCINE, V28, P3848, DOI 10.1016/j.vaccine.2010.03.005; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; JEiUBEK J. D L., 1981, ACTA VET BRNO, V50, P8; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Lugovtsev VY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075014; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; SCHEPETIUK SK, 1993, J VIROL METHODS, V42, P241, DOI 10.1016/0166-0934(93)90036-Q; Teferedegne B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056023; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; VISTICA DT, 1991, CANCER RES, V51, P2515; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Zhai WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052327	26	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172299	10.1371/journal.pone.0172299	http://dx.doi.org/10.1371/journal.pone.0172299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207898	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500116
J	Bielesz, B; Patsch, JM; Fischer, L; Bojic, M; Winnicki, W; Weber, M; Cejka, D				Bielesz, Bernhard; Patsch, Janina M.; Fischer, Lukas; Bojic, Marija; Winnicki, Wolfgang; Weber, Michael; Cejka, Daniel			Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture	PLOS ONE			English	Article							BONE-MINERAL DENSITY; DISTAL RADIUS; HR-PQCT; MICROARCHITECTURE; STRENGTH; RISK; TURNOVER; WOMEN	Hemodialysis (HD) patients face increased fracture risk, which is further associated with elevated risk of hospitalization and mortality. High-resolution peripheral computed tomography (HR-pQCT) has advanced our understanding of bone disease in chronic kidney disease by characterizing distinct changes in both the cortical and trabecular compartments. Increased cortical porosity (Ct.Po) has been shown to be associated with fracture in patients with osteopenia or in postmenopausal diabetic women. We tested whether the degree of Ct.Po identifies hemodialysis patients with prevalent fragility fractures in comparison to bone mineral density (BMD) assessed by dual X-ray absorptiometry (DXA). We performed a post hoc analysis of a cross-sectional study in 76 prevalent hemodialysis patients. Markers of mineral metabolism, coronary calcification score, DXA-, and HR-pQCT-data were analyzed, and Ct.Po determined at radius and tibia. Ct.Po was significantly higher in patients with fracture but association was lost after adjusting for age and gender (tibia p = 0.228, radius p = 0.5). Instead, femoral (F) BMD neck area (p = 0.03), F T-score neck area (p = 0.03), radius (R) BMD (p = 0.03), R T-score (p = 0.03), and cortical HR-pQCT indices such as cortical area (Ct.Ar) (tibia: p = 0.01; radius: p = 0.02) and cortical thickness (Ct.Th) (tibia: p = 0.03; radius: p = 0.02) correctly classified patients with fragility fractures. Area under receiver operating characteristic curves (AUC) for Ct.Po (tibia AUC: 0.711; p = 0.01; radius AUC: 0.666; p = 0.04), Ct.Ar (tibia AUC: 0.832; p<0.001; radius AUC: 0.796; p<0.001), and F neck BMD (AUC: 0.758; p= 0.002) did not differ significantly among each other. In conclusion, measuring Ct.Po is not superior to BMD determined by DXA for identification of HD patients with fragility fracture.	[Bielesz, Bernhard; Bojic, Marija; Winnicki, Wolfgang] Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Vienna, Austria; [Patsch, Janina M.; Weber, Michael] Dept Biomed Imaging & Image Guided Therapy, Div Gen Radiol & Pediat Radiol, Vienna, Austria; [Fischer, Lukas] Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res CIR Lab, Vienna, Austria; [Fischer, Lukas] Software Competence Ctr Hagenberg, Hagenberg, Austria; [Cejka, Daniel] Ordensklinikum Linz, Dept Med 3, Nephrol, Transplantat,Rheumatol,Geriatr, Linz, Austria	Medical University of Vienna; Softwarepark Hagenberg	Bielesz, B (corresponding author), Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Vienna, Austria.	bernhard.bielesz@meduniwien.ac.at	Winnicki, Wolfgang/ABB-1864-2021; Bielesz, Bernhard/AAQ-2683-2021; Patsch, Janina M/AAF-6040-2019; Fischer, Lukas/E-5573-2019; Weber, Michael/L-9836-2016	Winnicki, Wolfgang/0000-0002-0511-6120; Bielesz, Bernhard/0000-0002-4491-0562; Patsch, Janina M/0000-0002-5936-5608; Fischer, Lukas/0000-0001-5303-6638; Bojic, Marija/0000-0001-9732-4439; Cejka, Daniel/0000-0001-7162-1443; Weber, Michael/0000-0002-8507-2219				Akaberi S, 2008, AM J TRANSPLANT, V8, P2647, DOI 10.1111/j.1600-6143.2008.02423.x; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Bala Y, 2014, J BONE MINER RES, V29, P1356, DOI 10.1002/jbmr.2167; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Burghardt AJ, 2011, CLIN ORTHOP RELAT R, V469, P2179, DOI 10.1007/s11999-010-1766-x; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Cejka D, 2014, BONE, V64, P33, DOI 10.1016/j.bone.2014.03.048; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Davis KA, 2007, CALCIFIED TISSUE INT, V81, P364, DOI 10.1007/s00223-007-9076-3; Fischer L, 2015, RADIOLOGY, V274, P473, DOI 10.1148/radiol.14140201; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; GROTZ WH, 1994, TRANSPLANTATION, V58, P912, DOI 10.1097/00007890-199410270-00009; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Jamal SA, 2006, J BONE MINER RES, V21, P543, DOI 10.1359/JBMR.060105; Jamal SA, 2002, AM J KIDNEY DIS, V39, P843, DOI 10.1053/ajkd.2002.32006; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Malluche HH, 2012, J AM SOC NEPHROL, V23, P525, DOI 10.1681/ASN.2010121253; Naylor KL, 2014, KIDNEY INT, V86, P810, DOI 10.1038/ki.2013.547; Nickolas TL, 2013, J BONE MINER RES, V28, P1811, DOI 10.1002/jbmr.1916; Nickolas TL, 2011, J AM SOC NEPHROL, V22, P1560, DOI 10.1681/ASN.2010121275; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Nishiyama KK, 2015, J BONE MINER RES, V30, P456, DOI 10.1002/jbmr.2358; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; Prischl FC, 2015, NEPHROL DIAL TRANSPL, V30, P1920, DOI 10.1093/ndt/gfv113; Shanbhogue V.V., 2016, J BONE MINER RES; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Trombetti A, 2013, OSTEOPOROSIS INT, V24, P1721, DOI 10.1007/s00198-012-2133-4; Vilayphiou N, 2016, BONE, V83, P233, DOI 10.1016/j.bone.2015.10.012; West SL, 2015, J BONE MINER RES, V30, P913, DOI 10.1002/jbmr.2406; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171873	10.1371/journal.pone.0171873	http://dx.doi.org/10.1371/journal.pone.0171873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199411	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400055
J	Chen, ZJ; An, Y; Zhao, BF; Yang, WD; Yu, Q; Cai, L; Ni, HY; Yin, JZ				Chen, Zhijuan; An, Yang; Zhao, Bofeng; Yang, Weidong; Yu, Qing; Cai, Li; Ni, Hongyan; Yin, Jianzhong			The value of resting-state functional magnetic resonance imaging for detecting epileptogenic zones in patients with focal epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; LINE BRAIN ACTIVITY; REGIONAL HOMOGENEITY; FMRI; FLUCTUATION; FREQUENCY; AMPLITUDE; EEG/FMRI; SIGNAL; MRI	Objective To determine the value of resting-state functional magnetic resonance imaging (RS-fMRI) based on the local analysis methods regional homogeneity (ReHo), amplitude of low-frequency fluctuations (ALFF), and fractional ALFF (fALFF), for detecting epileptogenic zones (EZs). Methods A total of 42 consecutive patients with focal epilepsy were enrolled. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of visually assessed RS-fMRI, MRI, magnetic resonance spectroscopy (MRS), video electroencephalography (VEEG), and positron-emission tomography computed tomography (PET-CT) in EZ localization were evaluated to assess their diagnostic abilities. ReHo, ALFF, and fALFF were also compared for their diagnostic values. Results RS-fMRI showed comparable sensitivity to PET (83.3%) and specificity to VEEG (66.7%), respectively, for EZ localization in patients with focal epilepsy. There were no significant differences between RS-fMRI and the other localization techniques in terms of sensitivity, specificity, PPV, and NPV. The sensitivities of ReHo, ALFF, and fALFF were 69.4%, 52.8%, and 38.9%, respectively, and for specificities of 66.7%, 83.3%, and 66.7%, respectively. There were no significant differences among ReHo, ALFF, and fALFF, except that ReHo was more sensitive than fALFF. Conclusions RS-fMRI may be an efficient tool for detecting EZs in focal epilepsy patients.	[Chen, Zhijuan] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [An, Yang; Yang, Weidong] Tianjin Med Univ, Cent Clin Coll 1, Tianjin, Peoples R China; [Zhao, Bofeng; Ni, Hongyan; Yin, Jianzhong] Tianjin First Cent Hosp, Dept Radiol, Tianjin, Peoples R China; [Yu, Qing] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Cai, Li] Tianjin Med Univ, Gen Hosp, Clin PET CT Ctr, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yin, JZ (corresponding author), Tianjin First Cent Hosp, Dept Radiol, Tianjin, Peoples R China.	yin3000@126.com		Yin, Jianzhong/0000-0002-6821-1686	Tianjin Science and Technology Support Project [15ZCZDSY00520]; Tianjin Bureau of Public Health [13KG107]	Tianjin Science and Technology Support Project; Tianjin Bureau of Public Health	This work was supported by the Tianjin Science and Technology Support Project (15ZCZDSY00520) and Tianjin Bureau of Public Health (13KG107).	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; Di Bonaventura C, 2006, EPILEPSIA, V47, P52, DOI 10.1111/j.1528-1167.2006.00878.x; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Duncan J, 2009, CURR OPIN NEUROL, V22, P179, DOI 10.1097/WCO.0b013e328328f260; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; la Fougere C, 2009, EPILEPSY BEHAV, V15, P50, DOI 10.1016/j.yebeh.2009.02.025; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Marcar VL, 2006, AM J NEURORADIOL, V27, P799; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Matsuda K, 2001, EPILEPSIA, V42, P29, DOI 10.1046/j.1528-1157.42.s6.6.x; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Olson LD, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S012906571230001X; Pittau F, 2012, NEUROLOGY, V78, P1479, DOI 10.1212/WNL.0b013e3182553bf7; Restom K, 2008, NEUROIMAGE, V40, P1495, DOI 10.1016/j.neuroimage.2008.01.038; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stafstrom CE, 2006, J CEREBR BLOOD F MET, V26, P983, DOI 10.1038/sj.jcbfm.9600265; Thornton R, 2010, J NEUROL NEUROSUR PS, V81, P922, DOI 10.1136/jnnp.2009.196253; Urbach H, 2005, EUR RADIOL, V15, P494, DOI 10.1007/s00330-004-2629-1; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	30	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172094	10.1371/journal.pone.0172094	http://dx.doi.org/10.1371/journal.pone.0172094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199371	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400070
J	Elansary, HO; Ashfaq, M; Ali, HM; Yessoufou, K				Elansary, Hosam O.; Ashfaq, Muhammad; Ali, Hayssam M.; Yessoufou, Kowiyou			The first initiative of DNA barcoding of ornamental plants from Egypt and potential applications in horticulture industry	PLOS ONE			English	Article							TRNH-PSBA SPACER; SPECIES IDENTIFICATION; DIVERSITY; REVEALS; GENERA; RBCL	DNA barcoding relies on short and standardized gene regions to identify species. The agricultural and horticultural applications of barcoding such as for marketplace regulation and copyright protection remain poorly explored. This study examines the effectiveness of the standard plant barcode markers (matK and rbcL) for the identification of plant species in private and public nurseries in northern Egypt. These two markers were sequenced from 225 specimens of 161 species and 62 plant families of horticultural importance. The sequence recovery was similar for rbcL (96.4%) and matK (84%), but the number of specimens assigned correctly to the respective genera and species was lower for rbcL (75% and 29%) than matK (85% and 40%). The combination of rbcL and matKbrought the number of correct generic and species assignments to 83.4% and 40%, respectively. Individually, the efficiency of both markers varied among different plant families; for example, all palm specimens (Arecaceae) were correctly assigned to species while only one individual of Asteraceae was correctly assigned to species. Further, barcodes reliably assigned ornamental horticultural and medicinal plants correctly to genus while they showed a lower or no success in assigning these plants to species and cultivars. For future, we recommend the combination of a complementary barcode (e.g. ITS or trnH-psbA) with rbcL + matKto increase the performance of taxa identification. By aiding species identification of horticultural crops and ornamental palms, the analysis of the barcode regions will have large impact on horticultural industry.	[Elansary, Hosam O.] Univ Alexandria, Fac Agr El Shatby, Floriculture Ornamental Hort & Garden Design Dept, Alexandria, Egypt; [Ashfaq, Muhammad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON, Canada; [Ali, Hayssam M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia; [Ali, Hayssam M.] Agr Res Ctr, Inst Hort Res, Timber Trees Res Dept, Sabahia Hort Res Stn, Alexandria, Egypt; [Yessoufou, Kowiyou] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa	Egyptian Knowledge Bank (EKB); Alexandria University; University of Guelph; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; University of Johannesburg	Elansary, HO (corresponding author), Univ Alexandria, Fac Agr El Shatby, Floriculture Ornamental Hort & Garden Design Dept, Alexandria, Egypt.	hosammail2003@yahoo.com	Ali, Hayssam M./A-6054-2013; Elansary, Hosam O./E-3684-2019; Ashfaq, Muhammad/J-4723-2019	Ali, Hayssam M./0000-0001-6801-4263; Elansary, Hosam O./0000-0002-4476-2408; Ashfaq, Muhammad/0000-0003-1351-4126	King Saud University, Deanship of Scientific Research, College of Science Research Center; Government of Canada through Genome Canada; Ontario Genomics Institution; Faculty of Agriculture, Alexandria University	King Saud University, Deanship of Scientific Research, College of Science Research Center(King Saud University); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institution; Faculty of Agriculture, Alexandria University(Alexandria University)	This project was supported by the King Saud University, Deanship of Scientific Research, College of Science Research Center. Sequence analysis was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institution in support of the International Barcode of Life Project. The Faculty of Agriculture, Alexandria University funded the collection of material and delivery costs.	Ali MA, 2014, SAUDI J BIOL SCI, V21, P204, DOI 10.1016/j.sjbs.2014.03.003; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Besnard G, 2000, THEOR APPL GENET, V100, P1018, DOI 10.1007/s001220051383; Bezeng BS, 2013, BOT J LINN SOC, V172, P142, DOI 10.1111/boj.12030; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen XC, 2013, GENE, V530, P39, DOI 10.1016/j.gene.2013.07.097; Christina VLP, 2014, MOL ECOL RESOUR, V14, P60, DOI 10.1111/1755-0998.12167; CIOPORA Green Paper, 2002, CIOPORA GREEN PAPER; CIOPORA Strategy Paper, 2007, CIOPORA STRATEGY PAP; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Daru BH, 2016, J BIOGEOGR, V43, P155, DOI 10.1111/jbi.12619; Daru BH, 2016, TESTING THE RELIABIL; Davis AP, 2009, ANN MO BOT GARD, V96, P68, DOI 10.3417/2006205; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elansary H. O., 2013, DNA BARCODES, V1, P46, DOI DOI 10.2478/DNA-2013-0004; Elansary HO, 2015, ECON BOT, V69, P114, DOI 10.1007/s12231-015-9308-9; Elansary HO, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-11; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gere J, 2013, ZOOKEYS, P127, DOI 10.3897/zookeys.365.5728; Griffiths AJF, 2006, AN INTRODUCTION TO G; Guo YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146880; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoveka LN, 2016, S AFR J BOT, V102, P208, DOI 10.1016/j.sajb.2015.06.014; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; KEIL M, 1994, THEOR APPL GENET, V89, P442, DOI 10.1007/BF00225379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Liu YM, 2012, PHARMACOGN MAG, V8, P29, DOI 10.4103/0973-1296.93311; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Maurin O, 2014, NEW PHYTOL, V204, P201, DOI 10.1111/nph.12936; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monro AK, 2006, AM J BOT, V93, P426, DOI 10.3732/ajb.93.3.426; Nei M., 1987, MOLECULAR EVOLUTIONA; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Ochieng JW, 2007, GENET MOL BIOL, V30, P1125, DOI 10.1590/S1415-47572007000600016; Pardee WD, 2007, INTELLECTUAL PROPERT; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rikken M., 2011, FIFTH VIDEO CONFEREN; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Stoeckle MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100755; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Theodoridis S, 2012, MOL ECOL RESOUR, V12, P620, DOI 10.1111/j.1755-0998.2012.03129.x; Williamson J, 2016, GENOME; Yessoufou K, 2013, J ECOL, V101, P614, DOI 10.1111/1365-2745.12059	68	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172170	10.1371/journal.pone.0172170	http://dx.doi.org/10.1371/journal.pone.0172170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199378	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400078
J	Fiore, G; Anderson, E; Garborg, CS; Murray, M; Johnson, M; Moore, MJ; Howle, L; Shorter, KA				Fiore, Giovani; Anderson, Erik; Garborg, C. Spencer; Murray, Mark; Johnson, Mark; Moore, Michael J.; Howle, Laurens; Shorter, K. Alex			From the track to the ocean: Using flow control to improve marine bio-logging tags for cetaceans	PLOS ONE			English	Article							DOLPHIN TELEMETRY; DESIGN; DRAG; ATTACHMENT; BUOYANCY; BEHAVIOR; ENERGETICS; PENGUINS; ANIMALS; DEVICES	Bio-logging tags are an important tool for the study of cetaceans, but superficial tags inevitably increase hydrodynamic loading. Substantial forces can be generated by tags on fast-swimming animals, potentially affecting behavior and energetics or promoting early tag removal. Streamlined forms have been used to reduce loading, but these designs can accelerate flow over the top of the tag. This non-axisymmetric flow results in large lift forces (normal to the animal) that become the dominant force component at high speeds. In order to reduce lift and minimize total hydrodynamic loading this work presents a new tag design (Model A) that incorporates a hydrodynamic body, a channel to reduce fluid speed differences above and below the housing and wing to redirect flow to counter lift. Additionally, three derivatives of the Model A design were used to examine the contribution of individual flow control features to overall performance. Hydrodynamic loadings of four models were compared using computational fluid dynamics (CFD). The Model A design eliminated all lift force and generated up to similar to 30 N of downward force in simulated 6 m/s aligned flow. The simulations were validated using particle image velocimetry (PIV) to experimentally characterize the flow around the tag design. The results of these experiments confirm the trends predicted by the simulations and demonstrate the potential benefit of flow control elements for the reduction of tag induced forces on the animal.	[Fiore, Giovani] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA; [Anderson, Erik; Garborg, C. Spencer] Grove City Coll, Dept Mech Engn, Grove City, PA USA; [Murray, Mark] US Naval Acad, Dept Mech Engn, Annapolis, MD 21402 USA; [Johnson, Mark] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Johnson, Mark] Univ Aarhus, Dept Biosci, Aarhus, Denmark; [Moore, Michael J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Howle, Laurens] Duke Univ, Pratt Sch Engn, Durham, NC USA; [Howle, Laurens] BelleQuant Engn PLLC, Mebane, NC USA; [Shorter, K. Alex] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Defense; United States Navy; United States Naval Academy; University of St Andrews; Aarhus University; Woods Hole Oceanographic Institution; Duke University; University of Michigan System; University of Michigan	Shorter, KA (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	kshorter@umich.edu	Howle, Laurens/AAJ-2238-2021	Anderson, Erik/0000-0001-8508-0131; Johnson, Mark/0000-0001-8424-3197	National Oceanographic Partnership Program [National Science Foundation via the Office of Naval Research] [N00014-11-1-0113]; Grove City College Swezey Student Fellowship; Marie Curie-Sklodowska grant from the European Union; Natural Environment Research Council [smru10001] Funding Source: researchfish	National Oceanographic Partnership Program [National Science Foundation via the Office of Naval Research]; Grove City College Swezey Student Fellowship; Marie Curie-Sklodowska grant from the European Union; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the National Oceanographic Partnership Program [National Science Foundation via the Office of Naval Research N00014-11-1-0113]. C. Spencer Garborg was supported by a Grove City College Swezey Student Fellowship to Erik Anderson. Mark Johnson was funded by a Marie Curie-Sklodowska grant from the European Union.	Abbott IH., 1959, THEORY WING SECTIONS; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; [Anonymous], 1999, REV DOLPHIN HYDRODYN; Balmer BC, 2014, MAR MAMMAL SCI, V30, P656, DOI 10.1111/mms.12072; BANNASCH R, 1994, J EXP BIOL, V194, P83; Barnard R.H., 2001, ROAD VEHICLE AERODYN, V2nd; Cornick LA, 2006, J EXP MAR BIOL ECOL, V333, P306, DOI 10.1016/j.jembe.2006.01.010; Crossin GT, 2014, MAR ECOL PROG SER, V496, P1, DOI 10.3354/meps10691; CULIK BM, 1994, MAR BIOL, V118, P353, DOI 10.1007/BF00350291; FELDKAMP SD, 1987, J EXP BIOL, V131, P117; FISH FE, 1994, AUST J ZOOL, V42, P79, DOI 10.1071/ZO9940079; Fish FE, 2014, J EXP BIOL, V217, P252, DOI 10.1242/jeb.087924; Hucho W.H., 2013, AERODYNAMICS ROAD VE; Jepsen N., 2005, P255; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Katz J., 1995, RACE CARE AERODYNAMI; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; McCormick B.W., 1995, AERODYNAMICS AERONAU; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Munson B. R., 1990, N Y, V3, P4; Nowacek DP, 2001, P ROY SOC B-BIOL SCI, V268, P1811, DOI 10.1098/rspb.2001.1730; Pavlov VV, 2007, DEEP-SEA RES PT II, V54, P404, DOI 10.1016/j.dsr2.2006.11.010; Pavlov VV, 2012, MAR MAMMAL SCI, V28, pE16, DOI 10.1111/j.1748-7692.2011.00476.x; Shorter KA, 2014, MAR MAMMAL SCI, V30, P726, DOI 10.1111/mms.12083; van der Hoop JM, 2014, J EXP BIOL, V217, P4229, DOI 10.1242/jeb.108225; Webb PM, 1998, J EXP BIOL, V201, P2349; Weber PW, 2009, J EXP BIOL, V212, P2149, DOI 10.1242/jeb.029868; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2	30	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170962	10.1371/journal.pone.0170962	http://dx.doi.org/10.1371/journal.pone.0170962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196148	Green Published, gold			2022-12-26	WOS:000394423900009
J	Ko, PS; Liu, YC; Yeh, CM; Gau, JP; Yu, YB; Hsiao, LT; Tzeng, CH; Chen, PM; Chiou, TJ; Liu, CJ; Liu, JH				Ko, Po-Shen; Liu, Yao-Chung; Yeh, Chiu-Mei; Gau, Jyh-Pyng; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Tzeng, Cheng-Hwai; Chen, Po-Min; Chiou, Tzeon-Jye; Liu, Chia-Jen; Liu, Jin-Hwang			The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification	PLOS ONE			English	Article							MYELODYSPLASIA-RELATED CHANGES; STEM-CELL TRANSPLANTATION; ACUTE ERYTHROLEUKEMIA; SCORING SYSTEM; BLASTS; 50-PERCENT; AML	We reviewed 97 consecutive cases of myeloid neoplasm with erythroid predominance (MN-EP) between 2000 and 2015. Following 2016 WHO classification, MN-EP patients were classified into four groups. Eight pure erythroid leukemia (PEL) (including t-MN and AML-MRC morphologically fulfilled criteria for PEL) patients had dismal outcomes (median OS: 1 month) and showed more bone marrow fibrosis, worse performance status (PS) and higher serum lactate dehydrogenase (LDH) at diagnosis than the other groups. In the univariate analysis, risks of death in MN-EP patients included the morphologic features of PEL, very poor cytogenetic risk by IPSS-R, bone marrow fibrosis, leukocytosis, anemia, hypoalbuminemia, high LDH, and poor PS. In the multivariate analysis, independent predictors of death were morphologic features of PEL (adjusted hazards ratio [HR] 3.48, 95% confidence interval [CI] 1.24-9.74, p = 0.018), very poor cytogenetic risk by IPSS-R (adjusted HR 2.73, 95% CI 1.22-6.10, p = 0.015), hypoalbuminemia (< 3.7 g/dI) (adjusted HR 2.33, 95% CI 1.10-4.91, p = 0.026) and high serum LDH (>= 250 U/L) (adjusted HR 2.36, 95% CI 1.28-4.36, p = 0.006). Poor or unfavorable risk in different cytogenetic risk systems independently predicted death and UKMRC-R was the best model.	[Ko, Po-Shen; Liu, Yao-Chung; Yeh, Chiu-Mei; Gau, Jyh-Pyng; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Tzeng, Cheng-Hwai; Chen, Po-Min; Liu, Chia-Jen; Liu, Jin-Hwang] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Ko, Po-Shen; Liu, Yao-Chung; Gau, Jyh-Pyng; Yu, Yuan-Bin; Hsiao, Liang-Tsai; Tzeng, Cheng-Hwai; Chen, Po-Min; Chiou, Tzeon-Jye; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Liu, Jin-Hwang] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Liu, Jin-Hwang] Natl Yang Ming Univ, Chong Hin Loon Mem Canc & Biotherapy Res Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liu, CJ; Liu, JH (corresponding author), Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Liu, JH (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.; Liu, JH (corresponding author), Natl Yang Ming Univ, Chong Hin Loon Mem Canc & Biotherapy Res Ctr, Taipei, Taiwan.	chiajenliu@gmail.com; jhliu@vghtpe.gov.tw		Ko, Po-Shen/0000-0001-9299-0352	Taipei Veterans General Hospital [V105B-016, V105E10-002-MY2-1]; Ministry of Science and Technology [MOST 104-2314-B-075-085-MY2]; Taiwan Clinical Oncology Research Foundation; Szu-Yuan Research Foundation of Internal Medicine; Chong Hin Loon Memorial Cancer and Biotherapy Research Center at National Yang-Ming University	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan Clinical Oncology Research Foundation; Szu-Yuan Research Foundation of Internal Medicine; Chong Hin Loon Memorial Cancer and Biotherapy Research Center at National Yang-Ming University	This study was supported by grants from Taipei Veterans General Hospital (V105B-016 and V105E10-002-MY2-1), the Ministry of Science and Technology (MOST 104-2314-B-075-085-MY2), the Taiwan Clinical Oncology Research Foundation, Szu-Yuan Research Foundation of Internal Medicine, and Chong Hin Loon Memorial Cancer and Biotherapy Research Center at National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bacher U, 2011, HAEMATOL-HEMATOL J, V96, P1284, DOI 10.3324/haematol.2011.043687; BENNETT JM, 1981, CANCER RES, V41, P4833; Bennett JM, 2016, LEUKEMIA RES, V47, P63, DOI 10.1016/j.leukres.2016.05.006; Calvo X, 2016, MODERN PATHOL, V29, P1541, DOI 10.1038/modpathol.2016.146; Chen PM, 2008, BONE MARROW TRANSPL, V42, pS133, DOI 10.1038/bmt.2008.141; DAMESHEK W, 1958, BLOOD, V13, P192, DOI 10.1182/blood.V13.2.192.192; Devillier R, 2015, AM J HEMATOL, V90, pE22, DOI 10.1002/ajh.23850; Devillier R, 2012, AM J HEMATOL, V87, P659, DOI 10.1002/ajh.23211; Di Guglielmo G, 1917, FOLIA MED, V3, P386; Fouillard L, 2002, BLOOD, V100, P3135, DOI 10.1182/blood.V100.9.3135; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hasserjian RP, 2010, BLOOD, V115, P1985, DOI 10.1182/blood-2009-09-243964; Khan AM, 2011, BLOOD S, V118; Komrokji RS, 2012, AM J HEMATOL, V87, P1006, DOI 10.1002/ajh.23303; KORNBERG A, 1980, BLOOD, V56, P351; Lessard M, 2005, CANCER GENET CYTOGEN, V163, P113, DOI 10.1016/j.cancergencyto.2005.05.006; Liu CJ, 2012, LEUKEMIA LYMPHOMA, V53, P289, DOI 10.3109/10428194.2011.607526; Liu W, 2011, MODERN PATHOL, V24, P375, DOI 10.1038/modpathol.2010.194; MIHOVA D, 2012, N A J MED SCI, V5, P110, DOI DOI 10.7156/V5I2P110; OLOPADE OI, 1992, BLOOD, V80, P2873; Park S, 2002, LEUKEMIA RES, V26, P423, DOI 10.1016/S0145-2126(01)00146-1; Peng J, 2016, LEUKEMIA LYMPHOMA, V57, P812, DOI 10.3109/10428194.2015.1079318; Porwit A, 2011, HAEMATOL-HEMATOL J, V96, P1241, DOI 10.3324/haematol.2011.050526; Santos FPS, 2009, LEUKEMIA, V23, P2275, DOI 10.1038/leu.2009.181; Swerdlow SH, 2008, WHO CLASSIFICATION T; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Walter RB, 2013, BLOOD, V121, P2424, DOI 10.1182/blood-2012-10-462440; Wang SA, 2008, MODERN PATHOL, V21, P1394, DOI 10.1038/modpathol.2008.142; Wang SA, 2016, MODERN PATHOL, V29, P1221, DOI 10.1038/modpathol.2016.118; Wang SA, 2012, HUM PATHOL, V43, P153, DOI 10.1016/j.humpath.2011.08.008; Wimazal F, 2001, LEUKEMIA RES, V25, P287, DOI 10.1016/S0145-2126(00)00140-5; Wong E, 2015, PATHOLOGY, V47, P289, DOI 10.1097/PAT.0000000000000244; Wong E, 2015, J CLIN PATHOL, V68, P301, DOI 10.1136/jclinpath-2014-202740; Zuo Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041485	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172029	10.1371/journal.pone.0172029	http://dx.doi.org/10.1371/journal.pone.0172029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196090	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423900045
J	Ratnasiri, S; Bandara, J				Ratnasiri, Shyama; Bandara, Jayatilleke			Changing patterns of meat consumption and greenhouse gas emissions in Australia: Will kangaroo meat make a difference?	PLOS ONE			English	Article							IDEAL DEMAND SYSTEM; CLIMATE-CHANGE; FOOD-CONSUMPTION; METHANE PRODUCTION; DIETARY CHOICES; LIVESTOCK; MITIGATION; MODEL; RANGELANDS; IMPACTS	The Australian per capita consumption of ruminant meat such as beef and lamb has declined over the last two decades. Over the same period, however, per capita consumption of non-ruminant meat such as chicken and pork has continued to increase. Furthermore, it is now observed that the human consumption of kangaroo meat is on the rise. This study investigates the implications of these changes in meat consumption patterns on Green House Gases (GHGs) emission mitigation in Australia using a Vector Auto Regression (VAR) forecasting approach. Our results suggest that the increase will continue in non-ruminant meat consumption and this will not only offset the decline in ruminant meat consumption, but will also raise the overall per capita meat consumption by approximately 1% annually. The per capita GHGs emissions will likely decrease by approximately 2.3% per annum, due to the inclusion of non-ruminant meat in Australian diets. The GHGs emissions can further be reduced if the average Australian consumer partially replaces ruminant meat with kangaroo meat.	[Ratnasiri, Shyama; Bandara, Jayatilleke] Griffith Univ, Dept Accounting Finance & Econ, Brisbane, Qld, Australia	Griffith University	Ratnasiri, S (corresponding author), Griffith Univ, Dept Accounting Finance & Econ, Brisbane, Qld, Australia.	s.ratnasiri@griffith.edu.au	Ratnasiri, Shyama/AAP-9863-2021	Ratnasiri, Shyama/0000-0002-9295-4076	Griffith University New Researcher Grant Scheme [40642]; New Researcher Grant Scheme of Griffith University, Australia	Griffith University New Researcher Grant Scheme; New Researcher Grant Scheme of Griffith University, Australia	This study was supported by the Griffith University New Researcher Grant Scheme, project number 40642. The funders had no role in study design, data collection and anlaysis, decision to publish, or preparation of the manuscript.; We would like to thank financial support provided for this research under New Researcher Grant Scheme of Griffith University, Australia.; We also acknowledge the anonymous reviewers for their constructive comments.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Audsley E., 2010, LOW CAN WE GO ASSESS; Australian Bureau of Agriculture and Resource Economics ABARE, 2009, VAL RED MEAT IND AUS; Bajzelj B, 2014, NAT CLIM CHANGE, V4, P924, DOI [10.1038/nclimate2353, 10.1038/NCLIMATE2353]; Barai B. K., 1992, Trends in Food Science & Technology, V3, P69, DOI 10.1016/0924-2244(92)90133-H; Barten AP, 1966, THEORIE EMPIRE VOLLE; Beardsworth A., 1999, British Food Journal, V101, P289, DOI 10.1108/00070709910272169; Ben-Ami D., 2010, ADVOCATING KANGAROO; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Carlsson-Kanyama A, 1998, AMBIO, V27, P528; Carlsson-Kanyama A, 1998, FOOD POLICY, V23, P277, DOI 10.1016/S0306-9192(98)00037-2; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; CASHIN P, 1991, AUST J AGR ECON, V35, P263, DOI 10.1111/j.1467-8489.1991.tb00509.x; Chapman M, 2003, RANGELAND J, V25, P20, DOI 10.1071/RJ03003; CHEN PY, 1991, CAN J AGR ECON, V39, P223, DOI 10.1111/j.1744-7976.1991.tb03569.x; Climate Change Committee, 2008, BUILD LOW CARB EC UK; Cooney R., 2012, SCI UNDER SIEGE, P150, DOI [10.7882/FS.2012.051, DOI 10.7882/FS.2012.051]; Craw C, 2008, MEDIA INT AUST, P82; DEATON A, 1980, AM ECON REV, V70, P312; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Deparment of Agriculture and Water Resources, LIV EM AUSTR GOV; Department of Climate Change and Energy Efficiency, 2008, NAT GREENH GAS INV; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Duchin F, 2005, J IND ECOL, V9, P99, DOI 10.1162/1088198054084707; Edjabou LD, 2013, FOOD POLICY, V39, P84, DOI 10.1016/j.foodpol.2012.12.004; Edwards-Jones G, 2009, J AGR SCI-CAMBRIDGE, V147, P707, DOI 10.1017/S0021859609990165; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; Fiala N, 2008, ECOL ECON, V67, P412, DOI 10.1016/j.ecolecon.2007.12.021; Flachowsky G. H., 2007, ANIMAL FEED SCI TECH, V135, P188; Foster M., 2014, EMERGING ANIMAL PLAN; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Garnett T, 2009, ENVIRON SCI POLICY, V12, P491, DOI 10.1016/j.envsci.2009.01.006; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; Goodland R, 1997, ECOL ECON, V23, P189, DOI 10.1016/S0921-8009(97)00579-X; Griffith G, 2001, PREVIOUS DEMAND ELAS, P3; GRIGG G, 1989, CONSERV BIOL, V3, P194, DOI 10.1111/j.1523-1739.1989.tb00072.x; Hedenus F, 2014, CLIMATIC CHANGE, V124, P79, DOI 10.1007/s10584-014-1104-5; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/nclimate2925, 10.1038/NCLIMATE2925]; Hyde CE, 1998, APPL ECON, V30, P1169, DOI 10.1080/000368498325066; KEMPTON TJ, 1976, AUST J BIOL SCI, V29, P209, DOI 10.1071/BI9760209; Kim B, 2009, ECOL ECON, V69, P186, DOI 10.1016/j.ecolecon.2009.08.017; Madsen J, 2012, J ANIM SCI, V90, P1364, DOI 10.2527/jas.2011-4011; Maguire A, 2008, 12 INT S RUM MICR EC; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Nc S, 1983, FEASIBILITY FARMING; OECD, 2016, MEAT CONS IND; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Piggott NE, 1996, AM J AGR ECON, V78, P268, DOI 10.2307/1243701; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Ripple WJ, 2014, NAT CLIM CHANGE, V4, P2, DOI 10.1038/nclimate2081; Rutherford AS, 1999, AGR ECON, V21, P21, DOI 10.1016/S0169-5150(99)00008-0; Sabate J, 2014, AM J CLIN NUTR, V100, p476S, DOI 10.3945/ajcn.113.071522; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Schosler H, 2012, APPETITE, V58, P39, DOI 10.1016/j.appet.2011.09.009; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Stone R, 1954, ECON J, V64, P511, DOI 10.2307/2227743; THEIL H, 1965, ECONOMETRICA, V33, P67, DOI 10.2307/1911889; Verbeke W, 2001, AGR ECON-BLACKWELL, V25, P359, DOI 10.1111/j.1574-0862.2001.tb00215.x; Wang Z. J., 2003, Agribusiness (New York), V19, P505, DOI 10.1002/agr.10074; Williams P, 2007, NUTR DIET, V64, pS113, DOI 10.1111/j.1747-0080.2007.00197.x; Wilson GR, 2008, CONSERV LETT, V1, P119, DOI 10.1111/j.1755-263X.2008.00023.x; Wirsenius S, 2011, CLIMATIC CHANGE, V108, P159, DOI 10.1007/s10584-010-9971-x	68	10	10	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170130	10.1371/journal.pone.0170130	http://dx.doi.org/10.1371/journal.pone.0170130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196141	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900004
J	Pomowski, A; Uson, I; Nowakowska, Z; Veillard, F; Sztukowska, MN; Guevara, T; Goulas, T; Mizgalska, D; Nowak, M; Potempa, B; Huntington, JA; Potempa, J; Gomis-Ruth, FX				Pomowski, Anja; Uson, Isabel; Nowakowska, Zuzanna; Veillard, Florian; Sztukowska, Maryta N.; Guevara, Tibisay; Goulas, Theodoros; Mizgalska, Danuta; Nowak, Magdalena; Potempa, Barbara; Huntington, James A.; Potempa, Jan; Gomis-Rueth, F. Xavier			Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from Porphyromonas gingivalis, a causative agent of gum disease from the human oral microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; protein crystallization; protein degradation; protein domain; protein structure; proteinase; X-ray crystal structure; host-microbiome interaction; oral microbiota; zymogenic latency	IX SECRETION SYSTEM; STRUCTURE VALIDATION; GLIDING MOTILITY; BACTERIAL; PROTEINS; RGPB; ACTIVATION; REFINEMENT; MOLPROBITY; COMPONENT	Skewing of the human oral microbiome causes dysbiosis and preponderance of bacteria such as Porphyromonas gingivalis, the main etiological agent of periodontitis. P. gingivalis secretes proteolytic gingipains (Kgp and RgpA/B) as zymogens inhibited by a pro-domain that is removed during extracellular activation. Unraveling the molecular mechanism of Kgp zymogenicity is essential to design inhibitors blocking its activity. Here, we found that the isolated 209-residue Kgp pro-domain is a boomerang-shaped all- protein similar to the RgpB pro-domain. Using composite structural information of Kgp and RgpB, we derived a plausible homology model and mechanism of Kgp-regulating zymogenicity. Accordingly, the pro-domain would laterally attach to the catalytic moiety in Kgp and block the active site through an exposed inhibitory loop. This loop features a lysine (Lys(129)) likely occupying the S-1 specificity pocket and exerting latency. Lys(129) mutation to glutamate or arginine led to misfolded protein that was degraded in vivo. Mutation to alanine gave milder effects but still strongly diminished proteolytic activity, without affecting the subcellular location of the enzyme. Accordingly, the interactions of Lys(129) within the S-1 pocket are also essential for correct folding. Uniquely for gingipains, the isolated Kgp pro-domain dimerized through an interface, which partially overlapped with that between the catalytic moiety and the pro-domain within the zymogen, i.e. both complexes are mutually exclusive. Thus, pro-domain dimerization, together with partial rearrangement of the active site upon activation, explains the lack of inhibition of the pro-domain in trans. Our results reveal that the specific latency mechanism of Kgp differs from those of Rgps.	[Pomowski, Anja; Huntington, James A.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Uson, Isabel; Guevara, Tibisay; Goulas, Theodoros; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, Barcelona 08010, Catalonia, Spain; [Uson, Isabel; Guevara, Tibisay; Goulas, Theodoros; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Crystallog Methods Lab,Struct Biol Unit, Barcelona 08010, Catalonia, Spain; [Uson, Isabel] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain; [Nowakowska, Zuzanna; Mizgalska, Danuta; Nowak, Magdalena; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Veillard, Florian; Sztukowska, Maryta N.; Potempa, Barbara; Potempa, Jan] Univ Louisville, Dept Oral Immunol & Infect Dis, Sch Dent, Louisville, KY 40202 USA; [Veillard, Florian] CNRS, Inst Biol Mol & Cellulaire, URP9022, Strasbourg, France	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Jagiellonian University; University of Louisville; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Crystallog Methods Lab,Struct Biol Unit, Barcelona 08010, Catalonia, Spain.; Potempa, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland.; Potempa, J (corresponding author), Univ Louisville, Dept Oral Immunol & Infect Dis, Sch Dent, Louisville, KY 40202 USA.	jan.potempa@louisville.edu; fxgr@ibmb.csic.es	Potempa, Jan/AAA-6850-2021; Goulas, Theodoros/H-1951-2015; Nowak, Magdalena/HGB-7801-2022	Goulas, Theodoros/0000-0002-6938-5493; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Potempa, Jan/0000-0002-3600-7461; Nowakowska, Zuzanna/0000-0003-2848-7538; Veillard, Florian/0000-0003-1248-2396	"TRIGGER" from the Seventh Framework Programme [FP7-HEALTH-2012-306029-2]; Spanish Ministerio de Economia y Competitividad [BFU2015-64487R, MDM-2014-0435, BIO2013-49320-EXP, BIO2015-64216-P, BIO2013-49604-EXP]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014SGR9]; Polish Ministerstwo Nauki i Szkolnictwa Wyzszego [0218/DIA/2012/41]; Diamond Light Source; Ministry of Science and Higher Education; ICREA Funding Source: Custom	"TRIGGER" from the Seventh Framework Programme; Spanish Ministerio de Economia y Competitividad(Spanish Government); Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); Polish Ministerstwo Nauki i Szkolnictwa Wyzszego; Diamond Light Source; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); ICREA(ICREA)	This work was supported in part by Grant FP7-HEALTH-2012-306029-2 "TRIGGER" from the Seventh Framework Programme; Grants BFU2015-64487R, MDM-2014-0435, BIO2013-49320-EXP, BIO2015-64216-P, and BIO2013-49604-EXP from the Spanish Ministerio de Economia y Competitividad; Grant 2014SGR9 from the Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya; and Diamentowy Grant 0218/DIA/2012/41 from the Polish Ministerstwo Nauki i Szkolnictwa Wyzszego. The Structural Biology Unit of Molecular Biology Institute of Barcelona (IBMB) is a "Maria de Maeztu" Unit of Excellence from the Spanish Ministry of Economy, Innovation and Competitiveness. Funding for travelling and synchrotron data collection was provided in part by Diamond Light Source. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education. The authors declare that they have no conflicts of interest with the contents of this article.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BICKEL M, 1985, J DENT RES, V64, P1218, DOI 10.1177/00220345850640100801; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Diego I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23123; de Diego I, 2014, J BIOL CHEM, V289, P32291, DOI 10.1074/jbc.M114.602052; de Diego I, 2013, J BIOL CHEM, V288, P14287, DOI 10.1074/jbc.M112.444927; De La Fuente C, 2013, ARCHAEOMETRY, V55, DOI 10.1111/j.1475-4754.2012.00707.x; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubin G, 2013, CURR PHARM DESIGN, V19, P1090, DOI 10.2174/13816128130611; Eloe-Fadrosh EA, 2013, ANNU REV MED, V64, P145, DOI 10.1146/annurev-med-010312-133513; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Guentsch A, 2011, J PERIODONTOL, V82, P1051, DOI 10.1902/jop.2011.100565; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; HOLZER H, 1980, ANNU REV BIOCHEM, V49, P63, DOI 10.1146/annurev.bi.49.070180.000431; How KY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00053; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kataoka S, 2014, FASEB J, V28, P3564, DOI 10.1096/fj.14-252130; Khan AR, 1998, PROTEIN SCI, V7, P815; Kharade SS, 2015, J BACTERIOL, V197, P147, DOI 10.1128/JB.02085-14; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lasica AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37708; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Maixner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099994; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Mittl PRE, 2006, CURR OPIN STRUC BIOL, V16, P769, DOI 10.1016/j.sbi.2006.10.014; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pathirana RD, 2007, INFECT IMMUN, V75, P1436, DOI 10.1128/IAI.01627-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pike RN, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2337, DOI 10.1016/B978-0-12-382219-2.00521-4; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Potempa Jan, 2005, V12, P132, DOI 10.1159/000081693; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Sheldrick G. M., 2011, INT TABLES CRYSTALLO, P413; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Subramanian S, 2015, CELL, V161, P36, DOI 10.1016/j.cell.2015.03.013; Tang YQ, 2011, ADV EXP MED BIOL, V712, P15, DOI 10.1007/978-1-4419-8414-2_2; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Veillard F, 2013, BBA-GEN SUBJECTS, V1830, P4218, DOI 10.1016/j.bbagen.2013.04.005; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x	64	7	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5724	5735		10.1074/jbc.M117.776724	http://dx.doi.org/10.1074/jbc.M117.776724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196869	Green Published, hybrid			2022-12-26	WOS:000398813200010
J	Guo, GQ; Zhang, L; Ye, SS; Hu, YY; Li, BQ; Sun, XW; Mao, CC; Xu, JF; Chen, YP; Zhang, LF; Xue, XY				Guo, Gangqiang; Zhang, Liang; Ye, Sisi; Hu, Yingying; Li, Baoqing; Sun, Xiangwei; Mao, Chenchen; Xu, Jianfeng; Chen, Yiping; Zhang, Lifang; Xue, Xiangyang			Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement	PLOS ONE			English	Article							SEQUENCE VARIABILITY; ALPHA-CHEMOKINE; CLINICAL-MANIFESTATIONS; MIXED INFECTION; CMV INFECTION; STRAINS; GENES; CHILDREN; DISEASE; HYPERVARIABILITY	Human cytomegalovirus is a significant agent of hepatic involvement in neonates. In this study, we investigated the polymorphisms and features of the viral genes UL144 and UL146 as well as their significance to congenital hepatic involvement. In 79 neonates with congenital cytomegalovirus infection and hepatic involvement, full length UL144 and UL146 were successfully amplified in 73.42% and 60.76% of cases, respectively. Sequencing indicated that both genes were hypervariable. Notably, UL144 genotype B was highly associated with aspartate aminotransferase (P = 0.028) and lactate dehydrogenase (P = 0.046). Similarly, UL146 genotype G1 and G13 were significantly associated with CMV IgM (P = 0.026), CMV IgG (P = 0.034), alanine aminotransferase (P = 0.019), and aspartate aminotransferase (P = 0.032). In conclusion, dominant UL144 (genotype B) and UL146 (genotype G1 and G13) genotypes are associated with elevated levels of enzymes and CMV IgM and IgG of cytomegalovirus infection.	[Guo, Gangqiang; Ye, Sisi; Zhang, Lifang; Xue, Xiangyang] Wenzhou Med Univ, Dept Microbiol & Immunol, Inst Mol Virol & Immunol, Inst Trop Med, Wenzhou, Peoples R China; [Zhang, Liang; Sun, Xiangwei; Mao, Chenchen; Xu, Jianfeng] Wenzhou Med Univ, Dept Gen Surg, Affiliated Hosp 1, Wenzhou, Peoples R China; [Hu, Yingying] Wenzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Wenzhou, Peoples R China; [Li, Baoqing] Wenzhou Med Univ, Dept Lab Med, Affiliated Hosp 2, Wenzhou, Peoples R China; [Li, Baoqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Chen, Yiping] Wenzhou Med Univ, Dept Pediat Infect Dis, Affiliated Hosp 2, Wenzhou, Peoples R China; [Chen, Yiping] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Xue, XY (corresponding author), Wenzhou Med Univ, Dept Microbiol & Immunol, Inst Mol Virol & Immunol, Inst Trop Med, Wenzhou, Peoples R China.; Chen, YP (corresponding author), Wenzhou Med Univ, Dept Pediat Infect Dis, Affiliated Hosp 2, Wenzhou, Peoples R China.; Chen, YP (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.	cccyp@163.com; wzxxy001@163.com	Chen, Yi/HIR-2608-2022; Hu, Ying/GQZ-8100-2022	Xue, Xiangyang/0000-0002-8670-2016	National Nature Science Foundation of China [81001343, 81472308, 81672707]; Zhejiang Provincial Natural Science Foundation of China [Y2100909]; Zhejiang Science and Technology Bureau [2012C33126]; Wenzhou Municipal Science and Technology Bureau [Y20160018]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Science and Technology Bureau; Wenzhou Municipal Science and Technology Bureau	This work was supported by the National Nature Science Foundation of China (Grant Nos. 81001343, 81472308 and 81672707), the Zhejiang Provincial Natural Science Foundation of China (Y2100909), the Zhejiang Science and Technology Bureau (grant nos. 2012C33126), and the Wenzhou Municipal Science and Technology Bureau (grant nos. Y20160018).	Aguayo F, 2010, BIOL RES, V43, P475, DOI [10.4067/S0716-97602010000400013, /S0716-97602010000400013]; Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; Arav-Boger R, 2005, VIRUS GENES, V31, P65, DOI 10.1007/s11262-005-2201-3; Arav-Boger R, 2006, J INFECT DIS, V194, P464, DOI 10.1086/505427; Bale JF, 2001, J MED VIROL, V65, P90, DOI 10.1002/jmv.2006; Barbi M, 1998, EUR J EPIDEMIOL, V14, P791, DOI 10.1023/A:1007554726449; Bilavsky E, 2015, J VIRAL HEPATITIS, V22, P763, DOI 10.1111/jvh.12374; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Bradley AJ, 2008, J MED VIROL, V80, P1615, DOI 10.1002/jmv.21241; Branas P, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv151; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Chen HP, 2015, J GEN VIROL; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dreher AM, 2014, J PEDIATR-US, V164, P855, DOI 10.1016/j.jpeds.2013.12.007; Fu XX, 2014, CHINESE SCI BULL, V59, P3120, DOI 10.1007/s11434-014-0353-z; Guo Gangqiang, 2016, Bing Du Xue Bao, V32, P610; Hassan-Walker AF, 2004, J MED VIROL, V74, P573, DOI 10.1002/jmv.20210; He R, 2006, INTERVIROLOGY, V49, P215, DOI 10.1159/000091468; He R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-299; Heo JH, 2008, VIROLOGY, V378, P86, DOI 10.1016/j.virol.2008.05.002; Heo JH, 2015, J IMMUNOL, V195, P227, DOI 10.4049/jimmunol.1400291; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Lurain NS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-4; Lurain NS, 1999, J VIROL, V73, P10040, DOI 10.1128/JVI.73.12.10040-10050.1999; Luttichau HR, 2010, J BIOL CHEM, V285, P9137, DOI 10.1074/jbc.M109.002774; Mao ZQ, 2007, ARCH VIROL, V152, P115, DOI 10.1007/s00705-006-0826-8; Nijman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108018; Oka N, 2015, J MED VIROL, V87, P1441, DOI 10.1002/jmv.24239; Paradowska E, 2012, EUR J CLIN MICROBIOL, V31, P1335, DOI 10.1007/s10096-011-1447-z; Paradowska E, 2015, J MED VIROL, V87, P1737, DOI 10.1002/jmv.24222; Paradowska E, 2014, VIROLOGY, V462, P207, DOI 10.1016/j.virol.2014.06.020; Pati SK, 2013, PEDIATR INFECT DIS J, V32, P1050, DOI 10.1097/INF.0b013e31829bb0b9; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Picone O, 2005, J CLIN MICROBIOL, V43, P25, DOI 10.1128/JCM.43.1.25-29.2005; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Poole E, 2008, J VIROL, V82, P4250, DOI 10.1128/JVI.02156-07; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Ross SA, 2011, J INFECT DIS, V204, P1003, DOI 10.1093/infdis/jir457; Schleiss Mark R, 2003, Herpes, V10, P4; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; Sijmons S., 2015, J VIROL; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; Stanton R, 2005, J MED VIROL, V75, P42, DOI 10.1002/jmv.20235; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Walker A, 2001, J CLIN MICROBIOL, V39, P2219, DOI 10.1128/JCM.39.6.2219-2226.2001; Waters A, 2010, J CLIN MICROBIOL, V48, P3956, DOI 10.1128/JCM.01133-10; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018	50	4	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171959	10.1371/journal.pone.0171959	http://dx.doi.org/10.1371/journal.pone.0171959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222150	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800024
J	Teixeira, LB; Pilecco, FB; Vigo, A; Drachler, MD; Leite, JCD; Knauth, DR				Teixeira, Luciana Barcellos; Pilecco, Flavia Bulegon; Vigo, Alvaro; Drachler, Maria de Lourdes; de Carvalho Leite, Jose Carlos; Knauth, Daniela Riva			Factors associated with post-diagnosis pregnancies in women living with HIV in the south of Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POSITIVE WOMEN; REPRODUCTIVE HEALTH; MEN; TRANSMISSION; INTENTIONS; DECISIONS; CHOICES; DESIRE; CARE	Objectives To analyze the factors associated with the occurrence of pregnancies after the diagnosis of infection by HIV. Methods Cross-sectional study with women of a reproductive age living with HIV/AIDS cared for in the public services of the city of Porto Alegre, in southern Brazil. The data was analyzed from a comparison between two groups: women with and women without pregnancies after the diagnosis of HIV. Poisson regression models were used to estimate the reasons of prevalence (RP). Results The occurrence of pregnancies after the diagnosis of HIV is associated with a lower level of education (RP adjusted = 1.31; IC95%: 1.03-1.66), non-use of condoms in the first sexual intercourse (RP = 1.32; IC95%: 1.02-1.70), being 20 years old or less when diagnosed with HIV (RP = 3.48; IC95%: 2.02-6.01), and experience of violence related to the diagnosis of HIV (RP = 1.28; IC95%: 1.06-1.56). Conclusions The occurrence of pregnancies after the diagnosis of infection by HIV does not indicate the exercise of the reproductive rights of the women living with HIV/AIDS because these pregnancies occurred in contexts of great vulnerability.	[Teixeira, Luciana Barcellos] Univ Fed Rio Grande do Sul, Sch Nursing, Dept Profess Assistance & Guidance, Porto Alegre, RS, Brazil; [Teixeira, Luciana Barcellos; Drachler, Maria de Lourdes] Univ Fed Rio Grande do Sul, Grad Studies Program Publ Hlth, Porto Alegre, RS, Brazil; [Pilecco, Flavia Bulegon; Knauth, Daniela Riva] Univ Fed Rio Grande do Sul, Dept Social Med, Porto Alegre, RS, Brazil; [Pilecco, Flavia Bulegon; Vigo, Alvaro; Knauth, Daniela Riva] Univ Fed Rio Grande do Sul, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Vigo, Alvaro] Univ Fed Rio Grande do Sul, Dept Stat, Porto Alegre, RS, Brazil; [de Carvalho Leite, Jose Carlos] Univ Ctr UNILASALLE, Canoas, RS, Brazil; [Pilecco, Flavia Bulegon] Univ Fed Minas Gerais, Dept Prevent & Social Med, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Centro Universitario La Salle; Universidade Federal de Minas Gerais	Teixeira, LB (corresponding author), Univ Fed Rio Grande do Sul, Sch Nursing, Dept Profess Assistance & Guidance, Porto Alegre, RS, Brazil.; Teixeira, LB (corresponding author), Univ Fed Rio Grande do Sul, Grad Studies Program Publ Hlth, Porto Alegre, RS, Brazil.	luciana.bteixeira@gmail.com	Pilecco, Flávia/E-4221-2016; Vigo, Alvaro/S-2243-2019	Pilecco, Flávia/0000-0001-8316-8797; Vigo, Alvaro/0000-0002-5797-9470	National Scientific and Technological Development Council (CNPq) [14/2009 - Universal]	National Scientific and Technological Development Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project that originated data analyzed in this paper was fully funded by National Scientific and Technological Development Council (CNPq) (Process MCT/CNPq number 14/2009 - Universal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; Aska ML, 2011, WORLD J AIDS, V1, P198, DOI [10.4236/wja.2011.14029, DOI 10.4236/WJA.2011.14029]; Barbosa RM, 2003, CAD SAUDE PUBLICA, V19, P365; Barnes DB, 2009, QUAL HEALTH RES, V19, P481, DOI 10.1177/1049732309332835; Bedimo AL, 1998, SOC SCI MED, V46, P171, DOI 10.1016/S0277-9536(97)00157-3; Berquo A E, 2008, REV SAUDE PUBL S1, V42, P34; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Craft SM, 2007, AIDS BEHAV, V11, P927, DOI 10.1007/s10461-007-9219-6; Feldman R, 2003, REPROD HEALTH MATTER, V11, P162, DOI 10.1016/S0968-8080(03)02284-5; Fiore S, 2008, HUM REPROD, V23, P2140, DOI 10.1093/humrep/den232; Heard I, 2007, AIDS, V21, pS77, DOI 10.1097/01.aids.0000255089.44297.6f; KLINE A, 1995, SOC SCI MED, V40, P1539, DOI 10.1016/0277-9536(94)00280-7; KNAUTH DR, 1999, SEXUALIDADES PELO AV, V34, P121; Gogna ML, 2009, SOC SCI MED, V69, P813, DOI 10.1016/j.socscimed.2009.06.002; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Lusti-Narasimhan M, 2007, REPROD HEALTH MATTER, V15, P1, DOI 10.1016/S0968-8080(07)29033-0; Marcellin F, 2010, AIDS CARE, V22, P441, DOI 10.1080/09540120903202913; Murphy JJ, 1998, FAM PLANN PERSPECT, V30, P276, DOI 10.2307/2991503; Newell M-L, 1997, AIDS S11, P1165; Njabanou NM, 2011, J INT ASS PHYS AIDS, V12, P98; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; Paiva V, 2007, AIDS PATIENT CARE ST, V21, P268, DOI 10.1089/apc.2006.0129; Peltzer K, 2009, AIDS BEHAV, V13, P973, DOI 10.1007/s10461-008-9365-5; Phillips Deborah Y, 2014, J Assoc Nurses AIDS Care, V25, pS36, DOI 10.1016/j.jana.2012.12.006; Pilecco FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095570; Santos NJS, 2009, CAD SAUDE PUBLICA, V25, pS321, DOI 10.1590/S0102-311X2009001400014; Sowell RL, 2002, AIDS CARE, V14, P181, DOI 10.1080/09540120220104695; Steiner RJ, 2013, AM J PUBLIC HEALTH, V103, P1357, DOI 10.2105/AJPH.2013.301265; Teixeira Ana Maria Ferreira Borges, 2006, Cad. Saúde Pública, V22, P1385, DOI 10.1590/S0102-311X2006000700004; Teixeira LB, 2013, CAD SAUDE PUBLICA, V29, P609, DOI 10.1590/S0102-311X2013000300018; UNAIDS, 2011, GLOB HIV AIDS RESP E; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172514	10.1371/journal.pone.0172514	http://dx.doi.org/10.1371/journal.pone.0172514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222175	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800062
J	Majid, MAA; Mahboob, T; Mong, BGJ; Jaturas, N; Richard, RL; Tian-Chye, T; Phimphila, A; Mahaphonh, P; Aye, KN; Aung, WL; Chuah, J; Ziegler, AD; Yasiri, A; Sawangjaroen, N; Lim, YAL; Nissapatorn, V				Majid, Mohamad Azlan Abdul; Mahboob, Tooba; Mong, Brandon G. J.; Jaturas, Narong; Richard, Reena Leeba; Tian-Chye, Tan; Phimphila, Anusorn; Mahaphonh, Panomphanh; Aye, Kyaw Nyein; Aung, Wai Lynn; Chuah, Joon; Ziegler, Alan D.; Yasiri, Atipat; Sawangjaroen, Nongyao; Lim, Yvonne A. L.; Nissapatorn, Veeranoot			Pathogenic waterborne free-living amoebae: An update from selected Southeast Asian countries	PLOS ONE			English	Article							INCREASING IMPORTANCE; HARTMANNELLA-VERMIFORMIS; BALAMUTHIA-MANDRILLARIS; ACANTHAMOEBA SPP.; NAEGLERIA SPP.; KERATITIS; IDENTIFICATION; MENINGOENCEPHALITIS; PREVALENCE; BIOLOGY	Data on the distribution of free-living amoebae is still lacking especially in Southeast Asian region. The aquatic environment revealed a high occurrence of free-living amoebae ( FLA) due to its suitable condition and availability of food source, which subsequently causes infection to humans. A total of 94 water samples consisted of both treated and untreated from Laos ( 31), Myanmar ( 42), and Singapore ( 21) were investigated for the presence of pathogenic FLA. Each water sample was filtered and cultured onto non-nutrient agar seeded with live suspension of Escherichia coli and incubated at room temperature. Morphological identification was conducted for both trophozoites and cysts via microscopic stains ( Giemsa and immunofluorescence). The presence of Naegleria-like structures was the most frequently encountered in both treated and untreated water samples, followed by Acanthamoeba-like and Vermamoeba-like features. To identify the pathogenic isolates, species-specific primer sets were applied for molecular identification of Acanthamoeba, Naegleria, and Vermamoeba. The pathogenic species of Acanthamoeba lenticulata and A. triangularis were detected from untreated water samples, while Vermamoeba vermiformis was found in both treated and untreated water samples. Our results suggested that poor water quality as well as inadequate maintenance and treatment might be the cause of this alarming problem since chlorine disinfection is ineffective in eradicating these amoebas in treated water samples. Regular monitoring and examination of water qualities are necessary in order to control the growth, hence, further preventing the widespread of FLA infections among the public.	[Majid, Mohamad Azlan Abdul; Mahboob, Tooba; Mong, Brandon G. J.; Jaturas, Narong; Richard, Reena Leeba; Tian-Chye, Tan; Lim, Yvonne A. L.; Nissapatorn, Veeranoot] Univ Malaya, Fac Med, Dept Parasitol, Southeast Asia Water Team, Kuala Lumpur, Malaysia; [Phimphila, Anusorn; Mahaphonh, Panomphanh] Univ Hlth Sci, Dept Lab Med, Fac Med Technol, Viangchan, Laos; [Aye, Kyaw Nyein; Aung, Wai Lynn] Adv Life & Regenerating Motherland ALARM, Ecol Lab, Yangon, Myanmar; [Chuah, Joon] Natl Univ Singapore, Inst Water Policy, Singapore, Singapore; [Ziegler, Alan D.] Natl Univ Singapore, Dept Geog, Singapore, Singapore; [Yasiri, Atipat] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani, Thailand; [Sawangjaroen, Nongyao] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Thailand	Universiti Malaya; National University of Singapore; National University of Singapore; Chulabhorn Research Institute; Thammasat University; Prince of Songkla University	Nissapatorn, V (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Southeast Asia Water Team, Kuala Lumpur, Malaysia.	veeranoot@um.edu.my	, dr dr/AAA-5406-2022; Sawangjaroen, Nongyao/AAV-9785-2021; Richard, Reena Leeba/Q-5022-2017; LIM, YVONNE AL/B-5276-2010; ZIEGLER, ALAN/A-5463-2012; Abd Majid, Mohamad Azlan/B-9177-2017; Chuah, Joon Huang/F-9990-2010; Mahboob, Tooba/AAZ-8938-2021	LIM, YVONNE AL/0000-0003-4050-6332; ZIEGLER, ALAN/0000-0001-5305-2136; Abd Majid, Mohamad Azlan/0000-0002-8262-2764; Chuah, Joon Huang/0000-0001-9058-3497; Mahboob, Tooba/0000-0001-6476-776X	University of Malaya [UM.C/625/1/HIR/MoHE/MED/23, UM. 0000041/HIR.C3, UMRG 544/14HTM, UMRG 362/15AFR]	University of Malaya(Universiti Malaya)	University of Malaya High Impact Research Grant (UM.C/625/1/HIR/MoHE/MED/23 and UM. 0000041/HIR.C3) and University of Malaya Research Grants (UMRG 544/14HTM and UMRG 362/15AFR), received by VN and TTC.	Ab Rahim, 2010, J SAINS KESIHATAN, V8, P15; Abedkhojasteh H, 2013, IRAN J PARASITOL, V8, P481; Aitken D, 1996, OPHTHALMOLOGY, V103, P485, DOI 10.1016/S0161-6420(96)30667-2; Barete S, 2007, EMERG INFECT DIS, V13, P736, DOI 10.3201/eid1305.061347; Brieland JK, 1997, INFECT IMMUN, V65, P5330, DOI 10.1128/IAI.65.12.5330-5333.1997; Buerano Corazon C, 2014, Trop Med Health, V42, P145, DOI 10.2149/tmh.2014-15; Bunjongpuk S., 2000, THAI J PED, V39, P38; Corsaro D, 2015, PARASITOL RES, V114, P2481, DOI 10.1007/s00436-015-4445-8; De Jonckheere JF, 2004, PROTIST, V155, P89, DOI 10.1078/1434461000167; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; Dyakoya I, 2005, FOLIA PARASIT, V52, P295; Eikelboom DH, 2000, PROCESS CONTROL ACTI, P29; Ettinger MR, 2003, PARASITOL RES, V89, P6, DOI 10.1007/s00436-002-0707-3; Gartstecki T, 2005, EUR J PROTISTOL, V41, P119; Ghadar-ghadr Sh, 2012, J JAHROM U MED SCI, V10, P26; Ghani MKA, 2000, INT MED J IMJ, V7, P63; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2003, INFECT CONT HOSP EP, V24, P784, DOI 10.1086/502137; Harrington BJ, 2008, LABMEDICINE, V39, P231, DOI 10.1309/83G3PE2H1V2NY9FK; Herriman R., 2012, VIETNAM REPORTS 2 EV; Init I, 2010, TROP BIOMED, V27, P566; Intalapaporn P, 2004, AM J TROP MED HYG, V70, P666, DOI 10.4269/ajtmh.2004.70.666; Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327; Izumiyama S, 2003, J EUKARYOT MICROBIOL, V50, P514, DOI 10.1111/j.1550-7408.2003.tb00614.x; Jongwutiwes S, 2000, TROP MED INT HEALTH, V5, P335, DOI 10.1046/j.1365-3156.2000.00563.x; Kamel A G M, 2004, Trop Biomed, V21, P135; Kaushal V, 2008, J Assoc Physicians India, V56, P459; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kilvington S, 2004, INVEST OPHTH VIS SCI, V45, P165, DOI 10.1167/iovs.03-0559; KYLE DE, 1986, J PROTOZOOL, V33, P422, DOI 10.1111/j.1550-7408.1986.tb05634.x; Lasjerdi Z, 2011, PARASITOL RES, V109, P575, DOI 10.1007/s00436-011-2288-5; Lorenzo-Morales J, 2007, PARASITOL RES, V102, P167, DOI 10.1007/s00436-007-0754-x; MA P, 1990, REV INFECT DIS, V12, P490; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marciano-Cabral F, 2000, J EUKARYOT MICROBIOL, V47, P29, DOI 10.1111/j.1550-7408.2000.tb00007.x; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; Nacapunchai D, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P179; Natividad Filipinas F., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P991; Phu NH, 2013, LANCET, V381, P176, DOI 10.1016/S0140-6736(12)61730-9; Onichandran S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-244; PAGE FC, 1967, J PROTOZOOL, V14, P499, DOI 10.1111/j.1550-7408.1967.tb02036.x; Page FC, 1988, FRESHWATER BIOL ASS; Patil P.N., 2012, INT J ENV SCI, V3, P1194, DOI DOI 10.6088/IJES.2012030133028; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Pelandakis M, 2000, J EUKARYOT MICROBIOL, V47, P116, DOI 10.1111/j.1550-7408.2000.tb00020.x; Por Y.M., 2009, AM J OPHTHALMOL, V148, P1879; Putri DE, 2014, J CASE REP, V4, P419; Qvarnstrom Y, 2013, J EUKARYOT MICROBIOL, V60, P626, DOI 10.1111/jeu.12069; Qvarnstrom Y, 2009, J INFECT DIS, V199, P1139, DOI 10.1086/597473; Reyes-Batlle M, 2015, NOVELTY BIOMED, V3, P189, DOI [10.22037/nbm.v3i4.10386, DOI 10.22037/NBM.V3I4.10386]; Richard RL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070641; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Siripanth Chutatip, 2005, Journal of the Medical Association of Thailand, V88, P701; Sithinamsuwan P., 2001, INT MED J THAI, V17, P350; Smirnov Alexey V., 2004, Protistology, V3, P148; Solgi R, 2012, IRAN J PARASITOL, V7, P47; Szenasi Z, 1998, J MED MICROBIOL, V47, P5, DOI 10.1099/00222615-47-1-5; Teixeira LH, 2009, BRAZ J INFECT DIS, V13, P395, DOI 10.1590/S1413-86702009000600001; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; Tsvetkova N, 2004, PARASITOL RES, V92, P405, DOI 10.1007/s00436-003-1052-x; Valster RM, 2011, APPL ENVIRON MICROB, V77, P7321, DOI 10.1128/AEM.05575-11; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Xuan YH, 2008, KOREAN J PARASITOL, V46, P157, DOI 10.3347/kjp.2008.46.3.157	65	31	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0169448	10.1371/journal.pone.0169448	http://dx.doi.org/10.1371/journal.pone.0169448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212409	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700001
J	Vriend, J; Liu, WJ; Reiter, RJ				Vriend, Jerry; Liu, Wenjun; Reiter, Russel J.			The pineal gland: A model for adrenergic modulation of ubiquitin ligases	PLOS ONE			English	Article							ARYLALKYLAMINE-N-ACETYLTRANSFERASE; THYROXINE 5'-DEIODINASE ACTIVITY; KAPPA-B ACTIVATION; PHOTONEUROENDOCRINE TRANSDUCTION; PROTEASOMAL DEGRADATION; DEUBIQUITINATING ENZYME; II 5'-DEIODINASE; DOMAIN PROTEINS; GENE-EXPRESSION; MELATONIN	Introduction A recent study of the pineal gland of the rat found that the expression of more than 3000 genes showed significant day/night variations (The Hartley dataset). The investigators of this report made available a supplemental table in which they tabulated the expression of many genes that they did not discuss, including those coding for components of the ubiquitin proteasome system. Herein we identify the genes of the ubiquitin proteasome system whose expression were significantly influenced by environmental lighting in the Hartley dataset, those that were stimulated by DBcAMP in pineal glands in culture, and those that were stimulated by norepinephrine. Purpose Using the Ubiquitin and Ubiquitin-like Conjugation Database (UUCA) we identified ubiquitin ligases and conjugases, and deubiquitinases in the Hartley dataset for the purpose of determining whether expression of genes of the ubiquitin proteasome pathway were significantly influenced by day/night variations and if these variations were regulated by autonomic innervation of the pineal gland from the superior cervical ganglia. Methods In the Hartley experiments pineal glands groups of rats sacrificed during the day and groups sacrificed during the night were examined for gene expression. Additional groups of rats had their superior cervical ganglia removed surgically or surgically decentralized and the pineal glands likewise examined for gene expression. Results The genes with at least a 2-fold day/night significant difference in expression included genes for 5 ubiquitin conjugating enzymes, genes for 58 ubiquitin E3 ligases and genes for 6 deubiquitinases. A 35-fold day/night difference was noted in the expression of the gene Sik1, which codes for a protein containing both an ubiquitin binding domain (UBD) and an ubiquitin-associated (UBA) domain. Most of the significant differences in these genes were prevented by surgical removal, or disconnection, of the superior cervical ganglia, and most were responsive, in vitro, to treatment with a cyclic AMP analog, and norepinephrine. All previously described 24-hour rhythms in the pineal require an intact sympathetic input from the superior cervical ganglia. Conclusions The Hartley dataset thus provides evidence that the pineal gland is a highly useful model for studying adrenergically dependent mechanisms regulating variations in ubiquitin ligases, ubiquitin conjugases, and deubiquitinases, mechanisms that may be physiologically relevant not only in the pineal gland, but in all adrenergically innervated tissue.	[Vriend, Jerry] Univ Manitoba, Dept Human Anat & Cell Sci, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Liu, Wenjun] Univ Manitoba, Rady Fac Hlth Sci, Dept Pathol, Max Rady Coll Med, Winnipeg, MB, Canada; [Reiter, Russel J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Manitoba; University of Manitoba; University of Texas System; University of Texas Health San Antonio	Vriend, J (corresponding author), Univ Manitoba, Dept Human Anat & Cell Sci, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada.	Jerry.Vriend@umanitoba.ca		Vriend, Jerry/0000-0001-6435-755X				Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Aram L, 2016, DEV CELL, V37, P15, DOI 10.1016/j.devcel.2016.02.025; Drigo RAE, 2011, INT J BIOCHEM CELL B, V43, P1432, DOI 10.1016/j.biocel.2011.05.016; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Cao-Ehlker X, 2013, J BIOL CHEM, V288, P7580, DOI 10.1074/jbc.M112.434803; Chen CY, 2000, GENE DEV, V14, P1236; Choi HH, 2011, ONCOGENE, V30, P4791, DOI 10.1038/onc.2011.192; Conroy J, 2014, EUR J HUM GENET, V22, P505, DOI 10.1038/ejhg.2013.173; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; De Jong MC, 2015, AM J OPHTHALMOL, V160, P1116, DOI 10.1016/j.ajo.2015.09.009; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Flores AN, 2014, NAT REV UROL, V11, P499, DOI 10.1038/nrurol.2014.195; Flynn M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-235; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gu Y, 2016, P NATL ACAD SCI USA, V113, pE51, DOI 10.1073/pnas.1517041113; GUERRERO JM, 1990, P SOC EXP BIOL MED, V194, P327; GUERRERO JM, 1988, NEUROSCI LETT, V89, P229, DOI 10.1016/0304-3940(88)90386-2; GUERRERO JM, 1988, ENDOCRINOLOGY, V122, P236, DOI 10.1210/endo-122-1-236; Gulino A, 2012, VITAM HORM, V88, P211, DOI 10.1016/B978-0-12-394622-5.00009-2; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Hartley SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137548; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Ho AK, 2010, J NEUROCHEM, V112, P321, DOI 10.1111/j.1471-4159.2009.06457.x; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; HOWES KA, 1994, INVEST OPHTH VIS SCI, V35, P342; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Huang H, 2013, CELL BIOCHEM BIOPHYS, V67, P55, DOI 10.1007/s12013-013-9628-2; Huang ZP, 2010, J PINEAL RES, V48, P290, DOI 10.1111/j.1600-079X.2010.00753.x; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kanyo R, 2009, ENDOCRINOLOGY, V150, P4221, DOI 10.1210/en.2009-0275; Klein D C, 1970, Adv Biochem Psychopharmacol, V3, P241; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 2010, MOL CELL ENDOCRINOL, V314, P170, DOI 10.1016/j.mce.2009.07.010; Klein DC, 2003, J NEUROENDOCRINOL, V15, P370, DOI 10.1046/j.1365-2826.2003.01000.x; Klein DC, 2002, BIOCHEM SOC T, V30, P365, DOI 10.1042/bst0300365; Lehmann G, 2016, BIOCHEM BIOPH RES CO, V473, P80, DOI 10.1016/j.bbrc.2016.03.055; Lignitto L, 2011, NAT CELL BIOL, V13, P412, DOI 10.1038/ncb2209; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Lu A, 2013, J CELL BIOL, V203, P233, DOI 10.1083/jcb.201305158; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; Lu Z, 2007, J CELL BIOL, V177, P1077, DOI 10.1083/jcb.200610060; Ludgate M, 2011, J ENDOCRINOL, V210, P3, DOI 10.1530/JOE-11-0159; Lutz M, 2006, FEBS LETT, V580, P3921, DOI 10.1016/j.febslet.2006.06.023; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; Maurice P, 2010, EMBO J, V29, P3646, DOI 10.1038/emboj.2010.236; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Mittal R, 2009, EMBO REP, V10, P41, DOI 10.1038/embor.2008.240; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; REITER RJ, 1992, PROG BRAIN RES, V91, P315; Reiter RJ, 2014, BRAIN STRUCT FUNCT, V219, P1873, DOI 10.1007/s00429-014-0719-7; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Roy A, 2013, FEBS LETT, V587, P3567, DOI 10.1016/j.febslet.2013.09.020; RUBIO A, 1991, BIOSCIENCE REP, V11, P111, DOI 10.1007/BF01119198; Sagar GDV, 2007, MOL CELL BIOL, V27, P4774, DOI 10.1128/MCB.00283-07; Sato T, 2015, ONCOGENE, V34, P1280, DOI 10.1038/onc.2014.68; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Shitani M, 2012, TUMOR BIOL, V33, P1307, DOI 10.1007/s13277-012-0378-3; Silveira WA, 2014, J APPL PHYSIOL, V117, P11, DOI 10.1152/japplphysiol.01055.2013; Skieterska K, 2016, BIOCHEM SOC T, V44, P601, DOI 10.1042/BST20150281; Smaldone G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126808; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Soutto M, 1998, INT J BIOCHEM CELL B, V30, P235, DOI 10.1016/S1357-2725(97)00116-7; Su CH, 2011, CANCER RES, V71, P884, DOI 10.1158/0008-5472.CAN-10-2518; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vanecek J, 1998, PHYSIOL REV, V78, P687, DOI 10.1152/physrev.1998.78.3.687; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; Vriend J, 2016, BBA-REV CANCER, V1865, P176, DOI 10.1016/j.bbcan.2016.02.004; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Vriend J, 2014, CELL MOL LIFE SCI, V71, P3409, DOI 10.1007/s00018-014-1659-3; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Winkle CC, 2016, J NEUROSCI, V36, P4940, DOI 10.1523/JNEUROSCI.3876-15.2016; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Yang YM, 2014, J BIOL RHYTHM, V29, P243, DOI 10.1177/0748730414544741; Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605; Zhu X, 1998, Mol Vis, V4, P13; Zhuo XL, 2015, J CELL BIOL, V210, P727, DOI 10.1083/jcb.201502044	109	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172441	10.1371/journal.pone.0172441	http://dx.doi.org/10.1371/journal.pone.0172441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212404	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700052
J	Castillo, GM; Nishimoto-Ashfield, A; Jones, CC; Kabirov, KK; Zakharov, A; Lyubimov, AV				Castillo, Gerardo M.; Nishimoto-Ashfield, Akiko; Jones, Cynthia C.; Kabirov, Kasim K.; Zakharov, Alexander; Lyubimov, Alexander V.			Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACUTE GASTROINTESTINAL SYNDROME; ADENOVIRUS-MEDIATED TRANSFER; MYOCARDIAL INFARCT SIZE; THROMBOPOIETIN LEVELS; ORAL MUCOSITIS; CELL-SURVIVAL; RECEPTOR SPECIFICITY; ENDOTHELIAL-CELLS; RADIATION	We evaluated the mitigating effects of fibroblast growth factor 4 and 7 (FGF4 and FGF7, respectively) in comparison with long acting protected graft copolymer (PGC)-formulated FGF4 and 7 (PF4 and PF7, respectively) administered to C57BL/6J mice a day after exposure to LD50/30 (15.7 Gy) partial body irradiation (PBI) which targeted the gastrointestinal (GI) system. The PGC that we developed increased the bioavailability of FGF4 and FGF7 by 5- and 250-fold compared to without PGC, respectively, and also sustained a 24 hr presence in the blood after a single subcutaneous administration. The dose levels tested for mitigating effects on radiation injury were 3 mg/kg for the PF4 and PF7 and 1.5 mg each for their combination (PF4/7). Amifostine administered prior to PBI was used as a positive control. The PF4, PF7, or PF4/7 mitigated the radiation lethality in mice. The mitigating effect of PF4 and PF7 was similar to the positive control and PF7 was better than other mitigators tested. The plasma citrulline levels and hematology parameters were early markers of recovery and survival. GI permeability function appeared to be a late or full recovery indicator. The villus length and crypt number correlated with plasma citrulline level, indicating that it can act as a surrogate marker for these histology evaluations. The IL-18 concentrations in jejunum as early as day 4 and TPO levels in colon on day 10 following PBI showed statistically significant changes in irradiated versus non-irradiated mice which makes them potential biomarkers of radiation exposure. Other colon and jejunum cytokine levels are potentially useful but require larger numbers of samples than in the present study before their full utility can be realized.	[Castillo, Gerardo M.; Nishimoto-Ashfield, Akiko; Jones, Cynthia C.] PharmaIN Corp, Bothell, WA 98011 USA; [Kabirov, Kasim K.; Zakharov, Alexander; Lyubimov, Alexander V.] Univ Illinois, Dept Pharmacol, Toxicol Res Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Castillo, GM (corresponding author), PharmaIN Corp, Bothell, WA 98011 USA.; Lyubimov, AV (corresponding author), Univ Illinois, Dept Pharmacol, Toxicol Res Lab, Chicago, IL 60607 USA.	gcastillo@pharmain.com; alyubimov1@gmail.com			National Institutes of Health through SBIR grant [R43AI107953]	National Institutes of Health through SBIR grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the National Institutes of Health through SBIR grant R43AI107953 to G.M.C. who is an employee of PharmalN Corp. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of authors' salaries and/or research materials.	Akisu M, 2001, EUR J PEDIATR SURG, V11, P167, DOI 10.1055/s-2001-15485; Alvarez E, 2003, CLIN CANCER RES, V9, P3454; Baker JE, 2008, CARDIOVASC RES, V77, P44, DOI 10.1093/cvr/cvm026; Basilico C, 2005, CYTOKINE GROWTH F R, V16, P105, DOI 10.1016/j.cytogfr.2005.02.001; Beer HD, 2000, J BIOL CHEM, V275, P16091, DOI 10.1074/jbc.275.21.16091; Bogdanov AA, 2012, THERANOSTICS, V2, P553, DOI 10.7150/thno.4070; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Booth C, 2012, HEALTH PHYS, V103, P400, DOI 10.1097/HP.0b013e31826530e2; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929; Castillo GM, 2012, PHARM RES-DORDR, V29, P306, DOI 10.1007/s11095-011-0542-2; Cerutti A, 1997, BRIT J HAEMATOL, V99, P281, DOI 10.1046/j.1365-2141.1997.3823196.x; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; Cuccurullo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151088; de Groot MJM, 1999, CARDIOVASC RES, V44, P315, DOI 10.1016/S0008-6363(99)00199-6; Dorr W, 2002, CELL PROLIFERAT, V35, P86, DOI 10.1046/j.1365-2184.35.s1.9.x; Dorr W, 2001, INT J RADIAT BIOL, V77, P341, DOI 10.1080/09553000010018873; Dorr W, 2005, RADIOTHER ONCOL, V75, P99, DOI 10.1016/j.radonc.2004.12.006; Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068; Farrell CL, 2002, CELL PROLIFERAT, V35, P78, DOI 10.1046/j.1365-2184.35.s1.8.x; Farrell CL, 1998, CANCER RES, V58, P933; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Gomez-De-Segura IA, 1998, ACTA ONCOL, V37, P179, DOI 10.1080/028418698429748; HENDRY JH, 1983, RADIAT RES, V96, P100, DOI 10.2307/3576169; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Hsu E, 2006, PROTEIN ENG DES SEL, V19, P147, DOI 10.1093/protein/gzj013; Jilma-Stohlawetz P, 2001, J LAB CLIN MED, V137, P64, DOI 10.1067/mlc.2001.111468; Jones JW, 2015, HEALTH PHYS, V109, P452, DOI 10.1097/HP.0000000000000346; Jones JW, 2015, HEALTH PHYS, V109, P440, DOI 10.1097/HP.0000000000000347; Kabirov KK, 2015, 61 ANN M RAD RES SOC; Katoh M, 2006, INT J ONCOL, V29, P163; KONISHI H, 1995, J CLIN INVEST, V96, P1125, DOI 10.1172/JCI118099; Kosaka N, 2009, DEV DYNAM, V238, P265, DOI 10.1002/dvdy.21699; Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Lutgens LCHW, 2003, INT J RADIAT ONCOL, V57, P1067, DOI 10.1016/S0360-3016(03)00781-8; Lutgens L, 2007, WORLD J GASTROENTERO, V13, P3033, DOI 10.3748/wjg.v13.i22.3033; MacDonald KPA, 2002, CURR PHARM DESIGN, V8, P395, DOI 10.2174/1381612023396104; Maj JG, 2003, CANCER RES, V63, P4338; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Matthews MAB, 2013, J PEDIATR SURG, V48, P1316, DOI 10.1016/j.jpedsurg.2013.03.030; Niewold TA, 2004, RES VET SCI, V77, P89, DOI 10.1016/j.rvsc.2004.02.006; Nomura S, 1997, EXP HEMATOL, V25, P565; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Potten CS, 2002, CELL PROLIFERAT, V35, P32, DOI 10.1046/j.1365-2184.35.s1.4.x; Radtke Michelle L, 2005, J Oncol Pharm Pract, V11, P121, DOI 10.1191/1078155205jp159oa; Reichstetter S, 2012, PHARM RES IN PRESS; Reichstetter S, 2012, PHARM RES-DORDR, V29, P1033, DOI 10.1007/s11095-011-0646-8; Sasaki H, 2004, ONCOGENE, V23, P3681, DOI 10.1038/sj.onc.1207348; Sorg H, 2013, MED RES REV, V33, P637, DOI 10.1002/med.21259; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Sung C, 2002, AAPS PHARMSCI, V4; Takahama Y, 1999, ONCOGENE, V18, P5943, DOI 10.1038/sj.onc.1203171; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; Thiagarajah JR, 2000, GUT, V47, P675, DOI 10.1136/gut.47.5.675; Vigneulle RM, 2002, DIGEST DIS SCI, V47, P1480, DOI 10.1023/A:1015846514471; Wuechner C, 1996, INT J DEV BIOL, V40, P1185; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zakynthinos SG, 2004, CRIT CARE MED, V32, P1004, DOI 10.1097/01.CCM.0000121433.61546.A0; Zhang JA, 2010, J INTERF CYTOK RES, V30, P465, DOI 10.1089/jir.2009.0062; Zhang LR, 2010, INT J RADIAT ONCOL, V77, P261, DOI 10.1016/j.ijrobp.2009.11.026; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	69	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171703	10.1371/journal.pone.0171703	http://dx.doi.org/10.1371/journal.pone.0171703			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207794	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500048
J	Huang, XW; Zhang, HH; Yu, PQ				Huang, Xuewei; Zhang, Huihua; Yu, Peiqiang			Structural changes on a molecular basis of canola meal by conditioning temperature and time during pelleting process in relation to physiochemical (energy and protein) properties relevant to ruminants	PLOS ONE			English	Article							DRIED DISTILLERS GRAINS; RUMEN DEGRADATION KINETICS; COMMON PRAIRIE FEEDS; CLUSTER-ANALYSIS CLA; HORDEUM-VULGARE L.; DAIRY-CATTLE; METABOLIC CHARACTERISTICS; HULLESS BARLEY; FTIR MICROSPECTROSCOPY; INTESTINAL AVAILABILITY	The objectives of this study were: (1) To investigate the effects of conditioning temperature (70, 80, 90 degrees regression study with model variables selection showed that the energy and protein profiles in pelleted co-products could be predicted with the protein molecular structure profiles. This approach provides us a relatively new way to estimate protein value in dairy cows based on internal protein molecular structure profile.C), time (30, 60 sec), and interaction (temperature x time) during the pelleting process on internal protein molecular structure changes of the co-products; (2) To identify differences in protein molecular structures among pellets that were processed under different conditions, and between unprocessed mash and pellets; 3) To quantify protein molecular structure changes in relation to predicted energy and protein utilization in dairy cows. The final goal of this program was to show how processing conditions changed internal feed structure on a molecular basis and how molecular structure changes induced by feed processing affected feed milk value in dairy cows. The hypothesis in this study was that processing-induced protein inherent structure changes affected energy and protein availability in dairy cattle and the sensitivity and response of protein internal structure to the different pelleting process conditions could be detected by advanced molecular spectroscopy. The protein molecular structures, amides I and II, amide I to II ratios, a-helix structure, beta-sheet structure, and alpha to beta structure ratios, were determined using the advanced vibrational molecular spectroscopy (ATR-FT/IR). The energy values were determined using NRC2001 summary approach in terms of total digestible nutrients, metabolizable and net energy for lactation. The protein and carbohydrate subfactions that are related to rumen degradation characteristics and rumen undegraded protein supply were determined using updated CNCPS system. The experiment design was a RCBD and the treatment design was a 3x2 factorial design. The results showed that pelleting induced changes in protein molecular structure. The sensitivity and response of protein inherent structure to the pelleting depended on the conditioning temperature and time. The protein molecular structure changes were correlated (P < 0.05) with energy values and protein subfractions of the pelleted co-product. The results indicated that the protein internal molecular structure had significant roles in determining energy and protein nutritive values in dairy cows. Multiregression study with model variables selection showed that the energy and protein profiles in pelleted co-products could be predicted with the protein molecular structure profiles. This approach provides us a relatively new way to estimate protein value in dairy cows based on internal protein molecular structure profile.	[Huang, Xuewei; Yu, Peiqiang] Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK, Canada; [Zhang, Huihua; Yu, Peiqiang] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China	University of Saskatchewan; Foshan University	Yu, PQ (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK, Canada.; Yu, PQ (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.	peiqiang.yu@usask.ca	weixian, zhang/H-4046-2013	weixian, zhang/0000-0002-0250-4013	Natural Sciences and Engineering Research Council of Canada (NSERC- Individual Discovery Grant, Canadian federal government); Ministry of Agriculture Strategic Research Chair Program; Saskatchewan Agricultural Development Fund (ADF)	Natural Sciences and Engineering Research Council of Canada (NSERC- Individual Discovery Grant, Canadian federal government); Ministry of Agriculture Strategic Research Chair Program; Saskatchewan Agricultural Development Fund (ADF)	This research has been supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC- Individual Discovery Grant, Canadian federal government), the Ministry of Agriculture Strategic Research Chair Program, and the Saskatchewan Agricultural Development Fund (ADF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekara S, 2013, J DAIRY SCI, V96, P6631, DOI 10.3168/jds.2013-6841; Abeysekara S, 2012, SPECTROCHIM ACTA A, V90, P63, DOI 10.1016/j.saa.2011.12.045; Becker PM, 2013, MOL NUTR FOOD RES, V57, P1695, DOI 10.1002/mnfr.201200592; Damiran D, 2011, J DAIRY SCI, V94, P5151, DOI 10.3168/jds.2011-4564; Doiron K, 2009, J DAIRY SCI, V92, P3319, DOI 10.3168/jds.2008-1946; Gamage IH, 2013, J DAIRY SCI, V96, P5908, DOI 10.3168/jds.2012-6105; Gamage IH, 2012, J DAIRY SCI, V95, P6695, DOI 10.3168/jds.2012-5685; Heendeniya RG, 2012, J DAIRY SCI, V95, P4488, DOI 10.3168/jds.2011-5029; Huang XW, 2015, J DAIRY SCI, V98, P8836, DOI 10.3168/jds.2014-9295; Huang XW, 2015, J DAIRY SCI, V98, P4869, DOI 10.3168/jds.2014-9290; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Liu B, 2012, J AGR FOOD CHEM, V60, P10064, DOI 10.1021/jf302382b; Liu N, 2011, J CEREAL SCI, V53, P379, DOI 10.1016/j.jcs.2011.02.011; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Newkirk R, 2009, CANOLA CHEM PRODUCTI, P229; Nuez-Ortin WG, 2010, J DAIRY SCI, V93, P3775, DOI 10.3168/jds.2010-3143; Peng QH, 2014, ANIM FEED SCI TECH, V194, P58, DOI 10.1016/j.anifeedsci.2014.05.004; Peng QH, 2014, SPECTROCHIM ACTA A, V121, P14, DOI 10.1016/j.saa.2013.10.029; Peng QH, 2014, J DAIRY SCI, V97, P446, DOI 10.3168/jds.2013-7298; ROE MB, 1990, PROCEEDINGS 1990 : CORNELL NUTRITION CONFERENCE FOR FEED MANUFACTURERS, P81; Samadi, 2013, SPECTROCHIM ACTA A, V105, P304, DOI 10.1016/j.saa.2012.11.096; Samadi, 2011, J DAIRY SCI, V94, P6092, DOI 10.3168/jds.2011-4619; SMITH B. C., 2011, FUNDAMENTALS FOURIER; Theodoridou K, 2013, J AGR FOOD CHEM, V61, P5449, DOI 10.1021/jf400301y; Theodoridou K, 2013, J AGR FOOD CHEM, V61, P2820, DOI 10.1021/jf305171z; Thomas M, 1996, ANIM FEED SCI TECH, V61, P89, DOI 10.1016/0377-8401(96)00949-2; Van Amburgh ME, UPDATING CNCPS FEED; Van Amburgh ME, P CORN NUTR C FEED M; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wetzel DL, 1998, CELL MOL BIOL, V44, P145; Xin HS, 2013, J AGR FOOD CHEM, V61, P10118, DOI 10.1021/jf4020763; Xin HS, 2013, SPECTROCHIM ACTA A, V112, P318, DOI 10.1016/j.saa.2013.04.073; Xin HS, 2013, J AGR FOOD CHEM, V61, P3926, DOI 10.1021/jf400028n; Yang L, 2014, J CEREAL SCI, V60, P48, DOI 10.1016/j.jcs.2013.12.013; Yang L, 2013, J AGR FOOD CHEM, V61, P11250, DOI 10.1021/jf403196z; Yu P, 2004, BRIT J NUTR, V92, P869, DOI 10.1079/BJN20041298; Yu P, 2012, J DAIRY SCI, V95, P2091, DOI 10.3168/jds.2011-4885; Yu PQ, 2008, J AGR FOOD CHEM, V56, P3417, DOI 10.1021/jf800015x; Yu PQ, 2006, SPECTROSC-INT J, V20, P229, DOI 10.1155/2006/263634; Yu PQ, 2010, BRIT J NUTR, V104, P1429, DOI 10.1017/S0007114510002539; Yu PQ, 2008, CAN J ANAL SCI SPECT, V53, P220; Yu PQ, 2005, BRIT J NUTR, V94, P655, DOI 10.1079/BJN20051532; Yu PQ, 2005, J AGR FOOD CHEM, V53, P7115, DOI 10.1021/jf050959b; Yu PQ, 2005, J AGR FOOD CHEM, V53, P2872, DOI 10.1021/jf0479564; Yu PQ, 2004, J AGR FOOD CHEM, V52, P7353, DOI 10.1021/jf0490955; Zhang X, 2012, J DAIRY SCI, V95, P3363, DOI 10.3168/jds.2011-5308; Zhang XW, 2012, J DAIRY SCI, V95, P6624, DOI 10.3168/jds.2012-5450; Zhang XW, 2012, SPECTROCHIM ACTA A, V95, P53, DOI 10.1016/j.saa.2012.04.022	49	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170173	10.1371/journal.pone.0170173	http://dx.doi.org/10.1371/journal.pone.0170173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207756	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500007
J	Feng, ZY; Min, XD; Margolis, DJA; Duan, CH; Chen, YP; Sah, VK; Chaudhary, N; Li, BS; Ke, Z; Zhang, PP; Wang, L				Feng, Zhaoyan; Min, Xiangde; Margolis, Daniel J. A.; Duan, Caohui; Chen, Yuping; Sah, Vivek Kumar; Chaudhary, Nabin; Li, Basen; Ke, Zan; Zhang, Peipei; Wang, Liang			Evaluation of different mathematical models and different b-value ranges of diffusion weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm(2)	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; MULTIPARAMETRIC MRI; DIAGNOSIS; AGGRESSIVENESS; REPEATABILITY; SPECTROSCOPY; TISSUES	Objectives To evaluate the diagnostic performance of different mathematical models and different b value ranges of diffusion-weighted imaging (DWI) in peripheral zone prostate cancer (PZ PCa) detection. Methods Fifty-six patients with histologically proven PZ PCa who underwent DWI-magnetic resonance imaging (MRI) using 21 b-values (0-4500 s/mm(2)) were included. The mean signal intensities of the regions of interest (ROls) placed in benign PZs and cancerous tissues on DWI images were fitted using mono-exponential, bi-exponential, stretched-exponential, and kurtosis models. The b -values were divided into four ranges: 0-1000, 0-2000, 0-3200, and 0-4500 s/mm2, grouped as A, B, C, and D, respectively. ADC, <D>, D*, f, DDC, a, D-app, and K-app were estimated for each group. The adjusted coefficient of determination (R-2) was calculated to measure goodness-of-fit. Receiver operating characteristic curve analysis was performed to evaluate the diagnostic performance of the parameters. Results All parameters except D* showed significant differences between cancerous tissues and benign PZs in each group. The area under the curve values (AUCs) of ADC were comparable in groups C and D (p = 0.980) and were significantly higher than those in groups A and B (p<0.05 for all). The AUCs of ADC and Kapp in groups B and C were similar (p = 0.07 and p = 0.954), and were significantly higher than the other parameters (p<0.001 for all). The AUCs of ADC in group D was slightly higher than Kapp (p = 0.002), and both were significantly higher than the other parameters (p<0.001 for all). Conclusions ADC derived from conventional mono-exponential high b-value (3200 s/mm(2)) models is an optimal parameter for PZ PCa detection.	[Feng, Zhaoyan; Min, Xiangde; Sah, Vivek Kumar; Chaudhary, Nabin; Li, Basen; Ke, Zan; Zhang, Peipei; Wang, Liang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Margolis, Daniel J. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Ronald Reagan UCLA Med Ctr, Los Angeles, CA 90095 USA; [Duan, Caohui] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Natl Ctr Magnet Resonance,Wuhan Wuhan Inst Phys &, Wuhan, Hubei, Peoples R China; [Chen, Yuping] Univ Sci & Technol China, Ctr Biomed Engn, Hefei, Anhui, Peoples R China	Huazhong University of Science & Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ronald Reagan UCLA Medical Center; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	wang6@tjh.tjmu.edu.cn		Min, Xiangde/0000-0002-1589-6861				Bai Y, 2016, RADIOLOGY, V278, P496, DOI 10.1148/radiol.2015142173; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bourne R, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6020021; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fusco R, 2016, MAGN RESON IMAGING, V34, P839, DOI 10.1016/j.mri.2016.04.001; Futterer JJ, 2015, EUR UROL, V68, P1045, DOI 10.1016/j.eururo.2015.01.013; Han CK, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150220; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Jambor I, 2015, MAGN RESON MED, V73, P1988, DOI 10.1002/mrm.25323; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kitajima Kazuhiro, 2008, Magn Reson Med Sci, V7, P93, DOI 10.2463/mrms.7.93; Kobus T, 2012, RADIOLOGY, V265, P457, DOI 10.1148/radiol.12111744; Li B, 2013, J MAGN RESON IMAGING, V37, P194, DOI 10.1002/jmri.23809; Liu XH, 2015, J MAGN RESON IMAGING, V42, P1078, DOI 10.1002/jmri.24872; Mazzoni LN, 2014, J MAGN RESON IMAGING, V39, P512, DOI 10.1002/jmri.24184; Merisaari H, 2016, MAGN RESON MED; Merisaari H, 2015, MAGN RESON IMAGING, V33, P1212, DOI 10.1016/j.mri.2015.07.004; Merisaari H, 2015, MAGN RESON MED, V73, P1954, DOI 10.1002/mrm.25310; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Peng YH, 2013, RADIOLOGY, V267, P787, DOI 10.1148/radiol.13121454; Quentin M, 2012, MAGN RESON IMAGING, V30, P1468, DOI 10.1016/j.mri.2012.04.025; Riva-Amarante E, 2011, NEUROLOGIA, V26, P331, DOI 10.1016/j.nrl.2010.12.003; Roethke MC, 2015, INVEST RADIOL, V50, P483, DOI 10.1097/RLI.0000000000000155; Rosenkrantz AB, 2015, J MAGN RESON IMAGING; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Shinmoto H, 2012, AM J ROENTGENOL, V199, pW496, DOI 10.2214/AJR.11.8347; Tamada T, 2011, AM J ROENTGENOL, V197, P664, DOI 10.2214/AJR.10.5923; Taouli B, 2016, J MAGNETIC RESONANCE; Thormer G, 2012, EUR RADIOL, V22, P1820, DOI 10.1007/s00330-012-2432-3; Toivonen J, 2014, MAGNETIC RESONANCE M; Valerio M, 2016, EUR J RADIOL, V85, P790, DOI 10.1016/j.ejrad.2016.01.006; Vargas HA, 2012, RADIOLOGY, V262, P26, DOI 10.1148/radiol.11101996; Weinreb J, 2015, PI RADS PROSTATE IMA; Winfield JM, 2016, EUROPEAN RADIOLOGY; Zhang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151176	35	19	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172127	10.1371/journal.pone.0172127	http://dx.doi.org/10.1371/journal.pone.0172127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199367	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400073
J	Fruzangohar, M; Ebrahimie, E; Adelson, DL				Fruzangohar, Mario; Ebrahimie, Esmaeil; Adelson, David L.			A novel hypothesis-unbiased method for Gene Ontology enrichment based on transcriptome data	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; INTERLEUKIN-1; MOTILITY; VIRULENCE; DEFICITS; SYSTEM; INJURY; TOOL	Gene Ontology (GO) classification of statistically significantly differentially expressed genes is commonly used to interpret transcriptomics data as a part of functional genomic analysis. In this approach, all significantly expressed genes contribute equally to the final GO classification regardless of their actual expression levels. Gene expression levels can significantly affect protein production and hence should be reflected in GO term enrichment. Genes with low expression levels can also participate in GO term enrichment through cumulative effects. In this report, we have introduced a new GO enrichment method that is suitable for multiple samples and time series experiments that uses a statistical outlier test to detect GO categories with special patterns of variation that can potentially identify candidate biological mechanisms. To demonstrate the value of our approach, we have performed two case studies. Whole transcriptome expression profiles of Salmonella enteritidis and Alzheimer's disease (AD) were analysed in order to determine GO term enrichment across the entire transcriptome instead of a subset of differentially expressed genes used in traditional GO analysis. Our result highlights the key role of inflammation related functional groups in AD pathology as granulocyte colony-stimulating factor receptor binding, neuromedin U binding, and interleukin were remarkably upregulated in AD brain when all using all of the gene expression data in the transcriptome. Mitochondrial components and the molybdopterin synthase complex were identified as potential key cellular components involved in AD pathology.	[Fruzangohar, Mario; Adelson, David L.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Fruzangohar, Mario] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Med, Fac Hlth Sci, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ South Australia, Sch Informat Technol & Math Sci, Div Informat Technol Engn & Environm, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA, Australia; [Adelson, David L.] Univ Adelaide, Zhendong Australia, China Ctr Mol Chinese Med, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; University of South Australia; Flinders University South Australia; University of Adelaide	Fruzangohar, M; Adelson, DL (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Fruzangohar, M (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.; Adelson, DL (corresponding author), Univ Adelaide, Zhendong Australia, China Ctr Mol Chinese Med, Adelaide, SA, Australia.	mario.fruzangohar@adelaide.edu.au; david.adelson@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021; Adelson, David L/E-5506-2011	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Adelson, David L/0000-0003-2404-5636	PhD divisional scholarship of The University of Adelaide; NHMRC in the Alzheimer's Disease Genetics Laboratory, School of Biological Sciences [APP1061006]; Nectar; Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)	PhD divisional scholarship of The University of Adelaide; NHMRC in the Alzheimer's Disease Genetics Laboratory, School of Biological Sciences(National Health and Medical Research Council (NHMRC) of Australia); Nectar; Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	MF was supported by PhD divisional scholarship of The University of Adelaide. EE was partially supported by NHMRC APP1061006 in the Alzheimer's Disease Genetics Laboratory, School of Biological Sciences. We acknowledge funding from Nectar to host the web and database server of this study. Nectar is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS, V2008; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Franzen R, 2004, NEUROSCI LETT, V361, P76, DOI 10.1016/j.neulet.2003.12.018; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Garlind A, 1999, BRAIN RES, V826, P112, DOI 10.1016/S0006-8993(99)01092-6; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Laske C, 2015, ALZHEIMERS DEMENT, V11, P465, DOI 10.1016/j.jalz.2014.06.003; Ling H, 2010, BIOCHEM BIOPH RES CO, V401, P521, DOI 10.1016/j.bbrc.2010.09.080; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Shah DH, 2013, APPL ENV MICROBIOLOG; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Szklarczyk D, 2010, NUCLEIC ACIDS RES; Talamo BR, 1989, PATHOLOGICAL CHANGES; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Team RC, 2005, R LANG ENV STAT COMP; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006	37	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170486	10.1371/journal.pone.0170486	http://dx.doi.org/10.1371/journal.pone.0170486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199395	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000394424400015
J	Urrecha, M; Romero, I; DeFelipe, J; Merchan-Perez, A				Urrecha, Miguel; Romero, Ignacio; DeFelipe, Javier; Merchan-Perez, Angel			Influence of cerebral blood vessel movements on the position of perivascular synapses	PLOS ONE			English	Article							NEURONAL-ACTIVITY; BRAIN; CORTEX; FLOW; MICROVESSELS; MICROSCOPY; NEOCORTEX	Synaptic activity is regulated and limited by blood flow, which is controlled by blood vessel dilation and contraction. Traditionally, the study of neurovascular coupling has mainly focused on energy consumption and oxygen delivery. However, the mechanical changes that blood vessel movements induce in the surrounding tissue have not been considered. We have modeled the mechanical changes that movements of blood vessels cause in neighboring synapses. Our simulations indicate that synaptic densities increase or decrease during vascular dilation and contraction, respectively, near the blood vessel walls. This phenomenon may alter the concentration of neurotransmitters and vasoactive substances in the immediate vicinity of the vessel wall and thus may have an influence on local blood flow.	[Urrecha, Miguel; Romero, Ignacio] Univ Politecn Madrid, Dept Mech Engn, Madrid, Spain; [Romero, Ignacio] IMDEA Mat Inst, Madrid, Spain; [DeFelipe, Javier; Merchan-Perez, Angel] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain; [Merchan-Perez, Angel] Univ Politecn Madrid, Dept Arquitectura & Tecnol Sistemas Informat, Madrid, Spain	Universidad Politecnica de Madrid; IMDEA Materials Institute; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad Politecnica de Madrid	Merchan-Perez, A (corresponding author), Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain.; Merchan-Perez, A (corresponding author), Univ Politecn Madrid, Dept Arquitectura & Tecnol Sistemas Informat, Madrid, Spain.	amerchan@fi.upm.es	Romero, Ignacio/H-2129-2015; Merchan-Perez, Angel/D-7417-2014; Merchan-Perez, Angel/AAY-8947-2020; DEFELIPE, JAVIER/D-1195-2014	Romero, Ignacio/0000-0003-0364-6969; Merchan-Perez, Angel/0000-0002-7228-5821; Merchan-Perez, Angel/0000-0002-7228-5821; DEFELIPE, JAVIER/0000-0001-5484-0660	Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain) [CB06/05/0066]; Spanish Ministerio de Economia y Competitividad [BFU2012-34963]; Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; European Union Seventh Framework Programme (FP7) [604102]; European Union Horizon research and innovation programme [720270]	Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain); Spanish Ministerio de Economia y Competitividad(Spanish Government); Cajal Blue Brain Project, Spanish partner of the Blue Brain Project initiative from EPFL; European Union Seventh Framework Programme (FP7); European Union Horizon research and innovation programme	This work was supported by grants from the following entities: Centro de Investigacion en Red sobre Enfermedades Neurodegenerativas (CIBERNED, CB06/05/0066, Spain, https://www.ciberned.es/); the Spanish Ministerio de Economia y Competitividad (grant BFU2012-34963, http://www.mineco.gob.es/) and the Cajal Blue Brain Project, (http://cajalbbp.cesvima.upm.es/), Spanish partner of the Blue Brain Project initiative from EPFL); the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 604102 (Human Brain Project) and the European Union Horizon 2020 research and innovation programme under grant agreement No. 720270 (Human Brain Project, https://www.humanbrainproject.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2015, CEREB CORTEX, V25, P3673, DOI 10.1093/cercor/bhu221; Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Anton-Sanchez L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00085; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Dalkara T, 2015, BRAIN RES; Estrada C, 1998, CEREB CORTEX, V8, P193, DOI 10.1093/cercor/8.3.193; Fergus A, 1997, BRAIN RES, V754, P35, DOI 10.1016/S0006-8993(97)00040-1; Filosa JA, 2015, NEUROSCIENCE; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Gagnon L, 2015, J NEUROSCI, V35, P3663, DOI 10.1523/JNEUROSCI.3555-14.2015; Gao YR, 2015, NEUROIMAGE, V115, P162, DOI 10.1016/j.neuroimage.2015.04.054; Hotta H, 2016, PROG BRAIN RES, V225, P3, DOI 10.1016/bs.pbr.2016.03.001; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Hughes T.J.R, 1987, FINITE ELEMENT METHO, P311; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Merchan-Perez A, 2014, CEREB CORTEX, V24, P1579, DOI 10.1093/cercor/bht018; Munoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Slaughter W.S., 2002, LINEARIZED THEORY EL, P331; Srinivasan VJ, 2014, NEUROIMAGE, V102, P393, DOI 10.1016/j.neuroimage.2014.08.004; Wu JP, 2016, CEREB CORTEX, V26, P23, DOI 10.1093/cercor/bhu166; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172368	10.1371/journal.pone.0172368	http://dx.doi.org/10.1371/journal.pone.0172368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199396	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400089
J	Gao, XL; Hicks, KC; Neumann, P; Patel, TB				Gao, Xianlong; Hicks, Kristin C.; Neumann, Paul; Patel, Tarun B.			Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein	PLOS ONE			English	Article							DE-NOVO METHYLATION; CANDIDATE TUMOR-SUPPRESSOR; DNA-METHYLTRANSFERASE; PROGNOSTIC-SIGNIFICANCE; CELL-PROLIFERATION; DOWN-REGULATION; KINASE PATHWAY; UP-REGULATION; GROWTH; INHIBITOR	Receptor Tyrosine Kinase (RTK) signaling plays a major role in tumorigenesis and normal development. Sprouty2 (Spry2) attenuates RTK signaling and inhibits processes such as angiogenesis, cell proliferation, migration and survival, which are all upregulated in tumors. Indeed in cancers of the liver, lung, prostate and breast, Spry2 protein levels are markedly decreased correlating with poor patient prognosis and shorter survival. Thus, it is important to understand how expression of Spry2 is regulated. While prior studies have focused on the post-translation regulation of Spry2, very few studies have focused on the transcriptional regulation of SPRY2 gene. Here, we demonstrate that in the human hepatoma cell line, Hep3B, the transcription of SPRY2 is inhibited by the transcription regulating hypoxia inducible factors (HIFs). HIFs are composed of an oxygen regulated alpha subunit (HIF1 alpha or HIF2 alpha) and a beta subunit (HIF1 beta). Intriguingly, silencing of HIF1 alpha and HIF2 alpha elevates SPRY2 mRNA and protein levels suggesting HIFs reduce the transcription of the SPRY2 promoter. In silico analysis identified ten hypoxia response elements (HREs) in the proximal promoter and first intron of SPRY2. Using chromatin immunoprecipitation (ChIP), we show that HIF1 alpha/2 alpha bind near the putative HREs in the proximal promoter and intron of SPRY2. Our studies demonstrated that not only is the SPRY2 promoter methylated, but silencing HIF1 alpha/2 alpha reduced the methylation. ChIP assays also showed DNA methyltransferase1 (DNMT1) binding to the proximal promoter and first intron of SPRY2 and silencing HIF1 alpha/2 alpha decreased this association. Additionally, silencing of DNMT1 mimicked the HIF1 alpha/2 alpha silencing-mediated increase in SPRY2 mRNA and protein. While simultaneous silencing of HIF1 alpha/2 alpha and DNMT1 increased SPRY2 mRNA a little more, the increase was not additive suggesting a common mechanism by which DNMT1 and HIF1 alpha/2 alpha regulate SPRY2 transcription. Together these data suggest that the transcription of SPRY2 is inhibited by HIFs, in part, via DNMT1-mediated methylation.	[Gao, Xianlong] Loyola Univ, Dept Surg, Chicago, IL 60611 USA; [Hicks, Kristin C.; Neumann, Paul; Patel, Tarun B.] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA	Loyola University Chicago; Albany College of Pharmacy & Health Sciences	Patel, TB (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA.	Tarun.patel@acphs.edu		Hicks, Kristin/0000-0001-9192-875X				Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MOL CELL NEUROSCI, V15, P22, DOI 10.1006/mcne.1999.0801; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; De Bonis ML, 2006, HUM MOL GENET, V15, P1123, DOI 10.1093/hmg/ddl027; Denko N, 2003, J BIOL CHEM, V278, P5744, DOI 10.1074/jbc.M212534200; Ding W, 2003, GENE, V322, P175, DOI 10.1016/j.gene.2003.09.004; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haigl B, 2010, BIOL CHEM, V391, P813, DOI 10.1515/BC.2010.082; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hicks KC, 2016, J BIOL CHEM, V291, P16787, DOI 10.1074/jbc.M116.714139; Hubbi ME, 2015, AM J PHYSIOL-CELL PH, V309, pC775, DOI 10.1152/ajpcell.00279.2015; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; ISSA JPJ, 1993, J NATL CANCER I, V85, P1235, DOI 10.1093/jnci/85.15.1235; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10366, DOI 10.1073/pnas.93.19.10366; Lee SJ, 2010, MOL CELL BIOCHEM, V338, P255, DOI 10.1007/s11010-009-0359-z; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Lin W, 2005, GENESIS, V41, P110, DOI 10.1002/gene.20103; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Mastrogiannaki M, 2011, HAEMATOLOGICA; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mirabello L, 2012, INT J MOL EPIDEMIOL, V3, P213; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ordonez-Moran P, 2014, ONCOGENE, V33, P1975, DOI 10.1038/onc.2013.140; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Pradhan S, 1997, NUCLEIC ACIDS RES, V25, P4666, DOI 10.1093/nar/25.22.4666; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Reich A, 1999, DEVELOPMENT, V126, P4139; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Ryu K, 2011, BIOCHEM BIOPH RES CO, V407, P831, DOI 10.1016/j.bbrc.2011.03.119; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sirivatanauksorn Y, 2012, J SURG ONCOL, V105, P273, DOI 10.1002/jso.22095; Song K, 2012, HEPATOB PANCREAT DIS, V11, P177, DOI 10.1016/S1499-3872(12)60145-3; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Tanimoto Kousuke, 2010, Hugo J, V4, P35, DOI 10.1007/s11568-011-9150-9; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wietecha MS, 2011, AM J PHYSIOL-HEART C, V300, pH459, DOI 10.1152/ajpheart.00244.2010; Wigerup C, 2016, PHARMACOL THERAPEUT, V164, P152, DOI 10.1016/j.pharmthera.2016.04.009; WU JC, 1987, J BIOL CHEM, V262, P4778; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	91	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171616	10.1371/journal.pone.0171616	http://dx.doi.org/10.1371/journal.pone.0171616			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196140	Green Submitted, gold, Green Published			2022-12-26	WOS:000394423900025
J	ten Broeke, GA; van Voorn, GAK; Ligtenberg, A; Molenaar, J				ten Broeke, Guus A.; van Voorn, George A. K.; Ligtenberg, Arend; Molenaar, Jaap			Resilience through adaptation	PLOS ONE			English	Article							SOCIAL-ECOLOGICAL SYSTEMS; COMPLEX ADAPTIVE SYSTEMS; AGENT-BASED MODEL; SENSITIVITY-ANALYSIS; PERSPECTIVE; EMERGENCE	Adaptation of agents through learning or evolution is an important component of the resilience of Complex Adaptive Systems (CAS). Without adaptation, the flexibility of such systems to cope with outside pressures would be much lower. To study the capabilities of CAS to adapt, social simulations with agent-based models (ABMs) provide a helpful tool. However, the value of ABMs for studying adaptation depends on the availability of methodologies for sensitivity analysis that can quantify resilience and adaptation in ABMs. In this paper we propose a sensitivity analysis methodology that is based on comparing time-dependent probability density functions of output of ABMs with and without agent adaptation. The differences between the probability density functions are quantified by the socalled earth-mover's distance. We use this sensitivity analysis methodology to quantify the probability of occurrence of critical transitions and other long-term effects of agent adaptation. To test the potential of this new approach, it is used to analyse the resilience of an ABM of adaptive agents competing for a common-pool resource. Adaptation is shown to contribute positively to the resilience of this ABM. If adaptation proceeds sufficiently fast, it may delay or avert the collapse of this system.	[ten Broeke, Guus A.; van Voorn, George A. K.; Molenaar, Jaap] Wageningen Univ & Res, Biometris, Wageningen, Netherlands; [Ligtenberg, Arend] Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	ten Broeke, GA (corresponding author), Wageningen Univ & Res, Biometris, Wageningen, Netherlands.	guus.tenbroeke@wur.nl	ligtenberg, arend/L-4267-2019	ligtenberg, arend/0000-0002-2093-7947; ten Broeke, Guus/0000-0002-9956-7415	IO/OP theme Complex Adaptive Systems at Wageningen University Research	IO/OP theme Complex Adaptive Systems at Wageningen University Research	There search by GTB is funded by the IO/OP theme Complex Adaptive Systems at Wageningen University & Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SOLUTIONS; [Anonymous], 2011, RANDOM DATA ANAL MEA; Arthur WB, 2006, HANDB ECON, V13, P1551; Aubert-Kato N, 2015, ECAL 2015: THE THIRTEENTH EUROPEAN CONFERENCE ON ARTIFICIAL LIFE, P357, DOI 10.7551/978-0-262-33027-5-ch065; Auder B, 2009, SAFETY, RELIABILITY AND RISK ANALYSIS: THEORY, METHODS AND APPLICATIONS, VOLS 1-4, P2107; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Borgonovo E, 2007, RELIAB ENG SYST SAFE, V92, P771, DOI 10.1016/j.ress.2006.04.015; Broeke Ten GA, 2016, J ARTIF SOC SOC SIMU, V19; Burtsev M, 2006, NATURE, V440, P1041, DOI 10.1038/nature04470; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Colon C, 2015, ECOL MODEL, V317, P93, DOI 10.1016/j.ecolmodel.2015.09.004; Crooks A, 2008, COMPUT ENVIRON URBAN, V32, P417, DOI 10.1016/j.compenvurbsys.2008.09.004; Filatova T, 2013, ENVIRON MODELL SOFTW, V45, P1, DOI 10.1016/j.envsoft.2013.03.017; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Froncek P, 2015, JASSS-J ARTIF SOC S, V18, DOI 10.18564/jasss.2949; GELLMANN M, 1994, SFI S SCI C, V19, P17; Grazzini J, 2015, J ECON DYN CONTROL, V51, P148, DOI 10.1016/j.jedc.2014.10.006; Grazzini J, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.1929; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Holland J. H., 2006, Journal of Systems Science and Complexity, V19, P1, DOI 10.1007/s11424-006-0001-z; Holland JH, 1992, COMPLEX ADAPTIVE SYS, P17; Janssen MA, 1999, CONSERV ECOL, V3, P15; LEE JS, 2015, JASSS J ARTIF SOC S, V18; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Levin S, 2013, ENVIRON DEV ECON, V18, P111, DOI 10.1017/S1355770X12000460; Ling H, 2007, IEEE T PATTERN ANAL, V29, P840, DOI 10.1109/TPAMI.2007.1058; Liu HB, 2006, J MECH DESIGN, V128, P326, DOI 10.1115/1.2159025; Macal CM, 2016, J SIMUL, V10, P144, DOI 10.1057/jos.2016.7; Nelson BL, 2016, J SIMUL, V10, P2, DOI 10.1057/jos.2015.22; Nelson DR, 2011, WIRES CLIM CHANGE, V2, P113, DOI 10.1002/wcc.91; Rammel C, 2007, ECOL ECON, V63, P9, DOI 10.1016/j.ecolecon.2006.12.014; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Schluter M, 2007, ECOL SOC, V12; Schouten M, 2013, LAND USE POLICY, V30, P934, DOI 10.1016/j.landusepol.2012.06.008; ten Broeke GA, 2016, MATH MODEL NAT PHENO, V11, P47, DOI 10.1051/mmnp/201611405; The Resilience Alliance, 2010, ASSESSING RESILIENCE; Troitzsch K. G., 2014, ARTIFICIAL EC SELFOR, V669, P17; van Lith J, 2001, STUD HIST PHILOS M P, V32B, P581, DOI 10.1016/S1355-2198(01)00027-2; Venkatasubramanian Suresh, 2013, SIGACT News, V44, P56; Walker B, 2004, ECOL SOC, V9	41	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171833	10.1371/journal.pone.0171833	http://dx.doi.org/10.1371/journal.pone.0171833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196372	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900034
J	Burrell, LM; Gayed, D; Griggs, K; Patel, SK; Velkoska, E				Burrell, Louise M.; Gayed, Daniel; Griggs, Karen; Patel, Sheila K.; Velkoska, Elena			Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition	PLOS ONE			English	Article							COUPLED RECEPTOR MAS; CONVERTING-ENZYME; MYOCARDIAL-INFARCTION; EXPRESSION; FIBROSIS; HYPERTENSION; MOUSE; HEART; CARBOXYPEPTIDASE; TRANSFORMATION	We previously reported that exogenous angiotensin (Ang) 1-7 has adverse cardiac effects in experimental kidney failure due to its action to increase cardiac angiotensin converting enzyme (ACE) activity. This study investigated if the addition of an ACE inhibitor (ACEi) to Ang 1-7 infusion would unmask any beneficial effects of Ang 1-7 on the heart in experimental kidney failure. Male Sprague-Dawley rats underwent subtotal nephrectomy (STNx) and were treated with vehicle, the ACEi ramipril (oral 1mg/kg/day), Ang 1-7 (subcutaneous 24 lag/kg/h) or dual therapy (all groups, n = 12). A control group (n = 10) of sham-operated rats were also studied. STNx led to hypertension, renal impairment, cardiac hypertrophy and fibrosis, and increased both left ventricular ACE2 activity and ACE binding. STNx was not associated with changes in plasma levels of ACE, ACE2 or angiotensin peptides. Ramipril reduced blood pressure, improved cardiac hypertrophy and fibrosis and inhibited cardiac ACE. Ang 1-7 infusion increased blood pressure, cardiac interstitial fibrosis and cardiac ACE binding compared to untreated STNx rats. Although in STNx rats, the addition of ACEi to Ang 1-7 prevented any deleterious cardiac effects of Ang 1-7, a limitation of the study is that the large increase in plasma Ang 1-7 with ramipril may have masked any effect of infused Ang 1-7.	[Burrell, Louise M.; Gayed, Daniel; Griggs, Karen; Patel, Sheila K.; Velkoska, Elena] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Velkoska, E (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia.	velkoska@unimelb.edu.au			National Health and Medical Research Council of Australia [APP1048285]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding granted to EV from the National Health and Medical Research Council of Australia (APP1048285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzayadneh EM, 2014, CELL SIGNAL, V26, P3027, DOI 10.1016/j.cellsig.2014.09.010; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2006, AM J PHYSIOL-HEART C, V290, pH684, DOI 10.1152/ajpheart.00632.2005; Bi JL, 2013, J RENIN-ANGIO-ALDO S, V14, P290, DOI 10.1177/1470320312465217; Burgelova M, 2009, J HYPERTENS, V27, P1988, DOI 10.1097/HJH.0b013e32832f0d06; Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burns WC, 2010, AM J PHYSIOL-RENAL, V299, pF585, DOI 10.1152/ajprenal.00538.2009; Burrell LM, 2012, EXP PHYSIOL, V97, P477, DOI 10.1113/expphysiol.2011.063156; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Burrell LM, 2004, TRENDS ENDOCRIN MET, V15, P166, DOI 10.1016/j.tem.2004.03.001; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Ferrario CM, 2002, KIDNEY INT, V62, P1349, DOI 10.1111/j.1523-1755.2002.kid559.x; Fraga-Silva RA, 2014, THROMB HAEMOSTASIS, V111, P736, DOI 10.1160/TH13-06-0448; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Herath CB, 2007, J HEPATOL, V47, P387, DOI 10.1016/j.jhep.2007.03.008; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kim CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142664; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Liu EZ, 2010, REGUL PEPTIDES, V162, P73, DOI 10.1016/j.regpep.2009.12.020; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Papinska A.M., 2015, BR J PHARM; Papinska AM, 2016, PHARM RES; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Shi YX, 2015, CLIN SCI, V128, P649, DOI 10.1042/CS20140329; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Velez JCQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110083; Velez JCQ, 2009, NAT CLIN PRACT NEPHR, V5, P89, DOI 10.1038/ncpneph1015; Velkoska E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161760; Velkoska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118758; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Xu C, 2013, EURASIP J ADV SIG PR, V2013, P1, DOI DOI 10.1016/J.MFGLET.2013.09.003; Yamada K, 1998, HYPERTENSION, V32, P496, DOI 10.1161/01.HYP.32.3.496; Zimmerman DL, 2015, AM J PATHOL, V185, P729, DOI 10.1016/j.ajpath.2014.11.013	42	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171975	10.1371/journal.pone.0171975	http://dx.doi.org/10.1371/journal.pone.0171975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192475	Green Published, gold			2022-12-26	WOS:000394423800056
J	Yu, X; Zhang, XQ				Yu, Xiang; Zhang, Xueqing			Multiswarm comprehensive learning particle swarm optimization for solving multiobjective optimization problems	PLOS ONE			English	Article							EVOLUTIONARY ALGORITHMS; MULTIPLE OBJECTIVES; MOEA/D; DECOMPOSITION	Comprehensive learning particle swarm optimization (CLPSO) is a powerful state-of-the-art single-objective metaheuristic. Extending from CLPSO, this paper proposes multiswarm CLPSO (MSCLPSO) for multiobjective optimization. MSCLPSO involves multiple swarms, with each swarm associated with a separate original objective. Each particle's personal best position is determined just according to the corresponding single objective. Elitists are stored externally. MSCLPSO differs from existing multiobjective particle swarm optimizers in three aspects. First, each swarm focuses on optimizing the associated objective using CLPSO, without learning from the elitists or any other swarm. Second, mutation is applied to the elitists and the mutation strategy appropriately exploits the personal best positions and elitists. Third, a modified differential evolution (DE) strategy is applied to some extreme and least crowded elitists. The DE strategy updates an elitist based on the differences of the elitists. The personal best positions carry useful information about the Pareto set, and the mutation and DE strategies help MSCLPSO discover the true Pareto front. Experiments conducted on various benchmark problems demonstrate that MSCLPSO can find nondominated solutions distributed reasonably over the true Pareto front in a single run.	[Yu, Xiang] Nanchang Inst Technol, Prov Key Lab Water Informat Cooperat Sensing & In, Nanchang, Jiangxi, Peoples R China; [Zhang, Xueqing] Hong Kong Univ Sci & Technol, Dept Civil & Environm Engn, Hong Kong, Hong Kong, Peoples R China	Nanchang Institute Technology; Hong Kong University of Science & Technology	Yu, X (corresponding author), Nanchang Inst Technol, Prov Key Lab Water Informat Cooperat Sensing & In, Nanchang, Jiangxi, Peoples R China.	xiang.yu@nit.edu.cn	Zhang, Xueqing/ABC-3938-2020	Zhang, Xueqing/0000-0002-9397-1011	Jiangxi Province Department of Education Science and Technology Research Project [GJJ151099]; Public Benefit Special Research Fund of the Ministry of Water Resources of China [201201017]	Jiangxi Province Department of Education Science and Technology Research Project; Public Benefit Special Research Fund of the Ministry of Water Resources of China	This work was supported by the Jiangxi Province Department of Education Science and Technology Research Project (GJJ151099) and the Public Benefit Special Research Fund of the Ministry of Water Resources of China (201201017).	Ali H, 2013, APPL SOFT COMPUT, V13, P3903, DOI 10.1016/j.asoc.2013.04.015; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Bringmann K, INT S ALG COMP 2008, P436; Coello CAC, 2004, IEEE T EVOLUT COMPUT, V8, P256, DOI [10.1109/TEVC.2004.826067, 10.1109/tevc.2004.826067]; COHON JL, 1975, WATER RESOUR RES, V11, P208, DOI 10.1029/WR011i002p00208; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Eberhart R., 1995, INT S MICR HUM SCI; Fleischer M, 2003, INT C EV MULT OPT; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Gulcu S, 2015, ENG APPL ARTIF INTEL, V45, P33, DOI 10.1016/j.engappai.2015.06.013; Harrison KR, 2013, INT C EV MULT OPT; Horn J, 1994, IEEE C EV COMP; Huang VL, 2006, INT J INTELL SYST, V21, P209, DOI 10.1002/int.20128; Huband S, 2006, IEEE T EVOLUT COMPUT, V10, P477, DOI 10.1109/TEVC.2005.861417; Igel C, 2007, EVOL COMPUT, V15, P1, DOI 10.1162/evco.2007.15.1.1; Ke LJ, 2013, IEEE T CYBERNETICS, V43, P1845, DOI 10.1109/TSMCB.2012.2231860; Kennedy J., 1995, P ICNN 95 INT C NEUR; Knowles J, 1999, C EV COMP; Knowles JD, 2000, EVOL COMPUT, V8, P149, DOI 10.1162/106365600568167; Kukkonen S, INT C PAR PROBL SOLV, P553; Laumanns M, 2002, EVOL COMPUT, V10, P263, DOI 10.1162/106365602760234108; Li H, 2009, IEEE T EVOLUT COMPUT, V13, P284, DOI 10.1109/TEVC.2008.925798; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liu Y-M, 2013, INT C INT COMP, P200; Ma XL, 2014, NEUROCOMPUTING, V145, P336, DOI 10.1016/j.neucom.2014.05.025; Ma XY, 2014, AUSTIN J PATHOLOGY L, V1, P1, DOI DOI 10.1093/JXB/ERU447; Martinez SZ, 2011, INT C GEN EV COMP; Mashwani WK, SGAI INT C INN TECH, P217; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; Parsopoulos KE, IASTED INT C ART INT; Peng W, 2008, INT C GRAN COMP; Pires EJS, 2005, INT C EV MULT OPT; Qi YT, 2014, EVOL COMPUT, V22, P231, DOI 10.1162/EVCO_a_00109; Schaffer JD, 1985, INT C GEN ALG; Tan YY, 2013, COMPUT OPER RES, V40, P1648, DOI 10.1016/j.cor.2012.01.001; Tan YY, 2012, INFORM SCIENCES, V213, P14, DOI 10.1016/j.ins.2012.06.007; Yang DD, 2010, COMPUT INTELL-US, V26, P359, DOI 10.1111/j.1467-8640.2010.00363.x; Yao X, 1999, IEEE T EVOLUT COMPUT, V3, P82, DOI 10.1109/4235.771163; Yu X, 2016, ENERGIES, V9, DOI 10.3390/en9060438; Zhan ZH, 2013, IEEE T CYBERNETICS, V43, P445, DOI 10.1109/TSMCB.2012.2209115; Zhan ZH, 2011, IEEE T EVOLUT COMPUT, V15, P832, DOI 10.1109/TEVC.2010.2052054; Zhang Q., 2009, IEEE C EV COMP; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zhou B, 2013, IEEE T POWER SYST, V28, P3534, DOI 10.1109/TPWRS.2013.2259641; Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969; Zitzler E, 2001, EVOLUTIONARY METHODS; Zitzler E., 2007, INT C EV MULT OPT; Zitzler E, 2000, EVOL COMPUT, V8, P173, DOI 10.1162/106365600568202	49	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172033	10.1371/journal.pone.0172033	http://dx.doi.org/10.1371/journal.pone.0172033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192508	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800062
J	Borgatti, A; Winter, AL; Stuebner, K; Scott, R; Ober, CP; Anderson, KL; Feeney, DA; Vallera, DA; Koopmeiners, JS; Modiano, JF; Froelich, J				Borgatti, Antonella; Winter, Amber L.; Stuebner, Kathleen; Scott, Ruth; Ober, Christopher P.; Anderson, Kari L.; Feeney, Daniel A.; Vallera, Daniel A.; Koopmeiners, Joseph S.; Modiano, Jaime F.; Froelich, Jerry			Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography ( PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study	PLOS ONE			English	Article							CANINE HEMANGIOSARCOMA; F-18-FDG PET/CT; CANCER; TUMOR; DIAGNOSIS; LYMPHOMA; THERAPY; MASSES	Positron Emission Tomography-Computed Tomography (PET-CT) is routinely used for staging and monitoring of human cancer patients and is becoming increasingly available in veterinary medicine. In this study, 18-fluorodeoxyglucose ((18)FDG)-PET-CT was used in dogs with naturally occurring splenic hemangiosarcoma (HSA) to assess its utility as a staging and monitoring modality as compared to standard radiography and ultrasonography. Nine dogs with stage-2 HSA underwent (18)FDG-PET-CT following splenectomy and prior to commencement of chemotherapy. Routine staging (thoracic radiography and abdominal ultrasonography) was performed prior to (18)FDG-PET-CT in all dogs. When abnormalities not identified on routine tests were noted on (18)FDG-PET-CT, owners were given the option to repeat a PET-CT following treatment with eBAT. A PET-CT scan was repeated on Day 21 in three dogs. Abnormalities not observed on conventional staging tools, and most consistent with malignant disease based on location, appearance, and outcome, were detected in two dogs and included a right atrial mass and a hepatic nodule, respectively. These lesions were larger and had higher metabolic activity on the second scans. (18)FDG-PET-CT has potential to provide important prognostic information and influence treatment recommendations for dogs with stage-2 HSA. Additional studies will be needed to precisely define the value of this imaging tool for staging and therapy monitoring in dogs with this and other cancers.	[Borgatti, Antonella; Winter, Amber L.; Stuebner, Kathleen; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Anim Canc Care & Res ACCR Program, St Paul, MN 55108 USA; [Borgatti, Antonella; Ober, Christopher P.; Anderson, Kari L.; Feeney, Daniel A.; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Borgatti, Antonella; Vallera, Daniel A.; Koopmeiners, Joseph S.; Modiano, Jaime F.; Froelich, Jerry] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Winter, Amber L.; Stuebner, Kathleen; Scott, Ruth] Coll Vet Med, Clin Invest Ctr, St Paul, MN USA; [Vallera, Daniel A.] Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA; [Koopmeiners, Joseph S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Froelich, Jerry] Univ Minnesota, Sch Med, Ctr Clin Imaging Res CCIR Diagnost Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Borgatti, A (corresponding author), Univ Minnesota, Coll Vet Med, Anim Canc Care & Res ACCR Program, St Paul, MN 55108 USA.; Borgatti, A (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.; Borgatti, A (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	borgatti@umn.edu	MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	Office of The Director, National Institutes of Health [K01OD017242]; National Canine Cancer Foundation [AB15MN-002]; Masonic Cancer Center, University of Minnesota Sarcoma Translational Working Group; Randy Shaver Cancer Research and Community Fund; GREYIong; Angiosarcoma Awareness Foundation; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD017242] Funding Source: NIH RePORTER	Office of The Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Canine Cancer Foundation; Masonic Cancer Center, University of Minnesota Sarcoma Translational Working Group; Randy Shaver Cancer Research and Community Fund; GREYIong; Angiosarcoma Awareness Foundation; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grant K01OD017242 (AB) from the Office of The Director, National Institutes of Health, grant AB15MN-002 from the National Canine Cancer Foundation (AB), a grant from the Masonic Cancer Center, University of Minnesota Sarcoma Translational Working Group (JFM, DAV, AB, JSK), the Randy Shaver Cancer Research and Community Fund (DAV), and a grant from GREYIong (JFM). The authors gratefully acknowledge generous support from the Angiosarcoma Awareness Foundation and donations to the Animal Cancer Care and Research Program of the University of Minnesota that helped support this project. JFM is supported in part by the Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other supporting organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz MR, 2011, J NUCL MED, V52, P1684, DOI 10.2967/jnumed.111.095257; BERG RJ, 1984, J AM ANIM HOSP ASSOC, V20, P721; Bilski M, 2012, NUCL MED REV, V15, P83, DOI [10.5603/nmr-18736, 10.5603/NMR.2012.0015]; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Bomanji JB, 2001, LANCET ONCOL, V2, P157, DOI 10.1016/S1470-2045(00)00257-6; Borgatti A, MOL CANC TH IN PRESS; Boston SE, 2011, J AM ANIM HOSP ASSOC, V47, P336, DOI 10.5326/JAAHA-MS-5603; Ceriani L, 2015, BLOOD, V126, P950, DOI 10.1182/blood-2014-12-616474; Chon E, 2012, VET COMP ONCOL, V10, P184, DOI 10.1111/j.1476-5829.2011.00265.x; Clifford CA, 2000, J VET INTERN MED, V14, P479, DOI 10.1892/0891-6640(2000)014&lt;0479:TOCHAB&gt;2.3.CO;2; Cook GJR, 2007, Q J NUCL MED MOL IM, V51, P235; Dunning D, 1998, J AM VET MED ASSOC; FRUCHTER AM, 1992, CAN VET J, V33, P171; Gardner HL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0446-1; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Hansen AE, 2011, VET RADIOL ULTRASOUN, V52, P201, DOI 10.1111/j.1740-8261.2010.01757.x; HOLT D, 1992, J AM VET MED ASSOC, V200, P1535; Jain A, 2015, INDIAN J NUCL MED, V30, P51, DOI 10.4103/0972-3919.147541; Kim Jong-Hyuk, 2015, Vet Sci, V2, P388, DOI 10.3390/vetsci2040388; Lana S, 2007, J VET INTERN MED, V21, P764; LARSON SM, 1981, J NUCL MED, V22, P875; Lawrence J, 2010, VET COMP ONCOL, V8, P163, DOI 10.1111/j.1476-5829.2010.00218.x; LeBlanc AK, 2012, VET RADIOL ULTRASOUN, V53, P348, DOI 10.1111/j.1740-8261.2012.01925.x; Leblanc AK, 2009, VET RADIOL ULTRASOUN, V50, P215, DOI 10.1111/j.1740-8261.2009.01520.x; Quak E, 2011, EXPERT REV ANTICANC, V11, P195, DOI [10.1586/era.10.133, 10.1586/ERA.10.133]; Rahbar K, 2012, J NUCL MED, V53, P1657, DOI 10.2967/jnumed.112.110676; Schappa JT, 2013, INT J CANCER, V133, P1936, DOI 10.1002/ijc.28187; Seiler SMF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127800; Tan H, 2013, CLIN NUCL MED, V38, P1002, DOI 10.1097/RLU.0000000000000254; Thamm DH, 2013, SMALL ANIMAL CLIN ON, V5, P679; THOMAS WP, 1984, VET RADIOLOGY, V25, P65, DOI 10.1111/j.1740-8261.1984.tb01911.x; U'Ren LW, 2007, J VET INTERN MED, V21, P113, DOI 10.1892/0891-6640(2007)21[113:EOANTV]2.0.CO;2; WATERS DJ, 1988, J SMALL ANIM PRACT, V29, P805, DOI 10.1111/j.1748-5827.1988.tb01907.x; Weber WA, 1999, STRAHLENTHER ONKOL, V175, P356, DOI 10.1007/s000660050022; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172651	10.1371/journal.pone.0172651	http://dx.doi.org/10.1371/journal.pone.0172651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222142	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800075
J	Jaworski, JP; Bryk, P; Brower, Z; Zheng, B; Hessell, AJ; Rosenberg, AF; Wu, TT; Sanz, I; Keefer, MC; Haigwood, NL; Kobie, JJ				Jaworski, Juan Pablo; Bryk, Peter; Brower, Zachary; Zheng, Bo; Hessell, Ann J.; Rosenberg, Alexander F.; Wu, Tong Tong; Sanz, Ignacio; Keefer, Michael C.; Haigwood, Nancy L.; Kobie, James J.			Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-1/SIV CHIMERIC VIRUS; MONOCLONAL-ANTIBODIES; LAMINA PROPRIA; PERITONEAL-CAVITY; INFANT MACAQUES; LYMPHOID-TISSUE; PLASMA-CELLS; PROTECTION; VIREMIA	Our central hypothesis is that protection against HIV infection will be powerfully influenced by the magnitude and quality of the B cell response. Although sterilizing immunity, mediated by pre-formed abundant and potent antibodies is the ultimate goal for B cell-targeted HIV vaccine strategies, scenarios that fall short of this may still confer beneficial defenses against viremia and disease progression. We evaluated the impact of sub-sterilizing pre-existing neutralizing antibody on the B cell response to SHIV infection. Adult male rhesus macaques received passive transfer of a sub-sterilizing amount of polyclonal neutralizing immunoglobulin (Ig) purified from previously infected animals (SHIVIG) or control Ig prior to intra-rectal challenge with SHIVSF162P4 and extensive longitudinal sampling was performed. SHIVIG treated animals exhibited significantly reduced viral load and increased de novo Env-specific plasma antibody. Dysregulation of the B cell profile was grossly apparent soon after infection in untreated animals; exemplified by a approximate to 50% decrease in total B cells in the blood evident 2-3 weeks postinfection which was not apparent in SHIVIG treated animals. IgD+CD5+CD21+B cells phenotypically similar to marginal zone-like B cells were highly sensitive to SHIV infection, becoming significantly decreased as early as 3 days post-infection in control animals, while being maintained in SHIVIG treated animals, and were highly correlated with the induction of Env-specific plasma antibody. These results suggest that B cell dysregulation during the early stages of infection likely contributes to suboptimal Env-specific B cell and antibody responses, and strategies that limit this dysregulation may enhance the host's ability to eliminate HIV.	[Jaworski, Juan Pablo; Brower, Zachary; Hessell, Ann J.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Bryk, Peter] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Zheng, Bo; Keefer, Michael C.; Kobie, James J.] Univ Rochester, Med Ctr, Dept Med, Div Infect Dis, Rochester, NY 14642 USA; [Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Wu, Tong Tong] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Sanz, Ignacio] Emory Univ, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Sanz, Ignacio] Emory Univ, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA; [Jaworski, Juan Pablo] Natl Inst Agr Technol, Buenos Aires, DF, Argentina; [Jaworski, Juan Pablo] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina	Oregon Health & Science University; Oregon National Primate Research Center; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Emory University; Emory University; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Kobie, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Infect Dis, Rochester, NY 14642 USA.	james_kobie@urmc.rocheter.edu	Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020	Jaworski, Juan/0000-0002-1311-060X; Haigwood, Nancy/0000-0002-1477-9575; Hessell, Ann/0000-0001-7471-9366	NIH/NIAID/NIMH [5U19AI067854, 5R01AI117787]; University of Rochester Center for AIDS Research [P30AI078498, R37AI049660, U19AI110483, P51-OD011092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683, U19AI110483, P01AI125180, T32AI118689, R01AI117787, P30AI078498, UM1AI068614, R37AI049660, U19AI056390] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIH/NIAID/NIMH; University of Rochester Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NIH/NIAID/NIMH 5U19AI067854 (HVTN/CHAVI), 5R01AI117787 to JK, University of Rochester Center for AIDS Research P30AI078498 (NIH/NIAID), R37AI049660 and U19AI110483 to IS, P51-OD011092 (NIH).	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; BEAGLEY KW, 1995, IMMUNOL CELL BIOL, V73, P425, DOI 10.1038/icb.1995.66; Brocca-Cofano E, 2011, VACCINE, V29, P3310, DOI 10.1016/j.vaccine.2011.02.066; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chaoul N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-43; Das A, 2011, CLIN IMMUNOL, V140, P223, DOI 10.1016/j.clim.2011.04.018; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Demberg T, 2015, VIROLOGY, V484, P323, DOI 10.1016/j.virol.2015.06.022; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Gauvin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155868; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Haigwood NL, 1996, IMMUNOL LETT, V51, P107, DOI 10.1016/0165-2478(96)02563-1; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Kuwata T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000372; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lin M, 2013, MUCOSAL IMMUNOL; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Neumann B, 2015, J LEUKOCYTE BIOL, V97, P19, DOI 10.1189/jlb.1HI0514-243R; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Zhang ZQ, 2007, VIROLOGY, V361, P455, DOI 10.1016/j.virol.2006.12.006	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172524	10.1371/journal.pone.0172524	http://dx.doi.org/10.1371/journal.pone.0172524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222180	Green Published, gold			2022-12-26	WOS:000394676800064
J	Ngole-Jeme, VM; Fantke, P				Ngole-Jeme, Veronica Mpode; Fantke, Peter			Ecological and human health risks associated with abandoned gold mine tailings contaminated soil	PLOS ONE			English	Article							HEAVY-METAL CONTAMINATION; SEDIMENTS; POLLUTION; PLANTS; BIOREMEDIATION; ECOTOXICITY; TOXICITY; EXPOSURE; PROVINCE; DUST	Gold mining is a major source of metal and metalloid emissions into the environment. Studies were carried out in Krugersdorp, South Africa, to evaluate the ecological and human health risks associated with exposure to metals and metalloids in mine tailings contaminated soils. Concentrations of arsenic (As), cadmium (Cd), chromium (Cr), cobalt (Co), copper (Cu), lead (Pb), manganese (Mn), nickel (Ni), and zinc (Zn) in soil samples from the area varied with the highest contamination factors (expressed as ratio of metal or metalloid concentration in the tailings contaminated soil to that of the control site) observed for As (3.5x10(2)), Co (2.8x10(2)) and Ni (1.1x10(2)). Potential ecological risk index values for metals and metalloids determined from soil metal and metalloid concentrations and their respective risk factors were correspondingly highest for As (3.5x10(3)) and Co (1.4x10(3)), whereas Mn (0.6) presented the lowest ecological risk. Human health risk was assessed using Hazard Quotient (HQ), Chronic Hazard Index (CHI) and carcinogenic risk levels, where values of HQ > 1, CHI > 1 and carcinogenic risk values > 1x10(-4) represent elevated risks. Values for HQ indicated high exposure-related risk for As (53.7), Cr (14.8), Ni (2.2), Zn (2.64) and Mn (1.67). Children were more at risk from heavy metal and metalloid exposure than adults. Cancer-related risks associated with metal and metalloid exposure among children were also higher than in adults with cancer risk values of 3x10(-2) and 4x10(-2) for As and Ni respectively among children, and 5x10(-3) and 4x10(-3) for As and Ni respectively among adults. There is significant potential ecological and human health risk associated with metal and metalloid exposure from contaminated soils around gold mine tailings dumps. This could be a potential contributing factor to a setback in the health of residents in informal settlements dominating this mining area as the immune systems of some of these residents are already compromised by high HIV prevalence.	[Ngole-Jeme, Veronica Mpode] Univ South Africa, Dept Environm Sci, Sch Ecol & Human Sustainabil, Coll Agr & Environm Sci, Roodepoort, Gauteng Provinc, South Africa; [Fantke, Peter] Tech Univ Denmark, Dept Engn Management, Quantitat Sustainabil Assessment Div, Lyngby, Denmark	University of South Africa; Technical University of Denmark	Ngole-Jeme, VM (corresponding author), Univ South Africa, Dept Environm Sci, Sch Ecol & Human Sustainabil, Coll Agr & Environm Sci, Roodepoort, Gauteng Provinc, South Africa.	vm.ngole@gmail.com	Fantke, Peter/N-2704-2015; Jeme, Veronica/AFK-5964-2022; Fantke, Peter/GRO-6285-2022; Ngole-Jeme, Veronica/E-2932-2018; Fantke, Peter/N-3617-2019	Fantke, Peter/0000-0001-7148-6982; Jeme, Veronica/0000-0003-4470-2285; Fantke, Peter/0000-0001-7148-6982; Ngole-Jeme, Veronica/0000-0003-4470-2285; 	National Research Foundation of South Africa [82534]; Marie Curie project Quan-Tox - European Commission under the Seventh Framework Programme [631910]	National Research Foundation of South Africa(National Research Foundation - South Africa); Marie Curie project Quan-Tox - European Commission under the Seventh Framework Programme	This work is based on the research supported in part by the National Research Foundation of South Africa (Grant Number: 82534) and in part by the Marie Curie project Quan-Tox (grant agreement no. 631910) funded by the European Commission under the Seventh Framework Programme.	Abdul-Wahab SA, 2012, OPEN ENG, V2, P304, DOI 10.2478/s13531-011-0052-3; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; [Anonymous], 2016, CAS STUD ENV MED CSE; [Anonymous], 2013, INT J APPL SCI TECHN; Armah Frederick Ato, 2014, Int Sch Res Notices, V2014, P252148, DOI 10.1155/2014/252148; *ATSDR, 2016, TOX SUBST PORT TOX P; BRIME C, 1985, MINERAL MAG, V49, P531, DOI 10.1180/minmag.1985.049.353.06; Cairncross E, 2013, CASE STUDY EXTRACTIV; Candeias C, 2014, GEOSCIENCES, V4, P240, DOI 10.3390/geosciences4040240; Chamber of Mines, 2011, CHAMB MIN S AFR ANN; Chen SC, 2006, SCI TOTAL ENVIRON, V366, P112, DOI 10.1016/j.scitotenv.2005.08.047; Chen TB, 2005, CHEMOSPHERE, V60, P542, DOI 10.1016/j.chemosphere.2004.12.072; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; Coetzee H, 2009, 11 SAGA M EXH SWAZ 2, P461; CPCB, 2008, DISTR BROCH KANP NAG; Department of Environmental Affairs, 2014, 37603 GOV S AFR; Donkor AK, 2005, SOIL SEDIMENT CONTAM, V14, P479, DOI 10.1080/15320380500263675; Eisler R, 2004, REV ENVIRON CONTAM T, V180, P133, DOI 10.1007/0-387-21729-0_3; Emamverdian Abolghassem, 2015, ScientificWorldJournal, V2015, P756120, DOI 10.1155/2015/756120; Fayiga AO, 2004, ENVIRON POLLUT, V132, P289, DOI 10.1016/j.envpol.2004.04.020; Ferreira-Baptista L, 2005, ATMOS ENVIRON, V39, P4501, DOI 10.1016/j.atmosenv.2005.03.026; Finnegan PM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00182; Franco-Hernandez MO, 2010, BIORESOURCE TECHNOL, V101, P3864, DOI 10.1016/j.biortech.2010.01.013; Gall JE, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4436-3; Geosciences Cf, 2016, GUID SERV CGS AN LAB; Goddard SL, 2014, SENSORS-BASEL, V14, P21676, DOI 10.3390/s141121676; Gong QJ, 2008, J CHINA UNIV GEOSCI, V19, P230, DOI 10.1016/S1002-0705(08)60042-4; Grimalt JO, 1999, SCI TOTAL ENVIRON, V242, P3, DOI 10.1016/S0048-9697(99)00372-1; Gzik Axel, 2003, Journal of Soils and Sediments, V3, P29, DOI 10.1007/BF02989466; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Holtz RD., 2011, INTRO GEOTECHNICAL E, V2; Hu X, 2011, ENVIRON POLLUT, V159, P1215, DOI 10.1016/j.envpol.2011.01.037; ICDD, 2002, MIN POWD DIFFR FIL D; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Jiao XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127736; Kaasalainen M, 2003, ENVIRON POLLUT, V126, P225, DOI 10.1016/S0269-7491(03)00191-X; Kabata-Pendias A., 2001, TRACE METALS SOILS P, V3; Kong SF, 2012, J ENVIRON MONITOR, V14, P791, DOI 10.1039/c1em10555h; Kurt-Karakus PB, 2012, ENVIRON INT, V50, P47, DOI 10.1016/j.envint.2012.09.011; Lee JS, 2005, ENVIRON GEOCHEM HLTH, V27, P185, DOI 10.1007/s10653-005-0131-6; Lomonte C, 2008, CHEMOSPHERE, V72, P1420, DOI 10.1016/j.chemosphere.2008.05.033; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; McCarthy TS, 2011, S AFR J SCI, V107, P1, DOI 10.4102/sajs.v107i5/6.712; Meunier L, 2010, ENVIRON SCI TECHNOL, V44, P2667, DOI 10.1021/es9035682; Migliorini M, 2004, ENVIRON POLLUT, V129, P331, DOI 10.1016/j.envpol.2003.09.025; Monachese M, 2012, APPL ENVIRON MICROB, V78, P6397, DOI 10.1128/AEM.01665-12; Nengovhela AC, 2006, S AFRICA WATER SA, V32, P8; Ngole VM, 2012, J SCI RES ESSAY, V7, P12; Njinga RL, 2016, J RADIAT RES APPL SC, V9, P310, DOI 10.1016/j.jrras.2016.02.003; Owsianiak M, 2015, ENVIRON POLLUT, V206, P400, DOI 10.1016/j.envpol.2015.07.025; Percival JB, 2014, GEOCHEM-EXPLOR ENV A, V14, P3, DOI 10.1144/geochem2011-071; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Rasmussen PE, 1998, ENVIRON GEOL, V33, P96, DOI 10.1007/s002540050229; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Scragg A., 2006, ENV BIOTECHNOLOGY; Sethy Sunil Kumar, 2013, J Nat Sci Biol Med, V4, P272, DOI 10.4103/0976-9668.116964; Short R, 2008, GOLD S AFRICA MINING; Singh R, 2011, INDIAN J PHARM, V43, P7; Sobolev Dmitri, 2008, Int J Environ Res Public Health, V5, P450; Soliman NF, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0223-x; Song DP, 2015, INT J ENV RES PUB HE, V12, P7100, DOI 10.3390/ijerph120707100; Sreekanth TVM, 2013, INT J ENVIRON SCI TE, V10, P1129, DOI 10.1007/s13762-013-0245-9; Steenkamp L, 2014, AJAR-AFR J AIDS RES, V13, P271, DOI 10.2989/16085906.2014.952651; Straskraba V., 1990, INT J MINE WATER, V9, P181; Tahiri M, 2002, BRIT J NUTR, V87, P47, DOI 10.1079/BJN2001476; Tariq FS, 2016, APPL ENV SOIL SCI, V2016, P12; United States Environmental Protection Agency (US-EPA), 1989, EXP FACT HDB; USEPA, 2014, REM INV FEAS STUD, P483; USEPA, 2010, RISK ASSESSMENT GUID; USEPA (United States Environmental Protection Agency), 1996, SOIL SCREEN GUID TEC; Van Reeuwijk LP, 2002, 09 ISRIC, V6; Westh TB, 2015, INT J LIFE CYCLE ASS, V20, P299, DOI 10.1007/s11367-014-0829-8; Whitehead MW, 1996, GUT, V39, P625, DOI 10.1136/gut.39.5.625; Wu QH, 2014, ECOTOX ENVIRON SAFE, V104, P143, DOI 10.1016/j.ecoenv.2014.02.017; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075; Zhou JM, 2007, PEDOSPHERE, V17, P588, DOI 10.1016/S1002-0160(07)60069-1; Zhu W, 2008, ENVIRON MONIT ASSESS, V147, P171, DOI 10.1007/s10661-007-0108-2	77	110	113	7	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172517	10.1371/journal.pone.0172517	http://dx.doi.org/10.1371/journal.pone.0172517			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222184	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800063
J	Chan, RB; Perotte, AJ; Zhou, BW; Liong, C; Shorr, EJ; Marder, KS; Kang, UJ; Waters, CH; Levy, OA; Xu, YM; Bin Shim, H; Pe'er, I; Di Paolo, G; Alcalay, RN				Chan, Robin B.; Perotte, Adler J.; Zhou, Bowen; Liong, Christopher; Shorr, Evan J.; Marder, Karen S.; Kang, Un J.; Waters, Cheryl H.; Levy, Oren A.; Xu, Yimeng; Bin Shim, Hong; Pe'er, Itsik; Di Paolo, Gilbert; Alcalay, Roy N.			Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE ACTIVITY; APOLIPOPROTEIN A1; ALZHEIMER-DISEASE; GAUCHER-DISEASE; MEMBRANE-LIPIDS; GBA MUTATIONS; HUMAN BRAIN; BLOOD	Parkinson's disease ( PD) is a common neurodegenerative disease whose pathological hallmark is the accumulation of intracellular a-synuclein aggregates in Lewy bodies. Lipid metabolism dysregulation may play a significant role in PD pathogenesis; however, large plasma lipidomic studies in PD are lacking. In the current study, we analyzed the lipidomic profile of plasma obtained from 150 idiopathic PD patients and 100 controls, taken from the 'Spot' study at Columbia University Medical Center in New York. Our mass spectrometry based analytical panel consisted of 520 lipid species from 39 lipid subclasses including all major classes of glycerophospholipids, sphingolipids, glycerolipids and sterols. Each lipid species was analyzed using a logistic regression model. The plasma concentrations of two lipid subclasses, triglycerides and monosialodihexosylganglioside ( GM3), were different between PD and control participants. GM3 ganglioside concentration had the most significant difference between PD and controls ( 1.531+/-0.037 pmol/mu l versus 1.337+/-0.040 pmol/mu l respectively; p-value = 5.96E-04; q-value = 0.048; when normalized to total lipid: p-value = 2.890E-05; q-value = 2.933E-03). Next, we used a collection of 20 GM3 and glucosylceramide ( GlcCer) species concentrations normalized to total lipid to perform a ROC curve analysis, and found that these lipids compare favorably with biomarkers reported in previous studies ( AUC = 0.742 for males, AUC = 0.644 for females). Our results suggest that higher plasma GM3 levels are associated with PD. GM3 lies in the same glycosphingolipid metabolic pathway as GlcCer, a substrate of the enzyme glucocerebrosidase, which has been associated with PD. These findings are consistent with previous reports implicating lower glucocerebrosidase activity with PD risk.	[Chan, Robin B.; Zhou, Bowen; Xu, Yimeng; Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Chan, Robin B.; Marder, Karen S.; Xu, Yimeng; Di Paolo, Gilbert; Alcalay, Roy N.] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Perotte, Adler J.; Bin Shim, Hong; Pe'er, Itsik] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Liong, Christopher; Shorr, Evan J.; Marder, Karen S.; Kang, Un J.; Waters, Cheryl H.; Levy, Oren A.; Alcalay, Roy N.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA; [Di Paolo, Gilbert] Denali Therapeut, San Francisco, CA USA	Columbia University; Columbia University; Columbia University; Columbia University	Di Paolo, G (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.; Di Paolo, G; Alcalay, RN (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; Alcalay, RN (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.; Di Paolo, G (corresponding author), Denali Therapeut, San Francisco, CA USA.	gd2175@cumc.columbia.edu; rna2104@cumc.columbia.edu	Kang, Un/AAV-2858-2020; Levey, Allan/F-2104-2011	Kang, Un/0000-0002-5970-6839; Levey, Allan/0000-0002-3153-502X; Zhou, Bowen/0000-0003-4421-9787; Perotte, Adler/0000-0002-6695-0282	NINDS NIH HHS [K02 NS080915] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS080915] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Alcalay RN, 2014, JAMA NEUROL, V71, P752, DOI 10.1001/jamaneurol.2014.313; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Begum H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19139; Bjorkhem I, 2013, NEUROSCI LETT, V555, P102, DOI 10.1016/j.neulet.2013.09.003; Blanz J., 2016, J NEUROCHEM; Block RC, 2010, J CLIN LIPIDOL, V4, P17, DOI 10.1016/j.jacl.2009.11.003; Bray MS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R110.214643; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chiasserini D, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0010-2; Clague MJ, 2016, CURR BIOL, V26, pR332, DOI 10.1016/j.cub.2016.03.001; Clark LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125204; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Di Pasquale E, 2010, J MOL BIOL, V397, P202, DOI 10.1016/j.jmb.2010.01.046; Gan-Or Z, 2013, NEUROLOGY, V80, P1606, DOI 10.1212/WNL.0b013e31828f180e; Gegg ME, 2015, MOVEMENT DISORD, V30, P1085, DOI 10.1002/mds.26278; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Gulati S, 2015, CELL HOST MICROBE, V18, P371, DOI 10.1016/j.chom.2015.08.003; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Iyer A, 2014, BIOPHYS J, V106, P2585, DOI 10.1016/j.bpj.2014.05.001; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kim HJ, 2016, PARKINSONISM RELAT D, V23, P99, DOI 10.1016/j.parkreldis.2015.12.002; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Li ZG, 2015, J CLIN NEUROSCI, V22, P1268, DOI 10.1016/j.jocn.2015.02.013; Manzoni C, 2013, FASEB J, V27, P3424, DOI 10.1096/fj.12-223842; Marder K, 2003, NEUROLOGY, V61, P18, DOI 10.1212/01.WNL.0000074784.35961.C0; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; Meikle PJ, 2008, BLOOD CELL MOL DIS, V40, P420, DOI 10.1016/j.bcmd.2007.10.004; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Murphy KE, 2014, AUTOPHAGY, V10, P1350, DOI 10.4161/auto.29074; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pan Ping-Yue, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS154, DOI 10.1016/S1353-8020(13)70037-3; Papagiannakis N, 2015, MOVEMENT DISORD, V30, P1830, DOI 10.1002/mds.26433; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; Qiang JK, 2013, ANN NEUROL, V74, P119, DOI 10.1002/ana.23872; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sakanaka K, 2014, J GENET COUNS, V23, P114, DOI 10.1007/s10897-013-9618-y; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Swanson CR, 2015, MOVEMENT DISORD, V30, P1648, DOI 10.1002/mds.26290; Vlugt KGVD, 2008, CLIN CHIM ACTA, V389, P109, DOI 10.1016/j.cca.2007.12.001; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808	48	56	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172348	10.1371/journal.pone.0172348	http://dx.doi.org/10.1371/journal.pone.0172348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212433	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700036
J	Juan, C; Cappe, C; Alric, B; Roby, B; Gilardeau, S; Barone, P; Girard, P				Juan, Cecile; Cappe, Celine; Alric, Baptiste; Roby, Benoit; Gilardeau, Sophie; Barone, Pascal; Girard, Pascal			The variability of multisensory processes of natural stimuli in human and non-human primates in a detection task	PLOS ONE			English	Article							AUDITORY-VISUAL INTERACTIONS; GAMMA-BAND SYNCHRONIZATION; AUDIOVISUAL INTEGRATION; OBJECT DETECTION; REACTION-TIME; MODALITY; MONKEYS; CORTEX; PHASE; CATEGORIZATION	Background Behavioral studies in both human and animals generally converge to the dogma that multisensory integration improves reaction times (RTs) in comparison to unimodal stimulation. These multisensory effects depend on diverse conditions among which the most studied were the spatial and temporal congruences. Further, most of the studies are using relatively simple stimuli while in everyday life, we are confronted to a large variety of complex stimulations constantly changing our attentional focus over time, a modality switch that can impact on stimuli detection. In the present study, we examined the potential sources of the variability in reaction times and multisensory gains with respect to the intrinsic features of a large set of natural stimuli. Methodology/Principle findings Rhesus macaque monkeys and human subjects performed a simple audio-visual stimulus detection task in which a large collection of unimodal and bimodal natural stimuli with semantic specificities was presented at different saliencies. Although we were able to reproduce the well-established redundant signal effect, we failed to reveal a systematic violation of the race model which is considered to demonstrate multisensory integration. In both monkeys and human species, our study revealed a large range of multisensory gains, with negative and positive values. While modality switch has clear effects on reaction times, one of the main causes of the variability of multisensory gains appeared to be linked to the intrinsic physical parameters of the stimuli. Conclusion/Significance Based on the variability of multisensory benefits, our results suggest that the neuronal mechanisms responsible of the redundant effect (interactions vs. integration) are highly dependent on the stimulus complexity suggesting different implications of uni- and multisensory brain regions. Further, in a simple detection task, the semantic values of individual stimuli tend to have no significant impact on task performances, an effect which is probably present in more cognitive tasks.	[Juan, Cecile; Cappe, Celine; Alric, Baptiste; Roby, Benoit; Gilardeau, Sophie; Barone, Pascal; Girard, Pascal] CNRS UMR 5549, Cerco, Toulouse, France; [Juan, Cecile; Cappe, Celine; Alric, Baptiste; Roby, Benoit; Gilardeau, Sophie; Barone, Pascal; Girard, Pascal] Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France; [Girard, Pascal] INSERM, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Girard, P (corresponding author), CNRS UMR 5549, Cerco, Toulouse, France.; Girard, P (corresponding author), Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France.; Girard, P (corresponding author), INSERM, Toulouse, France.	Pascal.GIRARD@cnrs.fr	Barone, Pascal/A-4008-2009; BARONE, Pascal/AHE-2323-2022; Girard, Pascal/C-6427-2009	BARONE, Pascal/0000-0003-0125-7468; 	ANR Archicore [ANR-14-CE13-0033-02]; IBM [ANR-12-PDOC-0008]	ANR Archicore(French National Research Agency (ANR)); IBM(International Business Machines (IBM))	This work was supported by ANR Archicore (ANR-14-CE13-0033-02), IBM (ANR-12-PDOC-0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2003, NEUROPSYCHOLOGIA, V41, P1, DOI 10.1016/S0028-3932(02)00139-2; Bigelow J, 2016, ANIM COGN, V19, P799, DOI 10.1007/s10071-016-0979-0; Bonnefond M, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128667; Bonnefond Mathilde, 2013, Commun Integr Biol, V6, pe22702, DOI 10.4161/cib.22702; Brunet NM, 2014, P NATL ACAD SCI USA, V111, P3626, DOI 10.1073/pnas.1309714111; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2010, J COGNITIVE NEUROSCI, V22, P2850, DOI 10.1162/jocn.2010.21423; Chandrasekaran C, 2013, P NATL ACAD SCI USA, V110, pE4668, DOI 10.1073/pnas.1312518110; Chandrasekaran C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002165; Chen YC, 2013, MULTISENS RES, V26, P371, DOI 10.1163/22134808-00002420; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Cho RY, 2002, COGN AFFECT BEHAV NE, V2, P283, DOI 10.3758/CABN.2.4.283; COHEN R, 1992, ANN NY ACAD SCI, V658, P163, DOI 10.1111/j.1749-6632.1992.tb22844.x; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Colonius H, 2006, PSYCHOL REV, V113, P148, DOI 10.1037/0033-295X.113.1.148; Corballis MC, 1998, BRAIN, V121, P1795, DOI 10.1093/brain/121.9.1795; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Cox D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00722; Diederich A, 2003, EXP BRAIN RES, V148, P328, DOI 10.1007/s00221-002-1302-7; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Eramudugolla R, 2011, BRAIN COGNITION, V75, P60, DOI 10.1016/j.bandc.2010.09.005; Fabre-Thorpe M, 1998, CAH PSYCHOL COGN, V17, P791; Felleman DJ, 1991, DISTRIBUTED HIERARCH; Fiebelkorn IC, 2011, NEW HDB MULTISENSORY, P383; Fister JK, 2016, NEUROPSYCHOLOGIA, V88, P92, DOI 10.1016/j.neuropsychologia.2016.02.016; Fize D, 2011, P NATL ACAD SCI USA, V108, P7635, DOI 10.1073/pnas.1016213108; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Fort A, 2002, CEREB CORTEX, V12, P1031, DOI 10.1093/cercor/12.10.1031; Foxe JJ, 2014, EUR J NEUROSCI, V39, P1960, DOI 10.1111/ejn.12577; Foxton JM, 2010, COGNITION, V115, P71, DOI 10.1016/j.cognition.2009.11.009; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gelskov SV, 2010, COGNITION, V114, P285, DOI 10.1016/j.cognition.2009.09.012; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gleiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045677; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Gondan M, 2004, PSYCHON B REV, V11, P307, DOI 10.3758/BF03196575; Gondan M, 2007, EXP BRAIN RES, V182, P199, DOI 10.1007/s00221-007-0982-4; Greene AJ, 2001, CONSCIOUS COGN, V10, P425, DOI 10.1006/ccog.2001.0502; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrington LK, 1998, EXP BRAIN RES, V122, P247, DOI 10.1007/s002210050512; Hecht D, 2009, EXP BRAIN RES, V193, P307, DOI 10.1007/s00221-008-1626-z; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; HUGHES HC, 1994, J EXP PSYCHOL HUMAN, V20, P131, DOI 10.1037/0096-1523.20.1.131; Joly O, 2012, NEUROIMAGE, V62, P1376, DOI 10.1016/j.neuroimage.2012.05.070; Joly O, 2012, CEREB CORTEX, V22, P838, DOI 10.1093/cercor/bhr150; Kaas JH, 2013, AM J PRIMATOL, V75, P407, DOI 10.1002/ajp.22065; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lehmann S, 2005, COGNITIVE BRAIN RES, V24, P326, DOI 10.1016/j.cogbrainres.2005.02.005; Li FF, 2005, VIS COGN, V12, P893, DOI 10.1080/13506280444000571; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Lukas S, 2010, ACTA PSYCHOL, V134, P318, DOI 10.1016/j.actpsy.2010.03.004; Lukas S, 2010, PSYCHOL RES-PSYCH FO, V74, P255, DOI 10.1007/s00426-009-0246-y; Martinez L, 2009, BEHAV PROCESS, V82, P90, DOI 10.1016/j.beproc.2009.03.010; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mercier MR, 2015, J NEUROSCI, V35, P8546, DOI 10.1523/JNEUROSCI.4527-14.2015; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MEREDITH MA, 1986, BRAIN RES, V365, P350; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Mirzaei A, 2013, VISION RES, V81, P36, DOI 10.1016/j.visres.2013.02.003; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Nidiffer AR, 2016, NEUROPSYCHOLOGIA, V88, P83, DOI 10.1016/j.neuropsychologia.2016.01.031; Otto TU, 2012, CURR BIOL, V22, P1391, DOI 10.1016/j.cub.2012.05.031; Payne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081825; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Quak M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00197; Quinlan PT, 1999, PERCEPT PSYCHOPHYS, V61, P375, DOI 10.3758/BF03206894; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Rapela J, 2012, IEEE ENG MED BIO, P352, DOI 10.1109/EMBC.2012.6345941; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; REMINGTON RJ, 1969, J EXP PSYCHOL, V82, P250, DOI 10.1037/h0028122; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sandhu R, 2013, BRAIN COGNITION, V82, P90, DOI 10.1016/j.bandc.2013.02.011; Sandhu R, 2012, ACTA PSYCHOL, V140, P111, DOI 10.1016/j.actpsy.2012.04.003; Schneider TR, 2008, EXP PSYCHOL, V55, P121, DOI 10.1027/1618-3169.55.2.121; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Scott BH, 2012, P NATL ACAD SCI USA, V109, P12237, DOI 10.1073/pnas.1209685109; Senkowski D, 2011, OSCILLATORY ACTIVITY, P193, DOI 10.1163/22134808-00002420; Sliwa J, 2011, P NATL ACAD SCI USA, V108, P1735, DOI 10.1073/pnas.1008169108; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Sperdin HF, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.002.2009; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79; Wichmann FA, 2010, J VISION, V10, DOI 10.1167/10.4.6; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; WRIGHT AA, 1990, ANIM LEARN BEHAV, V18, P287, DOI 10.3758/BF03205288; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004	105	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172480	10.1371/journal.pone.0172480	http://dx.doi.org/10.1371/journal.pone.0172480			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212416	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700056
J	Rothery, L; Scott, GW; Morrell, LJ				Rothery, Luke; Scott, Graham W.; Morrell, Lesley J.			Colour preferences of UK garden birds at supplementary seed feeders	PLOS ONE			English	Article							DIETARY CONSERVATISM; MIMULUS-AURANTIACUS; DOMESTIC CHICKS; UNITED-STATES; FLOWER COLOR; HUMMINGBIRD; CONTEXT; URBAN; FOOD; SELECTION	Supplementary feeding of garden birds generally has benefits for both bird populations and human wellbeing. Birds have excellent colour vision, and show preferences for food items of particular colours, but research into colour preferences associated with artificial feeders is limited to hummingbirds. Here, we investigated the colour preferences of common UK garden birds foraging at seed-dispensing artificial feeders containing identical food. We presented birds simultaneously with an array of eight differently coloured feeders, and recorded the number of visits made to each colour over 370 30-minute observation periods in the winter of 2014/15. In addition, we surveyed visitors to a garden centre and science festival to determine the colour preferences of likely purchasers of seed feeders. Our results suggest that silver and green feeders were visited by higher numbers of individuals of several common garden bird species, while red and yellow feeders received fewer visits. In contrast, people preferred red, yellow, blue and green feeders. We suggest that green feeders may be simultaneously marketable and attractive to foraging birds.	[Rothery, Luke; Scott, Graham W.; Morrell, Lesley J.] Univ Hull, Sch Environm Sci, Kingston Upon Hull, Yorks, England	University of Hull	Morrell, LJ (corresponding author), Univ Hull, Sch Environm Sci, Kingston Upon Hull, Yorks, England.	l.morrell@hull.ac.uk	Morrell, Lesley J/A-4311-2008	Morrell, Lesley J/0000-0003-0256-7871; Scott, Graham/0000-0003-0896-0287	Westland Horticulture; former School of Biological, Biomedical & Environmental Sciences at the University of Hull	Westland Horticulture; former School of Biological, Biomedical & Environmental Sciences at the University of Hull	Funding was provided by Westland Horticulture and the former School of Biological, Biomedical & Environmental Sciences at the University of Hull. Westland Horticulture played a role in the conceptualisation of the research question, but no role in data collection and analysis, decision to publish or preparation of the manuscript.	Bateson M, 2003, P ROY SOC B-BIOL SCI, V270, P1271, DOI 10.1098/rspb.2003.2365; Bateson M, 2002, ANIM BEHAV, V63, P587, DOI 10.1006/anbe.2001.1925; BENE FRANK, 1941, CONDOR, V43, P237, DOI 10.2307/1364506; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Brigham A.J., 1999, P67; BRITTINGHAM MC, 1988, ECOLOGY, V69, P581, DOI 10.2307/1941007; COLLIAS NE, 1968, CONDOR, V70, P273, DOI 10.2307/1366705; COWIE RJ, 1988, J ANIM ECOL, V57, P611, DOI 10.2307/4928; Cuthill IC, 2006, BIRD COLOURATION MEC; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Davies NB, 2012, INTRO BEHAV ECOLOGY; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Department for Environment Food and Rural Affairs (DEFRA), 2002, WORK GRAIN NAT BIOD, P180; Duan Q, 2013, CONDOR, V115, P623, DOI 10.1525/cond.2013.120111; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Exnerova A, 2007, BEHAV ECOL, V18, P148, DOI 10.1093/beheco/arl061; Foy S, 2016, GFK POINT SALES TRAC; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; GOLDSMITH TH, 1979, J COMP PHYSIOL, V130, P209, DOI 10.1007/BF00614607; GRANT KA, 1966, AM NAT, V100, P85, DOI 10.1086/282403; GRUBB TC, 1990, ORNIS SCAND, V21, P277, DOI 10.2307/3676392; Handelman C, 2014, PLANT SPEC BIOL, V29, P65, DOI 10.1111/j.1442-1984.2012.00393.x; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hartley L, 1999, NEW ZEAL J ECOL, V23, P255; Horn DJ, 2013, WILDLIFE SOC B, V37, P293, DOI 10.1002/wsb.281; Horn DJ, 2014, WILDLIFE SOC B, V38, P18, DOI 10.1002/wsb.365; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelly DJ, 2004, ANIM BEHAV, V68, P1049, DOI 10.1016/j.anbehav.2004.07.001; Kemp DJ, 2015, AM NAT, V185, P705, DOI 10.1086/681021; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Marples G., 1933, British Birds, V26, P238; MARTIN TE, 1990, STUDIES AVIAN BIOL, V0013, P00353; MelendezAckerman E, 1997, ECOLOGY, V78, P2532, DOI 10.1890/0012-9658(1997)078[2532:HBAMOS]2.0.CO;2; MILLER RS, 1971, CONDOR, V73, P309, DOI 10.2307/1365757; Olsson O, 2000, P ROY SOC B-BIOL SCI, V267, P1457, DOI 10.1098/rspb.2000.1164; Peach WJ, 2014, BIRD STUDY, V61, P378, DOI 10.1080/00063657.2014.918577; Pet Food Manufacturers' Association, 2015, ANN REPORT; R Core Team, 2013, R LANG ENV STAT COMP; Richards EL, 2011, BEHAV ECOL, V22, P738, DOI 10.1093/beheco/arr047; Robinson R. A., 2006, Acta Zoologica Sinica, V52, P550; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Roper TJ, 1997, APPL ANIM BEHAV SCI, V54, P207, DOI 10.1016/S0168-1591(96)01178-1; ROPER TJ, 1990, ANIM BEHAV, V39, P466, DOI 10.1016/S0003-3472(05)80410-5; Ruiz-Rodriguez M, 2013, OECOLOGIA, V173, P83, DOI 10.1007/s00442-013-2599-6; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schuck-Paim C, 2004, PLOS BIOL, V2, P2305, DOI 10.1371/journal.pbio.0020402; Schuck-Paim C, 2002, ANIM BEHAV, V64, P869, DOI 10.1006/anbe.2003.2003; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; SIMONSON I, 1992, J MARKETING RES, V29, P281, DOI 10.2307/3172740; Stephens DW, 2008, COGN AFFECT BEHAV NE, V8, P475, DOI 10.3758/CABN.8.4.475; STILES FG, 1976, CONDOR, V78, P10, DOI 10.2307/1366912; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Thomas C., 2007, DO DIFFERENT COLOURE; Thomas RJ, 2010, BEHAV ECOL, V21, P669, DOI 10.1093/beheco/arq037; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; Tryjanowski P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28575; Tryjanowski P, 2015, ENVIRON SCI POLLUT R, V22, P15097, DOI 10.1007/s11356-015-4723-0; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; VICKERY RK, 1995, GREAT BASIN NAT, V55, P177; VICKERY RK, 1992, GREAT BASIN NAT, V52, P145; Wagner H.O., 1946, Wilson Bulletin Ann Arbor, V58, P69; WHEELER TG, 1980, WILSON BULL, V92, P53; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; WILLSON MF, 1990, CONDOR, V92, P545, DOI 10.2307/1368671	70	4	4	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172422	10.1371/journal.pone.0172422	http://dx.doi.org/10.1371/journal.pone.0172422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212435	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424700048
J	Saczynska, V; Romanik, A; Florys, K; Cecuda-Adamczewska, V; Kesik-Brodacka, M; Smietanka, K; Olszewska, M; Domanska-Blicharz, K; Minta, Z; Szewczyk, B; Plucienniczak, G; Plucienniczak, A				Saczynska, Violetta; Romanik, Agnieszka; Florys, Katarzyna; Cecuda-Adamczewska, Violetta; Kesik-Brodacka, Malgorzata; Smietanka, Krzysztof; Olszewska, Monika; Domanska-Blicharz, Katarzyna; Minta, Zenon; Szewczyk, Boguslaw; Plucienniczak, Grazyna; Plucienniczak, Andrzej			A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies	PLOS ONE			English	Article							CONSERVED EPITOPE; VACCINES PROTECT; FERRETS; HA; RECOGNITION; INFECTIONS; CHALLENGE	The highly pathogenic ( HP) H5N1 avian influenza viruses ( AIVs) cause a mortality rate of up to 100% in infected chickens and pose a permanent pandemic threat. Attempts to obtain effective vaccines against H5N1 HPAIVs have focused on hemagglutinin ( HA), an immunodominant viral antigen capable of eliciting neutralizing antibodies. The vast majority of vaccine projects have been performed using eukaryotic expression systems. In contrast, we used a bacterial expression system to produce vaccine HA protein ( bacterial HA) according to our own design. The HA protein with the sequence of the H5N1 HPAIV strain was efficiently expressed in Escherichia coli, recovered in the form of inclusion bodies and refolded by dilution between two chromatographic purification steps. Antigenicity studies showed that the resulting antigen, referred to as rH5-E. coli, preserves conformational epitopes targeted by antibodies specific for H5-subtype HAs, inhibiting hemagglutination and/ or neutralizing influenza viruses in vitro. The proper conformation of this protein and its ability to form functional oligomers were confirmed by a hemagglutination test. Consistent with the biochemical characteristics, prime-boost immunizations with adjuvanted rH5-E. coli protected 100% and 70% of specific pathogen-free, layer-type chickens against challenge with homologous and heterologous H5N1 HPAIVs, respectively. The observed protection was related to the positivity in the FluAC H5 test ( IDVet) but not to hemagglutination-inhibiting antibody titers. Due to full protection, the effective contact transmission of the homologous challenge virus did not occur. Survivors from both challenges did not or only transiently shed the viruses, as established by viral RNA detection in oropharyngeal and cloacal swabs. Our results demonstrate that vaccination with rH5-E. coli could confer control of H5N1 HPAIV infection and transmission rates in chicken flocks, accompanied by reduced virus shedding. Moreover, the role of H5 subtype-specific neutralizing antibodies in anti-influenza immunity and a novel correlate of protection are indicated.	[Saczynska, Violetta; Romanik, Agnieszka; Florys, Katarzyna; Cecuda-Adamczewska, Violetta; Kesik-Brodacka, Malgorzata; Plucienniczak, Grazyna; Plucienniczak, Andrzej] Inst Biotechnol & Antibiot, Warsaw, Poland; [Smietanka, Krzysztof; Olszewska, Monika; Domanska-Blicharz, Katarzyna; Minta, Zenon] Natl Inst Vet Res, Dept Poultry Dis, Pulawy, Poland; [Szewczyk, Boguslaw] Univ Gdansk, Dept Recombinant Vaccines, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Szewczyk, Boguslaw] Med Univ Gdansk, Gdansk, Poland	Institute of Biotechnology & Antibiotics (IBA); National Veterinary Institute - National Research Institute; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Saczynska, V (corresponding author), Inst Biotechnol & Antibiot, Warsaw, Poland.	saczynskav@iba.waw.pl	Sączyńska, Violetta/C-2074-2019; Romanik-Chruścielewska, Agnieszka/AAW-6799-2020; Domanska-Blicharz, Katarzyna/H-1671-2011; Kęsik-Brodacka, Małgorzata/ABG-7355-2021; Romanik, Agnieszka/B-3364-2019; Florys, Katarzyna/B-7947-2019; Cecuda-Adamczewska, Violetta/ABC-3432-2021	Sączyńska, Violetta/0000-0003-1828-6783; Domanska-Blicharz, Katarzyna/0000-0002-0642-3931; Romanik, Agnieszka/0000-0002-8537-5041; Florys, Katarzyna/0000-0001-9199-7237; Cecuda-Adamczewska, Violetta/0000-0001-6967-2970; Szewczyk, Boguslaw/0000-0003-4957-4059				Aguilar-Yanez J M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011694; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; Du LY, 2013, J VIROL, V87, P2215, DOI 10.1128/JVI.02344-12; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gromadzka B, 2008, MOL CELL PROBE, V22, P301, DOI 10.1016/j.mcp.2008.09.003; Horthongkham Navin, 2007, J Immune Based Ther Vaccines, V5, P10, DOI 10.1186/1476-8518-5-10; Hvistendahl M, 2015, SCIENCE, V348, P741, DOI 10.1126/science.348.6236.741; ICTV, 2014, INT COMM TAX VIR; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Jegerlehner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078947; Kesik-Brodacka M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-109; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; Kopera E, 2014, ACTA BIOCHIM POL, V61, P597; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; OIE, 2012, MANUAL DIAGNOSTIC TE; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Saczynska V, 2014, ACTA BIOCHIM POL, V61, P561; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Velkov T, 2013, MOL IMMUNOL, V56, P705, DOI 10.1016/j.molimm.2013.07.010; Verhagen JH, 2015, SCIENCE, V347, P616, DOI 10.1126/science.aaa6724; Verma S, 2012, J VIROL, V86, P12283, DOI 10.1128/JVI.01596-12; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; WHO, 2021, CUMULATIVE NUMBER CO; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xie QM, 2009, POULTRY SCI, V88, P1608, DOI 10.3382/ps.2009-00092; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Xuan CL, 2011, PROTEIN CELL, V2, P997, DOI 10.1007/s13238-011-1134-y	48	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172008	10.1371/journal.pone.0172008	http://dx.doi.org/10.1371/journal.pone.0172008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212428	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700016
J	Leelossy, A; Meszaros, R; Kovacs, A; Lagzi, I; Kovacs, T				Leelossy, Adam; Meszaros, Robert; Kovacs, Attila; Lagzi, Istvan; Kovacs, Tibor			Numerical simulations of atmospheric dispersion of iodine-131 by different models	PLOS ONE			English	Article							PARTICLE DISPERSION; IDENTIFICATION; VALIDATION; CHEMISTRY; FLEXPART	Nowadays, several dispersion models are available to simulate the transport processes of air pollutants and toxic substances including radionuclides in the atmosphere. Reliability of atmospheric transport models has been demonstrated in several recent cases from local to global scale; however, very few actual emission data are available to evaluate model results in real-life cases. In this study, the atmospheric dispersion of I-131 emitted to the atmosphere during an industrial process was simulated with different models, namely the WRF-Chem Eulerian online coupled model and the HYSPLIT and the RAPTOR Lagrangian models. Although only limited data of I-131 detections has been available, the accuracy of modeled plume direction could be evaluated in complex late autumn weather situations. For the studied cases, the general reliability of models has been demonstrated. However, serious uncertainties arise related to low level inversions, above all in case of an emission event on 4 November 2011, when an important wind shear caused a significant difference between simulated and real transport directions. Results underline the importance of prudent interpretation of dispersion model results and the identification of weather conditions with a potential to cause large model errors.	[Leelossy, Adam; Meszaros, Robert; Kovacs, Attila] Eotvos Lorand Univ, Dept Meteorol, Budapest, Hungary; [Lagzi, Istvan] Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary; [Kovacs, Tibor] Univ Pannonia, Inst Radiochem & Radioecol, Veszprem, Hungary	Eotvos Lorand University; Budapest University of Technology & Economics; University of Pannonia	Meszaros, R (corresponding author), Eotvos Lorand Univ, Dept Meteorol, Budapest, Hungary.	mrobi@nimbus.elte.hu	Leelossy, Adam/I-3183-2017; Kovacs, Tibor/H-1564-2017; Robert, Meszaros/I-5969-2017	Leelossy, Adam/0000-0001-9583-0127; Kovacs, Tibor/0000-0003-2606-0397; Robert, Meszaros/0000-0002-0550-9266	National Research, Development and Innovation Office of Hungary [K104666, K10909]	National Research, Development and Innovation Office of Hungary	Support was provided by the National Research, Development and Innovation Office of Hungary No. K104666 to IL and the National Research, Development and Innovation Office of Hungary No. K10909 to RM.	Baklanov A, 2014, ATMOS CHEM PHYS, V14, P317, DOI 10.5194/acp-14-317-2014; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler R, 2015, J ENVIRON RADIOACTIV, V139, P172, DOI 10.1016/j.jenvrad.2013.09.014; Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027; Hu XM, 2012, ATMOS ENVIRON, V46, P354, DOI 10.1016/j.atmosenv.2011.09.054; JANJIC Z.I., 2002, NCEP OFFICE NOTE, V437, P61; Jiang F, 2008, ATMOS ENVIRON, V42, P8717, DOI 10.1016/j.atmosenv.2008.08.034; Koracin D, 2011, J AIR WASTE MANAGE, V61, P660, DOI 10.3155/1047-3289.61.6.660; Leelossy A, 2014, CENT EUR J GEOSCI, V6, P257, DOI 10.2478/s13533-012-0188-6; Leelossy A, 2013, IDOJARAS, V117, P435; McGowan H, 2008, ATMOS ENVIRON, V42, P6915, DOI 10.1016/j.atmosenv.2008.05.053; Meszaros R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19915; Moreira V, 2011, ATMOS POLLUT RES; Ngan F, 2015, J APPL METEOROL CLIM, V54, P1162, DOI 10.1175/JAMC-D-14-0247.1; NOAA, NCEP GDAS GFS GLOB T; NOAA, WORK GROUP 11 ATM CH; Ott A De Vismes, 2014, ICRER 2014 3 INT C R; Reuters, 2011, LOW LEV RAD PART EUR; Ryall DB, 1998, ATMOS ENVIRON, V32, P4265, DOI 10.1016/S1352-2310(98)00177-0; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Tie XX, 2007, ATMOS ENVIRON, V41, P1989, DOI 10.1016/j.atmosenv.2006.10.053; Tuccella P, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016302; Wang XY, 2010, ATMOS ENVIRON, V44, P660, DOI 10.1016/j.atmosenv.2009.11.011; Wotawa G., 2014, S INT SAF VIENN AUST	26	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172312	10.1371/journal.pone.0172312	http://dx.doi.org/10.1371/journal.pone.0172312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207853	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500119
J	Li, WF; Chiu, KH; Tien, YC; Tsai, SF; Shih, LJ; Lee, CH; Toullec, JY; Lee, CY				Li, Wenfeng; Chiu, Kuo-Hsun; Tien, Yi-Chun; Tsai, Shih-Fu; Shih, Li-Jane; Lee, Chien-Hsun; Toullec, Jean-Yves; Lee, Chi-Ying			Differential effects of silencing crustacean hyperglycemic hormone gene expression on the metabolic profiles of the muscle and hepatopancreas in the crayfish Procambarus clarkii	PLOS ONE			English	Article							MOLT-INHIBITING HORMONE; HIGH-AFFINITY BINDING; CARBOHYDRATE-METABOLISM; CARCINUS-MAENAS; SHORE CRAB; CHH; HEMOLYMPH; EYESTALK; LOBSTER; LOCALIZATION	In order to functionally characterize the metabolic roles of crustacean hyperglycemic hormone (CHH), gene expression of CHH in the crayfish (Procambarus clarkii) was knocked down by in vivo injection of CHH double-stranded RNA (dsRNA), followed by metabolomic analysis of 2 CHH target tissues (the muscle and hepatopancreas) using nuclear magnetic resonance spectroscopy. Compared to the levels in untreated and saline-injected (SAI) animals, levels of CHH transcript, but not those of molt-inhibiting hormone (a CHH-family peptide), in the eyestalk ganglia of CHH dsRNA-injected (DSI) animals were significantly decreased at 24, 48, and 72 hour post injection (hpi), with concomitant changes in levels of CHH peptide in the sinus gland (a neurohemal organ) and hemolymph. Green fluorescence protein (GFP) dsRNA failed to affect levels of CHH transcript in the eyestalk ganglia of GFP DSI animals. Number of metabolites whose levels were significantly changed by CHH dsRNA was 149 and 181 in the muscle and 24 and 12 in the hepatopancreas, at 24 and 48 hpi, respectively. Principal component analysis of these metabolites show that metabolic effects of silencing CHH gene expression were more pronounced in the muscle (with the cluster of CHH DSI group clearly being separated from that of SAI group at 24 hpi) than in the hepatopancreas. Moreover, pathway analysis of the metabolites closely related to carbohydrate and energy metabolism indicate that, for CHH DSI animals at 24 hpi, metabolic profile of the muscle was characterized by reduced synthesis of NAD(+) and adenine ribonucleotides, diminished levels of ATP, lower rate of utilization of carbohydrates through glycolysis, and a partially rescued TCA cycle, whereas that of the hepatopancreas by unaffected levels of ATP, lower rate of utilization of carbohydrates, and increased levels of ketone bodies. The combined results of metabolic changes in response to silenced CHH gene expression reveal that metabolic functions of CHH on the muscle and hepatopancreas are more diverse than previously thought and are differential between the two tissues.	[Li, Wenfeng; Tien, Yi-Chun; Tsai, Shih-Fu; Lee, Chien-Hsun; Lee, Chi-Ying] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan; [Chiu, Kuo-Hsun] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Shih, Li-Jane] Taoyuan Armed Forces Gen Hosp, Dept Lab Med, Taoyuan, Taiwan; [Toullec, Jean-Yves] Univ Paris 06, UPMC, Sorbonne Univ, UMR CNRS 7144,Equipe ABICE,Stn Biol Roscoff, Roscoff, France; [Toullec, Jean-Yves] CNRS, UMR 7144, Adaptat & Divers Milieu Marin, Stn Biol Roscoff, Roscoff, France	National Changhua University of Education; National Kaohsiung University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Lee, CY (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan.	bicylee@cc.ncue.edu.tw		Lee, Chi-Ying/0000-0002-9591-1370	Ministry of Science and Technology, Taiwan [102-2311-B-018-002, 104-2311-B-018-002, 104-2811-B-018-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The present study was supported financially by Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/) through grants (102-2311-B-018-002 and 104-2311-B-018-002) to C-YL. WL was supported by a postdoctoral fellowship (104-2811-B-018-001) from Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chang CC, 2010, GEN COMP ENDOCR, V167, P68, DOI 10.1016/j.ygcen.2010.02.013; Chang ES, 1998, GEN COMP ENDOCR, V111, P359, DOI 10.1006/gcen.1998.7120; Chang ES, 1999, J COMP NEUROL, V414, P50; Chen HY, 2007, GEN COMP ENDOCR, V151, P72, DOI 10.1016/j.ygcen.2006.11.016; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chiu KH, 2011, FISH PHYSIOL BIOCHEM, V37, P701, DOI 10.1007/s10695-011-9470-7; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2011, GEN COMP ENDOCR, V170, P480, DOI 10.1016/j.ygcen.2010.11.002; Chung JS, 2006, GEN COMP ENDOCR, V147, P206, DOI 10.1016/j.ygcen.2006.01.002; Cooke I.M., 1982, BIOL CRUSTACEA VOL 3, P206; DeKleijn DPV, 1995, COMP BIOCHEM PHYS B, V112, P573, DOI 10.1016/0305-0491(95)00126-3; GORGELSKALLEN JL, 1985, CELL TISSUE RES, V241, P361, DOI 10.1007/BF00217181; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3; Katayama H, 2009, J EXP BIOL, V212, P542, DOI 10.1242/jeb.022889; KELLER R, 1973, GEN COMP ENDOCR, V20, P572, DOI 10.1016/0016-6480(73)90089-0; Keller R., 1992, CELL MOL LIFE SCI, V48, P439, DOI DOI 10.1007/BF01928162; KUMMER G, 1993, PEPTIDES, V14, P103, DOI 10.1016/0196-9781(93)90016-A; Lee CY, 2014, J MAR SCI TECH-TAIW, V22, P75, DOI 10.6119/JMST-013-0308-1; Lehninger AL, PRINCIPLES BIOCH, P2; Lin LJ, 2013, COMP BIOCHEM PHYS A, V164, P327, DOI 10.1016/j.cbpa.2012.11.009; Liu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134983; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzon S, 2004, J EXP BIOL, V207, P4205, DOI 10.1242/jeb.01264; Marco HG, 2000, PEPTIDES, V21, P19, DOI 10.1016/S0196-9781(99)00171-0; Montagne N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-62; Moran LA, 1994, BIOCHEMISTRY; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Nagai C, 2011, GEN COMP ENDOCR, V172, P293, DOI 10.1016/j.ygcen.2011.03.019; Nakatsuji T, 2000, ZOOL SCI, V17, P1129, DOI 10.2108/zsj.17.1129; PARVATHY K, 1972, MAR BIOL, V14, P58, DOI 10.1007/BF00365782; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P343, DOI 10.1016/0300-9629(93)90523-7; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P405, DOI 10.1016/0300-9629(93)90234-U; SANTOS EA, 1993, J COMP PHYSIOL B, V163, P374; SEDLMEIER D, 1981, GEN COMP ENDOCR, V45, P82, DOI 10.1016/0016-6480(81)90172-6; SEDLMEIER D, 1987, COMP BIOCHEM PHYS A, V87, P423, DOI 10.1016/0300-9629(87)90146-0; Sedlmeier D, 1981, BIOCHEM SOC T, V9, P240; Soyez D, 1997, ANN NY ACAD SCI, V814, P319, DOI 10.1111/j.1749-6632.1997.tb46174.x; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Teng Q, 2013, AQUAT TOXICOL, V130, P184, DOI 10.1016/j.aquatox.2013.01.011; WEBSTER SG, 1993, P ROY SOC B-BIOL SCI, V251, P53, DOI 10.1098/rspb.1993.0008; Webster SG, 1996, J EXP BIOL, V199, P1579; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wu HJ, 2012, ZOOL STUD, V51, P288; Wu SH, 2012, COMP BIOCHEM PHYS A, V161, P463, DOI 10.1016/j.cbpa.2012.01.007; Yeh FC, 2006, COMP BIOCHEM PHYS B, V144, P11, DOI 10.1016/j.cbpb.2006.01.007; Zou HS, 2003, J EXP ZOOL PART A, V298A, P44, DOI 10.1002/jez.a.10273	48	5	6	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172557	10.1371/journal.pone.0172557	http://dx.doi.org/10.1371/journal.pone.0172557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207859	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500146
J	Hileman, ET; King, RB; Adamski, JM; Anton, TG; Bailey, RL; Baker, SJ; Bieser, ND; Bell, TA; Bissell, KM; Bradke, DR; Campa, H; Casper, GS; Cedar, K; Cross, MD; DeGregorio, BA; Dreslik, MJ; Faust, LJ; Harvey, DS; Hay, RW; Jellen, BC; Johnson, BD; Johnson, G; Kiel, BD; Kingsbury, BA; Kowalski, MJ; Lee, YM; Lentini, AM; Marshall, JC; Mauger, D; Moore, JA; Paloski, RA; Phillips, CA; Pratt, PD; Preney, T; Prior, KA; Promaine, A; Redmer, M; Reinert, HK; Rouse, JD; Shoemaker, KT; Sutton, S; VanDeWalle, TJ; Weatherhead, PJ; Wynn, D; Yagi, A				Hileman, Eric T.; King, Richard B.; Adamski, John M.; Anton, Thomas G.; Bailey, Robyn L.; Baker, Sarah J.; Bieser, Nickolas D.; Bell, Thomas A., Jr.; Bissell, Kristin M.; Bradke, Danielle R.; Campa, Henry, III; Casper, Gary S.; Cedar, Karen; Cross, Matthew D.; DeGregorio, Brett A.; Dreslik, Michael J.; Faust, Lisa J.; Harvey, Daniel S.; Hay, Robert W.; Jellen, Benjamin C.; Johnson, Brent D.; Johnson, Glenn; Kiel, Brooke D.; Kingsbury, Bruce A.; Kowalski, Matthew J.; Lee, Yu Man; Lentini, Andrew M.; Marshall, John C.; Mauger, David; Moore, Jennifer A.; Paloski, Rori A.; Phillips, Christopher A.; Pratt, Paul D.; Preney, Thomas; Prior, Kent A.; Promaine, Andrew; Redmer, Michael; Reinert, Howard K.; Rouse, Jeremy D.; Shoemaker, Kevin T.; Sutton, Scott; VanDeWalle, Terry J.; Weatherhead, Patrick J.; Wynn, Doug; Yagi, Anne			Climatic and geographic predictors of life history variation in Eastern Massasauga (Sistrurus catenatus): A range-wide synthesis	PLOS ONE			English	Article							BODY-SIZE VARIATION; HABITAT SELECTION; REPRODUCTIVE STRATEGIES; NORTHERN POPULATION; THERMAL ECOLOGY; SPATIAL ECOLOGY; BERGMANNS RULE; RATTLESNAKE; SNAKES; GROWTH	Elucidating how life history traits vary geographically is important to understanding variation in population dynamics. Because many aspects of ectotherm life history are climate-dependent, geographic variation in climate is expected to have a large impact on population dynamics through effects on annual survival, body size, growth rate, age at first reproduction, size-fecundity relationship, and reproductive frequency. The Eastern Massasauga (Sistrurus catenatus) is a small, imperiled North American rattlesnake with a distribution centered on the Great Lakes region, where lake effects strongly influence local conditions. To address Eastern Massasauga life history data gaps, we compiled data from 47 study sites representing 38 counties across the range. We used multimodel inference and general linear models with geographic coordinates and annual climate normals as explanatory variables to clarify patterns of variation in life history traits. We found strong evidence for geographic variation in six of nine life history variables. Adult female snout-vent length and neonate mass increased with increasing mean annual precipitation. Litter size decreased with increasing mean temperature, and the size-fecundity relationship and growth prior to first hibernation both increased with increasing latitude. The proportion of gravid females also increased with increasing latitude, but this relationship may be the result of geographically varying detection bias. Our results provide insights into ectotherm life history variation and fill critical data gaps, which will inform Eastern Massasauga conservation efforts by improving biological realism for models of population viability and climate change.	[Hileman, Eric T.; King, Richard B.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Adamski, John M.] Seneca Pk Zoo, Rochester, NY USA; [Anton, Thomas G.] Field Museum, Dept Zool, Chicago, IL USA; [Bailey, Robyn L.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Baker, Sarah J.; Dreslik, Michael J.; Phillips, Christopher A.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL USA; [Bieser, Nickolas D.; Kingsbury, Bruce A.; Marshall, John C.] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA; [Bell, Thomas A., Jr.] New York State Dept Environm Conservat, Albany, NY USA; [Bissell, Kristin M.] Michigan Dept Nat Resources, Wildlife Div, Grass Lake, MI USA; [Bradke, Danielle R.; Kiel, Brooke D.; Moore, Jennifer A.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Campa, Henry, III] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Casper, Gary S.] Univ Wisconsin, Field Stn, Saukville, WI USA; [Cedar, Karen] Ojibway Nat Ctr, Windsor, ON, Canada; [Cross, Matthew D.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [DeGregorio, Brett A.; Harvey, Daniel S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Faust, Lisa J.] Lincoln Pk Zoo, Alexander Ctr Appl Populat Biol, Chicago, IL USA; [Hay, Robert W.] Turtles Tomorrow, Madison, WI USA; [Jellen, Benjamin C.] Urban Chestnut Brewing Co, St Louis, MO USA; [Johnson, Brent D.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Johnson, Glenn] SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA; [Kowalski, Matthew J.] Chesapeake Bay Fdn, Richmond, VA USA; [Lee, Yu Man] Michigan State Univ Extens, Michigan Nat Features Inventory, Lansing, MI USA; [Lentini, Andrew M.] Toronto Zoo, Scarborough, ON, Canada; [Mauger, David] Forest Preserve Dist Lake Cty, Libertyville, IL USA; [Paloski, Rori A.] Wisconsin Dept Nat Resources, Bur Nat Heritage Conservat, Madison, WI USA; [Pratt, Paul D.; Preney, Thomas] Ojibway Nat Ctr, Windsor, ON, Canada; [Prior, Kent A.] Pk Canada, Gatineau, PQ, Canada; [Promaine, Andrew; Sutton, Scott] Pk Canada, Midland, ON, Canada; [Redmer, Michael] US Fish & Wildlife Serv, Chicago, IL USA; [Reinert, Howard K.] Coll New Jersey, Dept Biol, Ewing, NJ USA; [Rouse, Jeremy D.] Ontario Minist Nat Resources, Parry Sound, ON, Canada; [Shoemaker, Kevin T.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [VanDeWalle, Terry J.] Stantec Consulting Serv Inc, Independence, IA USA; [Weatherhead, Patrick J.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Wynn, Doug] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Yagi, Anne] Minist Nat Resources, Vineland Stn, ON, Canada	Northern Illinois University; Field Museum of Natural History (Chicago); Cornell University; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Indiana University Purdue University Fort Wayne; Grand Valley State University; Michigan State University; University of Wisconsin System; University System of Ohio; Bowling Green State University; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; Michigan State University; United States Department of the Interior; US Fish & Wildlife Service; College of New Jersey; Ministry of Natural Resources & Forestry; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University; Natural Resources Canada	Hileman, ET (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	hileman.et@gmail.com	Dreslik, Michael J/G-5325-2012	Kingsbury, Bruce/0000-0003-3375-0193; Hileman, Eric/0000-0002-7044-370X; Bradke, Danielle/0000-0002-3037-1377	U.S. Fish and Wildlife Service; Edward Lowe Foundation; Northern Illinois University; Columbus Zoo; EMR SSP; Fort Wayne Children's Zoo; Potawatomi Zoo	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Edward Lowe Foundation; Northern Illinois University; Columbus Zoo; EMR SSP; Fort Wayne Children's Zoo; Potawatomi Zoo	This work was supported by U.S. Fish and Wildlife Service, Edward Lowe Foundation, Northern Illinois University, Columbus Zoo, EMR SSP, Fort Wayne Children's Zoo, and Potawatomi Zoo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adams DC, 2008, EVOLUTION, V62, P413, DOI 10.1111/j.1558-5646.2007.00297.x; Adler K. K., 1960, Herpetologica, V16, P38; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aldridge R.D., 2008, BIOL RATTLESNAKES, P403; ALDRIDGE RD, 1979, HERPETOLOGICA, V35, P256; Allender MC, 2006, J WILDLIFE DIS, V42, P107, DOI 10.7589/0090-3558-42.1.107; Anderson D. R., 2008, MODEL BASED INFERENC; Angilletta MJ, 2006, AM NAT, V168, pE123, DOI 10.1086/507880; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2016, AICCMODAVG MODEL SEL; Anton TG, 1999, 2 INT S WORKSH CONS, P94; Anton Thomas G., 2000, Herpetological Review, V31, P248; Anton Thomas G., 1993, P71; Arguez A, 2012, B AM METEOROL SOC, V93, P1687, DOI 10.1175/BAMS-D-11-00197.1; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Ashton KG, 2001, EVOLUTION, V55, P2523; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D., 1996, Society for Experimental Biology Seminar Series, V59, P183; BAILEY RA, 2010, THESIS; Bailey RL, 2011, HERPETOLOGICA, V67, P167, DOI 10.1655/HERPETOLOGICA-D-10-00005.1; Baron JP, 2013, FUNCT ECOL, V27, P173, DOI 10.1111/1365-2435.12023; BEAUPRE SJ, 1995, HERPETOLOGICA, V51, P45; Beissinger S. R., 2002, POPULATION VIABILITY; Bielema BJ., 1973, THESIS; Bieser N.D., 2008, THESIS PURDUE U; Bissell K. M., 2006, THESIS; BLACKBURN D G, 1985, Amphibia-Reptilia, V6, P259, DOI 10.1163/156853885X00290; BLEM C R, 1981, Brimleyana, P117; BLEM CR, 1982, COPEIA, P961, DOI 10.2307/1444108; Bonnet X, 1996, CAN J ZOOL, V74, P233, DOI 10.1139/z96-029; Brennan JM, 2004, E MASSASUGA RATTLESN; Bronikowski AM, 1999, ECOLOGY, V80, P2314, DOI 10.1890/0012-9658(1999)080[2314:TEEOLH]2.0.CO;2; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Brown GP, 2007, OECOLOGIA, V154, P361, DOI 10.1007/s00442-007-0842-8; Brown RP, 1999, ECOGRAPHY, V22, P277, DOI 10.1111/j.1600-0587.1999.tb00503.x; BROWN WS, 1991, HERPETOLOGICA, V47, P101; BURKETT RAY D., 1966, UNIV KANS PUBLICATIONS MUS NATUR HIST, V17, P435; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calder WA., 1984, SIZE FUNCTION LIFE H; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Conant R., 1951, THE REPTILES OF OHIO; CONANT ROGER, 1938, AMER MIDL NAT, V20, P1, DOI 10.2307/2485190; COSEWIC, COSEWIC ASS STAT REP; Cross M., 2009, THESIS; Cross MD, 2015, AM MIDL NAT, V173, P346, DOI 10.1674/amid-173-02-346-362.1; De Block M, 2003, J EVOLUTION BIOL, V16, P986, DOI 10.1046/j.1420-9101.2003.00581.x; DeGregorio B.A., 2008, THESIS; DeGregorio BA, 2011, HERPETOL CONSERV BIO, V6, P372; Degregorio BA, 2011, HERPETOLOGICA, V67, P71, DOI 10.1655/09-049R1.1; DILLER LV, 1984, HERPETOLOGICA, V40, P182; Dreslik M. J., 2005, THESIS; Dreslik MJ, 2011, 14 ILL NAT HIS SURV; Du WG, 2010, BIOL J LINN SOC, V101, P59, DOI 10.1111/j.1095-8312.2010.01492.x; Durbian FE, 2008, J WILDLIFE MANAGE, V72, P754, DOI 10.2193/2007-710; EICHENLAUB VL, 1979, WEATHER CLIMATE GREA; Faust L., 2011, RANGE WIDE EXTINCTIO; Fischer K, 2002, EVOL ECOL, V16, P333, DOI 10.1023/A:1020271600025; FITCH H S, 1985, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Food and Drug Administration, 2016, FED REG; Foster MA, 2009, HERPETOL CONSERV BIO, V4, P48; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; GREGORY PT, 1993, COPEIA, P946; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Gvozdik V, 2008, BIOL J LINN SOC, V95, P539; Harvey DS, 2011, CAN J ZOOL, V89, P60, DOI 10.1139/Z10-094; Harvey DS, 2010, ECOSCIENCE, V17, P411, DOI 10.2980/17-4-3363; Harvey DS, 2006, BIOL CONSERV, V130, P206, DOI 10.1016/j.biocon.2005.12.015; Harvey DS, 2006, J HERPETOL, V40, P66, DOI 10.1670/89-05A.1; Harvey DS., 2006, THESIS; Haufler JB, 2002, WILDL SOC TECH REV, V02, P33; Hay OP., 1887, AM NAT, V21, P211; Hecht SE, 2007, THESIS; Hileman ET, 2015, HERPETOL CONSERV BIO, V10, P654; Holycross AT, 2002, J HERPETOL, V36, P454, DOI 10.2307/1566190; Jaeger CP, 2016, ECOL EVOL, V6, P3991, DOI 10.1002/ece3.2159; Jaffe AL, 2016, BIOL J LINN SOC, V117, P760, DOI 10.1111/bij.12711; Jellen BC, 2005, THESIS; Johnson BD, 2016, J HERPETOL, V50, P534, DOI 10.1670/121; Johnson G, 1995, THESIS; Jones PC, 2016, J HERPETOLO IN PRESS; Jones PC, 2012, J WILDLIFE MANAGE, V76, P1576, DOI 10.1002/jwmg.418; KEENLYNE K D, 1973, Journal of Herpetology, V7, P381, DOI 10.2307/1562875; KEENLYNE K D, 1973, Journal of Herpetology, V7, P382, DOI 10.2307/1562876; Keenlyne KD, 1968, THESIS; Keenlyne KD, 1978, MIDLAND NATURALIST, V100, P368; King R, 2004, HERPETOLOGICA, V60, P429, DOI 10.1655/03-01; King RB, 2006, CAN J ZOOL, V84, P108, DOI 10.1139/Z05-182; King RB, 2000, J HERPETOL, V34, P148, DOI 10.2307/1565253; King Richard B., 2008, South American Journal of Herpetology, V3, P155, DOI 10.2994/1808-9798(2008)3[155:RCOACP]2.0.CO;2; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Kutner M., 2004, APPL LINEAR STAT MOD; Lourdais O, 2004, OIKOS, V104, P551, DOI 10.1111/j.0030-1299.2004.12961.x; Madsen T, 2006, AUSTRAL ECOL, V31, P30, DOI 10.1111/j.1442-9993.2006.01540.x; MADSEN T, 1993, EVOLUTION, V47, P321, DOI 10.1111/j.1558-5646.1993.tb01222.x; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Marshall JC, 2006, HERPETOLOGICA, V62, P141, DOI 10.1655/04-12.1; Martin William Henry, 2002, P285; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Middleton J, 2004, GEORGIAN BAY ISLANDS; Miller P, 2006, 3 INT E MASS S POP V; Moore J. M., 2004, THESIS; Moore JA, 2006, COPEIA, P742, DOI 10.1643/0045-8511(2006)6[742:SEAMHS]2.0.CO;2; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; Parent C, 2000, OECOLOGIA, V125, P170, DOI 10.1007/s004420000442; PARENT C. E., 1997, THESIS; Parker S, 1999, 2 INT S WORKSH CONS, P63; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pomara LY, 2014, GLOBAL CHANGE BIOL, V20, P2087, DOI 10.1111/gcb.12510; R Core Team, 2016, R LANG ENV STAT COMP; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; REINERT HK, 1981, AM MIDL NAT, V105, P393, DOI 10.2307/2424761; Reinert HK, 1978, THESIS; Roff Derek A., 1992; Roitberg ES, 2013, EVOL BIOL, V40, P420, DOI 10.1007/s11692-013-9247-2; Rouse JD, 2006, THESIS; Ryberg WA, 2015, J FISH WILDL MANAG, V6, P350, DOI 10.3996/122014-JFWM-093; Sage JR, 2005, THESIS; Scharf I, 2015, GLOBAL ECOL BIOGEOGR, V24, P396, DOI 10.1111/geb.12244; SEIGEL R A, 1987, P210; SEIGEL RA, 1985, J ANIM ECOL, V54, P497, DOI 10.2307/4494; Shepard DB, 2004, AM MIDL NAT, V152, P360, DOI 10.1674/0003-0031(2004)152[0360:PPADON]2.0.CO;2; SHINE R, 1981, COPEIA, P14, DOI 10.2307/1444037; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 2003, P ROY SOC B-BIOL SCI, V270, P995, DOI 10.1098/rspb.2002.2307; Shine R., 1985, Biology of Reptilia, V15, P605; Shoemaker KT, 2010, J WILDLIFE MANAGE, V74, P504, DOI 10.2193/2008-519; Smith C.A., 2009, THESIS; STAMPS JA, 1992, OECOLOGIA, V92, P503, DOI 10.1007/BF00317842; Stearns S.C., 1992, pi; Swanson P. L., 1933, Copeia Ann Arbor, V1933, P37, DOI 10.2307/1436191; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tobiasz EC, 1941, COPEIA, V1941, P269; Tuttle KN, 2014, COPEIA, P130, DOI 10.1643/CH-13-119; Tuttle KN, 2012, CAN J ZOOL, V90, P758, DOI 10.1139/Z2012-044; Volynchik Stanislav, 2014, International Journal of Zoology, P795387; Watkins-Colwell Gregory J., 1995, Herpetological Review, V26, P40; Weatherhead PJ, 2009, J HERPETOL, V43, P693, DOI 10.1670/08-244.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wittenberg RD, 2014, HERPETOLOGICA, V70, P171, DOI 10.1655/HERPETOLOGICA-D-12-00074R2; WORTHINGTON RD, 1982, J HERPETOL, V16, P332, DOI 10.2307/1563733; WRIGHT BERTRAND ALBERT, 1941, AMER MIDLAND NAT, V25, P659, DOI 10.2307/2420721; Zuffi MAL, 2009, BIOL J LINN SOC, V96, P383, DOI 10.1111/j.1095-8312.2008.01124.x	150	11	11	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172011	10.1371/journal.pone.0172011	http://dx.doi.org/10.1371/journal.pone.0172011			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196149	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900043
J	Carment, L; Maier, MA; Sangla, S; Guiraud, V; Mesure, S; Vidailhet, M; Lindberg, PG; Bleton, JP				Carment, Loic; Maier, Marc A.; Sangla, Sophie; Guiraud, Vincent; Mesure, Serge; Vidailhet, Marie; Lindberg, Pavel G.; Bleton, Jean-Pierre			Does dystonic muscle activity affect sense of effort in cervical dystonia?	PLOS ONE			English	Article							SENSORIMOTOR INTEGRATION; WRITERS CRAMP; VIBRATION; MOVEMENT; FORCE; TORTICOLLIS; THERAPY	Background Focal dystonia has been associated with deficient processing of sense of effort cues. However, corresponding studies are lacking in cervical dystonia (CD). We hypothesized that dystonic muscle activity would perturb neck force control based on sense of effort cues. Methods Neck extension force control was investigated in 18 CD patients with different clinical features (7 with and 11 without retrocollis) and in 19 control subjects. Subjects performed force matching and force-maintaining tasks at 5% and 20% of maximum voluntary contraction (MVC). Three task conditions were tested: i) with visual force feedback, ii) withoutvisual feedback (requiring use of sense of effort), iii) without visual feedback, but with neck extensor muscle vibration (modifying muscle afferent cues). Trapezius muscle activity was recorded using electromyography (EMG). Results CD patients did not differ in task performance from healthy subjects when using visual feedback (ANOVA, p>0.7). In contrast, when relying on sense of effort cues (without visual feedback, 5% MVC), force control was impaired in patients without retrocollis (p = 0.006), but not in patients with retrocollis (p>0.2). Compared to controls, muscle vibration without visual feedback significantly affected performance in patients with retrocollis (p<0.001), but not in patients without retrocollis. Extensor EMG during rest, included as covariate in ANOVA, explained these group differences. Conclusion This study shows that muscle afferent feedback biases sense of effort cues when controlling neck forces in patients with CD. The bias acts on peripheral or central sense of effort cues depending on whether the task involves dystonic muscles. This may explain why patients with retrocollis more accurately matched isometric neck extension forces. This highlights the need to consider clinical features (pattern of dystonic muscles) when evaluating sensorimotor integration in CD.	[Carment, Loic; Maier, Marc A.; Lindberg, Pavel G.] Univ Paris 05, FR3636, Sorbonne Paris Cite, CNRS, Paris, France; [Maier, Marc A.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Sangla, Sophie; Bleton, Jean-Pierre] Fondat OPH Rothschild, Serv Neurol, Paris, France; [Guiraud, Vincent] Univ Paris 05, Sorbonne Paris Cite, INSERM U894, Paris, France; [Guiraud, Vincent] Hop St Anne, Serv Neurol, Paris, France; [Guiraud, Vincent] Hop St Anne, Unite Neurovasc, Paris, France; [Mesure, Serge] Aix Marseille Univ, CNRS, UMR 7287, Inst Sci Mouvement, Marseille, France; [Vidailhet, Marie] UPMC Univ Paris 06, UMR S 1127, Sorbonne Univ, Paris, France; [Vidailhet, Marie] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Lindberg, Pavel G.] Inserm U894, Ctr Psychiat & Neurosci, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Carment, L (corresponding author), Univ Paris 05, FR3636, Sorbonne Paris Cite, CNRS, Paris, France.	loic.carment@inserm.fr	Lindberg, Pavel/P-9792-2019; MESURE, Serge/CAF-8351-2022; Maier, Marc/HGU-9498-2022; Lindberg, Pavel G/E-5926-2017	Lindberg, Pavel/0000-0001-6976-6387; Lindberg, Pavel G/0000-0001-6976-6387; Lindberg, Pavel/0000-0002-7507-7817; BLETON, Jean-Pierre/0000-0002-2313-2263	Rothschild Foundation Hospital; Association Frangaise pour la Recherche et I'Evaluation en Kinesitherapie	Rothschild Foundation Hospital; Association Frangaise pour la Recherche et I'Evaluation en Kinesitherapie	This work was supported by the Rothschild Foundation Hospital and the Association Frangaise pour la Recherche et I'Evaluation en Kinesitherapie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Avanzino L, 2015, NEUROPSYCHOLOGIA, V79, P288, DOI 10.1016/j.neuropsychologia.2015.07.008; Avanzino L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01000; Beck S, 2009, J APPL PHYSIOL, V107, P1513, DOI 10.1152/japplphysiol.91580.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleton JP, 2014, MOVEMENT DISORD, V29, P130, DOI 10.1002/mds.25690; Boccagni C, 2008, NEUROL SCI, V29, P375, DOI 10.1007/s10072-008-1033-z; Boyce MJ, 2012, PARKINSONISM RELAT D, V18, P635, DOI 10.1016/j.parkreldis.2012.02.007; Buccolieri A, 2004, MOVEMENT DISORD, V19, P681, DOI 10.1002/mds.10711; Gregori B, 2008, CLIN NEUROPHYSIOL, V119, P273, DOI 10.1016/j.clinph.2007.10.007; KAJI R, 1995, ANN NEUROL, V38, P155, DOI 10.1002/ana.410380206; Lekhel H, 1997, BRAIN, V120, P583, DOI 10.1093/brain/120.4.583; Obermann M, 2010, MOVEMENT DISORD, V25, P2627, DOI 10.1002/mds.23321; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Ronsse R, 2009, J NEUROSCI, V29, P8419, DOI 10.1523/JNEUROSCI.5734-08.2009; Rosenkranz K, 2009, J NEUROSCI, V29, P14627, DOI 10.1523/JNEUROSCI.2094-09.2009; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Sadnicka A, 2014, CEREBELLUM, V13, P558, DOI 10.1007/s12311-014-0569-0; Shaikh AG, 2016, BRAIN, V139, P2590, DOI 10.1093/brain/aww141; van den Dool J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-85; Vo A, 2015, CEREB CORTEX, V25, P3086, DOI 10.1093/cercor/bhu104; Zittel S, 2015, J NEUROL, P1	25	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172019	10.1371/journal.pone.0172019	http://dx.doi.org/10.1371/journal.pone.0172019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192488	Green Submitted, gold, Green Published			2022-12-26	WOS:000394423800060
J	Kang, JY; Chadchankar, J; Vien, TN; Mighdoll, MI; Hyde, TM; Mather, RJ; Deeb, TZ; Pangalos, MN; Brandon, NJ; Dunlop, J; Moss, SJ				Kang, Ji-Yong; Chadchankar, Jayashree; Vien, Thuy N.; Mighdoll, Michelle I.; Hyde, Thomas M.; Mather, Robert J.; Deeb, Tarek Z.; Pangalos, Menelas N.; Brandon, Nicholas J.; Dunlop, John; Moss, Stephen J.			Deficits in the activity of presynaptic gamma-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMORTEM HUMAN BRAIN; GABA(B) RECEPTOR; MOUSE MODEL; METABOTROPIC GLUTAMATE; SUSHI DOMAINS; KNOCKOUT MICE; PROTEIN; EXPRESSION; FMR1; GENE	The behavioral and anatomical deficits seen in fragile X syndrome (FXS) are widely believed to result from imbalances in the relative strengths of excitatory and inhibitory neurotransmission. Although modified neuronal excitability is thought to be of significance, the contribution that alterations in GABAergic inhibition play in the pathophysiology of FXS are ill defined. Slow sustained neuronal inhibition is mediated by alpha-aminobutyric acid type B (GABAB) receptors, which are heterodimeric G-protein-coupled receptors constructed from R1a and R2 or R1b and R2 subunits. Via the activation of Gi/o, they limit cAMP accumulation, diminish neurotransmitter release, and induce neuronal hyperpolarization. Here we reveal that selective deficits in R1a subunit expression are seen in Fmr1 knock-out mice (KO) mice, a widely used animal model of FXS, but the levels of the respective mRNAs were unaffected. Similar trends of R1a expression were seen in a subset of FXS patients. GABAB receptors (GABA(B)Rs) exert powerful pre-and postsynaptic inhibitory effects on neurotransmission. R1a-containing GABA(B)Rs are believed to mediate presynaptic inhibition in principal neurons. In accordance with this result, deficits in the ability of GABA(B)Rs to suppress glutamate release were seen in Fmr1-KO mice. In contrast, the ability of GABA(B)Rs to suppress GABA release and induce postsynaptic hyperpolarization was unaffected. Significantly, this deficit contributes to the pathophysiology of FXS as the GABA(B)R agonist (R)baclofen rescued the imbalances between excitatory and inhibitory neurotransmission evident in Fmr1-KO mice. Col-lectively, our results provided evidence that selective deficits in the activity of presynaptic GABA(B)Rs contribute to the pathophysiology of FXS.	[Kang, Ji-Yong; Chadchankar, Jayashree; Vien, Thuy N.; Mather, Robert J.; Deeb, Tarek Z.; Brandon, Nicholas J.; Dunlop, John; Moss, Stephen J.] Tufts Univ, Sch Med, AstraZeneca Tufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Mighdoll, Michelle I.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Mather, Robert J.; Brandon, Nicholas J.; Dunlop, John; Moss, Stephen J.] AstraZeneca, Neurosci Innovat Med & Early Dev, Waltham, MA 02451 USA; [Pangalos, Menelas N.] AstraZeneca, Innovat Med & Early Dev, Melbourn Sci Pk,Cambridge Rd, Royston SG8 6EE, Herts, England; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Tufts University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; AstraZeneca; AstraZeneca; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu		Brandon, Nicholas/0000-0002-3917-0096	National Institutes of Health NINDS [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIMH [MH097446]; United States Department of Defense [AR140209]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087662, R01NS056359, R21NS080064, R01NS051195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037170] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health NINDS Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 and NIMH Grant MH097446 and United States Department of Defense Grant AR140209 (to S. J. M.). S. J. M. serves as a consultant for AstraZeneca and SAGE Therapeutics, relationships that are regulated by Tufts University and do not impact this study. At the time this work was conducted, R. J. M., M. N. P., N. J. B., and J. D. were full-time employees and shareholders in AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bakker CE, 2003, CYTOGENET GENOME RES, V100, P111, DOI 10.1159/000072845; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Benke Dietmar, 2015, Adv Pharmacol, V73, P41, DOI 10.1016/bs.apha.2014.11.002; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Cea-Del Rio CA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00245; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Chiurazzi P, 2003, CURR OPIN PEDIATR, V15, P559, DOI 10.1097/00008480-200312000-00003; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cullen PK, 2014, LEARN MEMORY, V21, P180, DOI 10.1101/lm.032961.113; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; D'Hulst C, 2009, BRAIN RES, V1253, P176, DOI 10.1016/j.brainres.2008.11.075; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Erickson CA, 2014, J AUTISM DEV DISORD, V44, P958, DOI 10.1007/s10803-013-1963-z; Gao XP, 2011, J PHYSIOL-LONDON, V589, P1991, DOI 10.1113/jphysiol.2010.198945; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Hannan S, 2016, CELL REP, V16, P1962, DOI 10.1016/j.celrep.2016.07.021; Hannan S, 2012, P NATL ACAD SCI USA, V109, P12171, DOI 10.1073/pnas.1201660109; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jacob TC, 2012, P NATL ACAD SCI USA, V109, P18595, DOI 10.1073/pnas.1204994109; Jacobson LH, 2006, J NEUROSCI, V26, P8800, DOI 10.1523/JNEUROSCI.2076-06.2006; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kasten CR, 2015, NEUROSCI BIOBEHAV R, V57, P70, DOI 10.1016/j.neubiorev.2015.08.007; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kooy RF, 2003, TRENDS GENET, V19, P148; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; Kunii Y, 2014, MOL PSYCHIATR, V19, P192, DOI 10.1038/mp.2012.174; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Maurin T, 2014, NEUROSCI BIOBEHAV R, V46, P242, DOI 10.1016/j.neubiorev.2014.01.006; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pacey LKK, 2011, J PHARMACOL EXP THER, V338, P897, DOI 10.1124/jpet.111.183327; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Pasciuto E, 2014, CELL, V158, P1446, DOI 10.1016/j.cell.2014.08.035; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rotschafer SE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00019; Schaefer TL, 2015, APPL CLIN GENET, V8, P75, DOI 10.2147/TACG.S35673; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Skov J, 2011, CELL MOL NEUROBIOL, V31, P587, DOI 10.1007/s10571-011-9652-y; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Zhang Wen-liang, 2007, Proceedings of the CSEE, V27, P1	60	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6621	6632		10.1074/jbc.M116.772541	http://dx.doi.org/10.1074/jbc.M116.772541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28213518	Green Published, hybrid			2022-12-26	WOS:000399813400015
J	Wang, B; Wang, YJ; Frabutt, DA; Zhang, XH; Yao, XY; Hu, D; Zhang, Z; Liu, CN; Zheng, SM; Xiang, SH; Zheng, YH				Wang, Bin; Wang, Yujie; Frabutt, Dylan A.; Zhang, Xihe; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Liu, Chaonan; Zheng, Shimin; Xiang, Shi-Hua; Zheng, Yong-Hui			Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; Ebola virus; glycoprotein; glycosylation; virus entry; calnexin	SIMIAN IMMUNODEFICIENCY VIRUS; PROTEIN-DEGRADATION PATHWAY; ENDOPLASMIC-RETICULUM; VIRION GLYCOPROTEINS; LINKED GLYCANS; ANTIBODY; IDENTIFICATION; TRANSMISSION; INFECTIVITY; CEM.NKR	The Ebola virus (EBOV) trimeric envelope glycoprotein (GP) precursors are cleaved into the receptor-binding GP(1) and the fusion-mediating GP(2) subunits and incorporated into virions to initiate infection. GP(1) and GP(2) form heterodimers that have 15 or two N-glycosylation sites (NGSs), respectively. Here we investigated the mechanism of how N-glycosylation contributes to GP expression, maturation, and function. As reported before, we found that, although GP(1) NGSs are not critical, the two GP(2) NGSs, Asn(563) and Asn(618), are essential for GP function. Further analysis uncovered that Asn(563) and Asn(618) regulate GP processing, demannosylation, oligomerization, and conformation. Consequently, these two NGSs are required for GP incorporation into EBOV-like particles and HIV type 1 (HIV-1) pseudovirions and determine viral transduction efficiency. Using CRISPR/Cas9 technology, we knocked out the two classical endoplasmic reticulum chaperones calnexin (CNX) and/or calreticulin (CRT) and found that both CNX and CRT increase GP expression. Nevertheless, NGSs are not required for the GP interaction with CNX or CRT. Together, we conclude that, although Asn(563) and Asn(618) are not required for EBOV GP expression, they synergistically regulate its maturation, which determines its functionality.	[Wang, Bin; Wang, Yujie; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Zheng, Yong-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, CAAS Michigan State Univ Joint Lab Innate Immun, State Key Lab Vet Biotechnol, Harbin 150059, Peoples R China; [Liu, Chaonan; Zheng, Shimin] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China; [Xiang, Shi-Hua] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Xiang, Shi-Hua] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, 2215 BPS,567 Wilson Rd, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 BPS,567 Wilson Rd, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385; Frabutt, Dylan/0000-0002-8693-6656; Zhang, Xihe/0000-0002-4857-9774	National Natural Science Foundation of China [31502089]; Harbin Veterinary Research Institute Grant [SKLVBP2015012]; NIAID, National Institutes of Health [AI120189, AI106477, AI122863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122863, R01AI120189, R21AI106477] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Veterinary Research Institute Grant; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Natural Science Foundation of China Grant 31502089 and Harbin Veterinary Research Institute Grant SKLVBP2015012. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIAID, National Institutes of Health Grants AI120189, AI106477, and AI122863. To whom correspondence should be addressed: Dept. of Microbiology and Molecular Genetics, Michigan State University, 2215 BPS, 567 Wilson Rd., East Lansing, MI 48824. Tel.: 517-884-5314; Fax: 517-353-8957; E-mail: zhengyo@msu.edu.	Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gaskill PJ, 2008, J VIROL, V82, P1615, DOI 10.1128/JVI.01757-07; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Karsten CB, 2015, J VIROL, V89, P11727, DOI 10.1128/JVI.01358-15; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lennemann NJ, 2015, J INFECT DIS, V212, pS204, DOI 10.1093/infdis/jiv201; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Mohan GS, 2015, J VIROL, V89, P1205, DOI 10.1128/JVI.01810-14; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shen RZ, 2014, J VIROL, V88, P14258, DOI 10.1128/JVI.02164-14; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Vygen S, 2016, AM J TROP MED HYG, V95, P897, DOI 10.4269/ajtmh.16-0295; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wojczyk BS, 2005, GLYCOBIOLOGY, V15, P655, DOI 10.1093/glycob/cwi046; Wojczyk BS, 1998, GLYCOBIOLOGY, V8, P121, DOI 10.1093/glycob/8.2.121; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zhou T, 2015, J BIOL CHEM, V290, P22184, DOI 10.1074/jbc.M115.675207; Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13; Zhou T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-93; Zhou T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-31	37	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5860	5870		10.1074/jbc.M116.768168	http://dx.doi.org/10.1074/jbc.M116.768168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196864	hybrid, Green Published			2022-12-26	WOS:000398813200021
J	Hoffmann, S; Schmidt, C; Walter, S; Bender, JK; Gerlach, RG				Hoffmann, Stefanie; Schmidt, Christiane; Walter, Steffi; Bender, Jennifer K.; Gerlach, Roman G.			Scarless deletion of up to seven methyl-accepting chemotaxis genes with an optimized method highlights key function of CheM in Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHEMORECEPTORS; IDENTIFICATION; PATHOGENICITY; CONSTRUCTION; MUTAGENESIS; EXPRESSION; VECTORS; MANIPULATION; REPLACEMENT	Site-directed scarless mutagenesis is an essential tool of modern pathogenesis research. We describe an optimized two-step protocol for genome editing in Salmonella enterica serovar Typhimurium to enable multiple sequential mutagenesis steps in a single strain. The system is based on the. Red recombinase-catalyzed integration of a selectable antibiotics resistance marker followed by replacement of this cassette. Markerless mutants are selected by expressing the meganuclease I-SceI which induces double-strand breaks in bacteria still harboring the resistance locus. Our new dual-functional plasmid pWRG730 allows for heat-inducible expression of the. Red recombinase and tet-inducible production of I-SceI. Methyl-accepting chemotaxis proteins (MCP) are transmembrane chemoreceptors for a vast set of environmental signals including amino acids, sugars, ions and oxygen. Based on the sensory input of MCPs, chemotaxis is a key component for Salmonella virulence. To determine the contribution of individual MCPs we sequentially deleted seven MCP genes. The individual mutations were validated by PCR and genetic integrity of the final seven MCP mutant WRG279 was confirmed by whole genome sequencing. The successive MCP mutants were functionally tested in a HeLa cell infection model which revealed increased invasion rates for non-chemotactic mutants and strains lacking the MCP CheM (Tar). The phenotype of WRG279 was reversed with plasmid-based expression of CheM. The complemented WRG279 mutant showed also partially restored chemotaxis in swarming assays on semi-solid agar. Our optimized scarless deletion protocol enables efficient and precise manipulation of the Salmonella genome. As demonstrated with whole genome sequencing, multiple subsequent mutagenesis steps can be realized without the introduction of unwanted mutations. The sequential deletion of seven MCP genes revealed a significant role of CheM for the interaction of S. Typhimurium with host cells which might give new insights into mechanisms of Salmonella host cell sensing.	[Hoffmann, Stefanie; Schmidt, Christiane; Walter, Steffi; Gerlach, Roman G.] Robert Koch Inst, Project Grp 5, Wernigerode, Germany; [Bender, Jennifer K.] Robert Koch Inst, Div Nosocomial Pathogens & Antibiot Resistances, Dept Infect Dis, Wernigerode, Germany	Robert Koch Institute; Robert Koch Institute	Gerlach, RG (corresponding author), Robert Koch Inst, Project Grp 5, Wernigerode, Germany.	GerlachR@rki.de			Deutsche Forschungsgemeinschaft [GE 2533/2-2]; Robert Koch Insitute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Koch Insitute	This project was funded in part by the 'Deutsche Forschungsgemeinschaft' (www.dfg.de) grant GE 2533/2-2 and an intramural research grant of the Robert Koch Insitute (www.rki.de) to RGG.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Bender Jennifer K, 2013, PLoS One, V8, pe73287, DOI 10.1371/journal.pone.0073287; Bibikov SI, 2004, J BACTERIOL, V186, P3730, DOI 10.1128/JB.186.12.3730-3737.2004; Blank K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015763; BLAT Y, 1995, J BACTERIOL, V177, P1683, DOI 10.1128/jb.177.7.1683-1691.1995; Carter Z, 2010, YEAST, V27, P765, DOI 10.1002/yea.1774; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Cox MM, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dowd SE, 2008, FOODBORNE PATHOG DIS, V5, P205, DOI 10.1089/fpd.2007.0062; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erhardt M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004800; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gerlach RG, 2008, CELL MICROBIOL, V10, P2364, DOI 10.1111/j.1462-5822.2008.01218.x; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; Kalinin Y, 2010, J BACTERIOL, V192, P1796, DOI 10.1128/JB.01507-09; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Katashkina JI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-34; KHORAMIANFALSAFI T, 1990, MICROB PATHOGENESIS, V9, P47, DOI 10.1016/0882-4010(90)90039-S; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kolodziej AF, 1996, BIOCHEMISTRY-US, V35, P14782, DOI 10.1021/bi961481v; KONDOH H, 1979, P NATL ACAD SCI USA, V76, P260, DOI 10.1073/pnas.76.1.260; Lazova MD, 2012, MOL MICROBIOL, V84, P697, DOI 10.1111/j.1365-2958.2012.08051.x; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Lee Song-Choon, 2009, V530, P15, DOI 10.1007/978-1-59745-471-1_2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Marzel A, 2016, CLIN INFECT DIS, V62, P879, DOI 10.1093/cid/civ1221; McDonough E, 2014, MOL MICROBIOL, V92, P302, DOI 10.1111/mmi.12557; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Octavia S, 2015, J CLIN MICROBIOL, V53, P3507, DOI 10.1128/JCM.01733-15; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; R Core Team, 2021, R LANGUAGE ENV STAT; Ranallo RT, 2006, FEMS IMMUNOL MED MIC, V47, P462, DOI 10.1111/j.1574-695X.2006.00118.x; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Rivera-Chavez F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003267; Rivero-Muller A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm250; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Steglich M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139811; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wang HL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1339; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wille T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123646; YAMAMOTO K, 1993, P NATL ACAD SCI USA, V90, P217, DOI 10.1073/pnas.90.1.217; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42	67	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172630	10.1371/journal.pone.0172630	http://dx.doi.org/10.1371/journal.pone.0172630			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212413	gold, Green Published			2022-12-26	WOS:000394424700063
J	Yang, QX; Xu, J; Cao, BG; Li, XQ				Yang, Qingxia; Xu, Jun; Cao, Binggang; Li, Xiuqing			A simplified fractional order impedance model and parameter identification method for lithium-ion batteries	PLOS ONE			English	Article							CHARGE ESTIMATION; STATE; OPTIMIZATION; SOC	Identification of internal parameters of lithium-ion batteries is a useful tool to evaluate battery performance, and requires an effective model and algorithm. Based on the least square genetic algorithm, a simplified fractional order impedance model for lithium-ion batteries and the corresponding parameter identification method were developed. The simplified model was derived from the analysis of the electrochemical impedance spectroscopy data and the transient response of lithium-ion batteries with different states of charge. In order to identify the parameters of the model, an equivalent tracking system was established, and the method of least square genetic algorithm was applied using the time-domain test data. Experiments and computer simulations were carried out to verify the effectiveness and accuracy of the proposed model and parameter identification method. Compared with a second-order resistance-capacitance (2-RC) model and recursive least squares method, small tracing voltage fluctuations were observed. The maximum battery voltage tracing error for the proposed model and parameter identification method is within 0.5%; this demonstrates the good performance of the model and the efficiency of the least square genetic algorithm to estimate the internal parameters of lithium-ion batteries.	[Yang, Qingxia; Xu, Jun; Cao, Binggang] Xi An Jiao Tong Univ, Sch Mech Engn, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China; [Li, Xiuqing] Henan Univ Sci & Technol, Engn Res Ctr Tribol & Mat Protect, Minist Educ, Luoyang, Henan, Peoples R China	Xi'an Jiaotong University; Henan University of Science & Technology	Xu, J (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.; Li, XQ (corresponding author), Henan Univ Sci & Technol, Engn Res Ctr Tribol & Mat Protect, Minist Educ, Luoyang, Henan, Peoples R China.	xujun018@gmail.com; hkdlxq@yeah.net	li, xq/AAL-6475-2020; Xu, Jun/J-5945-2013	Xu, Jun/0000-0001-7255-9952; Li, Xiuqing/0000-0003-0034-2468	National Natural Science Foundation of China [51405374]; Postdoctoral Science Foundation of China [2014M560763]; Postdoctoral Science Special Foundation of China [2016T90904]; Scientific Research Staring Foundation for Doctor of Henan University of Science and Technology [13480001]; Key Scientific Research Project of High School in Henan Province [17A430015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Science Special Foundation of China(China Postdoctoral Science Foundation); Scientific Research Staring Foundation for Doctor of Henan University of Science and Technology; Key Scientific Research Project of High School in Henan Province	This work has been funded by the National Natural Science Foundation of China (grant no. 51405374), http://www.nsfc.gov.cn; the Postdoctoral Science Foundation of China (grant no. 2014M560763), http://jj.chinapostdoctor.org.cn; the Postdoctoral Science Special Foundation of China (grant no. 2016T90904), http://jj.chinapostdoctor.org.cn; the Scientific Research Staring Foundation for Doctor of Henan University of Science and Technology (grant no. 13480001), http://www.haust.edu.cn; and the Key Scientific Research Project of High School in Henan Province (grant no. 17A430015), http://cas.rcloud.edu.cn.	Andre D, 2013, J POWER SOURCES, V224, P20, DOI 10.1016/j.jpowsour.2012.10.001; Bizeray AM, 2015, J POWER SOURCES, V296, P400, DOI 10.1016/j.jpowsour.2015.07.019; Buller S, 2005, IEEE T IND APPL, V41, P742, DOI 10.1109/TIA.2005.847280; Chen ZY, 2016, APPL ENERG, V184, P365, DOI 10.1016/j.apenergy.2016.10.026; Chen Z, 2013, J POWER SOURCES, V240, P184, DOI 10.1016/j.jpowsour.2013.03.158; Cheng XM, 2016, ENERGIES, V9, DOI 10.3390/en9070539; Concepcion A. M., 2010, FRACTIONAL ORDER SYS; DOYLE M, 1993, J ELECTROCHEM SOC, V140, P1526, DOI 10.1149/1.2221597; Farmann A, 2015, J POWER SOURCES, V299, P176, DOI 10.1016/j.jpowsour.2015.08.087; Feng X, 2015, ELECTR POW SYST RES, V129, P150, DOI 10.1016/j.epsr.2015.08.011; Forman JC, 2012, J POWER SOURCES, V210, P263, DOI 10.1016/j.jpowsour.2012.03.009; Gallo D, 2013, ENERGIES, V6, P4572, DOI 10.3390/en6094572; He ZC, 2016, ENERGIES, V9, DOI 10.3390/en9060444; Hu XS, 2011, J ZHEJIANG UNIV-SC A, V12, P818, DOI 10.1631/jzus.A1100141; Kim T, 2015, J POWER SOURCES, V295, P16, DOI 10.1016/j.jpowsour.2015.03.184; Leith DJ, 2000, INT J CONTROL, V73, P1001, DOI 10.1080/002071700411304; Liu BH, 2016, APPL ENERG, V183, P278, DOI 10.1016/j.apenergy.2016.08.101; Long B, 2013, ENERGIES, V6, P5200, DOI 10.3390/en6105200; Mesbahi T, 2016, ELECTR POW SYST RES, V131, P195, DOI 10.1016/j.epsr.2015.10.018; Sabatier J, 2015, SIGNAL PROCESS, V107, P290, DOI 10.1016/j.sigpro.2014.06.008; Schmidt AP, 2010, J POWER SOURCES, V195, P5071, DOI 10.1016/j.jpowsour.2010.02.029; Schmidt JP, 2013, J POWER SOURCES, V221, P70, DOI 10.1016/j.jpowsour.2012.07.100; Wang BJ, 2015, J POWER SOURCES, V293, P151, DOI 10.1016/j.jpowsour.2015.05.059; Xu JG, 2015, J ELECTROCHEM SOC, V162, pA2026, DOI 10.1149/2.0291510jes; Xu JS, 2016, SCI REP-UK, V6, DOI [10.1038/srep21829, 10.1038/srep27524]; Xu J, 2016, APPL ENERG, V172, P180, DOI 10.1016/j.apenergy.2016.03.108; Xu J, 2013, J POWER SOURCES, V233, P277, DOI 10.1016/j.jpowsour.2013.01.094; Zahid T, 2016, ENERGIES, V9, DOI 10.3390/en9090720; Zhou DM, 2016, ENERGIES, V9, DOI 10.3390/en9030123; Zou ZY, 2014, ENERGIES, V7, P5065, DOI 10.3390/en7085065	30	25	25	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172424	10.1371/journal.pone.0172424	http://dx.doi.org/10.1371/journal.pone.0172424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212405	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700049
J	Burke, JL; Carroll, AL				Burke, Jordan Lewis; Carroll, Allan L.			Breeding matters: Natal experience influences population state-dependent host acceptance by an eruptive insect herbivore	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; DENDROCTONUS-PONDEROSAE COLEOPTERA; KILLING BARK BEETLES; LODGEPOLE PINE; BEHAVIORAL SYNDROMES; RANGE EXPANSION; IPS-PINI; MONOTERPENE COMPOSITION; BRITISH-COLUMBIA; CLIMATE-CHANGE	Eruptive forest insects are highly influential agents of change in forest ecosystems, and their effects have increased with recent climate change. State-dependent life histories contribute significantly to the population dynamics of eruptive forest insect herbivores; however, the proximate mechanisms by which these species shift between states is poorly understood. Laboratory bioassays were conducted using the mountain pine beetle (Dendroctonus ponderosae) to determine the effect of maternal host selection on offspring host preferences, as they apply to population state-dependent behaviors. Female mountain pine beetles exhibited state-dependent preference for artificial host material amended with monoterpenes in the absence of other cues, such that individuals reared in high-density epidemic-state simulations rejected low monoterpene conditions, while low-density endemic-state beetles accepted low monoterpene conditions. State-specific behavior in offspring was dependent on rearing conditions, as a function of maternal host selection, and these effects were observed within one generation. Density-dependent host selection behaviors exhibited by female mountain pine beetle offspring is reinforced by context-dependent maternal effects arising from parental host selection, and in situ exposure to conspecifics. These results demonstrate potential proximate mechanisms that control population dynamics in eruptive forest insects, and will allow for more accurate predictions of continued impact and spread of these species.	[Burke, Jordan Lewis; Carroll, Allan L.] Univ British Columbia, Dept Forest & Conservat Sci, Fac Forestry, Vancouver, BC, Canada	University of British Columbia	Burke, JL (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Fac Forestry, Vancouver, BC, Canada.	jordan.lewis.burke@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Network TRIA-Net Turning Risk Into Action for the Mountain Pine Beetle Epidemic; NSERC Discovery Grant	Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Network TRIA-Net Turning Risk Into Action for the Mountain Pine Beetle Epidemic; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by The Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Network TRIA-Net Turning Risk Into Action for the Mountain Pine Beetle Epidemic (tria-net.srv.ualberta.ca/) and a NSERC Discovery Grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/grants-subs/DGIGP-PSIGP_eng.asp) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Amman G.D., 1983, INT145 USDA FOR SERV; AMMAN GD, 1972, J ECON ENTOMOL, V65, P138, DOI 10.1093/jee/65.1.138; Amman GD, 1976, INT209 USDA FOR SERV; BERRYMAN AA, 1978, RES POPUL ECOL, V19, P181, DOI 10.1007/BF02518826; Boone CK, 2013, J CHEM ECOL, V39, P1003, DOI 10.1007/s10886-013-0313-0; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; BORDEN JH, 1987, CAN J FOREST RES, V17, P118, DOI 10.1139/x87-023; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Burke JL, 2016, FOREST ECOL MANAG, V359, P59, DOI 10.1016/j.foreco.2015.09.044; CARO TM, 1986, ANIM BEHAV, V34, P1483, DOI 10.1016/S0003-3472(86)80219-6; CARROLL AL, 2004, CHALLENGES SOLUTIONS, P221; CHITTY DENNIS, 1960, CANADIAN JOUR ZOOL, V38, P99, DOI 10.1139/z60-011; Chubaty AM, 2009, ECOL MODEL, V220, P1241, DOI 10.1016/j.ecolmodel.2009.01.039; Clark EL, 2014, PEERJ, V2, DOI 10.7717/peerj.240; Clark EL, 2010, CAN ENTOMOL, V142, P557, DOI 10.4039/n10-022; Cooke Barry J., 2007, P487; Czesak ME, 2003, EVOLUTION, V57, P1121; Dowdy S., 2004, STAT RES, V3rd; Elkin CM, 2005, FUNCT ECOL, V19, P102, DOI 10.1111/j.0269-8463.2005.00935.x; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; FURNISS MM, 1969, J ECON ENTOMOL, V62, P518, DOI 10.1093/jee/62.2.518; GINZBURG LR, 1994, J ANIM ECOL, V63, P79, DOI 10.2307/5585; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; Graf M, 2012, CAN ENTOMOL, V144, P467, DOI 10.4039/tce.2012.38; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; GUO PZ, 1991, P NATL ACAD SCI USA, V88, P10905, DOI 10.1073/pnas.88.23.10905; Hagen SB, 2007, ECOGRAPHY, V30, P299, DOI [10.1111/j.2007.0906-7590.04981.x, 10.1111/j.0906-7590.2007.04981.x]; Hall DE, 2013, PLANT PHYSIOL, V161, P600, DOI 10.1104/pp.112.208546; HOUSTON AI, 1992, EVOL ECOL, V6, P243, DOI 10.1007/BF02214164; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Inchausti P, 2009, PHILOS T R SOC B, V364, P1117, DOI 10.1098/rstb.2008.0292; Jepsen JU, 2008, J ANIM ECOL, V78, P182; Jonsson AM, 2009, GLOBAL CHANGE BIOL, V15, P486, DOI 10.1111/j.1365-2486.2008.01742.x; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Tran JK, 2007, ECOL APPL, V17, P882, DOI 10.1890/06-0512; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; Klutsch JG, 2016, OECOLOGIA, V182, P1, DOI 10.1007/s00442-016-3559-8; Kolb TE, 2016, FOREST ECOL MANAG, V380, P321, DOI 10.1016/j.foreco.2016.04.051; Lardies MA, 2004, OECOLOGIA, V138, P387, DOI 10.1007/s00442-003-1447-5; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; McGhehey JH, 1971, NORX9 NO FOR RES CTR; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; MICHAEL RR, 1972, J INSECT PHYSIOL, V18, P2189, DOI 10.1016/0022-1910(72)90248-X; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; PITMAN GB, 1971, J ECON ENTOMOL, V64, P426, DOI 10.1093/jee/64.2.426; Plaistow SJ, 2009, PHILOS T R SOC B, V364, P1049, DOI 10.1098/rstb.2008.0251; Powell JA, 2014, ECOL MODEL, V273, P173, DOI 10.1016/j.ecolmodel.2013.10.034; Pureswaran DS, 2005, AGR FOREST ENTOMOL, V7, P219, DOI 10.1111/j.1461-9555.2005.00264.x; Pureswaran DS, 2003, ENVIRON ENTOMOL, V32, P963, DOI 10.1603/0046-225X-32.5.963; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2015, CABI CLIM CHANGE SER, V7, P173, DOI 10.1079/9781780643786.0173; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, CAN ENTOMOL, V114, P97, DOI 10.4039/Ent11497-2; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; Rasanen K, 2005, OECOLOGIA, V142, P546, DOI 10.1007/s00442-004-1762-5; Reid ML, 2011, ARTHROPOD-PLANT INTE, V5, P331, DOI 10.1007/s11829-011-9137-4; Robert LE, 2012, CAN J FOREST RES, V42, P463, DOI [10.1139/x2012-005, 10.1139/X2012-005]; Robinson A., 2015, THESIS; Rosenberger DW, 2016, ENTOMOL EXP APPL, V160, P195, DOI 10.1111/eea.12463; Royama T., 1992, ANAL POPULATION ECOL; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; SAFRANYIK L, 1992, J APPL ENTOMOL, V113, P441, DOI 10.1111/j.1439-0418.1992.tb00687.x; Safranyik L., 1975, MANAGEMENT LODGEPOLE, P406; SHRIMPTON DM, 1968, CAN J BOTANY, V46, P757, DOI 10.1139/b68-104; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; Smith GD, 2011, AGR FOREST ENTOMOL, V13, P37, DOI 10.1111/j.1461-9563.2010.00499.x; Taft S, 2015, J CHEM ECOL, V41, P540, DOI 10.1007/s10886-015-0590-x; Taft S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00342; THOMSON AJ, 1984, CAN J FOREST RES, V14, P255, DOI 10.1139/x84-049; Turchin P., 2003, MONOGRAPHS POPULATIO, P472; Wallin KF, 2000, ENVIRON ENTOMOL, V29, P442, DOI 10.1603/0046-225X-29.3.442; Wallin KF, 2004, ECOL MONOGR, V74, P101, DOI 10.1890/02-4004; Wallin KF, 2002, ENVIRON ENTOMOL, V31, P1276, DOI 10.1603/0046-225X-31.6.1276; Wallin KF, 2002, ENTOMOL EXP APPL, V103, P205, DOI 10.1023/A:1021103320908; Wallin KF, 1999, J CHEM ECOL, V25, P861, DOI 10.1023/A:1020853019309; WHITE TCR, 1976, OECOLOGIA, V22, P119, DOI 10.1007/BF00344712; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Wood S. L., 1982, GREAT BASIN NATURALI	84	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172448	10.1371/journal.pone.0172448	http://dx.doi.org/10.1371/journal.pone.0172448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207862	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424500139
J	Cai, TT; Zhu, HL; Xu, J; Wu, SJ; Li, XG; He, SL				Cai, Tingting; Zhu, Huilin; Xu, Jie; Wu, Shijing; Li, Xinge; He, Sailing			Human cortical neural correlates of visual fatigue during binocular depth perception: An fNIRS study	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PROCESSING REGIONS; HUMAN BRAIN; DISPARITY; STEREOPSIS; RESPONSES; CORTEX; STIMULI; FMRI	Functional near-infrared spectroscopy (fNIRS) was adopted to investigate the cortical neural correlates of visual fatigue during binocular depth perception for different disparities (from 0.1 degrees to 1.5 degrees). By using a slow event-related paradigm, the oxyhaemoglobin (HbO) responses to fused binocular stimuli presented by the random-dot stereogram (RDS) were recorded over the whole visual dorsal area. To extract from an HbO curve the characteristics that are correlated with subjective experiences of stereopsis and visual fatigue, we proposed a novel method to fit the time-course HbO curve with various response functions which could reflect various processes of binocular depth perception. Our results indicate that the parietal-occipital cortices are spatially correlated with binocular depth perception and that the process of depth perception includes two steps, associated with generating and sustaining stereovision. Visual fatigue is caused mainly by generating stereovision, while the amplitude of the haemodynamic response corresponding to sustaining stereovision is correlated with stereopsis. Combining statistical parameter analysis and the fitted time-course analysis, fNIRS could be a promising method to study visual fatigue and possibly other multi-process neural bases.	[Cai, Tingting; Zhu, Huilin; Xu, Jie; Wu, Shijing; Li, Xinge; He, Sailing] South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagent Res, Guangzhou, Guangdong, Peoples R China; [Wu, Shijing] South China Normal Univ, Sch Informat & Optoelect Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Li, Xinge] South China Normal Univ, Guangzhou, Guangdong, Peoples R China; [He, Sailing] Royal Inst Technol, Dept Electromagnet Engn, Stockholm, Sweden	South China Normal University; South China Normal University; South China Normal University; Royal Institute of Technology	He, SL (corresponding author), South China Normal Univ, South China Acad Adv Optoelect, Ctr Opt & Electromagent Res, Guangzhou, Guangdong, Peoples R China.; He, SL (corresponding author), Royal Inst Technol, Dept Electromagnet Engn, Stockholm, Sweden.	sailing@jorcep.org	He, Sailing/C-2438-2009	He, Sailing/0000-0002-3401-1125	National Natural Science Foundation of China [11621101]; Guangdong Innovative Research Team Program [201001D0104799318]; Natural Science Foundation of Guangdong province [2014A030310502]; Chinese Postdoctoral Science Foundation [2015M580725, 2016T90791]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (NO. 11621101, http://www.nsfc.gov.cn/, SH); Guangdong Innovative Research Team Program (NO. 201001D0104799318, http://cxtd.gdstc.gov.cn/, SH); Natural Science Foundation of Guangdong province (NO. 2014A030310502, http://www.gdstc.gov.cn/, HZ); Chinese Postdoctoral Science Foundation (NO. 2015M580725 & NO. 2016T90791, http://chinapostdoctor.org.cn/WebSite/program/Default.aspx, HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PM, 2003, OPTOMETRY VISION SCI, V80, P245, DOI 10.1097/00006324-200303000-00014; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Cumming BG, 1999, J NEUROSCI, V19, P5602; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Ding XP, 2013, NEUROPSYCHOLOGIA, V51, P704, DOI 10.1016/j.neuropsychologia.2012.12.018; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Ehlis AC, 2005, BIOL PSYCHOL, V69, P315, DOI 10.1016/j.biopsycho.2004.09.003; Emoto M, 2005, J DISP TECHNOL, V1, P328, DOI 10.1109/JDT.2005.858938; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; Hagura H, 2006, ELECT IMAGING, V2006; Homae F, 2007, NEUROSCI RES, V59, P29, DOI 10.1016/j.neures.2007.05.005; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Iwami T, 2002, NEUROSCI LETT, V327, P29, DOI 10.1016/S0304-3940(02)00353-1; Jang K E, 2009, J BIOMEDICAL OPTICS, V14, P659; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kim D, 2014, INT J IMAG SYST TECH, V24, P94, DOI 10.1002/ima.22083; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; KUMAR T, 1992, VISION RES, V32, P1667, DOI 10.1016/0042-6989(92)90159-G; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Li H- CO, 2008, 3DTV C TRUE VIS CAPT; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Mapp AP, 2003, PERCEPT PSYCHOPHYS, V65, P310, DOI 10.3758/BF03194802; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Nishida Y, 2001, NEUROREPORT, V12, P2259, DOI 10.1097/00001756-200107200-00043; Orban GA, 2011, ANNU REV NEUROSCI, V34, P361, DOI 10.1146/annurev-neuro-061010-113819; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Rosen BR, 2010, NEURON, V39, P555; Roth HL, 2002, BRAIN, V125, P2023, DOI 10.1093/brain/awf210; Sai LY, 2014, BRAIN TOPOGR, V27, P652, DOI 10.1007/s10548-014-0352-z; Seraglia B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00176; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Speranza F, 2006, PROC SPIE, V6055, DOI 10.1117/12.640865; Suryakumar R, 2007, VISION RES, V47, P260, DOI 10.1016/j.visres.2006.10.003; Tak S, 2011, NEUROIMAGE, V55, P176, DOI 10.1016/j.neuroimage.2010.11.046; Tanabe S, 2005, J NEUROPHYSIOL, V94, P2683, DOI 10.1152/jn.00319.2005; Tsukuda S, 1988, CASE REPORT MANIFEST, V16, P69; Ward LM, 2016, BRAIN TOPOGR, P1; Wijeakumar S, 2012, INVEST OPHTH VIS SCI, V53, P5881, DOI 10.1167/iovs.12-10399; Zhu H, PROGR EL RES S 2016	43	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172426	10.1371/journal.pone.0172426	http://dx.doi.org/10.1371/journal.pone.0172426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207899	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500134
J	Karnes, JH; Shaffer, CM; Bastarache, L; Gaudieri, S; Glazer, AM; Steiner, HE; Mosley, JD; Mallal, S; Denny, JC; Phillips, EJ; Roden, DM				Karnes, Jason H.; Shaffer, Christian M.; Bastarache, Lisa; Gaudieri, Silvana; Glazer, Andrew M.; Steiner, Heidi E.; Mosley, Jonathan D.; Mallal, Simon; Denny, Joshua C.; Phillips, Elizabeth J.; Roden, Dan M.			Comparison of HLA allelic imputation programs	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RESOLUTION SNP DATA; POPULATION; ASSOCIATIONS; HLA-B-ASTERISK-5701; HYPERSENSITIVITY; HLA-DRB1; GENOTYPE; RISK	Imputation of human leukocyte antigen (HLA) alleles from SNP-level data is attractive due to importance of HLA alleles in human disease, widespread availability of genome-wide association study (GWAS) data, and expertise required for HLA sequencing. However, comprehensive evaluations of HLA imputations programs are limited. We compared HLA imputation results of HIBAG, SNP2HLA, and HLA* IMP: 02 to sequenced HLA alleles in 3,265 samples from BioVU, a de-identified electronic health record database coupled to a DNA biorepository. We performed four-digit HLA sequencing for HLA-A, -B, -C, -DRB1, -DPB1, and -DQB1 using long-read 454 FLX sequencing. All samples were genotyped using both the Illumina HumanExome BeadChip platform and a GWAS platform. Call rates and concordance rates were compared by platform, frequency of allele, and race/ethnicity. Overall concordance rates were similar between programs in European Americans (EA) (0.975 [SNP2HLA]; 0.939 [HLA* IMP: 02]; 0.976 [HIBAG]). SNP2HLA provided a significant advantage in terms of call rate and the number of alleles imputed. Concordance rates were lower overall for African Americans (AAs). These observations were consistent when accuracy was compared across HLA loci. All imputation programs performed similarly for low frequency HLA alleles. Higher concordance rates were observed when HLA alleles were imputed from GWAS platforms versus the HumanExome BeadChip, suggesting that high genomic coverage is preferred as input for HLA allelic imputation. These findings provide guidance on the best use of HLA imputation methods and elucidate their limitations.	[Karnes, Jason H.; Steiner, Heidi E.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Shaffer, Christian M.; Glazer, Andrew M.; Mosley, Jonathan D.; Denny, Joshua C.; Phillips, Elizabeth J.; Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Bastarache, Lisa; Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Gaudieri, Silvana; Mallal, Simon; Phillips, Elizabeth J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Gaudieri, Silvana] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA, Australia; [Gaudieri, Silvana; Mallal, Simon; Phillips, Elizabeth J.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia; [Mallal, Simon] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	University of Arizona; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Western Australia; Murdoch University; Vanderbilt University; Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN USA.; Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.; Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	dan.roden@vanderbilt.edu	Roden, Dan/ABD-5412-2021; Mallal, Simon Alexander/HDM-9561-2022; Denny, Josh/AAL-3359-2021	Mallal, Simon Alexander/0000-0002-7036-1309; Denny, Josh/0000-0002-3049-7332; , Silvana/0000-0001-6873-0198; Glazer, Andrew/0000-0002-3938-4713; Mosley, Jonathan/0000-0001-6421-2887	Vanderbilt CTSA grant from NCATS/NIH [ULTR000445]; HumanExome BeadChip; NIH [RC2GM092618, U01HG004603, U19HL065962]; NCATS/NIH [UL1TR000445]; VUMC Clinical Pharmacology Training grant [T32 GM07569]; American Heart Association [16SDG29090005, 15POST22660017]; ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy;  [5U01GM092691-04];  [1R01AR062886-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305, T32GM007569] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); HumanExome BeadChip; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); VUMC Clinical Pharmacology Training grant; American Heart Association(American Heart Association); ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The dataset used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. HumanExome BeadChip genotyping was supported institutionally. Genome-wide genotyping was funded by NIH grants RC2GM092618 from NIGMS/OD, U01HG004603 from NHGRI/NIGMS, and U19HL065962 from NHGRI/NIGMS. BioVU is supported by institutional funding and by the Vanderbilt CTSA grant UL1TR000445 from NCATS/NIH. JHK has been supported by the VUMC Clinical Pharmacology Training grant (T32 GM07569), the American Heart Association (16SDG29090005 and 15POST22660017), and an ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy. SR is supported by 5U01GM092691-04 and 1R01AR062886-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The dataset used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. HumanExome BeadChip genotyping was supported institutionally. Genome-wide genotyping was funded by NIH grants RC2GM092618 from NIGMS/OD, U01HG004603 from NHGRI/NIGMS, and U19HL065962 from NHGRI/NIGMS. BioVU is supported by institutional funding and by the Vanderbilt CTSA grant UL1TR000445 from NCATS/NIH.; JHK has been supported by the VUMC Clinical Pharmacology Training grant (T32 GM07569), the American Heart Association (16SDG29090005 and 15POST22660017), and an ACCP Research Institute Futures Grants Award from the American College of Clinical Pharmacy. SR is supported by 5U01GM092691-04 and 1R01AR062886-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowton E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008604; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cruz-Tapias P, 2012, AUTOIMMUN REV, V11, P281, DOI 10.1016/j.autrev.2011.10.002; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Guo Y, 2014, NAT PROTOC, V9, P2643, DOI 10.1038/nprot.2014.174; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Invernizzi P, 2012, GENES IMMUN, V13, P461, DOI 10.1038/gene.2012.17; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Karnes JH, 2014, THROMB HAEMOSTASIS, P113; Khor SS, 2015, PHARMACOGENOMICS J, V15, P530, DOI 10.1038/tpj.2015.4; Khor SS, 2015, PHARMACOGENOMICS J; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Levin AM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-72; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Milicic A, 2002, J RHEUMATOL, V29, P1821; Nunes K, 2016, HUM IMMUNOL, V77, P307, DOI 10.1016/j.humimm.2015.11.004; Okada Y, 2015, NAT GENET, V47, P798, DOI 10.1038/ng.3310; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Pritchard JK, 2000, GENETICS, V155, P945; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Vlachopoulou E, 2014, TISSUE ANTIGENS, V83, P350, DOI 10.1111/tan.12343; Yoshida K, 2011, ARTHRITIS RHEUM-US, V63, P3058, DOI 10.1002/art.30501; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	30	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172444	10.1371/journal.pone.0172444	http://dx.doi.org/10.1371/journal.pone.0172444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207879	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500137
J	Lacoste, S; Bhatia, S; Chen, YJ; Bhatia, R; O'Connor, TR				Lacoste, Sandrine; Bhatia, Smita; Chen, Yanjun; Bhatia, Ravi; O'Connor, Timothy R.			Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; CRYOPRESERVED ISOLATED LYMPHOCYTES; THERAPY-RELATED LEUKEMIA; NON-HODGKINS-LYMPHOMA; DNA-REPAIR; MYELODYSPLASTIC SYNDROME; HOMOLOGOUS RECOMBINATION; CANCER SUSCEPTIBILITY; MALIGNANT NEOPLASMS	Patients who undergo autologous hematopoietic stem cell transplantation (aHCT) for treatment of a relapsed or refractory lymphoma are at risk of developing therapy related-myelodysplasia/acute myeloid leukemia (t-MDS/AML). Part of the risk likely resides in inherent interindividual differences in their DNA repair capacity (DRC), which is thought to influence the effect chemotherapeutic treatments have on the patient's stem cells prior to aHCT. Measuring DRC involves identifying small differences in repair proficiency among individuals. Initially, we investigated the cell model in healthy individuals (primary lymphocytes and/or lymphoblastoid cell lines) that would be appropriate to measure genetically determined DRC using host-cell reactivation assays. We present evidence that interindividual differences in DRC double-strand break repair (by non-homologous end-joining [NHEJ] or single strand annealing [SSA]) are better preserved in non-induced primary lymphocytes. In contrast, lymphocytes induced to proliferate are required to assay base excision (BER) or nucleotide excision repair (NER). We established that both NHEJ and SSA DRCs in lymphocytes of healthy individuals were inversely correlated with the age of the donor, indicating that DSB repair in lymphocytes is likely not a constant feature but rather something that decreases with age (similar to 0.37% NHEJ DRC/year). To investigate the predictive value of preaHCT DRC on outcome in patients, we then applied the optimized assays to the analysis of primary lymphocytes from lymphoma patients and found that individuals who later developed t-MDS/AML (cases) were indistinguishable in their DRC from controls who never developed t-MDS/AML. However, when DRC was investigated shortly after aHCT in the same individuals (21.6 months later on average), aHCT patients (both cases and controls) showed a significant decrease in DSB repair measurements. The average decrease of 6.9% in NHEJ DRC observed among aHCT patients was much higher than the 0.65% predicted for such a short time frame, based on ageing results for healthy individuals.	[Lacoste, Sandrine; O'Connor, Timothy R.] Beckman Res Inst, Dept Canc Biol, Duarte, CA 91016 USA; [Bhatia, Smita; Chen, Yanjun] Univ Alabama Birmingham, Sch Med, Inst Canc Outcomes & Survivorship, Birmingham, AL USA; [Bhatia, Ravi] Univ Alabama Birmingham, Sch Med, Div Hematol & Oncol, Birmingham, AL USA	City of Hope; Beckman Research Institute of City of Hope; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lacoste, S (corresponding author), Beckman Res Inst, Dept Canc Biol, Duarte, CA 91016 USA.	sandrinelacoste@hotmail.com		O'Connor, Timothy/0000-0001-5848-3592	NIH SPORE grant [5 P50 CM 07399]; NIH City of Hope Comprehensive Cancer Center [NCI 5P30 CA033572]; NIH National Cancer Institute [1 R01 CA176611]; NATIONAL CANCER INSTITUTE [R01CA176611] Funding Source: NIH RePORTER	NIH SPORE grant; NIH City of Hope Comprehensive Cancer Center; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the NIH SPORE grant (5 P50 CM 07399, Project 2 to R. Bhatia/T.R. O'Connor, http//www.nih.gov/), the NIH City of Hope Comprehensive Cancer Center (NCI 5P30 CA033572), and the NIH National Cancer Institute (1 R01 CA176611, to T.R. O'Connor, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Akhtari M, 2013, CANCER BIOL THER, V14, P1077, DOI 10.4161/cbt.26342; ATHAS WF, 1991, CANCER RES, V51, P5786; Baeyens A, 2004, MUTAGENESIS, V19, P285, DOI 10.1093/mutage/geh029; Beck JC, 2001, CANCER EPIDEM BIOMAR, V10, P551; Bhatia S, 1996, BLOOD, V87, P3633, DOI 10.1182/blood.V87.9.3633.bloodjournal8793633; Bhatia S, 2015, CANCER-AM CANCER SOC, V121, P648, DOI 10.1002/cncr.29096; Bhatia S, 2013, SEMIN ONCOL, V40, P666, DOI 10.1053/j.seminoncol.2013.09.013; Brown JR, 2005, J CLIN ONCOL, V23, P2208, DOI 10.1200/JCO.2005.05.158; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chechlinska M, 2010, NAT REV CANCER, V10, P2, DOI 10.1038/nrc2782; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; Decordier I, 2010, MUTAT RES-REV MUTAT, V705, P107, DOI 10.1016/j.mrrev.2010.05.002; del Canizo MC, 2000, HAEMATOLOGICA, V85, P403; Deniz M, 2013, MUTAT RES-FUND MOL M, V743, P132, DOI 10.1016/j.mrfmmm.2013.03.009; Friedberg JW, 1999, J CLIN ONCOL, V17, P3128, DOI 10.1200/JCO.1999.17.10.3128; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Gilliland DG, 2002, BIOL BLOOD MARROW TR, V8, P9, DOI 10.1053/bbmt.2002.v8.pm11846355; Goncalves A. C., 2016, MOL CARCINOG; Goukassian D, 2000, FASEB J, V14, P1325, DOI 10.1096/fj.14.10.1325; Grabarz A, 2012, AM J CANCER RES, V2, P249; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Guillem V, 2008, LEUKEMIA LYMPHOMA, V49, P204, DOI 10.1080/10428190701769657; Guillem VM, 2011, LEUKEMIA LYMPHOMA, V52, P1249, DOI 10.3109/10428194.2011.564694; Hanssen-Bauer A, 2012, INT J MOL SCI, V13, P17210, DOI 10.3390/ijms131217210; Harrison CN, 1999, BRIT J CANCER, V81, P476, DOI 10.1038/sj.bjc.6690718; Hatzimichael E, 2010, STEM CELLS CLONING, V3, P105, DOI 10.2147/SCCAA.S6815; Howe R, 2003, BONE MARROW TRANSPL, V32, P317, DOI 10.1038/sj.bmt.1704124; Howlett NG, 2006, DNA REPAIR, V5, P251, DOI 10.1016/j.dnarep.2005.10.004; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Keimling M, 2012, FASEB J, V26, P2094, DOI 10.1096/fj.11-200790; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Krishnan A, 2000, BLOOD, V95, P1588, DOI 10.1182/blood.V95.5.1588.005k38_1588_1593; Lacoste S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093185; Li CY, 2009, INT J CANCER, V124, P999, DOI 10.1002/ijc.24126; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Li TL, 2016, GENOM PROTEOM BIOINF, V14, P147, DOI 10.1016/j.gpb.2016.04.002; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; Mayer C, 2002, DNA REPAIR, V1, P237, DOI 10.1016/S1568-7864(01)00019-2; Mazzei F, 2011, MUTAT RES-GEN TOX EN, V718, P62, DOI 10.1016/j.mrgentox.2010.10.004; Mendez P, 2011, DNA REPAIR, V10, P603, DOI 10.1016/j.dnarep.2011.04.001; Metayer C, 2003, BLOOD, V101, P2015, DOI 10.1182/blood-2002-04-1261; MILLER JS, 1994, BLOOD, V83, P3780; Nagel ZD, 2014, DNA REPAIR, V19, P199, DOI 10.1016/j.dnarep.2014.03.009; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Nissar S, 2014, ONCOL RES TREAT, V37, P418, DOI 10.1159/000364898; Pedersen-Bjergaard J, 2000, BLOOD, V95, P3273, DOI 10.1182/blood.V95.11.3273.011k15_3273_3279; PedersenBjergaard J, 1997, LEUKEMIA, V11, P1654, DOI 10.1038/sj.leu.2400809; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Ramos JM, 2004, CANCER-AM CANCER SOC, V100, P1352, DOI 10.1002/cncr.20135; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Sevilla J, 2002, ANN HEMATOL, V81, P11, DOI 10.1007/s00277-001-0400-0; Takahashi Y, 2005, J INVEST DERMATOL, V124, P435, DOI 10.1111/j.0022-202X.2004.23591.x; Thoms KM, 2007, SCAND J CLIN LAB INV, V67, P580, DOI 10.1080/00365510701230481; Thoms KM, 2007, EXP DERMATOL, V16, P532, DOI 10.1111/j.1600-0625.2007.00559.x; Tsoncheva VL, 2008, Z NATURFORSCH C, V63, P303; Vaidya A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004511; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Yakovlev VA, 2013, CANCER RES, V73, P706, DOI 10.1158/0008-5472.CAN-12-3270; Zijno A, 2010, MUTAT RES-FUND MOL M, V684, P98, DOI 10.1016/j.mrfmmm.2009.12.008	63	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171473	10.1371/journal.pone.0171473	http://dx.doi.org/10.1371/journal.pone.0171473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207808	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500030
J	Lede, V; Meusel, A; Garten, A; Popkova, Y; Penke, M; Franke, C; Ricken, A; Schulz, A; Kiess, W; Huster, D; Schoneberg, T; Schiller, J				Lede, Vera; Meusel, Andrej; Garten, Antje; Popkova, Yulia; Penke, Melanie; Franke, Christin; Ricken, Albert; Schulz, Angela; Kiess, Wieland; Huster, Daniel; Schoeneberg, Torsten; Schiller, Juergen			Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MOUSE MODELS; DEFICIENT MICE; HUMAN OBESITY; DIET; NAFLD; MUTATIONS; RATS; PATHOGENESIS	Obesity is often associated with dyslipidemia and hepatosteatosis. A number of animal models of non-alcoholic fatty liver disease (NAFLD) are established but they significantly differ in the molecular and biochemical changes depending on the genetic modification and diet used. Mice deficient for melanocortin type 4 receptor (Mc4r(mut)) develop hyperphagia, obesity, and subsequently NAFLD already under regular chow and resemble more closely the energy supply-driven obesity found in humans. This animal model was used to assess the molecular and biochemical consequences of hyperphagia-induced obesity on hepatic lipid metabolism. We analyzed transcriptome changes in Mc4r(mut) mice by RNA sequencing and used high resolution H-1 magic angle spinning NMR spectroscopy and MALDI-TOF mass spectrometry to assess changes in the lipid composition. On the transcriptomic level we found significant changes in components of the triacylglycerol metabolism, unsaturated fatty acids biosynthesis, peroxisome proliferator-activated receptor signaling pathways, and lipid transport and storage compared to the wild-type. These findings were supported by increases in triacylglycerol, monounsaturated fatty acid, and arachidonic acid levels. The transcriptome signatures significantly differ from those of other NAFLD mouse models supporting the concept of hepatic subphenotypes depending on the genetic background and diet. Comparative analyses of our data with previous studies allowed for the identification of common changes and genotype-specific components and pathways involved in obesity-associated NAFLD.	[Lede, Vera; Schulz, Angela; Schoeneberg, Torsten] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Mol Biochem, Leipzig, Germany; [Meusel, Andrej; Popkova, Yulia; Huster, Daniel; Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany; [Garten, Antje; Penke, Melanie; Kiess, Wieland] Univ Leipzig, Hosp Children & Adolescents, Dept Women & Child Hlth, Ctr Pediat Res Leipzig, Leipzig, Germany; [Franke, Christin] Heart & Vasc Ctr, Bad Bevensen, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Rudolf Schonheimer Inst Biochem, Mol Biochem, Leipzig, Germany.; Schiller, J (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de; juergen.schiller@medizin.uni-leipzig.de	Lede, Vera/C-7258-2014	Lede, Vera/0000-0001-6045-2605	Deutsche Forschungsgemeinschaft [SFB 1052/B6]; Open Access Publishing Program, Universitat Leipzig, Deutsche Forschungsgemeinschaft [C01665]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Program, Universitat Leipzig, Deutsche Forschungsgemeinschaft	This work was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) with the grant SFB 1052/B6 and the Open Access Publishing Program, Universitat Leipzig, Deutsche Forschungsgemeinschaft (C01665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Dunser MW, 2008, CURR OPIN ANESTHESIO, V21, P122, DOI 10.1097/ACO.0b013e3282f4571a; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Goh VJ, 2013, SEMIN LIVER DIS, V33, P312, DOI 10.1055/s-0033-1358521; Grosse J, 2006, PHYSIOL GENOMICS, V26, P209, DOI 10.1152/physiolgenomics.00289.2005; Guri AJ, 2006, CLIN NUTR, V25, P871, DOI 10.1016/j.clnu.2006.08.006; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Hui ST, 2015, ELIFE, V4, DOI 10.7554/eLife.05607; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Lede V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167888; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; MAYER J, 1951, SCIENCE, V113, P746, DOI 10.1126/science.113.2948.746; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Obici S, 2015, MOL METAB, V4, P692, DOI 10.1016/j.molmet.2015.07.003; Pan XL, 2015, ENDOCRINE, V48, P834, DOI 10.1007/s12020-014-0384-x; Penke M, 2015, MOL CELL ENDOCRINOL, V412, P65, DOI 10.1016/j.mce.2015.05.028; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schiller J, 2002, EUR J LIPID SCI TECH, V104, P496, DOI 10.1002/1438-9312(200208)104:8<496::AID-EJLT496>3.0.CO;2-6; Schuster S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091045; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Stojsavljevic S, 2014, WORLD J GASTROENTERO, V20, P18070, DOI 10.3748/wjg.v20.i48.18070; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tao YX, 2009, PROG MOL BIOL TRANSL, V88, P173, DOI 10.1016/S1877-1173(09)88006-X; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3375, DOI 10.3748/wjg.v19.i22.3375; Than NN, 2015, ATHEROSCLEROSIS, V239, P192, DOI 10.1016/j.atherosclerosis.2015.01.001; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Yaligar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091436; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang W, 2012, BIOMED RES-TOKYO, V33, P83, DOI 10.2220/biomedres.33.83	53	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172000	10.1371/journal.pone.0172000	http://dx.doi.org/10.1371/journal.pone.0172000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207798	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500070
J	Saur, T; Morin, E; Habouzit, F; Bernet, N; Escudie, R				Saur, Thibaut; Morin, Emilie; Habouzit, Frederic; Bernet, Nicolas; Escudie, Renaud			Impact of wall shear stress on initial bacterial adhesion in rotating annular reactor	PLOS ONE			English	Article							TURBULENT-FLOW REGIMES; BIOFILM FORMATION; QUANTITATIVE METHOD; MICROBIAL ADHESION; SURFACE-PROPERTIES; CANDIDA-KRUSEI; CO-ADHESION; CELL; CHAMBER; MICROORGANISMS	The objective of this study was to investigate the bacterial adhesion under different wall shear stresses in turbulent flow and using a diverse bacterial consortium. A better understanding of the mechanisms governing microbial adhesion can be useful in diverse domains such as industrial processes, medical fields or environmental biotechnologies. The impact of wall shear stress - four values ranging from 0.09 to 7.3 Pa on polypropylene (PP) and polyvinyl chloride (PVC) - was carried out in rotating annular reactors to evaluate the adhesion in terms of morphological and microbiological structures. A diverse inoculum consisting of activated sludge was used. Epifluorescence microscopy was used to quantitatively and qualitatively characterize the adhesion. Attached bacterial communities were assessed by molecular fingerprinting profiles (CE-SSCP). It has been demonstrated that wall shear stress had a strong impact on both quantitative and qualitative aspects of the bacterial adhesion. ANOVA tests also demonstrated the significant impact of wall shear stress on all three tested morphological parameters (surface coverage, number of objects and size of objects) (p-values < 2.10(-16)). High wall shear stresses increased the quantity of attached bacteria but also altered their spatial distribution on the substratum surface. As the shear increased, aggregates or clusters appeared and their size grew when increasing the shears. Concerning the microbiological composition, the adhered bacterial communities changed gradually with the applied shear.	[Saur, Thibaut; Morin, Emilie; Habouzit, Frederic; Bernet, Nicolas; Escudie, Renaud] INRA, LBE, Narbonne, France	INRAE	Escudie, R (corresponding author), INRA, LBE, Narbonne, France.	renaud.escudie@supagro.inra.fr	BERNET, Nicolas/B-7333-2011	BERNET, Nicolas/0000-0003-2710-3547; Escudie, Renaud/0000-0003-0736-0327	University of Montpellier II	University of Montpellier II	The authors are thankful to the University of Montpellier II and the LBE for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERECK CD, 1986, J FLUID MECH, V164, P155, DOI 10.1017/S0022112086002513; Andrews CS, 2001, BIOMATERIALS, V22, P3225, DOI 10.1016/S0142-9612(01)00160-0; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1986, ENCY FLUID MECH; Bakker DP, 2003, APPL ENVIRON MICROB, V69, P6280, DOI 10.1128/AEM.69.10.6280-6287.2003; BOS R, 1994, J MICROBIOL METH, V20, P289, DOI 10.1016/0167-7012(94)90053-1; BOS R, 1995, J MICROBIOL METH, V23, P169, DOI 10.1016/0167-7012(95)00013-B; Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006; Characklis W. G., 1990, BIOFILMS; FENSTERMACHER PR, 1979, J FLUID MECH, V94, P103, DOI 10.1017/S0022112079000963; Florjanic M, 2011, INT J PHARMACEUT, V405, P16, DOI 10.1016/j.ijpharm.2010.11.038; Habimana O, 2014, J MEMBRANE SCI, V454, P82, DOI 10.1016/j.memsci.2013.11.043; Habouzit F, 2011, BIORESOURCE TECHNOL, V102, P4054, DOI 10.1016/j.biortech.2010.12.023; Brugnoni LI, 2012, J FOOD ENG, V111, P546, DOI 10.1016/j.jfoodeng.2012.03.023; Brugnoni LI, 2011, J FOOD ENG, V102, P266, DOI 10.1016/j.jfoodeng.2010.08.029; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Lelievre C, 2002, CHEM ENG SCI, V57, P1287, DOI 10.1016/S0009-2509(02)00019-2; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; Meylheuc T, 2006, COLLOID SURFACE B, V52, P128, DOI 10.1016/j.colsurfb.2006.04.016; Michelland RJ, 2009, MOL ECOL RESOUR, V9, P1359, DOI 10.1111/j.1755-0998.2009.02609.x; Milferstedt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080692; Moreira JMR, 2014, COLLOID SURFACE B, V123, P1, DOI 10.1016/j.colsurfb.2014.08.016; Nicolella C, 2000, J BIOTECHNOL, V80, P1, DOI 10.1016/S0168-1656(00)00229-7; Ochoa JC, 2007, CHEM ENG SCI, V62, P3672, DOI 10.1016/j.ces.2007.03.023; Oksanen J., 2016, R PACKAG; Park A, 2011, BIOCHIP J, V5, P236, DOI 10.1007/s13206-011-5307-9; Perni S, 2006, FOOD CONTROL, V17, P875, DOI 10.1016/j.foodcont.2005.06.002; Racina A, 2006, EXP FLUIDS, V41, P513, DOI 10.1007/s00348-006-0178-x; Rasband W., 2006, IMAGEJ; Rochex A, 2008, WATER RES, V42, P4915, DOI 10.1016/j.watres.2008.09.015; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; Teodosio JS, 2011, BIOFOULING, V27, P1, DOI 10.1080/08927014.2010.535206; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; Wang H, 2011, COLLOID SURFACE B, V87, P415, DOI 10.1016/j.colsurfb.2011.05.053; Wery N, 2008, APPL ENVIRON MICROB, V74, P3030, DOI 10.1128/AEM.02760-07; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	38	40	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172113	10.1371/journal.pone.0172113	http://dx.doi.org/10.1371/journal.pone.0172113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207869	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500086
J	Confalonieri, M; Buratti, E; Grassi, G; Bussani, R; Chilosi, M; Farra, R; Abrami, M; Stuani, C; Salton, F; Ficial, M; Confalonieri, P; Zandona, L; Romano, M				Confalonieri, Marco; Buratti, Emanuele; Grassi, Gabriele; Bussani, Rossana; Chilosi, Marco; Farra, Rossella; Abrami, Michela; Stuani, Cristiana; Salton, Francesco; Ficial, Miriam; Confalonieri, Paola; Zandona, Lorenzo; Romano, Maurizio			Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; DOWN-REGULATION; STEM-CELLS; LUNG; PROLIFERATION; REGENERATION; DIFFERENTIATION; MECHANISMS; KNOCKOUT; CIRCUIT	The lung alveoli slowly self-renew pneumocytes, but their facultative regeneration capacity is rapidly efficient after an injury, so fibrosis infrequently occurs. We recently observed Keratin 14 (KRT14) expression during diffuse alveolar damage (DAD), but not in controls. We wonder if KRT14 may be a marker of pneumocyte transition from quiescence to regeneration. Quantitative PCR and Western blot analyses highlighted the presence of KRT14 (mRNA and protein) only in human lung samples with DAD or interstitial lung disease (ILD). In the exponentially growing cell lines A549 and H441, the mRNA and protein levels of KRT14 peaked at day one after cell seeding and decreased at day two, opposite to what observed for the proliferation marker E2F1. The inverse relation of KRT14 versus E2F1 expression holds true also for other proliferative markers, such as cyclin El and cyclin D1. Of interest, we also found that E2F1 silencing caused cell cycle arrest and increased KRT14 expression, whilst E2F1 stimulation induced cell cycle progression and decreased KRT14. KRT14 also increased in proliferative pneumocytes (HPAEpiC) just before transdifferentiation. Overall, our results suggest that KRT14 is a viable biomarker of pneumocyte activation, and repair/regeneration. The involvement of KRT14 in regenerative process may suggest a novel pharmaceutical target to accelerate lung repair.	[Confalonieri, Marco; Salton, Francesco; Confalonieri, Paola] Univ Hosp Cattinara, Dept Pulmonol, Trieste, Italy; [Buratti, Emanuele; Stuani, Cristiana; Romano, Maurizio] Int Ctr Genet Engn & Biotechnol, Mol Pathol, Trieste, Italy; [Grassi, Gabriele; Romano, Maurizio] Univ Trieste, Dept Life Sci, Trieste, Italy; [Bussani, Rossana; Zandona, Lorenzo] Univ Trieste, Inst Pathol Anat, Trieste, Italy; [Chilosi, Marco; Ficial, Miriam] Univ Verona, Dept Diagnost & Publ Hlth, Pathol Unit, Verona, Italy; [Farra, Rossella; Abrami, Michela] Univ Trieste, Dept Engn & Architecture, Trieste, Italy	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste; University of Verona; University of Trieste	Confalonieri, M (corresponding author), Univ Hosp Cattinara, Dept Pulmonol, Trieste, Italy.	marco.confalonieri@asuits.sanita.fvg.it	Buratti, Emanuele/K-4691-2016; CHILOSI, MARCO/ABB-8028-2021; Romano, Maurizio/G-9431-2012; Salton, Francesco/AAC-1992-2019; Confalonieri, Marco/AAA-3665-2019	Buratti, Emanuele/0000-0002-1356-9074; Romano, Maurizio/0000-0002-4820-2897; Salton, Francesco/0000-0002-0864-9766; Confalonieri, Marco/0000-0002-4791-768X; Bussani, Rossana/0000-0001-8241-9726; GRASSI, GABRIELE/0000-0001-9704-6651	"Beneficentia Stiftung" of Vaduz Liechtenstein; Italian Minister of Instruction, University and Research (MIUR) [20109PLMH2]; F.R.A., University of Trieste	"Beneficentia Stiftung" of Vaduz Liechtenstein; Italian Minister of Instruction, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); F.R.A., University of Trieste	This work was in part supported by the "Beneficentia Stiftung" of Vaduz Liechtenstein, by the Italian Minister of Instruction, University and Research (MIUR), PRIN 2010-11, number 20109PLMH2 and by F.R.A., University of Trieste 2015.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CRAPO JD, 1983, AM REV RESPIR DIS, V128, pS42; Dapas B, 2009, MOL MED, V15, P297, DOI 10.2119/molmed.2009.00030; Farra R, 2015, BIOCHIMIE, V112, P85, DOI 10.1016/j.biochi.2015.02.015; Farra R, 2011, DIGEST LIVER DIS, V43, P1006, DOI 10.1016/j.dld.2011.07.007; Farra R, 2010, BIOCHIMIE, V92, P455, DOI 10.1016/j.biochi.2010.01.007; Ficial M, 2014, SHORTNESS BREATH, V3, P102; Ficial M, 2014, AM J RESP CRIT CARE, V189, P1142, DOI 10.1164/rccm.201312-2134LE; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Haines RL, 2012, J CELL SCI, V125, P3923, DOI 10.1242/jcs.099655; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Honda T, 2003, RESP MED, V97, P80, DOI 10.1053/rmed.2002.1408; Kaarteenaho R, 2011, PULM MED, V2011, DOI 10.1155/2011/531302; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Liu YR, 2015, AM J RESP CELL MOL, V53, P113, DOI 10.1165/rcmb.2013-0497OC; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Porter RM, 1996, J CELL BIOL, V132, P925, DOI 10.1083/jcb.132.5.925; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; Rucka Z, 2013, INT J MOL MED, V32, P211, DOI 10.3892/ijmm.2013.1363; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Schilders KAA, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0358-z; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Smirnova NF, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0404-x; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172130	10.1371/journal.pone.0172130	http://dx.doi.org/10.1371/journal.pone.0172130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199407	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400074
J	Favaro, L; Gamba, M; Gili, C; Pessani, D				Favaro, Livio; Gamba, Marco; Gili, Claudia; Pessani, Daniela			Acoustic correlates of body size and individual identity in banded penguins	PLOS ONE			English	Article							SOURCE-FILTER THEORY; DEER DAMA-DAMA; VOCAL INDIVIDUALITY; SOUND PRODUCTION; INFORMATION; RECOGNITION; BEHAVIOR; CALLS; ENEMY; DEAR	Animal vocalisations play a role in individual recognition and mate choice. In nesting penguins, acoustic variation in vocalisations originates from distinctiveness in the morphology of the vocal apparatus. Using the source-filter theory approach, we investigated vocal individuality cues and correlates of body size and mass in the ecstatic display songs the Humboldt and Magellanic penguins. We demonstrate that both fundamental frequency (f(0)) and formants (F-1-F-4) are essential vocal features to discriminate among individuals. However, we show that only duration and f0 are honest indicators of the body size and mass, respectively. We did not find any effect of body dimension on formants, formant dispersion nor estimated vocal tract length of the emitters. Overall, our findings provide the first evidence that the resonant frequencies of the vocal tract do not correlate with body size in penguins. Our results add important information to a growing body of literature on the role of the different vocal parameters in conveying biologically meaningful information in bird vocalisations.	[Favaro, Livio; Gamba, Marco; Pessani, Daniela] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Gili, Claudia] Costa Edutainment SpA, Acquario Genova, Genoa, Italy	University of Turin	Favaro, L (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	livio.favaro@unito.it	Favaro, Livio/B-8337-2013; Gamba, Marco/I-1184-2012	Favaro, Livio/0000-0002-8698-472X; Gamba, Marco/0000-0001-9545-2242				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Aubin T, 2004, AN ACAD BRAS CIENC, V76, P279, DOI 10.1590/S0001-37652004000200015; Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckers GJL, 2003, P NATL ACAD SCI USA, V100, P7372, DOI 10.1073/pnas.1232227100; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; BOERSMA P D, 1976, Living Bird, V15, P43; Boersma Paul, 2002, GLOT INT, V5, P341; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002; Buchanan K., 2015, ANIM BEHAV, V99, pI, DOI DOI 10.1016/S0003-3472(14)00451-5; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Clark JA, 2006, ANIM BEHAV, V72, P1141, DOI 10.1016/j.anbehav.2006.04.002; Davis L.S., 1990, P377; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Elemans CPH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9978; Elemans CPH, 2009, J EXP BIOL, V212, P1212, DOI 10.1242/jeb.026872; Fairburn Daphne J., 2007, P1; Fant G., 1960, ACOUSTIC THEORY SPEE; Favaro L, 2016, BEHAV PROCESS, V128, P83, DOI 10.1016/j.beproc.2016.04.010; Favaro L, 2016, ANIM COGN, V19, P847, DOI 10.1007/s10071-016-0961-x; Favaro L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17255; Favaro L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103460; Favaro L, 2014, ACTA ACUST UNITED AC, V100, P782, DOI 10.3813/AAA.918758; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Fitch WT., 2006, ENCY LANGUAGE LINGUI, V2, P115, DOI DOI 10.1016/B0-08-044854-2/00821-X; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fox J., 2018, R COMPANION APPL REG, VThird; Gamba M, 2012, INT J PRIMATOL, V33, P1453, DOI 10.1007/s10764-012-9635-y; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P321; Garcia M, 2016, J EXP BIOL, V219, P1913, DOI 10.1242/jeb.138255; Hardouin LA, 2014, J AVIAN BIOL, V45, P157, DOI 10.1111/j.1600-048X.2013.00144.x; Holt MM, 2015, J EXP BIOL, V218, P1647, DOI 10.1242/jeb.122424; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; JOUVENTIN P, 1982, VISUAL VOCAL SIGNALS; M?ller-Schwarze, 1984, BEHAV PENGUINS ADAPT; Marks EJ, 2010, BEHAVIOUR, V147, P165, DOI 10.1163/000579509X12512863752751; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; Miyazaki M, 2003, IBIS, V145, P98, DOI 10.1046/j.1474-919X.2003.00126.x; Oberweger K, 2001, J EXP BIOL, V204, P3379; Ohms VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011923; Orben RA, 2015, J ANIM ECOL, V84, P1589, DOI 10.1111/1365-2656.12410; Pratt AE, 2006, BEHAVIOUR, V143, P597, DOI 10.1163/156853906776759501; R Core Team, 2021, R LANGUAGE ENV STAT; Reber SA, 2015, J EXP BIOL, V218, P2442, DOI 10.1242/jeb.119552; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Renison D, 2006, J ETHOL, V24, P189, DOI 10.1007/s10164-005-0180-4; Riede T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2306; Rosell F, 2002, ANIM BEHAV, V63, P1073, DOI 10.1006/anbe.2002.3010; Salton M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140390; Saraux C, 2011, BEHAV ECOL, V22, P837, DOI 10.1093/beheco/arr049; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Sheehan MJ, 2016, BEHAV ECOL, V27, P2, DOI 10.1093/beheco/arv109; STOKES DL, 1991, AUK, V108, P923; Stonehouse B., 1975, THE BIOLOGY OF PENGU; SUTHERS RA, 1994, J COMP PHYSIOL A, V175, P457; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Thumser N. N., 1998, Marine Ornithology, V26, P41; Thumser NN, 1996, WILSON BULL, V108, P72; Tibbetts EA, 2008, TRENDS ECOL EVOL, V23, P356, DOI 10.1016/j.tree.2008.03.007; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tripovich JS, 2008, BEHAV PROCESS, V79, P74, DOI 10.1016/j.beproc.2008.04.007; Tripovich JS, 2008, MAR MAMMAL SCI, V24, P941, DOI 10.1111/j.1748-7692.2008.00222.x; Tubaro PL, 1998, CONDOR, V100, P54, DOI 10.2307/1369896; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WAZA, 2005, 60 ANN C WORLD ASS Z; Zahavi A, 1997, HANDICAP PRINCIPLE M; ZEEK PM, 1951, ANAT REC, V111, P327, DOI 10.1002/ar.1091110305	74	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170001	10.1371/journal.pone.0170001	http://dx.doi.org/10.1371/journal.pone.0170001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199318	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400011
J	Schwarz, D; Raddatz, M; Wings, O				Schwarz, Daniela; Raddatz, Maik; Wings, Oliver			Knoetschkesuchus langenbergensis gen. nov sp nov., a new atoposaurid crocodyliform from the Upper Jurassic Langenberg Quarry (Lower Saxony, northwestern Germany), and its relationships to Theriosuchus	PLOS ONE			English	Article							MESOEUCROCODYLIA; CROCODYLOMORPHA; ORIGIN; GONIOPHOLIS; MORPHOLOGY; ALLIGATOR; GUIMAROTA; ANATOMY	We report a new, small-sized atoposaurid crocodyliform from the Upper Jurassic of Langenberg, Northeastern Germany. Atoposaurids are small-sized Mesozoic crocodyliforms of mainly European distribution, which are considered to be phylogenetically close to the origin of Eusuchia. Knoetschkesuchus langenbergensis gen. nov. sp. nov. is represented by two well-preserved skulls and additional cranial and postcranial remains representing different ontogenetic stages. 3D reconstructions of a juvenile skull based on micro-computed tomography allow the most detailed description of cranial remains of any atoposaurid hitherto presented. Our new analysis contradicts previous preliminary assignment of the Langenberg atoposaurids to Theriosuchus. Knoetschkesuchus gen. nov. is characterized in particular by the presence of two dental morphotypes in the maxilla and dentary, slit-like secondary choanae within a narrow groove on the surface of the pterygoid, absence of lacrimonasal contact, presence of an antorbital foramen and an external mandibular fenestra, and proportional characters of the interorbital and intertemporal region. A similar combination of characters allows attribution of Theriosuchus guimarotae to Knoetschkesuchus, forming the new combination Knoetschkesuchus guimarotae. Our analysis provides an osteological basis for the separation of Theriosuchus and Knoetschkesuchus and helps further delineate generic differences in other closely related crocodylomorphs. Our phylogenetic analysis corroborates inclusion of Knoetschkesuchus into Atoposauridae and supports a position of Atoposauridae within Eusuchia.	[Schwarz, Daniela; Raddatz, Maik] Museum Nat Kunde Berlin, Leibniz Inst Evolutionary & Biodivers Res, Berlin, Germany; [Wings, Oliver] Landesmuseum Hannover, Dept Nat Sci, Hannover, Germany; [Wings, Oliver] Museum Nat, Stiftung Schloss Friedenstein Gotha, Schloss Friedenstein, Gotha, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung	Schwarz, D (corresponding author), Museum Nat Kunde Berlin, Leibniz Inst Evolutionary & Biodivers Res, Berlin, Germany.	Daniela.Schwarz@mfn-berlin.de	Wings, Oliver/ABC-9644-2021	Schwarz, Daniela/0000-0003-4017-8914	Volkswagen Foundation [85 882]	Volkswagen Foundation(Volkswagen)	The Volkswagen Foundation generously funded the Europasaurus-Project (grant no. 85 882) and OW in the grant initiative "Research in Museums."	Adams TL, 2013, J VERTEBR PALEONTOL, V33, P85, DOI 10.1080/02724634.2012.713277; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Brinkmann W, 1989, DOCUMENTA NATURAE, V56, P1; Brinkmann W., 1992, BERLINER GEOWISSENSC, V5, P1; BUFFETAUT E, 1981, Geobios (Villeurbanne), V14, P815, DOI 10.1016/S0016-6995(81)80155-6; Buffetaut E., 1983, Bulletin of the British Museum (Natural History) Geology, V37, P93; Buffetaut E., 1982, ME MOIRES SOCIE TE G, V142, P1, DOI DOI 10.1016/S0016-6995(83)80048-5; Buscalioni A.D., 1990, Treballs del Museu de Geologia de Barcelona, V1, P77; Buscalioni A.D., 1990, Journal of Vertebrate Paleontology, V10, P244; BUSCALIONI A D, 1987, Estudios Geologicos (Madrid), P23; Buscalioni AD, 1996, J VERTEBR PALEONTOL, V16, P358, DOI 10.1080/02724634.1996.10011322; Buscalioni AD, 1988, HIST BIOL, V1988, P233; Buscalioni AD, 1988, INT S VERT BEH DER F, P65; Carballido JL, 2013, J SYSTEMATIC PALAEON, P1, DOI DOI 10.1080/14772019.2013.764935; Clark JM., 1986, THESIS; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Fiorillo A.R, 1999, UTAH GEOLOGICAL SURV, V1, P259; Fischer R., 1991, ARBEITSKREIS PAL ONT, V19, P21; Flynn JJ, NEW MEXICO MUSEUM NA, P476; GERKE O, 2014, J VERTEBR PALEONTOL, V2014, P137; Gervais P., 1871, CR HEBD ACAD SCI, V73, P603; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Hay OP, 1930, 2 BIBLIO CATALOG FOS, V2; Huxley T.H., 1875, Q J GEOLOGICAL SOC, V41, P423, DOI DOI 10.1144/GSL.JGS.1875.031.01-04.29; Iordansky N.N., 1973, P201; Jansen M, 2014, PALAEONTOLOGY, V57, P743, DOI 10.1111/pala.12085; Joffe J., 1967, Palaeontology, V10, P629; Kalin J, 1955, TRAITE PALEONTOL, V5, P695; KALIN JOSEF ALOIS, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P535; Karl H-V, 2006, CLAUSTHALER GEOWISSE, V5, P59; Krebs B., 1968, Mems Serves geol Port NS, V14, P21; Krebs B., 1967, Palaeontologische Zeitschrift, V41, P46; Krebs Bernard, 2000, P69; Lallensack J.N., 2015, PALAEONTOL ELECTRON, V18, P1, DOI DOI 10.26879/529; Lauprasert K, 2010, PALAEONTOL Z, V85, P37; Lotze F, 1968, NEUES JB GEOLOGIE PA, V1968, P730; Marpmann JS, 2015, J SYST PALAEONTOL, V13, P221, DOI 10.1080/14772019.2013.875074; Martin JE, 2014, J PALEONTOL, V88, P444, DOI 10.1666/13-106; Martin JE, 2010, NATURWISSENSCHAFTEN, V97, P845, DOI 10.1007/s00114-010-0702-y; Martin T, 2000, A JURASSIC ECOSYSTEM; Martin T, ACTA PALAEO IN PRESS; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mook CC, 1921, B AM MUS NAT HIST, V44, P51; MOOK CHARLES C., 1934, JOUR GEOL, V42, P295; Mudroch A, 2001, FISCHZAHNE OBERJURA; Mudroch Alexander, 1996, Geologica et Palaeontologica, V30, P239; Nopcsa F., 1928, GEOL HUNG SER PALAEO, V1, P75; NORELL M A, 1990, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V60, P115; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Osi A, 2012, TRIBUTE C DARWIN BER, P533; Osi A, 2014, HIST BIOL, V26, P279, DOI 10.1080/08912963.2013.777533; Owen R., 1879, PALAEONTOGRAPHICAL S, V33, P1; OWEN R, 1878, PALAEONTOGRAPHICAL S, V32, P1; Pape H, 1970, MITTEILUNGEN GEOLOGI, V9, P41; Pienkowski G., 2008, GEOLOGY CENTRAL EURO, P823, DOI [10.1144/CEV2P.2, DOI 10.1144/CEV2P.2]; Pol D, 2009, B AM MUS NAT HIST, P1; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; RICHTER A, 2013, J VERTEBR PALEONTOL, V2013, P198; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; Rogers JV, 2003, J VERTEBR PALEONTOL, V23, P128, DOI 10.1671/0272-4634(2003)23[128:PTANPC]2.0.CO;2; Salisbury Steven W., 2011, Palaeontological Association Field Guides to Fossils, V14, P305; Salisbury SW, 2002, SPEC PAP PALAEONTOL, P121; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Salisbury SW, 1999, SPEC PAP PALAEONTOL, P121; Salisbury SW, 2006, P ROYAL SOC B, P1; Salisbury SW., 2001, THESIS; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Schwarz D, 2005, GEOBIOS-LYON, V38, P779, DOI 10.1016/j.geobios.2004.04.005; Schwarz D, 2004, CAN J EARTH SCI, V41, P1259, DOI 10.1139/E04-059; Schwarz D, 2002, PALAEONTOLOGY, V45, P185, DOI 10.1111/1475-4983.00233; Schwarz-Wings D, 2009, CRETACEOUS RES, V30, P1345, DOI 10.1016/j.cretres.2009.07.011; Schweigert G., 1999, OSNABRUCKER NATURWIS, V25, P25; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; STEEL R, 1973, HDB PALAOHERPETOLOGI, V16, P1; Tennant JP, 2014, PEERJ, V2, DOI 10.7717/peerj.599; Thies D, 1995, J VERTEBR PALEONTOL, V15, P463, DOI 10.1080/02724634.1995.10011242; THIES D, 2001, GEOLOGISCHE BEITRAGE, V2, P65; Thies Detlev, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V205, P393; Turner AH, 2015, PEER J; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118116; WALKER AD, 1968, GEOL MAG, V105, P1, DOI 10.1017/S0016756800046434; Wellnhofer P., 1971, Palaeontographica A, V138, P133; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004; WILSON RCL, 1989, AAPG BULL, V46, P341, DOI DOI 10.1306/M46497C22; Wings O., 2015, 12 S MES TERR EC SHE, P99; Wings O, 2012, IFUNDAMENTAL, V20, P281; Wings Oliver, 2010, Palaeobiodiversity Palaeoenvironments, V90, P283, DOI 10.1007/s12549-010-0033-1; Woodward A. S., 1885, Geological Magazine, V(3), P496; Wu XC, 1996, CAN J EARTH SCI, V33, P599, DOI 10.1139/e96-044; Wu XC, 1996, PALAEONTOLOGY, V39, P351; Young MT, 2015, ZOOLOGICAL J LINNEAN; Ziegler P, 1988, MEMOIR AM ASS PETROL, V43, P63; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C; Zittel R., 1890, HDB PALAEONTOLOGIE, V3	97	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0160617	10.1371/journal.pone.0160617	http://dx.doi.org/10.1371/journal.pone.0160617			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199316	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400001
J	Hamza, E; Kittl, S; Kuhnert, P				Hamza, Eman; Kittl, Sonja; Kuhnert, Peter			Temporal induction of pro-inflammatory and regulatory cytokines in human peripheral blood mononuclear cells by Campylobacter jejuni and Campylobacter coli	PLOS ONE			English	Article							IN-VITRO; RECEPTOR; INFECTIONS; EXPRESSION; SECRETION; ACTIVATION; SIGLEC-10; RESPONSES; UPDATE; ACID	Campylobacter jejuni along with C. coli are major cause of human gastroenteritis worldwide. So far, the human immune response against Campylobacter is not entirely clear. We hypothesize that it is coordinated by an interaction between pro-inflammatory and regulatory cytokines which is influenced by bacterial and host-individual differences. Accordingly, we used peripheral blood mononuclear cells (PBMC) from healthy donors to study the primary systemic immune response to C. jejuni and C. coli PBMC were stimulated by different strains of C. jejuniand C. co/ifor three time points (5, 10, 24 hours). The production of the pro-inflammatory (IL-6, IL-8, IFN-gamma) and the regulatory (IL-10) cytokines were measured by ELISA. All strains induced higher levels of IL-8 and IL-6 than IFN-gamma and IL-10. In contrast to IL-8 and IL 6, IL-10 showed a steeper increase over time. While IFN-gamma did not show any further increase between 10 and 24 hours. Interestingly, there was a significant correlation between IL-8 and IL-10 which peaked at 24 hours. Despite the variability of the used bacterial strains, their effect on cytokine production was less pronounced than the inter-person differences. The strongest significant effect of the strain was on the level of IL-10. IL-10 and IL-6 were significantly influenced by strain-person interaction. In conclusion, the systemic immune response to C. coli and C. jejuni is characterized by an early pro-inflammatory reaction with later initiation of regulatory immune response which is influenced mainly by the host, explaining the individual variations in disease severity. Additional work is needed to determine the cellular sources of the produced cytokines as well as the campylobacter molecules that might contribute to this stimulation.	[Hamza, Eman; Kittl, Sonja; Kuhnert, Peter] Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland; [Hamza, Eman] Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo, Egypt	University of Bern; Egyptian Knowledge Bank (EKB); Cairo University	Hamza, E (corresponding author), Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland.; Hamza, E (corresponding author), Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo, Egypt.	e.hamza@gmx.ch	; Kuhnert, Peter/O-1651-2014	Hamza, Eman/0000-0001-9798-842X; Kuhnert, Peter/0000-0002-1575-5225				Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; [Anonymous], 2015, CELL MOL IMMUNOL; Baqar S, 2001, CLIN INFECT DIS, V33, P901, DOI 10.1086/322594; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; Fimlaid KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112513; Friis LM, 2009, INFECT IMMUN, V77, P1553, DOI 10.1128/IAI.00707-08; Haller D, 2000, INFECT IMMUN, V68, P752, DOI 10.1128/IAI.68.2.752-759.2000; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; Hu L, 2005, INFECT IMMUN, V73, P4437, DOI 10.1128/IAI.73.7.4437-4440.2005; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Islam D, 2014, APMIS, V122, P1102, DOI 10.1111/apm.12266; Jaekal J, 2007, J MICROBIOL BIOTECHN, V17, P1862; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; KIEHLBAUCH JA, 1985, INFECT IMMUN, V48, P446, DOI 10.1128/IAI.48.2.446-451.1985; Kirkpatrick BD, 2013, CLIN INFECT DIS; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Klancnlk A, 2016, VIRULENCE; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; MARTIN PMV, 1989, INFECT IMMUN, V57, P2542, DOI 10.1128/IAI.57.8.2542-2546.1989; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Murphy H, 2011, MICROBES INFECT, V13, P42, DOI 10.1016/j.micinf.2010.09.007; Naundorf S, 2009, EUR J IMMUNOL, V39, P1066, DOI 10.1002/eji.200838773; Stephenson HN, 2014, J INFECT DIS, V210, P1487, DOI 10.1093/infdis/jiu287; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; World Health Organization, 2013, GLOB VIEW CAMP REP E; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171350	10.1371/journal.pone.0171350	http://dx.doi.org/10.1371/journal.pone.0171350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196097	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900017
J	Casazza, G; Lumini, E; Ercole, E; Dovana, F; Guerrina, M; Arnulfo, A; Minuto, L; Fusconi, A; Mucciarelli, M				Casazza, Gabriele; Lumini, Erica; Ercole, Enrico; Dovana, Francesco; Guerrina, Maria; Arnulfo, Annamaria; Minuto, Luigi; Fusconi, Anna; Mucciarelli, Marco			The abundance and diversity of arbuscular mycorrhizal fungi are linked to the soil chemistry of screes and to slope in the Alpic paleo-endemic Berardia subacaulis	PLOS ONE			English	Article							MOLECULAR DIVERSITY; GLOBAL DIVERSITY; AMF COMMUNITIES; PLANT-ROOTS; COLONIZATION; ELEVATION; GRADIENT; BIODIVERSITY; RHIZOSPHERE; GRASSLANDS	Berardia subacaulis Vill. is a monospecific genus that is endemic to the South-western Alps, where it grows on alpine screes, which are extreme habitats characterized by soil disturbance and limiting growth conditions. Root colonization by arbuscular mycorrhizal fungi (AMF) is presumably of great importance in these environments, because of its positive effect on plant nutrition and stress tolerance, as well as on structuring the soil. However, there is currently a lack of information on this topic. In this paper, we tested which soil characteristics and biotic factors could contribute to determining the abundance and community composition of AMF in the roots of B. subacaulis, which had previously been found to be mycorrhizal. For such a reason, the influence of soil properties and environmental factors on AMF abundance and community composition in the roots of B. subacaulis, sampled on three different scree slopes, were analysed through microscopic and molecular analysis. The results have shown that the AMF community of Berardia roots was dominated by Glomeraceae, and included a core of AMF taxa, common to all three scree slopes. The vegetation coverage and dark septate endophytes were not related to the AMF colonization percentage and plant community did not influence the root AMF composition. The abundance of AMF in the roots was related to some chemical (available extractable calcium and potassium) and physical (cation exchange capacity, electrical conductivity and field capacity) properties of the soil, thus suggesting an effect of AMF on improving the soil quality. The non-metric multidimensional scaling (NMDS) ordination of the AMF community composition showed that the diversity of AMF in the various sites was influenced not only by the soil quality, but also by the slope. Therefore, the slopeinduced physical disturbance of alpine screes may contribute to the selection of disturbancetolerant AMF taxa, which in turn may lead to different plant-fungus assemblages.	[Casazza, Gabriele; Guerrina, Maria; Minuto, Luigi] Univ Genoa, DISTAV, Corso Europa 26, Genoa, Italy; [Lumini, Erica] CNR, Ist Protez Sostenibile Piante, Viale PA Mattioli 25, Turin, Italy; [Ercole, Enrico; Dovana, Francesco; Arnulfo, Annamaria; Fusconi, Anna; Mucciarelli, Marco] Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Viale PA Mattioli 25, Turin, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); University of Turin	Mucciarelli, M (corresponding author), Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Viale PA Mattioli 25, Turin, Italy.	marco.mucciarelli@unito.it	Dovana, Francesco/AAR-9737-2021; LUMINI, Erica/AAR-7802-2021; Mucciarelli, Marco/D-6054-2011; LUMINI, Erica/F-8901-2013	LUMINI, Erica/0000-0001-5864-8561; LUMINI, Erica/0000-0001-5864-8561; dovana, francesco/0000-0002-8556-7692; Mucciarelli, Marco/0000-0001-8256-7980				Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; Barres L, 2013, AM J BOT, V100, P867, DOI 10.3732/ajb.1200058; Becklin KM, 2012, MICROB ECOL, V63, P682, DOI 10.1007/s00248-011-9968-7; Berruti A, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01559; Binet MN, 2011, MYCORRHIZA, V21, P523, DOI 10.1007/s00572-010-0354-y; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Coutinho ES, 2015, MYCORRHIZA, V25, P627, DOI 10.1007/s00572-015-0636-5; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; Davison J, 2016, SOIL BIOL BIOCHEM, V97, P63, DOI 10.1016/j.soilbio.2016.03.003; De Caceres M., 2015, PACKAGE INDICSPECIES; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Estrada B, 2013, J ARID ENVIRON, V97, P170, DOI 10.1016/j.jaridenv.2013.05.019; Fisher MA, 2004, FOREST ECOL MANAG, V200, P293, DOI 10.1016/j.foreco.2004.07.003; Gai JP, 2012, PEDOBIOLOGIA, V55, P145, DOI 10.1016/j.pedobi.2011.12.004; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Guerrina M, 2016, J PLANT RES, V129, P477, DOI 10.1007/s10265-016-0796-1; Guerrina M, 2016, REG ENVIRON CHANGE, V16, P1035, DOI 10.1007/s10113-015-0816-z; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jurasinski G., 2015, SIMBA COLLECTION FUN; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawahara A, 2013, OECOLOGIA, V173, P533, DOI 10.1007/s00442-013-2622-y; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 2002, MYCORRHIZA, V12, P181, DOI 10.1007/s00572-002-0169-6; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leigh EG, 1999, TROPICAL FOREST ECOL; Lekberg Y, 2016, FUNGAL ECOL, V24, P135, DOI 10.1016/j.funeco.2016.05.012; Li XL, 2014, MYCORRHIZA, V24, P95, DOI 10.1007/s00572-013-0518-7; Liu W, 2014, FEMS MICROBIOL ECOL, V90, P436, DOI 10.1111/1574-6941.12405; Lukesova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124752; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Mandyam K, 2005, STUD MYCOL, P173; Mandyam KG, 2014, FRONT MICROBIOL, V5, P1; Martin SL, 2012, SOIL BIOL BIOCHEM, V49, P167, DOI 10.1016/j.soilbio.2012.02.036; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Murphy B., 2008, IOP C SERIES EARTH E; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oehl F, 2006, MYCOLOGIA, V98, P286, DOI 10.3852/mycologia.98.2.286; Oehl F, 2014, ALPINE BOT, V124, P193, DOI 10.1007/s00035-014-0138-7; Oehl F, 2012, NOVA HEDWIGIA, V95, P105, DOI 10.1127/0029-5035/2012/0038; Oehl F, 2011, PEDOBIOLOGIA, V54, P321, DOI 10.1016/j.pedobi.2011.07.006; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Ohsowski BM, 2014, NEW PHYTOL, V204, P171, DOI 10.1111/nph.12894; Oksanen J., 2015, PACKAGE VEGAN; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Ozenda P, 2009, CR BIOL, V332, P1092, DOI 10.1016/j.crvi.2009.09.018; Pellissier L, 2014, MOL ECOL, V23, P4274, DOI 10.1111/mec.12854; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1981, NEW PHYTOL, V88, P341, DOI 10.1111/j.1469-8137.1981.tb01729.x; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2008, ARCT ANTARCT ALP RES, V40, P576, DOI 10.1657/1523-0430(07-068)[SCHMIDT]2.0.CO;2; Schnoor TK, 2011, MYCORRHIZA, V21, P211, DOI 10.1007/s00572-010-0325-3; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Senes-Guerrero C, 2016, FUNGAL DIVERS, V77, P317, DOI 10.1007/s13225-015-0328-7; Shi ZY, 2014, CAN J MICROBIOL, V60, P811, DOI 10.1139/cjm-2014-0416; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sonjak S, 2009, PLANT SOIL, V314, P25, DOI 10.1007/s11104-008-9702-5; Stevens KJ, 2011, MYCORRHIZA, V21, P279, DOI 10.1007/s00572-010-0334-2; Sudduth KA, 2001, COMPUT ELECTRON AGR, V31, P239, DOI 10.1016/S0168-1699(00)00185-X; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Van Geel M, 2014, J MICROBIOL METH, V106, P93, DOI 10.1016/j.mimet.2014.08.006; Vandegrift R, 2015, PEERJ, V3, DOI 10.7717/peerj.1379; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Xiang D, 2014, NEW PHYTOL, V204, P968, DOI 10.1111/nph.12961; Yilmaz P., 2013, NUCL ACIDS RES; Zhang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130051; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zobel M, 2014, J VEG SCI, V25, P1133, DOI 10.1111/jvs.12191	83	29	30	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171866	10.1371/journal.pone.0171866	http://dx.doi.org/10.1371/journal.pone.0171866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192471	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800047
J	Minami, A; Meguro, Y; Ishibashi, S; Ishii, A; Shiratori, M; Sai, S; Horii, Y; Shimizu, H; Fukumoto, H; Shimba, S; Taguchi, R; Takahashi, T; Otsubo, T; Ikeda, K; Suzuki, T				Minami, Akira; Meguro, Yuko; Ishibashi, Sayaka; Ishii, Ami; Shiratori, Mako; Sai, Saki; Horii, Yuuki; Shimizu, Hirotaka; Fukumoto, Hokuto; Shimba, Sumika; Taguchi, Risa; Takahashi, Tadanobu; Otsubo, Tadamune; Ikeda, Kiyoshi; Suzuki, Takashi			Rapid regulation of sialidase activity in response to neural activity and sialic acid removal during memory processing in rat hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hippocampus; imaging; rat; sialic acid; sialidase	CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; POLYSIALIC ACID; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; PSA-NCAM; BRAIN; EXPRESSION; NEU4; GANGLIOSIDE	Sialidase cleaves sialic acids on the extracellular cell surface as well as inside the cell and is necessary for normal long-term potentiation (LTP) at mossy fiber-CA3 pyramidal cell synapses and for hippocampus-dependent spatial memory. Here, we investigated in detail the role of sialidase in memory processing. Sialidase activity measured with 4-methylumbelliferyl--d-N-acetylneuraminic acid (4MU-Neu5Ac) or 5-bromo-4-chloroindol-3-yl--d-N-acetylneuraminic acid (X-Neu5Ac) and Fast Red Violet LB was increased by high-K+-induced membrane depolarization. Sialidase activity was also increased by chemical LTP induction with forskolin and activation of BDNF signaling, non-NMDA receptors, or NMDA receptors. The increase in sialidase activity with neural excitation appears to be caused not by secreted sialidase or by an increase in sialidase expression but by a change in the subcellular localization of sialidase. Astrocytes as well as neurons are also involved in the neural activity-dependent increase in sialidase activity. Sialidase activity visualized with a benzothiazolylphenol-based sialic acid derivative (BTP3-Neu5Ac), a highly sensitive histochemical imaging probe for sialidase activity, at the CA3 stratum lucidum of rat acute hippocampal slices was immediately increased in response to LTP-inducible high-frequency stimulation on a time scale of seconds. To obtain direct evidence for sialic acid removal on the extracellular cell surface during neural excitation, the extracellular free sialic acid level in the hippocampus was monitored using in vivo microdialysis. The free sialic acid level was increased by high-K+-induced membrane depolarization. Desialylation also occurred during hippocampus-dependent memory formation in a contextual fear-conditioning paradigm. Our results show that neural activity-dependent desialylation by sialidase may be involved in hippocampal memory processing.	[Minami, Akira; Meguro, Yuko; Ishibashi, Sayaka; Ishii, Ami; Shiratori, Mako; Sai, Saki; Horii, Yuuki; Shimizu, Hirotaka; Fukumoto, Hokuto; Shimba, Sumika; Taguchi, Risa; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp			KAKENHI [24790080, 16K08277]; Hokuto Foundation for Bioscience; Futaba Electronics Memorial Foundation; Takahashi Industrial and Economic Research Foundation; Grants-in-Aid for Scientific Research [15K08037] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Futaba Electronics Memorial Foundation; Takahashi Industrial and Economic Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Young Scientists (B) KAKENHI 24790080 and for Scientific Research (C) KAKENHI 16K08277, the Hokuto Foundation for Bioscience, Futaba Electronics Memorial Foundation, and the Takahashi Industrial and Economic Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ando S, 1998, ANN NY ACAD SCI, V845, P232, DOI 10.1111/j.1749-6632.1998.tb09676.x; Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Boyzo A, 2003, BRAIN RES, V964, P211, DOI 10.1016/S0006-8993(02)03985-9; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; Fujii S, 2002, GLYCOBIOLOGY, V12, P339, DOI 10.1093/glycob/12.5.339; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hoffman KB, 1997, BRAIN RES, V753, P309, DOI 10.1016/S0006-8993(96)01468-0; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jung WR, 2008, NEUROSCI LETT, V439, P220, DOI 10.1016/j.neulet.2008.05.020; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kato K, 2008, NEUROSCI LETT, V441, P286, DOI 10.1016/j.neulet.2008.06.058; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Minami A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165257; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, P80; Prendergast J, 2014, J NEUROSCI, V34, P13246, DOI 10.1523/JNEUROSCI.1149-14.2014; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Shiozaki K, 2014, FISH PHYSIOL BIOCHEM, V40, P1461, DOI 10.1007/s10695-014-9940-9; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Takeda A, 2006, J NEUROCHEM, V99, P670, DOI 10.1111/j.1471-4159.2006.04092.x; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x	48	23	23	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5645	5654		10.1074/jbc.M116.764357	http://dx.doi.org/10.1074/jbc.M116.764357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213516	Green Published, hybrid			2022-12-26	WOS:000398813200003
J	Aramsangtienchai, P; Spiegelman, NA; Cao, J; Lin, HN				Aramsangtienchai, Pornpun; Spiegelman, Nicole A.; Cao, Ji; Lin, Hening			S-Palmitoylation of Junctional Adhesion Molecule C Regulates Its Tight Junction Localization and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAM FAMILY; IDENTIFICATION; METASTASIS; MECHANISM; POLARITY; CANCER; ALPHA; PALMITOYLTRANSFERASES; PROTEINS	Junctional adhesion molecule C (JAM-C) is an immunoglobulin superfamily protein expressed in epithelial cells, endothelial cells, and leukocytes. JAM-C has been implicated in leukocyte transendothelial migration, angiogenesis, cell adhesion, cell polarity, spermatogenesis, and metastasis. Here, we show that JAM-C undergoes S-palmitoylation on two juxtamembrane cysteine residues, Cys-264 and Cys-265. We have identified DHHC7 as a JAM-C palmitoylating enzyme by screening all known palmitoyltransferases (DHHCs). Ectopic expression of DHHC7, but not a DHHC7 catalytic mutant, enhances JAM-C S-palmitoylation. Moreover, DHHC7 knockdown decreases the S-palmitoylation level of JAM-C. Palmitoylation of JAM-C promotes its localization to tight junctions and inhibits transwell migration of A549 lung cancer cells. These results suggest that S-palmitoylation of JAM-C can be potentially targeted to control cancer metastasis.	[Aramsangtienchai, Pornpun; Spiegelman, Nicole A.; Cao, Ji; Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Howard Hughes Medical Institute	Lin, HN (corresponding author), Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	hl379@cornell.edu		Spiegelman, Nicole/0000-0001-8981-8375; Lin, Hening/0000-0002-0255-2701	National Institutes of Health [1S10RR025502]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The imaging data were enabled by the Cornell University Biotechnology Resource Center with National Institutes of Health Grant 1S10RR025502 funding for the Zeiss LSM 710 confocal microscope.	Akawi NA, 2013, HUM MUTAT, V34, P498, DOI 10.1002/humu.22263; Arcangeli ML, 2012, FEBS LETT, V586, P4046, DOI 10.1016/j.febslet.2012.10.005; Babina IS, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3614; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Chen BE, 2016, NAT CHEM BIOL, V12, P686, DOI 10.1038/nchembio.2119; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fuse C, 2007, J BIOL CHEM, V282, P8276, DOI 10.1074/jbc.M608836200; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Guo JS, 2014, ANN NEUROL, V75, P255, DOI 10.1002/ana.24086; Hao SN, 2014, TUMOR BIOL, V35, P5675, DOI 10.1007/s13277-014-1751-1; Iwamoto M, 2001, BBA-BIOMEMBRANES, V1514, P152, DOI 10.1016/S0005-2736(01)00380-7; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keiper T, 2005, HISTOL HISTOPATHOL, V20, P197, DOI 10.14670/HH-20.197; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Leinster DA, 2013, FASEB J, V27, P4244, DOI 10.1096/fj.13-230441; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Lu DM, 2012, J BIOL CHEM, V287, P21856, DOI 10.1074/jbc.M112.348094; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rossin A, 2015, CELL DEATH DIFFER, V22, P643, DOI 10.1038/cdd.2014.153; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Tenan M, 2010, GLIA, V58, P524, DOI 10.1002/glia.20941; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yount Jacob S, 2011, Curr Protoc Chem Biol, V3, P65	38	22	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5325	5334		10.1074/jbc.M116.730523	http://dx.doi.org/10.1074/jbc.M116.730523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196865	Green Published, hybrid			2022-12-26	WOS:000397875500015
J	Chen, ZY; Wang, XH; Yang, F; Hu, QQ; Tong, HC; Dong, XZ				Chen, Zhaoyuan; Wang, Xinhui; Yang, Fan; Hu, Qingqing; Tong, Huichun; Dong, Xiuzhu			Molecular Insights into Hydrogen Peroxide-sensing Mechanism of the Metalloregulator MntR in Controlling Bacterial Resistance to Oxidative Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-MUTANS; MANGANESE HOMEOSTASIS; BACILLUS-SUBTILIS; INTERSPECIES COMPETITION; SUPEROXIDE-DISMUTASE; LACTIC-ACID; SP-NOV.; VIRULENCE; OLIGOFERMENTANS; PNEUMONIAE	Manganese contributes to anti-oxidative stress particularly in catalase-devoid bacteria, and DtxR family metalloregulators, through sensing cellular Mn2+ content, regulate its homeostasis. Here, we show that metalloregulator MntR (So-MntR) functions dually as Mn2+ and H2O2 sensors in mediating H2O2 resistance by an oral streptococcus. H2O2 disrupted So-MntR binding to Mn2+ transporter mntABC promoter and induced disulfide-linked dimerization of the protein. Mass spectrometry identified Cys-11/Cys-156 and Cys-11/Cys-11 disulfide- linked peptides in H2O2-treated So-MntR. Site mutagenesis of Cys-11 and Cys-156 and particularly Cys-11 abolished H2O2-induced disulfide- linked dimers and weakened H2O2 damage on So-MntR binding, indicating that H2O2 inactivates So-MntR via disulfide- linked dimerization. So-MntR C123S mutant was extremely sensitive to H2O2 oxidization in dimerization/ oligomerization, probably because the mutagenesis caused a conformational change that facilitates Cys-11/Cys-156 disulfide linkage. Intermolecular Cys-11/Cys-11 disulfide was detected in C123S/C156S double mutant. Redox Western blot detected So-MntR oligomers in air-exposed cells but remarkably decreased upon H2O2 pulsing, suggesting a proteolysis of the disulfide-linked So-MntR oligomers. Remarkably, elevated C11S and C156S but much lower C123S proteins were detected in H2O2-pulsed cells, confirming Cys-11 and Cys-156 contributed to H2O2-induced oligomerization and degradation. Accordingly, in the C11S and C156S mutants, expression of mntABC and cellular Mn2+ decreased, but H2O2 susceptibility increased. In the C123S mutant, increased mntABC expression, cellular Mn2+ content, and manganese-mediated H2O2 survival were determined. Given the wide distribution of Cys-11 in streptococcal DtxR-like metalloregulators, the disclosed redox regulatory function and mechanism of So-MntR can be employed by the DtxR family proteins in bacterial resistance to oxidative stress.	[Chen, Zhaoyuan; Wang, Xinhui; Hu, Qingqing; Tong, Huichun; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Chen, Zhaoyuan; Wang, Xinhui; Hu, Qingqing; Tong, Huichun; Dong, Xiuzhu] Univ Chinese Acad Sci, Sch Life Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yang, Fan] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Tong, HC; Dong, XZ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China.; Tong, HC; Dong, XZ (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China.	tonghuichun@im.ac.cn; dongxz@im.ac.cn	Dong, Xiuzhu/EBF-2196-2022	Dong, Xiuzhu/0000-0002-6926-5459	National Natural Science Foundation of China [31370098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31370098. The authors declare that they have no conflicts of interest with the contents of this article.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Bates CS, 2005, INFECT IMMUN, V73, P5743, DOI 10.1128/IAI.73.9.5743-5753.2005; BOYD J, 1990, P NATL ACAD SCI USA, V87, P5968, DOI 10.1073/pnas.87.15.5968; Dahl JU, 2015, J MOL BIOL, V427, P1549, DOI 10.1016/j.jmb.2015.02.014; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Dong XZ, 2000, INT J SYST EVOL MICR, V50, P119, DOI 10.1099/00207713-50-1-119; Eijkelkamp BA, 2015, BIOMETALS, V28, P491, DOI 10.1007/s10534-015-9826-z; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Goldstein S, 1999, ACCOUNTS CHEM RES, V32, P547, DOI 10.1021/ar9800789; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Haswell JR, 2013, J BACTERIOL, V195, P126, DOI 10.1128/JB.01648-12; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Huang XJ, 2017, MOL MICROBIOL, V103, P253, DOI 10.1111/mmi.13554; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Jin D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-141; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Juttukonda LJ, 2015, MOL MICROBIOL, V97, P216, DOI 10.1111/mmi.13034; Kafle P, 2016, J BIOL CHEM, V291, P11776, DOI 10.1074/jbc.M116.719351; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; Liu L, 2012, APPL ENVIRON MICROB, V78, P2120, DOI 10.1128/AEM.07539-11; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Liu Z., 2016, ENV HLTH PREVENT MED, V1, P1; Martin JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004977; McGuire AM, 2013, BIOCHEMISTRY-US, V52, P701, DOI 10.1021/bi301550t; Merchant AT, 2014, MOL ORAL MICROBIOL, V29, P1, DOI 10.1111/omi.12039; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Rolerson E, 2006, J BACTERIOL, V188, P5033, DOI 10.1128/JB.00155-06; Spatafora G, 2015, J BACTERIOL, V197, P3601, DOI 10.1128/JB.00612-15; STADTMAN ER, 1990, P NATL ACAD SCI USA, V87, P384, DOI 10.1073/pnas.87.1.384; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Tong H., 2013, GENOME ANNOUNC, V1; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2008, J BACTERIOL, V190, P4716, DOI 10.1128/JB.00363-08; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tong HC, 2006, FEMS MICROBIOL LETT, V264, P213, DOI 10.1111/j.1574-6968.2006.00453.x; Turner AG, 2015, MBIO, V6, DOI 10.1128/mBio.00278-15; Wang XH, 2014, APPL ENVIRON MICROB, V80, P2351, DOI 10.1128/AEM.00064-14; Watts RJ, 2005, J ENVIRON ENG-ASCE, V131, P158, DOI 10.1061/(ASCE)0733-9372(2005)131:1(158); Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	55	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5519	5531		10.1074/jbc.M116.764126	http://dx.doi.org/10.1074/jbc.M116.764126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28223356	Green Published, hybrid			2022-12-26	WOS:000397875500031
J	Biswas, S; Subramanian, A; ELMojtaba, IM; Chattopadhyay, J; Sarkar, RR				Biswas, Santanu; Subramanian, Abhishek; ELMojtaba, Ibrahim M.; Chattopadhyay, Joydev; Sarkar, Ram Rup			Optimal combinations of control strategies and cost-effective analysis for visceral leishmaniasis disease transmission	PLOS ONE			English	Article							PHLEBOTOMUS-ARGENTIPES; MODEL; DYNAMICS; BIHAR; NETS; BIOLOGY; VECTOR; IMPACT; CANINE; STATE	Visceral leishmaniasis (VL) is a deadly neglected tropical disease that poses a serious problem in various countries all over the world. Implementation of various intervention strategies fail in controlling the spread of this disease due to issues of parasite drug resistance and resistance of sandfly vectors to insecticide sprays. Due to this, policy makers need to develop novel strategies or resort to a combination of multiple intervention strategies to control the spread of the disease. To address this issue, we propose an extensive SIR-type model for anthroponotic visceral leishmaniasis transmission with seasonal fluctuations modeled in the form of periodic sandfly biting rate. Fitting the model for real data reported in South Sudan, we estimate the model parameters and compare the model predictions with known VL cases. Using optimal control theory, we study the effects of popular control strategies namely, drug-based treatment of symptomatic and PKDL-infected individuals, insecticide treated bednets and spray of insecticides on the dynamics of infected human and vector populations. We propose that the strategies remain ineffective in curbing the disease individually, as opposed to the use of optimal combinations of the mentioned strategies. Testing the model for different optimal combinations while considering periodic seasonal fluctuations, we find that the optimal combination of treatment of individuals and insecticide sprays perform well in controlling the disease for the time period of intervention introduced. Performing a cost-effective analysis we identify that the same strategy also proves to be efficacious and cost-effective. Finally, we suggest that our model would be helpful for policy makers to predict the best intervention strategies for specific time periods and their appropriate implementation for elimination of visceral leishmaniasis.	[Biswas, Santanu] Adamas Univ, Dept Math, Kolkata, India; [Subramanian, Abhishek; Sarkar, Ram Rup] CSIR, Natl Chem Lab, Chem Engn & Proc Dev, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India; [Subramanian, Abhishek; Sarkar, Ram Rup] Acad Sci & Innovat Res AcSIR, CSIR NCL Campus, Pune 411008, Maharashtra, India; [ELMojtaba, Ibrahim M.] Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, POB 36, Muscat, Oman; [Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, 203 BT Rd, Kolkata 700108, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Academy of Scientific & Innovative Research (AcSIR); Sultan Qaboos University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Sarkar, RR (corresponding author), CSIR, Natl Chem Lab, Chem Engn & Proc Dev, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.; Sarkar, RR (corresponding author), Acad Sci & Innovat Res AcSIR, CSIR NCL Campus, Pune 411008, Maharashtra, India.	rr.sarkar@ncl.res.in	Subramanian, Abhishek/AAN-1302-2020; Elmojtaba, Ibrahim/AAH-4270-2020	Subramanian, Abhishek/0000-0002-4601-5991; SARKAR, RAM RUP/0000-0001-7115-163X; ELmojtaba, Ibrahim/0000-0001-6018-4671	Council of Scientific and Industrial Research (CSIR), India [BSC0114]; DBT-BINC	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT-BINC	This work was supported by grant from 12th FYP project HOPE (BSC0114) of Council of Scientific and Industrial Research (CSIR), India to RRS. AS acknowledges the Senior Research Fellowship from DBT-BINC.	Abubakar A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002720; Agyingi EO, 2011, J BIOL SYST, V19, P237, DOI 10.1142/S0218339011003841; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Biswas S., 2016, NONLINEAR DYNAMICS; Brahmachari U N, 1922, Ind Med Gaz, V57, P125; Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chaves LF, 2004, ACTA TROP, V92, P245, DOI 10.1016/j.actatropica.2004.08.004; Chowdhury R, 2011, AM J TROP MED HYG, V84, P662, DOI 10.4269/ajtmh.2011.10-0682; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Das P, 2007, J BIOL SYST, V15, P139, DOI 10.1142/S0218339007002155; Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000859; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; DYE C, 1992, PARASITOLOGY, V104, pS7, DOI 10.1017/S0031182000075211; DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2; ELmojtaba IM, 2013, MATH METHOD APPL SCI, V36, P216, DOI 10.1002/mma.2589; ELmojtaba IM, 2010, APPL MATH COMPUT, V217, P2567, DOI 10.1016/j.amc.2010.07.069; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Geweke J., 1991, ACCURACY SAMPLING BA, P148; Gradoni L, 2015, VET PARASITOL, V208, P94, DOI 10.1016/j.vetpar.2015.01.003; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Lee BY, 2012, AM J TROP MED HYG, V86, P417, DOI 10.4269/ajtmh.2012.10-0415; Lenhart S., 2007, OPTIMAL CONTROL APPL; LEWIS DJ, 1974, ANNU REV ENTOMOL, V19, P363, DOI 10.1146/annurev.en.19.010174.002051; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; Mubayi A, 2010, J THEOR BIOL, V262, P177, DOI 10.1016/j.jtbi.2009.09.012; Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008; Reithinger Richard, 2002, Trends in Parasitology, V18, P289, DOI 10.1016/S1471-4922(02)02296-1; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; Sardar T, 2016, MATH METHOD APPL SCI, V39, P4181, DOI 10.1002/mma.3855; Sardar T, 2016, VIRULENCE, V7, P187, DOI 10.1080/21505594.2015.1096470; Sardar T, 2015, MATH BIOSCI, V263, P18, DOI 10.1016/j.mbs.2015.01.009; Sardar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081231; Stauch Anette, 2012, PLoS Negl Trop Dis, V6, pe1973, DOI 10.1371/journal.pntd.0001973; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Stockdale L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002278; Subramanian A, 2015, MATHEMATICS, V3, P913, DOI 10.3390/math3030913; W. H. O, 2015, SUMM VISC LEISHM VL; World Health Organization, 2014, LEISHM FACT SHEET; Zamir M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160513	49	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172465	10.1371/journal.pone.0172465	http://dx.doi.org/10.1371/journal.pone.0172465			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222162	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800057
J	Ghielmetti, G; Scherrer, S; Friedel, U; Frei, D; Suter, D; Perler, L; Wittenbrink, MM				Ghielmetti, Giovanni; Scherrer, Simone; Friedel, Ute; Frei, Daniel; Suter, Dominique; Perler, Lukas; Wittenbrink, Max M.			Epidemiological tracing of bovine tuberculosis in Switzerland, multilocus variable number of tandem repeat analysis of Mycobacterium bovis and Mycobacterium caprae	PLOS ONE			English	Article							COMPLEX BACTERIA; STRAINS; LOCI; MICROEVOLUTION; IDENTIFICATION; SURVEILLANCE; WILDLIFE; PROPOSAL; EUROPE; GENOME	Background After 15 years of absence, in 2013 bovine tuberculosis (bTB), caused by Mycobacterium (M.) bovis and M. caprae, reemerged in the Swiss dairy cattle population. In order to identify the sources of infection as well as the spread of the agents, molecular-epidemiologic tracing by MIRU-VNTR analysis in combination with spoligotyping was performed. A total of 17 M. bovis and 7M. caprae isolates were cultured from tuberculous bovine lymph nodes and analyzed with a set of 49 genetic markers by using automated capillary electrophoresis. Results The outbreak in the western part of Switzerland was caused by M. bovis spoligotype SB0120. With the exception of four single-locus variations observed in MIRU 20, the MIRU-VNTR profiles of the 17 M. bovis isolates were identical, indicating a single source of infection. M. bovis detected in one archival bovine specimen from the outbreak region showed an identical MIRU-VNTR profile, suggesting persistence of the agent in a dairy herd for nearly fifteen years. The outbreak in the eastern part of Switzerland was caused by M. caprae spoligotype SB0418. All Swiss M. caprae isolates showed the Lechtal-type MIRU-VNTR profile, described as endemic in wild ruminants and in dairy cattle in Austrian bordering regions. This suggests the agent was most likely introduced by Swiss dairy cattle summering on Austrian pastures. Conclusions The present study is the first MIRU-VNTR analysis of Swiss bTB mycobacterial isolates. The genotyping assay was found to be highly discriminating and suitable for the epidemiological tracing of further outbreaks. These findings will contribute to the development of an international MIRU-VNTR database aiming to improve bTB surveillance.	[Ghielmetti, Giovanni; Scherrer, Simone; Friedel, Ute; Frei, Daniel; Wittenbrink, Max M.] Univ Zurich, Inst Vet Bacteriol, Vetsuisse Fac, CH-8006 Zurich, Switzerland; [Suter, Dominique; Perler, Lukas] Fed Food Safety & Vet Off, Bern, Switzerland	University of Zurich	Ghielmetti, G (corresponding author), Univ Zurich, Inst Vet Bacteriol, Vetsuisse Fac, CH-8006 Zurich, Switzerland.	giovanni.ghielmetti@vetbakt.uzh.ch	Ghielmetti, Giovanni/GVS-0748-2022; Scherrer, Simone/F-3663-2019	Scherrer, Simone/0000-0001-9548-8798; Ghielmetti, Giovanni/0000-0002-3936-9687	Swiss Federal Food Safety and Veterinary Office [710000136]	Swiss Federal Food Safety and Veterinary Office	This work was funded by the Swiss Federal Food Safety and Veterinary Office; contract number 710000136 to GG UF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajoj SAM, 2010, J CLIN MICROBIOL, V48, P3813, DOI 10.1128/JCM.00556-10; Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Ciliberti A, 2015, PREV VET MED, V118, P271, DOI 10.1016/j.prevetmed.2014.11.021; De Kantor IN, 1998, LAB SERVICES TUBERCU, P38; Erler W, 2004, J CLIN MICROBIOL, V42, P2234, DOI 10.1128/JCM.42.5.2234-2238.2004; Fine Amanda E, 2011, Vet Med Int, V2011, P765430, DOI 10.4061/2011/765430; Firdessa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052851; Fluckiger G, 1960, EIDGENOOSSISCHES VET, P5; Fritschi E, 1960, EIDGENOOSSISCHES VET, P12; Gormley E, 2014, RES VET SCI; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; Hur M, 2011, INT J TUBERC LUNG D, V15, P795, DOI 10.5588/ijtld.10.0367; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; McMurray CL, 2010, J MICROBIOL METH, V80, P109, DOI 10.1016/j.mimet.2009.10.016; Meylan M, 2013, SCHWEIZ ARCH TIERH, V155, P573, DOI 10.1024/0036-7281/a000514; Navarro Y, 2016, VET MICROBIOL, V183, P97, DOI 10.1016/j.vetmic.2015.11.032; Rodriguez-Campos S, 2014, RES VET SCI; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Roring S, 2004, VET MICROBIOL, V101, P65, DOI 10.1016/j.vetmic.2004.02.013; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Ruettger A, 2012, J CLIN MICROBIOL, V50, P2492, DOI 10.1128/JCM.00442-12; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Schoepf K, 2012, ISRN VET SCI, DOI DOI 10.5402/2012/245138; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Smittipat N, 2000, TUBERCLE LUNG DIS, V80, P69, DOI 10.1054/tuld.2000.0236; Suppiger F, 1999, SCHWEIZ ARCH TIERH, V141, P11; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tschopp A, 1985, THESIS; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12	38	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172474	10.1371/journal.pone.0172474	http://dx.doi.org/10.1371/journal.pone.0172474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222182	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800059
J	Marin, D; Marin, N; del Corral, H; Lopez, L; Ramirez-Agudelo, ME; Rojas, CA; Arbelaez, MP; Garcia, LF; Rojas, M				Marin, Diana; Marin, Nancy; del Corral, Helena; Lopez, Lucelly; Elena Ramirez-Agudelo, Maria; Rojas, Carlos A.; Arbelaez, Maria P.; Garcia, Luis F.; Rojas, Mauricio			PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-TUBERCULOSIS; MACROPHAGE APOPTOSIS; LATENT TUBERCULOSIS; CELL-DEATH; ACTIVE TUBERCULOSIS; INFECTION; NECROSIS; INDUCTION; DISEASE	Introduction The mechanisms of mononuclear phagocyte death have been associated with the permissiveness and resistance to mycobacterial replication, but it remains unknown whether or not they help predict the risk of developing TB. Objective To describe the factors associated with the induction of monocyte mitochondrial and membrane damage in response to PPD as well as determine if this type of damage might predict the susceptibility of developing active tuberculosis in a cohort of household contacts (HHCs) from Medellin, Colombia from 2005 to 2008. Methods The prospective cohort study contains 2060 HHCs patients with pulmonary tuberculosis who were meticulously followed for two years. A survey of the socio-demographic, clinical, epidemiological factors and blood samples were collected. Mononuclear cell cultures were stimulated with or without PPD and the type of monocyte death was determined by the flow of cytometry, an indicator was also used for its analysis. Logistic regression was adjusted by the Generalized Estimations Equations and the survival was estimated with the Kaplan-Meier and Cox regression. Confidence intervals were used for estimating the association. Results 1,859 out of 2,060 blood samples of the HHCs patients analyzed showed monocyte death. In response to PPD, 83.4% underwent mitochondrial damage while 50.9% had membrane damage. The membrane damage in response to PPD was higher in children under 4 years (OR: 1.57; (95% CI: 1.1 to 2.4) and the HHCs who slept regularly in the same household has an index case of (OR: 1.54; 95% CI: 1.0 to 2.3). After adjustment by age, comorbidities, nutritional status, proximity to index case and overcrowding, the risk of developing active TB among BCG vaccinated HHCs individuals with induction of mitochondrial damage was HR = 0.19 (95% CI: 0.1 to 0.5). Conclusions The induction of monocytes mitochondrial damage by PPD stimulation correlates with protection of TB disease development in BCG-vaccinated HHCs. This represents a potential tool to predict susceptibility of developing active disease in this population.	[Marin, Diana; del Corral, Helena; Lopez, Lucelly; Rojas, Carlos A.; Arbelaez, Maria P.] Univ Antioquia, Fac Nacl Salud Publ, Grp Epidemiol, Medellin, Colombia; [Marin, Diana; Marin, Nancy; del Corral, Helena; Lopez, Lucelly; Elena Ramirez-Agudelo, Maria; Rojas, Carlos A.; Arbelaez, Maria P.; Garcia, Luis F.; Rojas, Mauricio] CCITB, Medellin, Colombia; [Marin, Nancy; Elena Ramirez-Agudelo, Maria; Garcia, Luis F.; Rojas, Mauricio] Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; [Rojas, Mauricio] Univ Antioquia, Sede Invest Univ, Unidad Citometria Flujo, Medellin, Colombia; [Marin, Diana; Lopez, Lucelly] Univ Pontificia Bolivariana, Fac Med, Medellin, Colombia; [Marin, Nancy; del Corral, Helena] Univ Antioquia, Escuela Microbiol, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad Pontificia Bolivariana; Universidad de Antioquia	Marin, D (corresponding author), Univ Antioquia, Fac Nacl Salud Publ, Grp Epidemiol, Medellin, Colombia.; Marin, D; Rojas, M (corresponding author), CCITB, Medellin, Colombia.; Rojas, M (corresponding author), Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia.; Rojas, M (corresponding author), Univ Antioquia, Sede Invest Univ, Unidad Citometria Flujo, Medellin, Colombia.; Marin, D (corresponding author), Univ Pontificia Bolivariana, Fac Med, Medellin, Colombia.	dianamarcela.marin@upb.edu.co; mauricio.rojas@udea.edu.co	Rojas Cruz, Carlos Alberto/GZM-2307-2022; Rojas Lopez, Mauricio/P-4924-2018	Rojas Cruz, Carlos Alberto/0000-0003-0915-6653; Rojas Lopez, Mauricio/0000-0002-7791-9328; Marin Agudelo, Nancy Dora/0000-0002-2626-3349; Marin Pineda, Diana/0000-0002-4715-8388; Lopez Lopez, Lucelly/0000-0002-1534-520X	Colciencias (Colombian Administrative Department of Science, Technology and Innovation), Bogota Universidad de Antioquia [11150416335, 34261817270]	Colciencias (Colombian Administrative Department of Science, Technology and Innovation), Bogota Universidad de Antioquia	Funding for this research was gratefully received from Colciencias (Colombian Administrative Department of Science, Technology and Innovation, http://www.colciencias.gov.co/), Bogota Universidad de Antioquia (Grants: 11150416335 and 34261817270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was received from Colciencias (http://www.coiciencias.gov.coi), Bogota, (Grants: 11150416335 and 34261817270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo JI, 2013, CELL MICROBIOL, V15, P1994, DOI 10.1111/cmi.12169; Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2013, MEDELLIN SECRETARIA; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Campbell GR, 2013, AIDS, V27, P1397, DOI 10.1097/QAD.0b013e32836010dd; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Danelishvili L, 2003, CELL MICROBIOL, V5, P649, DOI 10.1046/j.1462-5822.2003.00312.x; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Elliott TOJP, 2015, J INFECT DIS, V212, P1469, DOI 10.1093/infdis/jiv238; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Gerber A, 2000, DERMATOLOGY, V201, P111, DOI 10.1159/000018472; Gil DP, 2004, J INFECT DIS, V189, P2120, DOI 10.1086/386369; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; He H, 2015, EUR J CLIN MICROBIOL, V34, P1103, DOI 10.1007/s10096-015-2335-8; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Kremer L, 1997, EUR J IMMUNOL, V27, P2450, DOI 10.1002/eji.1830270945; Kumar V, 2013, ROBBINS BASIC PATHOL, Vxii; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; McCormick AL, 2008, CURR TOP MICROBIOL, V325, P281; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Pai M, 2015, LUNG INDIA, V32, P205, DOI 10.4103/0970-2113.156210; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Rojas M, 2000, J INFECT DIS, V182, P240, DOI 10.1086/315676; Rojas M, 1999, J IMMUNOL, V162, P6122; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sanchez MD, 2006, MICROBES INFECT, V8, P2492, DOI 10.1016/j.micinf.2006.06.005; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Social SSdSyP, COB VAC VAC GRUP ED; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WHO, 2009, GLOB TUB CONTR 2009; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0; Zychlinsky Arturo, 1993, Trends in Microbiology, V1, P114, DOI 10.1016/0966-842X(93)90118-B	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171930	10.1371/journal.pone.0171930	http://dx.doi.org/10.1371/journal.pone.0171930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222109	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800020
J	Takara, K; Maruo, N; Oka, K; Kaji, C; Hatakeyama, Y; Sawa, N; Kato, Y; Yamashita, J; Kojima, H; Sawa, Y				Takara, Kenyo; Maruo, Naoki; Oka, Kyoko; Kaji, Chiaki; Hatakeyama, Yuji; Sawa, Naruhiko; Kato, Yukinari; Yamashita, Junro; Kojima, Hiroshi; Sawa, Yoshihiko			Morphological study of tooth development in podoplanin-deficient mice	PLOS ONE			English	Article							MUCIN-TYPE GLYCOPROTEIN; GERM-CELL TUMORS; PLATELET-AGGREGATION; EPITHELIAL-CELLS; IMMUNOHISTOCHEMICAL EXAMINATION; MARKER PODOPLANIN; EXPRESSING CELLS; MEMBRANE-PROTEIN; DENDRITIC CELLS; I CELLS	Podoplanin is a mucin-type highly O-glycosylated glycoprotein identified in several somatyic cells: podocytes, alveolar epithelial cells, lymphatic endothelial cells, lymph node stromal fibroblastic reticular cells, osteocytes, odontoblasts, mesothelial cells, glia cells, and others. It has been reported that podoplanin-RhoA interaction induces cytoskeleton relaxation and cell process stretching in fibroblastic cells and osteocytes, and that podoplanin plays a critical role in type I alveolar cell differentiation. It appears that podoplanin plays a number of different roles in contributing to cell functioning and growth by signaling. However, little is known about the functions of podoplanin in the somatic cells of the adult organism because an absence of podoplanin is lethal at birth by the respiratory failure. In this report, we investigated the tooth germ development in podoplanin-knockout mice, and the dentin formation in podoplanin-conditional knockout mice having neural crest-derived cells with deficiency in podoplanin by the Wnt1 promoter and enhancer-driven Cre recombinase: Wnt1-Cre; Pdpn(Delta/Delta) mice. In the Wnt1-Cre; Pdpn(Delta/Delta)mice, the tooth and alveolar bone showed no morphological abnormalities and grow normally, indicating that podoplanin is not critical in the development of the tooth and bone.	[Takara, Kenyo; Oka, Kyoko; Kaji, Chiaki; Kojima, Hiroshi] Fukuoka Dent Coll, Dept Oral Growth & Dev, Fukuoka, Japan; [Maruo, Naoki] Fukuoka Dent Coll, Dept Odontol, Fukuoka, Japan; [Hatakeyama, Yuji; Sawa, Yoshihiko] Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan; [Sawa, Naruhiko; Yamashita, Junro] Fukuoka Dent Coll, Dept Oral & Maxillofacial Surg, Fukuoka, Japan; [Kato, Yukinari] Tohoku Univ, Dept Reg Innovat, Grad Sch Med, Sendai, Miyagi, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Tohoku University	Sawa, Y (corresponding author), Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan.	ysawa@college.fdcnet.ac.jp	Yamashita, Junro/D-4787-2019	Yamashita, Junro/0000-0002-5486-1362; Kato, Yukinari/0000-0001-5385-8201	NIH/NIDCR grant [R01DE023538]; Japan Society for the Promotion of Science [15H05060]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023538] Funding Source: NIH RePORTER	NIH/NIDCR grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR grant R01DE023538 (Yamashita, J.) and Grant-in-Aid for Scientific Research (B) 15H05060 (principal investigator: Sawa, Y.) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH/NIDCR grant R01DE023538 (Yamashita, J.) and Grant-in-Aid for Scientific Research (B) 15H05060 (principal investigator: Sawa, Y.) from Japan Society for the Promotion of Science.	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Amano I, 2011, ACTA HISTOCHEM CYTOC, V44, P267, DOI 10.1267/ahc.11037; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chu AY, 2005, MODERN PATHOL, V18, P105, DOI 10.1038/modpathol.3800259; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Coleman JLJ, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00105; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; FARR A, 1992, J HISTOCHEM CYTOCHEM, V40, P651, DOI 10.1177/40.5.1374092; Gonzalez RF, 1998, BBA-PROTEIN STRUCT M, V1429, P208, DOI 10.1016/S0167-4838(98)00231-3; Hata M, 2008, ARCH ORAL BIOL, V53, P835, DOI 10.1016/j.archoralbio.2008.02.006; Hata M, 2010, ACTA HISTOCHEM CYTOC, V43, P77, DOI 10.1267/ahc.10011; Imaizumi Y, 2010, ACTA HISTOCHEM CYTOC, V43, P115, DOI 10.1267/ahc.10023; Ishizawa K, 2009, CLIN NEUROPATHOL, V28, P373, DOI 10.2379/NPX09169; Jokinen CH, 2008, AM J CLIN PATHOL, V129, P886, DOI 10.1309/M7D5KTVYYE51XYQA; Kaji C, 2012, J ANAT, V220, P435, DOI 10.1111/j.1469-7580.2012.01484.x; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Marsee DK, 2009, APPL IMMUNOHISTO M M, V17, P102, DOI 10.1097/PAI.0b013e318183a8e2; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Noda Y, 2010, ACTA HISTOCHEM CYTOC, V43, P61, DOI 10.1267/ahc.10008; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Sawa Y, 2008, ACTA HISTOCHEM CYTOC, V41, P121, DOI 10.1267/ahc.08019; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Scholl FG, 1999, J CELL SCI, V112, P4601; Schulze E, 1999, HISTOCHEM CELL BIOL, V111, P61, DOI 10.1007/s004180050334; Schwab W, 1999, ACTA HISTOCHEM, V101, P431, DOI 10.1016/S0065-1281(99)80043-9; Shibahara J, 2006, VIRCHOWS ARCH, V448, P493, DOI 10.1007/s00428-005-0133-x; Sonne SB, 2006, VIRCHOWS ARCH, V449, P200, DOI 10.1007/s00428-006-0223-4; Tomooka M, 2013, ACTA HISTOCHEM CYTOC, V46, P171, DOI 10.1267/ahc.13035; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Yamazaki H, 2007, STEM CELLS, V25, P78, DOI 10.1634/stemcells.2006-0360; Yu HB, 2007, AM J CLIN PATHOL, V128, P776, DOI 10.1309/7P8U659JBJCV6EEU; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zimmer G, 1999, BIOCHEM J, V341, P277, DOI 10.1042/0264-6021:3410277	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171912	10.1371/journal.pone.0171912	http://dx.doi.org/10.1371/journal.pone.0171912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222099	gold, Green Published, Green Submitted			2022-12-26	WOS:000394676800019
J	Wang, XY; Zhang, LS; Zhang, YN; Bai, ZQ; Liu, H; Zhang, DP				Wang, Xiaoyu; Zhang, Linsheng; Zhang, Yane; Bai, Zhenqing; Liu, Hao; Zhang, Dapeng			Triticum aestivum WRAB18 functions in plastids and confers abiotic stress tolerance when overexpressed in Escherichia coli and Nicotiania benthamiana	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; 3 LEA PROTEIN; AMINO-ACID MOTIF; GENE FAMILY; MODEL PEPTIDES; WATER-DEFICIT; ARABIDOPSIS; EXPRESSION; HVA1; PLANT	WRAB18, an ABA-inducible protein belongs to the third family of late embryogenesis abundant (LEA) proteins which can be induced by different biotic or abiotic stresses. In the present study, WRAB18 was cloned from the Zhengyin 1 cultivar of Triticum aestivum and overexpressed in Escherichia coli to explore its effects on the growth of E. coli under different abiotic stresses. Results suggested the enhanced exhibition of tolerance of E. coli to these stresses. Meanwhile, the WRAB18-transgenic tobacco plants were obtained to analyze the stress-related enzymatic activities of ascorbate peroxidase (APX), peroxidase (POD) and superoxide dismutase (SOD), and to quantify the content of malonaldehyde (MDA) under osmotic stress, high salinity, and low and high temperature stress. The activities of APX, POD and SOD in the transgenic tobacco lines were higher while the content of MDA was lower than those of WT lines. Moreover, plastid localization of WRAB18 in Nicotiana benthamiana plasma cells were found fusing with GFP. In addition, purified WRAB18 protein protected LDH (Lactate dehydrogenase) enzyme activity in vitro from various stress conditions. In brief, WRAB18 protein shows protective action behaving as a "molecular shield" in both prokaryotic and eukaryotic cells under various abiotic stresses, not only during ABA stress.	[Wang, Xiaoyu; Zhang, Linsheng; Zhang, Yane; Bai, Zhenqing; Liu, Hao; Zhang, Dapeng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Peoples R China	Northwest A&F University - China	Zhang, LS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Peoples R China.	linszhang@nwsuaf.edu.cn			State Key Laboratory of Crop Stress Biology for Arid Areas [CSBA2015007]; Specialized Research Fund for the Doctoral Program of Higher Education [20120204110033]	State Key Laboratory of Crop Stress Biology for Arid Areas; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by funding from the State Key Laboratory of Crop Stress Biology for Arid Areas (CSBA2015007) and the Specialized Research Fund for the Doctoral Program of Higher Education (20120204110033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara I, 2012, PLANT CELL PHYSIOL, V53, P312, DOI 10.1093/pcp/pcr183; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; BAXTER RM, 1956, CAN J MICROBIOL, V2, P599, DOI 10.1139/m56-072; Boswell LC, 2014, TISSUE CELL, V46, P514, DOI 10.1016/j.tice.2014.09.004; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chen YS, 2015, PLANT BIOTECHNOL J, V13, P105, DOI 10.1111/pbi.12241; Chen Yu, 2003, Yichuan, V25, P367; Da Silva JM, 2004, J PLANT PHYSIOL, V161, P551, DOI 10.1078/0176-1617-01109; Dalal M, 2013, ACTA PHYSIOL PLANT, V35, P979, DOI 10.1007/s11738-012-1123-7; Dong CN, 2002, PLANT PHYSIOL, V129, P1368, DOI 10.1104/pp.001925; Drira M, 2013, MOL BIOTECHNOL, V54, P643, DOI 10.1007/s12033-012-9606-8; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Furuki T, 2014, BBA-BIOMEMBRANES, V1838, P2757, DOI 10.1016/j.bbamem.2014.07.009; Furuki T, 2012, BBA-PROTEINS PROTEOM, V1824, P891, DOI 10.1016/j.bbapap.2012.04.013; Gao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19467; Gawel Stefan, 2004, Wiad Lek, V57, P453; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goyal K, 2005, FEBS LETT, V579, P4093, DOI 10.1016/j.febslet.2005.06.036; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; HARWOOD JL, 1982, PLANTA, V156, P152, DOI 10.1007/BF00395429; Hernandez-Sanchez IE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00520; HONG BM, 1988, PLANT MOL BIOL, V11, P495, DOI 10.1007/BF00039030; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu TZ, 2012, APPL BIOCHEM BIOTECH, V166, P222, DOI 10.1007/s12010-011-9418-5; Kanamori Y, 2006, GENES GENET SYST, V81, P420; Kobayashi F, 2004, PHYSIOL PLANTARUM, V120, P585, DOI 10.1111/j.0031-9317.2004.0293.x; Kobayashi F, 2008, TRANSGENIC RES, V17, P755, DOI 10.1007/s11248-007-9158-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Gang, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P535; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long RC, 2014, MOL BREEDING, V34, P1465, DOI 10.1007/s11032-014-0130-3; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NEWTON RJ, 1986, PLANT PHYSIOL, V81, P626, DOI 10.1104/pp.81.2.626; Paul A, 2014, MOL BIOL REP, V41, P7191, DOI 10.1007/s11033-014-3602-y; Rajesh S, 2006, BIOINFORMATION, V1, P133, DOI 10.6026/97320630001133; Rogalski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00586; ROTH WG, 1985, BIOCHEM BIOPH RES CO, V126, P434, DOI 10.1016/0006-291X(85)90624-2; Sasaki K, 2014, PLANT CELL PHYSIOL, V55, P136, DOI 10.1093/pcp/pct164; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Shinde S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22535; Shukla PS, 2015, PLANTA, V242, P1291, DOI 10.1007/s00425-015-2366-5; Simontacchi M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00977; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Solhlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI [10.1104/pp.008599, DOI 10.1104/PP.008599]; SUTTON F, 1992, PLANT PHYSIOL, V99, P338, DOI 10.1104/pp.99.1.338; Thalhammer A, 2010, BBA-BIOMEMBRANES, V1798, P1812, DOI 10.1016/j.bbamem.2010.05.015; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tsuda K, 2000, GENES GENET SYST, V75, P179, DOI 10.1266/ggs.75.179; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Udawat P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00518; Ukaji N, 2001, PLANT PHYSIOL, V126, P1588, DOI 10.1104/pp.126.4.1588; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Xue R, 2012, BIOPOLYMERS, V98, P59, DOI 10.1002/bip.21693; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	64	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171340	10.1371/journal.pone.0171340	http://dx.doi.org/10.1371/journal.pone.0171340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207772	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500024
J	Taguchi, Y; Nishida, N				Taguchi, Yuzuru; Nishida, Noriyuki			Secondary-structure prediction revisited: Theoretical beta-sheet propensity and coil propensity represent structures of amyloids and aid in elucidating phenomena involved in interspecies transmission of prions	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; PROTEIN; SCRAPIE; AGGREGATION; PARALLEL; SEQUENCE; FIBRILS; STRAINS; MODELS	Prions are unique infectious agents, consisting solely of abnormally-folded prion protein (PrPSc). However, they possess virus-like features, including strain diversity, the ability to adapt to new hosts and to be altered evolutionarily. Because prions lack genetic material (DNA and RNA), these biological phenomena have been attributed to the structural properties of PrPSc. Therefore, many structural models of the structure of PrPSc have been proposed based on the limited structural information available, regardless of the incompatibility with high-resolution structural analysis. Recently hypothesized models consist solely of beta sheets and intervening loops/ kinks; i.e. parallel in-register beta-sheet and beta-solenoid models. Owing to the relative simplicity of these structural models of PrPSc, we hypothesized that numerical conversion of the primary structures with a relevant algorithm would enable quantitative comparison between PrPs of distinct primary structures. We therefore used the theoretical values of beta-sheet (P beta) and random-coil (Pc) propensity calculated by secondary structure prediction with a neural network, to analyze interspecies transmission of prions. By reviewing experiments in the literature, we ascertained the biological relevance of P beta and Pc and found that these classical parameters surprisingly carry substantial information of amyloid structures. We also demonstrated how these parameters could aid in interpreting and explaining phenomena in interspecies transmissions. Our approach can lead to the development of a versatile tool for investigating not only prions but also other amyloids.	[Taguchi, Yuzuru; Nishida, Noriyuki] Nagasaki Univ, Div Cellular & Mol Biol, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University	Taguchi, Y (corresponding author), Nagasaki Univ, Div Cellular & Mol Biol, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan.	ytaguchi@nagasaki-u.ac.jp			Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	The study was supported by the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AB, 2013, FEBS LETT, V587, P1089, DOI 10.1016/j.febslet.2012.12.006; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hennetin J, 2006, J MOL BIOL, V358, P1094, DOI 10.1016/j.jmb.2006.02.039; Imamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082538; Jiji AC, 2016, ANGEW CHEM INT EDIT, V55, P11562, DOI 10.1002/anie.201606544; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kurt TD, 2015, J CLIN INVEST, V125, P1485, DOI 10.1172/JCI79408; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; LOWENSTEIN DH, 1990, MOL CELL BIOL, V10, P1153, DOI 10.1128/MCB.10.3.1153; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Meade-White KD, 2009, EMERG INFECT DIS, V15, P207, DOI 10.3201/eid1502.081173; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Pirisinu L, 2013, PATHOGENS, V2, P446, DOI 10.3390/pathogens2030446; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Shu YJ, 2011, PRION, V5, P103, DOI 10.4161/pri.5.2.15847; Taguchi Y, 2013, PRION, V7, P91; Taguchi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003466; Tamguney G, 2009, J GEN VIROL, V90, P1035, DOI 10.1099/vir.0.007500-0; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Watts JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003990; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499	36	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171974	10.1371/journal.pone.0171974	http://dx.doi.org/10.1371/journal.pone.0171974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199368	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400063
J	Choi, JE; Ahn, J; Park, HW; Baek, SY; Kim, S; Moon, IJ				Choi, Ji Eun; Ahn, Jungmin; Park, Hyun Woo; Baek, Sun-Young; Kim, Seonwoo; Moon, Il Joon			Prevalence of minimal hearing loss in South Korea	PLOS ONE			English	Article							SINGLE-SIDED DEAFNESS; OLDER-ADULTS; COCHLEAR IMPLANTATION; UNITED-STATES; IMPAIRMENT; DEMENTIA; DEVICES	This study evaluated the prevalence of minimal hearing loss (MHL) in South Korea based on the 2010 to 2012 Korea National Health and Nutrition Examination Survey. A total of 16,630 representative individuals (older than 12 years) who completed ear examinations and structured questionnaires were analyzed. Only participants who had normal tympanic membranes were included. MHL was categorized into the following three groups: 1) unilateral sensorineural hearing loss (USHL, pure-tone average (PTA) >= 15 dB in the affected ear), 2) bilateral sensorineural hearing loss (BSHL, 15 dB <= PTA < 40 dB in both ears), and 3) high-frequency sensorineural hearing loss (HFSHL, two or more high-frequency thresholds > 25 dB in either ear). To evaluate clinical symptoms, subjective hearing status, tinnitus, and quality of life of each MHL group were compared to those of normal-hearing listeners. The use of hearing aids (HAs) was also investigated in the MHL population. The prevalence of normal hearing and MHL were 58.4% and 37.4%, respectively. In univariate analyses, the prevalence of MHL increased with age. It was significantly increased in males. Regarding clinical symptoms, 13.0% and 92.1% of participants with MHL reported difficulties with hearing and annoying tinnitus, respectively. In multivariate analyses, these proportions were significantly higher in the MHL groups than in normal-hearing listeners. Participants with MHL also showed significantly lower Euro Qol-5D index scores than did normal-hearing listeners. Regarding hearing rehabilitation, among minimally hearing impaired participants with subjective hearing loss, only 0.47% of individuals used HAs. Our results reveal that MHL is common in South Korea. It is associated with significant subjective hearing loss, tinnitus, and poor quality of life. Therefore, clinicians need to pay attention to this special group and provide proper counselling and rehabilitative management.	[Choi, Ji Eun; Ahn, Jungmin; Park, Hyun Woo; Moon, Il Joon] Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Samsung Med Ctr, Seoul, South Korea; [Baek, Sun-Young; Kim, Seonwoo] Sungkyunkwan Univ, Sch Med, Biostat & Clin Epidemiol Ctr, Samsung Med Ctr,Res Inst Future Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, IJ (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Samsung Med Ctr, Seoul, South Korea.	moonij@skku.edu						Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; [Anonymous], 2018, WHO GLOB EST PREV HE; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Finbow J, 2015, OTOL NEUROTOL, V36, P819, DOI 10.1097/MAO.0000000000000762; Fitzpatrick EM, 2014, EAR HEARING, V35, P10, DOI 10.1097/AUD.0b013e31829e1ed9; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Indeyeva YA, 2015, AM J OTOLARYNG, V36, P810, DOI 10.1016/j.amjoto.2015.06.003; Kochkin S., 2012, HEAR REV, V19, P12; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; LUTMAN M E, 1987, British Journal of Audiology, V21, P45, DOI 10.3109/03005368709077774; Mamo SK, 2016, AM J MED, V129, P245, DOI 10.1016/j.amjmed.2015.09.014; McKay Sarah, 2008, Trends Amplif, V12, P43, DOI 10.1177/1084713807313570; Mertens G, 2015, AUDIOL NEURO-OTOL, V20, P67, DOI 10.1159/000380751; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Moon IJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001580; Newman CW, 1997, ANN OTO RHINOL LARYN, V106, P210, DOI 10.1177/000348949710600305; Peters JPM, 2015, LARYNGOSCOPE, V125, P218, DOI 10.1002/lary.24865; Scherer MJ, 1998, J REHABIL RES DEV, V35, P420; Sereda M, 2015, EAR HEARING, V36, P417, DOI 10.1097/AUD.0000000000000140; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; van Zon A, 2015, OTOL NEUROTOL, V36, P209, DOI 10.1097/MAO.0000000000000681; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	28	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171635	10.1371/journal.pone.0171635	http://dx.doi.org/10.1371/journal.pone.0171635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196098	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900026
J	Giraudo, M; Douville, M; Cottin, G; Houde, M				Giraudo, Maeva; Douville, Melanie; Cottin, Guillaume; Houde, Magali			Transcriptomic, cellular and life-history responses of Daphnia magna chronically exposed to benzotriazoles: Endocrine-disrupting potential and molting effects	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; RNA-SEQ DATA; WATER FLEA; JUVENILE-HORMONE; BISPHENOL-A; ECDYSTEROID BIOSYNTHESIS; GENE-TRANSCRIPTION; ENVIRONMENTAL FATE; AQUATIC ORGANISMS	Benzotriazoles (BZTs) are ubiquitous aquatic contaminants used in a wide range of industrial and domestic applications from aircraft deicers to dishwasher tablets. Acute toxicity has been reported in aquatic organisms for some of the BZTs but their mode of action remains unknown. The objectives of this study were to evaluate the transcriptomic response of D. magna exposed to sublethal doses of 1H-benzotriazole (BTR), 5-methyl-1H-benzotriazole (5MeBTR) and 5-chloro-1H-benzotriazole (5CIBTR) using RNA-sequencing and quantitative real-time PCR. Cellular and life-history endpoints (survival, number of neonates, growth) were also investigated. Significant effects on the molting frequency were observed after 21-d exposure to 5MeBTR and 5CIBTR. No effects on molting frequency were observed for BTR but RNA-seq results indicated that this BZT induced the up-regulation of genes coding for cuticular proteins, which could have compensated the molting disruption. Molting in cladocerans is actively controlled by ecdysteroid hormones. Complementary short-term temporal analysis (4-and 8-d exposure) of the transcription of genes related to molting and hormone-mediated processes indicated that the three compounds had specific modes of action. BTR induced the transcription of genes involved in 20-hydroxyecdysone synthesis, which suggests pro-ecdysteroid properties. 5CIBTR exposure induced protein activity and transcriptional levels of chitinase enzymes, associated with an impact on ecdysteroid signaling pathways, which could explain the decrease in molt frequency. Finally, 5MeBTR seemed to increase molt frequency through epigenetic processes. Overall, results suggested that molting effects observed at the physiological level could be linked to endocrine regulation impacts of BZTs at the molecular level.	[Giraudo, Maeva; Douville, Melanie; Cottin, Guillaume; Houde, Magali] Environm & Climate Change Canada, Aquat Contaminants Res Div, Water Sci & Technol Directorate, Montreal, PQ, Canada; [Cottin, Guillaume] Univ Paris 05, Paris, France	Environment & Climate Change Canada; UDICE-French Research Universities; Universite Paris Cite	Giraudo, M (corresponding author), Environm & Climate Change Canada, Aquat Contaminants Res Div, Water Sci & Technol Directorate, Montreal, PQ, Canada.	maeva.giraudo@gmail.com	Giraudo, Maeva/ABE-4328-2021; Giraudo, Maeva/GVS-6750-2022	Giraudo, Maeva/0000-0003-4296-146X; Houde, Magali/0000-0001-5013-6529	Natural Sciences and Engineering Research Council's Visiting Fellowship in Canadian Government Laboratories program; Environment and Climate Change Canada's Chemical Management Plan; Strategic Technology Application of Genomics in the Environment (STAGE) program	Natural Sciences and Engineering Research Council's Visiting Fellowship in Canadian Government Laboratories program; Environment and Climate Change Canada's Chemical Management Plan; Strategic Technology Application of Genomics in the Environment (STAGE) program	This work was supported by the Natural Sciences and Engineering Research Council's Visiting Fellowship in Canadian Government Laboratories program to MG, http://www.nsercc rsng.gc.ca/Students-Etudiants/PD-NP/ Laboratories-Laboratoires/index_eng.asp, and was funded by grants awarded to MH from Environment and Climate Change Canada's Chemical Management Plan (CMP), http://www. chemicalsubstanceschimiques.gc.ca/plan/indexeng.php, and the Strategic Technology Application of Genomics in the Environment (STAGE) program http://www.ec.gc.ca/scitech/default.asp?lang=En&n=BA7C049C-1. Funders approved the study design.	Alotaibi MD, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2469-4; Alotaibi MD, 2015, ENVIRON SCI-PROC IMP, V17, P448, DOI [10.1039/c4em00484a, 10.1039/C4EM00484A]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Asada M, 2014, MAR ENVIRON RES, V93, P118, DOI 10.1016/j.marenvres.2013.11.005; Asimakopoulos AG, 2013, ENVIRON INT, V59, P274, DOI 10.1016/j.envint.2013.06.007; Baldwin WS, 2001, ENVIRON TOXICOL CHEM, V20, P1564, DOI [10.1897/1551-5028(2001)020&lt;1564:IEIAIO&gt;2.0.CO;2, 10.1002/etc.5620200721]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bozinovic G, 2011, ENVIRON TOXICOL CHEM, V30, P283, DOI 10.1002/etc.403; Briguglio I, 2015, EUR J MED CHEM, V97, P612, DOI 10.1016/j.ejmech.2014.09.089; Campos B, 2013, ENVIRON SCI TECHNOL, V47, P9434, DOI 10.1021/es4012299; Cancilla DA, 2003, B ENVIRON CONTAM TOX, V70, P868, DOI 10.1007/s00128-003-0063-8; Cancilla DA, 2003, ENVIRON TOXICOL CHEM, V22, P134, DOI [10.1002/etc.5620220117, 10.1897/1551-5028(2003)022&lt;0134:SOTEFA&gt;2.0.CO;2]; Cancilla DA, 1998, ENVIRON SCI TECHNOL, V32, P3834, DOI 10.1021/es980489k; Cantwell M.G., 2015, COMPR ANAL CHEM, DOI [10.1016/B978-0-444-63299-9.00016-8, DOI 10.1016/B978-0-444-63299-9.00016-8]; Careghini A, 2015, ENVIRON SCI POLLUT R, V22, P5711, DOI 10.1007/s11356-014-3974-5; Casado J, 2014, J CHROMATOGR A, V1336, P1, DOI 10.1016/j.chroma.2014.01.068; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chen Y, 2014, ENVIRON SCI POLLUT R, V21, P234, DOI 10.1007/s11356-013-1692-z; Cheong SPS, 2015, INTEGR COMP BIOL, V55, P878, DOI 10.1093/icb/icv066; Chiaia-Hernandez AC, 2013, ENVIRON SCI TECHNOL, V47, P10667, DOI 10.1021/es401763d; Colbourne JK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-45; Cornell JS, 2000, ENVIRON TOXICOL CHEM, V19, P1465, DOI 10.1002/etc.5620190601; Corsi SR, 2006, ENVIRON SCI TECHNOL, V40, P7409, DOI 10.1021/es0603608; DauphinVillemant C, 1997, MOL CELL ENDOCRINOL, V128, P139, DOI 10.1016/S0303-7207(97)04031-8; David RM, 2011, AQUAT TOXICOL, V104, P192, DOI 10.1016/j.aquatox.2011.04.016; Davies R, 2012, ECOTOXICOLOGY, V21, P1371, DOI 10.1007/s10646-012-0891-6; De Silva AO, 2015, ORGANOPHOSPHORUS FLA; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Durjava MK, 2013, ATLA-ALTERN LAB ANIM, V41, P65, DOI 10.1177/026119291304100108; *ENV CAN, 1990, BIOL TEST METH AC LE; Environment and Climate Change Canada, 2016, EC RISK CALSS ORG SU; Focazio MJ, 2008, SCI TOTAL ENVIRON, V402, P201, DOI 10.1016/j.scitotenv.2008.02.021; Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P4188, DOI 10.1021/es803702a; Giger W, 2006, ENVIRON SCI TECHNOL, V40, P7186, DOI 10.1021/es061565j; Giraudo M, 2015, CHEMOSPHERE, V132, P159, DOI 10.1016/j.chemosphere.2015.03.028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hannas BR, 2010, MOL CELL ENDOCRINOL, V315, P208, DOI 10.1016/j.mce.2009.07.013; Harris CA, 2007, ENVIRON TOXICOL CHEM, V26, P2367, DOI 10.1897/06-587R.1; Hart DS, 2004, MICROCHEM J, V77, P9, DOI 10.1016/j.microc.2003.08.005; He TT, 2012, ECOTOX ENVIRON SAFE, V80, P327, DOI 10.1016/j.ecoenv.2012.03.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herrero P, 2013, J CHROMATOGR A, V1309, P22, DOI 10.1016/j.chroma.2013.08.018; Herrero P, 2014, TRAC-TREND ANAL CHEM, V62, P46, DOI 10.1016/j.trac.2014.06.017; Hilliou F, 2013, P INT C BIOINF MOD M; Houde M, 2016, ENVIRON POLLUT, V218, P950, DOI 10.1016/j.envpol.2016.08.043; Houde M, 2015, ECOTOX ENVIRON SAFE, V116, P10, DOI 10.1016/j.ecoenv.2015.02.031; Huntscha S, 2014, ENVIRON SCI TECHNOL, V48, P4435, DOI 10.1021/es405694z; Ishak NSM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154636; Janna H, 2011, ENVIRON SCI TECHNOL, V45, P3858, DOI 10.1021/es103267g; Jordao R, 2015, ENVIRON HEALTH PERSP, V123, P813, DOI 10.1289/ehp.1409163; Kato Y, 2007, J ENDOCRINOL, V193, P183, DOI 10.1677/JOE-06-0228; Kim HY, 2012, ECOTOXICOLOGY, V21, P993, DOI 10.1007/s10646-012-0853-z; Kim J, 2011, ECOTOXICOLOGY, V20, P1741, DOI 10.1007/s10646-011-0707-0; Kiss A, 2009, ENVIRON SCI POLLUT R, V16, P702, DOI 10.1007/s11356-009-0179-4; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; KORACH KS, 1988, MOL PHARMACOL, V33, P120; LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z; LeBlanc GA, 2015, FEBS J, V282, P4080, DOI 10.1111/febs.13393; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu YS, 2011, J CHROMATOGR A, V1218, P5328, DOI 10.1016/j.chroma.2011.05.100; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Miyakawa H, 2014, CURR OPIN INSECT SCI, V1, P81, DOI 10.1016/j.cois.2014.04.006; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X; Mu XY, 2002, J EXP ZOOL, V292, P287, DOI 10.1002/jez.10020; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; OECD-Organization for Economic Cooperation and Development, 2008, GUID TEST CHEM DAPHN; Orsini L, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.30; Overturf CL, 2015, COMP BIOCHEM PHYS C, V171, P49, DOI 10.1016/j.cbpc.2015.01.006; Palma P, 2009, CHEMOSPHERE, V74, P676, DOI 10.1016/j.chemosphere.2008.10.021; Palma P, 2009, ECOTOX ENVIRON SAFE, V72, P344, DOI 10.1016/j.ecoenv.2008.04.018; Pillard DA, 2001, WATER RES, V35, P557, DOI 10.1016/S0043-1354(00)00268-2; Plahuta M, 2015, ECOTOX ENVIRON SAFE, V117, P81, DOI [10.1016/J.ecoenv.2015.03.031, 10.1016/j.ecoenv.2015.03.031]; Pondeville E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079861; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783; Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Reemtsma T, 2006, ENVIRON SCI TECHNOL, V40, P5451, DOI 10.1021/es060908a; Reemtsma T, 2010, WATER RES, V44, P596, DOI 10.1016/j.watres.2009.07.016; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Richardson SD, 2014, ANAL CHEM, V86, P2813, DOI 10.1021/ac500508t; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Rotchell JM, 2003, J TOXICOL ENV HEAL B, V6, P453, DOI 10.1080/10937400306476; Schlotz N, 2012, COMP BIOCHEM PHYS A, V162, P449, DOI 10.1016/j.cbpa.2012.05.004; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Seeland A, 2012, ENVIRON SCI POLLUT R, V19, P1781, DOI 10.1007/s11356-011-0705-z; Soetaert A, 2007, CHEMOSPHERE, V67, P60, DOI 10.1016/j.chemosphere.2006.09.076; Stasinakis AS, 2013, SCI TOTAL ENVIRON, V463, P1067, DOI 10.1016/j.scitotenv.2013.06.087; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Tokishita S, 2006, BIOCHEM BIOPH RES CO, V345, P362, DOI 10.1016/j.bbrc.2006.04.102; Toyota K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1392-9; Toyota K, 2014, J APPL TOXICOL, V34, P537, DOI 10.1002/jat.2922; USEPA, 2011, HIGH PROD VOL HPV CH; van Leerdam JA, 2009, INT J MASS SPECTROM, V282, P99, DOI 10.1016/j.ijms.2009.02.018; Voutsa D, 2006, ENVIRON SCI POLLUT R, V13, P333, DOI 10.1065/espr2006.01.295; Waddy SL, 2002, CAN J FISH AQUAT SCI, V59, P1096, DOI [10.1139/f02-106, 10.1139/F02-106]; Webster TMU, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1254-5; Weiss S, 2005, ANAL CHEM, V77, P7415, DOI 10.1021/ac051203e; Wolschke H, 2011, WATER RES, V45, P6259, DOI 10.1016/j.watres.2011.09.028; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019; Zou E, 1997, B ENVIRON CONTAM TOX, V58, P596, DOI 10.1007/s001289900376; Zou EM, 2004, COMP BIOCHEM PHYS C, V139, P225, DOI 10.1016/j.cca.2004.11.003; Zou EM, 1997, ECOTOX ENVIRON SAFE, V38, P281, DOI 10.1006/eesa.1997.1589	112	33	34	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171763	10.1371/journal.pone.0171763	http://dx.doi.org/10.1371/journal.pone.0171763			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196088	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900032
J	Kim, K; Bloom, MS; Fujimoto, VY; Browne, RW				Kim, Keewan; Bloom, Michael S.; Fujimoto, Victor Y.; Browne, Richard W.			Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens	PLOS ONE			English	Article							LIPOPROTEIN PARTICLE COMPONENTS; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN; BIOLOGICAL VARIATION; OXIDATIVE STRESS; PARAOXONASE ACTIVITY; HDL; POLYMORPHISM; VARIABILITY; GENE	The importance of high-density lipoprotein (HDL) particle components to reproduction is increasingly recognized, including the constituent paraoxonase 1 (PON1). However, the reliability characteristics of PON1 enzymes in ovarian follicular fluid (FF) as biomarkers for clinical and epidemiologic studies have not been described. Therefore, we characterized PON1 enzymes in FF and serum and assessed the impact of the PON1 Q192R polymorphism on associations between enzyme activities in two compartments. We also evaluated associations between HDL particle size and enzyme activities. We collected FF and serum from 171 women undergoing in vitro fertilization. PON1 activities were measured as paraoxonase and arylesterase activities, and HDL particle size was determined by H-1 NMR spectrometry. Reliability indices for PON1 activities were characterized and we evaluated HDL particle sizes as predictors of PON1 enzyme activities. We found that PON1 enzyme activities were correlated between compartments, but higher in serum than in FF. For FF, the index of individuality (II) was low and the coefficient of variation (CV%) was high for paraoxonase activity overall (0.12 and 11.51%, respectively). However, IIs increased (0.33-1.30) and CV%s decreased (5.58%-8.52%) when stratified by PON1 Q192R phenotype. The intraclass correlation coefficient (ICC) for FF paraoxonase activity was high overall (0.89) but decreased when stratified by PON1 Q192R phenotype (0.43-0.75). We found similar, although more modest, patterns for FF arylesterase activity. For enzyme activities in serum, ICCs were close to 1.00 across all phenotypes. Additionally, different HDL particle sizes predicted PON1 enzyme activities according to PON1 Q192R phenotype. Overall, stratification by PON1 Q192R phenotype improved the reliability characteristics of FF PON1 enzymes as biomarkers for use in clinical investigations but diminished usefulness for epidemiologic studies. Thus, we recommend stratification by PON1 Q192R phenotype for clinical but not epidemiologic investigations, when employing FF PON1 enzyme activity biomarkers.	[Kim, Keewan; Bloom, Michael S.] SUNY Albany, Dept Environm Hlth Sci, Rensselaer, NY 12222 USA; [Bloom, Michael S.] SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY 12222 USA; [Fujimoto, Victor Y.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Browne, Richard W.] Univ Buffalo State Univ New York, Dept Biotech & Clin Lab Sci, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bloom, MS (corresponding author), SUNY Albany, Dept Environm Hlth Sci, Rensselaer, NY 12222 USA.; Bloom, MS (corresponding author), SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY 12222 USA.	mbloom@albany.edu	Bloom, Michael S/A-5743-2010	Bloom, Michael/0000-0002-0028-5494; Kim, Keewan/0000-0002-1892-6739	National Institute on Aging, National Institutes of Health [R21 AG031957-01A2]	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded through grant R21 AG031957-01A2, provided by the National Institute on Aging, National Institutes of Health (PI VYF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088; Ali SM, 2008, IND HEALTH, V46, P309, DOI 10.2486/indhealth.46.309; Bergmeier C, 2004, CLIN CHEM, V50, P2309, DOI 10.1373/clinchem.2004.034439; Bloom MS, 2014, FERTIL STERIL, V101, P1431, DOI 10.1016/j.fertnstert.2014.01.028; Browne RW, 2008, HUM REPROD, V23, P1884, DOI 10.1093/humrep/den183; Browne RW, 2008, BIOMARKERS, V13, P160, DOI [10.1080/13547500701775563, 10.1080/13547500701775563 ]; Browne RW, 2007, CLIN CHEM, V53, P310, DOI 10.1373/clinchem.2006.074559; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; Fujimoto VY, 2010, HUM REPROD UPDATE, V16, P20, DOI 10.1093/humupd/dmp029; Gaidukov L, 2007, J LIPID RES, V48, P1637, DOI 10.1194/jlr.D600045-JLR200; Gugliucci A, 2015, CLIN CHIM ACTA, V439, P5, DOI 10.1016/j.cca.2014.09.016; Gugliucci A, 2013, CLIN CHIM ACTA, V415, P162, DOI 10.1016/j.cca.2012.10.044; Hughes EG, 1996, FERTIL STERIL, V66, P679; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Julious SA, 2004, PHARM STAT, V3, P217, DOI 10.1002/pst.126; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim K, 2016, J ASSIST REPROD GEN, V33, P423, DOI 10.1007/s10815-016-0648-x; Kim K, 2014, FERTIL STERIL, V101, pE44, DOI 10.1016/j.fertnstert.2014.04.019; Kotani K, 2012, J INT MED RES, V40, P1513, DOI 10.1177/147323001204000431; Kuremoto Kenichi, 2003, J Atheroscler Thromb, V10, P85; La Du BN, 1999, CHEM-BIOL INTERACT, V119, P379, DOI 10.1016/S0009-2797(99)00049-6; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Maheshwari A, 2008, HUM REPROD, V23, P538, DOI 10.1093/humrep/dem431; McPherson PAC, 2007, J LIPID RES, V48, P86, DOI 10.1194/jlr.M600094-JLR200; Otocka-Kmiecik A, 2009, POSTEP HIG MED DOSW, V63, P668; Otvos James D, 2002, Clin Lab, V48, P171; Pandey Shilpi, 2010, J Hum Reprod Sci, V3, P62, DOI 10.4103/0974-1208.69332; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Straus III JF, 2004, REPROD ENDOCRINOLOGY, P125; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; VINEIS P, 1993, MOL EPIDEMIOLOGY PRI, P109; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Wang XL, 2003, ARTERIOSCL THROM VAS, V23, P328, DOI 10.1161/01.ATV.0000051702.38086.C1; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172193	10.1371/journal.pone.0172193	http://dx.doi.org/10.1371/journal.pone.0172193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196109	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900060
J	Naito, Y; Senchi, A; Sawada, H; Oboshi, M; Horimatsu, T; Okuno, K; Yasumura, S; Ishihara, M; Masuyama, T				Naito, Yoshiro; Senchi, Aya; Sawada, Hisashi; Oboshi, Makiko; Horimatsu, Tetsuo; Okuno, Keisuke; Yasumura, Seiki; Ishihara, Masaharu; Masuyama, Tohru			Iron-restricted pair-feeding affects renal damage in rats with chronic kidney disease	PLOS ONE			English	Article							REMNANT KIDNEY; RAC1 GTPASE; ACCUMULATION; PREVENTS; ANEMIA; GROWTH; MODEL	Background We have previously shown that dietary iron restriction prevents the development of renal damage in a rat model of chronic kidney disease (CKD). However, iron deficiency is associated with appetite loss. In addition, calorie restriction is reported to prevent the development of end-stage renal pathology in CKD rats. Thus, the beneficial effect of iron restriction on renal damage may depend on calorie restriction. Here, we investigate the effect of pair-feeding iron restriction on renal damage in a rat model of CKD. Methods First, to determine the amount of food intake, Sprague-Dawley (SD) rats were randomly given an ad libitum normal diet or an iron-restricted diet, and the food intake was measured. Second, CKD was induced by a 5/6 nephrectomy in SD rats, and CKD rats were given either a pair-feeding normal or iron-restricted diet. Results Food intake was reduced in the iron-restricted diet group compared to the normal diet group of SD rats for 16 weeks (mean food intake; normal diet group and iron-restricted diet group: 25 and 20 g/day, respectively). Based on the initial experiments, CKD rats received either a pair-feeding normal or iron-restricted diet (20 g/day) for 16 weeks. Importantly, pair-feeding iron restriction prevented the development of proteinuria, glomerulosclerosis, and tubulointerstitial damage in CKD rats. Interestingly, pair-feeding iron restriction attenuated renal expression of nuclear mineralocorticoid receptor in CKD rats. Conclusions Pair-feeding iron restriction affected renal damage in a rat model of CKD.	[Naito, Yoshiro; Senchi, Aya; Sawada, Hisashi; Oboshi, Makiko; Horimatsu, Tetsuo; Okuno, Keisuke; Yasumura, Seiki; Masuyama, Tohru] Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Ishihara, Masaharu] Hyogo Coll Med, Div Coronary Heart Dis, Dept Internal Med, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Naito, Y (corresponding author), Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo, Japan.	ynaito@hyo-med.ac.jp			JSPS KAKENHI [25460919, 16K09273]; Salt Science Research Foundation [1544, 1641]; Suzuken Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16K09273] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant No. 25460919 and 16K09273) and grants from The Salt Science Research Foundation (No. 1544 and 1641), Suzuken Memorial Foundation, and Takeda Science Foundation (to Y. Naito).	Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Gay HC, 2016, HYPERTENSION, V67, P733, DOI 10.1161/HYPERTENSIONAHA.115.06853; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KOBAYASHI S, 1992, KIDNEY INT, V42, P710, DOI 10.1038/ki.1992.338; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6; Ni ZM, 1997, KIDNEY INT, V52, P195, DOI 10.1038/ki.1997.319; Oboshi M, 2016, HYPERTENS RES, V39, P832, DOI 10.1038/hr.2016.93; Otis L, 1940, SCIENCE, V91, P146, DOI 10.1126/science.91.2354.146; SALMON HA, 1962, J PHYSIOL-LONDON, V164, P17, DOI 10.1113/jphysiol.1962.sp006999; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Stoltzfus RJ, 2004, J NUTR, V134, P348, DOI 10.1093/jn/134.2.348; TAPP DC, 1989, LAB INVEST, V60, P184; Vassalotti JA, 2016, AM J MED, V129, P153, DOI 10.1016/j.amjmed.2015.08.025	20	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172157	10.1371/journal.pone.0172157	http://dx.doi.org/10.1371/journal.pone.0172157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196143	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900058
J	Wu, LW; Lin, YY; Kao, TW; Lin, CM; Liaw, FY; Wang, CC; Peng, TC; Chen, WL				Wu, Li-Wei; Lin, Yuan-Yung; Kao, Tung-Wei; Lin, Chien-Ming; Liaw, Fang-Yih; Wang, Chung-Ching; Peng, Tao-Chun; Chen, Wei-Liang			Mid-arm muscle circumference as a significant predictor of all-cause mortality in male individuals	PLOS ONE			English	Article							SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; OLDER PERSONS; SARCOPENIA; STRENGTH; MEN; LIMITATIONS; DEFINITION; DISABILITY	Background Emerging evidences indicate that mid-arm muscle circumference (MAMC) is one of the anthropometric indicators that reflect health and nutritional status, but its correlative effectiveness in all-cause mortality prediction of United States individuals remains uncertain. Methods and findings design We investigated the joint association between MAMC and all-cause mortality in the US general population. A population-based longitudinal study of 6,769 participants aged 40 to 90 years in the third National Health and Nutrition Examination Survey (NHANES III) conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention. All participants were divided into two groups based on the gender: male and female group; each group was then divided into three subgroups depending on their MAMC level. The tertiles were as follows: T1 (18<27.3), T2 (27.3<29.6), T3 (29.6 <= 40.0) cm in the male group and T1 (15<22.3), T2 (22.3<24.6), T3 (24.6 <= 44.0) cm in the female group. Multivariable Cox regression analyses and Kaplan-Meier survival probabilities were utilized to jointly relate all-cause mortality risk to different MAMC level. For all-cause mortality in male participants, multivariable adjusted hazard ratios (HRs) were 0.83 (95% confidence interval (CI): 0.69-0.98; p = 0.033) for MAMC of 27.3-29.6 cm compared with 18-27.3cm, and 0.76 (95% CI: 0.61-0.95; p = 0.018) for MAMC of 29.6-40 cm compared with 18-27.3 cm. For all-cause mortality in female participants, multivariable adjusted hazard ratios (HRs) were 0.84 (95% confidence interval (CI): 0.69-1.02; p = 0.075) for MAMC of 22.3-24.6 cm compared with 15-22.3 cm, and 0.94 (95% CI: 0.75-1.17; p = 0.583) for MAMC of 24.6-44 cm compared with 15-22.3 cm.	[Wu, Li-Wei; Kao, Tung-Wei; Liaw, Fang-Yih; Wang, Chung-Ching; Peng, Tao-Chun; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Wu, Li-Wei; Lin, Yuan-Yung; Kao, Tung-Wei; Lin, Chien-Ming; Liaw, Fang-Yih; Wang, Chung-Ching; Peng, Tao-Chun; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Wu, Li-Wei; Kao, Tung-Wei; Liaw, Fang-Yih; Wang, Chung-Ching; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Wu, Li-Wei; Lin, Yuan-Yung; Lin, Chien-Ming; Liaw, Fang-Yih; Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Yuan-Yung] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Lin, Chien-Ming] Triserv Gen Hosp, Dept Pediat, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020					Batsis J.A., 2016, CLIN NUTR; Blaak EE, 2000, AM J PHYSIOL-ENDOC M, V279, pE146, DOI 10.1152/ajpendo.2000.279.1.E146; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; Blaak EE, 2002, DIABETES, V51, P784, DOI 10.2337/diabetes.51.3.784; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Gosker HR, 2000, AM J CLIN NUTR, V71, P1033; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Hyattsville, 2009, 3 NAT HLTH NUTR EX S; Hyattsville National Center for Health Statistics, 1994, VITAL HLTH STAT, V1, P1; Landi F, 2010, CLIN NUTR, V29, P441, DOI 10.1016/j.clnu.2009.12.006; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x; Muller MJ, 2014, EUR J CLIN NUTR, V68, P1220, DOI 10.1038/ejcn.2014.169; Noori N, 2010, CLIN J AM SOC NEPHRO, V5, P2258, DOI 10.2215/CJN.02080310; Olsen DB, 2005, J PHYSIOL-LONDON, V565, P555, DOI 10.1113/jphysiol.2004.081356; Preis SR, 2013, DIABETES CARE, V36, pE3, DOI 10.2337/dc12-0738; Rantanen T, 1997, J AM GERIATR SOC, V45, P1439, DOI 10.1111/j.1532-5415.1997.tb03193.x; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Roubenoff R, 2000, EUR J CLIN NUTR, V54, pS40, DOI 10.1038/sj.ejcn.1601024; Tian SM, 2016, GERIATR GERONTOL INT, V16, P155, DOI 10.1111/ggi.12579; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Woodrow G, 2009, CURR OPIN CLIN NUTR, V12, P8, DOI 10.1097/MCO.0b013e32831b9c5b; Zeng P, 2015, ARCH GERONTOL GERIAT, V60, P118, DOI 10.1016/j.archger.2014.08.010	28	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171707	10.1371/journal.pone.0171707	http://dx.doi.org/10.1371/journal.pone.0171707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196081	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900029
J	Gopinath, B; Moshtaghian, H; Flood, VM; Louie, JCY; Liew, G; Burlutsky, G; Mitchell, P				Gopinath, Bamini; Moshtaghian, Hanieh; Flood, Victoria M.; Louie, Jimmy C. Y.; Liew, Gerald; Burlutsky, George; Mitchell, Paul			Pattern of omega-3 polyunsaturated fatty acid intake and fish consumption and retinal vascular caliber in children and adolescents: A cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIETARY-INTAKE; HYPERCHOLESTEROLEMIC PATIENTS; ATHEROSCLEROSIS RISK; AUSTRALIAN CHILDREN; VESSEL DIAMETERS; FOOD SOURCES; POPULATION; OIL; MORTALITY	We aimed to investigate whether fish and long chain omega-3 polyunsaturated fatty acid (LCn-3 PUFA) consumption changed appreciably during adolescence. We also assessed whether these dietary variables are associated with retinal microvascular signs (possible markers of future cardiovascular disease risk). 633 children had dietary data at ages 12 and 17. Fish and LCn-3 PUFA [eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA)] intake was assessed by a food frequency questionnaire. Retinal vessel caliber was quantified from digital photographs using computer software. Mean energy-adjusted intakes (mg/day) of total LCn-3 PUFA, EPA, and DHA at age 12 were 297.1 +/- 261.1; 102.5 +/- 106.9; and 129.7 +/- 137.7, respectively; and this increased significantly at age 17 to: 347.0 +/- 324.0 (p<0.0001); 122.5 +/- 132.7 (p = 0.0001); and 160.3 +/- 171.4 (p < 0.0001), respectively. Increasing quartiles of LCn-3PUFA intake were associated with widening of mean retinal arteriolar caliber among 17-year old girls similar to 3.9 mu m (multivariable-adjusted P-trend = 0.001). Girls who consumed >= 2 serves of fish/week versus those who did not had similar to 2.1 mu m wider retinal arterioles (p = 0.03). No associations were observed among boys or with retinal venules. Mean dietary intakes of LCn-3 PUFA increased during adolescence, but are still below recommended levels of consumption. These results suggest that LCn-3 PUFA and fish intake might have a beneficial influence.	[Gopinath, Bamini; Liew, Gerald; Burlutsky, George; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Gopinath, Bamini; Liew, Gerald; Burlutsky, George; Mitchell, Paul] Univ Sydney, Westmead Inst, Sydney, NSW, Australia; [Moshtaghian, Hanieh] Univ Wollongong, Sch Med, Fac Sci Med & Hlth, Wollongong, NSW, Australia; [Flood, Victoria M.] St Vincents Hosp, Sydney, NSW, Australia; [Flood, Victoria M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Louie, Jimmy C. Y.] Univ Hong Kong, Sch Biol Sci, Fac Sci, Hong Kong, Hong Kong, Peoples R China; [Louie, Jimmy C. Y.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Wollongong; St Vincents Hospital Sydney; University of Sydney; University of Hong Kong; University of Sydney	Gopinath, B (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia.; Gopinath, B (corresponding author), Univ Sydney, Westmead Inst, Sydney, NSW, Australia.	bamini.gopinath@sydney.edu.au	Gopinath, Bamini/K-4286-2019; Liew, Gerald/AAB-6870-2022; Mitchell, Paul/P-1498-2014; Flood, Victoria M/A-8732-2016; Louie, Jimmy Chun Yu/B-6754-2008	Gopinath, Bamini/0000-0003-3573-359X; Flood, Victoria M/0000-0001-5310-7221; Louie, Jimmy Chun Yu/0000-0001-7736-605X	Australian National Health & Medical Research Council [253732, 512530]; Westmead Millennium Institute, University of Sydney; Vision Co-operative Research Centre, University of New South Wales, Sydney, Australia	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute, University of Sydney(University of Sydney); Vision Co-operative Research Centre, University of New South Wales, Sydney, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The Sydney Myopia Study (Sydney Childhood Eye Study) and Sydney Adolescent Vascular Eye Study were supported by the Australian National Health & Medical Research Council (Grant Nos. 253732, 512530); the Westmead Millennium Institute, University of Sydney; and the Vision Co-operative Research Centre, University of New South Wales, Sydney, Australia.	[Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cavadini C, 2000, ARCH DIS CHILD, V83, P18, DOI 10.1136/adc.83.1.18; CHIN JPF, 1995, CLIN EXP PHARMACOL P, V22, P71, DOI 10.1111/j.1440-1681.1995.tb01959.x; Clayton EH, 2009, BRIT J NUTR, V101, P1731, DOI 10.1017/S0007114508135887; Commonwealth Scientific Industrial Research Organisation (CSIRO) Preventative Health National Research Flagship and the University of South Australia, 2008, 2007 AUSTR NAT CHILD; Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089; Flood VM, 2007, ASIA PAC J CLIN NUTR, V16, P322; Food Standards Australia New Zealand, 2011, NUTTAB 2006; Food Standards Australia New Zealand, 2007, AUSNUT 2007; Food Standards Australia New Zealand, 2010, NUTTAB 2010; Goode GK, 1997, CIRCULATION, V96, P2802, DOI 10.1161/01.CIR.96.9.2802; Gopinath B, 2014, NUTR METAB CARDIOVAS; Gopinath B, 2013, NUTR METAB IN PRESS; Gopinath B, 2014, ASIA PAC J CLIN NUTR, V23, P612, DOI 10.6133/apjcn.2014.23.4.05; Gopinath B, 2014, ASIA PAC J CLIN NUTR, V23, P121, DOI 10.6133/apjcn.2014.23.1.13; Gopinath B, 2012, AM J CLIN NUTR, V95, P1215, DOI 10.3945/ajcn.111.031641; Gopinath B, 2012, J PAEDIATR CHILD H, V48, P44, DOI 10.1111/j.1440-1754.2011.02181.x; Gopinath B, 2011, ARTERIOSCL THROM VAS, V31, P1233, DOI 10.1161/ATVBAHA.110.219451; Gopinath B, 2011, AM J CLIN NUTR, V93, P1073, DOI 10.3945/ajcn.110.009977; Gopinath B, 2010, J HYPERTENS, V28, P1406, DOI 10.1097/HJH.0b013e3283395223; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, NEUROLOGY, V66, P1339, DOI 10.1212/01.wnl.0000210533.24338.ea; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kaushik S, 2007, MICROCIRCULATION, P1; Kaushik S, 2009, STROKE, V40, P206, DOI 10.1161/STROKEAHA.108.513812; Keel S, 2016, ACTA OPHTHALMOL; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Mann N. J., 2003, Nutrition & Dietetics, V60, P42; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; McLennan W, 1995, 48070 AUSTR BUR STAT; MCVEIGH GE, 1993, DIABETOLOGIA, V36, P33, DOI 10.1007/BF00399090; MCVEIGH GE, 1994, ARTERIOSCLER THROMB, V14, P1425, DOI 10.1161/01.ATV.14.9.1425; Mozaffarian D, 2005, ARCH INTERN MED, V165, P200, DOI 10.1001/archinte.165.2.200; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Murray CS, 2006, ALLERGY, V61, P438, DOI 10.1111/j.1398-9995.2005.00927.x; National Department of Health, 2008, POLICY IMPLEMENTATIO, P1; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rahmawaty S, 2014, NUTRITION, V30, P169, DOI 10.1016/j.nut.2013.07.014; Rahmawaty S, 2013, LIPIDS, V48, P869, DOI 10.1007/s11745-013-3812-4; Rodriguez BL, 1996, CIRCULATION, V94, P952, DOI 10.1161/01.CIR.94.5.952; Sasongko MB, 2010, MICROCIRCULATION, V17, P21, DOI 10.1111/j.1549-8719.2009.00007.x; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Shaw LJ, 2004, CIRCULATION, V109, pE56, DOI 10.1161/01.CIR.0000116210.70548.2A; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2006, OBESITY, V14, P206, DOI 10.1038/oby.2006.27; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172109	10.1371/journal.pone.0172109	http://dx.doi.org/10.1371/journal.pone.0172109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192538	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800070
J	Guan, L; He, P; Yang, F; Zhang, Y; Hu, YF; Ding, J; Hua, Y; Zhang, Y; Ye, Q; Hu, JZ; Wang, T; Jin, CW; Kong, DC				Guan, Ling; He, Peng; Yang, Fang; Zhang, Yuan; Hu, Yunfei; Ding, Jienv; Hua, Yu; Zhang, Yi; Ye, Qiong; Hu, Jiazhi; Wang, Tao; Jin, Changwen; Kong, Daochun			Sap1 is a replication-initiation factor essential for the assembly of pre-replicative complex in the fission yeast Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; ORC-BINDING; PROTEIN; P65(CDC18); CONSISTS; DOMAINS; SYSTEM; SITES	A central step in the initiation of chromosomal DNA replication in eukaryotes is the assembly of pre-replicative complex (pre-RC) at late M and early G(1) phase of the cell cycles. Since 1973, four proteins or protein complexes, including cell division control protein 6 (Cdc6)/Cdc18, minichromosome maintenance protein complex, origin recognition complex (ORC), and Cdt1, are known components of the pre-RC. Previously, we reported that a non-ORC protein binds to the essential element Delta 9 of the Schizosaccharomyces pombe DNA-replication origin ARS3001. In this study, we identified that the non-ORC protein is Sap1. Like ORC, Sap1 binds to DNA origins during cell growth cycles. But unlike ORC, which binds to asymmetric AT-rich sequences through its nine AT-hook motifs, Sap1 preferentially binds to a DNA sequence of 5'-(A/T)(n)(C/G)(A/T)(9-10)(G/C)(A/T)(n)-3' (n >= 1). We also found that Sap1 and ORC physically interact. We further demonstrated that Sap1 is required for the assembly of the pre-RC because of its essential role in recruiting Cdc18 to DNA origins. Thus, we conclude that Sap1 is a replication-initiation factor that directly participates in the assembly of the pre-RC. DNA-replication origins in fission yeast are defined by possessing two essential elements with one bound by ORC and the other by Sap1.	[Guan, Ling; He, Peng; Yang, Fang; Zhang, Yuan; Hua, Yu; Ye, Qiong; Hu, Jiazhi; Kong, Daochun] Peking Univ, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Yunfei; Ding, Jienv; Zhang, Yi; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Wang, Tao] South Univ Sci & Technol China, Dept Biol, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University; Southern University of Science & Technology	Kong, DC (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.; Wang, T (corresponding author), South Univ Sci & Technol China, Dept Biol, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China.	wangtao@sustc.edu.cn; changwen@pku.edu.cn; kongdc@pku.edu.cn	Zhang, Yi/J-7181-2019	Zhang, Yi/0000-0001-8170-9983; Hu, Jiazhi/0000-0002-6345-0039	National Natural Science Foundation of China [30770441, 31170739, 31230021, 31300600]; Ministry of Science and Technology of China [2006CB910300, 2010CB912201, 2013CB911000, 2013CB911500]; 985 Program; National Key Laboratory of Protein and Plant Gene Research; Peking-Tsinghua Center for Life Sciences; Shenzhen Science and technology Innovation (SZSTI) [JCYJ20160331115853521, GGJS20130329180714793]; National Key Research and Development Plan [2016YFA0501201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 985 Program; National Key Laboratory of Protein and Plant Gene Research; Peking-Tsinghua Center for Life Sciences; Shenzhen Science and technology Innovation (SZSTI); National Key Research and Development Plan	This work was supported by grants from the National Natural Science Foundation of China (30770441, 31170739, and 31230021 to D. K.; 31300600 to T. W.) and from the Ministry of Science and Technology of China (2006CB910300, 2010CB912201, and 2013CB911000 to D. K.; 2013CB911500 to T. W.). This work was also supported by the '985 Program,' the National Key Laboratory of Protein and Plant Gene Research and Peking-Tsinghua Center for Life Sciences (to D. K.) and grants from Shenzhen Science and technology Innovation (SZSTI) JCYJ20160331115853521 and GGJS20130329180714793 to T. W. All NMR experiments were performed at the Beijing NMR Center and the NMR facility of National Center for Protein Sciences at Peking University and supported by Grant 2016YFA0501201 from the National Key Research and Development Plan (to C. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARCANGIOLI B, 1994, MOL CELL BIOL, V14, P2058, DOI 10.1128/MCB.14.3.2058; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Bada M, 2000, J MOL BIOL, V300, P563, DOI 10.1006/jmbi.2000.3854; Baum B, 1998, EMBO J, V17, P5689, DOI 10.1093/emboj/17.19.5689; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; HARTWELL LH, 1973, GENETICS, V74, P267; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HUIBREGTSE J M, 1991, P550; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2012, J BIOL CHEM, V287, P23819, DOI 10.1074/jbc.M112.371492; KEARSEY S, 1983, EMBO J, V2, P1571, DOI 10.1002/j.1460-2075.1983.tb01626.x; Kim SM, 1998, MOL CELL BIOL, V18, P7294, DOI 10.1128/MCB.18.12.7294; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Kong DC, 2002, EMBO J, V21, P5567, DOI 10.1093/emboj/cdf546; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Kuszewski J, 2001, J AM CHEM SOC, V123, P3903, DOI 10.1021/ja010033u; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; MAINE GT, 1984, GENETICS, V106, P365; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Takahashi T, 2001, GENES CELLS, V6, P837, DOI 10.1046/j.1365-2443.2001.00468.x; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287	47	3	3	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6056	6075		10.1074/jbc.M116.767806	http://dx.doi.org/10.1074/jbc.M116.767806			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223353	Green Published, hybrid			2022-12-26	WOS:000399538700004
J	Kalantari, P; Harandi, OF; Agarwal, S; Rus, F; Kurt-Jones, EA; Fitzgerald, KA; Caffrey, DR; Golenbock, DT				Kalantari, Parisa; Harandi, Omid F.; Agarwal, Sarika; Rus, Florentina; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Caffrey, Daniel R.; Golenbock, Douglas T.			miR-718 represses proinflammatory cytokine production through targeting phosphatase and tensin homolog (PTEN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; bacterial pathogenesis; lipopolysaccharide (LPS); microRNA (miRNA); phosphatase and tensin homolog (PTEN); Toll-like receptor 4 (TLR4); miR-718	TUMOR-SUPPRESSOR GENE; MICE LACKING; EXPRESSION; RECEPTOR; LIPOPOLYSACCHARIDE; IDENTIFICATION; MICRORNAS; SEPSIS; KINASE; BRAIN	Bacterial sepsis involves a complex interaction between the host immune response and bacterial LPS. LPS binds Toll-like receptor (TLR) 4, which leads to the release of proinflammatory cytokines that are essential for a potent innate immune response against pathogens. The innate immune system is tightly regulated, as excessive inflammation can lead to organ failure and death. MicroRNAs have recently emerged as important regulators of the innate immune system. Here we determined the function of miR-718, which is conserved across mammals and overlaps with the 5 UTR of the interleukin 1 receptor-associated kinase (IRAK1) gene. As IRAK1 is a key component of innate immune signaling pathways that are downstream of most TLRs, we hypothesized that miR-718 helps regulate the innate immune response. Activation of TLR4, but not TLR3, induced the expression of miR-718 in macrophages. miR-718 expression was also induced in the spleens of mice upon LPS injection. miR-718 modulates PI3K/Akt signaling by directly down-regulating phosphatase and tensin homolog (PTEN), thereby promoting phosphorylation of Akt, which leads to a decrease in proinflammatory cytokine production. Phosphorylated Akt induces let-7e expression, which, in turn, down-regulates TLR4 and further diminishes TLR4-mediated proinflammatory signals. Decreased miR-718 expression is associated with bacterial burden during Neisseria gonorrhoeae infection and alters the infection dynamics of N. gonorrhoeae in vitro. Furthermore, miR-718 regulates the induction of LPS tolerance in macrophages. We propose a role for miR-718 in controlling TLR4 signaling and inflammatory cytokine signaling through a negative feedback regulation loop involving down-regulation of TLR4, IRAK1, and NF-B.	[Kalantari, Parisa; Agarwal, Sarika; Rus, Florentina; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Caffrey, Daniel R.; Golenbock, Douglas T.] Univ Massachusetts, Div Infect Dis & Immunol, Sch Med, Worcester, MA 01605 USA; [Harandi, Omid F.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Harandi, Omid F.] Rubius Therapeut, 325 Vassar St,Suite 1A, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kalantari, P (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, 150 Harrison Ave, Boston, MA 02111 USA.	Parisa.Kalantari@tufts.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [R37GM54060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37GM54060. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jeffrey PL, 2000, MOL CELL NEUROSCI, V16, P185, DOI 10.1006/mcne.2000.0866; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawagoe T., 2008, NAT IMMUNOL; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee ES, 2004, J IMMUNOL, V173, P6864, DOI 10.4049/jimmunol.173.11.6864; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Montaner S, 2007, CELL CYCLE, V6, P438, DOI 10.4161/cc.6.4.3843; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suffredini AF, 1999, J CLIN IMMUNOL, V19, P203, DOI 10.1023/A:1020563913045; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Thomas JA, 1999, J IMMUNOL, V163, P978; Wan XL, 2003, ONCOGENE, V22, P8205, DOI 10.1038/sj.onc.1206878; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	47	30	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5634	5644		10.1074/jbc.M116.749325	http://dx.doi.org/10.1074/jbc.M116.749325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28209713	Green Published, hybrid			2022-12-26	WOS:000398813200002
J	Burr, R; Stewart, EV; Espenshade, PJ				Burr, Risa; Stewart, Emerson V.; Espenshade, Peter J.			Coordinate Regulation of Yeast Sterol Regulatory Element-binding Protein (SREBP) and Mga2 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DSC E3 LIGASE; UNSATURATED FATTY-ACIDS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; ANTIBIOTIC CERULENIN; GENE-EXPRESSION; SYNTHASE PROMOTER; CLEAVAGE; REQUIRES; ACTIVATION	The Mga2 and Sre1 transcription factors regulate oxygen-responsive lipid homeostasis in the fission yeast Schizosaccharomyces pombe in a manner analogous to the mammalian sterol regulatory element-binding protein (SREBP)-1 and SREBP-2 transcription factors. Mga2 and SREBP-1 regulate triacylglycerol and glycerophospholipid synthesis, whereas Sre1 and SREBP-2 regulate sterol synthesis. In mammals, a shared activation mechanism allows for coordinate regulation of SREBP-1 and SREBP-2. In contrast, distinct pathways activate fission yeast Mga2 and Sre1. Therefore, it is unclear whether and how these two related pathways are coordinated to maintain lipid balance in fission yeast. Previously, we showed that Sre1 cleavage is defective in the absence of mga2. Here, we report that this defect is due to deficient unsaturated fatty acid synthesis, resulting in aberrant membrane transport. This defect is recapitulated by treatment with the fatty acid synthase inhibitor cerulenin and is rescued by addition of exogenous unsaturated fatty acids. Furthermore, sterol synthesis inhibition blocks Mga2 pathway activation. Together, these data demonstrate that Sre1 and Mga2 are each regulated by the lipid product of the other transcription factor pathway, providing a source of coordination for these two branches of lipid synthesis.	[Burr, Risa; Stewart, Emerson V.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Burr, Risa/AGK-7711-2022	Burr, Risa/0000-0001-6851-2932; Espenshade, Peter/0000-0002-6433-0178	National Institutes of Health [HL077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL077588 (to P. J. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AWAYA J, 1975, BIOCHIM BIOPHYS ACTA, V409, P267, DOI 10.1016/0005-2760(75)90022-3; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Burr R, 2016, J BIOL CHEM, V291, P12171, DOI 10.1074/jbc.M116.723650; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Jiang YD, 2002, EUKARYOT CELL, V1, P481, DOI 10.1128/EC.1.3.481-490.2002; Kandasamy P, 2004, J BIOL CHEM, V279, P36586, DOI 10.1074/jbc.M401557200; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lloyd SJA, 2013, J BIOL CHEM, V288, P21043, DOI 10.1074/jbc.M113.468215; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Los D A, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.62.pe1; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magdeleine M, 2016, ELIFE, V5, DOI 10.7554/eLife.16988; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Matynia A, 2002, J CELL SCI, V115, P421; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Melser S, 2011, PLANT CELL REP, V30, P177, DOI 10.1007/s00299-010-0954-1; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Raychaudhuri S, 2015, J BIOL CHEM, V290, P14430, DOI 10.1074/jbc.M114.630863; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Zhang SR, 1999, GENETICS, V151, P473	44	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5311	5324		10.1074/jbc.M117.778209	http://dx.doi.org/10.1074/jbc.M117.778209			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28202541	Green Published, hybrid			2022-12-26	WOS:000397875500014
J	Bizhang, M; Schmidt, I; Chun, YHP; Arnold, WH; Zimmer, S				Bizhang, Mozhgan; Schmidt, Ilka; Chun, Yong-Hee Patricia; Arnold, Wolfgang H.; Zimmer, Stefan			Toothbrush abrasivity in a long-term simulation on human dentin depends on brushing mode and bristle arrangement	PLOS ONE			English	Article							ELECTRIC TOOTHBRUSHES; CERVICAL LESIONS; PLAQUE REMOVAL; IN-VITRO; SONIC TOOTHBRUSHES; ERODED DENTIN; ENAMEL; FORCE; TOOTHPASTE; POWER	Objective The aim of this study was to evaluate the susceptibility of dentin to brushing abrasion using four different toothbrushes (rotating-oscillating, sonic and two types of manual toothbrushes) with the same brushing forces. Methods Dentin samples (n = 72) were selected from 72 impacted third molars. Half of the surface of dentin samples was covered with an adhesive tape, creating a protected and a freely exposed area in the same specimen. Brushing was performed with either a: sonic (Sonicare PowerUp, Philips GmbH, Hamburg, Germany), b: oscillating-rotating (Oral B Vitality Precisions Clean, Procter & Gamble, Schwalbach am Taunus, Germany) or two different manual toothbrushes c: flat trim brush head toothbrush (Dr. Best: Original, Glaxo-Smith-Kline, Buhl, Germany) and d: rippled-shaped brush head toothbrush (Blend-a-Dent, Complete V-Interdental, Blend-a-med, Schwalbach, Germany) in a custom made automatic brushing machine. The brushing force was set to 2 N and a whitening toothpaste (RDA = 150) was used. The simulation period was performed over a calculated period to mimic a brushing behavior of two times a day brushing for eight years and six months. Dentin loss was quantitatively determined by profilometry and statistically analyzed by Wilcoxon and Mann-Whitney-U Test (p < 0.05). Results The mean (standard deviation) surface loss was 21.03 (+/- 1.26) mu m for the sonic toothbrush, 15.71 (+/- 0.85) mu m for the oscillating-rotating toothbrush, 6.13 (+/- 1.24) mu m for the manual toothbrush with flat trim brush head and 2.50 (+/- 0.43) mu m for the manual toothbrush with rippled-shaped brush head. Differences between all groups were statistically significant at p<0.05. Conclusion Using the same brushing force and a highly abrasive toothpaste, manual toothbrushes are significantly less abrasive compared to power toothbrushes for an 8.5-year simulation.	[Bizhang, Mozhgan; Schmidt, Ilka; Zimmer, Stefan] Univ Witten Herdecke, Fac Hlth, Sch Dent, Dept Operat & Prevent Dent, Witten, Germany; [Chun, Yong-Hee Patricia] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, Dept Cellular Syst & Anat, San Antonio, TX 78229 USA; [Arnold, Wolfgang H.] Univ Witten Herdecke, Dept Biol & Mat Sci Dent, Witten, Germany	Witten Herdecke University; University of Texas System; University of Texas Health San Antonio; Witten Herdecke University	Bizhang, M (corresponding author), Univ Witten Herdecke, Fac Hlth, Sch Dent, Dept Operat & Prevent Dent, Witten, Germany.	mozhgan.bizhang@uni-wh.de		Bizhang, Mozhgan/0000-0001-6623-8466				ABSI EG, 1992, J ORAL REHABIL, V19, P101, DOI 10.1111/j.1365-2842.1992.tb01086.x; Addy M, 2008, PERIODONTOL 2000, V48, P54, DOI 10.1111/j.1600-0757.2008.00253.x; Bizhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153250; Boyd RL, 1997, J CLIN DENT, V8, P72; BREITENMOSER J, 1979, J PERIODONTOL, V50, P211; British Standards Institution, 1981, SPECIFICATION FOR TO, V5136, P1; Cho LR, 2002, J ORAL REHABIL, V29, P816, DOI 10.1046/j.1365-2842.2002.00877.x; Choi S, 2012, J MICROSC-OXFORD, V247, P176, DOI 10.1111/j.1365-2818.2012.03630.x; Creeth Jonathan E, 2009, J Dent Hyg, V83, P111; da Cas Natalia Ventura, 2013, Gen Dent, V61, pe8; Dyer D, 2000, J CLIN PERIODONTOL, V27, P99, DOI 10.1034/j.1600-051x.2000.027002099.x; EFRAIMSEN H E, 1990, Clinical Preventive Dentistry, V12, P13; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FRALEIGH CM, 1967, J DENT RES, V46, P209, DOI 10.1177/00220345670460011201; Ganss C, 2009, CLIN ORAL INVEST, V13, P203, DOI 10.1007/s00784-008-0230-8; Hellyer PH, 2011, BRIT DENT J, V211, P109, DOI 10.1038/sj.bdj.2011.618; Hooper S, 2003, J CLIN PERIODONTOL, V30, P802, DOI 10.1034/j.1600-051X.2003.00367.x; Janusz Karen, 2008, J Contemp Dent Pract, V9, P1; Knezevic Alena, 2010, J Calif Dent Assoc, V38, P109; Kuroe T, 2001, QUINTESSENCE INT, V32, P111; Lee WC, 1996, J PROSTHET DENT, V75, P487, DOI 10.1016/S0022-3913(96)90451-5; Litonjua LA, 2004, AM J DENT, V17, P237; Litonjua Luis A, 2005, Compend Contin Educ Dent, V26, P767; MANLY RS, 1966, J DENT RES, V45, P1822, DOI 10.1177/00220345660450064601; McCracken GI, 2003, J CLIN PERIODONTOL, V30, P409, DOI 10.1034/j.1600-051X.2003.20008.x; MIERAU HD, 1984, DEUT ZAHNAERZTL Z, V39, P634; Moore C, 2005, J CLIN PERIODONTOL, V32, P1242, DOI 10.1111/j.1600-051X.2005.00857.x; RADENTZ WH, 1976, J PERIODONTOL, V47, P148, DOI 10.1902/jop.1976.47.3.148; Sancakli HS, 2015, AUST DENT J, V60, P38, DOI 10.1111/adj.12271; Sanz M, 2015, J CLIN PERIODONTOL, V42, pS214, DOI 10.1111/jcpe.12367; Schemehorn BR, 1996, AM J DENT, V9, pS19; Sharma S, 2012, J ORAL SCI, V54, P183, DOI 10.2334/josnusd.54.183; Shay Kenneth, 2004, J Contemp Dent Pract, V5, P101; Sorensen JA, 2002, AM J DENT, V15, DOI [10.1016/j.jdent.2009.03.005, DOI 10.1016/J.DENT.2009.03.005]; Teixeira Erica C N, 2005, J Esthet Restor Dent, V17, P172, DOI 10.1111/j.1708-8240.2005.tb00109.x; Turssi CP, 2005, AM J DENT, V18, P251; Van der Weijden FA, 2015, J CLIN PERIODONTOL; VanderWeijden FA, 1996, AM J DENT, V9, pS31; VANDERWEIJDEN GA, 1995, J CLIN PERIODONTOL, V22, P648; Voronets J, 2008, CARIES RES, V42, P286, DOI 10.1159/000148160; Walters Patricia A, 2007, J Contemp Dent Pract, V8, P1; Wiegand A, 2006, J PERIODONTAL RES, V41, P221, DOI 10.1111/j.1600-0765.2005.00850.x; Wiegand A, 2006, CARIES RES, V40, P60, DOI 10.1159/000088908; Wiegand A, 2014, CARIES RES, V48, P154, DOI 10.1159/000353143; Wiegand A, 2008, AM J DENT, V21, P113; Wiegand A, 2013, CLIN ORAL INVEST, V17, P815, DOI 10.1007/s00784-012-0788-z; Wiegand A, 2009, J DENT, V37, P480, DOI 10.1016/j.jdent.2009.03.005; Wood I, 2008, J DENT, V36, P759, DOI 10.1016/j.jdent.2008.06.004; Yaacob M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002281.pub3	49	22	23	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172060	10.1371/journal.pone.0172060	http://dx.doi.org/10.1371/journal.pone.0172060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222156	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800030
J	Dumitrescu, L; Ritchie, MD; Denny, JC; El Rouby, NM; McDonough, CW; Bradford, Y; Ramirez, AH; Bielinski, SJ; Basford, MA; Chai, HS; Peissig, P; Carrell, D; Pathak, J; Rasmussen, LV; Wang, XM; Pacheco, JA; Kho, AN; Hayes, MG; Matsumoto, M; Smith, ME; Li, RL; Cooper-DeHoff, RM; Kullo, IJ; Chute, CG; Chisholm, RL; Jarvik, GP; Larson, EB; Carey, D; McCarty, CA; Williams, MS; Roden, DM; Bottinger, E; Johnson, JA; de Andrade, M; Crawford, DC				Dumitrescu, Logan; Ritchie, Marylyn D.; Denny, Joshua C.; El Rouby, Nihal M.; McDonough, Caitrin W.; Bradford, Yuki; Ramirez, Andrea H.; Bielinski, Suzette J.; Basford, Melissa A.; Chai, High Seng; Peissig, Peggy; Carrell, David; Pathak, Jyotishman; Rasmussen, Luke V.; Wang, Xiaoming; Pacheco, Jennifer A.; Kho, Abel N.; Hayes, M. Geoffrey; Matsumoto, Martha; Smith, Maureen E.; Li, Rongling; Cooper-DeHoff, Rhonda M.; Kullo, Iftikhar J.; Chute, Christopher G.; Chisholm, Rex L.; Jarvik, Gail P.; Larson, Eric B.; Carey, David; McCarty, Catherine A.; Williams, Marc S.; Roden, Dan M.; Bottinger, Erwin; Johnson, Julie A.; de Andrade, Mariza; Crawford, Dana C.			Genome-wide study of resistant hypertension identified from electronic health records	PLOS ONE			English	Article							GENETIC EPIDEMIOLOGY RESEARCH; CORONARY-ARTERY-DISEASE; BLOOD-PRESSURE RESPONSE; MEDICAL-RECORDS; EMERGE NETWORK; CONTROL RATES; QUALITY-CONTROL; PULSE PRESSURE; MEAN ARTERIAL; ADULT HEALTH	Resistant hypertension is defined as high blood pressure that remains above treatment goals in spite of the concurrent use of three antihypertensive agents from different classes. Despite the important health consequences of resistant hypertension, few studies of resistant hypertension have been conducted. To perform a genome-wide association study for resistant hypertension, we defined and identified cases of resistant hypertension and hypertensives with treated, controlled hypertension among > 47,500 adults residing in the US linked to electronic health records (EHRs) and genotyped as part of the electronic MEdical Records & GEnomics (eMERGE) Network. Electronic selection logic using billing codes, laboratory values, text queries, and medication records was used to identify resistant hypertension cases and controls at each site, and a total of 3,006 cases of resistant hypertension and 876 controlled hypertensives were identified among eMERGE Phase I and II sites. After imputation and quality control, a total of 2,530,150 SNPs were tested for an association among 2,830 multi-ethnic cases of resistant hypertension and 876 controlled hypertensives. No test of association was genome-wide significant in the full dataset or in the dataset limited to European American cases (n = 1,719) and controls (n = 708). The most significant finding was CLNK rs13144136 at p = 1.00x10(-6) (odds ratio = 0.68; 95% CI = 0.58-0.80) in the full dataset with similar results in the European American only dataset. We also examined whether SNPs known to influence blood pressure or hypertension also influenced resistant hypertension. None was significant after correction for multiple testing. These data highlight both the difficulties and the potential utility of EHR-linked genomic data to study clinically-relevant traits such as resistant hypertension.	[Dumitrescu, Logan] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Bradford, Yuki] Geisinger Hlth Syst, Biomed & Translat Informat, Danville, PA USA; [Denny, Joshua C.; Wang, Xiaoming] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Denny, Joshua C.; Ramirez, Andrea H.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [El Rouby, Nihal M.; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [El Rouby, Nihal M.; McDonough, Caitrin W.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Basford, Melissa A.] Vanderbilt Univ, Res Off, 221 Kirkland Hall, Nashville, TN 37235 USA; [Chai, High Seng; Pathak, Jyotishman; Matsumoto, Martha; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Peissig, Peggy] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Carrell, David; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Rasmussen, Luke V.] Northwestern Univ, Dept Prevent Med, Div Hlth & Biomed Informat, Chicago, IL 60611 USA; [Pacheco, Jennifer A.; Smith, Maureen E.; Chisholm, Rex L.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Kho, Abel N.; Hayes, M. Geoffrey] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Li, Rongling] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Cooper-DeHoff, Rhonda M.; Crawford, Dana C.] Case Western Reserve Univ, Inst Computat Biol, Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kullo, Iftikhar J.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA; [Chute, Christopher G.] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD USA; [Jarvik, Gail P.] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA; [Carey, David] Geisinger Hlth Syst, Weis Ctr Res, Danville, PA USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Bottinger, Erwin] Mt Sinai, Charles R Bronfman Inst Personalized Med, New York, NY USA; [Johnson, Julie A.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA	Vanderbilt University; Geisinger Health System; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mayo Clinic; Vanderbilt University; Mayo Clinic; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Case Western Reserve University; Mayo Clinic; Johns Hopkins University; University of Washington; University of Washington Seattle; Geisinger Health System; Geisinger Health System; Vanderbilt University; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of Florida	Crawford, DC (corresponding author), Case Western Reserve Univ, Inst Computat Biol, Epidemiol & Biostat, Cleveland, OH 44106 USA.	dana.crawford@case.edu	Chute, Christopher/AAT-8540-2021; Crawford, Dana/O-5578-2019; Denny, Josh/AAL-3359-2021; Roden, Dan/ABD-5412-2021; Bielinski, Suzette/A-2238-2009; Chisholm, Rex/B-3418-2009	Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Hayes, M Geoffrey/0000-0002-4617-3981; Rasmussen, Luke/0000-0002-4497-8049; McDonough, Caitrin/0000-0001-6393-7288; Bielinski, Suzette/0000-0002-2905-5430; Chisholm, Rex/0000-0002-5638-3990; Pacheco, Jennifer/0000-0001-8021-5818; McCarty, Catherine/0000-0003-1089-0142	NHGRI; NIGMS [U01HG04599, U01HG006379, U01HG004610, U01HG006375, U01HG004608, U01HG004609, U01HG006388, U01HG04603, U01HG006378, U01HG006385, U01HG006382, U01HG006380, U01HG006830, U01HG006828]; Vanderbilt CTSA grant from NCATS/NIH [UL1 TR000445]; Mayo Clinic Biobank - Mayo Clinic Center for Individualized Medicine; NIH [R01 HL074730, U01 GM074492, U01 NS038529, R01 NS073346];  [KL2 TR001429]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001429, UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006388, U01HG008672, U01HG008673, U01HG008701, U01HG008657] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Clinic Biobank - Mayo Clinic Center for Individualized Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The eMERGE Network is funded by NHGRI, with additional funding from NIGMS through the following grants: U01HG04599 and U01HG006379 to Mayo Clinic; U01HG004610 and U01HG006375 to Group Health Cooperative and University of Washington, Seattle; U01HG004608 to Marshfield Clinic; U01HG006389 to Essentia Institute of Rural Health; U01HG004609 and U01HG006388 to Northwestern University; U01HG04603 and U01HG006378 to Vanderbilt University; U01HG006385 to the Coordinating Center; U01HG006382 to Geisinger Clinic; U01HG006380 to Mount Sinai School of Medicine; U01HG006830 to The Children's Hospital of Philadelphia; and U01HG006828 to Cincinnati Children's Hospital and Boston Children's Hospital. A portion of the dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Centers BioVU, supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH, and the Mayo Clinic Biobank supported by the Mayo Clinic Center for Individualized Medicine. INVEST-GENES was funded by NIH grants R01 HL074730 and U01 GM074492. SPS3 and SPS3-GENES were funded by NIH grants U01 NS038529, U01 GM074492, and R01 NS073346. CWM was also supported by KL2 TR001429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2013, NAT GENET, DOI DOI 10.1038/NG.2797; Bakris G, 2014, J AM SOC HYPERTENS, V8, P127, DOI 10.1016/j.jash.2013.07.009; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Basson J, 2014, AM J HYPERTENS, V27, P431, DOI [10.1093/ajh/hpu149, 10.1093/ajh/hpt283]; Binder A, 2007, CURR OPIN CARDIOL, V22, P176, DOI 10.1097/HCO.0b013e3280d357f9; Blech I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018743; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Caro JJ, 1999, CAN MED ASSOC J, V160, P41; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crawford DC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00184; Cruz-Gonzalez I, 2009, J HUM HYPERTENS, V23, P556, DOI 10.1038/jhh.2009.19; Cruz-Gonzalez I, 2009, BMC CARDIOVASC DISOR, V9, P1; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Daly AK, 2012, ANNU REV PHARMACOL, V52, P21, DOI 10.1146/annurev-pharmtox-010611-134743; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Ehret GB, 2011, NATURE, P478; El Rouby N, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0583-8; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fontana V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001398; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Friedman O, 2010, AM J MED, V123, P173, DOI 10.1016/j.amjmed.2009.08.008; Gaziano JM, 2016, J CLIN EPIDEMIOLOGY; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gong Y, 2015, J HYPERTENS, V33, P2278, DOI 10.1097/HJH.0000000000000714; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Group PMIPW, 2015, PREC MED IN COH PROG; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Hall JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099161; Han D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-95, 10.1186/1471-2164-15-477]; Hannila-Handelberg T, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-4; He J, 2013, CIRC-CARDIOVASC GENE, V6, P598, DOI 10.1161/CIRCGENETICS.113.000307; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho H, 2005, HYPERTENSION, V45, P294, DOI 10.1161/01.HYP.0000151361.31736.96; Hong Kyung-Won, 2013, Genomics & Informatics, V11, P129, DOI 10.5808/GI.2013.11.3.129; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jachymova M, 2001, BIOCHEM BIOPH RES CO, V284, P426, DOI 10.1006/bbrc.2001.5007; Johnson JA, 2012, ANN MED, V44, pS17, DOI 10.3109/07853890.2011.653399; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kelly TN, 2013, HYPERTENSION, V62, P853, DOI 10.1161/HYPERTENSIONAHA.113.01148; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kim SJ, 2012, CIRC J, V76, P907, DOI 10.1253/circj.CJ-11-0713; Kirby JC, 2016, J AM MED INFORM ASS; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Lenfant C, 2002, ARCH INTERN MED, V162, P131, DOI 10.1001/archinte.162.2.131; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; Lupton SJ, 2011, TWIN RES HUM GENET, V14, P295, DOI 10.1375/twin.14.4.295; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Melka MG, 2012, J CLIN ENDOCR METAB, V97, pE145, DOI 10.1210/jc.2011-1801; Myat A, 2012, BMJ-BRIT MED J, P345; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Newton-Cheh C, 2009, NAT GENET, P41; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Payne K A, 2000, Curr Hypertens Rep, V2, P515, DOI 10.1007/s11906-996-0035-6; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roden DM, 2012, CLIN PHARMACOL THER, V91, P1083, DOI 10.1038/clpt.2012.42; Rolnick SJ, 2013, CLIN MED RES, V11, P54, DOI 10.3121/cmr.2013.1113; Salfati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133031; Salvi E, 2017, HYPERTENSION, V69, P51, DOI 10.1161/HYPERTENSIONAHA.116.08267; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; The SPSSG, LANCET, V382, P507; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; White WB, 2014, J AM SOC HYPERTENS, V8, P743, DOI 10.1016/j.jash.2014.06.005; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	93	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171745	10.1371/journal.pone.0171745	http://dx.doi.org/10.1371/journal.pone.0171745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222112	gold, Green Published, Green Submitted			2022-12-26	WOS:000394676800017
J	Girona, MM; Rossi, S; Lussier, JM; Walsh, D; Morin, H				Girona, Miguel Montoro; Rossi, Sergio; Lussier, Jean-Martin; Walsh, Denis; Morin, Hubert			Understanding tree growth responses after partial cuttings: A new approach	PLOS ONE			English	Article							HEIGHT-DIAMETER MODEL; BLACK SPRUCE STANDS; MARIANA MILL. BSP; BOREAL FOREST; PICEA-MARIANA; INDIVIDUAL-TREE; JACK PINE; FIR FORESTS; COMPETITION; MORTALITY	Forest ecosystem management heads towards the use of partial cuttings. However, the wide variation in growth response of residual trees remains unexplained, preventing a suitable prediction of forest productivity. The aim of the study was to assess individual growth and identify the driving factors involved in the responses of residual trees. Six study blocks in even-aged black spruce [Picea mariana (Mill.) B.S.P.] stands of the eastern Canadian boreal forest were submitted to experimental shelterwood and seed-tree treatments. Individual-tree models were applied to 1039 trees to analyze their patterns of radial growth during the 10 years after partial cutting by using the nonlinear Schnute function on tree-ring series. The trees exhibited different growth patterns. A sigmoid growth was detected in 32% of trees, mainly in control plots of older stands. Forty-seven percent of trees located in the interior of residual strips showed an S-shape, which was influenced by stand mortality, harvested intensity and dominant height. Individuals showing an exponential pattern produced the greatest radial growth after cutting and were edge trees of younger stands with higher dominant height. A steady growth decline was observed in 4% of trees, represented by the individuals suppressed and insensitive to the treatment. The analyses demonstrated that individual nonlinear models are able to assess the variability in growth within the stand and the factors involved in the occurrence of the different growth patterns, thus improving understanding of the tree responses to partial cutting. This new approach can sustain forest management strategies by defining the best conditions to optimize the growth yield of residual trees.	[Girona, Miguel Montoro; Rossi, Sergio; Walsh, Denis; Morin, Hubert] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Rossi, Sergio] Chinese Acad Sci, South China Bot Garden, Prov Key Lab Appl Bot, Key Lab Vegetat Restorat Management Degraded Ecos, Guangzhou, Guangdong, Peoples R China; [Lussier, Jean-Martin] Nat Resources Canada, Canadian Forest Serv, Canadian Wood Fibre Ctr, Quebec City, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; Chinese Academy of Sciences; South China Botanical Garden, CAS; Natural Resources Canada; Canadian Forest Service	Girona, MM (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada.	miguel.montoro1@uqac.ca	Girona, Miguel Montoro/AAH-1642-2020	Girona, Miguel Montoro/0000-0002-6916-3639; Lussier, Jean-Martin/0000-0003-1474-6674	Fonds de Recherche du Quebec - Nature et Technologies (FQRNT); Programme de mise en valeur des ressources forestieres (MFFPQ); Canadian Wood Fibre Centre of the Canadian Forest Service (Natural Resources Canada); Forest Complexity Modelling program of Center for Forest Research	Fonds de Recherche du Quebec - Nature et Technologies (FQRNT); Programme de mise en valeur des ressources forestieres (MFFPQ); Canadian Wood Fibre Centre of the Canadian Forest Service (Natural Resources Canada)(Natural Resources CanadaCanadian Forest Service); Forest Complexity Modelling program of Center for Forest Research	This project was supported by the Fonds de Recherche du Quebec - Nature et Technologies (FQRNT), the Programme de mise en valeur des ressources forestieres (MFFPQ), the Canadian Wood Fibre Centre of the Canadian Forest Service (Natural Resources Canada), and the Forest Complexity Modelling program of Center for Forest Research.	Adame P, 2008, FOREST ECOL MANAG, V256, P88, DOI 10.1016/j.foreco.2008.04.006; Alteyrac J, 2005, WOOD FIBER SCI, V37, P83; Bauhus J., 2013, MANAGING FORESTS COM, P187; Belien E, 2014, TREES-STRUCT FUNCT, V28, P1257, DOI 10.1007/s00468-014-1011-4; Bladon KD, 2008, FOREST CHRON, V84, P70, DOI 10.5558/tfc84070-1; BREDENKAMP BV, 1988, FOREST SCI, V34, P790; Bright RM, 2012, ENVIRON IMPACT ASSES, V37, P2, DOI 10.1016/j.eiar.2012.01.002; Burns RM., 1990, SILVICS N AM; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Castedo-Dorado F, 2006, FOREST ECOL MANAG, V229, P202, DOI 10.1016/j.foreco.2006.04.028; Cavazos T, 2002, J CLIMATE, V15, P2477, DOI 10.1175/1520-0442(2002)015<2477:IVAWWM>2.0.CO;2; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; De Grandpre L, 2009, ECOSYSTEM MANAGEMENT; Eerikainen K, 2003, FOREST ECOL MANAG, V175, P355, DOI 10.1016/S0378-1127(02)00138-X; Fernandez-de-Una L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122255; Fraver S, 2014, J VEG SCI, V25, P374, DOI 10.1111/jvs.12096; Fuller AK, 2004, FOREST ECOL MANAG, V191, P373, DOI 10.1016/j.foreco.2004.01.014; Gauthier S., 2009, ECOSYSTEM MANAGEMENT; Genet A, 2013, FOREST ECOL MANAG, V305, P158, DOI 10.1016/j.foreco.2013.05.046; Girona MM, 2016, FORESTS, V7, DOI 10.3390/f7100240; Giroud G, 2016, FOREST ECOL MANAG, V378, P131, DOI 10.1016/j.foreco.2016.07.031; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GROOT A, 1994, CAN J FOREST RES, V24, P225, DOI 10.1139/x94-033; GUAY R, 1992, FOREST CHRON, V68, P138, DOI 10.5558/tfc68138-1; Harper KA, 2015, J ECOL, V103, P550, DOI 10.1111/1365-2745.12398; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; Jamarillo- Correa JP, 2004, MOL ECOL, V13, P2735, DOI [10.1111/j.1365-294X.2004.02258.x, DOI 10.1111/J.1365-294X.2004.02258.X]; Krause C, 1995, FOREST CHRON, V71, P747, DOI 10.5558/tfc71747-6; Krause C, 2011, SCAND J FOREST RES, V26, P477, DOI 10.1080/02827581.2011.579995; Lei Y.C., 2004, NONLINEAR ANAL-MODEL, V9, P65, DOI [DOI 10.15388/NA.2004.9.1.15171, 10.15388/na.2004.9.1.15171]; Lemay A., 2016, GROWTH WOOD QUALITY; Lessard E, 2014, FOREST ECOL MANAG, V313, P307, DOI 10.1016/j.foreco.2013.10.030; Liu C, 2007, FOREST ECOL MANAG, V250, P148, DOI 10.1016/j.foreco.2007.05.010; Liu Zhao-gang, 2003, Journal of Forestry Research (Harbin), V14, P19, DOI 10.1007/BF02856757; Lussier JM, 2002, CAN J FOREST RES, V32, P539, DOI [10.1139/x01-201, 10.1139/X01-201]; Mailly D, 2003, CAN J FOREST RES, V33, P435, DOI 10.1139/X02-122; MCCOMB WC, 1993, J FOREST, V91, P31; Messier C, 2016, CURR FOR REP, V2, P150, DOI 10.1007/s40725-016-0036-x; MILLER GW, 1993, NE673 USDA FOR SERV; Ni FB, 2002, INT J CLIMATOL, V22, P1645, DOI 10.1002/joc.804; Orwig DA, 1997, TREES-STRUCT FUNCT, V11, P474, DOI 10.1007/s004680050110; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pamerleau-Couture E, 2015, FORESTRY, V88, P471, DOI 10.1093/forestry/cpv017; Peng Changhui, 2001, Northern Journal of Applied Forestry, V18, P87; Piepho HP, 2006, HORTSCIENCE, V41, P446, DOI 10.21273/HORTSCI.41.2.446; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; Rijal B, 2012, FORESTRY, V85, P379, DOI 10.1093/forestry/cps036; Rinntech, 2003, TSAP WIN TIM SER AN; Riopel M, 2010, CAN J FOREST RES, V40, P1458, DOI 10.1139/X10-059; Robitaille A., 1998, PAYSAGES REGIONAUX Q; Rossi S, 2011, GLOBAL CHANGE BIOL, V17, P614, DOI 10.1111/j.1365-2486.2010.02191.x; Rossi S, 2009, FOREST ECOL MANAG, V258, P2153, DOI 10.1016/j.foreco.2009.08.023; Rotzer T, 2010, FORESTRY; Ruel JC, 2000, FOREST ECOL MANAG, V135, P169, DOI 10.1016/S0378-1127(00)00308-X; Saucier J.-P., 1998, AUBELLE S, P1; SCHNUTE J, 1981, CAN J FISH AQUAT SCI, V38, P1128, DOI 10.1139/f81-153; Sharma M, 2004, SCAND J FOREST RES, V19, P442, DOI 10.1080/02827580410030163; Sharma M, 2007, FOREST ECOL MANAG, V249, P187, DOI 10.1016/j.foreco.2007.05.006; Smith D.M., 1997, PRACTICE SILVICULTUR; Subedi N, 2013, GLOBAL CHANGE BIOL, V19, P505, DOI 10.1111/gcb.12033; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thorpe HC, 2008, ECOL APPL, V18, P1652, DOI 10.1890/07-1697.1; Thorpe HC, 2007, CAN J FOREST RES, V37, P1563, DOI 10.1139/X07-148; Thorpe HC, 2007, FOREST CHRON, V83, P319, DOI 10.5558/tfc83319-3; Thurig E, 2005, FOREST ECOL MANAG, V204, P51, DOI [10.1016/j.foreco.2004.07.070, 10.1016/j.forceo.2004.07.070]; Vaganov E. A., 2006, GROWTH DYNAMICS CONI; Vincent M, 2009, FORESTRY, V82, P557, DOI 10.1093/forestry/cpp025; Wang YF, 2015, ENVIRON EARTH SCI, V74, P6471, DOI 10.1007/s12665-015-4168-2; Zhang LJ, 2004, FOREST CHRON, V80, P366, DOI 10.5558/tfc80366-3; Zhang LJ, 1997, ANN BOT-LONDON, V79, P251, DOI 10.1006/anbo.1996.0334; Zhang S, 2008, PUBLICATIONS, VSP-526E, P653; Zhang Shaoang, 1997, Southern Journal of Applied Forestry, V21, P199	72	50	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172653	10.1371/journal.pone.0172653	http://dx.doi.org/10.1371/journal.pone.0172653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222200	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800076
J	Malachowicz, M; Wenne, R; Burzynski, A				Malachowicz, Magdalena; Wenne, Roman; Burzynski, Artur			De novo assembly of the sea trout (Salmo trutta m. trutta) skin transcriptome to identify putative genes involved in the immune response and epidermal mucus secretion	PLOS ONE			English	Article							ATLANTIC SALMON; RAINBOW-TROUT; MUCIN BIOSYNTHESIS; FISH; EXPRESSION; SALAR; INFECTION; RECEPTOR; DIFFERENTIATION; IDENTIFICATION	In fish, the skin is a multifunctional organ and the first barrier against pathogens. Salmonids differ in their susceptibility to microorganisms due to varied skin morphology and gene expression patterns. The brown trout is a salmonid species with important commercial and ecological value in Europe. However, there is a lack of knowledge regarding the genes involved in the immune response and mucus secretion in the skin of this fish. Thus, we characterized the skin transcriptome of anadromous brown trout using next-generation sequencing ( NGS). A total of 1,348,306 filtered reads were obtained and assembled into 75,970 contigs. Of these contigs 48.57% were identified using BLAST tool searches against four public databases. KEGG pathway and Gene Ontology analyses revealed that 13.40% and 34.57% of the annotated transcripts, respectively, represent a variety of biological processes and functions. Among the identified KEGG Orthology categories, the best represented were signal transduction ( 23.28%) and immune system ( 8.82%), with a variety of genes involved in immune pathways, implying the differentiation of immune responses in the trout skin. We also identified and transcriptionally characterized 8 types of mucin proteins the main structural components of the mucosal layer. Moreover, 140 genes involved in mucin synthesis were identified, and 1,119 potential simple sequence repeats ( SSRs) were detected in 3,134 transcripts.	[Malachowicz, Magdalena; Wenne, Roman; Burzynski, Artur] Inst Oceanol PAS, Sopot, Poland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Malachowicz, M (corresponding author), Inst Oceanol PAS, Sopot, Poland.	mwarzecha@iopan.gda.pl	Burzynski, Artur/J-7048-2012; Malachowicz, Magdalena/M-9469-2017; Malachowicz, Magdalena/K-1436-2019; Wenne, Roman/S-8294-2017	Burzynski, Artur/0000-0002-0185-197X; Malachowicz, Magdalena/0000-0002-3088-9619; Malachowicz, Magdalena/0000-0002-3088-9619; Wenne, Roman/0000-0001-6994-1181				Alexander John B., 1992, Annual Review of Fish Diseases, V2, P249, DOI 10.1016/0959-8030(92)90066-7; Anderson D. P., 1989, Viruses of lower vertebrates., P469; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Aranishi F, 1997, FISH PHYSIOL BIOCHEM, V16, P471, DOI 10.1023/A:1007736804243; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bergsson G, 2005, FEBS J, V272, P4960, DOI 10.1111/j.1742-4658.2005.04906.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charles A, 2001, IMMUNOBIOL IMMUNE SY, V5th; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Du LM, 2013, J HERED, V104, P154, DOI 10.1093/jhered/ess082; Du YS, 2015, FISH SHELLFISH IMMUN, V44, P307, DOI 10.1016/j.fsi.2015.02.029; Elliott Diane G., 2000, P95, DOI 10.1016/B978-012529650-2/50008-1; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; ELLIS AE, 1988, MICROB PATHOGENESIS, V4, P299, DOI 10.1016/0882-4010(88)90090-3; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Esteban Angeles M, 2012, ISRN IMMUNOL, V2012, P853470, DOI [10.5402/2012/853470, DOI 10.5402/2012/853470]; Fast MD, 2002, COMP BIOCHEM PHYS A, V132, P645, DOI 10.1016/S1095-6433(02)00109-5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FREEDMAN SJ, 1991, COMP BIOCHEM PHYS B, V98, P549, DOI 10.1016/0305-0491(91)90252-9; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gonzalez SF, 2007, DEV COMP IMMUNOL, V31, P576, DOI 10.1016/j.dci.2006.08.010; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hashimoto M, 2007, GLYCOBIOLOGY, V17, P994, DOI 10.1093/glycob/cwm068; Hikima JI, 2011, DEV COMP IMMUNOL, V35, P924, DOI 10.1016/j.dci.2010.10.011; HJELMELAND K, 1983, J FISH BIOL, V23, P13, DOI 10.1111/j.1095-8649.1983.tb02878.x; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Hordvik I, 2015, BIOMOLECULES, V5, P166, DOI 10.3390/biom5010166; ICES, 2015, 2015ACOM08 ICES CM; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jevtov I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06653; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; LaPatra S. E., 1989, Journal of Aquatic Animal Health, V1, P277, DOI 10.1577/1548-8667(1989)001&lt;0277:IHNVII&gt;2.3.CO;2; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Long Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056998; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Malachowicz M, 2015, MAR GENOM, V23, P37, DOI 10.1016/j.margen.2015.04.005; Marel Maria van der, 2012, Fish Shellfish Immunol, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marshall WS, 2010, COMP BIOCHEM PHYS A, V155, P275, DOI 10.1016/j.cbpa.2009.11.016; Meng Z, 2012, J IMMUNOL, V189, P4024, DOI 10.4049/jimmunol.1201244; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Neuhaus H, 2007, DIS AQUAT ORGAN, V77, P17, DOI 10.3354/dao01836; Noga EJ, 2009, COMP BIOCHEM PHYS B, V152, P299, DOI 10.1016/j.cbpb.2008.12.018; Padra JT, 2014, INFECT IMMUN, V82, P5235, DOI 10.1128/IAI.01931-14; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Peatman E, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1068907; Perez-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065457; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; Pluta K, 2012, PHYSIOL GENOMICS, V44, P1165, DOI 10.1152/physiolgenomics.00088.2012; Pocwierz-Kotus A, 2014, ANIM GENET, V45, P96, DOI 10.1111/age.12095; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Soares-Silva M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00183; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Subramanian S, 2009, MAR BIOTECHNOL, V11, P748, DOI 10.1007/s10126-009-9189-y; Tacchi L, 2015, AQUACULTURE, V435, P120, DOI 10.1016/j.aquaculture.2014.09.027; Tsutsui S, 2011, J BIOCHEM, V150, P501, DOI 10.1093/jb/mvr085; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Was A, 2003, MAR BIOTECHNOL, V5, P234, DOI 10.1007/s10126-002-0068-z; Was A, 2002, AQUACULTURE, V204, P493, DOI 10.1016/S0044-8486(01)00835-3; Webster TMU, 2013, ENVIRON SCI TECHNOL, V47, P8869, DOI 10.1021/es401380p; Webster TMU, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1254-5; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Xu Y, 1998, J BIOL CHEM, V273, P21783, DOI 10.1074/jbc.273.34.21783; Yan HY, 2009, J FISH BIOL, V75, P845, DOI 10.1111/j.1095-8649.2009.02326.x; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	91	22	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172282	10.1371/journal.pone.0172282	http://dx.doi.org/10.1371/journal.pone.0172282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212382	Green Published, gold			2022-12-26	WOS:000394424700027
J	Cao, Z; Wang, ZJ; Shang, ZL; Zhao, JC				Cao, Zhen; Wang, Zhenjie; Shang, Zhonglin; Zhao, Jiancheng			Classification and identification of Rhodobryum roseum Limpr. and its adulterants based on fourier-transform infrared spectroscopy (FTIR) and chemometrics	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; WAVELET TRANSFORM; MOSSES; AUTHENTICATION; MICROORGANISMS; CHLOROPLAST; SPECTRA; AREAS; CWT	Fourier-transform infrared spectroscopy (FTIR) with the attenuated total reflectance technique was used to identify Rhodobryum roseum from its four adulterants. The FTIR spectra of six samples in the range from 4000 cm(-1) to 600 cm(-1) were obtained. The second-derivative transformation test was used to identify the small and nearby absorption peaks. A cluster analysis was performed to classify the spectra in a dendrogram based on the spectral similarity. Principal component analysis (PCA) was used to classify the species of six moss samples. A cluster analysis with PCA was used to identify different genera. However, some species of the same genus exhibited highly similar chemical components and FTIR spectra. Fourier self-deconvolution and discrete wavelet transform (DWT) were used to enhance the differences among the species with similar chemical components and FTIR spectra. Three scales were selected as the feature-extracting space in the DWT domain. The results show that FTIR spectroscopy with chemometrics is suitable for identifying Rhodobryum roseum and its adulterants.	[Cao, Zhen; Shang, Zhonglin; Zhao, Jiancheng] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China; [Cao, Zhen; Wang, Zhenjie] Hebei Coll Ind & Technol, Shijiazhuang, Peoples R China	Hebei Normal University	Zhao, JC (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China.	zhaojiancheng@mail.hebtu.edu.cn			Natural Science Foundation of China [31370237]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China 31370237 (JZ), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#.	Addison PS, 1997, INSIGHT, V39, P493; Asakawa Y, 2013, PHYTOCHEMISTRY, V91, P52, DOI 10.1016/j.phytochem.2012.04.012; Chan KLA, 2008, APPL SPECTROSC, V62, P1095, DOI 10.1366/000370208786049042; Cheng CG, 2008, ACTA CHIM SINICA, V66, P793; Cheng CG, 2010, VIB SPECTROSC, V54, P50, DOI 10.1016/j.vibspec.2010.06.004; Cox CJ, 1999, PLANT SYST EVOL, V215, P119, DOI 10.1007/BF00984651; Cox CJ, 2004, SYST BOT, V29, P234, DOI 10.1600/036364404774195458; Cox CJ, 2003, J BRYOL, V25, P31, DOI 10.1179/037366803125002635; Crandall-Stotler B, 2007, FLORA N AM N MEXICO, P3; Crosby M. R., 1999, CHECKLIST MOSSES; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; De Luca M, 2011, FOOD CHEM, V124, P1113, DOI 10.1016/j.foodchem.2010.07.010; DEFERNEZ M, 1995, J AGR FOOD CHEM, V43, P109, DOI 10.1021/jf00049a021; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Foan L, 2014, ENVIRON POLLUT, V184, P113, DOI 10.1016/j.envpol.2013.08.006; Forina M, 2008, CHEMOMETR INTELL LAB, V93, P132, DOI 10.1016/j.chemolab.2008.05.003; Giese AT, 1955, APPL SPECTROSC, V9, P78, DOI 10.1366/000370255774634089; Hu T, 2011, SPECTROSC-BIOMED APP, V25, P271, DOI 10.1155/2011/908150; KEMSLEY EK, 1994, FOOD CONTROL, V5, P241, DOI 10.1016/0956-7135(94)90023-X; Kohler A, 2007, ANAL BIOANAL CHEM, V389, P1143, DOI 10.1007/s00216-007-1414-9; Lu HF, 2004, ACTA BOT SIN, V46, P401; Marchant BP, 2003, BIOSYST ENG, V85, P261, DOI 10.1016/S1537-5110(03)00063-1; Mark H, 2003, SPECTROSCOPY, V18, P25; Montes J, 2011, NOVA HEDWIGIA, V93, P47; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Naumann A, 2010, FIELD CROP RES, V119, P78, DOI 10.1016/j.fcr.2010.06.017; Naumann A, 2009, ANALYST, V134, P1215, DOI 10.1039/b821286d; NAUMANN D, 1988, J MOL STRUCT, V174, P165, DOI 10.1016/0022-2860(88)80152-2; Naumann D, 1991, J GEN MICROBIOL, V137, P69, DOI [10.1099/00221287-137-1-69, DOI 10.1099/00221287-137-1-69]; Poulli KI, 2005, ANAL CHIM ACTA, V542, P151, DOI 10.1016/j.aca.2005.03.061; Qiao F, 2003, DRUG STANOAROS CHINA, V6, P3; Salzer R, 2000, FRESEN J ANAL CHEM, V366, P712, DOI 10.1007/s002160051565; Sockalingum GD, 1998, CELL MOL BIOL, V44, P261; Subasi A, 2012, COMPUT BIOL MED, V42, P806, DOI 10.1016/j.compbiomed.2012.06.004; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; Wang X, 2010, SPECTROCHIM ACTA A, V91, P165; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; WHITBECK MR, 1981, APPL SPECTROSC, V35, P93, DOI 10.1366/0003702814731851; Xu H-C, 2008, J SHAANXI NORMAL U, V36, P88; Yang JW, 2005, LECT NOTES COMPUT SC, V3522, P427; Zhang CJ, 2008, SPECTROSC-INT J, V22, P371, DOI 10.1155/2008/729607	41	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172359	10.1371/journal.pone.0172359	http://dx.doi.org/10.1371/journal.pone.0172359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207900	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500124
J	Nualsri, C; Kongjan, P; Reungsang, A; Imai, T				Nualsri, Chatchawin; Kongjan, Prawit; Reungsang, Alissara; Imai, Tsuyoshi			Effect of biogas sparging on the performance of bio-hydrogen reactor over a long-term operation	PLOS ONE			English	Article							BIOHYDROGEN PRODUCTION; METHANE PRODUCTION; CLOSTRIDIUM-BUTYRICUM; ANAEROBIC-DIGESTION; DARK FERMENTATION; WASTE; HYDROLYSATE; SLUDGE; H-2	This study aimed to enhance hydrogen production from sugarcane syrup by biogas sparging. Two-stage continuous stirred tank reactor (CSTR) and upflow anaerobic sludge blanket (UASB) reactor were used to produce hydrogen and methane, respectively. Biogas produced from the UASB was used to sparge into the CSTR. Results indicated that sparging with biogas increased the hydrogen production rate (HPR) by 35% (from 17.1 to 23.1 L/L.d) resulted from a reduction in the hydrogen partial pressure. A fluctuation of HPR was observed during a long term monitoring because CO2 in the sparging gas and carbon source in the feedstock were consumed by Enterobacter sp. to produce succinic acid without hydrogen production. Mixed gas released from the CSTR after the sparging can be considered as bio-hythane (H-2+CH4). In addition, a continuous sparging biogas into CSTR release a partial pressure in the headspace of the methane reactor. In consequent, the methane production rate is increased.	[Nualsri, Chatchawin; Reungsang, Alissara] Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand; [Nualsri, Chatchawin] Phibulsongkram Rajabhat Univ, Fac Food & Agr Technol, Phitsanulok, Thailand; [Kongjan, Prawit] Prince Songkla Univ, Fac Sci & Technol, Dept Sci, Div Chem, Muang, Pattani, Thailand; [Kongjan, Prawit] Prince Songkla Univ, Fac Sci & Technol, Dept Sci, Biomass Convers Energy & Chem Bio MEC Res Unit, Muang, Pattani, Thailand; [Reungsang, Alissara] Khon Kaen Univ, Res Grp Dev Microbial Hydrogen Prod Proc Biomass, Khon Kaen, Thailand; [Imai, Tsuyoshi] Yamaguchi Univ, Grad Sch Sci & Engn, Div Environm Sci & Engn, Yamaguchi, Japan	Khon Kaen University; Pibulsongkram Rajabhat University; Prince of Songkla University; Prince of Songkla University; Khon Kaen University; Yamaguchi University	Reungsang, A (corresponding author), Khon Kaen Univ, Fac Technol, Dept Biotechnol, Khon Kaen, Thailand.; Reungsang, A (corresponding author), Khon Kaen Univ, Res Grp Dev Microbial Hydrogen Prod Proc Biomass, Khon Kaen, Thailand.	alissara@kku.ac.th	Reungsang, Alissara/K-6978-2019; Kongjan, Prawit/AAB-1818-2021; Imai, Tsuyoshi/F-2515-2018; Nualsri, Chatchawin/GPP-2772-2022	Reungsang, Alissara/0000-0001-7836-032X; Kongjan, Prawit/0000-0001-5762-3733; Imai, Tsuyoshi/0000-0002-8891-0564; Nualsri, Chatchawin/0000-0002-9271-4187	Graduate School, Khon Kaen University [551T213]; Thailand Research Fund Research Scholar [RTA5980004]; Thailand Research Fund Senior Research Scholar [RTA5980004]	Graduate School, Khon Kaen University; Thailand Research Fund Research Scholar; Thailand Research Fund Senior Research Scholar(Thailand Research Fund (TRF))	This work was supported by Graduate School, Khon Kaen University, URL: gs.kku.ac.th, Recipient: Chatchawin Nualsri (Grant No. 551T213); Thailand Research Fund Research Scholar, URL: www.trf.or.th, Recipient: Alissara Reungsang (Grant No. RTA5980004). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ph.D. scholarship to CN was provided by Graduate School, Khon Kaen University (Grant No. 551T213). Research funds to AR were provided by Thailand Research Fund Senior Research Scholar (Grant No. RTA5980004).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; American Public Health Association A., 1995, STANDARD METHODS EXA; Argun H, 2011, INT J HYDROGEN ENERG, V36, P7443, DOI 10.1016/j.ijhydene.2011.03.116; BATTINO R, 1966, CHEM REV, V66, P395, DOI 10.1021/cr60242a003; Chong ML, 2009, INT J HYDROGEN ENERG, V34, P3277, DOI 10.1016/j.ijhydene.2009.02.010; Chou CH, 2008, INT J HYDROGEN ENERG, V33, P1550, DOI 10.1016/j.ijhydene.2007.09.031; Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Endo G., 1982, PROC SOC CIV ENG, V325, P61, DOI DOI 10.2208/JSCEJ1969.1982.325_61; Esquivel-Elizondo S, 2014, APPL BIOCHEM BIOTECH, V173, P1737, DOI 10.1007/s12010-014-0961-8; Fulton J, 2008, United States patent, Patent No. [US 7721682, 7721682]; Hawkes FR, 2007, INT J HYDROGEN ENERG, V32, P172, DOI 10.1016/j.ijhydene.2006.08.014; Junghare M, 2012, INT J HYDROGEN ENERG, V37, P3160, DOI 10.1016/j.ijhydene.2011.11.043; Khanal S. K., 2008, ANAEROBIC BIOTECHNOL; Kim DH, 2006, INT J HYDROGEN ENERG, V31, P2158, DOI 10.1016/j.ijhydene.2006.02.012; Kim DH, 2012, INT J HYDROGEN ENERG, V37, P15563, DOI 10.1016/j.ijhydene.2012.03.071; Kongjan P, 2014, INT J HYDROGEN ENERG, V39, P19343, DOI 10.1016/j.ijhydene.2014.06.057; Kongjan P, 2010, BIOTECHNOL BIOENG, V105, P899, DOI 10.1002/bit.22616; Levin DB, 2004, INT J HYDROGEN ENERG, V29, P173, DOI 10.1016/S0360-3199(03)00094-6; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; Leite WRM, 2016, RENEW ENERG, V86, P1324, DOI 10.1016/j.renene.2015.09.069; Nualsri C, 2016, INT J HYDROGEN ENERG, V41, P17884, DOI 10.1016/j.ijhydene.2016.07.135; Pattra S, 2008, INT J HYDROGEN ENERG, V33, P5256, DOI 10.1016/j.ijhydene.2008.05.008; Pattra S, 2011, INT J HYDROGEN ENERG, V36, P8697, DOI 10.1016/j.ijhydene.2010.05.120; Plangklang P, 2012, INT J HYDROGEN ENERG, V37, P15525, DOI 10.1016/j.ijhydene.2012.02.186; Spirito CM, 2014, CURR OPIN BIOTECH, V27, P115, DOI 10.1016/j.copbio.2014.01.003; Tanisho S, 1998, INT J HYDROGEN ENERG, V23, P559, DOI 10.1016/S0360-3199(97)00117-1; Willquist K, 2012, INT J HYDROGEN ENERG, V37, P17749, DOI 10.1016/j.ijhydene.2012.08.092; Zhang T, 2000, BIOTECHNOL LETT, V22, P399, DOI 10.1023/A:1005680803442	29	10	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171248	10.1371/journal.pone.0171248	http://dx.doi.org/10.1371/journal.pone.0171248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207755	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500021
J	Picazo, J; Ruiz-Contreras, J; Casado-Flores, J; Negreira, S; Baquero, F; Hernandez-Sampelayo, T; Otheo, E; Mendez, C				Picazo, Juan; Ruiz-Contreras, Jesus; Casado-Flores, Juan; Negreira, Sagrario; Baquero, Fernando; Hernandez-Sampelayo, Teresa; Otheo, Enrique; Mendez, Cristina		Heracles Study Grp	Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; SEROTYPES; COLONIZATION; VACCINES; TRENDS; PCV13; SCHEDULE	In the Community of Madrid, the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent (PCV7) in the fully government-funded Regional Immunization Program (RIP) in May, 2010, but was later excluded in May, 2012, and included again in January, 2015. These unique changes allowed us to assess the impact of the different pneumococcal vaccination policies on PCV13 uptake in infants and on the incidence rate (IR) of invasive pneumococcal disease (IPD) in children <15 years old. In this prospective, active, surveillance study, we estimated PCV13 uptakes, IR and incidence rate ratios (IRR) for total IPD and for IPD caused by PCV13- and non-PCV13 serotypes in children <15 years, stratified by age, in four periods with different vaccination policies: fully government-funded PCV7 vaccination, fully government-funded PCV13, mixed public/ private funding and only private funding. Vaccine uptakes reached 95% in periods with public-funded pneumococcal vaccination, but fell to 67% in the private funding period. Overall, IR of IPD decreased by 68% (p<0.001) in 2014-15, due to 93% reduction in the IR of PCV13-type IPD (p<0.001) without significant changes in non-PCV13-type IPD. A fully government-funded PCV13 vaccination program lead to high vaccine uptake and dramatic reductions in both overall and PCV13-type IPD IR. When this program was switched to private PCV13 vaccination, there was a fall in vaccine coverage and stagnation in the decline of PCV13-type IPD with data suggesting a weakening of herd immunity.	[Picazo, Juan] Univ Complutense, Sch Med, Dept Med, Madrid, Spain; [Ruiz-Contreras, Jesus; Negreira, Sagrario] Hosp Univ 12 Octubre, Dept Pediat, Madrid, Spain; [Ruiz-Contreras, Jesus; Negreira, Sagrario; Hernandez-Sampelayo, Teresa] Univ Complutense, Sch Med, Dept Pediat, Madrid, Spain; [Casado-Flores, Juan] Hosp Univ Infantil Nino Jesus, Pediat ICU, Madrid, Spain; [Casado-Flores, Juan; Baquero, Fernando] Univ Autonoma Madrid, Sch Med, Dept Pediat, Madrid, Spain; [Baquero, Fernando] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Hernandez-Sampelayo, Teresa] Hosp Gen Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Hernandez-Sampelayo, Teresa] CIBERES, CIBER Resp Dis, Madrid, Spain; [Otheo, Enrique] Hosp Univ Ramoon y Cajal, Dept Pediat, Madrid, Spain; [Mendez, Cristina] Pfizer SLU, Dept Med, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Autonomous University of Madrid; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Pfizer	Picazo, J (corresponding author), Univ Complutense, Sch Med, Dept Med, Madrid, Spain.	jpicazo@picazo.net	Matos, teresa ths Hernández-Sampelayo/M-7200-2018	Matos, teresa ths Hernández-Sampelayo/0000-0002-3296-6331; RUIZ-CONTRERAS, JESUS/0000-0002-2788-7524	Pfizer S.L.U., Madrid, Spain	Pfizer S.L.U., Madrid, Spain	This work was supported in part by an unrestricted grant from Pfizer S.L.U., Madrid, Spain. The funder played an indirect role through the participation of a co-author in study design, coordination of study centers, critical revision and final approval of the manuscript, and the agreement to be accountable for all aspects of the work.	Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Sanz JC, 2010, J CLIN MICROBIOL, V48, P593, DOI 10.1128/JCM.01651-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Centres for Disease Control and Prevention, 2014, ACT BACT COR SURV RE; Cohen R, 2015, VACCINE, V33, P5118, DOI 10.1016/j.vaccine.2015.08.010; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Dagan R, 2015, J INFECT DIS, V211, P1144, DOI 10.1093/infdis/jiu576; Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849; Fenoll A, 2015, VACCINE, V33, P5691, DOI 10.1016/j.vaccine.2015.08.009; Gervaix A, 2014, CLIN THER, V36, P802, DOI 10.1016/j.clinthera.2014.03.001; Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012; Gounder PP, 2014, J INFECT DIS, V209, P1251, DOI 10.1093/infdis/jit642; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Kalekar PS, TIME SERIES FORECAST; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Link-Gelles R, 2013, VACCINE, V31, P2572, DOI 10.1016/j.vaccine.2013.03.049; Loughlin AM, 2014, PEDIATR INFECT DIS J, V33, P504, DOI 10.1097/INF.0000000000000279; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Picazo J, 2011, VACCINE, V29, P1770, DOI 10.1016/j.vaccine.2010.12.114; Picazo J, 2011, CLIN VACCINE IMMUNOL, V18, P89, DOI 10.1128/CVI.00317-10; Picazo J, 2013, CLIN VACCINE IMMUNOL, V20, P1524, DOI 10.1128/CVI.00239-13; Picazo J, 2013, PEDIATR INFECT DIS J, V32, P656, DOI 10.1097/INF.0b013e31827e8594; Picazo J, 2011, PEDIATR INFECT DIS J, V30, P471, DOI 10.1097/INF.0b013e31820a418a; Shea KM, 2011, VACCINE, V29, P8042, DOI 10.1016/j.vaccine.2011.08.057; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; [No title captured]	33	20	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172222	10.1371/journal.pone.0172222	http://dx.doi.org/10.1371/journal.pone.0172222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207888	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500102
J	Wang, ZZ; Hu, BL; Yin, QY				Wang, Zhengzhou; Hu, Bingliang; Yin, Qinye			An improved schlieren method for measurement and automatic reconstruction of the far-field focal spot	PLOS ONE			English	Article							NATIONAL IGNITION FACILITY	The schlieren method of measuring far-field focal spots offers many advantages at the Shenguang III laser facility such as low cost and automatic laser-path collimation. However, current methods of far-field focal spot measurement often suffer from low precision and efficiency when the final focal spot is merged manually, thereby reducing the accuracy of reconstruction. In this paper, we introduce an improved schlieren method to construct the high dynamic-range image of far-field focal spots and improve the reconstruction accuracy and efficiency. First, a detection method based on weak light beam sampling and magnification imaging was designed; images of the main and side lobes of the focused laser irradiance in the far field were obtained using two scientific CCD cameras. Second, using a self correlation template matching algorithm, a circle the same size as the schlieren ball was dug from the main lobe cutting image and used to change the relative region of the main lobe cutting image within a 100x100 pixel region. The position that had the largest correlation coefficient between the side lobe cutting image and the main lobe cutting image when a circle was dug was identified as the best matching point. Finally, the least squares method was used to fit the center of the side lobe schlieren small ball, and the error was less than 1 pixel. The experimental results show that this method enables the accurate, high-dynamic-range measurement of a far-field focal spot and automatic image reconstruction. Because the best matching point is obtained through image processing rather than traditional reconstruction methods based on manual splicing, this method is less sensitive to the efficiency of focal spot reconstruction and thus offers better experimental precision.	[Wang, Zhengzhou] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China; [Wang, Zhengzhou; Yin, Qinye] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zhengzhou; Hu, Bingliang] Chinese Acad Sci, Xian Inst Opt & Precis Mech, Xian, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS	Hu, BL (corresponding author), Chinese Acad Sci, Xian Inst Opt & Precis Mech, Xian, Peoples R China.	wangbl_xa@163.com			National Natural Science Foundation of China [11327303, 61405244]; project titled "Research on underwater imaging technology based on compressive sensing via soft range gating and adaptive polarized light"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project titled "Research on underwater imaging technology based on compressive sensing via soft range gating and adaptive polarized light"	This study was supported by the National Natural Science Foundation of China (11327303, 61405244) and by the project titled "Research on underwater imaging technology based on compressive sensing via soft range gating and adaptive polarized light."	Cheng Juan, 2006, High Power Laser and Particle Beams, V18, P612; Du Xiangwan, 1997, Chinese Journal of Lasers, VA24, P327; Goshtasby AA, 2005, IMAGE VISION COMPUT, V23, P611, DOI 10.1016/j.imavis.2005.02.004; Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276; HE YX, 2012, CHINESE J LASERS PAP, V39, P1; Heestand GM, 2008, APPL OPTICS, V47, P3494, DOI 10.1364/AO.47.003494; Ishino Y, 2016, FLOW TURBUL COMBUST, V96, P819, DOI 10.1007/s10494-015-9658-5; Jain DS, 2016, INT J HEAT MASS TRAN, V98, P697, DOI 10.1016/j.ijheatmasstransfer.2016.03.062; Klimov AI, 2008, IEEE T PLASMA SCI, V36, P661, DOI 10.1109/TPS.2008.917300; Kong Bing, 2002, Infrared Laser Engineering, V31, P275; Lu Y, 2015, J APPL OPT, V36, P104; MANTIUK R, 2006, ACM T APPL PERCEPT, V3, P288; Mehfuz R, 2012, P SOC PHOTO-OPT INS, P8463; Raffel M, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-015-1927-5; Rudiger Foest, 2015, EUR PHYS J-APPL PHYS, V71, P20804; Shao M, 2007, OPTICS OPTOELECTRONI, V5, P1; Tomaszewska A, 2007, WSCG 2007, FULL PAPERS PROCEEDINGS I AND II, P49; Williams WH, 2004, P SOC PHOTO-OPT INS, V5341, P66, DOI 10.1117/12.538476; Xia Yanwei, 2014, ACTA PHOTONICA SINIC, V43; Yang Pengling, 2010, Chinese Journal of Lasers, V37, P521, DOI 10.3788/CJL20103702.0521; [杨作廷 Yang Zuoting], 2013, [光子学报, Acta Photonica Sinica], V42, P742; Zhang Z., 2013, DIGITAL IMAGE PROCES	22	1	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171415	10.1371/journal.pone.0171415	http://dx.doi.org/10.1371/journal.pone.0171415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207758	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424500028
J	Albano, PM; Holzinger, D; Salvador, C; Orosa, J; Racelis, S; Leano, M; Sanchez, D; Angeles, LM; Halec, G; Schmitt, M; Ramos, JD; Pawlita, M				Albano, Pia Marie; Holzinger, Dana; Salvador, Christianne; Orosa, Jose, III; Racelis, Sheryl; Leano, Modesty; Sanchez, Danilo, Jr.; Angeles, Lara Mae; Halec, Gordana; Schmitt, Markus; Ramos, John Donnie; Pawlita, Michael			Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; E6/E7 MESSENGER-RNA; OROPHARYNGEAL CANCER; ORAL-CAVITY; VIRAL LOAD; MALIGNANT-TRANSFORMATION; HPV; INFECTION; EPIDEMIOLOGY; EXPRESSION	Background Geographic heterogeneity of human papillomavirus (HPV) involvement in head and neck squamous cell carcinoma (HNSCC) has been observed over the last few years. This trend has not been evaluated in the Philippines. Hence, this study aims to provide for the first time a data on the prevalence of HPV in HNSCC in the northwestern region of the Philippines. Methods Two hundred one (201) biopsy samples (179 formalin fixed paraffin embedded and 22 fresh frozen) from 163 Filipino HNSCC cases (oral cavity = 88; larynx = 60; oropharynx = 15) diagnosed between 2003 to 2013 were initially included in this study. HPV DNA was detected by two methods: (1) BSGP5+/6+-PCR/multiplex human papillomavirus genotyping and (2) TaqMan probes-based real-time qPCR. Presence of HPV type-specific transcripts were also analyzed by reverse transcription-PCR with subsequent hybridization to oligonucleotide probes coupled to Luminex beads. Co-amplification of the beta-globin and ubiquitin C genes served as internal positive controls for DNA and RNA analyses, respectively. Results and conclusions Of the 163, 82 (50.3%) cases had at least one tissue sample that was valid for molecular analysis. Only two of the DNA valid cases (2.4%) were HPV DNA-positive (HPV11 and HPV33). All HPV mRNA assays rendered negative results except for HPV11 transcripts. Results of this study may indicate that there is probably very low prevalence of HPV-associated HNSCC among Filipino adults living in a rural region of the Philippines. This study could serve as a benchmark for designing follow-up studies that would assess possible changes in trends of HNSCC among Filipinos in different ethnic regions of the country, especially urban areas in which the population is expected to adapt Western style sexual behavior. A prospective sampling of fresh frozen tissue is also highly recommended to ensure better molecular analyses.	[Albano, Pia Marie; Holzinger, Dana; Halec, Gordana; Schmitt, Markus; Pawlita, Michael] German Canc Res Ctr, Res Program Infect & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany; [Albano, Pia Marie; Ramos, John Donnie] Univ Santo Tomas, Coll Sci, Dept Biol, Manila, Philippines; [Albano, Pia Marie; Ramos, John Donnie] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines; [Salvador, Christianne; Orosa, Jose, III; Sanchez, Danilo, Jr.] Mariano Marcos Mem Hosp & Med Ctr, Dept ENT Head & Neck Surg, Ilocos Norte, Philippines; [Racelis, Sheryl; Leano, Modesty] Mariano Marcos Mem Hosp & Med Ctr, Dept Pathol & Labs, Ilocos Norte, Philippines; [Angeles, Lara Mae] Univ Santo Tomas Hosp, Dept Clin Pathol, Manila, Philippines	Helmholtz Association; German Cancer Research Center (DKFZ); University of Santo Tomas; University of Santo Tomas; University of Santo Tomas	Albano, PM (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany.; Albano, PM (corresponding author), Univ Santo Tomas, Coll Sci, Dept Biol, Manila, Philippines.; Albano, PM (corresponding author), Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines.	psalbano@ust.edu.ph	Orosa, José A./D-9782-2012; Holzinger, Dana/I-3437-2013; Schmitt, Markus/B-6410-2008	Orosa, José A./0000-0002-8384-908X; Schmitt, Markus/0000-0002-7827-6694; Ramos, John Donnie/0000-0002-1404-4093; Pawlita, Michael/0000-0002-4720-8306	DKFZ; Roche; Qiagen	DKFZ(Helmholtz Association); Roche(Roche Holding); Qiagen	MP and MS have received royalties for patents owned by DKFZ and research support through cooperation contracts of DKFZ with Roche and Qiagen in the field of HPV diagnostics. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alechnowicz K, 2004, TOB CONTROL, V13, P71, DOI 10.1136/tc.2004.009324; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; Bahl A, 2014, HEAD NECK-J SCI SPEC, V36, P505, DOI 10.1002/hed.23317; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Boscolo-Rizzo P, 2013, ACTA OTORHINOLARYNGO, V33, P77; Chaturvedi AK, 2012, HEAD NECK PATHOL S1, V6, pS16, DOI [DOI 10.1007/s12105-012-0377-0, 10.1007/s12105-012-0377-0]; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; DSouza G, 2014, PLOS ONE, V9, P19; Evans M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-220; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Francoeur Robert T., 2004, CONTINUUM COMPLETE I, P834; Gerein V, 2005, OTOLARYNG HEAD NECK, V132, P392, DOI 10.1016/j.otohns.2004.09.035; Gheit T, 2014, J MED VIROL, V86, P642, DOI 10.1002/jmv.23866; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Halec G, 2013, INT J CANCER, V132, P63, DOI 10.1002/ijc.27605; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Hernandez BY, 2014, PLOS ONE, V9, P1; Holzinger D, 2012, CANCER RES, V72, P4993, DOI 10.1158/0008-5472.CAN-11-3934; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Huebbers CU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057207; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; Lee LA, 2008, LARYNGOSCOPE, V118, P50, DOI 10.1097/MLG.0b013e318155a288; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mehanna H, 2010, BMJ-BRIT MED J, V341, P663, DOI DOI 10.1136/BMJ.C4684; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Ndiaye C, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-14; Ngelangel CA, 2002, JPN J CLIN ONCOL, V32, pS52, DOI 10.1093/jjco/hye126; Oga EA, 2016, PLOS ONE, P1; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Rodrigo JP, 2014, INT J CANCER, V134, P487, DOI 10.1002/ijc.28355; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2013, INT J CANCER, V132, P2395, DOI 10.1002/ijc.27891; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003; Sudhoff HH, 2011, EUR ARCH OTO-RHINO-L, V268, P1541, DOI 10.1007/s00405-011-1714-8; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; van Monsjou HS, 2013, ORAL ONCOL, V49, P1097, DOI 10.1016/j.oraloncology.2013.09.001; Villa LL, 2006, INT J GYNECOL OBSTET, V94, pS71, DOI 10.1016/S0020-7292(07)60013-7	50	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172240	10.1371/journal.pone.0172240	http://dx.doi.org/10.1371/journal.pone.0172240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199413	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400084
J	D'Elia, L; Cappuccio, FP; Iacone, R; Russo, O; Galletti, F; Strazzullo, P				D'Elia, Lanfranco; Cappuccio, Francesco P.; Iacone, Roberto; Russo, Ornella; Galletti, Ferruccio; Strazzullo, Pasquale			Altered renal sodium handling and risk of incident hypertension: Results of the Olivetti Heart Study	PLOS ONE			English	Article							BLOOD-PRESSURE RESPONSE; ADDUCIN POLYMORPHISM; METABOLIC SYNDROME; MEN; REABSORPTION; ALDOSTERONE; SENSITIVITY; EXCRETION	Renal tubular sodium (Na) handling plays a key role in blood pressure (BP) regulation. Several cross-sectional studies reported a positive association between higher proximal tubule fractional reabsorption of Na and BP, but no prospective investigation has been reported of this possible association. Hence, the purpose of this study was to estimate the predictive role of renal Na handling on the risk of incident hypertension and the changes in BP occurring in the 8-year follow-up observation of a sample of initially normotensive men (The Olivetti Heart Study). The study included 294 untreated normotensive non-diabetic men with normal renal function examined twice (1994-95 and 2002-04). Renal tubular Na handling was estimated by exogenous lithium clearance. Fractional reabsorption of Na in proximal and distal tubules was calculated and included in the analysis. At baseline, there was no association between BP and either proximal or distal fractional reabsorption of Na. At the end of the 8-year follow-up, direct associations were observed between baseline proximal (but not distal) Na fractional reabsorption and the changes occurred in systolic and diastolic BP over time (+2.79 and +1.53 mmHg, respectively, per 1SD difference in proximal Na-FR; p<0.01). Also multivariable analysis showed a direct association between baseline proximal Na fractional reabsorption and risk of incident hypertension, independently of potential confounders (OR: 1.34, 95%Cl: 1.06-1.70). The results of this prospective investigation strongly suggest a causal relationship between an enhanced rate of Na reabsorption in the proximal tubule and the risk of incident hypertension in initially normotensive men.	[D'Elia, Lanfranco; Iacone, Roberto; Russo, Ornella; Galletti, Ferruccio; Strazzullo, Pasquale] Univ Naples Federico II, Dept Clin Med & Surg, ESH Excellence Ctr Hypertens, Sch Med, Naples, Italy; [Cappuccio, Francesco P.] Univ Warwick, Div Hlth Sci, WHO Collaborating Ctr Nutr, Coventry, W Midlands, England	University of Naples Federico II; University of Warwick	D'Elia, L (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, ESH Excellence Ctr Hypertens, Sch Med, Naples, Italy.	lanfranco.delia@unina.it	Iacone, Roberto/M-2867-2016; D'Elia, Lanfranco/U-6499-2017	Iacone, Roberto/0000-0003-3360-3855; Galletti, Ferruccio/0000-0001-7556-0254; D'Elia, Lanfranco/0000-0002-1782-0211				Barba G, 1996, HYPERTENSION, V27, P1160, DOI 10.1161/01.HYP.27.5.1160; Barba G, 2007, J HYPERTENS, V25, P1465, DOI 10.1097/HJH.0b013e3281139ebd; Barbato A, 2004, DIABETOLOGIA, V47, P40, DOI 10.1007/s00125-003-1260-z; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; CAPPUCCIO FP, 1991, EUR J CLIN INVEST, V21, P40, DOI 10.1111/j.1365-2362.1991.tb01356.x; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; D'Elia L, 2014, EUR J PUBLIC HEALTH, V24, P226, DOI 10.1093/eurpub/ckt041; Galletti F, 2008, J CLIN ENDOCR METAB, V93, P3922, DOI 10.1210/jc.2008-1280; Glorioso N, 1999, HYPERTENSION, V34, P649, DOI 10.1161/01.HYP.34.4.649; Goldring W, 1941, J CLIN INVEST, V20, P637, DOI 10.1172/JCI101257; GUYTON AC, 1990, HYPERTENSION, V16, P725, DOI 10.1161/01.HYP.16.6.725; HOLLENBERG NK, 1976, AM J MED, V60, P773, DOI 10.1016/0002-9343(76)90891-3; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Luft FC, 2002, SEMIN NEPHROL, V22, P115, DOI 10.1053/snep.2002.30211; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Manunta P, 1999, HYPERTENSION, V33, P694, DOI 10.1161/01.HYP.33.2.694; Meneton P, 2001, SEMIN NEPHROL, V21, P81, DOI 10.1053/snep.2001.21210; Pruijm M, 2010, NEPHROL DIAL TRANSPL, V25, P2225, DOI 10.1093/ndt/gfq008; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; Royston P, 1992, STATA TECHNICAL B RE, V2, P112; Siani A, 2004, HYPERTENSION, V43, P598, DOI 10.1161/01.HYP.0000117985.57001.b3; Strazzullo P, 2003, HYPERTENSION, V41, P1000, DOI 10.1161/01.HYP.0000066844.63035.3A; Strazzullo P, 2001, J HYPERTENS, V19, P2157, DOI 10.1097/00004872-200112000-00007; STRAZZULLO P, 1988, CLIN SCI, V74, P651, DOI 10.1042/cs0740651; Strazzullo P, 2001, J MOL MED, V79, P574, DOI 10.1007/s001090100257; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; ULICK S, 1977, J CLIN ENDOCR METAB, V44, P799, DOI 10.1210/jcem-44-4-799; WHO, 2012, WORLD HEAL ORGAN, P1	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171973	10.1371/journal.pone.0171973	http://dx.doi.org/10.1371/journal.pone.0171973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196131	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900039
J	DeLellis, P; DiMeglio, A; Garofalo, F; Lo Iudice, F				DeLellis, Pietro; DiMeglio, Anna; Garofalo, Franco; Lo Iudice, Francesco			The evolving cobweb of relations among partially rational investors	PLOS ONE			English	Article							COMPLEX NETWORKS; HERD BEHAVIOR; SOCIAL NETWORKS; MARKET; MODEL; FLUCTUATIONS; DYNAMICS; SYSTEMS	To overcome the limitations of neoclassical economics, researchers have leveraged tools of statistical physics to build novel theories. The idea was to elucidate the macroscopic features of financial markets from the interaction of its microscopic constituents, the investors. In this framework, the model of the financial agents has been kept separate from that of their interaction. Here, instead, we explore the possibility of letting the interaction topology emerge from the model of the agents' behavior. Then, we investigate how the emerging cobweb of relationship affects the overall market dynamics. To this aim, we leverage tools from complex systems analysis and nonlinear dynamics, and model the network of mutual influence as the output of a dynamical system describing the edge evolution. In this work, the driver of the link evolution is the relative reputation between possibly coupled agents. The reputation is built differently depending on the extent of rationality of the investors. The continuous edge activation or deactivation induces the emergence of leaders and of peculiar network structures, typical of real influence networks. The subsequent impact on the market dynamics is investigated through extensive numerical simulations in selected scenarios populated by partially rational investors.	[DeLellis, Pietro; DiMeglio, Anna; Garofalo, Franco; Lo Iudice, Francesco] Univ Naples Federico II, Dept Elect Engn & Informat Technol, Naples, Italy	University of Naples Federico II	DeLellis, P (corresponding author), Univ Naples Federico II, Dept Elect Engn & Informat Technol, Naples, Italy.	pietro.delellis@unina.it	Garofalo, Franco/J-7666-2013; DE LELLIS, Pietro/N-3928-2019	DE LELLIS, Pietro/0000-0002-2656-6454				Arthur WB, 1999, SCIENCE, V284, P107, DOI 10.1126/science.284.5411.107; Batista JD, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-50645-1; Bentley RA, 2014, EVOL HUM BEHAV, V35, P257, DOI 10.1016/j.evolhumbehav.2014.02.001; Bentley RA, 2011, BEHAV ECOL SOCIOBIOL, V65, P537, DOI 10.1007/s00265-010-1102-1; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonanno G, 2004, EUR PHYS J B, V38, P363, DOI 10.1140/epjb/e2004-00129-6; Brennan TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050310; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chakraborti A, 2011, QUANT FINANC, V11, P1013, DOI 10.1080/14697688.2010.539249; Cont R, 2000, MACROECON DYN, V4, P170; Curty P, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/03/P03013; DeLellis P, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/8/083003; DeLellis P, 2010, APPL MATH COMPUT, V217, P988, DOI 10.1016/j.amc.2010.01.126; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; Ehrhardt GCMA, 2006, PHYS REV E, V74, P1; ERDOS P, 1960, B INT STATIST INST, V38, P343; Estrada E, 2006, EUR PHYS J B, V52, P563, DOI 10.1140/epjb/e2006-00330-7; Farmer JD, 2012, EUR PHYS J-SPEC TOP, V214, P295, DOI 10.1140/epjst/e2012-01696-9; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Galbiati M, 2013, NAT PHYS, V9, P126, DOI 10.1038/nphys2581; Galbiati M, 2011, J ECON DYN CONTROL, V35, P859, DOI 10.1016/j.jedc.2010.11.001; Gilbert N., 2008, AGENT BASED MODELS; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Hall RE, 1995, FLAT TAX, V423; Hanke M, 2010, J ECON BEHAV ORGAN, V74, P58, DOI 10.1016/j.jebo.2010.02.004; Hirshleifer D., 2003, EUR FINANC MANAG, V9, P25, DOI DOI 10.1111/1468-036X.00207; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Holme P, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60657-4; Holme P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04999; Hommes C. H., 2001, Quantitative Finance, V1, P149, DOI 10.1088/1469-7688/1/1/311; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Khashanah K, 2016, COMPLEXITY, V21, P530, DOI 10.1002/cplx.21834; Lebaron B, 2006, HANDB ECON, V13, P1187; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; PALMER RG, 1994, PHYSICA D, V75, P264, DOI 10.1016/0167-2789(94)90287-9; Pan YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094998; Pincus S, 2004, P NATL ACAD SCI USA, V101, P13709, DOI 10.1073/pnas.0405168101; Raberto M, 2001, PHYSICA A, V299, P319, DOI 10.1016/S0378-4371(01)00312-0; Rivera MT, 2010, ANNU REV SOCIOL, V36, P91, DOI 10.1146/annurev.soc.34.040507.134743; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; Saramaki J, 2015, EUR PHYS J B, V88, DOI [10.1140/epjb/e2015-60106-6, 10.1140/epjb/e2015-60660-9]; Schleussner CF, 2016, SCI REPORTS, V6, P1; Schweitzer F, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026113; Shiller RJ, 2003, J ECON PERSPECT, V17, P83, DOI 10.1257/089533003321164967; Singer HM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026113; Stanley HE, 1996, PHYSICA A, V224, P302, DOI 10.1016/0378-4371(95)00409-2; Tesfatsion L, 2003, INFORM SCIENCES, V149, P263, DOI 10.1016/S0020-0255(02)00280-3; Toth B, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021006; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Uchida H, 2007, J FINANC INTERMED, V16, P555, DOI 10.1016/j.jfi.2007.03.007; Voit J., 2005, STAT MECH FINANCIAL; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	60	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171891	10.1371/journal.pone.0171891	http://dx.doi.org/10.1371/journal.pone.0171891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	28196144	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900037
J	Rodil, IF; Lucena-Moya, P; Jokinen, H; Ollus, V; Wennhage, H; Villnas, A; Norkko, A				Rodil, Ivan F.; Lucena-Moya, Paloma; Jokinen, Henri; Ollus, Victoria; Wennhage, Hakan; Villnas, Anna; Norkko, Alf			The role of dispersal mode and habitat specialization for metacommunity structure of shallow beach invertebrates	PLOS ONE			English	Article							AQUATIC MACROINVERTEBRATES; DIVERSITY; MARINE; EUTROPHICATION; HETEROGENEITY; CONNECTIVITY; GENERALISTS; ASSEMBLAGES; SPECIALISTS; DURATION	Metacommunity ecology recognizes the interplay between local and regional patterns in contributing to spatial variation in community structure. In aquatic systems, the relative importance of such patterns depends mainly on the potential connectivity of the specific system. Thus, connectivity is expected to increase in relation to the degree of water movement, and to depend on the specific traits of the study organism. We examined the role of environmental and spatial factors in structuring benthic communities from a highly connected shallow beach network using a metacommunity approach. Both factors contributed to a varying degree to the structure of the local communities suggesting that environmental filters and dispersal-related mechanisms played key roles in determining abundance patterns. We categorized benthic taxa according to their dispersal mode (passive vs. active) and habitat specialization (generalist vs. specialist) to understand the relative importance of environment and dispersal related processes for shallow beach metacommunities. Passive dispersers were predicted by a combination of environmental and spatial factors, whereas active dispersers were not spatially structured and responded only to local environmental factors. Generalists were predicted primarily by spatial factors, while specialists were only predicted by local environmental factors. The results suggest that the role of the spatial component in metacommunity organization is greater in open coastal waters, such as shallow beaches, compared to less-connected environmentally controlled aquatic systems. Our results also reveal a strong environmental role in structuring the benthic metacommunity of shallow beaches. Specifically, we highlight the sensitivity of shallow beach macrofauna to environmental factors related to eutrophication proxies.	[Rodil, Ivan F.; Lucena-Moya, Paloma; Jokinen, Henri; Ollus, Victoria; Villnas, Anna; Norkko, Alf] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Rodil, Ivan F.; Norkko, Alf] Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden; [Wennhage, Hakan] Swedish Univ Agr Sci, Havsfiskelab, Uppsala, Sweden	University of Helsinki; Stockholm University; Swedish University of Agricultural Sciences	Rodil, IF (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.; Rodil, IF (corresponding author), Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden.	ivan.rodil@helsinki.fi	Norkko, Alf/A-1856-2012; Norkko, Alf/L-8736-2019; Norkko, Alf/K-2341-2019; Rodil, Iván F./I-5305-2013; Jokinen, Henri/GQY-4490-2022	Norkko, Alf/0000-0002-9741-4458; Norkko, Alf/0000-0002-9741-4458; Rodil, Iván F./0000-0001-6375-1598; Jokinen, Henri/0000-0001-7617-7820; Villnas, Anna/0000-0003-3077-929X; Wennhage, Hakan/0000-0001-9631-5688; Lucena-Moya, Paloma/0000-0002-8095-7552; Ollus, Victoria Marja Sofia/0000-0002-3633-9079	Walter et Andree de Nottbeck Foundation; Svenska Kulturfonden [12/2258, 13/3919, 12/7244-1292]; Maj and Tor Nessling Foundation [2014322]; University of Helsinki; Stockholm University	Walter et Andree de Nottbeck Foundation; Svenska Kulturfonden; Maj and Tor Nessling Foundation; University of Helsinki; Stockholm University	This work was supported by the Walter et Andree de Nottbeck Foundation and Svenska Kulturfonden (grant numbers: 12/2258; 13/3919) as part of the PhD-work of HJ; The Maj and Tor Nessling Foundation (2014322) and Svenska Kulturfonden (12/7244-1292) supported AV; Strategic funding for collaboration between University of Helsinki and Stockholm University supported IFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bekkby T, 2008, MAR GEOD, V31, P117, DOI 10.1080/01490410802053674; Bendtsen J, 2013, ECOL MODEL, V264, P17, DOI 10.1016/j.ecolmodel.2012.06.018; Berglund J, 2003, ESTUAR COAST SHELF S, V56, P1167, DOI 10.1016/S0272-7714(02)00326-8; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bonsdorff E, 1997, ESTUAR COAST SHELF S, V44, P63, DOI 10.1016/S0272-7714(97)80008-X; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bostrom C, 2002, ESTUAR COAST SHELF S, V55, P795, DOI 10.1006/ecss.2001.0943; Canedo-Arguelles M, 2015, J BIOGEOGR, V42, P778, DOI 10.1111/jbi.12457; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Conley DJ, 2011, ENVIRON SCI TECHNOL, V43, P3412; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Donohue I, 2009, ECOLOGY, V90, P3470, DOI 10.1890/09-0415.1; Fleming-Lehtinen V, 2012, ESTUAR COAST SHELF S, V102, P1, DOI 10.1016/j.ecss.2012.02.015; Gascon S, 2016, OECOLOGIA, V181, P193, DOI 10.1007/s00442-015-3540-y; Gothe E, 2013, J ANIM ECOL, V82, P449, DOI 10.1111/1365-2656.12004; Grainger TN, 2016, OIKOS, V125, P1213, DOI 10.1111/oik.03018; Grantham BA, 2003, ECOL APPL, V13, pS108; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Guizien K, 2012, LIMNOL OCEANOGR, V57, P1099, DOI 10.4319/lo.2012.57.4.1099; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Heino J, 2013, ECOL EVOL, V3, P344, DOI 10.1002/ece3.470; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Horsak M, 2015, J BIOGEOGR, V42, P2112, DOI 10.1111/jbi.12569; Jokinen H, 2016, J SEA RES, V107, P67, DOI 10.1016/j.seares.2015.06.002; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Karna OM, 2015, J ANIM ECOL, V84, P1342, DOI 10.1111/1365-2656.12397; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levins R., 1968, EVOLUTION CHANGING E; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norkko A, 2001, MAR ECOL PROG SER, V212, P131, DOI 10.3354/meps212131; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peres-Neto PR, 2012, ECOLOGY, V93, pS14, DOI 10.1890/11-0494.1; Pilditch CA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0795; R Core Team, 2021, R LANGUAGE ENV STAT; Radkova V, 2014, FRESHWATER BIOL, V59, P2256, DOI 10.1111/fwb.12428; Reed DC, 2000, ECOLOGY, V81, P2011; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Snickars M, 2015, MAR BIOL, V162, P141, DOI 10.1007/s00227-014-2579-3; Tornroos A, 2012, ECOL APPL, V22, P2221; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Valanko S, 2015, ECOL EVOL, V5, P5203, DOI 10.1002/ece3.1767; Valanko S, 2010, J EXP MAR BIOL ECOL, V384, P51, DOI 10.1016/j.jembe.2009.12.012; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; van Noordwijk CGE, 2015, ECOLOGY, V96, P518, DOI 10.1890/14-0082.1; Vanschoenwinkel B, 2007, OIKOS, V116, P1255, DOI 10.1111/j.2007.0030-1299.15860.x; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Villnas A, 2013, ECOLOGY, V94, P2275, DOI 10.1890/12-1716.1; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376	62	18	19	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172160	10.1371/journal.pone.0172160	http://dx.doi.org/10.1371/journal.pone.0172160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196112	Green Published, gold			2022-12-26	WOS:000394423900059
J	Dai, RJ; Cowan, C; Heid, B; Khan, D; Liang, ZH; Pham, CTN; Ahmed, SA				Dai, Rujuan; Cowan, Catharine; Heid, Bettina; Khan, Deena; Liang, Zhihong; Pham, Christine T. N.; Ahmed, S. Ansar			Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice	PLOS ONE			English	Article							INTERFERON-GAMMA; CELL-DIFFERENTIATION; AUTOIMMUNE-DISEASES; MENSTRUAL-CYCLE; T-LYMPHOCYTES; NITRIC-OXIDE; CATHEPSIN-G; IN-VIVO; B-CELLS; 17-BETA-ESTRADIOL	Estrogen, a natural immunomodulator, regulates the development and function of diverse immune cell types. There is now renewed attention on neutrophils and neutrophil serine proteases (NSPs) such as neutrophil elastase (NE), proteinase 3 (PR3), and cathepsin G (CG) in inflammation and autoimmunity. In this study, we found that although estrogen treatment significantly reduced total splenocytes number, it markedly increased the splenic neutrophil absolute numbers in estrogen-treated C57BL/6 (B6) mice when compared to placebo controls. Concomitantly, the levels of NSPs and myeloperoxidase (MPO) were highly upregulated in the splenocytes from estrogen-treated mice. Despite the critical role of NSPs in the regulation of non-infectious inflammation, by employing NE-/-/PR3(-/-)/CG(-/-) triple knock out mice, we demonstrated that the absence of NSPs affected neither estrogen's ability to increase splenic neutrophils nor the induction of inflammatory mediators (IFN gamma, IL-1 beta, IL-6, TNF alpha, MCP-1, and NO) from ex vivo activated splenocytes. Depletion of neutrophils in vitro in splenocytes with anti-Ly6G antibody also had no obvious effect on NSP expression or LPS-induced IFN gamma and MCP-1. These data suggest that estrogen augments NSPs, which appears to be independent of enhancing ex vivo inflammatory responses. Since estrogen has been implicated in regulating several experimental autoimmune diseases, we extended our observations in estrogen-treated B6 mice to spontaneous autoimmune-prone female MRL-lpr, B6-lpr and NZB/W-F1 mice. There was a remarkable commonality with regards to the increase of neutrophils and concomitant increase of NSPs and MPO in the splenic cells of different strains of autoimmune-prone mice and estrogen-treated B6 mice. Collectively, since NSPs and neutrophils are involved in diverse pro-inflammatory activities, these data suggest a potential pathologic implication of increased neutrophils and NSPs that merits further investigation.	[Dai, Rujuan; Cowan, Catharine; Heid, Bettina; Khan, Deena; Liang, Zhihong; Ahmed, S. Ansar] Virginia Tech, IDRF, Dept Biomed Sci & Pathobiol, VMCVM, Blacksburg, VA 24061 USA; [Pham, Christine T. N.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Liang, Zhihong] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Safety & Mol Biol, Beijing, Peoples R China	Virginia Polytechnic Institute & State University; Washington University (WUSTL); China Agricultural University	Ahmed, SA (corresponding author), Virginia Tech, IDRF, Dept Biomed Sci & Pathobiol, VMCVM, Blacksburg, VA 24061 USA.	ansrahmd@vt.edu			National Institutes of Health (NIH) [5 RO1 AI051880]; NIH [AI049261, AI051436]; Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech's Open Access Subvention Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the grants from National Institutes of Health (NIH, 5 RO1 AI051880) and Interdepartmental Fund to SAA. The generation of NSP triple knock out mouse model was support by the grants from NIH (AI049261 and AI051436) to CP. The publication fee for this article is supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; AHMED SA, 1989, J IMMUNOL, V142, P2647; Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; BAIN BJ, 1975, BRIT MED J, V2, P473, DOI 10.1136/bmj.2.5969.473; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Blesson CS, 2011, UPDATE MECH HORMONE; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Calippe B, 2008, J IMMUNOL, V180, P7980, DOI 10.4049/jimmunol.180.12.7980; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; CRANDALL TL, 1980, J LAB CLIN MED, V95, P857; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dietsch V, 1996, RECEPT SIGNAL TRANS, V6, P63; GAUNT SD, 1985, VET PATHOL, V22, P403, DOI 10.1177/030098588502200416; Grimaldi CM, 2005, MOL IMMUNOL, V42, P811, DOI 10.1016/j.molimm.2004.05.014; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; JILKA RL, 1995, EXP HEMATOL, V23, P500; Karpuzoglu E, 2006, ENDOCRINOLOGY, V147, P662, DOI 10.1210/en.2005-0829; Karpuzoglu-Sahin E, 2001, J REPROD IMMUNOL, V52, P113, DOI 10.1016/S0165-0378(01)00117-6; Khan D, 2012, ADV NEUROIMMUNE BIOL, V3, P73, DOI 10.3233/NIB-2012-012039; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Lengi AJ, 2007, J LEUKOCYTE BIOL, V81, P1065, DOI 10.1189/jlb.0606391; MATHUR S, 1979, CLIN IMMUNOL IMMUNOP, V13, P246, DOI 10.1016/0090-1229(79)90069-2; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Molloy EJ, 2003, BLOOD, V102, P2653, DOI 10.1182/blood-2003-02-0649; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Robinson DP, 2014, J VIROL, V88, P4711, DOI 10.1128/JVI.02081-13; Salem Mohamed Labib, 2004, Current Drug Targets - Inflammation and Allergy, V3, P97, DOI 10.2174/1568010043483944; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Suzuki M, 2011, INT J ENDOCRINOL MET, V9, P347, DOI 10.5812/Kowsar.1726913X.2246; Tillack K, 2012, J IMMUNOL, V188, P3150, DOI 10.4049/jimmunol.1103414; Verthelyi DI, 1998, CELL IMMUNOL, V189, P125, DOI 10.1006/cimm.1998.1372; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Yan HM, 2016, ARTERIOSCL THROM VAS, V36, P1660, DOI 10.1161/ATVBAHA.116.307786; [No title captured]	45	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172105	10.1371/journal.pone.0172105	http://dx.doi.org/10.1371/journal.pone.0172105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192517	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800068
J	Huang, XB; Tang, WW; Liu, Y; Hu, R; Ouyang, LY; Liu, JX; Li, XJ; Yi, YJ; Wang, TD; Zhao, SP				Huang, Xiao-bo; Tang, Wei-wei; Liu, Ya; Hu, Rong; Ouyang, Ling-yun; Liu, Jian-xiong; Li, Xiu-jun; Yi, Yan-jing; Wang, Tzung-Dau; Zhao, Shui-ping			Prevalence of diabetes and unrecognized diabetes in hypertensive patients aged 40 to 79 years in southwest China	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; HYPERGLYCEMIA; WOMEN; RISK; MEN	This study aimed to assess the prevalence of diabetes and unrecognized diabetes in hypertensive patients aged 40 to 79 years in Southwest China. From September 2013 to March 2014, a cross-sectional survey was conducted in 4021 hypertensive patients aged 40 to 79 years living in Chengdu and Chongqing, China. Fasting plasma glucose (FPG) and 2h plasma glucose (2-hPG) in an oral glucose-tolerance test (OGTT) were used for assessments. Whether the patients previously had diabetes (DM) was determined by their own reports. The survey was carried out by the same questionnaire for all respondents. DM prevalence was 32.0% in hypertensive patients aged 40 to 79 years in Southwest China, with the rates of 29.6% and 33.5% in men and women, respectively (P<0.001). DM prevalence increased with age age and body-mass index. DM prevalence rates were 16.9%, 24.7%, 38.2% and 41.9% in hypertensive patients aged 40-49, 50-59, 60-69 and over 70, respectively. DM prevalence were 30.6%, 27.9%, 37.1%, and 37.4%, for BMI<18.5, 18.5-24.9, 25.0-29.9, and >= 30, respectively. Prevalence of unrecognized DM were 20.8% in hypertensive patients aged 40 to 79 years in Southwest China. Using only fasting blood glucose testing without OGTT would have resulted in 65.0% of missed DM diagnosis in these newly diagnosed patients. The prevalence of DM and unrecognized DM were high in hypertensive patients aged 40 to 79 years in Southwest China. These findings indicate that hypertensive patients aged 40 to 79 years should regularly submit to community-based OGTT screening for timely DM diagnosis.	[Huang, Xiao-bo; Zhao, Shui-ping] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China; [Huang, Xiao-bo; Liu, Ya; Liu, Jian-xiong; Yi, Yan-jing] Second Peoples Hosp Chengdu, Dept Cardiol, Chengdu, Sichuan Provinc, Peoples R China; [Tang, Wei-wei] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan Provinc, Peoples R China; [Hu, Rong] Chongqing Med Univ, Div Cardiol, Affiliated Hosp 2, Chongqing, Peoples R China; [Ouyang, Ling-yun] Second Peoples Hosp Chengdu, Dept Endocrinol & Metab, Chengdu, Sichuan Provinc, Peoples R China; [Li, Xiu-jun] Sichuan Univ, Dept Endocrinol & Metab, West China Hosp, Chengdu, Peoples R China; [Wang, Tzung-Dau] Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan	Central South University; Sichuan University; Chongqing Medical University; Sichuan University; National Taiwan University; National Taiwan University Hospital	Zhao, SP (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China.; Wang, TD (corresponding author), Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	tdwang@ntu.edu.tw; shuipingzhao@126.com	YI, YAN/GUS-2240-2022; li, xiu/GXV-1745-2022	WANG, TZUNG-DAU/0000-0002-7180-3607	Szechwan Province Science and Technology Agency Fund Project, Chengdu [2009FZ 0027]; China and Population and health project of Chengdu Municipal Science and Technology Bureau, Chengdu, China [10YTYB272SF-182]	Szechwan Province Science and Technology Agency Fund Project, Chengdu; China and Population and health project of Chengdu Municipal Science and Technology Bureau, Chengdu, China	This research was supported by the Szechwan Province Science and Technology Agency Fund Project (2009FZ 0027), Chengdu, China and Population and health project of Chengdu Municipal Science and Technology Bureau (10YTYB272SF-182), Chengdu, China.	[Anonymous], IDF CONS WORLDW DEF; [Anonymous], 1998, CLIN GUID ID EV TREA; Arauz-Pacheco C, 2004, DIABETES CARE S1, V27, P65; Bakris George L., 1999, J Clin Hypertens (Greenwich), V1, P141; Bakris George L, 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251.49515.c2, DOI 10.1161/01.HYP.0000107251.49515.C2]; Barrett-Connor E, 1998, DIABETES CARE, V21, P1236, DOI 10.2337/diacare.21.8.1236; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Garcia-Puig J, 2006, AM J MED, V119, P318, DOI 10.1016/j.amjmed.2005.09.010; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gu P, 2012, CLIN EXP HYPERTENS, V34, P474, DOI 10.3109/10641963.2012.666601; Jiang P, 2015, CLIN EXP RHEUMATOL, V33, P115; Jiang Y.-Y., 2015, SHOCK VIB, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0130400; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Liu J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003798; Liu XX, 2014, ANN NUTR METAB, V65, P324, DOI 10.1159/000365892; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; OUYANG LY, 2009, CHIN J DIABETES MELL, V1, P282; Qin XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042538; Rose G A, 1968, Monogr Ser World Health Organ, V56, P1; Tseng CC, 2016, JOINT BONE SPINE, V83, P307, DOI 10.1016/j.jbspin.2015.06.017; Ursini F, 2016, JOINT BONE SPINE, V83, P611, DOI 10.1016/j.jbspin.2016.07.006; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; Ursini F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000888; Ursini F, 2010, AUTOIMMUN REV, V9, P536, DOI 10.1016/j.autrev.2009.12.014; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170250	10.1371/journal.pone.0170250	http://dx.doi.org/10.1371/journal.pone.0170250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192474	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800008
J	Aluksanasuwan, S; Sueksakit, K; Fong-Ngern, K; Thongboonkerd, V				Aluksanasuwan, Siripat; Sueksakit, Kanyarat; Fong-ngern, Kedsarin; Thongboonkerd, Visith			Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress	FASEB JOURNAL			English	Article						chaperone; chaperonin; diabetic nephropathy; diabetic tubulopathy; high glucose	MONOHYDRATE CRYSTAL ADHESION; HIGH GLUCOSE-CONCENTRATIONS; PROTEOMIC-ANALYSIS; MESANGIAL CELLS; MOLECULAR CHAPERONES; MITOCHONDRIAL HSP60; CARDIAC MYOCYTES; ALTERED PROTEINS; MAMMALIAN-CELLS; PROXIMAL TUBULE	Because underlying mechanisms of diabetic nephropathy/tubulopathy remained poorly understood, we aimed to define a key protein involving in hyperglycemia-induced renal tubular dysfunction. All altered renal proteins identified from previous large-scale proteome studies were subjected to global protein network analysis, which revealed heat shock protein 60 (HSP60, also known as HSPD1) as the central node of protein-protein interactions. Functional validation was performed using small interfering RNA (siRNA) to knock down HSP60 (siHSP60). At 48 h after exposure to high-glucose (HG) (25 mM), Madin-Darby canine kidney (MDCK) renal tubular cells transfected with controlled siRNA (siControl) had significantly increased level of HSP60 compared to normal-glucose (NG) (5.5 mM), whereas siHSP60-transfected cells showed a dramatically decreased HSP60 level. siHSP60 modestly increased intracellular protein aggregates in both NG and HG conditions. Luciferin-luciferase assay showed that HG modestly increased intracellular ATP, and siHSP60 further enhanced such an increase. OxyBlot assay showed significantly increased level of oxidized proteins in HG-treated siControl-transfected cells, whereas siHSP60 caused marked increase of oxidized proteins under the NG condition. However, the siHSP60-induced accumulation of oxidized proteins was abolished by HG. In summary, our data demonstrated that HSP60 plays roles in regulation of intracellular protein aggregation, ATP production, and oxidative stress in renal tubular cells. Its involvement in HG-induced tubular cell dysfunction was most likely via regulation of intracellular ATP production.-Aluksanasuwan, S., Sueksakit, K., Fong-ngern, K., Thongboonkerd, V. Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress	Mahidol Univ, Fac Med, Siriraj Hosp, Med Prote Unit,Off Res & Dev, Bangkok, Thailand; Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Med Prote Unit, Off Res & Dev, Siriraj Hosp, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009; Aluksanasuwan, Siripat/AAS-5223-2021	Thongboonkerd, Visith/0000-0001-7865-0765; Aluksanasuwan, Siripat/0000-0002-3542-5880	Mahidol University; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Thailand Research Fund [RTA5680004, IRG5980006]; Siriraj Hospital Faculty of Medicine; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund [PHD/0084/2553]	Mahidol University; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); Siriraj Hospital Faculty of Medicine; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by a Mahidol University research grant, the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, and by the Thailand Research Fund (RTA5680004 and IRG5980006). V.T. was also supported by Chalermphrakiat and Research Staff grants from the Siriraj Hospital Faculty of Medicine. S.A. was supported by the Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund (PHD/0084/2553).	Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Barati MT, 2007, AM J PHYSIOL-RENAL, V293, pF1157, DOI 10.1152/ajprenal.00411.2006; Barutta F, 2008, AM J PHYSIOL-RENAL, V295, pF1817, DOI 10.1152/ajprenal.90234.2008; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738; Cornelius C, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-15; Cummins TD, 2010, BBA-PROTEINS PROTEOM, V1804, P653, DOI 10.1016/j.bbapap.2009.09.029; Fan QL, 2011, AM J NEPHROL, V34, P18, DOI 10.1159/000328733; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Fugmann T, 2011, KIDNEY INT, V80, P272, DOI 10.1038/ki.2011.116; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Gong DM, 2009, PROTEOMICS, V9, P4309, DOI 10.1002/pmic.200900285; Gonzalez-Ramos M, 2016, INT J BIOCHEM CELL B, V71, P119, DOI 10.1016/j.biocel.2015.12.013; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Han HJ, 2000, KIDNEY INT, V57, P918, DOI 10.1038/sj.ki.4491414; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; Kanlaya R, 2013, J PROTEOMICS, V80, P55, DOI 10.1016/j.jprot.2013.01.001; Karaagac N, 2011, ENDOCR RES, V36, P124, DOI 10.3109/07435800.2011.566237; Kenyon WJ, 2002, MICROBIOL-SGM, V148, P113, DOI 10.1099/00221287-148-1-113; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Li BY, 2008, J CELL BIOCHEM, V104, P668, DOI 10.1002/jcb.21658; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; Li ZG, 2010, BIOCHEM CELL BIOL, V88, P635, DOI 10.1139/O09-185; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Macario AJL, 2007, FRONT BIOSCI-LANDMRK, V12, P2588, DOI 10.2741/2257; Magnoni R, 2014, FREE RADICAL RES, V48, P168, DOI 10.3109/10715762.2013.858147; Magnoni R, 2013, NEUROBIOL DIS, V54, P12, DOI 10.1016/j.nbd.2013.02.012; Oksala NKJ, 2007, ANTIOXID REDOX SIGN, V9, P497, DOI 10.1089/ars.2006.1450; Peerapen P, 2016, BBA-PROTEINS PROTEOM, V1864, P683, DOI 10.1016/j.bbapap.2016.03.007; Phillips AO, 1997, KIDNEY INT, V52, P973, DOI 10.1038/ki.1997.419; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schordan S, 2009, PROTEOMICS, V9, P4519, DOI 10.1002/pmic.200800214; Semangoen T, 2008, PROTEOM CLIN APPL, V2, P1099, DOI 10.1002/prca.200780136; Semangoen T, 2008, J PROTEOME RES, V7, P2889, DOI 10.1021/pr800113k; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Singh LP, 2007, INT J BIOL SCI, V3, P27; So EJ, 2008, PROTEOM CLIN APPL, V2, P1118, DOI 10.1002/prca.200780151; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Thongboonkerd V, 2004, J AM SOC NEPHROL, V15, P650, DOI 10.1097/01.ASN.0000115334.65095.9B; Thongboonkerd V, 2008, J PROTEOME RES, V7, P4689, DOI 10.1021/pr8002408; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Xiao HB, 2012, AM J PHYSIOL-RENAL, V303, pF757, DOI 10.1152/ajprenal.00470.2011; Zhang DJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE287, DOI 10.1152/ajpendo.00308.2010	56	26	27	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2157	2167		10.1096/fj.201600910RR	http://dx.doi.org/10.1096/fj.201600910RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28196897				2022-12-26	WOS:000399195500034
J	South, K; Freitas, MO; Lane, DA				South, Kieron; Freitas, Marta O.; Lane, David A.			A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von willebrand factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS13; allosteric regulation; hemostasis; protein conformation; von Willebrand factor	THROMBOTIC THROMBOCYTOPENIC PURPURA; PLATELET GLYCOPROTEIN-IB; FACTOR A2 DOMAIN; VONWILLEBRAND-FACTOR; ISCHEMIC-STROKE; SCISSILE BOND; MYOCARDIAL-INFARCTION; VICINAL CYSTEINES; BINDING-SITES; HUMAN-PLASMA	Blood loss is prevented by the multidomain glycoprotein von Willebrand factor (VWF), which binds exposed collagen at damaged vessels and captures platelets. VWF is regulated by the metalloprotease ADAMTS13, which in turn is conformationally activated by VWF. To delineate the structural requirements for VWF-mediated conformational activation of ADAMTS13, we performed binding and functional studies with a panel of truncated ADAMTS13 variants. We demonstrate that both the isolated CUB1 and CUB2 domains in ADAMTS13 bind to the spacer domain exosite of a truncated ADAMTS13 variant, MDTCS (K-D of 135 +/- 1 0.1 nm and 86.9 +/- 9.0 nm, respectively). However, only the CUB1 domain inhibited proteolytic activity of MDTCS. Moreover, ADAMTS13CUB2, unlike ADAMTS13CUB1-2, exhibited activity similar to wild-type ADAMTS13 and could be activated by VWF D4-CK. The CUB2 domain is, therefore, not essential for maintaining the inactive conformation of ADAMTS13. Both CUB domains could bind to the VWF D4-CK domain fragment (K-D of 53.7 +/- 2.1 nm and 84.3 +/- 2.0 nm, respectively). However, deletion of both CUB domains did not prevent VWF D4-CK binding, suggesting that competition for CUB-domain binding to the spacer domain is not the dominant mechanism behind the conformational activation. ADAMTS13TSP8-CUB2 could no longer bind to VWF D4-CK, and deletion of TSP8 abrogated ADAMTS13 conformational activation. These findings support an ADAMTS13 activation model in which VWF D4-CK engages the TSP8-CUB2 domains, inducing the conformational change that disrupts the CUB1-spacer domain interaction and thereby activates ADAMTS13.	[South, Kieron; Freitas, Marta O.; Lane, David A.] Imperial Coll London, Ctr Haematol, London W12 0NN, England	Imperial College London	South, K; Lane, DA (corresponding author), Imperial Coll London, Hammersmith Hosp, Commonwealth Bldg 5S5,Du Cane Rd, London W12 0NN, England.	ksouth@imperial.ac.uk; d.lane@imperial.ac.uk	; Freitas, Marta/J-8699-2013	Lane, David/0000-0003-4283-3695; South, Kieron/0000-0002-9141-3438; Freitas, Marta/0000-0001-5779-2289	British Heart Foundation [PG/14/87/31181, PG/12/55/29740]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/14/87/31181 (to D. A. L. and K. S.) and PG/12/55/29740 (to D. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Chion CKNK, 2007, BLOOD, V109, P1998, DOI 10.1182/blood-2006-07-038166; Crawley JTB, 2008, J THROMB HAEMOST, V6, P583, DOI 10.1111/j.1538-7836.2008.02902.x; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; de Groot R, 2015, BLOOD, V125, P1968, DOI 10.1182/blood-2014-08-594556; de Groot R, 2010, BLOOD, V116, P3064, DOI 10.1182/blood-2009-12-258780; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Deforche L, 2015, J THROMB HAEMOST, V13, P2063, DOI 10.1111/jth.13149; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; HOYER LW, 1980, BLOOD, V55, P1056; Jian C, 2012, BLOOD, V119, P3836, DOI 10.1182/blood-2011-12-399501; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; Lynch CJ, 2016, BLOOD, V127, P1711, DOI 10.1182/blood-2015-09-672014; Lynch CJ, 2014, BLOOD, V123, P2585, DOI 10.1182/blood-2013-11-538173; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; Matsushita T, 2000, J BIOL CHEM, V275, P11044, DOI 10.1074/jbc.275.15.11044; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; MOHRI H, 1989, J BIOL CHEM, V264, P17361; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Qizilbash N, 1997, NEUROLOGY, V49, P1552, DOI 10.1212/WNL.49.6.1552; ROTH GJ, 1986, BIOCHEMISTRY-US, V25, P8357, DOI 10.1021/bi00374a004; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; South K, 2016, J THROMB HAEMOST, V14, P2011, DOI 10.1111/jth.13445; South K, 2014, P NATL ACAD SCI USA, V111, P18578, DOI 10.1073/pnas.1411979112; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	40	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5760	5769		10.1074/jbc.M117.776732	http://dx.doi.org/10.1074/jbc.M117.776732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28209710	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000398813200014
J	Devost, D; Sleno, R; Petrin, D; Zhang, A; Shinjo, Y; Okde, R; Aoki, J; Inoue, A; Hebert, TE				Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Zhang, Alice; Shinjo, Yuji; Okde, Rakan; Aoki, Junken; Inoue, Asuka; Hebert, Terence E.			Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AT(1) RECEPTOR; BIOSENSORS REVEAL; FUNCTIONAL SELECTIVITY; SIGNALING PATHWAYS; ACTIVATION; GPCRS; DETERMINANTS; MODULATION; MECHANISMS; COMPLEX	Here, we report the design and use of G protein-coupled receptor-based biosensors to monitor ligand-mediated conformational changes in receptors in intact cells. These biosensors use bioluminescence resonance energy transfer with Renilla luciferase (RlucII) as an energy donor, placed at the distal end of the receptor C-tail, and the small fluorescent molecule FlAsH as an energy acceptor, its binding site inserted at different positions throughout the intracellular loops and C-terminal tail of the angiotensin II type I receptor. We verified that the modifications did not compromise receptor localization or function before proceeding further. Our biosensors were able to capture effects of both canonical and biased ligands, even to the extent of discriminating between different biased ligands. Using a combination of G protein inhibitors and HEK 293 cell lines that were CRISPR/Cas9-engineered to delete G alpha(q), G alpha(11), G alpha(12), and G alpha(13) or beta-arrestins, we showed that G alpha(q) and G alpha(11) are required for functional responses in conformational sensors in ICL3 but not ICL2. Loss of beta-arrestin did not alter biased ligand effects on ICL2P2. We also demonstrate that such biosensors are portable between different cell types and yield context-dependent read-outs of G protein-coupled receptor conformation. Our study provides mechanistic insights into signaling events that depend on either G proteins or beta-arrestin.	[Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Zhang, Alice; Okde, Rakan; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada; [Shinjo, Yuji; Aoki, Junken; Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chiyoda Ku, Tokyo 1000004, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	McGill University; Tohoku University; Japan Science & Technology Agency (JST)	Hebert, TE (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca			Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research (CIHR) [MOP-130309]; PRESTO, JST; AMED-CREST; McGill-CIHR Drug Development Training Program	Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); PRESTO, JST(Japan Science & Technology Agency (JST)); AMED-CREST; McGill-CIHR Drug Development Training Program(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Consortium Quebecois sur la Decouverte du Medicament and Canadian Institutes of Health Research (CIHR) Grant MOP-130309 (to T. E. H.) as well as grants from PRESTO, JST (to A. I.) and AMED-CREST (to J. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the McGill-CIHR Drug Development Training Program.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Casiraghi M, 2016, J AM CHEM SOC, V138, P11170, DOI 10.1021/jacs.6b04432; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Devost D, 2016, METHOD CELL BIOL, V132, P319, DOI 10.1016/bs.mcb.2015.11.010; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Domazet I, 2015, MOL PHARMACOL, V87, P982, DOI 10.1124/mol.114.097337; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Hao Y, 2016, BIOINFORMATICS, V32, P3435, DOI 10.1093/bioinformatics/btw510; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kahsai AW, 2016, NAT CHEM BIOL, V12, P709, DOI 10.1038/nchembio.2126; Kenakin T, 2015, MOL PHARMACOL, V88, P1055, DOI 10.1124/mol.115.099770; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Maier-Peuschel M, 2010, J BIOL CHEM, V285, P8793, DOI 10.1074/jbc.M109.098517; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Namkung Y, 2016, METHODS, V92, P5, DOI 10.1016/j.ymeth.2015.04.010; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebois RV, 2012, CELL SIGNAL, V24, P2051, DOI 10.1016/j.cellsig.2012.06.011; Robertson DN, 2016, METHODS, V92, P19, DOI 10.1016/j.ymeth.2015.07.011; Ronan T, 2016, J BIOL CHEM, V291, P5528, DOI 10.1074/jbc.M115.710087; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sleno R, 2016, METHODS, V92, P11, DOI 10.1016/j.ymeth.2015.05.003; Spille JH, 2011, BIOPHYS J, V100, P1139, DOI 10.1016/j.bpj.2010.08.080; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Stumpf AD, 2016, BRIT J PHARMACOL, V173, P255, DOI 10.1111/bph.13382; Svensson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038517; Tian H, 2017, CHEM REV, V117, P186, DOI 10.1021/acs.chemrev.6b00084; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	50	53	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5443	5456		10.1074/jbc.M116.763854	http://dx.doi.org/10.1074/jbc.M116.763854			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213525	Green Published, hybrid			2022-12-26	WOS:000397875500024
J	Kotreka, UK; Davis, VL; Adeyeye, MC				Kotreka, Udaya K.; Davis, Vicki L.; Adeyeye, Moji C.			Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts	PLOS ONE			English	Article							LENS EPITHELIAL-CELLS; OCULAR DRUG-DELIVERY; BLUE MOUNTAINS EYE; ESTROGEN-RECEPTOR; PHYSIOLOGICAL CONDITIONS; 17-BETA-ESTRADIOL; HYDROGELS; TIMOLOL; VITRO; BETA	The goal of this study was to develop and characterize an ion-activated in situ gel-forming estradiol (E-2) solution eye drops intended for the prevention of age-related cataracts. Accordingly, in situ gelling eye drops were made using gellan gum as an ion-activated gel-forming polymer, polysorbate-80 as drug solubilizing agent, mannitol as tonicity agent, and combination of potassium sorbate and edetate disodium dihydrate (EDTA) as preservatives. The formulations were tested for the following characteristics: pH, clarity, osmolality, antimicrobial efficacy, rheological behavior, and in vitro drug release. Stability of the formulation was also monitored for 6 months at multiple storage conditions per ICH Q1A (R2) guidelines. The solution eye drops resulted in an in-situ phase change to gel-state when mixed with simulated tear fluid (STF). The gel structure formation was confirmed by viscoelastic measurements. Drug release from the gel followed non-fickian mechanism with 80% of drug released in 8 hr. The formulations were found to be clear, isotonic with suitable pH and viscoelastic behavior and stable at accelerated and long-term storage conditions for 6 months. In vitro results suggest that the developed formulation is suitable for further investigation in animal models to elucidate the ability of estrogen to prevent and delay cataracts.	[Kotreka, Udaya K.; Davis, Vicki L.; Adeyeye, Moji C.] Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15219 USA; [Kotreka, Udaya K.] Vanda Pharmaceut Inc, Washington, DC USA; [Adeyeye, Moji C.] Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA	Duquesne University	Adeyeye, MC (corresponding author), Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15219 USA.; Adeyeye, MC (corresponding author), Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA.	madeyeye@roosevelt.edu			CURE Grant, Pennsylvania Department of Health	CURE Grant, Pennsylvania Department of Health	This work was supported by the CURE Grant, Pennsylvania Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyeye CM, 2002, AAPS PHARMSCITECH, V3, pE8, DOI [10.1208/pt030208, DOI 10.1208/PT030208]; Adeyeye MC, 2011, US Patent Publication, Patent No. [0082128 A1, 0082128]; Al-Ghananeem A, 2002, AAPS PHARMSCITECH, V3, P40; [Anonymous], 1996, GUID IND Q2 R1 ICH H; [Anonymous], 1996, Santee Pharmaceutical Co, Ltd, Patent No. [US5559157, 5559157]; Bachmann GA, 1998, AM J OBSTET GYNECOL, V178, pS257, DOI 10.1016/S0002-9378(98)70558-7; Balasubramaniam Jagdish, 2003, Acta Pharmaceutica (Zagreb), V53, P251; Bigsby RM, 1999, P NATL ACAD SCI USA, V96, P9328, DOI 10.1073/pnas.96.16.9328; Cammarata PR, 2004, EXP EYE RES, V78, P861, DOI 10.1016/j.exer.2003.09.027; Carlfors J, 1998, EUR J PHARM SCI, V6, P113, DOI 10.1016/S0928-0987(97)00074-2; Centers for Disease Control and Prevention, 2011, STAT VIS AG PUBL HLT; Centers for Disease Control and Prevention, 1983, CAT MAJ BLIND DIS; Colitz CMH, 2009, MOL VIS, V15, P2259; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Cumming RG, 1997, AM J EPIDEMIOL, V145, P242; Davies NM, 2000, CLIN EXP PHARMACOL P, V27, P558, DOI 10.1046/j.1440-1681.2000.03288.x; Davis VL, 2002, P NATL ACAD SCI USA, V99, P9427, DOI 10.1073/pnas.132247999; delCastillo JMB, 1997, OPHTHALMOLOGY, V104, P970; Dikstein S, 1992, US Patent, Patent No. 5106615; Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804; *FDA, 1995, GUID IND IMM REL SOL; Flanner H.H., 1996, PHARM TECHNOL, V20, P64; Food and Drug Administration, 2003, GUID IND Q1AR2 STAB; Gongdon N, 2001, INVEST OPHTH VIS SCI, V42, P2478; Hagerstrom H, 2000, EUR J PHARM SCI, V9, P301, DOI 10.1016/S0928-0987(99)00070-6; Hales AM, 1997, J EXP MED, V185, P273, DOI 10.1084/jem.185.2.273; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Kalam MA, 2008, J DISPER SCI TECHNOL, V29, P89, DOI 10.1080/01932690701688482; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; Kirker MR, 2013, EXP EYE RES, V112, P1, DOI 10.1016/j.exer.2013.04.002; Kitano M, 1998, INT J PHARM, V174, P19, DOI 10.1016/S0378-5173(98)00234-8; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Kotreka UK, 2011, THESIS; Lai KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078647; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; LIVINGSTON PM, 1994, DEV OPHTHALMOL, V26, P1; LOFTSSON T, 1989, ACTA PHARM NORDICA, V1, P185; Lokind KB, 1996, INT J PHARM, V127, P155, DOI 10.1016/0378-5173(95)04118-4; Martens-Lobenhoffer J, 2002, CLIN PHARMACOKINET, V41, P197, DOI 10.2165/00003088-200241030-00004; MESEGUER G, 1994, J DRUG TARGET, V2, P269, DOI 10.3109/10611869409015908; Morishima K, 2007, US Patent, Patent No. [0248697A1, 0248697]; Munaut C, 2001, BRIT J OPHTHALMOL, V85, P877, DOI 10.1136/bjo.85.7.877; Mundada AS, 2009, CRIT REV THER DRUG, V26, P85, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i1.30; Nagarwal RC, 2009, AAPS PHARMSCITECH, V10, P977, DOI 10.1208/s12249-009-9285-3; Nanjawade BK, 2007, J CONTROL RELEASE, V122, P119, DOI 10.1016/j.jconrel.2007.07.009; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Oliveira Regina de Souza Carvalho de Salles, 2005, Clinics, V60, P455, DOI 10.1590/S1807-59322005000600005; Paulsson M, 1999, EUR J PHARM SCI, V9, P99, DOI 10.1016/S0928-0987(99)00051-2; Qian Y, 2010, DRUG DEV IND PHARM, V36, P1340, DOI 10.3109/03639041003801893; ROZIER A, 1989, INT J PHARM, V57, P163, DOI 10.1016/0378-5173(89)90305-0; RUCKER C W, 1965, Invest Ophthalmol, V4, P377; Rupenthal ID, 2011, INT J PHARMACEUT, V411, P69, DOI 10.1016/j.ijpharm.2011.03.042; Schenker HI, 2000, AM J OPHTHALMOL, V130, P145, DOI 10.1016/S0002-9394(00)00458-X; Shedden A, 2001, CLIN THER, V23, P440, DOI 10.1016/S0149-2918(01)80048-5; Singh BN, 2004, PHARM DEV TECHNOL, V9, P399, DOI 10.1081/PDT-200035793; Sultana Y, 2006, DRUG DELIV, V13, P215, DOI 10.1080/10717540500309164; Sunil T, 2012, J PHARM BIOALLIED SC, V4, pS6, DOI 10.4103/0975-7406.94117; Tsuji M, 2004, US Patent, Patent No. [0034042 A1, 0034042]; Variankaval NE, 2002, J MATER SCI-MATER M, V13, P271, DOI 10.1023/A:1014058817352; World Health Organization, 2012, GLOBAL DATA VISUAL I; World Health Organization, 2013, UN EYE HLTH GLOB ACT; Worzala K, 2001, ARCH INTERN MED, V161, P1448, DOI 10.1001/archinte.161.11.1448; Zhang XH, 2003, J CATARACT REFR SURG, V29, P71, DOI 10.1016/S0886-3350(02)01436-0; ZIGNANI M, 1995, ADV DRUG DELIVER REV, V16, P51, DOI 10.1016/0169-409X(95)00015-Y	67	37	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172306	10.1371/journal.pone.0172306	http://dx.doi.org/10.1371/journal.pone.0172306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222100	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800047
J	Rudqvist, N; Spetz, J; Schuler, E; Parris, TZ; Langen, B; Helou, K; Forssell-Aronsson, E				Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Parris, Toshima Z.; Langen, Britta; Helou, Khalil; Forssell-Aronsson, Eva			Transcriptional response to I-131 exposure of rat thyroid gland	PLOS ONE			English	Article							GENE-EXPRESSION; PROCEDURE GUIDELINES; MOUSE-TISSUES; DOSE-RATE; AT-211; CANCER; METAIODOBENZYLGUANIDINE; RADIOIODINE; RADIATION; THERAPY	Humans are exposed to (131) I in medical diagnostics and treatment but also from nuclear accidents, and better knowledge of the molecular response in thyroid is needed. The aim of the study was to examine the transcriptional response in thyroid tissue 24 h after (131) I administration in rats. The exposure levels were chosen to simulate both the clinical situation and the case of nuclear fallout. Thirty-six male rats were i.v. injected with 0-4700 kBq (131) I, and killed at 24 h after injection (Dthyroid = 0.0058-3.0 Gy). Total RNA was extracted from individual thyroid tissue samples and mRNA levels were determined using oligonucleotide microarray technique. Differentially expressed transcripts were determined using Nexus Expression 3.0. Hierarchical clustering was performed in the R statistical computing environment. Pathway analysis was performed using the Ingenuity Pathway Analysis tool and the Gene Ontology database. T4 and TSH plasma concentrations were measured using ELISA. Totally, 429 differentially regulated transcripts were identified. Downregulation of thyroid hormone biosynthesis associated genes (e.g. thyroglobulin, thyroid peroxidase, the sodium-iodine symporter) was identified in some groups, and an impact on thyroid function was supported by the pathway analysis. Recurring downregulation of Dbp and Slc47a2 was found. Dbp exhibited a pattern with monotonous reduction of downregulation with absorbed dose at 0.0058-0.22 Gy. T4 plasma levels were increased and decreased in rats whose thyroids were exposed to 0.057 and 0.22 Gy, respectively. Different amounts of injected (131) I gave distinct transcriptional responses in the rat thyroid. Transcriptional response related to thyroid function and changes in T4 plasma levels were found already at very low absorbed doses to thyroid.	[Rudqvist, Nils; Spetz, Johan; Schuler, Emil; Langen, Britta; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Oncol,Inst Clin Sci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Forssell-Aronsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci, Gothenburg, Sweden.	eva.forssell_aronsson@radfys.gu.se	Parris, Toshima/Q-5427-2018; Spetz, Johan/P-1662-2017	Parris, Toshima/0000-0003-0834-5540; Spetz, Johan/0000-0002-5216-9786; Forssell-Aronsson, Eva/0000-0002-7558-4368; Rudqvist, Nils/0000-0002-9720-3124	European Commission [TARCC HEALTH-F2-2007-201962]; Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Wilhelm and Martina Lundgren foundation; Assar Gabrielsson Cancer Research Foundation	This study was supported by grants from the European Commission FP7 Collaborative Project TARCC HEALTH-F2-2007-201962, the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Wilhelm and Martina Lundgren foundation and the Assar Gabrielsson Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend M, 2013, BRIT J CANCER, V109, P2286, DOI 10.1038/bjc.2013.574; Abend M, 2013, BR J CANC; Abend M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039103; Akahane Keiichi, 2012, Environmentalist, V32, P136, DOI 10.1007/s10669-011-9381-2; Amundson SA, 1999, RADIAT RES, V152, P225, DOI 10.2307/3580321; [Anonymous], [No title captured]; Bombardieri E, 2010, EUR J NUCL MED MOL I, V37, P2436, DOI 10.1007/s00259-010-1545-7; Bonnema SJ, 2012, ENDOCR REV, V33, P920, DOI 10.1210/er.2012-1030; Brans B, 2002, MED PEDIATR ONCOL, V38, P41, DOI 10.1002/mpo.1261; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Carrasquillo JA, 2013, 1311MIBG THER NUCL O, P691; CHAPMAN EM, 1946, JAMA-J AM MED ASSOC, V131, P86, DOI 10.1001/jama.1946.02870190010003; Forssell-Aronsson E, 2011, REP MED IMAGING, V4, P19; Giammarile F, 2008, EUR J NUCL MED MOL I, V35, P1039, DOI 10.1007/s00259-008-0715-3; HERTZ S, 1946, JAMA-J AM MED ASSOC, V131, P81, DOI 10.1001/jama.1946.02870190005002; JEEVANRAM RK, 1986, NUCL MED BIOL, V13, P277, DOI 10.1016/0883-2897(86)90108-X; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Langen B, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-014-0078-7; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Lorenz S, 2010, BBA-MOL CELL RES, V1803, P352, DOI 10.1016/j.bbamcr.2010.01.007; MANGNER TJ, 1986, J NUCL MED, V27, P37; Norden MM, 2007, CANCER RES, V67, P7512, DOI 10.1158/0008-5472.CAN-07-0823; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Rudqvist N, 2014, NUCL MED BIOL; Rudqvist N., 2015, THESIS; Rudqvist N, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0137-8; Rudqvist N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131686; Rudqvist N, 2015, NUCL MED BIOL, V42, P263, DOI 10.1016/j.nucmedbio.2014.11.006; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schipper ML, 2007, EUR J NUCL MED MOL I, V34, P638, DOI 10.1007/s00259-006-0254-8; Schuler E., 2014, THESIS; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Selmansberger M, 2014, ONCOGENE; Selmansberger M, 2015, CARCINOGENESIS; Spetz J, 2013, CANCER BIOTHER RADIO, V28, P657, DOI 10.1089/cbr.2013.1483; UN Sci. Comm. Eff. At. Radiat, 2000, REP GEN ASS SCI ANN, VII, P451; Wafelman AR, 1996, NUKLEARMED, V35, P122; WHO (World Health Organization), 1993, BIOM RISK ASS CONC P	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171797	10.1371/journal.pone.0171797	http://dx.doi.org/10.1371/journal.pone.0171797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222107	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800018
J	Viscardi, DZ; Arrigo, JD; Correia, CDC; Kassuya, CAL; Cardoso, CAL; Maldonade, IR; Argandona, EJS				Viscardi, Danieli Zuntini; Arrigo, Jucicleia da Silva; Chaves Correia, Camila de Azevedo; Leite Kassuya, Candida Aparecida; Lima Cardoso, Claudia Andrea; Maldonade, Iriani Rodrigues; Sanjinez Argandona, Eliana Janet			Seed and peel essential oils obtained from Campomanesia adamantium fruit inhibit inflammatory and pain parameters in rodents	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIINFLAMMATORY PROPERTIES; ANTIMICROBIAL ACTIVITY; FORMALIN TEST; GC-MS; ANTIOXIDANT; ANTICANCER; EXTRACT	Campomanesia adamantium (Myrtaceae) is popularly known as "gabiroba" and has been used in folk medicine as antirheumatic, antidiarrheal, hypocholesterolemic and anti-inflammatory. This study evaluated the anti-inflammatory and antinociceptive activities and toxicology of essential oils from peel (EOP) and seed (EOS) of C. adamantium fruits in animal models. Different groups were treated with doses of 100 and 300 mg/kg and the inflammatory parameters were evaluated in carrageenan induced paw oedema and leukocyte migration in pleurisy model, while antinociceptive activity was evaluated using formalin method in rodents. The major constituent of EOP and EOS was limonene with 13.07% and 20.89%, respectively. No clinical signs of toxicity have been observed in animals. It was observed a significant decreased (P<0.01) in leukocyte migration at the dose of 300 mg/kg of EOP and EOS, with maximal inhibition of 89 +/- 3% for EOP and 80 +/- 6% for EOS. Paw oedema was inhibited at all times, and maximal inhibition was at the dose of 100 mg/kg at 2 h after carrageenan injection with 72 +/- 2% for EOP and 74 +/- 2% for EOS. EOS and EOP also reduced the first and second phases of formalin-induced nociception test. In the first formalin-phase, maximal inhibitions were at 48 +/- 5% for EOP and 66 +/- 4% for EOS (300 mg/kg). At the inflammatory phase induced by formalin, maximal inhibitions were 72 +/- 2% for EOP and 80 +/- 2% for EOS at the dose of 100 mg/kg. Seed and peel essential oils from C. adamantium fruit inhibited leukocyte migration, inflammatory and neurogenic pain and oedema suggesting their use as nutraceutical or pharmacological agent.	[Viscardi, Danieli Zuntini; Arrigo, Jucicleia da Silva; Chaves Correia, Camila de Azevedo] Fed Univ Grande Dourados, Coll Exact & Technol Sci, Dourados, MS, Brazil; [Leite Kassuya, Candida Aparecida] Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Maldonade, Iriani Rodrigues] Brazilian Agr Res Agcy Embrapa, Brasilia, DF, Brazil; [Sanjinez Argandona, Eliana Janet] Fed Univ Grande Dourados, Coll Food Engn, Dourados, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Federal da Grande Dourados	Viscardi, DZ (corresponding author), Fed Univ Grande Dourados, Coll Exact & Technol Sci, Dourados, MS, Brazil.	danieliviscardi@ufgd.edu.br	Kassuya, Candida A. L./G-8329-2011; Maldonade, Iriani/AAT-7399-2021; Cardoso, Claudia Andrea Lima/AAK-5578-2020; Maldonade, Iriani/A-5953-2013	Maldonade, Iriani/0000-0003-2283-1270; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Maldonade, Iriani/0000-0003-2283-1270; Kassuya, Candida/0000-0002-8998-9219	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project FUNDECT/CAPES [45/2014]; Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project PAPOS REDE PRO-CENTRO-OESTE FASE II [23/200.622/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project FUNDECT/CAPES; Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) through the project PAPOS REDE PRO-CENTRO-OESTE FASE II; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors also wish to thank the Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) for financial support, through the projects FUNDECT/CAPES no 45/2014 - PAPOS REDE PRO-CENTRO-OESTE FASE II - No 23/200.622/2014 and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors kindly acknowledge the Study Group on Agro-Industrial Products and Processes of Cerrado (GEPPAC) for technical support. The authors also wish to thank the Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) for financial support, through the projects FUNDECT/CAPES no 45/2014 PAPOS REDE PRO-CENTROOESTE-FASE II -No 23/200.622/2014 and the Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq).	Adams RP, 2007, IDENTIFICATION ESSEN, P53; Afoulous S, 2013, FOOD CHEM TOXICOL, V56, P352, DOI 10.1016/j.fct.2013.02.008; AOAC, 1990, OFFICIAL METHODS ANA, V2, P4; Breda CA, 2012, FOOD CHEM, V135, P2960, DOI 10.1016/j.foodchem.2012.07.029; Cabrini DA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq026; Chi GF, 2013, INFLAMMATION, V36, P501, DOI 10.1007/s10753-012-9571-1; Coutinho ID, 2009, BRAZ J PHARM SCI, V45, P767, DOI 10.1590/S1984-82502009000400022; d'Alessio PA, 2013, LIFE SCI, V92, P1151, DOI 10.1016/j.lfs.2013.04.013; de Lima VT, 2014, PHYTOMEDICINE, V21, P1298, DOI 10.1016/j.phymed.2014.07.004; de Oliveira AM, 2012, INT J MOL SCI, V13, P1598, DOI 10.3390/ijms13021598; Decosterd I, 2012, PAIN, V2, P149; Esteves I, 2005, J ETHNOPHARMACOL, V101, P191, DOI 10.1016/j.jep.2005.04.020; Fernandes TD, 2015, TOXICOL REP, V2, P184, DOI 10.101611.toxrep.2014.11.018; Ferreira LC, 2013, J ETHNOPHARMACOL, V145, P100, DOI 10.1016/j.jep.2012.10.037; Formagio ASN, 2011, LAT AM J PHARM, V30, P1555; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; Kim MJ, 2014, NAT PROD COMMUN, V9, P727; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Cardoso CAL, 2010, J MED FOOD, V13, P1273, DOI 10.1089/jmf.2009.0047; Lima NGPB, 2013, PHARMACOL BIOCHEM BE, V103, P450, DOI 10.1016/j.pbb.2012.09.005; Lorenzi H., 2000, ARVORES BRASILEIRAS; Leite JFM, 2012, MOLECULES, V17, P3277, DOI 10.3390/molecules17033277; Organization for Economic Co-operation and Development, 2008, GUID 425 AC OR TOX U; Piccinelli AC, 2015, NUTR NEUROSCI, V18, P217, DOI 10.1179/1476830514Y.0000000119; Violante IMP, 2012, BRAZ J MICROBIOL, V43, P1302, DOI 10.1590/S1517-83822012000400009; Ramos D. D., 2007, REV BRAS BIOCIENCIAS, V5, P774; Pascoal ACRF, 2014, MOLECULES, V19, P1843, DOI 10.3390/molecules19021843; Sahranavard S, 2014, IRAN J PHARM RES, V13, P119; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Souza JC, 2014, NUTRITIONAL NEUROSCI, DOI 10.1179; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; VELO GP, 1973, J PATHOL, V111, P149, DOI 10.1002/path.1711110302	33	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0157107	10.1371/journal.pone.0157107	http://dx.doi.org/10.1371/journal.pone.0157107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222179	gold, Green Submitted, Green Published			2022-12-26	WOS:000394676800001
J	Zhang, JJ; Peng, K; Zhang, J; Meng, XW; Ji, FH				Zhang, Jing-jing; Peng, Ke; Zhang, Juan; Meng, Xiao-wen; Ji, Fu-hai			Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-kappa B signaling pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MOBILITY GROUP BOX-1; NF-KAPPA-B; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ENDOTOXIN-INDUCED SHOCK; INFLAMMATORY RESPONSES; SARCOPLASMIC-RETICULUM; MICE; ACTIVATION; PROTEIN	Aims To investigate whether dexmedetomidine (DEX) preconditioning could alleviate the inflammation caused by myocardial ischemia/reperfusion (I/R) injury by reducing HMGB1-TLR4MyD88-NF-kappa B signaling. Methods Seventy rats were randomly assigned into five groups: sham group, myocardial I/R group (I/R), DEX+I/R group (DEX), DEX+yohimbine+I/R group (DEX/YOH), and yohimbine+I/R group (YOH). Animals were subjected to 30 min of ischemia induced by occluding the left anterior descending artery followed by 120 min of reperfusion. Myocardial infarct size and histological scores were evaluated. The levels of IL-6 and TNF-alpha in serum and myocardium were quantified by enzyme-linked immunosorbent assay, and expression of HMGB1, TLR4, MyD88, I kappa B and NF-kappa B in the myocardial I/R area were determined with Western blot and immunocytochemistry. Results Myocardial infarct sizes, histological scores, levels of circulating and myocardial IL-6 and TNF-alpha, the expression of HMGB1, TLR4, MyD88 and NF-kappa B, and the degradation of I kappa B were significantly increased in the I/R group compared with the sham group (P<0.01). DEX preconditioning significantly reduced the myocardial infarct size and histological scores (P<0.01 vs. I/R group). Similarly, the serum and myocardial levels of IL-6 and TNF-alpha, the expression of HMGB1, TLR4, MyD88 and NF-kappa B, and the degradation of I kappa B were significantly reduced in the DEX group (P<0.01 vs. I/R group). These effects were partly reversed by yohimbine, a selective alpha(2)-adrenergic receptor antagonist, while yohimbine alone had no significant effect on any of the above indicators. Conclusion DEX preconditioning reduces myocardial I/R injury in part by attenuating inflammation, which may be attributed to the downregulation of the HMGB1-TLR4-MyD88-NF-kappa B signaling pathway mediated by the alpha 2-adrenergic receptor activation.	[Zhang, Jing-jing; Peng, Ke; Zhang, Juan; Meng, Xiao-wen; Ji, Fu-hai] Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Peoples R China	Soochow University - China	Ji, FH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Peoples R China.	jifuhai198901@163.com			National Natural Science Foundation of China (NSFC) [81471835, 81471889]; Key Provincial Talents of Jiangsu Province [RC201107]; Science and Technology Development Projects of Soochow [SYSD2013076]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Provincial Talents of Jiangsu Province; Science and Technology Development Projects of Soochow	This work was funded by the National Natural Science Foundation of China (NSFC) (81471835, 81471889), Key Provincial Talents of Jiangsu Province (RC201107), Science and Technology Development Projects of Soochow (SYSD2013076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Albus U., 2012, GUIDE CARE USE LAB A, DOI DOI 10.1258/LA.2012.150312; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Biccard BM, 2008, ANAESTHESIA, V63, P4, DOI 10.1111/j.1365-2044.2007.05306.x; Cho HI, 2013, J NAT PROD, V76, P1717, DOI 10.1021/np4004323; Fan HY, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/508938; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Friesen RH, 2013, ANESTH ANALG, V117, P953, DOI 10.1213/ANE.0b013e3182a15aa6; Giallauria F, 2010, ATHEROSCLEROSIS, V208, P280, DOI 10.1016/j.atherosclerosis.2009.07.025; Gilsbach R, 2012, BRIT J PHARMACOL, V165, P90, DOI 10.1111/j.1476-5381.2011.01533.x; Gordon S, 2012, CIRC RES, V110, P1546, DOI 10.1161/RES.0b013e31825ec26d; Gu J, 2011, ACTA ANAESTH SCAND, V55, P1272, DOI 10.1111/j.1399-6576.2011.02526.x; Gu JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10283; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Huang Y, 2014, INT J MOL SCI, V15, P4049, DOI 10.3390/ijms15034049; Ibacache M, 2012, BBA-MOL BASIS DIS, V1822, P537, DOI 10.1016/j.bbadis.2011.12.013; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Jiang LL, 2014, MOL MED REP, V9, P419, DOI 10.3892/mmr.2013.1867; Kawada T, 2013, ACTA PHYSIOL, V209, P55, DOI 10.1111/apha.12123; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kumar S, 2009, BIOCHEM BIOPH RES CO, V387, P77, DOI 10.1016/j.bbrc.2009.06.115; Leary S., 2013, AVMA GUIDELINES FOR; LEE JC, 1985, AM J PATHOL, V121, P316; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Niu XY, 2013, CNS NEUROSCI THER, V19, P897, DOI 10.1111/cns.12172; Obayah GM, 2010, EUR J ANAESTH, V27, P280, DOI 10.1097/EJA.0b013e3283347c15; Oda Y, 2012, RESUSCITATION, V83, P1006, DOI 10.1016/j.resuscitation.2012.01.030; Okada H, 2007, RESUSCITATION, V74, P538, DOI 10.1016/j.resuscitation.2007.01.032; Ostadal B, 2009, PHARMACOL REP, V61, P3, DOI 10.1016/S1734-1140(09)70002-7; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Tan F, 2015, BIOMED REP, V3, P365, DOI 10.3892/br.2015.427; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Taniguchi T, 2008, J ANESTH, V22, P221, DOI 10.1007/s00540-008-0611-9; Tsai CT, 2015, CARDIOVASC RES, V105, P318, DOI 10.1093/cvr/cvv008; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Volz HC, 2012, CLIN RES CARDIOL, V101, P427, DOI 10.1007/s00392-011-0409-x; Wang J, 2015, WORLD J GASTROENTERO, V21, P8314, DOI 10.3748/wjg.v21.i27.8314; Wijeysundera DN, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004126.pub2; Willigers HM, 2003, ANESTH ANALG, V96, P657, DOI 10.1213/01.ANE.0000048708.75957.FF; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1; Ye WB, 2016, INT IMMUNOPHARMACOL, V39, P149, DOI 10.1016/j.intimp.2016.07.018; Yoshitomi O, 2012, SHOCK, V38, P92, DOI 10.1097/SHK.0b013e318254d3fb; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15503	49	53	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172006	10.1371/journal.pone.0172006	http://dx.doi.org/10.1371/journal.pone.0172006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222157	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800028
J	Axton, RA; Haideri, SS; Lopez-Yrigoyen, M; Taylor, HA; Forrester, LM				Axton, Richard A.; Haideri, Sharmin S.; Lopez-Yrigoyen, Martha; Taylor, Helen A.; Forrester, Lesley M.			SplitAx: A novel method to assess the function of engineered nucleases	PLOS ONE			English	Article							GENOME; ACTIVATION	Engineered nucleases have been used to generate knockout or reporter cell lines and a range of animal models for human disease. These new technologies also hold great promise for therapeutic genome editing. Current methods to evaluate the activity of these nucleases are time consuming, require extensive optimization and are hampered by readouts with low signals and high background. We have developed a simple and easy to perform method ( SplitAx) that largely addresses these issues and provides a readout of nuclease activity. The assay involves splitting the N-terminal ( amino acid 1-158) coding region of GFP and an out-of-frame of C-terminal region with a nuclease binding site sequence. Following exposure to the test nuclease, cutting and repair by error prone non-homologous end joining ( NHEJ) restores the reading frame resulting in the production of a full length fluorescent GFP protein. Fluorescence can also be restored by complementation between the N-terminal and C-terminal coding sequences in trans. We demonstrate successful use of the SplitAx assay to assess the function of zinc finger nucleases, CRISPR hCAS9 and TALENS. We also test the activity of multiple gRNAs in CRISPR/hCas9/D10A systems. The zinc finger nucleases and guide RNAs that showed functional activity in the SplitAx assay were then used successfully to target the endogenous AAVS1, SOX6 and Cfms loci. This simple method can be applied to other unrelated proteins such as ZsGreen1 and provides a test system that does not require complex optimization.	[Axton, Richard A.; Haideri, Sharmin S.; Lopez-Yrigoyen, Martha; Taylor, Helen A.; Forrester, Lesley M.] Univ Edinburgh, Edinburgh bioQuarter, MRC, Ctr Regenerat Med, SCRM Bldg,5 Little France Dr, Edinburgh, Midlothian, Scotland	University of Edinburgh	Forrester, LM (corresponding author), Univ Edinburgh, Edinburgh bioQuarter, MRC, Ctr Regenerat Med, SCRM Bldg,5 Little France Dr, Edinburgh, Midlothian, Scotland.	L.Forrester@ed.ac.uk		Lopez-Yrigoyen, Martha/0000-0002-5115-3942	MRC [MR/L012766/1] Funding Source: UKRI; Medical Research Council [MR/L012766/1] Funding Source: Medline; Wellcome Trust [102610] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Chang CJ, 2012, BLOOD, V120, P3906, DOI 10.1182/blood-2012-03-420703; Cradick TJ, 2014, METHODS MOL BIOL, V1114, P339, DOI 10.1007/978-1-62703-761-7_22; Crone D. E., 2013, GFP BASED BIOSENSORS; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang YM, 2009, BIOCHEMISTRY-US, V48, P929, DOI 10.1021/bi802027g; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Li Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00897; Lohmann F, 2008, DEVELOPMENT, V135, P2071, DOI 10.1242/dev.018200; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Olenych S.G., 2007, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb2105-36, DOI 10.1002/0471143030.CB2105-36]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555	27	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171698	10.1371/journal.pone.0171698	http://dx.doi.org/10.1371/journal.pone.0171698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212417	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424700011
J	Brown, MA; Howatson, G; Quin, E; Redding, E; Stevenson, EJ				Brown, Meghan A.; Howatson, Glyn; Quin, Edel; Redding, Emma; Stevenson, Emma J.			Energy intake and energy expenditure of pre-professional female contemporary dancers	PLOS ONE			English	Article							DIETARY DATA-COLLECTION; FREE-LIVING CONDITIONS; BALLET DANCERS; PHYSICAL-ACTIVITY; BODY-COMPOSITION; ACTIVITY MONITOR; SOCCER PLAYERS; RECOVERY; EXERCISE; SPORTS	Many athletes in aesthetic and weight dependent sports are at risk of energy imbalance. However little is known about the exercise and eating behaviours of highly trained dance populations. This investigation sought to determine the energy intake and energy expenditure of pre-professional female contemporary dancers. Twenty-five female contemporary dance students completed the study. Over a 7-day period, including five week days ( with scheduled dance training at a conservatoire) and two weekend days ( with no scheduled dance training at the conservatoire), energy intake ( self-reported weighed food diary and 24 h dietary recall) and expenditure ( tri-axial accelerometry) were recorded. Mean daily energy intake and expenditure were different over the 7-day period ( P = 0.014) equating to an energy deficit of -356 +/- 668 kcal.day(-1) ( or -1.5 +/- 2.8 MJ.day(-1)). Energy expenditure was not different when comparing week and weekend days ( P = 0.297). However daily energy intake ( P = 0.002), energy availability ( P = 0.003), and energy balance ( P = 0.004) were lower during the week compared to the weekend, where energy balance became positive. The percentage contribution of macronutrients to total energy intake also differed; with higher fat ( P = 0.022) and alcohol ( P = 0.020), and lower carbohydrate ( P = 0.001) and a trend for lower protein ( P = 0.051) at the weekend. Energy balance and appropriate macronutrient intake are essential for maintaining the demands of training, performance and recovery. Whilst aesthetics are important, female contemporary dancers may be at risk of the numerous health and performance impairments associated with negative energy balance, particularly during periods of scheduled training.	[Brown, Meghan A.; Howatson, Glyn] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Brown, Meghan A.] Univ Gloucestershire, Sch Sport & Exercise, Gloucester GL2 9HW, England; [Howatson, Glyn] North West Univ, Sch Biol Sci, Water Res Grp, Potchefstroom, South Africa; [Quin, Edel; Redding, Emma] Trinity Laban Conservatoire Mus & Dance, Fac Dance, London SE8 3DZ, England; [Stevenson, Emma J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Northumbria University; University of Gloucestershire; North West University - South Africa; Newcastle University - UK	Howatson, G (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.; Howatson, G (corresponding author), North West Univ, Sch Biol Sci, Water Res Grp, Potchefstroom, South Africa.	glyn.howatson@northumbria.ac.uk	Howatson, Glyn/AAE-9508-2021	Howatson, Glyn/0000-0001-8494-2043; Brown, Meghan/0000-0003-3260-977X				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Angle S, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-41; Ashley J, 2007, OBESITY ETIOLOGY ASS, P99; Barnes MJ, 2014, SPORTS MED, V44, P909, DOI 10.1007/s40279-014-0192-8; Barnes MJ, 2010, J SCI MED SPORT, V13, P189, DOI 10.1016/j.jsams.2008.12.627; Beck KL, 2015, INT J SPORT NUTR EXE, V25, P335, DOI 10.1123/ijsnem.2014-0089; Beck S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00568; Beelen M, 2010, INT J SPORT NUTR EXE, V20, P515, DOI 10.1123/ijsnem.20.6.515; Bingham S. A., 1987, Nutrition Abstracts and Reviews. Series A-Human and Experimental, V57, P705; Briggs M, 2015, NUTRIENTS, V7, P5400; Briggs MA, 2015, NUTRIENTS, V7, P5948, DOI 10.3390/nu7075262; Brown MA, 2015, J SPORTS MED PHYS FI, DOI [10.1080/0264041031000140554, DOI 10.1080/0264041031000140554]; Burke LM, 2006, J SPORT SCI, V24, P675, DOI 10.1080/02640410500482602; Burke LM, 2003, J APPL PHYSIOL, V95, P983, DOI 10.1152/japplphysiol.00115.2003; Calabrese L H, 1983, Phys Sportsmed, V11, P86, DOI 10.1080/00913847.1983.11708458; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Cho Kang Ok, 2014, J Exerc Nutrition Biochem, V18, P169, DOI 10.5717/jenb.2014.18.2.169; CLAESSENS ALM, 1987, J SPORT MED PHYS FIT, V27, P310; DAHLSTROM M, 1990, CLIN PHYSIOL, V10, P11, DOI 10.1111/j.1475-097X.1990.tb00080.x; Davidsen L, 2007, INT J OBESITY, V31, P1777, DOI 10.1038/sj.ijo.0803699; Deakin V., 2000, CLIN SPORTS NUTR, P30; Doyle-Lucas Ashley F, 2010, J Dance Med Sci, V14, P146; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; HAMILTON LH, 1988, MED SCI SPORT EXER, V20, P560; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hassapidou MN, 2001, J HUM NUTR DIET, V14, P391, DOI 10.1046/j.1365-277X.2001.00307.x; HERGENROEDER AC, 1993, MED SCI SPORT EXER, V25, P145, DOI 10.1249/00005768-199301000-00020; Hill RJ, 1999, EUR J CLIN NUTR, V53, P752, DOI 10.1038/sj.ejcn.1600836; Hirsch NM., 2003, J DANCE MED SCI, V7, P73; Hoch AZ, 2011, CLIN J SPORT MED, V21, P119, DOI 10.1097/JSM.0b013e3182042a9a; Jarrett H, 2015, J PHYS ACT HEALTH, V12, P382, DOI 10.1123/jpah.2013-0070; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Kaufman BA, 2002, J CLIN ENDOCR METAB, V87, P2777, DOI 10.1210/jc.87.6.2777; Kostrzewa-Tarnowska Aleksandra, 2003, Polish Journal of Food and Nutrition Sciences, V12, P71; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; Laws H., 2005, FIT DANCE 2 REPORT 2; LICHTENBELT WDV, 1995, BRIT J NUTR, V74, P439, DOI 10.1079/BJN19950150; Loucks AB, 2004, J SPORT SCI, V22, P1, DOI 10.1080/0264041031000140518; Macfarlane DJ, 2006, J APPL PHYSIOL, V101, P1328, DOI 10.1152/japplphysiol.00336.2006; Magkos F, 2003, CURR OPIN CLIN NUTR, V6, P539, DOI 10.1097/00075197-200309000-00007; Mcminn D, 2013, INT J EXERC SCI, V6, P217; Ottevaere C, 2011, J SPORT SCI, V29, P103, DOI 10.1080/02640414.2010.521169; Pacy P, 1996, DANCE RES J SOC DANC, V14, P93; Parr EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088384; Pasiakos Cao JJ, 2013, FASEB J OFFICIAL PUB, V27, P3837; Pasiakos Margolis LM, 2015, FASEB J OFFICIAL PUB, V29, P1136; Redding E., 2004, J DANCE MED SCI, V8, P69; Robbeson JG, 2015, INT J SPORT NUTR EXE, V25, P344, DOI 10.1123/ijsnem.2013-0161; Rumbold PLS, 2011, APPETITE, V57, P443, DOI 10.1016/j.appet.2011.06.013; Russell M, 2011, J STRENGTH COND RES, V25, P1816, DOI 10.1519/JSC.0b013e3181e7fbdd; SANDRI SC, 1993, INT J SPORT NUTR, V3, P334, DOI 10.1123/ijsn.3.3.334; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Silva MR, 2014, ENCY SYSTEMS CONTROL, P1; Sirard JR, 2000, MED SCI SPORT EXER, V32, P695, DOI 10.1097/00005768-200003000-00022; Siri W., 1961, TECHNIQUES MEASURING, P223; Sousa M, 2013, MED PROBL PERFORM AR, V28, P119; Stewart A, 2011, INT SOC ADV KINANTHR; Sundgot-Borgen J, 2011, J SPORT SCI, V29, pS101, DOI 10.1080/02640414.2011.565783; Tipton KD, 2004, J SPORT SCI, V22, P65, DOI 10.1080/0264041031000140554; Twitchett Emily, 2010, J Dance Med Sci, V14, P127; Warren MP, 2002, J CLIN ENDOCR METAB, V87, P3162, DOI 10.1210/jc.87.7.3162; Wyon MA, 2011, INT J SPORTS MED, V32, P851, DOI 10.1055/s-0031-1279718	63	24	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171998	10.1371/journal.pone.0171998	http://dx.doi.org/10.1371/journal.pone.0171998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212449	Green Published, Green Accepted, gold			2022-12-26	WOS:000394424700015
J	Dekens, MPS; Foulkes, NS; Tessmar-Raible, K				Dekens, Marcus P. S.; Foulkes, Nicholas S.; Tessmar-Raible, Kristin			Instrument design and protocol for the study of light controlled processes in aquatic organisms, and its application to examine the effect of infrared light on zebrafish	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; DIEL VARIATIONS; CLOCK GENE; ENTRAINMENT; PHOTOPERIOD; EXPRESSION; THYROXINE; DIVERSITY; CORTISOL; RHYTHMS	The acquisition of reliable data strongly depends on experimental design. When studying the effects of light on processes such as behaviour and physiology it is crucial to maintain all environmental conditions constant apart from the one under study. Furthermore, the precise values of the environmental factors applied during the experiment should be known. Although seemingly obvious, these conditions are often not met when the effects of light are being studied. Here, we document and discuss the wavelengths and light intensities of natural and artificial light sources. We present standardised experimental protocols together with building plans of a custom made instrument designed to accurately control light and temperature for experiments using fresh water or marine species. Infrared light is commonly used for recording behaviour and in electrophysiological experiments although the properties of fish photoreceptors potentially allow detection into the far red. As an example of our experimental procedure we have applied our protocol and instrument to specifically test the impact of infrared light ( 840 nm) on the zebrafish circadian clock, which controls many aspects of behaviour, physiology and metabolism. We demonstrate that infrared light does not influence the zebrafish circadian clock. Our results help to provide a solid framework for the future study of light dependent processes in aquatic organisms.	[Dekens, Marcus P. S.; Tessmar-Raible, Kristin] Univ Vienna, Vienna Bioctr, Max Perutz Labs, Vienna, Austria; [Foulkes, Nicholas S.] Karlsruhe Inst Technol, Eggenstein, Germany; [Foulkes, Nicholas S.] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Tessmar-Raible, Kristin] Univ Vienna, Res Platform Rhythms Life, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; University of Vienna	Dekens, MPS; Tessmar-Raible, K (corresponding author), Univ Vienna, Vienna Bioctr, Max Perutz Labs, Vienna, Austria.; Foulkes, NS (corresponding author), Karlsruhe Inst Technol, Eggenstein, Germany.; Foulkes, NS (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany.; Tessmar-Raible, K (corresponding author), Univ Vienna, Res Platform Rhythms Life, Vienna, Austria.	marcus.dekens@gmail.com; nicholas.foulkes@kit.edu; kristin.tessmar@mfpl.ac.at	Tessmar-Raible, Kristin/F-9642-2011	Tessmar-Raible, Kristin/0000-0002-8038-1741; Dekens, Marcus P.S./0000-0003-1689-3491	Austrian Science Fund FWF [P 28970] Funding Source: Medline; European Research Council [337011] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission)		[Anonymous], 1908, BIOMETRIKA, V6, P1; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Davies WIL, 2015, GENOME RES, V25, P1666, DOI 10.1101/gr.189886.115; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; DAVIS RE, 1965, ANIM BEHAV, V13, P154, DOI 10.1016/0003-3472(65)90086-2; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Enright JM, 2015, CURR BIOL, V25, P3048, DOI 10.1016/j.cub.2015.10.018; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Livne ZB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006445; Lopez-Olmeda JF, 2010, CHRONOBIOL INT, V27, P1380, DOI 10.3109/07420528.2010.501926; Lythgoe J.N., 1988, P57; Mracek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067858; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NOESKE TA, 1983, J FISH BIOL, V23, P705, DOI 10.1111/j.1095-8649.1983.tb02947.x; Osborne NS, 1939, J RES NAT BUR STAND, V23, P197, DOI 10.6028/jres.023.008; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; SPIELER RE, 1984, T AM FISH SOC, V113, P528, DOI 10.1577/1548-8659(1984)113&lt;528:EOPAFS&gt;2.0.CO;2; SPIELER RE, 1992, NATO ADV SCI INST SE, V236, P137; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tarttelin EE, 2012, J EXP BIOL, V215, P2898, DOI 10.1242/jeb.071084; Villamizar N, 2014, ZEBRAFISH, V11, P173, DOI 10.1089/zeb.2013.0926; WEBER DN, 1987, EXPERIENTIA, V43, P621, DOI 10.1007/BF02126355; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Zantke J, 2013, CELL REP, V5, P99, DOI 10.1016/j.celrep.2013.08.031; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103	43	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172038	10.1371/journal.pone.0172038	http://dx.doi.org/10.1371/journal.pone.0172038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212399	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700017
J	Bradley, D; Conklin, E; Papastamatiou, YP; McCauley, DJ; Pollock, K; Kendall, BE; Gaines, SD; Caselle, JE				Bradley, Darcy; Conklin, Eric; Papastamatiou, Yannis P.; McCauley, Douglas J.; Pollock, Kydd; Kendall, Bruce E.; Gaines, Steven D.; Caselle, Jennifer E.			Growth and life history variability of the grey reef shark (Carcharhinus amblyrhynchos) across its range	PLOS ONE			English	Article							GULF-OF-MEXICO; REPRODUCTIVE-BIOLOGY; GALEOCERDO-CUVIER; LAMNA-NASUS; TIGER SHARK; BASE-LINES; POPULATION-STRUCTURE; AGE VALIDATION; SPHYRNA-TIBURO; BARRIER-REEF	For broadly distributed, often overexploited species such as elasmobranchs (sharks and rays), conservation management would benefit from understanding how life history traits change in response to local environmental and ecological factors. However, fishing obfuscates this objective by causing complex and often mixed effects on the life histories of target species. Disentangling the many drivers of life history variability requires knowledge of elasmobranch populations in the absence of fishing, which is rarely available. Here, we describe the growth, maximum size, sex ratios, size at maturity, and offer a direct estimate of survival of an unfished population of grey reef sharks (Carcharhinus amblyrhynchos) using data from an eight year tag-recapture study. We then synthesized published information on the life history of C. amblyrhynchos from across its geographic range, and for the first time, we attempted to disentangle the contribution of fishing from geographic variation in an elasmobranch species. For Palmyra's unfished C. amblyrhynchos population, the von Bertalanffy growth function (VBGF) growth coefficient k was 0.05 and asymptotic length L-infinity was 163.3 cm total length (TL). Maximum size was 175.5 cm TL from a female shark, length at maturity was estimated at 116.7-123.2 cm TL for male sharks, maximum lifespan estimated from VBGF parameters was 18.1 years for both sexes combined, and annual survival was 0.74 year(-1). Consistent with findings from studies on other elasmobranch species, we found significant intraspecific variability in reported life history traits of C. amblyrhynchos. However, contrary to what others have reported, we did not find consistent patterns in life history variability as a function of biogeography or fishing. Ultimately, the substantial, but not yet predictable variability in life history traits observed for C. amblyrhynchos across its geographic range suggests that regional management may be necessary to set sustainable harvest targets and to recover this and other shark species globally.	[Bradley, Darcy; Kendall, Bruce E.; Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Conklin, Eric; Pollock, Kydd] Nature Conservancy, Honolulu, HI USA; [Papastamatiou, Yannis P.] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [McCauley, Douglas J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [McCauley, Douglas J.; Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Nature Conservancy; State University System of Florida; Florida International University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bradley, D (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	darcybradley@ucsb.edu	Gaines, Steven/Y-3234-2019; Kendall, Bruce/C-1871-2008	Kendall, Bruce/0000-0003-1782-8106; Bradley, Darcy/0000-0003-2581-8768	Koaniani Foundation; Georgia Welles and Deke Welles; Marisla Foundation grant; NSF [DGE-114408]; Dr. Daniel Vapnek Fellowship (UCSB Bren School); AAUS Kathy Johnston English Scholarship	Koaniani Foundation; Georgia Welles and Deke Welles; Marisla Foundation grant; NSF(National Science Foundation (NSF)); Dr. Daniel Vapnek Fellowship (UCSB Bren School); AAUS Kathy Johnston English Scholarship	Funding was provided by the Koaniani Foundation (TNC), Georgia Welles and Deke Welles (TNC), and a Marisla Foundation grant (JEC). DB was supported by a NSF Graduate Research Fellowship (DGE-114408), a Dr. Daniel Vapnek Fellowship (UCSB Bren School), and an AAUS Kathy Johnston English Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Beverton R.J.H., 1959, CIBA FDN C AGEING, V5, P142, DOI DOI 10.1002/9780470715253.CH10; Bradley D, SCI REPORTS IN PRESS; Cailliet GM, 2015, J FISH BIOL, V87, P1271, DOI 10.1111/jfb.12829; Cailliet G. M., 1990, NOAA TECH REP NMFS, V90, P167; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana SE, 2009, SHARKS OPEN OCEAN BI; Carlson JK, 2003, MAR FRESHWATER RES, V54, P227, DOI 10.1071/MF02153; Carlson JK, 1997, ENVIRON BIOL FISH, V50, P331, DOI 10.1023/A:1007342203214; Carlson JK, 2006, ENVIRON BIOL FISH, V77, P279, DOI 10.1007/s10641-006-9129-x; Cassoff RM, 2007, CAN J FISH AQUAT SCI, V64, P19, DOI 10.1139/F06-167; Chin A, 2013, J FISH BIOL, V82, P1192, DOI 10.1111/jfb.12057; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Davidson LNK, 2015, FISH FISH; DAWSON E. YALE, 1959, PACIFIC NAT, V1, P1; DeCrosta MA, 1984, P 2 S RES INV NW HAW, V2, P75; Driggers WB, 2004, ENVIRON BIOL FISH, V71, P171, DOI 10.1007/s10641-004-0105-z; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dureuil M, 2015, J FISH BIOL, V87, P1389, DOI 10.1111/jfb.12830; Ebert D.A., 2013, FAO SPECIES CAT FISH, V7, P1; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Ellis JR, 2008, ICES J MAR SCI, V65, P979, DOI 10.1093/icesjms/fsn080; Espinoza M, 2014, MAR BIOL; Eveson JP, 2007, CAN J FISH AQUAT SCI, V64, P602, DOI 10.1139/F07-036; FABENS AJ, 1965, GROWTH, V29, P265; Farrell ED, 2010, J FISH BIOL, V77, P1505, DOI 10.1111/j.1095-8649.2010.02771.x; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; FRANCIS RICC, 1988, NEW ZEAL J MAR FRESH, V22, P43, DOI 10.1080/00288330.1988.9516276; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; Garrick JAF, 1982, NOAA TECH REP; GULLAND J. A., 1959, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V25, P47; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Hisano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025028; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Hoenig JM, 1990, ELASMOBRANCHS LIVING; Holmes BJ, 2015, J FISH BIOL, V87, P422, DOI 10.1111/jfb.12732; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JAMES IR, 1991, BIOMETRICS, V47, P1519, DOI 10.2307/2532403; Jiao Y, 2005, FISH RES, V72, P173, DOI 10.1016/j.fishres.2004.11.003; KIMURA DK, 1993, FISH B-NOAA, V91, P271; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; Knip DM, 2012, J FISH BIOL, V80, P767, DOI 10.1111/j.1095-8649.2012.03223.x; Kumoru L., 2003, 176 M STAND COMM TUN; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Lombardi-Carlson LA, 2003, MAR FRESHWATER RES, V54, P875, DOI 10.1071/MF03023; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MALLER RA, 1988, AUST J MAR FRESH RES, V39, P459; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Mourier J, 2013, J FISH BIOL, V82, P979, DOI 10.1111/jfb.12039; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Natanson LJ, 2002, FISH B-NOAA, V100, P266; Neer JA, 2005, ENVIRON BIOL FISH, V73, P321, DOI 10.1007/s10641-005-2136-5; Nelson GA, 2014, **DATA OBJECT**; Papastamatiou YP, 2009, J FISH BIOL, V75, P647, DOI 10.1111/j.1095-8649.2009.02329.x; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; PAULY D, 1980, J CONSEIL, V39, P175; Plummer M, 2014, RJAGS BAYESIAN GRAPH; R Core Team, 2021, R LANGUAGE ENV STAT; Radtke RL, 1984, P 2 S RES INV NWHI, V2, P121; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rizzari JR, 2014, MAR BIOL, V161, P2847, DOI 10.1007/s00227-014-2550-3; Robbins W.D, 2006, THESIS JAMES COOK U; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Robinson L, 2013, AFR J MAR SCI, V35, P9, DOI 10.2989/1814232X.2013.769906; Royle J. A., 2008, HIERARCHICAL MODELIN; SAINSBURY KJ, 1980, CAN J FISH AQUAT SCI, V37, P241, DOI 10.1139/f80-031; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Skomal GB, 2003, FISH B-NOAA, V101, P627; Skomal G, 2007, MAR TECHNOL SOC J, V41, P44, DOI 10.4031/002533207787441999; Smart JJ, 2015, AFR J MAR SCI, V37, P177, DOI 10.2989/1814232X.2015.1025428; Smart JJ, 2016, FISH FISHERIES; Smart JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153116; Sminkey TR, 1995, COPEIA, P871; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; STEVENS JD, 1984, PROC R SOC SER B-BIO, V222, P79, DOI 10.1098/rspb.1984.0050; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Tester A.L., 1969, COOPERATIVE SHARK RE; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Walker TI, 2007, MAR FRESHWATER RES, V58, P67, DOI 10.1071/MF06074; Walker TI, 1998, FISH RES, V39, P139, DOI 10.1016/S0165-7836(98)00180-5; Wass RC, 1971, THESIS; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; Wetherbee BM, 1996, ENVIRON BIOL FISH, V45, P299, DOI 10.1007/BF00003099; WOOD CC, 1979, J FISH RES BOARD CAN, V36, P647, DOI 10.1139/f79-094	107	27	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172370	10.1371/journal.pone.0172370	http://dx.doi.org/10.1371/journal.pone.0172370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207874	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500128
J	Guthrie, JL; Fisman, D; Gardy, JL				Guthrie, Jennifer L.; Fisman, David; Gardy, Jennifer L.			Self-rated health and reasons for nonvaccination against seasonal influenza in Canadian adults with asthma	PLOS ONE			English	Article							PNEUMOCOCCAL VACCINATION; ELDERLY OUTPATIENTS; MEDICAL-RECORDS; DISEASE; SURVEILLANCE; CHILDREN; FLU; US	Introduction While seasonal influenza vaccination is recommended for individuals with asthma, uptake in this population is low. We examined how self-rated health impacts reasons for not being immunized against influenza in Canadian adults with asthma, focusing on those who have never been immunized. Methods We pooled four cycles of the Canadian Community Health Survey (cycles 3.1(2005), 2007/ 08, 2009/10 and 2011/12), grouping individuals by whether their reasons for not having been vaccinated were perceptual or technical. We used a multivariable logistic regression model, adjusted for confounders, to quantify the relationship between self-rated health and their reported reasons for not vaccinating. Results Among the 9,836 respondents, 84.4% cited perceptual barriers as a reason for not being vaccinated. After adjusting for socio-demographic characteristics and province of residence, we determined that reporting perceptual barriers was associated with self-rated health status, with the adjusted odds ratios ranging from 1.42 (95% CI: 0.97, 2.09) to 2.64 (95% CI: 1.74, 3.99) for fair and excellent health versus poor health, respectively. Each increase in self-rated health category was associated with greater odds of citing a perceptual rather than technical barrier as a reason for non-vaccination. Discussion Self-reported health influences people's perception of the need for influenza vaccination. Viewing the results through the lens of the precaution adoption process model suggests that personalizing communication around both the risk of influenza and the effectiveness of the vaccine may improve uptake amongst adults with asthma.	[Guthrie, Jennifer L.; Gardy, Jennifer L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Fisman, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of British Columbia; University of Toronto	Guthrie, JL (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	jennifer.guthrie@alumni.ubc.ca	Guthrie, Jennifer/ABE-2378-2021	Guthrie, Jennifer/0000-0001-8565-203X; Gardy, Jennifer/0000-0001-7255-7631				Centers for Disease Control and Prevention, 2015, FLU PEOPL ASTHM SEAS; Chen Y, 2007, VACCINE, V25, P7436, DOI 10.1016/j.vaccine.2007.08.003; Chi RC, 2006, J AM GERIATR SOC, V54, P217, DOI 10.1111/j.1532-5415.2005.00577.x; Dube E, 2014, AM J INFECT CONTROL, V42, pE55, DOI 10.1016/j.ajic.2014.01.006; Government of Canada PHA of C, 2015, PUBL FUND INFL VACC; Government of Canada SC, 2015, CAN COMM HLTH SURV A; Government of Canada SC, 2013, ACC REG MED DOCT; Government of Canada SC, 2015, ASTHM AG GROUP SEX N; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Kam K, 2013, PAED CHILD HEALT-CAN, V18, pE55, DOI 10.1093/pch/18.9.e55; LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4; Locksley RM, 2014, IMMUNOL CELL BIOL, V92, P389, DOI 10.1038/icb.2014.24; Lu PJ, 2009, AM J PREV MED, V37, P109, DOI 10.1016/j.amepre.2009.03.021; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Manor O, 2001, INT J EPIDEMIOL, V30, P600, DOI 10.1093/ije/30.3.600; Mirabelli MC, 2014, J ASTHMA, V51, P956, DOI 10.3109/02770903.2014.930480; Nowak GJ, 2015, VACCINE, V33, P2741, DOI 10.1016/j.vaccine.2015.04.064; O'Halloran AC, 2016, AM J PREV MED, V50, pE15, DOI 10.1016/j.amepre.2015.06.008; Robinson C A, 1993, Qual Health Res, V3, P6, DOI 10.1177/104973239300300102; Santos-Sancho JM, 2013, INFECTION, V41, P465, DOI 10.1007/s15010-013-0414-2; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Statistics Canada, TRENDS INFL VACC CAN; Thomas Steven, 2009, Health Rep, V20, P53; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019; Villacorta Reginald, 2015, Prev Med Rep, V2, P355, DOI 10.1016/j.pmedr.2015.04.017; Vozoris NT, 2009, RESP MED, V103, P50, DOI 10.1016/j.rmed.2008.08.004; Webster RG, 2014, TXB INFLUENZA; Weinstein N.D., 2008, HLTH BEHAV HLTH ED T, V4th; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; Wu S, 2003, J HEALTH ECON, V22, P675, DOI 10.1016/S0167-6296(03)00042-0; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172117	10.1371/journal.pone.0172117	http://dx.doi.org/10.1371/journal.pone.0172117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207823	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500087
J	Kicken, CH; Roest, M; Henskens, YMC; de Laat, B; Huskens, D				Kicken, Cecile H.; Roest, Mark; Henskens, Yvonne M. C.; de laat, Bas; Huskens, Dana			Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates	PLOS ONE			English	Article							LIGHT TRANSMISSION; STORAGE; TRANSFUSION; BLOOD; AGGREGATION; SURVIVAL	Background Previous studies have shown that flow cytometry is a reliable test to quantify platelet function in stored platelet concentrates (PC). It is thought that flow cytometry is laborious and hence expensive. We have optimized the flow cytometry-based quantification of agonist induced platelet activation (PACT) to a labor, time and more cost-efficient test. Currently the quality of PCs is only monitored by visual inspection, because available assays are unreliable or too laborious for use in a clinical transfusion laboratory. Therefore, the PACT was applied to monitor PC activation during storage. Study design and methods The optimized PACT was used to monitor 5 PCs during 10 days of storage. In brief, optimized PACT uses a ready-to-use reaction mix, which is stable at -20 degrees C. When needed, a test strip is thawed and platelet activation is initiated by mixing PC with PACT. PACT was based on the following agonists: adenosine diphosphate (ADP), collagen-related peptide (CRP) and thrombin receptor -activating peptide (TRAP-6). Platelet activation was measured as P-selectin expression. Light transmission aggregometry (LTA) was performed as a reference. Results Both PACT and LTA showed platelet function decline during 10-day storage after stimulation with ADP and collagen/CRP; furthermore, PACT showed decreasing TRAP-induced activation. Major differences between the two tests are that PACT is able to measure the status of platelets in the absence of agonists, and it can differentiate between the number of activated platelets and the amount of activation, whereas LTA only measures aggregation in response to an agonist. Also, PACT is more time-efficient compared to LTA and allows high-throughput analysis. Conclusion PACT is an optimized platelet function test that can be used to monitor the activation of PCs. PACT has the same accuracy as LTA with regard to monitoring PCs, but it is superior to both LTA and conventional flow cytometry based tests with regard to labor-, time- and cost efficiency.	[Kicken, Cecile H.] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Therapy, Maastricht, Netherlands; [Kicken, Cecile H.; Roest, Mark; de laat, Bas; Huskens, Dana] Synapse Res Inst, Maastricht, Netherlands; [Roest, Mark; de laat, Bas; Huskens, Dana] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst, Maastricht, Netherlands; [Henskens, Yvonne M. C.] Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Kicken, CH (corresponding author), Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Therapy, Maastricht, Netherlands.; Kicken, CH (corresponding author), Synapse Res Inst, Maastricht, Netherlands.	c.kicken@thrombin.com	Henskens, Yvonne/AAD-8596-2020	Kicken, Cecile/0000-0002-8010-8091	Synapse Research Institute	Synapse Research Institute	The authors did not receive specific funding for this work, therefore it was funded with departmental funds from Synapse Research Institute.	Bertolini F, 1996, TRANSFUSION, V36, P128, DOI 10.1046/j.1537-2995.1996.36296181924.x; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Cattaneo M, 2013, J THROMB HAEMOST; Dumont LJ, 2002, TRANSFUSION, V42, P847, DOI 10.1046/j.1537-2995.2002.00147.x; Femia EA, 2013, J THROMB HAEMOST, V11, P2193, DOI 10.1111/jth.12432; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; Holme S, 1997, TRANSFUSION, V37, P12, DOI 10.1046/j.1537-2995.1997.37197176945.x; HOLME S, 1978, J LAB CLIN MED, V92, P53; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kicken C, 2015, THROMB RES, V135, P679, DOI 10.1016/j.thromres.2015.01.004; Kozek-Langenecker SA, 2013, EUR J ANAESTH, V30, P270, DOI 10.1097/EJA.0b013e32835f4d5b; Lance MD, 2012, VOX SANG, V103, P79, DOI 10.1111/j.1423-0410.2011.01580.x; Michelson AD, 2006, PATHOPHYSIOL HAEMO T, V35, P67, DOI 10.1159/000093547; Middelburg RA, 2013, TRANSFUSION, V53, P1780, DOI 10.1111/trf.12001; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Panzer S, 2011, VOX SANG, V101, P1, DOI 10.1111/j.1423-0410.2011.01467.x; Rinder HM, 2003, TRANSFUSION, V43, P2, DOI 10.1046/j.1537-2995.2003.00261.x; Roest M, 2013, TRANSFUS MED HEMOTH, V40, P117, DOI 10.1159/000350688; Sodergren AL, 2016, VOX SANG, V110, P116, DOI 10.1111/vox.12324; Tynngard N, 2015, PLATELETS, V26, P177, DOI 10.3109/09537104.2014.891728; van Bladel ER, 2014, BLOOD, V123, P1556, DOI 10.1182/blood-2013-08-519686	21	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172265	10.1371/journal.pone.0172265	http://dx.doi.org/10.1371/journal.pone.0172265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207883	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500110
J	Kim, SY; Kim, MS; Park, B; Kim, JH; Choi, HG				Kim, So Young; Kim, Min-Su; Park, Bumjung; Kim, Jin-Hwan; Choi, Hyo Geun			Allergic rhinitis, atopic dermatitis, and asthma are associated with differences in school performance among Korean adolescents	PLOS ONE			English	Article							QUALITY-OF-LIFE; LATER ACHIEVEMENT; CHILDREN; SLEEP; DEPRESSION; READINESS; BURDEN; HEALTH; IMPACT; REPLICATION	Several studies have reported negative relations between allergic diseases and school performance but have not simultaneously considered various allergic diseases, including allergic rhinitis, asthma, and atopic dermatitis, and only examined a limited number of participants. The present study investigated the associations of allergic rhinitis, asthma, and atopic dermatitis with school performance in a large, representative Korean adolescent population. A total of 299,695 7th through 12th grade students participated in the Korea Youth Risk Behaviour Web-based Survey (KYRBWS) from 2009 to 2013. The subjects' history of allergic rhinitis, asthma, and atopic dermatitis and number of school absences due to these diseases in the previous 12 months were examined and compared. School performance was classified into 5 levels. The relations between allergic disorders and school performance were analyzed using multiple logistic regressions with complex sampling and adjusted for the subjects' durations of sleep, days of physical activity, body mass indexes (BMIs), regions of residence, economic levels, parents' education levels, stress levels, smoking status, and alcohol use. A subgroup analysis of the economic groups was performed. Allergic rhinitis was positively correlated with better school performance in a dose-dependent manner (adjusted odds ratios, AOR, [95% confidence interval, CI] = 1.50 [1.43-1.56 > 1.33 [1.28-1.38] > 1.17 [1.13-1.22] > 1.09 [1.05-1.14] for grades A > B > C > D; P < 0.001). Asthma was negatively correlated with better school performance (AOR [95% CI] = 0.74 [0.66-0.83], 0.87 [0.79-0.96], 0.83 [0.75-0.91], 0.93 [0.85-1.02] for performance A, B, C, and D, respectively; P < 0.001). Atopic dermatitis was not significantly correlated with school performance. The subgroup analysis of the students' economic levels revealed associations between allergic diseases and school performance. Compared to other allergic disorders, the asthma group had more school absences due to their symptoms (P < 0.001). School performance was positively correlated with allergic rhinitis and negatively correlated with asthma in Korean adolescents, even after adjusting for other variables. The asthma group had an increased number of school absence days, which presumably contributes to these students' poor school performance.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Min-Su] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea; [Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, Jin-Hwan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38).	Adamia N, 2015, Georgian Med News, P38; Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; [Anonymous], 2009, RELIABILITY VALIDITY; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Bahreinian S, 2011, CHEST, V140, P1138, DOI 10.1378/chest.11-0219; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brockmann PE, 2015, SLEEP MED, V16, P1077, DOI 10.1016/j.sleep.2015.03.021; Camfferman D, 2013, INT J PSYCHOPHYSIOL, V89, P265, DOI 10.1016/j.ijpsycho.2013.01.006; Centers for Disease Control and Prevention, BMI CHILDR TEENS 201; Chen H, 2008, VALUE HEALTH, V11, P231, DOI 10.1111/j.1524-4733.2007.00229.x; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; Dean BB, 2009, J ASTHMA, V46, P861, DOI 10.3109/02770900903184237; Ferro MA, 2016, J ASTHMA, V53, P282, DOI 10.3109/02770903.2015.1104694; Gelis N, 2007, Hippokratia, V11, P138; Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Hunter SJ, 2016, AM J RESP CRIT CARE, V194, P739, DOI 10.1164/rccm.201510-2099OC; Jauregui I, 2009, J INVEST ALLERG CLIN, V19, P32; Kim SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003096; Kohlboeck G, 2013, PEDIAT ALLERG IMM-UK, V24, P230, DOI 10.1111/pai.12056; Kronholm E, 2015, J SLEEP RES, V24, P3, DOI 10.1111/jsr.12258; Lee Mee-Ri, 2012, J Prev Med Public Health, V45, P374, DOI 10.3961/jpmph.2012.45.6.374; Long A, 2002, Evid Rep Technol Assess (Summ), P1; Mansfield LE, 2004, ANN ALLERG ASTHMA IM, V92, P240, DOI 10.1016/S1081-1206(10)61554-2; Meltzer EO, 2016, IMMUNOL ALLERGY CLIN, V36, P235, DOI 10.1016/j.iac.2015.12.002; Mir E, 2012, ASIA PAC ALLERGY, V2, P93, DOI 10.5415/apallergy.2012.2.2.93; Montoro J, 2009, J INVEST ALLERG CLIN, V19, P40; Mortz CG, 2015, ALLERGY, V70, P836, DOI 10.1111/all.12619; Myong JP, 2012, ASIAN NURS RES, V6, P102, DOI 10.1016/j.anr.2012.08.001; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Ozdoganoglu T, 2012, THER ADV RESPIR DIS, V6, P11, DOI 10.1177/1753465811431975; Pagani LS, 2014, HEALTH EDUC BEHAV, V41, P25, DOI 10.1177/1090198113478818; Pagani LS, 2010, DEV PSYCHOL, V46, P984, DOI 10.1037/a0018881; Romano E, 2010, DEV PSYCHOL, V46, P995, DOI 10.1037/a0018880; Sanchez Jorge, 2016, Rev Alerg Mex, V63, P32; Schoeppe S., 2014, J PEDIAT RIO J, V14, P91, DOI DOI 10.1016/JJPED.2014.05.002; Seok H, 2016, TOHOKU J EXP MED, V238, P25, DOI 10.1620/tjem.238.25; Sole Dirceu, 2006, J Pediatr (Rio J), V82, P341, DOI [10.1590/S0021-75572006000600006, 10.2223/JPED.1521]; Sundbom F, 2016, J ASTHMA, V53, P398, DOI 10.3109/02770903.2015.1126846; The Global Asthma Network, INT STUD ASTH ALL CH; Tokunaga T, 2015, AM J RHINOL ALLERGY, V29, P94, DOI 10.2500/ajra.2015.29.4135; Vamanshankar H, 2013, J LARYNGOL OTOL, V127, P378, DOI 10.1017/S0022215113000170; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105	43	70	72	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171394	10.1371/journal.pone.0171394	http://dx.doi.org/10.1371/journal.pone.0171394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207843	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500027
J	Neeb, ZT; Hogan, DJ; Katzman, S; Zahler, AM				Neeb, Zachary T.; Hogan, Daniel J.; Katzman, Sol; Zahler, Alan M.			Preferential expression of scores of functionally and evolutionarily diverse DNA and RNA-binding proteins during Oxytricha trifallax macronuclear development	PLOS ONE			English	Article							INTERNAL ELIMINATED SEGMENTS; CILIATE PARAMECIUM-TETRAURELIA; PIWI-INTERACTING RNAS; GENOME-REARRANGEMENT; GENE-EXPRESSION; STYLONYCHIA-LEMNAE; EUPLOTES-CRASSUS; HISTONE H3; TETRAHYMENA-THERMOPHILA; MAXIMUM-LIKELIHOOD	During its sexual reproduction, the stichotrichous ciliate Oxytricha trifallax orchestrates a remarkable transformation of one of the newly formed germline micronuclear genomes. Hundreds of thousands of gene pieces are stitched together, excised from chromosomes, and replicated dozens of times to yield a functional somatic macronuclear genome composed of similar to 16,000 distinct DNA molecules that typically encode a single gene. Little is known about the proteins that carry out this process. We profiled mRNA expression as a function of macronuclear development and identified hundreds of mRNAs preferentially expressed at specific times during the program. We find that a disproportionate number of these mRNAs encode proteins that are involved in DNA and RNA functions. Many mRNAs preferentially expressed during macronuclear development have paralogs that are either expressed constitutively or are expressed at different times during macronuclear development, including many components of the RNA polymerase II machinery and homologous recombination complexes. Hundreds of macronuclear development-specific genes encode proteins that are well-conserved among multicellular eukaryotes, including many with links to germline functions or development. Our work implicates dozens of DNA and RNA-binding proteins with diverse evolutionary trajectories in macronuclear development in O. trifallax. It suggests functional connections between the process of macronuclear development in unicellular ciliates and germline specialization and differentiation in multicellular organisms, and argues that gene duplication is a key source of evolutionary innovation in this process.	[Neeb, Zachary T.; Zahler, Alan M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Neeb, Zachary T.; Zahler, Alan M.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Hogan, Daniel J.] Tocagen Inc, San Diego, CA 92109 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Neeb, Zachary T.] Univ Bern, Inst Cell Biol, Dept Biol, Bern, Switzerland	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Bern	Zahler, AM (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.; Zahler, AM (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.; Hogan, DJ (corresponding author), Tocagen Inc, San Diego, CA 92109 USA.	hogandj@alumni.stanford.edu; zahler@ucsc.edu		Zahler, Alan/0000-0003-0027-1647; Neeb, Zachary T./0000-0001-8930-3574	National Science Foundation EAGER award [MCB-1324780]; UCSC MCD Graduate Training Grant from National Institute of General Medical Sciences [T32-GM008646]; Div Of Molecular and Cellular Bioscience [1324780] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	National Science Foundation EAGER award; UCSC MCD Graduate Training Grant from National Institute of General Medical Sciences; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Science Foundation EAGER award, MCB-1324780, to AMZ. ZTN was supported in part by the UCSC MCD Graduate Training Grant, T32-GM008646, from the National Institute of General Medical Sciences. DJH is an employee of Tocagen, Inc., however his work on this project was done on his own time with no financial support or input from Tocagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2000, J EUKARYOT MICROBIOL, V47, P443, DOI 10.1111/j.1550-7408.2000.tb00073.x; Aeschlimann SH, 2014, GENOME BIOL EVOL, V6, P1707, DOI 10.1093/gbe/evu139; ALLIS CD, 1982, CELL, V31, P131, DOI 10.1016/0092-8674(82)90412-3; AMMERMAN.D, 1968, CHROMOSOMA, V25, P107, DOI 10.1007/BF00327172; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; BANNON GA, 1984, NUCLEIC ACIDS RES, V12, P1961, DOI 10.1093/nar/12.4.1961; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Bracht JR, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r99; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bulic A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-5; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chang WJ, 2004, PROTIST, V155, P245, DOI 10.1078/143446104774199628; Chen X, 2015, GENOME BIOL EVOL, V7, P2859, DOI 10.1093/gbe/evv172; Chen X, 2014, CELL, V158, P1187, DOI 10.1016/j.cell.2014.07.034; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Fetzer CP, 2002, NUCLEIC ACIDS RES, V30, P4380, DOI 10.1093/nar/gkf579; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Forcob S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-4; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GRESLIN AF, 1989, P NATL ACAD SCI USA, V86, P6264, DOI 10.1073/pnas.86.16.6264; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOFFMAN DC, 1995, NUCLEIC ACIDS RES, V23, P1279, DOI 10.1093/nar/23.8.1279; Hoffman DC, 1997, NUCLEIC ACIDS RES, V25, P1883, DOI 10.1093/nar/25.10.1883; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Huang H, 1999, MOL CELL BIOL, V19, P3624; Jacobs ME, 1996, J EUKARYOT MICROBIOL, V43, P442, DOI 10.1111/j.1550-7408.1996.tb04503.x; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jahn CL, 1997, P NATL ACAD SCI USA, V94, P1332, DOI 10.1073/pnas.94.4.1332; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khanduja JS, 2016, MOL CELL, V63, P7, DOI 10.1016/j.molcel.2016.06.011; Khurana JS, 2014, GENETICS, V197, P839, DOI 10.1534/genetics.114.163279; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KLOBUTCHER LA, 1984, CELL, V36, P1045, DOI 10.1016/0092-8674(84)90054-0; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; KLOETZEL JA, 1970, J CELL BIOL, V47, P395, DOI 10.1083/jcb.47.2.395; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kraus WL, 2015, MOL CELL, V58, P901, DOI 10.1016/j.molcel.2015.06.014; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LAUTH MR, 1976, CELL, V7, P67, DOI 10.1016/0092-8674(76)90256-7; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; LIPPS HJ, 1974, CHROMOSOMA, V45, P273; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Murti K.G., 1976, P113; MURTI KG, 1973, J CELL SCI, V13, P479; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Paschka AG, 2005, GENE, V359, P81, DOI 10.1016/j.gene.2005.06.024; Postberg J, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-3; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1998, J EUKARYOT MICROBIOL, V45, P575, DOI 10.1111/j.1550-7408.1998.tb04552.x; PRESCOTT DM, 1973, NATURE, V242, P576, DOI 10.1038/242576a0; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; Prescott DM, 2002, PROTIST, V153, P71, DOI 10.1078/1434-4610-00084; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Prescott DM, 1997, CURR OPIN GENET DEV, V7, P807, DOI 10.1016/S0959-437X(97)80044-5; PRESCOTT DM, 1971, EXP CELL RES, V67, P124, DOI 10.1016/0014-4827(71)90627-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROTH M, 1985, J CELL BIOL, V101, P79, DOI 10.1083/jcb.101.1.79; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; SWANTON MT, 1980, CHROMOSOMA, V77, P217, DOI 10.1007/BF00329546; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TEICHER DA, 1978, IEEE T BIO-MED ENG, V25, P105, DOI 10.1109/TBME.1978.326318; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tucker SL, 2010, COLD SH Q B, V75, P285, DOI 10.1101/sqb.2010.75.037; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004032; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003659; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wang RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21139; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zahler AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042371; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	109	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170870	10.1371/journal.pone.0170870	http://dx.doi.org/10.1371/journal.pone.0170870			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207760	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500014
J	Tian, H; Yuan, XL; Duan, JF; Li, WH; Zhai, BN; Gao, YJ				Tian, Hui; Yuan, Xiaolei; Duan, Jianfeng; Li, Wenhu; Zhai, Bingnian; Gao, Yajun			Influence of nutrient signals and carbon allocation on the expression of phosphate and nitrogen transporter genes in winter wheat ( Triticum aestivum L.) roots colonized by arbuscular mycorrhizal fungi	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA ROOTS; GROWTH; MAIZE; NITRATE; HYPHAE; PCR	Arbuscular mycorrhizal (AM) colonization of plant roots causes the down-regulation of expression of phosphate (Pi) or nitrogen (N) transporter genes involved in direct nutrient uptake pathways. The mechanism of this effect remains unknown. In the present study, we sought to determine whether the expression of Pi or N transporter genes in roots of winter wheat colonized by AM fungus responded to (1) Pi or N nutrient signals transferred from the AM extra-radical hyphae, or (2) carbon allocation changes in the AM association. A threecompartment culture system, comprising a root compartment (RC), a root and AM hyphae compartment (RHC), and an AM hyphae compartment (HC), was used to test whether the expression of Pi or N transporter genes responded to nutrients (Pi, NH4+ and NO3-) added only to the HC. Different AM inoculation density treatments (roots were inoculated with 0, 20, 50 and 200 g AM inoculum) and light regime treatments (6 hours light and 18 hours light) were established to test the effects of carbon allocation on the expression of Pi or N transporter genes in wheat roots. The expression of two Pi transporter genes (TaPT4 and TaPHT1.2), five nitrate transporter genes (TaNRT1.1, TaNRT1.2, TaNRT2.1, TaNRT2.2, and TaNRT2.3), and an ammonium transporter gene (TaAMT1.2) was quantified using realtime polymerase chain reaction. The expression of TaPT4, TaNRT2.2, and TaAMT1.2 was down-regulated by AM colonization only when roots of host plants received Pi or N nutrient signals. However, the expression of TaPHT1.2, TaNRT2.1, and TaNRT2.3 was down-regulated by AM colonization, regardless of whether there was nutrient transfer from AM hyphae. The expression of TaNRT1.2 was also down-regulated by AM colonization even when there was no nutrient transfer from AM hyphae. The present study showed that an increase in carbon consumption by the AM fungi did not necessarily result in greater down-regulation of expression of Pi or N transporter genes.	[Tian, Hui; Yuan, Xiaolei; Duan, Jianfeng; Li, Wenhu; Zhai, Bingnian; Gao, Yajun] Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhai, BN (corresponding author), Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.	zhaibingnian@nwsuaf.edu.cn			National Key Technology RD Program [2015BAD23B04]; Special Fund for Agro-scientific Research in the Public Interest [201503124]; Fundamental Research Funds for the Central Universities [2452015048]	National Key Technology RD Program(National Key Technology R&D Program); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was funded by the National Key Technology R&D Program (2015BAD23B04), Special Fund for Agro-scientific Research in the Public Interest (201503124) and the Fundamental Research Funds for the Central Universities (2452015048).	Avio L, 2006, NEW PHYTOL, V172, P347, DOI 10.1111/j.1469-8137.2006.01839.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; Bellefeuille SD, 2016, HARMFUL ALGAE, V55, P272, DOI 10.1016/j.hal.2016.03.021; Burleigh SH, 2002, PLANT SOIL, V244, P247, DOI 10.1023/A:1020227232140; Burleigh SH, 2001, PLANT SCI, V160, P899, DOI 10.1016/S0168-9452(00)00460-X; Calderon FJ, 2012, SOIL SCI SOC AM J, V76, P1614, DOI 10.2136/sssaj2011.0440; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Drissner D, 2007, SCIENCE, V318, P265, DOI 10.1126/science.1146487; Duan JF, 2015, PLANT PHYSIOL BIOCH, V96, P199, DOI 10.1016/j.plaphy.2015.08.006; Feddermann N, 2010, FUNGAL ECOL, V3, P1, DOI 10.1016/j.funeco.2009.07.003; Gobbato E, 2015, CURR OPIN PLANT BIOL, V26, P1, DOI 10.1016/j.pbi.2015.05.006; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; Harrison MJ, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P117, DOI 10.1007/978-90-481-9489-6_6; Hodge A, 2010, FUNGAL ECOL, V3, P267, DOI 10.1016/j.funeco.2010.02.002; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Horneck DA, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P75; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Konvalinkova T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00782; [李宝珍 LI Bao-Zhen], 2009, [植物生理学通讯, Plant Physiology Communications], V45, P80; Li JR, 2012, PLANT BIOTECHNOL REP, V6, P183, DOI 10.1007/s11816-011-0213-0; [刘芳朋 Liu Fangpeng], 2012, [河北农业大学学报, Journal of Agricultural University of Hebei], V35, P1; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu JQ, 2005, PLANT J, V41, P257, DOI 10.1111/j.1365-313X.2004.02289.x; Martin AB, 2000, PLANT SCI, V154, P143, DOI 10.1016/S0168-9452(99)00251-4; MCGONIGLE TP, 1990, NEW PHYTOL, V116, P629, DOI 10.1111/j.1469-8137.1990.tb00548.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Ruffel S, 2014, J EXP BOT, V65, P5509, DOI 10.1093/jxb/eru321; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz AM, 2014, J INTEGR PLANT BIOL, V56, P250, DOI 10.1111/jipb.12155; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Stonor RN, 2014, MYCORRHIZA, V24, P465, DOI 10.1007/s00572-014-0556-9; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tian H, 2013, MYCORRHIZA, V23, P507, DOI 10.1007/s00572-013-0491-1; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; van Aarle IM, 2002, MYCOL RES, V106, P1224, DOI 10.1017/S0953756202006470; [王萍 WANG Ping], 2006, [植物营养与肥料学报, Plant nutrition and fertitizer science], V12, P584; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Zhang L., 2011, THESIS	42	18	23	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172154	10.1371/journal.pone.0172154	http://dx.doi.org/10.1371/journal.pone.0172154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207830	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500090
J	Zhang, YH; Tang, L; Liu, XJ; Liu, LL; Cao, WX; Zhu, Y				Zhang, Yonghui; Tang, Liang; Liu, Xiaojun; Liu, Leilei; Cao, Weixing; Zhu, Yan			Modeling the leaf angle dynamics in rice plant	PLOS ONE			English	Article							FUNCTIONAL-STRUCTURAL MODEL; ARCHITECTURAL MODEL; LIGHT INTERCEPTION; DENSITY-FUNCTION; WHEAT; RECONSTRUCTION; VISUALIZATION; MORPHOLOGY; RADIATION; AREA	The leaf angle between stem and sheath (SSA) is an important rice morphological trait. The objective of this study was to develop and validate a dynamic SSA model under different nitrogen (N) rates for selected rice cultivars. The time-course data of SSA were collected in three years, and a dynamic SSA model was developed for different main stem leaf ranks under different N rates for two selected rice cultivars. SSA increased with tiller age. The SSA of the same leaf rank increased with increase in N rate. The maximum SSA increased with leaf rank from the first to the third leaf, then decreased from the third to the final leaf. The relationship between the maximum SSA and leaf rank on main stem could be described with a linear piecewise function. The change of SSA with thermal time (TT) was described by a logistic equation. A variety parameter (the maximum SSA of the 3rd leaf on main stem) and a nitrogen factor were introduced to quantify the effect of cultivar and N rate on SSA. The model was validated against data collected from both pot and field experiments. The relative root mean square error (RRMSE) was 11.56% and 14.05%, respectively. The resulting models could be used for virtual rice plant modeling and plant-type design.	[Zhang, Yonghui] Weifang Univ, Comp Engn Sch, Weifang, Peoples R China; [Zhang, Yonghui; Tang, Liang; Liu, Xiaojun; Liu, Leilei; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China	Weifang University; Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China.	zhuyannjau@163.com	Tang, Liang/L-2889-2019; Zhu, Yan/AAK-6927-2020	Tang, Liang/0000-0002-3483-0462; Zhu, Yan/0000-0002-8912-3888	National High-Tech R&D Program of China [2013M100404, 2012AA101306]; National Natural Science Foundation of China [31201130, 61471269, 31571566]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Shandong Province [BS2015DX001]; Science and Technology Development Project of Weifang [2016GX019]; Doctoral Foundation of Weifang University of China	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology Development Project of Weifang; Doctoral Foundation of Weifang University of China	The work is supported by the National High-Tech R&D Program of China (2013M100404, 2012AA101306), the National Natural Science Foundation of China (Grant No. 31201130, 61471269, 31571566), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Natural Science Foundation of Shandong Province (BS2015DX001), Science and Technology Development Project of Weifang (2016GX019), and the Doctoral Foundation of Weifang University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Buck-Sorlin GH, 2000, AGRONOMIE, V20, P691, DOI 10.1051/agro:2000161; Buck-Sorlin GH, 2005, NEW PHYTOL, V166, P859, DOI 10.1111/j.1469-8137.2005.01324.x; CAMPBELL GS, 1990, AGR FOREST METEOROL, V49, P173, DOI 10.1016/0168-1923(90)90030-A; Ding WL, 2011, RICE SCI, V18, P224, DOI 10.1016/S1672-6308(11)60031-0; Dornbusch T, 2007, VISUAL COMPUT, V23, P569, DOI 10.1007/s00371-007-0119-6; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Evers JB, 2007, ECOL MODEL, V200, P308, DOI 10.1016/j.ecolmodel.2006.07.042; Fournier C, 1998, ANN BOT-LONDON, V81, P233, DOI 10.1006/anbo.1997.0549; Fournier M, 2013, J EXP BOT, V64, P4793, DOI 10.1093/jxb/ert279; FUCHS M, 1984, AGR FOREST METEOROL, V32, P13, DOI 10.1016/0168-1923(84)90024-8; GAO LZ, 1987, AGR FOREST METEOROL, V39, P205, DOI 10.1016/0168-1923(87)90038-4; Guo Y, 2006, ANN BOT-LONDON, V97, P217, DOI 10.1093/aob/mcj033; Hanan JS, 2003, AGR SYST, V75, P47, DOI 10.1016/S0308-521X(01)00114-7; IVANOV N, 1995, AGR FOREST METEOROL, V75, P85, DOI 10.1016/0168-1923(94)02204-W; Kaitaniemi P, 2000, COMPUT ELECTRON AGR, V28, P195, DOI 10.1016/S0168-1699(00)00126-5; Khush GS, 2002, CROP IMPROVEMENT: CHALLENGES IN THE TWENTY-FIRST CENTURY, P17; LuLiHua, 2008, Scientia Agricultura Sinica, V41, P2624; NILSON T, 1971, AGR METEOROL, V8, P25, DOI 10.1016/0002-1571(71)90092-6; Peng S, 1994, BREAKING YIELD BARRI, P5; Ross J., 1981, THE RADIATION REGIME; Ruiz RA, 2008, EUR J AGRON, V29, P144, DOI 10.1016/j.eja.2008.05.003; Shi ChunLin, 2006, Acta Agronomica Sinica, V32, P656; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Tadrist L, 2014, J THEOR BIOL, V341, P9, DOI 10.1016/j.jtbi.2013.09.025; Thomas SC, 2000, AGR FOREST METEOROL, V100, P19, DOI 10.1016/S0168-1923(99)00089-1; Verhoef W., 1998, THEORY RADIATIVE TRA; Wang WM, 2007, AGR FOREST METEOROL, V143, P106, DOI 10.1016/j.agrformet.2006.12.003; Watanabe T, 2005, ANN BOT-LONDON, V95, P1131, DOI 10.1093/aob/mci136; Wit C. T de, 1965, Agricultural Research Report, Centre for Agricultural Publications and Documentation, Wageningen, P57; Xu LF, 2011, ANN BOT-LONDON, V107, P817, DOI 10.1093/aob/mcq264; Xu LiNa, 2012, Acta Agronomica Sinica, V38, P301; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang YH, 2014, J INTEGR AGR, V13, P749, DOI 10.1016/S2095-3119(13)60391-3; Zheng BY, 2008, FUNCT PLANT BIOL, V35, P900, DOI 10.1071/FP08060; Zhu Y, 2009, NJAS-WAGEN J LIFE SC, V57, P73, DOI 10.1016/j.njas.2009.11.001; Zou XC, 2015, AGR FOREST METEOROL, V205, P73, DOI 10.1016/j.agrformet.2015.02.016; Zou XC, 2014, AGR FOREST METEOROL, V184, P137, DOI 10.1016/j.agrformet.2013.09.010	38	7	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171890	10.1371/journal.pone.0171890	http://dx.doi.org/10.1371/journal.pone.0171890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207799	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500057
J	Toniti, W; Yoshida, T; Tsurumura, T; Irikura, D; Monma, C; Kamata, Y; Tsuge, H				Toniti, Waraphan; Yoshida, Toru; Tsurumura, Toshiharu; Irikura, Daisuke; Monma, Chie; Kamata, Yoichi; Tsuge, Hideaki			Crystal structure and structure-based mutagenesis of actin-specific ADP-ribosylating toxin CPILE-a as novel enterotoxin	PLOS ONE			English	Article							PERFRINGENS IOTA-TOXIN; ADENOSINE-DIPHOSPHATE RIBOSYLATION; PROTEIN-SYNTHESIS; BACTERIAL TOXINS; C3 EXOENZYME; CLOSTRIDIUM; RECOGNITION; MECHANISM; SITE; RIBOSYLTRANSFERASE	Unusual outbreaks of food poisoning in Japan were reported in which Clostridium perfringens was strongly suspected to be the cause based on epidemiological information and fingerprinting of isolates. The isolated strains lack the typical C. perfringens enterotoxin (CPE) but secrete a new enterotoxin consisting of two components: C. perfringens iota-like enterotoxin- a (CPILE-a), which acts as an enzymatic ADP-ribosyltransferase, and CPILE-b, a membrane binding component. Here we present the crystal structures of apo-CPILE-a, NAD(+) -CPILE-a and NADH-CPILE-a. Though CPILE-a structure has high similarity with known iota toxin-a (Ia) with NAD+, it possesses two extra-long protruding loops from G262S269 and E402-K408 that are distinct from Ia. Based on the Ia-actin complex structure, we focused on actin-binding interface regions (I-V) including two protruding loops (PT) and examined how mutations in these regions affect the ADP-ribosylation activity of CPILE-a. Though some site-directed mutagenesis studies have already been conducted on the actin binding site of Ia, in the present study, mutagenesis studies were conducted against both alpha- and beta/gamma-actin in CPILE-a and Ia. Interestingly, CPILE-a ADP-ribosylates both alpha- and beta/gamma-actin, but its sensitivity towards beta/gamma-actin is 36% compared with a-actin. Our results contrast to that only C2-I ADP-ribosylates beta/gamma-actin. We also showed that PT-I and two convex-concave interactions in CPILE-a are important for actin binding. The current study is the first detailed analysis of site-directed mutagenesis in the actin binding region of Ia and CPILE-a against both alpha- and beta/gamma-actin.	[Toniti, Waraphan; Yoshida, Toru; Tsurumura, Toshiharu; Tsuge, Hideaki] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan; [Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto, Japan; [Irikura, Daisuke] Horiba Ltd, Adv R&D Ctr, Kyoto, Japan; [Monma, Chie] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo, Japan; [Kamata, Yoichi] Iwate Univ, Dept Vet Med, Morioka, Iwate, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Horiba Ltd.; Tokyo Metropolitan Institute of Public Health; Iwate University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan.; Tsuge, H (corresponding author), Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163	Horiba Ltd.;  [16J09051];  [15K08289]	Horiba Ltd.; ; 	This work was funded by a Grant-in-Aid for JSPS Research Fellow (16J09051) and Grant-in-Aid for Scientific Research (C) (15K08289). Horiba Ltd. provided support in the form of salaries for author DI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2015, CURR TOP MICROBIOL, V384, P53, DOI 10.1007/82_2014_382; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Belyy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145708; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; CHUNG DW, 1977, INFECT IMMUN, V16, P832, DOI 10.1128/IAI.16.3.832-841.1977; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HONJO T, 1968, J BIOL CHEM, V243, P3553; HONJO T, 1971, J BIOL CHEM, V246, P4251; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; Irikura D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138183; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; KATADA T, 1982, J BIOL CHEM, V257, P7210; Kawahara K, 2016, BIOCHEM BIOPH RES CO, V480, P261, DOI 10.1016/j.bbrc.2016.10.042; Knapp O, 2016, BBA-BIOMEMBRANES, V1858, P512, DOI 10.1016/j.bbamem.2015.08.006; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lyras D, 2014, ANAEROBE, V30, P183, DOI 10.1016/j.anaerobe.2014.11.006; Marvaud JC, 2002, J BIOL CHEM, V277, P43659, DOI 10.1074/jbc.M207828200; Monma C, 2015, J CLIN MICROBIOL, V53, P859, DOI 10.1128/JCM.02859-14; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Nagahama M, 2002, INFECT IMMUN, V70, P1909, DOI 10.1128/IAI.70.4.1909-1914.2002; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2016, CURR TOP MICROBIOL I; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; vanDamme J, 1996, FEBS LETT, V380, P291, DOI 10.1016/0014-5793(96)00052-X; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Yonogi S, 2014, INFECT IMMUN, V82, P2390, DOI 10.1128/IAI.01759-14	53	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							0171278	10.1371/journal.pone.0171278	http://dx.doi.org/10.1371/journal.pone.0171278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199340	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424400028
J	Kapurubandara, S; Melov, SJ; Shalou, ER; Mukerji, M; Yim, S; Rao, U; Battikhi, Z; Karunaratne, N; Nayyar, R; Alahakoon, TI				Kapurubandara, Supuni; Melov, Sarah J.; Shalou, Evangeline R.; Mukerji, Monika; Yim, Stephen; Rao, Ujvala; Battikhi, Zain; Karunaratne, Nirusha; Nayyar, Roshini; Alahakoon, Thushari I.			A perinatal review of singleton stillbirths in an Australian metropolitan tertiary centre	PLOS ONE			English	Review							RISK; PREGNANCY; DEATHS; COHORT; RATES	It is estimated that everyday 7000 women worldwide have their pregnancy end with a stillbirth, however, research and data collection on stillbirth remains underfunded. This stillbirth case series audit investigates an apparent rise in stillbirths at a Sydney tertiary referral hospital in Australia. A retrospective case series of singleton stillbirths from 2005-2010 was conducted at Westmead Hospital. Stillbirth was defined as per the Perinatal Society of Australia and New Zealand classification as a death of a baby before or during birth, from the 20th week of pregnancy onwards, or a birth weight of 400 grams or more if gestational age is unknown. A total of 215 singleton stillbirths were identified in a cohort of 28 109, a rate of 7.6 per 1000 singleton births. There was a significant increase in annual stillbirth rate at our institution; the rate exceeded both Australian national and state singleton stillbirth rates. After pregnancy terminations over 20 weeks were excluded from the data, there was no statistical change in the stillbirth rate over time. Congenital anomalies (27%) and unexplained antepartum death (15%) remained as major causes; fetal growth restriction (17%) was also identified as an increasingly important cause, particularly in preterm gestations. Termination of pregnancy after 20 weeks was found to be the cause of rising stillbirth rate at our institution. Local and national data collection on stillbirth should be standardised and should include differentiation of termination of pregnancy as a separate entity so as to accurately assess stillbirth to target appropriate research and resource allocation.	[Kapurubandara, Supuni; Melov, Sarah J.; Shalou, Evangeline R.; Mukerji, Monika; Yim, Stephen; Rao, Ujvala; Nayyar, Roshini; Alahakoon, Thushari I.] Westmead Hosp, Westmead Inst Maternal & Fetal Med, Sydney, NSW, Australia; [Kapurubandara, Supuni; Alahakoon, Thushari I.] Univ Sydney, Sydney, NSW, Australia; [Battikhi, Zain] Liverpool Hosp, Sydney, NSW, Australia; [Karunaratne, Nirusha] Nepean Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; Liverpool Hospital; Nepean Hospital	Melov, SJ (corresponding author), Westmead Hosp, Westmead Inst Maternal & Fetal Med, Sydney, NSW, Australia.	Sarah.Melov@health.nsw.gov.au	Melov, Sarah J/AFK-4262-2022	Melov, Sarah J/0000-0002-7569-1016				Akseer N, 2015, INT J GYNECOL OBSTET, V131, pS43, DOI 10.1016/j.ijgo.2015.03.017; [Anonymous], 2012, PERINATAL STAT SERIE; [Anonymous], CLIN PRACT GUID PER; Australian Institute of Health and Welfare, 2015, PERINATAL STAT SERIE, V31; Bartsch E, 2015, J OBSTET GYNAECOL CA, V37, P314, DOI 10.1016/S1701-2163(15)30281-4; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Bythell M, 2008, BJOG-INT J OBSTET GY, V115, P664, DOI 10.1111/j.1471-0528.2008.01668.x; (CMACE) C. f.M.a.C.E, 2011, PER MORT 2009 UK; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Craig ED, 2004, AUST NZ J OBSTET GYN, V44, P441, DOI 10.1111/j.1479-828X.2004.00284.x; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; Drysdale H, 2012, MED J AUSTRALIA, V197, P278, DOI 10.5694/mja12.10125; Farrant BM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0904-1; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Flenady V, 2010, AUST NZ J OBSTET GYN, V50, P138, DOI 10.1111/j.1479-828X.2009.01125.x; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, P1; Gardosi J., 2013, BMJ-BRIT MED J, V346, P346; Gynecologists RCOG, 2010, GREEN TOP GUIDELINE, V55, P1; Hamamy H, 2012, J COMMUN GENET, V3, P185, DOI 10.1007/s12687-011-0072-y; Heazell AEP, 2009, J OBSTET GYNAECOL, V29, P225, DOI 10.1080/01443610802716042; Hilder L, 2014, PERINATAL STAT SERIE, V30; Horton R, 2016, LANCET, V387, P418, DOI 10.1016/S0140-6736(16)00159-8; Joseph KS, 2013, CAN MED ASSOC J, V185, pE345, DOI 10.1503/cmaj.121372; Kapurubandara S, 2016, AUST NZ J OBSTET GYN; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; LEISHER SH, 2016, BMC PREGNANCY CHILDB, V16, DOI DOI 10.1186/S12884-016-; Penn N, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0404-0; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Stacey T, 2012, AUST NZ J OBSTET GYN, V52, P242, DOI 10.1111/j.1479-828X.2011.01406.x; Stoltenberg C, 1999, AM J PUBLIC HEALTH, V89, P517, DOI 10.2105/AJPH.89.4.517; Treacy A, 2006, Ir Med J, V99, P22; Tucker A, 2010, ARCH GYNECOL OBSTET, V281, P613, DOI 10.1007/s00404-009-1152-7; Western Sydney Local Health District (WSLHD), 2013, W SYDN LOC HLTH DIST; World Health Organization, 2014, EV NEWB ACT PLAN END	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171829	10.1371/journal.pone.0171829	http://dx.doi.org/10.1371/journal.pone.0171829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192505	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800044
J	Peppoloni, L; Lawrence, EL; Ruffaldi, E; Valero-Cuevas, FJ				Peppoloni, Lorenzo; Lawrence, Emily L.; Ruffaldi, Emanuele; Valero-Cuevas, Francisco J.			Characterization of the disruption of neural control strategies for dynamic fingertip forces from attractor reconstruction	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; PARKINSONS-DISEASE; PHASE-SPACE; LYAPUNOV EXPONENTS; MANIPULATION; DEXTERITY; CLASSIFICATION; INSTABILITIES; COORDINATION; OSCILLATIONS	The Strength-Dexterity (SD) test measures the ability of the pulps of the thumb and index finger to compress a compliant and slender spring prone to buckling at low forces (<3N). We know that factors such as aging and neurodegenerative conditions bring deteriorating physiological changes (e.g., at the level of motor cortex, cerebellum, and basal ganglia), which lead to an overall loss of dexterous ability. However, little is known about how these changes reflect upon the dynamics of the underlying biological system. The spring-hand system exhibits nonlinear dynamical behavior and here we characterize the dynamical behavior of the phase portraits using attractor reconstruction. Thirty participants performed the SD test: 10 young adults, 10 older adults, and 10 older adults with Parkinson's disease (PD). We used delayed embedding of the applied force to reconstruct its attractor. We characterized the distribution of points of the phase portraits by their density (number of distant points and interquartile range) and geometric features (trajectory length and size). We find phase portraits from older adults exhibit more distant points (p = 0.028) than young adults and participants with PD have larger interquartile ranges (p = 0.001), trajectory lengths (p = 0.005), and size (p = 0.003) than their healthy counterparts. The increased size of the phase portraits with healthy aging suggests a change in the dynamical properties of the system, which may represent a weakening of the neural control strategy. In contrast, the distortion of the attractor in PD suggests a fundamental change in the underlying biological system, and disruption of the neural control strategy. This ability to detect differences in the biological mechanisms of dexterity in healthy and pathological aging provides a simple means to assess their disruption in neurodegenerative conditions and justifies further studies to understand the link with the physiological changes.	[Peppoloni, Lorenzo; Ruffaldi, Emanuele] Scuola Super Sant Anna, TeCIP Inst, PERCRO Lab, Via Alamanni 13B, I-56010 Pisa, Italy; [Lawrence, Emily L.; Valero-Cuevas, Francisco J.] Univ Southern Calif, Brain Body Dynam Lab, Dept Biomed Engn, 3710 McClintock Ave, Los Angeles, CA 90089 USA; [Valero-Cuevas, Francisco J.] Univ Southern Calif, Div Biokinesiol & Phys Therapy, 3710 McClintock Ave, Los Angeles, CA 90089 USA	Scuola Superiore Sant'Anna; University of Southern California; University of Southern California	Valero-Cuevas, FJ (corresponding author), Univ Southern Calif, Brain Body Dynam Lab, Dept Biomed Engn, 3710 McClintock Ave, Los Angeles, CA 90089 USA.; Valero-Cuevas, FJ (corresponding author), Univ Southern Calif, Div Biokinesiol & Phys Therapy, 3710 McClintock Ave, Los Angeles, CA 90089 USA.	valero@usc.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) [AR050520, AR052345]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052345] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under award numbers AR050520 and AR052345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BHATIA N., 2002, STABILITY THEORY DYN, V161; Dayanidhi S, 2014, J GERONTOL A-BIOL; Dayanidhi S, 2013, J NEUROPHYSIOL, V110, P1583, DOI 10.1152/jn.00320.2013; Dayanidhi S, 2013, J NEUROSCI, V33, P15050, DOI 10.1523/JNEUROSCI.1968-13.2013; Duff SV, 2015, J HAND THER, V28, P144, DOI 10.1016/j.jht.2015.01.004; Fedotenkova M., 2013, MATH MODELING LEVEL; Grassberger P., 2004, THEORY CHAOTIC ATTRA, P170, DOI [DOI 10.1007/978-0-387-21830-4_12, 10.1007/978-0-387-21830-4_12]; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Jaszuk M, 2000, SPATIAL DISTRIBUTION; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; JONES LA, 1989, J HAND SURG-AM, V14, P221, DOI 10.1016/0363-5023(89)90010-5; Kantz H., 2004, NONLINEAR TIME SERIE, V7; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Ko NH, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00151; Lawrence EL, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00053; Liao MJ, 1997, J EXP PSYCHOL HUMAN, V23, P1644, DOI 10.1037/0096-1523.23.6.1644; Lightdale-Miric N, 2015, J HAND THER, V28, P158, DOI 10.1016/j.jht.2014.11.003; Lightdale-Miric N, 2015, GAIT POSTURE, V41, P1, DOI 10.1016/j.gaitpost.2014.08.012; Lukos J. R., 2014, HAND FUNCTION, P133; McAuley JH, 2001, J NEUROL NEUROSUR PS, V70, P471, DOI 10.1136/jnnp.70.4.471; Mosier K, 2011, J NEUROPHYSIOL, V105, P1295, DOI 10.1152/jn.00757.2010; Oswal A, 2013, CURR OPIN NEUROL, V26, P662, DOI 10.1097/WCO.0000000000000034; Perc M, 2005, EUR J PHYS, V26, P757, DOI 10.1088/0143-0807/26/5/008; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Perlmutter JS, 2009, CURRENT PROTOCOLS NE, P10; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Povinelli RJ, 2006, IEEE T SIGNAL PROCES, V54, P2178, DOI 10.1109/TSP.2006.873479; ROBERTON MA, 1988, J MOTOR BEHAV, V20, P197, DOI 10.1080/00222895.1988.10735443; Rodriguez M, 2015, AGING CELL, V14, P293, DOI 10.1111/acel.12312; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sharma R, 2015, EXPERT SYST APPL, V42, P1106, DOI 10.1016/j.eswa.2014.08.030; Sherback M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000708; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Snider J, 2014, J NEUROPHYSIOL, V112, P300, DOI 10.1152/jn.00041.2014; Souza JA, 2015, MATH NACHRICHTEN; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; STEWART I., 1997, DOES GOD PLAY DICE N; Takens F., 1985, NUMERICAL DETERMINAT; Talati A, 2005, PERCEPT MOTOR SKILL, V101, P317, DOI 10.2466/PMS.101.5.317-334; TenBroek T., 2007, J BIOMECH, V40, P210, DOI DOI 10.1016/S0021-9290(07)70206-3; Vaillancourt DE, 2001, CLIN NEUROPHYSIOL, V112, P1594, DOI 10.1016/S1388-2457(01)00593-4; Valero-Cuevas FJ, 2003, J BIOMECH, V36, P265, DOI 10.1016/S0021-9290(02)00340-8; Venkadesan M, 2007, J BIOMECH, V40, P1653, DOI 10.1016/j.jbiomech.2007.01.022; Venkadesan M, 2009, PHILOS T R SOC A, V367, P1163, DOI 10.1098/rsta.2008.0261; Welford AT, 1980, REACTION TIMES, P321; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Zhao F., 1993, Annals of Mathematics and Artificial Intelligence, V8, P285, DOI 10.1007/BF01530794; ZHAO F, 1994, ARTIF INTELL, V69, P51, DOI 10.1016/0004-3702(94)90078-7	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172025	10.1371/journal.pone.0172025	http://dx.doi.org/10.1371/journal.pone.0172025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2AZ	28192482	Green Submitted, gold, Green Published			2022-12-26	WOS:000394423800061
J	Suda, K; Rozeboom, L; Yu, H; Ellison, K; Rivard, CJ; Mitsudomi, T; Hirsch, FR				Suda, Kenichi; Rozeboom, Leslie; Yu, Hui; Ellison, Kim; Rivard, Christopher J.; Mitsudomi, Tetsuya; Hirsch, Fred R.			Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status	PLOS ONE			English	Article							SOLID TUMORS; PHASE-I; IDENTIFICATION; RESISTANT; CARCINOMA; GROWTH; LINES; AMPLIFICATION; ESTABLISHMENT; EXPRESSION	Small cell lung cancer (SCLC) is a highly aggressive malignancy with few therapeutic advances in the treatment in recent decades. Based on a recent study that identified the spliceosome as a therapeutic vulnerability in MYC-driven breast cancers, we evaluated the efficacy of a spliceosome inhibitor in SCLC cell lines and analyzed the correlation with MYC status. Among 23 SCLC cell lines examined, eight showed high MYC protein expression (> 80% positive cells) by immunohistochemistry (IHC), while 10 cell lines demonstrated no staining for MYC. The remaining five cell lines showed weak staining (< 40% positive cells). All four cell lines that were previously demonstrated to have MYC gene amplification were positive for MYC by IHC. Four cell lines with high MYC expression and four with low MYC expression were used in further analysis. A spliceosome inhibitor, pladienolide B, showed high efficacy (IC50 < 12nM) in all eight cell lines tested, irrespective of the MYC IHC or MYC gene amplification status. We observed that the four cell lines with higher sensitivity to the spliceosome inhibitor were established from patients with prior chemotherapy. Therefore we chronically treated H1048 cells, that were established from a treatment-naive patient, with cisplatin for 4 weeks, and found that H1048-cisplatin treated cells became more sensitive to pladienolide B. In conclusion, our in vitro results indicate that spliceosome inhibitors would be promising molecular target drugs in SCLC irrespective of the MYC status, especially in the second-line settings after an effective front-line chemotherapy.	[Suda, Kenichi; Rozeboom, Leslie; Yu, Hui; Ellison, Kim; Rivard, Christopher J.; Hirsch, Fred R.] Univ Colorado, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA; [Suda, Kenichi; Mitsudomi, Tetsuya] Kindai Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan	University of Colorado System; University of Colorado Anschutz Medical Campus; Kindai University (Kinki University)	Hirsch, FR (corresponding author), Univ Colorado, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.	fred.hirsch@ucdenver.edu			International Association for the Study of Lung Cancer (IASLC) Young Investigator Award	International Association for the Study of Lung Cancer (IASLC) Young Investigator Award	The present study is partly supported by International Association for the Study of Lung Cancer (IASLC) Young Investigator Award to K. Suda (2015-2017), https://www.iasic.org/fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adler AS, 2014, GENE DEV, V28, P1068, DOI 10.1101/gad.237206.113; CARNEY DN, 1985, CANCER RES, V45, P2913; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Hirsch FR, 2016, LANCET, V388, P1012, DOI 10.1016/S0140-6736(16)31473-8; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; HONG WS, 1988, INT J CANCER, V41, P462, DOI 10.1002/ijc.2910410325; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Hwang DH, 2015, HISTOPATHOLOGY, V67, P81, DOI 10.1111/his.12622; Johnson BE, 1996, J CELL BIOCHEM, P210; Kashyap MK, 2015, HAEMATOLOGICA, V100, P945, DOI 10.3324/haematol.2014.122069; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; LONG BH, 1986, CANCER RES, V46, P3809; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Fiorentino FP, 2016, ONCOTARGET, V7, P31014, DOI 10.18632/oncotarget.8826; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Quidville V, 2013, CANCER RES, V73, P2247, DOI 10.1158/0008-5472.CAN-12-2501; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sato M, 2015, ONCOTARGET, V6, P3292, DOI 10.18632/oncotarget.3203; Schrodl K, 2009, CELL ONCOL, V31, P301, DOI 10.3233/CLO-2009-0472; Sirichanchuen B, 2012, MOL CELL BIOCHEM, V364, P11, DOI 10.1007/s11010-011-1199-1; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Zhou ZX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-944	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172209	10.1371/journal.pone.0172209	http://dx.doi.org/10.1371/journal.pone.0172209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192473	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800083
J	Wang, XXX; Levi, J; Luo, YH; Myakala, K; Herman-Edelstein, M; Qiu, LR; Wang, D; Peng, YQ; Grenz, A; Lucia, S; Dobrinskikh, E; D'Agati, VD; Koepsell, H; Kopp, JB; Rosenberg, AZ; Levi, M				Wang, Xiaoxin X.; Levi, Jonathan; Luo, Yuhuan; Myakala, Komuraiah; Herman-Edelstein, Michal; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; D'Agati, Vivette D.; Koepsell, Hermann; Kopp, Jeffrey B.; Rosenberg, Avi Z.; Levi, Moshe			SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL LIPID-METABOLISM; GLUCOSE COTRANSPORTER 2; CHRONIC KIDNEY-DISEASE; GLOMERULAR HYPERFILTRATION; OXIDATIVE STRESS; RECEPTOR ACTIVATION; SIGNALING PATHWAYS; INHIBITORS; HYPERGLYCEMIA; EMPAGLIFLOZIN	There is very limited human renal sodium gradient-dependent glucose transporter protein (SGLT2) mRNA and protein expression data reported in the literature. The first aim of this study was to determine SGLT2 mRNA and protein levels in human and animal models of diabetic nephropathy. We have found that the expression of SGLT2 mRNA and protein is increased in renal biopsies from human subjects with diabetic nephropathy. This is in contrast to db-db mice that had no changes in renal SGLT2 protein expression. Furthermore, the effect of SGLT2 inhibition on renal lipid content and inflammation is not known. The second aim of this study was to determine the potential mechanisms of beneficial effects of SGLT2 inhibition in the progression of diabetic renal disease. We treated db/db mice with a selective SGLT2 inhibitor JNJ 39933673. We found that SGLT2 inhibition caused marked decreases in systolic blood pressure, kidney weight/body weight ratio, urinary albumin, and urinary thiobarbituric acid-reacting substances. SGLT2 inhibition prevented renal lipid accumulation via inhibition of carbohydrate-responsive element-binding protein-beta, pyruvate kinase L, SCD-1, and DGAT1, key transcriptional factors and enzymes that mediate fatty acid and triglyceride synthesis. SGLT2 inhibition also prevented inflammation via inhibition of CD68 macrophage accumulation and expression of p65, TLR4, MCP-1, and osteopontin. These effects were associated with reduced mesangial expansion, accumulation of the extracellular matrix proteins fibronectin and type IV collagen, and loss of podocyte markers WT1 and synaptopodin, as deter-mined by immunofluorescence microscopy. In summary, our study showed that SGLT2 inhibition modulates renal lipid metabolism and inflammation and prevents the development of nephropathy in db/db mice.	[Wang, Xiaoxin X.; Luo, Yuhuan; Myakala, Komuraiah; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80220 USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Myakala, Komuraiah; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO 80220 USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Myakala, Komuraiah; Qiu, Liru; Wang, Dong; Peng, Yingqiong; Grenz, Almut; Lucia, Scott; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80220 USA; [Wang, Xiaoxin X.; Levi, Moshe] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [Levi, Jonathan; Kopp, Jeffrey B.] NIDDK, NIH, Bethesda, MD 20892 USA; [Herman-Edelstein, Michal] Tel Aviv Univ, Rabin Med Ctr, Dept Hypertens & Nephrol, Felsenstein Med Res Ctr,Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [D'Agati, Vivette D.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10027 USA; [Koepsell, Hermann] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Rosenberg, Avi Z.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Columbia University; University of Wurzburg; Johns Hopkins University	Levi, M (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, 12700 East 19th Ave,Res 2,Rm 7002,Box C281, Aurora, CO 80045 USA.	moshe.levi@ucdenver.edu	Komuraiah, Myakala/AAQ-9961-2021; Wang, Dong/A-6518-2018; Kopp, Jeffrey B/O-2681-2015; qiu, liru/AAA-4648-2022	Komuraiah, Myakala/0000-0003-3233-047X; Kopp, Jeffrey B/0000-0001-9052-186X; qiu, liru/0000-0002-1583-7183; Rosenberg, Avi/0000-0003-2356-950X	NIDDK Intramural Research Program, NIDDK, National Institutes of Health; Medical School grant by Janssen Research AMP; Development, LLC, Raritan, NJ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098336] Funding Source: NIH RePORTER	NIDDK Intramural Research Program, NIDDK, National Institutes of Health; Medical School grant by Janssen Research AMP; Development, LLC, Raritan, NJ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIDDK Intramural Research Program, NIDDK, National Institutes of Health (to J. L., J. B. K., and A. Z. R.). This work was funded in part by a Medical School grant provided by Janssen Research & Development, LLC, Raritan, NJ (to M. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; BANK N, 1990, J CLIN INVEST, V86, P309, DOI 10.1172/JCI114700; Barnett AH, 2014, LANCET DIABETES ENDO, V2, P369, DOI 10.1016/S2213-8587(13)70208-0; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brosius FC, 2014, ADV CHRONIC KIDNEY D, V21, P304, DOI 10.1053/j.ackd.2014.03.011; Caldas YA, 2011, KIDNEY INT, V80, P535, DOI 10.1038/ki.2011.159; Cardenas A, 2013, LAB INVEST, V93, P135, DOI 10.1038/labinvest.2012.143; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; De Nicola L, 2014, AM J KIDNEY DIS, V64, P16, DOI 10.1053/j.ajkd.2014.02.010; FARBER SJ, 1951, J CLIN INVEST, V30, P125, DOI 10.1172/JCI102424; Faulhaber-Walter R, 2008, J AM SOC NEPHROL, V19, P722, DOI 10.1681/ASN.2007060721; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Ferrannini E, 2013, DIABETES CARE, V36, P1260, DOI 10.2337/dc12-1503; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Gallo LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26428; Gallo LA, 2015, DIABETES VASC DIS RE, V12, P78, DOI 10.1177/1479164114561992; Gembardt F, 2014, AM J PHYSIOL-RENAL, V307, pF317, DOI 10.1152/ajprenal.00145.2014; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Giral H, 2012, J BIOL CHEM, V287, P35047, DOI 10.1074/jbc.M112.392415; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Guebre-Egziabher F, 2013, BIOCHIMIE, V95, P1971, DOI 10.1016/j.biochi.2013.07.017; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Hunley Tracy E, 2010, Curr Opin Nephrol Hypertens, V19, P227, DOI 10.1097/MNH.0b013e3283374c09; Ishibashi Y, 2016, HORM METAB RES, V48, P191, DOI 10.1055/s-0035-1555791; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Komala MG, 2013, CURR OPIN NEPHROL HY, V22, P113, DOI 10.1097/MNH.0b013e32835a17ae; Maeda S, 2013, DIABETES-METAB RES, V29, P406, DOI 10.1002/dmrr.2407; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; Mende CW, 2017, CURR MED RES OPIN, V33, P541, DOI 10.1080/03007995.2016.1271779; Mudaliar S, 2015, DIABETES CARE, V38, P2344, DOI 10.2337/dc15-0642; Novikov A, 2016, CURR OPIN NEPHROL HY, V25, P50, DOI 10.1097/MNH.0000000000000187; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Persson P, 2010, ACTA PHYSIOL, V200, P3, DOI 10.1111/j.1748-1716.2010.02147.x; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Roa H, 2009, FEBS LETT, V583, P3192, DOI 10.1016/j.febslet.2009.09.003; Rosolowsky ET, 2011, J AM SOC NEPHROL, V22, P545, DOI 10.1681/ASN.2010040354; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Schnermann J, 2015, ANNU REV PHYSIOL, V77, P301, DOI 10.1146/annurev-physiol-021014-071829; Skrtic M, 2015, CURR OPIN NEPHROL HY, V24, P96, DOI 10.1097/MNH.0000000000000084; Stanton RC, 2014, CIRCULATION, V129, P542, DOI 10.1161/CIRCULATIONAHA.113.007071; Tak E, 2014, J AM SOC NEPHROL, V25, P547, DOI 10.1681/ASN.2012101014; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Thomas MC, 2014, THER ADV ENDOCRINOL, V5, DOI 10.1177/2042018814544153; Thomson SC, 2012, AM J PHYSIOL-REG I, V302, pR75, DOI 10.1152/ajpregu.00357.2011; Tsimihodimos V, 2017, CURR VASC PHARMACOL, V15, P96, DOI 10.2174/1570161114666161007163426; Vallianou NG, 2017, DIABETES METAB SYND, V11, P311, DOI 10.1016/j.dsx.2016.12.003; Vallon V, 2017, DIABETOLOGIA, V60, P215, DOI 10.1007/s00125-016-4157-3; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7; Wang XXX, 2016, J AM SOC NEPHROL, V27, P1362, DOI 10.1681/ASN.2014121271; Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Zhu YQ, 2007, SEMIN NEPHROL, V27, P153, DOI 10.1016/j.semnephrol.2007.01.008	73	173	177	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5335	5348		10.1074/jbc.M117.779520	http://dx.doi.org/10.1074/jbc.M117.779520			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196866	hybrid, Green Published			2022-12-26	WOS:000397875500016
J	Huang, DZ; Wu, ZH				Huang, Daizheng; Wu, Zhihui			Forecasting outpatient visits using empirical mode decomposition coupled with back-propagation artificial neural networks optimized by particle swarm optimization	PLOS ONE			English	Article							PREDICTION; PSO; SPECTRUM; POWER	Accurately predicting the trend of outpatient visits by mathematical modeling can help policy makers manage hospitals effectively, reasonably organize schedules for human resources and finances, and appropriately distribute hospital material resources. In this study, a hybrid method based on empirical mode decomposition and back-propagation artificial neural networks optimized by particle swarm optimization is developed to forecast outpatient visits on the basis of monthly numbers. The data outpatient visits are retrieved from January 2005 to December 2013 and first obtained as the original time series. Second, the original time series is decomposed into a finite and often small number of intrinsic mode functions by the empirical mode decomposition technique. Third, a three-layer back-propagation artificial neural network is constructed to forecast each intrinsic mode functions. To improve network performance and avoid falling into a local minimum, particle swarm optimization is employed to optimize the weights and thresholds of back-propagation artificial neural networks. Finally, the super-position of forecasting results of the intrinsic mode functions is regarded as the ultimate forecasting value. Simulation indicates that the proposed method attains a better performance index than the other four methods.	[Huang, Daizheng; Wu, Zhihui] Guangxi Med Univ, Sch Preclin Med, Dept Biomed Engn, Nanning, Guangxi Provinc, Peoples R China	Guangxi Medical University	Huang, DZ (corresponding author), Guangxi Med Univ, Sch Preclin Med, Dept Biomed Engn, Nanning, Guangxi Provinc, Peoples R China.	daizheng-huang@qq.com			Basic Ability Promotion for Young Teachers of the Guangxi Education Department [KY2016YB093]	Basic Ability Promotion for Young Teachers of the Guangxi Education Department	This work was supported by the project of Basic Ability Promotion for Young Teachers of the Guangxi Education Department (KY2016YB093).	Abadan S., 2014, APPL MATH SCI, V8, P3133, DOI 10.12988/ams.2014.43189; Alavi AH, 2011, COMPUT STRUCT, V89, P2176, DOI 10.1016/j.compstruc.2011.08.019; Cheng CH, 2008, EXPERT SYST APPL, V34, P2568, DOI 10.1016/j.eswa.2007.04.007; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Montain ME, 2015, COMPUT CHEM ENG, V82, P13, DOI 10.1016/j.compchemeng.2015.05.026; Fakhar MS, 2015, INT J ELEC POWER, V73, P983, DOI 10.1016/j.ijepes.2015.06.030; Fu K, 2014, BIOMED SIGNAL PROCES, V13, P15, DOI 10.1016/j.bspc.2014.03.007; Gan RJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2684; Gan RJ, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/328273; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Hadavandi E, 2011, EXPERT SYST APPL, V38, P9392, DOI 10.1016/j.eswa.2011.01.132; Hoel T., 2018, DATA SCI HELPS NORWA; Huang DZ, 2015, J ELECTR ENG TECHNOL, V10, P41, DOI 10.5370/JEET.2015.10.1.041; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Illias HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129363; Jiang SY, 2008, J MATER PROCESS TECH, V196, P190, DOI 10.1016/j.jmatprotec.2007.05.034; KARUNANITHI N, 1994, J COMPUT CIVIL ENG, V8, P201, DOI 10.1061/(ASCE)0887-3801(1994)8:2(201); Kisi O, 2014, WATER RESOUR MANAG, V28, P4045, DOI 10.1007/s11269-014-0726-8; Leo M, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.11.112314; Momeni E, 2015, MEASUREMENT, V60, P50, DOI 10.1016/j.measurement.2014.09.075; Neshat N, 2015, J CLEAN PROD, V105, P206, DOI 10.1016/j.jclepro.2014.10.083; Pi EX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082413; Ratnaweera A, 2004, IEEE T EVOLUT COMPUT, V8, P240, DOI [10.1109/TEVC.2004.826071, 10.1109/tevc.2004.826071]; Ren P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132116; Sadati N, 2009, APPL SOFT COMPUT, V9, P652, DOI 10.1016/j.asoc.2008.09.005; Samanta B, 2004, MECH SYST SIGNAL PR, V18, P625, DOI 10.1016/S0888-3270(03)00020-7; Shakya P, 2014, J SOUND VIB, V333, P5614, DOI 10.1016/j.jsv.2014.04.058; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Sudheer C, 2014, NEURAL COMPUT APPL, V24, P1381, DOI 10.1007/s00521-013-1341-y; Teodoro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061180; Tsai YL, 2015, APPL OPTICS, V54, pE41, DOI 10.1364/AO.54.000E41; Wang SX, 2016, RENEW ENERG, V94, P629, DOI 10.1016/j.renene.2016.03.103; Wang WC, 2013, J HYDROINFORM, V15, P1377, DOI 10.2166/hydro.2013.134; Wang YN, 2015, IEEE T POWER ELECTR, V30, P7038, DOI 10.1109/TPEL.2014.2383443; Wang YM, 2015, KNOWL-BASED SYST, V88, P12, DOI 10.1016/j.knosys.2015.08.013; Warner B, 1996, AM STAT, V50, P284, DOI 10.2307/2684922; Yu JB, 2008, NEUROCOMPUTING, V71, P1054, DOI 10.1016/j.neucom.2007.10.013; Yu Y, 2015, J INTEL MAT SYST STR, V26, P1789, DOI 10.1177/1045389X15577649; Zabalza JM, 2014, IEEE GEOSCI REMOTE S, V11, P1886, DOI 10.1109/LGRS.2014.2312754; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang PP, 2015, BIOCHEM ENG J, V103, P138, DOI 10.1016/j.bej.2015.07.004; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	43	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172539	10.1371/journal.pone.0172539	http://dx.doi.org/10.1371/journal.pone.0172539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222194	Green Published, gold, Green Submitted			2022-12-26	WOS:000394676800065
J	Shimomoto, T; Collins, LB; Yi, XW; Holley, DW; Zhang, ZF; Tian, X; Uchida, K; Wang, CG; Horkko, S; Willis, MS; Gold, A; Bultman, SJ; Nakamura, J				Shimomoto, Takasumi; Collins, Leonard B.; Yi, Xianwen; Holley, Darcy W.; Zhang, Zhenfa; Tian, Xu; Uchida, Koji; Wang, Chunguang; Horkko, Sohvi; Willis, Monte S.; Gold, Avram; Bultman, Scott J.; Nakamura, Jun			A purified MAA-based ELISA is a useful tool for determining anti-MAA antibody titer with high sensitivity	PLOS ONE			English	Article							MALONDIALDEHYDE-ACETALDEHYDE ADDUCTS; LOW-DENSITY LIPOPROTEINS; PROTEIN ADDUCTS; LIPID-PEROXIDATION; APOPTOTIC CELLS; OXIDIZED LDL; LIVER; MICE; ATHEROSCLEROSIS; IMMUNIZATION	Atherosclerosis is widely accepted to be a chronic inflammatory disease, and the immunological response to the accumulation of LDL is believed to play a critical role in the development of this disease. 1,4-Dihydropyridine-type MAA-adducted LDL has been implicated in atherosclerosis. Here, we have demonstrated that pure MAA-modified residues can be chemically conjugated to large proteins without by-product contamination. Using this pure antigen, we established a purified MAA-ELISA, with which a marked increase in anti-MAA antibody titer was determined at a very early stage of atherosclerosis in 3-month ApoE (-/-)mice fed with a normal diet. Our methods of N-epsilon-MAA-L-lysine purification and purified antigen- based ELISA will be easily applicable for biomarker-based detection of early stage atherosclerosis in patients, as well as for the development of an adduct-specific Liquid Chromatography/ Mass Spectrometry-based quantification of physiological and pathological levels of MAA.	[Shimomoto, Takasumi; Collins, Leonard B.; Zhang, Zhenfa; Tian, Xu; Gold, Avram; Nakamura, Jun] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA; [Yi, Xianwen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Holley, Darcy W.; Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Uchida, Koji] Nagoya Univ, Sch Bioagr Sci, Nagoya, Aichi, Japan; [Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Res Unit Biomed, Med Microbiol & Immunol, Fac Med, Oulu, Finland; [Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Med Res Ctr, Oulu, Finland; [Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Nordlab Oulu, Oulu, Finland; [Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Oulu, Finland; [Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Willis, Monte S.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Nagoya University; University of Oulu; University of Oulu; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nakamura, J (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA.	junnakamura77777@gmail.com	Willis, Monte S/J-9994-2015; Wang, Chunguang/AAE-7054-2020; Wang, Chunguang/AAE-6997-2020	Willis, Monte S/0000-0002-0769-5816; Wang, Chunguang/0000-0001-5569-321X; , Xianwen/0000-0001-9320-2020; Uchida, Koji/0000-0003-3894-5299; Nakamura, Jun/0000-0002-1756-7199; Collins, Leonard/0000-0002-7734-9708	NIH [P42-ES05948, P30-ES10126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants P42-ES05948 and P30-ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115163; Antoniak DT, 2015, FREE RADICAL BIO MED, V89, P409, DOI 10.1016/j.freeradbiomed.2015.09.003; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; DONOHUE TM, 1983, ARCH BIOCHEM BIOPHYS, V220, P239, DOI 10.1016/0003-9861(83)90406-X; Duryee MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1931, DOI 10.1097/01.ALC.0000148115.90045.C5; Gonen A, 2014, J LIPID RES, V55, P2137, DOI 10.1194/jlr.M053256; HABERLAND ME, 1982, P NATL ACAD SCI-BIOL, V79, P1712, DOI 10.1073/pnas.79.6.1712; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Holvoet P, 1998, ATHEROSCLEROSIS, V137, pS33, DOI 10.1016/S0021-9150(97)00305-5; Ishii T, 2006, CHEM RES TOXICOL, V19, P122, DOI 10.1021/tx050231p; Kato R, 2009, ARTERIOSCL THROM VAS, V29, P33, DOI 10.1161/ATVBAHA.108.164723; Kearley ML, 1999, CHEM RES TOXICOL, V12, P100, DOI 10.1021/tx980132u; Kharbanda KK, 2002, BIOCHEM PHARMACOL, V63, P553, DOI 10.1016/S0006-2952(01)00883-8; KIKUGAWA K, 1988, ANAL BIOCHEM, V174, P512, DOI 10.1016/0003-2697(88)90051-6; KIKUGAWA K, 1984, ARCH BIOCHEM BIOPHYS, V229, P7, DOI 10.1016/0003-9861(84)90124-3; McCaskill ML, 2011, ALCOHOL CLIN EXP RES, V35, P1106, DOI 10.1111/j.1530-0277.2011.01443.x; OHYA T, 1993, BIOL PHARM BULL, V16, P137; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Robertson AKL, 2004, SCAND J IMMUNOL, V59, P285, DOI 10.1111/j.0300-9475.2004.01403.x; Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373; Silva GP, 2013, BRAZ J MED BIOL RES, V46, P148, DOI 10.1590/1414-431X20122556; Slatter DA, 1998, FEBS LETT, V421, P180, DOI 10.1016/S0014-5793(97)01554-8; Thiele GM, 2005, BIOCHEM PHARMACOL, V70, P1593, DOI 10.1016/j.bcp.2005.08.014; Thiele GM, 1998, ALCOHOL CLIN EXP RES, V22, P1731, DOI 10.1111/j.1530-0277.1998.tb03973.x; Tsimikas S, 2011, J AM COLL CARDIOL, V58, P1715, DOI 10.1016/j.jacc.2011.07.017; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; Uchida K, 1997, ARCH BIOCHEM BIOPHYS, V346, P45, DOI 10.1006/abbi.1997.0266; Uchida K, 2006, FREE RADICAL RES, V40, P1335, DOI 10.1080/10715760600902302; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; Willis MS, 2002, INT IMMUNOPHARMACOL, V2, P519, DOI 10.1016/S1567-5769(01)00195-3; XIANG ZQ, 1995, VIROLOGY, V209, P569, DOI 10.1006/viro.1995.1289; Xu DS, 1997, CHEM RES TOXICOL, V10, P978, DOI 10.1021/tx970069t; Yamada S, 2001, J LIPID RES, V42, P1187	35	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72172	10.1371/journal.pone.0172172	http://dx.doi.org/10.1371/journal.pone.0172172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222187	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800038
J	Estrada, F; Tol, RSJ; Botzen, WJW				Estrada, Francisco; Tol, Richard S. J.; Botzen, Wouter J. W.			Global economic impacts of climate variability and change during the 20th century	PLOS ONE			English	Article							DAMAGE COSTS; UNCERTAINTY; ADAPTATION; TEMPERATURES; OSCILLATION; WEATHER; MODELS; CMIP5	Estimates of the global economic impacts of observed climate change during the 20th century obtained by applying five impact functions of different integrated assessment models ( IAMs) are separated into their main natural and anthropogenic components. The estimates of the costs that can be attributed to natural variability factors and to the anthropogenic intervention with the climate system in general tend to show that: 1) during the first half of the century, the amplitude of the impacts associated with natural variability is considerably larger than that produced by anthropogenic factors and the effects of natural variability fluctuated between being negative and positive. These non-monotonic impacts are mostly determined by the low-frequency variability and the persistence of the climate system; 2) IAMs do not agree on the sign ( nor on the magnitude) of the impacts of anthropogenic forcing but indicate that they steadily grew over the first part of the century, rapidly accelerated since the mid 1970's, and decelerated during the first decade of the 21st century. This deceleration is accentuated by the existence of interaction effects between natural variability and natural and anthropogenic forcing. The economic impacts of anthropogenic forcing range in the tenths of percentage of the world GDP by the end of the 20th century; 3) the impacts of natural forcing are about one order of magnitude lower than those associated with anthropogenic forcing and are dominated by the solar forcing; 4) the interaction effects between natural and anthropogenic factors can importantly modulate how impacts actually occur, at least for moderate increases in external forcing. Human activities became dominant drivers of the estimated economic impacts at the end of the 20th century, producing larger impacts than those of low-frequency natural variability. Some of the uses and limitations of IAMs are discussed.	[Estrada, Francisco] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City, DF, Mexico; [Estrada, Francisco; Tol, Richard S. J.; Botzen, Wouter J. W.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Tol, Richard S. J.] Univ Sussex, Dept Econ, Falmer, England; [Tol, Richard S. J.] Vrije Univ Amsterdam, Dept Spatial Econ, Amsterdam, Netherlands; [Tol, Richard S. J.] Tinbergen Inst, Amsterdam, Netherlands; [Tol, Richard S. J.] CESifo, Munich, Germany; [Botzen, Wouter J. W.] Univ Utrecht, Utrecht Univ Sch Econ USE, Utrecht, Netherlands	Universidad Nacional Autonoma de Mexico; Vrije Universiteit Amsterdam; University of Sussex; Vrije Universiteit Amsterdam; Tinbergen Institute; Ifo Institut; Utrecht University	Estrada, F (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City, DF, Mexico.; Estrada, F (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands.	feporrua@atmosfera.unam.mx	Tol, Richard S. J./D-5245-2011; Botzen, Wouter/L-3123-2013	Tol, Richard S. J./0000-0002-8012-3988; Botzen, Wouter/0000-0002-8563-4963; Estrada Porrua, Francisco/0000-0002-1403-2180				Ackerman F, 2009, CLIMATIC CHANGE, V95, P297, DOI 10.1007/s10584-009-9570-x; Anthoff D, 2014, ANN OPER RES, V220, P223, DOI 10.1007/s10479-013-1343-2; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Costinot A, 2016, J POLIT ECON, V124, P205, DOI 10.1086/684719; de Bruin KC, 2009, CLIMATIC CHANGE, V95, P63, DOI 10.1007/s10584-008-9535-5; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Estrada F, 2015, CLIM CHANG ECON, V6, DOI 10.1142/S2010007815500153; Estrada F, 2015, ENVIRON MODELL SOFTW, V69, P155, DOI 10.1016/j.envsoft.2015.03.010; Estrada F, 2014, BOL SOC MAT MEX, V20, P107, DOI 10.1007/s40590-014-0009-7; Estrada F, 2013, NAT GEOSCI, V6, P1050, DOI 10.1038/NGEO1999; Estrada F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060017; Estrada F, 2010, CLIMATIC CHANGE, V101, P407, DOI 10.1007/s10584-010-9928-0; Gay-Garcia C, 2009, CLIMATIC CHANGE, V94, P333, DOI 10.1007/s10584-008-9524-8; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; HASSELMANN K, 1993, J CLIMATE, V6, P1957, DOI 10.1175/1520-0442(1993)006<1957:OFFTDO>2.0.CO;2; Hope C, 2006, INTEGRATED ASSESSMEN; Huber M, 2012, NAT GEOSCI, V5, P31, DOI [10.1038/ngeo1327, 10.1038/NGEO1327]; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kahn ME, 2016, REV ENV ECON POLICY, V10, P166, DOI 10.1093/reep/rev023; Kaufmann RK, 1997, NATURE, V388, P39, DOI 10.1038/40332; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Kirtman B., 2013, IPCC 2013 CLIMATE CH, P953; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Kumar A, 2009, MON WEATHER REV, V137, P2622, DOI 10.1175/2009MWR2814.1; Kurukulasuriya P, 2006, WORLD BANK ECON REV, V20, P367, DOI 10.1093/wber/lhl004; Miller RL, 2014, J ADV MODEL EARTH SY, V6, P441, DOI 10.1002/2013MS000266; Nordhaus W., 2013, DICE 2013R INTRO USE, P1; Nordhaus W. D., 2008, QUESTION BALANCE WEI; Nordhaus W.D., 2003, WARMING WORLD EC MOD; Nordhaus WD, 2011, SSRN ELECT J; Notz D, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0164; Oreskes N, 1994, SCIENCE, P263; Parson EA, 1997, ANNU REV ENERG ENV, V22, P589, DOI 10.1146/annurev.energy.22.1.589; Pindyck RS, 2013, J ECON LIT, V51, P860, DOI 10.1257/jel.51.3.860; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schneider SH., 1997, ENVIRON MODEL ASSESS, V2, P229, DOI [10.1023/A:1019090117643, DOI 10.1023/A:1019090117643]; Schwartz SE, 2012, SURV GEOPHYS, V33, P745, DOI 10.1007/s10712-012-9180-4; Stainforth DA, 2007, PHILOS T R SOC A, V365, P2145, DOI 10.1098/rsta.2007.2074; Stern N, 2008, AM ECON REV, V98, P1, DOI 10.1257/aer.98.2.1; Stern N, 2013, J ECON LIT, V51, P838, DOI 10.1257/jel.51.3.838; Swanson KL, 2009, P NATL ACAD SCI USA, V106, P16120, DOI 10.1073/pnas.0908699106; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tol R.S.J., 1998, ENVIRON MODEL ASSESS, V3, P63, DOI DOI 10.1023/A:1019050503531; Tol RSJ, 2014, J ECON PERSPECT, V28, P221, DOI 10.1257/jep.28.2.221; Tol RSJ, 2013, CLIMATIC CHANGE, V117, P795, DOI 10.1007/s10584-012-0613-3; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; TOL RSJ, 1993, THEOR APPL CLIMATOL, V48, P63, DOI 10.1007/BF00864914; Tol RSJ, 1998, CLIMATIC CHANGE, V38, P87, DOI 10.1023/A:1005390515242; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P135, DOI 10.1023/A:1014539414591; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P47, DOI 10.1023/A:1014500930521; TRENBERTH KE, 1984, MON WEATHER REV, V112, P326, DOI 10.1175/1520-0493(1984)112<0326:SVNITS>2.0.CO;2; van den Bergh JCJM, 2014, NAT CLIM CHANGE, V4, P253, DOI 10.1038/NCLIMATE2135; Weigel AP, 2010, J CLIMATE, V23, P4175, DOI 10.1175/2010JCLI3594.1; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4	58	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172201	10.1371/journal.pone.0172201	http://dx.doi.org/10.1371/journal.pone.0172201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BI	28212384	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000394424700022
J	Chiva-Blanch, G; Laake, K; Myhre, P; Bratseth, V; Arnesen, H; Solheim, S; Badimon, L; Seljeflot, I				Chiva-Blanch, Gemma; Laake, Kristian; Myhre, Peder; Bratseth, Vibeke; Arnesen, Harald; Solheim, Svein; Badimon, Lina; Seljeflot, Ingebjorg			Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity	PLOS ONE			English	Article							HIGH CARDIOVASCULAR RISK; ATHEROSCLEROTIC PLAQUES; INDUCE PROCOAGULANT; BLOOD; ACTIVATION; CORONARY; PHOSPHATIDYLSERINE; INTERVENTION; PROGNOSIS; OUTCOMES	Objective Circulating microparticles (cMPs) are phospholipid-rich vesicles released from cells when activated or injured, and contribute to the formation of intracoronary thrombi. Tissue factor (TF, CD142) is the main trigger of fibrin formation and TF-carrying cMPs are considered one of the most procoagulant cMPs. Similar types of atherosclerotic lesions may lead to different types of AMI, although the mechanisms behind are unresolved. Therefore, we aimed to investigate the phenotype of cMPs found in plasma of ACS patients and its relation to AMI severity and thrombotic burden. Methods In a cross-sectional study, two hundred patients aged 75 +/- 4 years were included in the study 2-8 weeks after suffering an AMI. Annexin V positive (AV(+))-cMPs derived from blood and vascular cells were measured by flow cytometry. Plasma procoagulant activity (TF-PCA) was measured through a chromogenic assay. Results STEMI patients (n = 75) showed higher levels of platelet-derived cMPs [CD61(+)/AV(+), CD31(+)/ AV(+), CD42b(+)/AV(+) and CD31(+)/ CD42b(+)/AV(+), P = 0.048, 0.038, 0.009 and 0.006, respectively], compared to NSTEMI patients (n = 125). Patients who suffered a heart failure during AMI (n = 17) had increased levels of platelet (CD61(+))- and monocyte (CD14(+))- derived cMPs carrying TF (CD142(+)) (P<0.0001 and 0.004, respectively). Additionally, NYHA class III (n = 23) patients showed higher levels of CD142(+)/AV +, CD14(+)/AV(+) and CD14(+)/CD142 +/AV(+) cMPs than those in class I/ II (P = 0.001, 0.015 and 0.014, respectively). The levels of these cMPs positively correlated with TF-PCA (r >= 0.166, P <= 0.027, all). Conclusions Platelets and monocytes remain activated in AMI patients treated as per guidelines and release cMPs that discriminate AMI severity. Therefore, TF-MPs, and platelet- and monocyte-MPs may reflect thrombotic burden in AMI patients.	[Chiva-Blanch, Gemma; Laake, Kristian; Myhre, Peder; Bratseth, Vibeke; Arnesen, Harald; Solheim, Svein; Seljeflot, Ingebjorg] Oslo Univ Hosp Ulleval, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway; [Chiva-Blanch, Gemma; Laake, Kristian; Myhre, Peder; Arnesen, Harald; Seljeflot, Ingebjorg] Univ Oslo, Fac Med, Oslo, Norway; [Chiva-Blanch, Gemma; Badimon, Lina] CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain; [Chiva-Blanch, Gemma; Badimon, Lina] Biomed Res Inst St Pau, IIB St Pau, Barcelona, Spain	University of Oslo; University of Oslo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Chiva-Blanch, G (corresponding author), Oslo Univ Hosp Ulleval, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway.; Chiva-Blanch, G (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.; Chiva-Blanch, G (corresponding author), CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain.; Chiva-Blanch, G (corresponding author), Biomed Res Inst St Pau, IIB St Pau, Barcelona, Spain.	GChiva@santpau.cat	Chiva-Blanch, Gemma/O-8072-2018; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Chiva-Blanch, Gemma/0000-0001-6093-0160; Badimon, Lina/0000-0002-9162-2459	Institute de Salud Carlos III (ISCIII), Spain [CD13/00023]; Stein Erik Hagens Foundation of Clinical Heart Research, Oslo, Norway	Institute de Salud Carlos III (ISCIII), Spain; Stein Erik Hagens Foundation of Clinical Heart Research, Oslo, Norway	GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Institute de Salud Carlos III (ISCIII), Spain. This work was supported by Stein Erik Hagens Foundation of Clinical Heart Research, Oslo, Norway.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Bogdanov VY, 2009, J THROMB HAEMOST, V7, P894, DOI 10.1111/j.1538-7836.2009.03315.x; Chiva-Blanch G, 2017, INT J CARDIOL, V227, P876, DOI 10.1016/j.ijcard.2016.11.302; Chiva-Blanch G, 2016, INT J CARDIOL, V208, P147, DOI 10.1016/j.ijcard.2016.01.211; Chiva-Blanch G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148176; Chung SY, 2016, INT J CARDIOL, V223, P412, DOI 10.1016/j.ijcard.2016.08.068; Hartopo AB, 2016, ARCH MED SCI, V12, P529, DOI 10.5114/aoms.2016.59926; Huisse MG, 2009, THROMB HAEMOSTASIS, V101, P734, DOI 10.1160/TH08-06-0407; Jung C, 2012, ATHEROSCLEROSIS, V221, P226, DOI 10.1016/j.atherosclerosis.2011.12.025; Kopp CW, 2011, PLATELETS, V22, P530, DOI 10.3109/09537104.2011.573599; Laake K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-74; Langer F, 2014, THROMB HAEMOSTASIS, V111, P590, DOI 10.1160/TH13-09-0802; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nomura S, 2008, THROMB RES, V123, P8, DOI 10.1016/j.thromres.2008.06.006; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Porto I, 2012, EUR HEART J, V33, P2928, DOI 10.1093/eurheartj/ehs065; SATTA N, 1994, J IMMUNOL, V153, P3245; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Stepien E, 2012, ARCH MED RES, V43, P31, DOI 10.1016/j.arcmed.2012.01.006; Steppich B, 2005, THROMB HAEMOSTASIS, V93, P35, DOI 10.1160/TH04-06-0393; Steppich BA, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-11; Suades R, 2016, INT J CARDIOL, V202, P378, DOI 10.1016/j.ijcard.2015.09.011; Suades R, 2015, J THROMB HAEMOST, V13, P1776, DOI 10.1111/jth.13065; Suades R, 2015, THROMB HAEMOSTASIS, V114, P1310, DOI 10.1160/TH15-04-0325; Suades R, 2015, SEMIN THROMB HEMOST, V41, P590, DOI 10.1055/s-0035-1556591; Suades R, 2012, THROMB HAEMOSTASIS, V108, P1208, DOI 10.1160/TH12-07-0486; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Wang LX, 2016, INT J CARDIOL, V223, P121, DOI 10.1016/j.ijcard.2016.07.260	30	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172558	10.1371/journal.pone.0172558	http://dx.doi.org/10.1371/journal.pone.0172558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207887	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500147
J	Feng, XD; Pi, LY; Sriram, S; Schultz, GS; Gibson, DJ				Feng, Xiaodi; Pi, Liya; Sriram, Sriniwas; Schultz, Gregory S.; Gibson, Daniel J.			Connective tissue growth factor is not necessary for haze formation in excimer laser wounded mouse corneas	PLOS ONE			English	Article							MYOFIBROBLAST DIFFERENTIATION; PHOTOREFRACTIVE KERATECTOMY; FIBROBLAST PROLIFERATION; FACTOR EXPRESSION; RABBIT CORNEAS; MESSENGER-RNA; FACTOR GENE; TEAR FLUID; PDGF-BB; CELLS	We sought to determine if connective tissue growth factor (CTGF) is necessary for the formation of corneal haze after corneal injury. Mice with post-natal, tamoxifen-induced, knockout of CTGF were subjected to excimer laser phototherapeutic keratectomy (PTK) and the corneas were allowed to heal. The extent of scaring was observed in non-induced mice, heterozygotes, and full homozygous knockout mice and quantified by macrophotography. The eyes from these mice were collected after euthanization for re-genotyping to control for possible Cre-mosaicism. Primary corneal fibroblasts from CTGF knockout corneas were established in a gel plug assay. The plug was removed, simulating an injury, and the rate of hole closure and the capacity for these cells to form light reflecting cells in response to CTGF and platelet-derived growth factor B (PDGF-B) were tested and compared to wild-type cells. We found that independent of genotype, each group of mice was still capable of forming light reflecting haze in the cornea after laser ablation (p = 0.40). Results from the gel plug closure rate in primary cell cultures of knockout cells were not statistically different from serum starved wild-type cells, independent of treatment. Compared to the serum starved wild-type cells, stimulation with PDGF-BB significantly increased the KO cell culture's light reflection (p = 0.03). Most interestingly, both reflective cultures were positive for alpha-SMA, but the cellular morphology and levels of alpha-SMA were distinct and not in proportion to the light reflection seen. This new work demonstrates that corneas without CTGF can still form sub-epithelial haze, and that the light reflecting phenotype can be reproduced in culture. These data support the possibilities of growth factor redundancy and that multiple pro-haze pathways exist.	[Feng, Xiaodi; Schultz, Gregory S.; Gibson, Daniel J.] Univ Florida, Inst Wound Res, Gainesville, FL 32611 USA; [Pi, Liya] Univ Florida, Dept Pediat, Gainesville, FL USA; [Sriram, Sriniwas] Univ Florida, Dept Biomed Engn, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gibson, DJ (corresponding author), Univ Florida, Inst Wound Res, Gainesville, FL 32611 USA.	gibsondj@ufl.edu		Gibson, Daniel/0000-0003-0379-0100	National Eye Institute R01 Regulation of Stromal Wound Healing [R01-EY05587]; National Eye Institute Vision Core [EY021721]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY005587, P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA024174] Funding Source: NIH RePORTER	National Eye Institute R01 Regulation of Stromal Wound Healing; National Eye Institute Vision Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Eye Institute R01 Regulation of Stromal Wound Healing (R01-EY05587), https://nei.nih.gov; National Eye Institute Vision Core (EY021721), https://nei.nih.gov; and Research to Prevent Blindness (Institutional), http://rpbusa.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R01 Regulation of Stromal Wound Healing (R01-EY05587), NEI Vision Core (EY021721), and supported in part by an unrestricted grant from Research to Prevent Blindness.	Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Blalock TD, 2004, EXP EYE RES, V78, P1127, DOI 10.1016/j.exer.2004.01.012; Blalock TD, 2012, INVEST OPHTH VIS SCI, V53, P3387, DOI 10.1167/iovs.12-9425; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Folger PA, 2001, INVEST OPHTH VIS SCI, V42, P2534; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gibson DJ, 2014, INVEST OPHTH VIS SCI, V55, P2062, DOI 10.1167/iovs.13-12735; Gibson DJ, 2013, INVEST OPHTH VIS SCI, V54, P4776, DOI 10.1167/iovs.13-11976; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; GROTENDORST GR, 1991, J CELL PHYSIOL, V149, P235, DOI 10.1002/jcp.1041490209; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Igarashi Atsuyuki, 1992, Journal of Dermatology (Tokyo), V19, P642; Kamiyama K, 1998, CORNEA, V17, P315, DOI 10.1097/00003226-199805000-00013; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Kaur H, 2009, EXP EYE RES, V88, P960, DOI 10.1016/j.exer.2008.12.006; Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200; Kim WJ, 1999, INVEST OPHTH VIS SCI, V40, P1364; Moller-Pedersen T, 2004, EXP EYE RES, V78, P553, DOI 10.1016/S0014-4835(03)00208-2; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Radhakrishnan SS, 2012, INVEST OPHTH VIS SCI, V53, P8076, DOI 10.1167/iovs.12-10790; Robinson PM, 2012, METHODS MOL BIOL, V820, P117, DOI 10.1007/978-1-61779-439-1_8; Sriram S, 2014, EXP EYE RES, V125, P173, DOI 10.1016/j.exer.2014.06.014; Sriram S, 2013, INVEST OPHTH VIS SCI, V54, P8214, DOI 10.1167/iovs.13-12758; Tuominen ISJ, 2001, EXP EYE RES, V72, P631, DOI 10.1006/exer.2001.0999; Vesaluoma M, 1997, CURR EYE RES, V16, P825, DOI 10.1076/ceyr.16.8.825.8984	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172304	10.1371/journal.pone.0172304	http://dx.doi.org/10.1371/journal.pone.0172304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207886	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500118
J	Klitzman, R				Klitzman, Robert			How much is a child worth? Providers' and patients' views and responses concerning ethical and policy challenges in paying for ART	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; AFFORDABLE CARE; FERTILITY CARE; PREGNANCY; HEALTH; FAMILY; WOMEN	Infertility treatments remain expensive and in many countries are covered by little, if any, insurance, raising critical questions concerning how patients and providers view and make decisions regarding these challenges. In-depth semi-structured interviews of approximately 1 hour were conducted with 37 IVF providers and 10 patients (17 physicians, 10 other providers and 10 patients), and were systematically analyzed. These data suggest current insurance policies and legislation pose critical ethical and logistical challenges for both patients and providers. These individuals face multiple uncertainties about costs and insurance, related to unclear causes of fertility, treatment length, costs and outcomes, and odds that insurers will cover expenses. Insurers frequently decline to agree to reimbursement beforehand, and decide only afterwards, case-by-case, generating stress. Patients and providers thus may not be able to predict how best to allocate limited resources. Providers may advocate for patients, but are usually unsuccessful. Patients may adopt several strategies: e.g., moving/seeking treatment elsewhere, switching or feeling "stuck" in jobs because of insurance, seeking "free" medications, going into debt, or using funds intended for other purposes. Patients do not perceive and respond to resource limitations as fixed phenomena-i.e., patients do not see treatment simply as "affordable" or not. Rather, patients face quandaries of how much to keep spending-how much a child is worth-and are forced to make complex risk/benefit calculations. Couples can disagree, straining relationships. In sum, these data, the first to explore how providers and patients struggle, view, and make decisions regarding limited insurance and resources for infertility, raise several critical ethical and policy issues. These data suggest that individuals have difficulty translating profoundly life-altering, deeply personal quests for meaning and fulfillment into purely economic terms. These findings thus have important implications for future policy, practice, research, and patient and provider education.	[Klitzman, Robert] Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA	Columbia University	Klitzman, R (corresponding author), Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA.	rlk2@columbia.edu			National Center for Research Resources (NCRR) [UL1 RR024156]; Greenwall Foundation; John Simon Guggenheim Memorial Foundation	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Greenwall Foundation; John Simon Guggenheim Memorial Foundation	This work was supported by #UL1 RR024156 from the National Center for Research Resources (NCRR): https://www.nih.gov/research-training/research-resources, The Greenwall Foundation: http://www.greenwall.org/, and The John Simon Guggenheim Memorial Foundation: http://www.gf.org/.	Akyuz A, 2009, J REPROD INFANT PSYC, V27, P258, DOI 10.1080/02646830802409652; American Society for Reproductive Medicine, 2017, STAT INF LAWS 2017; [Anonymous], 2015, FERTIL STERIL, V104, P1104, DOI [10.1016/j.fertnstert.2015.07.1139, DOI 10.1016/j.fertnstert.2015.07.1139, DOI 10.1016/J.FERTNSTERT.2015.07.1139]; [Anonymous], 2016, FERTIL STERIL, V106, pe8, DOI [10.1016/j.fertnstert.2016.07.003, DOI 10.1016/J.FERTNSTERT.2016.07.003]; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Cauchi R, 2016, STATE PRESCRIPTION D; Chambers GM, 2013, FERTIL STERIL, V100, P319, DOI 10.1016/j.fertnstert.2013.06.017; Chandra A, 2010, FERTIL STERIL, V93, P725, DOI 10.1016/j.fertnstert.2008.10.049; Cho YI, 2013, EVAL HEALTH PROF, V36, P382, DOI 10.1177/0163278713496425; Creswell J. W., 2013, RES DESIGN QUANTITAT; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; Desjarlais R, 2007, J ROY ANTHROPOL INST, V13, P1044, DOI 10.1111/j.1467-9655.2007.00472_20.x; Devine K, 2014, FERTIL STERIL, V101, P1224, DOI 10.1016/j.fertnstert.2014.01.024; Figueira JR, 2011, INT J MED INFORM, V80, P262, DOI 10.1016/j.ijmedinf.2010.12.001; Fisher PB, 2011, FERTIL STERIL, V96, pS30, DOI 10.1016/j.fertnstert.2011.07.123; FRIEDMAN D, 1994, DEMOGRAPHY, V31, P375, DOI 10.2307/2061749; Geertz C., 1973, INTERPREATION CULTUR; Green EC, 2014, HLTH BELIEF MODEL, P766; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hershberger P, 2007, FERTIL STERIL, V87, P288, DOI 10.1016/j.fertnstert.2006.06.036; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Iaconelli A, 2013, FERTIL STERIL, V100, pS66, DOI 10.1016/j.fertnstert.2013.07.1884; Johnston J, 2015, JAMA PEDIATR, V169, P287, DOI 10.1001/jamapediatrics.2014.3219; Katz P, 2011, FERTIL STERIL, V95, P915, DOI 10.1016/j.fertnstert.2010.11.026; Klitzman RL, 2005, SOC SCI MED, V61, P2396, DOI 10.1016/j.socscimed.2005.04.031; Klitzman R, 2007, AM J MED GENET A, V143A, P1835, DOI 10.1002/ajmg.a.31864; Klitzman Robert, 2016, Reprod Biomed Soc Online, V3, P1, DOI 10.1016/j.rbms.2016.07.001; Klitzman R, 2016, J LAW MED ETHICS, V44, P616, DOI 10.1177/1073110516684804; Klitzman R, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0151-z; Klitzman R, 2013, GENET MED, V15, P888, DOI 10.1038/gim.2013.87; Klitzman R, 2013, CLIN TRIALS, V10, P761, DOI 10.1177/1740774513500080; Klitzman R, 2012, ACAD MED, V87, P975, DOI 10.1097/ACM.0b013e3182578b54; Klitzman RL, 2016, HUM REPROD, V31, P2570, DOI 10.1093/humrep/dew231; Kulkarni AD, 2013, NEW ENGL J MED, V369, P2218, DOI 10.1056/NEJMoa1301467; Linkov L, 2011, MULTICRITERIA DECISI, P73, DOI [10.1016/j.ijmedinf.2010.12.001, DOI 10.1016/J.IJMEDINF.2010.12.001]; Marcus D, 2011, HUM FERTIL, V14, P29, DOI 10.3109/14647273.2010.541971; Omurtag K, 2013, FERTIL STERIL, V99, P652, DOI 10.1016/j.fertnstert.2012.10.001; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Prag P, 2015, FAMILIES SOC, V43, P1; Sazonova A, 2013, FERTIL STERIL, V99, P731, DOI 10.1016/j.fertnstert.2012.11.023; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; Smith JF, 2011, FERTIL STERIL, V96, P95, DOI 10.1016/j.fertnstert.2011.04.054; Strauss A., 1990, BASICS QUALITATIVE R; Trump B, 2015, BMJ EVID-BASED MED, V20, P193, DOI DOI 10.1136/EBMED-2015-110274; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Wu AK, 2013, FERTIL STERIL, V99, P2025, DOI 10.1016/j.fertnstert.2013.01.145	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171939	10.1371/journal.pone.0171939	http://dx.doi.org/10.1371/journal.pone.0171939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207807	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500063
J	Ning, PB; Zhou, YL; Gao, LF; Sun, YY; Zhou, WF; Liu, FR; Yao, ZY; Xie, LF; Wang, JH; Gong, CM				Ning, Pengbo; Zhou, Yulu; Gao, Lifang; Sun, Yingying; Zhou, Wenfei; Liu, Furong; Yao, Zhenye; Xie, Lifang; Wang, Junhui; Gong, Chunmei			Unraveling the microRNA of Caragana korshinskii along a precipitation gradient on the Loess Plateau, China, using high-throughput sequencing	PLOS ONE			English	Article							ARABIDOPSIS BAX INHIBITOR-1; RESPONSIVE MICRORNAS; IDENTIFICATION; EXPRESSION; STRESS; PLANT; SOIL; BIOGENESIS; CLEAVAGE; MIR319	Drought remains one of the main factors that negatively affect plant growth and development. Caragana korshinskii is widely distributed on the Loess Plateau, China, where it mediates soil and water loss and helps prevent desertification. However, little is known about the stress response mechanisms of C. korshinskii in water-starved environments. MicroRNAs (miRNAs) have been implicated in the regulation of plant responses to several types of biotic and abiotic stress. Here, we describe the miRNAs of wild C. korshinskii from Huangling, Yulin, and Dalad Banner, which occur along a precipitation gradient. Using next-generation sequencing technology, we obtained a total of 13 710 681, 15 048 945, and 15 198 442 reads for each location, respectively; after filtering and BLAST analysis, 490 conserved miRNAs and 96 novel miRNAs were characterized from the sRNAome data, with key functions determined using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. We also designed stem-loop qRT-PCR to validate the expression patterns of 5 conserved miRNAs (miR390, miR398, miR530, miR2119, and miR5559) that obviously responded to water stress in plants grown both under natural and experimental water stress conditions and found that the expression levels of miR2119 and miR5559 were negatively correlated with their predicted target genes. This study is the first to identify miRNAs from wild C. korshinskii and provides a basis for future studies of miRNA-mediated gene regulation of stress responses in C. korshinskii.	[Ning, Pengbo; Zhou, Yulu; Gao, Lifang; Sun, Yingying; Zhou, Wenfei; Liu, Furong; Yao, Zhenye; Xie, Lifang; Wang, Junhui; Gong, Chunmei] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Ning, Pengbo] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Xidian University	Gong, CM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	gcm228@nwsuaf.edu.cn			National Natural Science Foundation of China [31070538, 31370599]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31070538) and partially supported by the National Natural Science Foundation of China (No. 31370599).; This work was supported by the National Natural Science Foundation of China (No. 31070538) and partially supported by the National Natural Science Foundation of China (No. 31370599). We would like to thank the Guangzhou Gene Denovo Biotechnology Co., Ltd for assisting us with sequencing and technical support.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Froelich DR, 2011, PLANT CELL, V23, P4428, DOI 10.1105/tpc.111.093179; Gong CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28883; He XB, 2003, AGR ECOSYST ENVIRON, V94, P355, DOI 10.1016/S0167-8809(02)00039-7; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jian SQ, 2014, J HYDROL HYDROMECH, V62, P89, DOI 10.2478/johh-2014-0020; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kohli Deshika, 2014, PLoS One, V9, pe108851, DOI 10.1371/journal.pone.0108851; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudet O, 2008, P NATL ACAD SCI USA, V105, P17193, DOI 10.1073/pnas.0807264105; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu YZ, 2011, FUNCT PLANT BIOL, V38, P44, DOI 10.1071/FP10178; Ma CC, 2008, J ARID ENVIRON, V72, P247, DOI 10.1016/j.jaridenv.2007.05.009; Ma HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025184; Nagano M, 2009, PLANT J, V58, P122, DOI 10.1111/j.1365-313X.2008.03765.x; Ning PB, 2016, ECOL EVOL, V6, P3786, DOI 10.1002/ece3.2157; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Patel PK, 2012, AM J PLANT PHYSL, V10, P3932; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Qiu YP, 2004, CHINESE SCI BULL, V49, P2159, DOI 10.1360/982004-183; Qu D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00027; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Turner M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24918; Wang L, 2006, ENVIRON SCI POLICY, V9, P675, DOI 10.1016/j.envsci.2006.08.003; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702	52	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172017	10.1371/journal.pone.0172017	http://dx.doi.org/10.1371/journal.pone.0172017			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207805	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500073
J	Szucs, A; Marjai, T; Szentesi, A; Farkas, N; Parniczky, A; Nagy, G; Kui, B; Takacs, T; Czako, L; Szepes, Z; Nemeth, BC; Vincze, A; Par, G; Szabo, I; Sarlos, P; Illes, A; Godi, S; Izbeki, F; Gervain, J; Halasz, A; Farkas, G; Leindler, L; Kelemen, D; Papp, R; Szmola, R; Varga, M; Hamvas, J; Novak, J; Bod, B; Sahin-Toth, M; Hegyi, P				Szucs, Akos; Marjai, Tamas; Szentesi, Andrea; Farkas, Nelli; Parniczky, Andrea; Nagy, Gyorgy; Kui, Balazs; Takacs, Tamas; Czako, Laszlo; Szepes, Zoltan; Nemeth, Balazs Csaba; Vincze, Aron; Par, Gabriella; Szabo, Imre; Sarlos, Patricia; Illes, Anita; Godi, Szilard; Izbeki, Ferenc; Gervain, Judit; Halasz, Adrienn; Farkas, Gyula; Leindler, Laszlo; Kelemen, Dezso; Papp, Robert; Szmola, Richard; Varga, Marta; Hamvas, Jozsef; Novak, Janos; Bod, Barnabas; Sahin-Toth, Miklos; Hegyi, Peter		Hungarian Pancreatic Study Grp	Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group	PLOS ONE			English	Article							ALCOHOLIC CHRONIC-PANCREATITIS; COMMON BILE-DUCT; DUODENUM-PRESERVING RESECTION; MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; IDIOPATHIC CHRONIC-PANCREATITIS; LONG-TERM; CIGARETTE-SMOKING; LATE-ONSET; ENDOSCOPIC TREATMENT; BEGER PROCEDURE	Introduction Chronic pancreatitis is an inflammatory disease associated with structural and functional damage to the pancreas, causing pain, maldigestion and weight loss and thus worsening the quality of life. Aims and methods Our aim was to find correlations from a multicentre database representing the epidemiological traits, diagnosis and treatment of the disease in Hungary. The Hungarian Pancreatic Study Group collected data prospectively from 2012 to 2014 on patients suffering from chronic pancreatitis. Statistical analysis was performed on different questions. Results Data on 229 patients (74% male and 26% female) were uploaded from 14 centres. Daily alcohol consumption was present in the aetiology of 56% of the patients. 66% of the patients were previously treated for acute exacerbation. One third of the patients had had previous endoscopic or surgical interventions. Pain was present in 69% of the cases, endocrine insufficiency in 33%, diarrhoea in 13% and weight loss in 39%. Diagnosis was confirmed with US (80%), CT scan (52%), MRI-MRCP (6%), ERCP (39%), and EUS (7,4%). A functional test was carried out in 5% of the patients. In 31% of the cases, an endoscopic intervention was performed with the need for re-intervention in 5%. Further elective surgical intervention was necessitated in 44% of endoscopies. 20% of the registered patients were primarily treated with surgery. The biliary complication rate for surgery was significantly smaller (2%) than endoscopy (27%); however, pancreatic complications were higher in the patients treated with surgery. Patients who smoked regularly needed significantly more surgical intervention following endoscopy (66.7% vs. 26.9%, p = 0.002) than non-smokers, and the ratio of surgical intervention alone was also significantly higher (27.3% vs. 10.8%, p = 0.004). The ratio of surgery in patients who smoked and drank was significantly higher (30.09% vs. 12.5%, p = 0.012) than in abstinent and non-smoking patients, similarly to the need for further surgical intervention after endoscopic treatment (71.43% vs. 27.78%, p = 0.004). Conclusions According to the data analysed, the epidemiological data and the aetiological factors in our cohort differ little from European trends. The study highlighted the overuse of ERCP as a diagnostic modality and the low ratio of use of endoscopic ultrasonography. The results proved that alcohol consumption and smoking represent risk factors for the increased need for surgical intervention. Chronic pancreatitis should be treated by multidisciplinary consensus grounded in evidence-based medicine.	[Szucs, Akos; Marjai, Tamas] Semmelweis Univ, Dept Surg 1, Budapest, Hungary; [Szentesi, Andrea; Hegyi, Peter] Univ Pecs, Inst Translat Med, Pecs, Hungary; [Szentesi, Andrea; Kui, Balazs; Takacs, Tamas; Czako, Laszlo; Szepes, Zoltan; Nemeth, Balazs Csaba; Hegyi, Peter] Univ Szeged, Dept Med 1, Szeged, Hungary; [Farkas, Nelli] Univ Pecs, Inst Bioanal, Pecs, Hungary; [Parniczky, Andrea] Heim Pal Childrens Hosp, Budapest, Hungary; [Nagy, Gyorgy] Univ Debrecen, Dept Internal Med 2, Debrecen, Hungary; [Vincze, Aron; Par, Gabriella; Szabo, Imre; Sarlos, Patricia; Illes, Anita] Univ Pecs, Dept Med 1, Div Gastroenterol, Pecs, Hungary; [Godi, Szilard; Hegyi, Peter] Univ Pecs, Dept Med 1, Div Translat Med, Pecs, Hungary; [Izbeki, Ferenc; Gervain, Judit; Halasz, Adrienn] Szent Gyorgy Univ, Teaching Hosp Fejer Cty, Szekesfehervar, Hungary; [Farkas, Gyula; Leindler, Laszlo] Univ Szeged, Dept Surg, Szeged, Hungary; [Kelemen, Dezso; Papp, Robert] Univ Pecs, Dept Surg, Pecs, Hungary; [Szmola, Richard] Natl Inst Oncol, Dept Intervent Gastroenterol, Budapest, Hungary; [Varga, Marta] Dr Rethy Pal Hosp, Bekescsaba, Hungary; [Hamvas, Jozsef] Bajcsy Zsilinszky Hosp, Budapest, Hungary; [Novak, Janos] Pandy Kalman Hosp Bekes Cty, Gyula, Hungary; [Bod, Barnabas] Dr Bugyi Istvan Hosp, Szentes, Hungary; [Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Boston, MA 02215 USA; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary	Semmelweis University; University of Pecs; Szeged University; University of Pecs; University of Debrecen; University of Pecs; University of Pecs; Szeged University; University of Pecs; National Institute of Oncology Hungary; Boston University; Hungarian Academy of Sciences; Szeged University	Hegyi, P (corresponding author), Univ Pecs, Inst Translat Med, Pecs, Hungary.; Hegyi, P (corresponding author), Univ Szeged, Dept Med 1, Szeged, Hungary.; Hegyi, P (corresponding author), Univ Pecs, Dept Med 1, Div Translat Med, Pecs, Hungary.; Hegyi, P (corresponding author), Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary.	hegyi.peter@med.u-szeged.hu	Sarlos, Patricia/V-6890-2017; Vincze, Aron/J-6724-2019; Vincze, Aron/A-7048-2011	Sarlos, Patricia/0000-0002-5086-9455; Vincze, Aron/0000-0003-2217-7686; Vincze, Aron/0000-0003-2217-7686; Farkas, Gyula/0000-0001-7293-7546; Sahin-Toth, Miklos/0000-0003-4513-9922; Nemeth, Balazs/0000-0001-5338-7577; Farkas, Nelli/0000-0002-5349-6527; Leindler MD, Laszlo/0000-0001-9455-1775	Hungarian Scientific Research Fund [K116634]; Hungarian Academy of Sciences [LP2014-10/2014]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian Scientific Research Fund (K116634 to PH) and the Momentum Grant of the Hungarian Academy of Sciences (LP2014-10/2014 to PH).	AFROUDAKIS A, 1981, HEPATOLOGY, V1, P65, DOI 10.1002/hep.1840010111; AMMANN RW, 1988, GASTROENTEROLOGY, V95, P1018, DOI 10.1016/0016-5085(88)90178-3; Ammann RW, 2001, INTERNAL MED, V40, P368, DOI 10.2169/internalmedicine.40.368; ANDERSEN BN, 1982, SCAND J GASTROENTERO, V17, P247; Andren-Sandberg Ake, 2004, JOP, V5, P8; Angelopoulos N, 2005, PANCREATOLOGY, V5, P122, DOI 10.1159/000085264; ARANHA GV, 1984, ARCH SURG-CHICAGO, V119, P595; BANK S, 1975, AM J GASTROENTEROL, V64, P13; BEGER HG, 1985, SURGERY, V97, P467; BEGER HG, 1989, ANN SURG, V209, P273, DOI 10.1097/00000658-198903000-00004; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Buchler MW, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-93; BUSCAIL L, 1995, PANCREAS, V10, P251, DOI 10.1097/00006676-199504000-00006; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Cahen DL, 2005, EUR J GASTROEN HEPAT, V17, P103, DOI 10.1097/00042737-200501000-00019; Cataldegirmen G, 2008, BRIT J SURG, V95, P447, DOI 10.1002/bjs.6006; CAVALLINI G, 1994, PANCREAS, V9, P42, DOI 10.1097/00006676-199401000-00006; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Czako L, 2007, J GASTROENTEROL, V42, P113, DOI 10.1007/s00535-006-1919-6; Diener MK, 2008, ANN SURG, V247, P950, DOI 10.1097/SLA.0b013e3181724ee7; DIMAGNO EP, 1973, NEW ENGL J MED, V288, P813, DOI 10.1056/NEJM197304192881603; DiMagno MJ, 2006, CURR OPIN GASTROEN, V22, P487; DiMagno MJ, 2010, CURR OPIN GASTROEN, V26, P490, DOI 10.1097/MOG.0b013e32833d11b2; Dite P, 2003, ENDOSCOPY, V35, P553; Dite P, 2001, EUR J GASTROEN HEPAT, V13, P749; Frey CF, 2003, WORLD J SURG, V27, P1217, DOI 10.1007/s00268-003-7241-z; Frulloni L, 2009, DIGEST LIVER DIS, V41, P311, DOI 10.1016/j.dld.2008.07.316; Glasbrenner B, 2002, EUR J GASTROEN HEPAT, V14, P935, DOI 10.1097/00042737-200209000-00003; Hirota M, 2012, PANCREATOLOGY, V12, P79, DOI 10.1016/j.pan.2012.02.005; Hirota M, 2010, J HEPATO-BIL-PAN SCI, V17, P770, DOI 10.1007/s00534-009-0182-7; Hoffmeister A, 2012, Z GASTROENTEROL, V50, P1176, DOI 10.1055/s-0032-1325479; HOLLERBACH S, 1994, MED KLIN, V89, P7; HUIZINGA WKJ, 1992, ANN ROY COLL SURG, V74, P119; Imoto M, 2000, PANCREAS, V21, P115, DOI 10.1097/00006676-200008000-00002; Isaji S, 2010, J HEPATO-BIL-PAN SCI, V17, P763, DOI 10.1007/s00534-009-0181-8; JAAKKOLA M, 1993, GUT, V34, P1255, DOI 10.1136/gut.34.9.1255; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; Kahl S, 2003, AM J GASTROENTEROL, V98, P2448, DOI 10.1016/S0002-9270(03)01700-3; Lakatos G, 2016, J GASTROINTEST LIVER, V25, P219, DOI [10.15403/jgld.2014.1121.252.pcr, 10.15403/jgld.2014.1121.252.per]; Lankisch PG, 2002, PANCREATOLOGY, V2, P469, DOI 10.1159/000064713; Layer P, 2003, PANCREAS, V26, P1, DOI 10.1097/00006676-200301000-00001; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Layer P, 1999, SURG CLIN N AM, V79, P847, DOI 10.1016/S0039-6109(05)70047-5; Levy P, 2006, GASTROEN CLIN BIOL, V30, P838, DOI 10.1016/S0399-8320(06)73330-9; Levy P, 2014, UNITED EUR GASTROENT, V2, P345, DOI 10.1177/2050640614548208; Lohr J M, 2000, Z Gastroenterol, V38, P603, DOI 10.1055/s-2000-7444; LOWENFELS AB, 1994, AM J GASTROENTEROL, V89, P1467; Luaces-Regueira M, 2014, PANCREAS, V43, P275, DOI 10.1097/01.mpa.0000437324.52598.ee; LUETMER PH, 1989, RADIOLOGY, V171, P353, DOI 10.1148/radiology.171.2.2704799; Maisonneuve P, 2005, GUT, V54, P510, DOI 10.1136/gut.2004.039263; Maisonneuve P, 2006, PANCREAS, V33, P163, DOI 10.1097/01.mpa.0000227916.94073.fc; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Mullady DK, 2011, GUT, V60, P77, DOI 10.1136/gut.2010.213835; Nguyen-Tang T, 2010, BEST PRACT RES CL GA, V24, P281, DOI 10.1016/j.bpg.2010.03.002; Pelli Hanna, 2009, Duodecim, V125, P1195; PETROZZA JA, 1985, J CLIN GASTROENTEROL, V7, P447, DOI 10.1097/00004836-198510000-00018; Rebours V, 2012, PANCREAS, V41, P1219, DOI 10.1097/MPA.0b013e31825de97d; Sai JK, 2008, WORLD J GASTROENTERO, V14, P1218, DOI 10.3748/wjg.14.1218; SAND JA, 1995, EUR J SURG, V161, P587; Schneider A, 2007, J GASTROENTEROL, V42, P101, DOI 10.1007/s00535-006-1945-4; Schoenberg MH, 1998, CHIRURG, V69, P633, DOI 10.1007/s001040050467; Siddiqui UD, 2010, J CLIN GASTROENTEROL, V44, P1, DOI 10.1097/MCG.0b013e3181bb87f4; STABILE BE, 1987, SURG GYNECOL OBSTET, V165, P121; STRUM WB, 1995, J CLIN GASTROENTEROL, V20, P37, DOI 10.1097/00004836-199501000-00010; Talamini G, 1996, PANCREAS, V12, P131, DOI 10.1097/00006676-199603000-00004; Tamura R, 2006, RADIOLOGY, V238, P920, DOI 10.1148/radiol.2382041527; Thuluvath PJ, 2003, J CLIN GASTROENTEROL, V36, P159, DOI 10.1097/00004836-200302000-00014; Vijungco JD, 2003, WORLD J SURG, V27, P1258, DOI 10.1007/s00268-003-7246-7; WISLOFF F, 1982, BRIT J SURG, V69, P52, DOI 10.1002/bjs.1800690117; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Wittel UA, 2008, LANGENBECK ARCH SURG, V393, P581, DOI 10.1007/s00423-007-0273-3; Yadav D, 2011, AM J GASTROENTEROL, V106, P2192, DOI 10.1038/ajg.2011.328; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; YADEGAR J, 1980, ARCH SURG-CHICAGO, V115, P582; Zhou YM, 2015, PANCREATOLOGY, V15, P372, DOI 10.1016/j.pan.2015.05.466	76	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171420	10.1371/journal.pone.0171420	http://dx.doi.org/10.1371/journal.pone.0171420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207747	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500029
J	Iaia, FM; Fiorenza, M; Larghi, L; Alberti, G; Millet, GP; Girard, O				Iaia, F. Marcello; Fiorenza, Matteo; Larghi, Luca; Alberti, Giampietro; Millet, Gregoire P.; Girard, Olivier			Short- or long-rest intervals during repeated sprint training in soccer?	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; MUSCLE METABOLISM; OXYGEN-UPTAKE; PLAYERS; EXERCISE; ABILITY; RESPONSES; FOOTBALL; STRENGTH; SPORTS	The present study compared the effects of two repeated-sprint training (RST) programs, differing in duration of the between-sprint rest intervals, on various soccer-related exercise performances. For 5 weeks during the competitive season, twenty-nine young trained male soccer players either replaced two of their habitual fitness conditioning sessions with RST characterized by short (5-15; n = 9) or long (5-30; n = 10) rest intervals, or served as control (n = 10). The 5-15 and 5-30 protocols consisted of 6 repetitions of 30-m (similar to 5 s) straight-line sprints interspersed with 15 s or 30 s of passive recovery, respectively. 5-15 improved 200m sprint time (2.0 +/- 1.5%; p<0.05) and had a likely positive impact on 20-m sprint performance, whereas 5-30 lowered the 20-m sprint time (2.7 +/- 1.6%; p<0.05) but was only possiblyeffective for enhancing the 200-m sprint performance. The distance covered during the Yo-Yo Intermittent Recovery Test Level 2 increased following 5-15 (11.4 +/- 5.0%; p<0.05), which was possibly better than the non-significant 6.5% enhancement observed in 5-30. Improvements in the total time of a repeated-sprint ability test were possibly greater following 5-30 (3.6 +/- 0.9%; p<0.05) compared to 5-15 (2.6 +/- 1.1%; p<0.05). Both RST interventions led to similar beneficial (p<0.05) reductions in the percentage decrement score (similar to 30%) of the repeated-sprint ability test as well as in blood lactate concentration during submaximal exercise (17-18%). No changes occurred in the control group. In soccer players, RST over a 5-week in-season period is an efficient means to simultaneously develop different components of fitness relevant to match performance, with different benefits induced by shorter compared to longer rest intervals.	[Iaia, F. Marcello; Larghi, Luca; Alberti, Giampietro] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Fiorenza, Matteo] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Millet, Gregoire P.; Girard, Olivier] Univ Lausanne, Inst Sport Sci, ISSUL, Lausanne, Switzerland; [Girard, Olivier] Aspetar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, Doha, Qatar	University of Milan; University of Copenhagen; University of Lausanne; Aspetar Orthopaedic & Sports Medicine Hospital	Iaia, FM (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	marcello.iaia@unimi.it	Fiorenza, Matteo/AAA-1887-2020; Iaia, F. Marcello/L-6067-2015; Millet, Gregoire P/F-4104-2012; Alberti, Giampietro/M-4110-2016	Fiorenza, Matteo/0000-0002-8377-0857; Iaia, F. Marcello/0000-0003-0981-6471; Millet, Gregoire P/0000-0001-8081-4423; Alberti, Giampietro/0000-0002-5464-9644; girard, olivier/0000-0002-4797-182X				Al Haddad H, 2015, INT J SPORT PHYSIOL, V10, P888, DOI 10.1123/ijspp.2014-0539; Balsom PD, 1999, ACTA PHYSIOL SCAND, V165, P337, DOI 10.1046/j.1365-201x.1999.00517.x; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Brocherie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144446; Brocherie F, 2015, J STRENGTH COND RES, V29, P226, DOI 10.1519/JSC.0000000000000590; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Buchheit M, 2008, MED SCI SPORT EXER, V40, P362, DOI 10.1249/mss.0b013e31815aa2ee; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Buchheit M, 2012, SPORTS MED, V42, P169, DOI 10.2165/11598230-000000000-00000; Buchheit M, 2010, J STRENGTH COND RES, V24, P2715, DOI 10.1519/JSC.0b013e3181bf0223; Buchheit M, 2010, INT J SPORT PHYSIOL, V5, P152, DOI 10.1123/ijspp.5.2.152; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dawson B, 1998, EUR J APPL PHYSIOL O, V78, P163, DOI 10.1007/s004210050402; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Dupont G, 2005, EUR J APPL PHYSIOL, V95, P27, DOI 10.1007/s00421-005-1382-8; Edge J, 2013, EXP PHYSIOL, V98, P481, DOI 10.1113/expphysiol.2012.067603; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Galvin Harvey M, 2013, Br J Sports Med, V47 Suppl 1, pi74, DOI 10.1136/bjsports-2013-092826; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gatterer H, 2014, J SPORT SCI MED, V13, P731; Glaister M, 2008, J STRENGTH COND RES, V22, P1597, DOI 10.1519/JSC.0b013e318181ab80; Hader K, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-2; Hill-Haas S, 2007, J SPORT SCI, V25, P619, DOI 10.1080/02640410600874849; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Iaia FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138096; Impellizzeri FM, 2005, J SPORT SCI, V23, P583, DOI 10.1080/02640410400021278; McGawley K, 2015, J SCI MED SPORT, V18, P214, DOI 10.1016/j.jsams.2014.02.002; Mohr M, 2007, AM J PHYSIOL-REG I, V292, pR1594, DOI 10.1152/ajpregu.00251.2006; Mohr M, 2016, EUR J APPL PHYSIOL, V116, P179, DOI 10.1007/s00421-015-3245-2; Oliveira RS, 2013, INT J SPORTS MED, V34, P424, DOI 10.1055/s-0032-1323720; Ross A, 2001, SPORTS MED, V31, P409, DOI 10.2165/00007256-200131060-00002; Saraslanidis P, 2011, J SPORT SCI, V29, P1167, DOI 10.1080/02640414.2011.583672; Serpiello FR, 2011, EUR J APPL PHYSIOL, V111, P669, DOI 10.1007/s00421-010-1687-0; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Suarez-Arrones L, 2014, INT J SPORT PHYSIOL, V9, P667, DOI [10.1123/ijspp.2013-0238, 10.1123/IJSPP.2013-0238]; Taylor J, 2015, SPORTS MED, V45, P881, DOI 10.1007/s40279-015-0324-9; Thomassen M, 2010, J APPL PHYSIOL, V108, P898, DOI 10.1152/japplphysiol.01015.2009	42	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171462	10.1371/journal.pone.0171462	http://dx.doi.org/10.1371/journal.pone.0171462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199402	Green Published, gold			2022-12-26	WOS:000394424400032
J	Shimamura, S; Kaneko, T; Ozawa, G; Matsumoto, MN; Koshiishi, T; Takaki, Y; Kato, C; Takai, K; Yoshida, T; Fujikura, K; Barry, JP; Maruyama, T				Shimamura, Shigeru; Kaneko, Takashi; Ozawa, Genki; Matsumoto, Mamiko Nishino; Koshiishi, Takeru; Takaki, Yoshihiro; Kato, Chiaki; Takai, Ken; Yoshida, Takao; Fujikura, Katsunori; Barry, James P.; Maruyama, Tadashi			Loss of genes related to Nucleotide Excision Repair (NER) and implications for reductive genome evolution in symbionts of deep-sea vesicomyid clams	PLOS ONE			English	Article							SOS RESPONSE SYSTEM; ILLEGITIMATE RECOMBINATION; ENDOSYMBIOTIC BACTERIA; HYDROTHERMAL VENT; DNA-REPAIR; GROEL; CONSEQUENCES; PROTEIN; ROLES; UVRA	Intracellular thioautotrophic symbionts of deep-sea vesicomyid clams lack some DNA repair genes and are thought to be undergoing reductive genome evolution (RGE). In this study, we addressed two questions, 1) how these symbionts lost their DNA repair genes and 2) how such losses affect RGE. For the first question, we examined genes associated with nucleotide excision repair (NER; uvrA, uvrB, uvrC, uvrD, uvrD paralog [uvrDp] and mfd) in 12 symbionts of vesicomyid clams belonging to two clades (5 clade I and 7 clade II symbionts). While uvrA, uvrDp and mfd were conserved in all symbionts, uvrB and uvrC were degraded in all clade I symbionts but were apparently intact in clade II symbionts. UvrD was disrupted in two clade II symbionts. Among the intact genes in Ca. Vesicomyosocius okutanii (clade I), expressions of uvrD and mfd were detected by reverse transcription-polymerase chain reaction (RT-PCR), but those of uvrA and uvrDp were not. In contrast, all intact genes were expressed in the symbiont of Calyptogena pacifica (clade II). To assess how gene losses affect RGE (question 2), genetic distances of the examined genes in symbionts from Bathymodiolus septemdierum were shown to be larger in clade I than clade II symbionts. In addition, these genes had lower guanine+ cytosine (GC) content and higher repeat sequence densities in clade I than measured in clade II. Our results suggest that NER genes are currently being lost from the extant lineages of vesicomyid clam symbionts. The loss of NER genes and mutY in these symbionts is likely to promote increases in genetic distance and repeat sequence density as well as reduced GC content in genomic genes, and may have facilitated reductive evolution of the genome.	[Shimamura, Shigeru; Kaneko, Takashi; Ozawa, Genki; Matsumoto, Mamiko Nishino; Koshiishi, Takeru; Kato, Chiaki; Yoshida, Takao; Fujikura, Katsunori] Japan Agcy Marine Earth Sci & Technol, Dept Marine Biodivers Res, 2-15 Natsushima Cho, Yokosuka, Kanagawa, Japan; [Shimamura, Shigeru; Takaki, Yoshihiro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol, Dept Subsurface Geobiol Anal & Res, Natsushima Cho, Yokosuka, Kanagawa, Japan; [Kaneko, Takashi] Tokyo Coll Biotechnol, Ota Ku, Tokyo, Japan; [Ozawa, Genki; Yoshida, Takao; Maruyama, Tadashi] Kitasato Univ, Sch Marine Biosci, Kitasato Minami Ku, Sagamihara, Kanagawa, Japan; [Barry, James P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Submarine Resources, Natsushima Cho, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kitasato University; Monterey Bay Aquarium Research Institute; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Maruyama, T (corresponding author), Kitasato Univ, Sch Marine Biosci, Kitasato Minami Ku, Sagamihara, Kanagawa, Japan.; Maruyama, T (corresponding author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Submarine Resources, Natsushima Cho, Yokosuka, Kanagawa, Japan.	tadashim@jamstec.go.jp			Japan Agency for Marine-Earth Science and Technology; Monterey Bay Aquarium Research Institute [901007]	Japan Agency for Marine-Earth Science and Technology; Monterey Bay Aquarium Research Institute	This study was supported partly by the budget of Japan Agency for Marine-Earth Science and Technology and by the Monterey Bay Aquarium Research Institute, project number 901007.	AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; Batut B, 2014, NAT REV MICROBIOL, V12, P841, DOI 10.1038/nrmicro3331; Charmasson S, 2009, J ENVIRON RADIOACTIV, V100, P522, DOI 10.1016/j.jenvrad.2009.02.002; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DOOLITTLE RF, 1986, NATURE, V323, P451, DOI 10.1038/323451a0; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Fares MA, 2005, J EVOLUTION BIOL, V18, P651, DOI 10.1111/j.1420-9101.2004.00861.x; Fiala-Medioni A, 1986, MAR BIOL, V90, P8; Hanada K, 2000, P NATL ACAD SCI USA, V97, P5989, DOI 10.1073/pnas.100101297; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Janion C, 2001, ACTA BIOCHIM POL, V48, P599; Janion C, 2008, INT J BIOL SCI, V4, P338; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kimura M, 1983, NEUTRAL THEORY MOL E, P396, DOI DOI 10.1101/GR.966203; Kisker C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012591; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Kupper M, 2014, FEMS MICROBIOL LETT, V353, P1, DOI 10.1111/1574-6968.12390; Kuwahara H, 2008, EXTREMOPHILES, V12, P365, DOI 10.1007/s00792-008-0141-2; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Kuwahara H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-285; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Martinez-Cano DJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00742; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2014, ANNU REV MICROBIOL, V68, P195, DOI 10.1146/annurev-micro-091213-112901; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2009, FEMS MICROBIOL REV, V33, P225, DOI 10.1111/j.1574-6976.2008.00151.x; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Okutani T, 2000, VENUS, V59, P18; Palacios C, 2002, MOL BIOL EVOL, V19, P1575, DOI 10.1093/oxfordjournals.molbev.a004219; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Pruski AM, 2003, AQUAT TOXICOL, V64, P1, DOI 10.1016/S0166-445X(03)00010-9; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart FJ, 2009, MOL BIOL EVOL, V26, P1391, DOI 10.1093/molbev/msp049; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Yanai H, 2011, 4STEPS USEFUL ADD FO; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171274	10.1371/journal.pone.0171274	http://dx.doi.org/10.1371/journal.pone.0171274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199404	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424400027
J	Rizwan, M; Aslam, M; Asghar, MJ; Abbas, G; Shah, TM; Shimelis, H				Rizwan, Muhammad; Aslam, Muhammad; Asghar, Muhammad Jawad; Abbas, Ghulam; Shah, Tariq Mahmud; Shimelis, Hussein			Pre-breeding of lentil (Lens culinaris Medik.) for herbicide resistance through seed mutagenesis	PLOS ONE			English	Article							ACETOLACTATE SYNTHASE; TOLERANCE; SULFONYLUREA; MUTANTS	Lentil is a poor competitor of weeds and its sensitivity to herbicides is a major hurdle for large scale production. The present study was conducted to select herbicide resistant lentil genotypes through seed mutagenesis. Seeds of three advanced lentil genotypes (LPP 11001, LPP 11100 and LPP 11116) were treated with two different concentrations of ethyl methanesulfonate (EMS; 0.1 and 0.2%), hydrazine hydrate (HH; 0.02 and 0.03%) and sodium azide (SA; 0.01 and 0.02%) to develop M-1 seed. The M-2 was screened against two herbicides including Ally Max 28.6% SG (X = 34.58 g/ha and 1.5X = 51.87 g/ha) and Atlantis 3.6% WG (X = 395.2 g/ha and 1.5X = 592.8 g/ha) using the following three screening methods: post plant emergence (PPE), pre-plant incorporation (PPI) and seed priming (SP). Data were recorded on survival index and survival percentage from each experimental unit of every population. Plants in all populations were categorized following their reaction to herbicides. The newly developed populations showed greater variation for herbicide resistance when compared to their progenitors. Phenotypic traits were significantly reduced in all the screening environments. Overall, 671 herbicide resistant mutants were selected from all testing environments. The seeds from selected plants were re-mutagenized at 150 Gy of gamma radiation and evaluated against higher dose of herbicides. This allowed selection of 134 herbicide resistant mutants. The selected mutants are useful germplasm for herbicide resistance breeding of lentil.	[Rizwan, Muhammad; Asghar, Muhammad Jawad; Abbas, Ghulam; Shah, Tariq Mahmud] Nucl Inst Agr & Biol, Faisalabad, Pakistan; [Aslam, Muhammad] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Shimelis, Hussein] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, African Ctr Crop Improvement, Pietermaritzburg, South Africa	Nuclear Institute for Agriculture & Biology - Pakistan; University of Agriculture Faisalabad; University of Kwazulu Natal	Rizwan, M (corresponding author), Nucl Inst Agr & Biol, Faisalabad, Pakistan.	rzi_rizwan@yahoo.com	Shimelis, Hussein/N-5073-2013; shah, Tariqmahmud mahmud/D-2767-2017	Shimelis, Hussein/0000-0003-2793-8392; 				Alkadhi KA, 2012, INT J NEUROPSYCHOPH, V15, P223, DOI 10.1017/S1461145711000162; ANDERSON PC, 1989, GENOME, V31, P994, DOI 10.1139/g89-173; Barrentine W. L., 1979, Proceedings of the 32nd Annual Meeting of the Southern Weed Science Society., P97; Beckie HJ, 2006, CAN J PLANT SCI, V86, P1243, DOI 10.4141/P05-193; BERNASCONI P, 1995, J BIOL CHEM, V270, P17381, DOI 10.1074/jbc.270.29.17381; CHALEFF RS, 1984, SCIENCE, V223, P1148, DOI 10.1126/science.223.4641.1148; CHALEFF RS, 1984, SCIENCE, V224, P1443, DOI 10.1126/science.224.4656.1443; Chant SR, 2004, THESIS; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Federer WT, 2005, J CROP IMPROV, V14, P29, DOI [10.1300/J411v14n01_04, 10.1300/J411v15n01_07]; Federer WT, 2005, TECHNICAL REPORT SER; FRIESEN GH, 1986, CAN J PLANT SCI, V66, P131, DOI 10.4141/cjps86-017; Gaikwad N. B., 2004, Indian Journal of Genetics & Plant Breeding, V64, P73; Gaur PM, 2013, AGRONOMY-BASEL, V3, P524, DOI 10.3390/agronomy3030524; Malkawi HI, 2003, J AGR SCI, V140, P83, DOI 10.1017/S0021859602002733; Ndungu DK, 2009, THESIS; NEWHOUSE K, 1991, THEOR APPL GENET, V83, P65, DOI 10.1007/BF00229227; NEWHOUSE KE, 1992, PLANT PHYSIOL, V100, P882, DOI 10.1104/pp.100.2.882; Pandolfo CE, 2013, PLANTA DANINHA, V31, P657, DOI 10.1590/S0100-83582013000300017; PINTHUS MJ, 1972, SCIENCE, V177, P715, DOI 10.1126/science.177.4050.715; Rajasekaran K, 1996, PLANT SCI, V119, P115, DOI 10.1016/0168-9452(96)04444-5; Sala CA, 2008, CROP SCI, V48, P1817, DOI 10.2135/cropsci2007.11.0625; Sarker A, 2006, J AGR SCI-CAMBRIDGE, V144, P19, DOI 10.1017/S0021859605005800; SEBASTIAN SA, 1987, CROP SCI, V27, P948, DOI 10.2135/cropsci1987.0011183X002700050025x; Shamima Aktar, 2013, The Agriculturists, V11, P89; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993	26	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171846	10.1371/journal.pone.0171846	http://dx.doi.org/10.1371/journal.pone.0171846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196091	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900035
J	Li, YH; Zhuang, SF; Wu, YP; Ren, HL; Chen, FY; Lin, X; Wang, KJ; Beardall, J; Gao, KS				Li, Yahe; Zhuang, Shufang; Wu, Yaping; Ren, Honglin; Chen, Fangyi; Lin, Xin; Wang, Kejian; Beardall, John; Gao, Kunshan			Ocean acidification modulates expression of genes and physiological performance of a marine diatom	PLOS ONE			English	Article							CARBON CONCENTRATING MECHANISMS; ELEVATED CO2; ANHYDRASE; LIGHT; PHYTOPLANKTON; PH; PHOTOSYNTHESIS; EVOLUTION; RESPONSES; ECOLOGY	Ocean Acidification (OA) is known to affect various aspects of physiological performances of diatoms, but little is known about the underlining molecular mechanisms involved. Here, we show that in the model diatom Phaeodactylum tricornutum, the expression of key genes associated with photosynthetic light harvesting as well as those encoding Rubisco, carbonic anhydrase, NADH dehydrogenase and nitrite reductase, are modulated by OA (1000 mu atm, pH(nbs) 7.83). Growth and photosynthetic carbon fixation were enhanced by elevated CO2. OA treatment decreased the expression of beta-carbonic anhydrase (beta-ca), which functions in balancing intracellular carbonate chemistry and the CO2 concentrating mechanism (CCM). The expression of the genes encoding fucoxanthin chlorophyll a/c protein (lhcf type (fcp)), mitochondrial ATP synthase (mtATP), ribulose-1, 5-bisphosphate carboxylase/oxygenase large subunit gene (rbcl) and NADH dehydrogenase subunit 2 (ndh2), were down-regulated during the first four days (< 8 generations) after the cells were transferred from LC (cells grown under ambient air condition; 390 mu atm; pH(nbs) 8.19) to OA conditions, with no significant difference between LC and HC treatments with the time elapsed. The expression of nitrite reductase (nir) was up-regulated by the OA treatment. Additionally, the genes for these proteins (NiR, FCP, mtATP synthase, beta-CA) showed diel expression patterns. It appeared that the enhanced photosynthetic and growth rates under OA could be attributed to stimulated nitrogen assimilation, increased CO2 availability or saved energy from downregulation of the CCM and consequently lowered cost of protein synthesis versus that of non-nitrogenous cell components.	[Li, Yahe; Zhuang, Shufang; Wu, Yaping; Chen, Fangyi; Lin, Xin; Wang, Kejian; Gao, Kunshan] Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Ren, Honglin] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis Res, Changchun, Peoples R China; [Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Xiamen University; Jilin University; Monash University	Wang, KJ; Gao, KS (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	wkjian@xmu.edu.cn; ksgao@xmu.edu.cn	Wu, Yaping/C-7996-2014; Beardall, John/L-5262-2019; Wu, Yaping/AAK-2810-2021; gao, kunshan/G-3374-2010; Wang, KJ/G-4609-2010	Beardall, John/0000-0001-7684-446X; Gao, Kunshan/0000-0001-7365-6332	National Natural Science Foundation [41430967, 41120164007, 41206091, 41306096]; State Oceanic Administration (National Programme on Global Change and Air-Sea Interaction) [GASI-03-01-02-04]; NSFC [U1406403]; Strategic Priority Research Program of CAS [XDA11020302]; Fundamental Research Funds for the Central Universities [2013121049]; XMU president program [ZK1050]; Xiamen University; Shandong province [U1406403]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Oceanic Administration (National Programme on Global Change and Air-Sea Interaction); NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); XMU president program; Xiamen University(Xiamen University); Shandong province	This study was supported by the National Natural Science Foundation (41430967 and 41120164007 to KG, 41206091 to YW, 41306096 to XL), State Oceanic Administration (National Programme on Global Change and Air-Sea Interaction, GASI-03-01-02-04), the Joint project of NSFC and Shandong province (Grant No. U1406403) and the Strategic Priority Research Program of CAS (Grant No. XDA11020302), the Fundamental Research Funds for the Central Universities (2013121049) and XMU president program (ZK1050). JBs visit was supported by Xiamen University.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Beardall J, 2014, AQUAT BIOL, V22, P5, DOI 10.3354/ab00582; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Bender SJ, 2012, PROTIST, V163, P232, DOI 10.1016/j.protis.2011.07.008; BHAYA D, 1993, NUCLEIC ACIDS RES, V21, P4458; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Dubinsky Z, 2010, HYDROBIOLOGIA, V639, P153, DOI 10.1007/s10750-009-0026-0; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; GAO K, 1993, MAR BIOL, V117, P129, DOI 10.1007/BF00346434; Gao KS, 2007, PHOTOCHEM PHOTOBIOL, V83, P802, DOI 10.1111/j.1751-1097.2007.00154.x; Gao KS, 2014, FUNCT PLANT BIOL, V41, P449, DOI 10.1071/FP13247; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Giordano M, 2013, PLANT SCI, V211, P92, DOI 10.1016/j.plantsci.2013.07.008; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; Harada H, 2005, CAN J BOT, V83, P909, DOI 10.1139/B05-078; Harada H, 2005, PLANT PHYSIOL, V139, P1041, DOI 10.1104/pp.105.065185; Hennon GMM, 2015, NAT CLIM CHANGE, V5, P761, DOI [10.1038/NCLIMATE2683, 10.1038/nclimate2683]; Hofmann LC, 2013, J EXP BOT, V64, P899, DOI 10.1093/jxb/ers369; Hopkinson BM, 2016, CURR OPIN PLANT BIOL, V31, P51, DOI 10.1016/j.pbi.2016.03.013; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Jin P, 2013, EVOLUTION, V67, P1869, DOI 10.1111/evo.12112; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Lavoie M, 2016, J PHYCOL, V52, P239, DOI 10.1111/jpy.12390; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; Li FT, 2016, GLOBAL CHANGE BIOL; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051590; Li YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096173; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; Michaelis L, 1913, BIOCHEM Z, V49, P333; Milligan AJ, 2009, MAR CHEM, V114, P31, DOI 10.1016/j.marchem.2009.03.003; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Park S, 2010, PLANTA, V231, P349, DOI 10.1007/s00425-009-1044-x; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Portner H, 2011, OCEAN ACIDIFICATION, P154; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Rickaby REM, 2010, CLIM PAST, V6, P771, DOI 10.5194/cp-6-771-2010; Riebesell U, 2010, GUIDE TO BEST PRACTI, P84; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Shi DL, 2015, LIMNOL OCEANOGR, V60, P1805, DOI 10.1002/lno.10134; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Wu HY, 2009, FUNCT PLANT BIOL, V36, P137, DOI 10.1071/FP08172; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yamori W, 2016, ANNU REV PLANT BIOL, V67, P81, DOI 10.1146/annurev-arplant-043015-112002	53	11	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0170970	10.1371/journal.pone.0170970	http://dx.doi.org/10.1371/journal.pone.0170970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192486	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800013
J	Hohl, M; Stintzi, A; Schaller, A				Hohl, Mathias; Stintzi, Annick; Schaller, Andreas			A novel subtilase inhibitor in plants shows structural and functional similarities to protease propeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PROTEINASE-B; C-TERMINAL REGION; INTRAMOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; PLEUROTUS-OSTREATUS; PROTEOLYTIC-ENZYMES; PRO-SEQUENCE; SUBTILISIN-E; ACTIVATION; MECHANISMS	The propeptides of subtilisin-like serine proteinases (subtilases, SBTs) serve dual functions as intramolecular chaperones that are required for enzyme folding and as inhibitors of the mature proteases. SBT propeptides are homologous to the I9 family of protease inhibitors that have only been described in fungi. Here we report the identification and characterization of subtilisin propeptide-like inhibitor 1 (SPI-1) from Arabidopsis thaliana. Sequence similarity and the shared beta-alpha-beta-beta-alpha-beta core structure identified SPI-1 as a member of the I9 inhibitor family and as the first independent I9 inhibitor in higher eukaryotes. SPI-1 was characterized as a high-affinity, tight-binding inhibitor of Arabidopsis subtilase SBT4.13 with K-d and K-i values in the picomolar range. SPI-1 acted as a stable inhibitor of SBT4.13 over the physiologically relevant range of pH, and its inhibitory profile included many other SBTs from plants but not bovine chymotrypsin or bacterial subtilisin A. Upon binding to SBT4.13, the C-terminal extension of SPI-1 was proteolytically cleaved. The last four amino acids at the newly formed C terminus of SPI-1 matched both the cleavage specificity of SBT4.13 and the consensus sequence of Arabidopsis SBTs at the junction of the propeptide with the catalytic domain. The data suggest that the C terminus of SPI-1 acts as a competitive inhibitor of target proteases as it remains bound to the active site in a product-like manner. SPI-1 thus resembles SBT propeptides with respect to its mode of protease inhibition. However, in contrast to SBT propeptides, SPI-1 could not substitute as a folding assistant for SBT4.13.	[Hohl, Mathias; Stintzi, Annick; Schaller, Andreas] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany	University Hohenheim	Schaller, A (corresponding author), Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany.	andreas.schaller@uni-hohenheim.de	Schaller, Andreas/AAC-1940-2020	Schaller, Andreas/0000-0001-6872-9576; Hohl, Mathias/0000-0003-3676-6705				Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Birk Y., 2003, PLANT PROTEASE INHIB, P5; Bleckmann A, 2016, METHODS, V98, P66, DOI 10.1016/j.ymeth.2015.10.019; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; DOHMAE N, 1995, ARCH BIOCHEM BIOPHYS, V316, P498, DOI 10.1006/abbi.1995.1066; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Santamara ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-812; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Farmer Edward E., 1992, Trends in Cell Biology, V2, P236, DOI 10.1016/0962-8924(92)90311-A; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GRECO WR, 1979, J BIOL CHEM, V254, P2104; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Khan AR, 1998, PROTEIN SCI, V7, P815; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Kojima S, 2005, FEBS LETT, V579, P4430, DOI 10.1016/j.febslet.2005.06.083; Kojima S, 2001, BIOCHEM BIOPH RES CO, V281, P1271, DOI 10.1006/bbrc.2001.4515; Kojima S, 1999, J MOL BIOL, V286, P775, DOI 10.1006/jmbi.1998.2498; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Layton CJ, 2011, PROTEIN SCI, V20, P1439, DOI 10.1002/pro.674; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; MAIER K, 1979, J BIOL CHEM, V254, P8491; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meyer M, 2016, J BIOL CHEM, V291, P19449, DOI 10.1074/jbc.M116.744151; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sasakawa H, 2002, J MOL BIOL, V317, P159, DOI 10.1006/jmbi.2002.5412; Schaller A, 2012, PHYSIOL PLANTARUM, V145, P52, DOI 10.1111/j.1399-3054.2011.01529.x; Schardon K, 2016, SCIENCE, V354, P1594, DOI 10.1126/science.aai8550; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; SHINDE U, 1994, J BIOCHEM, V115, P629, DOI 10.1093/oxfordjournals.jbchem.a124386; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; Sotokawauchi A, 2017, J BIOCHEM, V161, P45, DOI 10.1093/jb/mvw053; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Williams J W, 1979, Methods Enzymol, V63, P437; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	65	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6389	6401		10.1074/jbc.M117.775445	http://dx.doi.org/10.1074/jbc.M117.775445			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223360	Green Published, hybrid			2022-12-26	WOS:000399538700031
J	Binsker, U; Kohler, TP; Krauel, K; Kohler, S; Habermeyer, J; Schwertz, H; Hammerschmidt, S				Binsker, Ulrike; Kohler, Thomas P.; Krauel, Krystin; Kohler, Sylvia; Habermeyer, Johanna; Schwertz, Hansjoerg; Hammerschmidt, Sven			Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; bacterial pathogenesis; extracellular matrix protein; surface plasmon resonance (SPR); thrombospondin; Hic; Streptococcus pneumoniae; human serum; pneumococcal surface protein C	STREPTOCOCCUS-PNEUMONIAE; FACTOR-H; SECRETE THROMBOSPONDIN; EPITHELIAL-CELLS; BINDING PROTEIN; SURFACE PROTEIN; PHASE VARIATION; PSPC; ADHERENCE; MATRIX	Streptococcus pneumoniae serotype 3 strains emerge frequently within clinical isolates of invasive diseases. Bacterial invasion into deeper tissues is associated with colonization and immune evasion mechanisms. Thus, pneumococci express a versatile repertoire of surface proteins sequestering and interacting specifically with components of the human extracellular matrix and serum. Hic, a PspC-like pneumococcal surface protein, possesses vitronectin and factor H binding activity. Here, we show that heterologously expressed Hic domains interact, similar to the classical PspC molecule, with human matricellular thrombospondin-1 (hTSP-1). Binding studies with isolated human thrombospondin-1 and various Hic domains suggest that the interaction between hTSP-1 and Hic differs from binding to vitronectin and factor H. Binding of Hic to hTSP-1 is inhibited by heparin and chondroitin sulfate A, indicating binding to the N-terminal globular domain or type I repeats of hTSP-1. Competitive inhibition experiments with other pneumococcal hTSP-1 adhesins demonstrated that PspC and PspC-like Hic recognize similar domains, whereas PavB and Hic can bind simultaneously to hTSP-1. In conclusion, Hic binds specifically hTSP-1; however, truncation in the N-terminal part of Hic decreases the binding activity, suggesting that the full length of the -helical regions of Hic is required for an optimal interaction.	[Binsker, Ulrike; Kohler, Thomas P.; Kohler, Sylvia; Habermeyer, Johanna; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany; [Krauel, Krystin; Schwertz, Hansjoerg] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17489 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School	Kohler, TP (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany.	kohlert@uni-greifswald.de	Habermeyer, Johanna/ABG-1984-2020; Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Krauel, Krystin/0000-0002-2030-1332	Deutsche Forschungsgemeinschaft [SFB TRR 34, HA 3125/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants from Deutsche Forschungsgemeinschaft Grant SFB TRR 34, Project C10 (to S. H.) and Deutsche Forschungsgemeinschaft Grant HA 3125/4-2. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Binsker U, 2015, J BIOL CHEM, V290, P14542, DOI 10.1074/jbc.M114.623876; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carron JA, 1996, BBA-GEN SUBJECTS, V1289, P305, DOI 10.1016/0304-4165(95)00095-X; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hayashi Masao, 1994, Journal of Tissue Culture Methods, V16, P193, DOI 10.1007/BF01540649; HOSTETTER MK, 1986, J INFECT DIS, V153, P682, DOI 10.1093/infdis/153.4.682; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; JAFFE EA, 1985, BLOOD, V65, P79; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kohler S, 2015, THROMB HAEMOSTASIS, V113, P125, DOI 10.1160/TH14-06-0561; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; LAWLER J, 1993, J MOL EVOL, V36, P509, DOI 10.1007/BF00556355; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Li-Korotky HS, 2010, MICROB PATHOGENESIS, V49, P204, DOI 10.1016/j.micpath.2010.05.014; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; MAJACK RA, 1985, J CELL BIOL, V101, P1059, DOI 10.1083/jcb.101.3.1059; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; REED MJ, 1995, AM J PATHOL, V147, P1068; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; SAGLIO SD, 1982, BLOOD, V59, P162; Sanchez CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026587; Selva L, 2012, EUR J CLIN MICROBIOL, V31, P1487, DOI 10.1007/s10096-011-1468-7; Starlinger P, 2010, J THROMB HAEMOST, V8, P1809, DOI 10.1111/j.1538-7836.2010.03908.x; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Vaziri-Sani F, 2005, J THROMB HAEMOST, V3, P154, DOI 10.1111/j.1538-7836.2004.01010.x; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597	50	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5770	5783		10.1074/jbc.M116.760504	http://dx.doi.org/10.1074/jbc.M116.760504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28209711	Green Published, hybrid			2022-12-26	WOS:000398813200015
J	Cao, SY; Liu, WB; Tan, YF; Yang, HY; Zhang, TT; Wang, T; Wang, XY; Song, YJ; Yang, RF; Du, ZM				Cao, Shi-Yang; Liu, Wan-Bin; Tan, Ya-Fang; Yang, Hui-Ying; Zhang, Ting-Ting; Wang, Tong; Wang, Xiao-Yi; Song, Ya-Jun; Yang, Rui-Fu; Du, Zong-Min			An Interaction between the Inner Rod Protein YscI and the Needle Protein YscF Is Required to Assemble the Needle Structure of the Yersinia Type Three Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION; SUBSTRATE-SPECIFICITY; EUKARYOTIC CELLS; MOLECULAR RULER; INJECTISOME; LENGTH; ENTEROCOLITICA; COMPLEX; PESTIS; POLYMERIZATION	The type III secretion system is a highly conserved virulence mechanism that is widely distributed in Gram-negative bacteria. It has a syringe-like structure composed of a multi-ring basal body that spans the bacterial envelope and a projecting needle that delivers virulence effectors into host cells. Here, we showed that the Yersinia inner rod protein YscI directly interacts with the needle protein YscF inside the bacterial cells and that this interaction depends on amino acid residues 83-102 in the carboxyl terminus of YscI. Alanine substitution of Trp-85 or Ser-86 abrogated the binding of YscI to YscF as well as needle assembly and the secretion of effectors (Yops) and the needle tip protein LcrV. However, yscI null mutants that were trans-complemented with YscI mutants that bind YscF still assembled the needle and secreted Yops, demonstrating that a direct interaction between YscF and YscI is critical for these processes. Consistently, YscI mutants that did not bind YscF resulted in greatly decreased HeLa cell cytotoxicity. Together, these results show that YscI participates in needle assembly by directly interacting with YscF.	[Cao, Shi-Yang; Liu, Wan-Bin; Tan, Ya-Fang; Yang, Hui-Ying; Zhang, Ting-Ting; Wang, Tong; Wang, Xiao-Yi; Song, Ya-Jun; Yang, Rui-Fu; Du, Zong-Min] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, RF; Du, ZM (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	ruifuyang@gmail.com; zmduams@163.com	Song, Yajun/F-3714-2011; Song, Yajun/GQQ-0476-2022	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747	National Basic Research Program of China (973 program) [2013CB910804, 2012CB518704]; National Natural Science Foundation of China [31470242, 81501716]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 program) Grants 2013CB910804 and 2012CB518704 and National Natural Science Foundation of China Grants 31470242 and 81501716. The authors declare that they have no conflicts of interest with the contents of this article.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blaylock B, 2010, MOL MICROBIOL, V75, P221, DOI 10.1111/j.1365-2958.2009.06988.x; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Diepold A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002039; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Du ZM, 2009, INT J MED MICROBIOL, V299, P355, DOI 10.1016/j.ijmm.2008.10.003; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Hamad MA, 2007, ADV EXP MED BIOL, V603, P225; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Lefebre MD, 2014, P NATL ACAD SCI USA, V111, P817, DOI 10.1073/pnas.1319698111; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Monlezun L, 2015, MOL MICROBIOL, V96, P419, DOI 10.1111/mmi.12947; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wagner S, 2009, MOL MICROBIOL, V71, P692, DOI 10.1111/j.1365-2958.2008.06556.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054121; Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005; Zhou DS, 2004, VACCINE, V22, P3367, DOI 10.1016/j.vaccine.2004.02.035; Zilkenat S, 2016, MOL CELL PROTEOMICS, V15, P1598, DOI 10.1074/mcp.M115.056598	38	13	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5488	5498		10.1074/jbc.M116.743591	http://dx.doi.org/10.1074/jbc.M116.743591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28196868	hybrid, Green Published			2022-12-26	WOS:000397875500028
J	Dayan, O; Nagarajan, A; Shah, R; Ben-Yona, A; Forrest, LR; Kanner, BI				Dayan, Oshrat; Nagarajan, Anu; Shah, Raven; Ben-Yona, Assaf; Forrest, Lucy R.; Kanner, Baruch I.			An Extra Amino Acid Residue in Transmembrane Domain 10 of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1 Is Required for Efficient Ion-coupled Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OOCYTE-MEMBRANE-PATCHES; CL-COTRANSPORT FUNCTION; X-RAY STRUCTURES; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GLYCINE TRANSPORTERS; SECONDARY STRUCTURE; PROTEIN STRUCTURES; XENOPUS OOCYTES	The GABA transporter GAT-1 mediates electrogenic transport of its substrate together with sodium and chloride. It is a member of the neurotransmitter: sodium: symporters, which are crucial for synaptic transmission. Compared with all other neurotransmitter: sodium: symporters, GAT-1 and other members of the GABA transporter subfamily all contain an extra amino acid residue at or near a conserved glycine in transmembrane segment 10. Therefore, we studied the functional impact of deletion and replacement mutants of Gly-457 and its two adjacent residues in GAT-1. The glycine replacement mutants were devoid of transport activity, but remarkably the deletion mutant was active, as were mutants obtained by deleting positions on either side of Gly-457. However, the inward rectification of GABA-induced transport currents by all three deletion mutants was diminished, and the charge-to-flux ratio was increased by more than 2.5-fold, both of which indicate substantial uncoupled transport. These observations suggest that the deletions render the transporters less tightly packed. Consistent with this interpretation, the inactive G457A mutant was partially rescued by removing the adjacent serine residue. Moreover, the activity of several gating mutants was also partially rescued upon deletion of Gly-457. Structural modeling showed that the stretch surrounding Gly-457 is likely to form a pi-helix. Our data indicate that the "extra" residue in transmembrane domain 10 of the GABA transporter GAT-1 provides extra bulk, probably in the form of a pi-helix, which is required for stringent gating and tight coupling of ion and substrate fluxes in the GABA transporter family.	[Dayan, Oshrat; Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel; [Nagarajan, Anu; Shah, Raven; Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Rm 3D991,35 Convent Dr MSC3761, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.; Forrest, LR (corresponding author), NINDS, Computat Struct Biol Sect, NIH, Rm 3D991,35 Convent Dr MSC3761, Bethesda, MD 20892 USA.	lucy.forrest@nih.gov; baruch.kanner@mail.huji.ac.il	Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985	Israel Science Foundation [531/15]; Rosetrees Trust; Division of Intramural Research of the National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003139] Funding Source: NIH RePORTER; Rosetrees Trust [M18-F1] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Division of Intramural Research of the National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rosetrees Trust(Rosetrees Trust)	This work was supported in part by Grant 531/15 from the Israel Science Foundation (to B. I. K.), a grant from the Rosetrees Trust (to B. I. K.), and a grant from the Division of Intramural Research of the National Institutes of Health, NINDS (to L. R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ben-Yona A, 2013, J BIOL CHEM, V288, P4549, DOI 10.1074/jbc.M112.430215; Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Cartailler JP, 2004, STRUCTURE, V12, P133, DOI 10.1016/j.str.2003.12.001; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Konagurthu AS, 2012, BIOINFORMATICS, V28, pI97, DOI 10.1093/bioinformatics/bts223; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; Olivella M, 2013, BIOINFORMATICS, V29, P1589, DOI 10.1093/bioinformatics/btt249; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Ray A, 2010, BIOINFORMATICS, V26, P3067, DOI 10.1093/bioinformatics/btq581; Riek RP, 2001, J MOL BIOL, V306, P349, DOI 10.1006/jmbi.2000.4402; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sonders MS, 1997, J NEUROSCI, V17, P960; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weaver TM, 2000, PROTEIN SCI, V9, P201; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Willford SL, 2015, J MEMBRANE BIOL, V248, P795, DOI 10.1007/s00232-015-9797-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	53	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5418	5428		10.1074/jbc.M117.775189	http://dx.doi.org/10.1074/jbc.M117.775189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28213519	hybrid, Green Published			2022-12-26	WOS:000397875500022
J	Liu, F; Pawan, KC; Zhang, G; Zhe, J				Liu, Fan; Pawan, K. C.; Zhang, Ge; Zhe, Jiang			In situ single cell detection via microfluidic magnetic bead assay	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; MESENCHYMAL STEM-CELLS; METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; IMPEDANCE CYTOMETRY; DRUG RESPONSES; BONE-MARROW; SEPARATION; PARTICLES; CHIP	We present a single cell detection device based on magnetic bead assay and micro Coulter counters. This device consists of two successive micro Coulter counters, coupled with a high gradient magnetic field generated by an external magnet. The device can identify single cells in terms of the transit time difference of the cell through the two micro Coulter counters. Target cells are conjugated with magnetic beads via specific antibody and antigen binding. A target cell traveling through the two Coulter counters interacts with the magnetic field, and have a longer transit time at the 1st counter than that at the 2nd counter. In comparison, a non-target cell has no interaction with the magnetic field, and hence has nearly the same transit times through the two counters. Each cell passing through the two counters generates two consecutive voltage pulses one after the other; the pulse widths and magnitudes indicating the cell's transit times through the counters and the cell's size respectively. Thus, by measuring the pulse widths (transit times) of each cell through the two counters, each single target cell can be differentiated from non-target cells even if they have similar sizes. We experimentally proved that the target human umbilical vein endothelial cells (HUVECs) and non-target rat adipose-derived stem cells (rASCs) have significant different transit time distribution, from which we can determine the recognition regions for both cell groups quantitatively. We further demonstrated that within a mixed cell population of rASCs and HUVECs, HUVECs can be detected in situ and the measured HUVECs ratios agree well with the preset ratios. With the simple device structure and easy sample preparation, this method is expected to enable single cell detection in a continuous flow and can be applied to facilitate general cell detection applications such as stem cell identification and enumeration.	[Liu, Fan; Zhe, Jiang] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Pawan, K. C.; Zhang, Ge] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Zhe, J (corresponding author), Univ Akron, Dept Mech Engn, Akron, OH 44325 USA.; Zhang, G (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.	ge10@uakron.edu; jzhe@uakron.edu		Liu, Fan/0000-0001-8827-2278	National Science Foundation [DBI-IDBR-1353720, ECCS-1625544]	National Science Foundation(National Science Foundation (NSF))	This work supported by National Science Foundation: DBI-IDBR-1353720, JZ, https://www.nsf.gov/awardsearch/showAward?AWD_ID=1353720; and National Science Foundation: ECCS-1625544, JZ, https://nsf.gov/awardsearch/showAward?AWD_ID=1625544&HistoricalAwards=false. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2009, ANAL BIOANAL CHEM, V395, P747, DOI 10.1007/s00216-009-3006-3; Adams JD, 2008, P NATL ACAD SCI USA, V105, P18165, DOI 10.1073/pnas.0809795105; Alunni-Fabbroni M, 2010, METHODS, V50, P289, DOI 10.1016/j.ymeth.2010.01.027; Arya SK, 2012, LAB CHIP, V12, P2362, DOI 10.1039/c2lc21174b; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; BERGE LI, 1990, MEAS SCI TECHNOL, V1, P471, DOI 10.1088/0957-0233/1/6/001; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Buggenthin F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-297; Carbonaro A, 2008, LAB CHIP, V8, P1478, DOI 10.1039/b801929k; Chen P, 2014, LAB CHIP MULTISCALE, P446; Cho SH, 2010, LAB CHIP, V10, P1567, DOI 10.1039/c000136h; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; DEBLOIS RW, 1970, REV SCI INSTRUM, V41, P909, DOI 10.1063/1.1684724; DEWYNTER EA, 1995, STEM CELLS, V13, P524, DOI 10.1002/stem.5530130510; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Fonnum G, 2005, J MAGN MAGN MATER, V293, P41, DOI 10.1016/j.jmmm.2005.01.041; Gassner AL, 2009, LAB CHIP, V9, P2356, DOI 10.1039/b901865d; Gawad S, 2001, LAB CHIP, V1, P76, DOI 10.1039/b103933b; Gijs MAM, 2010, CHEM REV, V110, P1518, DOI 10.1021/cr9001929; GOMM JJ, 1995, ANAL BIOCHEM, V226, P91, DOI 10.1006/abio.1995.1196; Gough AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102678; Han Y, 2016, LAB CHIP, V16, P773, DOI 10.1039/c5lc01207d; Hejazian M, 2015, LAB CHIP, V15, P959, DOI 10.1039/c4lc01422g; Holmes D, 2010, ANAL CHEM, V82, P1455, DOI 10.1021/ac902568p; Holmes D, 2009, LAB CHIP, V9, P2881, DOI 10.1039/b910053a; Inglis DW, 2004, APPL PHYS LETT, V85, P5093, DOI 10.1063/1.1823015; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jagtiani AV, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/4/045036; KATO K, 1993, CYTOMETRY, V14, P384, DOI 10.1002/cyto.990140407; KELLY BS, 1979, IMMUNOLOGY, V37, P45; Kim S, 2013, ANAL CHEM, V85, P2779, DOI 10.1021/ac303284u; Kozissnik B, 2013, MRS BULL, V38, P927, DOI 10.1557/mrs.2013.257; Kuhara M, 2004, ANAL CHEM, V76, P6207, DOI 10.1021/ac0493727; Lara O, 2004, EXP HEMATOL, V32, P891, DOI 10.1016/j.exphem.2004.07.007; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Liu C, 2007, CHINA COMMUN, V4, P8; Liu F, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-015-1672-3; Liu F, 2016, ANAL CHEM, V88, P711, DOI 10.1021/acs.analchem.5b02716; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; McCloskey KE, 2003, ANAL CHEM, V75, P6868, DOI 10.1021/ac034315j; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Moore LR, 2001, J MAGN MAGN MATER, V225, P277, DOI 10.1016/S0304-8853(00)01251-8; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Pamme N, 2004, ANAL CHEM, V76, P7250, DOI 10.1021/ac049183o; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Plouffe BD, 2012, ANAL CHEM, V84, P1336, DOI 10.1021/ac2022844; Qin ZP, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/4/045804; Reagan MR, 2011, STEM CELLS, V29, P920, DOI 10.1002/stem.645; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Robert D, 2011, LAB CHIP, V11, P1902, DOI 10.1039/c0lc00656d; Safarik I, 1999, J CHROMATOGR B, V722, P33, DOI 10.1016/S0378-4347(98)00338-7; Sivagnanam V, 2010, LANGMUIR, V26, P6091, DOI 10.1021/la9045572; Sun T, 2010, MICROFLUID NANOFLUID, V8, P423, DOI 10.1007/s10404-010-0580-9; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Valero A, 2010, LAB CHIP, V10, P2216, DOI 10.1039/c003982a; Van der Auwera I, 2010, BRIT J CANCER, V102, P276, DOI 10.1038/sj.bjc.6605472; van Reenen A, 2014, LAB CHIP, V14, P1966, DOI 10.1039/c3lc51454d; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Yuan HL, 2010, NANOSCALE RES LETT, V5, P1817, DOI 10.1007/s11671-010-9718-7; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2; Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.0404806101; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	73	13	13	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172697	10.1371/journal.pone.0172697	http://dx.doi.org/10.1371/journal.pone.0172697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222140	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800077
J	Santos, JA; Piccinelli, AC; Formagio, MD; Oliveira, CS; dos Santos, EP; Stefanello, MEA; Lanza, U; Oliveira, RJ; Sugizaki, MM; Kassuya, CAL				Santos, Joyce Alencar; Piccinelli, Ana Claudia; Formagio, Maira Dante; Oliveira, Cristhian Santos; dos Santos, Elide Pereira; Alves Stefanello, Maria Elida; Lanza Junior, Ubirajara; Oliveira, Rodrigo Juliano; Sugizaki, Mario Mateus; Kassuya, Caandida Aparecida Leite			Antidepressive and antinociceptive effects of ethanolic extract and fruticuline A from Salvia lachnostachys Benth leaves on rodents	PLOS ONE			English	Article							NEUROPATHIC PAIN; MICE; MODEL	Objectives This study investigated the antidepressant and antinociceptive effects of ethanolic extract (SLEE) and pure fruticuline A obtained from Salvia lachnostachys leaves on rats and mice. Methods In this study, SLEE (100 mg/kg, p. o. route) was evaluated for its effects on spared nerve injury (SNI) in rats. The animals were submitted to mechanical sensitivity, forced swim (FST) and cold sensitivity tests 10 and 15 days after surgery. SLEE (100 mg/kg, p. o.) and fruticuline A (3 mg/kg, p. o.) were also evaluated with respect to nociceptive behavior induced by formalin. In addition, clonidine-induced depressive-like behavior was also analyzed. Results The oral administration of SLEE for up to 15 days and the subcutaneous injection of 10 mg/ kg of ketamine (positive control) significantly inhibited SNI-induced mechanical hyperalgesia and decreased immobility in the FST. On the 15th day of oral treatment, SLEE prevented the SNI-induced increase in cold sensitivity. In the formalin test, SLEE and fruticuline A significantly reduced the frequency of paw licking during the first and second phases and decreased the formation of edema. In locomotor analysis (open field test without clonidine treatment), SLEE and fruticuline A did not alter the response. SLEE and fruticuline A significantly attenuated clonidine-induced suppression of spontaneous locomotor activity (squares invaded and licking) and emotionality (grooming and freezing) compared with controls, similar to the naive group. Conclusion SLEE exhibits antihyperalgesic, antidepressant, and antinociceptive effects, and fruticuline A appears to be at least partly responsible for the effects of SLEE. Together, these results demonstrate the antidepressive effects of SLEE and fruticuline A and indicate that both derivatives obtained from S. lachnostachys act against spontaneous neuropathic pain.	[Santos, Joyce Alencar] Fed Univ Grande Dourados, Coll Exact Sci & Technol, Dourados, MS, Brazil; [Piccinelli, Ana Claudia; Formagio, Maira Dante; Lanza Junior, Ubirajara; Kassuya, Caandida Aparecida Leite] Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil; [Oliveira, Cristhian Santos; Alves Stefanello, Maria Elida] Univ Fed Parana, Dept Chem, Curitiba, PR, Brazil; [dos Santos, Elide Pereira] Univ Fed Parana, Dept Bot, Curitiba, PR, Brazil; [Oliveira, Rodrigo Juliano] Univ Fed Mato Grosso do Sul, Coll Hlth Sci, Campo Grande, MS, Brazil; [Sugizaki, Mario Mateus] Univ Fed Mato Grosso, Coll Hlth Sci, Sinop, MT, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso	Santos, JA (corresponding author), Fed Univ Grande Dourados, Coll Exact Sci & Technol, Dourados, MS, Brazil.	joycealencarr@hotmail.com	Oliveira, Cristhian/AAU-9118-2020; Kassuya, Candida A. L./G-8329-2011; Oliveira, Rodrigo Juliano/M-3151-2018; Radai, Joyce Alencar Santos/AAF-2906-2019; LANZA, Ubirajara Lanza Jr ULJ/D-3691-2017; Oliveira, Rodrigo Juliano/AGQ-6655-2022; Oliveira, Rodrigo/D-9982-2013; sugizaki, mario/AAM-9904-2020; Santos, Elide/C-5841-2013	Oliveira, Rodrigo Juliano/0000-0003-3514-3346; LANZA, Ubirajara Lanza Jr ULJ/0000-0001-5461-3177; Oliveira, Rodrigo Juliano/0000-0003-3514-3346; Santos, Elide/0000-0002-8600-3039; Kassuya, Candida/0000-0002-8998-9219; Oliveira, Cristhian/0000-0001-5620-393X; Dante Formagio, Maira/0000-0003-0616-3305	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) [45/2014, 23/200.622/2014]	Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT)	The authors thank the Fundacao de Amparo a Pesquisa do Estado do Mato Grosso do Sul (FUNDECT) for financial support, through the projects FUNDECT/CAPES no 45/2014 - PAPOS REDE PRO-CENTRO-OESTE EASE II - No 23/200.622/2014 and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rodrigues MRA, 2012, J ETHNOPHARMACOL, V139, P519, DOI 10.1016/j.jep.2011.11.042; Barauna SC, 2006, PHARMACOL BIOCHEM BE, V85, P160, DOI 10.1016/j.pbb.2006.07.030; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Bisio A, 2008, J AGR FOOD CHEM, V56, P10468, DOI 10.1021/jf802200x; Bongiorno P, 2010, NAT MED J, V2, P3; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Boyce-Rustay JM, 2010, METHODS MOL BIOL, V617, P41, DOI 10.1007/978-1-60327-323-7_4; Braida D, 2009, BRIT J PHARMACOL, V157, P844, DOI 10.1111/j.1476-5381.2009.00230.x; de Almeida AAC, 2014, PHARMACOL BIOCHEM BE, V118, P69, DOI 10.1016/j.pbb.2014.01.006; Chang CY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/159015; Colla ARS, 2014, PHARMACOL BIOCHEM BE, V124, P108, DOI 10.1016/j.pbb.2014.05.015; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Erbano M, 2012, MICROSC RES TECHNIQ, V75, P1737, DOI 10.1002/jemt.22125; Gonzalez-Cortazar M, 2013, MOLECULES, V18, P13260, DOI 10.3390/molecules181113260; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Jung HJ, 2009, J ETHNOPHARMACOL, V126, P355, DOI 10.1016/j.jep.2009.08.031; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; Marcus DJ, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0031-4; Oliveira CS, 2016, PHYTOCHEM LETT, V17, P140, DOI 10.1016/j.phytol.2016.07.005; Piccinelli AC, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/835914; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Reuben SS, 1998, ANESTHESIOLOGY, V89, P527, DOI 10.1097/00000542-199808000-00034; Sagheddu C, 2015, NEUROPHARMACOLOGY, V97, P383, DOI 10.1016/j.neuropharm.2015.06.003; Snedecor SJ, 2013, J PAIN RES, V6, P539, DOI 10.2147/JPR.S45966; Walker JB, 2007, ANN BOT-LONDON, V100, P375, DOI 10.1093/aob/mcl176; Wang J, 2011, ANESTHESIOLOGY, V115, P812, DOI 10.1097/ALN.0b013e31822f16ae; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15; Yang LM, 2014, BRAIN RES BULL, V100, P22, DOI 10.1016/j.brainresbull.2013.10.007; Zaki H. F., 2013, African Journal of Pharmacy and Pharmacology, V7, P2960	31	13	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e72151	10.1371/journal.pone.0172151	http://dx.doi.org/10.1371/journal.pone.0172151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222143	gold, Green Submitted, Green Published			2022-12-26	WOS:000394676800035
J	Krawczenko, A; Bielawska-Pohl, A; Wojtowicz, K; Jura, R; Paprocka, M; Wojdat, E; Kozlowska, U; Klimczak, A; Grillon, C; Kieda, C; Dus, D				Krawczenko, Agnieszka; Bielawska-Pohl, Aleksandra; Wojtowicz, Karolina; Jura, Roksana; Paprocka, Maria; Wojdat, Elzbieta; Kozlowska, Urszula; Klimczak, Aleksandra; Grillon, Catherine; Kieda, Claudine; Dus, Danuta			Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation	PLOS ONE			English	Article							CANCER STEM-CELLS; P-GLYCOPROTEIN; DRUG-RESISTANCE; ABC TRANSPORTERS; GENE-EXPRESSION; BREAST-CANCER; SUBSTRATE; MECHANISMS; PHENOTYPE; MOLECULES	Active cellular transporters of harmful agents D multidrug resistance ( mdr) proteins D are present in tumor, stem and endothelial cells, among others. While mdr proteins are broadly studied in tumor cells, their role in non-tumor cells and the significance of their action not connected with removal of harmful xenobiotics is less extensively documented. Proper assessment of mdr proteins expression is difficult. Mdr mRNA presence is most often evaluated but that does not necessarily correlate with the protein level. The protein expression itself is difficult to determine; usually cells with mdr overexpression are studied, not cells under physiological conditions, in which a low expression level of mdr protein is often insufficient for detection in vitro. Various methods are used to identify mdr mRNA and protein expression, together with functional tests demonstrating their biological drug transporting activities. Data comparing different methods of investigating expression of mdr mRNAs and their corresponding proteins are still scarce. In this article we present the results of a study concerning mdr mRNA and protein expression. Our goal was to search for the best method to investigate the expression level and functional activity of five selected mdr proteins D MDR1, BCRP, MRP1, MRP4 and MRP5 D in established in vitro cell lines of human endothelial cells ( ECs) and their progenitors. Endothelial cells demonstrated mdr presence at the mRNA level, which was not always confirmed at the protein level or in functional tests. Therefore, several different assays had to be applied for evaluation of mdr proteins expression and functions in endothelial cells. Among them functional tests seemed to be the most conclusive, although not very specific.	[Krawczenko, Agnieszka; Bielawska-Pohl, Aleksandra; Paprocka, Maria; Wojdat, Elzbieta; Kozlowska, Urszula; Klimczak, Aleksandra; Dus, Danuta] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Wojtowicz, Karolina] Poznan Univ Med Sci, Dept Histol & Embryol, Poznan, Poland; [Jura, Roksana] Wroclaw Res Ctr EIT, Wroclaw, Poland; [Grillon, Catherine; Kieda, Claudine] CNRS UPR 4301, Ctr Biophys Mol, Cellular Microenvironm & Pharmacol Targets, Orleans, France	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Poznan University of Medical Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Krawczenko, A (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland.	krawczen@iitd.pan.wroc.pl	Grillon, Catherine/I-4974-2016; Klimczak, Aleksandra/AAF-6136-2020; Kieda, Claudine/U-1361-2019	Grillon, Catherine/0000-0001-5019-7831; Bielawska-Pohl, Aleksandra/0000-0002-2757-5571; Kozlowska, Urszula/0000-0003-0213-0215; Krawczenko, Agnieszka/0000-0003-4545-8843; Dus, Danuta/0000-0003-2429-7315; Paprocka, Maria/0000-0001-6673-9631; Elzbieta, Wojdat/0000-0001-5315-1468; Klimczak, Aleksandra/0000-0001-6590-4420; Wojtowicz, Karolina/0000-0003-1704-6542				Baker M, 2015, NATURE, V527, P545, DOI 10.1038/527545a; Beck WT, 1996, CANCER RES, V56, P3010; Begley DJ, 2003, PROG DRUG RES, V61, P39; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Breier A, 2013, ANTI-CANCER AGENT ME, V13, P159, DOI 10.2174/187152013804487380; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; GOSLAND M, 1993, CANCER RES, V53, P5382; GRANDI M, 1986, BRIT J CANCER, V54, P515, DOI 10.1038/bjc.1986.206; Hegewisch-Becker S, 1998, ANN ONCOL, V9, P85, DOI 10.1023/A:1008255725515; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Huang LM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-49; Iqbal M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12360; Jouan E, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8020012; Kappelmayer J, 2012, J INT FEDERATION CLI, V27, P12; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kieda C, 2002, ENDOTHELIUM-J ENDOTH, V9, P247, DOI 10.1080/10623320214736; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; Koshkin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041368; Kosztyu P, 2015, EUR J HAEMATOL, V95, P150, DOI 10.1111/ejh.12470; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; LEHNE G, 1995, CYTOMETRY, V20, P228, DOI 10.1002/cyto.990200306; Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320; Olson DP, 2001, CYTOMETRY, V46, P105, DOI 10.1002/cyto.1072; Paprocka M, 2011, CYTOM PART A, V79A, P594, DOI 10.1002/cyto.a.21092; Podolak-Dawidziak M, 2005, ADV CLIN EXP MED, V14, P1151; Pozniak B, 2015, IN VIVO, V29, P149; Russel FGM, 2010, ENZYME AND TRANSPORT; Scherrmann Jean-Michel, 2005, Expert Opin Drug Metab Toxicol, V1, P233, DOI 10.1517/17425255.1.2.233; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Sharom FJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00041; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Szyda A, 2006, ACTA BIOCHIM POL, V53, P815, DOI 10.18388/abp.2006_3311; VANDERHEYDEN S, 1995, CRIT REV CL LAB SCI, V32, P221, DOI 10.3109/10408369509084685; Vasconcelos FC, 2011, CYTOM PART B-CLIN CY, V80B, P158, DOI 10.1002/cyto.b.20580; Vilas-Boas V, 2011, CYTOM PART A, V79A, P912, DOI 10.1002/cyto.a.21135; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wartenberg M, 2002, BBA-MOL CELL RES, V1589, P49, DOI 10.1016/S0167-4889(01)00185-9; Webb M, 1996, BRIT J HAEMATOL, V93, P650, DOI 10.1046/j.1365-2141.1996.d01-1680.x; Yuan SY., 2010, REGULATION ENDOTHELI; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	46	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172371	10.1371/journal.pone.0172371	http://dx.doi.org/10.1371/journal.pone.0172371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212450	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424700039
J	Dasgupta, M; Kishore, N				Dasgupta, Moumita; Kishore, Nand			Selective inhibition of aggregation/fibrillation of bovine serum albumin by osmolytes: Mechanistic and energetics insights	PLOS ONE			English	Article							INCREASED THERMAL-STABILITY; PROTEIN AGGREGATION; ELECTROSTATIC INTERACTIONS; BETA-AGGREGATION; LIGHT-SCATTERING; FIBRIL FORMATION; AMYLOID FIBRILS; GLYCINE BETAINE; THIOFLAVIN T; LOW PH	Bovine serum albumin (BSA) is an important transport protein of the blood and its aggregation/fibrillation would adversely affect its transport ability leading to metabolic disorder. Therefore, understanding the mechanism of fibrillation/aggregation of BSA and design of suitable inhibitor molecules for stabilizing its native conformation, are of utmost importance. The qualitative and quantitative aspects of the effect of osmolytes (proline, hydroxyproline, glycine betaine, sarcosine and sorbitol) on heat induced aggregation/fibrillation of BSA at physiological pH (pH 7.4) have been studied employing a combination of fluorescence spectroscopy, Rayleigh scattering, isothermal titration calorimetry (ITC), dynamic light scattering (DLS) and transmission electron microscopy (TEM). Formation of fibrils by BSA under the given conditions was confirmed from increase in fluorescence emission intensities of Thioflavin T over a time period of 600 minutes and TEM images. Absence of change in fluorescence emission intensities of 8-Anilinonaphthalene-1-sulfonic acid (ANS) in presence of native and aggregated BSA signify the absence of any amorphous aggregates. ITC results have provided important insights on the energetics of interaction of these osmolytes with different stages of the fibrillar aggregates of BSA, thereby suggesting the possible modes/ mechanism of inhibition of BSA fibrillation by these osmolytes. The heats of interaction of the osmolytes with different stages of fibrillation of BSA do not follow a trend, suggesting that the interactions of stages of BSA aggregates are osmolyte specific. Among the osmolytes used here, we found glycine betaine to be supporting and promoting the aggregation process while hydroxyproline to be maximally efficient in suppressing the fibrillation process of BSA, followed by sorbitol, sarcosine and proline in the following order of their decreasing potency: Hydroxyproline> Sorbitol> Sarcosine> Proline> Glycine betaine.	[Dasgupta, Moumita; Kishore, Nand] Indian Inst Technol, Dept Chem, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kishore, N (corresponding author), Indian Inst Technol, Dept Chem, Bombay, Maharashtra, India.	nandk@chem.iitb.ac.in			Indian Institute of Technology, Bombay	Indian Institute of Technology, Bombay	Support was provided by the Indian Institute of Technology, Bombay.	ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Arosio P, 2013, PHARM RES-DORDR, V30, P641, DOI 10.1007/s11095-012-0885-3; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Borzova VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153495; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; CANETE M, 1987, CELL MOL BIOL, V33, P191; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Choudhary S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17599; Choudhary S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104600; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; GEKKO K, 1990, J BIOCHEM-TOKYO, V107, P572, DOI 10.1093/oxfordjournals.jbchem.a123088; Guo F, 2009, J PHYS CHEM B, V113, P16632, DOI 10.1021/jp9072284; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kachooei E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041344; Kar K, 2007, BIOPOLYMERS, V87, P339, DOI 10.1002/bip.20834; Khan JM, 2014, PHYS CHEM CHEM PHYS, V16, P5150, DOI 10.1039/c3cp54941k; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kirchoff W.H., EXAM PROGRAM; Krebs MRH, 2007, BIOPHYS J, V92, P1336, DOI 10.1529/biophysj.106.094342; Kumar N, 2013, BIOPHYS CHEM, V171, P9, DOI 10.1016/j.bpc.2012.11.004; Kumar R, 2009, ARCH BIOCHEM BIOPHYS, V491, P1, DOI 10.1016/j.abb.2009.09.007; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Kurganov B. I., 2015, BIOCH ANAL BIOCH, V4, pe 155, DOI [10.4172/2161-1009.1000e155, DOI 10.4172/2161-1009.1000E155]; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Kurganov BI, 2016, INT J BIOL MACROMOL; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030724; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Li Rui, 2016, Biotechnol Rep (Amst), V9, P46, DOI 10.1016/j.btre.2016.01.002; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Macchi F, 2012, INT J MOL SCI, V13, P3801, DOI 10.3390/ijms13033801; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Mishra R, 2005, J BIOL CHEM, V280, P15553, DOI 10.1074/jbc.M410947200; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Nandi P.K., 1976, J PHYS CHEM, V80, P249, DOI [DOI 10.1021/J100544A008, 10.1021/j100544a008]; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; POKLAR N, 1993, BIOPHYS CHEM, V47, P143, DOI 10.1016/0301-4622(93)85032-D; Saha S, 2014, J PHYS CHEM B, V118, P9155, DOI 10.1021/jp502435f; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P5278, DOI 10.1021/bi00138a006; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Singh LR, 2009, BBA-PROTEINS PROTEOM, V1794, P929, DOI 10.1016/j.bbapap.2009.02.005; Sober H.A., 1973, SELECTED DATA MOL BI, pC; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Trnkova L., 2010, NATURAL SCI, V2, P563, DOI DOI 10.4236/ns.2010.26071; Valstar A, 2000, LANGMUIR, V16, P922, DOI 10.1021/la990423i; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200; Yoshimoto N, 2003, BIOMACROMOLECULES, V4, P1530, DOI 10.1021/bm015662a; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	62	37	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172208	10.1371/journal.pone.0172208	http://dx.doi.org/10.1371/journal.pone.0172208			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207877	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500098
J	Hee, JS; Cresswell, P				Hee, Jia Shee; Cresswell, Peter			Viperin interaction with mitochondrial antiviral signaling protein (MAVS) limits viperin-mediated inhibition of the interferon response in macrophages	PLOS ONE			English	Article							C VIRUS-REPLICATION; WEST NILE VIRUS; NF-KAPPA-B; RIG-I; ENDOPLASMIC-RETICULUM; INDUCIBLE PROTEIN; INFLUENZA-VIRUS; MEMBRANES; ACID; IDENTIFICATION	Viperin is an antiviral protein that is upregulated by interferons and by ligands for a variety of innate immune receptors. It possesses diverse capabilities and functions in an array of viral infections. Studies have shown that it appears to be particularly important in defence against RNA viruses, such as West Nile, Dengue, and Chikungunya viruses, although the specific mechanisms involved are not well understood at the molecular level. Here we identify the mitochondrial antiviral signalling protein MAVS as a novel viperin interaction partner, most likely in mitochondria associated membranes, and characterize a more central, overarching role of viperin as a negative regulator of the interferon response, an ability that can be regulated by the viperin-MAVS interaction. This suggests a novel mechanism of viperin action in immune defence against RNA viruses by which it may prevent pathology from excessive immune responses.	[Hee, Jia Shee; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			NIH [R21-AI119837]; Agency of Science, Technology and Research, Singapore; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency of Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Howard Hughes Medical Institute and NIH grant R21-AI119837 awarded to PC. JSH was supported by a scholarship from the Agency of Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang X, 2011, IMMUNITY, V34, P285, DOI 10.1016/j.immuni.2011.03.012; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Magalhaes AC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26028; Qiu LQ, 2009, BLOOD, V113, P3520, DOI 10.1182/blood-2008-07-171942; Rayamajhi M, 2014, CELL, V156, P629, DOI 10.1016/j.cell.2014.01.045; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Waheed AA, 2007, CELL HOST MICROBE, V2, P71, DOI 10.1016/j.chom.2007.07.005; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151	45	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172236	10.1371/journal.pone.0172236	http://dx.doi.org/10.1371/journal.pone.0172236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207838	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500105
J	Kallemeijn, WW; Scheij, S; Hoogendoorn, S; Witte, MD; Chao, DHM; van Roomen, CPAA; Ottenhoff, R; Overkleeft, HS; Boot, RG; Aerts, JMFG				Kallemeijn, Wouter W.; Scheij, Saskia; Hoogendoorn, Sascha; Witte, Martin D.; Chao, Daniela Herrera Moro; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Overkleeft, Herman S.; Boot, Rolf G.; Aerts, Johannes M. F. G.			Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; TYPE-1 GAUCHER-DISEASE; MANNOSE-TERMINAL GLUCOCEREBROSIDASE; PLACENTAL BETA-GLUCOCEREBROSIDASE; LIVER ENDOTHELIAL-CELLS; RAT-LIVER; VELAGLUCERASE ALPHA; RECOMBINANT GLUCOCEREBROSIDASE; STORAGE DISEASES; IN-VIVO	Deficiency of glucocerebrosidase (GBA) causes Gaucher disease (GD). In the common non-neuronopathic GD type I variant, glucosylceramide accumulates primarily in the lysosomes of visceral macrophages. Supplementing storage cells with lacking enzyme is accomplished via chronic intravenous administration of recombinant GBA containing mannose-terminated N-linked glycans, mediating the selective uptake by macrophages expressing mannose-binding lectin(s). Two recombinant GBA preparations with distinct Nlinked glycans are registered in Europe for treatment of type I GD: imiglucerase (Genzyme), contains predominantly Man(mannose-binding lectins. Differences among cells from different donors (n = 12) were noted, but the same trends were always observed. Our study suggests that further insight in targeting and efficacy of enzyme therapy of individual Gaucher patients could be obtained by the use of recombinant GBA, trace-labeled with an ABP, preferably equipped with an infrared fluorophore or other reporter tag suitable for in vivo imaging.3) glycans, and velaglucerase (Shire PLC) Man(9) glycans. Activity-based probes (ABPs) enable fluorescent labeling of recombinant GBA preparations through their covalent attachment to the catalytic nucleophile E340 of GBA. We comparatively studied binding and uptake of ABP-labeled imiglucerase and velaglucerase in isolated dendritic cells, cultured human macrophages and living mice, through simultaneous detection of different GBAs by paired measurements. Uptake of ABP-labeled rGBAs by dendritic cells was comparable, as well as the bio-distribution following equimolar intravenous administration to mice. ABP-labeled rGBAs were recovered largely in liver, white-blood cells, bone marrow and spleen. Lungs, brain and skin, affected tissues in severe GD types II and III, were only poorly supplemented. Small, but significant differences were noted in binding and uptake of rGBAs in cultured human macrophages, in the absence and presence of mannan. Mannan-competed binding and uptake were largest for velaglucerase, when determined with single enzymes or as equimolar mixtures of both enzymes. Vice versa, imiglucerase showed more prominent binding and uptake not competed by mannan. Uptake of recombinant GBAs by cultured macrophages seems to involve multiple receptors, including several mannose-binding lectins. Differences among cells from different donors (n = 12) were noted, but the same trends were always observed. Our study suggests that further insight in targeting and efficacy of enzyme therapy of individual Gaucher patients could be obtained by the use of recombinant GBA, trace-labeled with an ABP, preferably equipped with an infrared fluorophore or other reporter tag suitable for in vivo imaging.	[Kallemeijn, Wouter W.; Boot, Rolf G.; Aerts, Johannes M. F. G.] Leiden Univ, Leiden Inst Chem, Dept Biochem, Leiden, Netherlands; [Kallemeijn, Wouter W.; Scheij, Saskia; Chao, Daniela Herrera Moro; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Hoogendoorn, Sascha; Witte, Martin D.] Leiden Univ, Leiden Inst Chem, Dept Bioorgan Synth, Leiden, Netherlands; [Hoogendoorn, Sascha] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Witte, Martin D.] Univ Groningen, Stratingh Inst Chem, Dept Bioorgan Chem, Groningen, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Stanford University; University of Groningen	Aerts, JMFG (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Biochem, Leiden, Netherlands.; Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Aerts, Johannes/A-1028-2009; Kallemeijn, W. W./P-2768-2019	Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, W. W./0000-0002-3660-2930; Herrera Moro Chao, Daniela/0000-0001-8406-1377; Overkleeft, Herman/0000-0001-6976-7005; Hoogendoorn, Sascha/0000-0002-1155-8697; Boot, Rolf/0000-0002-7031-3390	Netherlands Organization for Scientific Research (NWO-CW Chem Them "Chemical biology of glucosylceramide metabolism"); European Research Council (ERC) (ERC AdvGr CHEMBIOSPHING)	Netherlands Organization for Scientific Research (NWO-CW Chem Them "Chemical biology of glucosylceramide metabolism"); European Research Council (ERC) (ERC AdvGr CHEMBIOSPHING)	This work was supported by the Netherlands Organization for Scientific Research (NWO-CW Chem Them "Chemical biology of glucosylceramide metabolism") and the European Research Council (ERC) (ERC AdvGr CHEMBIOSPHING) to HS Overkleeft and JMFG Aerts.	AERTS JMFG, 1986, ANAL BIOCHEM, V154, P655, DOI 10.1016/0003-2697(86)90043-6; Aerts JMFG, 2010, NAT REV DRUG DISCOV, V9, P837, DOI 10.1038/nrd3311; Aviezer D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004792; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Ben Bdira F, 2016, BIOCHEMISTRY-US, V55, P4823, DOI 10.1021/acs.biochem.6b00363; Ben Turkia H, 2013, AM J HEMATOL, V88, P179, DOI 10.1002/ajh.23382; Berger J, 2012, BRIT J HAEMATOL, V157, P274, DOI 10.1111/j.1365-2141.2011.08989.x; BEUTLER E, 1988, BLOOD REV, V2, P59, DOI 10.1016/0268-960X(88)90009-4; Bijsterbosch MK, 1996, EUR J BIOCHEM, V237, P344, DOI 10.1111/j.1432-1033.1996.00344.x; Bleijlevens B, 2008, ANAL BIOCHEM, V372, P52, DOI 10.1016/j.ab.2007.09.033; Boven LA, 2004, AM J CLIN PATHOL, V122, P359, DOI 10.1309/BG5VA8JRDQH1M7HN; BRADY RO, 1975, FED PROC, V34, P1310; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1974, NEW ENGL J MED, V291, P989, DOI 10.1056/NEJM197411072911901; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; Cox TM, 1997, BAILLIERE CLIN HAEM, V10, P657, DOI 10.1016/S0950-3536(97)80033-9; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; DEMARSH QB, 1957, BLOOD, V12, P324, DOI 10.1182/blood.V12.4.324.324; DOEBBER TW, 1982, J BIOL CHEM, V257, P2193; ESSNER E, 1960, J BIOPHYS BIOCHEM CY, V7, P329, DOI 10.1083/jcb.7.2.329; EZEKOWITZ RAB, 1988, J CELL SCI, P121; Friedman BA, 1999, BLOOD, V93, P2807; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grabowski GA, 1998, BLOOD REV, V12, P115, DOI 10.1016/S0268-960X(98)90023-6; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P5696; Hijnen NM, 2012, CONTRAST MEDIA MOL I, V7, P214, DOI 10.1002/cmmi.485; Hollak CEM, 2010, BLOOD CELL MOL DIS, V44, P41, DOI 10.1016/j.bcmd.2009.09.006; Hopwood JJ, 2006, NAT REV DRUG DISCOV, V5, P101, DOI 10.1038/nrd1962; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; IHLER GM, 1973, P NATL ACAD SCI USA, V70, P2663, DOI 10.1073/pnas.70.9.2663; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; LENNARTZ MR, 1987, J BIOL CHEM, V262, P9942; Machaczka M, 2011, J INHERIT METAB DIS, V34, P233, DOI 10.1007/s10545-010-9241-0; MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651; MAGNUSSON S, 1993, BIOCHEM J, V291, P749, DOI 10.1042/bj2910749; Malini E, 2015, FASEB J, V29, P3839, DOI 10.1096/fj.15-271148; Mandlebaum FS, 1912, J EXP MED, V16, P797, DOI 10.1084/jem.16.6.797; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7; Mistry PK, 1996, LANCET, V348, P1555, DOI 10.1016/S0140-6736(96)04451-0; Morales LE, 1996, ANN PHARMACOTHER, V30, P381, DOI 10.1177/106002809603000411; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; MURRAY GJ, 1995, J HISTOCHEM CYTOCHEM, V43, P149, DOI 10.1177/43.2.7822772; MURRAY GJ, 1995, J CELL BIOCHEM, V57, P208, DOI 10.1002/jcb.240570205; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; PENTCHEV PG, 1973, J BIOL CHEM, V248, P5256; Phenix CP, 2010, P NATL ACAD SCI USA, V107, P10842, DOI 10.1073/pnas.1003247107; PHILIPPART M, 1965, J NEUROPATH EXP NEUR, V24, P290, DOI 10.1097/00005072-196504000-00009; Piepenhagen PA, 2010, MICROSC RES TECHNIQ, V73, P694, DOI 10.1002/jemt.20810; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; SATO Y, 1993, J CLIN INVEST, V91, P1909, DOI 10.1172/JCI116409; STANG E, 1990, EUR J CELL BIOL, V52, P67; Takahashi K, 1998, CELL TISSUE RES, V292, P311, DOI 10.1007/s004410051062; TAKASAKI S, 1984, J BIOL CHEM, V259, P112; Tekoah  Y., 2013, BIOSCI REP, V33; TRAYNOR K, 2012, AM J HEALTH SYST PH, V69, P1009; van den Berg LM, 2012, ANN NY ACAD SCI, V1253, P149, DOI 10.1111/j.1749-6632.2011.06392.x; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; van Dussen L, 2012, HAEMATOL-HEMATOL J, V97, P1850, DOI 10.3324/haematol.2011.059071; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Zeng DX, 2013, J NUCL MED, V54, P829, DOI 10.2967/jnumed.112.115550; Zhang XS, 2011, J INHERIT METAB DIS, V34, P795, DOI 10.1007/s10545-011-9285-9; Zhu YX, 2004, J PHARMACOL EXP THER, V308, P705, DOI 10.1124/jpet.103.060236; ZIMRAN A, 1995, LANCET, V345, P1479, DOI 10.1016/S0140-6736(95)91038-7; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955; Zimran A, 2010, BLOOD, V115, P4651, DOI 10.1182/blood-2010-02-268649	78	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0170268	10.1371/journal.pone.0170268	http://dx.doi.org/10.1371/journal.pone.0170268			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207759	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500008
J	Yin, ZY; Zou, FNA; Li, H; Cheng, Y; Zhang, JL; Li, BF				Yin Zongyi; Zou Funian; Li Hao; Cheng Ying; Zhang Jialin; Li Baifeng			A rapid, efficient, and economic device and method for the isolation and purification of mouse islet cells	PLOS ONE			English	Article							TRANSPLANTATION	Rapid, efficient, and economic method for the isolation and purification of islets has been pursued by numerous islet-related researchers. In this study, we compared the advantages and disadvantages of our developed patented method with those of commonly used conventional methods (Ficoll-400, 1077, and handpicking methods). Cell viability was assayed using Trypan blue, cell purity and yield were assayed using diphenylthiocarbazone, and islet function was assayed using acridine orange/ethidium bromide staining and enzyme-linked immunosorbent assay-glucose stimulation testing 4 days after cultivation. The results showed that our islet isolation and purification method required 12 +/- 3 min, which was significantly shorter than the time required in Ficoll-400, 1077, and HPU groups (34 +/- 3, 41 +/- 4, and 30 +/- 4 min, respectively; P < 0.05). There was no significant difference in islet viability among the four groups. The islet purity, function, yield, and cost of our method were superior to those of the Ficoll-400 and 1077 methods, but inferior to the handpicking method. However, the handpicking method may cause wrist injury and visual impairment in researchers during large-scale islet isolation (>1000 islets). In summary, the MCT method is a rapid, efficient, and economic method for isolating and purifying murine islet cell clumps. This method overcomes some of the shortcomings of conventional methods, showing a relatively higher quality and yield of islets within a shorter duration at a lower cost. Therefore, the current method provides researchers with an alternative option for islet isolation and should be widely generalized.	[Yin Zongyi; Zou Funian; Li Hao; Cheng Ying; Zhang Jialin; Li Baifeng] China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China; [Cheng Ying; Zhang Jialin; Li Baifeng] China Med Univ, Hosp 1, Natl Key Lab Gen Surg, Shenyang, Peoples R China; [Cheng Ying; Zhang Jialin; Li Baifeng] China Med Univ, Hosp 1, Multiple Organ Transplantat Inst, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Li, BF (corresponding author), China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China.; Li, BF (corresponding author), China Med Univ, Hosp 1, Natl Key Lab Gen Surg, Shenyang, Peoples R China.; Li, BF (corresponding author), China Med Univ, Hosp 1, Multiple Organ Transplantat Inst, Shenyang, Peoples R China.	bfli@cmu.edu.cn			National Nature and Science Funding of China [81370882]; Natural Science Foundation of Liaoning Province [2013021058]	National Nature and Science Funding of China; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Nature and Science Funding of China [grant numbers: 81370882] http://www.nsfc.gov.cn/, and the Natural Science Foundation of Liaoning Province (grant numbers: 2013021058) http://kjih. Ininfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn AJ, 2015, EXPERT REV CLIN IMMU, V11, P59, DOI 10.1586/1744666X.2015.978291; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Li Baifeng, 2016, China Patent, Patent No. [ZL201620214060.8 [P], 201620214060]; Min T, 2010, TRANSPL P, V42, P1825, DOI 10.1016/j.transproceed.2010.01.068; Mohammadi Ayenehdeh J, 2016, IRAN BIOMED J; MOSKALEW.S, 1965, GEN COMP ENDOCR, V5, P342, DOI 10.1016/0016-6480(65)90059-6; Moskalewski S, 1997, Ann Transplant, V2, P6; O'Dowd JF, 2009, METHODS MOL BIOL, V560, P37, DOI 10.1007/978-1-59745-448-3_3; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	11	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171618	10.1371/journal.pone.0171618	http://dx.doi.org/10.1371/journal.pone.0171618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207765	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500043
J	Auer, MK; Liedl, A; Fuss, J; Nieder, T; Briken, P; Stalla, GK; Hildebrandt, T; Biedermann, SV; Sievers, C				Auer, Matthias K.; Liedl, Anita; Fuss, Johannes; Nieder, Timo; Briken, Peer; Stalla, Guenter K.; Hildebrandt, Thomas; Biedermann, Sarah V.; Sievers, Caroline			High impact of sleeping problems on quality of life in transgender individuals: A crosssectional multicenter study	PLOS ONE			English	Article							SOCIAL SUPPORT; GENERAL-POPULATION; HORMONAL-THERAPY; GENDER IDENTITY; SEXUAL HEALTH; PAIN; FEMALE; DISCRIMINATION; ASSOCIATIONS; TRANSSEXUALS	Introduction Studies in the general population suggest that determinants of QoL are often sex-dependent. Sex-dependent analyses of QoL in transgender populations have not been performed so far. Aim To identify sex-specific and potentially modifiable determinants of QoL in transgender patients Methods In this cross-sectional multicentre study including 82 transwomen (TW) and 72 transmen (TM) at different treatment stages, we investigated potential determinants for QoL focusing on the impact of mood (BDI, STAI-X), sleep quality (PSQI), chronic pain (GPQ), body image (FBeK) and social support (SSS). Main outcome measure Health-related quality of life measured with the Short Form (36) Health Survey (SF-36). Results The age-adjusted SF-36 total score and its subscales did not significantly differ between TM and TW. Using a multivariate regression analysis approach, we identified common but also sex-dependent determinants for QoL (Adjusted R-2 = 0.228; 0.650 respectively). Accounting for general characteristics such as age, BMI and treatment status, sleep quality according to the PSQI was an independent and strong determinant of QoL in both sexes (beta =-0.451, p = 0.003 TM; beta =-0.320; p = 0.0029 TW). Chronic pain was a significant independent predictor of QoL in TM (beta =-0.298; p = 0.042) but not in TW. In contrast, anxiety (beta =-0.451; p< 0.001) being unemployed (beta =-0.206; p = 0.020) and insecurity about the own appearance (FBeK) (beta =-0.261; p = 0.01) were independent predictors of QoL in TW. The rate of those reporting high sleep disturbances (PSQI >= 5) was high with 79.2% in TW and 81.2% in TM. Accordingly, age-adjusted QoL was also significantly lower in those reporting poor sleep in both sexes. Conclusions Sleep strongly affected QoL in both genders, while other factors, like pain and body image, seem to be gender specific in transgender individuals.	[Auer, Matthias K.; Liedl, Anita; Stalla, Guenter K.; Sievers, Caroline] Max Planck Inst Psychiat, Res Grp Clin Neuroendocrinol, Munich, Germany; [Fuss, Johannes; Nieder, Timo; Briken, Peer] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany; [Hildebrandt, Thomas] Erlangen Univ Hosp, Dept Gynecol & Obstet, Erlangen, Germany; [Biedermann, Sarah V.] Univ Med Ctr Hamburg Eppendorf, Ctr Psychosocial Med, Clin Psychiat & Psychotherapy, Hamburg, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Auer, MK (corresponding author), Max Planck Inst Psychiat, Res Grp Clin Neuroendocrinol, Munich, Germany.	mauer@psych.mpg.de	Auer, Matthias/AAI-5449-2021; Fuss, Johannes/AAI-6580-2021	Nieder, Timo/0000-0003-3052-5169				Ainsworth TA, 2010, QUAL LIFE RES, V19, P1019, DOI 10.1007/s11136-010-9668-7; Aloisi AM, 2007, PAIN, V132, pS60, DOI 10.1016/j.pain.2007.02.006; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; Auer MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078469; Basar K, 2016, J SEX MED, V13, P1133, DOI 10.1016/j.jsxm.2016.04.071; Baum A., 1984, HDB PSYCHOL HLTH; Bellach Ellert M., 2000, BUNDESGESUNDHEITSBL, V43, P210, DOI DOI 10.1007/S001030050036]; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Bockting W, 2016, CURR OPIN ENDOCRINOL, V23, P188, DOI 10.1097/MED.0000000000000232; BOWSHER D, 1991, Pain Clinic, V4, P223; Buysse D J, 1989, Psychiatry Res, V28, P193; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Chatterjee B, 2014, SLEEP MED, V15, P1547, DOI 10.1016/j.sleep.2014.06.023; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Davey A, 2014, J SEX MED, V11, P2976, DOI 10.1111/jsm.12681; de Torres JP, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-72; Dimopoulou C, 2014, EUR J ENDOCRINOL, V171, P581, DOI 10.1530/EJE-14-0375; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; ERLIK Y, 1981, JAMA-J AM MED ASSOC, V245, P1741, DOI 10.1001/jama.245.17.1741; Franzen Peter L, 2008, Dialogues Clin Neurosci, V10, P473; Fuss J, 2013, J PSYCHIATR RES, V47, P2015, DOI 10.1016/j.jpsychires.2013.08.023; Fydrich T, 2007, FRAGEBOGEN SOZIALEN; Geraedts VJ, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00229; Gomez-Gil E, 2014, QUAL LIFE RES, V23, P671, DOI 10.1007/s11136-013-0497-3; Gorin-Lazard A, 2013, J NERV MENT DIS, V201, P996, DOI 10.1097/NMD.0000000000000046; Gorin-Lazard A, 2012, J SEX MED, V9, P531, DOI 10.1111/j.1743-6109.2011.02564.x; Hajek A, 2015, QUAL LIFE RES, P1; Hajek A, 2016, QUAL LIFE RES, V25, P1159, DOI 10.1007/s11136-015-1166-5; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Heylens G, 2014, BRIT J PSYCHIAT, V204, P151, DOI 10.1192/bjp.bp.112.121954; Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245; Imbimbo C, 2009, J SEX MED, V6, P2736, DOI 10.1111/j.1743-6109.2009.01379.x; Kim JS, 2015, ASIAN NURS RES, V9, P96, DOI 10.1016/j.anr.2014.12.001; Kunzel HE, 2011, PSYCHONEUROENDOCRINO, V36, P1005, DOI 10.1016/j.psyneuen.2010.12.014; Kuhn A, 2009, FERTIL STERIL, V92, P1685, DOI 10.1016/j.fertnstert.2008.08.126; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lacruz ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007919; Larios SE, 2009, ETHNIC DIS, V19, P65; Leistner SM, 2015, EUR J ENDOCRINOL, V172, P733, DOI 10.1530/EJE-14-0941; LeResche L, 2000, PROG PAIN RES MANAG, V17, P233; LITTLE BC, 1974, J NERV MENT DIS, V159, P256, DOI 10.1097/00005053-197410000-00004; Malchaire J, 2001, INT ARCH OCC ENV HEA, V74, P79, DOI 10.1007/s004200000212; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Manber R, 1999, SLEEP, V22, P540; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Morley S, 2011, PAIN, V152, pS99, DOI 10.1016/j.pain.2010.10.042; Motmans J, 2012, J SEX MED, V9, P743, DOI 10.1111/j.1743-6109.2011.02569.x; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Newfield E, 2006, QUAL LIFE RES, V15, P1447, DOI 10.1007/s11136-006-0002-3; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Spielberger CD, 1994, STATE TRAIT ANXIETY; Strauss B, 1996, HOGREFE VERLAG PSYCH; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Taziaux M, 2016, J CLIN ENDOCR METAB, V101, P2380, DOI 10.1210/jc.2015-4175; TERRY DJ, 1995, ANXIETY STRESS COPIN, V8, P1, DOI 10.1080/10615809508249360; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; Wierckx K, 2011, J SEX MED, V8, P3379, DOI 10.1111/j.1743-6109.2011.02348.x; Yang XS, 2016, J AFFECT DISORDERS, V203, P22, DOI 10.1016/j.jad.2016.05.051; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	63	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171640	10.1371/journal.pone.0171640	http://dx.doi.org/10.1371/journal.pone.0171640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BF	28199359	Green Published, gold			2022-12-26	WOS:000394424400038
J	Wu, Y; Liu, F; Adi, D; Yang, YN; Xie, X; Li, XM; Ma, X; Fu, ZY; Huang, Y; Chen, BD; Shan, CF; Ma, YT				Wu, Yun; Liu, Fen; Adi, Dilare; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Huang, Ying; Chen, Bang-Dang; Shan, Chun-Fang; Ma, Yi-Tong			Association between carotid atherosclerosis and different subtypes of hypertension in adult populations: A multiethnic study in Xinjiang, China	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK; CORONARY; PLAQUE; PROGRESSION; PREVALENCE; PREDICTION; IMPACT	Background Ethnic differences in non-invasive measurements of carotid atherosclerosis are being increasingly reported, but the association between carotid atherosclerosis and different subtypes of hypertension in adult populations is not fully understood in different ethnicities. We aimed to investigate the association of carotid atherosclerosis with different subtypes of hypertension in different ethnicities in Xinjiang, a northwestern province in China. Methods A total of 14,618 participants (5,757 Hans, 4,767 Uygurs, and 4,094 Kazakhs) from 26 villages of seven cities in Xinjiang were randomly selected from the Cardiovascular Risk Survey conducted during 2007 and 2010. A standard questionnaire, a physical examination and biochemical tests were employed. Results The mean common carotid intima-media thickness (CIMT) for the 14,618 participants was 0.86 +/- 0.003 mm. The CIMT gradually increased with age. Men (0.92 +/- 0.005 mm) had a higher CIMT than women (0.81 +/- 0.004 mm). The Uygur participants (0.82 +/- 0.006 mm) had a lower CIMT than the Han (0.88 +/- 0.005 mm) and Kazakh participants (0.88 +/- 0.005 mm). The overall prevalences of carotid intimal thickening and carotid plaques were 12.4% and 9.7%, respectively. The prevalence of CIMT varied for the different subtypes of hypertension. Multivariate logistic regression analysis showed different risk factors for abnormal CIMT in different ethnicities. The associations between abnormal CIMT and the different subtypes of hypertension within different ethnic backgrounds were also different. The risk factors for abnormal CIMT included systolic- diastolic hypertension (SDH) in Han participants (OR: 1.323, 95% CI: 1.100 -1.590), SDH ( OR: 1.426, 95% CI: 1.160 - 1.753) and isolated-systolic hypertension (ISH) (OR: 1.844, 95% CI: 1.470 - 2.313) in Uygur participants, and isolateddiastolic hypertension (IDH) (OR: 1.536, 95% CI: 1.170 - 2.016) in Kazakh participants. Conclusion There was an ethnic difference in the prevalence of abnormal CIMT in Xinjiang, a northwestern province in China. The associations between abnormal CIMT and the subtypes of hypertension varied among the different ethnic groups. Among the studied populations, Han participants with SDH, Uygur participants with SDH and ISH, and Kazakh with IDH were more likely to suffer carotid atherosclerosis than those with other subtypes of hypertension. Participants with different ethnic backgrounds had different sets of risk factors for abnormal CIMT.	[Wu, Yun; Adi, Dilare; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Huang, Ying; Shan, Chun-Fang; Ma, Yi-Tong] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China; [Wu, Yun] Xinjiang Med Univ, Dept Gen Practice, Affiliated Hosp 1, Urumqi, Peoples R China; [Liu, Fen; Adi, Dilare; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Huang, Ying; Chen, Bang-Dang; Shan, Chun-Fang; Ma, Yi-Tong] Xinjiang Med Univ, Xinjiang Key Lab Cardiovasc Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, Xinjiang Key Lab Cardiovasc Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China.	myt_xj@sina.com	xie, xiang/AAG-2128-2021	Wu, Yun/0000-0002-2692-9067	Key Laboratory of Xinjiang Uygur Autonomous Region [2014KL011]	Key Laboratory of Xinjiang Uygur Autonomous Region	This work was funded by the special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region (grant#2014KL011).	Arima H, 2012, HYPERTENSION, V59, P1118, DOI 10.1161/HYPERTENSIONAHA.111.187252; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; Bots ML, 2014, HYPERTENSION, V63, P1173, DOI 10.1161/HYPERTENSIONAHA.113.02683; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Huang LC, 2016, J ATHEROSCLER THROMB, V23, P940, DOI 10.5551/jat.32177; Ikeda N, 2015, ULTRASOUND MED BIOL, V41, P1247, DOI 10.1016/j.ultrasmedbio.2014.12.024; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Li W, 2016, J HYPERTENS, V34, P39, DOI 10.1097/HJH.0000000000000745; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu AY, 2015, INT J CLIN EXP MED, V8, P21932; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145325; Lu M, 2004, J HYPERTENS, V22, P1699, DOI 10.1097/00004872-200409000-00013; Manios E, 2015, BLOOD PRESS MONIT, V20, P64, DOI 10.1097/MBP.0000000000000093; Manolio TA, 2008, ATHEROSCLEROSIS, V197, P132, DOI 10.1016/j.atherosclerosis.2007.02.030; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Polak JF, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001492; Usman A, 2015, J ATHEROSCLER THROMB, V22, P739, DOI 10.5551/jat.30460; Wang MY, 2015, HYPERTENSION, V65, P698, DOI 10.1161/HYPERTENSIONAHA.114.03618; Xie W, 2014, HYPERTENS RES, V37, P960, DOI 10.1038/hr.2014.93; Xie WX, 2011, J AM SOC ECHOCARDIOG, V24, P729, DOI 10.1016/j.echo.2011.02.011; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Zielinski T, 2007, AM J HYPERTENS, V20, P1058, DOI 10.1016/j.amjhyper.2007.05.011	25	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171791	10.1371/journal.pone.0171791	http://dx.doi.org/10.1371/journal.pone.0171791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199358	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400049
J	Montesi, M; Panseri, S; Dapporto, M; Tampieri, A; Sprio, S				Montesi, Monica; Panseri, Silvia; Dapporto, Massimiliano; Tampieri, Anna; Sprio, Simone			Sr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; STRONTIUM RANELATE; IN-VITRO; NONVERTEBRAL FRACTURES; PHOSPHATE CEMENTS; DIFFERENTIATION; PROLIFERATION; RESORPTION; WOMEN; OSTEOPOROSIS	Strontium-substituted apatitic bone cements enriched with sodium alginate were developed as a potential modulator of bone cells fate. The biological impact of the bone cement were investigated in vitro through the study of the effect of the nanostructured apatitic composition and the doping of strontium on mesenchymal stem cells, pre-osteoblasts and osteoclasts behaviours. Up to 14 days of culture the bone cells viability, proliferation, morphology and gene expression profiles were evaluated. The results showed that different concentrations of strontium were able to evoke a cell-specific response, in fact an inductive effect on mesenchymal stem cells differentiation and pre-osteoblasts proliferation and an inhibitory effect on osteoclasts activity were observed. Moreover, the apatitic structure of the cements provided a biomimetic environment suitable for bone cells growth. Therefore, the combination of biological features of this bone cement makes it as promising biomaterials for tissue regeneration.	[Montesi, Monica; Panseri, Silvia; Dapporto, Massimiliano; Tampieri, Anna; Sprio, Simone] CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR)	Montesi, M (corresponding author), CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy.	monica.montesi@istec.cnr.it	Dapporto, Massimiliano/O-3740-2019; Panseri, Silvia/AAW-2856-2020; Montesi, Monica/J-8861-2018	Dapporto, Massimiliano/0000-0002-8783-4061; Panseri, Silvia/0000-0002-8099-7132; Sprio, Simone/0000-0003-1526-7915; Montesi, Monica/0000-0002-9192-8554; Panseri, Sara/0000-0001-6970-2009	European Union's Seventh Framework Programme (FP7) [NMP3-SL-2010-SMALL-3-246373]; European Union's Seventh Framework Programme (FP7), OPHIS [246373]	European Union's Seventh Framework Programme (FP7); European Union's Seventh Framework Programme (FP7), OPHIS	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement NMP3-SL-2010-SMALL-3-246373 (2010-2013), Composite Phenotypic triggers for bone and cartilage repair "OPHIS". AT is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 246373, OPHIS.	Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021; Bettencourt A, 2000, INT J PHARM, V197, P161, DOI 10.1016/S0378-5173(99)00468-8; Bohner M, 2000, Injury, V31 Suppl 4, P37; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Cianferotti L, 2015, OSTEOPOROSIS INT, V26, P2055, DOI 10.1007/s00198-015-3203-1; Cohen-Solal M, 2002, NEPHROL DIAL TRANSPL, V17, P30, DOI 10.1093/ndt/17.suppl_2.30; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; De Santis R, 2003, J MATER SCI-MATER M, V14, P583, DOI 10.1023/A:1024014822277; Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x; Ginebra MP, 2009, WOODHEAD PUBL MATER, P271, DOI 10.1533/9781845696610.2.271; Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kammerlander C, 2013, BEST PRACT RES CL RH, V27, P757, DOI 10.1016/j.berh.2014.02.005; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Kuang GM, 2015, J BIOMED MATER RES A, V103, P1613, DOI 10.1002/jbm.a.35298; Kumar S, 2010, BONE, V46, P534, DOI 10.1016/j.bone.2009.09.028; Li YF, 2012, BIOCHEM BIOPH RES CO, V418, P725, DOI 10.1016/j.bbrc.2012.01.088; Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048; Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Maenz S, 2014, J MECH BEHAV BIOMED, V39, P328, DOI 10.1016/j.jmbbm.2014.07.028; Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055; Montesi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132633; Nardone V, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/871863; Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026; Nouda S, 2009, SPINE, V34, P2613, DOI 10.1097/BRS.0b013e3181abc150; Oral A, 2013, EUR J PHYS REHAB MED, V49, P565; Pan HB, 2009, ACTA BIOMATER, V5, P1678, DOI 10.1016/j.actbio.2008.11.032; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; Rizzoli R, 2010, RHEUMATOL INT, V30, P1341, DOI 10.1007/s00296-010-1542-y; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Schumacher M, 2016, ACTA BIOMATER, V37, P184, DOI 10.1016/j.actbio.2016.04.016; Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027; Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014; Schumacher M, 2015, J MATER CHEM B, V3, P4626, DOI 10.1039/c5tb00654f; Seeman E, 2006, J BONE MINER RES, V21, P1113, DOI 10.1359/JBMR.060404; Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25; Sprio S, 2016, MATERIALS, V9, DOI 10.3390/ma9090763; Vaananen HK, 2000, J CELL SCI, V113, P377; Wade SW, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0182-3; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang W, 2013, BIOMATERIALS, V34, P631, DOI 10.1016/j.biomaterials.2012.10.021; Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646; Zhang YD, 2015, ACS APPL MATER INTER, V7, P2393, DOI 10.1021/am507008z; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104527; Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120	54	28	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172100	10.1371/journal.pone.0172100	http://dx.doi.org/10.1371/journal.pone.0172100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196118	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900050
J	Owen, LA; Morrison, MA; Hoffman, RO; Yoder, BA; DeAngelis, MM				Owen, Leah A.; Morrison, Margaux A.; Hoffman, Robert O.; Yoder, Bradley A.; DeAngelis, Margaret M.			Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease	PLOS ONE			English	Article							POSTNATAL WEIGHT-GAIN; BIRTH-WEIGHT; RETROLENTAL FIBROPLASIA; GESTATIONAL-AGE; INFANTS; PREVALENCE	Background Retinopathy of prematurity (ROP) is a blinding morbidity of preterm infants. Our current screening criteria have remained unchanged since their inception and lack the ability to identify those at greatest risk. Objectives We sought to comprehensively analyze numerous proposed maternal, infant, and environmental ROP risk variables in a robustly phenotyped population using logistic regression to determine the most predictive model for ROP development and severity. We further sought to determine the statistical interaction between significant ROP risk variables, which has not previously been done in the field of ROP. We hypothesize that our comprehensive analysis will allow for better identification of risk variables that independently correlate with ROP disease. Going forward, this may allow for improved infant risk stratification along a time continuum from prenatal to postnatal development, making prevention more feasible. Methods We performed a retrospective cohort analysis of preterm infants referred for ROP screening in one neonatal intensive care unit from 2010-2015. The primary outcome measure was presence of ROP. Secondary outcome measures were ROP requiring treatment and severe ROP not clearly meeting current treatment criteria. Univariate, stepwise regression and statistical interaction analyses of 57 proposed ROP risk variables was performed to identify variables which were significantly associated with each outcome measure. Results We identified 457 infants meeting our inclusion criteria. Within this cohort, numerous factors showed a significant individual association with our ROP outcome measures; however, stepwise regression analysis found the most predictive model for overall ROP risk included estimated gestational age, birth weight, the need for any surgery, and maternal magnesium prophylaxis. The corresponding Area Under the Curve (AUC) for this model was 0.8641, while the traditional model of gestational age and birth weight predicted ROP disease less well with an AUC of 0.8489. Development of severe ROP was best predicted by estimated gestational age (week), the need for any surgery and increased probability of death or moderate-severe BPD at 7 days. Finally, the model most predictive for type 1 ROP included estimated gestational age (week) and the presence of severe chronic lung disease. No significant statistical interaction was found between variables. Conclusions Our work is unique as we report comprehensive analysis of the greatest number of proposed ROP risk variables to date in a robustly phenotyped population. We describe novel risk models for our ROP outcome measures and demonstrate independence of these variables using statistical modeling not previously applied to ROP. This may better allow for individual infant risk stratification and importantly mitigation of future risk.	[Owen, Leah A.; Morrison, Margaux A.; Hoffman, Robert O.; DeAngelis, Margaret M.] Univ Utah, Sch Med, John Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA; [Owen, Leah A.; Morrison, Margaux A.; Hoffman, Robert O.; Yoder, Bradley A.; DeAngelis, Margaret M.] Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Owen, LA; DeAngelis, MM (corresponding author), Univ Utah, Sch Med, John Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA.; Owen, LA; DeAngelis, MM (corresponding author), Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA.	leah.owen@hsc.utah.edu; Margaret.deangelis@utah.edu		Owen, Leah/0000-0003-3802-3868	Unrestricted Grant from Research to Prevent Blindness; National Eye Institute Core grant [EY014800]; NATIONAL EYE INSTITUTE [P30EY014800] Funding Source: NIH RePORTER	Unrestricted Grant from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute Core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by an Unrestricted Grant from Research to Prevent Blindness to the John Moran Eye Center and a National Eye Institute (EY014800) Core grant to the John Moran Eye Center.	Alizadeh Yousef, 2015, J Ophthalmic Vis Res, V10, P424, DOI 10.4103/2008-322X.176907; Binenbaum G, 2012, ARCH OPHTHALMOL-CHIC, V130, P1560, DOI 10.1001/archophthalmol.2012.2524; Brown D R, 1990, J Pediatr Ophthalmol Strabismus, V27, P268; Cao JH, 2016, J AAPOS, V20, P19, DOI 10.1016/j.jaapos.2015.10.017; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; DeAngelis MM, 2004, ARCH OPHTHALMOL-CHIC, V122, P575, DOI 10.1001/archopht.122.4.575; Elsas FJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1110; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Fortes JB, 2009, REV PANAM SALUD PUBL, V26, P216; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Gergely K, 2010, BRATISL MED J, V111, P514; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert Clare, 2008, Community Eye Health, V21, P46; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; GUNN TR, 1980, PEDIATRICS, V65, P1096; Hakeem AHAA, 2012, MIDDLE EAST AFR J OP, V19, P289, DOI 10.4103/0974-9233.97927; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Holmstrom G, 1998, ACTA OPHTHALMOL SCAN, V76, P204, DOI 10.1034/j.1600-0420.1998.760216.x; Holmstrom G, 1996, ACTA OBSTET GYN SCAN, V75, P628, DOI 10.3109/00016349609054687; Hutchinson AK, 2016, OPHTHALMOLOGY, V123, P804, DOI 10.1016/j.ophtha.2015.11.003; Karna Padmani, 2005, BMC Pediatr, V5, P18, DOI 10.1186/1471-2431-5-18; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; LECHNER D, 1977, PEDIATRICS, V59, P916; Liu PM, 2005, AM J PERINAT, V22, P115, DOI 10.1055/s-2005-837276; Lundgren P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109460; Owen Leah A, 2014, J Ophthalmic Vis Res, V9, P94; Painter S. L., 2014, BR J OPHTHALMOL; PUROHIT DM, 1985, PEDIATRICS, V76, P339; SCHAFFER DB, 1993, OPHTHALMOLOGY, V100, P230; Shin DL, 2014, J AAPOS, V18, P124, DOI 10.1016/j.jaapos.2013.12.003; SHOHAT M, 1983, PEDIATRICS, V72, P159; Slidsborg C, 2016, OPHTHALMOLOGY, V123, P796, DOI 10.1016/j.ophtha.2015.12.019; TERRY TL, 1945, ARCH OPHTHALMOL-CHIC, V33, P203, DOI 10.1001/archopht.1945.00890150047006; Woo SJ, 2011, EYE, V25, P1478, DOI 10.1038/eye.2011.208; Yanovitch TL, 2006, J AAPOS, V10, P128, DOI 10.1016/j.jaapos.2005.08.005; Ying GS, 2015, JAMA OPHTHALMOL, V133, P304, DOI 10.1001/jamaophthalmol.2014.5185; Zin A, 2013, CLIN PERINATOL, V40, P185, DOI 10.1016/j.clp.2013.02.001	40	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171467	10.1371/journal.pone.0171467	http://dx.doi.org/10.1371/journal.pone.0171467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196114	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423900023
J	Wang, K; Jin, S; Fan, DD; Wang, MS; Xing, NAZ; Niu, YN				Wang, Kai; Jin, Song; Fan, Dongdong; Wang, Mingshuai; Xing, Nianzeng; Niu, Yinong			Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-jun gene	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; HYPERPLASIA; PROLIFERATION; CROSSTALK; ESTROGEN; ANDROGEN; CANCER; MEN	This study aimed to identify the role of mouse fibroblast-mediated c-Jun and IGF-1 signaling in the therapeutic effect of finasteride on benign prostatic epithelial cells. BPH-1 cells, alone or with fibroblasts (c-Jun+I+ or c-Jun-I-), were implanted subcutaneously in male nude mice who were then treated with finasteride. The degrees of cell proliferation, apoptosis, and sizes of the xenografts were determined. BPH-1 cells were grown alone or co-cultured with mouse fibroblasts in the presence of finasteride and the level of IGF-1 secreted into the medium by the fibroblasts was determined. The proliferation-associated signaling pathway in BPH-1 cells was also evaluated. Fibroblasts and c-Jun promoted xenograft growth, stimulated Ki-67 expression, and inhibited BPH-1 apoptosis. Finasteride did not induce the shrinkage of xenografts in the combined-grafted groups despite repressing Ki-67 expression and inducing cell apoptosis. The addition of c-Jurft-fibroblasts did not promote xenograft growth. In the absence of c-Jun and fibroblasts, finasteride did not alter xenograft growth, Ki-67 expression, or cell apoptosis. The in vitro results demonstrated that when BPH-1 cells were grown in monoculture, treatment with finasteride did not induce cell death and stimulated the expression of pro-proliferative signaling molecules, while in the presence of fibroblasts containing c-Jun, finasteride treatment repressed epithelial cell proliferation, the level of IGF-1 in the medium, and the activation of downstream pro-proliferative signaling pathways. Taken together, our results suggest that fibroblasts, c-Jun, and IGF-1 play key roles in mediating stromal-epithelial interactions that are required for the therapeutic effects of finasteride in benign prostate epithelial cells.	[Wang, Kai; Jin, Song; Fan, Dongdong; Wang, Mingshuai; Xing, Nianzeng; Niu, Yinong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China; [Wang, Kai] Weifang Hosp Tradit Chinese Med, Dept Urol, Weifang, Peoples R China	Capital Medical University	Niu, YN (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China.	18601020160@163.com	Yinong, Niu/J-9086-2019	Xing, Nianzeng/0000-0002-2696-5279	National Natural Science Foundation of China [30973015]; Beijing Natural Science Foundation at Beijing Chaoyang Hospital, Capital Medical University [7122074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation at Beijing Chaoyang Hospital, Capital Medical University	This study was supported by funding from the National Natural Science Foundation of China (No. 30973015) and the Beijing Natural Science Foundation (No. 7122074) at Beijing Chaoyang Hospital, Capital Medical University to Yinong Niu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne CW, 2003, EUR J CANCER, V39, P1004, DOI 10.1016/S0959-8049(03)00071-6; Carrasquillo RJ, 2014, CURR OPIN ENDOCRINOL, V21, P488, DOI 10.1097/MED.0000000000000110; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; Cunha GR, 2011, DIFFERENTIATION, V82, P168, DOI 10.1016/j.diff.2011.04.002; GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701; Hennenberg M, 2015, LIFE SCI, V123, P18, DOI 10.1016/j.lfs.2014.12.006; Kang DI, 2013, KOREAN J UROL, V54, P213, DOI 10.4111/kju.2013.54.4.213; Kim JH, 2016, PROSTATE, V76, P1431, DOI 10.1002/pros.23227; Li WH, 2007, AM J PATHOL, V171, P1189, DOI 10.2353/ajpath.2007.070285; Niu Y, 2011, REDUCED LEVELS 5 RED, P1317; Niu YN, 2009, ASIAN J ANDROL, V11, P28, DOI 10.1038/aja.2008.39; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Shao R, 2014, PROSTATE, V74, P970, DOI 10.1002/pros.22814; Song LM, 2016, BOSNIAN J BASIC MED, V16, P201, DOI 10.17305/bjbms.2016.1209; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Wadsworth TL, 2004, ENDOCRINOLOGY, V145, P3205, DOI 10.1210/en.2003-1716; Wang K, 2014, ASIAN J ANDROL, V16, P274, DOI 10.4103/1008-682X.123664; Webber JP, 2016, ONCOTARGET, V7, P20124, DOI 10.18632/oncotarget.7716; Yang XL, 2010, INT J MOL MED, V26, P17, DOI 10.3892/ijmm_00000429	20	8	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172233	10.1371/journal.pone.0172233	http://dx.doi.org/10.1371/journal.pone.0172233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196103	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900062
J	Kamfwa, K; Zhao, DY; Kelly, JD; Cichy, KA				Kamfwa, Kelvin; Zhao, Dongyan; Kelly, James D.; Cichy, Karen A.			Transcriptome analysis of two recombinant inbred lines of common bean contrasting for symbiotic nitrogen fixation	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; LOTUS-JAPONICUS; PURINE BIOSYNTHESIS; EXPRESSION ANALYSIS; NODULE DEVELOPMENT; NODULATION; LEGUME; GENE; RHIZOBIUM; TRANSPORT	Common bean (Phaseolus vulgaris L.) fixes atmospheric nitrogen (N-2) through symbiotic nitrogen fixation (SNF) at levels lower than other grain legume crops. An understanding of the genes and molecular mechanisms underlying SNF will enable more effective strategies for the genetic improvement of SNF traits in common bean. In this study, transcriptome profiling was used to identify genes and molecular mechanisms underlying SNF differences between two common bean recombinant inbred lines that differed in their N-fixing abilities. Differential gene expression and functional enrichment analyses were performed on leaves, nodules and roots of the two lines when grown under N-fixing and non-fixing conditions. Receptor kinases, transmembrane transporters, and transcription factors were among the differentially expressed genes identified under N-fixing conditions, but not under non-fixing conditions. Genes up-regulated in the stronger nitrogen fixer, SA36, included those involved in molecular functions such as purine nucleoside binding, oxidoreductase and transmembrane receptor activities in nodules, and transport activity in roots. Transcription factors identified in this study are candidates for future work aimed at understanding the functional role of these genes in SNF. Information generated in this study will support the development of gene-based markers to accelerate genetic improvement of SNF in common bean.	[Kamfwa, Kelvin] Univ Zambia, Dept Plant Sci, Lusaka, Zambia; [Zhao, Dongyan; Cichy, Karen A.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Kelly, James D.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Cichy, Karen A.] USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI USA	University of Zambia; Michigan State University; Michigan State University; United States Department of Agriculture (USDA)	Cichy, KA (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.; Cichy, KA (corresponding author), USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI USA.	karen.cichy@ars.usda.gov		Zhao, Dongyan/0000-0002-2080-8416; Cichy, Karen/0000-0002-4311-0774	USDA-ARS; Feed the Future Innovation Lab for Collaborative Research on Grain Legumes; Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005-00]; Norman Borlaug Commemorative Research Initiative (US Agency for International Development)	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Feed the Future Innovation Lab for Collaborative Research on Grain Legumes(United States Agency for International Development (USAID)); Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID)); Norman Borlaug Commemorative Research Initiative (US Agency for International Development)(United States Agency for International Development (USAID))	Research was supported by the USDA-ARS and was also made possible through support provided by the Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Cooperative Agreement No. EDH-A-00-07-00005-00, and this work was supported by funding from the Norman Borlaug Commemorative Research Initiative (US Agency for International Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akibode CS, 2012, GLOBAL REGIONAL TREN; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 1970, HDB RHIZOBIA; APPLEBY CA, 1984, ANNU REV PLANT PHYS, V35, P443, DOI 10.1146/annurev.pp.35.060184.002303; Chiasson DM, 2014, P NATL ACAD SCI USA, V111, P4814, DOI 10.1073/pnas.1312801111; Chungopast S, 2014, PLANT BIOTECHNOL, V31; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; DAY DA, 1991, PLANT PHYSIOL BIOCH, V29, P185; Denance N, 2014, PLANT CELL PHYSIOL, V55, P469, DOI 10.1093/pcp/pct198; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Godiard L, 2011, NEW PHYTOL, V191, P391, DOI 10.1111/j.1469-8137.2011.03718.x; Graham P., 2009, NITROGEN FIXATION CR, P171; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; GRAHAM PH, 1981, FIELD CROP RES, V4, P93, DOI 10.1016/0378-4290(81)90060-5; GRAHAM PH, 1994, CAN J MICROBIOL, V40, P198, DOI 10.1139/m94-033; Gresshoff PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-201; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI DOI 10.1093/nar/gkh066; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Institute S, 2011, SAS VERS 9 3; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Kusolwa PM, 2016, J PLANT REGIST, V10, P149, DOI 10.3198/jpr2015.10.0064crg; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Long SR, 2015, NATURE, V523, P298, DOI 10.1038/nature14632; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Noor SNM, 2015, BIOLOGICAL NITROGEN FIXATION, VOLS 1 AND 2, P683; Nova-Franco B, 2015, PLANT PHYSIOL, V168, P273, DOI 10.1104/pp.114.255547; O'Rourke JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-866; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Saito K, 2007, PLANT CELL, V19, P610, DOI 10.1105/tpc.106.046938; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Sinharoy S, 2013, BIOL NITROGEN FIXATI, V2, P823; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Vincent JM, 1970, IBP HDB; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	58	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172141	10.1371/journal.pone.0172141	http://dx.doi.org/10.1371/journal.pone.0172141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192540	gold, Green Published, Green Submitted			2022-12-26	WOS:000394423800077
J	Wu, B; Hu, YN; Huo, PJ; Zhang, Q; Chen, X; Zhang, ZW				Wu, Bin; Hu, Yani; Huo, Pengjie; Zhang, Qian; Chen, Xin; Zhang, Zongwen			Transcriptome analysis of hexaploid hulless oat in response to salinity stress	PLOS ONE			English	Article							PLANT SALT-TOLERANCE; RNA-SEQ; ANNOTATION; SODIUM; WHEAT; L.; MECHANISMS; GENERATION; POTASSIUM; PROTEINS	Background Oat is a cereal crop of global importance used for food, feed, and forage. Understanding salinity stress tolerance mechanisms in plants is an important step towards generating crop varieties that can cope with environmental stresses. To date, little is known about the salt tolerance of oat at the molecular level. To better understand the molecular mechanisms underlying salt tolerance in oat, we investigated the transcriptomes of control and salt-treated oat using RNA-Seq. Results Using Illumina HiSeq 4000 platform, we generated 72,291,032 and 356,891,432 reads from non-stressed control and salt-stressed oat, respectively. Assembly of 64 Gb raw sequence data yielded 128,414 putative unique transcripts with an average length of 1,189 bp. Analysis of the assembled unigenes from the salt stressed and control libraries indicated that about 65,000 unigenes were differentially expressed at different stages. Functional annotation showed that ABC transporters, plant hormone signal transduction, plant-pathogen interactions, starch and sucrose metabolism, arginine and proline metabolism, and other secondary metabolite pathways were enriched under salt stress. Based on the RPKM values of assembled unigenes, 24 differentially expressed genes under salt stress were selected for quantitative RT-PCR validation, which successfully confirmed the results of RNA-Seq. Furthermore, we identified 18,039 simple sequence repeats, which may help further elucidate salt tolerance mechanisms in oat. Conclusions Our global survey of transcriptome profiles of oat plants in response to salt stress provides useful insights into the molecular mechanisms underlying salt tolerance in this crop. These findings also represent a rich resource for further analysis of salt tolerance and for breeding oat with improved salt tolerance through the use of salt-related genes.	[Wu, Bin; Hu, Yani; Huo, Pengjie; Zhang, Qian; Chen, Xin; Zhang, Zongwen] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, ZW (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	zongwenzh@sina.com			Chinese Agricultural Research System [CARS-08-A-3]; Chinese Ministry of Agriculture; National Natural Science Foundation of China [30800699]	Chinese Agricultural Research System; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Agricultural Research System (grant number CARS-08-A-3) Chinese Ministry of Agriculture (http://www.moa.gov.cn/), and the National Natural Science Foundation of China (grant number 30800699) (http //www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashraf M, 2000, FIELD CROP RES, V66, P115, DOI 10.1016/S0378-4290(00)00064-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; [陈新 Chen Xin], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P2038; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gutierrez-Gonzalez JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-471; Han LP, 2013, ECOL ENG, V61, P274, DOI 10.1016/j.ecoleng.2013.09.034; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Jensen LJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000374; KINGSBURY RW, 1986, PLANT PHYSIOL, V80, P651, DOI 10.1104/pp.80.3.651; Kristensen M, 2011, EUR J CLIN NUTR, V65, P1053, DOI 10.1038/ejcn.2011.102; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reyes JL, 2010, METHODS MOL BIOL, V639, P239, DOI 10.1007/978-1-60761-702-0_14; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhling KH, 2003, PLANT SOIL, V253, P219, DOI 10.1023/A:1024517919764; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Ren CZ, 2013, CHINA OATS; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; [王波 Wang Bo], 2006, [生态环境, Ecology and Environment], V15, P625; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wanke D, 2010, PLANT BIOLOGY, V12, P15, DOI 10.1111/j.1438-8677.2010.00380.x; Yan XK, 2005, PEDOSPHERE, V15, P84; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	44	38	41	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171451	10.1371/journal.pone.0171451	http://dx.doi.org/10.1371/journal.pone.0171451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192458	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800027
J	Kulawik, A; Engesser, R; Ehlting, C; Raue, A; Albrecht, U; Hahn, B; Lehmann, WD; Gaestel, M; Klingmuller, U; Haussinger, D; Timmer, J; Bode, JG				Kulawik, Andreas; Engesser, Raphael; Ehlting, Christian; Raue, Andreas; Albrecht, Ute; Hahn, Bettina; Lehmann, Wolf-Dieter; Gaestel, Matthias; Klingmueller, Ursula; Haeussinger, Dieter; Timmer, Jens; Bode, Johannes G.			IL-1 beta-induced and p38(MAPK)-dependent activation of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) in hepatocytes: Signal transduction with robust and concentration-independent signal amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CELLS; PRO-INFLAMMATORY CYTOKINES; NF-KAPPA-B; TISSUE DISPERSION; GENE-EXPRESSION; IN-VITRO; SYSTEMS; MECHANISMS; PATHWAY; MODELS	The IL-1 beta-induced activation of the p38(MAPK)/MAPK-activated protein kinase 2 (MK2) pathway in hepatocytes is important for control of the acute phase response and regulation of liver regeneration. Many aspects of the regulatory relevance of this pathway have been investigated in immune cells in the context of inflammation. However, very little is known about concentration-dependent activation kinetics and signal propagation in hepatocytes and the role of MK2. We established a mathematical model for IL-1 beta-induced activation of the p38(MAPK)/MK2 pathway in hepatocytes that was calibrated to quantitative data on time-and IL-1 beta concentration-dependent phosphorylation of p38(MAPK) and MK2 in primary mouse hepatocytes. This analysis showed that, in hepatocytes, signal transduction from IL-1 beta via p38MAPK to MK2 is characterized by strong signal amplification. Quantification of p38MAPK and MK2 revealed that, in hepatocytes, at maximum, 11.3% of p38MAPK molecules and 36.5% of MK2 molecules are activated in response to IL-1 beta. The mathematical model was experimentally validated by employing phosphatase inhibitors and the p38MAPK inhibitor SB203580. Model simulations predicted an IC50 of 1-1.2 mu M for SB203580 in hepatocytes. In silico analyses and experimental validation demonstrated that the kinase activity of p38(MAPK) determines signal amplitude, whereas phosphatase activity affects both signal amplitude and duration. p38(MAPK) and MK2 concentrations and responsiveness toward IL-1 beta were quantitatively compared between hepatocytes and macrophages. In macrophages, the absolute p38(MAPK) and MK2 concentration was significantly higher. Finally, in line with experimental observations, the mathematical model predicted a significantly higher half-maximal effective concentration for IL-1 beta-induced pathway activation in macrophages compared with hepatocytes, underscoring the importance of cell type-specific differences in pathway regulation.	[Kulawik, Andreas; Ehlting, Christian; Albrecht, Ute; Haeussinger, Dieter; Bode, Johannes G.] Heinrich Heine Univ, Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany; [Engesser, Raphael; Raue, Andreas; Timmer, Jens] Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany; [Klingmueller, Ursula] German Canc Res Ctr, Div Syst Biol Signal Transduct, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Physiol Chem, D-30625 Hannover, Germany; [Engesser, Raphael; Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Schanzlestr 18, D-79104 Freiburg, Germany	Heinrich Heine University Dusseldorf; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School; University of Freiburg	Bode, JG (corresponding author), Heinrich Heine Univ, Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	Johannes.Bode@med.uni-duesseldorf.de	Ehlting, Christian/AAI-3791-2020; Klingmüller, Ursula/G-8477-2013; Gaestel, Matthias/A-6560-2013	Ehlting, Christian/0000-0003-0103-1856; Klingmüller, Ursula/0000-0001-9845-3099; Gaestel, Matthias/0000-0002-4944-4652	Virtual Liver Network - German Federal Ministry of Education and Research (BmBF); collaborative research center - Deutsche Forschungsgemeinschaft	Virtual Liver Network - German Federal Ministry of Education and Research (BmBF)(Federal Ministry of Education & Research (BMBF)); collaborative research center - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was mainly supported by the Virtual Liver Network funded by the German Federal Ministry of Education and Research (BmBF) and in part by the collaborative research center SFB 974 funded by the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht U, 2007, CELL SIGNAL, V19, P1866, DOI 10.1016/j.cellsig.2007.04.007; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bode JG, 2001, BIOL CHEM, V382, P1447, DOI 10.1515/BC.2001.178; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Ehlting C, 2016, J HEPATOL, V64, P380, DOI 10.1016/j.jhep.2015.08.012; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Espelin CW, 2010, MOL BIOSYST, V6, P1956, DOI 10.1039/c002848g; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Frantz S, 2002, NAT REV DRUG DISCOV, V1, P253, DOI 10.1038/nrd785; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Grubelnik V, 2009, BIOPHYS CHEM, V143, P132, DOI 10.1016/j.bpc.2009.04.009; Hahn B, 2013, J PROTEOME RES, V12, P637, DOI 10.1021/pr3007232; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Hendriks BS, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-23; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Ligeti E, 2012, ACTA PHYSIOL, V204, P469, DOI 10.1111/j.1748-1716.2012.02414.x; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Mavropoulos A, 2013, AUTOIMMUN REV, V12, P580, DOI 10.1016/j.autrev.2012.10.019; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074335; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; SEGLEN PO, 1973, EXP CELL RES, V76, P25, DOI 10.1016/0014-4827(73)90414-X; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6291	6302		10.1074/jbc.M117.775023	http://dx.doi.org/10.1074/jbc.M117.775023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28223354	hybrid, Green Published			2022-12-26	WOS:000399538700023
J	Stalnecker, CA; Erickson, JW; Cerione, RA				Stalnecker, Clint A.; Erickson, Jon W.; Cerione, Richard A.			Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; RAT-LIVER GLUTAMINASE; PHOSPHATE ACTIVATION; BPTES INHIBITION; CELL BIOLOGY; METABOLISM; CANCER; MECHANISM; GROWTH; GLUTAMINOLYSIS	The first step in glutamine catabolism is catalysis by the mitochondrial enzyme glutaminase, with a specific isoform, glutaminase C (GAC), being highly expressed in cancer cells. GAC activation requires the formation of homotetramers, promoted by anionic allosteric activators such as inorganic phosphate. This leads to the proper orientation of a flexible loop proximal to the dimer-dimer interface that is essential for catalysis (i.e. the "activation loop"). A major class of allosteric inhibitors of GAC, with the prototype being bis-2-(5-phenylacetamido-1,2,4-thiadiazol- 2-yl) ethyl sulfide (BPTES) and the related molecule CB-839, binds to the activation loop and induces the formation of an inactive tetramer (two inhibitors bound per active tetramer). Here we describe a direct readout for monitoring the dynamics of the activation loop of GAC in response to these allosteric inhibitors, as well as allosteric activators, through the substitution of phenylalanine at position 327 with tryptophan (F327W). The tryptophan fluorescence of the GAC(F327W) mutant undergoes a marked quenching upon the binding of BPTES or CB-839, yielding titration profiles that make it possible to measure the binding affinities of these inhibitors for the enzyme. Allosteric activators like phosphate induce the opposite effect (i.e. fluorescence enhancement). These results describe direct readouts for the binding of the BPTES class of allosteric inhibitors as well as for inorganic phosphate and related activators of GAC, which should facilitate screening for additional modulators of this important metabolic enzyme.	[Stalnecker, Clint A.; Erickson, Jon W.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Stalnecker, Clint A.] Albright Coll, Dept Chem & Biochem, Reading, PA 19612 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.; Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Stalnecker, Clint/0000-0002-0570-4416	NIGMS; National Institutes of Health Grants [R01 GM040654, R01 GM047458]; NCI; National Institutes of Health National Research Service Award Predoctoral Fellowship [F31 CA180650]; NATIONAL CANCER INSTITUTE [R01CA201402, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R35GM122575, R01GM040654] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01 GM040654 and R01 GM047458 (to R.A.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NCI, National Institutes of Health National Research Service Award Predoctoral Fellowship F31 CA180650. Present address: Dept. of Chemistry and Biochemistry, Albright College, Reading, PA 19612.	Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V174, P82, DOI 10.1016/0003-9861(76)90326-X; DARMAUN D, 1986, AM J PHYSIOL, V251, pE117, DOI 10.1152/ajpendo.1986.251.1.E117; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hartwick EW, 2012, J ENZYM INHIB MED CH, V27, P861, DOI 10.3109/14756366.2011.622272; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; HUANG YZ, 1976, ENZYME, V21, P408; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Krall AS, 2015, NAT CELL BIOL, V17, P1515, DOI 10.1038/ncb3278; Laake JH, 1999, NEUROSCIENCE, V88, P1137, DOI 10.1016/S0306-4522(98)00298-X; Li YX, 2016, J BIOL CHEM, V291, P20900, DOI 10.1074/jbc.M116.720268; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Lukey MJ, 2013, FUTURE MED CHEM, V5, P1685, DOI 10.4155/fmc.13.130; Matre P, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.3763.3763; McDermott LA, 2016, BIOORGAN MED CHEM, V24, P1819, DOI 10.1016/j.bmc.2016.03.009; McDonald CJ, 2015, NEUROCHEM INT, V88, P10, DOI 10.1016/j.neuint.2014.12.003; MCGIVAN J, 1985, EUR J BIOCHEM, V148, P323, DOI 10.1111/j.1432-1033.1985.tb08842.x; Moller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074783; Newcomb R.W., 2002, U.S. Pat., Patent No. 6451828; PATEL M, 1984, BIOCHEM J, V220, P583, DOI 10.1042/bj2200583; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Shukla K, 2012, J MED CHEM, V55, P10551, DOI 10.1021/jm301191p; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Thomas AG, 2014, BIOCHEM BIOPH RES CO, V443, P32, DOI 10.1016/j.bbrc.2013.11.043; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zimmermann SC, 2016, ACS MED CHEM LETT, V7, P520, DOI 10.1021/acsmedchemlett.6b00060	39	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6095	6107		10.1074/jbc.M116.758219	http://dx.doi.org/10.1074/jbc.M116.758219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES4XE	28196863	Green Published, hybrid			2022-12-26	WOS:000399538700008
J	Dauner, K; Eid, W; Raghupathy, R; Presley, JF; Zha, XH				Dauner, Kristin; Eid, Walaa; Raghupathy, Riya; Presley, John F.; Zha, Xiaohui			mTOR complex 1 activity is required to maintain the canonical endocytic recycling pathway against lysosomal delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; endocytosis; endosomal sorting complexes required for transport (ESCRT); lysosome; membrane recycling; mTOR complex (mTORC); receptor recycling; transferrin; Hrs	MEMBRANE; AUTOPHAGY; TRANSPORT; METABOLISM; CELLS	The plasma membrane of mammalian cells undergoes constitutive endocytosis, endocytic sorting, and recycling, which delivers nutrients to the lysosomes. The receptors, along with membrane lipids, are normally returned to the plasma membrane to sustain this action. It is not known, however, whether this process is influenced by metabolic conditions. Here we report that endocytic recycling requires active mechanistic target of rapamycin (aka mammalian target of rapamycin) (mTORC1), a master metabolic sensor. Upon mTORC1 inactivation, either by starvation or by inhibitor, recycling receptors and plasma membrane lipids, such as transferrin receptors and sphingomyelin, are delivered to the lysosomes. This lysosomal targeting is independent of canonical autophagy: both WT and Atg5(-/-) mouse embryonic fibroblasts responded similarly. Furthermore, we identify hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), an endosomal sorting complexes required for transport (ESCORT-0) component, as a downstream target of mTORC1. Hrs requires mTORC1 activity to maintain its protein expression level. Silencing Hrs without decreasing mTORC1 activity is sufficient to target transferrin and sphingomyelin to the lysosomes. It is thus evident that the canonical recycling pathway is under the regulation of mTORC1 and likely most predominant in proliferating cells where mTORC1 is highly active.	[Dauner, Kristin; Raghupathy, Riya; Zha, Xiaohui] Univ Ottawa, Chron Dis Program, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Eid, Walaa; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada; [Presley, John F.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McGill University	Zha, XH (corresponding author), Ottawa Hosp, Res Inst, Chron Dis Program, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	xzha@ohri.ca			Canadian Institutes of Health Research [MOP-130453]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-130453. The authors declare that they have no conflicts of interest with the contents of this article.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Dobzinski N, 2015, CELL REP, V12, P1876, DOI 10.1016/j.celrep.2015.08.026; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Giordano F, 2011, P NATL ACAD SCI USA, V108, P11906, DOI 10.1073/pnas.1103381108; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim J, 2011, CELL CYCLE, V10, P1337, DOI 10.4161/cc.10.9.15291; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mueller M, 2015, ELIFE, V4, DOI 10.7554/eLife.07736; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RUTLEDGE EA, 1991, J BIOL CHEM, V266, P21125; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	24	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5737	5747		10.1074/jbc.M116.771451	http://dx.doi.org/10.1074/jbc.M116.771451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28196862	Green Published, hybrid			2022-12-26	WOS:000398813200012
J	Oakley, RH; Busillo, JM; Cidlowski, JA				Oakley, Robert H.; Busillo, John M.; Cidlowski, John A.			Cross-talk between the glucocorticoid receptor and MyoD family inhibitor domain-containing protein provides a new mechanism for generating tissue-specific responses to glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; gene regulation; glucocorticoid; glucocorticoid receptor; phosphorylation; MyoD family inhibitor domain-containing protein	GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; NUCLEAR-LOCALIZATION; PHOSPHORYLATION; INTERACT; MATURATION; DISEASE; CELLS; SEQUESTRATION; RESISTANCE	Glucocorticoids are primary stress hormones that regulate many physiological processes, and synthetic derivatives of these molecules are widely used in the clinic. The molecular factors that govern tissue specificity of glucocorticoids, however, are poorly understood. The actions of glucocorticoids are mediated by the glucocorticoid receptor (GR). To discover new proteins that interact with GR and modulate its function, we performed a yeast two-hybrid assay. The MyoD family inhibitor domain-containing protein (MDFIC) was identified as a binding partner for GR. MDFIC associated with GR in the cytoplasm of cells, and treatment with glucocorticoids resulted in the dissociation of the GR-MDFIC complex. To investigate the function of the GR-MDFIC interaction, we performed a genome-wide microarray in intact and MDFIC-deficient A549 cells that were treated with glucocorticoids. A large cohort of genes was differentially regulated by GR depending on the presence or absence of MDFIC. These gene changes were strongly associated with inflammation, and glucocorticoid regulation of the inflammatory response was altered in MDFIC-deficient cells. At a molecular level, the interaction of MDFIC with GR altered the phosphorylation status of the receptor. We demonstrate in COS-1 cells that changes in receptor phosphorylation underlie the ability of MDFIC to regulate the transcriptional activity of GR. Finally, we show that GR directly represses the MDFIC gene, revealing a negative feedback loop by which glucocorticoids limit MDFIC activity. These findings identify a new binding partner for cytoplasmic GR that modulates the receptor transcriptome and contributes to the tissue-specific actions of glucocorticoids.	[Oakley, Robert H.; Busillo, John M.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, NIH, Dept Hlth & Human Serv, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	Intramural Research Program of the NIEHS, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090079, ZIAES090057, ZICES102445] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; GOROVITS R, 1994, P NATL ACAD SCI USA, V91, P4786, DOI 10.1073/pnas.91.11.4786; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Gu L, 2009, IMMUNOL LETT, V123, P179, DOI 10.1016/j.imlet.2009.03.010; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Kusano S, 2015, VIROLOGY, V486, P219, DOI 10.1016/j.virol.2015.09.020; Kusano S, 2010, BIOCHEM BIOPH RES CO, V396, P608, DOI 10.1016/j.bbrc.2010.04.111; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Lamberts SWJ, 1996, STEROIDS, V61, P157, DOI 10.1016/0039-128X(96)00005-0; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; LIGGINS GC, 1976, AM J OBSTET GYNECOL, V126, P931, DOI 10.1016/0002-9378(76)90680-3; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Miracle X, 2008, J PERINAT MED, V36, P191, DOI 10.1515/JPM.2008.032; NATHANIELSZ PW, 1978, Q J EXP PHYSIOL CMS, V63, P211, DOI 10.1113/expphysiol.1978.sp002436; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Peffer ME, 2014, MOL CELL BIOL, V34, P2611, DOI 10.1128/MCB.01121-13; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ren RQ, 2012, ENDOCRINOLOGY, V153, P5346, DOI 10.1210/en.2012-1563; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Scoltock AB, 2007, CELL DEATH DIFFER, V14, P840, DOI 10.1038/sj.cdd.4402071; Snider L, 2005, MOL CELL BIOL, V25, P5061, DOI 10.1128/MCB.25.12.5061-5072.2005; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; te Pas MFW, 2000, MOL BIOL REP, V27, P87, DOI 10.1023/A:1007120921064; Thebault S, 2001, CURR PROTEIN PEPT SC, V2, P155, DOI 10.2174/1389203013381143; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Wang Q, 2007, J MOL BIOL, V367, P630, DOI 10.1016/j.jmb.2007.01.020; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007; Young TM, 2003, MOL CELL BIOL, V23, P6373, DOI 10.1128/MCB.23.18.6373-6384.2003; Zhou J, 2008, MOL ENDOCRINOL, V22, P1521, DOI 10.1210/me.2007-0273	54	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5825	5844		10.1074/jbc.M116.758888	http://dx.doi.org/10.1074/jbc.M116.758888			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223352	hybrid, Green Published			2022-12-26	WOS:000398813200019
J	Arnold, T; Brinkley-Rubinstein, L; Chan, PA; Perez-Brumer, A; Bologna, ES; Beauchamps, L; Johnson, K; Mena, L; Nunn, A				Arnold, Trisha; Brinkley-Rubinstein, Lauren; Chan, Philip A.; Perez-Brumer, Amaya; Bologna, Estefany S.; Beauchamps, Laura; Johnson, Kendra; Mena, Leandro; Nunn, Amy			Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi	PLOS ONE			English	Article							PREVENT HIV-INFECTION; NEW-YORK-CITY; TRANSGENDER WOMEN; CASE-MANAGEMENT; YOUNG MEN; SEX; HEALTH; BARRIERS; BLACK; ACCEPTABILITY	Pre-exposure prophylaxis (PrEP) is a biomedical intervention that can reduce rates of HIV transmission when taken once daily by HIV-negative individuals. Little is understood about PrEP uptake and retention in care among the populations most heavily impacted by the HIV epidemic, particularly among young men who have sex with men (YMSM) in the Deep South. Therefore, this study explored the structural, social, behavioral, and clinical factors that affect PrEP use and retention in care among YMSM in Jackson, Mississippi. Thirty MSM who were prescribed PrEP at an outpatient primary care clinic were interviewed and included 23 men who had been retained in PrEP care and seven who had not been retained. The mean age of participants was 26.6 years. Most (23) participants were African American. Major factors affecting PrEP use and retention in PrEP care included 1) structural factors such as cost and access to financial assistance for medications and clinical services; 2) social factors such as stigma and relationship status; 3) behavioral factors including sexual risk behaviors; and 4) clinical factors such as perceived and actual side effects. Many participants also discussed the positive spillover effects of PrEP use and reported that PrEP had a positive impact on their health. Four of the seven individuals who had not been retained re-enrolled in PrEP care after completing their interviews, suggesting that case management and ongoing outreach can enhance retention in PrEP care. Interventions to enhance retention in PrEP care among MSM in the Deep South will be most effective if they address the complex structural, social, clinical, and behavioral factors that influence PrEP uptake and retention in PrEP care.	[Arnold, Trisha; Bologna, Estefany S.; Beauchamps, Laura; Mena, Leandro] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Arnold, Trisha; Bologna, Estefany S.] Jackson State Univ, Jackson, MS 39217 USA; [Brinkley-Rubinstein, Lauren] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA; [Brinkley-Rubinstein, Lauren] Univ N Carolina, Ctr Hlth Equity Res, Chapel Hill, NC USA; [Chan, Philip A.; Nunn, Amy] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Chan, Philip A.; Nunn, Amy] Miriam Hosp, Providence, RI 02906 USA; [Perez-Brumer, Amaya] Columbia Univ, Dept Sociomed Sci, New York, NY USA; [Johnson, Kendra] Mississippi Dept Hlth, Jackson, MS USA; [Nunn, Amy] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA	University of Mississippi; University of Mississippi Medical Center; Jackson State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Columbia University; Brown University	Arnold, T (corresponding author), Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA.; Arnold, T (corresponding author), Jackson State Univ, Jackson, MS 39217 USA.	tarnold@umc.edu	Perez-Brumer, Amaya/AAF-6336-2021	Chan, Philip/0000-0003-0964-5895; Perez-Brumer, Amaya/0000-0003-2441-4358	Gilead Sciences [K23AI096923, K01AA020228]; Lifespan/Tufts/Brown Center for AIDS Research - National Institute of Allergy And Infectious Diseases [P30AI042853]; Brown Initiative in HIV and AIDS Clinical Research for Minority Communities [R25MH083620]; UCLA HIV/AIDS, Substance Abuse and Trauma Training Program (HA-STTP) [R25DA035692]; HIV and Other Infectious Consequences of Substance Abuse [T32DA013911]; Lifespan/Brown Criminal Justice Research Program on HIV and Substance Use [R23DA037190, R25-DA037190-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH109371, R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); Lifespan/Tufts/Brown Center for AIDS Research - National Institute of Allergy And Infectious Diseases; Brown Initiative in HIV and AIDS Clinical Research for Minority Communities; UCLA HIV/AIDS, Substance Abuse and Trauma Training Program (HA-STTP); HIV and Other Infectious Consequences of Substance Abuse; Lifespan/Brown Criminal Justice Research Program on HIV and Substance Use; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	PH received funding from Gilead Sciences, K23AI096923, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8525338. AN received funding from Gilead Sciences, K01AA020228, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8499170. PH received funding from Lifespan/Tufts/Brown Center for AIDS Research funded by the National Institute of Allergy And Infectious Diseases, P30AI042853, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8685871. AN received funding from Lifespan/Tufts/Brown Center for AIDS Research funded by the National Institute of Allergy And Infectious Diseases, P30AI042853, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8685871. LB's efforts are supported by The Brown Initiative in HIV and AIDS Clinical Research for Minority Communities, R25MH083620, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8296333. LB efforts are supported by UCLA HIV/AIDS, Substance Abuse and Trauma Training Program (HA-STTP), R25DA035692, http://www.ha-sttp.com/pdf/HA-STTP_Recruitment_Flyer_2015.pdf. LB efforts are supported by HIV and Other Infectious Consequences of Substance Abuse, T32DA013911, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8871700. LB efforts are supported by Lifespan/Brown Criminal Justice Research Program on HIV and Substance Use, R23DA037190, http://grantome.com/grant/NIH/R25-DA037190-02. TA efforts are supported by The Brown Initiative in HIV and AIDS Clinical Research for Minority Communities, R25MH083620, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8296333. EB efforts are supported by The Brown Initiative in HIV and AIDS Clinical Research for Minority Communities, R25MH083620, http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8296333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Bush S, 2016, ASM ICAAC RACIAL CHA; Centers for Disease Control and Prevention, 2015, EPIDEMIOLOGY OF HIV; Centers for Disease Control and Prevention, 2013, DIAGNOSES OF HIV INF; Centers for Disease Control and Prevention, 2015, HIV SURVEILLANCE MEN; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V68, P439, DOI 10.1097/QAI.0000000000000479; Cunningham CO, 2007, AIDS PATIENT CARE ST, V21, P177, DOI 10.1089/apc.2006.103; Cunningham WE, 2008, J NATL MED ASSOC, V100, P840, DOI 10.1016/S0027-9684(15)31379-1; Gengiah TN, 2014, INT J CLIN PHARM-NET, V36, P70, DOI 10.1007/s11096-013-9861-1; Gilmore HJ, 2013, AIDS PATIENT CARE ST, V27, P560, DOI 10.1089/apc.2013.0116; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant R, 2014, LANCET INFECT DIS, P1; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Haire BG, 2015, HIV AIDS-RES PALLIAT, V7, P241, DOI 10.2147/HIV.S72419; Herron PD, 2016, LGBT HEALTH, V3, P103, DOI 10.1089/lgbt.2014.0114; Juliet Corbin AS, 2008, BASICS OF QUALITATIV; Katz MH, 2001, ANN INTERN MED, V135, P557, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00006; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Marcus JL, 2016, CURR HIV-AIDS REP, V13, P116, DOI 10.1007/s11904-016-0308-x; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; McCallister S, 2016, ASM HIV 1 SEROCONVER; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mississippi State Department of Health, 2006, REPORT NO 1545 861X; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mutchler MG, 2015, AIDS PATIENT CARE ST, V29, P490, DOI 10.1089/apc.2015.0002; Oldenburg C, 2015, STATE LEVEL STRUCTUR; Parker S, 2015, AIDS PATIENT CARE ST, V29, P639, DOI 10.1089/apc.2015.0186; Perez-Figueroa RE, 2015, AIDS EDUC PREV, V27, P112, DOI 10.1521/aeap.2015.27.2.112; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rosenberg Eli Samuel, 2016, JMIR Public Health Surveill, V2, pe22, DOI 10.2196/publichealth.5684; Rucinski KB, 2013, AIDS BEHAV, V17, P2180, DOI 10.1007/s10461-013-0443-y; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; US Public Health Service Center for Disease Control and Prevention, PREEXPOSURE PROPHYLA; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	45	119	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172354	10.1371/journal.pone.0172354	http://dx.doi.org/10.1371/journal.pone.0172354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5QV	28222118	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800053
J	Garcia-Garcia, M; Via, M; Zarnowiec, K; SanMiguel, I; Escera, C; Clemente, IC				Garcia-Garcia, Manuel; Via, Marc; Zarnowiec, Katarzyna; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.			COMT and DRD2/ANKK-1 gene-gene interaction account for resetting of gamma neural oscillations to auditory stimulus-driven attention	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; DOPAMINE-RECEPTOR GENE; WORKING-MEMORY; PARKINSONS-DISEASE; DRD2 POLYMORPHISMS; PREFRONTAL CORTEX; INVOLUNTARY ATTENTION; COGNITIVE FUNCTION; HUMAN STRIATUM; BAND ACTIVITY	Attention capture by potentially relevant environmental stimuli is critical for human survival, yet it varies considerably among individuals. A large series of studies has suggested that attention capture may depend on the cognitive balance between maintenance and manipulation of mental representations and the flexible switch between goal-directed representations and potentially relevant stimuli outside the focus of attention; a balance that seems modulated by a prefrontostriatal dopamine pathway. Here, we examined inter-individual differences in the cognitive control of attention through studying the effects of two single nucleotide polymorphisms regulating dopamine at the prefrontal cortex and the striatum (i.e., COMTMet108/158Val and ANKK1/DRD2TaqIA) on stimulus-driven attention capture. Healthy adult participants (N = 40) were assigned to different groups according to the combination of the polymorphisms COMTMet108/158Val and ANKK1/DRD2TaqIA, and were instructed to perform on a well-established distraction protocol. Performance in individuals with a balance between prefrontal dopamine display and striatal receptor density was slowed down by the occurrence of unexpected distracting events, while those with a rather unbalanced dopamine activity were able maintain task performance with no time delay, yet at the expense of a slightly lower accuracy. This advantage, associated to their distinct genetic profiles, was paralleled by an electrophysiological mechanism of phase-resetting of gamma neural oscillation to the novel, distracting events. Taken together, the current results suggest that the epistatic interaction between COMTVal108/158Met and ANKK1/DRD2 TaqIa genetic polymorphisms lies at the basis of stimulus-driven attention capture.	[Garcia-Garcia, Manuel; Via, Marc; Zarnowiec, Katarzyna; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.] Univ Barcelona, Inst Neurosci, Barcelona, Spain; [Garcia-Garcia, Manuel; Via, Marc; Zarnowiec, Katarzyna; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.] Univ Barcelona, Dept Clin Psychol & Psychobiol, Brainlab Cognit Neurosci Res Grp, Barcelona, Spain; [Via, Marc; SanMiguel, Iria; Escera, Carles; Clemente, Immaculada C.] IR SJD, Barcelona, Spain	University of Barcelona; University of Barcelona	Escera, C (corresponding author), Univ Barcelona, Inst Neurosci, Barcelona, Spain.; Escera, C (corresponding author), Univ Barcelona, Dept Clin Psychol & Psychobiol, Brainlab Cognit Neurosci Res Grp, Barcelona, Spain.; Escera, C (corresponding author), IR SJD, Barcelona, Spain.	cescera@ub.edu	Escera, Carles/A-8658-2010; SanMiguel, Iria/C-2909-2013; Clemente, I Concepcion/H-5399-2013; Via, Marc/L-6511-2014	Escera, Carles/0000-0001-8203-2951; SanMiguel, Iria/0000-0002-7462-8621; Clemente, I Concepcion/0000-0003-0728-0925; Via, Marc/0000-0002-9966-9921	Spanish Ministry of Economy and Knowledge [PSI 2015-63664-P]; Catalan Government [SGR2014-177]; ICREA Academia Distinguished Professorship	Spanish Ministry of Economy and Knowledge(Spanish Government); Catalan Government; ICREA Academia Distinguished Professorship(ICREA)	This work was supported by grants from the Spanish Ministry of Economy and Knowledge (PSI 2015-63664-P), the Catalan Government (SGR2014-177), and the ICREA Academia Distinguished Professorship awarded to CE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2016, NEUROSCI LETT, V610, P86, DOI 10.1016/j.neulet.2015.10.018; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Berryhill ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055862; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Birkas E, 2006, BRAIN RES, V1103, P150, DOI 10.1016/j.brainres.2006.03.021; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CAMPS M, 1989, NEUROSCIENCE, V28, P275, DOI 10.1016/0306-4522(89)90179-6; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Debener S, 2003, NEUROREPORT, V14, P683, DOI 10.1097/00001756-200304150-00005; do Vale S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104869; Dominguez-Borras J, 2009, CEREB CORTEX, V19, P1521, DOI 10.1093/cercor/bhn188; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Escera C, 2003, EUR J NEUROSCI, V18, P2408, DOI 10.1046/j.1460-9568.2003.02937.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Garcia-Garcia M, 2011, NEUROIMAGE, V56, P1641, DOI 10.1016/j.neuroimage.2011.02.053; Garcia-Garcia M, 2010, NEUROIMAGE, V49, P1038, DOI 10.1016/j.neuroimage.2009.07.059; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Good P, 2005, PERMUTATION PARAMETR; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kaplan F, 2007, FRONT NEUROSCI-SWITZ, V1, P225, DOI 10.3389/neuro.01.1.1.017.2007; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Komek K, 2012, EUR J NEUROSCI, V36, P2146, DOI 10.1111/j.1460-9568.2012.08071.x; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lehikoinen P, 1998, MOL PSYCHIATR, V3, P256; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Reuter M, 2006, INT J NEUROPSYCHOPH, V9, P155, DOI 10.1017/S1461145705005419; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tian T, 2013, J NEUROSCI, V33, P17519, DOI 10.1523/JNEUROSCI.2163-13.2013; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Yordanova J, 1997, INT J NEUROSCI, V92, P241, DOI 10.3109/00207459708986404; Yordanova J, 2000, NEUROREPORT, V11, P2325, DOI 10.1097/00001756-200007140-00051; Yordanova J, 2001, CLIN NEUROPHYSIOL, V112, P1096, DOI 10.1016/S1388-2457(01)00524-7; Zhao FS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17996	58	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172362	10.1371/journal.pone.0172362	http://dx.doi.org/10.1371/journal.pone.0172362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222164	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800054
J	Ikeda, S; Yamashita, H; Kondo, S; Inoue, K; Morishima, S; Koike, K				Ikeda, Shota; Yamashita, Hiroshi; Kondo, Shi-nobu; Inoue, Ken; Morishima, Shin-ya; Koike, Kazuhiko			Zooxanthellal genetic varieties in giant clams are partially determined by species-intrinsic and growth-related characteristics	PLOS ONE			English	Article							CORAL-ALGAL SYMBIOSES; SYMBIODINIUM-MICROADRIATICUM; TRIDACNA-GIGAS; EARLY ONTOGENY; CLADE-D; DIVERSITY; ECOLOGY; REEF; SPECIFICITY; IDENTITY	Giant clams ( tridacnine shellfishes) are large bivalves that inhabit tropical and subtropical waters and harbor the symbiotic microalgae zooxanthellae, which consist of diverse phylotypes ( clades). Each clade exhibits unique physiological characteristics, and the cladal composition may influence the host's survival and its ability to tolerate environmental changes. Using quantitative PCR ( qPCR) assays, we investigated the zooxanthellal genetic clades in Tridacna crocea ( n = 93) and Tridacna squamosa ( n = 93). These two clam species were artificially bred and maintained for an extended time period under an equivalent environment in an outdoor pond. Results showed that T. crocea had a simpler cladal composition and with an apparent dominance of clade A, whereas multiple clades were present in T. squamosa. The zooxanthellae clade A is known to occur in other zooxanthellae-bearing animals that inhabit shallow waters, which is consistent to the shallow water habitat preference of T. crocea. Interestingly, in larger individuals of T. squamosa, the main zooxanthellal clade was C rather than A. The mechanism underlying the dominance of clade C in the larger T. squamosa has not yet been clarified. However, the additional photosynthates supplied by clade C may be preferable for growing clams, as is observed in corals. The cladal composition of giant clams has previously been reported to be primarily controlled by environmental factors. However, our experiments subjected different clam species to the same environmental conditions, and our results suggested that species-intrinsic and/ or growth-related processes may also influence the cladal composition.	[Ikeda, Shota; Morishima, Shin-ya; Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan; [Yamashita, Hiroshi] Japan Fisheries Res & Educ Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Kondo, Shi-nobu; Inoue, Ken] Okinawa Prefectural Fisheries Res & Extens Ctr, Itoman, Okinawa, Japan	Hiroshima University; Japan Fisheries Research & Education Agency (FRA)	Koike, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan.	kazkoike@hiroshima-u.ac.jp	Koike, Kazuhiko/A-3392-2019	Yamashita, Hiroshi/0000-0002-3909-5073; Kazuhiko, Koike/0000-0001-5380-5839	Grants-in-Aid for Scientific Research [26660164] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Baillie BK, 2000, J PHYCOL, V36, P1153, DOI 10.1046/j.1529-8817.2000.00010.x; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BECKVAR N, 1981, AQUACULTURE, V24, P21, DOI 10.1016/0044-8486(81)90040-5; Belda-Baillie CA, 1999, J EXP MAR BIOL ECOL, V241, P207, DOI 10.1016/S0022-0981(99)00079-9; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Carlos AA, 2000, MAR ECOL PROG SER, V195, P93, DOI 10.3354/meps195093; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; DeBoer TS, 2012, MAR ECOL PROG SER, V444, P117, DOI 10.3354/meps09413; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FITT WK, 1986, AQUACULTURE, V55, P5, DOI 10.1016/0044-8486(86)90051-7; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Glynn PW, 2001, B MAR SCI, V69, P79; Gomez-Cabrera del C. M, 2008, CORAL REEFS, V27, P219; Hirose E, 2006, MAR BIOL, V148, P551, DOI 10.1007/s00227-005-0119-x; Ishikura M, 2004, MAR BIOTECHNOL, V6, P378, DOI 10.1007/s10126-004-1800-7; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; KLUMPP DW, 1994, MAR ECOL PROG SER, V107, P147, DOI 10.3354/meps107147; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; Lee SY, 2015, EUR J PHYCOL, V50, P155, DOI 10.1080/09670262.2015.1018336; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Neo ML, 2015, BIOL CONSERV, V181, P111, DOI 10.1016/j.biocon.2014.11.004; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sison MP, 2003, THESIS; STREAMER M, 1988, SYMBIOSIS, V6, P237; Suwa R, 2008, MAR ECOL PROG SER, V361, P129, DOI 10.3354/meps07372; TAYLOR DL, 1969, J PHYCOL, V5, P336, DOI 10.1111/j.1529-8817.1969.tb02623.x; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Team R Core, 2014, R LANG ENV STAT COMP; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; TRENCH RK, 1981, BIOL BULL-US, V161, P180, DOI 10.2307/1541117; Winters G, 2009, MAR ECOL PROG SER, V384, P107, DOI 10.3354/meps08036; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z	44	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172285	10.1371/journal.pone.0172285	http://dx.doi.org/10.1371/journal.pone.0172285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212387	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424700028
J	Baah-Acheamfour, M; Bourque, CPA; Meng, FR; Swift, DE				Baah-Acheamfour, Mark; Bourque, Charles P. -A.; Meng, Fan-Rui; Swift, D. Edwin			Incorporating interspecific competition into species-distribution mapping by upward scaling of small-scale model projections to the landscape	PLOS ONE			English	Article							CLIMATE-CHANGE; BIOTIC INTERACTIONS; ACADIAN FOREST; NOVA-SCOTIA; DYNAMICS; IMPACTS; KAPPA	There are a number of overarching questions and debate in the scientific community concerning the importance of biotic interactions in species distribution models at large spatial scales. In this paper, we present a framework for revising the potential distribution of tree species native to the Western Ecoregion of Nova Scotia, Canada, by integrating the long-term effects of interspecific competition into an existing abiotic-factor-based definition of potential species distribution (PSD). The PSD model is developed by combining spatially explicit data of individualistic species' response to normalized incident photosynthetically active radiation, soil water content, and growing degree days. A revised PSD model adds biomass output simulated over a 100-year timeframe with a robust forest gap model and scaled up to the landscape using a forestland classification technique. To demonstrate the method, we applied the calculation to the natural range of 16 target tree species as found in 1,240 provincial forest-inventory plots. The revised PSD model, with the long-term effects of interspecific competition accounted for, predicted that eastern hemlock (Tsuga canadensis), American beech (Fagus grandifolia), white birch (Betula papyrifera), red oak (Quercus rubra), sugar maple (Acer saccharum), and trembling aspen (Populus tremuloides) would experience a significant decline in their original distribution compared with balsam fir (Abies balsamea), black spruce (Picea mariana), red spruce (Picea rubens), red maple (Acer rubrum L.), and yellow birch (Betula alleghaniensis). True model accuracy improved from 64.2% with original PSD evaluations to 81.7% with revised PSD. Kappa statistics slightly increased from 0.26 (fair) to 0.41 (moderate) for original and revised PSDs, respectively.	[Baah-Acheamfour, Mark] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Bourque, Charles P. -A.; Meng, Fan-Rui] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada; [Swift, D. Edwin] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Canadian Wood Fibre Ctr, Fredericton, NB, Canada	University of Alberta; University of New Brunswick; Natural Resources Canada; Canadian Forest Service	Bourque, CPA (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada.	cbourque@unb.ca			Natural Sciences and Engineering Research Council of Canada Discovery Grant; Natural Science and Engineering Council of Canada in the form of an Discovery Grant	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Council of Canada in the form of an Discovery Grant	Funding for this work was provided by a Natural Sciences and Engineering Research Council of Canada Discovery Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for funding provided by the Natural Science and Engineering Council of Canada in the form of an Discovery Grant to Dr. Charles P.-A. Bourque under the direction of the Faculty of Forestry and Environmental Management, University of New Brunswick, New Brunswick, Canada. We are also grateful to the Nova Scotia Department of Natural Resources for providing forest-inventory data in order that we may assess the accuracy of the predicted PSD surfaces against independent field-based information.	Afkhami ME, 2014, ECOL LETT, V17, P1265, DOI 10.1111/ele.12332; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Baah-Acheamfour M, 2017, DRYAD DIGITAL REPOSI; Baah-Acheamfour M, 2013, CAN J FOREST RES, V43, P517, DOI 10.1139/cjfr-2012-0476; BETTS MG, 2002, FOREST CHRON, V18, P123; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Bourque CPA, 2008, FOREST CHRON, V84, P553, DOI 10.5558/tfc84553-4; Bourque CPA, 2000, CAN J FOREST RES, V30, P1179, DOI 10.1139/cjfr-30-8-1179; BURNS RM, 1990, SILVICS N AM, V2, P1; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Clark JS, 2011, GLOBAL CHANGE BIOL, V17, P1834, DOI 10.1111/j.1365-2486.2010.02380.x; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Environment Canada, 2012, NAT CLIM DAT INF ARC; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gravel D, 2010, AM NAT, V176, P289, DOI 10.1086/655426; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hassan QK, 2009, REMOTE SENS-BASEL, V1, P393, DOI 10.3390/rs1030393; Kaye TN, 2009, 22 S CURR THREAT CAL; Kienast F., 2007, LANDSC SER, P1; Kohyama T, 2005, ECOL RES, V20, P305, DOI 10.1007/s11284-005-0046-9; Kozlowski TT, 1968, WATER DEFICITS PLANT, VI; Loo J, 2003, FOREST CHRON, V79, P462, DOI 10.5558/tfc79462-3; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Nova Scotia Department of Natural Resources (NS DNR), 2012, 201201 NS DNR; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Rowe JS, 1972, DEP ENV CANADA PUBL, V1300; Shugart H.H., 1984, THEORY FOREST DYNAMI; SVENNING JC, 2014, ECOGRAPHY, V37, P1198, DOI DOI 10.1111/J.1600-0587.2013.00574.X; Urban D. L., 1990, VERSATILE MODEL SIMU; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350	41	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171487	10.1371/journal.pone.0171487	http://dx.doi.org/10.1371/journal.pone.0171487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207782	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500031
J	Gotschy, A; Bauer, WR; Winter, P; Nordbeck, P; Rommel, E; Jakob, PM; Herold, V				Gotschy, Alexander; Bauer, Wolfgang R.; Winter, Patrick; Nordbeck, Peter; Rommel, Eberhard; Jakob, Peter M.; Herold, Volker			Local versus global aortic pulse wave velocity in early atherosclerosis: An animal study in ApoEi(-/-) mice using ultrahigh field MRI	PLOS ONE			English	Article							E-DEFICIENT MOUSE; IN-VIVO; ARTERIAL STIFFNESS; APOLIPOPROTEIN-E; KNOCKOUT MICE; 17.6 TESLA; DISEASE; LESIONS; EVENTS; MODELS	Increased aortic stiffness is known to be associated with atherosclerosis and has a predictive value for cardiovascular events. This study aims to investigate the local distribution of early arterial stiffening due to initial atherosclerotic lesions. Therefore, global and local pulse wave velocity (PWV) were measured in ApoE(-/-) and wild type (WT) mice using ultrahigh field MRI. For quantification of global aortic stiffness, a new multi-point transit-time (TT) method was implemented and validated to determine the global PWV in the murine aorta. Local aortic stiffness was measured by assessing the local PWV in the upper abdominal aorta, using the flow/area (QA) method. Significant differences between age matched ApoE(-/-) and WT mice were determined for global and local PWV measurements (global PWV: ApoE(-/-) : 2.7 +/- 0.2m/s vs WT: 2.1 +/- 0.2m/s, P<0.03; local PWV: ApoE(-/-) : 2.9 0.2m/s vs WT: 2.2 0.2m/s, P<0.03). Within the WT mouse group, the global PWV correlated well with the local PWV in the upper abdominal aorta (R-2 = 0.75, P<0.01), implying a widely uniform arterial elasticity. In ApoE/-animals, however, no significant correlation between individual local and global PWV was present (R-2 = 0.07, P = 0.53), implying a heterogeneous distribution of vascular stiffening in early atherosclerosis. The assessment of global PWV using the new multi-point TT measurement technique was validated against a pressure wire measurement in a vessel phantom and showed excellent agreement. The experimental results demonstrate that vascular stiffening caused by early atherosclerosis is unequally distributed over the length of large vessels. This finding implies that assessing heterogeneity of arterial stiffness by multiple local measurements of PWV might be more sensitive than global PWV to identify early atherosclerotic lesions.	[Gotschy, Alexander; Winter, Patrick; Rommel, Eberhard; Jakob, Peter M.; Herold, Volker] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Gotschy, Alexander] Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland; [Gotschy, Alexander] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Gotschy, Alexander] ETH, Zurich, Switzerland; [Bauer, Wolfgang R.; Nordbeck, Peter] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Gotschy, Alexander; Nordbeck, Peter; Jakob, Peter M.] Univ Wurzburg, Deutsch Zentrum Herzinsuffizienz, Comprehens Heart Failure Ctr, Wurzburg, Germany	University of Wurzburg; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wurzburg; University of Wurzburg	Gotschy, A (corresponding author), Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany.; Gotschy, A (corresponding author), Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland.; Gotschy, A (corresponding author), Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.; Gotschy, A (corresponding author), ETH, Zurich, Switzerland.	alexander.gotschy@usz.ch	Nordbeck, Peter/D-4771-2018	Nordbeck, Peter/0000-0002-2560-4068; Bauer, Wolfgang/0000-0002-4652-7313	German Research Foundation [SFB 688]; Federal Ministry of Education and Research [BM BF01 E01504]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (www.dfg.de) research grant SFB 688 (TP B5, Z) to WRB and the Federal Ministry of Education and Research (www.bmbf.de) research grant BM BF01 E01504 to WRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Briley-Saebo KC, 2012, J AM COLL CARDIOL, V59, P616, DOI 10.1016/j.jacc.2011.10.881; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230; Fayad ZA, 1998, CIRCULATION, V98, P1541, DOI 10.1161/01.CIR.98.15.1541; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; Itskovich VV, 2003, MAGNET RESON MED, V49, P381, DOI 10.1002/mrm.10360; Klug G, 2011, METHODS MOL BIOL, V771, P407, DOI 10.1007/978-1-61779-219-9_21; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Makowski MR, 2012, ATHEROSCLEROSIS, V222, P43, DOI 10.1016/j.atherosclerosis.2012.01.008; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Ohyama Y, 2016, EUR HEART J-CARD IMG, V17, P1044, DOI 10.1093/ehjci/jev332; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Teixeira R, 2016, EUR HEART J-CARD IMG, V17, P233, DOI 10.1093/ehjci/jev287; Vulliemoz S, 2002, MAGNET RESON MED, V47, P649, DOI 10.1002/mrm.10100; Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04; Zhao XD, 2009, J MAGN RESON IMAGING, V30, P286, DOI 10.1002/jmri.21846	28	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171603	10.1371/journal.pone.0171603	http://dx.doi.org/10.1371/journal.pone.0171603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207773	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500042
J	Lea, T; Kolstee, J; Lambert, S; Ness, R; Hannan, S; Holt, M				Lea, Toby; Kolstee, Johann; Lambert, Sarah; Ness, Ross; Hannan, Siobhan; Holt, Martin			Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia	PLOS ONE			English	Article							SUBSTANCE-ABUSE TREATMENT; COGNITIVE-BEHAVIORAL INTERVENTIONS; AMPHETAMINE-TYPE STIMULANTS; SEXUAL RISK BEHAVIORS; DEPENDENCE SCALE SDS; BISEXUAL MEN; DRUG-USE; CRYSTAL METHAMPHETAMINE; TREATMENT PROGRAM; HIV-INFECTION	Gay and bisexual men (GBM) report higher rates of methamphetamine use compared to heterosexual men, and thus have a heightened risk of developing problems from their use. We examined treatment outcomes among GBM clients receiving outpatient counseling at a lesbian, gay, bisexual, transgender and intersex (LGBTI)-specific, harm reduction treatment service in Sydney, Australia. GBM receiving treatment for methamphetamine use from ACON's Substance Support Service between 2012-15 (n = 101) were interviewed at treatment commencement, and after 4 sessions (n = 60; follow-up 1) and 8 sessions (n = 32; follow-up 2). At each interview, clients completed measures of methamphetamine use and dependence, other substance use, injecting risk practices, psychological distress and quality of life. The median age of participants was 41 years and 56.4% identified as HIV-positive. Participants attended a median of 5 sessions and attended treatment for a median of 112 days. There was a significant reduction in the median days of methamphetamine use in the previous 4 weeks between baseline (4 days), follow-up 1 (2 days) and follow-up 2 (2 days; p =.001). There was a significant reduction in the proportion of participants reporting methamphetamine dependence between baseline (92.1%), follow-up 1 (78.3%) and follow-up 2 (71.9%, p<.001). There were also significant reductions in psychological distress (p<.001), and significant improvements in quality of life (p<.001). Clients showed reductions in methamphetamine use and improved psychosocial functioning over time, demonstrating the potential effectiveness of a LGBTI-specific treatment service.	[Lea, Toby; Holt, Martin] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Kolstee, Johann; Lambert, Sarah; Ness, Ross; Hannan, Siobhan] ACON, Sydney, NSW, Australia	University of New South Wales Sydney	Lea, T (corresponding author), UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia.	toby.lea@unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Lea, Toby/0000-0001-5942-0550	Australian Government Department of Health; NSW Ministry of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); NSW Ministry of Health	The Centre for Social Research in Health receives funding from the Australian Government Department of Health. ACON receives funding from the NSW Ministry of Health, and the Substance Support Service is funded by the Australian Government Department of Health. The funding bodies had no involvement in the conduct of this study or the preparation of this manuscript. The authors received no specific funding for this work.	[Anonymous], [No title captured]; Australian Institute of Health and Welfare, 2014, DRUG STAT SER, V28; Australian Institute of Health and Welfare, 2015, DRUG TREATM SER, V25; Baker A, 2005, ADDICTION, V100, P367, DOI 10.1111/j.1360-0443.2005.01002.x; Baker A, 2001, ADDICTION, V96, P1279, DOI 10.1046/j.1360-0443.2001.96912797.x; Bariola, 2015, CLOSER LOOK PRIVATE; Bourne A, 2015, SEX TRANSM INFECT, V91, P564, DOI 10.1136/sextrans-2015-052052; Brecht ML, 2005, J SUBST ABUSE TREAT, V29, P295, DOI 10.1016/j.jsat.2005.08.012; Brensilver M, 2013, DRUG ALCOHOL REV, V32, P449, DOI 10.1111/dar.12048; Center for Substance Abuse Treatment, 2012, PROV INTR SUBST AB T; Cochran BN, 2006, J SUBST ABUSE TREAT, V30, P135, DOI 10.1016/j.jsat.2005.11.009; Cochran BN, 2007, SUBST USE MISUSE, V42, P161, DOI 10.1080/10826080601094207; Courtney KE, 2014, DRUG ALCOHOL DEPEN, V143, P11, DOI 10.1016/j.drugalcdep.2014.08.003; Findlay J., 2015, GAY NEWS NETWOR 0817; Flentje A, 2015, J CONSULT CLIN PSYCH, V83, P325, DOI 10.1037/a0038724; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Green AI, 2006, CULT HEALTH SEX, V8, P317, DOI 10.1080/13691050600783320; Halkitis PN., 2014, CURR ADDICT REP, V1, P206, DOI [10.1007/s40429-014-0023-x, DOI 10.1007/S40429-014-0023-X]; Hayes S.C., 2011, ACCEPTANCE COMMITMEN; Hillhouse MP, 2007, ADDICTION, V102, P84, DOI 10.1111/j.1360-0443.2007.01768.x; Hopwood M, 2015, INT J DRUG POLICY, V26, P210, DOI 10.1016/j.drugpo.2014.10.013; Hurley M, 2009, CULT HEALTH SEX, V11, P597, DOI 10.1080/13691050902721853; Jaffe A, 2007, EXP CLIN PSYCHOPHARM, V15, P301, DOI 10.1037/1064-1297.15.3.301; Jenner L, 2008, TREATMENT APPROACHES; Kenny P, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-3; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lea T, 2016, INT J DRUG POLICY, V29, P66, DOI 10.1016/j.drugpo.2016.01.003; Lee NK, 2008, DRUG ALCOHOL REV, V27, P309, DOI 10.1080/09595230801919494; Lombardi E., 2007, J LGBT HLTH RES, V3, P37, DOI DOI 10.1300/J463V03N02_; Matheson A., 2010, DRUG USE DEPENDENCE; Matthews CR, 2006, J MENT HLTH COUNS, V28, P111, DOI DOI 10.17744/mehc.28.2.9m35re2aj9l28j47; McCann E, 2014, INT J MENT HEALTH NU, V23, P118, DOI 10.1111/inm.12018; McKetin R, 2006, DRUG ALCOHOL DEPEN, V85, P198, DOI 10.1016/j.drugalcdep.2006.04.007; McKetin R, 2013, DRUG ALCOHOL REV, V32, P80, DOI 10.1111/j.1465-3362.2012.00471.x; Vu NTT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19273; Peck JA, 2005, J URBAN HEALTH, V82, pI100, DOI 10.1093/jurban/jti029; Pennay AE, 2009, DRUG ALCOHOL REV, V28, P636, DOI 10.1111/j.1465-3362.2009.00074.x; Prestage G, 2007, DRUG ALCOHOL DEPEN, V91, P260, DOI 10.1016/j.drugalcdep.2007.06.009; Prestage G, 2009, SEX HEALTH, V6, P310, DOI 10.1071/SH09014; Rawstorne P, 2007, ARCH SEX BEHAV, V36, P646, DOI 10.1007/s10508-007-9206-z; Reback Cathy, 1997, SOCIAL CONSTRUCTION; Reback CJ, 2014, ADDICT BEHAV, V39, P1286, DOI 10.1016/j.addbeh.2011.11.029; Reback CJ, 2003, AIDS CARE, V15, P775, DOI 10.1080/09540120310001618621; Ritter A., 2012, DRUG POLICY MODELLIN, V23; Roxburgh A., 2015, DRUG RELATED HOSP ST; Roxburgh A, 2016, INT J DRUG POLICY, V28, P76, DOI 10.1016/j.drugpo.2015.11.005; Schmidt S, 2006, EUR J PUBLIC HEALTH, V16, P420, DOI 10.1093/eurpub/cki155; Scott N, 2015, ADDICTION, V110, P120, DOI 10.1111/add.12740; Scott S., 2015, ABC NEWS; Senreich E, 2009, J GAY LESBIAN MENT H, V13, P145, DOI 10.1080/19359700902870072; Senreich E, 2010, SUBST USE MISUSE, V45, P1077, DOI 10.3109/10826080903483855; Shoptaw S, 2005, DRUG ALCOHOL DEPEN, V78, P125, DOI 10.1016/j.drugalcdep.2004.10.004; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; SLAVIN S, 2004, CONTEMP DRUG PROBL, V31, P425; Topp L, 1997, ADDICTION, V92, P839, DOI 10.1046/j.1360-0443.1997.9278397.x; Vosburgh HW, 2012, AIDS BEHAV, V16, P1394, DOI 10.1007/s10461-011-0131-8; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566	57	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172560	10.1371/journal.pone.0172560	http://dx.doi.org/10.1371/journal.pone.0172560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207902	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500148
J	Peng, YF; Yang, H; Ye, Q; Zhou, HM; Zheng, MH; Shi, YH				Peng, Yuanfei; Yang, Hua; Ye, Qing; Zhou, Houming; Zheng, Minhua; Shi, Yinghong			Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC-CANCER; CYTOREDUCTIVE SURGERY; RAT MODEL; CARCINOMATOSIS; PNEUMOPERITONEUM; CHEMOTHERAPY; LAPAROSCOPY; CELLS; FEASIBILITY	Background The increasing use of laparoscopic surgery for advanced gastrointestinal cancer raises concerns about intra-peritoneal tumor spread. Prevention of peritoneal dissemination is extremely important but a preventive modality is lacking. The aim of this study was to examine a novel approach (hyperthermic CO2 insufflation, HT-CO2) for preventing peritoneal dissemination during laparoscopic surgery. Methods A peritoneal dissemination model was established in Balb/c nu/nu mice by intraperitoneal injection of human colon cancer cells (SW1116, 1x10(6)). The mice (n = 48) were subsequently randomized into two groups and subjected to hyperthermic CO2 (43 degrees C, > 95% humidity, HT-CO2 group) or standard normothermic CO2 (21 degrees C, < 1% relative humidity, NTCO2 group) insufflation for 3 hours. The mice were sacrificed 28 days later. The peritoneal dissemination was quantitatively analyzed by counting and weighing the peritoneal nodules. The port sites and ascites volume were measured. The peritoneal damage of HT-CO2 was histologically examined with light microscopy and scanning electron microscopy. Intraabdominal adhesions were evaluated 4 weeks later. Results The number of peritoneal nodules in the HT-CO2 group was significantly less than that in the NT-CO2 group (10.21 +/- 3.72 vs. 67.12 +/- 5.49, P< 0.01). The mean weight of metastatic tumors in the HT-CO2 group was significantly lower than that in the NT-CO2 group (0.31 +/- 0.10g vs. 2.16 +/- 0.31g, P< 0.01). Massive ascites were found in the NT-CO2 group while significantly less ascites developed in HT-CO2-treated mice (8.26 +/- 0.31ml vs. 1.27 +/- 0.28ml, P< 0.01). No port-site metastases were detected in the HT-CO2 group while the incidence of the NT-CO2 group was 12.5% (3/24). HT-CO2 subjection resulted in slight peritoneal damage; the peritoneum returned to normal within five days. No adhesions formed after HT-CO2 treatment. Conclusions HT-CO2 can suppress peritoneal dissemination of colon cancer cells and only causes slight and transient peritoneal damage. HT-CO2 may serve as a promising adjuvant treatment for preventing peritoneal dissemination in laparoscopic resection of advanced colorectal cancer.	[Peng, Yuanfei; Yang, Hua; Shi, Yinghong] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai, Peoples R China; [Peng, Yuanfei; Yang, Hua; Shi, Yinghong] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Ye, Qing] Fujian Med Univ, Dept Gastrointestinal Tumor Surg, Fujian Prov Tumor Hosp, Fujian, Peoples R China; [Zhou, Houming; Zheng, Minhua] Shanghai Jiao Tong Univ, Dept Gen Surg, Shanghai Minimally Invas Surg Ctr, Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai, Peoples R China	Fudan University; Fujian Medical University; Shanghai Jiao Tong University	Shi, YH (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai, Peoples R China.; Shi, YH (corresponding author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China.	peng.yuanfei@zs-hospital.sh.cn			National Natural Science Foundation of China [81572296]; Young Backbone talents Training Foundation of the Fujian healthcare system [2013-ZQN-JC-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Backbone talents Training Foundation of the Fujian healthcare system	This work was supported by the grants from National Natural Science Foundation of China (No. 81572296), the Young Backbone talents Training Foundation of the Fujian healthcare system (No.2013-ZQN-JC-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2016, WORLD J GASTROENTERO, V22, P718, DOI 10.3748/wjg.v22.i2.718; Aoyagi T, 2014, WORLD J GASTROENTERO, V20, P12493, DOI 10.3748/wjg.v20.i35.12493; ASAO T, 1994, CANCER LETT, V78, P57, DOI 10.1016/0304-3835(94)90031-0; Baratti D, 2014, DIS COLON RECTUM, V57, P858, DOI 10.1097/DCR.0000000000000149; Barchi LC, 2016, ABCD-ARQ BRAS CIR DI, V29, P117, DOI 10.1590/0102-6720201600020013; Gupta A, 2002, ANZ J SURG, V72, P254, DOI 10.1046/j.1445-2197.2002.02385.x; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hirabayashi Y, 2002, SURG ENDOSC, V16, P864, DOI 10.1007/s00464-001-9121-7; Jung DH, 2015, SURG ENDOSCOPY; Kim IY, 2015, ONCOTARGETS THER, V8, P3441, DOI 10.2147/OTT.S93420; Kudo M, 2004, INT J HYPERTHER, V20, P441, DOI 10.1080/02656730310001637352; Lee SW, 1998, SURG ENDOSC-ULTRAS, V12, P828, DOI 10.1007/s004649900723; Loggie BW, 2015, ONCOLOGY-NY, V29, P515; Marz L, 2015, GASTROENTEROL REP, V3, P298, DOI 10.1093/gastro/gov044; Mutter D, 1999, SURG ENDOSC, V13, P365, DOI 10.1007/s004649900991; Peng YF, 2008, ONCOL REP, V19, P73; Peng YF, 2009, J SURG RES, V151, P40, DOI 10.1016/j.jss.2008.03.039; Pestieau SR, 2000, DIS COLON RECTUM, V43, P1341, DOI 10.1007/BF02236627; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Sloothaak DAM, 2014, EJSO-EUR J SURG ONC, V40, P1453, DOI 10.1016/j.ejso.2014.06.012; Sloothaak DAM, 2014, BRIT J CANCER, V111, P1112, DOI 10.1038/bjc.2014.369; Sugarbaker PH, 2005, CANCER INVEST, V23, P155, DOI 10.1081/CNV-200050478; Takeuchi H, 2004, SURG ENDOSC, V18, P1795, DOI 10.1007/s00464-003-9322-3; Volz J, 1999, CANCER, V86, P770, DOI 10.1002/(SICI)1097-0142(19990901)86:5<770::AID-CNCR11>3.0.CO;2-3; Zayyan KS, 2003, SURG ENDOSC, V17, P273, DOI 10.1007/s00464-002-8824-8; Zhou HM, 2012, ASIAN PAC J CANCER P, V13, P117, DOI 10.7314/APJCP.2012.13.1.117	26	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172097	10.1371/journal.pone.0172097	http://dx.doi.org/10.1371/journal.pone.0172097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207849	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500083
J	Sergeant, K; Printz, B; Gutsch, A; Behr, M; Renaut, J; Hausman, JF				Sergeant, Kjell; Printz, Bruno; Gutsch, Annelie; Behr, Marc; Renaut, Jenny; Hausman, Jean-Francois			Didehydrophenylalanine, an abundant modification in the beta subunit of plant polygalacturonases	PLOS ONE			English	Article							CELL-WALL; CONFORMATIONAL-CHANGES; PROTEOMIC ANALYSIS; PROTEIN; DOMAIN; BINDING; PECTIN; ATLAS; PHOSPHORYLATION; IDENTIFICATION	The structure and the activity of proteins are often regulated by transient or stable post-translational modifications (PTM). Different from well-known, abundant modifications such as phosphorylation and glycosylation some modifications are limited to one or a few proteins across a broad range of related species. Although few examples of the latter type are known, the evolutionary conservation of these modifications and the enzymes responsible for their synthesis suggest an important physiological role. Here, the first observation of a new, fold-directing PTM is described. During the analysis of alfalfa cell wall proteins a -2Da mass shift was observed on phenylalanine residues in the repeated tetrapeptide FxxY of the beta-subunit of polygalacturonase. This modular protein is known to be involved in developmental and stress-responsive processes. The presence of this modification was confirmed using in-house and external datasets acquired by different commonly used techniques in proteome studies. Based on these analyses it was found that all identified phenylalanine residues in the sequence FxxY of this protein were modified to a, alpha,beta-didehydro-Phe (Delta Phe). Besides showing the reproducible identification of Delta Phe in different species arguments that substantiate the fold-determining role of Delta Phe are given.	[Sergeant, Kjell; Printz, Bruno; Gutsch, Annelie; Behr, Marc; Renaut, Jenny; Hausman, Jean-Francois] LIST, Environm Res & Innovat ERIN Dept, Esch Sur Alzette, Luxembourg; [Printz, Bruno; Behr, Marc] Catholic Univ Louvain, Earth & Life Inst Agron, Grp Rech Physiol Vegetale Louvain la Neuve, Louvain La Neuve, Belgium; [Gutsch, Annelie] Univ Hasselt, Ctr Environm Sci, Environm Biol, Diepenbeek, Belgium	Luxembourg Institute of Science & Technology; Universite Catholique Louvain; Hasselt University	Sergeant, K (corresponding author), LIST, Environm Res & Innovat ERIN Dept, Esch Sur Alzette, Luxembourg.	kjell.sergeant@list.lu	sergeant, kjell/M-9789-2015; Behr, Marc/J-5582-2019; Hausman, Jean-Francois/AAB-6208-2020	sergeant, kjell/0000-0003-2071-3510; Hausman, Jean-Francois/0000-0001-6103-7817; Behr, Marc/0000-0002-5907-9185; Renaut, Jenny/0000-0002-0450-3866	National Research Fund (FNR) Luxembourg: FNR Project CANCAN [C13/SR/5774202]; FNR Project CADWALL [INTER/FWO/13/14]	National Research Fund (FNR) Luxembourg: FNR Project CANCAN(Luxembourg National Research Fund); FNR Project CADWALL(Luxembourg National Research Fund)	The authors thank for financial support obtained through the National Research Fund (FNR) Luxembourg: FNR Project CANCAN C13/SR/5774202 and FNR Project CADWALL INTER/FWO/13/14.	Abdallah C, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-37; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Buczek AM, 2011, MAGN RESON CHEM, V49, P343, DOI 10.1002/mrc.2753; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Chun JP, 1997, PHYSIOL PLANTARUM, V101, P283, DOI 10.1034/j.1399-3054.1997.1010205.x; Crisma M, 1999, J AM CHEM SOC, V121, P3272, DOI 10.1021/ja9842114; De Vijlder T, 2015, J CHROMATOGR B, V974, P48, DOI 10.1016/j.jchromb.2014.10.024; Decreux A, 2006, PHYTOCHEMISTRY, V67, P1068, DOI 10.1016/j.phytochem.2006.03.009; DELLAPENNA D, 1990, PLANT PHYSIOL, V94, P1882, DOI 10.1104/pp.94.4.1882; Ding XP, 2009, PLANTA, V230, P149, DOI 10.1007/s00425-009-0929-z; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; ENGLISH ML, 1978, BIOCHEM BIOPH RES CO, V85, P780, DOI 10.1016/0006-291X(78)91229-9; Fermani S, 2012, J BIOL CHEM, V287, P21372, DOI 10.1074/jbc.M112.350355; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Francin-Allami M, 2015, PROTEOMICS, V15, P2296, DOI 10.1002/pmic.201400485; Gavrilov Y, 2015, J PHYS CHEM LETT, V6, P3572, DOI 10.1021/acs.jpclett.5b01588; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Gupta M, 2011, BIOPOLYMERS, V95, P161, DOI 10.1002/bip.21561; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; Herbert B, 2003, PROTEOMICS, V3, P826, DOI 10.1002/pmic.200300414; Liu HH, 2014, PLANT CELL ENVIRON, V37, P1144, DOI 10.1111/pce.12223; Maathuis FJM, 2008, PLANT SIGNAL BEHAV, V3, P1011, DOI 10.4161/psb.6721; McLachlin DT, 2003, ANAL CHEM, V75, P6826, DOI 10.1021/ac034989u; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Miernyk JA, 2013, J PROTEOMICS, V89, P265, DOI 10.1016/j.jprot.2013.05.013; Nguyen-Kim H, 2015, PROTEOMICS; O'Connor SE, 1998, CHEM BIOL, V5, P427, DOI 10.1016/S1074-5521(98)90159-4; O'Rourke JA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1718-7; Park J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00412; Printz B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00237; Rink R, 2007, APPL ENVIRON MICROB, V73, P1792, DOI 10.1128/AEM.02350-06; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P8433, DOI 10.1073/pnas.92.18.8433; Siodlak D, 2015, AMINO ACIDS, V47, P1, DOI 10.1007/s00726-014-1846-4; Spadoni S, 2006, PLANT PHYSIOL, V141, P557, DOI 10.1104/pp.106.076950; Sultana N, 2015, PLANT CELL ENVIRON, V38, P375, DOI 10.1111/pce.12267; Twomey D, 2002, ANTON LEEUW INT J G, V82, P165, DOI 10.1023/A:1020660321724; VANNESS BG, 1980, J BIOL CHEM, V255, P710; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Verdonk JC, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00279; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V; Walley JW, 2016, SCIENCE, V353, P814, DOI 10.1126/science.aag1125; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wei H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00315; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuyama PM, 2015, MOL GENET GENOMICS; ZHENG LS, 1992, PLANT CELL, V4, P1147, DOI 10.1105/tpc.4.9.1147	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171990	10.1371/journal.pone.0171990	http://dx.doi.org/10.1371/journal.pone.0171990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207764	gold, Green Published			2022-12-26	WOS:000394424500068
J	Stefanko, A; Thiede, C; Ehninger, G; Simons, K; Grzybek, M				Stefanko, Adam; Thiede, Christian; Ehninger, Gerhard; Simons, Kai; Grzybek, Michal			Lipidomic approach for stratification of acute myeloid leukemia patients	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; THROUGHPUT SHOTGUN LIPIDOMICS; ACUTE MYELOGENOUS LEUKEMIA; MASS-SPECTROMETRY; BREAST-CANCER; GLUCOSYLCERAMIDE SYNTHASE; SPHINGOLIPID METABOLISM; MULTIDRUG-RESISTANCE; CELL-PROLIFERATION; SIGNALING PATHWAYS	The pathogenesis and progression of many tumors, including hematologic malignancies is highly dependent on enhanced lipogenesis. De novo fatty-acid synthesis permits accelerated proliferation of tumor cells by providing membrane components but these may also alter physicochemical properties of lipid bilayers, which can impact signaling or even increase drug resistance in cancer cells. Cancer type-specific lipid profiles would permit us to monitor and interpret actual effects of lipid changes, potential fingerprints of individual tumors to be explored as diagnostic markers. We have used the shotgun MS approach to identify lipid patterns in different types of acute myeloid leukemia (AML) patients that either show no karyotype change or belong to t(8; 21) or inv 16 types. Differences in lipidomes of t(8; 21) and inv(16) patients, as compared to AML patients without karyotype change, presented mostly as substantial modulation of ceramide/sphingolipid synthesis. Furthermore, between the t(8; 21) and all other patients we observed significant changes in physicochemical membrane properties. These were related to a marked alteration in lipid saturation levels. The discovered differences in lipid profiles of various AML types improve our understanding of the pathobiochemical pathways involved and may serve in the development of diagnostic tools.	[Stefanko, Adam; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Thiede, Christian; Ehninger, Gerhard] Univ Hosp TU Dresden, Med Clin & Polyclin 1, Dresden, Germany; [Simons, Kai] Lipotype GmbH, Dresden, Germany; [Grzybek, Michal] Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Clin Carl Gustav Carus, Dresden, Germany; [Grzybek, Michal] German Ctr Diabet Res DZD eV, Neuherberg, Germany	Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Grzybek, M (corresponding author), Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Clin Carl Gustav Carus, Dresden, Germany.; Grzybek, M (corresponding author), German Ctr Diabet Res DZD eV, Neuherberg, Germany.	Michal.Grzybek@tu-dresden.de	; Grzybek, Michal/D-3802-2017	Simons, Kai/0000-0002-9231-9996; Grzybek, Michal/0000-0003-2083-0506; Thiede, Christian/0000-0003-1241-2048	German Federal Ministry of Education and Research grant	German Federal Ministry of Education and Research grant	The results of this research have been achieved using the German Federal Ministry of Education and Research grant to the German Center for Diabetes Research (DZD e.V.) (M.G.).	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Alo PL, 1999, TUMORI, V85, P35, DOI 10.1177/030089169908500108; Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Campanella R, 1992, J Neurosurg Sci, V36, P11; Casalou C, 2011, MOL CANCER RES, V9, P215, DOI 10.1158/1541-7786.MCR-10-0155; Corominas-Faja B, 2014, ONCOTARGET, V5, P8306, DOI 10.18632/oncotarget.2059; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; Funaki NO, 2001, ONCOL REP, V8, P527; Gosse G, 2015, LEUKEMIA RES, V39, P709, DOI 10.1016/j.leukres.2015.03.017; Gouaze V, 2005, CANCER RES, V65, P3861, DOI 10.1158/0008-5472.CAN-04-2329; Greer AH, 2013, J CELL PHYSIOL, V228, P2350, DOI 10.1002/jcp.24406; Hatzimichael E, 2013, AM J BLOOD RES, V3, P29; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; HORAN KL, 1994, FREE RADICAL BIO MED, V17, P587, DOI 10.1016/0891-5849(94)90098-1; Hou HA, 2014, LEUKEMIA, V28, P50, DOI 10.1038/leu.2013.236; Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kilbey A, 2008, CELL CYCLE, V7, P2333; Kilbey A, 2010, CANCER RES, V70, P5860, DOI 10.1158/0008-5472.CAN-10-0726; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Luczak M, 2012, J PROTEOMICS, V75, P5734, DOI 10.1016/j.jprot.2012.07.030; Luck SC, 2011, LEUKEMIA, V25, P1728, DOI 10.1038/leu.2011.154; Mardis ER, 2014, SEMIN HEMATOL, V51, P250, DOI 10.1053/j.seminhematol.2014.08.003; Marien E, 2015, INT J CANCER, V137, P1539, DOI 10.1002/ijc.29517; Martens JHA, 2010, FEBS LETT, V584, P2662, DOI 10.1016/j.febslet.2010.04.002; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; MEDES G, 1953, CANCER RES, V13, P27; Miljan EA, 2002, SCIENCE, V2002, P10; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Pullarkat V, 2015, CRIT REV ONCOL HEMAT, V95, P38, DOI 10.1016/j.critrevonc.2015.01.005; Ratajczak MZ, 2015, LEUKEMIA, V29, P1452, DOI 10.1038/leu.2015.66; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; SAKAI K, 1992, CARCINOGENESIS, V13, P579, DOI 10.1093/carcin/13.4.579; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Southam AD, 2015, CANCER RES, V75, P2530, DOI 10.1158/0008-5472.CAN-15-0202; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Tarasov K, 2014, MOL BIOSYST, V10, P1364, DOI 10.1039/c3mb70599d; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; Xie P, 2008, LEUKEMIA RES, V32, P475, DOI 10.1016/j.leukres.2007.07.006; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhao W, 2016, CANC RES; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	72	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0168781	10.1371/journal.pone.0168781	http://dx.doi.org/10.1371/journal.pone.0168781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207743	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500002
J	Azzollini, J; Pesenti, C; Ferrari, L; Fontana, L; Calvello, M; Peissel, B; Portera, G; Tabano, S; Carcangiu, ML; Riva, P; Miozzo, M; Manoukian, S				Azzollini, Jacopo; Pesenti, Chiara; Ferrari, Luca; Fontana, Laura; Calvello, Mariarosaria; Peissel, Bernard; Portera, Giorgio; Tabano, Silvia; Carcangiu, Maria Luisa; Riva, Paola; Miozzo, Monica; Manoukian, Siranoush			Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies	PLOS ONE			English	Article							BREAST-CANCER RISK; NATURAL GENE-THERAPY; POSITIVE FAMILIES; DETECTION RATES; FANCONI-ANEMIA; NEGATIVE WOMEN; WOMAN; PATIENT; DELETION; CARRIERS	In BRCA1/2 families, early-onset breast cancer (BrCa) cases may be also observed among non-carrier relatives. These women are considered phenocopies and raise difficult counselling issues concerning the selection of the index case and the residual risks estimate in negative family members. Few studies investigated the presence of potential genetic susceptibility factors in phenocopies, mainly focussing on BrCa-associated single-nucleotide polymorphisms. We hypothesized that, as for other Mendelian diseases, a revertant somatic mosaicism, resulting from spontaneous correction of a pathogenic mutation, might occur also in BRCA pedigrees. A putative low-level mosaicism in phenocopies, which has never been investigated, might be the causal factor undetected by standard diagnostic testing. We selected 16 non-carriers BrCa-affected from 15 BRCA1/2 families, and investigated the presence of mosaicism through MALDI-TOF mass spectrometry. The analyses were performed on available tumour samples (7 cases), blood leukocytes, buccal mucosa and urine samples (2 cases) or on blood only (7 cases). In one family (n. 8), real-time PCR was also performed to analyse the phenocopy and her healthy parents. On the 16 phenocopies we did not detect the family mutations neither in the tumour, expected to display the highest mutation frequency, nor in the other analysed tissues. In family 8, all the genotyping assays did not detect mosaicism in the phenocopy or her healthy parents, supporting the hypothesis of a de novo occurrence of the BRCA2 mutation identified in the proband. These results suggest that somatic mosaicism is not likely to be a common phenomenon in BRCA1/2 families. As our families fulfilled high-risk selection criteria, other genetic factors might be responsible for most of these cases and have a significant impact on risk assessment in BRCA1/2 families. Finally, we found a de novo BRCA2 mutation, suggesting that, although rare, this event should be taken into account in the evaluation of high-risk families.	[Azzollini, Jacopo; Calvello, Mariarosaria; Peissel, Bernard; Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Med Genet Unit, Milan, Italy; [Pesenti, Chiara; Fontana, Laura; Tabano, Silvia; Miozzo, Monica] Univ Milan, Dept Pathophysiol & Transplantat, Div Pathol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Ferrari, Luca; Portera, Giorgio; Riva, Paola] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Carcangiu, Maria Luisa] Fdn IRCCS Ist Nazl Tumori, Pathol Unit, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Miozzo, M (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Div Pathol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.	monica.miozzo@unimi.it	Pesenti, Chiara/AEO-4195-2022; Fontana, Laura/AAB-9869-2019; Azzollini, Jacopo/E-7134-2017; Riva, Paola/K-7871-2016; Peissel, Bernard/E-8187-2017; manoukian, siranoush/E-7132-2017; Calvello, Mariarosaria/AAM-8866-2020; Miozzo, Monica Rosa/AAC-6401-2022; Pesenti, Chiara/P-2031-2017	Fontana, Laura/0000-0001-9517-6997; Azzollini, Jacopo/0000-0002-9364-9778; Riva, Paola/0000-0001-6481-8467; Peissel, Bernard/0000-0001-9233-3571; manoukian, siranoush/0000-0002-6034-7562; Miozzo, Monica Rosa/0000-0002-6523-4575; Pesenti, Chiara/0000-0002-7277-1205; Ferrari, Luca/0000-0003-0103-2170	Fondazione IRCCS Istituto Nazionale dei Tumori	Fondazione IRCCS Istituto Nazionale dei Tumori	The study was financed by funds from Italian citizens who allocated the 5 x 1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale dei Tumori, according to Italian laws (INT-Institutional strategic projects "5 x 1000") to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was financed by funds from Italian citizens who allocated the 5 x 1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale dei Tumori, according to Italian laws (INT-Institutional strategic projects "5 x 1000") and to the initiative "Prove Aperte" (Filarmonica della Scala of Milan in collaboration with Unicredit Foundation) to SM. We thank Dr. Daniela Zaffaroni for her support as data manager in the study.	Azzollini J, 2016, EUR J INTERN MED, V32, P65, DOI 10.1016/j.ejim.2016.03.010; Diez O, 2010, BREAST CANCER RES TR, V121, P221, DOI 10.1007/s10549-009-0494-y; Edwards E, 2009, FAM CANCER, V8, P479, DOI 10.1007/s10689-009-9270-8; Evans DGR, 2013, CANCER EPIDEM BIOMAR, V22, P2269, DOI 10.1158/1055-9965.EPI-13-0316-T; Fischer C, 2012, CLIN GENET, V82, P478, DOI 10.1111/j.1399-0004.2011.01788.x; Friedman E, 2015, BRIT J CANCER, V112, P765, DOI 10.1038/bjc.2015.14; Garcia-Casado Z, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-134; Gronwald J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048462; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Hadiji-Abbes N, 2015, PATHOL BIOL, V63, P185, DOI 10.1016/j.patbio.2015.07.009; Hansen TVO, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-58; Harvey SL, 2011, BREAST CANCER RES TR, V130, P1057, DOI 10.1007/s10549-011-1733-6; Jonkman MF, 2009, NEW ENGL J MED, V360, P1680, DOI 10.1056/NEJMc0809896; Korde LA, 2011, BREAST CANCER RES TR, V125, P169, DOI 10.1007/s10549-010-0923-y; Kurian AW, 2011, J CLIN ONCOL, V29, P4505, DOI 10.1200/JCO.2010.34.4440; Kwiatkowski F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127363; Kwong A, 2011, FAM CANCER, V10, P233, DOI 10.1007/s10689-011-9429-y; Lai-Cheong JE, 2011, TRENDS MOL MED, V17, P140, DOI 10.1016/j.molmed.2010.11.003; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Mankad A, 2006, BLOOD, V107, P3084, DOI 10.1182/blood-2005-07-2638; Marshall M, 2009, CLIN GENET, V76, P427, DOI 10.1111/j.1399-0004.2009.01246.x; Nielsen HR, 2016, FAM CANC; Pearce M, 2010, NATURE METHODS APPL; Robson M, 2002, J MED GENET, V39, P126, DOI 10.1136/jmg.39.2.126; Rowan E, 2007, J MED GENET, V44; Smith A, 2007, J MED GENET, V44, P10, DOI 10.1136/jmg.2006.043091; Spurdle AB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0474-y; Tesoriero A, 1999, AM J HUM GENET, V65, P567, DOI 10.1086/302503; van der Luijt RB, 2001, J MED GENET, V38, P102, DOI 10.1136/jmg.38.2.102; Wada T, 2008, CURR OPIN ALLERGY CL, V8, P510, DOI 10.1097/ACI.0b013e328314b651	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171663	10.1371/journal.pone.0171663	http://dx.doi.org/10.1371/journal.pone.0171663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199346	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400041
J	Foster, E; Hawkins, A; Barton, KL; Stamp, E; Matthews, JNS; Adamson, AJ				Foster, Emma; Hawkins, Adrian; Barton, Karen L.; Stamp, Elaine; Matthews, John N. S.; Adamson, Ashley J.			Development of food photographs for use with children aged 18 months to 16 years: Comparison against weighed food diaries - The Young Person's Food Atlas (UK)	PLOS ONE			English	Article							PORTION SIZE; ACCURACY; SYSTEM	Traditional dietary assessment methods, used in the UK, such as weighed food diaries impose a large participant burden, often resulting in difficulty recruiting representative samples and underreporting of energy intakes. One approach to reducing the burden placed on the participant is to use portion size assessment tools to obtain an estimate of the amount of food consumed, removing the need to weigh all foods. An age range specific food atlas was developed for use in assessing children's dietary intakes. The foods selected and portion sizes depicted were derived from intakes recorded during the UK National Diet and Nutrition Surveys of children aged 1.5 to 16 years. Estimates of food portion sizes using the food atlas were compared against 4-day weighed intakes along with in-school/nursery observations, by the research team. Interviews were conducted with parents the day after completion of the diary, and for children aged 4 to 16 years, also with the child. Mean estimates of portion size consumed were within 7% of the weight of food recorded in the weighed food diary. The limits of agreement were wide indicating high variability of estimates at the individual level but the precision increased with increasing age. For children 11 years and over, agreement with weighed food diaries, was as good as that of their parents in terms of total weight of food consumed and of intake of energy and key nutrients. The age appropriate food photographs offer an alternative to weighed intakes for dietary assessment with children.	[Foster, Emma; Hawkins, Adrian; Stamp, Elaine; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Barton, Karen L.] Abertay Univ, Sch Sci Engn & Technol, Div Food & Drink, Dundee, Scotland; [Matthews, John N. S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; University of Abertay Dundee; Newcastle University - UK	Foster, E (corresponding author), Newcastle Univ, Inst Hlth & Soc, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	Emma.Foster@ncl.ac.uk		Adamson, Ashley/0000-0003-3735-2846; Barton, Karen/0000-0003-2074-005X	Food Standards Agency [N08027]; National Institutes for Health Research, Research Professorship; Medical Research Council [MR/K02325X/1B] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001, PDA/03/07/022] Funding Source: researchfish	Food Standards Agency; National Institutes for Health Research, Research Professorship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Food Standards Agency (project number N08027) funded the research, EF was PI on this project, EF, AH, KB, ES and JNSM all received funding as members of the project team. www.food.gov.uk. AJA is funded by a National Institutes for Health Research, Research Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski T, 2002, J AM DIET ASSOC, V102, P380, DOI 10.1016/S0002-8223(02)90088-X; Bates CJ, 2000, NATL DIET NUTR SURVE; Berg C, 1998, EUR J CLIN NUTR, V52, P663, DOI 10.1038/sj.ejcn.1600620; Black AE, 1996, P NUTR SOC, V56, p121A; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Foster E, 2008, BRIT J NUTR, V99, P175, DOI 10.1017/S000711450779390X; Foster E, 2008, BRIT J NUTR, V99, P185, DOI 10.1017/S0007114507791882; Foster E, 2014, J HUM NUTR DIET, V27, P18, DOI 10.1111/jhn.12127; Foster E, 2006, PUBLIC HEALTH NUTR, V9, P509, DOI 10.1079/PHN2005872; Frobisher C, 2003, J HUM NUTR DIET, V16, P181, DOI 10.1046/j.1365-277X.2003.00434.x; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Government CaL, 2007, IND DEPR 2007; Gregory J., 1995, NATIONAL DIET AND NU; Hernandez T, 2006, J FOOD COMPOS ANAL, V19, pS14, DOI 10.1016/j.jfca.2006.02.010; Holmes B, 2008, PUBLIC HEALTH NUTR, V11, P444, DOI 10.1017/S1368980007000559; Korkalo L, 2013, PUBLIC HEALTH NUTR, V16, P1558, DOI 10.1017/S1368980012003655; LIVINGSTONE MBE, 1990, BRIT MED J, V300, P708, DOI 10.1136/bmj.300.6726.708; LUCAS F, 1995, J HUM NUTR DIET, V8, P65, DOI 10.1111/j.1365-277X.1995.tb00296.x; Macmillan N. A., 1991, DETECTION THEORY USE; NELSON M, 1994, BRIT J NUTR, V72, P649, DOI 10.1079/BJN19940069; Nelson M, 1996, BRIT J NUTR, V76, P31, DOI 10.1079/BJN19960007; Nelson M, 1997, PHOTOGRAPHIC ATLAS F; Piaget J, 1974, THE CHILDS CONCEPTIO; Robinson F, 1997, J HUM NUTR DIET, V10, P117, DOI 10.1046/j.1365-277X.1997.00043.x; Shaffer D.R., 1999, DEV PSYCHOL CHILDHOO; Subar AF, 2010, J AM DIET ASSOC, V110, P55, DOI 10.1016/j.jada.2009.10.007; THANE CW, 2006, PUBLIC HLTH NUTR, V0009; Timon CM, 2011, P NUTR SOC, V70, pE51, DOI 10.1017/S0029665111000917; Turconi G, 2005, EUR J CLIN NUTR, V59, P923, DOI 10.1038/sj.ejcn.1602162; Vereecken CA, 2008, INT J OBESITY, V32, pS26, DOI 10.1038/ijo.2008.180	30	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169084	10.1371/journal.pone.0169084	http://dx.doi.org/10.1371/journal.pone.0169084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199319	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400005
J	Rodriguez-Martin, D; Sama, A; Perez-Lopez, C; Catala, A; Arostegui, JMM; Cabestany, J; Bayes, A; Alcaine, S; Mestre, B; Prats, A; Crespo, MC; Counihan, TJ; Browne, P; Quinlan, LR; OLaighin, G; Sweeney, D; Lewy, H; Azuri, J; Vainstein, G; Annicchiarico, R; Costa, A; Rodriguez-Molinero, A				Rodriguez-Martin, Daniel; Sama, Albert; Perez-Lopez, Carlos; Catala, Andreu; Moreno Arostegui, Joan M.; Cabestany, Joan; Bayes, Angels; Alcaine, Sheila; Mestre, Berta; Prats, Anna; Cruz Crespo, M.; Counihan, Timothy J.; Browne, Patrick; Quinlan, Leo R.; OLaighin, Gearoido; Sweeney, Dean; Lewy, Hadas; Azuri, Joseph; Vainstein, Gabriel; Annicchiarico, Roberta; Costa, Alberto; Rodriguez-Molinero, Alejandro			Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENTS; PHYSICAL-ACTIVITY; SYSTEM; MOTOR; IDENTIFICATION; QUESTIONNAIRE; ABNORMALITIES; FREQUENCY; SYMPTOM; SENSOR	Among Parkinson's disease (PD) symptoms, freezing of gait (FoG) is one of the most debilitating. To assess FoG, current clinical practice mostly employs repeated evaluations over weeks and months based on questionnaires, which may not accurately map the severity of this symptom. The use of a non-invasive system to monitor the activities of daily living (ADL) and the PD symptoms experienced by patients throughout the day could provide a more accurate and objective evaluation of FoG in order to better understand the evolution of the disease and allow for a more informed decision-making process in making adjustments to the patient's treatment plan. This paper presents a new algorithm to detect FoG with a machine learning approach based on Support Vector Machines (SVM) and a single tri-axial accelerometer worn at the waist. The method is evaluated through the acceleration signals in an outpatient setting gathered from 21 PD patients at their home and evaluated under two different conditions: first, a generic model is tested by using a leave-one-out approach and, second, a personalised model that also uses part of the dataset from each patient. Results show a significant improvement in the accuracy of the personalised model compared to the generic model, showing enhancement in the specificity and sensitivity geometric mean (GM) of 7.2%. Furthermore, the SVM approach adopted has been compared to the most comprehensive FoG detection method currently in use (referred to as MBFA in this paper). Results of our novel generic method provide an enhancement of 11.2% in the GM compared to the MBFA generic model and, in the case of the personalised model, a 10% of improvement with respect to the MBFA personalised model. Thus, our results show that a machine learning approach can be used to monitor FoG during the daily life of PD patients and, furthermore, personalised models for FoG detection can be used to improve monitoring accuracy.	[Rodriguez-Martin, Daniel; Sama, Albert; Perez-Lopez, Carlos; Catala, Andreu; Moreno Arostegui, Joan M.; Cabestany, Joan] Univ Politecn Cataluna, BarcelonaTech UPC, Tech Res Ctr Dependency Care & Autonomous Living, Vilanova I La Geltru, Spain; [Sama, Albert; Perez-Lopez, Carlos; Catala, Andreu; Moreno Arostegui, Joan M.; Cabestany, Joan; Rodriguez-Molinero, Alejandro] Sense4Care, Barcelona, Spain; [Bayes, Angels; Alcaine, Sheila; Mestre, Berta; Prats, Anna; Cruz Crespo, M.] Unidad Parkinson Trastornos Movimiento UParkinson, Barcelona, Spain; [Counihan, Timothy J.; Browne, Patrick] Natl Univ Ireland Galway, Sch Med, Galway, Ireland; [Quinlan, Leo R.; OLaighin, Gearoido; Sweeney, Dean; Rodriguez-Molinero, Alejandro] Natl Univ Ireland Galway, Dept Elect & Elect Engn, Galway, Ireland; [Lewy, Hadas; Azuri, Joseph; Vainstein, Gabriel] Maccabi Healthcare Serv, Tel Aviv, Israel; [Azuri, Joseph] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Annicchiarico, Roberta; Costa, Alberto] IRCCS Fdn Santa Lucia, Rome, Italy; [Rodriguez-Molinero, Alejandro] Consorci Sanitari Garraf, Clin Res Unit, Vilanova I La Geltru, Spain	Universitat Politecnica de Catalunya; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Tel Aviv University; Sackler Faculty of Medicine; IRCCS Santa Lucia	Rodriguez-Martin, D (corresponding author), Univ Politecn Cataluna, BarcelonaTech UPC, Tech Res Ctr Dependency Care & Autonomous Living, Vilanova I La Geltru, Spain.	daniel.rodriguez-martin@upc.edu	Cabestany, Joan/F-2281-2015; CATALA, Andreu/G-4038-2015; Quinlan, Leo R/N-4117-2014; Pérez López, Carlos/GSM-9311-2022; ÓLaighin, Gearóid/A-5239-2009; Costa, Alberto/AAA-7038-2019; ÓLaighin, Gearóid/AAC-2198-2019; Azuri, Joseph/ABD-5871-2021; Bayés, Àngels/AAB-3873-2019	Cabestany, Joan/0000-0002-6926-3322; Quinlan, Leo R/0000-0002-4011-6732; ÓLaighin, Gearóid/0000-0002-1885-814X; Azuri, Joseph/0000-0003-1049-9848; Catala, Andreu/0000-0001-8775-1955; Sweeney, Dean/0000-0002-9834-923X; Rodriguez Martin, Daniel/0000-0002-2598-6772; Rodriguez-Molinero, Alejandro/0000-0002-9678-2654; Prats, Anna/0000-0002-3586-4525	La Fundacio La Marato de [TV3 20140431]; European Community [ICT-287677]	La Fundacio La Marato de; European Community(European Commission)	This project has been performed within the framework of the "Freezing in Parkinsons Disease: Improving Quality of Life with an Automatic Control System" (MASPARK) project which is funded by La Fundacio La Marato de TV3 20140431 [http://www.tv3.cat/marato/es/projectes_financats_2013]. This work also forms part of the framework of the FP7 project "Personal Health Device for the Remote and Autonomous Management of Parkinsons Disease" (REMPARK) ICT-287677, which is funded by the European Community [http://www.rempark.eu/].; Part of this project has been performed within the framework of the MASPARK project which is funded by La Fundacio La Marato de TV3 20140431. This work also forms part of the framework of the FP7 project REMPARK ICT-287677, which is funded by the European Community. The authors, thus, would like to acknowledge the contributions of their colleagues from MASPARK and REMPARK consortium.	Aarsland D, 2007, J NEUROL NEUROSUR PS, V78, P36, DOI 10.1136/jnnp.2005.083113; Ahlrichs C, 2016, MED BIOL ENG COMPUT, V54, P223, DOI 10.1007/s11517-015-1395-3; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Amboni M, 2010, MOVEMENT DISORD, V25, P800, DOI 10.1002/mds.23033; [Anonymous], 2011, FP7ICT20117287677; Arias P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009675; Bachlin M., DAPHNET PROJECT DYNA; Bachlin M., 2009, P 4 INT ICST C BOD A; Bachlin M, 2010, METHOD INFORM MED, V49, P88, DOI 10.3414/ME09-02-0003; Bachlin M, 2010, IEEE T INF TECHNOL B, V14, P436, DOI 10.1109/TITB.2009.2036165; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Boni A, 2007, IEEE T INSTRUM MEAS, V56, P39, DOI 10.1109/TIM.2006.887319; Cabestany J, 2013, 20 INT C MIX DES INT; Cole BT, 2011, IEEE ENG MED BIO, P5649, DOI 10.1109/IEMBS.2011.6091367; Coste CA, 2014, SENSORS-BASEL, V14, P6819, DOI 10.3390/s140406819; Delval A, 2010, MOVEMENT DISORD, V25, P1684, DOI 10.1002/mds.23159; European Parkinson's Disease Association Working Group on Parkinson's Disease (World Health Organization), 2015, PREV PARK DIS; FAHN S, 1995, ADV NEUROL, V67, P53; Geebelen D, 2012, IEEE T NEUR NET LEAR, V23, P682, DOI 10.1109/TNNLS.2012.2186314; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Han JH, 2003, P ANN INT IEEE EMBS, V25, P1863; Handojoseno AMA, 2012, IEEE ENG MED BIO, P69, DOI 10.1109/EMBC.2012.6345873; Hausdorff JM, 2003, PHYSICA A, V321, P565, DOI 10.1016/S0378-4371(02)01744-2; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jovanov E, 2009, IEEE ENG MED BIO, P5151, DOI 10.1109/IEMBS.2009.5334257; Khan AM, 2008, IEEE ENG MED BIO, P5172, DOI 10.1109/IEMBS.2008.4650379; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Lieberman A, 2006, J NEUROL SCI, V248, P219, DOI 10.1016/j.jns.2006.05.023; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Maidan I, 2015, J NEUROL, V262, P899, DOI 10.1007/s00415-015-7650-6; Maidan I, 2010, MOVEMENT DISORD, V25, P2346, DOI 10.1002/mds.23280; Mancini M, 2012, IEEE ENG MED BIO, P1198, DOI 10.1109/EMBC.2012.6346151; MASPARK, 2015, FREEZING PARKINSONS; Mathie MJ, 2001, P ANN INT IEEE EMBS, V23, P3654, DOI 10.1109/IEMBS.2001.1019627; Mazilu Sinziana, 2013, Machine Learning and Data Mining in Pattern Recognition. 9th International Conference, MLDM 2013. Proceedings: LNCS 7988, P144, DOI 10.1007/978-3-642-39712-7_11; Mazilu S., 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P123, DOI 10.4108/icst.pervasivehealth.2012.248680; Mazilu S, 2015, IEEE J BIOMED HEALTH, V6, P1; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Moore ST, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-19; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Niazmand K, 2011, BIOMED CIRC SYST C, P201, DOI 10.1109/BioCAS.2011.6107762; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 1998, DISABIL REHABIL, V20, P142, DOI 10.3109/09638289809166074; Nilsson MH, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-85; Nonnekes J, 2014, J NEUROL, V261, P1763, DOI 10.1007/s00415-014-7422-8; Papapetropoulos S, 2012, CNS NEUROSCI THER, V18, P380, DOI 10.1111/j.1755-5949.2011.00253.x; Perez-Lopez C, 2016, ARTIF INTELL MED, V67, P47, DOI 10.1016/j.artmed.2016.01.001; Perez-Lopez C, 2015, LECT NOTES COMPUT SC, V9094, P461, DOI 10.1007/978-3-319-19258-1_38; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rodriguez-Martin D., 2015, RECENT ADV AMBIENT A, P3; Rodriguez-Martin D, 2014, ENVIRON TECHNOL, P1; Rodriguez-Martin D, 2015, NEUROCOMPUTING, V164, P144, DOI 10.1016/j.neucom.2014.09.084; Rodriguez-Martin D, 2013, SENSORS-BASEL, V13, P14079, DOI 10.3390/s131014079; Rodriguez-Martin D, 2013, EXPERT SYST APPL, V40, P7203, DOI 10.1016/j.eswa.2013.07.028; Sama A., 2013, EUR S ART NEUR NETW; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Stamatakis J, 2011, IEEE ENG MED BIO, P7900, DOI 10.1109/IEMBS.2011.6091948; Takac B, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2539; Tay A, 2015, 2015 10 AS CONTR C A, P1, DOI [10.1109/ASCC.2015.7244608, DOI 10.1109/ASCC.2015.7244608]; Tripoliti EE, 2013, COMPUT METH PROG BIO, V110, P12, DOI 10.1016/j.cmpb.2012.10.016; Vapnik V., 2013, NATURE STAT LAERNING; Weiss A, 2015, J NEURAL TRANSM, V122, P403, DOI 10.1007/s00702-014-1279-y; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zabaleta H., 2008, GERONTECHNOLOGY, V7, P4, DOI DOI 10.4017/GT.2008.07.02.184.00; Zach H, 2015, PARKINSONISM RELAT D, V21, P1362, DOI 10.1016/j.parkreldis.2015.09.051; Zhao Y., 2012, 2012 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI), P192, DOI 10.1109/BH1.2012.6211542; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001	73	88	90	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171764	10.1371/journal.pone.0171764	http://dx.doi.org/10.1371/journal.pone.0171764			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199357	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400048
J	Gliszczynska, A; Niezgoda, N; Gladkowski, W; Switalska, M; Wietrzyk, J				Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold; Switalska, Marta; Wietrzyk, Joanna			Isoprenoid-phospholipid conjugates as potential therapeutic agents: Synthesis, characterization and antiproliferative studies	PLOS ONE			English	Article							HL-60 LEUKEMIA-CELLS; PANCREATIC-CANCER; D-LIMONENE; PERILLYL ALCOHOL; PRODRUG; FARNESOL; GROWTH; RATS; CHEMOPREVENTION; INHIBITION	The aim of this research was to extend application field of isoprenoid compounds by their introduction into phospholipid structure as the transport vehicle. The series of novel isoprenoid phospholipids were synthesized in high yields (24-97%), their structures were fully characterized and its anticancer activity was investigated in vitro towards several cell lines of different origin. Most of synthesized compounds showed a significantly higher antiproliferative effect on tested cell lines than free terpene acids. The most active phosphatidylcholine analogue, containing 2,3-dihydro-3-vinylfarnesoic acids instead of fatty acids in both sn-1 and sn-2 position, inhibits the proliferation of colon cancer cells at 13.6 mu M.	[Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold] Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland; [Switalska, Marta; Wietrzyk, Joanna] Polish Acad Sci, Dept Expt Oncol, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Gliszczynska, A (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland.	anna.gliszczynska@wp.pl	Gładkowski, Witold/A-5750-2017; Niezgoda, Natalia/HHN-1650-2022; Wietrzyk, Joanna/O-4392-2018; Gliszczyńska, Anna/A-2601-2017	Gładkowski, Witold/0000-0002-3271-779X; Niezgoda, Natalia/0000-0002-1154-9707; Wietrzyk, Joanna/0000-0003-4980-6606; Gliszczyńska, Anna/0000-0002-0218-6369; Switalska, Marta/0000-0001-7920-2251	National Science Center of Poland [2013/09/D/NZ9/02457]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	National Science Center of Poland(National Science Centre, Poland); Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This project was financed by National Science Center of Poland no. 2013/09/D/NZ9/02457. Publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (http://know.wroc.pl).	Alexander RL, 2005, CURR PHARM DESIGN, V11, P1079, DOI 10.2174/1381612053507602; Biodrowska K, 2012, PRZEM CHEM, V91, P692; Burke YD, 2002, ANTICANCER RES, V22, P3127; Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y; Casado V, 2013, FOOD BIOPROD PROCESS, V91, P599, DOI 10.1016/j.fbp.2013.02.002; CROWELL PL, 1994, CRIT REV ONCOGENESIS, V5, P1; Deepika R, 2003, PROSTATE, V57, P14, DOI 10.1002/pros.10269; DEVERRE JR, 1989, J PHARM PHARMACOL, V41, P191, DOI 10.1111/j.2042-7158.1989.tb06428.x; GARZONABURBEH A, 1986, J MED CHEM, V29, P687, DOI 10.1021/jm00155a018; Gliszczynska A, 2014, RSC ADV, V4, P39248, DOI 10.1039/c4ra03939d; Gliszczynska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157278; Gliszczynska A, 2011, PRZEM CHEM, V90, P759; Gliszczynska A, 2011, NAT PROD COMMUN, V6, P367; HAAG JD, 1992, CANCER RES, V52, P4021; HARKER WG, 1991, BIOCHEMISTRY-US, V30, P9953, DOI 10.1021/bi00105a020; He L, 1997, J NUTR, V127, P668, DOI 10.1093/jn/127.5.668; Howard HB, 2004, CANCER CHEMOTH PHARM, V54, P368, DOI 10.1007/s00280-004-0788-z; Howard HB, 2008, CANCER CHEMOTH PHARM, V62, P149, DOI 10.1007/s00280-007-0585-6; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Kaki SS, 2014, EUR J LIPID SCI TECH, V116, P1347, DOI 10.1002/ejlt.201400202; KUMAR R, 1978, J PHARM PHARMACOL, V30, P754, DOI 10.1111/j.2042-7158.1978.tb13386.x; Kurz M, 2000, CHEM PHYS LIPIDS, V107, P143, DOI 10.1016/S0009-3084(00)00167-5; Lambert DM, 2000, EUR J PHARM SCI, V11, pS15, DOI 10.1016/S0928-0987(00)00161-5; Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004; LIDBETTER PS, 1986, SYNTHETIC COMMUN, V16, P1529, DOI 10.1080/00397918608056406; MALTZMAN TH, 1989, CARCINOGENESIS, V10, P781, DOI 10.1093/carcin/10.4.781; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; PARIS GY, 1980, J MED CHEM, V23, P9, DOI 10.1021/jm00175a003; SCRIBA GKE, 1995, J PHARM SCI, V84, P300, DOI 10.1002/jps.2600840307; Smith-Warner S. A., 1999, NUTR ONCOLOGY, P153; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Smuga DA, 2010, STEROIDS, V75, P1146, DOI 10.1016/j.steroids.2010.08.001; STARK MJ, 1995, CANCER LETT, V96, P15, DOI 10.1016/0304-3835(95)03912-G; SUGIHARA J, 1988, J PHARMACOBIO-DYNAM, V11, P555, DOI 10.1248/bpb1978.11.555; Tatman D, 2002, CANCER LETT, V175, P129, DOI 10.1016/S0304-3835(01)00723-6; Wang T, 2008, OILY PRESS LIPID LIB; WATTENBERG LW, 1991, CARCINOGENESIS, V12, P115, DOI 10.1093/carcin/12.1.115; Yamamoto Y, 2008, BIOORG MED CHEM LETT, V18, P4044, DOI 10.1016/j.bmcl.2008.05.113; Yamamoto Y, 2008, J AM OIL CHEM SOC, V85, P313, DOI 10.1007/s11746-008-1206-1; Yamamoto Y, 2011, NEW BIOTECHNOL, V28, P1, DOI 10.1016/j.nbt.2010.06.014; YU SG, 1995, J NUTR, V125, P2763	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172238	10.1371/journal.pone.0172238	http://dx.doi.org/10.1371/journal.pone.0172238			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196124	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900063
J	Ji, YJ; Kong, XF; Li, HW; Zhu, Q; Guo, QP; Yin, YL				Ji, Yujiao; Kong, Xiangfeng; Li, Huawei; Zhu, Qian; Guo, Qiuping; Yin, Yulong			Effects of dietary nutrient levels on microbial community composition and diversity in the ileal contents of pregnant Huanjiang mini-pigs	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; LUMINAL CONTENT; METABOLISM; ILEUM; SUPPLEMENTATION; BACTEROIDES; EXPRESSION; NUTRITION; SEQUENCES	The mammalian gut microbiota influences various metabolic and physiological processes. Substantial metabolic changes occur during a healthy pregnancy that may be related to microbiota composition dynamics. However, the effect of diet on intestinal microbiota composition and diversity during pregnancy remains unclear. We examined the ileal contents of Huanjiang mini-pigs at two pregnancy stages to determine the effects of dietary nutrient levels on such microbial communities. Animals received either a higher-nutrient (HN) diet formulated to meet US National Research Council requirements or a lower-nutrient (LN) diet that met the Chinese National Feeding Standard recommendations. On day 45 or 75 of pregnancy, sows were euthanized and their ileal contents sampled. Experimental diet and pregnancy stage did not affect ileal bacterial richness or diversity, as determined by Chao1 and ACE species richness measures and Shannon and Simpson indices, respectively. The phyla Firmicutes and Proteobacteria, accounting for 69.99-85.44% and 5.82-15.17% of the total reads, respectively, predominated regardless of diet. At the genus level, diet significantly affected the abundance of Lactobacillus species, which was greater in pigs given HN feed (P < 0.05), but had little impact on that of Megasphaera species (P = 0.096). Pregnancy stage had a minimal effect on Proteobacteria numbers (P = 0.053). The number of bacteria of the phylum Firmicutes and genus Lactobacillus decreased, while that of the phylum Proteobacteria, family Enterobacteriaceae, and genus Bacteroides increased between days 45 and 75 of pregnancy. Of the short-chain fatty acids (SCFAs) measured, only propionate levels changed significantly, with higher concentrations observed on day 45 than on day 75. Our findings indicate that Firmicutes and Proteobacteria dominate pregnant sow ileal bacterial profiles. Excepting a tendency for the number of Proteobacteria to increase as pregnancy progressed, pregnancy stage and diet had little effect on ileal microbiotic composition and diversity and luminal SCFA concentrations.	[Ji, Yujiao; Kong, Xiangfeng; Li, Huawei; Zhu, Qian; Guo, Qiuping; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Kong, Xiangfeng; Yin, Yulong] Huanjiang Observat & Res Stn Karst Ecosysterms, Res Ctr Mini Pig, Huanjiang, Guangxi, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Kong, XF; Yin, YL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.; Kong, XF; Yin, YL (corresponding author), Huanjiang Observat & Res Stn Karst Ecosysterms, Res Ctr Mini Pig, Huanjiang, Guangxi, Peoples R China.	nnkxf@isa.ac.cn; yinyulong@isa.ac.cn			Chinese Academy of Sciences; National Nature Science Foundation of China [31270044, 31572421]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAC17130102, 2014BAD08B06]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2013T2S0014]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists	The present work was jointly supported by grants from the "Western Light" key Program for Talent Cultivation from Chinese Academy of Sciences, National Nature Science Foundation of China (31270044, 31572421), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAC17130102, 2014BAD08B06), and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (F. Blachier, 2013T2S0014).	Ai J, 2010, BIORESOURCE TECHNOL, V101, P215, DOI 10.1016/j.biortech.2009.07.090; Andriamihaja M, 2010, AM J PHYSIOL-GASTR L, V299, pG1030, DOI 10.1152/ajpgi.00149.2010; Basson A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00290; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Booijink CCGM, 2009, AN DIV FUNCT HUM SMA; Boudry G, 2013, J NUTR, V143, P1225, DOI 10.3945/jn.113.175828; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Dai ZL, 2015, MOL HUM REPROD, V21, P389, DOI 10.1093/molehr/gav003; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egshatyan L, 2016, ENDOCR CONNECT, V5, P1, DOI 10.1530/EC-15-0094; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Jindal R, 1996, J ANIM SCI, V74, P620; Johnston L, 1999, FEEDSTUFFS, V10, P12; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Kim J, 2015, ARCH MICROBIOL, V197, P753, DOI 10.1007/s00203-015-1108-1; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Kong XF, 2007, ASIAN AUSTRAL J ANIM, V20, P1453, DOI 10.5713/ajas.2007.1453; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lan A, 2015, J NUTR BIOCHEM, V26, P91, DOI 10.1016/j.jnutbio.2014.09.007; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138277; Liu YY, 2015, BRIT J NUTR, V113, P1069, DOI 10.1017/S0007114514004310; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; National Research Council (NRC), 1998, INSIDE NRC, V10th, P1; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Nielsen S, 2007, J PEDIATR GASTR NUTR, V44, P613, DOI 10.1097/MPG.0b013e3180406a11; Pedersen R, 2013, GUT MICROBES, V4, P371, DOI 10.4161/gmic.26108; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rettedal E, 2009, APPL ENVIRON MICROB, V75, P5489, DOI 10.1128/AEM.02220-08; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; SALYERS AA, 1984, ANNU REV MICROBIOL, V38, P293, DOI 10.1146/annurev.mi.38.100184.001453; Sera N, 2005, J NUTR BIOCHEM, V16, P50, DOI 10.1016/j.jnutbio.2004.09.005; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WELDON WC, 1994, J ANIM SCI, V72, P387, DOI 10.2527/1994.722387x; Zhou LP, 2016, ANAEROBE, V38, P61, DOI 10.1016/j.anaerobe.2015.12.009; Zhou XL, 2012, J ANIM SCI, V90, P37, DOI 10.2527/jas.50269; Zhou XL, 2014, NUTR RES, V34, P780, DOI 10.1016/j.nutres.2014.08.008; Zhu Qian, 2016, Chinese Journal of Animal Nutrition, V28, P1534	61	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172086	10.1371/journal.pone.0172086	http://dx.doi.org/10.1371/journal.pone.0172086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196137	Green Submitted, gold, Green Published			2022-12-26	WOS:000394423900049
J	Kallistova, A; Horacek, I; Slouf, M; Skala, R; Fridrichova, M				Kallistova, Anna; Horacek, Ivan; Slouf, Miroslav; Skala, Roman; Fridrichova, Michaela			Mammalian enamel maturation: Crystallographic changes prior to tooth eruption	PLOS ONE			English	Article							RESOLUTION ELECTRON-MICROSCOPY; ATOMIC-FORCE MICROSCOPY; DENTAL ENAMEL; VERTEBRATE DENTITION; RAT ENAMEL; PROTEIN; EVOLUTION; CRYSTALS; SHAPE; AMELOBLASTIN	Using the distal molar of a minipig as a model, we studied changes in the microstructural characteristics of apatite crystallites during enamel maturation (16-23 months of postnatal age), and their effects upon the mechanical properties of the enamel coat. The slow rate of tooth development in a pig model enabled us to reveal essential heterochronies in particular components of the maturation process. The maturation changes began along the enamel dentine junction (EDJ) of the trigonid, spreading subsequently to the outer layers of the enamel coat to appear at the surface zone with a 2-month delay. Correspondingly, at the distal part of the tooth the timing of maturation processes is delayed by 3-5 month compared to the mesial part of the tooth. The early stage of enamel maturation (16-20 months), when the enamel coat is composed almost exclusively of radial prismatic enamel, is characterized by a gradual increase in crystallite thickness (by a mean monthly increment of 3.8 nm); and an increase in the prism width and thickness of crystals composed of elementary crystallites. The late stage of maturation (the last two months prior to tooth eruption), marked with the rapid appearance of the interprismatic matrix (IPM) during which the crystals densely infill spaces between prisms, is characterized by an abrupt decrease in microstrain and abrupt changes in the micromechanical properties of the enamel: a rapid increase in its ability to resist long-term load and its considerable hardening. The results suggest that in terms of crystallization dynamics the processes characterizing the early and late stage of mammalian enamel maturation represent distinct entities. In regards to common features with enamel formation in the tribosphenic molar we argue that the separation of these processes could be a common apomorphy of mammalian amelogenetic dynamics in general.	[Kallistova, Anna; Skala, Roman] Charles Univ Prague, Inst Geochem Mineral & Mineral Resources, Fac Sci, Albertov 6, Prague, Czech Republic; [Kallistova, Anna; Skala, Roman; Fridrichova, Michaela] CAS, Inst Geol, Vvi, Rozvojova 269, Prague 6, Czech Republic; [Horacek, Ivan] Charles Univ Prague, Dept Zool, Fac Sci, Vinicna 7, Prague, Czech Republic; [Slouf, Miroslav] Inst Macromol Chem CAS Vvi, Heyrovskeho Namesti 2, Prague 6, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Geology of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Horacek, I (corresponding author), Charles Univ Prague, Dept Zool, Fac Sci, Vinicna 7, Prague, Czech Republic.	horacek@natur.cuni.cz	Skala, Roman/C-4442-2008; Fridrichova, Michaela/GVS-4377-2022; Fridrichova, Michaela/A-7017-2013; Horacek, Ivan/V-9741-2017; Slouf, Miroslav/F-6311-2012; Kallistova, Anna/I-8773-2014	Skala, Roman/0000-0002-5168-1585; Fridrichova, Michaela/0000-0002-3636-723X; Horacek, Ivan/0000-0002-8356-5554; Slouf, Miroslav/0000-0003-1528-802X; Kallistova, Anna/0000-0003-1320-0071	Charles University Grant Agency [742213]; University Student Project [SVV260197]; research plan of the Institute of Geology of the CAS, v.v.i. [RVO67985831]; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I) [POLYMAT LO1507]	Charles University Grant Agency; University Student Project; research plan of the Institute of Geology of the CAS, v.v.i.; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I)	This work was supported by Charles University Grant Agency, project No. 742213, University Student Project No. SVV260197, and the research plan of the Institute of Geology of the CAS, v.v.i. RVO67985831. The work at the Institute of Macromolecular Chemistry was supported by the Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I), project POLYMAT LO1507.	Baxa M, 2013, J HUNTINGTONS DIS, V2, P47, DOI 10.3233/JHD-130001; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; BOYDE A, 1989, TEETH, P309; Clemens WA, 1997, TOOTH ENAMEL MICROSTRUCTURE, P85; COOPER WEG, 1968, ARCH ORAL BIOL, V13, P27, DOI 10.1016/0003-9969(68)90035-6; CUISINIER FJG, 1992, CALCIFIED TISSUE INT, V51, P259, DOI 10.1007/BF00334485; CUISINIER FJG, 1990, J BIOL BUCCALE, V18, P149; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364; Davis BM, 2011, J MAMM EVOL, V18, P227, DOI 10.1007/s10914-011-9168-8; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Duverger O, 2014, J CLIN INVEST, V124, P5219, DOI 10.1172/JCI78272; ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704; Enamel I., 2010, J MORPHOL, V271, P1204, DOI [10.1002/jmor.10867, DOI 10.1002/JMOR.10867]; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Ganss B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00371; Gasse B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0329-x; GLIMCHER MJ, 1964, BIOCHEM J, V93, P202, DOI 10.1042/bj0930202; Horacek I, 2012, CAM STUD MORPHOL MOL, P410; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Iijima M, 2001, J CRYST GROWTH, V222, P615, DOI 10.1016/S0022-0248(00)00984-2; Instruments C., 2013, INDENTATION SOFTWARE, P135; Jernvall J, 1995, ACTA ZOOLOGICA FENNI; Kallistova A, 2015, J APPL CRYSTALLOGR, V48, P763, DOI 10.1107/S1600576715005208; Kallonen A, 2014, B INT ASS PALEODONTO, V8, P103; Kawasaki K, 2008, J DENT RES, V87, P520, DOI 10.1177/154405910808700608; Kirkham J, 1998, CONNECT TISSUE RES, V38, P91, DOI 10.3109/03008209809017025; KLUG HP, 1974, XRAY DIFFRACTION PRO, P618; Koenigswald W. von, 1997, TOOTH ENAMEL MICROST, P267; Lester K S, 1987, Adv Dent Res, V1, P181; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P421; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Margolis HC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00339; Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034; Nanci A., 2008, 10 CATES ORAL HISTOL; NYLEN MU, 1963, J CELL BIOL, V18, P109, DOI 10.1083/jcb.18.1.109; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; Osborn HF., 1907, EVOLUTION MAMMALIAN, V1; Planska D, 2015, ACTA HISTOCHEM CYTOC, V48, P15, DOI 10.1267/ahc.14020; Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x; Robinson C, 2003, CONNECT TISSUE RES, V44, P65, DOI 10.1080/03008200390152115; ROBINSON C, 1975, ARCH ORAL BIOL, V20, P29, DOI 10.1016/0003-9969(75)90149-1; ROBINSON C, 1995, INT J DEV BIOL, V39, P145; Robinson C, 1982, J DENT RES, P1490; Robinson C, 2006, EUR J ORAL SCI, V114, P99, DOI 10.1111/j.1600-0722.2006.00275.x; Robinson C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00388; Rodriguez-Carvajal J., 2001, NEWSL, V26, P12; Sander PM, 1997, TOOTH ENAMEL MICROSTRUCTURE, P41; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Slouf M, 2015, POLYM TEST, V41, P191, DOI 10.1016/j.polymertesting.2014.12.003; Stembirek J, 2010, EUR J ORAL SCI, V118, P547, DOI 10.1111/j.1600-0722.2010.00772.x; Stock DW, 2001, PHILOS T R SOC B, V356, P1633, DOI 10.1098/rstb.2001.0917; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; TONGE CH, 1973, J ANAT, V115, P1; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wald T, 2013, J BIOL CHEM, V288, P22333, DOI 10.1074/jbc.M113.456012; Wang F, 2014, ORAL DIS, V20, P367, DOI 10.1111/odi.12126; WARSHAWSKY H, 1981, ANAT RECORD, V200, P371, DOI 10.1002/ar.1092000402; Yoshizaki K, 2013, ORTHOD WAVES, V72, P1, DOI 10.1016/j.odw.2013.01.040	69	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171424	10.1371/journal.pone.0171424	http://dx.doi.org/10.1371/journal.pone.0171424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196135	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900019
J	Meng, FY; Sun, Y; Shen, YG; Pan, HF; Tang, JH; Wang, BB; Wu, CH; Ye, DQ				Meng, Fan-Ya; Sun, Yong; Shen, Yong-Gang; Pan, Hai-Feng; Tang, Ji-Hai; Wang, Bin-Bing; Wu, Chang-Hao; Ye, Dong-Qing			Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China	PLOS ONE			English	Article							EVENT FOLLOWING IMMUNIZATION; CASE-DEFINITION; DATA-COLLECTION; FEBRILE SEIZURES; GUIDELINES; ELIMINATION; CHILDREN; AGE; FEVER	The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live attenuated measles vaccine, live attenuated measles and rubella combined vaccine, live attenuated measles and mumps combined vaccine, live attenuated Measles, Mumps and Rubella Combined Vaccine) in Anhui Province, China. From 2009 to 2014, 9.9 million doses of measles-containing vaccines were administrated and 1893 AEFIs were found (191.4 per million doses), of which, 33 serious AEFIs (3.3 per million vaccine doses) were reported. 59.4% (1124 cases) were male cases, and 85.1% (1611 cases) occurred in persons aged < 1 year. 93.3% (1766 cases) occurred at the first dose of vaccination and 95.9% (1815 cases) were found within 3 days after vaccination. This study presents up-to-date data and suggests that the measles-containing vaccines used in Anhui Province of China are safe.	[Meng, Fan-Ya; Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Meng, Fan-Ya; Pan, Hai-Feng; Ye, Dong-Qing] Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China; [Meng, Fan-Ya; Sun, Yong; Shen, Yong-Gang; Tang, Ji-Hai; Wang, Bin-Bing] Anhui Ctr Dis Control & Prevent, Dept Immunizat & Prevent, Hefei, Anhui, Peoples R China; [Wu, Chang-Hao] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England	Anhui Medical University; University of Surrey	Ye, DQ (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.; Ye, DQ (corresponding author), Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China.	ydqahmu@gmail.com	Yue, Yuhang/AAW-9279-2021	Ye, Dongqing/0000-0001-6604-9614; Pan, Hai-Feng/0000-0001-8218-5747	Chinese national high level personnel special support plan for design, Research Funds of Collaborative innovation center for major autoimmune disease [CXNLX-1401]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I025379/1, BB/P004695/1]; National Institute of Aging (NIA) [1R01AG049321-01A1]; Royal Society; NSFC [IE151259]; BBSRC [BB/I025379/1, BB/P004695/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P004695/1, BB/I025379/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG049321] Funding Source: NIH RePORTER	Chinese national high level personnel special support plan for design, Research Funds of Collaborative innovation center for major autoimmune disease; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Royal Society(Royal Society of London); NSFC(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Chinese national high level personnel special support plan for design, Research Funds of Collaborative innovation center for major autoimmune disease (CXNLX-1401) for data collection. CW gratefully acknowledges support from Biotechnology and Biological Sciences Research Council (BBSRC) (BB/I025379/1, BB/P004695/1) for analysis, National Institute of Aging (NIA, 1R01AG049321-01A1) for decision to publish, The Royal Society and NSFC (IE151259) for preparation of the manuscript. http://www.nsfc.gov.cn/. http://www.governmentfunding.org.uk/default.aspx.	Beigel J, 2007, VACCINE, V25, P5697, DOI 10.1016/j.vaccine.2007.02.066; Beijing Tiantan of Biological Products, MEASL RUB COMB VACC; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Gidudu J, 2011, VACCINE, V29, P1053, DOI 10.1016/j.vaccine.2010.11.065; Gidudu J, 2008, VACCINE, V26, P6800, DOI 10.1016/j.vaccine.2008.10.006; Jones JF, 2007, VACCINE, V25, P5685, DOI 10.1016/j.vaccine.2007.02.065; Klein NP, 2015, PEDIATRICS, V135, pE321, DOI 10.1542/peds.2014-1822; Klein NP, 2012, PEDIATRICS, V129, P809, DOI 10.1542/peds.2011-3198; Li J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-986; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Liu SJ, 2013, HUM VACC IMMUNOTHER, V9, P1296, DOI 10.4161/hv.24032; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Macartney KK, 2015, VACCINE, V33, P1412, DOI 10.1016/j.vaccine.2014.10.071; Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007; Naim HY, 2015, HUM VACC IMMUNOTHER, V11, P21, DOI 10.4161/hv.34298; National Health and Family Planning Commission of the People's Republic of China, CHIN INF SYST DIS CO; National Health and Family Planning Commission of the People's Republic of China, 2010, NAT GUID SURV ADV EV; Rowhani-Rahbar A, 2013, JAMA PEDIATR, V167, P1111, DOI 10.1001/jamapediatrics.2013.2745; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Rumke HC, 2011, VACCINE, V29, P3842, DOI 10.1016/j.vaccine.2011.02.067; Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060; Shanghai Institute of Biological Products, MEASL VACC LIV; Shanghai Institute of Biological Products, MEASL MUMPS RUB COMB; Shanghai Institute of Biological Products, MEASL MUMPS COMB VAC; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; van den Ent MMVX, 2011, J INFECT DIS, V204, pS18, DOI 10.1093/infdis/jir081; Wang XY, 2014, CHINESE J STRUC CHEM, V33, P33; WHO, 2015, IMM SAF SURV GUID IM; Wise RP, 2007, VACCINE, V25, P5717, DOI 10.1016/j.vaccine.2007.02.067; Wu W., 2013, CHINA VACCINES IMMUN, V19, P97; Wu WD, 2011, CHINESE J VACCINES I, V2, P99; Wu WD, 2012, CHINESE J VACCINES I, V5, P385; Wu Wei, 2014, POWER MEASUREMENT IN, V1, P12; Ye JK, 2015, CHIN J VAC IMMUN, V2, P200; Ye JK, 2016, CHINESE J VACCINES I, V2, P125; Zuo SY, 2015, VACCINE, V33, P2050, DOI 10.1016/j.vaccine.2015.02.078	38	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0172108	10.1371/journal.pone.0172108	http://dx.doi.org/10.1371/journal.pone.0172108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192490	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800069
J	Liu, XL; Xia, YJ; Tang, JX; Ma, L; Li, CC; Ma, PC; Mao, BY				Liu, Xiaoliang; Xia, Yingjie; Tang, Jixin; Ma, Li; Li, Chaocui; Ma, Pengcheng; Mao, Bingyu			Dual roles of Akirin2 protein during Xenopus neural development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; chromatin remodeling; embryo; neurodevelopment; Xenopus	CELL-CYCLE; PLURIPOTENT CELLS; NERVOUS-SYSTEM; STEM-CELLS; CHROMATIN; GEMININ; DIFFERENTIATION; EXPRESSION; GENES; SOX2	To ensure correct spatial and temporal patterning, embryos must maintain pluripotent cell populations and control when cells undergo commitment. The newly identified nucleoprotein Akirin has been shown to modulate the innate immune response through epigenetic regulation and to play important roles in other physiological processes, but its role in neural development remains unknown. Here we show that Akirin2 is required for neural development in Xenopus and that knockdown of Akirin2 expands the expression of the neural progenitor marker Sox2 and inhibits expression of the differentiated neuronal marker N-tubulin. Akirin2 acts antagonistically to Geminin, thus regulating Sox2 expression, and maintains the neural precursor state by participating in the Brg1/Brm-associated factor (BAF) complex mediated by BAF53a. Additionally, Akirin2 also modulates N-tubulin expression by acting upstream of neuronal differentiation 1 (NeuroD) and in parallel with neurogenin-related 1 (Ngnr1) during terminal neuronal differentiation. Thus, our results reveal a novel model in which Akirin2 precisely coordinates and temporally controls Xenopus neural development.	[Liu, Xiaoliang; Xia, Yingjie; Tang, Jixin; Ma, Li; Li, Chaocui; Ma, Pengcheng; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, 32 Jiaochang East Rd, Kunming 650223, Peoples R China; [Liu, Xiaoliang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650223, Peoples R China; [Xia, Yingjie] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Tang, Jixin] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Ma, Li] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University System of Maryland; University of Maryland College Park	Ma, PC; Mao, BY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, 32 Jiaochang East Rd, Kunming 650223, Peoples R China.	kunmapch@mail.kiz.ac.cn; mao@mail.kiz.ac.cn		Mao, Bingyu/0000-0002-7993-3158; Ma, Pengcheng/0000-0002-1067-8021	National Natural Science Foundation of China [31171404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31171404 (to B.Y.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aigner S, 2005, DEV CELL, V9, P171, DOI 10.1016/j.devcel.2005.07.005; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bally-Cuif L, 2003, CURR OPIN NEUROBIOL, V13, P16, DOI 10.1016/S0959-4388(03)00015-1; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Bosch PJ, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0076-8; Chen XL, 2012, ANIM BIOTECHNOL, V23, P124, DOI 10.1080/10495398.2011.652326; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Farah MH, 2000, DEVELOPMENT, V127, P693; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hou FJ, 2013, DEV COMP IMMUNOL, V41, P703, DOI 10.1016/j.dci.2013.08.005; Kishi M, 2000, DEVELOPMENT, V127, P791; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroll KL, 2007, FRONT BIOSCI, V12, P1395, DOI 10.2741/2156; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Liu N, 2016, DEV COMP IMMUNOL, V55, P80, DOI 10.1016/j.dci.2015.10.015; Liu TX, 2015, DEV COMP IMMUNOL, V52, P17, DOI 10.1016/j.dci.2015.04.010; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; Ma PC, 2013, DEV GENES EVOL, V223, P253, DOI 10.1007/s00427-013-0437-9; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Macqueen DJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-34; Mathis L, 2002, TRENDS GENET, V18, P627, DOI 10.1016/S0168-9525(02)02806-8; Narayanan R, 2014, CELL TISSUE RES, V356, P575, DOI 10.1007/s00441-013-1791-7; Neilson KM, 2012, DEV BIOL, V365, P363, DOI 10.1016/j.ydbio.2012.03.004; Nowak Scott J, 2012, Bioarchitecture, V2, P209, DOI 10.4161/bioa.22907; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Salerno MS, 2009, EXP CELL RES, V315, P2012, DOI 10.1016/j.yexcr.2009.04.014; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Tartey S, 2015, BIOMOLECULES, V5, P1618, DOI 10.3390/biom5031618; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yan J, 2013, FISH SHELLFISH IMMUN, V35, P564, DOI 10.1016/j.fsi.2013.05.020; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Yellajoshyula D, 2012, MOL CELL BIOL, V32, P4549, DOI 10.1128/MCB.00737-12; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006	47	13	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5676	5684		10.1074/jbc.M117.777110	http://dx.doi.org/10.1074/jbc.M117.777110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28193841	Green Published, hybrid			2022-12-26	WOS:000398813200006
J	Lin, HC; Xirasagar, S; Chung, SD; Huang, CC; Tsai, MC; Chen, CH				Lin, Herng-Ching; Xirasagar, Sudha; Chung, Shiu-Dong; Huang, Chung-Chien; Tsai, Ming-Chieh; Chen, Chao-Hung			Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease	PLOS ONE			English	Article							CARE RESOURCE UTILIZATION; PROTON PUMP INHIBITORS; EXTRAOESOPHAGEAL MANIFESTATIONS; CLINICAL SPECTRUM; CHRONIC COUGH; LANSOPRAZOLE; EPIDEMIOLOGY; POPULATION; RANITIDINE; OMEPRAZOLE	Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization. To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients' subsequent healthcare utilization for acute respiratory infections (ARIs). This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment. We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to 2012 with 21,486 age-sex matched comparison patients without GERD. Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart). Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate. We found that the mean annual ARI episode rate among GERD patients reduced by 11.4%, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95% confidence interval (CI) = (-0.64, -0.36)). In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p<0.001). The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.	[Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Herng-Ching; Chen, Chao-Hung] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Xirasagar, Sudha] Univ South Carolina, Dept Hlth Serv Policy & Management, Arnold Sch Publ Hlth, Columbia, SC USA; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Div Gastroenterol, Dept Internal Med, Hsinchu Branch, Hsinchu, Taiwan; [Chen, Chao-Hung] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Chao-Hung] MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; University of South Carolina System; University of South Carolina Columbia; Far Eastern Memorial Hospital; Cathay General Hospital; National Yang Ming Chiao Tung University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Chen, CH (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Chen, CH (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan.; Chen, CH (corresponding author), Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan.; Chen, CH (corresponding author), MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan.	s448@eip.mkc.edu.tw	Huang, CC/AAX-5872-2021; Xirasagar, Sudha/AAA-2350-2022	Huang, CC/0000-0003-0818-7175; 				D'Urzo A, 2002, CAN FAM PHYSICIAN, V48, P1311; Dal-Paz K, 2012, DIS ESOPHAGUS, V25, P107, DOI 10.1111/j.1442-2050.2011.01227.x; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P979; Gerson LB, 2012, DIS ESOPHAGUS, V25, P694, DOI 10.1111/j.1442-2050.2011.01313.x; Gibson PG, 2003, COCHRANE DATABASE SY, pCD001496, DOI DOI 10.1002/14651858.CD001496; Gosselin A, 2009, VALUE HEALTH, V12, P34, DOI 10.1111/j.1524-4733.2008.00399.x; Gunaratnam NT, 2006, ALIMENT PHARM THERAP, V23, P1473, DOI 10.1111/j.1365-2036.2006.02911.x; Gurski Richard Ricachenevski, 2006, J. bras. pneumol., V32, P150, DOI 10.1590/S1806-37132006000200011; HAVELUND T, 1988, BRIT MED J, V296, P89, DOI 10.1136/bmj.296.6615.89; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Irwin RS, 2000, AM J GASTROENTEROL, V95, pS9, DOI 10.1016/S0002-9270(00)01073-X; Katz PO, 2010, J GASTROINTEST SURG, V14, P62, DOI 10.1007/s11605-009-1015-3; Lewis JV, 2009, SOUTH MED J, V102, P995, DOI 10.1097/SMJ.0b013e3181b666e5; Littner MR, 2005, CHEST, V128, P1128, DOI 10.1378/chest.128.3.1128; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Maher Maha M, 2010, Saudi J Gastroenterol, V16, P84, DOI 10.4103/1319-3767.61233; Noordzij JP, 2001, LARYNGOSCOPE, V111, P2147, DOI 10.1097/00005537-200112000-00013; Nwokediuko Sylvester Chuks, 2012, ISRN Gastroenterol, V2012, P391631, DOI 10.5402/2012/391631; Pisegna JM, 2016, J VOICE IN PRESS; Poelmans J, 2005, GUT, V54, P1492, DOI 10.1136/gut.2004.053025; Poh CH, 2010, GASTROINTEST ENDOSC, V71, P28, DOI 10.1016/j.gie.2009.08.024; Richter JE, 2005, ALIMENT PHARM THER, V22, P70, DOI 10.1111/j.1365-2036.2005.02613.x; ROBINSON M, 1995, ALIMENT PHARM THERAP, V9, P25; Stanghellini V, 1999, SCAND J GASTROENTERO, V34, P29; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wahlqvist P, 2006, ALIMENT PHARM THERAP, V24, P259, DOI 10.1111/j.1365-2036.2006.02996.x; Watanabe Y, 2003, SCAND J GASTROENTERO, V38, P807, DOI 10.1080/00365520310004506; Wong WM, 2003, ALIMENT PHARM THER, V18, P595, DOI 10.1046/j.1365-2036.2003.01737.x; Yoshida N, 2000, ALIMENT PHARM THERAP, V14, P74, DOI 10.1046/j.1365-2036.2000.014s1074.x; Yuksel ES, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13544	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172436	10.1371/journal.pone.0172436	http://dx.doi.org/10.1371/journal.pone.0172436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222168	Green Submitted, Green Published, gold			2022-12-26	WOS:000394676800056
J	Liu, Y; Buck, JR; Ikonomidou, VN				Liu, Yang; Buck, John R.; Ikonomidou, Vasiliki N.			Generalized min-max bound-based MRI pulse sequence design framework for wide-range T1 relaxometry: A case study on the tissue specific imaging sequence	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; MAGNETIZATION-TRANSFER; RELAXATION-TIMES; BRAIN; T-1; ACQUISITION; SIGNAL; NOISE; CONTRAST; DISEASE	This paper proposes a new design strategy for optimizing MRI pulse sequences for T-1 relaxometry. The design strategy optimizes the pulse sequence parameters to minimize the maximum variance of unbiased T-1 estimates over a range of T-1 values using the Crame A r-Rao bound. In contrast to prior sequences optimized for a single nominal T-1 value, the optimized sequence using our bound-based strategy achieves improved precision and accuracy for a broad range of T-1 estimates within a clinically feasible scan time. The optimization combines the downhill simplex method with a simulated annealing process. To show the effectiveness of the proposed strategy, we optimize the tissue specific imaging (TSI) sequence. Preliminary Monte Carlo simulations demonstrate that the optimized TSI sequence yields improved precision and accuracy over the popular driven-equilibrium single- pulse observation of T-1 (DESPOT1) approach for normal brain tissues (estimated T-1 700-2000 ms at 3.0T). The relative mean estimation error (MSE) for T-1 estimation is less than 1.7% using the optimized TSI sequence, as opposed to less than 7.0% using DESPOT1 for normal brain tissues. The optimized TSI sequence achieves good stability by keeping the MSE under 7.0% over larger T-1 values corresponding to different lesion tissues and the cerebrospinal fluid (up to 5000 ms). The T-1 estimation accuracy using the new pulse sequence also shows improvement, which is more pronounced in low SNR scenarios.	[Liu, Yang; Buck, John R.] Univ Massachusetts Dartmouth, Dept Elect & Comp Engn, Dartmouth, MA 02747 USA; [Ikonomidou, Vasiliki N.] George Mason Univ, Dept Bioengn, Fairfax, VA 22030 USA	University of Massachusetts System; University Massachusetts Dartmouth; George Mason University	Liu, Y (corresponding author), Univ Massachusetts Dartmouth, Dept Elect & Comp Engn, Dartmouth, MA 02747 USA.	yang.liu@umassd.edu	Liu, Yang/AAH-8479-2019	Liu, Yang/0000-0001-9322-7543				Akcakaya M, 2015, MAGN RESON MED, V73, P1741, DOI 10.1002/mrm.25285; Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Bagnato F, 2011, MULT SCLER J, V17, P1424, DOI 10.1177/1352458511414601; BERNSTEIN MA, 1989, MED PHYS, V16, P813, DOI 10.1118/1.596304; BYDDER GM, 1985, J COMPUT ASSIST TOMO, V9, P659, DOI 10.1097/00004728-198507010-00002; Cercignani M, 2006, MAGN RESON MED, V56, P803, DOI 10.1002/mrm.21003; Chang LC, 2008, MAGN RESON MED, V60, P496, DOI 10.1002/mrm.21669; CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni SCL, 2006, MAGN RESON IMAGING, V24, P1241, DOI 10.1016/j.mri.2006.03.015; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; EDELSTEIN WA, 1983, J COMPUT ASSIST TOMO, V7, P391, DOI 10.1097/00004728-198306000-00001; Fera F, 2004, J MAGN RESON IMAGING, V19, P19, DOI 10.1002/jmri.10440; Funai A, 2010, I S BIOMED IMAGING, P712, DOI 10.1109/ISBI.2010.5490075; Giovanni BF, 2010, NAT REV NEUROL, V6, P67, DOI [10.1038/nrneurol.2009.215, DOI 10.1038/NRNEUROL.2009.215]; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Ikonomidou VN, 2005, MAGN RESON MED, V54, P373, DOI 10.1002/mrm.20561; Kay S. M., 1993, FUNDAMENTALS OF STAT, V1; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koohi A, 2011, P INT SOC MAGN RES M, P4369; Lankford CL, 2013, MAGN RESON MED, V69, P127, DOI 10.1002/mrm.24241; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Li K, 2010, MAGN RESON MED, V64, P491, DOI 10.1002/mrm.22440; Liu Y, 2013, P BIOM ENG SOC BMES; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Manfredonia F, 2007, ARCH NEUROL-CHICAGO, V64, P411, DOI 10.1001/archneur.64.3.411; MCDONALD GG, 1973, J MAGN RESON, V9, P358, DOI 10.1016/0022-2364(73)90177-7; McRobbie D. W., 2006, MRI PICTURE PROTON; Neema M, 2007, J NEUROIMAGING, V17, p16S, DOI 10.1111/j.1552-6569.2007.00131.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Press W. H., 1992, NUMERICAL RECIPES FO, V77; Riva M, 2009, AM J NEURORADIOL, V30, P1394, DOI 10.3174/ajnr.A1573; SCHARF LL, 1993, SIGNAL PROCESS, V31, P301, DOI 10.1016/0165-1684(93)90088-R; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Steenwijk MD, 2016, MULT SCLER J, V22, P1279, DOI 10.1177/1352458515615953; Teixeira R, 2014, P INT SOC MAGN RES M, P3200; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Zhao B, 2014, IEEE T MED IMAGING, V33, P1832, DOI 10.1109/TMI.2014.2322815	42	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0172573	10.1371/journal.pone.0172573	http://dx.doi.org/10.1371/journal.pone.0172573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222197	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800069
J	Lima, DCD; do Vale, CR; Veras, JH; Bernardes, A; Perez, CN; Chen-Chen, L				da Silva Lima, Debora Cristina; do Vale, Camila Regina; Veras, Jefferson Hollanda; Bernardes, Aline; Perez, Caridad Noda; Chen-Chen, Lee			Absence of genotoxic effects of the chalcone (E)-1-(2-hydroxyphenyl)-3-(4-methylphenyl)-prop-2-en-1-one) and its potential chemoprevention against DNA damage using in vitro and in vivo assays	PLOS ONE			English	Article							COMET ASSAY; MICRONUCLEUS TEST; ANTIOXIDANT PROPERTIES; SODIUM-AZIDE; MUTAGENICITY; HYDROXYCHALCONES; DERIVATIVES; INHIBITORS; CRYSTAL; LEADS	The chalcone (E)-1-(2-hydroxyphenyl)-3-(4-methylphenyl)-prop-2-en-1-one), or 2HMC, displays antileishmanial, antimalarial, and antioxidant activities. The aim of this study was to investigate the cytotoxic, genotoxic, mutagenic, and protective effects of 2HMC using the Ames mutagenicity test, the mouse bone marrow micronucleus test, and the comet assay in mice. In the assessment using the Ames test, 2HMC did not increase the number of His + revertants in Salmonella typhimurium strains, demonstrating lack of mutagenicity. 2HMC showed no significant increase in micronucleated polychromatic erythrocyte frequency (MNPCE) in the micronucleus test, or in DNA strand breaks using the comet assay, evidencing absence of genotoxicity. Regarding cytotoxicity, 2HMC exhibited moderate cytotoxicity in mouse bone marrow cells by micronucleus test. 2HMC showed antimutagenic action in co-administration with the positive controls, sodium azide (SA) and 4-nitroquinoline-1-oxide (4NQO), in the Ames test. Co-administered and mainly pre-administered with cyclophosphamide (CPA), 2HMC caused a decrease in the frequency of MNPCE using the micronucleus test and in DNA strand breaks using the comet assay. Thus, 2HMC exhibited antimutagenic and antigenotoxic effects, displaying a DNA-protective effect against CPA, SA, and 4NQO carcinogens. In conclusion, 2HMC presented antimutagenic, antigenotoxic and moderate cytotoxic effects; therefore it is a promising molecule for cancer prevention.	[da Silva Lima, Debora Cristina; do Vale, Camila Regina; Veras, Jefferson Hollanda; Chen-Chen, Lee] Univ Fed Goias, Inst Biol Sci, Dept Genet, Goiania, Go, Brazil; [Bernardes, Aline; Perez, Caridad Noda] Univ Fed Goias, Inst Chem, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Chen-Chen, L (corresponding author), Univ Fed Goias, Inst Biol Sci, Dept Genet, Goiania, Go, Brazil.	chenleego@yahoo.com.br	Noda-Perez, Caridad/AAO-1659-2021; Perez, Caridad C. Noda Noda/M-6704-2013; Chen-Chen, Lee/Q-9797-2019; Véras, Jefferson Hollanda/B-5181-2013; Chen, Lee Chen/B-1668-2013	Noda-Perez, Caridad/0000-0003-0586-0774; Perez, Caridad C. Noda Noda/0000-0003-0586-0774; Chen-Chen, Lee/0000-0002-0386-247X; Véras, Jefferson Hollanda/0000-0001-9959-6411; Chen, Lee Chen/0000-0002-0386-247X	Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under auspices of the Federal University of Goias (UFG)	Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under auspices of the Federal University of Goias (UFG)	This study was financially supported by the Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under the auspices of the Federal University of Goias (UFG).	Al-Qurainy F., 2009, World Applied Sciences Journal, V6, P1589; Augustyniak M, 2014, CHEMOSPHERE, V96, P180, DOI 10.1016/j.chemosphere.2013.10.033; Balsera B, 2014, EUR J MED CHEM, V86, P724, DOI 10.1016/j.ejmech.2014.09.039; Batagin-Neto A, 2014, MED CHEM RES, V23, P580, DOI 10.1007/s00044-013-0667-4; Bukhari SNA, 2012, MINI-REV MED CHEM, V12, P1394; Chakraborty P., 2009, J CANC MOL, V4, P183; CHENG XY, 1988, ENVIRON EXP BOT, V28, P281, DOI 10.1016/0098-8472(88)90051-2; Corcuera LA, 2015, FOOD CHEM TOXICOL, V76, P116, DOI 10.1016/j.fct.2014.12.003; Das S, 2014, BIOORG MED CHEM LETT, V24, P5050, DOI 10.1016/j.bmcl.2014.09.028; de Lima JP, 2015, FOOD RES INT, V75, P216, DOI 10.1016/j.foodres.2015.05.045; Detsi A, 2009, BIOORGAN MED CHEM, V17, P8073, DOI 10.1016/j.bmc.2009.10.002; Echeverria C, 2009, INT J MOL SCI, V10, P221, DOI 10.3390/ijms10010221; Fedato RP, 2014, J APPL TOXICOL, V34, P33, DOI 10.1002/jat.2823; Goodarzi M, 2014, EUR J PHARM SCI, V51, P189, DOI 10.1016/j.ejps.2013.09.019; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; HALES BF, 1982, CANCER RES, V42, P3016; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Kim IY, 2006, ECOTOX ENVIRON SAFE, V64, P288, DOI 10.1016/j.ecoenv.2005.05.019; Kozlowski D, 2007, J PHYS CHEM A, V111, P1138, DOI 10.1021/jp066496+; KRAMER A, 1993, MUTAT RES, V290, P165, DOI 10.1016/0027-5107(93)90156-A; Lapchak PA, 2013, TRANSL STROKE RES, V4, P328, DOI 10.1007/s12975-012-0200-y; Lee RF, 2013, MAR POLLUT BULL, V77, P355, DOI 10.1016/j.marpolbul.2013.06.017; Leon-Mejia G, 2011, SCI TOTAL ENVIRON, V409, P686, DOI 10.1016/j.scitotenv.2010.10.049; Liu M, 2003, BIOORGAN MED CHEM, V11, P2729, DOI 10.1016/S0968-0896(03)00233-5; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Maronpot RR, 2015, FOOD CHEM TOXICOL, V77, P111, DOI 10.1016/j.fct.2014.12.021; Martinez-Cifuentes M, 2015, RSC ADV, V5, P1; Mersch-Sundermann V, 2004, TOXICOLOGY, V198, P329, DOI 10.1016/j.tox.2004.02.009; Mondal R, 2011, TETRAHEDRON LETT, V52, P5020, DOI 10.1016/j.tetlet.2011.07.072; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Mostahar S, 2006, INDIAN J CHEM B, V45, P1478; Muthukumar M, 2008, SPECTROCHIM ACTA A, V70, P1222, DOI 10.1016/j.saa.2007.10.043; Noroozi M, 1998, AM J CLIN NUTR, V67, P1210, DOI 10.1093/ajcn/67.6.1210; Parmar AR, 2014, REPROD TOXICOL, V49, P171, DOI 10.1016/j.reprotox.2014.08.004; Patel M. M., 2014, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V5, P187; Qian H, 2013, IND ENG CHEM RES, V52, P13272, DOI 10.1021/ie401557j; Qin CX, 2008, J MED CHEM, V51, P1874, DOI 10.1021/jm070352h; Qu Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/603415; Raghav N, 2014, EUR J PHARM SCI, V60, P55, DOI 10.1016/j.ejps.2014.04.006; RASHID KA, 1986, MUTAT RES, V169, P71, DOI 10.1016/0165-1218(86)90086-8; Resende FA, 2015, REGUL TOXICOL PHARM, V72, P506, DOI 10.1016/j.yrtph.2015.05.014; Ross L, 2009, PHENOLS ANTIOXIDANTS, P1; Rossi M, 2013, BIOCHIMIE, V95, P1954, DOI 10.1016/j.biochi.2013.07.002; Rothfuss A, 2011, MUTAT RES-GEN TOX EN, V723, P108, DOI 10.1016/j.mrgentox.2010.12.005; Sakirolla R, 2012, MONATSH CHEM, V143, P797, DOI 10.1007/s00706-011-0663-7; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Serifi O, 2013, J PHYS ORG CHEM, V26, P226, DOI 10.1002/poc.3071; Serpeloni JM, 2013, HUM EXP TOXICOL, V32, P828, DOI 10.1177/0960327112468911; Sghaier MB, 2011, S AFR J BOT, V77, P730, DOI 10.1016/j.sajb.2011.03.014; Shoja M, 1999, Z KRIST-NEW CRYST ST, V214, P235; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stoyanov EV, 2002, BIOORG MED CHEM LETT, V12, P2685, DOI 10.1016/S0960-894X(02)00553-X; Tran TD, 2009, BIOORG MED CHEM LETT, V19, P1650, DOI 10.1016/j.bmcl.2009.02.001; TORIGOE T, 1983, BIOCHEM BIOPH RES CO, V112, P833, DOI 10.1016/0006-291X(83)91693-5; Trivedi PP, 2010, MUTAT RES-GEN TOX EN, V703, P115, DOI 10.1016/j.mrgentox.2010.08.005; Uno Y, 2015, MUTAT RES-GEN TOX EN, V783, P19, DOI 10.1016/j.mrgentox.2015.03.001; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Vinod V, 2011, J ETHNOPHARMACOL, V134, P931, DOI 10.1016/j.jep.2011.02.003; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Wang GR, 2015, FOOD CHEM, V171, P89, DOI 10.1016/j.foodchem.2014.08.106; Wang H, 2005, TOXICOLOGY, V207, P303, DOI 10.1016/j.tox.2004.10.005; WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E; Xue YS, 2013, J PHYS ORG CHEM, V26, P240, DOI 10.1002/poc.3074; Xue YS, 2012, COMPUT THEOR CHEM, V982, P74, DOI 10.1016/j.comptc.2011.12.020; YAMAMOTO K, 1992, PLANTA MED, V58, P389, DOI 10.1055/s-2006-961498	66	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171224	10.1371/journal.pone.0171224	http://dx.doi.org/10.1371/journal.pone.0171224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207781	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500019
J	Mern, DS; Tschugg, A; Hartmann, S; Thome, C				Mern, Demissew Shenegelegn; Tschugg, Anja; Hartmann, Sebastian; Thome, Claudius			Self-complementary adeno-associated virus serotype 6 mediated knockdown of ADAMTS4 induces long-term and effective enhancement of aggrecan in degenerative human nucleus pulposus cells: A new therapeutic approach for intervertebral disc disorders	PLOS ONE			English	Article							EFFICIENT TRANSDUCTION; GENE-TRANSFER; THROMBOSPONDIN-1 REPEATS; ANIMAL-MODELS; IN-VITRO; VECTORS; EXPRESSION; FAMILY; METALLOPROTEINASES; COTRANSFECTION	Inhibition of intervertebral disc (IVD) degeneration, which is often accompanied by painful inflammatory and immunopathological processes, is challenging. Current IVD gene therapeutic approaches are based on adenoviral gene delivery systems, which are limited by immune reactions to their viral proteins. Their applications in IVDs near to sensitive neural structure could provoke toxicity and immunological side-effects with neurological deficits. Self-complementary adeno-associated virus (scAAV) vectors, which do not express any viral gene and are not linked with any known disease in humans, are attractive therapeutic gene delivery vectors in degenerative IVDs. However, scAAV-based silencing of catabolic or inflammatory factor has not yet been investigated in human IVD cells. Therefore, we used scAAV6, the most suitable serotype for transduction of human nucleus pulposus (NP) cells, to knockdown the major catabolic gene (ADAMTS4) of IVD degeneration. IVD degeneration grades were determined by preoperative magnetic resonance imaging. Lumbar NP tissues of degeneration grade III were removed from 12 patients by nucleotomy. NP cells were isolated and cultured with low-glucose. Titre of recombinant scAAV6 vectors targeting ADAMTS4, transduction efficiencies, transduction units, cell viabilities and expression levels of target genes were analysed using quantitative PCR, fluorescence microscopy, fluorescence -activated cell sorting, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assays, quantitative reverse transcription PCR, western blot and enzyme-linked immunosorbent assays during 48 days of post-transduction. Transduction efficiencies between 98.2% and 37.4% and transduction units between 611 and 245 TU/cell were verified during 48 days of post-transduction (p<0.001). scAAV6-mediated knockdown of ADAMTS4 with maximum 87.7% and minimum 40.1% was confirmed on day 8 and 48 with enhanced the level of aggrecan 48.5% and 30.2% respectively (p<0.001). scAAV6-mediated knockdown of ADAMTS4 showed no impact on cell viability and expression levels of other inflammatory catabolic proteins. Thus, our results are promising and may help to design long-term and less immunogenic gene therapeutic approaches in IVD disorders, which usually need prolonged therapeutic period between weeks and months.	[Mern, Demissew Shenegelegn; Tschugg, Anja; Hartmann, Sebastian; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria	Medical University of Innsbruck	Mern, DS (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.	demissew.shenegelegn@i-med.ac.at		Shenegelegn Mern, Demissew/0000-0001-5893-981X	Innsbruck Medical University	Innsbruck Medical University	The study is funded by Innsbruck Medical University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chen SF, 2005, HUM GENE THER, V16, P235, DOI 10.1089/hum.2005.16.235; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006; Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Kaneyama S, 2008, J ORTHOP SCI, V13, P130, DOI 10.1007/s00776-007-1204-4; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lattermann C, 2005, SPINE, V30, P497, DOI 10.1097/01.brs.0000154764.62072.44; Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200; Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9; Lozier JN, 2002, HUM GENE THER, V13, P113, DOI 10.1089/10430340152712665; Mazzolini G, 2001, GENE THER, V8, P259, DOI 10.1038/sj.gt.3301387; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Mern DS, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0799-4; Mern DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096870; Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467; Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583; Moon SH, 2008, SPINE, V33, P1850, DOI 10.1097/BRS.0b013e31817e1cd7; Nemunaitis J, 2001, GENE THER, V8, P746, DOI 10.1038/sj.gt.3301424; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ren S, 2013, INT J MOL MED, V32, P1063, DOI 10.3892/ijmm.2013.1497; Ren XF, 2015, GENET MOL RES, V14, P3736, DOI 10.4238/2015.April.22.1; Rothe D, 2010, OLIGONUCLEOTIDES, V20, P191, DOI 10.1089/oli.2010.0236; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Tang BL, 1999, FEBS LETT, V445, P223, DOI 10.1016/S0014-5793(99)00119-2; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Wagner A, 2013, HUM GENE THER METHOD, V24, P355, DOI 10.1089/hgtb.2013.095; Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wu JQ, 2007, HUM GENE THER, V18, P171, DOI 10.1089/hum.2006.088; Xi YM, 2013, GENET MOL RES, V12, P4895, DOI 10.4238/2013.February.28.11; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	49	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172181	10.1371/journal.pone.0172181	http://dx.doi.org/10.1371/journal.pone.0172181			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207788	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500094
J	Ni, JB; Bai, SL; Gao, L; Qian, MJ; Zhong, LB; Teng, YW				Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Zhong, Linbing; Teng, Yuanwen			Identification, classification, and transcription profiles of the B-type response regulator family in pear	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; SIGNAL-TRANSDUCTION; SEED DEVELOPMENT; CELL-DIVISION; GENE FAMILY; CYTOKININ; ROLES; EVOLUTION; DORMANCY; CULTURES	Type-B response regulators (B-RRs) are transcription factors that function in the final step of two-component signaling systems. In model plants, B-RRs have been shown to play important roles in cytokinin signal transduction. However, the functions of B-RRs in pear have not been well studied. In this report, we conducted a genome-wide analysis and identified 11 putative genes encoding B-PpRR proteins based on the published genome sequence of Pyrus bretschneideri. A phylogenetic tree of the B-PpRR family was constructed, and the motif distribution, chromosome localization, and gene structure of B-PpRR family genes were determined. Gene transcript profiles, which were determined from transcriptome data, indicated that B-PpRR genes potentially function during pear fruit development, bud dormancy, and light/hormone-induced anthocyanin accumulation. Treatment of the fruitlets of 'Cuiguan' pear (Pyrus pyrifolia), which never accumulates anthocyanin, with the cytokinin N-(2-chloro-4-pyridyl)-N ' phenylurea (CPPU) clearly induced anthocyanin accumulation. Anthocyanins accumulated in the skin of fruitlets by 16 days after CPPU treatment, along with the significant activation of most anthocyanin biosynthetic genes. Analyses of B-PpRR transcript levels suggested that B-PpRR genes mediated this accumulation of anthocyanins. These findings enrich our understanding of the function of B-PpRR genes in the physiological processes of pear.	[Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Teng, Yuanwen] Zhejiang Univ, Dept Hort, Hangzhou, Zhejiang, Peoples R China; [Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Teng, Yuanwen] Minist Agr China, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Ni, Junbei; Bai, Songling; Gao, Ling; Qian, Minjie; Teng, Yuanwen] Zhejiang Prov Key Lab Integrat Biol Hort Plants, Hangzhou, Zhejiang, Peoples R China; [Zhong, Linbing] Tonglu Extens Ctr Agr & Forestal Technol, Tonglu, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	Teng, YW (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou, Zhejiang, Peoples R China.; Teng, YW (corresponding author), Minist Agr China, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China.; Teng, YW (corresponding author), Zhejiang Prov Key Lab Integrat Biol Hort Plants, Hangzhou, Zhejiang, Peoples R China.	ywteng@zju.edu.cn	Ni, Junbei/GXN-0224-2022; Bai, Songling/X-9850-2019; Teng, Yuanwen/A-3515-2015	Bai, Songling/0000-0002-8103-3095; Teng, Yuanwen/0000-0001-8656-9035	National Natural Science Foundation of China [31471852, 31272141, 31501736]; Earmarked Fund for Modern Agro-industry Technology Research Systems [CARS-29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research Systems	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31471852, 31272141) (YT), the Earmarked Fund for Modern Agro-industry Technology Research Systems (CARS-29) (YT), and the National Natural Science Foundation of China (Grant No. 31501736) (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant Nos. 31471852, 31272141) (YT), the Earmarked Fund for Modern Agro-industry Technology Research Systems (CARS-29) (YT), and the National Natural Science Foundation of China (Grant No. 31501736) (SB).	Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; Bai SL, 2014, PLANTA, V240, P1051, DOI 10.1007/s00425-014-2129-8; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bhattacharya Amita, 2006, Indian Journal of Plant Physiology, V11, P287; CROSBY KE, 1981, PLANT PHYSIOL, V68, P985, DOI 10.1104/pp.68.5.985; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Das PK, 2012, MOL CELLS, V34, P93, DOI 10.1007/s10059-012-0114-2; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Ji XH, 2015, PLANT CELL TISS ORG, V120, P325, DOI 10.1007/s11240-014-0609-y; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mason MG, 2004, PLANT PHYSIOL, V135, P927, DOI 10.1104/pp.103.038109; Matsuo S, 2012, J EXP BOT, V63, P5569, DOI 10.1093/jxb/ers207; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MORI T, 1994, J SCI FOOD AGR, V65, P271, DOI 10.1002/jsfa.2740650303; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Ramirez-Carvajal GA, 2008, NEW PHYTOL, V177, P77, DOI 10.1111/j.1469-8137.2007.02240.x; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Schaller GE, 2007, PLANT PHYSIOL, V143, P555, DOI 10.1104/pp.106.093666; Suttle JC, 1998, PHYSIOL PLANTARUM, V103, P59, DOI 10.1034/j.1399-3054.1998.1030108.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Zhang CX, 2006, ANN BOT-LONDON, V98, P537, DOI 10.1093/aob/mcl144; Zhang D, 2012, SCI HORTIC, V134, P53	44	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171523	10.1371/journal.pone.0171523	http://dx.doi.org/10.1371/journal.pone.0171523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207822	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500033
J	Stahel, P; Kim, JJ; Xiao, CT; Cant, JP				Stahel, Priska; Kim, Julie J.; Xiao, Changting; Cant, John P.			Of the milk sugars, galactose, but not prebiotic galacto-oligosaccharide, improves insulin sensitivity in male Sprague-Dawley rats	PLOS ONE			English	Article							HEPATIC GLYCOGEN-SYNTHESIS; RESISTANCE SYNDROME; GLUCOSE-METABOLISM; DAIRY CONSUMPTION; HEALTHY-SUBJECTS; GUT MICROFLORA; WHEY-PROTEIN; FRUCTOSE; ADULTS; RISK	Background Consumption of dairy products reduces risk of type 2 diabetes. Milk proteins and fats exhibit anti-diabetic properties but milk sugars have been studied little in this context. Galactose from milk lactose is readily converted to glycogen in the liver but its effects on insulin sensitivity have not been assessed. Prebiotic oligosaccharides from milk alter gut microbiota and can thereby influence host metabolism. Our objective was to assess the effect on insulin sensitivity of dietary galactose compared to glucose and fructose, and fermentable galactooligosaccharides compared to non-fermentable methylcellulose. Methods Diets containing 15% of dry matter from glucose, fructose, galactose, galacto-oligosaccharides, or methylcellulose were fed to 36 rats per diet for 9 weeks. Hyperinsulinemic-euglycemic clamps with [3-H-3]glucose infusion and a steady-state 2-[1-C-14]deoxyglucose bolus injection were used to assess insulin sensitivity and glucose uptake indices. Tissue was collected in fed, fasted and fasted, insulin-stimulated states. Results Galactose increased glucose infusion rate during the clamp by 53% and decreased endogenous glucose production by 57% compared to glucose and fructose. Fed-state hepatic glycogen content was greater with galactose compared to glucose and fructose, consistent with a potentiation of the insulin effect on glycogen synthase by dephosphorylation. Galactose decreased the fecal Firmicutes:Bacteroidetes ratio while galacto-oligosaccharides increased abundance of fecal Bifidobacterium spp. 481-fold compared to methylcellulose, and also increased abundance of Lactobacillus spp. and Bacteroidetes. Galacto-oligosaccharides did not affect glucose infusion rate or endogenous glucose production during basal or clamp periods compared to methylcellulose. Conclusions Galactose at 15% of daily intake improved hepatic insulin sensitivity in rats compared to glucose and fructose. Galactose caused an increase in fed-state hepatic glycogen content and a favourable shift in gut microbial populations. Intake of galacto-oligosaccharides improved the gut microbial profile but did not improve insulin sensitivity.	[Stahel, Priska; Kim, Julie J.; Cant, John P.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Xiao, Changting] Univ Toronto, Dept Physiol & Med, Toronto, ON, Canada	University of Guelph; University of Toronto	Cant, JP (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada.	jcant@uoguelph.ca	Cant, John/ABF-5323-2021	Cant, John/0000-0003-2021-1764; Xiao, Changting/0000-0002-4432-5689	Dairy Farmers of Ontario; Canadian Dairy Commission; OMAFRA HQP Program	Dairy Farmers of Ontario; Canadian Dairy Commission; OMAFRA HQP Program	This study was funded in part by Dairy Farmers of Ontario, which is a non-profit marketing group owned and operated by dairy farmers. The funding body was not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JPC received this funding [https://www.milk.org/corporate/main.asp]. PS was supported by scholarships from the Canadian Dairy Commission and OMAFRA HQP Program.	Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; AOAC International, 1996, OFFICIAL METHODS ANA, V16th; Barosa C, 2012, METABOLISM, V61, P250, DOI 10.1016/j.metabol.2011.06.022; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bhatia S, 2015, MOL NUTR FOOD RES, V59, P566, DOI 10.1002/mnfr.201400639; Bowen J, 2005, INT J OBESITY, V29, P957, DOI 10.1038/sj.ijo.0802895; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Cani PD, 2005, J ENDOCRINOL, V185, P457, DOI 10.1677/joe.1.06100; Marin-Manzano MC, 2013, J AGR FOOD CHEM, V61, P7560, DOI 10.1021/jf402218z; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; De Angel RE, 2009, IN VIVO, V23, P527; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; ERCAN N, 1994, ARCH BIOCHEM BIOPHYS, V315, P35, DOI 10.1006/abbi.1994.1467; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Hernandez-Hernandez O, 2012, J NUTR, V142, P1232, DOI 10.3945/jn.111.155762; Jakubowicz D, 2014, DIABETOLOGIA, V57, P1807, DOI 10.1007/s00125-014-3305-x; Josse AR, 2011, J NUTR, V141, P1626, DOI 10.3945/jn.111.141028; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KLIEGMAN RM, 1988, PEDIATR RES, V24, P302, DOI 10.1203/00006450-198809000-00005; Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Leforestier G, 2009, EUR J NUTR, V48, P457, DOI 10.1007/s00394-009-0036-8; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Liu WJ, 2011, AM J PATHOL, V178, P1489, DOI 10.1016/j.ajpath.2010.12.052; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; NIEWOEHNER CB, 1992, AM J PHYSIOL, V263, pE42, DOI 10.1152/ajpendo.1992.263.1.E42; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Otsyula M, 2003, INT J TOXICOL, V22, P423, DOI 10.1080/10915810390251410; Pantophlet AJ, 2016, J DAIRY SCI, V99, P3072, DOI 10.3168/jds.2015-10277; Parnell JA, 2012, J NUTR, V107, P1; Paturi G, 2012, J FUNCT FOODS, V4, P520, DOI 10.1016/j.jff.2012.02.013; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Ramana BV, 2006, ACTA DIABETOL, V43, P135, DOI 10.1007/s00592-006-0229-z; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Tuohy KM, 2005, CURR PHARM DESIGN, V11, P75, DOI 10.2174/1381612053382331; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Xiao CT, 2005, J DAIRY SCI, V88, P2794, DOI 10.3168/jds.S0022-0302(05)72959-3; ZAVARONI I, 1980, METABOLISM, V29, P970, DOI 10.1016/0026-0495(80)90041-4; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	45	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172260	10.1371/journal.pone.0172260	http://dx.doi.org/10.1371/journal.pone.0172260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207812	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500108
J	Vidal, M				Vidal, Manuel			Hearing flashes and seeing beeps: Timing audiovisual events	PLOS ONE			English	Article							TEMPORAL VENTRILOQUISM; PERCEPTUAL LATENCY; RECALIBRATION; DURATION; SOUND; SIMULTANEITY; VISION; INTEGRATION; TIME; DISCRIMINATION	Many events from daily life are audiovisual (AV). Handclaps produce both visual and acoustic signals that are transmitted in air and processed by our sensory systems at different speeds, reaching the brain multisensory integration areas at different moments. Signals must somehow be associated in time to correctly perceive synchrony. This project aims at quantifying the mutual temporal attraction between senses and characterizing the different interaction modes depending on the offset. In every trial participants saw four beep-flash pairs regularly spaced in time, followed after a variable delay by a fifth event in the test modality (auditory or visual). A large range of AV offsets was tested. The task was to judge whether the last event came before/after what was expected given the perceived rhythm, while attending only to the test modality. Flashes were perceptually shifted in time toward beeps, the attraction being stronger for lagging than leading beeps. Conversely, beeps were not shifted toward flashes, indicating a nearly total auditory capture. The subjective timing of the visual component resulting from the AV interaction could easily be forward but not backward in time, an intuitive constraint stemming from minimum visual processing delays. Finally, matching auditory and visual time-sensitivity with beeps embedded in pink noise produced very similar mutual attractions of beeps and flashes. Breaking the natural auditory preference for timing allowed vision to take over as well, showing that this preference is not hardwired.	[Vidal, Manuel] Aix Marseille Univ, CNRS, UMR 7289, Inst Neurosci Timone, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vidal, M (corresponding author), Aix Marseille Univ, CNRS, UMR 7289, Inst Neurosci Timone, Marseille, France.	manuel.vidal@univ-amu.fr		Vidal, Manuel/0000-0002-8504-1500				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Di Luca M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28563; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; HALPERN AR, 1982, PERCEPT PSYCHOPHYS, V31, P86, DOI 10.3758/BF03206204; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Hartcher-O'Brien J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089339; Hartcher-O'Brien J, 2011, J EXP PSYCHOL HUMAN, V37, P1383, DOI 10.1037/a0024234; Heron J, 2004, VISION RES, V44, P2875, DOI 10.1016/j.visres.2004.07.001; Horr NK, 2015, ATTEN PERCEPT PSYCHO, V77, P592, DOI 10.3758/s13414-014-0787-z; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Keetels M, 2012, NEURAL BASEMULTISE; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Kuling IA, 2013, ATTEN PERCEPT PSYCHO, V75, P1583, DOI 10.3758/s13414-013-0511-4; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Linares D, 2014, I-PERCEPTION, V5, P559, DOI 10.1068/i0675; Machulla TK, 2012, EXP BRAIN RES, V217, P89, DOI 10.1007/s00221-011-2976-5; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Ortega L, 2014, ATTEN PERCEPT PSYCHO, V76, P1485, DOI 10.3758/s13414-014-0663-x; POPPEL E, 1990, NATURWISSENSCHAFTEN, V77, P89, DOI 10.1007/BF01131783; Poppel E., 1988, MINDWORKS TIME CONSC; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Ten Hoopen G, 2011, ATTEN PERCEPT PSYCHO, V73, P2249, DOI 10.3758/s13414-011-0171-1; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Yarrow K, 2011, CONSCIOUS COGN, V20, P1518, DOI 10.1016/j.concog.2011.07.003	39	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172028	10.1371/journal.pone.0172028	http://dx.doi.org/10.1371/journal.pone.0172028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207786	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500075
J	Wei, BF; Wei, W; Zhao, BX; Guo, XX; Liu, S				Wei, Biaofang; Wei, Wei; Zhao, Baoxiang; Guo, Xiaxia; Liu, Song			Long non-coding RNA HOTAIR inhibits miR-17-5p to regulate osteogenic differentiation and proliferation in nontraumatic osteonecrosis of femoral head	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTES; IDENTIFICATION; EXPRESSION; MICRORNAS; GROWTH; RISK	Background and aim The biological functions of non-coding RNAs (ncRNAs) have been widely identified in many human diseases. In the present study, the relationship between long non-coding RNA HOTAIR and microRNA-17-5p (miR-17-5p) and their roles in osteogenic differentiation and proliferation in non-traumatic osteonecrosis of femoral head (ONFH) were investigated. Methods The expression levels of HOTAIR and miR-17-5p in the mesenchymal stem cells (MSCs) derived from patients with non-traumatic ONFH and osteoarthritis (OA) were examined by real-time PCR. BMP-2 induced human MSCs from bone marrow (hMSC-BM) were used for osteogenic differentiation. Results It was observed that the expression level of miR-17-5p was lower and the level of HOTAIR was higher in samples of non-traumatic ONFH compared with OA. HOTAIR downregulation induced by si-HOTAIR led to the increase of miR-17-5p expression and the decrease of miR-17-5p target gene SMAD7 expression. The values of osteogenic differentiation markers, including RUNX2 and COL1A1 mRNA expression and ALP activity, were also elevated by si-HOTAIR. However, the increase of these values was canceled by miR-17-5p inhibitor or SMAD7 upregulation. Conclusion HOTAIR played a role in regulating osteogenic differentiation and proliferation through modulating miR-17-5p and its target gene SMAD7 in non-traumatic ONFH.	[Wei, Biaofang; Zhao, Baoxiang; Guo, Xiaxia; Liu, Song] Linyi Peoples Hosp, Dept Orthopaed, Linyi, Shandong, Peoples R China; [Wei, Wei] Guangzhou Univ Chinese Med, Sch Clin Med 1, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine	Wei, BF (corresponding author), Linyi Peoples Hosp, Dept Orthopaed, Linyi, Shandong, Peoples R China.	weibiaofang@126.com			Science and Technology Development Plan of Shandong Province [2014GSF119022]	Science and Technology Development Plan of Shandong Province	The work was funded by the Science and Technology Development Plan of Shandong Province (Grant Number: 2014GSF119022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrion K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096577; Fang T, 2016, EXPERIMENTAL CELL RE; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Ji X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030349; Jia J, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.43; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lee JS, 2006, J ORTHOP RES, V24, P604, DOI 10.1002/jor.20078; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Liu S, 2016, CURR NEUROVASC RES, V13, P115, DOI 10.2174/1567202613666160316155228; Miao CG, 2013, CELL SIGNAL, V25, P1118, DOI 10.1016/j.cellsig.2013.01.024; Qu Y, 2016, ONCOTARGET; Svoboda M, 2014, CARCINOGENESIS, V35, P1510, DOI 10.1093/carcin/bgu055; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Wang W, 2016, ONCOL REP, V35, P1473, DOI 10.3892/or.2016.4542; Wei Q, 2012, IUBMB LIFE, V64, P697, DOI 10.1002/iub.1051; Wu Q, 2014, FEBS LETT, V588, P2055, DOI 10.1016/j.febslet.2014.04.036; Wu XJ, 2015, GENE, V565, P22, DOI 10.1016/j.gene.2015.03.072; Wu YS, 2014, TUMOR BIOL, V35, P9531, DOI 10.1007/s13277-014-2523-7; Xing D, 2014, ORTHOP SURG, V6, P288, DOI 10.1111/os.12147; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Zhang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/175940; Zhang L, 2015, MABS, V8, P205; Zhou Q, 2016, ONCOTARGET, V7, P19928, DOI 10.18632/oncotarget.7957	25	107	114	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0169097	10.1371/journal.pone.0169097	http://dx.doi.org/10.1371/journal.pone.0169097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207735	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500003
J	Heaney, M; Gray, RD; Taylor, AH				Heaney, Megan; Gray, Russell D.; Taylor, Alex H.			Keas Perform Similarly to Chimpanzees and Elephants when Solving Collaborative Tasks	PLOS ONE			English	Article							NESTOR-NOTABILIS; CORVUS-FRUGILEGUS; HUMAN COOPERATION; CALEDONIAN CROWS; PAN-TROGLODYTES; EVOLUTION; COGNITION; BEHAVIOR; PARTNER; PREFER	Cooperation between individuals is one of the defining features of our species. While other animals, such as chimpanzees, elephants, coral trout and rooks also exhibit cooperative behaviours, it is not clear if they think about cooperation in the same way as humans do. In this study we presented the kea, a parrot endemic to New Zealand, with a series of tasks designed to assess cooperative cognition. We found that keas were capable of working together, even when they had to wait for their partner for up to 65 seconds. The keas also waited for a partner only when a partner was actually needed to gain food. This is the first demonstration that any non-human animal can wait for over a minute for a cooperative partner, and the first conclusive evidence that any bird species can successful track when a cooperative partner is required, and when not. The keas did not attend to whether their partner could actually access the apparatus themselves, which may have been due to issues with task demands, but one kea did show a clear preference for working together with other individuals, rather than alone. This preference has been shown to be present in humans but absent in chimpanzees. Together these results provide the first evidence that a bird species can perform at a similar level to chimpanzees and elephants across a range of collaborative tasks. This raises the possibility that aspects of the cooperative cognition seen in the primate lineage have evolved convergently in birds.	[Heaney, Megan; Gray, Russell D.; Taylor, Alex H.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Gray, Russell D.] Max Planck Inst Sci Human Hist, Jena, Germany; [Gray, Russell D.] Australian Natl Univ, Res Sch Social Sci, Canberra, ACT, Australia	University of Auckland; Australian National University	Taylor, AH (corresponding author), Univ Auckland, Sch Psychol, Auckland, New Zealand.	alexander.taylor@auckland.ac.nz	Taylor, Alex H/D-6428-2012	Taylor, Alex/0000-0003-3492-7667	University of Auckland Doctoral Scholarship; Rutherford Discovery Fellowship	University of Auckland Doctoral Scholarship; Rutherford Discovery Fellowship	This work was supported by a University of Auckland Doctoral Scholarship (MH) and a Rutherford Discovery Fellowship (AHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Boyd R, 2009, PHILOS T R SOC B, V364, P3281, DOI 10.1098/rstb.2009.0134; Brownell CA, 2006, CHILD DEV, V77, P803, DOI 10.1111/j.1467-8624.2006.00904.x; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Diamond J, 2004, BEHAVIOUR, V141, P777, DOI 10.1163/1568539042265680; DIAMOND J, 1991, ETHOLOGY, V88, P128; Diamond J., 1998, KEA BIRD PARADOX EVO; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Henrich J., 2007, WHY HUMANS COOPERATE; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Jelbert SA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0871; Kabadayi C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160104; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Massen JJ, 2015, SCI REPORTS; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostojic L, 2014, ANIM COGN, V17, P445, DOI 10.1007/s10071-013-0676-1; Peron F, 2011, ANIM COGN, V14, P545, DOI 10.1007/s10071-011-0389-2; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Rekers Y, 2011, CURR BIOL, V21, P1756, DOI 10.1016/j.cub.2011.08.066; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Seed AM, 2011, NATURE, V472, P424, DOI 10.1038/472424a; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Tebbich S, 1996, ANIM BEHAV, V52, P1, DOI 10.1006/anbe.1996.0147; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; Vail AL, 2014, CURR BIOL, V24, pR791, DOI 10.1016/j.cub.2014.07.033; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018	30	29	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0169799	10.1371/journal.pone.0169799	http://dx.doi.org/10.1371/journal.pone.0169799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199322	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400010
J	Di Giminiani, R; Visca, C				Di Giminiani, Riccardo; Visca, Christiano			Explosive strength and endurance adaptations in young elite soccer players during two soccer seasons	PLOS ONE			English	Article							LEG EXTENSOR MUSCLES; JUMP PERFORMANCE; YOUTH SOCCER; MATCH-PLAY; FIBER COMPOSITION; MECHANICAL POWER; RUNNING SPEED; HEART-RATE; AGE-GROUP; EXERCISE	The purpose of the present study was to investigate the explosive strength and endurance adaptations in young elite soccer players who underwent a supervised training program for a period of two years. Nineteen players, with seven years of training experience (age: 13.3 0.1 years; body weight: 57.9 4.9 kg; height: 168.9 4.7 cm; BMI: 20.1 1.1 kg/m(2)), voluntarily participated in the present study. The testing sessions were performed at the beginning of the preparation period in the first (T1), second (T2), and third year (T3). The following performance variables were measured: explosive strength [squat-jump (SJ) and countermovement -jump (CMJ)], pre-stretch augmentation (CMJ-SJ), leg stiffness [hopping test (HT)], short sprint performance [15 m (SSP15) and 30 m (SSP30)], aerobic endurance [test of Leger (VO2max)], maximal heart rate [at the last step of Leger (HR)], and speed-strength endurance [continuous counter-movement-jumps (CCMJ)]. A significant main effect on the VO2Max (+5.72%; F(2.45) = 3.822; p= 0.029; ES = 1.00), HR (-1.70%; F-(2.54) = 3.472; p = 0.038; ES = 0.97), CCMJ (+7.64%; F-(2.54) = 5.438; p = 0.007; ES = 1.15), SJ (+10.26%; F-(2.54) = 15.254; p = 0.0001; ES = 1.53), CMJ (+7.36; F-(2.54) = 8.270; p= 0.001; ES = 1.33), HT (+8.34%; F-(2.45) = 3.297; p= 0.046; ES = 1.01), SSP15 (-3.50%; F-(2.44) = 12.760; p = 0.0001; ES = 1.53), and SSP30 (-4.44%; F-(2.44) = 5.797; p= 0.006; ES = 1.16) was observed in the two soccer seasons. These results highlight that, in long-term training, the monitoring of the adaptive responses in relation to the training load may provide a guideline to optimize the trainability of some performance variables in young elite soccer players (13-15 years). In the present study, we cannot exclude the influence of growth and maturation on some performance variables; therefore, the monitored adaptive responses should be considered as the possible results of an interaction between the applied training load and maturation.	[Di Giminiani, Riccardo; Visca, Christiano] Univ Aquila, Lab Biomech Musculoskeletal Syst & Motion Anal, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy	University of L'Aquila	Di Giminiani, R (corresponding author), Univ Aquila, Lab Biomech Musculoskeletal Syst & Motion Anal, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	riccardo.digiminiani@univaq.it	Di Giminiani, Riccardo/AAB-1207-2020	Di Giminiani, Riccardo/0000-0003-3574-3114				Baar K, 2006, MED SCI SPORT EXER, V38, P1939, DOI 10.1249/01.mss.0000233799.62153.19; Baker D, 1999, J STRENGTH COND RES, V13, P230; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; BAXTERJONES A, 1993, J APPL PHYSIOL, V75, P1160, DOI 10.1152/jappl.1993.75.3.1160; BERG KE, 1985, MED SCI SPORT EXER, V17, P656, DOI 10.1249/00005768-198512000-00006; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P129, DOI 10.1007/BF00952545; BOSCO C, 1980, EUR J APPL PHYSIOL O, V45, P209, DOI 10.1007/BF00421329; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Buchheit M, 2010, J STRENGTH COND RES, V24, P2715, DOI 10.1519/JSC.0b013e3181bf0223; Capranica L, 2001, J SPORT SCI, V19, P379, DOI 10.1080/026404101300149339; Castagna C, 2003, J STRENGTH COND RES, V17, P775; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Christou M, 2006, J STRENGTH COND RES, V20, P783, DOI 10.1519/00124278-200611000-00010; COLLIANDER EB, 1988, EUR J APPL PHYSIOL O, V58, P81, DOI 10.1007/BF00636607; Comfort P, 2014, J STRENGTH COND RES, V28, P173, DOI 10.1519/JSC.0b013e318291b8c7; Comfort P, 2012, J STRENGTH COND RES, V26, P937, DOI 10.1519/JSC.0b013e31822e5889; Dalleau G, 2004, INT J SPORTS MED, V25, P170, DOI 10.1005/s-2003-45252; Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Hebestreit H., 2007, YOUNG ATHLETE, P3, DOI DOI 10.1002/9780470696255.CH1; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hobara H, 2009, J BIOMECH, V42, P1768, DOI 10.1016/j.jbiomech.2009.04.047; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jastrzebski Z, 2013, J STRENGTH COND RES, V27, P916, DOI 10.1519/JSC.0b013e31825c327a; Kraemer WJ., 2007, OPTIMIZING STRENGTH; Kraemer WJ., 1989, PEDIATR EXERC SCI, V1, P336, DOI [10.1123/pes.1.4.336, DOI 10.1123/PES.1.4.336]; Kubo K, 1999, J APPL PHYSIOL, V87, P2090, DOI 10.1152/jappl.1999.87.6.2090; KUNO SY, 1995, EUR J APPL PHYSIOL O, V70, P301, DOI 10.1007/BF00865026; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Makhlouf I, 2015, J STRENGTH COND RES; Marques MC, 2013, J HUM KINET, V39, P157, DOI 10.2478/hukin-2013-0078; McMillan K, 2005, BRIT J SPORT MED, V39, P273, DOI 10.1136/bjsm.2004.012526; Mirkov DM, 2010, J STRENGTH COND RES, V24, P2677, DOI 10.1519/JSC.0b013e3181e27245; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Newton RU, 1996, J APPL BIOMECH, V12, P31, DOI 10.1123/jab.12.1.31; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1884, DOI 10.1519/JSC.0000000000000836; Ramirez-Campillo R, 2015, J STRENGTH COND RES, V29, P1784, DOI 10.1519/JSC.0000000000000827; Ramirez-Campillo R, 2014, J STRENGTH COND RES, V28, P1335, DOI 10.1519/JSC.0000000000000284; Riddell MC, 2008, J APPL PHYSIOL, V105, P725, DOI 10.1152/japplphysiol.00031.2008; Stolen T, 2005, SPORTS MED, V35, P501; Stoyer J, 2004, MED SCI SPORTS EXERC, V36, P168, DOI [10.1249/01.MSS.0000106187.05259.96, DOI 10.1249/01.MSS.0000106187.05259.96]; TIHANYI J, 1982, EUR J APPL PHYSIOL, V48, P331, DOI 10.1007/BF00430223; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Vesterinen V, 2014, J STRENGTH COND RES, V28, P902, DOI 10.1519/JSC.0000000000000349; Walshe AD, 1996, EUR J APPL PHYSIOL O, V73, P332, DOI 10.1007/BF02425495; Walter G, 1999, J PHYSIOL-LONDON, V519, P901, DOI 10.1111/j.1469-7793.1999.0901n.x; WASHINGTON RL, 1994, CIRCULATION, V90, P2166, DOI 10.1161/01.CIR.90.4.2166; Williams CA, 2011, INT J SPORT PHYSIOL, V6, P264, DOI 10.1123/ijspp.6.2.264	50	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171734	10.1371/journal.pone.0171734	http://dx.doi.org/10.1371/journal.pone.0171734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192512	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423800039
J	Rojo, JU; Melkus, MW; Kottapalli, KR; Okiya, OE; Sudduth, J; Zhang, WD; Molehin, AJ; Carter, D; Siddiqui, AA				Rojo, Juan U.; Melkus, Michael W.; Kottapalli, Kameswara Rao; Okiya, Oscar E.; Sudduth, Justin; Zhang, Weidong; Molehin, Adebayo J.; Carter, Darrick; Siddiqui, Afzal A.			Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; PROTECTIVE IMMUNITY; SYSTEMS BIOLOGY; DENDRITIC CELLS; DNA VACCINE; MANSONI; RESPONSES; INFECTION; RECEPTOR; IMMUNOGENICITY	Schistosomiasis is a neglected parasitic disease of major public health concern as it affects over 250 million people in developing countries. Currently there is no licensed vaccine available against schistosomiasis. The Schistosoma mansoni calpain protein, Sm-p80, is a leading vaccine candidate now ready to move to clinical trials. In order to better assess Sm-p80 vaccine immunogenicity; here we used a systems biology approach employing RNA-sequencing to identify gene signatures and epistatic interactions following Sm-p80 vaccination in mouse and baboon models that may predict vaccine efficacy. Recombinant Sm-p80 + CpG-oligodeoxynucleotide (ODN) vaccine formulation induced both cellular and humoral immunity genes with a predominant TH1 response as well as TH2 and TH17 gene signatures. Early gene responses and gene -network interactions in mice immunized with rSm-p80 + ODN appear to be initiated through TLR4 signaling. CSFgenes, S100A alarmin genes and TNFRSF genes appear to be a signature of vaccine immunogenicity/efficacy as identified by their participation in gene network interactions in both mice and baboons. These gene families may provide a basis for predicting desirable outcomes for vaccines against schistosomiasis leading to a better understanding of the immune system response to vaccination.	[Rojo, Juan U.; Okiya, Oscar E.; Sudduth, Justin; Zhang, Weidong; Molehin, Adebayo J.; Siddiqui, Afzal A.] Texas Tech Univ, Sch Med, Ctr Trop Med & Infect Dis, Lubbock, TX 79409 USA; [Melkus, Michael W.] Texas Tech Univ, Sch Med, Ctr Trop Med & Infect Dis, Amarillo, TX USA; [Kottapalli, Kameswara Rao] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Zhang, Weidong; Molehin, Adebayo J.; Siddiqui, Afzal A.] Texas Tech Univ, Dept Internal Med, Sch Med, Lubbock, TX 79409 USA; [Carter, Darrick] PAI Life Sci, Seattle, WA USA; [Carter, Darrick] Infect Dis Res Inst, Seattle, WA USA; [Carter, Darrick] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; University of Washington; University of Washington Seattle	Siddiqui, AA (corresponding author), Texas Tech Univ, Sch Med, Ctr Trop Med & Infect Dis, Lubbock, TX 79409 USA.; Siddiqui, AA (corresponding author), Texas Tech Univ, Dept Internal Med, Sch Med, Lubbock, TX 79409 USA.	Afzal.Siddiqui@ttuhsc.edu	Carter, Darrick/N-3304-2016	Carter, Darrick/0000-0001-5901-3402; Rojo, Juan Ulises/0000-0002-3769-0047	NIH [R43A1103983, R44A1103983]; Bill and Melinda Gates Foundation [OPP1097535]; South Plains Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); South Plains Foundation	This work was supported by NIH grants [R43A1103983, R44A1103983]; Bill and Melinda Gates Foundation Grant [OPP1097535]; and the South Plains Foundation. The funder provided support in the form of salaries for authors [JUR, MWM, OEO, JS, WZ, AJM, DC, and MS], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The collaboration with PAI Life Sciences in this study includes data analysis and preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahmad G, 2009, PARASITE IMMUNOL, V31, P156, DOI 10.1111/j.1365-3024.2008.01091.x; Ahmad G, 2011, J INFECT DIS, V204, P1437, DOI 10.1093/infdis/jir545; Ahmad G, 2009, PARASITOL RES, V105, P1767, DOI 10.1007/s00436-009-1646-z; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Boissier J, 2015, LANCET INFECT DIS, V15, P757, DOI 10.1016/S1473-3099(15)00084-5; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Burland T G, 2000, Methods Mol Biol, V132, P71; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Gao JL, 2007, J IMMUNOL, V178, P1450, DOI 10.4049/jimmunol.178.3.1450; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Karmakar S, 2014, VACCINE, V32, P1296, DOI 10.1016/j.vaccine.2013.12.057; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Merrifield M, 2016, VACCINE, V34, P2988, DOI 10.1016/j.vaccine.2016.03.079; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nyindo M, 1999, PARASITOL TODAY, V15, P478, DOI 10.1016/S0169-4758(99)01569-0; Ozawa S, 2011, HEALTH AFFAIR, V30, P1010, DOI 10.1377/hlthaff.2011.0381; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Podesta R. B. KS, 1987, P UCLA S MOL CELL BI; Pulendran B, 2004, EUR J IMMUNOL, V34, P66, DOI 10.1002/eji.200324567; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ricciardi A, 2015, HUM VACC IMMUNOTHER, V11, P2504, DOI 10.1080/21645515.2015.1059981; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santini-Oliveira M, 2016, VACCINE, V34, P586, DOI 10.1016/j.vaccine.2015.10.027; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIDDIQUI AA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P37, DOI 10.1016/0925-4439(93)90087-H; Siddiqui AA, 2003, INFECT IMMUN, V71, P3844, DOI 10.1128/IAI.71.7.3844-3851.2003; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; [WHO WHO], 2015, SHIST PCT DAT; World Health Organization, 2013, GLOB VACC ACT PLAN M; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zepp F, 2016, METHODS MOL BIOL, V1403, P57, DOI 10.1007/978-1-4939-3387-7_3; Zhang W, 2010, PARASITE IMMUNOL, V32, P252, DOI 10.1111/j.1365-3024.2009.01181.x; Zhang WD, 2014, PARASITOL RES, V113, P2239, DOI 10.1007/s00436-014-3879-8; Zhang WD, 2011, ACTA TROP, V118, P142, DOI 10.1016/j.actatropica.2011.01.010	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171677	10.1371/journal.pone.0171677	http://dx.doi.org/10.1371/journal.pone.0171677			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192534	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423800038
J	Wu, MJ; Kim, MR; Chen, YS; Yang, JY; Chang, CJ				Wu, M-J; Kim, M. R.; Chen, Y-S; Yang, J-Y; Chang, C-J			Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKC zeta pathway	ONCOGENE			English	Article							PROTEIN-KINASE-C; EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL; PKC-ZETA; PROGRESSION; METASTASIS; TRIAL; FATE	The key molecular mechanism governing the cancer cell state (stem cell-like state vs differentiation state) to control the cancer stem cell (CSC) pool remains elusive. This study provides the first evidence showing that all-trans retinoic acid (ATRA) induces the interaction and chromatin recruitment of a novel RAR beta-TET2 complex to epigenetically activate a specific cohort of gene targets, including MiR-200c. TET2-activated miR-200c further targets and suppresses PKC zeta, a cell polarity protein that has a pivotal role in directing asymmetric division of mammalian stem cells to sustain the stem cell pool. Our data reveal that pharmacological concentration of ATRA effectively downregulates PKC zeta through activation of miR-200c, leading to a decrease of the stem cell-like populations from non-tumorigenic mammary epithelial cells and non-aggressive breast cancer cells. However, aggressive breast cancer cells that manifest TET2-miR-200c dysregulation sustain a CSC pool highly resistant to ATRA, where inhibition of PKC zeta directs the resistant CSCs to the luminal cell-like state and sensitization to tamoxifen, resulting in abrogation of mammary tumor growth and progression. Together, these findings elucidate a novel RAR beta-TET2-miR-200c-PKC zeta signaling pathway that directs cancer cell state changes and also provide previously unidentified therapeutic implications for PKC zeta inhibitors in diminishment of breast CSCs to eradicate breast cancer.	[Wu, M-J; Kim, M. R.; Chen, Y-S; Yang, J-Y; Chang, C-J] Purdue Univ, Dept Basic Med Sci, 625 Harrison St, W Lafayette, IN 47907 USA; [Wu, M-J; Kim, M. R.; Chen, Y-S; Yang, J-Y; Chang, C-J] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chang, CJ (corresponding author), Purdue Univ, Dept Basic Med Sci, 625 Harrison St, W Lafayette, IN 47907 USA.	chunjuchang@purdue.edu	Wu, Meng-Ju/AAY-9406-2021; Wu, Meng-Ju/AAY-9410-2021	Wu, Meng-Ju/0000-0001-6847-7065; Chang, Chunju/0000-0003-2887-9603	Department of Defense Breast Cancer Breakthrough Award [W81XWH-15-1-0644]; V foundation for Cancer Research Grant [V2015-019];  [P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Breakthrough Award; V foundation for Cancer Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the assistance of Dr Chao-Ching Chang as well as Dr Chi-Hong Chao with advice on animal and biochemical experiments, and Mr Chun-Chih Hsu with LC-MS/MS analysis. This study was supported by Department of Defense Breast Cancer Breakthrough Award (W81XWH-15-1-0644 to C-J Chang), V foundation for Cancer Research Grant (V2015-019 to C-J Chang), and P30 CA023168 to the Purdue University Center for Cancer Research in support of the use of facilities.	Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Bryan M, 2011, INVEST NEW DRUG, V29, P1482, DOI 10.1007/s10637-010-9478-3; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Chang CC, 2015, CANCER RES, V75, P2375, DOI 10.1158/0008-5472.CAN-14-3076; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chao CH, 2014, J CLIN INVEST, V124, P3093, DOI 10.1172/JCI73351; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cuzick J, 2011, LANCET ONCOL, V12, P496, DOI 10.1016/S1470-2045(11)70030-4; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Garattini E, 2007, VITAM HORM, V75, P301, DOI 10.1016/S0083-6729(06)75012-9; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kumar BNP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-273; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Paul A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12520; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sutton LM, 1997, CANCER CHEMOTH PHARM, V40, P335, DOI 10.1007/s002800050666; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Veronesi U, 1999, J NATL CANCER I, V91, P1847, DOI 10.1093/jnci/91.21.1847; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207	32	26	27	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3193	3206		10.1038/onc.2016.467	http://dx.doi.org/10.1038/onc.2016.467			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28218902	Green Published, hybrid			2022-12-26	WOS:000402617900011
J	Zhang, AL; Peng, B; Huang, P; Chen, JJ; Gong, ZH				Zhang, Aili; Peng, Bo; Huang, Ping; Chen, Junjie; Gong, Zihua			The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5' END RESECTION; HOMOLOGOUS RECOMBINATION; 53BP1; BREAKS; RIF1; PATHWAY; BINDING; CELLS	The 53BP1-dependent end-joining pathway plays a critical role in double strand break repair and is uniquely responsible for cellular sensitivity to poly(ADP-ribose) polymerase inhibitors (PARPi) in BRCA1-deficient cancers. We and others have investigated the downstream effectors of 53BP1, including replication timing regulatory factor 1 (RIF1) and Pax transactivation domain-interacting protein (PTIP), in the past few years to elucidate how loss of the 53BP1-dependent repair pathway results in PARPi resistance in BRCA1 patients. However, questions regarding the upstream regulation of the 53BP1 pathway remain unanswered. In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1. 53BP1 and TIRR form a stable complex, which is required for their expression. Moreover, the 53BP1-TIRR complex dissociates afterDNAdamage, and this dissociation may be ataxia telangiectasia mutated-dependent. Similar to 53BP1, loss of TIRR restores PARPi resistance in BRCA1-deficient cells. Collectively, our data identified a novel 53BP1-TIRR complex in DNA damage response. TIRR may play both positive and negative roles in 53BP1 regulation. On the one hand, it stabilizes 53BP1 and thus positively regulates 53BP1. On the other hand, its association with 53BP1 prevents 53BP1 localization to sites of DNA damage, and thus TIRR is also an inhibitor of 53BP1.	[Zhang, Aili; Peng, Bo; Huang, Ping; Gong, Zihua] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center	Gong, ZH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.; Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org; gongz@ccf.org		Chen, Junjie/0000-0002-1493-2189	National Institutes of Health [CA089239, CA092312, CA100109]; Ovarian Cancer Research Fund Alliance [373376]; National Institutes of Health Grant from NCI [CA192052]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA092312, R21CA192052, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund Alliance; National Institutes of Health Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.), an Ovarian Cancer Research Fund Alliance Grant 373376 (to Z. G.), and National Institutes of Health Grant CA192052 from NCI (to Z. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	22	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6461	6467		10.1074/jbc.M117.777474	http://dx.doi.org/10.1074/jbc.M117.777474			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28213517	hybrid, Green Published			2022-12-26	WOS:000399813400004
J	Liu, YL; Qin, S; Lei, M; Tempel, W; Zhang, YZ; Loppnau, P; Li, YJ; Min, JR				Liu, Yanli; Qin, Su; Lei, Ming; Tempel, Wolfram; Zhang, Yuzhe; Loppnau, Peter; Li, Yanjun; Min, Jinrong			Peptide recognition by heterochromatin protein 1 (HP1) chromoshadow domains revisited: Plasticity in the pseudosymmetric histone binding site of human HP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; chromatin structure; heterochromatin; histone; peptide interaction	X-RAY-DIFFRACTION; LYSINE 9; H3; FAMILY; ELECTROSTATICS; LOCALIZATION; METHYLATION; VALIDATION; MECHANISMS; HP1-ALPHA	Heterochromatin protein 1 (HP1), a highly conserved non-histone chromosomal protein in eukaryotes, plays important roles in the regulation of gene transcription. Each of the three human homologs of HP1 includes a chromoshadow domain (CSD). The CSD interacts with various proteins bearing the PXVXL motif but also with a region of histone H3 that bears the similar PXXVXL motif. The latter interaction has not yet been resolved in atomic detail. Here we demonstrate that the CSDs of all three human HP1 homologs have comparable affinities to the PXXVXL motif of histone H3. The HP1 C-terminal extension enhances the affinity, as does the increasing length of the H3 peptide. The crystal structure of the human HP1 CSD (CSD) in complex with an H3 peptide suggests that recognition of H3 by CSD to some extent resembles CSD-PXVXL interaction. Nevertheless, the prolyl residue of the PXXVXL motif appears to play a role distinct from that of Pro in the known HP1 CSD-PXVXL complexes. We consequently generalize the historical CSD-PXVXL interaction model and expand the search scope for additional CSD binding partners.	[Liu, Yanli; Qin, Su; Lei, Ming; Tempel, Wolfram; Zhang, Yuzhe; Loppnau, Peter; Li, Yanjun; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	jr.min@utoronto.ca	QIN, SU/H-8735-2015; zhang, yuzhe/ABC-8021-2021; Qin, Su/Y-3750-2019; Liu, Yanli/AAA-3283-2019; Min, Jinrong/G-3449-2011	Qin, Su/0000-0001-9437-6292; Liu, Yanli/0000-0003-0197-7617; Min, Jinrong/0000-0001-5210-3130	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank Masoud Vedadi and Irene Chau for the generous gift of nucleosome. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Chandra T, 2013, NUCLEUS-PHILA, V4, P23, DOI 10.4161/nucl.23189; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Jang SM, 2014, EMBO REP, V15, P686, DOI 10.15252/embr.201338356; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; KELLUM R, 1995, J CELL SCI, V108, P1419; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Richart AN, 2012, J BIOL CHEM, V287, P18730, DOI 10.1074/jbc.M111.337204; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Smart O., 2014, GRADE VERSION 12 9; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Stephens GE, 2005, BIOCHEMISTRY-US, V44, P13394, DOI 10.1021/bi051006+; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; WILL H, 1980, EXP CELL RES, V125, P401, DOI 10.1016/0014-4827(80)90134-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	59	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5655	5664		10.1074/jbc.M116.768374	http://dx.doi.org/10.1074/jbc.M116.768374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28223359	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000398813200004
J	Wang, JJ; Luo, JS; Aryal, DK; Wetsel, WC; Nass, R; Benovic, JL				Wang, Jianjun; Luo, Jiansong; Aryal, Dipendra K.; Wetsel, William C.; Nass, Richard; Benovic, Jeffrey L.			G protein-coupled receptor kinase-2 (GRK-2) regulates serotonin metabolism through the monoamine oxidase AMX-2 in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); protein kinase; serotonin; signal transduction; 5-hydroxyindole acetic acid; egg laying; monoamine oxidase	BIPOLAR DISORDER; GENE; TRAFFICKING; G-ALPHA(O); PROMOTER; PATHWAY	G protein-coupled receptors (GPCRs) regulate many animal behaviors. GPCR signaling is mediated by agonist-promoted interactions of GPCRs with heterotrimeric G proteins, GPCR kinases (GRKs), and arrestins. To further elucidate the role of GRKs in regulating GPCR-mediated behaviors, we utilized the genetic model system Caenorhabditis elegans. Our studies demonstrate that grk-2 loss-of-function strains are egg laying-defective and contain low levels of serotonin (5-HT) and high levels of the 5-HT metabolite 5-hydroxyindole acetic acid (5-HIAA). The egg laying defect could be rescued by the expression of wild type but not by catalytically inactive grk-2 or by the selective expression of grk-2 in hermaphrodite-specific neurons. The addition of 5-HT or inhibition of 5-HT metabolism also rescued the egg laying defect. Furthermore, we demonstrate that AMX-2 is the primary monoamine oxidase that metabolizes 5-HT in C. elegans, and we also found that grk-2 loss-of-function strains have abnormally high levels of AMX-2 compared with wild-type nematodes. Interestingly, GRK-2 was also found to interact with and promote the phosphorylation of AMX-2. Additional studies reveal that 5-HIAA functions to inhibit egg laying in a manner dependent on the 5-HT receptor SER-1 and the G protein GOA-1. These results demonstrate that GRK-2 modulates 5-HT metabolism by regulating AMX-2 function and that 5-HIAA may function in the SER-1 signaling pathway.	[Wang, Jianjun; Luo, Jiansong; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Aryal, Dipendra K.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Nass, Richard] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Jefferson University; Duke University; Duke University; Duke University; Duke University; Indiana University System; Indiana University Bloomington	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu			North Carolina Biotechnology Center; Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Michael Koelle for providing the cell type-specific promoter constructs; Dr. Anne Hart for providing the grk-2(rt97) strain; Drs. Janet Duerr, Denise Ferkey, Bryan Roth, and Konstantin Komolov for helpful comments; the Sidney Kimmel Cancer Center Bioimaging Facility for technical advice and support; and the Caenorhabditis Genetics Center for providing multiple C. elegans strains. The neurochemistry experiments were conducted with equipment purchased with a grant from the North Carolina Biotechnology Center.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Barrett TB, 2003, MOL PSYCHIATR, V8, P546, DOI 10.1038/sj.mp.4001268; Bastiani CA, 2003, GENETICS, V165, P1805; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Carnell L, 2005, J NEUROSCI, V25, P10671, DOI 10.1523/JNEUROSCI.3399-05.2005; Carre-Pierrat Maite, 2006, Invertebrate Neuroscience, V6, P189, DOI 10.1007/s10158-006-0033-z; Chase Daniel L, 2007, WormBook, P1; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Duerr Janet S, 2006, WormBook, P1; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; Ezak MJ, 2010, GENETICS, V185, P233, DOI 10.1534/genetics.110.115188; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Garcia-Sevilla JA, 1999, J NEUROCHEM, V72, P282, DOI 10.1046/j.1471-4159.1999.0720282.x; Grange-Midroit M, 2003, MOL BRAIN RES, V111, P31, DOI 10.1016/S0169-328X(02)00667-8; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Matuzany-Ruban A, 2010, INT J NEUROPSYCHOPH, V13, P83, DOI 10.1017/S1461145709000364; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Murphy DL, 1998, J NEURAL TRANSM-SUPP, P39; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; Rebrin I, 2001, J BIOL CHEM, V276, P29499, DOI 10.1074/jbc.M100431200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Schafer WF, 2006, ANNU REV GENET, V40, P487, DOI 10.1146/annurev.genet.40.110405.090527; Schmid T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005236; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; So CH, 2013, MOL BIOL CELL, V24, P2795, DOI 10.1091/mbc.E13-01-0013; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Taneja M, 2011, BEHAV BRAIN RES, V221, P25, DOI 10.1016/j.bbr.2011.02.018; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; TRENT C, 1983, GENETICS, V104, P619; Wani KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037831; Wood JF, 2012, J BIOL CHEM, V287, P12634, DOI 10.1074/jbc.M111.336818; Zhou XJ, 2008, BIOL PSYCHIAT, V64, P104, DOI 10.1016/j.biopsych.2007.12.017	46	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5943	5956		10.1074/jbc.M116.760850	http://dx.doi.org/10.1074/jbc.M116.760850			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	28213524	Green Published, hybrid			2022-12-26	WOS:000398813200028
J	Karamintziou, SD; Custodio, AL; Piallat, B; Polosan, M; Chabardes, S; Stathis, PG; Tagaris, GA; Sakas, DE; Polychronaki, GE; Tsirogiannis, GL; David, O; Nikita, KS				Karamintziou, Sofia D.; Custodio, Ana Luisa; Piallat, Brigitte; Polosan, Mircea; Chabardes, Stephan; Stathis, Pantelis G.; Tagaris, George A.; Sakas, Damianos E.; Polychronaki, Georgia E.; Tsirogiannis, George L.; David, Olivier; Nikita, Konstantina S.			Algorithmic design of a noise-resistant and efficient closed-loop deep brain stimulation system: A computational approach	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; HUMAN SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; NEURONAL OSCILLATIONS; GLOBUS-PALLIDUS; BASAL GANGLIA; NEUROMODULATION; PARAMETERS; SEVERITY; DEVICE	Advances in the field of closed-loop neuromodulation call for analysis and modeling approaches capable of confronting challenges related to the complex neuronal response to stimulation and the presence of strong internal and measurement noise in neural recordings. Here we elaborate on the algorithmic aspects of a noise-resistant closed-loop subthalamic nucleus deep brain stimulation system for advanced Parkinson's disease and treatment-refractory obsessive-compulsive disorder, ensuring remarkable performance in terms of both efficiency and selectivity of stimulation, as well as in terms of computational speed. First, we propose an efficient method drawn from dynamical systems theory, for the reliable assessment of significant nonlinear coupling between beta and high-frequency subthalamic neuronal activity, as a biomarker for feedback control. Further, we present a model-based strategy through which optimal parameters of stimulation for minimum energy desynchronizing control of neuronal activity are being identified. The strategy integrates stochastic modeling and derivative-free optimization of neural dynamics based on quadratic modeling. On the basis of numerical simulations, we demonstrate the potential of the presented modeling approach to identify, at a relatively low computational cost, stimulation settings potentially associated with a significantly higher degree of efficiency and selectivity compared with stimulation settings determined post-operatively. Our data reinforce the hypothesis that model-based control strategies are crucial for the design of novel stimulation protocols at the backstage of clinical applications.	[Karamintziou, Sofia D.; Polychronaki, Georgia E.; Tsirogiannis, George L.; Nikita, Konstantina S.] Natl Tech Univ Athens, Sch Elect & Comp Engn, Athens, Greece; [Karamintziou, Sofia D.] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Custodio, Ana Luisa] FCT UNL CMA, Dept Math, Caparica, Portugal; [Piallat, Brigitte; Chabardes, Stephan; David, Olivier] Univ Grenoble Alpes, Grenoble Inst Neurosci, GIN, Grenoble, France; [Piallat, Brigitte; Chabardes, Stephan; David, Olivier] INSERM, U1216, Grenoble, France; [Polosan, Mircea] Univ Hosp Grenoble, Dept Psychiat, Grenoble, France; [Chabardes, Stephan] Univ Hosp Grenoble, Dept Neurosurg, Grenoble, France; [Stathis, Pantelis G.] Mediterraneo Hosp, Dept Neurol, Athens, Greece; [Tagaris, George A.] G Gennimatas Gen Hosp Athens, Dept Neurol, Athens, Greece; [Sakas, Damianos E.] Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens, Greece	National Technical University of Athens; University of California System; University of California Riverside; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens	Karamintziou, SD; Nikita, KS (corresponding author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Athens, Greece.; Karamintziou, SD (corresponding author), Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA.	skaram@biosim.ntua.gr; knikita@ece.ntua.gr	Ferrat, Frederique/E-9929-2011; Custodio, Ana Luisa/A-1657-2012; David, Olivier/A-6068-2009; David, Olivier/S-9463-2019	Ferrat, Frederique/0000-0003-3629-1965; Custodio, Ana Luisa/0000-0003-0890-7398; David, Olivier/0000-0003-0776-0216; David, Olivier/0000-0003-0776-0216; Nikita, Konstantina/0000-0001-8255-4354	Faculdade de Ciencias e Tecnologia (FCT) [UID/MAT/00297/2013]; Agence Nationale pour la Recherche [ANR-14-CE13-0030-01 PHYSIOBS]	Faculdade de Ciencias e Tecnologia (FCT); Agence Nationale pour la Recherche(French National Research Agency (ANR))	Support for A. L. Custodio was provided by Faculdade de Ciencias e Tecnologia (FCT) under the project UID/MAT/00297/2013 (Centro de Matematica e Aplicacoes). Support for B. Piallat, M. Polosan, S. Chabardes and O. David was provided by Agence Nationale pour la Recherche, grant ANR-14-CE13-0030-01 PHYSIOBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011911; Adamchic I, 2014, MOVEMENT DISORD, V29, P1679, DOI 10.1002/mds.25923; Afshar P, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00117; Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Bahramisharif A, 2015, BIOL PSYCHIAT; Bastin J, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.73; Bikson M, 2015, PROG BRAIN RES, V222, P1, DOI 10.1016/bs.pbr.2015.08.005; Bronstein JM, 2015, NEUROMODULATION, V18, P85, DOI 10.1111/ner.12227; Canavier CC, 2015, CURR OPIN NEUROBIOL, V31, P206, DOI 10.1016/j.conb.2014.12.003; Carron R, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00112; Connolly AT, 2015, J NEUROPHYSIOL, V114, P209, DOI 10.1152/jn.00840.2014; Connolly AT, 2015, J NEUROSCI, V35, P6231, DOI 10.1523/JNEUROSCI.4137-14.2015; Connolly AT, 2015, P 7 INT IEEE EMBS C; Custodio AL, 2008, IMA J NUMER ANAL, V28, P770, DOI 10.1093/imanum/drn045; Custodio AL, 2007, SIAM J OPTIMIZ, V18, P537, DOI 10.1137/050646706; Custodio AL, 2010, COMPUT OPTIM APPL, V46, P265, DOI 10.1007/s10589-009-9283-0; Davis C., 1954, AM J MATH, V76, P733, DOI [10.2307/2372648, DOI 10.2307/2372648]; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Ermentrout GB, 2011, J COMPUT NEUROSCI, V31, P185, DOI 10.1007/s10827-010-0305-9; Feng XJ, 2007, J COMPUT NEUROSCI, V23, P265, DOI 10.1007/s10827-007-0031-0; Feng X, 2007, J NEURAL ENG, V4, pL14, DOI 10.1088/1741-2560/4/2/L03; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Galan RF, 2009, SPR SER COMPUT NEURO, V2, P65, DOI 10.1007/978-0-387-93797-7_4; Gottwald GA, 2005, PHYSICA D, V212, P100, DOI 10.1016/j.physd.2005.09.011; Gottwald GA, 2009, SIAM J APPL DYN SYST, V8, P129, DOI 10.1137/080718851; Grahn PJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00169; Grill WM, 2015, PROG BRAIN RES, V222, P147, DOI 10.1016/bs.pbr.2015.07.031; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Hauptmann C, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056008; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Iolov A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046004; Karamintziou S D, 2015, P 7 INT IEEE EMBS C; Karamintziou SD, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016013; Karamintziou SD, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056019; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Kumar R, 1999, NEUROLOGY, V53, P871, DOI 10.1212/WNL.53.4.871; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Lai HY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036001; Lee HM, 2015, IEEE J SOLID-ST CIRC, V50, P360, DOI 10.1109/JSSC.2014.2355814; Lipsman N, 2013, LANCET, V381, P1361, DOI 10.1016/S0140-6736(12)62188-6; Little S, 2015, PROG BRAIN RES, V222, P163, DOI 10.1016/bs.pbr.2015.09.002; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Liu JB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045002; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Lourens MAJ, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026005; Mauroy A, 2014, SIAM J APPL DYN SYST, V13, P306, DOI 10.1137/130931151; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McConnell GC, 2012, J NEUROSCI, V32, P15657, DOI 10.1523/JNEUROSCI.2824-12.2012; Metman LV, 2015, MOVEMENT DISORD, V30, P1461, DOI 10.1002/mds.26338; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Muller UJ, 2009, PHARMACOPSYCHIATRY, V42, P288, DOI 10.1055/s-0029-1233489; Nabi A, 2013, J COMPUT NEUROSCI, V34, P259, DOI 10.1007/s10827-012-0419-3; Nakao H., 2015, CONTEMP PHYS, P1, DOI DOI 10.1080/00107514.2015.1094987; NGUYEN TAD, 2014, BIOSCI BIOTECHNOL RE, V11, P11; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Piallat B, 2011, ANN NEUROL, V69, P793, DOI 10.1002/ana.22222; Reich MM, 2015, ANN CLIN TRANSL NEUR, V2, P427, DOI 10.1002/acn3.168; Rise M. T., 1998, Patent No. [US 5,716,377, 5716377]; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Rosenblum M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.064101; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rossberg AG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.016216; Ryapolova-Webb E, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016009; Sanders TH, 2013, J NEUROPHYSIOL, V110, P720, DOI 10.1152/jn.00672.2012; Santaniello S, 2015, P NATL ACAD SCI USA, V112, pE586, DOI 10.1073/pnas.1406549111; Sharott A, 2014, J NEUROSCI, V34, P6273, DOI 10.1523/JNEUROSCI.1803-13.2014; Sherwood WE, 2010, SIAM J APPL DYN SYST, V9, P659, DOI 10.1137/090773519; Stanslaski S, 2012, IEEE T NEUR SYS REH, V20, P410, DOI 10.1109/TNSRE.2012.2183617; Steigerwald F, 2008, J NEUROPHYSIOL, V100, P2515, DOI 10.1152/jn.90574.2008; Sun JF, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046213; Syta A, 2015, MECCANICA, V50, P1961, DOI 10.1007/s11012-015-0140-1; Tass PA, 2003, NEUROPSYCHOPHARMACOL, V28, pS27, DOI 10.1038/sj.npp.1300144; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tsang EW, 2012, NEUROLOGY, V78, P1930, DOI 10.1212/WNL.0b013e318259e183; Tukhlina N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011918; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Voloh B, DETAILED CHARACTERIZ; Voytek B, 2015, BIOL PSYCHIAT, V77, P1089, DOI 10.1016/j.biopsych.2015.04.016; Ward Matthew P, 2010, Front Neuroeng, V3, P7, DOI 10.3389/fneng.2010.00007; Welter ML, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.5; Widge AS, 2016, BIOL PSYCHIAT, V79, pE9, DOI 10.1016/j.biopsych.2015.06.005; Widge AS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/024001; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Williams ZM, 2015, NAT NEUROSCI, V18, P618, DOI 10.1038/nn.4007; Wilson D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004673; Wilson D, 2014, J COMPUT NEUROSCI, V37, P243, DOI 10.1007/s10827-014-0499-3; Wong S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026006; Yang AI, 2014, J NEUROSCI, V34, P12816, DOI 10.1523/JNEUROSCI.1895-14.2014; Zhang K, 2010, J NEUROSURG, V112, P1271, DOI 10.3171/2009.10.JNS09371	94	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2017	12	2							e0171458	10.1371/journal.pone.0171458	http://dx.doi.org/10.1371/journal.pone.0171458			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5QV	28222198	Green Published, Green Submitted, gold			2022-12-26	WOS:000394676800012
J	Louis, J; Pedrotti, ML; Gazeau, F; Guieu, C				Louis, Justine; Pedrotti, Maria Luiza; Gazeau, Frederic; Guieu, Cecile			Experimental evidence of formation of Transparent Exopolymer Particles (TEP) and POC export provoked by dust addition under current and high pCO(2) conditions	PLOS ONE			English	Article							NORTHWESTERN MEDITERRANEAN SEA; DISSOLVED ORGANIC-MATTER; SAHARAN DUST; ATMOSPHERIC DEPOSITION; CARBON FLUXES; MINERAL DUST; TIME-SERIES; AGGREGATION; DYNAMICS; CO2	The evolution of organic carbon export to the deep ocean, under anthropogenic forcing such as ocean warming and acidification, needs to be investigated in order to evaluate potential positive or negative feedbacks on atmospheric CO2 concentrations, and therefore on climate. As such, modifications of aggregation processes driven by transparent exopolymer particles ( TEP) formation have the potential to affect carbon export. The objectives of this study were to experimentally assess the dynamics of organic matter, after the simulation of a Saharan dust deposition event, through the measurement over one week of TEP abundance and size, and to evaluate the effects of ocean acidification on TEP formation and carbon export following a dust deposition event. Three experiments were performed in the laboratory using 300 L tanks filled with filtered seawater collected in the Mediterranean Sea, during two 'no bloom' periods ( spring at the start of the stratification period and autumn at the end of this stratification period) and during the winter bloom period. For each experiment, one of the two tanks was acidified to reach pH conditions slightly below values projected for 2100 (similar to 7.6-7.8). In both tanks, a dust deposition event of 10 g m(-2) was simulated at the surface. Our results suggest that Saharan dust deposition triggered the abiotic formation of TEP, leading to the formation of organic-mineral aggregates. The amount of particulate organic carbon ( POC) exported was proportional to the flux of lithogenic particles to the sediment traps. Depending on the season, the POC flux following artificial dust deposition ranged between 38 and 90 mg m(-2) over six experimental days. Such variability is likely linked to the seasonal differences in the quality and quantity of TEP-precursors initially present in seawater. Finally, these export fluxes were not significantly different at the completion of the three experiments between the two pH conditions.	[Louis, Justine; Pedrotti, Maria Luiza; Gazeau, Frederic; Guieu, Cecile] UPMC Univ Paris 06, Sorbonne Univ, INSU CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Louis, Justine] Univ Rennes 1, IUT St Brieuc, Dept Genie Biol, St Brieuc, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite de Rennes	Louis, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSU CNRS, Lab Oceanog Villefranche, Villefranche Sur Mer, France.; Louis, J (corresponding author), Univ Rennes 1, IUT St Brieuc, Dept Genie Biol, St Brieuc, France.	justine.louis35@gmail.com	Gazeau, Frédéric/G-3050-2011; Guieu, Cecile/AAU-6883-2021	Gazeau, Frédéric/0000-0001-8807-4597; Guieu, Cecile/0000-0001-6373-8326; Louis, Justine/0000-0002-8589-5768				ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Avril B, 2002, DEEP-SEA RES PT II, V49, P2163, DOI 10.1016/S0967-0645(02)00033-4; Beauvais S, 2003, MAR ECOL PROG SER, V262, P97, DOI 10.3354/meps262097; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; BERGAMETTI G, 1989, J GEOPHYS RES-ATMOS, V94, P14855, DOI 10.1029/JD094iD12p14855; BERGAMETTI G, 1989, NATO ADV SCI I C-MAT, V282, P227; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; Bonnet S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003213; Bressac M, 2014, BIOGEOSCIENCES, V11, P1007, DOI 10.5194/bg-11-1007-2014; Bressac M, 2013, GLOBAL BIOGEOCHEM CY, V27, P859, DOI 10.1002/gbc.20076; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Desboeufs K, 2014, BIOGEOSCIENCES, V11, P5581, DOI 10.5194/bg-11-5581-2014; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, P21, DOI DOI 10.1029/2006GB002907.GB4006; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Guerzoni S, 1999, PROG OCEANOGR, V44, P147, DOI 10.1016/S0079-6611(99)00024-5; Guieu C, 2014, BIOGEOSCIENCES, V11, P425, DOI 10.5194/bg-11-425-2014; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; Guieu C, 2015, ENCY MAR GEOSCI, V611, P94; Journel B, 1998, THESIS; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; Kovac N, 2002, MAR CHEM, V78, P205, DOI 10.1016/S0304-4203(02)00033-6; Lavigne H, 2016, SEACARB SEAWATER CAR; Lee C, 2009, DEEP-SEA RES PT II, V56, P1420, DOI 10.1016/j.dsr2.2008.11.029; Liu Q, 2000, INT J MINER PROCESS, V60, P229, DOI 10.1016/S0301-7516(00)00018-1; LOGAN BE, 1995, DEEP-SEA RES PT II, V42, P203, DOI 10.1016/0967-0645(95)00012-F; LOYEPILOT MD, 1986, NATURE, V321, P427, DOI 10.1038/321427a0; LoyePilot MD, 1996, ENVIR SCI TECH LIB, V11, P191; Mari X, 2001, LIMNOL OCEANOGR, V46, P1831, DOI 10.4319/lo.2001.46.7.1831; Marty JC, 2002, DEEP-SEA RES PT II, V49, P1965, DOI 10.1016/S0967-0645(02)00022-X; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; Miquel JC, 2011, PROG OCEANOGR, V91, P461, DOI 10.1016/j.pocean.2011.07.018; Moulin C, 1997, J GEOPHYS RES-ATMOS, V102, P16947, DOI 10.1029/96JD02620; OBERNOSTERER I, 1995, MAR ECOL PROG SER, V116, P247, DOI 10.3354/meps116247; Pachauri R.K., 2015, IPCC 2014 CLIMATE CH, P151; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000670; PASSOW U, 1994, MAR ECOL PROG SER, V113, P185, DOI 10.3354/meps113185; Passow U, 2000, MAR ECOL PROG SER, V192, P1, DOI 10.3354/meps192001; Passow U, 2014, LIMNOL OCEANOGR, V59, P532, DOI 10.4319/lo.2014.59.2.0532; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; Pedrotti ML, 2010, MAR ECOL PROG SER, V419, P57, DOI 10.3354/meps08840; Pedrotti ML, 2012, J PLANKTON RES, V34, P388, DOI 10.1093/plankt/fbs012; Rochelle-Newall EJ, 2010, J PLANKTON RES, V32, P1433, DOI 10.1093/plankt/fbq060; Salter I, 2010, LIMNOL OCEANOGR, V55, P2207, DOI 10.4319/lo.2010.55.5.2207; Sinking G., 2009, BIOGEOSCIENCES, V6, P85; Ternon E, 2010, BIOGEOSCIENCES, V7, P809, DOI 10.5194/bg-7-809-2010; Touratier F, 2011, DEEP-SEA RES PT I, V58, P1, DOI 10.1016/j.dsr.2010.10.002; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Vincent J, 2016, ATMOS CHEM PHYS, V16, P8749, DOI 10.5194/acp-16-8749-2016	55	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0171980	10.1371/journal.pone.0171980	http://dx.doi.org/10.1371/journal.pone.0171980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212418	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424700014
J	Di Gregorio, J; Sferra, R; Speca, S; Vetuschi, A; Dubuquoy, C; Desreumaux, P; Pompili, S; Cristiano, L; Gaudio, E; Flati, V; Latella, G				Di Gregorio, Jacopo; Sferra, Roberta; Speca, Silvia; Vetuschi, Antonella; Dubuquoy, Caroline; Desreumaux, Pierre; Pompili, Simona; Cristiano, Loredana; Gaudio, Eugenio; Flati, Vincenzo; Latella, Giovanni			Role of glycogen synthase kinase-3 beta and PPAR-gamma on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; BETA-CATENIN; INTESTINAL FIBROSIS; MECHANISMS; PATHWAY; DYSFUNCTION; INHIBITION; EXPRESSION; COLLAGEN; AGONIST	Background Intestinal fibrosis is characterized by abnormal production and deposition of extracellular matrix (ECM) proteins by activated myofibroblasts. The main progenitor cells of activated myofibroblasts are the fibroblasts and the epithelial cells, the latter through the epithelial-mesenchymal transition (EMT). Aim To evaluate the action of the new PPAR-gamma modulator, GED-0507-34 Levo (GED) on the expression of EMT associated and regulatory proteins such as TGF-beta, Smad3, E-cadherin, Snail, ZEB1, beta-catenin, and GSK-3 beta, in a mouse model of DSS-induced intestinal fibrosis. Methods Chronic colitis and fibrosis were induced by oral administration of 2.5% DSS (w/v) for 6 weeks. GW9662 (GW), a selective PPAR-gamma inhibitor, was also administered by intraperitoneal injection at the dose of 1 mg/kg/day combined with GED treatment. All drugs were administered at the beginning of the second cycle of DSS (day 12). 65 mice were randomly divided into five groups (H2O as controls n = 10, H2O+GED n = 10, DSS n = 15, DSS+GED n = 15, DSS+GED+GW n = 15). The colon was excised for macroscopic examination and histological and morphometric analyses. The level of expression of molecules involved in EMT and fibrosis, like TGF-beta, Smad3, E-cadherin, Snail, ZEB1, beta-catenin, GSK-3 beta and PPAR-gamma, was assessed by immunohistochemistry, immunofluorescence, western blot and Real Time PCR. Results GED improved the DSS-induced chronic colitis and fibrosis. GED was able to reduce the expression of the main fibrosis markers (alpha-SMA, collagen I-III and fibronectin) as well as the pivotal pro-fibrotic molecules IL-13, TGF-beta and Smad3, while it increased the anti-fibrotic PPAR-gamma. All these GED effects were nullified by co-administration of GW with GED. Furthermore, GED was able to normalize the expression levels of E-cadherin and beta-catenin and upregulated GSK-3 beta, that are all known to be involved both in EMT and fibrosis. Conclusions The DSS-induced intestinal fibrosis was improved by the new PPAR-gamma modulator GED-0507-34 Levo through the modulation of EMT mediators and pro-fibrotic molecules and through GSK-3 beta induction.	[Di Gregorio, Jacopo; Sferra, Roberta; Vetuschi, Antonella; Pompili, Simona; Flati, Vincenzo] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Speca, Silvia; Desreumaux, Pierre] Univ Lille, Lille Inflammat Res Int Ctr, U995, F-59000 Lille, France; [Speca, Silvia; Dubuquoy, Caroline; Desreumaux, Pierre] IBD, Lille, France; [Desreumaux, Pierre] CHR Lille, Serv Malad Appareil Digestif & Nutr, Hop Claude Huriez, Lille, France; [Cristiano, Loredana] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Gaudio, Eugenio] Univ Roma La Sapienza, Dept Human Anat, Rome, Italy; [Latella, Giovanni] Univ Aquila, Dept Life Hlth & Environm Sci, Gastroenterol Unit, Laquila, Italy	University of L'Aquila; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; University of L'Aquila; Sapienza University Rome; University of L'Aquila	Vetuschi, A (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy.	antonella.vetuschi@univaq.it	Desreumaux, Pierre F/R-6877-2018; Pompili, Simona/AAL-2988-2021; Speca, Silvia/S-8547-2016; FLATI, VINCENZO/R-6231-2018	Desreumaux, Pierre F/0000-0002-6127-5281; Pompili, Simona/0000-0001-8628-1517; Speca, Silvia/0000-0001-8494-3329; FLATI, VINCENZO/0000-0003-1014-297X; Latella, Giovanni/0000-0001-6341-5711	University of L'Aquila, L'Aquila, Italy; Inserm, Lille, France [U995]; Nogra Pharma Ltd, Dublin, Ireland; Intestinal Biotech Development of Lille, France; Digest Science foundation; association F. Aupetit, Lille, France	University of L'Aquila, L'Aquila, Italy; Inserm, Lille, France; Nogra Pharma Ltd, Dublin, Ireland; Intestinal Biotech Development of Lille, France; Digest Science foundation; association F. Aupetit, Lille, France	This study was supported by the University of L'Aquila, L'Aquila, Italy; the Inserm U995, Lille, France; Nogra Pharma Ltd, Dublin, Ireland; the Intestinal Biotech Development of Lille, France; the Digest Science foundation and the association F. Aupetit, Lille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Awuah PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039771; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bauer K, 2009, CARCINOGENESIS, V30, P1781, DOI 10.1093/carcin/bgp175; Bertin B, 2013, CURR DRUG TARGETS, V14, P1501, DOI 10.2174/13894501113149990162; Bettenworth D, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-5; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi SS, 2009, HEPATOLOGY; Dantas AT, 2015, PPAR RES, V2015, DOI 10.1155/2015/124624; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Drygiannakis I, 2013, J CROHNS COLITIS, V7, P286, DOI 10.1016/j.crohns.2012.04.008; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736; Glaser S, 2010, DIG LIV DIS; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Jeon KI, 2014, AM J PATHOL, V184, P1429, DOI 10.1016/j.ajpath.2014.01.026; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kumar V, 2014, PHARM RES-DORDR, V31, P1158, DOI 10.1007/s11095-013-1239-5; Kweon SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156111; Lakatos G, 2012, DIGEST DIS, V30, P289, DOI 10.1159/000336995; Lan AP, 2014, CELL PHYSIOL BIOCHEM, V34, P368, DOI 10.1159/000363006; Latella G, 2013, EUR REV MED PHARMACO, V17, P1283; Latella G, 2009, EUR J CLIN INVEST, V39, P145, DOI 10.1111/j.1365-2362.2008.02076.x; Latella G, 2014, J CROHNS COLITIS; Latella G, 2015, SCAND J GASTROENTERO, V50, P53, DOI 10.3109/00365521.2014.968863; Lee YH, 2013, CELL MOL LIFE SCI, V70, P3959, DOI 10.1007/s00018-013-1363-8; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Li QH, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/26/265101; Liu H, 2013, ACTA PHARMACOL SIN, V34, P26; Liu JQ, 2012, J DERMATOL SCI, V65, P38, DOI 10.1016/j.jdermsci.2011.09.012; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Lu J, 2014, EUR J PHARMACOL, V737, P133, DOI 10.1016/j.ejphar.2014.05.008; Miao CG, 2013, BIOCHIMIE, V95, P2326, DOI 10.1016/j.biochi.2013.09.003; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Pirat C, 2012, J MED CHEM, V55, P4027, DOI 10.1021/jm101360s; Qian JJ, 2012, PHARMACOL RES, V66, P219, DOI 10.1016/j.phrs.2012.06.003; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Rieder F, 2013, DIGEST DIS, V31, P186, DOI 10.1159/000353364; Rieder F, 2012, J CROHNS COLITIS, V6, P373, DOI 10.1016/j.crohns.2011.11.009; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Segel MJ, 2003, AM J PHYSIOL-LUNG C, V285, pL1255, DOI 10.1152/ajplung.00303.2002; Shim CY, 2014, J DIABETES INVEST, V5, P362, DOI 10.1111/jdi.12153; Shimshoni E, 2015, GUT, V64, P367, DOI 10.1136/gutjnl-2014-308048; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Speca S, 2016, INFLAMM BOWEL DIS, V22, P279, DOI 10.1097/MIB.0000000000000618; Speca S, 2012, WORLD J GASTROENTERO, V18, P3635, DOI 10.3748/wjg.v18.i28.3635; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Wei J, 2012, ARTHRITIS RHEUM-US, V64, P2734, DOI 10.1002/art.34424; Wei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013778; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yanagid A, 2011, BBA-MOL BASIS DIS, V1812, P1403, DOI 10.1016/j.bbadis.2011.06.015; Yang MC, 2014, AM J CANCER RES, V4, P751; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhu HY, 2015, BIOCHEM BIOPH RES CO, V459, P49, DOI 10.1016/j.bbrc.2015.02.061; Zhu M, 2011, AM J RESP CELL MOL, V45, P111, DOI 10.1165/rcmb.2009-0445OC	62	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171093	10.1371/journal.pone.0171093	http://dx.doi.org/10.1371/journal.pone.0171093			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207769	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500015
J	Li, T; Li, W; Yang, YH; Zhang, WS				Li, Tao; Li, Wu; Yang, Yehui; Zhang, Wensheng			Classification of brain disease in magnetic resonance images using two-stage local feature fusion	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PRODROMAL ALZHEIMERS-DISEASE; CORTICAL THICKNESS; MRI; DIAGNOSIS; PATTERN; SCALE; PROGRESSION; BIOMARKER; ATROPHY	Background Many classification methods have been proposed based on magnetic resonance images. Most methods rely on measures such as volume, the cerebral cortical thickness and grey matter density. These measures are susceptible to the performance of registration and limited in representation of anatomical structure. This paper proposes a two-stage local feature fusion method, in which deformable registration is not desired and anatomical information is represented from moderate scale. Methods Keypoints are firstly extracted from scale-space to represent anatomical structure. Then, two kinds of local features are calculated around the keypoints, one for correspondence and the other for representation. Scores are assigned for keypoints to quantify their effect in classification. The sum of scores for all effective keypoints is used to determine which group the test subject belongs to. Results We apply this method to magnetic resonance images of Alzheimer's disease and Parkinson's disease. The advantage of local feature in correspondence and representation contributes to the final classification. With the help of local feature (Scale Invariant Feature Transform, SIFT) in correspondence, the performance becomes better. Local feature (Histogram of Oriented Gradient, HOG) extracted from 16x16 cell block obtains better results compared with 4x4 and 8x8 cell block. Discussion This paper presents a method which combines the effect of SIFT descriptor in correspondence and the representation ability of HOG descriptor in anatomical structure. This method has the potential in distinguishing patients with brain disease from controls.	[Li, Tao; Li, Wu; Yang, Yehui; Zhang, Wensheng] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Li, Tao; Li, Wu; Yang, Yehui; Zhang, Wensheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, W; Zhang, WS (corresponding author), Chinese Acad Sci, Inst Automat, Beijing, Peoples R China.; Li, W; Zhang, WS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	wu.li@ia.ac.cn; wensheng.zhang@ia.ac.cn	Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Yang, Ye/GZM-4812-2022; Li, Wu/AHA-4320-2022		National Natural Science Foundation of China [61432008, 81171314, 61532006, 61305018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is supported by the National Natural Science Foundation of China grant 61432008, 81171314,61532006, 61305018 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir A, 2011, NEUROIMAGE, V58, P785, DOI 10.1016/j.neuroimage.2011.06.029; Ahmed OB, 2015, MULTIMED TOOLS APPL, V74, P1249, DOI DOI 10.1007/s11042-014-2123-y; Arimura H, 2006, INT J COMPUT ASS RAD, V1, P19; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Behera NKS, 2015, SMART INNOV SYST TEC, V33, DOI 10.1007/978-81-322-2202-6_27; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Burns A, 2009, BMJ-BRIT MED J, V338, pb157; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen Y, 2014, J NEUROSCI METH, V221, P22, DOI 10.1016/j.jneumeth.2013.09.001; Costafreda SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006353; Cui Y, 2012, NEUROIMAGE, V59, P1209, DOI 10.1016/j.neuroimage.2011.08.013; Daliri MR, 2012, J MED SYST, V36, P995, DOI 10.1007/s10916-011-9738-6; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Oliveira PPD, 2010, J ALZHEIMERS DIS, V19, P1263, DOI 10.3233/JAD-2010-1322; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Donoho DL, 2010, P IEEE, V98, P913, DOI 10.1109/JPROC.2010.2045630; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Duncan GW, 2013, MOVEMENT DISORD, V28, P425, DOI 10.1002/mds.25352; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Farhan S, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/862307; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jung WB, 2015, PSYCHIAT INVEST, V12, P92, DOI 10.4306/pi.2015.12.1.92; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Liu F, 2013, LECT NOTES COMPUT SC, V8150, P311, DOI 10.1007/978-3-642-40763-5_39; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu L, 2016, INF SCI, V358, P358; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mikolajczyk K, 2002, LECT NOTES COMPUT SC, V2350, P128, DOI 10.1007/3-540-47969-4_9; Mizotin M, 2012, IEEE IMAGE PROC, P1241, DOI 10.1109/ICIP.2012.6467091; Moradi M, 2006, MED IMAGING PROCESSI; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pedrosa DJ, 2012, EXP NEUROL, V237, P435, DOI 10.1016/j.expneurol.2012.07.002; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rueda Andrea, 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P559, DOI 10.1007/978-3-642-33275-3_69; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Simoes R, 2014, NEURORADIOLOGY, V56, P709, DOI 10.1007/s00234-014-1385-4; Smith EE, 2009, COGNITIVE PSYCHOL MI; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Sun DQ, 2009, BIOL PSYCHIAT, V66, P1055, DOI 10.1016/j.biopsych.2009.07.019; Sveinbjornsdottir S, 2016, J NEUROCHEM, V139, P318, DOI 10.1111/jnc.13691; Thung KH, 2016, BRAIN STRUCT FUNCT, V221, P3979, DOI 10.1007/s00429-015-1140-6; Toews M, 2010, NEUROIMAGE, V49, P2318, DOI 10.1016/j.neuroimage.2009.10.032; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Yuan L, 2015, NEUROCOMPUTING, V170, P213, DOI 10.1016/j.neucom.2014.05.095; Zeng LL, 2017, CLIM DYNAM, V48, P1911, DOI 10.1007/s00382-016-3182-8; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang H, 2011, NEUROIMAGE, V54, P2885, DOI 10.1016/j.neuroimage.2010.10.051; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhou L, 2013, NEUROCOMPUTING, V122, P284, DOI 10.1016/j.neucom.2013.06.023; Zhu XF, 2016, IEEE T BIO-MED ENG, V63, P607, DOI 10.1109/TBME.2015.2466616; Zhu XF, 2014, NEUROIMAGE, V100, P91, DOI 10.1016/j.neuroimage.2014.05.078; 2011, PROG NEUROBIOL, V95, P629, DOI DOI 10.1016/J.PNEUROBIO.2011.09.005	73	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171749	10.1371/journal.pone.0171749	http://dx.doi.org/10.1371/journal.pone.0171749			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207873	Green Submitted, Green Published, gold			2022-12-26	WOS:000394424500051
J	de Queiroz, KB; Honorato-Sampaio, K; Rossoni, JV; Leal, DA; Pinto, ABG; Kappes-Becker, L; Evangelista, EA; Guerra-Sa, R				de Queiroz, Karina Barbosa; Honorato-Sampaio, Kinulpe; Rossoni Junior, Joamyr Victor; Leal, Diego Andrade; Pinto, Angelica Barbosa G.; Kappes-Becker, Lenice; Evangelista, Elisio Alberto; Guerra-Sa, Renata			Physical activity prevents alterations in mitochondrial ultrastructure and glucometabolic parameters in a high-sugar diet model	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; OXIDATIVE STRESS; GENE-EXPRESSION; ADIPOSE-TISSUE; MESSENGER-RNA; UP-REGULATION; EXERCISE	Endurance exercise is a remarkable intervention for the treatment of many diseases. Mitochondria) changes on skeletal muscle are likely important for many of the benefits provided by exercise. In this study, we aimed to evaluate the effects that a regular physical activity (swimming withoutworkload) has on mitochondrial morphological alterations and glucometabolic parameters induced by a high-sugar diet (HSD). Weaned male Wistar rats fed with a standard diet or a HSD (68% carbohydrate) were subjected to 60 minutes of regular physical activity by swimming (without workload) for four- (20 sessions) or eight-week (40 sessions) periods. After training, animals were euthanized and the sera, adipose tissues, and skeletal muscles were collected for further analysis. The HSD increased body weight after an 8 week period; it also increased the fat pads and the adipose index, resulting in glucose intolerance and insulin resistance (IR). Transmission electron microscopy showed an increase in alterations of mitochondrial ultrastructure in the gastrocnemius muscle, as well as a decrease in superoxide dismutase (SOD) activity, and an increase in protein carbonylation. Regular physical activity partially reverted these alterations in rats fed a HSD, preventing mitochondrial morphological alterations and IR. Moreover, we observed a decrease in Pgcla expression (qPCR analysis) in STD-EXE group and a less pronounced reduction in HSD-EXE group after an 8-week period. Thus, regular physical activity (swimming without workload) in rats fed a HSD can prevent mitochondrial dysfunction and IR, highlighting the crucial role for physical activity on metabolic homeostasis.	[de Queiroz, Karina Barbosa; Leal, Diego Andrade; Evangelista, Elisio Alberto; Guerra-Sa, Renata] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Bioquim & Biol Mol, Ouro Preto, MG, Brazil; [Honorato-Sampaio, Kinulpe] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Campus JK, Diamantina, MG, Brazil; [Rossoni Junior, Joamyr Victor] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Bioquim Metab, Ouro Preto, MG, Brazil; [Pinto, Angelica Barbosa G.; Kappes-Becker, Lenice] Univ Fed Ouro Preto, Ctr Esportes, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto	de Queiroz, KB (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Lab Bioquim & Biol Mol, Ouro Preto, MG, Brazil.	karinabq@gmail.com	de Queiroz, Karina Barbosa/S-9628-2017; Honorato-Sampaio, Kinulpe/AAX-3742-2021	de Queiroz, Karina Barbosa/0000-0002-8171-435X; Honorato-Sampaio, Kinulpe/0000-0002-8154-9606; Rossoni Junior, Joamyr Victor/0000-0002-1882-4249	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES), and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Barbieri E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/917085; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bhatt BA, 2006, AM J PHYSIOL-REG I, V290, pR233, DOI 10.1152/ajpregu.00097.2005; Bluher S, 2014, METABOLISM; Broskey NT, 2013, J APPL PHYSIOL, V115, P765, DOI 10.1152/japplphysiol.00063.2013; Chan CYY, 2013, EUR J NUTR, V52, P1721, DOI 10.1007/s00394-012-0475-5; Chu L, 2011, EUR J APPL PHYSIOL, V111, P3135, DOI 10.1007/s00421-011-1940-1; de Lima DC, 2008, METAB BRAIN DIS, V23, P361, DOI 10.1007/s11011-008-9101-x; de Queiroz KB, 2014, MOL NUTR FOOD RES, V58, P2331, DOI 10.1002/mnfr.201400241; de Queiroz KB, 2014, LIPIDS, V49, P85, DOI 10.1007/s11745-013-3854-7; de Queiroz KB, 2012, NUTR RES, V32, P709, DOI 10.1016/j.nutres.2012.06.020; de Souza MO, 2010, NUTRITION, V26, P804, DOI 10.1016/j.nut.2009.09.007; Evangelista FS, 2003, BRAZ J MED BIOL RES, V36, P1751, DOI 10.1590/S0100-879X2003001200018; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Freyssenet D, 1996, ARCH PHYSIOL BIOCHEM, V104, P129, DOI 10.1076/apab.104.2.129.12878; Gatineau E, 2015, J NUTR, V145, P923, DOI 10.3945/jn.114.205583; GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gomez-Cabrera MC, 2006, BRIT J NUTR, V96, pS31, DOI 10.1079/BJN20061696; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guran T, 2011, MINERVA PEDIATR, V63, P483; Hackman CL, 2014, ADOLESC HEALTH MED T, V5, P101, DOI 10.2147/AHMT.S56207; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; Joslowski G, 2012, INT J OBES LOND; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kregel KC, 2006, EXERCISE PROTOCOLS U, P35; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI [10.1139/H11-076, 10.1139/h11-076]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McDevitt RM, 2001, AM J CLIN NUTR, V74, P737; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Mittendorfer B, 2003, NUTR RES REV, V16, P97, DOI 10.1079/NRR200357; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Morton TL, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00080; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; PITTS GC, 1984, AM J PHYSIOL, V246, pR495, DOI 10.1152/ajpregu.1984.246.4.R495; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sidossis LS, 1996, J CLIN INVEST, V98, P2244, DOI 10.1172/JCI119034; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Skledar MT, 2015, CENT EUR J PUBL HEAL, V23, P26, DOI 10.21101/cejph.a3956; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stephen A, 2012, EUR J CLIN NUTR, V66, P765, DOI 10.1038/ejcn.2012.27; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Ustunel I, 1997, ACTA ANAT, V158, P279; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiao T, 2015, EUR REV MED PHARMACO, V19, P1779; YAMADA T, 1975, J LAB CLIN MED, V86, P38; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; YANG XL, 1995, ANAT RECORD, V241, P255, DOI 10.1002/ar.1092410212	80	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172103	10.1371/journal.pone.0172103	http://dx.doi.org/10.1371/journal.pone.0172103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199417	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424400072
J	Issa, H; Huc-Claustre, E; Reddad, T; Bottino, NB; Tropis, M; Houssin, C; Daffe, M; Bayan, N; Dautin, N				Issa, Hanane; Huc-Claustre, Emilie; Reddad, Thamila; Bottino, Nolwenn Bonade; Tropis, Maryelle; Houssin, Christine; Daffe, Mamadou; Bayan, Nicolas; Dautin, Nathalie			Click-chemistry approach to study mycoloylated proteins: Evidence for PorB and PorC porins mycoloylation in Corynebacterium glutamicum	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; CELL-WALL CHANNEL; MYCOBACTERIUM-TUBERCULOSIS; FORMING PROTEIN; BETA-BARREL; IDENTIFICATION; GENE; PALMITOYLATION; EXPRESSION; LOCALIZATION	Protein mycoloylation is a recently identified, new form of protein acylation. This post -translational modification consists in the covalent attachment of mycolic acids residues to serine. Mycolic acids are long chain, alpha-branched, beta-hydroxylated fatty acids that are exclusively found in the cell envelope of Corynebacteriales, a bacterial order that includes important genera such as Mycobacterium, Nocardia or Corynebacterium. So far, only 3 mycoloylated proteins have been identified: PorA, PorH and ProtX from C. glutamicum. Whereas the identity and function of ProtX is unknown, PorH and PorA associate to form a membrane channel, the activity of which is dependent upon PorA mycoloylation. However, the exact role of mycoloylation and the generality of this phenomenon are still unknown. In particular, the identity of other mycoloylated proteins, if any, needs to be determined together with establishing whether such modification occurs in Corynebacteriales genera other than Corynebacterium. Here, we tested whether a metabolic labeling and click -chemistry approach could be used to detect mycoloylated proteins. Using a fatty acid alkyne analogue, we could indeed label PorA, PorH and ProtX and determine ProtX mycoloylation site. Importantly, we also show that two other porins from C. glutamicum, PorB and PorC are mycoloylated.	[Issa, Hanane; Reddad, Thamila; Bottino, Nolwenn Bonade; Houssin, Christine; Bayan, Nicolas; Dautin, Nathalie] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France; [Issa, Hanane] Holy Spirit Univ Kaslik USEK, Jounieh, Mt Lebanon, Lebanon; [Huc-Claustre, Emilie; Tropis, Maryelle; Daffe, Mamadou] Inst Pharmacol & Struct Biol, UMR 5089, Paris, France; [Huc-Claustre, Emilie] Canc Res Ctr Toulouse, Toulouse, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dautin, N (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, Gif Sur Yvette, France.	nathalie.dautin@i2bc.paris-saclay.fr	Bayan, Nicolas/AAI-5034-2020; Claustre, Emilie Huc/M-6693-2016	Claustre, Emilie Huc/0000-0002-8856-207X; Bayan, Nicolas/0000-0001-7760-0811	Centre National de la Recherche Scientifique; Paris-Sud University; USEK-Lebanese CNRS doctoral fellowship	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Paris-Sud University; USEK-Lebanese CNRS doctoral fellowship	This work was supported by the Centre National de la Recherche Scientifique and the Paris-Sud University. HI is supported by a USEK-Lebanese CNRS doctoral fellowship.	Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; Baumgart M, 2011, J BACTERIOL, V193, P6864, DOI 10.1128/JB.05465-11; BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z; Buddelmeijer N, 2015, FEMS MICROBIOL REV, V39, P246, DOI 10.1093/femsre/fuu006; Charlton TM, 2015, CHEM BIOL, V22, P1562, DOI 10.1016/j.chembiol.2015.10.006; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Costa-Riu N, 2003, J BACTERIOL, V185, P4779, DOI 10.1128/JB.185.16.4779-4786.2003; Daffe AM, 2015, TUBERCULOSIS EDIN S1, pS155; Dautin N, 2016, BIOCH BIOPHYS ACTA; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Foley HN, 2016, ANGEW CHEM INT EDIT, V55, P2053, DOI 10.1002/anie.201509216; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Houston S, 2011, INFECT IMMUN, V79, P1386, DOI 10.1128/IAI.01083-10; Huc E, 2013, J BACTERIOL, V195, P4121, DOI 10.1128/JB.00285-13; Huc E, 2010, J BIOL CHEM, V285, P21908, DOI 10.1074/jbc.C110.133033; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Huysmans GHM, 2016, BIOCHEM SOC T, V44, P845, DOI 10.1042/BST20160003; JOLIFF G, 1992, MOL MICROBIOL, V6, P2349, DOI 10.1111/j.1365-2958.1992.tb01410.x; Kavunja HW, 2016, CHEM COMMUN, V52, P13795, DOI 10.1039/c6cc07143k; Klackta C, 2011, BBA-BIOMEMBRANES, V1808, P1601, DOI 10.1016/j.bbamem.2010.11.011; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Kumari B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089246; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Lichtinger T, 2001, EUR J BIOCHEM, V268, P462; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mohiman N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046225; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Quevillon-Cheruel S, 2009, J BIOL CHEM, V284, P3552, DOI 10.1074/jbc.M808334200; Radmacher E, 2005, MICROBIOL-SGM, V151, P2421, DOI 10.1099/mic.0.28012-0; Rangan KJ, 2010, J AM CHEM SOC, V132, P10628, DOI 10.1021/ja101387b; Rath P, 2013, FEBS LETT, V587, P3687, DOI 10.1016/j.febslet.2013.09.032; Rath P, 2011, J BIOL CHEM, V286, P32525, DOI 10.1074/jbc.M111.276956; Raynaud C, 2002, MOL MICROBIOL, V46, P191, DOI 10.1046/j.1365-2958.2002.03152.x; Reilly L, 2015, FASEB J, V29, P4532, DOI 10.1096/fj.15-276493; Rietschel B, 2009, MOL CELL PROTEOMICS, V8, P1029, DOI 10.1074/mcp.M800223-MCP200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Siegrist MS, 2015, FEMS MICROBIOL REV, V39, P184, DOI 10.1093/femsre/fuu012; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Tate EW, 2015, CURR OPIN CHEM BIOL, V24, P48, DOI 10.1016/j.cbpa.2014.10.016; Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s; van der Woude AD, 2013, J BACTERIOL, V195, P2050, DOI 10.1128/JB.02236-12; Walsh C, 2006, POSTTRANSLATIONAL MO, Vxxi; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Yang YS, 2011, PROTEINS, V79, P645, DOI 10.1002/prot.22912; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017	65	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171955	10.1371/journal.pone.0171955	http://dx.doi.org/10.1371/journal.pone.0171955			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199365	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424400060
J	Pruszynski, CA; Hribar, LJ; Mickle, R; Leal, AL				Pruszynski, Catherine A.; Hribar, Lawrence J.; Mickle, Robert; Leal, Andrea L.			A Large Scale Biorational Approach Using Bacillus thuringiensis israeliensis (Strain AM65-52) for Managing Aedes aegypti Populations to Prevent Dengue, Chikungunya and Zika Transmission	PLOS ONE			English	Article							VAR. ISRAELENSIS; KEY-WEST; DIPTERA-CULICIDAE; ALBOPICTUS; MOSQUITO; SUSCEPTIBILITY; INVERTEBRATES; FORMULATIONS; RESIDENTS; FLORIDA	Background Aedes aegypti is a container-inhabiting mosquito and a vector of dengue, chikungunya, and Zika viruses. In 2009 several cases of autochthonous dengue transmission were reported in Key West, Florida, USA prompting a comprehensive response to control A. aegypti. In Key West, larvae of this mosquito develop in containers around human habitations which can be numerous and labor intensive to find and treat. Aerial applications of larvicide covering large areas in a short time can be an efficient and economical method to control A. aegypti. Bacillus thuringiensis israelensis (Bti) is a bacterial larvicide which is highly target specific and appropriate for wide area spraying over urban areas, but to date, there are no studies that evaluate aerial spraying of Bti to control container mosquitoes like A. aegypti. Methodology This paper examines the effectiveness of aerial larvicide applications using VectoBac (R) WG, a commercially available Bti formulation, for A. aegypti control in an urban setting in the USA. Droplet characteristics and spray drop deposition were evaluated in Key West, Florida, USA. The mortality of A. aegypti in containers placed under canopy in an urban environment was also evaluated. Efficacy of multiple larvicide applications on adult female A. aegypti population reduction was compared between an untreated control and treatment site. Conclusions Droplet characteristics showed that small droplets can penetrate through dense canopy to reach small containers. VectoBac WG droplets reached small containers under heavy canopy in sufficient amounts to cause >55% mortality on all application days and >90% mortality on 3 of 5 application days while controls had <5% mortality. Aerial applications of dVectoBac WG caused significant decrease in adult female populations throughout the summer and during the 38 th week (last application) the difference in adult female numbers between untreated and treated sites was >50%. Aerial larvicide applications using VectoBac WG can cover wide areas in a short period of time and can be effective in controlling A. aegypti and reducing A. aegypti-borne transmission in urban areas similar to Key West, Florida, USA.	[Pruszynski, Catherine A.; Hribar, Lawrence J.; Leal, Andrea L.] Florida Keys Mosquito Control Dist, Coll Rd, Key West, FL 33040 USA; [Mickle, Robert] REMSpC Spray Consulting, Welsh Dr, Ayr, ON, Canada		Pruszynski, CA (corresponding author), Florida Keys Mosquito Control Dist, Coll Rd, Key West, FL 33040 USA.	cpruz@keysmosquito.org			Florida Keys Mosquito Control District; Monroe County property taxes	Florida Keys Mosquito Control District; Monroe County property taxes	The authors received no specific funding for this work. Author Robert Mickle is the owner of the commercial company "REMSpC Spray Consulting" and was paid a consulting fee by the government agency, Florida Keys Mosquito Control District, for his evaluation of the droplet analysis evaluated for this experiment. The Florida Keys Mosquito Control District is an independent taxing district in Monroe County, Florida. The FKMCD budget is funded by a percentage of Monroe County property taxes. The funders (tax-payers of Monroe Co.) did not play a role in the study design, collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702; Aldemir A, 2009, J AM MOSQUITO CONTR, V25, P113, DOI 10.2987/08-5836.1; [Anonymous], 2016, ZIK VIR CAS COUNTS U; Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297; Attar N., 2016, NAT REV MICROBIOL, V2016, P14; Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Becker N, 2003, J AM MOSQUITO CONTR, V19, P63; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Boisvert M, 2005, UTILIZATION BACILLUS, P87; Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2; Caquet T, 2011, ECOTOX ENVIRON SAFE, V74, P1122, DOI 10.1016/j.ecoenv.2011.04.028; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dunford JC, 2014, J AM MOSQUITO CONTR, V30, P191, DOI 10.2987/14-6400R.1; Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; Glare TR, 1998, ENV HLTH IMPACTS BAC, P81; Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419; Guide Who, 1994, WHO GUIDEL DRINK QUA, P1; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hribar Lawrence J., 2011, Studia Dipterologica, V17, P237; Huber Karine, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P81; Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844; Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Key West Chamber of Commerce, 2015, KEY W MONR COUNT DEM; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lagadic L, 2014, J APPL ECOL, V51, P102, DOI 10.1111/1365-2664.12165; Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071; Lee H. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P601; Lee YW, 2006, J AM MOSQUITO CONTR, V22, P97, DOI 10.2987/8756-971X(2006)22[97:SOLAFA]2.0.CO;2; Mao T, 1997, AICHE J, V43, P2169, DOI 10.1002/aic.690430903; Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665; Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Reece AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004521; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y; Rodriguez MM, 2004, J MEDIAL ENTOMOL, V38, P623; Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1; Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296; To Setha, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P261; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Vilarinhos PTR, 2004, J AM MOSQUITO CONTR, V20, P311; WHO, 1999, IPCS ENV HLTH CRIT 2; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-38798141-3, DOI 10.1007/978-0-38798141-3]; Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035; World Health Organization, 2016, ZIK FACT SHEET; World Health Organization, 2015, CHIK FACT SHEET; World Health Organization, 2016, WHOPES REC COMP FORM	53	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0170079	10.1371/journal.pone.0170079	http://dx.doi.org/10.1371/journal.pone.0170079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199323	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424400013
J	Ruocco, N; Costantini, S; Zupo, V; Romano, G; Ianora, A; Fontana, A; Costantini, M				Ruocco, Nadia; Costantini, Susan; Zupo, Valerio; Romano, Giovanna; Ianora, Adrianna; Fontana, Angelo; Costantini, Maria			High-quality RNA extraction from the sea urchin Paracentrotus lividus embryos	PLOS ONE			English	Article							MOLECULAR ECOLOGY; STRESS; PRESERVATION; TRANSCRIPTOMES; CELOMOCYTES; ECHINODERMS; RESPONSES; TISSUES; DNA	The sea urchin Paracentrotus lividus (Lamarck, 1816) is a keystone herbivore in the Mediterranean Sea due to its ability to transform macroalgal-dominated communities into barren areas characterized by increased cover of bare substrates and encrusting coralline algae, reduced biodiversity and altered ecosystem functions. P. lividus is also an excellent animal model for toxicology, physiology and biology investigations having been used for more than a century as a model for embryological studies with synchronously developing embryos which are easy to manipulate and analyze for morphological aberrations. Despite its importance for the scientific community, the complete genome is still not fully annotated. To date, only a few molecular tools are available and a few Next Generation Sequencing (NGS) studies have been performed. Here we aimed at setting-up an RNA extraction method to obtain high quality and sufficient quantity of RNA for NGS from P. lividus embryos at the pluteus stage. We compared five different RNA extraction protocols from four different pools of plutei (500, 1000, 2500 and 5000 embryos): TRIzol, and four widely-used Silica Membrane kits, GenElute TM Mammalian Total RNA Miniprep Kit, RNAqueous Micro Kit, RNeasy Micro Kit and Aurum TM Total RNA Mini Kit. The quantity of RNA isolated was evaluated using NanoDrop. The quality, considering the purity, was measured as A260/A280 and A260/230 ratios. The integrity was measured by RNA Integrity Number (RIN). Our results demonstrated that the most efficient procedures were GenElute, RNeasy and Aurum, producing a sufficient quantity of RNA for NGS. The Bioanalyzer profiles and RIN values revealed that the most efficient methods guaranteeing for RNA integrity were RNeasy and Aurum combined with an initial preservation in RNAlater. This research represents the first attempt to standardize a method for high-quality RNA extraction from sea urchin embryos at the pluteus stage, providing a new resource for this established model marine organism.	[Ruocco, Nadia; Costantini, Maria] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Ruocco, Nadia] Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, Via Cinthia, Naples, Italy; [Ruocco, Nadia; Fontana, Angelo] CNR, Inst Biomol Chem, Bioorgan Chem Unit, Via Campi Flegrei 34, Naples, Italy; [Costantini, Susan] Fdn G Pascale, Ist Nazl Tumori, CROM, Naples, Italy; [Zupo, Valerio] Ctr Villa Dohrn Ischia Benth Ecol, Dept Integrat Marine Ecol, Stn Zool Anton Dohrn, Naples, Italy; [Romano, Giovanna; Ianora, Adrianna] Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli	Costantini, M (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.; Fontana, A (corresponding author), CNR, Inst Biomol Chem, Bioorgan Chem Unit, Via Campi Flegrei 34, Naples, Italy.	afontana@icb.cnr.it; maria.costantini@szn.it	Ianora, Adrianna/O-3408-2019; Fontana, Angelo/AAO-2741-2021; Costantini, Susan/J-9914-2018; Costantini, Maria/AGH-4080-2022; Ruocco, Nadia/HGA-2143-2022; Fontana, Angelo/C-3354-2012; Romano, Giovanna/F-4561-2015	Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Romano, Giovanna/0000-0002-4898-7153; Costantini, Susan/0000-0002-7538-4657	PhD (PhD in Biology, University of Naples Federico II) fellowship; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples	PhD (PhD in Biology, University of Naples Federico II) fellowship; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples	Nadia Ruocco has been supported by a PhD (PhD in Biology, University of Naples Federico II) fellowship co-funded by the Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RL, 2013, MOL ECOL, V22, P2605, DOI 10.1111/mec.12319; Asai S, 2015, MAR GENOM, V24, P115, DOI 10.1016/j.margen.2014.12.004; Bellas J, 2008, AQUAT TOXICOL, V88, P308, DOI 10.1016/j.aquatox.2008.05.011; Bonaventura R, 2011, CELL STRESS CHAPERON, V16, P681, DOI 10.1007/s12192-011-0277-3; Bosnjak I, 2011, WATER AIR SOIL POLL, V217, P627, DOI 10.1007/s11270-010-0615-6; Boudouresque CF, 2007, DEV AQUAC FISH SCI, V37, P243; Boudouresque Charles F., 2001, Developments in Aquaculture and Fisheries Science, V32, P177; Dinnel P.A., 1988, P611; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; Hillyard G, 2012, POLAR BIOL, V35, P633, DOI 10.1007/s00300-011-1088-9; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Kobayashi N, 2005, CHEMOSPHERE, V61, P1198, DOI 10.1016/j.chemosphere.2005.02.071; Kominami T, 2004, DEV GROWTH DIFFER, V46, P309; Lawrence JM, 2007, SEA URCHINS BIOLOGY; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Morale A, 1998, CHEMOSPHERE, V37, P3001, DOI 10.1016/S0045-6535(98)00341-5; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Paredes E, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4010007; Perez-Portela R, 2013, MOL ECOL RESOUR, V13, P884, DOI 10.1111/1755-0998.12122; Pinsino A, 2008, CELL BIOL TOXICOL, V24, P541, DOI 10.1007/s10565-008-9055-0; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Riesgo A, 2012, MOL ECOL RESOUR, V12, P312, DOI 10.1111/j.1755-0998.2011.03097.x; Ruocco N, 2016, AQUAT TOXICOL, V176, P128, DOI 10.1016/j.aquatox.2016.04.012; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCONZO G, 1995, PHARMAZIE, V50, P616; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simister RL, 2011, J EXP MAR BIOL ECOL, V397, P38, DOI 10.1016/j.jembe.2010.11.004; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wangensteen OS, 2011, MAR ECOL PROG SER, V441, P117, DOI 10.3354/meps09359; Zito F, 2005, PROG MOLEC, V39, P7	44	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172171	10.1371/journal.pone.0172171	http://dx.doi.org/10.1371/journal.pone.0172171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199408	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400079
J	Wisowski, G; Kozma, EM; Bielecki, T; Pudelko, A; Olczyk, K				Wisowski, Grzegorz; Kozma, Ewa M.; Bielecki, Tomasz; Pudelko, Adam; Olczyk, Krystyna			Dermatan sulfate is a player in the transglutaminase 2 interaction network	PLOS ONE			English	Article							FIBROSIS-AFFECTED FASCIA; HEPARIN-BINDING-SITE; TISSUE TRANSGLUTAMINASE; CELL-ADHESION; CHONDROITIN SULFATE; MATRIX-DEPOSITION; GROWTH; FIBRONECTIN; BIGLYCAN; PROTEOGLYCANS	Transglutaminase 2 (TG2) is a multifunctional protein that is primarily engaged in cell adhesion/signaling or shows Ca2+ -dependent transglutaminase activity in the extracellular space of tissues. This latter action leads to the cross-linking of the extracellular matrix (ECM) proteins. The enhanced extracellular expression of TG2 is associated with processes such as wound healing, fibrosis or vascular remodeling that are also characterized by a high deposition of dermatan sulfate (DS) proteoglycans in the ECM. However, it is unknown whether DS may bind to TG2 or affect its function. Using the plasmon surface resonance method, we showed that DS chains, especially those of biglycan, are good binding partners for TG2. The interaction has some requirements as to the DS structure. The competitive effect of heparin on DS binding to TG2 suggests that both glycosaminoglycans occupy the same binding site(s) on the protein molecule. An occurrence of the DS-TG2 interaction was confirmed by the co-immunoprecipitation of this protein with native decorin that is a DS-bearing proteoglycan rather than with the decorin core protein. Moreover, in vivo DS is responsible for both TG2 binding and the regulation of the location of this protein in the ECM as can be suggested from an increased extraction of TG2 from the human fascia only when an enzymatic degradation of the tissue DS was conducted in the presence of the anti-collagen type I antiserum. In addition, DS with a low affinity for TG2 exerted an inhibitory effect on the protein transamidating activity most probably via the control of the accessibility of a substrate. Our data show that DS can affect several aspects of TG2 biology in both physiological and pathological conditions.	[Wisowski, Grzegorz; Kozma, Ewa M.; Pudelko, Adam; Olczyk, Krystyna] Med Univ Silesia, Div Lab Med Sosnowiec, Sch Pharm, Dept Clin Chem & Lab Diagnost, Katowice, Poland; [Bielecki, Tomasz] Med Univ Silesia, Div Dent Zabrze, Sch Med, Dept & Clin Orthoped & Trauma Surg, Katowice, Poland	Medical University Silesia; Medical University Silesia	Wisowski, G (corresponding author), Med Univ Silesia, Div Lab Med Sosnowiec, Sch Pharm, Dept Clin Chem & Lab Diagnost, Katowice, Poland.	vis@sum.edu.pl		Kozma, Ewa Maria/0000-0002-4502-0828; Pudelko, Adam/0000-0003-4558-8437; Wisowski, Grzegorz/0000-0001-8781-0011; Olczyk, Krystyna/0000-0002-5833-2628	Medical University of Silesia in Katowice [KNW-1-030/K/3/0]	Medical University of Silesia in Katowice	Grant of Medical University of Silesia in Katowice, number KNW-1-030/K/3/0; http://www.sum.edu.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Cardoso I, 2015, FEBS J, V282, P2063, DOI 10.1111/febs.13276; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chou CY, 2011, J BIOL CHEM, V286, P27825, DOI 10.1074/jbc.M111.226340; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dolynchuk Kenneth N., 1996, Wound Repair and Regeneration, V4, P16, DOI 10.1046/j.1524-475X.1996.40105.x; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; GENTILE V, 1991, J BIOL CHEM, V266, P478; Huelsz-Prince G, 2013, J VASC RES, V50, P383, DOI 10.1159/000354222; Jandu SK, 2013, AMINO ACIDS, V44, P261, DOI 10.1007/s00726-011-1090-0; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; JUPRELLESORET M, 1988, BIOCHEM J, V250, P421, DOI 10.1042/bj2500421; Kozma EM, 2005, J BIOCHEM, V137, P463, DOI 10.1093/jb/mvi054; Kozma EM, 2014, EXP BIOL MED, V239, P1575, DOI 10.1177/1535370214538590; Kozma EM, 2011, GLYCOBIOLOGY, V21, P1301, DOI 10.1093/glycob/cwr065; Kozma EM, 2009, BIOCHIMIE, V91, P1394, DOI 10.1016/j.biochi.2009.07.010; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Schaefer L, 2003, J BIOL CHEM, V278, P26227, DOI 10.1074/jbc.M210574200; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; van den Akker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023067; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhao WJ, 2012, BIOSCIENCE REP, V32, P71, DOI 10.1042/BSR20110077	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0172263	10.1371/journal.pone.0172263	http://dx.doi.org/10.1371/journal.pone.0172263			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199387	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400086
J	Atee, HA; Ahmad, R; Noor, NM; Rahma, AMS; Aljeroudi, Y				Atee, Hayfaa Abdulzahra; Ahmad, Robiah; Noor, Norliza Mohd; Rahma, Abdul Monem S.; Aljeroudi, Yazan			Extreme learning machine based optimal embedding location finder for image steganography	PLOS ONE			English	Article							NEURAL-NETWORKS; ALGORITHM; CAPACITY; STEGANALYSIS; SCHEME	In image steganography, determining the optimum location for embedding the secret message precisely with minimum distortion of the host medium remains a challenging issue. Yet, an effective approach for the selection of the best embedding location with least deformation is far from being achieved. To attain this goal, we propose a novel approach for image steganography with high-performance, where extreme learning machine (ELM) algorithm is modified to create a supervised mathematical model. This ELM is first trained on a part of an image or any host medium before being tested in the regression mode. This allowed us to choose the optimal location for embedding the message with best values of the predicted evaluation metrics. Contrast, homogeneity, and other texture features are used for training on a new metric. Furthermore, the developed ELM is exploited for counter over-fitting while training. The performance of the proposed steganography approach is evaluated by computing the correlation, structural similarity (SSIM) index, fusion matrices, and mean square error (MSE). The modified ELM is found to outperform the existing approaches in terms of imperceptibility. Excellent features of the experimental results demonstrate that the proposed steganographic approach is greatly proficient for preserving the visual information of an image. An improvement in the imperceptibility as much as 28% is achieved compared to the existing state of the art methods.	[Atee, Hayfaa Abdulzahra] Fdn Tech Educ, Higher Educ & Sci Res, Baghdad, Iraq; [Atee, Hayfaa Abdulzahra; Ahmad, Robiah; Noor, Norliza Mohd] UTM Kuala Lumpur, UTM Razak Sch Engn & Adv Technol, Dept Engn, Kuala Lumpur, Malaysia; [Rahma, Abdul Monem S.] Univ Technol Baghdad, Dept Comp Sci, Baghdad, Iraq; [Aljeroudi, Yazan] Int Islamic Univ Malaysia, Dept Mech Engn, Kuala Lumpur, Malaysia	Universiti Teknologi Malaysia; University of Technology- Iraq; International Islamic University Malaysia	Atee, HA (corresponding author), Fdn Tech Educ, Higher Educ & Sci Res, Baghdad, Iraq.; Atee, HA (corresponding author), UTM Kuala Lumpur, UTM Razak Sch Engn & Adv Technol, Dept Engn, Kuala Lumpur, Malaysia.	haifaa_atee@yahoo.com	aljeroudi, yazan/AAU-8971-2021; AHMAD, ROBIAH/J-2107-2019; Noor, Norliza Mohd/AAF-5733-2020; Atee, Hayfaa A./AAX-4633-2020; Rahma, Abdul Monem Salih/AAR-4753-2021; Atee, Hayfaa/G-6826-2019	AHMAD, ROBIAH/0000-0001-6461-9564; Rahma, Abdul Monem Salih/0000-0001-6323-9148; Atee, Hayfaa/0000-0001-5647-9215				Al-Jbara HAG, 2012, AIP CONF PROC, V1482, P20, DOI 10.1063/1.4757431; Almohammad A, 2010, THESIS; Atawneh S, 2013, IETE TECH REV, V30, P344, DOI 10.4103/0256-4602.116724; Banerjee I, 2013, PROC TECH, V10, P157, DOI 10.1016/j.protcy.2013.12.348; Barni M, 2011, IEEE SIGNAL PROCESS, V28, P142, DOI DOI 10.1109/MSP.2011.941841; Cheddad A, 2010, SIGNAL PROCESS, V90, P727, DOI 10.1016/j.sigpro.2009.08.010; Cho SG, 2013, J VIS COMMUN IMAGE R, V24, P846, DOI 10.1016/j.jvcir.2013.05.007; Paulson LD, 2006, COMPUTER, V39, P25, DOI 10.1109/MC.2006.273; Deng ZH, 2014, IEEE T NEUR NET LEAR, V25, P664, DOI 10.1109/TNNLS.2013.2280171; Dwd Q, 2015, CONTR C ASCC 2015 10; El-Alfy EM, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P160, DOI 10.1109/CIDM.2013.6597231; El-Emam NN, 2013, J SYST SOFTWARE, V86, P1465, DOI 10.1016/j.jss.2012.12.006; Elshoura SM, 2013, SIGNAL PROCESS-IMAGE, V28, P531, DOI 10.1016/j.image.2012.12.005; Filler T, 2011, IEEE T INF FOREN SEC, V6, P920, DOI 10.1109/TIFS.2011.2134094; Filler T, 2011, PROC SPIE, V7880, DOI 10.1117/12.872192; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hassaan, 2008, P IEEE SWARM INT S, P1; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Husien S, 2015, NEURAL COMPUT APPL, V26, P111, DOI 10.1007/s00521-014-1702-1; Iranpour M, 2015, MULTIMED TOOLS APPL, V74, P11429, DOI 10.1007/s11042-014-2237-2; Islam S, 2014, 10 INT C ICIC TAIYUA, P803; Kanan HR, 2014, EXPERT SYST APPL, V41, P6123, DOI 10.1016/j.eswa.2014.04.022; Ker A, 2008, ESECURITY FORENSICS; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Luo JH, 2014, IEEE T NEUR NET LEAR, V25, P836, DOI 10.1109/TNNLS.2013.2281839; Luo WQ, 2010, IEEE T INF FOREN SEC, V5, P201, DOI 10.1109/TIFS.2010.2041812; Ma XY, 2009, L N INST COMP SCI SO, V18, P152; Najafi HL, 2010, INT J INTELL COMPUT, V3, P391, DOI 10.1108/17563781011066693; Oplatkova Zuzana Kominkova, 2013, International Journal of Innovative Computing and Applications, V5, P184; Pathak P, 2014, DIGIT INVEST, V11, P67, DOI 10.1016/j.diin.2013.12.002; Pevny T., 2010, USING HIGH DIMENSION, P161; Prabakaran G., 2012, 2012 International Conference on Computing, Electronics and Electrical Technologies (ICCEET 2012), P1096, DOI 10.1109/ICCEET.2012.6203811; Pratt MA, 2008, INT J INTELL COMPUT, V1, P549, DOI 10.1108/17563780810919122; Qi M, 2010, J NETW COMPUT APPL, V33, P247, DOI 10.1016/j.jnca.2009.12.004; Roy R, 2015, PROCEDIA COMPUT SCI, V60, P468, DOI 10.1016/j.procs.2015.08.168; Tsai DS, 2009, INFORM SCIENCES, V179, P3247, DOI 10.1016/j.ins.2009.05.020; Wang ST, 2015, APPL SOFT COMPUT, V37, P125, DOI 10.1016/j.asoc.2015.07.040; Wu HC, 2009, J SYST SOFTWARE, V82, P1966, DOI 10.1016/j.jss.2009.06.056; Zhang F, 2008, INFORM SCIENCES, V178, P2950, DOI 10.1016/j.ins.2008.03.011	39	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0170329	10.1371/journal.pone.0170329	http://dx.doi.org/10.1371/journal.pone.0170329			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196080	Green Published, Green Submitted, gold			2022-12-26	WOS:000394423900005
J	Hoffman, O; Burns, N; Vadasz, I; Eltzschig, HK; Edwards, MG; Vohwinkel, CU				Hoffman, Olivia; Burns, Nana; Vadasz, Istvan; Eltzschig, Holger K.; Edwards, Michael G.; Vohwinkel, Christine U.			Detrimental ELAVL-1/HuR-dependent GSK3 beta mRNA stabilization impairs resolution in acute respiratory distress syndrome	PLOS ONE			English	Article							ACUTE LUNG INJURY; BINDING PROTEIN; EXPRESSION; PROTECTION; CLEARANCE; HUR; INFLAMMATION; INHIBITION; ACTIVATION; MECHANISMS	A hallmark of acute respiratory distress syndrome (ARDS) is accumulation of protein-rich edema in the distal airspaces and its removal is critical for patient survival. Previous studies have shown a detrimental role of Glycogen Synthase Kinase (GSK) 3 beta during ARDS via inhibition of alveolar epithelial protein transport. We hypothesized that post-transcriptional regulation of GSK3 beta could play a functional role in ARDS resolution. To address this hypothesis, we performed an in silico analysis to identify regulatory genes whose expression correlation to GSK3 beta messenger RNA utilizing two lung cancer cell line array datasets. Among potential regulatory partners of GSK3 beta, these studies identified the RNA-binding protein ELAVL-1/HuR (Embryonic Lethal, Abnormal Vision, Drosophila-Like) as a central component in a likely GSK3 beta signaling network. ELAVL-1/HuR is a RNA-binding protein that selectively binds to AU-rich elements of mRNA and enhances its stability thereby increasing target gene expression. Subsequent studies with siRNA suppression of ELAVL-1/HuR demonstrated deceased GSK3 beta mRNA and protein expression and improved clearance of FITC-albumin in A549 cells. Conversely, stabilization of ELAVL-1/HuR with the proteasome inhibitor MG-132 resulted in induction of GSK3 beta at mRNA and protein level and attenuated FITC-albumin clearance. Utilizing ventilator-induced lung injury or intra-tracheal installation of hydrochloric acid to induce ARDS in mice, we observed increased mRNA and protein expression of ELAVL-1/HuR and GSK3 beta. Together, our findings indicate a previously unknown interaction between GSK3 beta and ELAV-1 during ARDS, and suggest the inhibition of the ELAV-1- GSK3 beta pathways as a novel ARDS treatment approach.	[Hoffman, Olivia; Vohwinkel, Christine U.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Burns, Nana; Edwards, Michael G.; Vohwinkel, Christine U.] Univ Colorado, Cardio Vasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Div Pediat Crit Care,Dev Lung Biol,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Burns, Nana; Edwards, Michael G.; Vohwinkel, Christine U.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA; [Vadasz, Istvan] Justus Liebig Univ, Dept Internal Med, Univ Giessen & Marburg Lung Ctr, Giessen, Germany; [Vadasz, Istvan] German Ctr Lung Res, Giessen, Germany; [Eltzschig, Holger K.] Univ Colorado, Sch Med, Dept Anesthesiol, Organ Protect Program, Aurora, CO USA; [Hoffman, Olivia] Harvard Univ, Boston Childrens Hosp, Div Crit Med, Dept Anesthesiol, Boston, MA 02115 USA; [Eltzschig, Holger K.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA; [Edwards, Michael G.] Bioinfo Solut, Parker, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Justus Liebig University Giessen; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Boston Children's Hospital; University of Texas System; University of Texas Health Science Center Houston	Vohwinkel, CU (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.; Vohwinkel, CU (corresponding author), Univ Colorado, Cardio Vasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Div Pediat Crit Care,Dev Lung Biol,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Vohwinkel, CU (corresponding author), Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	Christine.vohwinkel@ucdenver.edu	Vadasz, Istvan/AAO-8288-2021	Vohwinkel, Christine/0000-0001-8959-157X; Vadasz, Istvan/0000-0003-1370-9783	Department of Pediatrics, University of Colorado School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068372] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119837, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075] Funding Source: NIH RePORTER	Department of Pediatrics, University of Colorado School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded through start-up funding given to CV by the Department of Pediatrics, University of Colorado School of Medicine.	Abdallah Claude, 2014, J Anaesthesiol Clin Pharmacol, V30, P7, DOI 10.4103/0970-9185.125685; Agrawal MS, 2009, INDIAN J UROL, V25, P474, DOI 10.4103/0970-1591.57917; BACHOFEN M, 1977, AM REV RESPIR DIS, V116, P589, DOI 10.1164/arrd.1977.116.4.589; Buchackert Y, 2012, J PHYSIOL-LONDON, V590, P5167, DOI 10.1113/jphysiol.2012.233403; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cerutti A, 2015, J AM COLL SURGEONS, V221, pS41, DOI 10.1016/j.jamcollsurg.2015.07.085; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Giaginis C, 2015, CLIN SIGNIFICANCE HU; Giaginis C, 2015, TUMOR BIOL, V36, P315, DOI 10.1007/s13277-014-2637-y; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hastings RH, 2004, AM J PHYSIOL-LUNG C, V286, pL679, DOI 10.1152/ajplung.00205.2003; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hoegl S, 2015, J IMMUNOL, V195, P1815, DOI 10.4049/jimmunol.1401957; Hudy MH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-88; Hummler SC, 2013, AM J RESP CELL MOL, V48, P578, DOI 10.1165/rcmb.2012-0383OC; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neumann P, 2013, PULM PHARMACOL THER, V26, P685, DOI 10.1016/j.pupt.2013.06.001; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sklepkiewicz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018883; Tanaka A, 2012, AM J RESP CELL MOL, V46, P507, DOI 10.1165/rcmb.2009-0415OC; Thangavel J, 2015, J CELL SCI, V128, P3094, DOI 10.1242/jcs.170258; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Wada A, 2009, FRONT BIOSCI-LANDMRK, V14, P1558, DOI 10.2741/3324; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; Wu T, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0247-8; Xing B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128068; Yogosawa S, 1999, BIOCHEM BIOPH RES CO, V266, P123, DOI 10.1006/bbrc.1999.1773; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172116	10.1371/journal.pone.0172116	http://dx.doi.org/10.1371/journal.pone.0172116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196122	gold, Green Published			2022-12-26	WOS:000394423900051
J	Babu, BK; Mathur, RK; Kumar, PN; Ramajayam, D; Ravichandran, G; Venu, MVB; Babu, SS				Babu, B. Kalyana; Mathur, R. K.; Kumar, P. Naveen; Ramajayam, D.; Ravichandran, G.; Venu, M. V. B.; Babu, S. Sparjan			Development, identification and validation of CAPS marker for SHELL trait which governs dura, pisifera and tenera fruit forms in oil palm (Elaeis guineensis Jacq.)	PLOS ONE			English	Article							OVULE DEVELOPMENT; LINKAGE MAP; CARPEL; LOCI; SNP	The oil palm fruit forms (dura, pisifera and tenera) governed by the shell thickness gene (Sh) plays a major role in identification of fruit type and also influences palm oil yield. Identification of desired fruit type is a major asset to the breeders and oil palm workers for applications in breeding, seed certification and to reduce time, space and money spent on identification of fruit form. In the present study, we developed Sh gene specific primer pairs and bulk segregant analysis was done using 300 genomic and 8 genic SSR markers. We identified one cleaved amplified polymorphic site (CAPS) marker for differentiation of oil palm fruit type which produced two alleles (280 and 250bp) in dura genotypes, three alleles in tenera genotypes (550, 280, and 250bp) and one allele in pisifera genotypes (550bp). The shell allele sequencing results showed that two SNPs were present, of which SNP2 contributed for variation of fruit forms. The nucleotide 'A' was present in only dura genotypes, where as 'T' was present only in pisifera genotypes, which in turn led to the change of amino acid lysine to aspargine. The identified CAPS marker was validated on 300 dura, 25 pisifera and 80 tenera genotypes, 80 dura/pisifera cross progenies and 60 lines of tenera/tenera cross progeny. Association mapping of marker data with phenotypic data of eight oil yield related traits resulted in identification of seven significant QTLs by GLM approach, four by MLM approach at a significant threshold (P) level of 0.001. Significant QTLs were identified for fruit to bunch and oil to bunch traits, which explained R2 of 12.9% and 11.5% respectively. The CAPS marker used in the present study facilitate selection and timely distribution of desirable high yielding tenera sprouts to the farmers instead of waiting for 4-5 years. This saves a lot of land, time and money which will be a major breakthrough to the oil palm community.	[Babu, B. Kalyana; Mathur, R. K.; Kumar, P. Naveen; Ramajayam, D.; Ravichandran, G.; Venu, M. V. B.; Babu, S. Sparjan] ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India; [Babu, S. Sparjan] KL Univ, Guntur, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Oil Palm Research; Koneru Lakshmaiah Education Foundation (K L Deemed to be University)	Babu, BK (corresponding author), ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India.	kalyan_biotek@yahoo.co.in	Kumar, Naveen/GZK-9881-2022; Devarajan, Ramajayam/J-1236-2019; D, SAMUEL SPARJAN BABU/N-8120-2017	Kumar, Naveen/0000-0003-2529-8344; D, SAMUEL SPARJAN BABU/0000-0002-8158-1411	Department of Science and Technology (DST), New Delhi, India; DST	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); DST(Department of Science & Technology (India))	The authors thankful to Department of Science and Technology (DST), New Delhi, India for partial support of the project. The author MVB thankful to DST for providing fellowship.	Bakoume C, 2014, GENET RESOUR CROP EV, V62, P349; Basiron Y, 2000, ADV OIL PALM RES, V1, P1; Beirnaert A, 1941, CONGO BELGE SER SCI, V27, P1; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Corley R., 2003, OIL PALM; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; HARTLEY C, 1988, OIL PALM, P47; Jeennor S, 2014, TREE GENET GENOMES, V10, P1, DOI 10.1007/s11295-013-0655-3; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Pootakham W, 2015, GENOMICS, V105, P288, DOI 10.1016/j.ygeno.2015.02.002; Rance KA, 2001, THEOR APPL GENET, V103, P1302, DOI 10.1007/s122-001-8204-z; Reyes Paola A., 2015, Agron. colomb., V33, P5, DOI 10.15446/agron.colomb.v33n1.47988; Ritter E, 2016, EUPHYTICA, V207, P367, DOI 10.1007/s10681-015-1553-6; Sathish D. K., 2007, Indian Journal of Biotechnology, V6, P354; Singh R, 2013, NATURE; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Ting NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-309; USDA, 2014, OILS WORLD MARK TRAD; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936	23	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171933	10.1371/journal.pone.0171933	http://dx.doi.org/10.1371/journal.pone.0171933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192462	gold, Green Submitted, Green Published			2022-12-26	WOS:000394423800053
J	Li, GL; Qian, H				Li, Gen-Liang; Qian, Hui			Transcriptome using Illumina sequencing reveals the traits of spermatogenesis and developing testes in Eriocheir sinensis	PLOS ONE			English	Article							CHINESE MITTEN CRAB; SPERMATOGONIAL STEM-CELLS; RNA-SEQ; SACCHAROMYCES-CEREVISIAE; EXPRESSION ANALYSIS; BUDDING YEAST; CYCLE; GENE; DYNAMICS; MEIOSIS	Chinese mitten crab (Eriocheir sinensis) has the spermatozoa with typical aflagellate, decondensed chromatin, cup-shaped nuclei, and radial arms. However, the mechanism of spermatogenesis during which the specific spermatozoa are generated in this species is yet unclear. Here, the transcriptome of developing testis in E. sinensis was analyzed using the ways of RNA-seq and bioinformatics analysis to identify candidate genes potentially involved in development of testis and spermatogenesis. The Illumina HiSeq2500 sequencing of three replicons of samples produced a total of 145.19 M clean reads representing with a total of 21.34 Gb bases and 45.48% GC content. 56.30% clean reads were mapped to the draft genome of E. sinensis. The assembly of the transcriptome yielded contigs of 5691802 sequences and unigenes of 406527 sequences. Total 24246 and 40793 transcripts were annotated using Swissprot and Nr database, respectively. There were 48213 (70.31%) and 7858 (46.25%) transcripts with identity of more than 99 matching to mature testis unigenes in the databases of Nr and EST, respectively. The analytic results of KOG, GO and KEGG showed wide potential molecular functions of transcripts in the developing testes. KEGG analysis of unigenes yielded total 9422 predicted genes. Those predicted genes were involved in total 216 KEGG pathways related to the physiological activities of developing testis. 1975 predicted genes were involved in cellular and subcellular structural alteration of male germ cells. There were important roles of some pathways in the processes of morphological and structural biogenesis pertaining to testis development and spermatogenesis. Other 583 unigenes encoding the genetic and epigenetic factors also be found, which might contribute to the decondensation and stability of decondensed nuclei in the spermatozoa. These predicted events provide a view of the potential molecular mechanisms of development of testis and spermatogenesis in E. sinensis.	[Li, Gen-Liang; Qian, Hui] Youjiang Med Univ Nationalities, Baise, Guangxi, Peoples R China	Youjiang Medical University for Nationalities	Li, GL (corresponding author), Youjiang Med Univ Nationalities, Baise, Guangxi, Peoples R China.	ligenliang@163.com	li, genliang/AAV-8643-2020	Li, Genliang/0000-0001-6037-0458	National Natural Science Foundation of China [31260635]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 31260635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BROWN VI, 1991, DNA CELL BIOL, V10, P399, DOI 10.1089/dna.1991.10.399; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; Cooke PS, 2015, ASIAN J ANDROL, V17, P355, DOI 10.4103/1008-682X.148072; Dai W, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-9; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Demidova AR, 2009, J BIOL CHEM, V284, P4132, DOI 10.1074/jbc.M808118200; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; DU N, 1988, Acta Zoologica Sinica, V34, P329; Du Nanshan, 1987, Oceanologia et Limnologia Sinica, V18, P119; Du NS, 1987, OCEANOL LIMNOL SINIC, V18, P216; Dupont J, 2014, MOL CELL ENDOCRINOL, V382, P527, DOI 10.1016/j.mce.2013.09.028; Eom KS, 2016, J MICROBIOL BIOTECHN, V26, P2019, DOI 10.4014/jmb.1609.09021; Gutierrez-Escribano P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7871; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hou CC, 2013, MOL BIOL REP, V40, P1043, DOI 10.1007/s11033-012-2145-3; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kimura H, 2015, SCHIZOPHRENIA BULL, V41, P744, DOI 10.1093/schbul/sbu147; Komeya M, 2015, ASIAN J ANDROL, V17, P771, DOI 10.4103/1008-682X.154995; KRON SJ, 1995, CURR OPIN CELL BIOL, V7, P845, DOI 10.1016/0955-0674(95)80069-7; Kumar A., 2012, INT J APPL ENG RES, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0043761; Lee GE, 2010, J BIOL CHEM, V285, P37630, DOI 10.1074/jbc.M110.148536; Li G, 2017, MITOCHONDRIAL DNA A; Li GL, 2017, CYTOTECHNOLOGY, V69, P75, DOI 10.1007/s10616-016-0038-3; Li Q., 2016, CELL MOL NEUROBIOL, V3, P3; Li Q, 2015, GENE, V562, P117, DOI 10.1016/j.gene.2015.02.060; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097645; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Mao H, 2012, MOL BIOL REP, V39, P7031, DOI 10.1007/s11033-012-1534-y; Mazzolini L, 2016, CELL CYCLE, V15, P2742, DOI 10.1080/15384101.2016.1220455; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano MC, 2013, CURR TOP DEV BIOL, V102, P61, DOI 10.1016/B978-0-12-416024-8.00003-9; Nusse O, 2011, THESCIENTIFICWORLDJO, V11, P2364, DOI 10.1100/2011/741046; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Song LS, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0112-y; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Sun X, 2012, GENE, V508, P78, DOI 10.1016/j.gene.2012.07.035; Sun XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012738; Tang EI, 2016, SEMIN CELL DEV BIOL; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visone V, 2014, INT J MOL SCI, V15, P17162, DOI 10.3390/ijms150917162; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wang Q, 2000, J E CHINA NORMAL U N, V3, P98; Wang YL, 2014, GENE, V536, P9, DOI 10.1016/j.gene.2013.11.099; Wong C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033635; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070078; Wu J, 2008, CELL SIGNAL, V20, P1052, DOI 10.1016/j.cellsig.2008.01.011; Wu JL, 2016, GENE, V575, P276, DOI 10.1016/j.gene.2015.09.005; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhang ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25089	65	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2017	12	2							e0172478	10.1371/journal.pone.0172478	http://dx.doi.org/10.1371/journal.pone.0172478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BI	28212420	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424700055
J	Cagno, V; Sgorbini, B; Sanna, C; Cagliero, C; Ballero, M; Civra, A; Donalisio, M; Bicchi, C; Lembo, D; Rubiolo, P				Cagno, Valeria; Sgorbini, Barbara; Sanna, Cinzia; Cagliero, Cecilia; Ballero, Mauro; Civra, Andrea; Donalisio, Manuela; Bicchi, Carlo; Lembo, David; Rubiolo, Patrizia			In vitro anti-herpes simplex virus-2 activity of Salvia desoleana Atzei & V. Picci essential oil	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ACQUISITION; HERPESVIRUSES; INFECTIVITY; INHIBITION; EXTRACT	Salvia desoleana Atzei & V. Picci is an indigenous species in Sardinia island used in folk medicine to treat menstrual, digestive and central nervous system diseases. Nowadays, it is widely cultivated for the pleasant smell of its essential oil (EO), whose antimicrobial and antifungal activities have already been screened. This study evaluated the in vitro anti-Herpes Simplex Virus-2 (HSV-2) activity of S. desoleana EO, fractions and main components: linalyl acetate, alpha terpinyl acetate, and germacrene D. Phytochemical composition of S. desoleana EO was studied by GC-FID/MS analysis and the active fraction(s) and/or compounds in S. desoleana EO were identified with a bioassay-guided fractionation procedure through in vitro assays on cell viability and HSV-2 and RSV inhibition. S. desoleana EO inhibits both acyclovir sensitive and acyclovir resistant HSV-2 strains with EC50 values of 23.72 mu g/ml for the former and 28.57 mu g/ml for the latter. Moreover, a significant suppression of HSV-2 replication was observed with an EC50 value of 33.01 mu g/ml (95% CI: 26.26 to 41.49) when the EO was added post-infection. Among the fractions resulting from flash column chromatography on silica gel, the one containing 54% of germacrene D showed a similar spectrum of activity of S. desoleana EO with a stronger suppression in post-infection stage. These results indicated that S. desoleana EO can be of interest to develop new and alternative anti-HSV-2 products active also against acyclovir-resistant HSV-2 strains.	[Cagno, Valeria; Civra, Andrea; Donalisio, Manuela; Lembo, David] Univ Turin, Dept Clin & Biol Sci, Mol Virol Lab, Turin, Italy; [Sgorbini, Barbara; Cagliero, Cecilia; Bicchi, Carlo; Rubiolo, Patrizia] Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy; [Sanna, Cinzia; Ballero, Mauro] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy	University of Turin; University of Turin; University of Cagliari	Lembo, D (corresponding author), Univ Turin, Dept Clin & Biol Sci, Mol Virol Lab, Turin, Italy.; Rubiolo, P (corresponding author), Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy.	david.lembo@unito.it; patrizia.rubiolo@unito.it	Cagno, Valeria/AAE-7612-2020; Sgorbini, Barbara/AAL-6368-2020	Sgorbini, Barbara/0000-0001-6848-1304; Cagno, Valeria/0000-0002-5597-334X; RUBIOLO, Patrizia/0000-0002-6819-2614	Turin University, Turin (Italy) [Ex60%2015]	Turin University, Turin (Italy)	BS, CC, CB, PR are indebted with the project Studio di metaboliti secondari biologicamente attivi da matrici di origine vegetale financially supported by Ricerca Locale (Ex60%2015) of Turin University, Turin (Italy). DL was supported by a donation from Mrs. Silvana Legnani.	Adams RP, 2007, IDENTIFICATION EO CO; Astani A, 2014, IRAN J MICROBIOL, V6, P149; Astani A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep187; Astani A, 2010, PHYTOTHER RES, V24, P673, DOI 10.1002/ptr.2955; ATZEI A D, 1982, Webbia, V36, P71; Atzei A.D., 2003, PIANTE NELLA TRADIZI; Bankova V, 2014, PHYTOMEDICINE, V21, P1432, DOI 10.1016/j.phymed.2014.04.026; Bicchi C, 2008, FLAVOUR FRAG J, V23, P382, DOI 10.1002/ffj.1905; Brady RC, 2004, ANTIVIR RES, V61, P73, DOI 10.1016/j.antiviral.2003.09.006; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Chiang LC, 2005, CLIN EXP PHARMACOL P, V32, P811, DOI 10.1111/j.1440-1681.2005.04270.x; Civitelli L, 2014, PHYTOMEDICINE, V21, P857, DOI 10.1016/j.phymed.2014.01.013; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Donalisio M, 2016, BIOMATERIALS, V85, P40, DOI 10.1016/j.biomaterials.2016.01.055; Donalisio M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-266; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; KIMBERLIN DW, 1995, ANTIVIR RES, V26, P369, DOI 10.1016/0166-3542(95)00027-J; Koch C, 2008, J PHARM PHARMACOL, V60, P1545, DOI 10.1211/jpp/60.11.0017; Loizzo MR, 2008, PHYTOMEDICINE, V15, P79, DOI 10.1016/j.phymed.2007.03.013; Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d; Peana AT, 1999, PLANTA MED, V65, P752, DOI 10.1055/s-2006-960857; Rapposelli E, 2015, GENET RESOUR CROP EV, V62, P959, DOI 10.1007/s10722-015-0263-1; Schnitzler P, 2008, PHYTOMEDICINE, V15, P734, DOI 10.1016/j.phymed.2008.04.018; Sokovic MD, 2009, FLAVOUR FRAG J, V24, P83, DOI 10.1002/ffj.1920; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9	27	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172322	10.1371/journal.pone.0172322	http://dx.doi.org/10.1371/journal.pone.0172322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207861	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500122
J	Gotte, M; Seidel, CC; Kesting, SV; Rosenbaum, D; Boos, J				Goette, Miriam; Seidel, Corinna Caroline; Kesting, Sabine Verena; Rosenbaum, Dieter; Boos, Joachim			Objectively measured versus self-reported physical activity in children and adolescents with cancer	PLOS ONE			English	Article							MOTOR-PERFORMANCE; PEDIATRIC CANCER; FITNESS; LEUKEMIA; BENEFITS; MONITOR; HEALTH; SCHOOL; YOUTH	Objective Existing research recognizes low levels of physical activity in pediatric patients with cancer, but much uncertainty exists about their capability to self-reflect physical activity levels. The objective of this study was to compare results of subjective self-reports and objective accelerometers regarding levels of daily walking as well as moderate-to-vigorous physical activities. Methods Results of the objective assessment tool StepWatchTM Activity Monitor and self-reporting with a standardized questionnaire were compared in 28 children and adolescents during cancer treatment. Results The patients were 13.8 +/- 2.8 years of age and 3.4 +/- 2.0 months after cancer diagnosis. The Bland-Altman plots indicated a fairly symmetrical under- and over-estimation for daily minutes of walking with the limits of agreement ranging from -100.8 to 87.3 min (d = -6.7 min). Mean difference for moderate-to-vigorous physical activity was almost zero but limits of agreement are ranging from-126.8 to 126.9 min. The comparison for the days with at least 60 min of moderate-to-vigorous physical activity showed a marked difference with 3.0 2.6 self-reported days versus only 0.1 +/- 0.4 measured days. Conclusions These findings suggest that physical activity in pediatric cancer patients should preferably be assessed with objective methods. Greater efforts are needed to implement supervised exercise interventions during treatment incorporating methods to improve self-reflection of physical activity.	[Goette, Miriam; Kesting, Sabine Verena; Boos, Joachim] Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, Munster, Germany; [Seidel, Corinna Caroline; Rosenbaum, Dieter] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Movement Anal Lab, Munster, Germany	University of Munster; University of Munster	Gotte, M (corresponding author), Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, Munster, Germany.	miriam.goette@ukmuenster.de	Rosenbaum, Dieter/U-6089-2019	Gotte, Miriam/0000-0003-0841-8738	Cora-Lobscheid Stiftung; Kinderkrebshilfe Munster e.V.	Cora-Lobscheid Stiftung; Kinderkrebshilfe Munster e.V.	This work was funded by the Cora-Lobscheid Stiftung https://www.deutsches-stiftungszentrum.de/stiftungen/cora-lobscheid-stiftung and the Kinderkrebshilfe Munster e.V. http://www.kinderkrebshilfe-muenster.de/.	Aznar S, 2006, APPL PHYSIOL NUTR ME, V31, P407, DOI 10.1139/H06-014; Beulertz J, 2013, PEDIATR HEMAT ONCOL, V30, P336, DOI 10.3109/08880018.2013.776155; Bos K, 2009, MOTORIK MODUL PHYS F; Braam KI, 2016, SUPPORT CARE CANCER, V24, P2259, DOI 10.1007/s00520-015-2993-1; Darcy L, 2016, J PEDIATR ONCOL NURS, V33, P173, DOI 10.1177/1043454215610489; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Finnegan L, 2007, ONCOL NURS FORUM, V34, P201, DOI 10.1188/07.ONF.E60-E69; Fraser BJ, 2016, MED SCI SPORT EXER, V48, P1715, DOI 10.1249/MSS.0000000000000955; Gotte M, 2015, EUR J PEDIATR, V174, P791, DOI 10.1007/s00431-014-2460-x; Gotte M, 2014, PEDIATR BLOOD CANCER, V61, P1023, DOI 10.1002/pbc.24898; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Juan AFS, 2008, INT J SPORTS MED, V29, P163, DOI 10.1055/s-2007-964908; Kesting SV, 2016, PEDIATR BLOOD CANCER, V63, P737, DOI 10.1002/pbc.25852; Kesting SV, 2015, J PEDIAT HEMATOL ONC, V37, P509, DOI 10.1097/MPH.0000000000000396; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Manios Y, 2013, J SPORT MED PHYS FIT, V53, P502; McDonald CM, 2005, ARCH PHYS MED REHAB, V86, P793, DOI 10.1016/j.apmr.2004.10.011; Muller C, 2014, INT J SPORTS MED, V35, P696, DOI 10.1055/s-0033-1358475; Orsey AD, 2013, PEDIATR BLOOD CANCER, V60, P1908, DOI 10.1002/pbc.24641; Ozdoba R, 2004, PEDIATR EXERC SCI, V16, P158, DOI 10.1123/pes.16.2.158; Pinto AJ, 2016, CLIN RHEUMATOL, V35, P1507, DOI 10.1007/s10067-016-3234-9; Rueegg CS, 2013, PEDIATR BLOOD CANCER, V60, P1714, DOI 10.1002/pbc.24595; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Storti KL, 2008, MED SCI SPORT EXER, V40, P59, DOI 10.1249/mss.0b013e318158b504; Tan SY, 2013, LEUKEMIA RES, V37, P14, DOI 10.1016/j.leukres.2012.09.005; Timmons BW, 2007, APPL PHYSIOL NUTR ME, V32, pS122, DOI 10.1139/H07-112; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Winter C, 2009, PEDIATR BLOOD CANCER, V53, P438, DOI 10.1002/pbc.22055; Winter CC, 2013, SUPPORT CARE CANCER, V21, P1629, DOI 10.1007/s00520-012-1707-1; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4	33	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172216	10.1371/journal.pone.0172216	http://dx.doi.org/10.1371/journal.pone.0172216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207820	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424500100
J	Kim, SH; Shin, DW; Yun, JM; Lee, JE; Lim, JS; Cho, BL; Kwon, HM; Park, JH				Kim, Sang Hyuck; Shin, Dong Wook; Yun, Jae Moon; Lee, Ji Eun; Lim, Jae-Sung; Cho, Be Long; Kwon, Hyung-Min; Park, Jin-Ho			Kidney dysfunction and cerebral microbleeds in neurologically healthy adults	PLOS ONE			English	Article							SMALL VESSEL DISEASE; INTRACEREBRAL HEMORRHAGE; ATRIAL-FIBRILLATION; RENAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; STROKE; ASSOCIATIONS; GUIDELINES; PREDICTOR	Introduction Cerebral microbleed (CMB) is a potent risk factor for overt cerebrovascular disease. Although some studies indicated the possible role of renal dysfunction as a risk factor of CMB, the findings could not be generalized. This study aimed to investigate the association between renal dysfunction and cerebral microbleed (CMB) in neurologically healthy adults. Materials and methods A total of 2,518 subjects who underwent brain MRI as part of health screening were involved in the study. CMBs were defined as well-demarcated focal areas of low signal intensity with associated blooming on the T2-weighted MRI measuring less than 5 mm in diameter. The glomerular filtration rate (GFR) was estimated using the Modification of Diet in Renal Disease formula. Kidney function was classified as normal (>90), mild (60 to 89.9), moderate (30 to 59.9), and severe (<30 mL/min/1.73 m(2)) renal dysfunction according to the GFR. Results The mean age of the participants was 57.5 +/- 8.3 years (ranged 40 to 79), and 1,367 subjects (54.3%) were male. The mean GFR level was 81.5 +/- 15.5, and the prevalence of CMB was 4.1% (n = 103). Subjects with CMB demonstrated a higher proportion of moderate-to-severe renal dysfunction than those without CMB (15.5% vs. 5.0%, p < 0.001). In the multivariate logistic regression analysis, moderate-to-severe renal dysfunction showed a significant association with CMB (adjusted odd ratio = 2.63; p = 0.008). Furthermore, a decrease in the GFR level was associated with an increasing trend of the presence of CMB (p for trend = 0.031) and number of CMB lesions (p for trend = 0.003). Conclusions Renal dysfunction was significantly associated with the presence of CMB in neurologically healthy adults. More studies are needed to evaluate if treatment of kidney disease and risk factor modification may prevent further progress of CMB.	[Kim, Sang Hyuck; Shin, Dong Wook; Yun, Jae Moon; Lee, Ji Eun; Cho, Be Long; Park, Jin-Ho] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lim, Jae-Sung] Hallym Univ, Dept Neurol, Sacred Heart Hosp, Anyang, South Korea; [Kwon, Hyung-Min] Seoul Natl Univ, Dept Neurol, Seoul Municipal Govt Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU)	Park, JH (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea.; Kwon, HM (corresponding author), Seoul Natl Univ, Dept Neurol, Seoul Municipal Govt Boramae Med Ctr, Seoul, South Korea.	hmkwon@snu.ac.kr; kkolzzi0@gmail.com	Lim, Jae-Sung/D-5555-2012; Cho, Belong/GLU-3443-2022	Lim, Jae-Sung/0000-0001-6157-2908; Cho, Belong/0000-0001-9558-689X; Kim, Sang Hyuck/0000-0002-4851-396X; Kwon, Hyung-Min/0000-0002-6101-7127	Hanmi Pharmaceutical Company [06-2015-0810]	Hanmi Pharmaceutical Company	This study was supported in part by Hanmi Pharmaceutical Company (Grant No. 06-2015-0810, www.hanmi.co.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoudad S, 2015, CIRCULATION, V132, P509, DOI 10.1161/CIRCULATIONAHA.115.016261; Akoudad S, 2015, INT J STROKE, V10, P603, DOI 10.1111/ijs.12465; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Charidimou A, 2014, INT J STROKE, V9, P457, DOI 10.1111/ijs.12280; Cho AH, 2009, NEUROLOGY, V73, P1645, DOI 10.1212/WNL.0b013e3181c1defa; Darweesh SKL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000359; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregg NM, 2015, JAMA NEUROL, V72, P1021, DOI 10.1001/jamaneurol.2015.1359; Hanyu H, 2003, J NEUROL, V250, P1496, DOI 10.1007/s00415-003-0245-7; Horstmann S, 2015, EUR J NEUROL, V22, P1355, DOI 10.1111/ene.12608; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Kim BJ, 2015, J STROKE, V17, P101, DOI 10.5853/jos.2015.17.2.101; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kim CK, 2012, J NEUROL SCI, V319, P56, DOI 10.1016/j.jns.2012.05.017; Kim SG, 2007, J CLIN ONCOL, V25, P5267, DOI 10.1200/JCO.2007.11.9651; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Kwon HM, 2016, CEREBROVASC DIS, V42, P90, DOI 10.1159/000445300; Laible M, 2015, J NEUROL, V262, P2312, DOI 10.1007/s00415-015-7840-2; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lim JS, 2015, JAMA NEUROL, V72, P301, DOI 10.1001/jamaneurol.2014.3958; Luchsinger JA, 2009, NEUROLOGY, V73, P450, DOI 10.1212/WNL.0b013e3181b1636a; Naganuma T, 2015, STROKE, V46, P2107, DOI 10.1161/STROKEAHA.115.009324; Naka H, 2013, J STROKE CEREBROVASC, V22, P834, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.001; Nakata Y, 2002, ANN NY ACAD SCI, V977, P169, DOI 10.1111/j.1749-6632.2002.tb04813.x; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Saji N, 2015, J STROKE CEREBROVASC, V24, P2572, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.010; Shima H, 2009, NEPHROL DIAL TRANSPL, V25, P1554; Tsushima Y, 2002, NEURORADIOLOGY, V44, P31, DOI 10.1007/s002340100649; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Vernooij MW, 2012, INT J STROKE, V7, P565, DOI 10.1111/j.1747-4949.2012.00886.x; Vernooij MW, 2009, ARCH NEUROL-CHICAGO, V66, P714, DOI 10.1001/archneurol.2009.42; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253	39	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172210	10.1371/journal.pone.0172210	http://dx.doi.org/10.1371/journal.pone.0172210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207801	gold, Green Submitted, Green Published			2022-12-26	WOS:000394424500099
J	Klotz, P; Gottig, S; Leidner, U; Semmler, T; Scheufen, S; Ewers, C				Klotz, Peter; Goettig, Stephan; Leidner, Ursula; Semmler, Torsten; Scheufen, Sandra; Ewers, Christa			Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PSEUDOMONAS-AERUGINOSA; GALLERIA-MELLONELLA; ESCHERICHIA-COLI; GENOME SEQUENCE; BAUMANNII; IDENTIFICATION; EMERGENCE; STRAIN; RADIORESISTENS	The objective of this study was to characterize bla(OXA-23) harbouring Acinetobacter indicus-like strains from cattle including genomic and phylogenetic analyses, antimicrobial susceptibility testing and evaluation of pathogenicity in vitro and in vivo. Nasal and rectal swabs (n = 45) from cattle in Germany were screened for carbapenem-non-susceptible Acinetobacter spp. Thereby, two carbapenem resistant Acinetobacter spp. from the nasal cavities of two calves could be isolated. MALDI-TOF mass spectrometry and 16S rDNA sequencing identified these isolates as A. indicus-like. A phylogenetic tree based on partial rpoB sequences indicated closest relation of the two bovine isolates to the A. indicus type strain A648(T) and human clinical A. indicus isolates, while whole genome comparison revealed considerable intraspecies diversity. High mimimum inhibitory concentrations were observed for carbapenems and other antibiotics including fluoroquinolones and gentamicin. Whole genome sequencing and PCR mapping revealed that both isolates harboured bla(OXA-23) localized on the chromosome and surrounded by interrupted Tn2008 transposon structures. Since the pathogenic potential of A. indicus is unknown, pathogenicity was assessed employing the Galleria (G.) mellonella infection model and an in vitro cytotoxicity assay using A549 human lung epithelial cells. Pathogenicity in vivo (G. mellonella killing assay) and in vitro (cytotoxicity assay) of the two A. indicus-like isolates was lower compared to A. baumannii ATCC 17978 and similar to A. lwoffii ATCC 15309. The reduced pathogenicity of A. indicus compared to A. baumannii correlated with the absence of important virulence genes encoding like phospholipase C1+C2, acinetobactin outer membrane protein BauA, RND-type efflux system proteins AdeRS and AdeAB or the trimeric autotransporter adhesin Ata. The emergence of carbapenem-resistant A. indicus-like strains from cattle carrying bla(OXA-23) on transposable elements and revealing genetic relatedness to isolates from human clinical sources requires further investigations regarding the pathogenic potential, genomic characteristics, zoonotic risk and putative additional sources of this new Acinetobacter species.	[Klotz, Peter; Leidner, Ursula; Scheufen, Sandra; Ewers, Christa] Justus Liebig Univ Giessen, Inst Hyg & Infect Dis Anim, Giessen, Germany; [Goettig, Stephan] Hosp Johann Wolfgang von Goethe Univ, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Semmler, Torsten] Robert Koch Inst, Berlin, Germany	Justus Liebig University Giessen; Robert Koch Institute	Ewers, C (corresponding author), Justus Liebig Univ Giessen, Inst Hyg & Infect Dis Anim, Giessen, Germany.	christa.ewers@vetmed.uni-giessen.de	Ewers, Christa/AAL-9186-2020; Semmler, Torsten/O-9540-2019; Semmler, Torsten/Q-7716-2018	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Ewers, Christa/0000-0001-6167-1340	Engemann Family Foundation; German Research Foundation [DFG FOR 2251]	Engemann Family Foundation; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Engemann Family Foundation providing a grant to P.K. and by the German Research Foundation (DFG FOR 2251 Adaption and Persistence of the Emerging Pathogen Acinetobacter baumannii) to S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2008, ANTIMICROB AGENTS CH, V52, P3837, DOI 10.1128/AAC.00570-08; Al Bayssari C, 2015, J ANTIMICROB CHEMOTH, V70, P950, DOI 10.1093/jac/dku469; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bonnin RA, 2014, INT J ANTIMICROB AG, V44, P345, DOI 10.1016/j.ijantimicag.2014.05.022; CLSI, 2016, M100 PERF STAND ANT, V26; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Ewers C, 2017, INT J ANTIMICROB AG, V49, P37, DOI 10.1016/j.ijantimicag.2016.09.033; Ewers C, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0119-z; Fiester SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167068; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Gruber TM, 2015, J ANTIMICROB CHEMOTH, V70, P1026, DOI 10.1093/jac/dku482; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamidian M, 2013, J ANTIMICROB CHEMOTH, V68, P2682, DOI 10.1093/jac/dkt233; Heindorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101033; Higgins PG, 2013, J ANTIMICROB CHEMOTH, V68, P720, DOI 10.1093/jac/dks446; Higgins PG, 2010, J CLIN MICROBIOL, V48, P4592, DOI 10.1128/JCM.01765-10; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krizova L, 2015, INT J SYST EVOL MICR, V65, P3905, DOI 10.1099/ijsem.0.000511; Liu D, 2016, VET MICROBIOL, V186, P126, DOI 10.1016/j.vetmic.2016.02.018; LIU SL, 1993, P NATL ACAD SCI USA, V90, P6874, DOI 10.1073/pnas.90.14.6874; Malhotra J, 2012, INT J SYST EVOL MICR, V62, P2883, DOI 10.1099/ijs.0.037721-0; Malhotra J, 2012, J BACTERIOL, V194, P5156, DOI 10.1128/JB.01194-12; Marra A, 2012, ANTIMICROB AGENTS CH, V56, P4671, DOI 10.1128/AAC.00276-12; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Nguyen VH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-329; Nigro SJ, 2016, J ANTIMICROBIAL CHEM; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Pomba C, 2014, ANTIMICROB AGENTS CH, V58, P1267, DOI 10.1128/AAC.02527-13; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Repizo GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138265; Richmond GE, 2016, MBIO, V7, DOI 10.1128/mBio.00430-16; Schumann G, 2002, CLIN CHEM LAB MED, V40, P643, DOI 10.1515/CCLM.2002.111; Segal H, 2007, ANTIMICROB AGENTS CH, V51, P3040, DOI 10.1128/AAC.00594-07; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P3009, DOI 10.1093/jac/dks311; Stahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138360; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tipton KA, 2016, MICROBIOLOGYOPEN; Touchon M, 2014, GENOME BIOL EVOL, V6, P2866, DOI 10.1093/gbe/evu225; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Wang XH, 2011, DIAGN MICR INFEC DIS, V69, P218, DOI 10.1016/j.diagmicrobio.2010.10.018; Weidensdorfer M, 2016, INFECT IMMUN, V84, P711, DOI 10.1128/IAI.01502-15; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	51	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0171986	10.1371/journal.pone.0171986	http://dx.doi.org/10.1371/journal.pone.0171986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207789	Green Published, gold			2022-12-26	WOS:000394424500067
J	Puglisi, I; De Patrizio, A; Schena, L; Jung, T; Evoli, M; Pane, A; Hoa, NV; Tri, MV; Wright, S; Ramstedt, M; Olsson, C; Faedda, R; di San Lio, GM; Cacciola, SO				Puglisi, Ivana; De Patrizio, Alessandro; Schena, Leonardo; Jung, Thomas; Evoli, Maria; Pane, Antonella; Nguyen Van Hoa; Mai Van Tri; Wright, Sandra; Ramstedt, Mauritz; Olsson, Christer; Faedda, Roberto; di San Lio, Gaetano Magnano; Cacciola, Santa Olga			Two previously unknown Phytophthora species associated with brown rot of Pomelo (Citrus grandis) fruits in Vietnam	PLOS ONE			English	Article							ROOT-ROT; SP NOV.; MOLECULAR PHYLOGENY; LEAF-BLIGHT; 1ST REPORT; IDENTIFICATION; COLOCASIAE; TREES; DNA; MITOCHONDRIAL	Two distinct Phytophthora taxa were found to be associated with brown rot of pomelo (Citrus grandis), a new disease of this ancestral Citrus species, in the Vinh Long province, Mekong River Delta area, southern Vietnam. On the basis of morphological characters and using the ITS1-5.8S-ITS2 region of the rDNA and the cytochrome oxidase subunit 1 (COI) as barcode genes, one of the two taxa was provisionally named as Phytophthora sp. prodigiosa, being closely related to but distinct from P. insolita, a species in Phytophthora Clade 9, while the other one, was closely related to but distinct from the Clade 2 species P. meadii and was informally designated as Phytophthora sp. mekongensis. Isolates of P. sp. prodigiosa and P. sp. mekongensis were also obtained from necrotic fibrous roots of Volkamer lemon (C. volkameriana) rootstocks grafted with 'King' mandarin (Citrus nobilis) and from trees of pomelo, respectively, in other provinces of the Mekong River Delta, indicating a widespread occurrence of both Phytophthora species in this citrus-growing area. Koch's postulates were fulfilled via pathogenicity tests on fruits of various Citrus species, including pomelo, grapefruit (Citrus x paradisi), sweet orange (Citrus x sinensis) and bergamot (Citrus x bergamia) as well as on the rootstock of 2-year-old trees of pomelo and sweet orange on 'Carrizo' citrange (C. sinensis 'Washington Navel' x Poncirus trifoliata). This is the first report of a Phytophthora species from Clade 2 other than P. citricola and P. citrophthora as causal agent of fruit brown rot of Citrus worldwide and the first report of P. insolita complex in Vietnam. Results indicate that likely Vietnam is still an unexplored reservoir of Phytophthora diversity.	[Puglisi, Ivana; De Patrizio, Alessandro; Evoli, Maria; Pane, Antonella; Faedda, Roberto; Cacciola, Santa Olga] Univ Catania, Dept Agr Food & Environm, Catania, Italy; [Puglisi, Ivana; Schena, Leonardo; di San Lio, Gaetano Magnano] Univ Mediterranea Reggio Calabria, Dipartimento Agr, Reggio Di Calabria, Italy; [Jung, Thomas] Mendel Univ Brno, Phytophthora Res Ctr, Zemedelska 1, Brno 61300, Czech Republic; [Jung, Thomas] Phytophthora Res & Consultancy, Rain 9, Nussdorf, Germany; [Nguyen Van Hoa; Mai Van Tri] Southern Hort Res Inst, My Tho, Tien Giang, Vietnam; [Wright, Sandra] Univ Gavle, Dept Elect Math & Nat Sci, Gavle, Sweden; [Ramstedt, Mauritz] Swedish Agr Univ SLU, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Olsson, Christer] Gothenburg Univ, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Catania; Universita Mediterranea di Reggio Calabria; Mendel University in Brno; University of Gavle; Swedish University of Agricultural Sciences; University of Gothenburg	Cacciola, SO (corresponding author), Univ Catania, Dept Agr Food & Environm, Catania, Italy.	olgacacciola@unict.it	Jung, Thomas/F-1665-2013; di San Lio, Gaetano Magnano/E-9778-2016; Wright, Sandra A. I./AAG-6424-2019; , Santa Olga Cacciola/H-7416-2019; Schena, Leonardo/A-7492-2018	Jung, Thomas/0000-0003-2034-0718; di San Lio, Gaetano Magnano/0000-0002-4835-4874; Wright, Sandra A. I./0000-0002-8895-5631; Schena, Leonardo/0000-0002-9737-2593	STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); SAMAGRUMI (Sensori Ambientali per il Miglioramento della Qualita delle Produzioni Agrumicole) [PO. FESR 2007-2013]; Italian Ministry of Education, University and Research (MIUR) [RBFR10PZ4N]	STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); SAMAGRUMI (Sensori Ambientali per il Miglioramento della Qualita delle Produzioni Agrumicole); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was funded by an initiation grant of STINT (The Swedish Foundation for International Cooperation in Research and Higher Education), SAMAGRUMI (Sensori Ambientali per il Miglioramento della Qualita delle Produzioni Agrumicole) - PO. FESR 2007-2013-Sicily, and a grant MIUR-FIRB 2010 (RBFR10PZ4N) from the Italian Ministry of Education, University and Research (MIUR) Metagenomic strategies to assess genetic diversity in soil-borne Phytophthora species.; This research was funded by an initiation grant of STINT (The Swedish Foundation for International Cooperation in Research and Higher Education), SAMAGRUMI (Sensori Ambientali per it Miglioramento della Qualita delle Produzioni Agrumicole) PO. FESR 2007-2013-Sicily, and a grant MIUR-FIRB 2010 (RBFR1OPZ4N) from the Italian Ministry of Education, University and Research (MIUR) "Metagenomic strategies to assess genetic diversity in soil-borne Phytophthora species." The authors wish to thank Mrs. Ann Davies for the English revision of the manuscript.	Abad ZG, 2014, MYCOLOGIA, V106, P431, DOI 10.3852/12-119; Agosteo GE, 2014, BERGAMOT DISEASES CI, P37; ANN PJ, 1980, MYCOLOGIA, V72, P1180, DOI 10.2307/3759572; Bandyopadhyay R, 2011, PLANT DIS, V95, P618, DOI 10.1094/PDIS-12-10-0890; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bawage S, 2013, J MYCOLOGY; Biasi A, 2016, GENETIC ANAL PHYTOPH; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Brasier CM, 2003, MYCOL RES, V107, P477, DOI 10.1017/S0953756203007548; Cacciola SO, 2011, PLANT DIS, V95, P769, DOI 10.1094/PDIS-11-10-0823; Cacciola Santa Olga, 2008, V3, P61, DOI 10.1007/978-1-4020-8571-0_4; Catala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119311; CHEE KH, 1969, T BRIT MYCOL SOC, V52, P425, DOI 10.1016/S0007-1536(69)80126-9; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Das AK, 2012, AUSTRALAS PLANT DIS, V7, P131, DOI 10.1007/s13314-012-0066-6; De Patrizio A, 2013, J PLANT PATHOL, V95, p[S4, S41]; Erwin DC, PHYTOPHTHORA DIS WOR; Evoli M, 2016, THESIS; Ferguson L, 1990, USITC PUBL, P18; Gallegly ME, 2008, PHYTOPHTHORA IDENTIF, P158; Graham JH, 2000, COMPENDIUM CITRUS DI, P12; Grunwald NJ, 2011, PLANT DIS, V95, P337, DOI 10.1094/PDIS-08-10-0609; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Jung T, 2016, FOREST PATHOL, V46, P134, DOI 10.1111/efp.12239; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 1996, PHYTON-ANN REI BOT A, V36, P95; KO WH, 1979, MYCOLOGIA, V71, P434, DOI 10.2307/3759163; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Tri MV, 2015, PHYTOPATHOL MEDITERR, V54, P275; Mammella MA, 2013, PHYTOPATHOLOGY, V103, P610, DOI 10.1094/PHYTO-10-12-0263-R; Mammella MA, 2011, FUNGAL BIOL-UK, V115, P432, DOI 10.1016/j.funbio.2011.02.018; Man in 't Veld W. A., 2015, MYCOLOGIA, V107, P54, DOI DOI 10.3852/12-371; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Miyasaka SC, 2013, CABI PLANT PROT SER, P104, DOI 10.1079/9781780640938.0104; Nath VS, 2014, FEMS MICROBIOL LETT, V352, P174, DOI 10.1111/1574-6968.12395; Nechwatal J, 2013, PLANT PATHOL, V62, P355, DOI 10.1111/j.1365-3059.2012.02638.x; Omane E, 2012, PLANT DIS, V96, P292, DOI 10.1094/PDIS-09-11-0789; OUDEMANS P, 1991, MYCOL RES, V95, P1025, DOI 10.1016/S0953-7562(09)80543-1; Pane A, 2008, PLANT DIS, V92, P313, DOI 10.1094/PDIS-92-2-0313B; Pane A., 2001, Plant Disease, V85, P97, DOI 10.1094/PDIS.2001.85.1.97A; Pane A, 2009, PLANT DIS, V93, P844, DOI 10.1094/PDIS-93-8-0844C; Park J, 2008, PLANT DIS, V92, P966, DOI 10.1094/PDIS-92-6-0966; Paull RE, 2012, CROP PRODUCTION SCI, V2, P381; Prigigallo MI, 2015, PLANT PATHOL, V64, P1308, DOI 10.1111/ppa.12362; Prigigallo MI, 2015, PHYTOPATHOLOGY; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Scanu B, 2016, PLANT PATHOL, V65, P26, DOI 10.1111/ppa.12399; Scibetta S, 2012, J MICROBIOL METH, V88, P356, DOI 10.1016/j.mimet.2011.12.012; Stamps DJ, 1985, IMI DESCRIPTIONS FUN, V84, P834; STAMPS DJ, 1990, MYCOL PAP, V162, P1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thanh DVT, 2004, DIVERSITY MANAGEMENT, P238; Timmer LW, 1999, CITRUS HLTH MANAGEME, P197; Vavilov N.I, 1951, ORIGIN VARIATION IMM; Vettraino AM, 2012, LETT APPL MICROBIOL, V55, P390, DOI 10.1111/j.1472-765x.2012.03310.x; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103450; Yang X, 2013, MYCOTAXON, V126, P167, DOI 10.5248/126.167	61	27	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172085	10.1371/journal.pone.0172085	http://dx.doi.org/10.1371/journal.pone.0172085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28208159	Green Published, gold, Green Submitted			2022-12-26	WOS:000394424500080
J	Tsumura, Y; Tsushima, Y; Tamura, A; Hasebe, M; Kanou, M; Kato, H; Kobayashi, T				Tsumura, Yoshinori; Tsushima, Yu; Tamura, Azusa; Hasebe, Makiko; Kanou, Masanobu; Kato, Hirotsugu; Kobayashi, Tsunefumi			TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models	PLOS ONE			English	Article							TRANSGENIC MICE; TYPE-2; LIVER; HOMEOSTASIS; EXPRESSION; MANAGEMENT; METFORMIN; MK-0941; AZD1656; CELLS	Glucokinase (GK) plays a critical role for maintaining glucose homeostasis with regulating glucose uptake in liver and insulin secretion in pancreas. GK activators have been reported to decrease blood glucose levels in patients with type 2 diabetes mellitus. However, clinical development of GK activators has failed due to the loss of glucose-lowering effects and increased plasma triglyceride levels after chronic treatment. Here, we generated a novel GK activator, TMG-123, examined its in vitro and in vivo pharmacological characteristics, and evaluated its risks of aforementioned clinical issues. TMG-123 selectively activated GK enzyme activity without increasing Vmax. TMG-123 improved glucose tolerance without increasing plasma insulin levels in both insulin-deficient (Goto-Kakizaki rats) and insulin resistant (db/db mice) models. The beneficial effect on glucose tolerance was greater than results observed with clinically available antidiabetic drugs such as metformin and glibenclamide in Zucker Diabetic Fatty rats. TMG-123 also improved glucose tolerance in combination with metformin. After 4 weeks of administration, TMG-123 reduced the Hemoglobin A1c levels without affecting liver and plasma triglyceride levels in Goto-Kakizaki rats and Diet Induced Obesity mice. Moreover, TMG-123 sustained its effect on Hemoglobin Al c levels even after 24 weeks of administration without affecting triglycerides. Taken together, these data indicate that TMG-123 exerts glucose-lowering effects in both insulin-deficient and -resistant diabetes, and sustains reduced Hemoglobin Al c levels without affecting hepatic and plasma triglycerides even after chronic treatment. Therefore, TMG-123 is expected to be an antidiabetic drug that overcomes the concerns previously reported with other GK activators.	[Tsumura, Yoshinori; Tsushima, Yu; Tamura, Azusa; Hasebe, Makiko; Kanou, Masanobu; Kato, Hirotsugu; Kobayashi, Tsunefumi] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Hino, Tokyo, Japan; [Kanou, Masanobu; Kato, Hirotsugu] Teijin Pharma Ltd, Pharmaceut Discovery Res Labs, Hino, Tokyo, Japan	Teijin Pharma Limited; Teijin Pharma Limited	Tsushima, Y (corresponding author), Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Hino, Tokyo, Japan.	y.tsushima@teijin.co.jp		Tsumura, Yoshinori/0000-0002-7223-6018	Teijin Pharma Limited	Teijin Pharma Limited(Teijin Pharma Limited)	This study was supported by Teijin Pharma Limited. Teijin Pharma Limited provided support in the form of salaries for all authors [Y. Tsumura, Y. Tsushima, AT, MH, MK, HK, and TK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Amin NB, 2015, DIABETES OBES METAB, V17, P751, DOI 10.1111/dom.12474; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Erion DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097139; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Grewala AS, 2014, MINI-REV MED CHEM, V14, P585, DOI 10.2174/1389557514666140722082713; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Inzucchi SE, 2016, OBSTET GYNECOL, V127, P780, DOI 10.1097/AOG.0000000000001332; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Kazierad D, 2013, DIABETES S1, V62, pA1; Kiyosue A, 2013, DIABETES OBES METAB, V15, P923, DOI 10.1111/dom.12100; LIANG Y, 1991, J BIOL CHEM, V266, P6999; MACKINNON AM, 1987, J LIPID RES, V28, P847; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Matschinsky FM, 2006, DIABETES, V55, P1; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Mittermayer F, 2015, CURR DIABETES REV, V11, P17, DOI 10.2174/1573399810666141224121927; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Roma LP, 2015, AM J PHYSIOL-ENDOC M, V309, pE632, DOI 10.1152/ajpendo.00154.2015; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Tourrel C, 2002, DIABETES, V51, P1443, DOI 10.2337/diabetes.51.5.1443; Wilding JPH, 2013, DIABETES OBES METAB, V15, P750, DOI 10.1111/dom.12088; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Winzell MS, 2011, EUR J PHARMACOL, V663, P80, DOI 10.1016/j.ejphar.2011.05.009; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172252	10.1371/journal.pone.0172252	http://dx.doi.org/10.1371/journal.pone.0172252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BG	28207836	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424500106
J	Ye, T; Wang, Y; Guo, ZX; Li, YJ				Ye, Tao; Wang, Yao; Guo, Zhixing; Li, Yijia			Factor contribution to fire occurrence, size, and burn probability in a subtropical coniferous forest in East China	PLOS ONE			English	Article							SPATIAL-PATTERNS; WILDFIRE; CLASSIFICATION; REGRESSION; MODELS; REGIME; SIMULATION; CALIFORNIA; SEVERITY; PROVINCE	The contribution of factors including fuel type, fire-weather conditions, topography and human activity to fire regime attributes (e.g. fire occurrence, size distribution and severity) has been intensively discussed. The relative importance of those factors in explaining the burn probability (BP), which is critical in terms of fire risk management, has been insufficiently addressed. Focusing on a subtropical coniferous forest with strong human disturbance in East China, our main objective was to evaluate and compare the relative importance of fuel composition, topography, and human activity for fire occurrence, size and BP. Local BP distribution was derived with stochastic fire simulation approach using detailed historical fire data (1990-2010) and forest-resource survey results, based on which our factor contribution analysis was carried out. Our results indicated that fuel composition had the greatest relative importance in explaining fire occurrence and size, but human activity explained most of the variance in BP. This implies that the influence of human activity is amplified through the process of overlapping repeated ignition and spreading events. This result emphasizes the status of strong human disturbance in local fire processes. It further confirms the need for a holistic perspective on factor contribution to fire likelihood, rather than focusing on individual fire regime attributes, for the purpose of fire risk management.	[Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, Minist Civil Affairs, Beijing, Peoples R China; [Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Minist Educ, Beijing, Peoples R China; [Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China; [Ye, Tao; Wang, Yao; Li, Yijia] Beijing Normal Univ, Catastrophe Res Ctr, Beijing, Peoples R China; [Guo, Zhixing] State Ocean Adm Peoples Republ China, Natl Marine Hazard Mitigat Serv, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Acad Disaster Reduct & Emergency Management, Minist Civil Affairs, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Minist Educ, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Normal Univ, Catastrophe Res Ctr, Beijing, Peoples R China.	wangyao@mail.bnu.edu.cn		Ye, Tao/0000-0002-5037-8410	National Key Research and Development Program of China [2016YFA0602404]	National Key Research and Development Program of China	This reseach was funded by National Key Research and Development Program of China under grant No. 2016YFA0602404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager AA, 2013, RISK ANAL, V33, P1000, DOI 10.1111/j.1539-6924.2012.01911.x; Almeida RM, 2011, J PHYS C SER, P285; Arpaci A, 2014, APPL GEOGR, V53, P258, DOI 10.1016/j.apgeog.2014.05.015; Barros AMG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084760; Biswas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124346; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Canada Forestry Canada Fire Danger Group, 1992, Information Report ST-X, Forestry Canada; Casella G, 2004, GEN ACCEPT REJECT SA, V45, P342; Chang Y, 2016, NAT HAZARDS, V81, P981, DOI 10.1007/s11069-015-2116-9; Chuvieco E, 2009, INT J WILDLAND FIRE, V18, P430, DOI 10.1071/WF08020; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De Angelis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116875; DeWilde L, 2006, ECOSYSTEMS, V9, P1342, DOI 10.1007/s10021-006-0095-0; Finney MA, 2011, STOCH ENV RES RISK A, V25, P973, DOI 10.1007/s00477-011-0462-z; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Haas JR, 2015, RISK ANAL, V35, P226, DOI 10.1111/risa.12270; Haas JR, 2013, LANDSCAPE URBAN PLAN, V119, P44, DOI 10.1016/j.landurbplan.2013.06.011; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Iudin DI, 2015, COMMUN NONLINEAR SCI, V21, P190, DOI 10.1016/j.cnsns.2014.10.019; Joel LS, 2012, CELLULAR AUTOMATA DI; Johnson JW, 2004, ORGAN RES METHODS, V7, P238, DOI 10.1177/1094428104266510; Kellogg LKB, 2008, LANDSCAPE ECOL, V23, P227, DOI 10.1007/s10980-007-9188-1; Krebs P, 2010, THEOR BIOSCI, V129, P53, DOI 10.1007/s12064-010-0082-z; Lindeman RH, 1979, INTRO BIVARIATE MULT; Liu XP, 2012, NAT HAZARDS, V64, P381, DOI 10.1007/s11069-012-0244-z; Liu ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127690; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Lozano FJ, 2008, REMOTE SENS ENVIRON, V112, P708, DOI 10.1016/j.rse.2007.06.006; Mao X., 1993, J APPL METEOROL, V4, P100; Metropolis N., 1987, LOS ALAMOS SCI, V15, P125, DOI DOI 10.1128/JCM.05092-11; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pan JH, 2016, NAT HAZARDS, V81, P1879, DOI 10.1007/s11069-016-2160-0; Parisien M-A, 2005, FORESTRY; Parisien MA, 2013, NAT HAZARDS, V66, P439, DOI 10.1007/s11069-012-0495-8; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Pastor E, 2003, PROG ENERG COMBUST, V29, P139, DOI 10.1016/S0360-1285(03)00017-0; Pereira AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102380; Pierce AD, 2012, FOREST ECOL MANAG, V279, P77, DOI 10.1016/j.foreco.2012.05.010; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Pyne S, 1996, INTRO WILDLAND FIRE, P1; Rollins MG, 2002, LANDSCAPE ECOL, V17, P539, DOI 10.1023/A:1021584519109; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Salis M, 2014, NAT HAZARDS, V71, P1389, DOI 10.1007/s11069-013-0951-0; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; State Forestry Administration of PR China, 2014, CHIN FOR RES 2009 20; State Forestry Administration of PR China, CHIN FOR STAT YB; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Thompson MP, 2011, STOCH ENV RES RISK A, V25, P761, DOI 10.1007/s00477-011-0461-0; Viedma O, 2009, INT J WILDLAND FIRE, V18, P575, DOI 10.1071/WF08030; Wang LT, 2013, NAT HAZARDS, V65, P819, DOI 10.1007/s11069-012-0391-2; Wang Z, 1992, J NAT DISASTERS, V3, P39, DOI DOI 10.13577/J.JND.1992.0306; Wer B, 2004, NAT RESOUR MODEL, V17, P359; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wotton BM, 2009, ENVIRON ECOL STAT, V16, P107, DOI 10.1007/s10651-007-0084-2	60	23	24	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2017	12	2							e0172110	10.1371/journal.pone.0172110	http://dx.doi.org/10.1371/journal.pone.0172110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BG	28207837	Green Submitted, gold, Green Published			2022-12-26	WOS:000394424500085
J	Phillips, DR; Clark, KD				Phillips, Dennis R.; Clark, Kevin D.			Bombyx mori and Aedes aegypti form multi-functional immune complexes that integrate pattern recognition, melanization, coagulants, and hemocyte recruitment	PLOS ONE			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; PROPHENOLOXIDASE PROPO ACTIVATION; DOPACHROME CONVERSION ENZYME; LECTIN-DOMAIN PROTEINS; MANDUCA-SEXTA; APOLIPOPHORIN-III; SERINE PROTEASES; FOREIGN TARGETS; SURFACE CHARACTERISTICS; INSECT APOLIPOPROTEIN	The innate immune system of insects responds to wounding and pathogens by mobilizing multiple pathways that provide both systemic and localized protection. Key localized responses in hemolymph include melanization, coagulation, and hemocyte encapsulation, which synergistically seal wounds and envelop and destroy pathogens. To be effective, these pathways require a targeted deposition of their components to provide protection without compromising the host. Extensive research has identified a large number of the effectors that comprise these responses, but questions remain regarding their post-translational processing, function, and targeting. Here, we used mass spectrometry to demonstrate the integration of pathogen recognition proteins, coagulants, and melanization components into stable, high-mass, multi-functional Immune Complexes (ICs) in Bombyx mori and Aedes aegypti. Essential proteins common to both include phenoloxidases, apolipophorins, serine protease homologs, and a serine protease that promotes hemocyte recruitment through cytokine activation. Pattern recognition proteins included C-type Lectins in B. mori, while A. aegypti contained a protein homologous to Plasmodium-resistant LRIM1 from Anopheles gambiae. We also found that the B. mori IC is stabilized by extensive transglutaminase-catalyzed cross-linking of multiple components. The melanization inhibitor Egf1.0, from the parasitoid wasp Microplitis demolitor, blocked inclusion of specific components into the IC and also inhibited transglutaminase activity. Our results show how coagulants, melanization components, and hemocytes can be recruited to a wound surface or pathogen, provide insight into the mechanism by which a parasitoid evades this immune response, and suggest that insects as diverse as Lepidoptera and Diptera utilize similar defensive mechanisms.	[Phillips, Dennis R.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Clark, Kevin D.] Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Clark, KD (corresponding author), Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA.	kclark@uga.edu	Clark, Kevin/GQA-9811-2022	Clark, Kevin/0000-0002-7392-2730	National Science Foundation [IOS-1121006]	National Science Foundation(National Science Foundation (NSF))	Support was generously provided by a grant from the National Science Foundation (IOS-1121006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agianian B, 2007, DEV COMP IMMUNOL, V31, P879, DOI 10.1016/j.dci.2006.12.006; Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001; BARWIG B, 1985, J COMP PHYSIOL B, V155, P135, DOI 10.1007/BF00685206; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beck MH, 2011, J VIROL, V85, P11685, DOI 10.1128/JVI.05726-11; Beresford PJ, 1997, DEV COMP IMMUNOL, V21, P253, DOI 10.1016/S0145-305X(97)00011-6; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bryant WB, 2016, DEV COMP IMMUNOL, V55, P119, DOI 10.1016/j.dci.2015.10.020; Cerenius L, 2013, J EXP BIOL, V216, P4313, DOI 10.1242/jeb.085191; Cerenius L, 2011, J INNATE IMMUN, V3, P3, DOI 10.1159/000322066; Chang HJ, 2012, DEV COMP IMMUNOL, V36, P274, DOI 10.1016/j.dci.2011.04.009; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 1998, BIOCHEM BIOPH RES CO, V250, P479, DOI 10.1006/bbrc.1998.9145; Clark KD, 2015, INSECT BIOCHEM MOLEC, V58, P66, DOI 10.1016/j.ibmb.2015.01.002; Clark KD, 2013, J BIOL CHEM, V288, P14476, DOI 10.1074/jbc.M113.459222; Clark KD, 2010, INSECT BIOCHEM MOLEC, V40, P460, DOI 10.1016/j.ibmb.2010.04.005; COLE KD, 1987, J BIOL CHEM, V262, P11794; Dettloff M, 2001, CELL TISSUE RES, V306, P449, DOI 10.1007/s00441-001-0468-9; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Gold KS, 2015, SEMIN IMMUNOL, V27, P357, DOI 10.1016/j.smim.2016.03.010; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Gorman MJ, 1998, J INSECT PHYSIOL, V44, P947, DOI 10.1016/S0022-1910(98)00056-0; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Halwani AE, 2000, J INVERTEBR PATHOL, V76, P233, DOI 10.1006/jipa.2000.4978; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; He Y, 2016, MOL CELL PROTEOMICS, V15, P1176, DOI 10.1074/mcp.M115.054296; Huang CY, 2005, INSECT MOL BIOL, V14, P675, DOI 10.1111/j.1365-2583.2005.00597.x; Iatrou K, 2005, J BIOTECHNOL, V120, P237, DOI 10.1016/j.jbiotec.2005.06.037; Iimura Y, 1998, ARCH INSECT BIOCHEM, V38, P119, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;119::AID-ARCH2&gt;3.0.CO;2-N; Jiang H, 1999, INSECT MOL BIOL, V8, P39, DOI 10.1046/j.1365-2583.1999.810039.x; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Kamareddine L, 2016, J INNATE IMMUN, V8, P314, DOI 10.1159/000443883; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanaya T, 2000, J GEN VIROL, V81, P1135, DOI 10.1099/0022-1317-81-4-1135; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Krautz R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00342; Lavine MD, 2001, J INSECT PHYSIOL, V47, P965, DOI 10.1016/S0022-1910(01)00071-3; Lesch C, 2007, DEV COMP IMMUNOL, V31, P1255, DOI 10.1016/j.dci.2007.03.012; Lombardo F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003145; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Matsumoto H, 2012, INSECT BIOCHEM MOLEC, V42, P446, DOI 10.1016/j.ibmb.2012.03.001; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Pech LL, 1996, J CELL SCI, V109, P2053; Pinto SB, 2009, P NATL ACAD SCI USA, V106, P21270, DOI 10.1073/pnas.0909463106; Poopathi S, 2014, APPL BIOCHEM BIOTECH, V172, P2299, DOI 10.1007/s12010-013-0681-5; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Pratt CC, 2004, BIOL CHEM, V385, P1113, DOI 10.1515/BC.2004.145; Rao XJ, 2015, DEV COMP IMMUNOL, V53, P328, DOI 10.1016/j.dci.2015.07.005; Rao XJ, 2015, INSECT BIOCHEM MOLEC, V62, P75, DOI 10.1016/j.ibmb.2014.12.006; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Shi XF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev057; Sideri M, 2008, IMMUNOLOGY, V123, P528, DOI 10.1111/j.1365-2567.2007.02722.x; Sigle LT, 2016, DEV COMP IMMUNOL, V55, P90, DOI 10.1016/j.dci.2015.10.018; Soliman DE, 2016, J MED ENTOMOL, V53, P262, DOI 10.1093/jme/tjv245; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Sun Q, 2007, INSECT SCI, V14, P5, DOI 10.1111/j.1744-7919.2007.00121.x; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Theopold U, 2002, CELL MOL LIFE SCI, V59, P363, DOI 10.1007/s00018-002-8428-4; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Ujita M, 2002, BIOSCI BIOTECH BIOCH, V66, P2264, DOI 10.1271/bbb.66.2264; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wiesner A, 1997, J INSECT PHYSIOL, V43, P383, DOI 10.1016/S0022-1910(96)00113-8; Williams M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118911; Yang F, 2016, INSECT BIOCHEM MOLEC, V76, P1, DOI 10.1016/j.ibmb.2016.06.009; Yokoyama H, 2013, J LIPID RES, V54, P2379, DOI 10.1194/jlr.M037093; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zdybicka-Barabas A, 2013, BBA-BIOMEMBRANES, V1828, P1449, DOI 10.1016/j.bbamem.2013.02.004; Zhang Y, 2012, FUNCT INTEGR GENOMIC, V12, P705, DOI 10.1007/s10142-012-0281-4; Zhao P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-405; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	100	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171447	10.1371/journal.pone.0171447	http://dx.doi.org/10.1371/journal.pone.0171447			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199361	Green Published, Green Submitted, gold			2022-12-26	WOS:000394424400030
J	Zhang, R; Dong, S; Ma, WW; Cai, XP; Le, ZY; Xiao, R; Zhou, Q; Yu, HL				Zhang, Ran; Dong, Shan; Ma, Wei-wei; Cai, Xue-ping; Le, Zhi-yin; Xiao, Rong; Zhou, Qi; Yu, Huan-ling			Modulation of cholesterol transport by maternal hypercholesterolemia in human full term placenta	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; GESTATIONAL DIABETES-MELLITUS; PLASMA-CHOLESTEROL; TROPHOBLAST CELLS; LIPID-METABOLISM; PREGNANT-WOMEN; SR-BI; EXPRESSION; RECEPTOR; FETUS	The significance of maternal cholesterol transporting to the fetus under normal as well as pathological circumstances is less understood. The objective of this study was to observe the effects of maternal hypercholesterolemia on placental cholesterol transportation. Human full-time placenta, maternal and venous cord blood were sampled at delivery from the pregnant women with serum total cholesterol (TC) concentrations at third trimester higher than 7.25 mM (n = 19) and the pregnant women with normal TC concentrations (n = 19). Serum lipids and expression of genes related to cholesterol transportation were measured by western blot or real-time PCR. The results indicated that serum TC, high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) levels were significantly increased, in pregnancies, but decreased in cord blood in hypercholesterolemic group compared to the matched control group. All the subjects were no-drinking, nonsmoker, and gestational disease free. The mRNA expression of lipoprotein receptors, including LDLR and VLDLR were significantly increased, while the protein expression of PCSK9 was significantly increased in hypercholesterolemic placenta. In conclusion, maternal hypercholesterolemia might decrease the transportation of cholesterol from mother to fetus because of the high levels of PCSK9 protein expression.	[Zhang, Ran; Dong, Shan; Ma, Wei-wei; Cai, Xue-ping; Le, Zhi-yin; Xiao, Rong; Yu, Huan-ling] Capital Med Univ, Beijing Key Lab Environm Toxicol, Sch Publ Hlth, Beijing, Peoples R China; [Zhou, Qi] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Xiao, R; Yu, HL (corresponding author), Capital Med Univ, Beijing Key Lab Environm Toxicol, Sch Publ Hlth, Beijing, Peoples R China.; Zhou, Q (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China.	xiaor22@ccmu.edu.cn; lk602@sina.com; yuhlzjl@ccmu.edu.cn			National Natural Science Foundation of China [81273070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81273070) HLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035027; Aye ILMH, 2010, BBA-MOL CELL BIOL L, V1801, P1013, DOI 10.1016/j.bbalip.2010.05.015; Baardman ME, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.102442; Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Burke KT, 2009, J LIPID RES, V50, P1146, DOI 10.1194/jlr.M800538-JLR200; Busso D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/280497; Catov JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.024; Daoud G, 2005, BBA-MOL CELL BIOL L, V1687, P181, DOI 10.1016/j.bbalip.2004.11.017; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Dong B, 2014, ATHEROSCLEROSIS, V235, P449, DOI 10.1016/j.atherosclerosis.2014.05.931; Dube E, 2007, BIOL REPROD, V76, P1034, DOI 10.1095/biolreprod.106.059246; Dube E, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105619; Ethier-Chiasson M, 2007, BIOCHEM BIOPH RES CO, V359, P8, DOI 10.1016/j.bbrc.2007.05.002; FURUHASHI M, 1989, MOL ENDOCRINOL, V3, P1252, DOI 10.1210/mend-3-8-1252; Grozdanov PN, 2013, BIOCH CELL BIOL, V84, P80; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Jan MR, 2012, HYPERTENS PREGNANCY, V31, P292, DOI 10.3109/10641955.2010.507843; Jurevics HA, 1997, J LIPID RES, V38, P723; Kushtagi P, 2009, INT J GYNECOL OBSTET, V106, P258, DOI 10.1016/j.ijgo.2009.03.004; Leiva A, 2015, PLACENTA, V36, P895, DOI 10.1016/j.placenta.2015.05.012; Liguori A, 2007, BJOG-INT J OBSTET GY, V114, P1547, DOI 10.1111/j.1471-0528.2007.01510.x; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Marseille-Tremblay C, 2008, MOL REPROD DEV, V75, P1054, DOI 10.1002/mrd.20842; MAZURKIEWICZ JC, 1994, J CLIN PATHOL, V47, P728, DOI 10.1136/jcp.47.8.728; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Narverud I, 2013, THROMB RES, V131, P178, DOI 10.1016/j.thromres.2012.11.008; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; PIECHOTA W, 1992, EUR J OBSTET GYN R B, V45, P27, DOI 10.1016/0028-2243(92)90190-A; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Tabatabaei Mozhgan, 2011, J Prenat Med, V5, P35; Vuorio AF, 2002, J LAB CLIN MED, V140, P35, DOI 10.1067/mlc.2002.125214; Wadsack C, 2003, PLACENTA, V24, P131, DOI 10.1053/plac.2002.0912; WITTMAACK FM, 1995, ENDOCRINOLOGY, V136, P340, DOI 10.1210/en.136.1.340; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Yoshida S, 2005, J LIPID RES, V46, P2168, DOI 10.1194/jlr.M500096-JLR200	39	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2017	12	2							e0171934	10.1371/journal.pone.0171934	http://dx.doi.org/10.1371/journal.pone.0171934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BF	28199412	gold, Green Published, Green Submitted			2022-12-26	WOS:000394424400059
J	Tian, JS; Hu, L				Tian, Jiansheng; Hu, Li			Anchorage performance of a high-pressure pre-tightening resin anchor with a compressed grouting body	PLOS ONE			English	Article							SUPPORT DESIGN; ROADWAY; TECHNOLOGY; STRESS; ROCK; DEEP	Supports for deep mine roadways located in soft surrounding rock face several problems: difficulty in applying pre-tightening force, low bearing capacity, and poor initial support. To solve these problems, this study proposes a high-pressure pre-tightening resin anchor with a compressed grouting body for use in soft and fractured rock surrounding a deep roadway. Using model experiments, we analyzed the anchorage performance of the proposed anchor and a conventional tensile-type anchor for three different values of the elastic modulus of the surrounding rock. The results showed that regardless of the surrounding rock type, the peak micro-strain (642-541) and displacement (6.09-6.5 mm) at the pull-out end of the proposed anchor were always smaller than the peak micro-strain (1433-1105) and displacement (8.77-9.2 mm) at the pull-out end of the conventional anchor. Furthermore, as the anchor's pre-tightening force increased from 20 kN to 120 kN, the anchor's strain remained concentrated over a length of 0.4 m from the bearing end. Compared with conventional tensile-type anchors, the proposed high-pressure pre-tightening resin anchor with a compressed grouting body has a higher ultimate bearing capacity, allows the grouting length to be decreased to 0.4 m, and provides initial support resistance.	[Tian, Jiansheng] China Univ Min & Technol, Sch Mech & Civil Engn, Xuzhou, Peoples R China; [Hu, Li] PowerChina Roadbridge Grp Co Ltd, Beijing, Peoples R China	China University of Mining & Technology	Hu, L (corresponding author), PowerChina Roadbridge Grp Co Ltd, Beijing, Peoples R China.	hulichi@yeah.net						Guo ZB, 2012, INT J MIN SCI TECHNO, V22, P665, DOI 10.1016/j.ijmst.2012.08.012; Huang Y.G., 2014, ELECTRON J GEOTECH E, V19, P6319; Kang H., 2014, INT J COAL SCI TECHN, V1, P261, DOI 10.1007/s40789-014-0043-0; Kang H. P., 2011, COAL MINING TECHNOLO, V16, P25; Kang HP., 2013, J MIN STRATA CONTROL, V18, P1, DOI [10.13532/j.cnki.cn11-3677/td.2013.03.004, DOI 10.13532/J.CNKI.CN11-3677/TD.2013.03.004]; Li H, 2013, APPL MECH MATER, V353-356, P1675, DOI 10.4028/www.scientific.net/AMM.353-356.1675; Li SC, 2016, J CENT SOUTH UNIV, V23, P440, DOI 10.1007/s11771-016-3089-x; Liu Q.S., 2014, J MIN SAF ENG, V31, P333; Meng Q, 2016, INT J MIN SCI TECHNO; Meng QB, 2015, INT J MIN SCI TECHNO, V25, P113, DOI 10.1016/j.ijmst.2014.11.010; Pengfei J, 2016, PHYS NUMERICAL SIMUL, V22, P55; Xie SR, 2015, INT J MIN SCI TECHNO, V25, P429, DOI 10.1016/j.ijmst.2015.03.016; Yan H, 2015, J CENT SOUTH UNIV, V22, P4385, DOI 10.1007/s11771-015-2987-7; Yang RS., 2014, COAL SCI TECHNOL, V42, P1; Yang XJ, 2013, INT J MIN SCI TECHNO, V23, P307, DOI 10.1016/j.ijmst.2013.04.002; Zhang K, 2015, ROCK MECH ROCK ENG, V48, P333, DOI 10.1007/s00603-014-0546-4	16	4	4	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171653	10.1371/journal.pone.0171653	http://dx.doi.org/10.1371/journal.pone.0171653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196084	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900027
J	Veto, B; Bojcsuk, D; Bacquet, C; Kiss, J; Sipeki, S; Martin, L; Buday, L; Balint, BL; Aranyi, T				Veto, Borbala; Bojcsuk, Dora; Bacquet, Caroline; Kiss, Judit; Sipeki, Szabolcs; Martin, Ludovic; Buday, Laszlo; Balint, Balint L.; Aranyi, Tamas			The transcriptional activity of hepatocyte nuclear factor 4 alpha is inhibited via phosphorylation by ERK1/2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FARNESOID X RECEPTOR; FACTOR 4-ALPHA; GENE-EXPRESSION; BINDING DOMAIN; FACTOR-4-ALPHA PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; PSEUDOXANTHOMA ELASTICUM; LIGAND-BINDING; TARGET GENES	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) nuclear receptor is a master regulator of hepatocyte development, nutrient transport and metabolism. HNF4 alpha is regulated both at the transcriptional and post-transcriptional levels by different mechanisms. Several kinases (PKA, PKC, AMPK) were shown to phosphorylate and decrease the activity of HNF4 alpha. Activation of the ERK1/2 signalling pathway, inducing proliferation and survival, inhibits the expression of HNF4a. However, based on our previous results we hypothesized that HNF4 alpha is also regulated at the post-transcriptional level by ERK1/2. Here we show that ERK1/2 is capable of directly phosphorylating HNF4 alpha in vitro at several phosphorylation sites including residues previously shown to be targeted by other kinases, as well. Furthermore, we also demonstrate that phosphorylation of HNF4 alpha leads to a reduced trans-activational capacity of the nuclear receptor in luciferase reporter gene assay. We confirm the functional relevance of these findings by demonstrating with ChIP-qPCR experiments that 30-minute activation of ERK1/2 leads to reduced chromatin binding of HNF4 alpha. Accordingly, we have observed decreasing but not disappearing binding of HNF4 alpha to the target genes. In addition, 24-hour activation of the pathway further decreased HNF4 alpha chromatin binding to specific loci in ChIP-qPCR experiments, which confirms the previous reports on the decreased expression of the HNF4 alpha gene due to ERK1/2 activation. Our data suggest that the ERK1/2 pathway plays an important role in the regulation of HNF4 alpha-dependent hepatic gene expression.	[Veto, Borbala; Bacquet, Caroline; Kiss, Judit; Buday, Laszlo; Aranyi, Tamas] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Veto, Borbala] Semmelweis Univ, Doctoral Sch Mol Med, Budapest, Hungary; [Bojcsuk, Dora; Balint, Balint L.] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Debrecen, Hungary; [Sipeki, Szabolcs; Buday, Laszlo] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Martin, Ludovic; Aranyi, Tamas] Univ Angers, CNRS UMR 6214, INSERM U1083, Angers, France	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; University of Debrecen; Semmelweis University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Aranyi, T (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	aranyi.tamas@ttk.mta.hu	Aranyi, Tamas/AAJ-9629-2021	Aranyi, Tamas/0000-0002-2087-6275; Balint, Balint/0000-0002-6163-7190; Bojcsuk, Dora/0000-0001-5091-7237; , Caroline/0000-0002-1954-1806	MedinProt Program of the Hungarian Academy of Sciences; Internal Research University Grant entitled, "Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project"; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, Hungarian National Research Fund) [K100638, K104227, NN 110115]	MedinProt Program of the Hungarian Academy of Sciences; Internal Research University Grant entitled, "Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project"; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, Hungarian National Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The work was supported by grants from the MedinProt Program of the Hungarian Academy of Sciences (LB and TA). BLB is a Szodoray Fellow of the University of Debrecen, Medical Faculty, in which his research was funded by an Internal Research University Grant entitled, "Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project". This work was also supported by the Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, Hungarian National Research Fund) through grants K100638, K104227, and NN 110115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarenstrup L, 2002, CELL BIOL INT, V26, P615, DOI 10.1006/cbir.2002.0896; Aranyi Tamas, 2013, Frontiers in Genetics, V4, P27, DOI 10.3389/fgene.2013.00027; Barta E., 2011, EMBNET J, V17; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Caron S, 2013, MOL CELL BIOL, V33, P2202, DOI 10.1128/MCB.01004-12; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Drewes T, 1996, MOL CELL BIOL, V16, P925; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eeckhoute J, 2004, NUCLEIC ACIDS RES, V32, P2586, DOI 10.1093/nar/gkh581; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guo HT, 2007, J BIOCHEM, V141, P635, DOI 10.1093/jb/mvm066; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Illes A, 2006, CELL SIGNAL, V18, P830, DOI 10.1016/j.cellsig.2005.07.012; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kir S, 2012, J BIOL CHEM, V287, P41334, DOI 10.1074/jbc.M112.421834; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Lin CY, 2016, ONCOTARGET, V7, P11067, DOI 10.18632/oncotarget.7093; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Malik S, 2003, FRONT BIOSCI, V8, pD360, DOI 10.2741/1005; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratajewski M, 2012, J INVEST DERMATOL, V132, P2709, DOI 10.1038/jid.2012.218; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Song YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13409; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Varadi A, 2011, CURR DRUG TARGETS, V12, P671, DOI 10.2174/138945011795378612; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wang ZY, 2011, BIOCHEMISTRY-US, V50, P5292, DOI 10.1021/bi200540w; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu ZM, 2007, J BIOL CHEM, V282, P24607, DOI 10.1074/jbc.M611481200; Xue TC, 2014, ONCOL REP, V32, P2387, DOI 10.3892/or.2014.3501; Yokoyama A, 2011, BIOCHEM BIOPH RES CO, V410, P749, DOI 10.1016/j.bbrc.2011.06.033	57	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0172020	10.1371/journal.pone.0172020	http://dx.doi.org/10.1371/journal.pone.0172020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196117	Green Published, gold, Green Accepted			2022-12-26	WOS:000394423900044
J	Welsch, C; Efinger, M; von Wagner, M; Herrmann, E; Zeuzem, S; Welzel, TM; Lange, CM				Welsch, Christoph; Efinger, Mira; von Wagner, Michael; Herrmann, Eva; Zeuzem, Stefan; Welzel, Tania M.; Lange, Christian M.			Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response	PLOS ONE			English	Article							AMINOTRANSFERASE LEVELS; FIBROSIS PROGRESSION; STEATOSIS; CIRRHOSIS; CURE	Background Novel direct-acting antiviral DAA combination therapies tremendously improved sustained virologic response (SVR) rates in patients with chronic HCV infection. SVR is typically accompanied by normalization of liver enzymes, however, hepatic inflammation, i. e. persistently elevated aminotransferase levels may persist despite HCV eradication. Aim: To investigate prevalence and risk factors for ongoing hepatic inflammation after SVR in two large patient cohorts. Methods This post-hoc analysis was based on prospectively collected demographic and clinical data from 834 patients with SVR after HCV treatment with either PegIFN-or DAA-based treatment regimens from the PRAMA trial (n = 341) or patients treated at our outpatient clinic (n = 493). Results We observed an unexpected high prevalence of post-SVR inflammation, including patients who received novel IFN-free DAA-based therapies. Up to 10% of patients had ongoing elevation of aminotransferase levels and another 25% showed aminotransferase activity above the so-called healthy range. Several baseline factors were independently associated with post-SVR aminotransferase elevation. Among those, particularly male gender, advanced liver disease and markers for liver steatosis were strongly predictive for persistent ALT elevation. The use of IFN-based antiviral treatment was independently correlated with postSVR inflammation, further supporting the overall benefit of IFN-free combination regimens. Conclusion This is the first comprehensive study on a large patient cohort investigating the prevalence and risk factors for ongoing liver inflammation after eradication of HCV. Our data show a high proportion of patients with ongoing hepatic inflammation despite HCV eradication with potential implications for the management of approximately one third of all patients upon SVR.	[Welsch, Christoph; Efinger, Mira; von Wagner, Michael; Zeuzem, Stefan; Welzel, Tania M.; Lange, Christian M.] JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ, Inst Biostat & Math Modelling, Fac Med, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Welsch, C (corresponding author), JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany.	christoph.welsch@kgu.de	Welsch, Christoph/AAF-6785-2020; Zeuzem, Stefan/AAE-7435-2019	Welsch, Christoph/0000-0002-1823-4863; 	research funding programm Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma TRIP; Deutsche Forschungsgemeinschaft [WE4388/6-1, LA2806/2-1]	research funding programm Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma TRIP; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the research funding programm Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP, and the Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma TRIP). Grant support from the Deutsche Forschungsgemeinschaft is acknowledged for C. W. (WE4388/6-1) and C. M. L. (LA2806/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascione Antonio, 2007, Dig Liver Dis, V39 Suppl 1, pS4, DOI 10.1016/S1590-8658(07)80003-X; Bataller R, 2012, P NATL ACAD SCI USA, V109, P14293, DOI 10.1073/pnas.1212048109; Bugianesi E, 2004, DIGEST LIVER DIS, V36, P165, DOI 10.1016/j.dld.2003.12.008; Castera L, 2003, GUT, V52, P288, DOI 10.1136/gut.52.2.288; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; Farci P, 2012, P NATL ACAD SCI USA, V109, P14562, DOI 10.1073/pnas.1210592109; Gentile I, 2015, EXPERT OPIN DRUG SAF, V14, P1631, DOI 10.1517/14740338.2015.1084287; Hill AM, 2014, HEPATOLOGY, V60, p218A; Innes HA, 2015, HEPATOLOGY, V62, P355, DOI 10.1002/hep.27766; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lonardo A, 2006, J VIRAL HEPATITIS, V13, P73, DOI 10.1111/j.1365-2893.2005.00669.x; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Schlevogt B, 2016, J HEPATOL, V64, pS750, DOI 10.1016/S0168-8278(16)01461-6; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	21	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171755	10.1371/journal.pone.0171755	http://dx.doi.org/10.1371/journal.pone.0171755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196130	Green Submitted, Green Published, gold			2022-12-26	WOS:000394423900031
J	Zhai, HH; Shi, YQ; Chen, X; Wang, J; Lu, YY; Zhang, FM; Liu, ZX; Lei, T; Fan, DM				Zhai, Huihong; Shi, Yongquan; Chen, Xiong; Wang, Jun; Lu, Yuanyuan; Zhang, Faming; Liu, Zhengxiong; Lei, Ting; Fan, Daiming			CacyBP/SIP promotes the proliferation of colon cancer cells	PLOS ONE			English	Article							CALCYCLIN-BINDING-PROTEIN; TUMOR PROMOTER; GASTRIN; TRANSLOCATION; DEGRADATION; PROTEOLYSIS; P27(KIP1); PATHWAY; GROWTH; MECHANISMS	CacyBP/SIP is a component of the ubiquitin pathway and is overexpressed in several transformed tumor tissues, including colon cancer, which is one of the most common cancers worldwide. It is unknown whether CacyBP/SIP promotes the proliferation of colon cancer cells. This study examined the expression level, subcellular localization, and binding activity of CacyBP/SIP in human colon cancer cells in the presence and absence of the hormone gastrin. We found that CacyBP/SIP was expressed in a high percentage of colon cancer cells, but not in normal colonic surface epithelium. CacyBP/SIP promoted the cell proliferation of colon cancer cells under both basal and gastrin stimulated conditions as shown by knockdown studies. Gastrin stimulation triggered the translocation of CacyBP/SIP to the nucleus, and enhanced interaction between CacyBP/SIP and SKP1, a key component of ubiquitination pathway which further mediated the proteasome-dependent degradation of p27(kip1) protein. The gastrin induced reduction in p27(kip1) was prevented when cells were treated with the proteasome inhibitor MG132. These results suggest that CacyBP/SIP may be promoting growth of colon cancer cells by enhancing ubiquitin-mediated degradation of p27(kip1).	[Zhai, Huihong; Shi, Yongquan; Chen, Xiong; Wang, Jun; Lu, Yuanyuan; Zhang, Faming; Liu, Zhengxiong; Lei, Ting; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China; [Zhai, Huihong] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China	Air Force Military Medical University; Capital Medical University	Fan, DM (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China.	daimingfan@fmmu.edu.cn	Shi, Yongquan/AAE-3954-2020	Zhai, Hui-Hong/0000-0002-8452-6311	National Natural Science Foundation of China [30860321]; National Key Technologies RD Program [2015BAI13B09]; Science Foundation of Ningxia [NZ0897]; Research Fund of Ningxia Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Science Foundation of Ningxia; Research Fund of Ningxia Medical University	This work was funded by the National Natural Science Foundation of China (No. 30860321), National Key Technologies R&D Program (No.2015BAI13B09), the Science Foundation of Ningxia (NZ0897) and the Research Fund of Ningxia Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BERTRAND V, 1994, INT J CANCER, V56, P427, DOI 10.1002/ijc.2910560324; Birt DF, 2014, TOXICOL PATHOL, V42, P182, DOI 10.1177/0192623313506791; Calvert PM, 2002, ANN INTERN MED, V137, P603, DOI 10.7326/0003-4819-137-7-200210010-00012; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Fan DN, 2008, SHIJIE HUAREN XIAOHU, V16, P3953, DOI [10.3969/j.issn.1009-3079.2008.35.005, DOI 10.3969/J.ISSN.1009-3079.2008.35.005]; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 2002, J BIOL CHEM, V277, P21103, DOI 10.1074/jbc.M111010200; Garcia-Ibarbia C, 2013, GENE, V532, P165, DOI 10.1016/j.gene.2013.09.080; GRANA X, 1995, ONCOGENE, V11, P211; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kilanczyk E, 2015, J NEUROSCI RES, V93, P75, DOI 10.1002/jnr.23466; Liu DF, 1999, J CLIN LAB ANAL, V13, P291, DOI 10.1002/(SICI)1098-2825(1999)13:6<291::AID-JCLA7>3.0.CO;2-K; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; SEVA C, 1994, REGUL PEPTIDES, V52, P31, DOI 10.1016/0167-0115(94)90018-3; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Singh SP, 1998, CANCER RES, V58, P1730; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; Thorburn CM, 1998, GASTROENTEROLOGY, V115, P275, DOI 10.1016/S0016-5085(98)70193-3; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wan ES, 2015, MOL REPROD DEV, V82, P377, DOI 10.1002/mrd.22483; WATSON SA, 1989, INT J CANCER, V43, P692, DOI 10.1002/ijc.2910430425; Watson SA, 2001, CANCER RES, V61, P625; Wu J, 2003, J BIOCHEM MOL BIOL, V36, P354; Xie FL, 2012, SHANDONG YIXUE ZAZHI, V52, P1, DOI [10.3969/j.issn.1002-266X.2012.23.001, DOI 10.3969/J.ISSN.1002-266X.2012.23.001]; [谢福利 Xie Fuli], 2012, [基础医学与临床, Basic & Clinical Medicine], V32, P1312; [谢福利 Xie Fuli], 2012, [重庆医学, Chongqing Medicine], V41, P3020; Yew PR, 2001, J CELL PHYSIOL, V187, P1, DOI 10.1002/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO;2-O; Zhai H-H., 2014, WORLD CHINESE J DIGE, V22, P1328; Zhai HH, 2006, HYBRIDOMA, V25, P91, DOI 10.1089/hyb.2006.25.91; Zhai HH, 2014, WORLD J GASTROENTERO, V20, P10062, DOI 10.3748/wjg.v20.i29.10062; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	38	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0169959	10.1371/journal.pone.0169959	http://dx.doi.org/10.1371/journal.pone.0169959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	28196083	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423900003
J	Keum, J; Nam, H				Keum, Jongsoo; Nam, Hojung			SELF-BLM: Prediction of drug-target interactions via self-training SVM	PLOS ONE			English	Article							WEB SERVER; MI-DRAGON; PROTEIN; INHIBITORS; IDENTIFICATION; INFORMATION; ALGORITHM; DATABASE; NETWORK; KERNELS	Predicting drug-target interactions is important for the development of novel drugs and the repositioning of drugs. To predict such interactions, there are a number of methods based on drug and target protein similarity. Although these methods, such as the bipartite local model (BLM), show promise, they often categorize unknown interactions as negative interaction. Therefore, these methods are not ideal for finding potential drug-target interactions that have not yet been validated as positive interactions. Thus, here we propose a method that integrates machine learning techniques, such as self-training support vector machine (SVM) and BLM, to develop a self-training bipartite local model (SELF-BLM) that facilitates the identification of potential interactions. The method first categorizes unlabeled interactions and negative interactions among unknown interactions using a clustering method. Then, using the BLM method and self-training SVM, the unlabeled interactions are self-trained and final local classification models are constructed. When applied to four classes of proteins that include enzymes, G-protein coupled receptors (GPCRs), ion channels, and nuclear receptors, SELF-BLM showed the best performance for predicting not only known interactions but also potential interactions in three protein classes compare to other related studies. The implemented software and supporting data are available at https://github.com/GIST-CSBL/SELF-BLM.	[Keum, Jongsoo; Nam, Hojung] Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, 123 Cheomdangwgi Ro, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Nam, H (corresponding author), Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, 123 Cheomdangwgi Ro, Gwangju, South Korea.	hjnam@gist.ac.kr	Nam, Hojung/AAR-4065-2020	Nam, Hojung/0000-0002-5109-9114	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2014M3A9C4066449]; National Research Foundation of Korea grant - the Korea government (MSIP) [NRF-2015R1C1A1A01051578]	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea grant - the Korea government (MSIP)(National Research Foundation of Korea)	This work was supported by the Bio-Synergy Research Project (NRF-2014M3A9C4066449, http://nrf.re.kr/) of the Ministry of Science, ICT and Future Planning through the National Research Foundation, and supported by the National Research Foundation of Korea grant funded by the Korea government (MSIP) (NRF-2015R1C1A1A01051578, http://nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen X, 2016, BRIEF BIOINFORM, V17, P696, DOI 10.1093/bib/bbv066; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Ding H, 2014, BRIEF BIOINFORM, V15, P734, DOI 10.1093/bib/bbt056; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; Gonzalez-Diaz H, 2011, J PROTEOME RES, V10, P1698, DOI 10.1021/pr101009e; Gonzalez-Diaz H, 2011, J THEOR BIOL, V276, P229, DOI 10.1016/j.jtbi.2011.01.010; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nickel J, 2014, NUCLEIC ACIDS RES, V42, pW26, DOI 10.1093/nar/gku477; Perlman L, 2011, J COMPUT BIOL, V18, P133, DOI 10.1089/cmb.2010.0213; Prado-Prado F, 2012, CURR TOP MED CHEM, V12, P1843; Prado-Prado F, 2011, EUR J MED CHEM, V46, P5838, DOI 10.1016/j.ejmech.2011.09.045; Romero-Duran FJ, 2016, NEUROPHARMACOLOGY, V103, P270, DOI 10.1016/j.neuropharm.2015.12.019; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wang YC, 2016, BIOINFORMATICS, V32, P226, DOI 10.1093/bioinformatics/btv528; Wang YC, 2011, COMPUT BIOL CHEM, V35, P353, DOI 10.1016/j.compbiolchem.2011.10.003; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yoo M, 2015, BIOINFORMATICS, V31, P3069, DOI 10.1093/bioinformatics/btv313; Zhao XM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-57	33	43	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171839	10.1371/journal.pone.0171839	http://dx.doi.org/10.1371/journal.pone.0171839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192537	gold, Green Published			2022-12-26	WOS:000394423800045
J	Lieder, B; Hoi, JK; Holik, AK; Geissler, K; Hans, J; Friedl, B; Liszt, K; Krammer, GE; Ley, JP; Somoza, V				Lieder, Barbara; Hoi, Julia Katharina; Holik, Ann-Katrin; Geissler, Katrin; Hans, Joachim; Friedl, Barbara; Liszt, Kathrin; Krammer, Gerhard E.; Ley, Jakob P.; Somoza, Veronika			The flavanone homoeriodictyol increases SGLT-1-mediated glucose uptake but decreases serotonin release in differentiated Caco-2 cells	PLOS ONE			English	Article							SUGAR ABSORPTION; SH-SY5Y CELLS; GLUT2; EXPRESSION; 5-HYDROXYTRYPTAMINE; MECHANISMS; TRANSPORT; RECEPTOR; PATHWAY	Flavanoids and related polyphenols, among them hesperitin, have been shown to modulate cellular glucose transport by targeting SGLT-1 and GLUT-2 transport proteins. We aimed to investigate whether homoeriodictyol, which is structurally related to hesperitin, affects glucose uptake in differentiated Caco-2 cells as a model for the intestinal barrier. The results revealed that, in contrast to other polyphenols, the flavanon homoeriodictyol promotes glucose uptake by 29.0 3.83% at a concentration of 100 pM. The glucose uptake stimulating effect was sensitive to phloridzin, but not to phloretin, indicating an involvement of the sodium-coupled glucose transporter SGLT-1, but not of sodium-independent glucose transporters (GLUT). In addition, in contrast to the increased extracellular serotonin levels by stimulation with 500 mM D-(+)-glucose, treatment with 100 pM homoeriodictyol decreased serotonin release by 48.8 7.57% in Caco-2 cells via a phloridzin-sensitive signaling pathway. Extracellular serotonin levels were also reduced by 57.1 5.43% after application of 0.01 pM homoeriodictyol to human neural SH-SY5Y cells. In conclusion, we demonstrate that homoeriodictyol affects both the glucose metabolism and the serotonin system in Caco-2 cells via a SGLT-1-meditated pathway. Furthermore, the results presented here support the usage of Caco-2 cells as a model for peripheral serotonin release. Further investigations may address the value of homoeriodictyol in the treatment of anorexia and malnutrition through the targeting of SGLT-1.	[Lieder, Barbara; Hoi, Julia Katharina; Friedl, Barbara; Liszt, Kathrin; Somoza, Veronika] Univ Vienna, Fac Chem, Christian Doppler Lab Bioact Aroma Cpds, Vienna, Austria; [Lieder, Barbara; Holik, Ann-Katrin; Somoza, Veronika] Univ Vienna, Fac Chem, Dept Nutr & Physiol Chem, Vienna, Austria; [Geissler, Katrin; Hans, Joachim; Krammer, Gerhard E.; Ley, Jakob P.] Symrise AG, Muhlenfeldstr 1, Holzminden, Germany	University of Vienna; University of Vienna; Symrise	Lieder, B (corresponding author), Univ Vienna, Fac Chem, Christian Doppler Lab Bioact Aroma Cpds, Vienna, Austria.; Lieder, B (corresponding author), Univ Vienna, Fac Chem, Dept Nutr & Physiol Chem, Vienna, Austria.	barbara.lieder@univie.ac.at	Somoza, Veronika/D-4141-2013	Somoza, Veronika/0000-0003-2456-9245; Hoi, Julia Katharina/0000-0003-3201-5365; Liszt, Kathrin/0000-0003-2507-0630; Lieder, Barbara/0000-0002-0527-8330	Austrian Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; Sym rise AG	Austrian Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; Sym rise AG	The financial support by the Austrian Federal Ministry of Economy, Family and Youth and the Austrian National Foundation for Research, Technology and Development and the Sym rise AG is gratefully acknowledged. KG contributed to the glucose uptake experiments, JH, JPL and GEK contributed to the study design and preparation of the manuscript.	Alzaid F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078932; Doihara H, 2009, MOL CELL BIOCHEM, V331, P239, DOI 10.1007/s11010-009-0165-7; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Grefner N. M., 2010, Cell and Tissue Biology, V4, P354, DOI 10.1134/S1990519X10040085; Grefner N.M., 2012, CELL TISSUE BIOL, V6, P335, DOI [10.1134/S1990519X12040062., DOI 10.1134/S1990519X12040062]; Hajduch E, 1999, J BIOL CHEM, V274, P13563, DOI 10.1074/jbc.274.19.13563; Holik AK, 2013, FOOD FUNCT, V4, P1111, DOI 10.1039/c3fo60097a; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kim MS, 2001, GASTROENTEROLOGY, V121, P1400, DOI 10.1053/gast.2001.29567; Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Park JB, 1999, BIOCHEM BIOPH RES CO, V260, P568, DOI 10.1006/bbrc.1999.0890; Raybould HE, 2010, AUTON NEUROSCI-BASIC, V153, P41, DOI 10.1016/j.autneu.2009.07.007; Riedel A, 2014, J NUTR BIOCHEM, V25, P750, DOI 10.1016/j.jnutbio.2014.03.002; Rohm B, 2015, FOOD FUNCT, V6, P173, DOI 10.1039/c4fo00435c; Rohm B, 2013, MOL NUTR FOOD RES, V57, P2008, DOI 10.1002/mnfr.201200846; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Yanai H, 2010, DIABETES METAB SYNDR, V3, P1; Yang Y, 2013, CELL BIOCHEM FUNCT, V31, P374, DOI 10.1002/cbf.2905; Young RL, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00023; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010	26	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2017	12	2							e0171580	10.1371/journal.pone.0171580	http://dx.doi.org/10.1371/journal.pone.0171580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2AZ	28192456	Green Published, gold, Green Submitted			2022-12-26	WOS:000394423800031
